{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "name": "Prepare CoNLL Data Format.ipynb",
      "provenance": [],
      "collapsed_sections": [],
      "authorship_tag": "ABX9TyPJ1r45p8b4+6m+ibXkeZkv"
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "source": [
        "# Setup & Raw Data Import"
      ],
      "metadata": {
        "id": "2o7RvdJZv6bN"
      }
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "metadata": {
        "id": "WAJwF-JiS6Hc"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "import numpy as np\n",
        "pd.set_option(\"max_rows\",100)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!wget -q https://raw.githubusercontent.com/cambridgeltl/MTL-Bioinformatics-2016/master/data/NCBI-disease-IOB/devel.tsv\n",
        "!wget -q https://raw.githubusercontent.com/cambridgeltl/MTL-Bioinformatics-2016/master/data/NCBI-disease-IOB/train.tsv\n",
        "!wget -q https://raw.githubusercontent.com/cambridgeltl/MTL-Bioinformatics-2016/master/data/NCBI-disease-IOB/test.tsv"
      ],
      "metadata": {
        "id": "pncQBM1uTDgK"
      },
      "execution_count": 3,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "with open(\"train.tsv\") as f:\n",
        "  train_data = f.read()\n",
        "train_data"
      ],
      "metadata": {
        "id": "DRvuXsh4TPlv",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 192
        },
        "outputId": "f1e67e58-73dd-4873-8baa-baee891a3b37"
      },
      "execution_count": 56,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'Identification\\tO\\nof\\tO\\nAPC2\\tO\\n,\\tO\\na\\tO\\nhomologue\\tO\\nof\\tO\\nthe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\ntumour\\tI-Disease\\nsuppressor\\tO\\n.\\tO\\n\\nThe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tI-Disease\\nAPC\\tI-Disease\\n)\\tI-Disease\\ntumour\\tI-Disease\\n-\\tO\\nsuppressor\\tO\\nprotein\\tO\\ncontrols\\tO\\nthe\\tO\\nWnt\\tO\\nsignalling\\tO\\npathway\\tO\\nby\\tO\\nforming\\tO\\na\\tO\\ncomplex\\tO\\nwith\\tO\\nglycogen\\tO\\nsynthase\\tO\\nkinase\\tO\\n3beta\\tO\\n(\\tO\\nGSK\\tO\\n-\\tO\\n3beta\\tO\\n)\\tO\\n,\\tO\\naxin\\tO\\n/\\tO\\nconductin\\tO\\nand\\tO\\nbetacatenin\\tO\\n.\\tO\\n\\nComplex\\tO\\nformation\\tO\\ninduces\\tO\\nthe\\tO\\nrapid\\tO\\ndegradation\\tO\\nof\\tO\\nbetacatenin\\tO\\n.\\tO\\n\\nIn\\tO\\ncolon\\tB-Disease\\ncarcinoma\\tI-Disease\\ncells\\tO\\n,\\tO\\nloss\\tO\\nof\\tO\\nAPC\\tO\\nleads\\tO\\nto\\tO\\nthe\\tO\\naccumulation\\tO\\nof\\tO\\nbetacatenin\\tO\\nin\\tO\\nthe\\tO\\nnucleus\\tO\\n,\\tO\\nwhere\\tO\\nit\\tO\\nbinds\\tO\\nto\\tO\\nand\\tO\\nactivates\\tO\\nthe\\tO\\nTcf\\tO\\n-\\tO\\n4\\tO\\ntranscription\\tO\\nfactor\\tO\\n(\\tO\\nreviewed\\tO\\nin\\tO\\n[\\tO\\n1\\tO\\n]\\tO\\n[\\tO\\n2\\tO\\n]\\tO\\n)\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\nidentification\\tO\\nand\\tO\\ngenomic\\tO\\nstructure\\tO\\nof\\tO\\nAPC\\tO\\nhomologues\\tO\\n.\\tO\\n\\nMammalian\\tO\\nAPC2\\tO\\n,\\tO\\nwhich\\tO\\nclosely\\tO\\nresembles\\tO\\nAPC\\tO\\nin\\tO\\noverall\\tO\\ndomain\\tO\\nstructure\\tO\\n,\\tO\\nwas\\tO\\nfunctionally\\tO\\nanalyzed\\tO\\nand\\tO\\nshown\\tO\\nto\\tO\\ncontain\\tO\\ntwo\\tO\\nSAMP\\tO\\ndomains\\tO\\n,\\tO\\nboth\\tO\\nof\\tO\\nwhich\\tO\\nare\\tO\\nrequired\\tO\\nfor\\tO\\nbinding\\tO\\nto\\tO\\nconductin\\tO\\n.\\tO\\n\\nLike\\tO\\nAPC\\tO\\n,\\tO\\nAPC2\\tO\\nregulates\\tO\\nthe\\tO\\nformation\\tO\\nof\\tO\\nactive\\tO\\nbetacatenin\\tO\\n-\\tO\\nTcf\\tO\\ncomplexes\\tO\\n,\\tO\\nas\\tO\\ndemonstrated\\tO\\nusing\\tO\\ntransient\\tO\\ntranscriptional\\tO\\nactivation\\tO\\nassays\\tO\\nin\\tO\\nAPC\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\ncolon\\tB-Disease\\ncarcinoma\\tI-Disease\\ncells\\tO\\n.\\tO\\n\\nHuman\\tO\\nAPC2\\tO\\nmaps\\tO\\nto\\tO\\nchromosome\\tO\\n19p13\\tO\\n.\\tO\\n\\n3\\tO\\n.\\tO\\n\\nAPC\\tO\\nand\\tO\\nAPC2\\tO\\nmay\\tO\\ntherefore\\tO\\nhave\\tO\\ncomparable\\tO\\nfunctions\\tO\\nin\\tO\\ndevelopment\\tO\\nand\\tO\\ncancer\\tB-Disease\\n.\\tO\\n\\nA\\tO\\ncommon\\tO\\nMSH2\\tO\\nmutation\\tO\\nin\\tO\\nEnglish\\tO\\nand\\tO\\nNorth\\tO\\nAmerican\\tO\\nHNPCC\\tB-Disease\\nfamilies\\tO\\n:\\tO\\norigin\\tO\\n,\\tO\\nphenotypic\\tO\\nexpression\\tO\\n,\\tO\\nand\\tO\\nsex\\tO\\nspecific\\tO\\ndifferences\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nfrequency\\tO\\n,\\tO\\norigin\\tO\\n,\\tO\\nand\\tO\\nphenotypic\\tO\\nexpression\\tO\\nof\\tO\\na\\tO\\ngermline\\tO\\nMSH2\\tO\\ngene\\tO\\nmutation\\tO\\npreviously\\tO\\nidentified\\tO\\nin\\tO\\nseven\\tO\\nkindreds\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nnon\\tI-Disease\\n-\\tI-Disease\\npolyposis\\tI-Disease\\ncancer\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nHNPCC\\tB-Disease\\n)\\tO\\nwas\\tO\\ninvestigated\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\n(\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\nat\\tO\\nnt943\\tO\\n+\\tO\\n3\\tO\\n)\\tO\\ndisrupts\\tO\\nthe\\tO\\n3\\tO\\nsplice\\tO\\nsite\\tO\\nof\\tO\\nexon\\tO\\n5\\tO\\nleading\\tO\\nto\\tO\\nthe\\tO\\ndeletion\\tO\\nof\\tO\\nthis\\tO\\nexon\\tO\\nfrom\\tO\\nMSH2\\tO\\nmRNA\\tO\\nand\\tO\\nrepresents\\tO\\nthe\\tO\\nonly\\tO\\nfrequent\\tO\\nMSH2\\tO\\nmutation\\tO\\nso\\tO\\nfar\\tO\\nreported\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthis\\tO\\nmutation\\tO\\nwas\\tO\\ninitially\\tO\\ndetected\\tO\\nin\\tO\\nfour\\tO\\nof\\tO\\n33\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nanalysed\\tO\\nfrom\\tO\\neastern\\tO\\nEngland\\tO\\n,\\tO\\nmore\\tO\\nextensive\\tO\\nanalysis\\tO\\nhas\\tO\\nreduced\\tO\\nthe\\tO\\nfrequency\\tO\\nto\\tO\\nfour\\tO\\nof\\tO\\n52\\tO\\n(\\tO\\n8\\tO\\n%\\tO\\n)\\tO\\nEnglish\\tO\\nHNPCC\\tB-Disease\\nkindreds\\tO\\nanalysed\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nthe\\tO\\nMSH2\\tO\\nmutation\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\n10\\tO\\nof\\tO\\n20\\tO\\n(\\tO\\n50\\tO\\n%\\tO\\n)\\tO\\nseparately\\tO\\nidentified\\tO\\ncolorectal\\tB-Disease\\nfamilies\\tO\\nfrom\\tO\\nNewfoundland\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nthe\\tO\\norigin\\tO\\nof\\tO\\nthis\\tO\\nmutation\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nfrom\\tO\\nEngland\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n4\\tO\\n)\\tO\\n,\\tO\\nNewfoundland\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n10\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nUnited\\tO\\nStates\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n3\\tO\\n)\\tO\\n,\\tO\\nhaplotype\\tO\\nanalysis\\tO\\nusing\\tO\\nmicrosatellite\\tO\\nmarkers\\tO\\nlinked\\tO\\nto\\tO\\nMSH2\\tO\\nwas\\tO\\nperformed\\tO\\n.\\tO\\n\\nWithin\\tO\\nthe\\tO\\nEnglish\\tO\\nand\\tO\\nUS\\tO\\nfamilies\\tO\\nthere\\tO\\nwas\\tO\\nlittle\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\nrecent\\tO\\ncommon\\tO\\norigin\\tO\\nof\\tO\\nthe\\tO\\nMSH2\\tO\\nsplice\\tO\\nsite\\tO\\nmutation\\tO\\nin\\tO\\nmost\\tO\\nfamilies\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\na\\tO\\ncommon\\tO\\nhaplotype\\tO\\nwas\\tO\\nidentified\\tO\\nat\\tO\\nthe\\tO\\ntwo\\tO\\nflanking\\tO\\nmarkers\\tO\\n(\\tO\\nCA5\\tO\\nand\\tO\\nD2S288\\tO\\n)\\tO\\nin\\tO\\neight\\tO\\nof\\tO\\nthe\\tO\\nNewfoundland\\tO\\nfamilies\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggested\\tO\\na\\tO\\nfounder\\tO\\neffect\\tO\\nwithin\\tO\\nNewfoundland\\tO\\nsimilar\\tO\\nto\\tO\\nthat\\tO\\nreported\\tO\\nby\\tO\\nothers\\tO\\nfor\\tO\\ntwo\\tO\\nMLH1\\tO\\nmutations\\tO\\nin\\tO\\nFinnish\\tO\\nHNPCC\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\ncalculated\\tO\\nage\\tO\\nrelated\\tO\\nrisks\\tO\\nof\\tO\\nall\\tO\\n,\\tO\\ncolorectal\\tB-Disease\\n,\\tI-Disease\\nendometrial\\tI-Disease\\n,\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\nin\\tO\\nnt943\\tO\\n+\\tO\\n3\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\nMSH2\\tO\\nmutation\\tO\\ncarriers\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n76\\tO\\n)\\tO\\nfor\\tO\\nall\\tO\\npatients\\tO\\nand\\tO\\nfor\\tO\\nmen\\tO\\nand\\tO\\nwomen\\tO\\nseparately\\tO\\n.\\tO\\n\\nFor\\tO\\nboth\\tO\\nsexes\\tO\\ncombined\\tO\\n,\\tO\\nthe\\tO\\npenetrances\\tO\\nat\\tO\\nage\\tO\\n60\\tO\\nyears\\tO\\nfor\\tO\\nall\\tO\\ncancers\\tB-Disease\\nand\\tO\\nfor\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nwere\\tO\\n0\\tO\\n.\\tO\\n\\n86\\tO\\nand\\tO\\n0\\tO\\n.\\tO\\n\\n57\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nThe\\tO\\nrisk\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nwas\\tO\\nsignificantly\\tO\\nhigher\\tO\\n(\\tO\\np\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n01\\tO\\n)\\tO\\nin\\tO\\nmales\\tO\\nthan\\tO\\nfemales\\tO\\n(\\tO\\n0\\tO\\n.\\tO\\n63\\tO\\nv\\tO\\n0\\tO\\n.\\tO\\n30\\tO\\nand\\tO\\n0\\tO\\n.\\tO\\n84\\tO\\nv\\tO\\n0\\tO\\n.\\tO\\n44\\tO\\nat\\tO\\nages\\tO\\n50\\tO\\nand\\tO\\n60\\tO\\nyears\\tO\\n,\\tO\\nrespectively\\tO\\n)\\tO\\n.\\tO\\n\\nFor\\tO\\nfemales\\tO\\nthere\\tO\\nwas\\tO\\na\\tO\\nhigh\\tO\\nrisk\\tO\\nof\\tO\\nendometrial\\tB-Disease\\ncancer\\tI-Disease\\n(\\tO\\n0\\tO\\n.\\tO\\n5\\tO\\nat\\tO\\nage\\tO\\n60\\tO\\nyears\\tO\\n)\\tO\\nand\\tO\\npremenopausal\\tB-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n(\\tO\\n0\\tO\\n.\\tO\\n2\\tO\\nat\\tO\\n50\\tO\\nyears\\tO\\n)\\tO\\n.\\tO\\n\\nThese\\tO\\nintersex\\tO\\ndifferences\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nrisks\\tO\\nhave\\tO\\nimplications\\tO\\nfor\\tO\\nscreening\\tO\\nprogrammes\\tO\\nand\\tO\\nfor\\tO\\nattempts\\tO\\nto\\tO\\nidentify\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\nmodifiers\\tO\\n.\\tO\\n\\nAge\\tO\\nof\\tO\\nonset\\tO\\nin\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n:\\tO\\nsex\\tO\\nspecific\\tO\\ninfluence\\tO\\nof\\tO\\napolipoprotein\\tO\\nE\\tO\\ngenotype\\tO\\nand\\tO\\nnormal\\tO\\nCAG\\tO\\nrepeat\\tO\\nlength\\tO\\n.\\tO\\n\\nAge\\tO\\nof\\tO\\nonset\\tO\\n(\\tO\\nAO\\tO\\n)\\tO\\nof\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nis\\tO\\nknown\\tO\\nto\\tO\\nbe\\tO\\ncorrelated\\tO\\nwith\\tO\\nthe\\tO\\nlength\\tO\\nof\\tO\\nan\\tO\\nexpanded\\tO\\nCAG\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nApolipoprotein\\tO\\nE\\tO\\n(\\tO\\nAPOE\\tO\\n)\\tO\\ngenotype\\tO\\n,\\tO\\nin\\tO\\nturn\\tO\\n,\\tO\\nis\\tO\\nknown\\tO\\nto\\tO\\ninfluence\\tO\\nAO\\tO\\nin\\tO\\nAlzheimer\\tB-Disease\\ndisease\\tI-Disease\\n,\\tO\\nrendering\\tO\\nthe\\tO\\nAPOE\\tO\\ngene\\tO\\na\\tO\\nlikely\\tO\\ncandidate\\tO\\nto\\tO\\naffect\\tO\\nAO\\tO\\nin\\tO\\nother\\tO\\nneurological\\tB-Disease\\ndiseases\\tI-Disease\\ntoo\\tO\\n.\\tO\\n\\nWe\\tO\\ntherefore\\tO\\ndetermined\\tO\\nAPOE\\tO\\ngenotype\\tO\\nand\\tO\\nnormal\\tO\\nCAG\\tO\\nrepeat\\tO\\nlength\\tO\\nin\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\nfor\\tO\\n138\\tO\\nHD\\tB-Disease\\npatients\\tO\\nwho\\tO\\nwere\\tO\\npreviously\\tO\\nanalysed\\tO\\nwith\\tO\\nrespect\\tO\\nto\\tO\\nCAG\\tO\\nrepeat\\tO\\nlength\\tO\\n.\\tO\\n\\nGenotyping\\tO\\nfor\\tO\\nAPOE\\tO\\nwas\\tO\\nperformed\\tO\\nblind\\tO\\nto\\tO\\nclinical\\tO\\ninformation\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\nto\\tO\\nhighlighting\\tO\\nthe\\tO\\neffect\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nrepeat\\tO\\nlength\\tO\\nupon\\tO\\nAO\\tO\\nin\\tO\\nmaternally\\tO\\ninherited\\tO\\nHD\\tB-Disease\\nand\\tO\\nin\\tO\\nmale\\tO\\npatients\\tO\\n,\\tO\\nwe\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nAPOE\\tO\\nepsilon2epsilon3\\tO\\ngenotype\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nsignificantly\\tO\\nearlier\\tO\\nAO\\tO\\nin\\tO\\nmales\\tO\\nthan\\tO\\nin\\tO\\nfemales\\tO\\n.\\tO\\n\\nSuch\\tO\\na\\tO\\nsex\\tO\\ndifference\\tO\\nin\\tO\\nAO\\tO\\nwas\\tO\\nnot\\tO\\napparent\\tO\\nfor\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\nother\\tO\\nAPOE\\tO\\ngenotypes\\tO\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nsubtle\\tO\\ndifferences\\tO\\nin\\tO\\nthe\\tO\\ncourse\\tO\\nof\\tO\\nthe\\tO\\nneurodegeneration\\tB-Disease\\nin\\tO\\nHD\\tB-Disease\\nmay\\tO\\nallow\\tO\\ninteracting\\tO\\ngenes\\tO\\nto\\tO\\nexert\\tO\\ngender\\tO\\nspecific\\tO\\neffects\\tO\\nupon\\tO\\nAO\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nseventh\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nrecurrent\\tO\\nbacteremic\\tB-Disease\\ninfections\\tI-Disease\\ndue\\tI-Disease\\nto\\tI-Disease\\nNeisseria\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nserum\\tO\\nof\\tO\\na\\tO\\n29\\tO\\n-\\tO\\nyear\\tO\\nold\\tO\\nwoman\\tO\\nwith\\tO\\na\\tO\\nrecent\\tO\\nepisode\\tO\\nof\\tO\\ndisseminated\\tB-Disease\\ngonococcal\\tI-Disease\\ninfection\\tI-Disease\\nand\\tO\\na\\tO\\nhistory\\tO\\nof\\tO\\nmeningococcal\\tB-Disease\\nmeningitis\\tI-Disease\\nand\\tO\\narthritis\\tB-Disease\\nas\\tO\\na\\tO\\nchild\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nlack\\tO\\nserum\\tO\\nhemolytic\\tO\\ncomplement\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\nseventh\\tO\\ncomponent\\tO\\nof\\tO\\ncomplement\\tO\\n(\\tO\\nC7\\tO\\n)\\tO\\nwas\\tO\\nnot\\tO\\ndetected\\tO\\nby\\tO\\nfunctional\\tO\\nor\\tO\\nimmunochemical\\tO\\nassays\\tO\\n,\\tO\\nwhereas\\tO\\nother\\tO\\ncomponents\\tO\\nwere\\tO\\nnormal\\tO\\nby\\tO\\nhemolytic\\tO\\nand\\tO\\nimmunochemical\\tO\\nassessment\\tO\\n.\\tO\\n\\nHer\\tO\\nfresh\\tO\\nserum\\tO\\nlacked\\tO\\ncomplement\\tO\\n-\\tO\\nmediated\\tO\\nbactericidal\\tO\\nactivity\\tO\\nagainst\\tO\\nNeisseria\\tO\\ngonorrhoeae\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\naddition\\tO\\nof\\tO\\nfresh\\tO\\nnormal\\tO\\nserum\\tO\\nor\\tO\\npurified\\tO\\nC7\\tO\\nrestored\\tO\\nbactericidal\\tO\\nactivity\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nhemolytic\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\nabsence\\tB-Disease\\nof\\tI-Disease\\nfunctional\\tI-Disease\\nC7\\tI-Disease\\nactivity\\tO\\ncould\\tO\\nnot\\tO\\nbe\\tO\\naccounted\\tO\\nfor\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nan\\tO\\ninhibitor\\tO\\n.\\tO\\n\\nOpsonization\\tO\\nand\\tO\\ngeneration\\tO\\nof\\tO\\nchemotactic\\tO\\nactivity\\tO\\nfunctioned\\tO\\nnormally\\tO\\n.\\tO\\n\\nComplete\\tB-Disease\\nabsence\\tI-Disease\\nof\\tI-Disease\\nC7\\tI-Disease\\nwas\\tO\\nalso\\tO\\nfound\\tO\\nin\\tO\\none\\tO\\nsibling\\tO\\nwho\\tO\\nhad\\tO\\nthe\\tO\\nclinical\\tO\\nsyndrome\\tO\\nof\\tO\\nmeningococcal\\tB-Disease\\nmeningitis\\tI-Disease\\nand\\tO\\narthritis\\tB-Disease\\nas\\tO\\na\\tO\\nchild\\tO\\nand\\tO\\nin\\tO\\nthis\\tO\\nsiblings\\tO\\nclinically\\tO\\nwell\\tO\\neight\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nson\\tO\\n.\\tO\\n\\nHLA\\tO\\nhistocompatibility\\tO\\ntyping\\tO\\nof\\tO\\nthe\\tO\\nfamily\\tO\\nmembers\\tO\\ndid\\tO\\nnot\\tO\\ndemonstrate\\tO\\nevidence\\tO\\nfor\\tO\\ngenetic\\tO\\nlinkage\\tO\\nof\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\nwith\\tO\\nthe\\tO\\nmajor\\tO\\nhistocompatibility\\tO\\nloci\\tO\\n.\\tO\\n\\nThis\\tO\\nreport\\tO\\nrepresents\\tO\\nthe\\tO\\nfirst\\tO\\ncases\\tO\\nof\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\nassociated\\tO\\nwith\\tO\\ninfectious\\tO\\ncomplications\\tO\\nand\\tO\\nsuggests\\tO\\nthat\\tO\\nbactericidal\\tO\\nactivity\\tO\\nmay\\tO\\nbe\\tO\\nimportant\\tO\\nin\\tO\\nhost\\tO\\ndefense\\tO\\nagainst\\tO\\nbacteremic\\tB-Disease\\nneisseria\\tI-Disease\\ninfections\\tI-Disease\\n.\\tO\\n\\nIncreased\\tO\\nincidence\\tO\\nof\\tO\\ncancer\\tB-Disease\\nin\\tO\\npatients\\tO\\nwith\\tO\\ncartilage\\tB-Disease\\n-\\tI-Disease\\nhair\\tI-Disease\\nhypoplasia\\tI-Disease\\n.\\tO\\n\\nOBJECTIVE\\tO\\nPrevious\\tO\\nreports\\tO\\nhave\\tO\\nsuggested\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\ncancer\\tB-Disease\\namong\\tO\\npatients\\tO\\nwith\\tO\\ncartilage\\tB-Disease\\n-\\tI-Disease\\nhair\\tI-Disease\\nhypoplasia\\tI-Disease\\n(\\tO\\nCHH\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\nwas\\tO\\ncarried\\tO\\nout\\tO\\nto\\tO\\nfurther\\tO\\nevaluate\\tO\\nthis\\tO\\nrisk\\tO\\namong\\tO\\npatients\\tO\\nwith\\tO\\nCHH\\tB-Disease\\nand\\tO\\ntheir\\tO\\nfirst\\tO\\n-\\tO\\ndegree\\tO\\nrelatives\\tO\\n.\\tO\\n\\nSTUDY\\tO\\nDESIGN\\tO\\nOne\\tO\\nhundred\\tO\\ntwenty\\tO\\n-\\tO\\ntwo\\tO\\npatients\\tO\\nwith\\tO\\nCHH\\tB-Disease\\nwere\\tO\\nidentified\\tO\\nthrough\\tO\\n2\\tO\\ncountrywide\\tO\\nepidemiologic\\tO\\nsurveys\\tO\\nin\\tO\\n1974\\tO\\nand\\tO\\nin\\tO\\n1986\\tO\\n.\\tO\\n\\nTheir\\tO\\nparents\\tO\\nand\\tO\\nnonaffected\\tO\\nsiblings\\tO\\nwere\\tO\\nidentified\\tO\\nthrough\\tO\\nthe\\tO\\nPopulation\\tO\\nRegister\\tO\\nCenter\\tO\\n.\\tO\\n\\nThis\\tO\\ncohort\\tO\\nunderwent\\tO\\nfollow\\tO\\n-\\tO\\nup\\tO\\nfor\\tO\\ncancer\\tB-Disease\\nincidence\\tO\\nthrough\\tO\\nthe\\tO\\nFinnish\\tO\\nCancer\\tO\\nRegistry\\tO\\nto\\tO\\nthe\\tO\\nend\\tO\\nof\\tO\\n1995\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nA\\tO\\nstatistically\\tO\\nsignificant\\tO\\nexcess\\tO\\nrisk\\tO\\nof\\tO\\ncancer\\tB-Disease\\nwas\\tO\\nseen\\tO\\namong\\tO\\nthe\\tO\\npatients\\tO\\nwith\\tO\\nCHH\\tB-Disease\\n(\\tO\\nstandardized\\tO\\nincidence\\tO\\nratio\\tO\\n6\\tO\\n.\\tO\\n9\\tO\\n,\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\n2\\tO\\n.\\tO\\n3\\tO\\nto\\tO\\n16\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nwas\\tO\\nmainly\\tO\\nattributable\\tO\\nto\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nHodgkins\\tI-Disease\\nlymphoma\\tI-Disease\\n(\\tO\\nstandardized\\tO\\nincidence\\tO\\nratio\\tO\\n90\\tO\\n,\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\n18\\tO\\nto\\tO\\n264\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\na\\tO\\nsignificant\\tO\\nexcess\\tO\\nrisk\\tO\\nof\\tO\\nbasal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\nwas\\tO\\nseen\\tO\\n(\\tO\\nstandardized\\tO\\nincidence\\tO\\nratio\\tO\\n35\\tO\\n,\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\n7\\tO\\n.\\tO\\n2\\tO\\nto\\tO\\n102\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ncancer\\tB-Disease\\nincidence\\tO\\namong\\tO\\nthe\\tO\\nsiblings\\tO\\nor\\tO\\nthe\\tO\\nparents\\tO\\ndid\\tO\\nnot\\tO\\ndiffer\\tO\\nfrom\\tO\\nthe\\tO\\naverage\\tO\\ncancer\\tB-Disease\\nincidence\\tO\\nin\\tO\\nthe\\tO\\nFinnish\\tO\\npopulation\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nThis\\tO\\nstudy\\tO\\nconfirms\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\ncancer\\tB-Disease\\n,\\tO\\nespecially\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nHodgkins\\tI-Disease\\nlymphoma\\tI-Disease\\n,\\tO\\nprobably\\tO\\nattributable\\tO\\nto\\tO\\ndefective\\tO\\nimmunity\\tO\\n,\\tO\\namong\\tO\\npatients\\tO\\nwith\\tO\\nCHH\\tB-Disease\\n.\\tO\\n\\nGenotype\\tO\\nand\\tO\\nphenotype\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\ndihydropyrimidine\\tB-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nDihydropyrimidine\\tB-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nDPD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisease\\tI-Disease\\ncharacterised\\tO\\nby\\tO\\nthymine\\tO\\n-\\tO\\nuraciluria\\tO\\nin\\tO\\nhomozygous\\tO\\ndeficient\\tO\\npatients\\tO\\nand\\tO\\nhas\\tO\\nbeen\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nvariable\\tO\\nclinical\\tO\\nphenotype\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\nunderstand\\tO\\nthe\\tO\\ngenetic\\tO\\nand\\tO\\nphenotypic\\tO\\nbasis\\tO\\nfor\\tO\\nDPD\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nwe\\tO\\nhave\\tO\\nreviewed\\tO\\n17\\tO\\nfamilies\\tO\\npresenting\\tO\\n22\\tO\\npatients\\tO\\nwith\\tO\\ncomplete\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nDPD\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\ngroup\\tO\\nof\\tO\\npatients\\tO\\n,\\tO\\n7\\tO\\ndifferent\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\n,\\tO\\nincluding\\tO\\n2\\tO\\ndeletions\\tO\\n[\\tO\\n295\\tO\\n-\\tO\\n298delTCAT\\tO\\n,\\tO\\n1897delC\\tO\\n]\\tO\\n,\\tO\\n1\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\n[\\tO\\nIVS14\\tO\\n+\\tO\\n1G\\tO\\n>\\tO\\nA\\tO\\n)\\tO\\n]\\tO\\nand\\tO\\n4\\tO\\nmissense\\tO\\nmutations\\tO\\n(\\tO\\n85T\\tO\\n>\\tO\\nC\\tO\\n,\\tO\\n703C\\tO\\n>\\tO\\nT\\tO\\n,\\tO\\n2658G\\tO\\n>\\tO\\nA\\tO\\n,\\tO\\n2983G\\tO\\n>\\tO\\nT\\tO\\n)\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nthe\\tO\\nprevalence\\tO\\nof\\tO\\nthe\\tO\\nvarious\\tO\\nmutations\\tO\\namong\\tO\\nDPD\\tB-Disease\\npatients\\tO\\nhas\\tO\\nshown\\tO\\nthat\\tO\\nthe\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\npoint\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ninvariant\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nis\\tO\\nby\\tO\\nfar\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\n(\\tO\\n52\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nother\\tO\\nsix\\tO\\nmutations\\tO\\nare\\tO\\nless\\tO\\nfrequently\\tO\\nobserved\\tO\\n.\\tO\\n\\nA\\tO\\nlarge\\tO\\nphenotypic\\tO\\nvariability\\tO\\nhas\\tO\\nbeen\\tO\\nobserved\\tO\\n,\\tO\\nwith\\tO\\nconvulsive\\tB-Disease\\ndisorders\\tI-Disease\\n,\\tO\\nmotor\\tB-Disease\\nretardation\\tI-Disease\\nand\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\nbeing\\tO\\nthe\\tO\\nmost\\tO\\nabundant\\tO\\nmanifestations\\tO\\n.\\tO\\n\\nA\\tO\\nclear\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\ngenotype\\tO\\nand\\tO\\nphenotype\\tO\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\nestablished\\tO\\n.\\tO\\n\\nAn\\tO\\naltered\\tO\\nbeta\\tO\\n-\\tO\\nalanine\\tO\\n,\\tO\\nuracil\\tO\\nand\\tO\\nthymine\\tO\\nhomeostasis\\tO\\nmight\\tO\\nunderlie\\tO\\nthe\\tO\\nvarious\\tO\\nclinical\\tB-Disease\\nabnormalities\\tI-Disease\\nencountered\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nDPD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nFibroblast\\tO\\ngrowth\\tO\\nfactor\\tO\\nhomologous\\tO\\nfactor\\tO\\n2\\tO\\n(\\tO\\nFHF2\\tO\\n)\\tO\\n:\\tO\\ngene\\tO\\nstructure\\tO\\n,\\tO\\nexpression\\tO\\nand\\tO\\nmapping\\tO\\nto\\tO\\nthe\\tO\\nBorjeson\\tB-Disease\\n-\\tI-Disease\\nForssman\\tI-Disease\\n-\\tI-Disease\\nLehmann\\tI-Disease\\nsyndrome\\tI-Disease\\nregion\\tO\\nin\\tO\\nXq26\\tO\\ndelineated\\tO\\nby\\tO\\na\\tO\\nduplication\\tO\\nbreakpoint\\tO\\nin\\tO\\na\\tO\\nBFLS\\tB-Disease\\n-\\tO\\nlike\\tO\\npatient\\tO\\n.\\tO\\n\\nBorjeson\\tB-Disease\\n-\\tI-Disease\\nForssman\\tI-Disease\\n-\\tI-Disease\\nLehmann\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nBFLS\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nsyndromal\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nmental\\tI-Disease\\nretardation\\tI-Disease\\n,\\tO\\nwhich\\tO\\nmaps\\tO\\nby\\tO\\nlinkage\\tO\\nto\\tO\\nthe\\tO\\nq26\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\na\\tO\\nmale\\tO\\npatient\\tO\\nwith\\tO\\nBFLS\\tB-Disease\\n-\\tO\\nlike\\tO\\nfeatures\\tO\\nand\\tO\\na\\tO\\nduplication\\tO\\n,\\tO\\n46\\tO\\n,\\tO\\nY\\tO\\n,\\tO\\ndup\\tO\\n(\\tO\\nX\\tO\\n)\\tO\\n(\\tO\\nq26q28\\tO\\n)\\tO\\n,\\tO\\ninherited\\tO\\nfrom\\tO\\nhis\\tO\\nphenotypically\\tO\\nnormal\\tO\\nmother\\tO\\n.\\tO\\n\\nFluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridisation\\tO\\nusing\\tO\\nyeast\\tO\\nartificial\\tO\\nchromosome\\tO\\nclones\\tO\\nfrom\\tO\\nXq26\\tO\\nlocalised\\tO\\nthe\\tO\\nduplication\\tO\\nbreakpoint\\tO\\nto\\tO\\nan\\tO\\napproximately\\tO\\n400\\tO\\n-\\tO\\nkb\\tO\\ninterval\\tO\\nin\\tO\\nthe\\tO\\nXq26\\tO\\n.\\tO\\n\\n3\\tO\\nregion\\tO\\nbetween\\tO\\nDXS155\\tO\\nand\\tO\\nDXS294\\tO\\n/\\tO\\nDXS730\\tO\\n.\\tO\\n\\nDatabase\\tO\\nsearches\\tO\\nand\\tO\\nanalysis\\tO\\nof\\tO\\navailable\\tO\\ngenomic\\tO\\nDNA\\tO\\nsequence\\tO\\nfrom\\tO\\nthe\\tO\\nregion\\tO\\nrevealed\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nfibroblast\\tO\\ngrowth\\tO\\nfactor\\tO\\nhomologous\\tO\\nfactor\\tO\\ngene\\tO\\n,\\tO\\nFHF2\\tO\\n,\\tO\\nwithin\\tO\\nthe\\tO\\nduplication\\tO\\nbreakpoint\\tO\\ninterval\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nstructure\\tO\\nof\\tO\\nFHF2\\tO\\nwas\\tO\\ndetermined\\tO\\nand\\tO\\ntwo\\tO\\nnew\\tO\\nexons\\tO\\nwere\\tO\\nidentified\\tO\\n,\\tO\\nincluding\\tO\\na\\tO\\nnew\\tO\\n5\\tO\\nend\\tO\\nexon\\tO\\n,\\tO\\n1B\\tO\\n.\\tO\\n\\nFHF2\\tO\\nis\\tO\\na\\tO\\nlarge\\tO\\ngene\\tO\\nextending\\tO\\nover\\tO\\napproximately\\tO\\n200\\tO\\nkb\\tO\\nin\\tO\\nXq26\\tO\\n.\\tO\\n\\n3\\tO\\nand\\tO\\nis\\tO\\ncomposed\\tO\\nof\\tO\\nat\\tO\\nleast\\tO\\nseven\\tO\\nexons\\tO\\n.\\tO\\n\\nIt\\tO\\nshows\\tO\\ntissue\\tO\\n-\\tO\\nspecific\\tO\\nalternative\\tO\\nsplicing\\tO\\nand\\tO\\nalternative\\tO\\ntranscription\\tO\\nstarts\\tO\\n.\\tO\\n\\nNorthern\\tO\\nblot\\tO\\nhybridisation\\tO\\nshowed\\tO\\nhighest\\tO\\nexpression\\tO\\nin\\tO\\nbrain\\tO\\nand\\tO\\nskeletal\\tO\\nmuscle\\tO\\n.\\tO\\n\\nThe\\tO\\nFHF2\\tO\\ngene\\tO\\nlocalisation\\tO\\nand\\tO\\ntissue\\tO\\n-\\tO\\nspecific\\tO\\nexpression\\tO\\npattern\\tO\\nsuggest\\tO\\nit\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nfamilial\\tO\\ncases\\tO\\nof\\tO\\nthe\\tO\\nBFLS\\tB-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nother\\tO\\nsyndromal\\tO\\nand\\tO\\nnon\\tO\\n-\\tO\\nspecific\\tO\\nforms\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nmental\\tI-Disease\\nretardation\\tI-Disease\\nmapping\\tO\\nto\\tO\\nthe\\tO\\nregion\\tO\\n.\\tO\\n\\nGermline\\tO\\nE\\tO\\n-\\tO\\ncadherin\\tO\\ngene\\tO\\n(\\tO\\nCDH1\\tO\\n)\\tO\\nmutations\\tO\\npredispose\\tO\\nto\\tO\\nfamilial\\tB-Disease\\ngastric\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nInherited\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nE\\tO\\n-\\tO\\ncadherin\\tO\\ngene\\tO\\n(\\tO\\nCDH1\\tO\\n)\\tO\\nwere\\tO\\ndescribed\\tO\\nrecently\\tO\\nin\\tO\\nthree\\tO\\nMaori\\tO\\nkindreds\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\ngastric\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nFamilial\\tB-Disease\\ngastric\\tI-Disease\\ncancer\\tI-Disease\\nis\\tO\\ngenetically\\tO\\nheterogeneous\\tO\\nand\\tO\\nit\\tO\\nis\\tO\\nnot\\tO\\nclear\\tO\\nwhat\\tO\\nproportion\\tO\\nof\\tO\\ngastric\\tB-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nMaori\\tO\\npopulations\\tO\\nis\\tO\\ndue\\tO\\nto\\tO\\ngermline\\tO\\nCDH1\\tO\\nmutations\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\nwe\\tO\\nscreened\\tO\\neight\\tO\\nfamilial\\tB-Disease\\ngastric\\tI-Disease\\ncancer\\tI-Disease\\nkindreds\\tO\\nof\\tO\\nBritish\\tO\\nand\\tO\\nIrish\\tO\\norigin\\tO\\nfor\\tO\\ngermline\\tO\\nCDH1\\tO\\nmutations\\tO\\n,\\tO\\nby\\tO\\nSSCP\\tO\\nanalysis\\tO\\nof\\tO\\nall\\tO\\n16\\tO\\nexons\\tO\\nand\\tO\\nflanking\\tO\\nsequences\\tO\\n.\\tO\\n\\nEach\\tO\\nfamily\\tO\\ncontained\\tO\\n(\\tO\\ni\\tO\\n)\\tO\\ntwo\\tO\\ncases\\tO\\nof\\tO\\ngastric\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\nfirst\\tO\\ndegree\\tO\\nrelatives\\tO\\nwith\\tO\\none\\tO\\naffected\\tO\\nbefore\\tO\\nage\\tO\\n50\\tO\\nyears\\tO\\n;\\tO\\nor\\tO\\n(\\tO\\nii\\tO\\n)\\tO\\nthree\\tO\\nor\\tO\\nmore\\tO\\ncases\\tO\\nof\\tO\\ngastric\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nNovel\\tO\\ngermline\\tO\\nCDH1\\tO\\nmutations\\tO\\n(\\tO\\na\\tO\\nnonsense\\tO\\nand\\tO\\na\\tO\\nsplice\\tO\\nsite\\tO\\n)\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\ntwo\\tO\\nfamilies\\tO\\n(\\tO\\n25\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nBoth\\tO\\nmutations\\tO\\nwere\\tO\\npredicted\\tO\\nto\\tO\\ntruncate\\tO\\nthe\\tO\\nE\\tO\\n-\\tO\\ncadherin\\tO\\nprotein\\tO\\nin\\tO\\nthe\\tO\\nsignal\\tO\\npeptide\\tO\\ndomain\\tO\\n.\\tO\\n\\nIn\\tO\\none\\tO\\nfamily\\tO\\nthere\\tO\\nwas\\tO\\nevidence\\tO\\nof\\tO\\nnon\\tO\\n-\\tO\\npenetrance\\tO\\nand\\tO\\nsusceptibility\\tO\\nto\\tO\\nboth\\tO\\ngastric\\tB-Disease\\nand\\tI-Disease\\ncolorectal\\tI-Disease\\ncancer\\tI-Disease\\n;\\tO\\nthus\\tO\\n,\\tO\\nin\\tO\\naddition\\tO\\nto\\tO\\nsix\\tO\\ncases\\tO\\nof\\tO\\ngastric\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\na\\tO\\nCDH1\\tO\\nmutation\\tO\\ncarrier\\tO\\ndeveloped\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nat\\tO\\nage\\tO\\n30\\tO\\nyears\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nconfirmed\\tO\\nthat\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nCDH1\\tO\\ngene\\tO\\ncause\\tO\\nfamilial\\tB-Disease\\ngastric\\tI-Disease\\ncancer\\tI-Disease\\nin\\tO\\nnon\\tO\\n-\\tO\\nMaori\\tO\\npopulations\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nonly\\tO\\na\\tO\\nminority\\tO\\nof\\tO\\nfamilial\\tO\\ngastric\\tB-Disease\\ncancers\\tI-Disease\\ncan\\tO\\nbe\\tO\\naccounted\\tO\\nfor\\tO\\nby\\tO\\nCDH1\\tO\\nmutations\\tO\\n.\\tO\\n\\nLoss\\tO\\nof\\tO\\nE\\tO\\n-\\tO\\ncadherin\\tO\\nfunction\\tO\\nhas\\tO\\nbeen\\tO\\nimplicated\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nsporadic\\tO\\ncolorectal\\tB-Disease\\nand\\tI-Disease\\nother\\tI-Disease\\ncancers\\tI-Disease\\n,\\tO\\nand\\tO\\nour\\tO\\nfindings\\tO\\nprovide\\tO\\nevidence\\tO\\nthat\\tO\\ngermline\\tO\\nCDH1\\tO\\nmutations\\tO\\npredispose\\tO\\nto\\tO\\nearly\\tO\\nonset\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nCDH1\\tO\\nshould\\tO\\nbe\\tO\\ninvestigated\\tO\\nas\\tO\\na\\tO\\ncause\\tO\\nof\\tO\\ninherited\\tO\\nsusceptibility\\tO\\nto\\tO\\nboth\\tO\\ngastric\\tB-Disease\\nand\\tI-Disease\\ncolorectal\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nzinc\\tO\\nfinger\\tO\\ntruncation\\tO\\nof\\tO\\nmurine\\tO\\nWT1\\tO\\nresults\\tO\\nin\\tO\\nthe\\tO\\ncharacteristic\\tO\\nurogenital\\tB-Disease\\nabnormalities\\tI-Disease\\nof\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\n,\\tO\\nWT1\\tO\\n,\\tO\\nplays\\tO\\na\\tO\\nkey\\tO\\nrole\\tO\\nin\\tO\\nurogenital\\tO\\ndevelopment\\tO\\n,\\tO\\nand\\tO\\nWT1\\tB-Disease\\ndysfunction\\tI-Disease\\nis\\tO\\nimplicated\\tO\\nin\\tO\\nboth\\tO\\nneoplastic\\tB-Disease\\n(\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\n,\\tO\\nmesothelioma\\tB-Disease\\n,\\tO\\nleukemias\\tB-Disease\\n,\\tO\\nand\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n)\\tO\\nand\\tO\\nnonneoplastic\\tB-Disease\\n(\\tO\\nglomerulosclerosis\\tB-Disease\\n)\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\nanalysis\\tO\\nof\\tO\\ndiseases\\tO\\nlinked\\tO\\nspecifically\\tO\\nwith\\tO\\nWT1\\tO\\nmutations\\tO\\n,\\tO\\nsuch\\tO\\nas\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nDDS\\tB-Disease\\n)\\tO\\n,\\tO\\ncan\\tO\\nprovide\\tO\\nvaluable\\tO\\ninsight\\tO\\nconcerning\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nWT1\\tO\\nin\\tO\\ndevelopment\\tO\\nand\\tO\\ndisease\\tO\\n.\\tO\\n\\nDDS\\tB-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\nchildhood\\tO\\ndisease\\tO\\ncharacterized\\tO\\nby\\tO\\na\\tO\\nnephropathy\\tB-Disease\\ninvolving\\tO\\nmesangial\\tB-Disease\\nsclerosis\\tI-Disease\\n,\\tO\\nXY\\tO\\npseudohermaphroditism\\tB-Disease\\n,\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\n(\\tO\\nWT\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nDDS\\tB-Disease\\npatients\\tO\\nare\\tO\\nconstitutionally\\tO\\nheterozygous\\tO\\nfor\\tO\\nexonic\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nWT1\\tO\\n,\\tO\\nwhich\\tO\\ninclude\\tO\\nmutations\\tO\\npredicted\\tO\\nto\\tO\\ntruncate\\tO\\nthe\\tO\\nprotein\\tO\\nwithin\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nzinc\\tO\\nfinger\\tO\\n(\\tO\\nZF\\tO\\n)\\tO\\nregion\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nthat\\tO\\nheterozygosity\\tO\\nfor\\tO\\na\\tO\\ntargeted\\tO\\nmurine\\tO\\nWt1\\tO\\nallele\\tO\\n,\\tO\\nWt1\\tO\\n(\\tO\\ntmT396\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\ntruncates\\tO\\nZF3\\tO\\nat\\tO\\ncodon\\tO\\n396\\tO\\n,\\tO\\ninduces\\tO\\nmesangial\\tB-Disease\\nsclerosis\\tI-Disease\\ncharacteristic\\tO\\nof\\tO\\nDDS\\tB-Disease\\nin\\tO\\nadult\\tO\\nheterozygous\\tO\\nand\\tO\\nchimeric\\tO\\nmice\\tO\\n.\\tO\\n\\nMale\\tB-Disease\\ngenital\\tI-Disease\\ndefects\\tI-Disease\\nalso\\tO\\nwere\\tO\\nevident\\tO\\nand\\tO\\nthere\\tO\\nwas\\tO\\na\\tO\\nsingle\\tO\\ncase\\tO\\nof\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\nin\\tO\\nwhich\\tO\\nthe\\tO\\ntranscript\\tO\\nof\\tO\\nthe\\tO\\nnontargeted\\tO\\nallele\\tO\\nshowed\\tO\\nan\\tO\\nexon\\tO\\n9\\tO\\nskipping\\tO\\nevent\\tO\\n,\\tO\\nimplying\\tO\\na\\tO\\ncausal\\tO\\nlink\\tO\\nbetween\\tO\\nWt1\\tB-Disease\\ndysfunction\\tI-Disease\\nand\\tO\\nWilms\\tB-Disease\\ntumorigenesis\\tI-Disease\\nin\\tO\\nmice\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nmutant\\tO\\nWT1\\tO\\n(\\tO\\ntmT396\\tO\\n)\\tO\\nprotein\\tO\\naccounted\\tO\\nfor\\tO\\nonly\\tO\\n5\\tO\\n%\\tO\\nof\\tO\\nWT1\\tO\\nin\\tO\\nboth\\tO\\nheterozygous\\tO\\nembryonic\\tO\\nstem\\tO\\ncells\\tO\\nand\\tO\\nthe\\tO\\nWT\\tB-Disease\\n.\\tO\\n\\nThis\\tO\\nhas\\tO\\nimplications\\tO\\nregarding\\tO\\nthe\\tO\\nmechanism\\tO\\nby\\tO\\nwhich\\tO\\nthe\\tO\\nmutant\\tO\\nallele\\tO\\nexerts\\tO\\nits\\tO\\neffect\\tO\\n.\\tO\\n\\nMechanism\\tO\\nof\\tO\\nincreased\\tO\\niron\\tO\\nabsorption\\tO\\nin\\tO\\nmurine\\tO\\nmodel\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\n:\\tO\\nincreased\\tO\\nduodenal\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\niron\\tO\\ntransporter\\tO\\nDMT1\\tO\\n.\\tO\\n\\nHereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\n(\\tO\\nHH\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\ncommon\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\ntissue\\tO\\niron\\tO\\ndeposition\\tO\\nsecondary\\tO\\nto\\tO\\nexcessive\\tO\\ndietary\\tO\\niron\\tO\\nabsorption\\tO\\n.\\tO\\n\\nWe\\tO\\nrecently\\tO\\nreported\\tO\\nthat\\tO\\nHFE\\tO\\n,\\tO\\nthe\\tO\\nprotein\\tO\\ndefective\\tO\\nin\\tO\\nHH\\tB-Disease\\n,\\tO\\nwas\\tO\\nphysically\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\ntransferrin\\tO\\nreceptor\\tO\\n(\\tO\\nTfR\\tO\\n)\\tO\\nin\\tO\\nduodenal\\tO\\ncrypt\\tO\\ncells\\tO\\nand\\tO\\nproposed\\tO\\nthat\\tO\\nmutations\\tO\\nin\\tO\\nHFE\\tO\\nattenuate\\tO\\nthe\\tO\\nuptake\\tO\\nof\\tO\\ntransferrin\\tO\\n-\\tO\\nbound\\tO\\niron\\tO\\nfrom\\tO\\nplasma\\tO\\nby\\tO\\nduodenal\\tO\\ncrypt\\tO\\ncells\\tO\\n,\\tO\\nleading\\tO\\nto\\tO\\nup\\tO\\n-\\tO\\nregulation\\tO\\nof\\tO\\ntransporters\\tO\\nfor\\tO\\ndietary\\tO\\niron\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\ntested\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nHFE\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\nhave\\tO\\nincreased\\tO\\nduodenal\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\ndivalent\\tO\\nmetal\\tO\\ntransporter\\tO\\n(\\tO\\nDMT1\\tO\\n)\\tO\\n.\\tO\\n\\nBy\\tO\\n4\\tO\\nweeks\\tO\\nof\\tO\\nage\\tO\\n,\\tO\\nthe\\tO\\nHFE\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\ndemonstrated\\tO\\niron\\tO\\nloading\\tO\\nwhen\\tO\\ncompared\\tO\\nwith\\tO\\nHFE\\tO\\n+\\tO\\n/\\tO\\n+\\tO\\nlittermates\\tO\\n,\\tO\\nwith\\tO\\nelevated\\tO\\ntransferrin\\tO\\nsaturations\\tO\\n(\\tO\\n68\\tO\\n.\\tO\\n4\\tO\\n%\\tO\\nvs\\tO\\n.\\tO\\n49\\tO\\n.\\tO\\n8\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\nelevated\\tO\\nliver\\tO\\niron\\tO\\nconcentrations\\tO\\n(\\tO\\n985\\tO\\nmicrograms\\tO\\nvs\\tO\\n.\\tO\\n381\\tO\\nmicrograms\\tO\\n)\\tO\\n.\\tO\\n\\nBy\\tO\\nusing\\tO\\nNorthern\\tO\\nblot\\tO\\nanalyses\\tO\\n,\\tO\\nwe\\tO\\nquantitated\\tO\\nduodenal\\tO\\nexpression\\tO\\nof\\tO\\nboth\\tO\\nclasses\\tO\\nof\\tO\\nDMT1\\tO\\ntranscripts\\tO\\none\\tO\\ncontaining\\tO\\nan\\tO\\niron\\tO\\nresponsive\\tO\\nelement\\tO\\n(\\tO\\nIRE\\tO\\n)\\tO\\n,\\tO\\ncalled\\tO\\nDMT1\\tO\\n(\\tO\\nIRE\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\none\\tO\\ncontaining\\tO\\nno\\tO\\nIRE\\tO\\n,\\tO\\ncalled\\tO\\nDMT1\\tO\\n(\\tO\\nnon\\tO\\n-\\tO\\nIRE\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\npositive\\tO\\ncontrol\\tO\\nfor\\tO\\nDMT1\\tO\\nup\\tO\\n-\\tO\\nregulation\\tO\\nwas\\tO\\na\\tO\\nmurine\\tO\\nmodel\\tO\\nof\\tO\\ndietary\\tB-Disease\\niron\\tI-Disease\\ndeficiency\\tI-Disease\\nthat\\tO\\ndemonstrated\\tO\\ngreatly\\tO\\nincreased\\tO\\nlevels\\tO\\nof\\tO\\nduodenal\\tO\\nDMT1\\tO\\n(\\tO\\nIRE\\tO\\n)\\tO\\nmRNA\\tO\\n.\\tO\\n\\nHFE\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\nalso\\tO\\ndemonstrated\\tO\\nan\\tO\\nincrease\\tO\\nin\\tO\\nduodenal\\tO\\nDMT1\\tO\\n(\\tO\\nIRE\\tO\\n)\\tO\\nmRNA\\tO\\n(\\tO\\naverage\\tO\\n7\\tO\\n.\\tO\\n7\\tO\\n-\\tO\\nfold\\tO\\n)\\tO\\n,\\tO\\ndespite\\tO\\ntheir\\tO\\nelevated\\tO\\ntransferrin\\tO\\nsaturation\\tO\\nand\\tO\\nhepatic\\tO\\niron\\tO\\ncontent\\tO\\n.\\tO\\n\\nDuodenal\\tO\\nexpression\\tO\\nof\\tO\\nDMT1\\tO\\n(\\tO\\nnon\\tO\\n-\\tO\\nIRE\\tO\\n)\\tO\\nwas\\tO\\nnot\\tO\\nincreased\\tO\\n,\\tO\\nnor\\tO\\nwas\\tO\\nhepatic\\tO\\nexpression\\tO\\nof\\tO\\nDMT1\\tO\\nincreased\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsupport\\tO\\nthe\\tO\\nmodel\\tO\\nfor\\tO\\nHH\\tO\\nin\\tO\\nwhich\\tO\\nHFE\\tO\\nmutations\\tO\\nlead\\tO\\nto\\tO\\ninappropriately\\tO\\nlow\\tO\\ncrypt\\tO\\ncell\\tO\\niron\\tO\\n,\\tO\\nwith\\tO\\nresultant\\tO\\nstabilization\\tO\\nof\\tO\\nDMT1\\tO\\n(\\tO\\nIRE\\tO\\n)\\tO\\nmRNA\\tO\\n,\\tO\\nup\\tO\\n-\\tO\\nregulation\\tO\\nof\\tO\\nDMT1\\tO\\n,\\tO\\nand\\tO\\nincreased\\tO\\nabsorption\\tO\\nof\\tO\\ndietary\\tO\\niron\\tO\\n.\\tO\\n\\nNeurophysiologic\\tO\\nfollow\\tO\\n-\\tO\\nup\\tO\\nof\\tO\\nlong\\tO\\n-\\tO\\nterm\\tO\\ndietary\\tO\\ntreatment\\tO\\nin\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\nadrenoleukodystrophy\\tB-Disease\\n.\\tO\\n\\nOBJECTIVE\\tO\\nTo\\tO\\nmonitor\\tO\\nthe\\tO\\neffects\\tO\\nof\\tO\\ndietary\\tO\\ntreatment\\tO\\nin\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\nadrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\nby\\tO\\nmeans\\tO\\nof\\tO\\nsomatosensory\\tO\\nevoked\\tO\\npotentials\\tO\\n(\\tO\\nSEPs\\tO\\n)\\tO\\nand\\tO\\nmotor\\tO\\nevoked\\tO\\npotentials\\tO\\n(\\tO\\nMEPs\\tO\\n)\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\nSEPs\\tO\\nand\\tO\\nMEPs\\tO\\nhave\\tO\\nproved\\tO\\nuseful\\tO\\nin\\tO\\nrevealing\\tO\\nsigns\\tO\\nof\\tO\\nprogressively\\tO\\nsevere\\tO\\n,\\tO\\ncentral\\tO\\ndying\\tB-Disease\\n-\\tI-Disease\\nback\\tI-Disease\\naxonopathy\\tI-Disease\\nin\\tO\\nearly\\tO\\nstages\\tO\\nof\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\nALD\\tB-Disease\\n.\\tO\\n\\nMETHODS\\tO\\nEight\\tO\\npatients\\tO\\nwith\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\nALD\\tB-Disease\\nunderwent\\tO\\nclinical\\tO\\nexamination\\tO\\n,\\tO\\nbrain\\tO\\nand\\tO\\nspine\\tO\\nMRI\\tO\\n,\\tO\\nand\\tO\\nSEP\\tO\\nand\\tO\\nMEP\\tO\\nstudies\\tO\\nbefore\\tO\\nand\\tO\\nafter\\tO\\n3\\tO\\nyears\\tO\\nof\\tO\\nLorenzos\\tO\\noil\\tO\\ndietary\\tO\\ntherapy\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nBefore\\tO\\ntreatment\\tO\\n,\\tO\\nbrain\\tO\\nMRI\\tO\\nwas\\tO\\nnormal\\tO\\nin\\tO\\nfive\\tO\\npatients\\tO\\n.\\tO\\n\\nThree\\tO\\nof\\tO\\nthese\\tO\\npatients\\tO\\nhad\\tO\\npure\\tO\\nspinal\\tB-Disease\\nSEP\\tI-Disease\\nabnormalities\\tI-Disease\\nand\\tO\\nin\\tO\\nthe\\tO\\nremaining\\tO\\ntwo\\tO\\npatients\\tO\\nSEPs\\tO\\nshowed\\tO\\nsigns\\tO\\nof\\tO\\ninvolvement\\tO\\nof\\tO\\nboth\\tO\\nthe\\tO\\nspinal\\tO\\nand\\tO\\ncerebral\\tO\\nsomatosensory\\tO\\ntracts\\tO\\n.\\tO\\n\\nAfter\\tO\\ntreatment\\tO\\n,\\tO\\nthe\\tO\\nthree\\tO\\npatients\\tO\\nwith\\tO\\npure\\tO\\nspinal\\tB-Disease\\nabnormalities\\tI-Disease\\nshowed\\tO\\nclinical\\tO\\nand\\tO\\nneurophysiologic\\tO\\nworsening\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\ntwo\\tO\\npatients\\tO\\nwith\\tO\\na\\tO\\nmore\\tO\\nadvanced\\tO\\nstage\\tO\\nof\\tO\\ndisease\\tO\\n(\\tO\\nexhibited\\tO\\nby\\tO\\nSEPs\\tO\\n)\\tO\\nshowed\\tO\\nsubstantially\\tO\\nunchanged\\tO\\nclinical\\tO\\nand\\tO\\nneurophysiologic\\tO\\nfeatures\\tO\\n.\\tO\\n\\nThe\\tO\\npatients\\tO\\nwith\\tO\\nabnormal\\tO\\nbrain\\tO\\nMRI\\tO\\nat\\tO\\nthe\\tO\\nonset\\tO\\nof\\tO\\ntreatment\\tO\\nshowed\\tO\\nclinical\\tO\\nand\\tO\\nneurophysiologic\\tO\\nworsening\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nLorenzos\\tO\\noil\\tO\\ntherapy\\tO\\nhad\\tO\\nno\\tO\\neffect\\tO\\non\\tO\\npatients\\tO\\nwith\\tO\\nevidence\\tO\\nof\\tO\\ninflammatory\\tB-Disease\\nbrain\\tI-Disease\\nlesions\\tI-Disease\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nin\\tO\\npatients\\tO\\nwithout\\tO\\nclear\\tO\\nsigns\\tO\\nof\\tO\\ninflammatory\\tO\\ndamage\\tO\\n,\\tO\\nthis\\tO\\ntreatment\\tO\\ndoes\\tO\\nnot\\tO\\nmodify\\tO\\nsignificantly\\tO\\nthe\\tO\\nnatural\\tO\\ncourse\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nbecause\\tO\\neffective\\tO\\ntreatments\\tO\\nshould\\tO\\nbegin\\tO\\nbefore\\tO\\nthe\\tO\\nonset\\tO\\nof\\tO\\nsevere\\tO\\nneurologic\\tO\\nsymptoms\\tO\\n,\\tO\\nSEPs\\tO\\nand\\tO\\nMEPs\\tO\\nshould\\tO\\nbe\\tO\\nconsidered\\tO\\nto\\tO\\nevaluate\\tO\\nthe\\tO\\neffectiveness\\tO\\nof\\tO\\nother\\tO\\nexperimental\\tO\\ntreatments\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\nwith\\tO\\na\\tO\\nnegative\\tO\\nbrain\\tO\\nMRI\\tO\\n.\\tO\\n\\nGCH1\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\noromandibular\\tB-Disease\\ndystonia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nauthors\\tO\\nreport\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n5\\tO\\nof\\tO\\nGCH1\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\noromandibular\\tB-Disease\\ndystonia\\tI-Disease\\nand\\tO\\nno\\tO\\nobvious\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\ndystonia\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\nresponded\\tO\\npositively\\tO\\nto\\tO\\ntreatment\\tO\\nwith\\tO\\nL\\tO\\n-\\tO\\ndopa\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\ndemonstrate\\tO\\nthat\\tO\\nGCH1\\tO\\nmutations\\tO\\nmust\\tO\\nbe\\tO\\nconsidered\\tO\\neven\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\ndystonic\\tB-Disease\\nsymptoms\\tO\\nnot\\tO\\ntypical\\tO\\nof\\tO\\ndopa\\tB-Disease\\n-\\tI-Disease\\nresponsive\\tI-Disease\\ndystonia\\tI-Disease\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nin\\tO\\nKorean\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nWe\\tO\\nextensively\\tO\\nanalyzed\\tO\\ngenomic\\tO\\nDNA\\tO\\nand\\tO\\nmessenger\\tO\\nRNA\\tO\\n(\\tO\\nmRNA\\tO\\n)\\tO\\nfrom\\tO\\n62\\tO\\nunrelated\\tO\\nKorean\\tO\\npatients\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\nfor\\tO\\nidentification\\tO\\nof\\tO\\ngermline\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\ngene\\tO\\nmutations\\tO\\n.\\tO\\n\\nWe\\tO\\nadopted\\tO\\nboth\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\nanalysis\\tO\\nand\\tO\\na\\tO\\nmethod\\tO\\nof\\tO\\nanalysis\\tO\\ninvolving\\tO\\nthe\\tO\\nreverse\\tO\\ntranscription\\tO\\n-\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\n)\\tO\\nfollowed\\tO\\nby\\tO\\na\\tO\\nprotein\\tO\\ntruncation\\tO\\ntest\\tO\\n(\\tO\\nPTT\\tO\\n)\\tO\\n.\\tO\\n\\nDNA\\tO\\nsequencing\\tO\\nconfirmed\\tO\\nall\\tO\\nalterations\\tO\\nrepresented\\tO\\nby\\tO\\naberrant\\tO\\nbands\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\n38\\tO\\npatients\\tO\\n(\\tO\\n61\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nNineteen\\tO\\nof\\tO\\nthe\\tO\\ndetected\\tO\\nmutations\\tO\\nwere\\tO\\npresumed\\tO\\nto\\tO\\nbe\\tO\\nnovel\\tO\\n,\\tO\\nthus\\tO\\nemphasizing\\tO\\nthe\\tO\\nheterogeneity\\tO\\nof\\tO\\nthe\\tO\\nmutational\\tO\\nspectrum\\tO\\nin\\tO\\nKorean\\tO\\nFAP\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\ninitial\\tO\\n48\\tO\\npatients\\tO\\n,\\tO\\nSSCP\\tO\\nanalysis\\tO\\nwas\\tO\\nfollowed\\tO\\nby\\tO\\nPTT\\tO\\nfor\\tO\\nthose\\tO\\npatients\\tO\\nfor\\tO\\nwhom\\tO\\nno\\tO\\ndetectable\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nby\\tO\\nSSCP\\tO\\n.\\tO\\n\\nUsing\\tO\\nthis\\tO\\ncombined\\tO\\napproach\\tO\\n,\\tO\\nwe\\tO\\nidentified\\tO\\ngermline\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nmutations\\tO\\nin\\tO\\n29\\tO\\nof\\tO\\nthe\\tO\\n48\\tO\\nFAP\\tB-Disease\\npatients\\tO\\n(\\tO\\n60\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nincluding\\tO\\n6\\tO\\npatients\\tO\\nin\\tO\\nwhom\\tO\\nSSCP\\tO\\nanalysis\\tO\\nfailed\\tO\\nto\\tO\\ndistinguish\\tO\\nthe\\tO\\nmutant\\tO\\nallele\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\n14\\tO\\nlater\\tO\\npatients\\tO\\n,\\tO\\nwe\\tO\\nidentified\\tO\\ntruncating\\tO\\nmutations\\tO\\nin\\tO\\n9\\tO\\npatients\\tO\\n(\\tO\\n64\\tO\\n%\\tO\\n)\\tO\\nusing\\tO\\nPTT\\tO\\nonly\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nconfirm\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\ndetection\\tO\\nrate\\tO\\nwith\\tO\\nPTT\\tO\\nwas\\tO\\nsuperior\\tO\\nto\\tO\\nthat\\tO\\nwith\\tO\\nSSCP\\tO\\n,\\tO\\nand\\tO\\nsuggest\\tO\\nthat\\tO\\nPTT\\tO\\nwould\\tO\\nbe\\tO\\na\\tO\\nmore\\tO\\npractical\\tO\\nscreening\\tO\\nmethod\\tO\\nto\\tO\\ndetect\\tO\\ngermline\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nin\\tO\\nFAP\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nMolecular\\tO\\nepidemiology\\tO\\nof\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\nheterozygotes\\tO\\nwith\\tO\\nan\\tO\\nArg95Stop\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nC9\\tO\\ngene\\tO\\nin\\tO\\nJapan\\tO\\n.\\tO\\n\\nDeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nninth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\nhuman\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC9\\tO\\n)\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\ncomplement\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nJapan\\tO\\n,\\tO\\nwith\\tO\\nan\\tO\\nincidence\\tO\\nof\\tO\\napproximately\\tO\\none\\tO\\nhomozygote\\tO\\nin\\tO\\n1000\\tO\\n,\\tO\\nbut\\tO\\nis\\tO\\nvery\\tO\\nrare\\tO\\nin\\tO\\nother\\tO\\ncountries\\tO\\n.\\tO\\n\\nGenetic\\tO\\nanalyses\\tO\\nof\\tO\\nJapanese\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\nhave\\tO\\nshown\\tO\\nthat\\tO\\na\\tO\\nC\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nT\\tO\\ntransition\\tO\\nleading\\tO\\nto\\tO\\nTGA\\tO\\nstop\\tO\\ncodon\\tO\\nfor\\tO\\nArg95\\tO\\nin\\tO\\nexon\\tO\\n4\\tO\\nof\\tO\\nthe\\tO\\nC9\\tO\\ngene\\tO\\n(\\tO\\nArg95Stop\\tO\\n)\\tO\\nis\\tO\\ncommon\\tO\\nin\\tO\\nJapanese\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nprevalence\\tO\\nof\\tO\\nheterozygous\\tO\\ncarriers\\tO\\nof\\tO\\nthe\\tO\\nArg95Stop\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nJapanese\\tO\\npopulation\\tO\\n,\\tO\\nwe\\tO\\ncollected\\tO\\nDNA\\tO\\nsamples\\tO\\nfrom\\tO\\n300\\tO\\nindividuals\\tO\\nin\\tO\\ntwo\\tO\\nof\\tO\\nthe\\tO\\nfour\\tO\\nmain\\tO\\nislands\\tO\\nof\\tO\\nJapan\\tO\\n.\\tO\\n\\nHeterozygote\\tO\\ndetection\\tO\\nwas\\tO\\nperformed\\tO\\nwith\\tO\\nan\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\nsystem\\tO\\ndesigned\\tO\\nto\\tO\\ndetect\\tO\\nexclusively\\tO\\nonly\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\nmutant\\tO\\nalleles\\tO\\n,\\tO\\nfollowed\\tO\\nby\\tO\\nconfirmation\\tO\\nwith\\tO\\nPCR\\tO\\n/\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\nanalysis\\tO\\nand\\tO\\ndirect\\tO\\nsequencing\\tO\\n.\\tO\\n\\nTwenty\\tO\\nindividuals\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nArg95Stop\\tO\\nmutation\\tO\\n.\\tO\\n\\nNone\\tO\\nwas\\tO\\nhomozygous\\tO\\n.\\tO\\n\\nThe\\tO\\nprevalence\\tO\\nof\\tO\\ncarriers\\tO\\nof\\tO\\nthe\\tO\\nArg95Stop\\tO\\nmutation\\tO\\nwas\\tO\\n6\\tO\\n.\\tO\\n\\n7\\tO\\n%\\tO\\n(\\tO\\n20\\tO\\n/\\tO\\n300\\tO\\n)\\tO\\n.\\tO\\n\\nAn\\tO\\nestimated\\tO\\nfrequency\\tO\\n(\\tO\\n0\\tO\\n.\\tO\\n12\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\ncomplete\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\ndue\\tO\\nto\\tO\\nhomozygous\\tO\\nArg95Stop\\tO\\nmutation\\tO\\nwas\\tO\\nconsistent\\tO\\nwith\\tO\\nfrequencies\\tO\\ndetermined\\tO\\nby\\tO\\nserological\\tO\\nstudies\\tO\\n\\nThe\\tO\\nhereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\nprotein\\tO\\n,\\tO\\nHFE\\tO\\n,\\tO\\nspecifically\\tO\\nregulates\\tO\\ntransferrin\\tO\\n-\\tO\\nmediated\\tO\\niron\\tO\\nuptake\\tO\\nin\\tO\\nHeLa\\tO\\ncells\\tO\\n.\\tO\\n\\nHFE\\tO\\nis\\tO\\nthe\\tO\\nprotein\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nmutated\\tO\\nin\\tO\\nthe\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisease\\tI-Disease\\nhereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\n(\\tO\\nFeder\\tO\\n,\\tO\\nJ\\tO\\n.\\tO\\n\\nN\\tO\\n.\\tO\\n,\\tO\\nGnirke\\tO\\n,\\tO\\nA\\tO\\n.\\tO\\n,\\tO\\nThomas\\tO\\n,\\tO\\nW\\tO\\n.\\tO\\n,\\tO\\nTsuchihashi\\tO\\n,\\tO\\nZ\\tO\\n.\\tO\\n,\\tO\\nRuddy\\tO\\n,\\tO\\nD\\tO\\n.\\tO\\n\\nA\\tO\\n.\\tO\\n,\\tO\\nBasava\\tO\\n,\\tO\\nA\\tO\\n.\\tO\\n,\\tO\\nDormishian\\tO\\n,\\tO\\nF\\tO\\n.\\tO\\n,\\tO\\nDomingo\\tO\\n,\\tO\\nR\\tO\\n.\\tO\\n\\nJ\\tO\\n.\\tO\\n,\\tO\\nEllis\\tO\\n,\\tO\\nM\\tO\\n.\\tO\\n\\nC\\tO\\n.\\tO\\n,\\tO\\nFullan\\tO\\n,\\tO\\nA\\tO\\n.\\tO\\n,\\tO\\nHinton\\tO\\n,\\tO\\nL\\tO\\n.\\tO\\n\\nM\\tO\\n.\\tO\\n,\\tO\\nJones\\tO\\n,\\tO\\nN\\tO\\n.\\tO\\n\\nL\\tO\\n.\\tO\\n,\\tO\\nKimmel\\tO\\n,\\tO\\nB\\tO\\n.\\tO\\n\\nE\\tO\\n.\\tO\\n,\\tO\\nKronmal\\tO\\n,\\tO\\nG\\tO\\n.\\tO\\n\\nS\\tO\\n.\\tO\\n,\\tO\\nLauer\\tO\\n,\\tO\\nP\\tO\\n.\\tO\\n,\\tO\\nLee\\tO\\n,\\tO\\nV\\tO\\n.\\tO\\n\\nK\\tO\\n.\\tO\\n,\\tO\\nLoeb\\tO\\n,\\tO\\nD\\tO\\n.\\tO\\n\\nB\\tO\\n.\\tO\\n,\\tO\\nMapa\\tO\\n,\\tO\\nF\\tO\\n.\\tO\\n\\nA\\tO\\n.\\tO\\n,\\tO\\nMcClelland\\tO\\n,\\tO\\nE\\tO\\n.\\tO\\n,\\tO\\nMeyer\\tO\\n,\\tO\\nN\\tO\\n.\\tO\\n\\nC\\tO\\n.\\tO\\n,\\tO\\nMintier\\tO\\n,\\tO\\nG\\tO\\n.\\tO\\n\\nA\\tO\\n.\\tO\\n,\\tO\\nMoeller\\tO\\n,\\tO\\nN\\tO\\n.\\tO\\n,\\tO\\nMoore\\tO\\n,\\tO\\nT\\tO\\n.\\tO\\n,\\tO\\nMorikang\\tO\\n,\\tO\\nE\\tO\\n.\\tO\\n,\\tO\\nPrasss\\tO\\n,\\tO\\nC\\tO\\n.\\tO\\n\\nE\\tO\\n.\\tO\\n,\\tO\\nQuintana\\tO\\n,\\tO\\nL\\tO\\n.\\tO\\n,\\tO\\nStarnes\\tO\\n,\\tO\\nS\\tO\\n.\\tO\\n\\nM\\tO\\n.\\tO\\n,\\tO\\nSchatzman\\tO\\n,\\tO\\nR\\tO\\n.\\tO\\n\\nC\\tO\\n.\\tO\\n,\\tO\\nBrunke\\tO\\n,\\tO\\nK\\tO\\n.\\tO\\n\\nJ\\tO\\n.\\tO\\n,\\tO\\nDrayna\\tO\\n,\\tO\\nD\\tO\\n.\\tO\\n\\nT\\tO\\n.\\tO\\n,\\tO\\nRisch\\tO\\n,\\tO\\nN\\tO\\n.\\tO\\n\\nJ\\tO\\n.\\tO\\n,\\tO\\nBacon\\tO\\n,\\tO\\nB\\tO\\n.\\tO\\n\\nR\\tO\\n.\\tO\\n,\\tO\\nand\\tO\\nWolff\\tO\\n,\\tO\\nR\\tO\\n.\\tO\\n\\nR\\tO\\n.\\tO\\n\\n(\\tO\\n1996\\tO\\n)\\tO\\nNat\\tO\\n.\\tO\\n\\nGenet\\tO\\n.\\tO\\n\\n13\\tO\\n,\\tO\\n399\\tO\\n-\\tO\\n408\\tO\\n)\\tO\\n.\\tO\\n\\nAt\\tO\\nthe\\tO\\ncell\\tO\\nsurface\\tO\\n,\\tO\\nHFE\\tO\\ncomplexes\\tO\\nwith\\tO\\ntransferrin\\tO\\nreceptor\\tO\\n(\\tO\\nTfR\\tO\\n)\\tO\\n,\\tO\\nincreasing\\tO\\nthe\\tO\\ndissociation\\tO\\nconstant\\tO\\nof\\tO\\ntransferrin\\tO\\n(\\tO\\nTf\\tO\\n)\\tO\\nfor\\tO\\nits\\tO\\nreceptor\\tO\\n10\\tO\\n-\\tO\\nfold\\tO\\n(\\tO\\nGross\\tO\\n,\\tO\\nC\\tO\\n.\\tO\\n\\nN\\tO\\n.\\tO\\n,\\tO\\nIrrinki\\tO\\n,\\tO\\nA\\tO\\n.\\tO\\n,\\tO\\nFeder\\tO\\n,\\tO\\nJ\\tO\\n.\\tO\\nN\\tO\\n.\\tO\\n,\\tO\\nand\\tO\\nEnns\\tO\\n,\\tO\\nC\\tO\\n.\\tO\\nA\\tO\\n.\\tO\\n(\\tO\\n1998\\tO\\n)\\tO\\nJ\\tO\\n.\\tO\\nBiol\\tO\\n.\\tO\\nChem\\tO\\n.\\tO\\n273\\tO\\n,\\tO\\n22068\\tO\\n-\\tO\\n22074\\tO\\n;\\tO\\nFeder\\tO\\n,\\tO\\nJ\\tO\\n.\\tO\\nN\\tO\\n.\\tO\\n,\\tO\\nPenny\\tO\\n,\\tO\\nD\\tO\\n.\\tO\\nM\\tO\\n.\\tO\\n,\\tO\\nIrrinki\\tO\\n,\\tO\\nA\\tO\\n.\\tO\\n,\\tO\\nLee\\tO\\n,\\tO\\nV\\tO\\n.\\tO\\nK\\tO\\n.\\tO\\n,\\tO\\nLebron\\tO\\n,\\tO\\nJ\\tO\\n.\\tO\\nA\\tO\\n.\\tO\\n,\\tO\\nWatson\\tO\\n,\\tO\\nN\\tO\\n.\\tO\\n,\\tO\\nTsuchihashi\\tO\\n,\\tO\\nZ\\tO\\n.\\tO\\n,\\tO\\nSigal\\tO\\n,\\tO\\nE\\tO\\n.\\tO\\n,\\tO\\nBjorkman\\tO\\n,\\tO\\nP\\tO\\n.\\tO\\nJ\\tO\\n.\\tO\\n,\\tO\\nand\\tO\\nSchatzman\\tO\\n,\\tO\\nR\\tO\\n.\\tO\\nC\\tO\\n.\\tO\\n(\\tO\\n1998\\tO\\n)\\tO\\nProc\\tO\\n.\\tO\\nNatl\\tO\\n.\\tO\\n\\nAcad\\tO\\n.\\tO\\n\\nSci\\tO\\n.\\tO\\n\\nU\\tO\\nS\\tO\\nA\\tO\\n95\\tO\\n,\\tO\\n1472\\tO\\n-\\tO\\n1477\\tO\\n)\\tO\\n.\\tO\\n\\nHFE\\tO\\ndoes\\tO\\nnot\\tO\\nremain\\tO\\nat\\tO\\nthe\\tO\\ncell\\tO\\nsurface\\tO\\n,\\tO\\nbut\\tO\\ntraffics\\tO\\nwith\\tO\\nTfR\\tO\\nto\\tO\\nTf\\tO\\n-\\tO\\npositive\\tO\\ninternal\\tO\\ncompartments\\tO\\n(\\tO\\nGross\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1998\\tO\\n)\\tO\\n.\\tO\\n\\nUsing\\tO\\na\\tO\\nHeLa\\tO\\ncell\\tO\\nline\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nHFE\\tO\\nis\\tO\\ncontrolled\\tO\\nby\\tO\\ntetracycline\\tO\\n,\\tO\\nwe\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nHFE\\tO\\nreduces\\tO\\n55Fe\\tO\\nuptake\\tO\\nfrom\\tO\\nTf\\tO\\nby\\tO\\n33\\tO\\n%\\tO\\nbut\\tO\\ndoes\\tO\\nnot\\tO\\naffect\\tO\\nthe\\tO\\nendocytic\\tO\\nor\\tO\\nexocytic\\tO\\nrates\\tO\\nof\\tO\\nTfR\\tO\\ncycling\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\nHFE\\tO\\nappears\\tO\\nto\\tO\\nreduce\\tO\\ncellular\\tO\\nacquisition\\tO\\nof\\tO\\niron\\tO\\nfrom\\tO\\nTf\\tO\\nwithin\\tO\\nendocytic\\tO\\ncompartments\\tO\\n.\\tO\\n\\nHFE\\tO\\nspecifically\\tO\\nreduces\\tO\\niron\\tO\\nuptake\\tO\\nfrom\\tO\\nTf\\tO\\n,\\tO\\nas\\tO\\nnon\\tO\\n-\\tO\\nTf\\tO\\n-\\tO\\nmediated\\tO\\niron\\tO\\nuptake\\tO\\nfrom\\tO\\nFe\\tO\\n-\\tO\\nnitrilotriacetic\\tO\\nacid\\tO\\nis\\tO\\nnot\\tO\\naltered\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nexplain\\tO\\nthe\\tO\\ndecreased\\tO\\nferritin\\tO\\nlevels\\tO\\nseen\\tO\\nin\\tO\\nour\\tO\\nHeLa\\tO\\ncell\\tO\\nsystem\\tO\\nand\\tO\\ndemonstrate\\tO\\nthe\\tO\\nspecific\\tO\\ncontrol\\tO\\nof\\tO\\nHFE\\tO\\nover\\tO\\nthe\\tO\\nTf\\tO\\n-\\tO\\nmediated\\tO\\npathway\\tO\\nof\\tO\\niron\\tO\\nuptake\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nalso\\tO\\nhave\\tO\\nimplications\\tO\\nfor\\tO\\nthe\\tO\\nunderstanding\\tO\\nof\\tO\\ncellular\\tO\\niron\\tO\\nhomeostasis\\tO\\nin\\tO\\norgans\\tO\\nsuch\\tO\\nas\\tO\\nthe\\tO\\nliver\\tO\\n,\\tO\\npancreas\\tO\\n,\\tO\\nheart\\tO\\n,\\tO\\nand\\tO\\nspleen\\tO\\nthat\\tO\\nare\\tO\\niron\\tO\\nloaded\\tO\\nin\\tO\\nhereditary\\tB-Disease\\nhemochromatotic\\tI-Disease\\nindividuals\\tO\\nlacking\\tO\\nfunctional\\tO\\nHFE\\tO\\n.\\tO\\n\\nMutation\\tO\\nand\\tO\\nhaplotype\\tO\\nstudies\\tO\\nof\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\nreveal\\tO\\nnew\\tO\\nancestral\\tO\\nrelationships\\tO\\nand\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\nhigh\\tO\\ncarrier\\tO\\nfrequency\\tO\\nwith\\tO\\nreduced\\tO\\npenetrance\\tO\\nin\\tO\\nthe\\tO\\nAshkenazi\\tO\\nJewish\\tO\\npopulation\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n(\\tO\\nFMF\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nrecessive\\tB-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nepisodes\\tO\\nof\\tO\\nfever\\tO\\nwith\\tO\\nserositis\\tB-Disease\\nor\\tO\\nsynovitis\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nFMF\\tB-Disease\\ngene\\tO\\n(\\tO\\nMEFV\\tO\\n)\\tO\\nwas\\tO\\ncloned\\tO\\nrecently\\tO\\n,\\tO\\nand\\tO\\nfour\\tO\\nmissense\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\npresent\\tO\\ndata\\tO\\nfrom\\tO\\nnon\\tO\\n-\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nand\\tO\\nArab\\tO\\npatients\\tO\\nin\\tO\\nwhom\\tO\\nwe\\tO\\nhad\\tO\\nnot\\tO\\noriginally\\tO\\nfound\\tO\\nmutations\\tO\\nand\\tO\\nfrom\\tO\\na\\tO\\nnew\\tO\\n,\\tO\\nmore\\tO\\nethnically\\tO\\ndiverse\\tO\\npanel\\tO\\n.\\tO\\n\\nAmong\\tO\\n90\\tO\\nsymptomatic\\tO\\nmutation\\tO\\n-\\tO\\npositive\\tO\\nindividuals\\tO\\n,\\tO\\n11\\tO\\nmutations\\tO\\naccounted\\tO\\nfor\\tO\\n79\\tO\\n%\\tO\\nof\\tO\\ncarrier\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\ntwo\\tO\\nmutations\\tO\\nthat\\tO\\nare\\tO\\nnovel\\tO\\n,\\tO\\none\\tO\\nalters\\tO\\nthe\\tO\\nsame\\tO\\nresidue\\tO\\n(\\tO\\n680\\tO\\n)\\tO\\nas\\tO\\na\\tO\\npreviously\\tO\\nknown\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nother\\tO\\n(\\tO\\nP369S\\tO\\n)\\tO\\nis\\tO\\nlocated\\tO\\nin\\tO\\nexon\\tO\\n3\\tO\\n.\\tO\\n\\nConsistent\\tO\\nwith\\tO\\nanother\\tO\\nrecent\\tO\\nreport\\tO\\n,\\tO\\nthe\\tO\\nE148Q\\tO\\nmutation\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\npatients\\tO\\nof\\tO\\nseveral\\tO\\nethnicities\\tO\\nand\\tO\\non\\tO\\nmultiple\\tO\\nmicrosatellite\\tO\\nhaplotypes\\tO\\n,\\tO\\nbut\\tO\\nhaplotype\\tO\\ndata\\tO\\nindicate\\tO\\nan\\tO\\nancestral\\tO\\nrelationships\\tO\\nbetween\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nItalian\\tO\\nand\\tO\\nAshkenazi\\tO\\nJewish\\tO\\npatients\\tO\\nwith\\tO\\nFMF\\tB-Disease\\nand\\tO\\nother\\tO\\naffected\\tO\\npopulations\\tO\\n.\\tO\\n\\nAmong\\tO\\napproximately\\tO\\n200\\tO\\nanonymous\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nDNA\\tO\\nsamples\\tO\\n,\\tO\\nthe\\tO\\nMEFV\\tO\\ncarrier\\tO\\nfrequency\\tO\\nwas\\tO\\n21\\tO\\n%\\tO\\n,\\tO\\nwith\\tO\\nE148Q\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nmutation\\tO\\n.\\tO\\n\\nSeveral\\tO\\nlines\\tO\\nof\\tO\\nevidence\\tO\\nindicate\\tO\\nreduced\\tO\\npenetrance\\tO\\namong\\tO\\nAshkenazi\\tO\\nJews\\tO\\n,\\tO\\nespecially\\tO\\nfor\\tO\\nE148Q\\tO\\n,\\tO\\nP369S\\tO\\n,\\tO\\nand\\tO\\nK695R\\tO\\n.\\tO\\n\\nNevertheless\\tO\\n,\\tO\\nE148Q\\tO\\nhelps\\tO\\naccount\\tO\\nfor\\tO\\nrecessive\\tO\\ninheritance\\tO\\nin\\tO\\nan\\tO\\nAshkenazi\\tO\\nfamily\\tO\\npreviously\\tO\\nreported\\tO\\nas\\tO\\nan\\tO\\nunusual\\tO\\ncase\\tO\\nof\\tO\\ndominantly\\tO\\ninherited\\tO\\nFMF\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\npresence\\tO\\nof\\tO\\nthree\\tO\\nfrequent\\tO\\nMEFV\\tO\\nmutations\\tO\\nin\\tO\\nmultiple\\tO\\nMediterranean\\tO\\npopulations\\tO\\nstrongly\\tO\\nsuggests\\tO\\na\\tO\\nheterozygote\\tO\\nadvantage\\tO\\nin\\tO\\nthis\\tO\\ngeographic\\tO\\nregion\\tO\\n.\\tO\\n\\nAutoimmune\\tB-Disease\\nlymphoproliferative\\tI-Disease\\nsyndrome\\tI-Disease\\nwith\\tO\\ndefective\\tO\\nFas\\tO\\n:\\tO\\ngenotype\\tO\\ninfluences\\tO\\npenetrance\\tO\\n.\\tO\\n\\nAutoimmune\\tB-Disease\\nlymphoproliferative\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nALPS\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\ndisorder\\tB-Disease\\nof\\tI-Disease\\nlymphocyte\\tI-Disease\\nhomeostasis\\tI-Disease\\nand\\tI-Disease\\nimmunological\\tI-Disease\\ntolerance\\tI-Disease\\n.\\tO\\n\\nMost\\tO\\npatients\\tO\\nhave\\tO\\na\\tO\\nheterozygous\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nAPT1\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nencodes\\tO\\nFas\\tO\\n(\\tO\\nCD95\\tO\\n,\\tO\\nAPO\\tO\\n-\\tO\\n1\\tO\\n)\\tO\\n,\\tO\\nmediator\\tO\\nof\\tO\\nan\\tO\\napoptotic\\tO\\npathway\\tO\\ncrucial\\tO\\nto\\tO\\nlymphocyte\\tO\\nhomeostasis\\tO\\n.\\tO\\n\\nOf\\tO\\n17\\tO\\nunique\\tO\\nAPT1\\tO\\nmutations\\tO\\nin\\tO\\nunrelated\\tO\\nALPS\\tB-Disease\\nprobands\\tO\\n,\\tO\\n12\\tO\\n(\\tO\\n71\\tO\\n%\\tO\\n)\\tO\\noccurred\\tO\\nin\\tO\\nexons\\tO\\n7\\tO\\n-\\tO\\n9\\tO\\n,\\tO\\nwhich\\tO\\nencode\\tO\\nthe\\tO\\nintracellular\\tO\\nportion\\tO\\nof\\tO\\nFas\\tO\\n.\\tO\\n\\nIn\\tO\\nvitro\\tO\\n,\\tO\\nactivated\\tO\\nlymphocytes\\tO\\nfrom\\tO\\nall\\tO\\n17\\tO\\npatients\\tO\\nshowed\\tO\\napoptotic\\tO\\ndefects\\tO\\nwhen\\tO\\nexposed\\tO\\nto\\tO\\nan\\tO\\nanti\\tO\\n-\\tO\\nFas\\tO\\nagonist\\tO\\nmonoclonal\\tO\\nantibody\\tO\\n.\\tO\\n\\nSimilar\\tO\\ndefects\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\na\\tO\\nFas\\tO\\n-\\tO\\nnegative\\tO\\ncell\\tO\\nline\\tO\\ntransfected\\tO\\nwith\\tO\\ncDNAs\\tO\\nbearing\\tO\\neach\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\n.\\tO\\n\\nIn\\tO\\ncotransfection\\tO\\nexperiments\\tO\\n,\\tO\\nFas\\tO\\nconstructs\\tO\\nwith\\tO\\neither\\tO\\nintra\\tO\\n-\\tO\\nor\\tO\\nextracellular\\tO\\nmutations\\tO\\ncaused\\tO\\ndominant\\tO\\ninhibition\\tO\\nof\\tO\\napoptosis\\tO\\nmediated\\tO\\nby\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nFas\\tO\\n.\\tO\\n\\nTwo\\tO\\nmissense\\tO\\nFas\\tO\\nvariants\\tO\\n,\\tO\\nnot\\tO\\nrestricted\\tO\\nto\\tO\\npatients\\tO\\nwith\\tO\\nALPS\\tB-Disease\\n,\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nVariant\\tO\\nA\\tO\\n(\\tO\\n-\\tO\\n1\\tO\\n)\\tO\\nT\\tO\\nat\\tO\\nthe\\tO\\nFas\\tO\\nsignal\\tO\\n-\\tO\\nsequence\\tO\\ncleavage\\tO\\nsite\\tO\\n,\\tO\\nwhich\\tO\\nmediates\\tO\\napoptosis\\tO\\nless\\tO\\nwell\\tO\\nthan\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nFas\\tO\\nand\\tO\\nis\\tO\\npartially\\tO\\ninhibitory\\tO\\n,\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\n13\\tO\\n%\\tO\\nof\\tO\\nAfrican\\tO\\nAmerican\\tO\\nalleles\\tO\\n.\\tO\\n\\nAmong\\tO\\nthe\\tO\\nALPS\\tB-Disease\\n-\\tO\\nassociated\\tO\\nFas\\tO\\nmutants\\tO\\n,\\tO\\ndominant\\tO\\ninhibition\\tO\\nof\\tO\\napoptosis\\tO\\nwas\\tO\\nmuch\\tO\\nmore\\tO\\npronounced\\tO\\nin\\tO\\nmutants\\tO\\naffecting\\tO\\nthe\\tO\\nintracellular\\tO\\n,\\tO\\nversus\\tO\\nextracellular\\tO\\n,\\tO\\nportion\\tO\\nof\\tO\\nthe\\tO\\nFas\\tO\\nreceptor\\tO\\n.\\tO\\n\\nMutations\\tO\\ncausing\\tO\\ndisruption\\tO\\nof\\tO\\nthe\\tO\\nintracellular\\tO\\nFas\\tO\\ndeath\\tO\\ndomain\\tO\\nalso\\tO\\nshowed\\tO\\na\\tO\\nhigher\\tO\\npenetrance\\tO\\nof\\tO\\nALPS\\tB-Disease\\nphenotype\\tO\\nfeatures\\tO\\nin\\tO\\nmutation\\tO\\n-\\tO\\nbearing\\tO\\nrelatives\\tO\\n.\\tO\\n\\nSignificant\\tO\\nALPS\\tB-Disease\\n-\\tO\\nrelated\\tO\\nmorbidity\\tO\\noccurred\\tO\\nin\\tO\\n44\\tO\\n%\\tO\\nof\\tO\\nrelatives\\tO\\nwith\\tO\\nintracellular\\tO\\nmutations\\tO\\n,\\tO\\nversus\\tO\\n0\\tO\\n%\\tO\\nof\\tO\\nrelatives\\tO\\nwith\\tO\\nextracellular\\tO\\nmutations\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\nlocation\\tO\\nof\\tO\\nmutations\\tO\\nwithin\\tO\\nAPT1\\tO\\nstrongly\\tO\\ninfluences\\tO\\nthe\\tO\\ndevelopment\\tO\\nand\\tO\\nthe\\tO\\nseverity\\tO\\nof\\tO\\nALPS\\tB-Disease\\n.\\tO\\n\\nMulticentric\\tO\\norigin\\tO\\nof\\tO\\nhemochromatosis\\tB-Disease\\ngene\\tO\\n(\\tO\\nHFE\\tO\\n)\\tO\\nmutations\\tO\\n.\\tO\\n\\nGenetic\\tB-Disease\\nhemochromatosis\\tI-Disease\\n(\\tO\\nGH\\tB-Disease\\n)\\tO\\nis\\tO\\nbelieved\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\ndisease\\tO\\nrestricted\\tO\\nto\\tO\\nthose\\tO\\nof\\tO\\nEuropean\\tO\\nancestry\\tO\\n.\\tO\\n\\nIn\\tO\\nnorthwestern\\tO\\nEurope\\tO\\n,\\tO\\n>\\tO\\n80\\tO\\n%\\tO\\nof\\tO\\nGH\\tB-Disease\\npatients\\tO\\nare\\tO\\nhomozygous\\tO\\nfor\\tO\\none\\tO\\nmutation\\tO\\n,\\tO\\nthe\\tO\\nsubstitution\\tO\\nof\\tO\\ntyrosine\\tO\\nfor\\tO\\ncysteine\\tO\\nat\\tO\\nposition\\tO\\n282\\tO\\n(\\tO\\nC282Y\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nunprocessed\\tO\\nprotein\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nproportion\\tO\\nof\\tO\\nGH\\tB-Disease\\npatients\\tO\\n,\\tO\\ntwo\\tO\\nmutations\\tO\\nare\\tO\\npresent\\tO\\n,\\tO\\nC282Y\\tO\\nand\\tO\\nH63D\\tO\\n.\\tO\\n\\nThe\\tO\\nclinical\\tO\\nsignificance\\tO\\nof\\tO\\nthis\\tO\\nsecond\\tO\\nmutation\\tO\\nis\\tO\\nsuch\\tO\\nthat\\tO\\nit\\tO\\nappears\\tO\\nto\\tO\\npredispose\\tO\\n1\\tO\\n%\\tO\\n-\\tO\\n2\\tO\\n%\\tO\\nof\\tO\\ncompound\\tO\\nheterozygotes\\tO\\nto\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\ndistribution\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nmutations\\tO\\ndiffer\\tO\\n,\\tO\\nC282Y\\tO\\nbeing\\tO\\nlimited\\tO\\nto\\tO\\nthose\\tO\\nof\\tO\\nnorthwestern\\tO\\nEuropean\\tO\\nancestry\\tO\\nand\\tO\\nH63D\\tO\\nbeing\\tO\\nfound\\tO\\nat\\tO\\nallele\\tO\\nfrequencies\\tO\\n>\\tO\\n5\\tO\\n%\\tO\\n,\\tO\\nin\\tO\\nEurope\\tO\\n,\\tO\\nin\\tO\\ncountries\\tO\\nbordering\\tO\\nthe\\tO\\nMediterranean\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nMiddle\\tO\\nEast\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\nthe\\tO\\nIndian\\tO\\nsubcontinent\\tO\\n.\\tO\\n\\nThe\\tO\\nC282Y\\tO\\nmutation\\tO\\noccurs\\tO\\non\\tO\\na\\tO\\nhaplotype\\tO\\nthat\\tO\\nextends\\tO\\n<\\tO\\n/\\tO\\n=\\tO\\n6\\tO\\nMb\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthis\\tO\\nmutation\\tO\\nhas\\tO\\narisen\\tO\\nduring\\tO\\nthe\\tO\\npast\\tO\\n2\\tO\\n,\\tO\\n000\\tO\\nyears\\tO\\n.\\tO\\n\\nThe\\tO\\nH63D\\tO\\nmutation\\tO\\nis\\tO\\nolder\\tO\\nand\\tO\\ndoes\\tO\\nnot\\tO\\noccur\\tO\\non\\tO\\nsuch\\tO\\na\\tO\\nlarge\\tO\\nextended\\tO\\nhaplotype\\tO\\n,\\tO\\nthe\\tO\\nhaplotype\\tO\\nin\\tO\\nthis\\tO\\ncase\\tO\\nextending\\tO\\n<\\tO\\n/\\tO\\n=\\tO\\n700\\tO\\nkb\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\nfinding\\tO\\nof\\tO\\nthe\\tO\\nH63D\\tO\\nand\\tO\\nC282Y\\tO\\nmutations\\tO\\non\\tO\\nnew\\tO\\nhaplotypes\\tO\\n.\\tO\\n\\nIn\\tO\\nSri\\tO\\nLanka\\tO\\nwe\\tO\\nhave\\tO\\nfound\\tO\\nH63D\\tO\\non\\tO\\nthree\\tO\\nnew\\tO\\nhaplotypes\\tO\\nand\\tO\\nhave\\tO\\nfound\\tO\\nC282Y\\tO\\non\\tO\\none\\tO\\nnew\\tO\\nhaplotype\\tO\\n,\\tO\\ndemonstrating\\tO\\nthat\\tO\\nthese\\tO\\nmutations\\tO\\nhave\\tO\\narisen\\tO\\nindependently\\tO\\non\\tO\\nthis\\tO\\nisland\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nHFE\\tO\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nthe\\tO\\nsubject\\tO\\nof\\tO\\nselection\\tO\\npressure\\tO\\n.\\tO\\n\\nThese\\tO\\nselection\\tO\\npressures\\tO\\ncould\\tO\\nbe\\tO\\ndue\\tO\\nto\\tO\\ninfectious\\tB-Disease\\ndiseases\\tI-Disease\\n,\\tO\\nenvironmental\\tO\\nconditions\\tO\\n,\\tO\\nor\\tO\\nother\\tO\\ngenetic\\tB-Disease\\ndisorders\\tI-Disease\\nsuch\\tO\\nas\\tO\\nanemia\\tB-Disease\\n.\\tO\\n\\nA\\tO\\nretrospective\\tO\\nanonymous\\tO\\npilot\\tO\\nstudy\\tO\\nin\\tO\\nscreening\\tO\\nnewborns\\tO\\nfor\\tO\\nHFE\\tO\\nmutations\\tO\\nin\\tO\\nScandinavian\\tO\\npopulations\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nretrospectively\\tO\\nanalyzed\\tO\\n837\\tO\\nrandom\\tO\\nanonymized\\tO\\ndried\\tO\\nblood\\tO\\nspot\\tO\\n(\\tO\\nDBS\\tO\\n)\\tO\\nsamples\\tO\\nfrom\\tO\\nneonatal\\tO\\nscreening\\tO\\nprograms\\tO\\nin\\tO\\nScandinavia\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nHFE\\tO\\n,\\tO\\nthe\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nhemochromatosis\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nfound\\tO\\nC282Y\\tO\\nallele\\tO\\nfrequencies\\tO\\nof\\tO\\n2\\tO\\n.\\tO\\n\\n3\\tO\\n%\\tO\\n(\\tO\\n+\\tO\\n2\\tO\\n.\\tO\\n0\\tO\\n%\\tO\\n)\\tO\\n(\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n3\\tO\\n%\\tO\\n)\\tO\\nin\\tO\\nGreenland\\tO\\n,\\tO\\n4\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n\\n9\\tO\\n%\\tO\\nin\\tO\\nIceland\\tO\\n,\\tO\\n5\\tO\\n.\\tO\\n\\n1\\tO\\n%\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n2\\tO\\n.\\tO\\n\\n3\\tO\\n%\\tO\\nin\\tO\\nthe\\tO\\nFaeroe\\tO\\nIslands\\tO\\n,\\tO\\nand\\tO\\n8\\tO\\n.\\tO\\n\\n2\\tO\\n%\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n2\\tO\\n.\\tO\\n\\n7\\tO\\n%\\tO\\nin\\tO\\nDenmark\\tO\\n.\\tO\\n\\nThe\\tO\\nhigh\\tO\\nprevalence\\tO\\nof\\tO\\nHFE\\tO\\nmutations\\tO\\nin\\tO\\nDenmark\\tO\\nsuggests\\tO\\nthat\\tO\\npopulation\\tO\\nscreening\\tO\\nfor\\tO\\nthe\\tO\\nC282Y\\tO\\nmutation\\tO\\ncould\\tO\\nbe\\tO\\nhighly\\tO\\nadvantageous\\tO\\nin\\tO\\nterms\\tO\\nof\\tO\\npreventive\\tO\\nhealth\\tO\\ncare\\tO\\n.\\tO\\n\\nLong\\tO\\n-\\tO\\nterm\\tO\\nfollow\\tO\\n-\\tO\\nup\\tO\\nevaluation\\tO\\nof\\tO\\nC282Y\\tO\\nhomozygotes\\tO\\nand\\tO\\nH63D\\tO\\n/\\tO\\nC282Y\\tO\\ncompound\\tO\\nheterozygotes\\tO\\nwill\\tO\\ngive\\tO\\nan\\tO\\nindication\\tO\\nof\\tO\\nthe\\tO\\npenetrance\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nalkaptonuria\\tB-Disease\\nmouse\\tO\\nmodel\\tO\\n.\\tO\\n\\nAlkaptonuria\\tB-Disease\\n(\\tO\\naku\\tB-Disease\\n)\\tO\\n,\\tO\\nan\\tO\\ninborn\\tB-Disease\\nerror\\tI-Disease\\nof\\tI-Disease\\nmetabolism\\tI-Disease\\ncaused\\tO\\nby\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\nhomogentisate\\tO\\n1\\tO\\n,\\tO\\n2\\tO\\n-\\tO\\ndioxygenase\\tO\\n(\\tO\\nHGD\\tO\\n)\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\ndescribed\\tO\\nin\\tO\\na\\tO\\nmouse\\tO\\nmodel\\tO\\ncreated\\tO\\nby\\tO\\nethylnitrosourea\\tO\\nmutagenesis\\tO\\nbut\\tO\\nthe\\tO\\nmutation\\tO\\nin\\tO\\nthese\\tO\\nmice\\tO\\nhas\\tO\\nnot\\tO\\npreviously\\tO\\nbeen\\tO\\nidentified\\tO\\n.\\tO\\n\\nWe\\tO\\nused\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nto\\tO\\namplify\\tO\\nthe\\tO\\nHgd\\tO\\ncDNA\\tO\\nfrom\\tO\\nHgd\\tO\\n(\\tO\\naku\\tO\\n)\\tO\\n/\\tO\\nHgd\\tO\\n(\\tO\\naku\\tO\\n)\\tO\\nmice\\tO\\n.\\tO\\n\\nTwo\\tO\\nproducts\\tO\\nshorter\\tO\\nthan\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nproduct\\tO\\nwere\\tO\\namplified\\tO\\n.\\tO\\n\\nRestriction\\tO\\nmapping\\tO\\nand\\tO\\nDNA\\tO\\nsequencing\\tO\\nwere\\tO\\nthen\\tO\\nused\\tO\\nto\\tO\\nidentify\\tO\\nthe\\tO\\nHgd\\tO\\n(\\tO\\naku\\tO\\n)\\tO\\nmouse\\tO\\nmutation\\tO\\n,\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nsingle\\tO\\nbase\\tO\\nchange\\tO\\nin\\tO\\na\\tO\\nsplice\\tO\\ndonor\\tO\\nconsensus\\tO\\nsequence\\tO\\n,\\tO\\ncausing\\tO\\nexon\\tO\\nskipping\\tO\\nand\\tO\\nframe\\tO\\n-\\tO\\nshifted\\tO\\nproducts\\tO\\n.\\tO\\n\\nThis\\tO\\nbase\\tO\\nchange\\tO\\nallowed\\tO\\nus\\tO\\nto\\tO\\ncreate\\tO\\na\\tO\\nnon\\tO\\n-\\tO\\nradioactive\\tO\\ngenotyping\\tO\\nassay\\tO\\nfor\\tO\\nthis\\tO\\nallele\\tO\\n.\\tO\\n\\nNon\\tB-Disease\\n-\\tI-Disease\\nsyndromic\\tI-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nenlarged\\tB-Disease\\nvestibular\\tI-Disease\\naqueduct\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\nPDS\\tB-Disease\\nmutations\\tO\\n.\\tO\\n\\nEnlarged\\tB-Disease\\nvestibular\\tI-Disease\\naqueduct\\tI-Disease\\n(\\tO\\nEVA\\tB-Disease\\n)\\tO\\n,\\tO\\nknown\\tO\\nas\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nform\\tO\\nof\\tO\\ninner\\tB-Disease\\near\\tI-Disease\\nabnormality\\tI-Disease\\n,\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nof\\tO\\nparticular\\tO\\ngenetic\\tO\\ninterest\\tO\\nbecause\\tO\\nthis\\tO\\nanomaly\\tO\\nis\\tO\\ninherited\\tO\\nin\\tO\\na\\tO\\nrecessive\\tO\\nmanner\\tO\\n.\\tO\\n\\nThe\\tO\\nlocus\\tO\\nfor\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nsyndromic\\tI-Disease\\nsensorineural\\tI-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\nwith\\tO\\nEVA\\tB-Disease\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\nsame\\tO\\nchromosomal\\tO\\nregion\\tO\\n,\\tO\\n7q31\\tO\\n,\\tO\\nas\\tO\\nthe\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\nlocus\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n,\\tO\\nseven\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\n(\\tO\\nPDS\\tO\\n)\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nhave\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\nfamilies\\tO\\nof\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nsyndromic\\tI-Disease\\nsensorineural\\tI-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\nwith\\tO\\nEVA\\tB-Disease\\n.\\tO\\n\\nOne\\tO\\nfamily\\tO\\nis\\tO\\nhomozygous\\tO\\n,\\tO\\nthree\\tO\\nfamilies\\tO\\nare\\tO\\ncompound\\tO\\nheterozygotes\\tO\\n,\\tO\\nand\\tO\\ntwo\\tO\\nfamilies\\tO\\nare\\tO\\nheterozygous\\tO\\nbut\\tO\\nwith\\tO\\nno\\tO\\nother\\tO\\nmutation\\tO\\ndetected\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nresults\\tO\\nprovide\\tO\\nevidence\\tO\\nthat\\tO\\nmutations\\tO\\nin\\tO\\nPDS\\tO\\ncause\\tO\\nboth\\tO\\nsyndromic\\tB-Disease\\nand\\tI-Disease\\nnon\\tI-Disease\\n-\\tI-Disease\\nsyndromic\\tI-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nMutational\\tO\\nanalysis\\tO\\nand\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelation\\tO\\nof\\tO\\n29\\tO\\nunrelated\\tO\\nJapanese\\tO\\npatients\\tO\\nwith\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\n.\\tO\\n\\nBACKGROUND\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\ninherited\\tB-Disease\\ndisease\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nprogressive\\tO\\nneurologic\\tB-Disease\\ndysfunction\\tI-Disease\\n,\\tO\\noccasionally\\tO\\nassociated\\tO\\nwith\\tO\\nadrenal\\tB-Disease\\ninsufficiency\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nclassic\\tO\\nform\\tO\\nof\\tO\\nALD\\tB-Disease\\nusually\\tO\\nhas\\tO\\nonset\\tO\\nin\\tO\\nchildhood\\tO\\n(\\tO\\nchildhood\\tB-Disease\\ncerebral\\tI-Disease\\nALD\\tI-Disease\\n)\\tO\\n,\\tO\\nwith\\tO\\nrapid\\tO\\nneurologic\\tB-Disease\\ndeterioration\\tI-Disease\\nleading\\tO\\nto\\tO\\na\\tO\\nvegetative\\tO\\nstate\\tO\\n.\\tO\\n\\nAdult\\tO\\n-\\tO\\nonset\\tO\\ncerebral\\tB-Disease\\nALD\\tI-Disease\\nalso\\tO\\npresents\\tO\\nwith\\tO\\nrapidly\\tO\\nprogressive\\tO\\nneurologic\\tB-Disease\\ndysfunction\\tI-Disease\\n.\\tO\\n\\nMilder\\tO\\nphenotypes\\tO\\nsuch\\tO\\nas\\tO\\nadrenomyeloneuropathy\\tB-Disease\\nand\\tO\\nAddison\\tB-Disease\\ndisease\\tI-Disease\\nonly\\tO\\nalso\\tO\\nhave\\tO\\nbeen\\tO\\nrecognized\\tO\\n.\\tO\\n\\nDespite\\tO\\ndiscovery\\tO\\nof\\tO\\nthe\\tO\\ncausative\\tO\\ngene\\tO\\n,\\tO\\na\\tO\\nmolecular\\tO\\nbasis\\tO\\nfor\\tO\\nthe\\tO\\ndiverse\\tO\\nclinical\\tO\\npresentations\\tO\\nremains\\tO\\nto\\tO\\nbe\\tO\\nelucidated\\tO\\n.\\tO\\n\\nOBJECTIVES\\tO\\nTo\\tO\\nconduct\\tO\\nmutational\\tO\\nanalyses\\tO\\nin\\tO\\n29\\tO\\nJapanese\\tO\\npatients\\tO\\nwith\\tO\\nALD\\tB-Disease\\nfrom\\tO\\n29\\tO\\nunrelated\\tO\\nfamilies\\tO\\n,\\tO\\nto\\tO\\nobtain\\tO\\nknowledge\\tO\\nof\\tO\\nthe\\tO\\nspectrum\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthis\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nto\\tO\\nstudy\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nin\\tO\\nJapanese\\tO\\npatients\\tO\\n.\\tO\\n\\nMETHODS\\tO\\nThe\\tO\\n29\\tO\\npatients\\tO\\ncomprised\\tO\\n13\\tO\\npatients\\tO\\nwith\\tO\\nchildhood\\tB-Disease\\ncerebral\\tI-Disease\\nALD\\tI-Disease\\n,\\tO\\n11\\tO\\npatients\\tO\\nwith\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\ncerebral\\tB-Disease\\nALD\\tI-Disease\\n,\\tO\\nand\\tO\\n5\\tO\\npatients\\tO\\nwith\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nconducted\\tO\\ndetailed\\tO\\nmutational\\tO\\nanalyses\\tO\\nof\\tO\\n29\\tO\\nunrelated\\tO\\nJapanese\\tO\\npatients\\tO\\nwith\\tO\\nALD\\tB-Disease\\nby\\tO\\ngenomic\\tO\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\nand\\tO\\ndirect\\tO\\nnucleotide\\tO\\nsequence\\tO\\nanalysis\\tO\\nof\\tO\\nreverse\\tO\\ntranscriptase\\tO\\n-\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nproducts\\tO\\nderived\\tO\\nfrom\\tO\\ntotal\\tO\\nRNA\\tO\\nthat\\tO\\nwas\\tO\\nextracted\\tO\\nfrom\\tO\\ncultured\\tO\\nskin\\tO\\nfibroblasts\\tO\\n,\\tO\\nlymphoblastoid\\tO\\ncells\\tO\\n,\\tO\\nor\\tO\\nperipheral\\tO\\nblood\\tO\\nleukocytes\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nThree\\tO\\npatients\\tO\\nwith\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\ncerebral\\tB-Disease\\nALD\\tI-Disease\\nwere\\tO\\nidentified\\tO\\nas\\tO\\nhaving\\tO\\nlarge\\tO\\ngenomic\\tO\\nrearrangements\\tO\\n.\\tO\\n\\nThe\\tO\\nremaining\\tO\\n26\\tO\\npatients\\tO\\nwere\\tO\\nidentified\\tO\\nas\\tO\\nhaving\\tO\\n21\\tO\\nindependent\\tO\\nmutations\\tO\\n,\\tO\\nincluding\\tO\\n12\\tO\\nnovel\\tO\\nmutations\\tO\\nresulting\\tO\\nin\\tO\\nsmall\\tO\\nnucleotide\\tO\\nalterations\\tO\\nin\\tO\\nthe\\tO\\nALD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nEighteen\\tO\\n(\\tO\\n69\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n26\\tO\\nmutations\\tO\\nwere\\tO\\nmissense\\tO\\nmutations\\tO\\n.\\tO\\n\\nMost\\tO\\nmissense\\tO\\nmutations\\tO\\ninvolved\\tO\\namino\\tO\\nacids\\tO\\nconserved\\tO\\nin\\tO\\nhomologous\\tO\\ngene\\tO\\nproducts\\tO\\n,\\tO\\nincluding\\tO\\nPMP70\\tO\\n,\\tO\\nmALDRP\\tO\\n,\\tO\\nand\\tO\\nPxa1p\\tO\\n.\\tO\\n\\nThe\\tO\\nAG\\tO\\ndinucleotide\\tO\\ndeletion\\tO\\nat\\tO\\nposition\\tO\\n1081\\tO\\n-\\tO\\n1082\\tO\\n,\\tO\\nwhich\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\npreviously\\tO\\nto\\tO\\nbe\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nmutation\\tO\\nin\\tO\\nwhite\\tO\\npatients\\tO\\n(\\tO\\n12\\tO\\n%\\tO\\n-\\tO\\n17\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nwas\\tO\\nalso\\tO\\nidentified\\tO\\nas\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nmutation\\tO\\nin\\tO\\nJapanese\\tO\\npatients\\tO\\n(\\tO\\n12\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nAll\\tO\\nphenotypes\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\nmutations\\tO\\nresulting\\tO\\nin\\tO\\nprotein\\tO\\ntruncation\\tO\\nor\\tO\\nsubtle\\tO\\namino\\tO\\nacid\\tO\\nchanges\\tO\\n.\\tO\\n\\nThere\\tO\\nwere\\tO\\nno\\tO\\ndifferences\\tO\\nin\\tO\\nphenotypic\\tO\\nexpressions\\tO\\nbetween\\tO\\nmissense\\tO\\nmutations\\tO\\ninvolving\\tO\\nconserved\\tO\\namino\\tO\\nacids\\tO\\nand\\tO\\nthose\\tO\\ninvolving\\tO\\nnonconserved\\tO\\namino\\tO\\nacids\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nThere\\tO\\nare\\tO\\nno\\tO\\nobvious\\tO\\ncorrelations\\tO\\nbetween\\tO\\nthe\\tO\\nphenotypes\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nALD\\tB-Disease\\nand\\tO\\ntheir\\tO\\ngenotypes\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nother\\tO\\ngenetic\\tO\\nor\\tO\\nenvironmental\\tO\\nfactors\\tO\\nmodify\\tO\\nthe\\tO\\nphenotypic\\tO\\nexpressions\\tO\\nof\\tO\\nALD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nA\\tO\\ncommon\\tO\\nhuman\\tO\\nskin\\tB-Disease\\ntumour\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\nactivating\\tO\\nmutations\\tO\\nin\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n.\\tO\\n\\nWNT\\tO\\nsignalling\\tO\\norchestrates\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\ndevelopmental\\tO\\nprograms\\tO\\n.\\tO\\n\\nIn\\tO\\nresponse\\tO\\nto\\tO\\nthis\\tO\\nstimulus\\tO\\n,\\tO\\ncytoplasmic\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n(\\tO\\nencoded\\tO\\nby\\tO\\nCTNNB1\\tO\\n)\\tO\\nis\\tO\\nstabilized\\tO\\n,\\tO\\nenabling\\tO\\ndownstream\\tO\\ntranscriptional\\tO\\nactivation\\tO\\nby\\tO\\nmembers\\tO\\nof\\tO\\nthe\\tO\\nLEF\\tO\\n/\\tO\\nTCF\\tO\\nfamily\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthe\\tO\\ntarget\\tO\\ngenes\\tO\\nfor\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n/\\tO\\nTCF\\tO\\nencodes\\tO\\nc\\tO\\n-\\tO\\nMYC\\tO\\n,\\tO\\nexplaining\\tO\\nwhy\\tO\\nconstitutive\\tO\\nactivation\\tO\\nof\\tO\\nthe\\tO\\nWNT\\tO\\npathway\\tO\\ncan\\tO\\nlead\\tO\\nto\\tO\\ncancer\\tB-Disease\\n,\\tO\\nparticularly\\tO\\nin\\tO\\nthe\\tO\\ncolon\\tO\\n.\\tO\\n\\nMost\\tO\\ncolon\\tB-Disease\\ncancers\\tI-Disease\\narise\\tO\\nfrom\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nencoding\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nprotein\\tO\\nrequired\\tO\\nfor\\tO\\nubiquitin\\tO\\n-\\tO\\nmediated\\tO\\ndegradation\\tO\\nof\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n,\\tO\\nbut\\tO\\na\\tO\\nsmall\\tO\\npercentage\\tO\\nof\\tO\\ncolon\\tB-Disease\\nand\\tI-Disease\\nsome\\tI-Disease\\nother\\tI-Disease\\ncancers\\tI-Disease\\nharbour\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n-\\tO\\nstabilizing\\tO\\nmutations\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nwe\\tO\\ndiscovered\\tO\\nthat\\tO\\ntransgenic\\tO\\nmice\\tO\\nexpressing\\tO\\nan\\tO\\nactivated\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\nare\\tO\\npredisposed\\tO\\nto\\tO\\ndeveloping\\tO\\nskin\\tB-Disease\\ntumours\\tI-Disease\\nresembling\\tO\\npilomatricomas\\tB-Disease\\n.\\tO\\n\\nGiven\\tO\\nthat\\tO\\nthe\\tO\\nskin\\tO\\nof\\tO\\nthese\\tO\\nadult\\tO\\nmice\\tO\\nalso\\tO\\nexhibits\\tO\\nsigns\\tO\\nof\\tO\\nde\\tO\\nnovo\\tO\\nhair\\tO\\n-\\tO\\nfollicle\\tO\\nmorphogenesis\\tO\\n,\\tO\\nwe\\tO\\nwondered\\tO\\nwhether\\tO\\nhuman\\tO\\npilomatricomas\\tB-Disease\\nmight\\tO\\noriginate\\tO\\nfrom\\tO\\nhair\\tO\\nmatrix\\tO\\ncells\\tO\\nand\\tO\\nwhether\\tO\\nthey\\tO\\nmight\\tO\\npossess\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n-\\tO\\nstabilizing\\tO\\nmutations\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nexplore\\tO\\nthe\\tO\\ncell\\tO\\norigin\\tO\\nand\\tO\\naetiology\\tO\\nof\\tO\\nthis\\tO\\ncommon\\tO\\nhuman\\tO\\nskin\\tB-Disease\\ntumour\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nnuclear\\tO\\nLEF\\tO\\n-\\tO\\n1\\tO\\nin\\tO\\nthe\\tO\\ndividing\\tO\\ntumour\\tB-Disease\\ncells\\tO\\n,\\tO\\nproviding\\tO\\nbiochemical\\tO\\nevidence\\tO\\nthat\\tO\\npilomatricomas\\tB-Disease\\nare\\tO\\nderived\\tO\\nfrom\\tO\\nhair\\tO\\nmatrix\\tO\\ncells\\tO\\n.\\tO\\n\\nAt\\tO\\nleast\\tO\\n75\\tO\\n%\\tO\\nof\\tO\\nthese\\tO\\ntumours\\tB-Disease\\npossess\\tO\\nmutations\\tO\\naffecting\\tO\\nthe\\tO\\namino\\tO\\n-\\tO\\nterminal\\tO\\nsegment\\tO\\n,\\tO\\nnormally\\tO\\ninvolved\\tO\\nin\\tO\\nphosphorylation\\tO\\n-\\tO\\ndependent\\tO\\n,\\tO\\nubiquitin\\tO\\n-\\tO\\nmediated\\tO\\ndegradation\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n.\\tO\\n\\nThis\\tO\\npercentage\\tO\\nof\\tO\\nCTNNB1\\tO\\nmutations\\tO\\nis\\tO\\ngreater\\tO\\nthan\\tO\\nin\\tO\\nall\\tO\\nother\\tO\\nhuman\\tO\\ntumours\\tB-Disease\\nexamined\\tO\\nthus\\tO\\nfar\\tO\\n,\\tO\\nand\\tO\\ndirectly\\tO\\nimplicates\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n/\\tO\\nLEF\\tO\\nmisregulation\\tO\\nas\\tO\\nthe\\tO\\nmajor\\tO\\ncause\\tO\\nof\\tO\\nhair\\tO\\nmatrix\\tO\\ncell\\tO\\ntumorigenesis\\tO\\nin\\tO\\nhumans\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\ngene\\tO\\nencodes\\tO\\na\\tO\\nchloride\\tO\\n-\\tO\\niodide\\tO\\ntransport\\tO\\nprotein\\tO\\n.\\tO\\n\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nform\\tO\\nof\\tO\\nsyndromic\\tB-Disease\\ndeafness\\tI-Disease\\nand\\tO\\ncharacterized\\tO\\nby\\tO\\ncongenital\\tO\\nsensorineural\\tB-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\nand\\tO\\ngoitre\\tB-Disease\\n.\\tO\\n\\nThis\\tO\\ndisorder\\tO\\nwas\\tO\\nmapped\\tO\\nto\\tO\\nchromosome\\tO\\n7\\tO\\nand\\tO\\nthe\\tO\\ngene\\tO\\ncausing\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPDS\\tB-Disease\\n)\\tO\\nwas\\tO\\nsubsequently\\tO\\nidentified\\tO\\nby\\tO\\npositional\\tO\\ncloning\\tO\\n.\\tO\\n\\nPDS\\tO\\nencodes\\tO\\na\\tO\\nputative\\tO\\ntransmembrane\\tO\\nprotein\\tO\\ndesignated\\tO\\npendrin\\tO\\n.\\tO\\n\\nPendrin\\tO\\nis\\tO\\nclosely\\tO\\nrelated\\tO\\nto\\tO\\na\\tO\\nfamily\\tO\\nof\\tO\\nsulfate\\tO\\ntransport\\tO\\nproteins\\tO\\nthat\\tO\\nincludes\\tO\\nthe\\tO\\nrat\\tO\\nsulfate\\tO\\n-\\tO\\nanion\\tO\\ntransporter\\tO\\n(\\tO\\nencoded\\tO\\nby\\tO\\nSat\\tO\\n-\\tO\\n1\\tO\\n;\\tO\\n29\\tO\\n%\\tO\\namino\\tO\\nacid\\tO\\nsequence\\tO\\nidentity\\tO\\n)\\tO\\n,\\tO\\nthe\\tO\\nhuman\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\nsulfate\\tO\\ntransporter\\tO\\n(\\tO\\nencoded\\tO\\nby\\tO\\nDTD\\tO\\n;\\tO\\n32\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nhuman\\tO\\nsulfate\\tO\\ntransporter\\tO\\ndownregulated\\tO\\nin\\tO\\nadenoma\\tB-Disease\\n(\\tO\\nencoded\\tO\\nby\\tO\\nDRA\\tO\\n;\\tO\\n45\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthis\\tO\\nhomology\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nslightly\\tO\\nmodified\\tO\\nsulfate\\tO\\n-\\tO\\ntransporter\\tO\\nsignature\\tO\\nsequence\\tO\\ncomprising\\tO\\nits\\tO\\nputative\\tO\\nsecond\\tO\\ntransmembrane\\tO\\ndomain\\tO\\n,\\tO\\npendrin\\tO\\nhas\\tO\\nbeen\\tO\\nproposed\\tO\\nto\\tO\\nfunction\\tO\\nas\\tO\\na\\tO\\nsulfate\\tO\\ntransporter\\tO\\n.\\tO\\n\\nWe\\tO\\nwere\\tO\\nunable\\tO\\nto\\tO\\ndetect\\tO\\nevidence\\tO\\nof\\tO\\nsulfate\\tO\\ntransport\\tO\\nfollowing\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\npendrin\\tO\\nin\\tO\\nXenopus\\tO\\nlaevis\\tO\\noocytes\\tO\\nby\\tO\\nmicroinjection\\tO\\nof\\tO\\nPDS\\tO\\ncRNA\\tO\\nor\\tO\\nin\\tO\\nSf9\\tO\\ncells\\tO\\nfollowing\\tO\\ninfection\\tO\\nwith\\tO\\nPDS\\tO\\n-\\tO\\nrecombinant\\tO\\nbaculovirus\\tO\\n.\\tO\\n\\nThe\\tO\\nrates\\tO\\nof\\tO\\ntransport\\tO\\nfor\\tO\\niodide\\tO\\nand\\tO\\nchloride\\tO\\nwere\\tO\\nsignificantly\\tO\\nincreased\\tO\\nfollowing\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\npendrin\\tO\\nin\\tO\\nboth\\tO\\ncell\\tO\\nsystems\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\ndemonstrate\\tO\\nthat\\tO\\npendrin\\tO\\nfunctions\\tO\\nas\\tO\\na\\tO\\ntransporter\\tO\\nof\\tO\\nchloride\\tO\\nand\\tO\\niodide\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nsulfate\\tO\\n,\\tO\\nand\\tO\\nmay\\tO\\nprovide\\tO\\ninsight\\tO\\ninto\\tO\\nthyroid\\tO\\nphysiology\\tO\\nand\\tO\\nthe\\tO\\npathophysiology\\tO\\nof\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nHFE\\tO\\nmutations\\tO\\nanalysis\\tO\\nin\\tO\\n711\\tO\\nhemochromatosis\\tB-Disease\\nprobands\\tO\\n:\\tO\\nevidence\\tO\\nfor\\tO\\nS65C\\tO\\nimplication\\tO\\nin\\tO\\nmild\\tO\\nform\\tO\\nof\\tO\\nhemochromatosis\\tB-Disease\\n.\\tO\\n\\nHereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\n(\\tO\\nHH\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\ncommon\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ngenetic\\tI-Disease\\ndisorder\\tI-Disease\\nof\\tO\\niron\\tO\\nmetabolism\\tO\\n.\\tO\\n\\nThe\\tO\\nHFE\\tO\\ncandidate\\tO\\ngene\\tO\\nencoding\\tO\\nan\\tO\\nHLA\\tO\\nclass\\tO\\nI\\tO\\n-\\tO\\nlike\\tO\\nprotein\\tO\\ninvolved\\tO\\nin\\tO\\nHH\\tB-Disease\\nwas\\tO\\nidentified\\tO\\nin\\tO\\n1996\\tO\\n.\\tO\\n\\nTwo\\tO\\nmissense\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\nC282Y\\tO\\n,\\tO\\naccounting\\tO\\nfor\\tO\\n80\\tO\\n%\\tO\\nto\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\nHH\\tB-Disease\\nchromosomes\\tO\\n,\\tO\\nand\\tO\\nH63D\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nmilder\\tO\\nform\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nrepresenting\\tO\\n40\\tO\\n%\\tO\\nto\\tO\\n70\\tO\\n%\\tO\\nof\\tO\\nnon\\tO\\n-\\tO\\nC282Y\\tO\\nHH\\tB-Disease\\nchromosomes\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\non\\tO\\nthe\\tO\\nanalysis\\tO\\nof\\tO\\nC282Y\\tO\\n,\\tO\\nH63D\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\n193A\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\nsubstitution\\tO\\nleading\\tO\\nto\\tO\\nthe\\tO\\nS65C\\tO\\nmissense\\tO\\nsubstitution\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nseries\\tO\\nof\\tO\\nprobands\\tO\\nand\\tO\\ncontrols\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nconfirm\\tO\\nthat\\tO\\nthe\\tO\\nC282Y\\tO\\nsubstitution\\tO\\nwas\\tO\\nthe\\tO\\nmain\\tO\\nmutation\\tO\\ninvolved\\tO\\nin\\tO\\nhemochromatosis\\tB-Disease\\n,\\tO\\naccounting\\tO\\nfor\\tO\\n85\\tO\\n%\\tO\\nof\\tO\\ncarrier\\tO\\nchromosomes\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nH63D\\tO\\nsubstitution\\tO\\nrepresented\\tO\\n39\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nHH\\tB-Disease\\nchromosomes\\tO\\nthat\\tO\\ndid\\tO\\nnot\\tO\\ncarry\\tO\\nthe\\tO\\nC282Y\\tO\\nmutation\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nour\\tO\\nscreening\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nS65C\\tO\\nsubstitution\\tO\\nwas\\tO\\nsignificantly\\tO\\nenriched\\tO\\nin\\tO\\nprobands\\tO\\nwith\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\nchromosome\\tO\\nwithout\\tO\\nan\\tO\\nassigned\\tO\\nmutation\\tO\\n.\\tO\\n\\nThis\\tO\\nsubstitution\\tO\\naccounted\\tO\\nfor\\tO\\n7\\tO\\n.\\tO\\n\\n8\\tO\\n%\\tO\\nof\\tO\\nHH\\tB-Disease\\nchromosomes\\tO\\nthat\\tO\\nwere\\tO\\nneither\\tO\\nC282Y\\tO\\nnor\\tO\\nH63D\\tO\\n.\\tO\\n\\nThis\\tO\\nenrichment\\tO\\nof\\tO\\nS65C\\tO\\namong\\tO\\nHH\\tB-Disease\\nchromosomes\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nS65C\\tO\\nsubstitution\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nmild\\tO\\nform\\tO\\nof\\tO\\nhemochromatosis\\tB-Disease\\n.\\tO\\n\\nGermline\\tO\\nBRCA1\\tO\\nalterations\\tO\\nin\\tO\\na\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\nseries\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\ncases\\tO\\n.\\tO\\n\\nThe\\tO\\nobjective\\tO\\nof\\tO\\nthis\\tO\\nstudy\\tO\\nwas\\tO\\nto\\tO\\nprovide\\tO\\nmore\\tO\\naccurate\\tO\\nfrequency\\tO\\nestimates\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\ngene\\tO\\n1\\tO\\n(\\tO\\nBRCA1\\tO\\n)\\tO\\ngermline\\tO\\nalterations\\tO\\nin\\tO\\nthe\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\npopulation\\tO\\n.\\tO\\n\\nTo\\tO\\nachieve\\tO\\nthis\\tO\\n,\\tO\\nwe\\tO\\ndetermined\\tO\\nthe\\tO\\nprevalence\\tO\\nof\\tO\\nBRCA1\\tO\\nalterations\\tO\\nin\\tO\\na\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\nseries\\tO\\nof\\tO\\nconsecutive\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\ncases\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nstudy\\tO\\nreporting\\tO\\nBRCA1\\tO\\nalterations\\tO\\nderived\\tO\\nfrom\\tO\\na\\tO\\ncomprehensive\\tO\\nscreen\\tO\\nof\\tO\\nthe\\tO\\nentire\\tO\\ncoding\\tO\\nregion\\tO\\n.\\tO\\n\\nOne\\tO\\nhundred\\tO\\nand\\tO\\nseven\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\ncases\\tO\\nwere\\tO\\nanalyzed\\tO\\nfor\\tO\\nBRCA1\\tO\\nalterations\\tO\\nusing\\tO\\nthe\\tO\\nRNase\\tO\\nmismatch\\tO\\ncleavage\\tO\\nassay\\tO\\nfollowed\\tO\\nby\\tO\\ndirect\\tO\\nsequencing\\tO\\n.\\tO\\n\\nTwo\\tO\\ntruncating\\tO\\nmutations\\tO\\n,\\tO\\n962del4\\tO\\nand\\tO\\n3600del11\\tO\\n,\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nBoth\\tO\\npatients\\tO\\nhad\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nbreast\\tB-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nSeveral\\tO\\nnovel\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\npreviously\\tO\\nreported\\tO\\nuncharacterized\\tO\\nvariants\\tO\\nwere\\tO\\nalso\\tO\\nidentified\\tO\\n,\\tO\\nsome\\tO\\nof\\tO\\nwhich\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\ncancer\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nfrequency\\tO\\ndistribution\\tO\\nof\\tO\\ncommon\\tO\\npolymorphisms\\tO\\nwas\\tO\\ndetermined\\tO\\nin\\tO\\nthe\\tO\\n91\\tO\\nCaucasian\\tO\\ncancer\\tB-Disease\\ncases\\tO\\nin\\tO\\nthis\\tO\\nseries\\tO\\nand\\tO\\n24\\tO\\nsister\\tO\\ncontrols\\tO\\nusing\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\namplification\\tO\\n.\\tO\\n\\nThe\\tO\\nrare\\tO\\nform\\tO\\nof\\tO\\nthe\\tO\\nQ356R\\tO\\npolymorphism\\tO\\nwas\\tO\\nsignificantly\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n03\\tO\\n)\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthis\\tO\\npolymorphism\\tO\\nmay\\tO\\ninfluence\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nrisk\\tO\\n.\\tO\\n\\nIn\\tO\\nsummary\\tO\\n,\\tO\\nour\\tO\\ndata\\tO\\nsuggest\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nsome\\tO\\nuncharacterized\\tO\\nvariants\\tO\\nand\\tO\\nrare\\tO\\nforms\\tO\\nof\\tO\\npolymorphisms\\tO\\nin\\tO\\ndetermining\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nrisk\\tO\\n,\\tO\\nand\\tO\\nhighlight\\tO\\nthe\\tO\\nnecessity\\tO\\nto\\tO\\nscreen\\tO\\nfor\\tO\\nmissense\\tO\\nalterations\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\ntruncating\\tO\\nmutations\\tO\\nin\\tO\\nthis\\tO\\npopulation\\tO\\n.\\tO\\n\\nAdrenoleukodystrophy\\tO\\n-\\tO\\nrelated\\tO\\nprotein\\tO\\ncan\\tO\\ncompensate\\tO\\nfunctionally\\tO\\nfor\\tO\\nadrenoleukodystrophy\\tB-Disease\\nprotein\\tI-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\n)\\tO\\n:\\tO\\nimplications\\tO\\nfor\\tO\\ntherapy\\tO\\n.\\tO\\n\\nInherited\\tB-Disease\\ndefects\\tI-Disease\\nin\\tO\\nthe\\tO\\nperoxisomal\\tO\\nATP\\tO\\n-\\tO\\nbinding\\tO\\ncassette\\tO\\n(\\tO\\nABC\\tO\\n)\\tO\\ntransporter\\tO\\nadrenoleukodystrophy\\tB-Disease\\nprotein\\tO\\n(\\tO\\nALDP\\tO\\n)\\tO\\nlead\\tO\\nto\\tO\\nthe\\tO\\nlethal\\tO\\nperoxisomal\\tB-Disease\\ndisorder\\tI-Disease\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\n(\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\n)\\tO\\n,\\tO\\nfor\\tO\\nwhich\\tO\\nno\\tO\\nefficient\\tO\\ntreatment\\tO\\nhas\\tO\\nbeen\\tO\\nestablished\\tO\\nso\\tO\\nfar\\tO\\n.\\tO\\n\\nThree\\tO\\nother\\tO\\nperoxisomal\\tO\\nABC\\tO\\ntransporters\\tO\\ncurrently\\tO\\nare\\tO\\nknown\\tO\\nadrenoleukodystrophy\\tO\\n-\\tO\\nrelated\\tO\\nprotein\\tO\\n(\\tO\\nALDRP\\tO\\n)\\tO\\n,\\tO\\n70\\tO\\nkDa\\tO\\nperoxisomal\\tO\\nmembrane\\tO\\nprotein\\tO\\n(\\tO\\nPMP70\\tO\\n)\\tO\\nand\\tO\\nPMP70\\tO\\n-\\tO\\nrelated\\tO\\nprotein\\tO\\n.\\tO\\n\\nBy\\tO\\nusing\\tO\\ntransient\\tO\\nand\\tO\\nstable\\tO\\noverexpression\\tO\\nof\\tO\\nhuman\\tO\\ncDNAs\\tO\\nencoding\\tO\\nALDP\\tO\\nand\\tO\\nits\\tO\\nclosest\\tO\\nrelative\\tO\\nALDRP\\tO\\n,\\tO\\nwe\\tO\\ncould\\tO\\nrestore\\tO\\nthe\\tO\\nimpaired\\tO\\nperoxisomal\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\nin\\tO\\nfibroblasts\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\npathognomonic\\tO\\naccumulation\\tO\\nof\\tO\\nvery\\tO\\nlong\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\ncould\\tO\\nalso\\tO\\nbe\\tO\\nprevented\\tO\\nby\\tO\\noverexpression\\tO\\nof\\tO\\nALDRP\\tO\\nin\\tO\\nimmortalized\\tO\\nX\\tO\\n-\\tO\\nALD\\tO\\ncells\\tO\\n.\\tO\\n\\nImmunofluorescence\\tO\\nanalysis\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nfunctional\\tO\\nreplacement\\tO\\nof\\tO\\nALDP\\tO\\nby\\tO\\nALDRP\\tO\\nwas\\tO\\nnot\\tO\\ndue\\tO\\nto\\tO\\nstabilization\\tO\\nof\\tO\\nthe\\tO\\nmutated\\tO\\nALDP\\tO\\nitself\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nwe\\tO\\nwere\\tO\\nable\\tO\\nto\\tO\\nrestore\\tO\\nthe\\tO\\nperoxisomal\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\ndefect\\tO\\nin\\tO\\nthe\\tO\\nliver\\tO\\nof\\tO\\nALDP\\tO\\n-\\tO\\ndeficient\\tO\\nmice\\tO\\nby\\tO\\nstimulation\\tO\\nof\\tO\\nALDRP\\tO\\nand\\tO\\nPMP70\\tO\\ngene\\tO\\nexpression\\tO\\nthrough\\tO\\na\\tO\\ndietary\\tO\\ntreatment\\tO\\nwith\\tO\\nthe\\tO\\nperoxisome\\tO\\nproliferator\\tO\\nfenofibrate\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\na\\tO\\ncorrection\\tO\\nof\\tO\\nthe\\tO\\nbiochemical\\tO\\ndefect\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\ncould\\tO\\nbe\\tO\\npossible\\tO\\nby\\tO\\ndrug\\tO\\n-\\tO\\ninduced\\tO\\noverexpression\\tO\\nor\\tO\\nectopic\\tO\\nexpression\\tO\\nof\\tO\\nALDRP\\tO\\n.\\tO\\n.\\tO\\n\\nCentrosome\\tO\\namplification\\tO\\nand\\tO\\na\\tO\\ndefective\\tO\\nG2\\tO\\n-\\tO\\nM\\tO\\ncell\\tO\\ncycle\\tO\\ncheckpoint\\tO\\ninduce\\tO\\ngenetic\\tO\\ninstability\\tO\\nin\\tO\\nBRCA1\\tO\\nexon\\tO\\n11\\tO\\nisoform\\tO\\n-\\tO\\ndeficient\\tO\\ncells\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nBrca1\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\npredispose\\tO\\nwomen\\tO\\nto\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\nstudy\\tO\\nmechanisms\\tO\\nunderlying\\tO\\nBRCA1\\tO\\n-\\tO\\nrelated\\tO\\ntumorigenesis\\tO\\n,\\tO\\nwe\\tO\\nderived\\tO\\nmouse\\tO\\nembryonic\\tO\\nfibroblast\\tO\\ncells\\tO\\ncarrying\\tO\\na\\tO\\ntargeted\\tO\\ndeletion\\tO\\nof\\tO\\nexon\\tO\\n11\\tO\\nof\\tO\\nthe\\tO\\nBrca1\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nmutant\\tO\\ncells\\tO\\nmaintain\\tO\\nan\\tO\\nintact\\tO\\nG1\\tO\\n-\\tO\\nS\\tO\\ncell\\tO\\ncycle\\tO\\ncheckpoint\\tO\\nand\\tO\\nproliferate\\tO\\npoorly\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\na\\tO\\ndefective\\tO\\nG2\\tO\\n-\\tO\\nM\\tO\\ncheckpoint\\tO\\nin\\tO\\nthese\\tO\\ncells\\tO\\nis\\tO\\naccompanied\\tO\\nby\\tO\\nextensive\\tO\\nchromosomal\\tB-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nMutant\\tO\\nfibroblasts\\tO\\ncontain\\tO\\nmultiple\\tO\\n,\\tO\\nfunctional\\tO\\ncentrosomes\\tO\\n,\\tO\\nwhich\\tO\\nlead\\tO\\nto\\tO\\nunequal\\tO\\nchromosome\\tO\\nsegregation\\tO\\n,\\tO\\nabnormal\\tO\\nnuclear\\tO\\ndivision\\tO\\n,\\tO\\nand\\tO\\naneuploidy\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nuncover\\tO\\nan\\tO\\nessential\\tO\\nrole\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\nmaintaining\\tO\\ngenetic\\tO\\nstability\\tO\\nthrough\\tO\\nthe\\tO\\nregulation\\tO\\nof\\tO\\ncentrosome\\tO\\nduplication\\tO\\nand\\tO\\nthe\\tO\\nG2\\tO\\n-\\tO\\nM\\tO\\ncheckpoint\\tO\\nand\\tO\\nprovide\\tO\\na\\tO\\nmolecular\\tO\\nbasis\\tO\\nfor\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\ntumorigenesis\\tO\\n.\\tO\\n.\\tO\\n\\nDefective\\tO\\nCD95\\tO\\n/\\tO\\nAPO\\tO\\n-\\tO\\n1\\tO\\n/\\tO\\nFas\\tO\\nsignal\\tO\\ncomplex\\tO\\nformation\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nautoimmune\\tB-Disease\\nlymphoproliferative\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tI-Disease\\ntype\\tI-Disease\\nIa\\tI-Disease\\n.\\tO\\n\\nHeterozygous\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nCD95\\tO\\n(\\tO\\nAPO\\tO\\n-\\tO\\n1\\tO\\n/\\tO\\nFas\\tO\\n)\\tO\\nreceptor\\tO\\noccur\\tO\\nin\\tO\\nmost\\tO\\nindividuals\\tO\\nwith\\tO\\nautoimmune\\tB-Disease\\nlymphoproliferative\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nALPS\\tB-Disease\\n)\\tO\\nand\\tO\\ndominantly\\tO\\ninterfere\\tO\\nwith\\tO\\napoptosis\\tO\\nby\\tO\\nan\\tO\\nunknown\\tO\\nmechanism\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nlocal\\tO\\nor\\tO\\nglobal\\tO\\nalterations\\tO\\nin\\tO\\nthe\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\ncytoplasmic\\tO\\ndeath\\tO\\ndomain\\tO\\nfrom\\tO\\nnine\\tO\\nindependent\\tO\\nALPS\\tB-Disease\\nCD95\\tO\\ndeath\\tO\\n-\\tO\\ndomain\\tO\\nmutations\\tO\\nresult\\tO\\nin\\tO\\na\\tO\\nfailure\\tO\\nto\\tO\\nbind\\tO\\nthe\\tO\\nFADD\\tO\\n/\\tO\\nMORT1\\tO\\nsignaling\\tO\\nprotein\\tO\\n.\\tO\\n\\nDespite\\tO\\nheterozygosity\\tO\\nfor\\tO\\nthe\\tO\\nabnormal\\tO\\nallele\\tO\\n,\\tO\\nlymphocytes\\tO\\nfrom\\tO\\nALPS\\tB-Disease\\npatients\\tO\\nshowed\\tO\\nmarkedly\\tO\\ndecreased\\tO\\nFADD\\tO\\nassociation\\tO\\nand\\tO\\na\\tO\\nloss\\tO\\nof\\tO\\ncaspase\\tO\\nrecruitment\\tO\\nand\\tO\\nactivation\\tO\\nafter\\tO\\nCD95\\tO\\ncrosslinking\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nintracytoplasmic\\tO\\nCD95\\tO\\nmutations\\tO\\nin\\tO\\nALPS\\tB-Disease\\nimpair\\tO\\napoptosis\\tO\\nchiefly\\tO\\nby\\tO\\ndisrupting\\tO\\ndeath\\tO\\n-\\tO\\ndomain\\tO\\ninteractions\\tO\\nwith\\tO\\nthe\\tO\\nsignaling\\tO\\nprotein\\tO\\nFADD\\tO\\n/\\tO\\nMORT1\\tO\\n.\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nalkaptonuria\\tB-Disease\\n(\\tO\\nAKU\\tB-Disease\\n)\\tO\\nmutations\\tO\\nand\\tO\\npolymorphisms\\tO\\nreveals\\tO\\nthat\\tO\\nthe\\tO\\nCCC\\tO\\nsequence\\tO\\nmotif\\tO\\nis\\tO\\na\\tO\\nmutational\\tO\\nhot\\tO\\nspot\\tO\\nin\\tO\\nthe\\tO\\nhomogentisate\\tO\\n1\\tO\\n,\\tO\\n2\\tO\\ndioxygenase\\tO\\ngene\\tO\\n(\\tO\\nHGO\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nrecently\\tO\\nshowed\\tO\\nthat\\tO\\nalkaptonuria\\tB-Disease\\n(\\tO\\nAKU\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nloss\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\nfunction\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhomogentisate\\tO\\n1\\tO\\n,\\tO\\n2\\tO\\ndioxygenase\\tO\\ngene\\tO\\n(\\tO\\nHGO\\tO\\n)\\tO\\n.\\tO\\n\\nHerein\\tO\\nwe\\tO\\ndescribe\\tO\\nhaplotype\\tO\\nand\\tO\\nmutational\\tO\\nanalyses\\tO\\nof\\tO\\nHGO\\tO\\nin\\tO\\nseven\\tO\\nnew\\tO\\nAKU\\tB-Disease\\npedigrees\\tO\\n.\\tO\\n\\nThese\\tO\\nanalyses\\tO\\nidentified\\tO\\ntwo\\tO\\nnovel\\tO\\nsingle\\tO\\n-\\tO\\nnucleotide\\tO\\npolymorphisms\\tO\\n(\\tO\\nINV4\\tO\\n+\\tO\\n31A\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\nand\\tO\\nINV11\\tO\\n+\\tO\\n18A\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\n)\\tO\\nand\\tO\\nsix\\tO\\nnovel\\tO\\nAKU\\tB-Disease\\nmutations\\tO\\n(\\tO\\nINV1\\tO\\n-\\tO\\n1G\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n,\\tO\\nW60G\\tO\\n,\\tO\\nY62C\\tO\\n,\\tO\\nA122D\\tO\\n,\\tO\\nP230T\\tO\\n,\\tO\\nand\\tO\\nD291E\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nfurther\\tO\\nillustrates\\tO\\nthe\\tO\\nremarkable\\tO\\nallelic\\tO\\nheterogeneity\\tO\\nfound\\tO\\nin\\tO\\nAKU\\tB-Disease\\n.\\tO\\n\\nReexamination\\tO\\nof\\tO\\nall\\tO\\n29\\tO\\nmutations\\tO\\nand\\tO\\npolymorphisms\\tO\\nthus\\tO\\nfar\\tO\\ndescribed\\tO\\nin\\tO\\nHGO\\tO\\nshows\\tO\\nthat\\tO\\nthese\\tO\\nnucleotide\\tO\\nchanges\\tO\\nare\\tO\\nnot\\tO\\nrandomly\\tO\\ndistributed\\tO\\n;\\tO\\nthe\\tO\\nCCC\\tO\\nsequence\\tO\\nmotif\\tO\\nand\\tO\\nits\\tO\\ninverted\\tO\\ncomplement\\tO\\n,\\tO\\nGGG\\tO\\n,\\tO\\nare\\tO\\npreferentially\\tO\\nmutated\\tO\\n.\\tO\\n\\nThese\\tO\\nanalyses\\tO\\nalso\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nnucleotide\\tO\\nsubstitutions\\tO\\nin\\tO\\nHGO\\tO\\ndo\\tO\\nnot\\tO\\ninvolve\\tO\\nCpG\\tO\\ndinucleotides\\tO\\n,\\tO\\nwhich\\tO\\nillustrates\\tO\\nimportant\\tO\\ndifferences\\tO\\nbetween\\tO\\nHGO\\tO\\nand\\tO\\nother\\tO\\ngenes\\tO\\nfor\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nmutation\\tO\\nat\\tO\\nspecific\\tO\\nshort\\tO\\n-\\tO\\nsequence\\tO\\nmotifs\\tO\\n.\\tO\\n\\nBecause\\tO\\nthe\\tO\\nCCC\\tO\\nsequence\\tO\\nmotifs\\tO\\ncomprise\\tO\\na\\tO\\nsignificant\\tO\\nproportion\\tO\\n(\\tO\\n34\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nall\\tO\\nmutated\\tO\\nbases\\tO\\nthat\\tO\\nhave\\tO\\nbeen\\tO\\nobserved\\tO\\nin\\tO\\nHGO\\tO\\n,\\tO\\nwe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\nCCC\\tO\\ntriplet\\tO\\nis\\tO\\na\\tO\\nmutational\\tO\\nhot\\tO\\nspot\\tO\\nin\\tO\\nHGO\\tO\\n.\\tO\\n\\nFabry\\tB-Disease\\ndisease\\tI-Disease\\n:\\tO\\nidentification\\tO\\nof\\tO\\nnovel\\tO\\nalpha\\tO\\n-\\tO\\ngalactosidase\\tO\\nA\\tO\\nmutations\\tO\\nand\\tO\\nmolecular\\tO\\ncarrier\\tO\\ndetection\\tO\\nby\\tO\\nuse\\tO\\nof\\tO\\nfluorescent\\tO\\nchemical\\tO\\ncleavage\\tO\\nof\\tO\\nmismatches\\tO\\n.\\tO\\n\\nFabry\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nFD\\tB-Disease\\n)\\tO\\n(\\tO\\nangiokeratoma\\tB-Disease\\ncorporis\\tI-Disease\\ndiffusum\\tI-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ninborn\\tI-Disease\\nerror\\tI-Disease\\nof\\tI-Disease\\nglycosphingolipid\\tI-Disease\\nmetabolism\\tI-Disease\\ncaused\\tO\\nby\\tO\\ndefects\\tO\\nin\\tO\\nthe\\tO\\nlysosomal\\tO\\nalpha\\tO\\n-\\tO\\ngalactosidase\\tO\\nA\\tO\\ngene\\tO\\n(\\tO\\nGLA\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nenzymatic\\tO\\ndefect\\tO\\nleads\\tO\\nto\\tO\\nthe\\tO\\nsystemic\\tO\\naccumulation\\tO\\nof\\tO\\nneutral\\tO\\nglycosphingolipids\\tO\\nwith\\tO\\nterminal\\tO\\nalpha\\tO\\n-\\tO\\ngalactosyl\\tO\\nmoieties\\tO\\n.\\tO\\n\\nClinically\\tO\\n,\\tO\\naffected\\tO\\nhemizygous\\tO\\nmales\\tO\\nhave\\tO\\nangiokeratoma\\tB-Disease\\n,\\tO\\nsevere\\tB-Disease\\nacroparesthesia\\tI-Disease\\n,\\tO\\nrenal\\tB-Disease\\nfailure\\tI-Disease\\n,\\tO\\nand\\tO\\nvasculopathy\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nheart\\tI-Disease\\nand\\tI-Disease\\nbrain\\tI-Disease\\n.\\tO\\n\\nWhile\\tO\\ndemonstration\\tO\\nof\\tO\\nalpha\\tB-Disease\\n-\\tI-Disease\\ngalactosidase\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nleukocytes\\tO\\nis\\tO\\ndiagnostic\\tO\\nin\\tO\\naffected\\tO\\nmales\\tO\\n,\\tO\\nenzymatic\\tO\\ndetection\\tO\\nof\\tO\\nfemale\\tO\\ncarriers\\tO\\nis\\tO\\noften\\tO\\ninconclusive\\tO\\n,\\tO\\ndue\\tO\\nto\\tO\\nrandom\\tO\\nX\\tO\\n-\\tO\\nchromosomal\\tO\\ninactivation\\tO\\n,\\tO\\nunderlining\\tO\\nthe\\tO\\nneed\\tO\\nof\\tO\\nmolecular\\tO\\ninvestigations\\tO\\nfor\\tO\\naccurate\\tO\\ngenetic\\tO\\ncounseling\\tO\\n.\\tO\\n\\nBy\\tO\\nuse\\tO\\nof\\tO\\nchemical\\tO\\ncleavage\\tO\\nof\\tO\\nmismatches\\tO\\nadapted\\tO\\nto\\tO\\nfluorescence\\tO\\n-\\tO\\nbased\\tO\\ndetection\\tO\\nsystems\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ncharacterized\\tO\\nthe\\tO\\nmutations\\tO\\nunderlying\\tO\\nalpha\\tB-Disease\\n-\\tI-Disease\\nGal\\tI-Disease\\nA\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\n16\\tO\\nindividuals\\tO\\nfrom\\tO\\nsix\\tO\\nunrelated\\tO\\nfamilies\\tO\\nwith\\tO\\nFD\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nmutational\\tO\\nspectrum\\tO\\nincluded\\tO\\nfive\\tO\\nmissense\\tO\\nmutations\\tO\\n(\\tO\\nC202W\\tO\\n,\\tO\\nC223G\\tO\\n,\\tO\\nN224D\\tO\\n,\\tO\\nR301Q\\tO\\n,\\tO\\nand\\tO\\nQ327K\\tO\\n)\\tO\\nand\\tO\\none\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\n[\\tO\\nIVS3\\tO\\nG\\tO\\n(\\tO\\n-\\tO\\n1\\tO\\n)\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\n]\\tO\\n.\\tO\\n\\nStudies\\tO\\nat\\tO\\nthe\\tO\\nmRNA\\tO\\nlevel\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nlatter\\tO\\nled\\tO\\nto\\tO\\naltered\\tO\\npre\\tO\\n-\\tO\\nmRNA\\tO\\nsplicing\\tO\\nwith\\tO\\nconsequent\\tO\\nalteration\\tO\\nof\\tO\\nthe\\tO\\nmRNA\\tO\\ntranslational\\tO\\nreading\\tO\\nframe\\tO\\nand\\tO\\ngeneration\\tO\\nof\\tO\\na\\tO\\npremature\\tO\\ntermination\\tO\\ncodon\\tO\\nof\\tO\\ntranslation\\tO\\n.\\tO\\n\\nBy\\tO\\nuse\\tO\\nof\\tO\\nthis\\tO\\nstrategy\\tO\\n,\\tO\\ncarrier\\tO\\nstatus\\tO\\nwas\\tO\\naccurately\\tO\\nassessed\\tO\\nin\\tO\\nall\\tO\\nseven\\tO\\nat\\tO\\n-\\tO\\nrisk\\tO\\nfemales\\tO\\ntested\\tO\\n,\\tO\\nwhereas\\tO\\nenzymatic\\tO\\ndosages\\tO\\nfailed\\tO\\nto\\tO\\ndiagnose\\tO\\nor\\tO\\nexclude\\tO\\nheterozygosity\\tO\\n.\\tO\\n.\\tO\\n\\nPrenatal\\tO\\ndiagnosis\\tO\\nby\\tO\\nFISH\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\ncaused\\tO\\nby\\tO\\nduplication\\tO\\nof\\tO\\nPLP\\tO\\ngene\\tO\\n.\\tO\\n\\nA\\tO\\ndiagnosis\\tO\\nof\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nMIM\\tO\\n312080\\tO\\n)\\tO\\nwas\\tO\\nmade\\tO\\nin\\tO\\na\\tO\\nyoung\\tO\\nboy\\tO\\n.\\tO\\n\\nNo\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\ngene\\tO\\nhad\\tO\\nbeen\\tO\\nfound\\tO\\n.\\tO\\n\\nThe\\tO\\nboys\\tO\\nmaternal\\tO\\naunt\\tO\\ncame\\tO\\nfor\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\nwhen\\tO\\n16\\tO\\n+\\tO\\nweeks\\tO\\npregnant\\tO\\nand\\tO\\ncarrying\\tO\\na\\tO\\nmale\\tO\\nfetus\\tO\\n.\\tO\\n\\nSamples\\tO\\nwere\\tO\\ntested\\tO\\nfor\\tO\\nduplication\\tO\\nof\\tO\\nthe\\tO\\nPLP\\tO\\ngene\\tO\\n,\\tO\\nby\\tO\\ninterphase\\tO\\nFISH\\tO\\n,\\tO\\nin\\tO\\nlymphocyte\\tO\\npreparations\\tO\\nfrom\\tO\\nthe\\tO\\nproband\\tO\\n,\\tO\\nhis\\tO\\naunt\\tO\\nand\\tO\\nan\\tO\\namniotic\\tO\\nfluid\\tO\\ncell\\tO\\npreparation\\tO\\nfrom\\tO\\nthe\\tO\\nfetus\\tO\\n.\\tO\\n\\nThe\\tO\\nproband\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\ncarry\\tO\\nthe\\tO\\nduplication\\tO\\n,\\tO\\nthus\\tO\\nconfirming\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nPelizaeus\\tB-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nbut\\tO\\nneither\\tO\\nthe\\tO\\naunt\\tO\\nnor\\tO\\nthe\\tO\\nfetus\\tO\\ncarried\\tO\\na\\tO\\nduplication\\tO\\n.\\tO\\n.\\tO\\n\\nDominant\\tO\\nnegative\\tO\\neffect\\tO\\nof\\tO\\nthe\\tO\\nAPC1309\\tO\\nmutation\\tO\\n:\\tO\\na\\tO\\npossible\\tO\\nexplanation\\tO\\nfor\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n.\\tO\\n\\nInactivation\\tO\\nof\\tO\\nthe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\ngene\\tO\\nproduct\\tO\\ninitiates\\tO\\ncolorectal\\tO\\ntumorigenesis\\tO\\n.\\tO\\n\\nPatients\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\nAPC\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\ncarry\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nand\\tO\\ndevelop\\tO\\nmultiple\\tO\\ncolorectal\\tB-Disease\\nadenomas\\tI-Disease\\nand\\tO\\nsubsequent\\tO\\ncarcinomas\\tB-Disease\\nearly\\tO\\nin\\tO\\nlife\\tO\\n.\\tO\\n\\nThe\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\ncorrelates\\tO\\nwith\\tO\\nthe\\tO\\nposition\\tO\\nof\\tO\\nthe\\tO\\ninherited\\tO\\nAPC\\tB-Disease\\nmutation\\tO\\n(\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelation\\tO\\n)\\tO\\n.\\tO\\n\\nTogether\\tO\\nwith\\tO\\nthe\\tO\\nfact\\tO\\nthat\\tO\\nboth\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nand\\tO\\nsporadic\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\ncluster\\tO\\nin\\tO\\nthe\\tO\\ncentral\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n,\\tO\\nthis\\tO\\npoints\\tO\\nto\\tO\\na\\tO\\ndominant\\tO\\nnegative\\tO\\neffect\\tO\\nof\\tO\\ncertain\\tO\\nAPC\\tB-Disease\\nmutants\\tO\\n.\\tO\\n\\nLoss\\tO\\nof\\tO\\nAPC\\tB-Disease\\nfunction\\tO\\nwas\\tO\\nrecently\\tO\\nshown\\tO\\nto\\tO\\nresult\\tO\\nin\\tO\\nenhanced\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n-\\tO\\n/\\tO\\nTcf\\tO\\n-\\tO\\nmediated\\tO\\ntranscription\\tO\\nin\\tO\\ncolon\\tO\\nepithelial\\tO\\ncells\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nprovide\\tO\\nexperimental\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\ndominant\\tO\\nnegative\\tO\\neffect\\tO\\nof\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nproducts\\tO\\nassociated\\tO\\nwith\\tO\\nsevere\\tO\\npolyposis\\tB-Disease\\n.\\tO\\n\\nWild\\tO\\n-\\tO\\ntype\\tO\\nAPC\\tB-Disease\\nactivity\\tO\\nin\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n-\\tO\\n/\\tO\\nTcf\\tO\\n-\\tO\\nmediated\\tO\\ntranscription\\tO\\nwas\\tO\\nstrongly\\tO\\ninhibited\\tO\\nby\\tO\\na\\tO\\nmutant\\tO\\nAPC\\tB-Disease\\nthat\\tO\\nis\\tO\\ntruncated\\tO\\nat\\tO\\ncodon\\tO\\n1309\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nmutant\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nproducts\\tO\\nthat\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nattenuated\\tB-Disease\\npolyposis\\tI-Disease\\n(\\tO\\ncodon\\tO\\n386\\tO\\nor\\tO\\n1465\\tO\\n)\\tO\\ninterfered\\tO\\nonly\\tO\\nweakly\\tO\\nwith\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nAPC\\tB-Disease\\nactivity\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\na\\tO\\nmolecular\\tO\\nexplanation\\tO\\nfor\\tO\\nthe\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelation\\tO\\nin\\tO\\nFAP\\tB-Disease\\npatients\\tO\\nand\\tO\\nsupport\\tO\\nthe\\tO\\nidea\\tO\\nthat\\tO\\ncolorectal\\tB-Disease\\ntumor\\tI-Disease\\ngrowth\\tO\\nmight\\tO\\nbe\\tO\\n,\\tO\\nin\\tO\\npart\\tO\\n,\\tO\\ndriven\\tO\\nby\\tO\\nselection\\tO\\nfor\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nmutation\\tO\\ncluster\\tO\\nregion\\tO\\n.\\tO\\n.\\tO\\n\\nBRCA1\\tO\\ninteracts\\tO\\nwith\\tO\\ncomponents\\tO\\nof\\tO\\nthe\\tO\\nhistone\\tO\\ndeacetylase\\tO\\ncomplex\\tO\\n.\\tO\\n\\nGerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ntumor\\tO\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nincreased\\tO\\nsusceptibility\\tO\\nto\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nBRCA1\\tO\\ncontains\\tO\\na\\tO\\ncarboxyl\\tO\\n-\\tO\\nterminal\\tO\\ndomain\\tO\\n(\\tO\\nBRCT\\tO\\n)\\tO\\nthat\\tO\\nis\\tO\\nshared\\tO\\nwith\\tO\\nseveral\\tO\\nother\\tO\\nproteins\\tO\\ninvolved\\tO\\nin\\tO\\nmaintaining\\tO\\ngenome\\tO\\nintegrity\\tO\\n.\\tO\\n\\nIn\\tO\\nan\\tO\\neffort\\tO\\nto\\tO\\nunderstand\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\nBRCA1\\tO\\n,\\tO\\nwe\\tO\\nsought\\tO\\nto\\tO\\nisolate\\tO\\nproteins\\tO\\nthat\\tO\\ninteract\\tO\\nwith\\tO\\nthe\\tO\\nBRCT\\tO\\ndomain\\tO\\n.\\tO\\n\\nPurified\\tO\\nBRCT\\tO\\npolypeptide\\tO\\nwas\\tO\\nused\\tO\\nas\\tO\\na\\tO\\nprobe\\tO\\nto\\tO\\nscreen\\tO\\na\\tO\\nhuman\\tO\\nplacenta\\tO\\ncDNA\\tO\\nexpression\\tO\\nlibrary\\tO\\nby\\tO\\nFar\\tO\\nWestern\\tO\\nanalysis\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\nBRCA1\\tO\\ninteracts\\tO\\nin\\tO\\nvivo\\tO\\nand\\tO\\nin\\tO\\nvitro\\tO\\nwith\\tO\\nthe\\tO\\nRb\\tO\\n-\\tO\\nbinding\\tO\\nproteins\\tO\\n,\\tO\\nRbAp46\\tO\\nand\\tO\\nRbAp48\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nwith\\tO\\nRb\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nthe\\tO\\nBRCT\\tO\\ndomain\\tO\\nassociates\\tO\\nwith\\tO\\nthe\\tO\\nhistone\\tO\\ndeacetylases\\tO\\nHDAC1\\tO\\nand\\tO\\nHDAC2\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\ndemonstrate\\tO\\nthat\\tO\\nBRCA1\\tO\\ninteracts\\tO\\nwith\\tO\\ncomponents\\tO\\nof\\tO\\nthe\\tO\\nhistone\\tO\\ndeacetylase\\tO\\ncomplex\\tO\\n,\\tO\\nand\\tO\\ntherefore\\tO\\nmay\\tO\\nexplain\\tO\\nthe\\tO\\ninvolvement\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\nmultiple\\tO\\nprocesses\\tO\\nsuch\\tO\\nas\\tO\\ntranscription\\tO\\n,\\tO\\nDNA\\tO\\nrepair\\tO\\n,\\tO\\nand\\tO\\nrecombination\\tO\\n.\\tO\\n.\\tO\\n\\nCombined\\tB-Disease\\ngenetic\\tI-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nC6\\tI-Disease\\nand\\tI-Disease\\nC7\\tI-Disease\\nin\\tO\\nman\\tO\\n.\\tO\\n\\nBy\\tO\\nroutine\\tO\\nscreening\\tO\\nof\\tO\\nsera\\tO\\n,\\tO\\na\\tO\\nsubject\\tO\\nwas\\tO\\ndiscovered\\tO\\nwho\\tO\\nshowed\\tO\\na\\tO\\nsub\\tB-Disease\\n-\\tI-Disease\\ntotal\\tI-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nC6\\tI-Disease\\nand\\tI-Disease\\nC7\\tI-Disease\\n.\\tO\\n\\nNo\\tO\\nclinical\\tO\\ndisease\\tO\\nwas\\tO\\nassociated\\tO\\nwith\\tO\\nthis\\tO\\ndeficiency\\tO\\nwhich\\tO\\nwas\\tO\\ntransmitted\\tO\\nthrough\\tO\\nthe\\tO\\nsubjects\\tO\\nfamily\\tO\\nas\\tO\\na\\tO\\nsingle\\tO\\ngenetic\\tO\\ncharacteristic\\tO\\n,\\tO\\nthe\\tO\\nC6\\tB-Disease\\ndeficiency\\tI-Disease\\nbeing\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nsilent\\tO\\nallele\\tO\\nat\\tO\\nthe\\tO\\nstructural\\tO\\nlocus\\tO\\n.\\tO\\n\\nThe\\tO\\npropositus\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nlow\\tO\\nquantities\\tO\\nof\\tO\\nan\\tO\\nabnormal\\tO\\nC6\\tO\\nwhich\\tO\\nwas\\tO\\nboth\\tO\\nantigenically\\tO\\ndeficient\\tO\\nand\\tO\\nsmaller\\tO\\nin\\tO\\nsize\\tO\\nthan\\tO\\nnormal\\tO\\nC6\\tO\\n(\\tO\\n110\\tO\\n,\\tO\\n000\\tO\\ndaltons\\tO\\ncompared\\tO\\nwith\\tO\\n140\\tO\\n,\\tO\\n000\\tO\\ndaltons\\tO\\n)\\tO\\nand\\tO\\nsmall\\tO\\nquantities\\tO\\nof\\tO\\napparently\\tO\\nnormal\\tO\\nC7\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nconcluded\\tO\\nthat\\tO\\nthe\\tO\\nmost\\tO\\nlikely\\tO\\nexplanation\\tO\\nfor\\tO\\nthis\\tO\\ndefect\\tO\\nis\\tO\\nthat\\tO\\nthe\\tO\\nsubject\\tO\\nhas\\tO\\na\\tO\\nstructural\\tO\\nmutation\\tO\\nin\\tO\\nhis\\tO\\nC6\\tO\\ngene\\tO\\nwhich\\tO\\nproduces\\tO\\nhyopsynthesis\\tO\\nnot\\tO\\nonly\\tO\\nof\\tO\\nC6\\tO\\nbut\\tO\\nalso\\tO\\nof\\tO\\nthe\\tO\\nclosely\\tO\\nlinked\\tO\\ngene\\tO\\nfor\\tO\\nC7\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggest\\tO\\nthe\\tO\\npossibility\\tO\\nthat\\tO\\nC6\\tO\\nand\\tO\\nC7\\tO\\nmay\\tO\\nfunction\\tO\\nas\\tO\\na\\tO\\nsingle\\tO\\ngenetic\\tO\\nunit\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\nprimary\\tO\\ntranscript\\tO\\ncopied\\tO\\nfrom\\tO\\nthe\\tO\\ngenome\\tO\\nincludes\\tO\\ninformation\\tO\\nfor\\tO\\nboth\\tO\\nproteins\\tO\\n.\\tO\\n.\\tO\\n\\nChanges\\tO\\nat\\tO\\nP183\\tO\\nof\\tO\\nemerin\\tO\\nweaken\\tO\\nits\\tO\\nprotein\\tO\\n-\\tO\\nprotein\\tO\\ninteractions\\tO\\nresulting\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nEmery\\tI-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nEmery\\tB-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nEDMD\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nearly\\tO\\ncontractures\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nelbows\\tI-Disease\\n,\\tI-Disease\\nAchilles\\tI-Disease\\ntendons\\tI-Disease\\nand\\tI-Disease\\nspine\\tI-Disease\\n,\\tO\\nslowly\\tO\\nprogressive\\tO\\nmuscle\\tB-Disease\\nwasting\\tI-Disease\\nand\\tO\\nweakness\\tB-Disease\\n,\\tO\\nand\\tO\\ncardiomyopathy\\tB-Disease\\nassociated\\tO\\nwith\\tO\\ncardiac\\tB-Disease\\nconduction\\tI-Disease\\ndefects\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nemerin\\tO\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nXq28\\tO\\nand\\tO\\nencodes\\tO\\na\\tO\\n34\\tO\\n-\\tO\\nkDa\\tO\\nserine\\tO\\n-\\tO\\nrich\\tO\\nprotein\\tO\\n,\\tO\\nemerin\\tO\\n,\\tO\\nwhich\\tO\\nhas\\tO\\nbeen\\tO\\nlocalized\\tO\\nto\\tO\\nthe\\tO\\nnuclear\\tO\\nenvelope\\tO\\nin\\tO\\na\\tO\\nwide\\tO\\nvariety\\tO\\nof\\tO\\ntissues\\tO\\n,\\tO\\nincluding\\tO\\nskeletal\\tO\\nand\\tO\\ncardiac\\tO\\nmuscle\\tO\\n.\\tO\\n\\nMutations\\tO\\nspanning\\tO\\nthe\\tO\\nemerin\\tO\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nEDMD\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\npresent\\tO\\nhere\\tO\\nthe\\tO\\neffect\\tO\\n,\\tO\\non\\tO\\nemerin\\tO\\nprotein\\tO\\nexpression\\tO\\n,\\tO\\nof\\tO\\ntwo\\tO\\nmissense\\tO\\nmutations\\tO\\nidentified\\tO\\nin\\tO\\nunrelated\\tO\\nEDMD\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nThese\\tO\\nalterations\\tO\\npredict\\tO\\nthe\\tO\\nreplacement\\tO\\nof\\tO\\na\\tO\\nproline\\tO\\nresidue\\tO\\nat\\tO\\nposition\\tO\\n183\\tO\\nwith\\tO\\neither\\tO\\na\\tO\\nhistidine\\tO\\nor\\tO\\na\\tO\\nthreonine\\tO\\n.\\tO\\n\\nBiochemical\\tO\\nanalysis\\tO\\nhas\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nmobility\\tO\\nand\\tO\\nexpression\\tO\\nlevels\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nforms\\tO\\nof\\tO\\nemerin\\tO\\nare\\tO\\nindistinguishable\\tO\\nfrom\\tO\\nthat\\tO\\nof\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nemerin\\tO\\n,\\tO\\nbut\\tO\\nthat\\tO\\nthey\\tO\\nhave\\tO\\nweakened\\tO\\ninteractions\\tO\\nwith\\tO\\nnuclear\\tO\\nlamina\\tO\\ncomponents\\tO\\n.\\tO\\n\\nIn\\tO\\ncomparison\\tO\\nwith\\tO\\nthe\\tO\\nusual\\tO\\nEDMD\\tB-Disease\\nphenotype\\tO\\n,\\tO\\npatients\\tO\\nwith\\tO\\nP183\\tO\\nmissense\\tO\\nmutations\\tO\\nhave\\tO\\na\\tO\\nlater\\tO\\nage\\tO\\nat\\tO\\nonset\\tO\\nof\\tO\\nfirst\\tO\\nsymptoms\\tO\\n,\\tO\\nelbow\\tB-Disease\\ncontractures\\tI-Disease\\n,\\tO\\nankle\\tB-Disease\\ncontractures\\tI-Disease\\n,\\tO\\nupper\\tB-Disease\\nlimb\\tI-Disease\\nweakness\\tI-Disease\\nand\\tO\\nlower\\tB-Disease\\nlimb\\tI-Disease\\nweakness\\tI-Disease\\n,\\tO\\nbut\\tO\\nthere\\tO\\nis\\tO\\nno\\tO\\ndifference\\tO\\nfor\\tO\\nthe\\tO\\nage\\tO\\nat\\tO\\nonset\\tO\\nof\\tO\\ncardiac\\tB-Disease\\ninvolvement\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nreport\\tO\\nof\\tO\\nprotein\\tO\\nstudies\\tO\\non\\tO\\npatients\\tO\\nwith\\tO\\nmissense\\tO\\nmutations\\tO\\nresulting\\tO\\nin\\tO\\nthe\\tO\\nclinical\\tO\\nfeatures\\tO\\nof\\tO\\nEDMD\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\nstudies\\tO\\ndemonstrate\\tO\\nthe\\tO\\nimportance\\tO\\nof\\tO\\nproline\\tO\\n183\\tO\\nfor\\tO\\nthe\\tO\\nproper\\tO\\nstructure\\tO\\n/\\tO\\nfunction\\tO\\nof\\tO\\nemerin\\tO\\n.\\tO\\n.\\tO\\n\\nMicrodeletions\\tO\\nat\\tO\\nchromosome\\tO\\nbands\\tO\\n1q32\\tO\\n-\\tO\\nq41\\tO\\nas\\tO\\na\\tO\\ncause\\tO\\nof\\tO\\nVan\\tB-Disease\\nder\\tI-Disease\\nWoude\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nVan\\tB-Disease\\nder\\tI-Disease\\nWoude\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nVWS\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisorder\\tI-Disease\\ncomprising\\tO\\ncleft\\tB-Disease\\nlip\\tI-Disease\\nand\\tO\\n/\\tO\\nor\\tO\\ncleft\\tB-Disease\\npalate\\tI-Disease\\nand\\tO\\nlip\\tB-Disease\\npits\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreported\\tO\\npreviously\\tO\\na\\tO\\nfamily\\tO\\nwhose\\tO\\nunderlying\\tO\\nmutation\\tO\\nis\\tO\\na\\tO\\n500\\tO\\n-\\tO\\n800\\tO\\nkb\\tO\\ndeletion\\tO\\nlocalized\\tO\\nto\\tO\\nchromosome\\tO\\nbands\\tO\\n1q32\\tO\\n-\\tO\\nq41\\tO\\n[\\tO\\nSander\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1994\\tO\\nHum\\tO\\nMol\\tO\\nGenet\\tO\\n3\\tO\\n576\\tO\\n-\\tO\\n578\\tO\\n]\\tO\\n.\\tO\\n\\nAlong\\tO\\nwith\\tO\\ncleft\\tB-Disease\\nlip\\tI-Disease\\n/\\tI-Disease\\npalate\\tI-Disease\\nand\\tO\\nlip\\tB-Disease\\npits\\tI-Disease\\n,\\tO\\naffected\\tO\\nrelatives\\tO\\nexhibit\\tO\\ndevelopmental\\tB-Disease\\ndelays\\tI-Disease\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\na\\tO\\ngene\\tO\\nnearby\\tO\\nmay\\tO\\nalso\\tO\\nbe\\tO\\ndisrupted\\tO\\n.\\tO\\n\\nTo\\tO\\nfurther\\tO\\nlocalize\\tO\\nthe\\tO\\nVWS\\tB-Disease\\ngene\\tO\\nwe\\tO\\nsearched\\tO\\nfor\\tO\\nother\\tO\\ndeletions\\tO\\nthat\\tO\\ncause\\tO\\nVWS\\tB-Disease\\n.\\tO\\n\\nAn\\tO\\nallele\\tO\\nloss\\tO\\nassay\\tO\\nwas\\tO\\nperformed\\tO\\nusing\\tO\\na\\tO\\nnovel\\tO\\nhighly\\tO\\npolymorphic\\tO\\nmarker\\tO\\n,\\tO\\nD1S3753\\tO\\n.\\tO\\n\\nFrom\\tO\\na\\tO\\npanel\\tO\\nof\\tO\\n37\\tO\\nunrelated\\tO\\nindividuals\\tO\\n,\\tO\\nwe\\tO\\ndetected\\tO\\nan\\tO\\nallele\\tO\\nloss\\tO\\nin\\tO\\none\\tO\\nfamily\\tO\\n,\\tO\\nindicating\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\ndeletion\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nfamily\\tO\\n,\\tO\\nthe\\tO\\nphenotype\\tO\\nin\\tO\\nthree\\tO\\ngenerations\\tO\\nof\\tO\\naffected\\tO\\nindividuals\\tO\\nwas\\tO\\nconfined\\tO\\nto\\tO\\nthe\\tO\\ncardinal\\tO\\nsigns\\tO\\nof\\tO\\nVWS\\tB-Disease\\n.\\tO\\n\\nSurprisingly\\tO\\n,\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\nnew\\tO\\ndeletion\\tO\\nshowed\\tO\\nthat\\tO\\nit\\tO\\nextended\\tO\\n0\\tO\\n.\\tO\\n\\n2\\tO\\n-\\tO\\n1\\tO\\nMb\\tO\\nbeyond\\tO\\nthe\\tO\\nproximal\\tO\\nbreakpoint\\tO\\nfor\\tO\\nthe\\tO\\ndeletion\\tO\\ndescribed\\tO\\npreviously\\tO\\n.\\tO\\n\\nNo\\tO\\ndeletions\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nseven\\tO\\ncases\\tO\\nof\\tO\\npopliteal\\tB-Disease\\npterygia\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\n76\\tO\\ncases\\tO\\nof\\tO\\nmixed\\tO\\nsyndromic\\tB-Disease\\nforms\\tI-Disease\\nof\\tI-Disease\\ncleft\\tI-Disease\\nlip\\tI-Disease\\nand\\tI-Disease\\npalate\\tI-Disease\\n,\\tO\\nand\\tO\\n178\\tO\\ncases\\tO\\nof\\tO\\nnonsyndromic\\tB-Disease\\ncleft\\tI-Disease\\nlip\\tI-Disease\\nand\\tI-Disease\\npalate\\tI-Disease\\n.\\tO\\n\\nSplicing\\tO\\ndefects\\tO\\nin\\tO\\nthe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\ngene\\tO\\n,\\tO\\nATM\\tO\\n:\\tO\\nunderlying\\tO\\nmutations\\tO\\nand\\tO\\nconsequences\\tO\\n.\\tO\\n\\nMutations\\tO\\nresulting\\tO\\nin\\tO\\ndefective\\tO\\nsplicing\\tO\\nconstitute\\tO\\na\\tO\\nsignificant\\tO\\nproportion\\tO\\n(\\tO\\n30\\tO\\n/\\tO\\n62\\tO\\n[\\tO\\n48\\tO\\n%\\tO\\n]\\tO\\n)\\tO\\nof\\tO\\na\\tO\\nnew\\tO\\nseries\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nAT\\tB-Disease\\n)\\tO\\nthat\\tO\\nwere\\tO\\ndetected\\tO\\nby\\tO\\nthe\\tO\\nprotein\\tO\\n-\\tO\\ntruncation\\tO\\nassay\\tO\\nfollowed\\tO\\nby\\tO\\nsequence\\tO\\nanalysis\\tO\\nof\\tO\\ngenomic\\tO\\nDNA\\tO\\n.\\tO\\n\\nFewer\\tO\\nthan\\tO\\nhalf\\tO\\nof\\tO\\nthe\\tO\\nsplicing\\tO\\nmutations\\tO\\ninvolved\\tO\\nthe\\tO\\ncanonical\\tO\\nAG\\tO\\nsplice\\tO\\n-\\tO\\nacceptor\\tO\\nsite\\tO\\nor\\tO\\nGT\\tO\\nsplice\\tO\\n-\\tO\\ndonor\\tO\\nsite\\tO\\n.\\tO\\n\\nA\\tO\\nhigher\\tO\\npercentage\\tO\\nof\\tO\\nmutations\\tO\\noccurred\\tO\\nat\\tO\\nless\\tO\\nstringently\\tO\\nconserved\\tO\\nsites\\tO\\n,\\tO\\nincluding\\tO\\nsilent\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nlast\\tO\\nnucleotide\\tO\\nof\\tO\\nexons\\tO\\n,\\tO\\nmutations\\tO\\nin\\tO\\nnucleotides\\tO\\nother\\tO\\nthan\\tO\\nthe\\tO\\nconserved\\tO\\nAG\\tO\\nand\\tO\\nGT\\tO\\nin\\tO\\nthe\\tO\\nconsensus\\tO\\nsplice\\tO\\nsites\\tO\\n,\\tO\\nand\\tO\\ncreation\\tO\\nof\\tO\\nsplice\\tO\\n-\\tO\\nacceptor\\tO\\nor\\tO\\nsplice\\tO\\n-\\tO\\ndonor\\tO\\nsites\\tO\\nin\\tO\\neither\\tO\\nintrons\\tO\\nor\\tO\\nexons\\tO\\n.\\tO\\n\\nThese\\tO\\nsplicing\\tO\\nmutations\\tO\\nled\\tO\\nto\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nconsequences\\tO\\n,\\tO\\nincluding\\tO\\nexon\\tO\\nskipping\\tO\\nand\\tO\\n,\\tO\\nto\\tO\\na\\tO\\nlesser\\tO\\ndegree\\tO\\n,\\tO\\nintron\\tO\\nretention\\tO\\n,\\tO\\nactivation\\tO\\nof\\tO\\ncryptic\\tO\\nsplice\\tO\\nsites\\tO\\n,\\tO\\nor\\tO\\ncreation\\tO\\nof\\tO\\nnew\\tO\\nsplice\\tO\\nsites\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\n5\\tO\\nof\\tO\\n12\\tO\\nnonsense\\tO\\nmutations\\tO\\nand\\tO\\n1\\tO\\nmissense\\tO\\nmutation\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\ncDNA\\tO\\nof\\tO\\nthe\\tO\\nexons\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nmutations\\tO\\noccurred\\tO\\n.\\tO\\n\\nNo\\tO\\nATM\\tO\\nprotein\\tO\\nwas\\tO\\ndetected\\tO\\nby\\tO\\nwestern\\tO\\nblotting\\tO\\nin\\tO\\nany\\tO\\nAT\\tB-Disease\\ncell\\tO\\nline\\tO\\nin\\tO\\nwhich\\tO\\nsplicing\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nSeveral\\tO\\ncases\\tO\\nof\\tO\\nexon\\tO\\nskipping\\tO\\nin\\tO\\nboth\\tO\\nnormal\\tO\\ncontrols\\tO\\nand\\tO\\npatients\\tO\\nfor\\tO\\nwhom\\tO\\nno\\tO\\nunderlying\\tO\\ndefect\\tO\\ncould\\tO\\nbe\\tO\\nfound\\tO\\nin\\tO\\ngenomic\\tO\\nDNA\\tO\\nwere\\tO\\nalso\\tO\\nobserved\\tO\\n,\\tO\\nsuggesting\\tO\\ncaution\\tO\\nin\\tO\\nthe\\tO\\ninterpretation\\tO\\nof\\tO\\nexon\\tO\\ndeletions\\tO\\nobserved\\tO\\nin\\tO\\nATM\\tO\\ncDNA\\tO\\nwhen\\tO\\nthere\\tO\\nis\\tO\\nno\\tO\\naccompanying\\tO\\nidentification\\tO\\nof\\tO\\ngenomic\\tO\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nAlpha\\tO\\n-\\tO\\ncardiac\\tO\\nactin\\tO\\nis\\tO\\na\\tO\\nnovel\\tO\\ndisease\\tO\\ngene\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nhypertrophic\\tI-Disease\\ncardiomyopathy\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\nthe\\tO\\nalpha\\tO\\n-\\tO\\ncardiac\\tO\\nactin\\tO\\ngene\\tO\\n(\\tO\\nACTC\\tO\\n)\\tO\\nas\\tO\\na\\tO\\nnovel\\tO\\ndisease\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\npedigree\\tO\\nsuffering\\tO\\nfrom\\tO\\nfamilial\\tB-Disease\\nhypertrophic\\tI-Disease\\ncardiomyopathy\\tI-Disease\\n(\\tO\\nFHC\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nLinkage\\tO\\nanalyses\\tO\\nexcluded\\tO\\nall\\tO\\nthe\\tO\\npreviously\\tO\\nreported\\tO\\nFHC\\tB-Disease\\nloci\\tO\\nas\\tO\\npossible\\tO\\ndisease\\tO\\nloci\\tO\\nin\\tO\\nthe\\tO\\nfamily\\tO\\nstudied\\tO\\n,\\tO\\nwith\\tO\\nlod\\tO\\nscores\\tO\\nvarying\\tO\\nbetween\\tO\\n-\\tO\\n2\\tO\\n.\\tO\\n\\n5\\tO\\nand\\tO\\n-\\tO\\n6\\tO\\n.\\tO\\n\\n0\\tO\\n0\\tO\\n.\\tO\\n\\nFurther\\tO\\nlinkage\\tO\\nanalyses\\tO\\nof\\tO\\nplausible\\tO\\ncandidate\\tO\\ngenes\\tO\\nhighly\\tO\\nexpressed\\tO\\nin\\tO\\nthe\\tO\\nadult\\tO\\nhuman\\tO\\nheart\\tO\\nidentified\\tO\\nACTC\\tO\\nas\\tO\\nthe\\tO\\nmost\\tO\\nlikely\\tO\\ndisease\\tO\\ngene\\tO\\n,\\tO\\nshowing\\tO\\na\\tO\\nmaximal\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\n3\\tO\\n.\\tO\\n\\n6\\tO\\n6\\tO\\n.\\tO\\n\\nMutation\\tO\\nanalysis\\tO\\nof\\tO\\nACTC\\tO\\nrevealed\\tO\\nan\\tO\\nAla295Ser\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n5\\tO\\nclose\\tO\\nto\\tO\\n2\\tO\\nmissense\\tO\\nmutations\\tO\\nrecently\\tO\\ndescribed\\tO\\nto\\tO\\ncause\\tO\\nthe\\tO\\ninherited\\tO\\nform\\tO\\nof\\tO\\nidiopathic\\tB-Disease\\ndilated\\tI-Disease\\ncardiomyopathy\\tI-Disease\\n(\\tO\\nIDC\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nOvergrowth\\tB-Disease\\nof\\tI-Disease\\noral\\tI-Disease\\nmucosa\\tI-Disease\\nand\\tI-Disease\\nfacial\\tI-Disease\\nskin\\tI-Disease\\n,\\tO\\na\\tO\\nnovel\\tO\\nfeature\\tO\\nof\\tO\\naspartylglucosaminuria\\tB-Disease\\n.\\tO\\n\\nAspartylglucosaminuria\\tB-Disease\\n(\\tO\\nAGU\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nlysosomal\\tB-Disease\\nstorage\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\naspartylglucosaminidase\\tI-Disease\\n(\\tO\\nAGA\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmain\\tO\\nsymptom\\tO\\nis\\tO\\nprogressive\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nspectrum\\tO\\nof\\tO\\ndifferent\\tO\\nmutations\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\nthis\\tO\\ndisease\\tO\\n,\\tO\\none\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nCys163Ser\\tO\\n)\\tO\\nbeing\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nFinnish\\tO\\ncases\\tO\\n.\\tO\\n\\nWe\\tO\\nwere\\tO\\nable\\tO\\nto\\tO\\nexamine\\tO\\n66\\tO\\nFinnish\\tO\\nAGU\\tB-Disease\\npatients\\tO\\nfor\\tO\\nchanges\\tO\\nin\\tO\\nthe\\tO\\noral\\tO\\nmucosa\\tO\\nand\\tO\\n44\\tO\\nof\\tO\\nthese\\tO\\nfor\\tO\\nchanges\\tO\\nin\\tO\\nfacial\\tO\\nskin\\tO\\n.\\tO\\n\\nBiopsy\\tO\\nspecimens\\tO\\nof\\tO\\n16\\tO\\noral\\tO\\nlesions\\tO\\n,\\tO\\n12\\tO\\nof\\tO\\nthem\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nteeth\\tO\\n,\\tO\\nplus\\tO\\ntwo\\tO\\nfacial\\tB-Disease\\nlesions\\tI-Disease\\nwere\\tO\\nstudied\\tO\\nhistologically\\tO\\n.\\tO\\n\\nImmunohistochemical\\tO\\nstaining\\tO\\nfor\\tO\\nAGA\\tO\\nwas\\tO\\nperformed\\tO\\non\\tO\\n15\\tO\\noral\\tO\\nspecimens\\tO\\n.\\tO\\n\\nSkin\\tO\\nwas\\tO\\nseborrhoeic\\tO\\nin\\tO\\nadolescent\\tO\\nand\\tO\\nadult\\tO\\npatients\\tO\\n,\\tO\\nwith\\tO\\nerythema\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfacial\\tI-Disease\\nskin\\tI-Disease\\nalready\\tO\\ncommon\\tO\\nin\\tO\\nchildhood\\tO\\n.\\tO\\n\\nOf\\tO\\n44\\tO\\npatients\\tO\\n,\\tO\\nnine\\tO\\n(\\tO\\n20\\tO\\n%\\tO\\n)\\tO\\nhad\\tO\\nfacial\\tB-Disease\\nangiofibromas\\tI-Disease\\n,\\tO\\ntumours\\tB-Disease\\nprimarily\\tO\\noccurring\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\ntuberous\\tB-Disease\\nsclerosis\\tI-Disease\\n.\\tO\\n\\nOedemic\\tB-Disease\\nbuccal\\tI-Disease\\nmucosa\\tI-Disease\\n(\\tO\\nleucoedema\\tB-Disease\\n)\\tO\\nand\\tO\\ngingival\\tB-Disease\\novergrowths\\tI-Disease\\nwere\\tO\\nmore\\tO\\nfrequent\\tO\\nin\\tO\\nAGU\\tB-Disease\\npatients\\tO\\nthan\\tO\\nin\\tO\\ncontrols\\tO\\n(\\tO\\np\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n001\\tO\\n)\\tO\\n.\\tO\\n\\nOf\\tO\\n16\\tO\\noral\\tB-Disease\\nmucosal\\tI-Disease\\nlesions\\tI-Disease\\nstudied\\tO\\nhistologically\\tO\\n,\\tO\\n15\\tO\\nrepresented\\tO\\nfibroepithelial\\tB-Disease\\nor\\tI-Disease\\nepithelial\\tI-Disease\\nhyperplasias\\tI-Disease\\nand\\tO\\nwere\\tO\\nreactive\\tO\\nin\\tO\\nnature\\tO\\n.\\tO\\n\\nCytoplasmic\\tO\\nvacuolisation\\tO\\nwas\\tO\\nevident\\tO\\nin\\tO\\nfour\\tO\\n.\\tO\\n\\nImmunohistochemically\\tO\\n,\\tO\\nexpression\\tO\\nof\\tO\\nAGA\\tO\\nin\\tO\\nAGU\\tB-Disease\\npatients\\tO\\nmucosal\\tB-Disease\\nlesions\\tI-Disease\\ndid\\tO\\nnot\\tO\\ndiffer\\tO\\nfrom\\tO\\nthat\\tO\\nseen\\tO\\nin\\tO\\ncorresponding\\tO\\nlesions\\tO\\nof\\tO\\nnormal\\tO\\nsubjects\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\nhigh\\tO\\nfrequency\\tO\\nof\\tO\\nmucosal\\tB-Disease\\novergrowth\\tI-Disease\\nin\\tO\\nAGU\\tB-Disease\\npatients\\tO\\ndoes\\tO\\nnot\\tO\\nappear\\tO\\nto\\tO\\nbe\\tO\\ndirectly\\tO\\nassociated\\tO\\nwith\\tO\\nlysosomal\\tO\\nstorage\\tO\\nor\\tO\\nwith\\tO\\nalterations\\tO\\nin\\tO\\nthe\\tO\\nlevel\\tO\\nof\\tO\\nAGA\\tO\\nexpression\\tO\\n.\\tO\\n\\nCharacterization\\tO\\nof\\tO\\na\\tO\\ngermline\\tO\\nmosaicism\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\nLowe\\tB-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nand\\tO\\nidentification\\tO\\nof\\tO\\nseven\\tO\\nnovel\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nOCRL1\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\noculocerebrorenal\\tB-Disease\\nsyndrome\\tI-Disease\\nof\\tI-Disease\\nLowe\\tI-Disease\\n(\\tO\\nOCRL\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nmajor\\tO\\nabnormalities\\tB-Disease\\nof\\tI-Disease\\neyes\\tI-Disease\\n,\\tI-Disease\\nnervous\\tI-Disease\\nsystem\\tI-Disease\\n,\\tI-Disease\\nand\\tI-Disease\\nkidneys\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nOCRL1\\tO\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nOCRL1\\tO\\nencodes\\tO\\na\\tO\\nphosphatidylinositol\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n-\\tO\\nbiphosphate\\tO\\n(\\tO\\nPtdIns\\tO\\n[\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n]\\tO\\nP2\\tO\\n)\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexamined\\tO\\nthe\\tO\\nOCRL1\\tO\\ngene\\tO\\nin\\tO\\neight\\tO\\nunrelated\\tO\\npatients\\tO\\nwith\\tO\\nOCRL\\tB-Disease\\nand\\tO\\nhave\\tO\\nfound\\tO\\nseven\\tO\\nnew\\tO\\nmutations\\tO\\nand\\tO\\none\\tO\\nrecurrent\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletion\\tO\\n.\\tO\\n\\nAmong\\tO\\nthe\\tO\\nnew\\tO\\nmutations\\tO\\n,\\tO\\ntwo\\tO\\nnonsense\\tO\\nmutations\\tO\\n(\\tO\\nR317X\\tO\\nand\\tO\\nE558X\\tO\\n)\\tO\\nand\\tO\\nthree\\tO\\nother\\tO\\nframeshift\\tO\\nmutations\\tO\\ncaused\\tO\\npremature\\tO\\ntermination\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n.\\tO\\n\\nA\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\nR483G\\tO\\n,\\tO\\nwas\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\nhighly\\tO\\nconserved\\tO\\nPtdIns\\tO\\n(\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n)\\tO\\nP2\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\ndomain\\tO\\n.\\tO\\n\\nFinally\\tO\\n,\\tO\\none\\tO\\nframeshift\\tO\\nmutation\\tO\\n,\\tO\\n2799delC\\tO\\n,\\tO\\nmodifies\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\npart\\tO\\nof\\tO\\nOCRL1\\tO\\n,\\tO\\nwith\\tO\\nan\\tO\\nextension\\tO\\nof\\tO\\nsix\\tO\\namino\\tO\\nacids\\tO\\n.\\tO\\n\\nAltogether\\tO\\n,\\tO\\n70\\tO\\n%\\tO\\nof\\tO\\nmissense\\tO\\nmutations\\tO\\nare\\tO\\nlocated\\tO\\nin\\tO\\nexon\\tO\\n15\\tO\\n,\\tO\\nand\\tO\\n52\\tO\\n%\\tO\\nof\\tO\\nall\\tO\\nmutations\\tO\\ncluster\\tO\\nin\\tO\\nexons\\tO\\n11\\tO\\n-\\tO\\n15\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nidentified\\tO\\ntwo\\tO\\nnew\\tO\\nmicrosatellite\\tO\\nmarkers\\tO\\nfor\\tO\\nthe\\tO\\nOCRL1\\tO\\nlocus\\tO\\n,\\tO\\nand\\tO\\nwe\\tO\\ndetected\\tO\\na\\tO\\ngermline\\tO\\nmosaicism\\tO\\nin\\tO\\none\\tO\\nfamily\\tO\\n.\\tO\\n\\nThis\\tO\\nobservation\\tO\\nhas\\tO\\ndirect\\tO\\nimplications\\tO\\nfor\\tO\\ngenetic\\tO\\ncounseling\\tO\\nof\\tO\\nLowe\\tB-Disease\\nsyndrome\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n.\\tO\\n\\nMEFV\\tO\\n-\\tO\\nGene\\tO\\nanalysis\\tO\\nin\\tO\\narmenian\\tO\\npatients\\tO\\nwith\\tO\\nFamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n:\\tO\\ndiagnostic\\tO\\nvalue\\tO\\nand\\tO\\nunfavorable\\tO\\nrenal\\tO\\nprognosis\\tO\\nof\\tO\\nthe\\tO\\nM694V\\tO\\nhomozygous\\tO\\ngenotype\\tO\\n-\\tO\\ngenetic\\tO\\nand\\tO\\ntherapeutic\\tO\\nimplications\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n(\\tO\\nFMF\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nrecessively\\tB-Disease\\ninherited\\tI-Disease\\ndisorder\\tI-Disease\\nthat\\tO\\nis\\tO\\ncommon\\tO\\nin\\tO\\npatients\\tO\\nof\\tO\\nArmenian\\tO\\nancestry\\tO\\n.\\tO\\n\\nTo\\tO\\ndate\\tO\\n,\\tO\\nits\\tO\\ndiagnosis\\tO\\n,\\tO\\nwhich\\tO\\ncan\\tO\\nbe\\tO\\nmade\\tO\\nonly\\tO\\nretrospectively\\tO\\n,\\tO\\nis\\tO\\none\\tO\\nof\\tO\\nexclusion\\tO\\n,\\tO\\nbased\\tO\\nentirely\\tO\\non\\tO\\nnonspecific\\tO\\nclinical\\tO\\nsigns\\tO\\nthat\\tO\\nresult\\tO\\nfrom\\tO\\nserosal\\tB-Disease\\ninflammation\\tI-Disease\\nand\\tO\\nthat\\tO\\nmay\\tO\\nlead\\tO\\nto\\tO\\nunnecessary\\tO\\nsurgery\\tO\\n.\\tO\\n\\nRenal\\tB-Disease\\namyloidosis\\tI-Disease\\n,\\tO\\nprevented\\tO\\nby\\tO\\ncolchicine\\tO\\n,\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\nsevere\\tO\\ncomplication\\tO\\nof\\tO\\nFMF\\tB-Disease\\n,\\tO\\na\\tO\\ndisorder\\tO\\nassociated\\tO\\nwith\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nMEFV\\tO\\ngene\\tO\\n.\\tO\\n\\nTo\\tO\\nevaluate\\tO\\nthe\\tO\\ndiagnostic\\tO\\nand\\tO\\nprognostic\\tO\\nvalue\\tO\\nof\\tO\\nMEFV\\tO\\n-\\tO\\ngene\\tO\\nanalysis\\tO\\n,\\tO\\nwe\\tO\\ninvestigated\\tO\\n90\\tO\\nArmenian\\tO\\nFMF\\tB-Disease\\npatients\\tO\\nfrom\\tO\\n77\\tO\\nunrelated\\tO\\nfamilies\\tO\\nthat\\tO\\nwere\\tO\\nnot\\tO\\nselected\\tO\\nthrough\\tO\\ngenetic\\tO\\n-\\tO\\nlinkage\\tO\\nanalysis\\tO\\n.\\tO\\n\\nEight\\tO\\nmutations\\tO\\n,\\tO\\none\\tO\\nof\\tO\\nwhich\\tO\\n(\\tO\\nR408Q\\tO\\n)\\tO\\nis\\tO\\nnew\\tO\\n,\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\naccount\\tO\\nfor\\tO\\n93\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\n163\\tO\\nindependent\\tO\\nFMF\\tB-Disease\\nalleles\\tO\\n,\\tO\\nwith\\tO\\nboth\\tO\\nFMF\\tB-Disease\\nalleles\\tO\\nidentified\\tO\\nin\\tO\\n89\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\nseveral\\tO\\ninstances\\tO\\n,\\tO\\nfamily\\tO\\nstudies\\tO\\nprovided\\tO\\nmolecular\\tO\\nevidence\\tO\\nfor\\tO\\npseudodominant\\tO\\ntransmission\\tO\\nand\\tO\\nincomplete\\tO\\npenetrance\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nphenotype\\tO\\n.\\tO\\n\\nThe\\tO\\nM694V\\tO\\nhomozygous\\tO\\ngenotype\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nhigher\\tO\\nprevalence\\tO\\nof\\tO\\nrenal\\tB-Disease\\namyloidosis\\tI-Disease\\nand\\tO\\narthritis\\tB-Disease\\n,\\tO\\ncompared\\tO\\nwith\\tO\\nother\\tO\\ngenotypes\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n0002\\tO\\nand\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n006\\tO\\n,\\tO\\nrespectively\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ndemonstration\\tO\\nof\\tO\\nboth\\tO\\nthe\\tO\\ndiagnostic\\tO\\nand\\tO\\nprognostic\\tO\\nvalue\\tO\\nof\\tO\\nMEFV\\tO\\nanalysis\\tO\\nand\\tO\\nparticular\\tO\\nmodes\\tO\\nof\\tO\\ninheritance\\tO\\nshould\\tO\\nlead\\tO\\nto\\tO\\nnew\\tO\\nways\\tO\\nfor\\tO\\nmanagement\\tO\\nof\\tO\\nFMF\\tO\\n-\\tO\\nincluding\\tO\\ngenetic\\tO\\ncounseling\\tO\\nand\\tO\\ntherapeutic\\tO\\ndecisions\\tO\\nin\\tO\\naffected\\tO\\nfamilies\\tO\\n.\\tO\\n\\nNoninvasive\\tO\\ntest\\tO\\nfor\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nusing\\tO\\nhair\\tO\\nroot\\tO\\nanalysis\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nthe\\tO\\nFMR1\\tO\\ngene\\tO\\nand\\tO\\nthe\\tO\\nrepeat\\tO\\n-\\tO\\namplification\\tO\\nmechanism\\tO\\ncausing\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\nled\\tO\\nto\\tO\\ndevelopment\\tO\\nof\\tO\\nreliable\\tO\\nDNA\\tO\\n-\\tO\\nbased\\tO\\ndiagnostic\\tO\\nmethods\\tO\\n,\\tO\\nincluding\\tO\\nSouthern\\tO\\nblot\\tO\\nhybridization\\tO\\nand\\tO\\nPCR\\tO\\n.\\tO\\n\\nBoth\\tO\\nmethods\\tO\\nare\\tO\\nperformed\\tO\\non\\tO\\nDNA\\tO\\nisolated\\tO\\nfrom\\tO\\nperipheral\\tO\\nblood\\tO\\ncells\\tO\\nand\\tO\\nmeasure\\tO\\nthe\\tO\\nrepeat\\tO\\nsize\\tO\\nin\\tO\\nFMR1\\tO\\n.\\tO\\n\\nUsing\\tO\\nan\\tO\\nimmunocytochemical\\tO\\ntechnique\\tO\\non\\tO\\nblood\\tO\\nsmears\\tO\\n,\\tO\\nwe\\tO\\nrecently\\tO\\ndeveloped\\tO\\na\\tO\\nnovel\\tO\\ntest\\tO\\nfor\\tO\\nidentification\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nmethod\\tO\\n,\\tO\\nalso\\tO\\ncalled\\tO\\n\"\\tO\\nantibody\\tO\\ntest\\tO\\n,\\tO\\n\"\\tO\\nuses\\tO\\nmonoclonal\\tO\\nantibodies\\tO\\nagainst\\tO\\nthe\\tO\\nFMR1\\tO\\ngene\\tO\\nproduct\\tO\\n(\\tO\\nFMRP\\tO\\n)\\tO\\nand\\tO\\nis\\tO\\nbased\\tO\\non\\tO\\nabsence\\tO\\nof\\tO\\nFMRP\\tO\\nin\\tO\\npatients\\tO\\ncells\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\ndescribe\\tO\\na\\tO\\nnew\\tO\\ndiagnostic\\tO\\ntest\\tO\\nto\\tO\\nidentify\\tO\\nmale\\tO\\npatients\\tO\\nwith\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nlack\\tO\\nof\\tO\\nFMRP\\tO\\nin\\tO\\ntheir\\tO\\nhair\\tO\\nroots\\tO\\n.\\tO\\n\\nExpression\\tO\\nof\\tO\\nFMRP\\tO\\nin\\tO\\nhair\\tO\\nroots\\tO\\nwas\\tO\\nstudied\\tO\\nby\\tO\\nuse\\tO\\nof\\tO\\nan\\tO\\nFMRP\\tO\\n-\\tO\\nspecific\\tO\\nantibody\\tO\\ntest\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\npercentage\\tO\\nof\\tO\\nFMRP\\tO\\n-\\tO\\nexpressing\\tO\\nhair\\tO\\nroots\\tO\\nin\\tO\\ncontrols\\tO\\nand\\tO\\nin\\tO\\nmale\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\npatients\\tO\\nwas\\tO\\ndetermined\\tO\\n.\\tO\\n\\nControl\\tO\\nindividuals\\tO\\nshowed\\tO\\nclear\\tO\\nexpression\\tO\\nof\\tO\\nFMRP\\tO\\nin\\tO\\nnearly\\tO\\nevery\\tO\\nhair\\tO\\nroot\\tO\\n,\\tO\\nwhereas\\tO\\nmale\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\npatients\\tO\\nlacked\\tO\\nexpression\\tO\\nof\\tO\\nFMRP\\tO\\nin\\tO\\nalmost\\tO\\nall\\tO\\ntheir\\tO\\nhair\\tO\\nroots\\tO\\n.\\tO\\n\\nMentally\\tB-Disease\\nretarded\\tI-Disease\\nfemale\\tO\\npatients\\tO\\nwith\\tO\\na\\tO\\nfull\\tO\\nmutation\\tO\\nshowed\\tO\\nFMRP\\tO\\nexpression\\tO\\nin\\tO\\nonly\\tO\\nsome\\tO\\nof\\tO\\ntheir\\tO\\nhair\\tO\\nroots\\tO\\n(\\tO\\n<\\tO\\n55\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nno\\tO\\noverlap\\tO\\nwith\\tO\\nnormal\\tO\\nfemale\\tO\\ncontrols\\tO\\nwas\\tO\\nobserved\\tO\\n.\\tO\\n\\nThe\\tO\\nadvantages\\tO\\nof\\tO\\nthis\\tO\\ntest\\tO\\nare\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nplucking\\tO\\nof\\tO\\nhair\\tO\\nfollicles\\tO\\ndoes\\tO\\nno\\tO\\nappreciable\\tO\\nharm\\tO\\nto\\tO\\nthe\\tO\\nmentally\\tB-Disease\\nretarded\\tI-Disease\\npatient\\tO\\n,\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nhairs\\tO\\ncan\\tO\\nbe\\tO\\nsent\\tO\\nin\\tO\\na\\tO\\nsimple\\tO\\nenvelope\\tO\\nto\\tO\\na\\tO\\ndiagnostic\\tO\\ncenter\\tO\\n,\\tO\\nand\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\nthe\\tO\\ntest\\tO\\nis\\tO\\navailable\\tO\\nwithin\\tO\\n5\\tO\\nh\\tO\\nof\\tO\\nplucking\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nthis\\tO\\ntest\\tO\\nenabled\\tO\\nus\\tO\\nto\\tO\\nidentify\\tO\\ntwo\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\npatients\\tO\\nwho\\tO\\ndid\\tO\\nnot\\tO\\nshow\\tO\\nthe\\tO\\nfull\\tO\\nmutation\\tO\\nby\\tO\\nanalysis\\tO\\nof\\tO\\nDNA\\tO\\nisolated\\tO\\nfrom\\tO\\nblood\\tO\\ncells\\tO\\n.\\tO\\n.\\tO\\n\\nIn\\tO\\nSwedish\\tO\\nfamilies\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nlinkage\\tO\\nto\\tO\\nthe\\tO\\nHPC1\\tO\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n1q24\\tO\\n-\\tO\\n25\\tO\\nis\\tO\\nrestricted\\tO\\nto\\tO\\nfamilies\\tO\\nwith\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nProstate\\tB-Disease\\ncancer\\tI-Disease\\nclusters\\tO\\nin\\tO\\nsome\\tO\\nfamilies\\tO\\n,\\tO\\nand\\tO\\nan\\tO\\nestimated\\tO\\n5\\tO\\n%\\tO\\n-\\tO\\n10\\tO\\n%\\tO\\nof\\tO\\nall\\tO\\ncases\\tO\\nare\\tO\\nestimated\\tO\\nto\\tO\\nresult\\tO\\nfrom\\tO\\ninheritance\\tO\\nof\\tO\\nprostate\\tO\\ncancer\\tO\\n-\\tO\\nsusceptibility\\tO\\ngenes\\tO\\n.\\tO\\n\\nWe\\tO\\npreviously\\tO\\nreported\\tO\\nevidence\\tO\\nof\\tO\\nlinkage\\tO\\nto\\tO\\nthe\\tO\\n1q24\\tO\\n-\\tO\\n25\\tO\\nregion\\tO\\n(\\tO\\nHPC1\\tO\\n)\\tO\\nin\\tO\\n91\\tO\\nNorth\\tO\\nAmerican\\tO\\nand\\tO\\nSwedish\\tO\\nfamilies\\tO\\neach\\tO\\nwith\\tO\\nmultiple\\tO\\ncases\\tO\\nof\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\n(\\tO\\nSmith\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n1996\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nreport\\tO\\nwe\\tO\\nanalyze\\tO\\n40\\tO\\n(\\tO\\n12\\tO\\noriginal\\tO\\nand\\tO\\n28\\tO\\nnewly\\tO\\nidentified\\tO\\n)\\tO\\nSwedish\\tO\\nfamilies\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\n(\\tO\\nHPC\\tB-Disease\\n)\\tO\\nthat\\tO\\n,\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\n40\\tO\\nmarkers\\tO\\nspanning\\tO\\na\\tO\\n25\\tO\\n-\\tO\\ncM\\tO\\ninterval\\tO\\nwithin\\tO\\n1q24\\tO\\n-\\tO\\n25\\tO\\n,\\tO\\nhave\\tO\\nevidence\\tO\\nof\\tO\\nlinkage\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\ncomplete\\tO\\nset\\tO\\nof\\tO\\nfamilies\\tO\\n,\\tO\\na\\tO\\nmaximum\\tO\\ntwo\\tO\\n-\\tO\\npoint\\tO\\nLOD\\tO\\nscore\\tO\\nof\\tO\\n1\\tO\\n.\\tO\\n\\n10\\tO\\nwas\\tO\\nobserved\\tO\\nat\\tO\\nD1S413\\tO\\n(\\tO\\nat\\tO\\na\\tO\\nrecombination\\tO\\nfraction\\tO\\n[\\tO\\ntheta\\tO\\n]\\tO\\nof\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\nmaximum\\tO\\nNPL\\tO\\n(\\tO\\nnonparametric\\tO\\nlinkage\\tO\\n)\\tO\\nZ\\tO\\nscore\\tO\\nof\\tO\\n1\\tO\\n.\\tO\\n\\n64\\tO\\nat\\tO\\nD1S202\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n05\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nevidence\\tO\\nof\\tO\\nlinkage\\tO\\nto\\tO\\nthis\\tO\\nregion\\tO\\noriginated\\tO\\nalmost\\tO\\nexclusively\\tO\\nfrom\\tO\\nthe\\tO\\nsubset\\tO\\nof\\tO\\n12\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\n(\\tO\\nage\\tO\\n<\\tO\\n65\\tO\\nyears\\tO\\n)\\tO\\nfamilies\\tO\\n,\\tO\\nwhich\\tO\\nyielded\\tO\\na\\tO\\nmaximum\\tO\\nLOD\\tO\\nscore\\tO\\nof\\tO\\n2\\tO\\n.\\tO\\n\\n38\\tO\\nat\\tO\\nD1S413\\tO\\n(\\tO\\nstraight\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n)\\tO\\nand\\tO\\nan\\tO\\nNPL\\tO\\nZ\\tO\\nscore\\tO\\nof\\tO\\n1\\tO\\n.\\tO\\n\\n95\\tO\\nat\\tO\\nD1S422\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n03\\tO\\n)\\tO\\n.\\tO\\n\\nEstimates\\tO\\nfrom\\tO\\nheterogeneity\\tO\\ntests\\tO\\nsuggest\\tO\\nthat\\tO\\n,\\tO\\nwithin\\tO\\nSweden\\tO\\n,\\tO\\nas\\tO\\nmany\\tO\\nas\\tO\\n50\\tO\\n%\\tO\\nof\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nfamilies\\tO\\nhad\\tO\\nevidence\\tO\\nof\\tO\\nlinkage\\tO\\nto\\tO\\nthe\\tO\\nHPC1\\tO\\nregion\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nhypothesis\\tO\\nof\\tO\\nlinkage\\tO\\nto\\tO\\nHPC1\\tO\\nin\\tO\\na\\tO\\nsubset\\tO\\nof\\tO\\nfamilies\\tO\\nwith\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nparticularly\\tO\\nthose\\tO\\nwith\\tO\\nan\\tO\\nearly\\tO\\nage\\tO\\nat\\tO\\ndiagnosis\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbasis\\tO\\nof\\tO\\nfeline\\tO\\nbeta\\tB-Disease\\n-\\tI-Disease\\nglucuronidase\\tI-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\nan\\tO\\nanimal\\tO\\nmodel\\tO\\nof\\tO\\nmucopolysaccharidosis\\tB-Disease\\nVII\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nfamily\\tO\\nof\\tO\\ndomestic\\tO\\ncats\\tO\\nwas\\tO\\nfound\\tO\\nthat\\tO\\nexhibited\\tO\\nclinical\\tO\\nand\\tO\\nbiochemical\\tO\\nabnormalities\\tO\\nconsistent\\tO\\nwith\\tO\\nmucopolysaccharidosis\\tB-Disease\\nVII\\tI-Disease\\n,\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nlysosomal\\tI-Disease\\nstorage\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\nbeta\\tB-Disease\\n-\\tI-Disease\\nglucuronidase\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nbeta\\tO\\n-\\tO\\nGlucuronidase\\tO\\nactivity\\tO\\nwas\\tO\\nundetectable\\tO\\nin\\tO\\naffected\\tO\\ncat\\tO\\nfibroblasts\\tO\\nand\\tO\\nrestored\\tO\\nby\\tO\\nretroviral\\tO\\ngene\\tO\\ntransfer\\tO\\nof\\tO\\nrat\\tO\\nbeta\\tO\\n-\\tO\\nglucuronidase\\tO\\ncDNA\\tO\\n.\\tO\\n\\nbeta\\tO\\n-\\tO\\nGlucuronidase\\tO\\nmRNA\\tO\\nwas\\tO\\nnormal\\tO\\nin\\tO\\naffected\\tO\\ncat\\tO\\ntestis\\tO\\nby\\tO\\nNorthern\\tO\\nblot\\tO\\nanalysis\\tO\\n.\\tO\\n\\nNormal\\tO\\nfeline\\tO\\nbeta\\tO\\n-\\tO\\nglucuronidase\\tO\\ncDNA\\tO\\nwas\\tO\\ncloned\\tO\\nand\\tO\\ncharacterized\\tO\\n,\\tO\\nand\\tO\\namplified\\tO\\nfrom\\tO\\naffected\\tO\\ncat\\tO\\nfibroblasts\\tO\\nby\\tO\\nreverse\\tO\\ntranscription\\tO\\ncoupled\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n.\\tO\\n\\nThere\\tO\\nwas\\tO\\na\\tO\\nG\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nA\\tO\\ntransition\\tO\\nin\\tO\\nthe\\tO\\naffected\\tO\\ncat\\tO\\ncDNA\\tO\\nthat\\tO\\npredicted\\tO\\nan\\tO\\nE351K\\tO\\nsubstitution\\tO\\n,\\tO\\ndestroyed\\tO\\na\\tO\\nBssSI\\tO\\nsite\\tO\\n,\\tO\\nand\\tO\\neliminated\\tO\\nGUSB\\tO\\nenzymatic\\tO\\nactivity\\tO\\nin\\tO\\nexpression\\tO\\nstudies\\tO\\n.\\tO\\n\\nMultiple\\tO\\nspecies\\tO\\ncomparison\\tO\\nand\\tO\\nthe\\tO\\ncrystal\\tO\\nstructure\\tO\\nof\\tO\\nhuman\\tO\\nbeta\\tO\\n-\\tO\\nglucuronidase\\tO\\nindicated\\tO\\nthat\\tO\\nE351\\tO\\nis\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\nresidue\\tO\\nmost\\tO\\nlikely\\tO\\nessential\\tO\\nin\\tO\\nmaintenance\\tO\\nof\\tO\\nthe\\tO\\nenzymes\\tO\\nconformation\\tO\\n.\\tO\\n\\nBssSI\\tO\\ndigestion\\tO\\nof\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nproducts\\tO\\namplified\\tO\\nfrom\\tO\\ngenomic\\tO\\nDNA\\tO\\nindicated\\tO\\nthat\\tO\\naffected\\tO\\ncats\\tO\\nwere\\tO\\nhomozygous\\tO\\nand\\tO\\ncats\\tO\\nwith\\tO\\nhalf\\tO\\n-\\tO\\nnormal\\tO\\nbeta\\tO\\n-\\tO\\nglucuronidase\\tO\\nactivity\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nmissense\\tO\\nmutation\\tO\\n.\\tO\\n\\nCarriers\\tO\\nidentified\\tO\\nin\\tO\\nthis\\tO\\nmanner\\tO\\nproduced\\tO\\naffected\\tO\\nkittens\\tO\\nin\\tO\\nprospective\\tO\\nbreedings\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nfeline\\tO\\nMPS\\tB-Disease\\nVII\\tI-Disease\\nbreeding\\tO\\ncolony\\tO\\nhas\\tO\\nbeen\\tO\\nestablished\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\ncommon\\tO\\nmolecular\\tO\\nbasis\\tO\\nfor\\tO\\nrearrangement\\tB-Disease\\ndisorders\\tI-Disease\\non\\tO\\nchromosome\\tO\\n22q11\\tO\\n.\\tO\\n\\nThe\\tO\\nchromosome\\tO\\n22q11\\tO\\nregion\\tO\\nis\\tO\\nsusceptible\\tO\\nto\\tO\\nrearrangements\\tO\\nthat\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\nanomaly\\tI-Disease\\ndisorders\\tI-Disease\\nand\\tO\\nmalignant\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nThree\\tO\\ncongenital\\tB-Disease\\nanomaly\\tI-Disease\\ndisorders\\tI-Disease\\n,\\tO\\ncat\\tB-Disease\\n-\\tI-Disease\\neye\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nder\\tB-Disease\\n(\\tI-Disease\\n)\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nvelo\\tB-Disease\\n-\\tI-Disease\\ncardio\\tI-Disease\\n-\\tI-Disease\\nfacial\\tI-Disease\\nsyndrome\\tI-Disease\\n/\\tO\\nDiGeorge\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nVCFS\\tB-Disease\\n/\\tO\\nDGS\\tB-Disease\\n)\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\ntetrasomy\\tO\\n,\\tO\\ntrisomy\\tO\\nor\\tO\\nmonosomy\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nfor\\tO\\npart\\tO\\nof\\tO\\nchromosome\\tO\\n22q11\\tO\\n.\\tO\\n\\nVCFS\\tB-Disease\\n/\\tO\\nDGS\\tB-Disease\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nsyndrome\\tO\\nassociated\\tO\\nwith\\tO\\n22q11\\tO\\nrearrangements\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\ndetermine\\tO\\nwhether\\tO\\nthere\\tO\\nare\\tO\\nparticular\\tO\\nregions\\tO\\non\\tO\\n22q11\\tO\\nthat\\tO\\nare\\tO\\nprone\\tO\\nto\\tO\\nrearrangements\\tO\\n,\\tO\\nthe\\tO\\ndeletion\\tO\\nend\\tO\\n-\\tO\\npoints\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nnumber\\tO\\nof\\tO\\nVCFS\\tB-Disease\\n/\\tO\\nDGS\\tB-Disease\\npatients\\tO\\nwere\\tO\\ndefined\\tO\\nby\\tO\\nhaplotype\\tO\\nanalysis\\tO\\n.\\tO\\n\\nMost\\tO\\nVCFS\\tB-Disease\\n/\\tO\\nDGS\\tB-Disease\\npatients\\tO\\nhave\\tO\\na\\tO\\nsimilar\\tO\\n3\\tO\\nMb\\tO\\ndeletion\\tO\\n,\\tO\\nsome\\tO\\nhave\\tO\\na\\tO\\nnested\\tO\\ndistal\\tO\\ndeletion\\tO\\nbreakpoint\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\n1\\tO\\n.\\tO\\n\\n5\\tO\\nMb\\tO\\ndeletion\\tO\\nand\\tO\\na\\tO\\nfew\\tO\\nrare\\tO\\npatients\\tO\\nhave\\tO\\nunique\\tO\\ndeletions\\tO\\nor\\tO\\ntranslocations\\tO\\n.\\tO\\n\\nThe\\tO\\nhigh\\tO\\nprevalence\\tO\\nof\\tO\\nthe\\tO\\ndisorder\\tO\\nin\\tO\\nthe\\tO\\npopulation\\tO\\nand\\tO\\nthe\\tO\\nfact\\tO\\nthat\\tO\\nmost\\tO\\ncases\\tO\\noccur\\tO\\nsporadically\\tO\\nsuggest\\tO\\nthat\\tO\\nsequences\\tO\\nat\\tO\\nor\\tO\\nnear\\tO\\nthe\\tO\\nbreakpoints\\tO\\nconfer\\tO\\nsusceptibility\\tO\\nto\\tO\\nchromosome\\tO\\nrearrangements\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nthis\\tO\\nhypothesis\\tO\\n,\\tO\\nwe\\tO\\ndeveloped\\tO\\nhamster\\tO\\n-\\tO\\nhuman\\tO\\nsomatic\\tO\\nhybrid\\tO\\ncell\\tO\\nlines\\tO\\nfrom\\tO\\nVCFS\\tB-Disease\\n/\\tO\\nDGS\\tB-Disease\\npatients\\tO\\nwith\\tO\\nall\\tO\\nthree\\tO\\nclasses\\tO\\nof\\tO\\ndeletions\\tO\\nand\\tO\\nwe\\tO\\nnow\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nbreakpoints\\tO\\noccur\\tO\\nwithin\\tO\\nsimilar\\tO\\nlow\\tO\\ncopy\\tO\\nrepeats\\tO\\n,\\tO\\ntermed\\tO\\nLCR22s\\tO\\n.\\tO\\n\\nTo\\tO\\nsupport\\tO\\nthis\\tO\\nidea\\tO\\nfurther\\tO\\n,\\tO\\nwe\\tO\\nidentified\\tO\\na\\tO\\nfamily\\tO\\nthat\\tO\\ncarries\\tO\\nan\\tO\\ninterstitial\\tO\\nduplication\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\n3\\tO\\nMb\\tO\\nregion\\tO\\nthat\\tO\\nis\\tO\\ndeleted\\tO\\nin\\tO\\nVCFS\\tB-Disease\\n/\\tO\\nDGS\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nWe\\tO\\npresent\\tO\\nmodels\\tO\\nto\\tO\\nexplain\\tO\\nhow\\tO\\nthe\\tO\\nLCR22s\\tO\\ncan\\tO\\nmediate\\tO\\ndifferent\\tO\\nhomologous\\tO\\nrecombination\\tO\\nevents\\tO\\n,\\tO\\nthereby\\tO\\ngenerating\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nrearrangements\\tO\\nthat\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\nanomaly\\tI-Disease\\ndisorders\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\nfive\\tO\\nadditional\\tO\\ncopies\\tO\\nof\\tO\\nthe\\tO\\nLCR22\\tO\\non\\tO\\n22q11\\tO\\nthat\\tO\\nmay\\tO\\nmediate\\tO\\nother\\tO\\nrearrangements\\tO\\nleading\\tO\\nto\\tO\\ndisease\\tO\\n.\\tO\\n\\nFunctional\\tO\\nconsequences\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nearly\\tO\\ngrowth\\tO\\nresponse\\tO\\n2\\tO\\ngene\\tO\\n(\\tO\\nEGR2\\tO\\n)\\tO\\ncorrelate\\tO\\nwith\\tO\\nseverity\\tO\\nof\\tO\\nhuman\\tO\\nmyelinopathies\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nearly\\tO\\ngrowth\\tO\\nresponse\\tO\\n2\\tO\\ngene\\tO\\n(\\tO\\nEGR2\\tO\\n)\\tO\\nis\\tO\\na\\tO\\nCys2His2zinc\\tO\\nfinger\\tO\\ntranscription\\tO\\nfactor\\tO\\nwhich\\tO\\nis\\tO\\nthought\\tO\\nto\\tO\\nplay\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\nregulation\\tO\\nof\\tO\\nperipheral\\tO\\nnervous\\tO\\nsystem\\tO\\nmyelination\\tO\\n.\\tO\\n\\nThis\\tO\\nidea\\tO\\nis\\tO\\nbased\\tO\\npartly\\tO\\non\\tO\\nthe\\tO\\nphenotype\\tO\\nof\\tO\\nhomozygous\\tO\\nKrox20\\tO\\n(\\tO\\nEgr2\\tO\\n)\\tO\\nknockout\\tO\\nmice\\tO\\n,\\tO\\nwhich\\tO\\ndisplay\\tO\\nhypomyelination\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nPNS\\tI-Disease\\nand\\tO\\na\\tO\\nblock\\tO\\nof\\tO\\nSchwann\\tO\\ncells\\tO\\nat\\tO\\nan\\tO\\nearly\\tO\\nstage\\tO\\nof\\tO\\ndifferentiation\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nEGR2\\tO\\ngene\\tO\\nhave\\tO\\nrecently\\tO\\nbeen\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\ninherited\\tB-Disease\\nperipheral\\tI-Disease\\nneuropathies\\tI-Disease\\nCharcot\\tB-Disease\\n-\\tI-Disease\\nMarie\\tI-Disease\\n-\\tI-Disease\\nTooth\\tI-Disease\\ntype\\tI-Disease\\n1\\tI-Disease\\n,\\tO\\nDejerine\\tB-Disease\\n-\\tI-Disease\\nSottas\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\ncongenital\\tB-Disease\\nhypomyelinating\\tI-Disease\\nneuropathy\\tI-Disease\\n.\\tO\\n\\nThree\\tO\\nof\\tO\\nthe\\tO\\nfour\\tO\\nEGR2\\tO\\nmutations\\tO\\nare\\tO\\ndominant\\tO\\nand\\tO\\noccur\\tO\\nwithin\\tO\\nthe\\tO\\nzinc\\tO\\nfinger\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\n.\\tO\\n\\nThe\\tO\\nfourth\\tO\\nmutation\\tO\\nis\\tO\\nrecessive\\tO\\nand\\tO\\naffects\\tO\\nthe\\tO\\ninhibitory\\tO\\ndomain\\tO\\n(\\tO\\nR1\\tO\\n)\\tO\\nthat\\tO\\nbinds\\tO\\nthe\\tO\\nNAB\\tO\\ntranscriptional\\tO\\nco\\tO\\n-\\tO\\nrepressors\\tO\\n.\\tO\\n\\nA\\tO\\ncombination\\tO\\nof\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\nassays\\tO\\nand\\tO\\ntranscriptional\\tO\\nanalysis\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\nfunctional\\tO\\nconsequences\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nzinc\\tO\\nfinger\\tO\\nmutations\\tO\\naffect\\tO\\nDNA\\tO\\nbinding\\tO\\nand\\tO\\nthe\\tO\\namount\\tO\\nof\\tO\\nresidual\\tO\\nbinding\\tO\\ndirectly\\tO\\ncorrelates\\tO\\nwith\\tO\\ndisease\\tO\\nseverity\\tO\\n.\\tO\\n\\nThe\\tO\\nR1\\tO\\ndomain\\tO\\nmutation\\tO\\nprevents\\tO\\ninteraction\\tO\\nof\\tO\\nEGR2\\tO\\nwith\\tO\\nthe\\tO\\nNAB\\tO\\nco\\tO\\n-\\tO\\nrepressors\\tO\\nand\\tO\\nthereby\\tO\\nincreases\\tO\\ntranscriptional\\tO\\nactivity\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nprovide\\tO\\ninsight\\tO\\ninto\\tO\\nthe\\tO\\npossible\\tO\\ndisease\\tO\\nmechanisms\\tO\\nunderlying\\tO\\nEGR2\\tO\\nmutations\\tO\\nand\\tO\\nthe\\tO\\nreason\\tO\\nfor\\tO\\nvarying\\tO\\nseverity\\tO\\nand\\tO\\ndifferences\\tO\\nin\\tO\\ninheritance\\tO\\npatterns\\tO\\n.\\tO\\n.\\tO\\n\\nAutosomal\\tB-Disease\\nrecessive\\tI-Disease\\nfamilial\\tI-Disease\\nneurohypophyseal\\tI-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\nwith\\tO\\ncontinued\\tO\\nsecretion\\tO\\nof\\tO\\nmutant\\tO\\nweakly\\tO\\nactive\\tO\\nvasopressin\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\nneurohypophyseal\\tI-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\npost\\tO\\n-\\tO\\nnatal\\tO\\ndevelopment\\tO\\nof\\tO\\narginine\\tB-Disease\\nvasopressin\\tI-Disease\\n(\\tI-Disease\\nAVP\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\ndue\\tO\\nto\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nAVP\\tO\\ngene\\tO\\n.\\tO\\n\\nAll\\tO\\npublished\\tO\\nmutations\\tO\\naffect\\tO\\nthe\\tO\\nsignal\\tO\\npeptide\\tO\\nor\\tO\\nthe\\tO\\nneurophysin\\tO\\n-\\tO\\nII\\tO\\ncarrier\\tO\\nprotein\\tO\\nand\\tO\\nare\\tO\\npresumed\\tO\\nto\\tO\\ninterfere\\tO\\nwith\\tO\\nprocessing\\tO\\nof\\tO\\nthe\\tO\\npreprohormone\\tO\\n,\\tO\\nleading\\tO\\nto\\tO\\nneuronal\\tB-Disease\\ndamage\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\nan\\tO\\nunusual\\tO\\nPalestinian\\tO\\nfamily\\tO\\nconsisting\\tO\\nof\\tO\\nasymptomatic\\tO\\nfirst\\tO\\ncousin\\tO\\nparents\\tO\\nand\\tO\\nthree\\tO\\nchildren\\tO\\naffected\\tO\\nwith\\tO\\nneurohypophyseal\\tB-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\n,\\tO\\nsuggesting\\tO\\nautosomal\\tO\\nrecessive\\tO\\ninheritance\\tO\\n.\\tO\\n\\nAll\\tO\\nthree\\tO\\naffected\\tO\\nchildren\\tO\\nwere\\tO\\nhomozygous\\tO\\nand\\tO\\nthe\\tO\\nparents\\tO\\nheterozygous\\tO\\nfor\\tO\\na\\tO\\nsingle\\tO\\nnovel\\tO\\nmutation\\tO\\n(\\tO\\nC301\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n)\\tO\\nin\\tO\\nexon\\tO\\n1\\tO\\n,\\tO\\nreplacing\\tO\\nPro7\\tO\\nof\\tO\\nmature\\tO\\nAVP\\tO\\nwith\\tO\\nLeu\\tO\\n(\\tO\\nLeu\\tO\\n-\\tO\\nAVP\\tO\\n)\\tO\\n.\\tO\\n\\nLeu\\tO\\n-\\tO\\nAVP\\tO\\nwas\\tO\\na\\tO\\nweak\\tO\\nagonist\\tO\\nwith\\tO\\napproximately\\tO\\n30\\tO\\n-\\tO\\nfold\\tO\\nreduced\\tO\\nbinding\\tO\\nto\\tO\\nthe\\tO\\nhuman\\tO\\nV2\\tO\\nreceptor\\tO\\n.\\tO\\n\\nMeasured\\tO\\nby\\tO\\nradioimmunoassay\\tO\\nwith\\tO\\na\\tO\\nsynthetic\\tO\\nLeu\\tO\\n-\\tO\\nAVP\\tO\\nstandard\\tO\\n,\\tO\\nserum\\tO\\nLeu\\tO\\n-\\tO\\nAVP\\tO\\nlevels\\tO\\nwere\\tO\\nelevated\\tO\\nin\\tO\\nall\\tO\\nthree\\tO\\nchildren\\tO\\nand\\tO\\nfurther\\tO\\nincreased\\tO\\nduring\\tO\\nwater\\tO\\ndeprivation\\tO\\nto\\tO\\nas\\tO\\nhigh\\tO\\nas\\tO\\n30\\tO\\ntimes\\tO\\nnormal\\tO\\n.\\tO\\n\\nThe\\tO\\nyoungest\\tO\\nchild\\tO\\n(\\tO\\n2\\tO\\nyears\\tO\\nold\\tO\\n)\\tO\\nwas\\tO\\nonly\\tO\\nmildly\\tO\\naffected\\tO\\nbut\\tO\\nhad\\tO\\nLeu\\tO\\n-\\tO\\nAVP\\tO\\nlevels\\tO\\nsimilar\\tO\\nto\\tO\\nher\\tO\\nseverely\\tO\\naffected\\tO\\n8\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nbrother\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nunknown\\tO\\nmechanisms\\tO\\nmay\\tO\\npartially\\tO\\ncompensate\\tO\\nfor\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nactive\\tI-Disease\\nAVP\\tI-Disease\\nin\\tO\\nvery\\tO\\nyoung\\tO\\nchildren\\tO\\n.\\tO\\n.\\tO\\n\\nX\\tO\\ninactivation\\tO\\nand\\tO\\nsomatic\\tO\\ncell\\tO\\nselection\\tO\\nrescue\\tO\\nfemale\\tO\\nmice\\tO\\ncarrying\\tO\\na\\tO\\nPiga\\tO\\n-\\tO\\nnull\\tO\\nmutation\\tO\\n.\\tO\\n\\nA\\tO\\nsomatic\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nX\\tO\\nlinked\\tO\\nPIGA\\tO\\ngene\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nglycosyl\\tI-Disease\\nphosphatidylinositol\\tI-Disease\\n(\\tI-Disease\\nGPI\\tI-Disease\\n)\\tI-Disease\\n-\\tI-Disease\\nanchored\\tI-Disease\\nproteins\\tI-Disease\\non\\tO\\nblood\\tO\\ncells\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nparoxysmal\\tB-Disease\\nnocturnal\\tI-Disease\\nhemoglobinuria\\tI-Disease\\n.\\tO\\n\\nNo\\tO\\ninherited\\tO\\nform\\tO\\nof\\tO\\nGPI\\tB-Disease\\n-\\tI-Disease\\nanchor\\tI-Disease\\ndeficiency\\tI-Disease\\nhas\\tO\\nbeen\\tO\\ndescribed\\tO\\n.\\tO\\n\\nBecause\\tO\\nconventional\\tO\\nPiga\\tO\\ngene\\tO\\nknockout\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nhigh\\tO\\nembryonic\\tB-Disease\\nlethality\\tI-Disease\\nin\\tO\\nchimeric\\tO\\nmice\\tO\\n,\\tO\\nwe\\tO\\nused\\tO\\nthe\\tO\\nCre\\tO\\n/\\tO\\nloxP\\tO\\nsystem\\tO\\n.\\tO\\n\\nWe\\tO\\ngenerated\\tO\\nmice\\tO\\nin\\tO\\nwhich\\tO\\ntwo\\tO\\nloxP\\tO\\nsites\\tO\\nflank\\tO\\npart\\tO\\nof\\tO\\nPiga\\tO\\nexon\\tO\\n2\\tO\\n.\\tO\\n\\nAfter\\tO\\ncrossbreeding\\tO\\nwith\\tO\\nfemale\\tO\\nmice\\tO\\nof\\tO\\nthe\\tO\\nEIIa\\tO\\n-\\tO\\ncre\\tO\\nstrain\\tO\\n,\\tO\\nthe\\tO\\nfloxed\\tO\\nallele\\tO\\nundergoes\\tO\\nCre\\tO\\n-\\tO\\nmediated\\tO\\nrecombination\\tO\\nwith\\tO\\nhigh\\tO\\nefficiency\\tO\\nduring\\tO\\nearly\\tO\\nembryonic\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nBecause\\tO\\nof\\tO\\nX\\tO\\nchromosome\\tO\\ninactivation\\tO\\n,\\tO\\nfemale\\tO\\noffspring\\tO\\nare\\tO\\nmosaic\\tO\\nfor\\tO\\ncells\\tO\\nthat\\tO\\nexpress\\tO\\nor\\tO\\nlack\\tO\\nGPI\\tO\\n-\\tO\\nlinked\\tO\\nproteins\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nmosaic\\tO\\nmice\\tO\\nshowed\\tO\\nthat\\tO\\nin\\tO\\nheart\\tO\\n,\\tO\\nlung\\tO\\n,\\tO\\nkidney\\tO\\n,\\tO\\nbrain\\tO\\n,\\tO\\nand\\tO\\nliver\\tO\\n,\\tO\\nmainly\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nPiga\\tO\\nis\\tO\\nactive\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthese\\tO\\ntissues\\tO\\nrequire\\tO\\nGPI\\tO\\n-\\tO\\nlinked\\tO\\nproteins\\tO\\n.\\tO\\n\\nThe\\tO\\nsalient\\tO\\nexceptions\\tO\\nwere\\tO\\nspleen\\tO\\n,\\tO\\nthymus\\tO\\n,\\tO\\nand\\tO\\nred\\tO\\nblood\\tO\\ncells\\tO\\n,\\tO\\nwhich\\tO\\nhad\\tO\\nalmost\\tO\\nequal\\tO\\nnumbers\\tO\\nof\\tO\\ncells\\tO\\nexpressing\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nor\\tO\\nthe\\tO\\nrecombined\\tO\\nallele\\tO\\n,\\tO\\nimplying\\tO\\nthat\\tO\\nGPI\\tO\\n-\\tO\\nlinked\\tO\\nproteins\\tO\\nare\\tO\\nnot\\tO\\nessential\\tO\\nfor\\tO\\nthe\\tO\\nderivation\\tO\\nof\\tO\\nthese\\tO\\ntissues\\tO\\n.\\tO\\n\\nPIGA\\tO\\n(\\tO\\n-\\tO\\n)\\tO\\ncells\\tO\\nhad\\tO\\nno\\tO\\ngrowth\\tO\\nadvantage\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nother\\tO\\nfactors\\tO\\nare\\tO\\nneeded\\tO\\nfor\\tO\\ntheir\\tO\\nclonal\\tO\\ndominance\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nparoxysmal\\tB-Disease\\nnocturnal\\tI-Disease\\nhemoglobinuria\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nC282Y\\tO\\nmutation\\tO\\ncausing\\tO\\nhereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\ndoes\\tO\\nnot\\tO\\nproduce\\tO\\na\\tO\\nnull\\tO\\nallele\\tO\\n.\\tO\\n\\nTargeted\\tO\\nmutagenesis\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nproduce\\tO\\ntwo\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nmurine\\tO\\nhemochromatosis\\tB-Disease\\ngene\\tO\\n(\\tO\\nHfe\\tO\\n)\\tO\\nlocus\\tO\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\nmutation\\tO\\ndeletes\\tO\\na\\tO\\nlarge\\tO\\nportion\\tO\\nof\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\n,\\tO\\ngenerating\\tO\\na\\tO\\nnull\\tO\\nallele\\tO\\n.\\tO\\n\\nThe\\tO\\nsecond\\tO\\nmutation\\tO\\nintroduces\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nC282Y\\tO\\n)\\tO\\ninto\\tO\\nthe\\tO\\nHfe\\tO\\nlocus\\tO\\n,\\tO\\nbut\\tO\\notherwise\\tO\\nleaves\\tO\\nthe\\tO\\ngene\\tO\\nintact\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nis\\tO\\nidentical\\tO\\nto\\tO\\nthe\\tO\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\nmutation\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\n.\\tO\\n\\nMice\\tO\\ncarrying\\tO\\neach\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nmutations\\tO\\nwere\\tO\\nbred\\tO\\nand\\tO\\nanalyzed\\tO\\n.\\tO\\n\\nHomozygosity\\tO\\nfor\\tO\\neither\\tO\\nmutation\\tO\\nresults\\tO\\nin\\tO\\npostnatal\\tO\\niron\\tO\\nloading\\tO\\n.\\tO\\n\\nThe\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\nnull\\tO\\nmutation\\tO\\nare\\tO\\nmore\\tO\\nsevere\\tO\\nthan\\tO\\nthe\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\nC282Y\\tO\\nmutation\\tO\\n.\\tO\\n\\nMice\\tO\\nheterozygous\\tO\\nfor\\tO\\neither\\tO\\nmutation\\tO\\naccumulate\\tO\\nmore\\tO\\niron\\tO\\nthan\\tO\\nnormal\\tO\\ncontrols\\tO\\n.\\tO\\n\\nInterestingly\\tO\\n,\\tO\\nalthough\\tO\\nliver\\tO\\niron\\tO\\nstores\\tO\\nare\\tO\\ngreatly\\tO\\nincreased\\tO\\n,\\tO\\nsplenic\\tO\\niron\\tO\\nis\\tO\\ndecreased\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\nC282Y\\tO\\nmutation\\tO\\ndoes\\tO\\nnot\\tO\\nresult\\tO\\nin\\tO\\na\\tO\\nnull\\tO\\nallele\\tO\\n.\\tO\\n.\\tO\\n\\nGenotype\\tO\\n-\\tO\\nphenotype\\tO\\nanalysis\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nEmery\\tI-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nand\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nmilder\\tO\\nphenotype\\tO\\n.\\tO\\n\\nDirect\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\nemerin\\tO\\ngene\\tO\\nin\\tO\\n22\\tO\\nfamilies\\tO\\nwith\\tO\\nEmery\\tB-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nEMD\\tB-Disease\\n)\\tO\\nrevealed\\tO\\nmutations\\tO\\nin\\tO\\n21\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nconfirming\\tO\\nthat\\tO\\nemerin\\tO\\nmutations\\tO\\ncan\\tO\\nbe\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nfamilies\\tO\\nwith\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nEMD\\tI-Disease\\n.\\tO\\n\\nMost\\tO\\nemerin\\tO\\nmutations\\tO\\nresult\\tO\\nin\\tO\\nabsence\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\nthree\\tO\\nmutations\\tO\\n(\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nPro183Thr\\tO\\nand\\tO\\ntwo\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletions\\tO\\nremoving\\tO\\nresidues\\tO\\n95\\tO\\n-\\tO\\n99\\tO\\nand\\tO\\n236\\tO\\n-\\tO\\n241\\tO\\n,\\tO\\nrespectively\\tO\\n)\\tO\\nwere\\tO\\nunusual\\tO\\nin\\tO\\nbeing\\tO\\nassociated\\tO\\nwith\\tO\\nexpression\\tO\\nof\\tO\\nmutant\\tO\\nprotein\\tO\\n.\\tO\\n\\nThe\\tO\\nphenotype\\tO\\nin\\tO\\nthese\\tO\\nfamilies\\tO\\nwas\\tO\\ncompared\\tO\\nin\\tO\\ndetail\\tO\\nwith\\tO\\nthe\\tO\\nclinical\\tO\\nfeatures\\tO\\nin\\tO\\ncases\\tO\\nwith\\tO\\ntypical\\tO\\nnull\\tO\\nmutations\\tO\\n.\\tO\\n\\nFor\\tO\\nthe\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletions\\tO\\nthere\\tO\\nwere\\tO\\nno\\tO\\nsignificant\\tO\\ndifferences\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nfamily\\tO\\nwith\\tO\\nthe\\tO\\nmissense\\tO\\nmutation\\tO\\nthe\\tO\\nphenotype\\tO\\nwas\\tO\\nmilder\\tO\\n.\\tO\\n\\nAge\\tO\\nat\\tO\\nonset\\tO\\nwas\\tO\\nlater\\tO\\nfor\\tO\\nfirst\\tO\\nsymptoms\\tO\\nand\\tO\\nfor\\tO\\ndevelopment\\tO\\nof\\tO\\nankle\\tB-Disease\\ncontractures\\tI-Disease\\nand\\tO\\nmuscle\\tB-Disease\\nweakness\\tI-Disease\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nhave\\tO\\ndiagnostic\\tO\\nimplications\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\npointing\\tO\\nto\\tO\\nfunctionally\\tO\\nimportant\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\nemerin\\tO\\nprotein\\tO\\n.\\tO\\n.\\tO\\n\\nSevere\\tO\\nclinical\\tO\\nexpression\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nEmery\\tI-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nEmery\\tI-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nEDMD\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nrelatively\\tO\\nrare\\tO\\nbenign\\tB-Disease\\nneuromuscular\\tI-Disease\\ndisorder\\tI-Disease\\nwhich\\tO\\ncan\\tO\\nvary\\tO\\nremarkably\\tO\\nin\\tO\\nonset\\tO\\n,\\tO\\ncourse\\tO\\nand\\tO\\nseverity\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n,\\tO\\na\\tO\\nTCTAC\\tO\\ndeletion\\tO\\nspanning\\tO\\nthe\\tO\\nnucleotides\\tO\\n631\\tO\\n-\\tO\\n635\\tO\\nof\\tO\\nthe\\tO\\nemerin\\tO\\ngene\\tO\\ncaused\\tO\\nan\\tO\\nunusually\\tO\\nsevere\\tO\\ndisease\\tO\\nphenotype\\tO\\nincluding\\tO\\nloss\\tB-Disease\\nof\\tI-Disease\\nambulation\\tI-Disease\\nand\\tO\\nsevere\\tO\\nmuscle\\tB-Disease\\nwasting\\tI-Disease\\nin\\tO\\ntwo\\tO\\naffected\\tO\\nbrothers\\tO\\n.\\tO\\n\\nThe\\tO\\nsame\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\npreviously\\tO\\nin\\tO\\nan\\tO\\nunrelated\\tO\\nfamily\\tO\\nshowing\\tO\\na\\tO\\nsignificantly\\tO\\nmilder\\tO\\nphenotype\\tO\\n.\\tO\\n\\nThe\\tO\\ninterfamilial\\tO\\nheterogeneity\\tO\\nin\\tO\\ndistribution\\tO\\nand\\tO\\nin\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\nfeatures\\tO\\nin\\tO\\nthe\\tO\\ntwo\\tO\\nfamilies\\tO\\npoint\\tO\\nto\\tO\\nenvironmental\\tO\\nor\\tO\\ngenetic\\tO\\nmodification\\tO\\nas\\tO\\nthe\\tO\\ncause\\tO\\nof\\tO\\nclinical\\tO\\nvariability\\tO\\nin\\tO\\nEmery\\tB-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nCommon\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\ndo\\tO\\nnot\\tO\\ncontribute\\tO\\nto\\tO\\nearly\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\nJewish\\tO\\nmen\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\nFamilies\\tO\\nwith\\tO\\na\\tO\\nhigh\\tO\\nincidence\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nand\\tO\\nsubsequently\\tO\\nshown\\tO\\nto\\tO\\nhave\\tO\\nterminating\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\n,\\tO\\nappear\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nhigher\\tO\\nincidence\\tO\\nof\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\namong\\tO\\nmale\\tO\\nrelatives\\tO\\n.\\tO\\n\\nWe\\tO\\naimed\\tO\\nto\\tO\\ndetermine\\tO\\nwhether\\tO\\nthe\\tO\\ncommon\\tO\\ngermline\\tO\\nmutations\\tO\\nof\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\nin\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nmen\\tO\\npredisposed\\tO\\nthem\\tO\\nto\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nMETHODS\\tO\\nWe\\tO\\nexamined\\tO\\ngenomic\\tO\\nDNA\\tO\\nfrom\\tO\\n83\\tO\\n(\\tO\\nfor\\tO\\nBRCA1\\tO\\n185delAG\\tO\\n)\\tO\\nor\\tO\\n82\\tO\\n(\\tO\\nfor\\tO\\nBRCA2\\tO\\n6174delT\\tO\\n)\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\n,\\tO\\nmost\\tO\\nof\\tO\\nwhom\\tO\\nwere\\tO\\ntreated\\tO\\nat\\tO\\na\\tO\\nrelatively\\tO\\nyoung\\tO\\nage\\tO\\n,\\tO\\nfor\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\ngermline\\tO\\nmutation\\tO\\nin\\tO\\neach\\tO\\ngene\\tO\\nseen\\tO\\nin\\tO\\nthe\\tO\\nAshkenazi\\tO\\npopulation\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nOur\\tO\\nstudy\\tO\\nshould\\tO\\nhave\\tO\\nbeen\\tO\\nable\\tO\\nto\\tO\\ndetect\\tO\\na\\tO\\n4\\tO\\n-\\tO\\n5\\tO\\n-\\tO\\nfold\\tO\\nincrease\\tO\\nin\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\ndue\\tO\\nto\\tO\\nmutation\\tO\\nof\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nonly\\tO\\none\\tO\\n(\\tO\\n1\\tO\\n.\\tO\\n15\\tO\\n%\\tO\\n;\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\n,\\tO\\n0\\tO\\n-\\tO\\n3\\tO\\n.\\tO\\n6\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nwas\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nBRCA1\\tO\\nmutant\\tO\\nallele\\tO\\n,\\tO\\nand\\tO\\nonly\\tO\\ntwo\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nBRCA2\\tO\\nmutation\\tO\\n(\\tO\\n2\\tO\\n.\\tO\\n4\\tO\\n%\\tO\\n;\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\n,\\tO\\n0\\tO\\n-\\tO\\n6\\tO\\n.\\tO\\n2\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nThe\\tO\\nincidence\\tO\\nof\\tO\\neach\\tO\\nof\\tO\\nthe\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nthese\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\nclosely\\tO\\nmatched\\tO\\ntheir\\tO\\nincidence\\tO\\n(\\tO\\nabout\\tO\\n1\\tO\\n%\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\ngeneral\\tO\\nAshkenazi\\tO\\nJewish\\tO\\npopulation\\tO\\n.\\tO\\n\\nThis\\tO\\nsuggests\\tO\\nthat\\tO\\nunlike\\tO\\ncases\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\n,\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\ndo\\tO\\nnot\\tO\\nsignificantly\\tO\\npredispose\\tO\\nmen\\tO\\nto\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\n\\nBeta\\tO\\n-\\tO\\ncatenin\\tO\\naccumulation\\tO\\nand\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nCTNNB1\\tO\\ngene\\tO\\nin\\tO\\nhepatoblastoma\\tB-Disease\\n.\\tO\\n\\nHepatoblastoma\\tB-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\nmalignant\\tB-Disease\\ntumor\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nliver\\tI-Disease\\nthat\\tO\\noccurs\\tO\\nin\\tO\\nchildren\\tO\\nat\\tO\\nan\\tO\\naverage\\tO\\nage\\tO\\nof\\tO\\n2\\tO\\nto\\tO\\n3\\tO\\nyears\\tO\\n.\\tO\\n\\nEpidemiologic\\tO\\nstudies\\tO\\nhave\\tO\\nshown\\tO\\nan\\tO\\nincreased\\tO\\nfrequency\\tO\\nof\\tO\\nthis\\tO\\ntumor\\tB-Disease\\ntype\\tO\\nin\\tO\\nfamilies\\tO\\naffected\\tO\\nby\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\nto\\tO\\nthe\\tO\\nepidemiologic\\tO\\ndata\\tO\\n,\\tO\\nmolecular\\tO\\ngenetic\\tO\\nstudies\\tO\\nsuggest\\tO\\nthat\\tO\\ninactivation\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ntumor\\tI-Disease\\nsuppressor\\tO\\nmay\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\nhepatoblastoma\\tB-Disease\\ntumorigenesis\\tO\\n.\\tO\\n\\nA\\tO\\nmajor\\tO\\nfunction\\tO\\nof\\tO\\nAPC\\tO\\nis\\tO\\nthe\\tO\\ndownregulation\\tO\\nof\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n,\\tO\\na\\tO\\ntranscription\\tO\\n-\\tO\\nactivating\\tO\\nprotein\\tO\\nwith\\tO\\noncogenic\\tO\\npotential\\tO\\n.\\tO\\n\\nIn\\tO\\nan\\tO\\nongoing\\tO\\nimmunohistochemical\\tO\\nstudy\\tO\\nof\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\nexpression\\tO\\nin\\tO\\nsporadic\\tO\\ncases\\tO\\nof\\tO\\ntumor\\tB-Disease\\ntypes\\tO\\nthat\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n,\\tO\\nwe\\tO\\nobserved\\tO\\nincreased\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\nlevels\\tO\\nin\\tO\\nthe\\tO\\ncytoplasm\\tO\\nand\\tO\\nin\\tO\\nthe\\tO\\nnuclei\\tO\\nof\\tO\\nthree\\tO\\ninvestigated\\tO\\nhepatoblastomas\\tB-Disease\\n.\\tO\\n\\nSequencing\\tO\\nof\\tO\\nexon\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\ngene\\tO\\n(\\tO\\nCTNNB1\\tO\\n)\\tO\\nrevealed\\tO\\nan\\tO\\nactivating\\tO\\nmutation\\tO\\nin\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ntumor\\tB-Disease\\nsamples\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nindicate\\tO\\nfor\\tO\\nthe\\tO\\nfirst\\tO\\ntime\\tO\\nthat\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\naccumulation\\tO\\nmay\\tO\\nplay\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nhepatoblastoma\\tB-Disease\\nand\\tO\\nthat\\tO\\nactivating\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\ngene\\tO\\nmay\\tO\\nsubstitute\\tO\\nbiallelic\\tO\\nAPC\\tO\\ninactivation\\tO\\nin\\tO\\nthis\\tO\\ntumor\\tB-Disease\\ntype\\tO\\n.\\tO\\n\\nGenes\\tO\\nChromosomes\\tO\\nCancer\\tO\\n25\\tO\\n399\\tO\\n-\\tO\\n402\\tO\\n,\\tO\\n1999\\tO\\n.\\tO\\n.\\tO\\n\\nDecrease\\tO\\nin\\tO\\nGTP\\tO\\ncyclohydrolase\\tO\\nI\\tO\\ngene\\tO\\nexpression\\tO\\ncaused\\tO\\nby\\tO\\ninactivation\\tO\\nof\\tO\\none\\tO\\nallele\\tO\\nin\\tO\\nhereditary\\tB-Disease\\nprogressive\\tI-Disease\\ndystonia\\tI-Disease\\nwith\\tO\\nmarked\\tO\\ndiurnal\\tO\\nfluctuation\\tO\\n.\\tO\\n\\nHereditary\\tB-Disease\\nprogressive\\tI-Disease\\ndystonia\\tI-Disease\\nwith\\tO\\nmarked\\tO\\ndiurnal\\tO\\nfluctuation\\tO\\n(\\tO\\nHPD\\tB-Disease\\n;\\tO\\ndopa\\tB-Disease\\n-\\tI-Disease\\nresponsive\\tI-Disease\\ndystonia\\tI-Disease\\n,\\tO\\nDRD\\tB-Disease\\n)\\tO\\nhave\\tO\\nbeen\\tO\\nrecently\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\nin\\tO\\nthe\\tO\\nGTP\\tO\\ncyclohydrolase\\tO\\nI\\tO\\n(\\tO\\nGCH1\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nquantified\\tO\\nthe\\tO\\nmRNA\\tO\\nlevel\\tO\\nof\\tO\\nGCH1\\tO\\nin\\tO\\nphytohemagglutinin\\tO\\n(\\tO\\nPHA\\tO\\n)\\tO\\n-\\tO\\nstimulated\\tO\\nmononuclear\\tO\\nblood\\tO\\ncells\\tO\\nfrom\\tO\\none\\tO\\nJapanese\\tO\\nfamily\\tO\\nthat\\tO\\ndo\\tO\\nnot\\tO\\nhave\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nor\\tO\\nsplice\\tO\\njunctions\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\namounts\\tO\\nof\\tO\\nthe\\tO\\nGCH1\\tO\\nmRNA\\tO\\nwere\\tO\\ndecreased\\tO\\nto\\tO\\nabout\\tO\\n40\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nlevel\\tO\\nin\\tO\\nboth\\tO\\npatients\\tO\\nand\\tO\\ncarriers\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nfound\\tO\\nthat\\tO\\nthe\\tO\\nGCH1\\tO\\nmRNA\\tO\\nwas\\tO\\ntranscribed\\tO\\nfrom\\tO\\nonly\\tO\\none\\tO\\nallele\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nthe\\tO\\nother\\tO\\nallele\\tO\\nwas\\tO\\nin\\tO\\nan\\tO\\ninactive\\tO\\nstate\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nsome\\tO\\nnovel\\tO\\nmutations\\tO\\nshould\\tO\\nexist\\tO\\non\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nalleles\\tO\\nin\\tO\\nsome\\tO\\nunknown\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nGCH1\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nmay\\tO\\ndecrease\\tO\\nthe\\tO\\nGCH1\\tO\\nmRNA\\tO\\ncausing\\tO\\nthe\\tO\\nHPD\\tB-Disease\\n/\\tO\\nDRD\\tB-Disease\\nsymptoms\\tO\\n.\\tO\\n.\\tO\\n\\nSulfate\\tO\\ntransport\\tO\\nis\\tO\\nnot\\tO\\nimpaired\\tO\\nin\\tO\\npendred\\tB-Disease\\nsyndrome\\tI-Disease\\nthyrocytes\\tO\\n.\\tO\\n\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nform\\tO\\nof\\tO\\nsyndromic\\tB-Disease\\ndeafness\\tI-Disease\\n,\\tO\\ncharacterized\\tO\\nby\\tO\\ndyshormonogenic\\tB-Disease\\ngoiter\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nsensory\\tB-Disease\\n-\\tI-Disease\\nneural\\tI-Disease\\ndeafness\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\ndisease\\tO\\n(\\tO\\nPDS\\tB-Disease\\n)\\tO\\nhas\\tO\\nbeen\\tO\\ncloned\\tO\\n,\\tO\\nbut\\tO\\nits\\tO\\nfunction\\tO\\nis\\tO\\nas\\tO\\nyet\\tO\\nunknown\\tO\\nand\\tO\\nthe\\tO\\nconnection\\tO\\nbetween\\tO\\nthyroid\\tB-Disease\\ngoiter\\tI-Disease\\nand\\tO\\nsensory\\tB-Disease\\n-\\tI-Disease\\nneural\\tI-Disease\\ndeafness\\tI-Disease\\nremains\\tO\\nan\\tO\\nenigma\\tO\\n.\\tO\\n\\nPDS\\tO\\ncodes\\tO\\nfor\\tO\\na\\tO\\nnovel\\tO\\nprotein\\tO\\n,\\tO\\npendrin\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nclosely\\tO\\nrelated\\tO\\nto\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nsufate\\tO\\ntransporters\\tO\\n.\\tO\\n\\nMechanisms\\tO\\nby\\tO\\nwhich\\tO\\nabnormal\\tO\\nsulfate\\tO\\ntransport\\tO\\ncould\\tO\\ndeleteriously\\tO\\naffect\\tO\\niodide\\tO\\norganification\\tO\\nhave\\tO\\nbeen\\tO\\nproposed\\tO\\n.\\tO\\n\\nWe\\tO\\ntested\\tO\\nsulfate\\tO\\ntransport\\tO\\nin\\tO\\nthyrocytes\\tO\\nobtained\\tO\\nfrom\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\npatients\\tO\\nand\\tO\\nfound\\tO\\nthat\\tO\\nit\\tO\\nwas\\tO\\nnot\\tO\\ndefective\\tO\\n.\\tO\\n\\nThis\\tO\\nsuggests\\tO\\nthat\\tO\\npendrin\\tO\\nin\\tO\\nfact\\tO\\nmay\\tO\\nnot\\tO\\nbe\\tO\\na\\tO\\nsulfate\\tO\\ntransporter\\tO\\n,\\tO\\nand\\tO\\nemphasizes\\tO\\nthe\\tO\\nimportance\\tO\\nof\\tO\\nfunctional\\tO\\nstudies\\tO\\non\\tO\\nthis\\tO\\nnovel\\tO\\nprotein\\tO\\n.\\tO\\n.\\tO\\n\\nSmall\\tO\\ndeletions\\tO\\nin\\tO\\nthe\\tO\\ntype\\tO\\nII\\tO\\ncollagen\\tO\\ntriple\\tO\\nhelix\\tO\\nproduce\\tO\\nkniest\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\nis\\tO\\na\\tO\\nmoderately\\tO\\nsevere\\tO\\ntype\\tB-Disease\\nII\\tI-Disease\\ncollagenopathy\\tI-Disease\\n,\\tO\\ncharacterized\\tO\\nby\\tO\\nshort\\tO\\ntrunk\\tO\\nand\\tO\\nlimbs\\tO\\n,\\tO\\nkyphoscoliosis\\tB-Disease\\n,\\tO\\nmidface\\tB-Disease\\nhypoplasia\\tI-Disease\\n,\\tO\\nsevere\\tO\\nmyopia\\tB-Disease\\n,\\tO\\nand\\tO\\nhearing\\tB-Disease\\nloss\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nthat\\tO\\nencodes\\tO\\ntype\\tO\\nII\\tO\\ncollagen\\tO\\n(\\tO\\nCOL2A1\\tO\\n)\\tO\\n,\\tO\\nthe\\tO\\npredominant\\tO\\nprotein\\tO\\nof\\tO\\ncartilage\\tO\\n,\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nindividuals\\tO\\nwith\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nAll\\tO\\nbut\\tO\\ntwo\\tO\\nof\\tO\\nthese\\tO\\npreviously\\tO\\ndescribed\\tO\\nmutations\\tO\\ncause\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletions\\tO\\nin\\tO\\ntype\\tO\\nII\\tO\\ncollagen\\tO\\n,\\tO\\neither\\tO\\nby\\tO\\nsmall\\tO\\ndeletions\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nor\\tO\\nsplice\\tO\\nsite\\tO\\nalterations\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nall\\tO\\nbut\\tO\\none\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nis\\tO\\nlocated\\tO\\nbetween\\tO\\nexons\\tO\\n12\\tO\\nand\\tO\\n24\\tO\\nin\\tO\\nthe\\tO\\nCOL2A1\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nused\\tO\\nheteroduplex\\tO\\nanalysis\\tO\\nto\\tO\\nidentify\\tO\\nsequence\\tO\\nanomalies\\tO\\nin\\tO\\nfive\\tO\\nindividuals\\tO\\nwith\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nSequencing\\tO\\nof\\tO\\nthe\\tO\\nindex\\tO\\npatients\\tO\\ngenomic\\tO\\nDNA\\tO\\nidentified\\tO\\nfour\\tO\\nnew\\tO\\ndominant\\tO\\nmutations\\tO\\nin\\tO\\nCOL2A1\\tO\\nthat\\tO\\nresult\\tO\\nin\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\na\\tO\\n21\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nin\\tO\\nexon\\tO\\n16\\tO\\n,\\tO\\nan\\tO\\n18\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nin\\tO\\nexon\\tO\\n19\\tO\\n,\\tO\\nand\\tO\\n4\\tO\\n-\\tO\\nbp\\tO\\ndeletions\\tO\\nin\\tO\\nthe\\tO\\nsplice\\tO\\ndonor\\tO\\nsites\\tO\\nof\\tO\\nintrons\\tO\\n14\\tO\\nand\\tO\\n20\\tO\\n.\\tO\\n\\nA\\tO\\npreviously\\tO\\ndescribed\\tO\\n28\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nat\\tO\\nthe\\tO\\nCOL2A1\\tO\\nexon\\tO\\n12\\tO\\n-\\tO\\nintron\\tO\\n12\\tO\\njunction\\tO\\n,\\tO\\ndeleting\\tO\\nthe\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\n,\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\nfifth\\tO\\ncase\\tO\\n.\\tO\\n\\nThe\\tO\\nlatter\\tO\\nthree\\tO\\nmutations\\tO\\nare\\tO\\npredicted\\tO\\nto\\tO\\nresult\\tO\\nin\\tO\\nexon\\tO\\nskipping\\tO\\nin\\tO\\nthe\\tO\\nmRNA\\tO\\nencoded\\tO\\nfrom\\tO\\nthe\\tO\\nmutant\\tO\\nallele\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\nresults\\tO\\nfrom\\tO\\nshorter\\tO\\ntype\\tO\\nII\\tO\\ncollagen\\tO\\nmonomers\\tO\\n,\\tO\\nand\\tO\\nsupport\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nalteration\\tO\\nof\\tO\\na\\tO\\nspecific\\tO\\nCOL2A1\\tO\\ndomain\\tO\\n,\\tO\\nwhich\\tO\\nmay\\tO\\nspan\\tO\\nfrom\\tO\\nexons\\tO\\n12\\tO\\nto\\tO\\n24\\tO\\n,\\tO\\nleads\\tO\\nto\\tO\\nthe\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\nphenotype\\tO\\n.\\tO\\n.\\tO\\n\\nClassical\\tB-Disease\\ngalactosemia\\tI-Disease\\nand\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridyl\\tO\\ntransferase\\tO\\n(\\tO\\nGALT\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nClassical\\tB-Disease\\ngalactosemia\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tO\\nin\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nenzyme\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridyl\\tO\\ntransferase\\tO\\n(\\tO\\nGALT\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\n,\\tO\\nin\\tO\\nturn\\tO\\n,\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nGALT\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\ndisorder\\tO\\nexhibits\\tO\\nconsiderable\\tO\\nallelic\\tO\\nheterogeneity\\tO\\nand\\tO\\n,\\tO\\nat\\tO\\nthe\\tO\\nend\\tO\\nof\\tO\\n1998\\tO\\n,\\tO\\nmore\\tO\\nthan\\tO\\n150\\tO\\ndifferent\\tO\\nbase\\tO\\nchanges\\tO\\nwere\\tO\\nrecorded\\tO\\nin\\tO\\n24\\tO\\ndifferent\\tO\\npopulations\\tO\\nand\\tO\\nethnic\\tO\\ngroups\\tO\\nin\\tO\\n15\\tO\\ncountries\\tO\\nworldwide\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\nmost\\tO\\nfrequently\\tO\\ncited\\tO\\nare\\tO\\nQ188R\\tO\\n,\\tO\\nK285N\\tO\\n,\\tO\\nS135L\\tO\\n,\\tO\\nand\\tO\\nN314D\\tO\\n.\\tO\\n\\nQ188R\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nmutation\\tO\\nin\\tO\\nEuropean\\tO\\npopulations\\tO\\nor\\tO\\nin\\tO\\nthose\\tO\\npredominantly\\tO\\nof\\tO\\nEuropean\\tO\\ndescent\\tO\\n.\\tO\\n\\nOverall\\tO\\n,\\tO\\nit\\tO\\naccounts\\tO\\nfor\\tO\\n60\\tO\\n-\\tO\\n70\\tO\\n%\\tO\\nof\\tO\\nmutant\\tO\\nchromosomes\\tO\\n,\\tO\\nbut\\tO\\nthere\\tO\\nare\\tO\\nsignificant\\tO\\ndifferences\\tO\\nin\\tO\\nits\\tO\\nrelative\\tO\\nfrequency\\tO\\nin\\tO\\nindividual\\tO\\npopulations\\tO\\n.\\tO\\n\\nIndividuals\\tO\\nhomoallelic\\tO\\nfor\\tO\\nQ188R\\tO\\ntend\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nsevere\\tO\\nphenotype\\tO\\nand\\tO\\nthis\\tO\\nis\\tO\\nin\\tO\\nkeeping\\tO\\nwith\\tO\\nthe\\tO\\nvirtually\\tO\\ncomplete\\tO\\nloss\\tO\\nof\\tO\\nenzyme\\tO\\nactivity\\tO\\nobserved\\tO\\nin\\tO\\nin\\tO\\nvitro\\tO\\nexpression\\tO\\nsystems\\tO\\n.\\tO\\n\\nGlobally\\tO\\n,\\tO\\nK285N\\tO\\nis\\tO\\nrarer\\tO\\n,\\tO\\nbut\\tO\\nin\\tO\\nmany\\tO\\nEuropean\\tO\\npopulations\\tO\\nit\\tO\\ncan\\tO\\nbe\\tO\\nfound\\tO\\non\\tO\\n25\\tO\\n-\\tO\\n40\\tO\\n%\\tO\\nof\\tO\\nmutant\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\ninvariably\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nsevere\\tO\\nphenotype\\tO\\n.\\tO\\n\\nS135L\\tO\\nis\\tO\\nfound\\tO\\nalmost\\tO\\nexclusively\\tO\\nin\\tO\\nAfrican\\tO\\nAmericans\\tO\\n.\\tO\\n\\nIn\\tO\\nvitro\\tO\\nexpression\\tO\\nresults\\tO\\nare\\tO\\ndiscrepant\\tO\\n,\\tO\\nbut\\tO\\nsome\\tO\\nindividuals\\tO\\ncarrying\\tO\\nS135L\\tO\\nappear\\tO\\nto\\tO\\nexhibit\\tO\\nGALT\\tO\\nactivity\\tO\\nin\\tO\\nsome\\tO\\ntissues\\tO\\n.\\tO\\n\\nDuarte\\tO\\n1\\tO\\n(\\tO\\nor\\tO\\nLos\\tO\\nAngeles\\tO\\n)\\tO\\nand\\tO\\nDuarte\\tO\\n2\\tO\\n(\\tO\\nor\\tO\\nDuarte\\tO\\n)\\tO\\nvariants\\tO\\ncarry\\tO\\nthe\\tO\\nsame\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\n,\\tO\\nN314D\\tO\\n,\\tO\\neven\\tO\\nthough\\tO\\nD1\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nincreased\\tO\\nerythrocyte\\tO\\nGALT\\tO\\nactivity\\tO\\nand\\tO\\nD2\\tO\\nwith\\tO\\nreduced\\tO\\nactivity\\tO\\n.\\tO\\n\\nN314D\\tO\\nis\\tO\\nin\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nwith\\tO\\nother\\tO\\nbase\\tO\\nchanges\\tO\\nthat\\tO\\ndiffer\\tO\\non\\tO\\nthe\\tO\\nD1\\tO\\nand\\tO\\nD2\\tO\\nalleles\\tO\\n.\\tO\\n\\nN314D\\tO\\ndoes\\tO\\nnot\\tO\\nimpair\\tO\\nGALT\\tO\\nactivity\\tO\\nin\\tO\\nin\\tO\\nvitro\\tO\\nexpression\\tO\\nsystems\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthere\\tO\\nare\\tO\\ndifferences\\tO\\nin\\tO\\nthe\\tO\\nabundance\\tO\\nof\\tO\\nGALT\\tO\\nprotein\\tO\\nin\\tO\\nlymphoblastoid\\tO\\ncells\\tO\\nlines\\tO\\nfrom\\tO\\nD2\\tO\\nand\\tO\\nD1\\tO\\nindividuals\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nunclear\\tO\\nwhether\\tO\\nthe\\tO\\nspecific\\tO\\nmolecular\\tO\\nchanges\\tO\\nthat\\tO\\ndistinguish\\tO\\nthe\\tO\\nD1\\tO\\nand\\tO\\nD2\\tO\\nalleles\\tO\\naccount\\tO\\nfor\\tO\\nthe\\tO\\ndifferent\\tO\\nactivities\\tO\\n.\\tO\\n\\nThe\\tO\\nconsiderable\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\ndocumented\\tO\\nto\\tO\\ndate\\tO\\nundoubtedly\\tO\\ncontributes\\tO\\nto\\tO\\nthe\\tO\\nphenotypic\\tO\\nheterogeneity\\tO\\nthat\\tO\\nis\\tO\\nobserved\\tO\\nin\\tO\\ngalactosemia\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nadditional\\tO\\neffects\\tO\\nof\\tO\\nnonallelic\\tO\\nvariation\\tO\\nand\\tO\\nother\\tO\\nconstitutional\\tO\\nfactors\\tO\\non\\tO\\nphenotypic\\tO\\nvariability\\tO\\nremain\\tO\\nto\\tO\\nbe\\tO\\nelucidated\\tO\\n.\\tO\\n.\\tO\\n\\nMutations\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nin\\tO\\nsporadic\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\n:\\tO\\ndefinition\\tO\\nof\\tO\\na\\tO\\nrisk\\tO\\nfactor\\tO\\nfor\\tO\\nVHL\\tB-Disease\\npatients\\tO\\nto\\tO\\ndevelop\\tO\\nan\\tO\\nRCC\\tB-Disease\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nthe\\tO\\nnature\\tO\\nof\\tO\\nsomatic\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\n(\\tO\\nVHL\\tB-Disease\\n)\\tO\\nmutations\\tO\\n,\\tO\\nwe\\tO\\nanalyzed\\tO\\n173\\tO\\nprimary\\tO\\nsporadic\\tO\\nhuman\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\nfor\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ntumor\\tI-Disease\\nsuppressor\\tO\\ngene\\tO\\n,\\tO\\nusing\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\nand\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformational\\tO\\npolymorphism\\tO\\nanalysis\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\nof\\tO\\nDNA\\tO\\n.\\tO\\n\\nWe\\tO\\ndetected\\tO\\nabnormal\\tO\\nSSCP\\tO\\npattern\\tO\\nin\\tO\\n73\\tO\\nsamples\\tO\\n.\\tO\\n\\nAfter\\tO\\nsequencing\\tO\\n,\\tO\\nwe\\tO\\nidentified\\tO\\nmicrodeletions\\tO\\nin\\tO\\n58\\tO\\n%\\tO\\nof\\tO\\ncases\\tO\\n,\\tO\\nmicroinsertions\\tO\\nin\\tO\\n17\\tO\\n%\\tO\\n,\\tO\\nnonsense\\tO\\nmutations\\tO\\nin\\tO\\n8\\tO\\n%\\tO\\n,\\tO\\nand\\tO\\nmissense\\tO\\nmutations\\tO\\nin\\tO\\n17\\tO\\n%\\tO\\n.\\tO\\n\\nAmong\\tO\\nthese\\tO\\nmutations\\tO\\n,\\tO\\n50\\tO\\n%\\tO\\ncorrespond\\tO\\nto\\tO\\nnew\\tO\\nmutations\\tO\\n.\\tO\\n\\nVHL\\tB-Disease\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nonly\\tO\\nin\\tO\\nthe\\tO\\nnonpapillary\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\n(\\tO\\nRCC\\tB-Disease\\n)\\tO\\nsubtype\\tO\\n,\\tO\\nas\\tO\\npreviously\\tO\\nreported\\tO\\n.\\tO\\n\\nTo\\tO\\ncompare\\tO\\nsomatic\\tO\\nand\\tO\\ngermline\\tO\\nmutations\\tO\\n,\\tO\\nwe\\tO\\nused\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ndatabase\\tO\\n,\\tO\\nwhich\\tO\\nincludes\\tO\\n507\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nstudy\\tO\\nof\\tO\\nmutational\\tO\\nevents\\tO\\nrevealed\\tO\\na\\tO\\nsignificant\\tO\\ndifference\\tO\\nbetween\\tO\\nsomatic\\tO\\nand\\tO\\ngermline\\tO\\nmutations\\tO\\nwith\\tO\\nmutations\\tO\\nleading\\tO\\nto\\tO\\ntruncated\\tO\\nproteins\\tO\\nobserved\\tO\\nin\\tO\\n78\\tO\\n%\\tO\\nof\\tO\\nsomatic\\tO\\nmutations\\tO\\nvs\\tO\\nonly\\tO\\n37\\tO\\n%\\tO\\nin\\tO\\ngermline\\tO\\nmutations\\tO\\n(\\tO\\nP\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n001\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\npostulated\\tO\\nthat\\tO\\na\\tO\\nspecific\\tO\\npattern\\tO\\nof\\tO\\nVHL\\tB-Disease\\nmutations\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nsporadic\\tB-Disease\\nRCC\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\npattern\\tO\\ncorresponds\\tO\\nto\\tO\\nmutations\\tO\\nleading\\tO\\nmainly\\tO\\nto\\tO\\ntruncated\\tO\\nproteins\\tO\\nwith\\tO\\nfew\\tO\\nspecific\\tO\\nmissense\\tO\\nmutations\\tO\\n.\\tO\\n\\nWe\\tO\\nthen\\tO\\nanalyzed\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nRCC\\tB-Disease\\nin\\tO\\nVHL\\tB-Disease\\nfamilies\\tO\\n,\\tO\\nbased\\tO\\non\\tO\\nthe\\tO\\nnature\\tO\\nof\\tO\\nmutations\\tO\\n.\\tO\\n\\nWe\\tO\\nobserved\\tO\\nRCC\\tB-Disease\\nin\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\nfamilies\\tO\\nin\\tO\\n77\\tO\\n%\\tO\\nof\\tO\\ncases\\tO\\nwith\\tO\\nmutations\\tO\\nleading\\tO\\nto\\tO\\ntruncated\\tO\\nproteins\\tO\\nversus\\tO\\n55\\tO\\n%\\tO\\nin\\tO\\ncases\\tO\\nwith\\tO\\nmissense\\tO\\nmutations\\tO\\n(\\tO\\nP\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n05\\tO\\n)\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nmutations\\tO\\nresulting\\tO\\nin\\tO\\ntruncated\\tO\\nproteins\\tO\\nmay\\tO\\nlead\\tO\\nto\\tO\\na\\tO\\nhigher\\tO\\nrisk\\tO\\nof\\tO\\nRCC\\tB-Disease\\nin\\tO\\nVHL\\tB-Disease\\npatients\\tO\\n\\nDefective\\tO\\nCTLA\\tO\\n-\\tO\\n4\\tO\\ncycling\\tO\\npathway\\tO\\nin\\tO\\nChediak\\tB-Disease\\n-\\tI-Disease\\nHigashi\\tI-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\na\\tO\\npossible\\tO\\nmechanism\\tO\\nfor\\tO\\nderegulation\\tO\\nof\\tO\\nT\\tO\\nlymphocyte\\tO\\nactivation\\tO\\n.\\tO\\n\\nCytotoxic\\tO\\nT\\tO\\nlymphocyte\\tO\\n-\\tO\\nassociated\\tO\\nantigen\\tO\\n4\\tO\\n(\\tO\\nCTLA\\tO\\n-\\tO\\n4\\tO\\n,\\tO\\nalso\\tO\\nknown\\tO\\nas\\tO\\nCD152\\tO\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nplay\\tO\\na\\tO\\nmajor\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\nregulation\\tO\\nof\\tO\\nT\\tO\\ncell\\tO\\nactivation\\tO\\n.\\tO\\n\\nIts\\tO\\nmembrane\\tO\\nexpression\\tO\\nis\\tO\\nhighly\\tO\\nregulated\\tO\\nby\\tO\\nendocytosis\\tO\\nand\\tO\\ntrafficking\\tO\\nthrough\\tO\\nthe\\tO\\nsecretory\\tO\\nlysosome\\tO\\npathway\\tO\\n.\\tO\\n\\nChediak\\tB-Disease\\n-\\tI-Disease\\nHigashi\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nCHS\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\ninherited\\tB-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nlysosomal\\tO\\ntrafficking\\tO\\nregulator\\tO\\ngene\\tO\\n,\\tO\\nLYST\\tO\\n.\\tO\\n\\nIt\\tO\\nresults\\tO\\nin\\tO\\ndefective\\tO\\nmembrane\\tO\\ntargeting\\tO\\nof\\tO\\nthe\\tO\\nproteins\\tO\\npresent\\tO\\nin\\tO\\nsecretory\\tO\\nlysosomes\\tO\\n,\\tO\\nand\\tO\\nit\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nfeatures\\tO\\n,\\tO\\nincluding\\tO\\na\\tO\\nlymphoproliferative\\tB-Disease\\nsyndrome\\tI-Disease\\nwith\\tO\\nhemophagocytosis\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nmurine\\tO\\nequivalent\\tO\\nof\\tO\\nCHS\\tB-Disease\\n,\\tO\\nbeige\\tO\\nmice\\tO\\n,\\tO\\npresent\\tO\\nsimilar\\tO\\ncharacteristics\\tO\\nbut\\tO\\ndo\\tO\\nnot\\tO\\ndevelop\\tO\\nthe\\tO\\nlymphoproliferative\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nherein\\tO\\nthat\\tO\\nCTLA\\tO\\n-\\tO\\n4\\tO\\nis\\tO\\npresent\\tO\\nin\\tO\\nenlarged\\tO\\n,\\tO\\nabnormal\\tO\\nvesicles\\tO\\nin\\tO\\nCHS\\tB-Disease\\nT\\tO\\ncells\\tO\\nand\\tO\\nis\\tO\\nnot\\tO\\nproperly\\tO\\nexpressed\\tO\\nat\\tO\\nthe\\tO\\ncell\\tO\\nsurface\\tO\\nafter\\tO\\nT\\tO\\ncell\\tO\\nactivation\\tO\\n,\\tO\\nwhereas\\tO\\nits\\tO\\nsurface\\tO\\nexpression\\tO\\nis\\tO\\nnot\\tO\\nimpaired\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\ntherefore\\tO\\nproposed\\tO\\nthat\\tO\\nthe\\tO\\ndefective\\tO\\nsurface\\tO\\nexpression\\tO\\nof\\tO\\nCTLA\\tO\\n-\\tO\\n4\\tO\\nby\\tO\\nCHS\\tB-Disease\\nT\\tO\\ncells\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\ngeneration\\tO\\nof\\tO\\nlymphoproliferative\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nobservation\\tO\\nmay\\tO\\nprovide\\tO\\ninsight\\tO\\ninto\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nCTLA\\tO\\n-\\tO\\n4\\tO\\nin\\tO\\nhumans\\tO\\n.\\tO\\n.\\tO\\n\\nProteolipoprotein\\tO\\ngene\\tO\\nanalysis\\tO\\nin\\tO\\n82\\tO\\npatients\\tO\\nwith\\tO\\nsporadic\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\nDisease\\tI-Disease\\n:\\tO\\nduplications\\tO\\n,\\tO\\nthe\\tO\\nmajor\\tO\\ncause\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n,\\tO\\noriginate\\tO\\nmore\\tO\\nfrequently\\tO\\nin\\tO\\nmale\\tO\\ngerm\\tO\\ncells\\tO\\n,\\tO\\nbut\\tO\\npoint\\tO\\nmutations\\tO\\ndo\\tO\\nnot\\tO\\n.\\tO\\n\\nThe\\tO\\nClinical\\tO\\nEuropean\\tO\\nNetwork\\tO\\non\\tO\\nBrain\\tB-Disease\\nDysmyelinating\\tI-Disease\\nDisease\\tI-Disease\\n.\\tO\\n\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\nDisease\\tI-Disease\\n(\\tO\\nPMD\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndevelopmental\\tI-Disease\\ndefect\\tI-Disease\\nof\\tI-Disease\\nmyelination\\tI-Disease\\naffecting\\tO\\nthe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\nand\\tO\\nsegregating\\tO\\nwith\\tO\\nthe\\tO\\nproteolipoprotein\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\nlocus\\tO\\n.\\tO\\n\\nInvestigating\\tO\\n82\\tO\\nstrictly\\tO\\nselected\\tO\\nsporadic\\tO\\ncases\\tO\\nof\\tO\\nPMD\\tB-Disease\\n,\\tO\\nwe\\tO\\nfound\\tO\\nPLP\\tO\\nmutations\\tO\\nin\\tO\\n77\\tO\\n%\\tO\\n;\\tO\\ncomplete\\tO\\nPLP\\tO\\n-\\tO\\ngene\\tO\\nduplications\\tO\\nwere\\tO\\nthe\\tO\\nmost\\tO\\nfrequent\\tO\\nabnormality\\tO\\n(\\tO\\n62\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nwhereas\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\ncoding\\tO\\nor\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nwere\\tO\\ninvolved\\tO\\nless\\tO\\nfrequently\\tO\\n(\\tO\\n38\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nanalyzed\\tO\\nthe\\tO\\nmaternal\\tO\\nstatus\\tO\\nof\\tO\\n56\\tO\\ncases\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\norigin\\tO\\nof\\tO\\nboth\\tO\\ntypes\\tO\\nof\\tO\\nPLP\\tO\\nmutation\\tO\\n,\\tO\\nsince\\tO\\nthis\\tO\\nis\\tO\\nrelevant\\tO\\nto\\tO\\ngenetic\\tO\\ncounseling\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\n22\\tO\\npoint\\tO\\nmutations\\tO\\n,\\tO\\n68\\tO\\n%\\tO\\nof\\tO\\nmothers\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nmutation\\tO\\n,\\tO\\na\\tO\\nvalue\\tO\\nidentical\\tO\\nto\\tO\\nthe\\tO\\ntwo\\tO\\n-\\tO\\nthirds\\tO\\nof\\tO\\ncarrier\\tO\\nmothers\\tO\\nthat\\tO\\nwould\\tO\\nbe\\tO\\nexpected\\tO\\nif\\tO\\nthere\\tO\\nwere\\tO\\nan\\tO\\nequal\\tO\\nmutation\\tO\\nrate\\tO\\nin\\tO\\nmale\\tO\\nand\\tO\\nfemale\\tO\\ngerm\\tO\\ncells\\tO\\n.\\tO\\n\\nIn\\tO\\nsharp\\tO\\ncontrast\\tO\\n,\\tO\\namong\\tO\\nthe\\tO\\n34\\tO\\nduplicated\\tO\\ncases\\tO\\n,\\tO\\n91\\tO\\n%\\tO\\nof\\tO\\nmothers\\tO\\nwere\\tO\\ncarriers\\tO\\n,\\tO\\na\\tO\\nvalue\\tO\\nsignificantly\\tO\\n(\\tO\\nchi2\\tO\\n=\\tO\\n9\\tO\\n.\\tO\\n20\\tO\\n,\\tO\\nP\\tO\\n<\\tO\\n.\\tO\\n01\\tO\\n)\\tO\\nin\\tO\\nfavor\\tO\\nof\\tO\\na\\tO\\nmale\\tO\\nbias\\tO\\n,\\tO\\nwith\\tO\\nan\\tO\\nestimation\\tO\\nof\\tO\\nthe\\tO\\nmale\\tO\\n/\\tO\\nfemale\\tO\\nmutation\\tO\\nfrequency\\tO\\n(\\tO\\nk\\tO\\n)\\tO\\nof\\tO\\n9\\tO\\n.\\tO\\n\\n3\\tO\\n3\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nwe\\tO\\nobserved\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nde\\tO\\nnovo\\tO\\nmutations\\tO\\nbetween\\tO\\nparental\\tO\\nand\\tO\\ngrandparental\\tO\\ngenerations\\tO\\nin\\tO\\n17\\tO\\nthree\\tO\\n-\\tO\\ngeneration\\tO\\nfamilies\\tO\\n,\\tO\\nwhich\\tO\\nallowed\\tO\\na\\tO\\ndirect\\tO\\nestimation\\tO\\nof\\tO\\nthe\\tO\\nk\\tO\\nvalue\\tO\\n(\\tO\\nk\\tO\\n=\\tO\\n11\\tO\\n)\\tO\\n.\\tO\\n\\nAgain\\tO\\n,\\tO\\na\\tO\\nsignificant\\tO\\nmale\\tO\\nmutation\\tO\\nimbalance\\tO\\nwas\\tO\\nobserved\\tO\\nonly\\tO\\nfor\\tO\\nthe\\tO\\nduplications\\tO\\n.\\tO\\n\\nChromosome\\tO\\nbreakage\\tO\\nin\\tO\\nthe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nand\\tI-Disease\\nAngelman\\tI-Disease\\nsyndromes\\tI-Disease\\ninvolves\\tO\\nrecombination\\tO\\nbetween\\tO\\nlarge\\tO\\n,\\tO\\ntranscribed\\tO\\nrepeats\\tO\\nat\\tO\\nproximal\\tO\\nand\\tO\\ndistal\\tO\\nbreakpoints\\tO\\n.\\tO\\n\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\nand\\tO\\nAngelman\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nAS\\tB-Disease\\n)\\tO\\nare\\tO\\ndistinct\\tO\\nneurobehavioral\\tB-Disease\\ndisorders\\tI-Disease\\nthat\\tO\\nmost\\tO\\noften\\tO\\narise\\tO\\nfrom\\tO\\na\\tO\\n4\\tO\\n-\\tO\\nMb\\tO\\ndeletion\\tO\\nof\\tO\\nchromosome\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\nduring\\tO\\npaternal\\tO\\nor\\tO\\nmaternal\\tO\\ngametogenesis\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nAt\\tO\\na\\tO\\nde\\tO\\nnovo\\tO\\nfrequency\\tO\\nof\\tO\\napproximately\\tO\\n.\\tO\\n\\n67\\tO\\n-\\tO\\n1\\tO\\n/\\tO\\n10\\tO\\n,\\tO\\n000\\tO\\nbirths\\tO\\n,\\tO\\nthese\\tO\\ndeletions\\tO\\nrepresent\\tO\\na\\tO\\ncommon\\tO\\nstructural\\tO\\nchromosome\\tO\\nchange\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\ngenome\\tO\\n.\\tO\\n\\nTo\\tO\\nelucidate\\tO\\nthe\\tO\\nmechanism\\tO\\nunderlying\\tO\\nthese\\tO\\nevents\\tO\\n,\\tO\\nwe\\tO\\ncharacterized\\tO\\nthe\\tO\\nregions\\tO\\nthat\\tO\\ncontain\\tO\\ntwo\\tO\\nproximal\\tO\\nbreakpoint\\tO\\nclusters\\tO\\nand\\tO\\na\\tO\\ndistal\\tO\\ncluster\\tO\\n.\\tO\\n\\nNovel\\tO\\nDNA\\tO\\nsequences\\tO\\npotentially\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nbreakpoints\\tO\\nwere\\tO\\npositionally\\tO\\ncloned\\tO\\nfrom\\tO\\nYACs\\tO\\nwithin\\tO\\nor\\tO\\nnear\\tO\\nthese\\tO\\nregions\\tO\\n.\\tO\\n\\nAnalyses\\tO\\nof\\tO\\nrodent\\tO\\n-\\tO\\nhuman\\tO\\nsomatic\\tO\\n-\\tO\\ncell\\tO\\nhybrids\\tO\\n,\\tO\\nYAC\\tO\\ncontigs\\tO\\n,\\tO\\nand\\tO\\nFISH\\tO\\nof\\tO\\nnormal\\tO\\nor\\tO\\nrearranged\\tO\\nchromosomes\\tO\\n15\\tO\\nidentified\\tO\\nduplicated\\tO\\nsequences\\tO\\n(\\tO\\nthe\\tO\\nEND\\tO\\nrepeats\\tO\\n)\\tO\\nat\\tO\\nor\\tO\\nnear\\tO\\nthe\\tO\\nbreakpoints\\tO\\n.\\tO\\n\\nThe\\tO\\nEND\\tO\\n-\\tO\\nrepeat\\tO\\nunits\\tO\\nare\\tO\\nderived\\tO\\nfrom\\tO\\nlarge\\tO\\ngenomic\\tO\\nduplications\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\ngene\\tO\\n(\\tO\\nHERC2\\tO\\n)\\tO\\n,\\tO\\nmany\\tO\\ncopies\\tO\\nof\\tO\\nwhich\\tO\\nare\\tO\\ntranscriptionally\\tO\\nactive\\tO\\nin\\tO\\ngermline\\tO\\ntissues\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nfive\\tO\\nPWS\\tB-Disease\\n/\\tO\\nAS\\tB-Disease\\npatients\\tO\\nanalyzed\\tO\\nto\\tO\\ndate\\tO\\nhas\\tO\\nan\\tO\\nidentifiable\\tO\\n,\\tO\\nrearranged\\tO\\nHERC2\\tO\\ntranscript\\tO\\nderived\\tO\\nfrom\\tO\\nthe\\tO\\ndeletion\\tO\\nevent\\tO\\n.\\tO\\n\\nWe\\tO\\npostulate\\tO\\nthat\\tO\\nthe\\tO\\nEND\\tO\\nrepeats\\tO\\nflanking\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\nmediate\\tO\\nhomologous\\tO\\nrecombination\\tO\\nresulting\\tO\\nin\\tO\\ndeletion\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nwe\\tO\\npropose\\tO\\nthat\\tO\\nactive\\tO\\ntranscription\\tO\\nof\\tO\\nthese\\tO\\nrepeats\\tO\\nin\\tO\\nmale\\tO\\nand\\tO\\nfemale\\tO\\ngerm\\tO\\ncells\\tO\\nmay\\tO\\nfacilitate\\tO\\nthe\\tO\\nhomologous\\tO\\nrecombination\\tO\\nprocess\\tO\\n.\\tO\\n\\nLinkage\\tO\\nanalysis\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nBrazilian\\tO\\nfamily\\tO\\nwith\\tO\\nvan\\tB-Disease\\nder\\tI-Disease\\nWoude\\tI-Disease\\nsyndrome\\tI-Disease\\nsuggests\\tO\\nthe\\tO\\nexistence\\tO\\nof\\tO\\na\\tO\\nsusceptibility\\tO\\nlocus\\tO\\nfor\\tO\\ncleft\\tB-Disease\\npalate\\tI-Disease\\nat\\tO\\n17p11\\tO\\n.\\tO\\n2\\tO\\n-\\tO\\n11\\tO\\n.\\tO\\n1\\tO\\n.\\tO\\n\\nvan\\tB-Disease\\nder\\tI-Disease\\nWoude\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nVWS\\tB-Disease\\n)\\tO\\n,\\tO\\nwhich\\tO\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\n1q32\\tO\\n-\\tO\\n41\\tO\\n,\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\npits\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\nsinuses\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nlower\\tI-Disease\\nlip\\tI-Disease\\n,\\tO\\ncleft\\tB-Disease\\nlip\\tI-Disease\\n/\\tI-Disease\\npalate\\tI-Disease\\n(\\tO\\nCL\\tB-Disease\\n/\\tI-Disease\\nP\\tI-Disease\\n)\\tO\\n,\\tO\\ncleft\\tB-Disease\\npalate\\tI-Disease\\n(\\tO\\nCP\\tB-Disease\\n)\\tO\\n,\\tO\\nbifid\\tB-Disease\\nuvula\\tI-Disease\\n,\\tO\\nand\\tO\\nhypodontia\\tB-Disease\\n(\\tO\\nH\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nexpression\\tO\\nof\\tO\\nVWS\\tB-Disease\\n,\\tO\\nwhich\\tO\\nhas\\tO\\nincomplete\\tO\\npenetrance\\tO\\n,\\tO\\nis\\tO\\nhighly\\tO\\nvariable\\tO\\n.\\tO\\n\\nBoth\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nCL\\tB-Disease\\n/\\tI-Disease\\nP\\tI-Disease\\nand\\tO\\nCP\\tB-Disease\\nwithin\\tO\\nthe\\tO\\nsame\\tO\\ngenealogy\\tO\\nand\\tO\\na\\tO\\nrecurrence\\tO\\nrisk\\tO\\n<\\tO\\n40\\tO\\n%\\tO\\nfor\\tO\\nCP\\tB-Disease\\namong\\tO\\ndescendants\\tO\\nwith\\tO\\nVWS\\tB-Disease\\nhave\\tO\\nsuggested\\tO\\nthat\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nclefts\\tB-Disease\\nin\\tO\\nthis\\tO\\nsyndrome\\tO\\nis\\tO\\ninfluenced\\tO\\nby\\tO\\nmodifying\\tO\\ngenes\\tO\\nat\\tO\\nother\\tO\\nloci\\tO\\n.\\tO\\n\\nTo\\tO\\ntest\\tO\\nthis\\tO\\nhypothesis\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nconducted\\tO\\nlinkage\\tO\\nanalysis\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nBrazilian\\tO\\nkindred\\tO\\nwith\\tO\\nVWS\\tB-Disease\\n,\\tO\\nconsidering\\tO\\nas\\tO\\naffected\\tO\\nthe\\tO\\nindividuals\\tO\\nwith\\tO\\nCP\\tB-Disease\\n,\\tO\\nregardless\\tO\\nof\\tO\\nwhether\\tO\\nit\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nother\\tO\\nclinical\\tO\\nsigns\\tO\\nof\\tO\\nVWS\\tB-Disease\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\na\\tO\\ngene\\tO\\nat\\tO\\n17p11\\tO\\n.\\tO\\n\\n2\\tO\\n-\\tO\\n11\\tO\\n2\\tO\\n-\\tO\\n11\\tO\\n.\\tO\\n\\n1\\tO\\n,\\tO\\ntogether\\tO\\nwith\\tO\\nthe\\tO\\nVWS\\tB-Disease\\ngene\\tO\\nat\\tO\\n1p32\\tO\\n-\\tO\\n41\\tO\\n,\\tO\\nenhances\\tO\\nthe\\tO\\nprobability\\tO\\nof\\tO\\nCP\\tB-Disease\\nin\\tO\\nan\\tO\\nindividual\\tO\\ncarrying\\tO\\nthe\\tO\\ntwo\\tO\\nat\\tO\\n-\\tO\\nrisk\\tO\\ngenes\\tO\\n.\\tO\\n\\nIf\\tO\\nthis\\tO\\nhypothesis\\tO\\nis\\tO\\nconfirmed\\tO\\nin\\tO\\nother\\tO\\nVWS\\tB-Disease\\npedigrees\\tO\\n,\\tO\\nit\\tO\\nwill\\tO\\nrepresent\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nfirst\\tO\\nexamples\\tO\\nof\\tO\\na\\tO\\ngene\\tO\\n,\\tO\\nmapped\\tO\\nthrough\\tO\\nlinkage\\tO\\nanalysis\\tO\\n,\\tO\\nwhich\\tO\\nmodifies\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\na\\tO\\nmajor\\tO\\ngene\\tO\\n.\\tO\\n\\nNew\\tO\\nmutations\\tO\\n,\\tO\\npolymorphisms\\tO\\n,\\tO\\nand\\tO\\nrare\\tO\\nvariants\\tO\\nin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\ndetected\\tO\\nby\\tO\\na\\tO\\nnovel\\tO\\nSSCP\\tO\\nstrategy\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nfor\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n,\\tO\\nATM\\tO\\n,\\tO\\nspans\\tO\\nabout\\tO\\n150\\tO\\nkb\\tO\\nof\\tO\\ngenomic\\tO\\nDNA\\tO\\n.\\tO\\n\\nATM\\tO\\nmutations\\tO\\nare\\tO\\nfound\\tO\\nalong\\tO\\nthe\\tO\\nentire\\tO\\ngene\\tO\\n,\\tO\\nwith\\tO\\nno\\tO\\nevidence\\tO\\nof\\tO\\na\\tO\\nmutational\\tO\\nhot\\tO\\nspot\\tO\\n.\\tO\\n\\nUsing\\tO\\nDNA\\tO\\nas\\tO\\nthe\\tO\\nstarting\\tO\\nmaterial\\tO\\n,\\tO\\nwe\\tO\\nscreened\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nin\\tO\\n92\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\n,\\tO\\nusing\\tO\\nan\\tO\\noptimized\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\ntechnique\\tO\\nthat\\tO\\ndetected\\tO\\nall\\tO\\npreviously\\tO\\nknown\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\nsegments\\tO\\nbeing\\tO\\nanalyzed\\tO\\n.\\tO\\n\\nTo\\tO\\nexpedite\\tO\\nscreening\\tO\\n,\\tO\\nwe\\tO\\nsequentially\\tO\\nloaded\\tO\\nthe\\tO\\nSSCP\\tO\\ngels\\tO\\nwith\\tO\\nthree\\tO\\ndifferent\\tO\\nsets\\tO\\nof\\tO\\nPCR\\tO\\nproducts\\tO\\nthat\\tO\\nwere\\tO\\npretested\\tO\\nto\\tO\\navoid\\tO\\noverlapping\\tO\\npatterns\\tO\\n.\\tO\\n\\nMany\\tO\\nof\\tO\\nthe\\tO\\nDNA\\tO\\nchanges\\tO\\nwe\\tO\\ndetected\\tO\\nwere\\tO\\nintragenic\\tO\\npolymorphisms\\tO\\n.\\tO\\n\\nOf\\tO\\nan\\tO\\nexpected\\tO\\n177\\tO\\nunknown\\tO\\nmutations\\tO\\n,\\tO\\nwe\\tO\\ndetected\\tO\\napproximately\\tO\\n70\\tO\\n%\\tO\\n,\\tO\\nmostly\\tO\\nprotein\\tO\\ntruncating\\tO\\nmutations\\tO\\n(\\tO\\nthat\\tO\\nwould\\tO\\nhave\\tO\\nbeen\\tO\\ndetectable\\tO\\nby\\tO\\nprotein\\tO\\ntruncation\\tO\\ntesting\\tO\\nif\\tO\\nRNA\\tO\\nstarting\\tO\\nmaterial\\tO\\nhad\\tO\\nbeen\\tO\\navailable\\tO\\n)\\tO\\n.\\tO\\n\\nMutations\\tO\\nhave\\tO\\nnow\\tO\\nbeen\\tO\\ndefined\\tO\\nfor\\tO\\nevery\\tO\\nexon\\tO\\nof\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\n.\\tO\\n\\nHerein\\tO\\n,\\tO\\nwe\\tO\\npresent\\tO\\n35\\tO\\nnew\\tO\\nmutations\\tO\\nand\\tO\\n34\\tO\\nnew\\tO\\nintragenic\\tO\\npolymorphisms\\tO\\nor\\tO\\nrare\\tO\\nvariants\\tO\\nwithin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncomprehensive\\tO\\ncompilation\\tO\\nof\\tO\\nATM\\tO\\npolymorphisms\\tO\\nassembled\\tO\\nto\\tO\\ndate\\tO\\n.\\tO\\n\\nDefining\\tO\\npolymorphic\\tO\\nsites\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nwill\\tO\\nbe\\tO\\nof\\tO\\ngreat\\tO\\nimportance\\tO\\nin\\tO\\ndesigning\\tO\\nautomated\\tO\\nmethods\\tO\\nfor\\tO\\ndetecting\\tO\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nnovel\\tO\\nframeshift\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nMcLeod\\tB-Disease\\nsyndrome\\tI-Disease\\ngene\\tO\\nin\\tO\\na\\tO\\nJapanese\\tO\\nfamily\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\na\\tO\\nnovel\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nXK\\tO\\ngene\\tO\\n(\\tO\\nXK\\tO\\n)\\tO\\nin\\tO\\na\\tO\\nJapanese\\tO\\npatient\\tO\\nwith\\tO\\nMcLeod\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nA\\tO\\n50\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nman\\tO\\nshowed\\tO\\nprogressive\\tO\\nmuscular\\tB-Disease\\natrophy\\tI-Disease\\n,\\tO\\nchoreic\\tB-Disease\\nmovement\\tI-Disease\\n,\\tO\\nelevated\\tO\\nlevel\\tO\\nof\\tO\\nserum\\tO\\ncreatinine\\tO\\nkinase\\tO\\n,\\tO\\nand\\tO\\nacanthocytosis\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nexpression\\tO\\nlevel\\tO\\nof\\tO\\nall\\tO\\nthe\\tO\\nKell\\tO\\nantigens\\tO\\nin\\tO\\nerythrocyte\\tO\\nwas\\tO\\ndecreased\\tO\\nand\\tO\\nmolecular\\tO\\nanalysis\\tO\\nrevealed\\tO\\na\\tO\\nsingle\\tO\\n-\\tO\\nbase\\tO\\n(\\tO\\nT\\tO\\n)\\tO\\ndeletion\\tO\\nat\\tO\\nthe\\tO\\nnucleotide\\tO\\nposition\\tO\\n1095\\tO\\nin\\tO\\nXK\\tO\\n.\\tO\\n\\nThis\\tO\\ndeletion\\tO\\ncaused\\tO\\na\\tO\\nframeshift\\tO\\nin\\tO\\ntranslation\\tO\\n,\\tO\\nleading\\tO\\nto\\tO\\na\\tO\\npremature\\tO\\nstop\\tO\\ncodon\\tO\\nat\\tO\\nthe\\tO\\namino\\tO\\nacid\\tO\\nposition\\tO\\n408\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthis\\tO\\nsingle\\tO\\n-\\tO\\nbase\\tO\\ndeletion\\tO\\ncauses\\tO\\ndefective\\tO\\nKx\\tO\\nprotein\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nMcLeod\\tB-Disease\\nphenotype\\tO\\nin\\tO\\nthis\\tO\\npatient\\tO\\n.\\tO\\n.\\tO\\n\\nAssociation\\tO\\nof\\tO\\nBRCA1\\tO\\nwith\\tO\\nthe\\tO\\nhRad50\\tO\\n-\\tO\\nhMre11\\tO\\n-\\tO\\np95\\tO\\ncomplex\\tO\\nand\\tO\\nthe\\tO\\nDNA\\tO\\ndamage\\tO\\nresponse\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nencodes\\tO\\na\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\nthat\\tO\\nis\\tO\\nmutated\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nit\\tO\\nis\\tO\\nshown\\tO\\nthat\\tO\\nBRCA1\\tO\\ninteracts\\tO\\nin\\tO\\nvitro\\tO\\nand\\tO\\nin\\tO\\nvivo\\tO\\nwith\\tO\\nhRad50\\tO\\n,\\tO\\nwhich\\tO\\nforms\\tO\\na\\tO\\ncomplex\\tO\\nwith\\tO\\nhMre11\\tO\\nand\\tO\\np95\\tO\\n/\\tO\\nnibrin\\tO\\n.\\tO\\n\\nUpon\\tO\\nirradiation\\tO\\n,\\tO\\nBRCA1\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\ndiscrete\\tO\\nfoci\\tO\\nin\\tO\\nthe\\tO\\nnucleus\\tO\\n,\\tO\\nwhich\\tO\\ncolocalize\\tO\\nwith\\tO\\nhRad50\\tO\\n.\\tO\\n\\nFormation\\tO\\nof\\tO\\nirradiation\\tO\\n-\\tO\\ninduced\\tO\\nfoci\\tO\\npositive\\tO\\nfor\\tO\\nBRCA1\\tO\\n,\\tO\\nhRad50\\tO\\n,\\tO\\nhMre11\\tO\\n,\\tO\\nor\\tO\\np95\\tO\\nwas\\tO\\ndramatically\\tO\\nreduced\\tO\\nin\\tO\\nHCC\\tO\\n/\\tO\\n1937\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\ncells\\tO\\ncarrying\\tO\\na\\tO\\nhomozygous\\tO\\nmutation\\tO\\nin\\tO\\nBRCA1\\tO\\nbut\\tO\\nwas\\tO\\nrestored\\tO\\nby\\tO\\ntransfection\\tO\\nof\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nEctopic\\tO\\nexpression\\tO\\nof\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nmutated\\tO\\n,\\tO\\nBRCA1\\tO\\nin\\tO\\nthese\\tO\\ncells\\tO\\nrendered\\tO\\nthem\\tO\\nless\\tO\\nsensitive\\tO\\nto\\tO\\nthe\\tO\\nDNA\\tO\\ndamage\\tO\\nagent\\tO\\n,\\tO\\nmethyl\\tO\\nmethanesulfonate\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nBRCA1\\tO\\nis\\tO\\nimportant\\tO\\nfor\\tO\\nthe\\tO\\ncellular\\tO\\nresponses\\tO\\nto\\tO\\nDNA\\tO\\ndamage\\tO\\nthat\\tO\\nare\\tO\\nmediated\\tO\\nby\\tO\\nthe\\tO\\nhRad50\\tO\\n-\\tO\\nhMre11\\tO\\n-\\tO\\np95\\tO\\ncomplex\\tO\\n.\\tO\\n.\\tO\\n\\nRelationship\\tO\\namong\\tO\\ngenotype\\tO\\n,\\tO\\nbiochemical\\tO\\nphenotype\\tO\\n,\\tO\\nand\\tO\\ncognitive\\tO\\nperformance\\tO\\nin\\tO\\nfemales\\tO\\nwith\\tO\\nphenylalanine\\tB-Disease\\nhydroxylase\\tI-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\nreport\\tO\\nfrom\\tO\\nthe\\tO\\nMaternal\\tB-Disease\\nPhenylketonuria\\tI-Disease\\nCollaborative\\tO\\nStudy\\tO\\n.\\tO\\n\\nOBJECTIVE\\tO\\nTo\\tO\\nexamine\\tO\\nthe\\tO\\nrelationship\\tO\\nof\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n(\\tO\\nPAH\\tO\\n)\\tO\\ngenotypes\\tO\\nto\\tO\\nbiochemical\\tO\\nphenotype\\tO\\nand\\tO\\ncognitive\\tO\\ndevelopment\\tO\\nin\\tO\\nmaternal\\tB-Disease\\nphenylketonuria\\tI-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nMETHODOLOGY\\tO\\nPAH\\tO\\ngene\\tO\\nmutations\\tO\\nwere\\tO\\nexamined\\tO\\nin\\tO\\n222\\tO\\nhyperphenylalaninemic\\tB-Disease\\nfemales\\tO\\nenrolled\\tO\\nin\\tO\\nthe\\tO\\nMaternal\\tB-Disease\\nPKU\\tI-Disease\\nCollaborative\\tO\\nStudy\\tO\\n(\\tO\\nMPKUCS\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n84\\tO\\ndifferent\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\n,\\tO\\nand\\tO\\ncomplete\\tO\\ngenotype\\tO\\nwas\\tO\\nobtained\\tO\\nin\\tO\\n199\\tO\\nindividuals\\tO\\n.\\tO\\n\\nBased\\tO\\non\\tO\\nprevious\\tO\\nknowledge\\tO\\nabout\\tO\\nmutation\\tO\\n-\\tO\\nphenotype\\tO\\nassociations\\tO\\n,\\tO\\n78\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\ncould\\tO\\nbe\\tO\\nassigned\\tO\\nto\\tO\\none\\tO\\nof\\tO\\nfour\\tO\\nclasses\\tO\\nof\\tO\\nseverity\\tO\\n(\\tO\\nsevere\\tO\\nPKU\\tB-Disease\\n,\\tO\\nmoderate\\tO\\nPKU\\tB-Disease\\n,\\tO\\nmild\\tO\\nPKU\\tB-Disease\\n,\\tO\\nand\\tO\\nmild\\tB-Disease\\nhyperphenylalaninemia\\tI-Disease\\n[\\tO\\nMHP\\tB-Disease\\n]\\tO\\n)\\tO\\n.\\tO\\n\\nThen\\tO\\n,\\tO\\n189\\tO\\nMPKUCS\\tO\\nsubjects\\tO\\nwere\\tO\\ngrouped\\tO\\naccording\\tO\\nto\\tO\\nthe\\tO\\nvarious\\tO\\ncombinations\\tO\\nof\\tO\\nmutation\\tO\\nclassifications\\tO\\n.\\tO\\n\\nThe\\tO\\nsample\\tO\\nsizes\\tO\\nwere\\tO\\nlarge\\tO\\nenough\\tO\\nfor\\tO\\nstatistical\\tO\\ntesting\\tO\\nin\\tO\\nfour\\tO\\ngroups\\tO\\nwith\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\nmutation\\tO\\nthat\\tO\\ncompletely\\tO\\nabolishes\\tO\\nenzyme\\tO\\nactivity\\tO\\n.\\tO\\n\\nThese\\tO\\npatients\\tO\\nare\\tO\\nconsidered\\tO\\nfunctionally\\tO\\nhemizygous\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nThe\\tO\\nbiochemical\\tO\\nphenotype\\tO\\npredicted\\tO\\nfrom\\tO\\nthe\\tO\\ngenotype\\tO\\nin\\tO\\nfunctionally\\tO\\nhemizygous\\tO\\npatients\\tO\\nwas\\tO\\nrelated\\tO\\nsignificantly\\tO\\nto\\tO\\nthe\\tO\\nassigned\\tO\\nphenylalanine\\tO\\nlevel\\tO\\n.\\tO\\n\\nCognitive\\tO\\nperformance\\tO\\n(\\tO\\nIQ\\tO\\n)\\tO\\nwas\\tO\\nalso\\tO\\nsignificantly\\tO\\nrelated\\tO\\nto\\tO\\ngenotype\\tO\\n.\\tO\\n\\nThe\\tO\\nIQ\\tO\\nof\\tO\\nPAH\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nmothers\\tO\\nwith\\tO\\na\\tO\\nsevere\\tO\\nPKU\\tB-Disease\\nmutation\\tO\\nin\\tO\\ncombination\\tO\\nwith\\tO\\na\\tO\\nMHP\\tB-Disease\\nmutation\\tO\\nor\\tO\\na\\tO\\nmild\\tO\\nPKU\\tB-Disease\\nmutation\\tO\\nwas\\tO\\n99\\tO\\nand\\tO\\n96\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nIQ\\tO\\nof\\tO\\nPKU\\tB-Disease\\nmothers\\tO\\nwith\\tO\\ntwo\\tO\\nsevere\\tO\\nPKU\\tB-Disease\\nmutations\\tO\\nor\\tO\\nwith\\tO\\none\\tO\\nsevere\\tO\\nand\\tO\\none\\tO\\nmoderate\\tO\\nPKU\\tB-Disease\\nmutation\\tO\\nwas\\tO\\n83\\tO\\nand\\tO\\n84\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\npatients\\tO\\nwith\\tO\\nPKU\\tB-Disease\\n,\\tO\\n92\\tO\\n%\\tO\\nhad\\tO\\nbeen\\tO\\ntreated\\tO\\nduring\\tO\\nchildhood\\tO\\n.\\tO\\n\\nThose\\tO\\nwho\\tO\\nwere\\tO\\nuntreated\\tO\\nor\\tO\\ntreated\\tO\\nlate\\tO\\nhad\\tO\\nlower\\tO\\nthan\\tO\\naverage\\tO\\nIQ\\tO\\nscores\\tO\\nfor\\tO\\ntheir\\tO\\ngroup\\tO\\nof\\tO\\nmutation\\tO\\ncombinations\\tO\\n.\\tO\\n\\nFemales\\tO\\nwith\\tO\\nmoderate\\tO\\nor\\tO\\nmild\\tO\\nPKU\\tB-Disease\\nwho\\tO\\nwere\\tO\\ntreated\\tO\\nearly\\tO\\nand\\tO\\ntreated\\tO\\nfor\\tO\\n>\\tO\\n6\\tO\\nyears\\tO\\nshowed\\tO\\nIQ\\tO\\nscores\\tO\\n10\\tO\\npoints\\tO\\nabove\\tO\\naverage\\tO\\nfor\\tO\\ntheir\\tO\\ngroup\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nThe\\tO\\nreproductive\\tO\\noutcome\\tO\\nin\\tO\\nmaternal\\tB-Disease\\nphenylketonuria\\tI-Disease\\nis\\tO\\ndependent\\tO\\non\\tO\\nprenatal\\tO\\nmetabolic\\tO\\ncontrol\\tO\\nand\\tO\\npostnatal\\tO\\nenvironmental\\tO\\ncircumstances\\tO\\n.\\tO\\n\\nBoth\\tO\\nfactors\\tO\\ndepend\\tO\\non\\tO\\nthe\\tO\\nintellectual\\tO\\nresources\\tO\\nof\\tO\\nthe\\tO\\nmother\\tO\\nwith\\tO\\nPKU\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nsignificant\\tO\\nrelationship\\tO\\namong\\tO\\ngenotype\\tO\\n,\\tO\\nbiochemical\\tO\\nphenotype\\tO\\n,\\tO\\nand\\tO\\ncognitive\\tO\\nperformance\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\nis\\tO\\nof\\tO\\nimportance\\tO\\nfor\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nan\\tO\\noptimal\\tO\\nstrategy\\tO\\nfor\\tO\\nfuture\\tO\\ntreatment\\tO\\nof\\tO\\nfemales\\tO\\nwith\\tO\\nPKU\\tB-Disease\\nwho\\tO\\nplan\\tO\\npregnancy\\tO\\n.\\tO\\n.\\tO\\n\\nSpinal\\tB-Disease\\nxanthomatosis\\tI-Disease\\n:\\tO\\na\\tO\\nvariant\\tO\\nof\\tO\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nseven\\tO\\nDutch\\tO\\npatients\\tO\\nfrom\\tO\\nsix\\tO\\nfamilies\\tO\\nwith\\tO\\na\\tO\\nslowly\\tO\\nprogressive\\tO\\n,\\tO\\nmainly\\tO\\nspinal\\tB-Disease\\ncord\\tI-Disease\\nsyndrome\\tI-Disease\\nthat\\tO\\nremained\\tO\\nfor\\tO\\nmany\\tO\\nyears\\tO\\nthe\\tO\\nsole\\tO\\nexpression\\tO\\nof\\tO\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n(\\tO\\nCTX\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nMRI\\tO\\ndemonstrated\\tO\\nwhite\\tB-Disease\\nmatter\\tI-Disease\\nabnormalities\\tI-Disease\\nin\\tO\\nthe\\tO\\nlateral\\tO\\nand\\tO\\ndorsal\\tO\\ncolumns\\tO\\nof\\tO\\nthe\\tO\\nspinal\\tO\\ncord\\tO\\n.\\tO\\n\\nPost\\tO\\n-\\tO\\nmortem\\tO\\nexamination\\tO\\nof\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nshowed\\tO\\nextensive\\tO\\nmyelin\\tO\\nloss\\tO\\nin\\tO\\nthese\\tO\\ncolumns\\tO\\n.\\tO\\n\\nAn\\tO\\narray\\tO\\nof\\tO\\ngenotypes\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nthese\\tO\\npatients\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nspinal\\tB-Disease\\nxanthomatosis\\tI-Disease\\nis\\tO\\na\\tO\\nclinical\\tO\\nand\\tO\\nradiological\\tO\\nseparate\\tO\\nentity\\tO\\nof\\tO\\nCTX\\tB-Disease\\nthat\\tO\\nshould\\tO\\nbe\\tO\\nincluded\\tO\\nin\\tO\\nthe\\tO\\ndifferential\\tO\\ndiagnosis\\tO\\nof\\tO\\nchronic\\tB-Disease\\nmyelopathy\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nA\\tO\\ntransgene\\tO\\ninsertion\\tO\\ncreating\\tO\\na\\tO\\nheritable\\tO\\nchromosome\\tO\\ndeletion\\tO\\nmouse\\tO\\nmodel\\tO\\nof\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nand\\tI-Disease\\nangelman\\tI-Disease\\nsyndromes\\tI-Disease\\n.\\tO\\n\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\nand\\tO\\nAngelman\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nAS\\tB-Disease\\n)\\tO\\nresult\\tO\\nfrom\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\nfunction\\tO\\nof\\tO\\nimprinted\\tO\\ngenes\\tO\\nin\\tO\\nhuman\\tO\\nchromosome\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\n.\\tO\\n\\nThe\\tO\\ncentral\\tO\\npart\\tO\\nof\\tO\\nmouse\\tO\\nchromosome\\tO\\n7\\tO\\nis\\tO\\nhomologous\\tO\\nto\\tO\\nhuman\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\n,\\tO\\nwith\\tO\\nconservation\\tO\\nof\\tO\\nboth\\tO\\ngene\\tO\\norder\\tO\\nand\\tO\\nimprinted\\tO\\nfeatures\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthe\\tO\\ncharacterization\\tO\\nof\\tO\\na\\tO\\ntransgene\\tO\\ninsertion\\tO\\n(\\tO\\nEpstein\\tO\\n-\\tO\\nBarr\\tO\\nvirus\\tO\\nLatent\\tO\\nMembrane\\tO\\nProtein\\tO\\n2A\\tO\\n,\\tO\\nLMP2A\\tO\\n)\\tO\\ninto\\tO\\nmouse\\tO\\nchromosome\\tO\\n7C\\tO\\n,\\tO\\nwhich\\tO\\nhas\\tO\\nresulted\\tO\\nin\\tO\\nmouse\\tO\\nmodels\\tO\\nfor\\tO\\nPWS\\tB-Disease\\nand\\tO\\nAS\\tB-Disease\\ndependent\\tO\\non\\tO\\nthe\\tO\\nsex\\tO\\nof\\tO\\nthe\\tO\\ntransmitting\\tO\\nparent\\tO\\n.\\tO\\n\\nEpigenotype\\tO\\n(\\tO\\nallelic\\tO\\nexpression\\tO\\nand\\tO\\nDNA\\tO\\nmethylation\\tO\\n)\\tO\\nand\\tO\\nfluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\nanalyses\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\ntransgene\\tO\\n-\\tO\\ninduced\\tO\\nmutation\\tO\\nhas\\tO\\ngenerated\\tO\\na\\tO\\ncomplete\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nPWS\\tB-Disease\\n/\\tO\\nAS\\tB-Disease\\n-\\tO\\nhomologous\\tO\\nregion\\tO\\nbut\\tO\\nhas\\tO\\nnot\\tO\\ndeleted\\tO\\nflanking\\tO\\nloci\\tO\\n.\\tO\\n\\nBecause\\tO\\nthe\\tO\\nintact\\tO\\nchromosome\\tO\\n7\\tO\\n,\\tO\\nopposite\\tO\\nthe\\tO\\ndeleted\\tO\\nhomolog\\tO\\n,\\tO\\nmaintains\\tO\\nthe\\tO\\ncorrect\\tO\\nimprint\\tO\\nin\\tO\\nsomatic\\tO\\ncells\\tO\\nof\\tO\\nPWS\\tB-Disease\\nand\\tO\\nAS\\tB-Disease\\nmice\\tO\\nand\\tO\\nestablishes\\tO\\nthe\\tO\\ncorrect\\tO\\nimprint\\tO\\nin\\tO\\nmale\\tO\\nand\\tO\\nfemale\\tO\\ngerm\\tO\\ncells\\tO\\nof\\tO\\nAS\\tB-Disease\\nmice\\tO\\n,\\tO\\nhomologous\\tO\\nassociation\\tO\\nand\\tO\\nreplication\\tO\\nasynchrony\\tO\\nare\\tO\\nnot\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nimprinting\\tO\\nmechanism\\tO\\n.\\tO\\n\\nThis\\tO\\nheritable\\tO\\n-\\tO\\ndeletion\\tO\\nmouse\\tO\\nmodel\\tO\\nwill\\tO\\nbe\\tO\\nparticularly\\tO\\nuseful\\tO\\nfor\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\nthe\\tO\\netiological\\tO\\ngenes\\tO\\nand\\tO\\nmechanisms\\tO\\n,\\tO\\nphenotypic\\tO\\nbasis\\tO\\n,\\tO\\nand\\tO\\ninvestigation\\tO\\nof\\tO\\ntherapeutic\\tO\\napproaches\\tO\\nfor\\tO\\nPWS\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nLinkage\\tO\\nanalysis\\tO\\nof\\tO\\n5\\tO\\nnovel\\tO\\nvan\\tB-Disease\\nder\\tI-Disease\\nWoude\\tI-Disease\\nsyndrome\\tI-Disease\\nkindreds\\tO\\nto\\tO\\n1q32\\tO\\n-\\tO\\nq41\\tO\\nmarkers\\tO\\nfurther\\tO\\nsupports\\tO\\nlocus\\tO\\nhomogeneity\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\ntrait\\tO\\n.\\tO\\n\\nvan\\tB-Disease\\nder\\tI-Disease\\nWoude\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nvWS\\tB-Disease\\n,\\tO\\nMIM\\tO\\n119300\\tO\\n)\\tO\\nis\\tO\\na\\tO\\nrare\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nclefting\\tI-Disease\\ncondition\\tI-Disease\\nwith\\tO\\ncardinal\\tO\\nfeatures\\tO\\nof\\tO\\nmucous\\tB-Disease\\ncysts\\tI-Disease\\n(\\tO\\nlower\\tB-Disease\\n-\\tI-Disease\\nlip\\tI-Disease\\npits\\tI-Disease\\n)\\tO\\nand\\tO\\nclefts\\tB-Disease\\nto\\tI-Disease\\nthe\\tI-Disease\\nlip\\tI-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\npalate\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nvWS\\tB-Disease\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nassigned\\tO\\nto\\tO\\na\\tO\\nlocus\\tO\\nin\\tO\\n1q32\\tO\\n-\\tO\\nq41\\tO\\nby\\tO\\nlinkage\\tO\\nanalysis\\tO\\nand\\tO\\nphysical\\tO\\nmapping\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ninvestigated\\tO\\n5\\tO\\nnovel\\tO\\nvWS\\tB-Disease\\nfamilies\\tO\\nthrough\\tO\\nprobands\\tO\\nattended\\tO\\nfor\\tO\\ncleft\\tB-Disease\\nlip\\tI-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\npalate\\tI-Disease\\nrepair\\tO\\nat\\tO\\nthe\\tO\\nDepartment\\tO\\nof\\tO\\nMaxillofacial\\tO\\nSurgery\\tO\\nof\\tO\\nHopital\\tO\\nTrousseau\\tO\\n,\\tO\\nParis\\tO\\n,\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\ntentatively\\tO\\nrefine\\tO\\nthe\\tO\\ngenetic\\tO\\nmap\\tO\\nof\\tO\\nthe\\tO\\nvWS\\tB-Disease\\nregion\\tO\\nin\\tO\\n1q32\\tO\\n-\\tO\\nq41\\tO\\nand\\tO\\npossibly\\tO\\nidentify\\tO\\nunlinked\\tO\\npedigrees\\tO\\n.\\tO\\n\\nLinkage\\tO\\nanalysis\\tO\\nwas\\tO\\ncarried\\tO\\nout\\tO\\nto\\tO\\n6\\tO\\nmicrosatellite\\tO\\nmarkers\\tO\\n(\\tO\\nD1S249\\tO\\n,\\tO\\nD1S425\\tO\\n,\\tO\\nD1S491\\tO\\n,\\tO\\nD1S205\\tO\\n,\\tO\\nD1S414\\tO\\n,\\tO\\nD1S425\\tO\\n)\\tO\\n,\\tO\\nyielding\\tO\\na\\tO\\nmaximum\\tO\\ncumulative\\tO\\nLOD\\tO\\nscore\\tO\\nof\\tO\\nZ\\tO\\n=\\tO\\n3\\tO\\n.\\tO\\n\\n27\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\n00\\tO\\nfor\\tO\\nD1S245\\tO\\n.\\tO\\n\\nThe\\tO\\ninnermost\\tO\\nfour\\tO\\nmarkers\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ntightly\\tO\\nlinked\\tO\\nto\\tO\\none\\tO\\nanother\\tO\\n,\\tO\\nwith\\tO\\nno\\tO\\nevidence\\tO\\nfor\\tO\\nrecombination\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nsupport\\tO\\nlinkage\\tO\\nof\\tO\\nvWS\\tB-Disease\\nwithin\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\ntightly\\tO\\nlinked\\tO\\nmarkers\\tO\\nand\\tO\\ndo\\tO\\nnot\\tO\\nfavour\\tO\\nlocus\\tO\\nheterogeneity\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\ntrait\\tO\\n.\\tO\\n\\nNull\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nmurine\\tO\\nATP7B\\tO\\n(\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n)\\tO\\ngene\\tO\\nresults\\tO\\nin\\tO\\nintracellular\\tB-Disease\\ncopper\\tI-Disease\\naccumulation\\tI-Disease\\nand\\tO\\nlate\\tB-Disease\\n-\\tI-Disease\\nonset\\tI-Disease\\nhepatic\\tI-Disease\\nnodular\\tI-Disease\\ntransformation\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nAtp7b\\tO\\nprotein\\tO\\nis\\tO\\na\\tO\\ncopper\\tO\\n-\\tO\\ntransporting\\tO\\nATPase\\tO\\nexpressed\\tO\\npredominantly\\tO\\nin\\tO\\nthe\\tO\\nliver\\tO\\nand\\tO\\nto\\tO\\na\\tO\\nlesser\\tO\\nextent\\tO\\nin\\tO\\nmost\\tO\\nother\\tO\\ntissues\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nATP7B\\tO\\ngene\\tO\\nlead\\tO\\nto\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n,\\tO\\na\\tO\\ncopper\\tB-Disease\\ntoxicity\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\ndramatic\\tO\\nbuild\\tO\\n-\\tO\\nup\\tO\\nof\\tO\\nintracellular\\tO\\nhepatic\\tO\\ncopper\\tO\\nwith\\tO\\nsubsequent\\tO\\nhepatic\\tB-Disease\\nand\\tI-Disease\\nneuro\\tI-Disease\\n-\\tI-Disease\\nlogical\\tI-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nUsing\\tO\\nhomologous\\tO\\nrecombination\\tO\\nto\\tO\\ndisrupt\\tO\\nthe\\tO\\nnormal\\tO\\ntranslation\\tO\\nof\\tO\\nATP7B\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ngenerated\\tO\\na\\tO\\nstrain\\tO\\nof\\tO\\nmice\\tO\\nthat\\tO\\nare\\tO\\nhomozygous\\tO\\nmutants\\tO\\n(\\tO\\nnull\\tO\\n)\\tO\\nfor\\tO\\nthe\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nATP7B\\tO\\nnull\\tO\\nmice\\tO\\ndisplay\\tO\\na\\tO\\ngradual\\tO\\naccumulation\\tO\\nof\\tO\\nhepatic\\tO\\ncopper\\tO\\nthat\\tO\\nincreases\\tO\\nto\\tO\\na\\tO\\nlevel\\tO\\n60\\tO\\n-\\tO\\nfold\\tO\\ngreater\\tO\\nthan\\tO\\nnormal\\tO\\nby\\tO\\n5\\tO\\nmonths\\tO\\nof\\tO\\nage\\tO\\n.\\tO\\n\\nAn\\tO\\nincrease\\tO\\nin\\tO\\ncopper\\tO\\nconcentration\\tO\\nwas\\tO\\nalso\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\nkidney\\tO\\n,\\tO\\nbrain\\tO\\n,\\tO\\nplacenta\\tO\\nand\\tO\\nlactating\\tO\\nmammary\\tO\\nglands\\tO\\nof\\tO\\nhomo\\tO\\n-\\tO\\nzygous\\tO\\nmutants\\tO\\n,\\tO\\nalthough\\tO\\nmilk\\tO\\nfrom\\tO\\nthe\\tO\\nmutant\\tO\\nglands\\tO\\nwas\\tO\\ncopper\\tB-Disease\\ndeficient\\tI-Disease\\n.\\tO\\n\\nMorphological\\tB-Disease\\nabnormalities\\tI-Disease\\nresembling\\tO\\ncirrhosis\\tB-Disease\\ndeveloped\\tO\\nin\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nthe\\tO\\nlivers\\tO\\nfrom\\tO\\nhomozygous\\tO\\nmutants\\tO\\nolder\\tO\\nthan\\tO\\n7\\tO\\nmonths\\tO\\nof\\tO\\nage\\tO\\n.\\tO\\n\\nProgeny\\tO\\nof\\tO\\nthe\\tO\\nhomozygous\\tO\\nmutant\\tO\\nfemales\\tO\\ndemonstrated\\tO\\nneurological\\tB-Disease\\nabnormalities\\tI-Disease\\nand\\tO\\ngrowth\\tB-Disease\\nretardation\\tI-Disease\\ncharacteristic\\tO\\nof\\tO\\ncopper\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nCopper\\tO\\nconcentration\\tO\\nin\\tO\\nthe\\tO\\nlivers\\tO\\nof\\tO\\nthe\\tO\\nnewborn\\tO\\nhomozygous\\tO\\nnull\\tO\\nmutants\\tO\\nwas\\tO\\ndecreased\\tO\\ndramatically\\tO\\n.\\tO\\n\\nIn\\tO\\nsummary\\tO\\n,\\tO\\ninactivation\\tO\\nof\\tO\\nthe\\tO\\nmurine\\tO\\nATP7B\\tO\\ngene\\tO\\nproduces\\tO\\na\\tO\\nform\\tO\\nof\\tO\\ncirrhotic\\tB-Disease\\nliver\\tI-Disease\\ndisease\\tI-Disease\\nthat\\tO\\nresembles\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\nin\\tO\\nhumans\\tO\\nand\\tO\\nthe\\tO\\ntoxic\\tO\\nmilk\\tO\\nphenotype\\tO\\nin\\tO\\nthe\\tO\\nmouse\\tO\\n.\\tO\\n.\\tO\\n\\nFrench\\tO\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\npatients\\tO\\ndo\\tO\\nnot\\tO\\nexhibit\\tO\\ngametic\\tO\\nsegregation\\tO\\ndistortion\\tO\\n:\\tO\\na\\tO\\nsperm\\tO\\ntyping\\tO\\nanalysis\\tO\\n.\\tO\\n\\nSegregation\\tO\\ndistortion\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\nto\\tO\\noccur\\tO\\nin\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nthe\\tO\\ntrinucleotide\\tB-Disease\\nrepeat\\tI-Disease\\ndisorders\\tI-Disease\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\na\\tO\\nsperm\\tO\\ntyping\\tO\\nstudy\\tO\\nperformed\\tO\\nin\\tO\\npatients\\tO\\nof\\tO\\nJapanese\\tO\\ndescent\\tO\\nwith\\tO\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nMJD\\tB-Disease\\n)\\tO\\n,\\tO\\nit\\tO\\nwas\\tO\\nreported\\tO\\nthat\\tO\\ndisease\\tO\\nalleles\\tO\\nare\\tO\\npreferentially\\tO\\ntransmitted\\tO\\nduring\\tO\\nmeiosis\\tO\\n.\\tO\\n\\nWe\\tO\\nperformed\\tO\\na\\tO\\nsperm\\tO\\ntyping\\tO\\nstudy\\tO\\nof\\tO\\nfive\\tO\\nMJD\\tB-Disease\\npatients\\tO\\nof\\tO\\nFrench\\tO\\ndescent\\tO\\nand\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\npooled\\tO\\ndata\\tO\\nshows\\tO\\na\\tO\\nratio\\tO\\nof\\tO\\nmutant\\tO\\nto\\tO\\nnormal\\tO\\nalleles\\tO\\nof\\tO\\n379\\tO\\n436\\tO\\n(\\tO\\n46\\tO\\n.\\tO\\n5\\tO\\n53\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\ndoes\\tO\\nnot\\tO\\nsupport\\tO\\nmeiotic\\tO\\nsegregation\\tO\\ndistortion\\tO\\n.\\tO\\n\\nTo\\tO\\nconfirm\\tO\\nthese\\tO\\nresults\\tO\\n,\\tO\\nsperm\\tO\\ntyping\\tO\\nanalysis\\tO\\nwas\\tO\\nalso\\tO\\nperformed\\tO\\nusing\\tO\\na\\tO\\npolymorphic\\tO\\nmarker\\tO\\n,\\tO\\nD14S1050\\tO\\n,\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nMJD1\\tO\\ngene\\tO\\n.\\tO\\n\\nAmong\\tO\\n910\\tO\\nsperm\\tO\\nanalyzed\\tO\\n,\\tO\\nthe\\tO\\nallele\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\ndisease\\tO\\nchromosome\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\n50\\tO\\n.\\tO\\n\\n3\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nsamples\\tO\\nand\\tO\\nthe\\tO\\nallele\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nnormal\\tO\\nchromosome\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\n49\\tO\\n.\\tO\\n\\n6\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nsperm\\tO\\n.\\tO\\n\\nThe\\tO\\ndifference\\tO\\nin\\tO\\nfrequency\\tO\\nof\\tO\\nthese\\tO\\ntwo\\tO\\nalleles\\tO\\nis\\tO\\nnot\\tO\\nsignificant\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n8423\\tO\\n)\\tO\\n.\\tO\\n\\nLikelihood\\tO\\n-\\tO\\nbased\\tO\\nanalysis\\tO\\nof\\tO\\nsegregation\\tO\\ndistortion\\tO\\nin\\tO\\nthe\\tO\\nsingle\\tO\\nsperm\\tO\\ndata\\tO\\nusing\\tO\\nthe\\tO\\nSPERMSEG\\tO\\nprogram\\tO\\nalso\\tO\\nshowed\\tO\\nno\\tO\\nsupport\\tO\\nfor\\tO\\nsegregation\\tO\\ndistortion\\tO\\nat\\tO\\nthe\\tO\\ngamete\\tO\\nlevel\\tO\\nin\\tO\\nthis\\tO\\npatient\\tO\\npopulation\\tO\\n.\\tO\\n\\nThe\\tO\\nprevious\\tO\\nreport\\tO\\non\\tO\\nthe\\tO\\nJapanese\\tO\\npatients\\tO\\nalso\\tO\\nsuggested\\tO\\nthat\\tO\\ndisease\\tO\\nallele\\tO\\nstability\\tO\\nmay\\tO\\nbe\\tO\\ninfluenced\\tO\\nby\\tO\\na\\tO\\ntrans\\tO\\neffect\\tO\\nof\\tO\\nan\\tO\\nintragenic\\tO\\npolymorphism\\tO\\n(\\tO\\n987\\tO\\nG\\tO\\n/\\tO\\nC\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nallele\\tO\\n.\\tO\\n\\nAll\\tO\\nof\\tO\\nthe\\tO\\nFrench\\tO\\npatients\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nthis\\tO\\npolymorphism\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nvariance\\tO\\nin\\tO\\nrepeat\\tO\\nnumber\\tO\\nin\\tO\\nsperm\\tO\\nfrom\\tO\\nthe\\tO\\nFrench\\tO\\nMJD\\tB-Disease\\npatients\\tO\\noverlapped\\tO\\nsignificantly\\tO\\nwith\\tO\\nthe\\tO\\nvariance\\tO\\nin\\tO\\nrepeat\\tO\\nnumber\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\nC\\tO\\n/\\tO\\nC\\tO\\nhomozygous\\tO\\nJapanese\\tO\\npatients\\tO\\n.\\tO\\n\\nMissense\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nalternative\\tO\\nsplice\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nPAX6\\tO\\ngene\\tO\\nin\\tO\\neye\\tB-Disease\\nanomalies\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nPAX6\\tO\\ngene\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nocular\\tO\\nmorphogenesis\\tO\\n,\\tO\\nand\\tO\\nPAX6\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\nvarious\\tO\\ntypes\\tO\\nof\\tO\\nocular\\tB-Disease\\nanomalies\\tI-Disease\\n,\\tO\\nincluding\\tO\\naniridia\\tB-Disease\\n,\\tO\\nPeters\\tB-Disease\\nanomaly\\tI-Disease\\n,\\tO\\ncorneal\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\ncongenital\\tB-Disease\\ncataract\\tI-Disease\\n,\\tO\\nand\\tO\\nfoveal\\tB-Disease\\nhypoplasia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nencodes\\tO\\na\\tO\\ntranscriptional\\tO\\nregulator\\tO\\nthat\\tO\\nrecognizes\\tO\\ntarget\\tO\\ngenes\\tO\\nthrough\\tO\\nits\\tO\\npaired\\tO\\n-\\tO\\ntype\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\n.\\tO\\n\\nThe\\tO\\npaired\\tO\\ndomain\\tO\\nis\\tO\\ncomposed\\tO\\nof\\tO\\ntwo\\tO\\ndistinct\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\nsubdomains\\tO\\n,\\tO\\nthe\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\nsubdomain\\tO\\n(\\tO\\nNTS\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nsubdomain\\tO\\n(\\tO\\nCTS\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nbind\\tO\\nrespective\\tO\\nconsensus\\tO\\nDNA\\tO\\nsequences\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\nPAX6\\tO\\ngene\\tO\\nproduces\\tO\\ntwo\\tO\\nalternative\\tO\\nsplice\\tO\\nisoforms\\tO\\nthat\\tO\\nhave\\tO\\nthe\\tO\\ndistinct\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\npaired\\tO\\ndomain\\tO\\n.\\tO\\n\\nThe\\tO\\ninsertion\\tO\\n,\\tO\\ninto\\tO\\nthe\\tO\\nNTS\\tO\\n,\\tO\\nof\\tO\\n14\\tO\\nadditional\\tO\\namino\\tO\\nacids\\tO\\nencoded\\tO\\nby\\tO\\nexon\\tO\\n5a\\tO\\nabolishes\\tO\\nthe\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nNTS\\tO\\nand\\tO\\nunmasks\\tO\\nthe\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\nability\\tO\\nof\\tO\\nthe\\tO\\nCTS\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nexon\\tO\\n5a\\tO\\nappears\\tO\\nto\\tO\\nfunction\\tO\\nas\\tO\\na\\tO\\nmolecular\\tO\\nswitch\\tO\\nthat\\tO\\nspecifies\\tO\\ntarget\\tO\\ngenes\\tO\\n.\\tO\\n\\nWe\\tO\\nascertained\\tO\\na\\tO\\nnovel\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nfour\\tO\\npedigrees\\tO\\nwith\\tO\\nPeters\\tB-Disease\\nanomaly\\tI-Disease\\n,\\tO\\ncongenital\\tB-Disease\\ncataract\\tI-Disease\\n,\\tO\\nAxenfeldt\\tB-Disease\\nanomaly\\tI-Disease\\n,\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nfoveal\\tB-Disease\\nhypoplasia\\tI-Disease\\n,\\tO\\nwhich\\tO\\n,\\tO\\nto\\tO\\nour\\tO\\nknowledge\\tO\\n,\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nmutation\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\nsplice\\tO\\n-\\tO\\nvariant\\tO\\nregion\\tO\\n.\\tO\\n\\nA\\tO\\nT\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nthe\\tO\\n20th\\tO\\nnucleotide\\tO\\nposition\\tO\\nof\\tO\\nexon\\tO\\n5a\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nVal\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nAsp\\tO\\n(\\tO\\nGTC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nGAC\\tO\\n)\\tO\\nsubstitution\\tO\\nat\\tO\\nthe\\tO\\n7th\\tO\\ncodon\\tO\\nof\\tO\\nthe\\tO\\nalternative\\tO\\nsplice\\tO\\nregion\\tO\\n.\\tO\\n\\nFunctional\\tO\\nanalyses\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nV54D\\tO\\nmutation\\tO\\nslightly\\tO\\nincreased\\tO\\nNTS\\tO\\nbinding\\tO\\nand\\tO\\ndecreased\\tO\\nCTS\\tO\\ntransactivation\\tO\\nactivity\\tO\\nto\\tO\\nalmost\\tO\\nhalf\\tO\\n.\\tO\\n.\\tO\\n\\nPenetrances\\tO\\nof\\tO\\nBRCA1\\tO\\n1675delA\\tO\\nand\\tO\\n1135insA\\tO\\nwith\\tO\\nrespect\\tO\\nto\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nFor\\tO\\ngenetic\\tO\\ncounseling\\tO\\nand\\tO\\npredictive\\tO\\ntesting\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\ninherited\\tB-Disease\\nbreast\\tI-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\npenetrances\\tO\\nand\\tO\\nexpressions\\tO\\nof\\tO\\nthe\\tO\\nunderlying\\tO\\nmutations\\tO\\nshould\\tO\\nbe\\tO\\nknown\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\npreviously\\tO\\nreported\\tO\\ntwo\\tO\\nBRCA1\\tO\\nfounder\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nNorwegian\\tO\\npopulation\\tO\\n.\\tO\\n\\nIndex\\tO\\ncases\\tO\\nfor\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\nwere\\tO\\nfound\\tO\\ntwo\\tO\\ndifferent\\tO\\nways\\tO\\nthrough\\tO\\na\\tO\\nseries\\tO\\nof\\tO\\nconsecutive\\tO\\novarian\\tB-Disease\\ncancers\\tI-Disease\\n(\\tO\\nn\\tO\\n=\\tO\\n16\\tO\\n)\\tO\\nand\\tO\\nthrough\\tO\\nour\\tO\\nfamily\\tO\\ncancer\\tB-Disease\\nclinic\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n14\\tO\\n)\\tO\\n.\\tO\\n\\nAltogether\\tO\\n,\\tO\\n20\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nhad\\tO\\nBRCA1\\tO\\n1675delA\\tO\\n,\\tO\\nand\\tO\\n10\\tO\\nhad\\tO\\n1135insA\\tO\\n.\\tO\\n\\nTheir\\tO\\nrelatives\\tO\\nwere\\tO\\ndescribed\\tO\\nwith\\tO\\nrespect\\tO\\nto\\tO\\nabsence\\tO\\n/\\tO\\npresence\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nOf\\tO\\n133\\tO\\nliving\\tO\\nfemale\\tO\\nrelatives\\tO\\n,\\tO\\n83\\tO\\n(\\tO\\n62\\tO\\n%\\tO\\n)\\tO\\nwere\\tO\\ntested\\tO\\nfor\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nmutation\\tO\\n.\\tO\\n\\nNo\\tO\\ndifference\\tO\\n,\\tO\\nin\\tO\\npenetrance\\tO\\nand\\tO\\nexpression\\tO\\n,\\tO\\nbetween\\tO\\nthe\\tO\\ntwo\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\n,\\tO\\nwhereas\\tO\\ndifferences\\tO\\naccording\\tO\\nto\\tO\\nmethod\\tO\\nof\\tO\\nascertainment\\tO\\nwere\\tO\\nseen\\tO\\n.\\tO\\n\\nThe\\tO\\noverall\\tO\\nfindings\\tO\\nwere\\tO\\nthat\\tO\\ndisease\\tO\\nstarted\\tO\\nto\\tO\\noccur\\tO\\nat\\tO\\nage\\tO\\n30\\tO\\nyears\\tO\\nand\\tO\\nthat\\tO\\nby\\tO\\nage\\tO\\n50\\tO\\nyears\\tO\\n48\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\n-\\tO\\ncarrying\\tO\\nwomen\\tO\\nhad\\tO\\nexperienced\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nMore\\tO\\novarian\\tB-Disease\\ncancers\\tI-Disease\\nthan\\tO\\nbreast\\tB-Disease\\ncancers\\tI-Disease\\nwere\\tO\\nrecorded\\tO\\n.\\tO\\n\\nBoth\\tO\\npenetrance\\tO\\nand\\tO\\nexpression\\tO\\n(\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nvs\\tO\\n.\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n)\\tO\\nwere\\tO\\ndifferent\\tO\\nfrom\\tO\\nthose\\tO\\nin\\tO\\nreports\\tO\\nof\\tO\\nthe\\tO\\nAshkenazi\\tO\\nfounder\\tO\\nmutations\\tO\\n.\\tO\\n\\nWhether\\tO\\nthe\\tO\\nreported\\tO\\ndifferences\\tO\\nreflect\\tO\\ntrue\\tO\\ndifferences\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nmethodological\\tO\\nproblems\\tO\\nis\\tO\\ndiscussed\\tO\\n.\\tO\\n\\nAn\\tO\\nobserved\\tO\\nexcess\\tO\\nof\\tO\\nmutation\\tO\\ncarriers\\tO\\ncould\\tO\\nnot\\tO\\nbe\\tO\\naccounted\\tO\\nfor\\tO\\nby\\tO\\nmethodological\\tO\\nproblems\\tO\\n;\\tO\\npossible\\tO\\nexplanations\\tO\\nwere\\tO\\na\\tO\\n\"\\tO\\ntrue\\tO\\n\"\\tO\\nlow\\tO\\npenetrance\\tO\\nor\\tO\\npreferential\\tO\\nsegregation\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\ndermatofibrosarcoma\\tB-Disease\\nprotuberans\\tI-Disease\\n-\\tO\\nassociated\\tO\\ncollagen\\tO\\ntype\\tO\\nIalpha1\\tO\\n/\\tO\\nplatelet\\tO\\n-\\tO\\nderived\\tO\\ngrowth\\tO\\nfactor\\tO\\n(\\tO\\nPDGF\\tO\\n)\\tO\\nB\\tO\\n-\\tO\\nchain\\tO\\nfusion\\tO\\ngene\\tO\\ngenerates\\tO\\na\\tO\\ntransforming\\tO\\nprotein\\tO\\nthat\\tO\\nis\\tO\\nprocessed\\tO\\nto\\tO\\nfunctional\\tO\\nPDGF\\tO\\n-\\tO\\nBB\\tO\\n.\\tO\\n\\nDermatofibrosarcoma\\tB-Disease\\nprotuberans\\tI-Disease\\n(\\tO\\nDFSP\\tB-Disease\\n)\\tO\\ndisplays\\tO\\nchromosomal\\tO\\nrearrangements\\tO\\ninvolving\\tO\\nchromosome\\tO\\n17\\tO\\nand\\tO\\n22\\tO\\n,\\tO\\nwhich\\tO\\nfuse\\tO\\nthe\\tO\\ncollagen\\tO\\ntype\\tO\\nIalpha1\\tO\\n(\\tO\\nCOLIA1\\tO\\n)\\tO\\ngene\\tO\\nto\\tO\\nthe\\tO\\nplatelet\\tO\\n-\\tO\\nderived\\tO\\ngrowth\\tO\\nfactor\\tO\\n(\\tO\\nPDGF\\tO\\n)\\tO\\nB\\tO\\n-\\tO\\nchain\\tO\\n(\\tO\\nPDGFB\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nTo\\tO\\ncharacterize\\tO\\nthe\\tO\\nfunctional\\tO\\nand\\tO\\nstructural\\tO\\nproperties\\tO\\nof\\tO\\nthe\\tO\\nCOLIA1\\tO\\n/\\tO\\nPDGFB\\tO\\nfusion\\tO\\nprotein\\tO\\n,\\tO\\nwe\\tO\\ngenerated\\tO\\na\\tO\\nstable\\tO\\nNIH3T3\\tO\\ncell\\tO\\nline\\tO\\nthat\\tO\\ncontained\\tO\\na\\tO\\ntumor\\tO\\n-\\tO\\nderived\\tO\\nchimeric\\tO\\ngene\\tO\\nresulting\\tO\\nfrom\\tO\\na\\tO\\nCOIA1\\tO\\nintron\\tO\\n7\\tO\\n-\\tO\\nPDGFB\\tO\\nintron\\tO\\n1\\tO\\nfusion\\tO\\n.\\tO\\n\\nExpression\\tO\\nof\\tO\\nthe\\tO\\nfusion\\tO\\nprotein\\tO\\nled\\tO\\nto\\tO\\nmorphological\\tO\\ntransformation\\tO\\nand\\tO\\nincreased\\tO\\ngrowth\\tO\\nrate\\tO\\nof\\tO\\nthese\\tO\\ncells\\tO\\n.\\tO\\n\\nThe\\tO\\nPDGF\\tO\\nreceptor\\tO\\nkinase\\tO\\ninhibitor\\tO\\nCGP57148B\\tO\\nreversed\\tO\\nthe\\tO\\ntransformed\\tO\\nphenotype\\tO\\nand\\tO\\nreduced\\tO\\nthe\\tO\\ngrowth\\tO\\nrate\\tO\\nof\\tO\\nCOLIA1\\tO\\n/\\tO\\nPDGFB\\tO\\n-\\tO\\nexpressing\\tO\\ncells\\tO\\nbut\\tO\\nhad\\tO\\nno\\tO\\neffects\\tO\\non\\tO\\ncontrol\\tO\\ncells\\tO\\n.\\tO\\n\\nThe\\tO\\npresence\\tO\\nof\\tO\\ndimeric\\tO\\nCOLIA1\\tO\\n/\\tO\\nPDGFB\\tO\\nprecursors\\tO\\nwas\\tO\\ndemonstrated\\tO\\nthrough\\tO\\nPDGFB\\tO\\nimmunoprecipitations\\tO\\nof\\tO\\nmetabolically\\tO\\nlabeled\\tO\\ncells\\tO\\nand\\tO\\nalso\\tO\\nby\\tO\\nPDGFB\\tO\\nimmunoprecipitations\\tO\\nfollowed\\tO\\nby\\tO\\nimmunoblotting\\tO\\nwith\\tO\\nCOLIA1\\tO\\nantibodies\\tO\\n.\\tO\\n\\nPulse\\tO\\n-\\tO\\nchase\\tO\\nstudies\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nCOLIA1\\tO\\n/\\tO\\nPDGFB\\tO\\nprecursor\\tO\\nwas\\tO\\nprocessed\\tO\\nto\\tO\\nan\\tO\\nend\\tO\\nproduct\\tO\\nthat\\tO\\nwas\\tO\\nindistinguishable\\tO\\nfrom\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nPDGF\\tO\\n-\\tO\\nBB\\tO\\n.\\tO\\n\\nFinally\\tO\\n,\\tO\\nCOLIA1\\tO\\n/\\tO\\nPDGFB\\tO\\n-\\tO\\nexpressing\\tO\\ncells\\tO\\ngenerated\\tO\\ntumors\\tB-Disease\\nafter\\tO\\ns\\tO\\n.\\tO\\n\\nc\\tO\\nc\\tO\\n.\\tO\\ninjection\\tO\\ninto\\tO\\nnude\\tO\\nmice\\tO\\n,\\tO\\nand\\tO\\ntumor\\tB-Disease\\ngrowth\\tO\\nwas\\tO\\nreduced\\tO\\nby\\tO\\ntreatment\\tO\\nwith\\tO\\nCGP57148B\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\nCOLIA1\\tO\\n/\\tO\\nPDGFB\\tO\\nfusion\\tO\\nassociated\\tO\\nwith\\tO\\nDFSP\\tB-Disease\\ncontributes\\tO\\nto\\tO\\ntumor\\tB-Disease\\ndevelopment\\tO\\nthrough\\tO\\nectopic\\tO\\nproduction\\tO\\nof\\tO\\nPDGF\\tO\\n-\\tO\\nBB\\tO\\nand\\tO\\nthe\\tO\\nformation\\tO\\nof\\tO\\nan\\tO\\nautocrine\\tO\\nloop\\tO\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\n,\\tO\\nthus\\tO\\n,\\tO\\nsuggest\\tO\\nthat\\tO\\nPDGF\\tO\\nreceptors\\tO\\ncould\\tO\\nbe\\tO\\na\\tO\\ntarget\\tO\\nfor\\tO\\npharmacological\\tO\\ntreatment\\tO\\nof\\tO\\nDFSP\\tB-Disease\\nand\\tO\\ngiant\\tB-Disease\\ncell\\tI-Disease\\nfibroblastoma\\tI-Disease\\n,\\tO\\ne\\tO\\n.\\tO\\ng\\tO\\n.\\tO\\n,\\tO\\nthrough\\tO\\nthe\\tO\\nuse\\tO\\nof\\tO\\nPDGF\\tO\\nreceptor\\tO\\nkinase\\tO\\ninhibitors\\tO\\nsuch\\tO\\nas\\tO\\nCGP57148B\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\na\\tO\\ncommon\\tO\\nPEX1\\tO\\nmutation\\tO\\nin\\tO\\nZellweger\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nZellweger\\tB-Disease\\nspectrum\\tI-Disease\\nof\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nencompassing\\tO\\nZellweger\\tB-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nthe\\tO\\nprogressively\\tO\\nmilder\\tO\\nphenotypes\\tO\\nof\\tO\\nneonatal\\tB-Disease\\nadrenoleukodystrophy\\tI-Disease\\nand\\tO\\ninfantile\\tB-Disease\\nRefsum\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nis\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nfailure\\tO\\nto\\tO\\nform\\tO\\nfunctional\\tO\\nperoxisomes\\tO\\n.\\tO\\n\\nCell\\tO\\nfusion\\tO\\ncomplementation\\tO\\nstudies\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthese\\tO\\ndiseases\\tO\\nare\\tO\\ngenetically\\tO\\nheterogeneous\\tO\\n,\\tO\\nwith\\tO\\ntwo\\tO\\n-\\tO\\nthirds\\tO\\nof\\tO\\nall\\tO\\npatients\\tO\\nlying\\tO\\nwithin\\tO\\na\\tO\\nsingle\\tO\\ncomplementation\\tO\\ngroup\\tO\\n,\\tO\\nCG1\\tO\\n.\\tO\\n\\nMolecular\\tO\\ngenetic\\tO\\nand\\tO\\ncell\\tO\\nbiology\\tO\\nstudies\\tO\\nhave\\tO\\nshown\\tO\\nthat\\tO\\nPEX1\\tO\\nis\\tO\\ndeficient\\tO\\nin\\tO\\nmany\\tO\\nCG1\\tO\\npatients\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nprevious\\tO\\nstudies\\tO\\nhave\\tO\\nfocused\\tO\\non\\tO\\nmildly\\tO\\naffected\\tO\\npatients\\tO\\nand\\tO\\nthere\\tO\\nis\\tO\\nstill\\tO\\nno\\tO\\nreport\\tO\\nof\\tO\\ntwo\\tO\\nmutant\\tO\\nPEX1\\tO\\nalleles\\tO\\nin\\tO\\nany\\tO\\nZellweger\\tB-Disease\\nsyndrome\\tI-Disease\\npatient\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nPMP70\\tO\\ngene\\tO\\nhave\\tO\\nalso\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\ntwo\\tO\\nZellweger\\tB-Disease\\nsyndrome\\tI-Disease\\npatients\\tO\\nfrom\\tO\\nCG1\\tO\\n,\\tO\\nraising\\tO\\nthe\\tO\\npossibility\\tO\\nthat\\tO\\nCG1\\tO\\npatients\\tO\\nmay\\tO\\nrepresent\\tO\\na\\tO\\nmixture\\tO\\nof\\tO\\nPEX1\\tO\\n-\\tO\\ndeficient\\tO\\nand\\tO\\nPMP70\\tO\\n-\\tO\\ndeficient\\tO\\nindividuals\\tO\\n.\\tO\\n\\nTo\\tO\\naddress\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\ndisease\\tO\\nin\\tO\\nZellweger\\tB-Disease\\nsyndrome\\tI-Disease\\npatients\\tO\\nfrom\\tO\\nCG1\\tO\\n,\\tO\\nwe\\tO\\nexamined\\tO\\nall\\tO\\n24\\tO\\nPEX1\\tO\\nexons\\tO\\nin\\tO\\nfour\\tO\\npatients\\tO\\n,\\tO\\nincluding\\tO\\nboth\\tO\\npatients\\tO\\nthat\\tO\\nhave\\tO\\nmutations\\tO\\nin\\tO\\nPMP70\\tO\\n.\\tO\\n\\nPEX1\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nall\\tO\\nfour\\tO\\npatients\\tO\\n,\\tO\\nincluding\\tO\\na\\tO\\n1\\tO\\n-\\tO\\nbp\\tO\\ninsertion\\tO\\n(\\tO\\nc\\tO\\n.\\tO\\n2097insT\\tO\\n)\\tO\\nin\\tO\\nexon\\tO\\n13\\tO\\nthat\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\nthree\\tO\\nof\\tO\\nthe\\tO\\nfour\\tO\\npatients\\tO\\n.\\tO\\n\\nSubsequent\\tO\\nstudies\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthis\\tO\\nmutation\\tO\\nis\\tO\\npresent\\tO\\nin\\tO\\none\\tO\\n-\\tO\\nhalf\\tO\\nof\\tO\\nall\\tO\\nCG1\\tO\\npatients\\tO\\nand\\tO\\ncorrelates\\tO\\nwith\\tO\\nthe\\tO\\nZellweger\\tB-Disease\\nsyndrome\\tI-Disease\\nphenotype\\tO\\n.\\tO\\n\\nAs\\tO\\nthis\\tO\\nmutation\\tO\\nleads\\tO\\nto\\tO\\na\\tO\\nloss\\tO\\nof\\tO\\nprotein\\tO\\nfunction\\tO\\nits\\tO\\nfrequency\\tO\\nmakes\\tO\\nit\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\ncause\\tO\\nof\\tO\\nZellweger\\tB-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nhelping\\tO\\nto\\tO\\nexplain\\tO\\nthe\\tO\\nhigh\\tO\\npercentage\\tO\\nof\\tO\\npatients\\tO\\nthat\\tO\\nbelong\\tO\\nto\\tO\\nCG1\\tO\\n.\\tO\\n\\nNovel\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nprotein\\tO\\ngene\\tO\\nand\\tO\\ntheir\\tO\\neffects\\tO\\non\\tO\\ntranscriptional\\tO\\n,\\tO\\ntranslational\\tO\\n,\\tO\\nand\\tO\\nclinical\\tO\\nphenotypes\\tO\\n.\\tO\\n\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\nimmunodeficiency\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nthrombocytopenia\\tB-Disease\\n,\\tO\\neczema\\tB-Disease\\n,\\tO\\nand\\tO\\nrecurrent\\tO\\ninfections\\tO\\n,\\tO\\nand\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nWAS\\tB-Disease\\nprotein\\tO\\n(\\tO\\nWASP\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nWASP\\tO\\ncontains\\tO\\nseveral\\tO\\nfunctional\\tO\\ndomains\\tO\\nthrough\\tO\\nwhich\\tO\\nit\\tO\\ninteracts\\tO\\nwith\\tO\\nproteins\\tO\\ninvolved\\tO\\nin\\tO\\nintracellular\\tO\\nsignaling\\tO\\nand\\tO\\nregulation\\tO\\nof\\tO\\nthe\\tO\\nactin\\tO\\ncytoskeleton\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nreport\\tO\\n,\\tO\\n17\\tO\\nWASP\\tO\\ngene\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\n,\\tO\\n12\\tO\\nof\\tO\\nwhich\\tO\\nare\\tO\\nnovel\\tO\\n.\\tO\\n\\nDNA\\tO\\nof\\tO\\naffected\\tO\\nmales\\tO\\nand\\tO\\nobligate\\tO\\ncarriers\\tO\\nwas\\tO\\nPCR\\tO\\namplified\\tO\\nand\\tO\\nanalyzed\\tO\\nby\\tO\\nSSCA\\tO\\n,\\tO\\nheteroduplex\\tO\\nanalysis\\tO\\n,\\tO\\nand\\tO\\ndirect\\tO\\nsequencing\\tO\\n.\\tO\\n\\nThe\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nmRNA\\tO\\nand\\tO\\nprotein\\tO\\nlevel\\tO\\nwere\\tO\\nascertained\\tO\\nby\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nand\\tO\\nWestern\\tO\\nblot\\tO\\nanalyses\\tO\\n.\\tO\\n\\nAll\\tO\\nmissense\\tO\\nmutations\\tO\\nwere\\tO\\nlocated\\tO\\nin\\tO\\nexons\\tO\\n1\\tO\\n-\\tO\\n4\\tO\\n.\\tO\\n\\nMost\\tO\\nof\\tO\\nthe\\tO\\nnonsense\\tO\\n,\\tO\\nframeshift\\tO\\nand\\tO\\nsplice\\tO\\nsite\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nexons\\tO\\n6\\tO\\n-\\tO\\n11\\tO\\n.\\tO\\n\\nMutations\\tO\\nthat\\tO\\nalter\\tO\\nsplice\\tO\\nsites\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nsynthesis\\tO\\nof\\tO\\nseveral\\tO\\ntypes\\tO\\nof\\tO\\nmRNAs\\tO\\n,\\tO\\na\\tO\\nfraction\\tO\\nof\\tO\\nwhich\\tO\\nrepresented\\tO\\nthe\\tO\\nnormally\\tO\\nspliced\\tO\\nproduct\\tO\\n.\\tO\\n\\nThe\\tO\\npresence\\tO\\nof\\tO\\nnormally\\tO\\nspliced\\tO\\ntranscripts\\tO\\nwas\\tO\\ncorrelated\\tO\\nwith\\tO\\na\\tO\\nmilder\\tO\\nphenotype\\tO\\n.\\tO\\n\\nWhen\\tO\\none\\tO\\nsuch\\tO\\ncase\\tO\\nwas\\tO\\nstudied\\tO\\nby\\tO\\nWestern\\tO\\nblotting\\tO\\n,\\tO\\nreduced\\tO\\namounts\\tO\\nof\\tO\\nnormal\\tO\\n-\\tO\\nsize\\tO\\nWASP\\tO\\nwere\\tO\\npresent\\tO\\n.\\tO\\n\\nIn\\tO\\nother\\tO\\ncases\\tO\\nas\\tO\\nwell\\tO\\n,\\tO\\na\\tO\\ncorrelation\\tO\\nwas\\tO\\nfound\\tO\\nbetween\\tO\\nthe\\tO\\namount\\tO\\nof\\tO\\nnormal\\tO\\nor\\tO\\nmutant\\tO\\nWASP\\tO\\npresent\\tO\\nand\\tO\\nthe\\tO\\nphenotypes\\tO\\nof\\tO\\nthe\\tO\\naffected\\tO\\nindividuals\\tO\\n.\\tO\\n\\nNo\\tO\\nprotein\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\ntwo\\tO\\nindividuals\\tO\\nwith\\tO\\nsevere\\tO\\nWAS\\tB-Disease\\n.\\tO\\n\\nReduced\\tO\\nlevels\\tO\\nof\\tO\\na\\tO\\nnormal\\tO\\n-\\tO\\nsize\\tO\\nWASP\\tO\\nwith\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nwere\\tO\\nseen\\tO\\nin\\tO\\ntwo\\tO\\nindividuals\\tO\\nwith\\tO\\nXLT\\tB-Disease\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nconcluded\\tO\\nthat\\tO\\nmutation\\tO\\nanalysis\\tO\\nat\\tO\\nthe\\tO\\nDNA\\tO\\nlevel\\tO\\nis\\tO\\nnot\\tO\\nsufficient\\tO\\nfor\\tO\\npredicting\\tO\\nclinical\\tO\\ncourse\\tO\\n.\\tO\\n\\nStudies\\tO\\nat\\tO\\nthe\\tO\\ntranscript\\tO\\nand\\tO\\nprotein\\tO\\nlevel\\tO\\nare\\tO\\nneeded\\tO\\nfor\\tO\\na\\tO\\nbetter\\tO\\nassessment\\tO\\n.\\tO\\n.\\tO\\n\\nAminoglycoside\\tO\\nantibiotics\\tO\\nrestore\\tO\\ndystrophin\\tO\\nfunction\\tO\\nto\\tO\\nskeletal\\tO\\nmuscles\\tO\\nof\\tO\\nmdx\\tO\\nmice\\tO\\n.\\tO\\n\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ndystrophin\\tO\\ngene\\tO\\n,\\tO\\nleading\\tO\\nto\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nthe\\tO\\ndystrophin\\tO\\nprotein\\tO\\nin\\tO\\nstriated\\tO\\nmuscle\\tO\\n.\\tO\\n\\nA\\tO\\nsignificant\\tO\\nnumber\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nare\\tO\\npremature\\tO\\nstop\\tO\\ncodons\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\nobservation\\tO\\nthat\\tO\\naminoglycoside\\tO\\ntreatment\\tO\\ncan\\tO\\nsuppress\\tO\\nstop\\tO\\ncodons\\tO\\nin\\tO\\ncultured\\tO\\ncells\\tO\\n,\\tO\\nwe\\tO\\ntested\\tO\\nthe\\tO\\neffect\\tO\\nof\\tO\\ngentamicin\\tO\\non\\tO\\ncultured\\tO\\nmuscle\\tO\\ncells\\tO\\nfrom\\tO\\nthe\\tO\\nmdx\\tO\\nmouse\\tO\\n-\\tO\\nan\\tO\\nanimal\\tO\\nmodel\\tO\\nfor\\tO\\nDMD\\tB-Disease\\nthat\\tO\\npossesses\\tO\\na\\tO\\npremature\\tO\\nstop\\tO\\ncodon\\tO\\nin\\tO\\nthe\\tO\\ndystrophin\\tO\\ngene\\tO\\n.\\tO\\n\\nExposure\\tO\\nof\\tO\\nmdx\\tO\\nmyotubes\\tO\\nto\\tO\\ngentamicin\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nexpression\\tO\\nand\\tO\\nlocalization\\tO\\nof\\tO\\ndystrophin\\tO\\nto\\tO\\nthe\\tO\\ncell\\tO\\nmembrane\\tO\\n.\\tO\\n\\nWe\\tO\\nthen\\tO\\nevaluated\\tO\\nthe\\tO\\neffects\\tO\\nof\\tO\\ndiffering\\tO\\ndosages\\tO\\nof\\tO\\ngentamicin\\tO\\non\\tO\\nexpression\\tO\\nand\\tO\\nfunctional\\tO\\nprotection\\tO\\nof\\tO\\nthe\\tO\\nmuscles\\tO\\nof\\tO\\nmdx\\tO\\nmice\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\na\\tO\\ntreatment\\tO\\nregimen\\tO\\nthat\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\ndystrophin\\tO\\nin\\tO\\nthe\\tO\\ncell\\tO\\nmembrane\\tO\\nin\\tO\\nall\\tO\\nstriated\\tO\\nmuscles\\tO\\nexamined\\tO\\nand\\tO\\nthat\\tO\\nprovided\\tO\\nfunctional\\tO\\nprotection\\tO\\nagainst\\tO\\nmuscular\\tB-Disease\\ninjury\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\nour\\tO\\nknowledge\\tO\\n,\\tO\\nour\\tO\\nresults\\tO\\nare\\tO\\nthe\\tO\\nfirst\\tO\\nto\\tO\\ndemonstrate\\tO\\nthat\\tO\\naminoglycosides\\tO\\ncan\\tO\\nsuppress\\tO\\nstop\\tO\\ncodons\\tO\\nnot\\tO\\nonly\\tO\\nin\\tO\\nvitro\\tO\\nbut\\tO\\nalso\\tO\\nin\\tO\\nvivo\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nthese\\tO\\nresults\\tO\\nraise\\tO\\nthe\\tO\\npossibility\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\ntreatment\\tO\\nregimen\\tO\\nfor\\tO\\nmuscular\\tB-Disease\\ndystrophy\\tI-Disease\\nand\\tO\\nother\\tO\\ndiseases\\tO\\ncaused\\tO\\nby\\tO\\npremature\\tO\\nstop\\tO\\ncodon\\tO\\nmutations\\tO\\n.\\tO\\n\\nThis\\tO\\ntreatment\\tO\\ncould\\tO\\nprove\\tO\\neffective\\tO\\nin\\tO\\nup\\tO\\nto\\tO\\n15\\tO\\n%\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nDMD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nLoss\\tO\\nof\\tO\\nthe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\ngene\\tO\\nproduct\\tO\\ncauses\\tO\\noxidative\\tO\\ndamage\\tO\\nin\\tO\\ntarget\\tO\\norgans\\tO\\n.\\tO\\n\\nAtaxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\na\\tO\\nmarkedly\\tO\\nincreased\\tO\\nsensitivity\\tO\\nto\\tO\\nionizing\\tO\\nradiation\\tO\\n,\\tO\\nincreased\\tO\\nincidence\\tO\\nof\\tO\\ncancer\\tB-Disease\\n,\\tO\\nand\\tO\\nneurodegeneration\\tB-Disease\\n,\\tO\\nespecially\\tO\\nof\\tO\\nthe\\tO\\ncerebellar\\tO\\nPurkinje\\tO\\ncells\\tO\\n.\\tO\\n\\nIonizing\\tO\\nradiation\\tO\\noxidizes\\tO\\nmacromolecules\\tO\\nand\\tO\\ncauses\\tO\\ntissue\\tO\\ndamage\\tO\\nthrough\\tO\\nthe\\tO\\ngeneration\\tO\\nof\\tO\\nreactive\\tO\\noxygen\\tO\\nspecies\\tO\\n(\\tO\\nROS\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\ntherefore\\tO\\nhypothesized\\tO\\nthat\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nis\\tO\\ndue\\tO\\nto\\tO\\noxidative\\tO\\ndamage\\tO\\nresulting\\tO\\nfrom\\tO\\nloss\\tO\\nof\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\ngene\\tO\\nproduct\\tO\\n.\\tO\\n\\nTo\\tO\\nassess\\tO\\nthis\\tO\\nhypothesis\\tO\\n,\\tO\\nwe\\tO\\nemployed\\tO\\nan\\tO\\nanimal\\tO\\nmodel\\tO\\nof\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n,\\tO\\nthe\\tO\\nmouse\\tO\\nwith\\tO\\na\\tO\\ndisrupted\\tO\\nAtm\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\norgans\\tO\\nwhich\\tO\\ndevelop\\tO\\npathologic\\tO\\nchanges\\tO\\nin\\tO\\nthe\\tO\\nAtm\\tO\\n-\\tO\\ndeficient\\tO\\nmice\\tO\\nare\\tO\\ntargets\\tO\\nof\\tO\\noxidative\\tO\\ndamage\\tO\\n,\\tO\\nand\\tO\\nthat\\tO\\ncerebellar\\tO\\nPurkinje\\tO\\ncells\\tO\\nare\\tO\\nparticularly\\tO\\naffected\\tO\\n.\\tO\\n\\nThese\\tO\\nobservations\\tO\\nprovide\\tO\\na\\tO\\nmechanistic\\tO\\nbasis\\tO\\nfor\\tO\\nthe\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nphenotype\\tO\\nand\\tO\\nlay\\tO\\na\\tO\\nrational\\tO\\nfoundation\\tO\\nfor\\tO\\ntherapeutic\\tO\\nintervention\\tO\\n.\\tO\\n.\\tO\\n\\nRecessively\\tO\\ninherited\\tO\\nmultiple\\tB-Disease\\nepiphyseal\\tI-Disease\\ndysplasia\\tI-Disease\\nwith\\tO\\nnormal\\tO\\nstature\\tO\\n,\\tO\\nclub\\tB-Disease\\nfoot\\tI-Disease\\n,\\tO\\nand\\tO\\ndouble\\tB-Disease\\nlayered\\tI-Disease\\npatella\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\nDTDST\\tO\\nmutation\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nobserved\\tO\\nover\\tO\\n25\\tO\\ndifferent\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\nsulphate\\tO\\ntransporter\\tO\\ngene\\tO\\n(\\tO\\nDTDST\\tO\\n)\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\nthe\\tO\\nrecessive\\tB-Disease\\ndisorders\\tI-Disease\\nachondrogenesis\\tB-Disease\\n1B\\tI-Disease\\n,\\tO\\natelosteogenesis\\tB-Disease\\n2\\tI-Disease\\n,\\tO\\nand\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nc862t\\tO\\n(\\tO\\nR279W\\tO\\n)\\tO\\ntransition\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nmutation\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nFinnish\\tO\\npatients\\tO\\n,\\tO\\nbut\\tO\\nin\\tO\\nthese\\tO\\ndisorders\\tO\\nit\\tO\\nis\\tO\\nusually\\tO\\ncombined\\tO\\nwith\\tO\\nother\\tO\\nDTDST\\tO\\nmutations\\tO\\n.\\tO\\n\\nWe\\tO\\nhad\\tO\\nnot\\tO\\nseen\\tO\\na\\tO\\ncase\\tO\\nof\\tO\\nhomozygosity\\tO\\nfor\\tO\\nc862t\\tO\\n(\\tO\\nR279W\\tO\\n)\\tO\\nuntil\\tO\\nwe\\tO\\nanalysed\\tO\\nDNA\\tO\\nfrom\\tO\\na\\tO\\n36\\tO\\nyear\\tO\\nold\\tO\\nmale\\tO\\nwith\\tO\\ntall\\tO\\n-\\tO\\nnormal\\tO\\nstature\\tO\\n(\\tO\\n180\\tO\\ncm\\tO\\n)\\tO\\nwho\\tO\\nasked\\tO\\nfor\\tO\\ngenetic\\tO\\ncounselling\\tO\\nfor\\tO\\nsuspected\\tO\\nmultiple\\tB-Disease\\nepiphyseal\\tI-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nHe\\tO\\nwas\\tO\\ntreated\\tO\\nfor\\tO\\nclub\\tB-Disease\\nfoot\\tI-Disease\\nand\\tO\\nhip\\tB-Disease\\ndysplasia\\tI-Disease\\nat\\tO\\nbirth\\tO\\n.\\tO\\n\\nSkeletal\\tO\\nchanges\\tO\\nconsistent\\tO\\nwith\\tO\\nmultiple\\tB-Disease\\nepiphyseal\\tI-Disease\\ndysplasia\\tI-Disease\\n,\\tO\\nwith\\tO\\nthe\\tO\\npeculiar\\tO\\nfinding\\tO\\nof\\tO\\na\\tO\\ndouble\\tB-Disease\\nlayered\\tI-Disease\\npatella\\tI-Disease\\n,\\tO\\nwere\\tO\\nrecognised\\tO\\nduring\\tO\\nchildhood\\tO\\n.\\tO\\n\\nCleft\\tB-Disease\\npalate\\tI-Disease\\n,\\tO\\nswelling\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\near\\tI-Disease\\npinna\\tI-Disease\\n,\\tO\\nand\\tO\\nhitch\\tB-Disease\\nhiker\\tI-Disease\\nthumb\\tI-Disease\\nwere\\tO\\nabsent\\tO\\n.\\tO\\n\\nHe\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nhomozygous\\tO\\n,\\tO\\nand\\tO\\nboth\\tO\\nhealthy\\tO\\nparents\\tO\\nheterozygous\\tO\\n,\\tO\\nfor\\tO\\nthe\\tO\\nR279W\\tO\\nmutation\\tO\\nin\\tO\\nDTDST\\tO\\n,\\tO\\nand\\tO\\nhis\\tO\\nfibroblasts\\tO\\nshowed\\tO\\na\\tO\\nsulphate\\tO\\nincorporation\\tO\\ndefect\\tO\\ntypical\\tO\\nof\\tO\\nDTDST\\tB-Disease\\ndisorders\\tI-Disease\\n.\\tO\\n\\nCounselling\\tO\\nwas\\tO\\ngiven\\tO\\nfor\\tO\\na\\tO\\nrecessive\\tB-Disease\\ndisorder\\tI-Disease\\n,\\tO\\nthereby\\tO\\nconsiderably\\tO\\nreducing\\tO\\nthe\\tO\\nprobability\\tO\\nof\\tO\\naffected\\tO\\noffspring\\tO\\n.\\tO\\n\\nMultiple\\tB-Disease\\nepiphyseal\\tI-Disease\\ndysplasia\\tI-Disease\\nis\\tO\\nmore\\tO\\nfrequently\\tO\\ncaused\\tO\\nby\\tO\\ndominant\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nCOMP\\tO\\n(\\tO\\nEDM1\\tB-Disease\\n,\\tO\\nMcKusick\\tO\\n132400\\tO\\n)\\tO\\nand\\tO\\nCOL9A2\\tO\\ngenes\\tO\\n(\\tO\\nEDM2\\tB-Disease\\n,\\tO\\nMcKusick\\tO\\n600204\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nfew\\tO\\nother\\tO\\npatients\\tO\\nand\\tO\\nfamilies\\tO\\nwith\\tO\\nfeatures\\tO\\nsimilar\\tO\\nto\\tO\\nour\\tO\\nproband\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\npreviously\\tO\\nand\\tO\\nconsidered\\tO\\nto\\tO\\nhave\\tO\\nautosomal\\tO\\nrecessive\\tO\\nMED\\tB-Disease\\n(\\tO\\nEDM4\\tB-Disease\\n,\\tO\\nMcKusick\\tO\\n226900\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nobservation\\tO\\nconfirms\\tO\\nthe\\tO\\nexistence\\tO\\nof\\tO\\nthis\\tO\\nentity\\tO\\nand\\tO\\nassigns\\tO\\nit\\tO\\nto\\tO\\nthe\\tO\\nphenotypic\\tO\\nspectrum\\tO\\nassociated\\tO\\nwith\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nDTDST\\tO\\nlocus\\tO\\n.\\tO\\n.\\tO\\n\\nHomozygosity\\tO\\nfor\\tO\\na\\tO\\nnovel\\tO\\nDTDST\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nchild\\tO\\nwith\\tO\\na\\tO\\n\\'\\tO\\nbroad\\tO\\nbone\\tO\\n-\\tO\\nplatyspondylic\\tO\\n\\'\\tO\\nvariant\\tO\\nof\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nAtypical\\tO\\nor\\tO\\nvariant\\tO\\nforms\\tO\\nof\\tO\\nwell\\tO\\n-\\tO\\nknown\\tO\\nchondrodysplasias\\tB-Disease\\nmay\\tO\\npose\\tO\\ndiagnostic\\tO\\nproblems\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\na\\tO\\ngirl\\tO\\nwith\\tO\\nclinical\\tO\\nfeatures\\tO\\nsuggesting\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\nbut\\tO\\nwith\\tO\\nunusual\\tO\\nradiographic\\tO\\nfeatures\\tO\\nincluding\\tO\\nsevere\\tO\\nplatyspondyly\\tB-Disease\\n,\\tO\\nwide\\tO\\nmetaphyses\\tO\\n,\\tO\\nand\\tO\\nfibular\\tO\\novergrowth\\tO\\n,\\tO\\nwhich\\tO\\nare\\tO\\npartially\\tO\\nreminiscent\\tO\\nof\\tO\\nmetatropic\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ndiagnosis\\tO\\nwas\\tO\\nclarified\\tO\\nby\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nDTDST\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nrevealed\\tO\\nhomozygosity\\tO\\nfor\\tO\\na\\tO\\npreviously\\tO\\nundescribed\\tO\\nmutation\\tO\\nleading\\tO\\nto\\tO\\na\\tO\\nQ454P\\tO\\nsubstitution\\tO\\nin\\tO\\nthe\\tO\\n10th\\tO\\ntransmembrane\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nDTDST\\tO\\nsulfate\\tO\\ntransporter\\tO\\n.\\tO\\n\\nMolecular\\tO\\nanalysis\\tO\\nmay\\tO\\nbe\\tO\\nof\\tO\\nparticular\\tO\\nvalue\\tO\\nin\\tO\\nsuch\\tO\\natypical\\tO\\ncases\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\ntype\\tO\\nof\\tO\\nsomatic\\tO\\nmutation\\tO\\nat\\tO\\nAPC\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\nis\\tO\\ndetermined\\tO\\nby\\tO\\nthe\\tO\\nsite\\tO\\nof\\tO\\nthe\\tO\\ngermline\\tO\\nmutation\\tO\\n:\\tO\\na\\tO\\nnew\\tO\\nfacet\\tO\\nto\\tO\\nKnudson\\tO\\n\\'\\tO\\ns\\tO\\n\\'\\tO\\ntwo\\tO\\n-\\tO\\nhit\\tO\\n\\'\\tO\\nhypothesis\\tO\\n.\\tO\\n\\nAPC\\tO\\nis\\tO\\noften\\tO\\ncited\\tO\\nas\\tO\\na\\tO\\nprime\\tO\\nexample\\tO\\nof\\tO\\na\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n.\\tO\\n\\nTruncating\\tO\\ngermline\\tO\\nand\\tO\\nsomatic\\tO\\nmutations\\tO\\n(\\tO\\nor\\tO\\n,\\tO\\ninfrequently\\tO\\n,\\tO\\nallelic\\tO\\nloss\\tO\\n)\\tO\\noccur\\tO\\nin\\tO\\ntumors\\tB-Disease\\nin\\tO\\nFAP\\tB-Disease\\n(\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nMost\\tO\\nsporadic\\tB-Disease\\ncolorectal\\tI-Disease\\ncancers\\tI-Disease\\nalso\\tO\\nhave\\tO\\ntwo\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\n.\\tO\\n\\nClues\\tO\\nfrom\\tO\\nattenuated\\tB-Disease\\npolyposis\\tI-Disease\\n,\\tO\\nmissense\\tO\\ngermline\\tO\\nvariants\\tO\\nwith\\tO\\nmild\\tO\\ndisease\\tO\\nand\\tO\\nthe\\tO\\nsomatic\\tO\\nmutation\\tO\\ncluster\\tO\\nregion\\tO\\n(\\tO\\ncodons\\tO\\n1\\tO\\n,\\tO\\n250\\tO\\n-\\tO\\n1\\tO\\n,\\tO\\n450\\tO\\n)\\tO\\nindicate\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nthat\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\nmight\\tO\\nnot\\tO\\nresult\\tO\\nin\\tO\\nsimple\\tO\\nloss\\tO\\nof\\tO\\nprotein\\tO\\nfunction\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nfound\\tO\\nthat\\tO\\nFAP\\tB-Disease\\npatients\\tO\\nwith\\tO\\ngermline\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\nwithin\\tO\\na\\tO\\nsmall\\tO\\nregion\\tO\\n(\\tO\\ncodons\\tO\\n1\\tO\\n,\\tO\\n194\\tO\\n-\\tO\\n1\\tO\\n,\\tO\\n392\\tO\\nat\\tO\\nmost\\tO\\n)\\tO\\nmainly\\tO\\nshow\\tO\\nallelic\\tO\\nloss\\tO\\nin\\tO\\ntheir\\tO\\ncolorectal\\tB-Disease\\nadenomas\\tI-Disease\\n,\\tO\\nin\\tO\\ncontrast\\tO\\nto\\tO\\nother\\tO\\nFAP\\tB-Disease\\npatients\\tO\\n,\\tO\\nwhose\\tO\\nsecond\\tO\\nhits\\tO\\ntend\\tO\\nto\\tO\\noccur\\tO\\nby\\tO\\ntruncating\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nmutation\\tO\\ncluster\\tO\\nregion\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\ndifferent\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\nprovide\\tO\\ncells\\tO\\nwith\\tO\\ndifferent\\tO\\nselective\\tO\\nadvantages\\tO\\n,\\tO\\nwith\\tO\\nmutations\\tO\\nclose\\tO\\nto\\tO\\ncodon\\tO\\n1\\tO\\n,\\tO\\n300\\tO\\nproviding\\tO\\nthe\\tO\\ngreatest\\tO\\nadvantage\\tO\\n.\\tO\\n\\nAllelic\\tO\\nloss\\tO\\nis\\tO\\nselected\\tO\\nstrongly\\tO\\nin\\tO\\ncells\\tO\\nwith\\tO\\none\\tO\\nmutation\\tO\\nnear\\tO\\ncodon\\tO\\n1\\tO\\n,\\tO\\n300\\tO\\n.\\tO\\n\\nA\\tO\\ndifferent\\tO\\ngermline\\tO\\n-\\tO\\nsomatic\\tO\\nAPC\\tB-Disease\\nmutation\\tO\\nassociation\\tO\\nexists\\tO\\nin\\tO\\nFAP\\tB-Disease\\ndesmoids\\tI-Disease\\n.\\tO\\n\\nAPC\\tO\\nis\\tO\\nnot\\tO\\n,\\tO\\ntherefore\\tO\\n,\\tO\\na\\tO\\nclassical\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nalso\\tO\\nindicate\\tO\\na\\tO\\nnew\\tO\\nmechanism\\tO\\nfor\\tO\\ndisease\\tO\\nseverity\\tO\\nif\\tO\\na\\tO\\nbroader\\tO\\nspectrum\\tO\\nof\\tO\\nmutations\\tO\\nis\\tO\\nselected\\tO\\nin\\tO\\ntumors\\tB-Disease\\n,\\tO\\nthe\\tO\\nsomatic\\tO\\nmutation\\tO\\nrate\\tO\\nis\\tO\\neffectively\\tO\\nhigher\\tO\\nand\\tO\\nmore\\tO\\ntumors\\tB-Disease\\ngrow\\tO\\n.\\tO\\n.\\tO\\n\\nMxi1\\tO\\nmutations\\tO\\nin\\tO\\nhuman\\tO\\nneurofibrosarcomas\\tB-Disease\\n.\\tO\\n\\nMxi1\\tO\\nis\\tO\\nthought\\tO\\nto\\tO\\nnegatively\\tO\\nregulate\\tO\\nMyc\\tO\\nfunction\\tO\\nand\\tO\\nmay\\tO\\ntherefore\\tO\\nbe\\tO\\na\\tO\\npotential\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n.\\tO\\n\\nLittle\\tO\\neffort\\tO\\nhas\\tO\\nyet\\tO\\nbeen\\tO\\nmade\\tO\\nto\\tO\\nfind\\tO\\nalterations\\tO\\ninvolving\\tO\\nthis\\tO\\ngene\\tO\\nin\\tO\\nhuman\\tO\\nsolid\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nscreened\\tO\\n31\\tO\\nhuman\\tO\\ngastric\\tB-Disease\\ncancers\\tI-Disease\\n,\\tO\\n7\\tO\\nesophageal\\tB-Disease\\ncancers\\tI-Disease\\n,\\tO\\n85\\tO\\nbone\\tB-Disease\\nand\\tI-Disease\\nsoft\\tI-Disease\\ntissue\\tI-Disease\\ntumors\\tI-Disease\\nof\\tO\\nvarious\\tO\\ntypes\\tO\\n,\\tO\\nincluding\\tO\\n4\\tO\\nneurofibrosarcomas\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nexamined\\tO\\n29\\tO\\nhuman\\tO\\ntumor\\tB-Disease\\ncell\\tO\\nlines\\tO\\nconsisting\\tO\\nof\\tO\\n12\\tO\\nesophageal\\tB-Disease\\ncancers\\tI-Disease\\n,\\tO\\n7\\tO\\nglioma\\tB-Disease\\n/\\tO\\nglioblastomas\\tB-Disease\\nand\\tO\\n10\\tO\\nothers\\tO\\nfor\\tO\\nMxi1\\tO\\nmutations\\tO\\nin\\tO\\nexons\\tO\\n1\\tO\\n,\\tO\\n2\\tO\\n,\\tO\\n4\\tO\\n(\\tO\\nHLH\\tO\\ndomain\\tO\\n)\\tO\\n,\\tO\\n5\\tO\\nand\\tO\\n6\\tO\\n.\\tO\\n\\nPolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n-\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nPCR\\tO\\n-\\tO\\nSSCP\\tO\\n)\\tO\\nand\\tO\\nsubsequent\\tO\\nsequencing\\tO\\nrevealed\\tO\\nthree\\tO\\ndistinct\\tO\\npolymorphisms\\tO\\nin\\tO\\nthe\\tO\\nintron\\tO\\n-\\tO\\nexon\\tO\\nboundary\\tO\\nupstream\\tO\\nfrom\\tO\\nexon\\tO\\n6\\tO\\n.\\tO\\n\\nWe\\tO\\ndiscovered\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\nGCA\\tO\\nto\\tO\\nGTA\\tO\\n(\\tO\\nAla\\tO\\n54\\tO\\nVal\\tO\\n)\\tO\\n,\\tO\\nin\\tO\\nexon\\tO\\n2\\tO\\nin\\tO\\na\\tO\\nneurofibrosarcoma\\tB-Disease\\npatient\\tO\\n(\\tO\\ncase\\tO\\n1\\tO\\n)\\tO\\n,\\tO\\ntwo\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\nAAA\\tO\\nto\\tO\\nCAA\\tO\\n(\\tO\\nLys\\tO\\n118\\tO\\nGln\\tO\\n)\\tO\\nand\\tO\\nGAA\\tO\\nto\\tO\\nGGA\\tO\\n(\\tO\\nGlu\\tO\\n154\\tO\\nGly\\tO\\n)\\tO\\nin\\tO\\nexon\\tO\\n5\\tO\\nof\\tO\\nanother\\tO\\nneurofibrosarcoma\\tB-Disease\\npatient\\tO\\n(\\tO\\ncase\\tO\\n2\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\n3\\tO\\namino\\tO\\nacid\\tO\\nsubstitutions\\tO\\n,\\tO\\nGTG\\tO\\nto\\tO\\nGCG\\tO\\n(\\tO\\nVal\\tO\\n179\\tO\\nAla\\tO\\n)\\tO\\n,\\tO\\nGTT\\tO\\nto\\tO\\nGCT\\tO\\n(\\tO\\nVal\\tO\\n181\\tO\\nAla\\tO\\n)\\tO\\nand\\tO\\nTTC\\tO\\nto\\tO\\nCTC\\tO\\n(\\tO\\nPhe\\tO\\n186\\tO\\nLeu\\tO\\n)\\tO\\n,\\tO\\nin\\tO\\na\\tO\\nthird\\tO\\nneurofibrosarcoma\\tB-Disease\\npatient\\tO\\n(\\tO\\ncase\\tO\\n3\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\ncase\\tO\\n3\\tO\\n,\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\nwas\\tO\\nalso\\tO\\ndemonstrated\\tO\\nby\\tO\\ninformative\\tO\\n(\\tO\\nTTC\\tO\\n)\\tO\\n3\\tO\\n/\\tO\\n(\\tO\\nTTC\\tO\\n)\\tO\\n2\\tO\\npolymorphism\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\ndemonstrate\\tO\\nthat\\tO\\nmutations\\tO\\noccur\\tO\\nin\\tO\\nthe\\tO\\nMxi1\\tO\\ngene\\tO\\nin\\tO\\nneurofibrosarcoma\\tB-Disease\\n.\\tO\\n\\nMissense\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nfunctional\\tO\\ndomain\\tO\\nof\\tO\\nMxi1\\tO\\nin\\tO\\nthese\\tO\\ncases\\tO\\nmay\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nneurofibrosarcoma\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nA\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\nstudy\\tO\\nof\\tO\\nthe\\tO\\nclinical\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nhemochromatosis\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\nAND\\tO\\nMETHODS\\tO\\nHereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nhomozygosity\\tO\\nfor\\tO\\nthe\\tO\\nC282Y\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nhemochromatosis\\tB-Disease\\n(\\tO\\nHFE\\tO\\n)\\tO\\ngene\\tO\\non\\tO\\nchromosome\\tO\\n6\\tO\\n,\\tO\\nelevated\\tO\\nserum\\tO\\ntransferrin\\tO\\nsaturation\\tO\\n,\\tO\\nand\\tO\\nexcess\\tB-Disease\\niron\\tI-Disease\\ndeposits\\tI-Disease\\nthroughout\\tO\\nthe\\tO\\nbody\\tO\\n.\\tO\\n\\nTo\\tO\\nassess\\tO\\nthe\\tO\\nprevalence\\tO\\nand\\tO\\nclinical\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nHFE\\tO\\ngene\\tO\\n,\\tO\\nwe\\tO\\nconducted\\tO\\na\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\nstudy\\tO\\nin\\tO\\nBusselton\\tO\\n,\\tO\\nAustralia\\tO\\n.\\tO\\n\\nIn\\tO\\n1994\\tO\\n,\\tO\\nwe\\tO\\nobtained\\tO\\nblood\\tO\\nsamples\\tO\\nfor\\tO\\nthe\\tO\\ndetermination\\tO\\nof\\tO\\nserum\\tO\\ntransferrin\\tO\\nsaturation\\tO\\nand\\tO\\nferritin\\tO\\nlevels\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\nor\\tO\\nabsence\\tO\\nof\\tO\\nthe\\tO\\nC282Y\\tO\\nmutation\\tO\\nand\\tO\\nthe\\tO\\nH63D\\tO\\nmutation\\tO\\n(\\tO\\nwhich\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\nincreased\\tO\\nhepatic\\tO\\niron\\tO\\nlevels\\tO\\n)\\tO\\nin\\tO\\n3011\\tO\\nunrelated\\tO\\nwhite\\tO\\nadults\\tO\\n.\\tO\\n\\nWe\\tO\\nevaluated\\tO\\nall\\tO\\nsubjects\\tO\\nwho\\tO\\nhad\\tO\\npersistently\\tO\\nelevated\\tO\\ntransferrin\\tO\\n-\\tO\\nsaturation\\tO\\nvalues\\tO\\n(\\tO\\n45\\tO\\npercent\\tO\\nor\\tO\\nhigher\\tO\\n)\\tO\\nor\\tO\\nwere\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\nC282Y\\tO\\nmutation\\tO\\n.\\tO\\n\\nWe\\tO\\nrecommended\\tO\\nliver\\tO\\nbiopsy\\tO\\nfor\\tO\\nsubjects\\tO\\nwith\\tO\\nserum\\tO\\nferritin\\tO\\nlevels\\tO\\nof\\tO\\n300\\tO\\nng\\tO\\nper\\tO\\nmilliliter\\tO\\nor\\tO\\nhigher\\tO\\n.\\tO\\n\\nThe\\tO\\nsubjects\\tO\\nwere\\tO\\nfollowed\\tO\\nfor\\tO\\nup\\tO\\nto\\tO\\nfour\\tO\\nyears\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nSixteen\\tO\\nof\\tO\\nthe\\tO\\nsubjects\\tO\\n(\\tO\\n0\\tO\\n.\\tO\\n5\\tO\\npercent\\tO\\n)\\tO\\nwere\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\nC282Y\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\n424\\tO\\n(\\tO\\n14\\tO\\n.\\tO\\n1\\tO\\npercent\\tO\\n)\\tO\\nwere\\tO\\nheterozygous\\tO\\n.\\tO\\n\\nThe\\tO\\nserum\\tO\\ntransferrin\\tO\\nsaturation\\tO\\nwas\\tO\\n45\\tO\\npercent\\tO\\nor\\tO\\nhigher\\tO\\nin\\tO\\n15\\tO\\nof\\tO\\nthe\\tO\\n16\\tO\\nwho\\tO\\nwere\\tO\\nhomozygous\\tO\\n;\\tO\\nin\\tO\\n1\\tO\\nsubject\\tO\\nit\\tO\\nwas\\tO\\n43\\tO\\npercent\\tO\\n.\\tO\\n\\nFour\\tO\\nof\\tO\\nthe\\tO\\nhomozygous\\tO\\nsubjects\\tO\\nhad\\tO\\npreviously\\tO\\nbeen\\tO\\ngiven\\tO\\na\\tO\\ndiagnosis\\tO\\nof\\tO\\nhemochromatosis\\tB-Disease\\n,\\tO\\nand\\tO\\n12\\tO\\nhad\\tO\\nnot\\tO\\n.\\tO\\n\\nSeven\\tO\\nof\\tO\\nthese\\tO\\n12\\tO\\npatients\\tO\\nhad\\tO\\nelevated\\tO\\nserum\\tO\\nferritin\\tO\\nlevels\\tO\\nin\\tO\\n1994\\tO\\n;\\tO\\n6\\tO\\nof\\tO\\nthe\\tO\\n7\\tO\\nhad\\tO\\nfurther\\tO\\nincreases\\tO\\nin\\tO\\n1998\\tO\\n,\\tO\\nand\\tO\\n1\\tO\\nhad\\tO\\na\\tO\\ndecrease\\tO\\n,\\tO\\nalthough\\tO\\nthe\\tO\\nvalue\\tO\\nremained\\tO\\nelevated\\tO\\n.\\tO\\n\\nThe\\tO\\nserum\\tO\\nferritin\\tO\\nlevels\\tO\\nin\\tO\\nthe\\tO\\nfour\\tO\\nother\\tO\\nhomozygous\\tO\\npatients\\tO\\nremained\\tO\\nin\\tO\\nthe\\tO\\nnormal\\tO\\nrange\\tO\\n.\\tO\\n\\nEleven\\tO\\nof\\tO\\nthe\\tO\\n16\\tO\\nhomozygous\\tO\\nsubjects\\tO\\nunderwent\\tO\\nliver\\tO\\nbiopsy\\tO\\n;\\tO\\n3\\tO\\nhad\\tO\\nhepatic\\tB-Disease\\nfibrosis\\tI-Disease\\n,\\tO\\nand\\tO\\n1\\tO\\n,\\tO\\nwho\\tO\\nhad\\tO\\na\\tO\\nhistory\\tO\\nof\\tO\\nexcessive\\tB-Disease\\nalcohol\\tI-Disease\\nconsumption\\tI-Disease\\n,\\tO\\nhad\\tO\\ncirrhosis\\tB-Disease\\nand\\tO\\nmild\\tO\\nmicrovesicular\\tB-Disease\\nsteatosis\\tI-Disease\\n.\\tO\\n\\nEight\\tO\\nof\\tO\\nthe\\tO\\n16\\tO\\nhomozygous\\tO\\nsubjects\\tO\\nhad\\tO\\nclinical\\tO\\nfindings\\tO\\nthat\\tO\\nwere\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\n,\\tO\\nsuch\\tO\\nas\\tO\\nhepatomegaly\\tB-Disease\\n,\\tO\\nskin\\tB-Disease\\npigmentation\\tI-Disease\\n,\\tO\\nand\\tO\\narthritis\\tB-Disease\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nIn\\tO\\na\\tO\\npopulation\\tO\\nof\\tO\\nwhite\\tO\\nadults\\tO\\nof\\tO\\nnorthern\\tO\\nEuropean\\tO\\nancestry\\tO\\n,\\tO\\n0\\tO\\n.\\tO\\n\\n5\\tO\\npercent\\tO\\nwere\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\nC282Y\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nHFE\\tO\\ngene\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nonly\\tO\\nhalf\\tO\\nof\\tO\\nthose\\tO\\nwho\\tO\\nwere\\tO\\nhomozygous\\tO\\nhad\\tO\\nclinical\\tO\\nfeatures\\tO\\nof\\tO\\nhemochromatosis\\tB-Disease\\n,\\tO\\nand\\tO\\none\\tO\\nquarter\\tO\\nhad\\tO\\nserum\\tO\\nferritin\\tO\\nlevels\\tO\\nthat\\tO\\nremained\\tO\\nnormal\\tO\\nover\\tO\\na\\tO\\nfour\\tO\\n-\\tO\\nyear\\tO\\nperiod\\tO\\n.\\tO\\n\\nLarge\\tO\\nheterozygous\\tO\\ndeletion\\tO\\nmasquerading\\tO\\nas\\tO\\nhomozygous\\tO\\nmissense\\tO\\nmutation\\tO\\n:\\tO\\na\\tO\\npitfall\\tO\\nin\\tO\\ndiagnostic\\tO\\nmutation\\tO\\nanalysis\\tO\\n.\\tO\\n\\nThe\\tO\\nclinical\\tO\\nuse\\tO\\nof\\tO\\nmolecular\\tO\\nanalyses\\tO\\nin\\tO\\nrecessive\\tB-Disease\\ndisorders\\tI-Disease\\nrelies\\tO\\non\\tO\\nthe\\tO\\nexact\\tO\\ncharacterization\\tO\\nof\\tO\\nboth\\tO\\nmutant\\tO\\nalleles\\tO\\nin\\tO\\nthe\\tO\\naffected\\tO\\npatient\\tO\\n.\\tO\\n\\nThis\\tO\\ncan\\tO\\nbe\\tO\\nproblematic\\tO\\nwhen\\tO\\nonly\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nis\\tO\\nexamined\\tO\\nor\\tO\\nwhen\\tO\\nrelevant\\tO\\nDNA\\tO\\nalterations\\tO\\nare\\tO\\nnot\\tO\\nrecognized\\tO\\nby\\tO\\nstandard\\tO\\nmethods\\tO\\n.\\tO\\n\\nWe\\tO\\npresent\\tO\\na\\tO\\nchild\\tO\\nin\\tO\\nwhom\\tO\\nphenylketonuria\\tB-Disease\\nwas\\tO\\napparently\\tO\\ncaused\\tO\\nby\\tO\\nhomozygosity\\tO\\nfor\\tO\\nthe\\tO\\nmutation\\tO\\nE390G\\tO\\nin\\tO\\nexon\\tO\\n11\\tO\\nof\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n(\\tO\\nPAH\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nclinical\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nwas\\tO\\nnot\\tO\\nquite\\tO\\nas\\tO\\nmild\\tO\\nas\\tO\\nexpected\\tO\\n,\\tO\\nthe\\tO\\nmutation\\tO\\nwas\\tO\\nnot\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\nfather\\tO\\ndespite\\tO\\nconfirmed\\tO\\npaternity\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\npaternal\\tO\\nallele\\tO\\nshowed\\tO\\na\\tO\\nhighly\\tO\\nunusual\\tO\\npattern\\tO\\nof\\tO\\npolymorphic\\tO\\nmarkers\\tO\\nin\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\n.\\tO\\n\\nPresence\\tO\\nof\\tO\\na\\tO\\nlarge\\tO\\ndeletion\\tO\\ninvolving\\tO\\nexons\\tO\\n9\\tO\\n,\\tO\\n10\\tO\\nand\\tO\\n11\\tO\\nof\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\ngene\\tO\\nwas\\tO\\nconfirmed\\tO\\nby\\tO\\nlong\\tO\\n-\\tO\\nrange\\tO\\nPCR\\tO\\n.\\tO\\n\\nDiagnostic\\tO\\nDNA\\tO\\nanalyses\\tO\\nshould\\tO\\ninclude\\tO\\na\\tO\\ncomprehensive\\tO\\nexamination\\tO\\nof\\tO\\nthe\\tO\\nwhole\\tO\\nrelevant\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\nand\\tO\\nconfirmation\\tO\\nof\\tO\\ncarrier\\tO\\nstatus\\tO\\nin\\tO\\nboth\\tO\\nparents\\tO\\n.\\tO\\n.\\tO\\n\\nEarly\\tO\\nonset\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nEmery\\tI-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nin\\tO\\na\\tO\\nboy\\tO\\nwith\\tO\\nemerin\\tO\\ngene\\tO\\ndeletion\\tO\\n.\\tO\\n\\nA\\tO\\nboy\\tO\\ndeveloped\\tO\\ncontractures\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nAchilles\\tI-Disease\\ntendons\\tI-Disease\\nat\\tO\\n3\\tO\\nyears\\tO\\nand\\tO\\nof\\tO\\nthe\\tO\\npostcervical\\tO\\nmuscles\\tO\\nat\\tO\\n7\\tO\\nyears\\tO\\n,\\tO\\nalthough\\tO\\nneither\\tO\\ncontractures\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nelbows\\tI-Disease\\nnor\\tO\\ncardiac\\tB-Disease\\nabnormality\\tI-Disease\\nwere\\tO\\nrecognized\\tO\\nby\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\n9\\tO\\nyears\\tO\\n.\\tO\\n\\nMuscle\\tO\\ncomputed\\tO\\ntomography\\tO\\nscanning\\tO\\nrevealed\\tO\\nchanges\\tO\\ncharacteristic\\tO\\nof\\tO\\nmuscle\\tO\\ninvolvement\\tO\\n.\\tO\\n\\nEmerin\\tO\\nwas\\tO\\nnot\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nbiopsied\\tO\\nmuscle\\tO\\n,\\tO\\nand\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nand\\tO\\nPCR\\tO\\n-\\tO\\nbased\\tO\\ngenomic\\tO\\nDNA\\tO\\nanalyses\\tO\\nof\\tO\\nthe\\tO\\nemerin\\tO\\ngene\\tO\\ndemonstrated\\tO\\nno\\tO\\namplification\\tO\\nproduct\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nconfirmed\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nEmery\\tI-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nEDMD\\tB-Disease\\n)\\tO\\n,\\tO\\nand\\tO\\nreinforce\\tO\\nthe\\tO\\nnecessity\\tO\\nof\\tO\\nmolecular\\tO\\ngenetic\\tO\\ndiagnosis\\tO\\nof\\tO\\nthe\\tO\\nmembrane\\tO\\nprotein\\tO\\nemerin\\tO\\nin\\tO\\nyounger\\tO\\npatients\\tO\\nwith\\tO\\npossible\\tO\\nEDMD\\tB-Disease\\nbefore\\tO\\nappearance\\tO\\nof\\tO\\nthe\\tO\\ntypical\\tO\\nsymptoms\\tO\\n,\\tO\\nto\\tO\\navoid\\tO\\nsudden\\tB-Disease\\ncardiac\\tI-Disease\\ndeath\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nDuchenne\\tB-Disease\\n/\\tI-Disease\\nBecker\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n:\\tO\\ncorrelation\\tO\\nof\\tO\\nphenotype\\tO\\nby\\tO\\nelectroretinography\\tO\\nwith\\tO\\nsites\\tO\\nof\\tO\\ndystrophin\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\ndark\\tO\\n-\\tO\\nadapted\\tO\\nelectroretinogram\\tO\\n(\\tO\\nERG\\tO\\n)\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nand\\tI-Disease\\nBecker\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n/\\tO\\nBMD\\tB-Disease\\n)\\tO\\nshows\\tO\\na\\tO\\nmarked\\tO\\nreduction\\tO\\nin\\tO\\nb\\tO\\n-\\tO\\nwave\\tO\\namplitude\\tO\\n.\\tO\\n\\nGenotype\\tO\\n-\\tO\\nphenotype\\tO\\nstudies\\tO\\nof\\tO\\nmouse\\tO\\nmodels\\tO\\nfor\\tO\\nDMD\\tB-Disease\\nshow\\tO\\nposition\\tO\\n-\\tO\\nspecific\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nupon\\tO\\nthe\\tO\\nphenotype\\tO\\nmice\\tO\\nwith\\tO\\n5\\tO\\ndefects\\tO\\nof\\tO\\ndystrophin\\tO\\nhave\\tO\\nnormal\\tO\\nERGs\\tO\\n,\\tO\\nthose\\tO\\nwith\\tO\\ndefects\\tO\\nin\\tO\\nthe\\tO\\ncentral\\tO\\nregion\\tO\\nhave\\tO\\na\\tO\\nnormal\\tO\\nb\\tO\\n-\\tO\\nwave\\tO\\namplitude\\tO\\nassociated\\tO\\nwith\\tO\\nprolonged\\tO\\nimplicit\\tO\\ntimes\\tO\\nfor\\tO\\nboth\\tO\\nthe\\tO\\nb\\tO\\n-\\tO\\nwave\\tO\\nand\\tO\\noscillatory\\tO\\npotentials\\tO\\n,\\tO\\nand\\tO\\nmice\\tO\\nwith\\tO\\n3\\tO\\ndefects\\tO\\nhave\\tO\\na\\tO\\nphenotype\\tO\\nsimilar\\tO\\nto\\tO\\nthat\\tO\\nseen\\tO\\nin\\tO\\nDMD\\tB-Disease\\n/\\tO\\nBMD\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\nmouse\\tO\\nstudies\\tO\\nsuggest\\tO\\na\\tO\\nkey\\tO\\nrole\\tO\\nfor\\tO\\nthe\\tO\\ncarboxyl\\tO\\nterminal\\tO\\ndystrophin\\tO\\nisoform\\tO\\n,\\tO\\nDp260\\tO\\n,\\tO\\nin\\tO\\nretinal\\tO\\nelectrophysiology\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nundertaken\\tO\\na\\tO\\nsystematic\\tO\\nevaluation\\tO\\nof\\tO\\nDMD\\tB-Disease\\n/\\tO\\nBMD\\tB-Disease\\npatients\\tO\\nthrough\\tO\\nclinical\\tO\\nexamination\\tO\\nand\\tO\\nreview\\tO\\nof\\tO\\nthe\\tO\\nliterature\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\ndetermine\\tO\\nwhether\\tO\\nthe\\tO\\nposition\\tO\\n-\\tO\\nspecific\\tO\\neffects\\tO\\nof\\tO\\nmutations\\tO\\nnoted\\tO\\nin\\tO\\nthe\\tO\\nmouse\\tO\\nare\\tO\\npresent\\tO\\nin\\tO\\nman\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nfound\\tO\\nthat\\tO\\n,\\tO\\nin\\tO\\nman\\tO\\n,\\tO\\na\\tO\\nwider\\tO\\nvariation\\tO\\nof\\tO\\nDMD\\tB-Disease\\ndefects\\tI-Disease\\ncorrelate\\tO\\nwith\\tO\\nreductions\\tO\\nin\\tO\\nthe\\tO\\nb\\tO\\n-\\tO\\nwave\\tO\\namplitude\\tO\\n.\\tO\\n\\nIndividuals\\tO\\nwith\\tO\\nnormal\\tO\\nERGs\\tO\\nhave\\tO\\nmutations\\tO\\npredominantly\\tO\\nlocated\\tO\\n5\\tO\\nof\\tO\\nthe\\tO\\ntranscript\\tO\\ninitiation\\tO\\nsite\\tO\\nof\\tO\\nDp260\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nmost\\tO\\nimportant\\tO\\ndeterminant\\tO\\nin\\tO\\nthe\\tO\\nERG\\tO\\nb\\tO\\n-\\tO\\nwave\\tO\\nphenotype\\tO\\nis\\tO\\nthe\\tO\\nmutation\\tO\\nposition\\tO\\n,\\tO\\nrather\\tO\\nthan\\tO\\nmuscle\\tB-Disease\\ndisease\\tI-Disease\\nseverity\\tO\\n.\\tO\\n\\nForty\\tO\\n-\\tO\\nsix\\tO\\nper\\tO\\ncent\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nmutations\\tO\\n5\\tO\\nof\\tO\\nthe\\tO\\nDp260\\tO\\ntranscript\\tO\\nstart\\tO\\nsite\\tO\\nhave\\tO\\nabnormal\\tO\\nERGs\\tO\\n,\\tO\\nas\\tO\\nopposed\\tO\\nto\\tO\\n94\\tO\\n%\\tO\\nwith\\tO\\nmore\\tO\\ndistal\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nDp260\\tO\\nin\\tO\\nnormal\\tO\\nretinal\\tO\\nelectrophysiology\\tO\\nand\\tO\\nmay\\tO\\nalso\\tO\\nreflect\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nother\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\ndystrophin\\tO\\nisoforms\\tO\\nand\\tO\\ntheir\\tO\\ncontributions\\tO\\nto\\tO\\nretinal\\tO\\nsignal\\tO\\ntransmission\\tO\\n.\\tO\\n.\\tO\\n\\nCis\\tO\\nand\\tO\\ntrans\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\ncell\\tO\\nculture\\tO\\nmodel\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\ncausing\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nas\\tO\\na\\tO\\nCTG\\tO\\nexpansion\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\n-\\tO\\nuntranslated\\tO\\nregion\\tO\\n(\\tO\\n3\\tO\\n-\\tO\\nUTR\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nprotein\\tO\\nkinase\\tO\\ngene\\tO\\n(\\tO\\nDMPK\\tO\\n)\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nmechanism\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\nof\\tO\\npathogenesis\\tO\\nremain\\tO\\nunknown\\tO\\n.\\tO\\n\\nStudies\\tO\\nusing\\tO\\nDM\\tB-Disease\\npatient\\tO\\nmaterials\\tO\\nhave\\tO\\noften\\tO\\nproduced\\tO\\nconfusing\\tO\\nresults\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\nto\\tO\\nstudy\\tO\\nthe\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nmutation\\tO\\nin\\tO\\na\\tO\\ncontrolled\\tO\\nenvironment\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nestablished\\tO\\na\\tO\\ncell\\tO\\nculture\\tO\\nmodel\\tO\\nsystem\\tO\\nusing\\tO\\nC2C12\\tO\\nmouse\\tO\\nmyoblasts\\tO\\n.\\tO\\n\\nBy\\tO\\nexpressing\\tO\\nchimeric\\tO\\nreporter\\tO\\nconstructs\\tO\\ncontaining\\tO\\na\\tO\\nreporter\\tO\\ngene\\tO\\nfused\\tO\\nto\\tO\\na\\tO\\nhuman\\tO\\nDMPK\\tO\\n3\\tO\\n-\\tO\\nUTR\\tO\\n,\\tO\\nwe\\tO\\nidentified\\tO\\nboth\\tO\\ncis\\tO\\nand\\tO\\ntrans\\tO\\neffects\\tO\\nthat\\tO\\nare\\tO\\nmediated\\tO\\nby\\tO\\nthe\\tO\\nDM\\tB-Disease\\nmutation\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nshow\\tO\\nthat\\tO\\na\\tO\\nmutant\\tO\\nDMPK\\tO\\n3\\tO\\n-\\tO\\nUTR\\tO\\n,\\tO\\nwith\\tO\\nas\\tO\\nfew\\tO\\nas\\tO\\n57\\tO\\nCTGs\\tO\\n,\\tO\\nhad\\tO\\na\\tO\\nnegative\\tO\\ncis\\tO\\neffect\\tO\\non\\tO\\nprotein\\tO\\nexpression\\tO\\nand\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\naggregation\\tO\\nof\\tO\\nreporter\\tO\\ntranscripts\\tO\\ninto\\tO\\ndiscrete\\tO\\nnuclear\\tO\\nfoci\\tO\\n.\\tO\\n\\nWe\\tO\\ndetermined\\tO\\nby\\tO\\ndeletion\\tO\\nanalysis\\tO\\nthat\\tO\\nan\\tO\\nexpanded\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\n(\\tO\\nn\\tO\\n)\\tO\\ntract\\tO\\nalone\\tO\\nwas\\tO\\nsufficient\\tO\\nto\\tO\\nmediate\\tO\\nthese\\tO\\ncis\\tO\\neffects\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nin\\tO\\ncontrast\\tO\\nto\\tO\\nthe\\tO\\nnormal\\tO\\nDMPK\\tO\\n3\\tO\\n-\\tO\\nUTR\\tO\\nmRNA\\tO\\n,\\tO\\na\\tO\\nmutant\\tO\\nDMPK\\tO\\n3\\tO\\n-\\tO\\nUTR\\tO\\nmRNA\\tO\\nwith\\tO\\n(\\tO\\nCUG\\tO\\n)\\tO\\n(\\tO\\n200\\tO\\n)\\tO\\nselectively\\tO\\ninhibited\\tO\\nmyogenic\\tO\\ndifferentiation\\tO\\nof\\tO\\nC2C12\\tO\\nmyoblasts\\tO\\n.\\tO\\n\\nGenetic\\tO\\nanalysis\\tO\\nand\\tO\\nthe\\tO\\nCre\\tO\\n-\\tO\\nloxP\\tO\\nsystem\\tO\\nwere\\tO\\nused\\tO\\nto\\tO\\nclearly\\tO\\ndemonstrate\\tO\\nthat\\tO\\nthe\\tO\\nmyoblast\\tO\\nfusion\\tO\\ndefect\\tO\\ncould\\tO\\nbe\\tO\\nrescued\\tO\\nby\\tO\\neliminating\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nDMPK\\tO\\n3\\tO\\n-\\tO\\nUTR\\tO\\ntranscript\\tO\\n.\\tO\\n\\nCharacterization\\tO\\nof\\tO\\nspontaneous\\tO\\ndeletion\\tO\\nevents\\tO\\nmapped\\tO\\nthe\\tO\\ninhibitory\\tO\\neffect\\tO\\nto\\tO\\nthe\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\n(\\tO\\nn\\tO\\n)\\tO\\nexpansion\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nthe\\tO\\n3\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\nDMPK\\tO\\n3\\tO\\n-\\tO\\nUTR\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nprovide\\tO\\nevidence\\tO\\nthat\\tO\\nthe\\tO\\nDM\\tB-Disease\\nmutation\\tO\\nacts\\tO\\nin\\tO\\ncis\\tO\\nto\\tO\\nreduce\\tO\\nprotein\\tO\\nproduction\\tO\\n(\\tO\\nconsistent\\tO\\nwith\\tO\\nDMPK\\tB-Disease\\nhaploinsufficiency\\tI-Disease\\n)\\tO\\nand\\tO\\nin\\tO\\ntrans\\tO\\nas\\tO\\na\\tO\\nriboregulator\\tO\\nto\\tO\\ninhibit\\tO\\nmyogenesis\\tO\\n.\\tO\\n.\\tO\\n\\nCoats\\tB-Disease\\n\\'\\tI-Disease\\ndisease\\tI-Disease\\nof\\tO\\nthe\\tO\\nretina\\tO\\n(\\tO\\nunilateral\\tB-Disease\\nretinal\\tI-Disease\\ntelangiectasis\\tI-Disease\\n)\\tO\\ncaused\\tO\\nby\\tO\\nsomatic\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nNDP\\tO\\ngene\\tO\\n:\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nnorrin\\tO\\nin\\tO\\nretinal\\tO\\nangiogenesis\\tO\\n.\\tO\\n\\nCoats\\tB-Disease\\ndisease\\tI-Disease\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nabnormal\\tB-Disease\\nretinal\\tI-Disease\\nvascular\\tI-Disease\\ndevelopment\\tI-Disease\\n(\\tO\\nso\\tO\\n-\\tO\\ncalled\\tO\\nretinal\\tB-Disease\\ntelangiectasis\\tI-Disease\\n)\\tO\\nwhich\\tO\\nresults\\tO\\nin\\tO\\nmassive\\tO\\nintraretinal\\tB-Disease\\nand\\tI-Disease\\nsubretinal\\tI-Disease\\nlipid\\tI-Disease\\naccumulation\\tI-Disease\\n(\\tO\\nexudative\\tB-Disease\\nretinal\\tI-Disease\\ndetachment\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nclassical\\tO\\nform\\tO\\nof\\tO\\nCoats\\tB-Disease\\ndisease\\tI-Disease\\nis\\tO\\nalmost\\tO\\ninvariably\\tO\\nisolated\\tO\\n,\\tO\\nunilateral\\tO\\nand\\tO\\nseen\\tO\\nin\\tO\\nmales\\tO\\n.\\tO\\n\\nA\\tO\\nfemale\\tO\\nwith\\tO\\na\\tO\\nunilateral\\tO\\nvariant\\tO\\nof\\tO\\nCoats\\tB-Disease\\ndisease\\tI-Disease\\ngave\\tO\\nbirth\\tO\\nto\\tO\\na\\tO\\nson\\tO\\naffected\\tO\\nby\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nBoth\\tO\\ncarried\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nwithin\\tO\\nthe\\tO\\nNDP\\tO\\ngene\\tO\\non\\tO\\nchromosome\\tO\\nXp11\\tO\\n.\\tO\\n\\n2\\tO\\n2\\tO\\n.\\tO\\n\\nSubsequently\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nretinas\\tO\\nof\\tO\\nnine\\tO\\nenucleated\\tO\\neyes\\tO\\nfrom\\tO\\nmales\\tO\\nwith\\tO\\nCoats\\tB-Disease\\ndisease\\tI-Disease\\ndemonstrated\\tO\\nin\\tO\\none\\tO\\na\\tO\\nsomatic\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nNDP\\tO\\ngene\\tO\\nwhich\\tO\\nwas\\tO\\nnot\\tO\\npresent\\tO\\nwithin\\tO\\nnon\\tO\\n-\\tO\\nretinal\\tO\\ntissue\\tO\\n.\\tO\\n\\nWe\\tO\\nsuggest\\tO\\nthat\\tO\\nCoats\\tB-Disease\\ntelangiectasis\\tI-Disease\\nis\\tO\\nsecondary\\tO\\nto\\tO\\nsomatic\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nNDP\\tO\\ngene\\tO\\nwhich\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nnorrin\\tI-Disease\\n(\\tO\\nthe\\tO\\nprotein\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\nNDP\\tO\\ngene\\tO\\n)\\tO\\nwithin\\tO\\nthe\\tO\\ndeveloping\\tO\\nretina\\tO\\n.\\tO\\n\\nThis\\tO\\nsupports\\tO\\nrecent\\tO\\nobservations\\tO\\nthat\\tO\\nthe\\tO\\nprotein\\tO\\nis\\tO\\ncritical\\tO\\nfor\\tO\\nnormal\\tO\\nretinal\\tO\\nvasculogenesis\\tO\\n.\\tO\\n\\nHereditary\\tO\\nTP53\\tO\\ncodon\\tO\\n292\\tO\\nand\\tO\\nsomatic\\tO\\nP16INK4A\\tO\\ncodon\\tO\\n94\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\nLi\\tB-Disease\\n-\\tI-Disease\\nFraumeni\\tI-Disease\\nsyndrome\\tI-Disease\\nfamily\\tO\\n.\\tO\\n\\nLi\\tB-Disease\\n-\\tI-Disease\\nFraumeni\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisorder\\tI-Disease\\nthat\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nvarious\\tO\\ntypes\\tO\\nof\\tO\\ncancer\\tB-Disease\\nin\\tO\\nchildhood\\tO\\nand\\tO\\nadult\\tO\\ncases\\tO\\n.\\tO\\n\\nAlthough\\tO\\nhereditary\\tO\\nTP53\\tO\\nmutation\\tO\\nis\\tO\\nvery\\tO\\nrare\\tO\\nin\\tO\\ndifferent\\tO\\nhuman\\tO\\ncancers\\tB-Disease\\n,\\tO\\nit\\tO\\nhas\\tO\\nbeen\\tO\\nfrequently\\tO\\nreported\\tO\\nin\\tO\\nLi\\tB-Disease\\n-\\tI-Disease\\nFraumeni\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nother\\tO\\nhand\\tO\\n,\\tO\\nhereditary\\tO\\nmutations\\tO\\nof\\tO\\nTP57KIP2\\tO\\n,\\tO\\nP15INK4B\\tO\\n,\\tO\\nand\\tO\\nP16INK4A\\tO\\n,\\tO\\nwhich\\tO\\naffect\\tO\\nthe\\tO\\ncell\\tO\\ncycle\\tO\\nsimilar\\tO\\nto\\tO\\nTP53\\tO\\n,\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nsome\\tO\\ntypes\\tO\\nof\\tO\\ncancer\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nTurkish\\tO\\nfamily\\tO\\nwith\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nLi\\tB-Disease\\n-\\tI-Disease\\nFraumeni\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nwe\\tO\\nanalyzed\\tO\\nthe\\tO\\nmutation\\tO\\npattern\\tO\\nof\\tO\\nTP53\\tO\\n,\\tO\\nP57KIP2\\tO\\n,\\tO\\nP15INK4B\\tO\\n,\\tO\\nand\\tO\\nP16INK4A\\tO\\nin\\tO\\nthe\\tO\\nperipheral\\tO\\nblood\\tO\\n,\\tO\\nand\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\n(\\tO\\nhomo\\tO\\n/\\tO\\nhemizygous\\tO\\ndeletion\\tO\\n)\\tO\\npattern\\tO\\nof\\tO\\nTP53\\tO\\nand\\tO\\nP15INK4B\\tO\\n/\\tO\\nP16INK4A\\tO\\nin\\tO\\ntwo\\tO\\ntumor\\tB-Disease\\ntissues\\tO\\n.\\tO\\n\\nThe\\tO\\npropositus\\tO\\nhad\\tO\\na\\tO\\nseminoma\\tB-Disease\\n,\\tO\\nhis\\tO\\ndaughter\\tO\\na\\tO\\nmedulloblastoma\\tB-Disease\\n,\\tO\\nand\\tO\\none\\tO\\nof\\tO\\nhis\\tO\\nhealthy\\tO\\ncousins\\tO\\n,\\tO\\na\\tO\\nTP53\\tO\\ncodon\\tO\\n292\\tO\\nmissense\\tO\\npoint\\tO\\nmutation\\tO\\n(\\tO\\nAAA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nATA\\tO\\n;\\tO\\nLys\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nIle\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nperipheral\\tO\\nblood\\tO\\ncells\\tO\\n.\\tO\\n\\nTumor\\tO\\ntissue\\tO\\nobtained\\tO\\nfrom\\tO\\nthe\\tO\\npropositus\\tO\\nwith\\tO\\nthe\\tO\\nseminoma\\tB-Disease\\nrevealed\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\nin\\tO\\nthe\\tO\\nTP53\\tO\\ngene\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nanalyses\\tO\\nof\\tO\\ntumor\\tB-Disease\\ntissues\\tO\\nfrom\\tO\\nthe\\tO\\npropositus\\tO\\nand\\tO\\nhis\\tO\\ndaughter\\tO\\n,\\tO\\na\\tO\\nP16INK4A\\tO\\ncodon\\tO\\n94\\tO\\nmissense\\tO\\npoint\\tO\\nmutation\\tO\\n(\\tO\\nGCG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nGAG\\tO\\n;\\tO\\nAla\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nGlu\\tO\\n)\\tO\\nwas\\tO\\nobserved\\tO\\nwith\\tO\\nthe\\tO\\nhereditary\\tO\\nTP53\\tO\\nmutation\\tO\\n.\\tO\\n\\nP16INK4A\\tO\\ncodon\\tO\\n94\\tO\\nmutation\\tO\\nobserved\\tO\\nin\\tO\\nour\\tO\\nfamily\\tO\\nis\\tO\\na\\tO\\nnovel\\tO\\nmutation\\tO\\nin\\tO\\nLi\\tB-Disease\\n-\\tI-Disease\\nFraumeni\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nNo\\tO\\nother\\tO\\ngene\\tO\\nalteration\\tO\\nin\\tO\\nTP53\\tO\\n,\\tO\\nP57KIP2\\tO\\n,\\tO\\nP15INK4B\\tO\\n,\\tO\\nand\\tO\\nP16INK4A\\tO\\nwas\\tO\\nobserved\\tO\\n.\\tO\\n\\nExistence\\tO\\nof\\tO\\nthe\\tO\\nP16INK4A\\tO\\nmutation\\tO\\nand\\tO\\nthe\\tO\\nhereditary\\tO\\nTP53\\tO\\nmutation\\tO\\nwith\\tO\\nor\\tO\\nwithout\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\nin\\tO\\nthe\\tO\\nTP53\\tO\\ngene\\tO\\n(\\tO\\nseminoma\\tB-Disease\\n/\\tO\\nmedulloblastoma\\tB-Disease\\n)\\tO\\nmay\\tO\\nbe\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\ncommon\\tO\\nmechanism\\tO\\ninvolved\\tO\\nin\\tO\\ntumorogenesis\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nalterations\\tO\\nin\\tO\\nTP53\\tO\\nand\\tO\\nP16INK4A\\tO\\ngenes\\tO\\nmay\\tO\\nbe\\tO\\nused\\tO\\nas\\tO\\ntumor\\tB-Disease\\nmarkers\\tO\\nin\\tO\\nour\\tO\\nfamily\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nnovel\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nsodium\\tO\\n/\\tO\\niodide\\tO\\nsymporter\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\nlargest\\tO\\nfamily\\tO\\nwith\\tO\\niodide\\tB-Disease\\ntransport\\tI-Disease\\ndefect\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\npreviously\\tO\\nreported\\tO\\nnine\\tO\\nchildren\\tO\\nwith\\tO\\nan\\tO\\nautosomally\\tO\\nrecessive\\tO\\nform\\tO\\nof\\tO\\ncongenital\\tB-Disease\\nhypothyroidism\\tI-Disease\\ndue\\tO\\nto\\tO\\nan\\tO\\niodide\\tB-Disease\\ntransport\\tI-Disease\\ndefect\\tI-Disease\\nin\\tO\\na\\tO\\nlarge\\tO\\nHutterite\\tO\\nfamily\\tO\\nwith\\tO\\nextensive\\tO\\nconsanguinity\\tO\\nliving\\tO\\nin\\tO\\ncentral\\tO\\nCanada\\tO\\n.\\tO\\n\\nSince\\tO\\nthe\\tO\\noriginal\\tO\\nreport\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ndiagnosed\\tO\\ncongenital\\tB-Disease\\nhypothyroidism\\tI-Disease\\nby\\tO\\nnewborn\\tO\\nTSH\\tO\\nscreening\\tO\\nin\\tO\\n9\\tO\\nadditional\\tO\\nchildren\\tO\\nfrom\\tO\\nthe\\tO\\nfamily\\tO\\n.\\tO\\n\\nWe\\tO\\nperformed\\tO\\ndirect\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\nPCR\\tO\\nproducts\\tO\\nof\\tO\\neach\\tO\\nNIS\\tO\\n(\\tO\\nsodium\\tO\\n/\\tO\\niodide\\tO\\nsymporter\\tO\\n)\\tO\\ngene\\tO\\nexon\\tO\\nwith\\tO\\nflanking\\tO\\nintrons\\tO\\namplified\\tO\\nfrom\\tO\\ngenomic\\tO\\nDNA\\tO\\nextracted\\tO\\nfrom\\tO\\nperipheral\\tO\\nblood\\tO\\ncells\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\na\\tO\\nnovel\\tO\\nNIS\\tO\\ngene\\tO\\nmutation\\tO\\n,\\tO\\nG395R\\tO\\n(\\tO\\nGly395\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nArg\\tO\\n;\\tO\\nGGA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nAGA\\tO\\n)\\tO\\n,\\tO\\nin\\tO\\n10\\tO\\npatients\\tO\\nexamined\\tO\\nin\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n.\\tO\\n\\nAll\\tO\\nof\\tO\\nthe\\tO\\nparents\\tO\\ntested\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nmutation\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthe\\tO\\npatients\\tO\\nwere\\tO\\nhomozygous\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nwas\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\n10th\\tO\\ntransmembrane\\tO\\nhelix\\tO\\n.\\tO\\n\\nExpression\\tO\\nexperiments\\tO\\nby\\tO\\ntransfection\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nNIS\\tO\\ncomplimentary\\tO\\nDNA\\tO\\ninto\\tO\\nCOS\\tO\\n-\\tO\\n7\\tO\\ncells\\tO\\nshowed\\tO\\nno\\tO\\nperchlorate\\tO\\n-\\tO\\nsensitive\\tO\\niodide\\tO\\nuptake\\tO\\n,\\tO\\nconfirming\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\nis\\tO\\nthe\\tO\\ndirect\\tO\\ncause\\tO\\nof\\tO\\nthe\\tO\\niodide\\tB-Disease\\ntransport\\tI-Disease\\ndefect\\tI-Disease\\nin\\tO\\nthese\\tO\\npatients\\tO\\n.\\tO\\n\\nA\\tO\\npatient\\tO\\nwho\\tO\\nshowed\\tO\\nan\\tO\\nintermediate\\tO\\nsaliva\\tO\\n/\\tO\\nserum\\tO\\ntechnetium\\tO\\nratio\\tO\\n(\\tO\\n14\\tO\\n.\\tO\\n0\\tO\\n;\\tO\\nnormal\\tO\\n,\\tO\\n>\\tO\\nor\\tO\\n=\\tO\\n20\\tO\\n)\\tO\\nand\\tO\\nwas\\tO\\nconsidered\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\npartial\\tO\\nor\\tO\\nless\\tO\\nsevere\\tO\\ndefect\\tO\\nin\\tO\\nthe\\tO\\nprevious\\tO\\nreport\\tO\\n(\\tO\\nIX\\tO\\n-\\tO\\n24\\tO\\n)\\tO\\ndid\\tO\\nnot\\tO\\nhave\\tO\\na\\tO\\nNIS\\tO\\ngene\\tO\\nmutation\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nnow\\tO\\npossible\\tO\\nto\\tO\\nuse\\tO\\ngene\\tO\\ndiagnostics\\tO\\nof\\tO\\nthis\\tO\\nunique\\tO\\nNIS\\tO\\nmutation\\tO\\nto\\tO\\nidentify\\tO\\npatients\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\nhypothyroidism\\tI-Disease\\ndue\\tO\\nto\\tO\\nan\\tO\\niodide\\tB-Disease\\ntransport\\tI-Disease\\ndefect\\tI-Disease\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nand\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\ncarrier\\tO\\nstate\\tO\\nof\\tO\\npotential\\tO\\nparents\\tO\\nfor\\tO\\ngenetic\\tO\\ncounseling\\tO\\nand\\tO\\narranging\\tO\\nrapid\\tO\\nand\\tO\\nearly\\tO\\ndiagnosis\\tO\\nof\\tO\\ntheir\\tO\\ninfants\\tO\\n.\\tO\\n\\nMolecular\\tO\\nanalysis\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nneurohypophyseal\\tI-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\n:\\tO\\nearly\\tO\\ndiagnosis\\tO\\nof\\tO\\nan\\tO\\nasymptomatic\\tO\\ncarrier\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\nneurohypophyseal\\tI-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\n(\\tO\\nFNDI\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\ninherited\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nhormone\\tI-Disease\\narginine\\tI-Disease\\nvasopressin\\tI-Disease\\n(\\tO\\nAVP\\tO\\n)\\tO\\nand\\tO\\nis\\tO\\ntransmitted\\tO\\nas\\tO\\nan\\tO\\nautosomal\\tO\\ndominant\\tO\\ntrait\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\nwe\\tO\\nhave\\tO\\nanalyzed\\tO\\nthe\\tO\\nAVP\\tO\\n-\\tO\\nneurophysin\\tO\\nII\\tO\\n(\\tO\\nAVP\\tO\\n-\\tO\\nNPII\\tO\\n)\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nSpanish\\tO\\nkindred\\tO\\n.\\tO\\n\\nStudies\\tO\\nwere\\tO\\nperformed\\tO\\non\\tO\\nseven\\tO\\nmembers\\tO\\n(\\tO\\nfour\\tO\\nclinically\\tO\\naffected\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nfamily\\tO\\n.\\tO\\n\\nPatients\\tO\\nwere\\tO\\ndiagnosed\\tO\\nat\\tO\\nthe\\tO\\nHospital\\tO\\nUniversitario\\tO\\nGregorio\\tO\\nMaranon\\tO\\n(\\tO\\nMadrid\\tO\\n,\\tO\\nSpain\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nentire\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nAVP\\tO\\n-\\tO\\nNPII\\tO\\ngene\\tO\\nof\\tO\\nall\\tO\\nfamily\\tO\\nmembers\\tO\\nwas\\tO\\namplified\\tO\\nby\\tO\\nPCR\\tO\\nand\\tO\\nsequenced\\tO\\n.\\tO\\n\\nAll\\tO\\naffected\\tO\\nindividuals\\tO\\npresented\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nG1757\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n)\\tO\\nthat\\tO\\nreplaces\\tO\\nglycine\\tO\\nat\\tO\\nposition\\tO\\n23\\tO\\nwith\\tO\\narginine\\tO\\nwithin\\tO\\nthe\\tO\\nNPII\\tO\\ndomain\\tO\\n.\\tO\\n\\nThe\\tO\\nsubstitution\\tO\\nwas\\tO\\nconfirmed\\tO\\nby\\tO\\nrestriction\\tO\\nendonuclease\\tO\\nanalysis\\tO\\nand\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\nheterozygosis\\tO\\n.\\tO\\n\\nAdditionally\\tO\\n,\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nasymptomatic\\tO\\nrelatives\\tO\\n(\\tO\\na\\tO\\ngirl\\tO\\n8\\tO\\nmonths\\tO\\nold\\tO\\nat\\tO\\nthe\\tO\\ntime\\tO\\nof\\tO\\nstudy\\tO\\n)\\tO\\nwas\\tO\\nidentified\\tO\\nas\\tO\\ncarrier\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\nmutation\\tO\\nand\\tO\\ndeveloped\\tO\\nthe\\tO\\ndisease\\tO\\n3\\tO\\nmonths\\tO\\nlater\\tO\\n.\\tO\\n\\nThe\\tO\\nalteration\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nsecond\\tO\\nexon\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nseems\\tO\\nto\\tO\\nbe\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\ndisease\\tO\\n,\\tO\\nas\\tO\\nall\\tO\\nindividuals\\tO\\nharboring\\tO\\nthe\\tO\\nmutation\\tO\\nhad\\tO\\nbeen\\tO\\npreviously\\tO\\ndiagnosed\\tO\\nor\\tO\\nhave\\tO\\neventually\\tO\\ndeveloped\\tO\\nFNDI\\tB-Disease\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nthe\\tO\\nmolecular\\tO\\ndefect\\tO\\nunderlying\\tO\\nFNDI\\tB-Disease\\nin\\tO\\naffected\\tO\\nfamilies\\tO\\nis\\tO\\na\\tO\\npowerful\\tO\\ntool\\tO\\nfor\\tO\\nearly\\tO\\nasymptomatic\\tO\\ndiagnosis\\tO\\nin\\tO\\ninfants\\tO\\n.\\tO\\n.\\tO\\n\\nDeficit\\tO\\nof\\tO\\nin\\tO\\nvivo\\tO\\nmitochondrial\\tO\\nATP\\tO\\nproduction\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n.\\tO\\n\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n(\\tO\\nFRDA\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nof\\tO\\nthe\\tO\\ninherited\\tB-Disease\\nataxias\\tI-Disease\\n,\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndegenerative\\tI-Disease\\ndisorder\\tI-Disease\\n,\\tO\\ncharacterized\\tO\\nclinically\\tO\\nby\\tO\\nonset\\tO\\nbefore\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\n25\\tO\\nof\\tO\\nprogressive\\tB-Disease\\ngait\\tI-Disease\\nand\\tI-Disease\\nlimb\\tI-Disease\\nataxia\\tI-Disease\\n,\\tO\\nabsence\\tB-Disease\\nof\\tI-Disease\\ndeep\\tI-Disease\\ntendon\\tI-Disease\\nreflexes\\tI-Disease\\n,\\tO\\nextensor\\tB-Disease\\nplantar\\tI-Disease\\nresponses\\tI-Disease\\n,\\tO\\nand\\tO\\nloss\\tB-Disease\\nof\\tI-Disease\\nposition\\tI-Disease\\nand\\tI-Disease\\nvibration\\tI-Disease\\nsense\\tI-Disease\\nin\\tO\\nthe\\tO\\nlower\\tO\\nlimbs\\tO\\n.\\tO\\n\\nFRDA\\tB-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\nGAA\\tO\\ntriplet\\tO\\nexpansion\\tO\\nin\\tO\\nthe\\tO\\nfirst\\tO\\nintron\\tO\\nof\\tO\\nthe\\tO\\nFRDA\\tB-Disease\\ngene\\tO\\non\\tO\\nchromosome\\tO\\n9q13\\tO\\nin\\tO\\n97\\tO\\n%\\tO\\nof\\tO\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\nFRDA\\tB-Disease\\ngene\\tO\\nencodes\\tO\\na\\tO\\nwidely\\tO\\nexpressed\\tO\\n210\\tO\\n-\\tO\\naa\\tO\\nprotein\\tO\\n,\\tO\\nfrataxin\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nlocated\\tO\\nin\\tO\\nmitochondria\\tO\\nand\\tO\\nis\\tO\\nseverely\\tO\\nreduced\\tO\\nin\\tO\\nFRDA\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nFrataxin\\tO\\nfunction\\tO\\nis\\tO\\nstill\\tO\\nunknown\\tO\\nbut\\tO\\nthe\\tO\\nknockout\\tO\\nof\\tO\\nthe\\tO\\nyeast\\tO\\nfrataxin\\tO\\nhomologue\\tO\\ngene\\tO\\n(\\tO\\nYFH1\\tO\\n)\\tO\\nshowed\\tO\\na\\tO\\nsevere\\tO\\ndefect\\tO\\nof\\tO\\nmitochondrial\\tO\\nrespiration\\tO\\nand\\tO\\nloss\\tO\\nof\\tO\\nmtDNA\\tO\\nassociated\\tO\\nwith\\tO\\nelevated\\tO\\nintramitochondrial\\tO\\niron\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nin\\tO\\nvivo\\tO\\nevidence\\tO\\nof\\tO\\nimpaired\\tO\\nmitochondrial\\tO\\nrespiration\\tO\\nin\\tO\\nskeletal\\tO\\nmuscle\\tO\\nof\\tO\\nFRDA\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nUsing\\tO\\nphosphorus\\tO\\nmagnetic\\tO\\nresonance\\tO\\nspectroscopy\\tO\\nwe\\tO\\ndemonstrated\\tO\\na\\tO\\nmaximum\\tO\\nrate\\tO\\nof\\tO\\nmuscle\\tO\\nmitochondrial\\tO\\nATP\\tO\\nproduction\\tO\\n(\\tO\\nV\\tO\\n(\\tO\\nmax\\tO\\n)\\tO\\n)\\tO\\nbelow\\tO\\nthe\\tO\\nnormal\\tO\\nrange\\tO\\nin\\tO\\nall\\tO\\n12\\tO\\nFRDA\\tB-Disease\\npatients\\tO\\nand\\tO\\na\\tO\\nstrong\\tO\\nnegative\\tO\\ncorrelation\\tO\\nbetween\\tO\\nmitochondrial\\tO\\nV\\tO\\n(\\tO\\nmax\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\nGAA\\tO\\nrepeats\\tO\\nin\\tO\\nthe\\tO\\nsmaller\\tO\\nallele\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nshow\\tO\\nthat\\tO\\nFRDA\\tB-Disease\\nis\\tO\\na\\tO\\nnuclear\\tO\\n-\\tO\\nencoded\\tO\\nmitochondrial\\tB-Disease\\ndisorder\\tI-Disease\\naffecting\\tO\\noxidative\\tO\\nphosphorylation\\tO\\nand\\tO\\ngive\\tO\\na\\tO\\nrationale\\tO\\nfor\\tO\\ntreatments\\tO\\naimed\\tO\\nto\\tO\\nimprove\\tO\\nmitochondrial\\tO\\nfunction\\tO\\nin\\tO\\nthis\\tO\\ncondition\\tO\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\nR21X\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nliver\\tO\\n-\\tO\\ntype\\tO\\narginase\\tO\\ngene\\tO\\n(\\tO\\nARG1\\tO\\n)\\tO\\nin\\tO\\nfour\\tO\\nPortuguese\\tO\\npatients\\tO\\nwith\\tO\\nargininemia\\tB-Disease\\n.\\tO\\n\\nArgininemia\\tB-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\nautossomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\ndeficiency\\tB-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\ncytosolic\\tI-Disease\\nliver\\tI-Disease\\n-\\tI-Disease\\ntype\\tI-Disease\\narginase\\tI-Disease\\nenzyme\\tI-Disease\\n(\\tO\\nL\\tO\\n-\\tO\\narginine\\tO\\nurea\\tO\\n-\\tO\\nhydrolase\\tO\\n;\\tO\\nE\\tO\\n.\\tO\\nC\\tO\\n.\\tO\\n3\\tO\\n.\\tO\\n5\\tO\\n.\\tO\\n3\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nfor\\tO\\nargininemia\\tB-Disease\\nin\\tO\\nfour\\tO\\nunrelated\\tO\\nPortuguese\\tO\\npatients\\tO\\n(\\tO\\ntwo\\tO\\nfrom\\tO\\nnorthern\\tO\\nPortugal\\tO\\nand\\tO\\ntwo\\tO\\nfrom\\tO\\nMadeira\\tO\\nIsland\\tO\\n)\\tO\\nwe\\tO\\nperformed\\tO\\na\\tO\\nDNA\\tO\\nsequence\\tO\\nanalysis\\tO\\nof\\tO\\nall\\tO\\nthe\\tO\\nexons\\tO\\nand\\tO\\nexon\\tO\\n/\\tO\\nintron\\tO\\nboundaries\\tO\\nof\\tO\\nthe\\tO\\nliver\\tO\\n-\\tO\\ntype\\tO\\narginase\\tO\\ngene\\tO\\n(\\tO\\nARG1\\tO\\n)\\tO\\n.\\tO\\n\\nAll\\tO\\npatients\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nnewly\\tO\\nidentified\\tO\\nC\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransition\\tO\\nin\\tO\\ncodon\\tO\\n21\\tO\\n(\\tO\\nexon\\tO\\n2\\tO\\n)\\tO\\nsubstituting\\tO\\narginine\\tO\\nfor\\tO\\na\\tO\\npremature\\tO\\nstop\\tO\\ncodon\\tO\\n(\\tO\\nR21X\\tO\\nCGA\\tO\\nto\\tO\\nTGA\\tO\\n)\\tO\\nand\\tO\\ngenerating\\tO\\na\\tO\\nNlaIII\\tO\\nrestriction\\tO\\nsite\\tO\\n.\\tO\\n\\nRestriction\\tO\\ndigestion\\tO\\nfollowing\\tO\\nPCR\\tO\\namplification\\tO\\nof\\tO\\nARG1\\tO\\nexon\\tO\\n2\\tO\\nconfirmed\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\n.\\tO\\n\\nMutation\\tO\\nof\\tO\\nthe\\tO\\nsterol\\tO\\n27\\tO\\n-\\tO\\nhydroxylase\\tO\\ngene\\tO\\n(\\tO\\nCYP27\\tO\\n)\\tO\\nresults\\tO\\nin\\tO\\ntruncation\\tO\\nof\\tO\\nmRNA\\tO\\nexpressed\\tO\\nin\\tO\\nleucocytes\\tO\\nin\\tO\\na\\tO\\nJapanese\\tO\\nfamily\\tO\\nwith\\tO\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n.\\tO\\n\\nOBJECTIVES\\tO\\nA\\tO\\nJapanese\\tO\\nfamily\\tO\\nwith\\tO\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n(\\tO\\nCTX\\tB-Disease\\n)\\tO\\nwas\\tO\\ninvestigated\\tO\\nfor\\tO\\na\\tO\\nsequence\\tO\\nalteration\\tO\\nin\\tO\\nthe\\tO\\nsterol\\tO\\n27\\tO\\n-\\tO\\nhydroxylase\\tO\\ngene\\tO\\n(\\tO\\nCYP27\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nexpression\\tO\\nof\\tO\\nCYP27\\tO\\nhas\\tO\\nbeen\\tO\\nmostly\\tO\\nexplored\\tO\\nusing\\tO\\ncultured\\tO\\nfibroblasts\\tO\\n,\\tO\\nprompting\\tO\\nthe\\tO\\nexamination\\tO\\nof\\tO\\nthe\\tO\\ntranscripts\\tO\\nfrom\\tO\\nblood\\tO\\nleucocytes\\tO\\nas\\tO\\na\\tO\\nsimple\\tO\\nand\\tO\\nrapid\\tO\\ntechnique\\tO\\n.\\tO\\n\\nMETHODS\\tO\\nAn\\tO\\nalteration\\tO\\nin\\tO\\nCYP27\\tO\\nof\\tO\\nthe\\tO\\nproband\\tO\\nwas\\tO\\nsearched\\tO\\nfor\\tO\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n-\\tO\\nsingle\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nPCR\\tO\\n-\\tO\\nSSCP\\tO\\n)\\tO\\nanalysis\\tO\\nand\\tO\\nsubsequent\\tO\\nsequencing\\tO\\n.\\tO\\n\\nSamples\\tO\\nof\\tO\\nRNA\\tO\\nwere\\tO\\nsubjected\\tO\\nto\\tO\\nreverse\\tO\\ntranscription\\tO\\nPCR\\tO\\n(\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\nproband\\tO\\nwas\\tO\\namplified\\tO\\nwith\\tO\\nnested\\tO\\nprimers\\tO\\nand\\tO\\nsequenced\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nA\\tO\\nhomozygous\\tO\\nG\\tO\\nto\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nthe\\tO\\n5\\tO\\nend\\tO\\nof\\tO\\nintron\\tO\\n7\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\n.\\tO\\n\\nIn\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nanalysis\\tO\\n,\\tO\\nonly\\tO\\na\\tO\\ntruncated\\tO\\ntranscript\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\n,\\tO\\nwhereas\\tO\\nboth\\tO\\nnormal\\tO\\nand\\tO\\ntruncated\\tO\\ntranscripts\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nsiblings\\tO\\n.\\tO\\n\\nThe\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\ncDNA\\tO\\nfragment\\tO\\ndisclosed\\tO\\na\\tO\\ndirect\\tO\\nconjuction\\tO\\nof\\tO\\nexon\\tO\\n6\\tO\\nand\\tO\\nexon\\tO\\n8\\tO\\n.\\tO\\n\\nCONCLUSION\\tO\\nThe\\tO\\nmutation\\tO\\nat\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nand\\tO\\nthe\\tO\\ntruncation\\tO\\nof\\tO\\nmRNA\\tO\\nwere\\tO\\nidentical\\tO\\nwith\\tO\\nthose\\tO\\nof\\tO\\na\\tO\\nrecently\\tO\\nreported\\tO\\nItalian\\tO\\npatient\\tO\\n,\\tO\\nalthough\\tO\\ndifferent\\tO\\nin\\tO\\nsymptomatology\\tO\\n.\\tO\\n\\nThe\\tO\\napplication\\tO\\nof\\tO\\nblood\\tO\\nleucocytes\\tO\\ncan\\tO\\nbe\\tO\\na\\tO\\nsimple\\tO\\ntechnique\\tO\\non\\tO\\nanalysing\\tO\\na\\tO\\nconstructive\\tO\\nabnormality\\tB-Disease\\nof\\tI-Disease\\nCYP27\\tI-Disease\\nmRNA\\tO\\n.\\tO\\n.\\tO\\n\\nClinical\\tO\\nand\\tO\\nmolecular\\tO\\ngenetic\\tO\\nanalysis\\tO\\nof\\tO\\n19\\tO\\nWolfram\\tB-Disease\\nsyndrome\\tI-Disease\\nkindreds\\tO\\ndemonstrating\\tO\\na\\tO\\nwide\\tO\\nspectrum\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nWFS1\\tO\\n.\\tO\\n\\nWolfram\\tB-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nneurodegenerative\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\njuvenile\\tB-Disease\\n-\\tI-Disease\\nonset\\tI-Disease\\ndiabetes\\tI-Disease\\nmellitus\\tI-Disease\\nand\\tO\\nprogressive\\tO\\noptic\\tB-Disease\\natrophy\\tI-Disease\\n.\\tO\\n\\nmtDNA\\tO\\ndeletions\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\n,\\tO\\nand\\tO\\na\\tO\\ngene\\tO\\n(\\tO\\nWFS1\\tO\\n)\\tO\\nrecently\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\n,\\tO\\non\\tO\\nchromosome\\tO\\n4p16\\tO\\n,\\tO\\nencoding\\tO\\na\\tO\\npredicted\\tO\\n890\\tO\\namino\\tO\\nacid\\tO\\ntransmembrane\\tO\\nprotein\\tO\\n.\\tO\\n\\nDirect\\tO\\nDNA\\tO\\nsequencing\\tO\\nwas\\tO\\ndone\\tO\\nto\\tO\\nscreen\\tO\\nthe\\tO\\nentire\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nWFS1\\tO\\ngene\\tO\\nin\\tO\\n30\\tO\\npatients\\tO\\nfrom\\tO\\n19\\tO\\nBritish\\tO\\nkindreds\\tO\\nwith\\tO\\nWolfram\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nDNA\\tO\\nwas\\tO\\nalso\\tO\\nscreened\\tO\\nfor\\tO\\nstructural\\tO\\nrearrangements\\tO\\n(\\tO\\ndeletions\\tO\\nand\\tO\\nduplications\\tO\\n)\\tO\\nand\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nmtDNA\\tO\\n.\\tO\\n\\nNo\\tO\\npathogenic\\tO\\nmtDNA\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nour\\tO\\ncohort\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\n24\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nWFS1\\tO\\ngene\\tO\\n8\\tO\\nnonsense\\tO\\nmutations\\tO\\n,\\tO\\n8\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\n3\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletions\\tO\\n,\\tO\\n1\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ninsertion\\tO\\n,\\tO\\nand\\tO\\n4\\tO\\nframeshift\\tO\\nmutations\\tO\\n.\\tO\\n\\nOf\\tO\\nthese\\tO\\n,\\tO\\n23\\tO\\nwere\\tO\\nnovel\\tO\\nmutations\\tO\\n,\\tO\\nand\\tO\\nmost\\tO\\noccurred\\tO\\nin\\tO\\nexon\\tO\\n8\\tO\\n.\\tO\\n\\nThe\\tO\\nmajority\\tO\\nof\\tO\\npatients\\tO\\nwere\\tO\\ncompound\\tO\\nheterozygotes\\tO\\nfor\\tO\\ntwo\\tO\\nmutations\\tO\\n,\\tO\\nand\\tO\\nthere\\tO\\nwas\\tO\\nno\\tO\\ncommon\\tO\\nfounder\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\ndata\\tO\\nwere\\tO\\nalso\\tO\\nanalyzed\\tO\\nfor\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\nrelationships\\tO\\n.\\tO\\n\\nAlthough\\tO\\nsome\\tO\\ninteresting\\tO\\ncases\\tO\\nwere\\tO\\nnoted\\tO\\n,\\tO\\nconsideration\\tO\\nof\\tO\\nthe\\tO\\nsmall\\tO\\nsample\\tO\\nsize\\tO\\nand\\tO\\nfrequency\\tO\\nof\\tO\\neach\\tO\\nmutation\\tO\\nindicated\\tO\\nno\\tO\\nclear\\tO\\n-\\tO\\ncut\\tO\\ncorrelations\\tO\\nbetween\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\nobserved\\tO\\nmutations\\tO\\nand\\tO\\ndisease\\tO\\nseverity\\tO\\n.\\tO\\n\\nThere\\tO\\nwere\\tO\\nno\\tO\\nobvious\\tO\\nmutation\\tO\\nhot\\tO\\nspots\\tO\\nor\\tO\\nclusters\\tO\\n.\\tO\\n\\nHence\\tO\\n,\\tO\\nmolecular\\tO\\nscreening\\tO\\nfor\\tO\\nWolfram\\tB-Disease\\nsyndrome\\tI-Disease\\nin\\tO\\naffected\\tO\\nfamilies\\tO\\nand\\tO\\nfor\\tO\\nWolfram\\tB-Disease\\nsyndrome\\tI-Disease\\n-\\tO\\ncarrier\\tO\\nstatus\\tO\\nin\\tO\\nsubjects\\tO\\nwith\\tO\\npsychiatric\\tB-Disease\\ndisorders\\tI-Disease\\nor\\tO\\ndiabetes\\tB-Disease\\nmellitus\\tI-Disease\\nwill\\tO\\nrequire\\tO\\ncomplete\\tO\\nanalysis\\tO\\nof\\tO\\nexon\\tO\\n8\\tO\\nand\\tO\\nupstream\\tO\\nexons\\tO\\n.\\tO\\n.\\tO\\n\\nLate\\tO\\n-\\tO\\nonset\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n(\\tO\\nFMF\\tB-Disease\\n)\\tO\\n:\\tO\\na\\tO\\nsubset\\tO\\nwith\\tO\\ndistinct\\tO\\nclinical\\tO\\n,\\tO\\ndemographic\\tO\\n,\\tO\\nand\\tO\\nmolecular\\tO\\ngenetic\\tO\\ncharacteristics\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nprevalence\\tO\\nand\\tO\\ncharacterize\\tO\\ndemographic\\tO\\n,\\tO\\nclinical\\tO\\n,\\tO\\nand\\tO\\ngenetic\\tO\\nfeatures\\tO\\nof\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n(\\tO\\nFMF\\tB-Disease\\n)\\tO\\nof\\tO\\nlate\\tO\\nonset\\tO\\n,\\tO\\nall\\tO\\npatients\\tO\\nexperiencing\\tO\\ntheir\\tO\\nfirst\\tO\\nFMF\\tB-Disease\\nattack\\tO\\nat\\tO\\nage\\tO\\n40\\tO\\nyears\\tO\\nor\\tO\\nmore\\tO\\nwere\\tO\\nidentified\\tO\\nusing\\tO\\nthe\\tO\\ncomputerized\\tO\\nregistry\\tO\\nof\\tO\\nour\\tO\\nFMF\\tB-Disease\\nclinic\\tO\\n,\\tO\\nand\\tO\\nthen\\tO\\nthoroughly\\tO\\ninterviewed\\tO\\nand\\tO\\nexamined\\tO\\n.\\tO\\n\\nThe\\tO\\ncontrol\\tO\\ngroup\\tO\\nconsisted\\tO\\nof\\tO\\n40\\tO\\nconsecutive\\tO\\nFMF\\tB-Disease\\npatients\\tO\\n,\\tO\\nwho\\tO\\narrived\\tO\\nat\\tO\\nthe\\tO\\nFMF\\tB-Disease\\nclinic\\tO\\nfor\\tO\\ntheir\\tO\\nregular\\tO\\nfollow\\tO\\n-\\tO\\nup\\tO\\nvisit\\tO\\nand\\tO\\nwere\\tO\\n40\\tO\\nyears\\tO\\nof\\tO\\nage\\tO\\nor\\tO\\nolder\\tO\\nat\\tO\\nthe\\tO\\ntime\\tO\\nof\\tO\\nthe\\tO\\nexamination\\tO\\n.\\tO\\n\\nThe\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nin\\tO\\npatients\\tO\\nand\\tO\\ncontrols\\tO\\nwas\\tO\\ndetermined\\tO\\nusing\\tO\\na\\tO\\nmodified\\tO\\nscore\\tO\\n,\\tO\\ndeveloped\\tO\\npreviously\\tO\\n.\\tO\\n\\nMutational\\tO\\nanalysis\\tO\\nin\\tO\\nthe\\tO\\nFMF\\tB-Disease\\ngene\\tO\\nwas\\tO\\nperformed\\tO\\nusing\\tO\\na\\tO\\ncommercial\\tO\\nkit\\tO\\n.\\tO\\n\\nOnly\\tO\\n20\\tO\\nof\\tO\\n4000\\tO\\n(\\tO\\n0\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\npatients\\tO\\nhad\\tO\\nlate\\tO\\n-\\tO\\nonset\\tO\\nFMF\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\npatients\\tO\\nwere\\tO\\nmostly\\tO\\nmen\\tO\\n,\\tO\\nof\\tO\\nnon\\tO\\n-\\tO\\nNorth\\tO\\nAfrican\\tO\\norigin\\tO\\n,\\tO\\nP\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n\\n05\\tO\\ncompared\\tO\\nto\\tO\\ncontrols\\tO\\n.\\tO\\n\\nAll\\tO\\nhad\\tO\\nabdominal\\tO\\nattacks\\tO\\nand\\tO\\nin\\tO\\nmost\\tO\\nthese\\tO\\nwere\\tO\\nthe\\tO\\nonly\\tO\\nmanifestation\\tO\\nof\\tO\\ntheir\\tO\\ndisease\\tO\\n,\\tO\\nP\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n\\n001\\tO\\n001\\tO\\n.\\tO\\n\\nNone\\tO\\nhad\\tO\\nchronic\\tO\\nor\\tO\\nprolonged\\tO\\nmanifestations\\tO\\nof\\tO\\nFMF\\tB-Disease\\n,\\tO\\nfor\\tO\\nexample\\tO\\n,\\tO\\namyloidosis\\tB-Disease\\n,\\tO\\nchronic\\tB-Disease\\narthritis\\tI-Disease\\n,\\tO\\nor\\tO\\nprotracted\\tO\\nmyalgia\\tB-Disease\\n,\\tO\\nP\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n\\n001\\tO\\n.\\tO\\n\\nThe\\tO\\nresponse\\tO\\nto\\tO\\ntreatment\\tO\\nwas\\tO\\ngood\\tO\\ndespite\\tO\\nusing\\tO\\nlow\\tO\\ncolchicine\\tO\\ndose\\tO\\n,\\tO\\nP\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n\\n05\\tO\\n.\\tO\\n\\nThe\\tO\\noverall\\tO\\nseverity\\tO\\nscore\\tO\\nindicated\\tO\\na\\tO\\nmild\\tO\\ndisease\\tO\\n,\\tO\\nP\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n\\n001\\tO\\n.\\tO\\n\\nMutational\\tO\\nanalysis\\tO\\nrevealed\\tO\\nabsence\\tO\\nof\\tO\\nM694V\\tO\\nhomozygosity\\tO\\n,\\tO\\nP\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n\\n01\\tO\\n,\\tO\\ncompared\\tO\\nto\\tO\\nour\\tO\\nregular\\tO\\nFMF\\tB-Disease\\npopulation\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\nonset\\tO\\nof\\tO\\nFMF\\tB-Disease\\nin\\tO\\na\\tO\\nlate\\tO\\nage\\tO\\ndefines\\tO\\na\\tO\\nmilder\\tO\\nform\\tO\\nof\\tO\\ndisease\\tO\\nwith\\tO\\ntypical\\tO\\nclinical\\tO\\n,\\tO\\ndemographic\\tO\\n,\\tO\\nand\\tO\\nmolecular\\tO\\ngenetic\\tO\\ncharacteristics\\tO\\n\\nA\\tO\\nhighly\\tO\\naccurate\\tO\\n,\\tO\\nlow\\tO\\ncost\\tO\\ntest\\tO\\nfor\\tO\\nBRCA1\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nhigh\\tO\\nfrequency\\tO\\nof\\tO\\nBRCA1\\tO\\nmutations\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nwidespread\\tO\\nuse\\tO\\nof\\tO\\nBRCA1\\tO\\ntesting\\tO\\nhas\\tO\\nbeen\\tO\\nlimited\\tO\\nto\\tO\\ndate\\tO\\nby\\tO\\nthree\\tO\\nprincipal\\tO\\nconcerns\\tO\\nthe\\tO\\nfear\\tO\\nof\\tO\\nloss\\tO\\nof\\tO\\nhealth\\tO\\nand\\tO\\nlife\\tO\\ninsurance\\tO\\n,\\tO\\nthe\\tO\\nuncertain\\tO\\nclinical\\tO\\nvalue\\tO\\nof\\tO\\na\\tO\\npositive\\tO\\ntest\\tO\\nresult\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\ncurrent\\tO\\nlack\\tO\\nof\\tO\\nan\\tO\\ninexpensive\\tO\\nand\\tO\\nsensitive\\tO\\nscreening\\tO\\ntest\\tO\\nfor\\tO\\nBRCA1\\tO\\nmutations\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndeveloped\\tO\\nan\\tO\\ninexpensive\\tO\\nsystem\\tO\\nfor\\tO\\ngene\\tO\\nmutational\\tO\\nscanning\\tO\\n,\\tO\\nbased\\tO\\non\\tO\\na\\tO\\ncombination\\tO\\nof\\tO\\nextensive\\tO\\nmultiplex\\tO\\nPCR\\tO\\namplification\\tO\\nand\\tO\\ntwo\\tO\\ndimensional\\tO\\nelectrophoresis\\tO\\n.\\tO\\n\\nThe\\tO\\nefficiency\\tO\\nof\\tO\\nthis\\tO\\nsystem\\tO\\n,\\tO\\nas\\tO\\na\\tO\\nscreening\\tO\\ntest\\tO\\nfor\\tO\\nBRCA1\\tO\\nmutations\\tO\\n,\\tO\\nwas\\tO\\nevaluated\\tO\\nin\\tO\\na\\tO\\npanel\\tO\\nof\\tO\\n60\\tO\\nsamples\\tO\\nfrom\\tO\\nhigh\\tO\\nrisk\\tO\\nwomen\\tO\\n,\\tO\\n14\\tO\\nof\\tO\\nwhich\\tO\\ncontained\\tO\\na\\tO\\npreviously\\tO\\nidentified\\tO\\nmutation\\tO\\nin\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nAll\\tO\\n14\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nan\\tO\\nadditional\\tO\\nfive\\tO\\nthat\\tO\\nhad\\tO\\npreviously\\tO\\nescaped\\tO\\ndetection\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\nto\\tO\\nthe\\tO\\n19\\tO\\nmutations\\tO\\n,\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\n15\\tO\\ndifferent\\tO\\npolymorphic\\tO\\nvariants\\tO\\nwere\\tO\\nscored\\tO\\n,\\tO\\nmost\\tO\\nof\\tO\\nwhich\\tO\\nwere\\tO\\nrecurring\\tO\\n.\\tO\\n\\nAll\\tO\\nwere\\tO\\nconfirmed\\tO\\nby\\tO\\nnucleotide\\tO\\nsequencing\\tO\\n.\\tO\\n\\nThe\\tO\\ncost\\tO\\nof\\tO\\nscreening\\tO\\nper\\tO\\nsample\\tO\\nwas\\tO\\ncalculated\\tO\\nto\\tO\\nbe\\tO\\napproximately\\tO\\nUS\\tO\\n$\\tO\\n70\\tO\\nfor\\tO\\nthe\\tO\\nmanual\\tO\\ntechnique\\tO\\nused\\tO\\nin\\tO\\nthis\\tO\\nstudy\\tO\\n,\\tO\\nand\\tO\\nmay\\tO\\nbe\\tO\\nreduced\\tO\\nto\\tO\\napproximately\\tO\\nUS\\tO\\n$\\tO\\n10\\tO\\nwith\\tO\\nthe\\tO\\nintroduction\\tO\\nof\\tO\\ncommercially\\tO\\navailable\\tO\\nPCR\\tO\\nrobotics\\tO\\nand\\tO\\nfluorescent\\tO\\nimaging\\tO\\n.\\tO\\n\\nImplementation\\tO\\nof\\tO\\nthis\\tO\\nmethod\\tO\\nof\\tO\\nmutation\\tO\\nscreening\\tO\\nin\\tO\\nthe\\tO\\nresearch\\tO\\nand\\tO\\nclinical\\tO\\nsetting\\tO\\nshould\\tO\\npermit\\tO\\nrapid\\tO\\naccrual\\tO\\nof\\tO\\nquantitative\\tO\\ndata\\tO\\non\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\nassociations\\tO\\nfor\\tO\\nthe\\tO\\nevaluation\\tO\\nof\\tO\\ndiagnostic\\tO\\ntesting\\tO\\n.\\tO\\n.\\tO\\n\\nMaternal\\tB-Disease\\nuniparental\\tI-Disease\\ndisomy\\tI-Disease\\nfor\\tI-Disease\\nchromosome\\tI-Disease\\n14\\tI-Disease\\nin\\tO\\na\\tO\\nboy\\tO\\nwith\\tO\\na\\tO\\nnormal\\tO\\nkaryotype\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\na\\tO\\nboy\\tO\\nwith\\tO\\na\\tO\\nmaternal\\tB-Disease\\nuniparental\\tI-Disease\\ndisomy\\tI-Disease\\nfor\\tI-Disease\\nchromosome\\tI-Disease\\n14\\tI-Disease\\n(\\tO\\nUPD\\tB-Disease\\n(\\tO\\n14\\tO\\n)\\tO\\n)\\tO\\n.\\tO\\n\\nAt\\tO\\n7\\tO\\nyears\\tO\\nof\\tO\\nage\\tO\\nhe\\tO\\nwas\\tO\\nreferred\\tO\\nto\\tO\\nus\\tO\\nby\\tO\\nthe\\tO\\npaediatrician\\tO\\nbecause\\tO\\nof\\tO\\nsymptoms\\tO\\nof\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nHe\\tO\\nshowed\\tO\\nshort\\tB-Disease\\nstature\\tI-Disease\\n,\\tO\\nobesity\\tB-Disease\\n,\\tO\\nmild\\tO\\ndevelopmental\\tB-Disease\\ndelay\\tI-Disease\\n,\\tO\\ncryptorchidism\\tB-Disease\\n,\\tO\\nand\\tO\\nsome\\tO\\nmild\\tO\\ndysmorphic\\tB-Disease\\nfeatures\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nhistory\\tO\\nfurther\\tO\\nindicated\\tO\\nintrauterine\\tB-Disease\\ngrowth\\tI-Disease\\nretardation\\tI-Disease\\nat\\tO\\nthe\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\npregnancy\\tO\\n.\\tO\\n\\nHis\\tO\\nmother\\tO\\nwas\\tO\\n44\\tO\\nyears\\tO\\nof\\tO\\nage\\tO\\nat\\tO\\nthe\\tO\\ntime\\tO\\nof\\tO\\nhis\\tO\\nbirth\\tO\\n.\\tO\\n\\nAfter\\tO\\nbirth\\tO\\nhe\\tO\\nshowed\\tO\\nhypotonia\\tB-Disease\\nwith\\tO\\npoor\\tO\\nsucking\\tO\\n,\\tO\\nfor\\tO\\nwhich\\tO\\ngavage\\tO\\nfeeding\\tO\\nwas\\tO\\nneeded\\tO\\n.\\tO\\n\\nMotor\\tO\\ndevelopment\\tO\\nwas\\tO\\ndelayed\\tO\\n.\\tO\\n\\nAfter\\tO\\n1\\tO\\nyear\\tO\\nhe\\tO\\nbecame\\tO\\nobese\\tB-Disease\\ndespite\\tO\\na\\tO\\nnormal\\tO\\nappetite\\tO\\n.\\tO\\n\\nRecurrent\\tO\\nmiddle\\tB-Disease\\near\\tI-Disease\\ninfections\\tI-Disease\\n,\\tO\\na\\tO\\nhigh\\tO\\npain\\tO\\nthreshold\\tO\\n,\\tO\\nand\\tO\\na\\tO\\ngreat\\tO\\nskill\\tO\\nwith\\tO\\njigsaw\\tO\\npuzzles\\tO\\nwere\\tO\\nreported\\tO\\n.\\tO\\n\\nThere\\tO\\nwere\\tO\\nno\\tO\\nbehavioural\\tO\\nproblems\\tO\\nor\\tO\\nsleep\\tO\\ndisturbance\\tO\\n.\\tO\\n\\nChromosomal\\tO\\nanalysis\\tO\\nwas\\tO\\nnormal\\tO\\n(\\tO\\n46\\tO\\n,\\tO\\nXY\\tO\\n)\\tO\\n.\\tO\\n\\nDNA\\tO\\nanalysis\\tO\\nfor\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\nshowed\\tO\\nno\\tO\\nabnormalities\\tO\\n.\\tO\\n\\nTwo\\tO\\nyears\\tO\\nlater\\tO\\nhe\\tO\\nwas\\tO\\nre\\tO\\n-\\tO\\nexamined\\tO\\nbecause\\tO\\nwe\\tO\\nthought\\tO\\nhis\\tO\\nfeatures\\tO\\nfitted\\tO\\nthe\\tO\\nPWS\\tB-Disease\\n-\\tO\\nlike\\tO\\nphenotype\\tO\\nassociated\\tO\\nwith\\tO\\nmaternal\\tO\\nUPD\\tB-Disease\\n(\\tO\\n14\\tO\\n)\\tO\\n.\\tO\\n\\nAt\\tO\\nthat\\tO\\ntime\\tO\\nprecocious\\tO\\npuberty\\tO\\nwas\\tO\\nevident\\tO\\n.\\tO\\n\\nDNA\\tO\\nanalysis\\tO\\nshowed\\tO\\nmaternal\\tB-Disease\\nheterodisomy\\tI-Disease\\nfor\\tO\\nchromosome\\tO\\n14\\tO\\n.\\tO\\n\\nIn\\tO\\nall\\tO\\nthe\\tO\\npreviously\\tO\\ndescribed\\tO\\n11\\tO\\ncases\\tO\\nwith\\tO\\nmaternal\\tO\\nUPD\\tB-Disease\\n(\\tO\\n14\\tO\\n)\\tO\\n,\\tO\\na\\tO\\nRobertsonian\\tO\\ntranslocation\\tO\\ninvolving\\tO\\nchromosome\\tO\\n14\\tO\\nwas\\tO\\ndetected\\tO\\ncytogenetically\\tO\\nbefore\\tO\\nDNA\\tO\\nanalysis\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nreport\\tO\\nof\\tO\\ndiagnosis\\tO\\nof\\tO\\nmaternal\\tO\\nUPD\\tB-Disease\\n(\\tO\\n14\\tO\\n)\\tO\\nbased\\tO\\non\\tO\\nclinical\\tO\\nfeatures\\tO\\n.\\tO\\n\\nThis\\tO\\nfinding\\tO\\nunderlines\\tO\\nthe\\tO\\nimportance\\tO\\nof\\tO\\nDNA\\tO\\nanalysis\\tO\\nfor\\tO\\nmaternal\\tO\\nUPD\\tO\\n(\\tO\\n14\\tO\\n)\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\na\\tO\\nsimilar\\tO\\nPWS\\tB-Disease\\n-\\tO\\nlike\\tO\\nphenotype\\tO\\neven\\tO\\nwithout\\tO\\nprevious\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nRobertsonian\\tO\\ntranslocation\\tO\\ninvolving\\tO\\nchromosome\\tO\\n14\\tO\\n.\\tO\\n.\\tO\\n\\nClinical\\tO\\nand\\tO\\ngenetic\\tO\\nstudy\\tO\\nof\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\nin\\tO\\nan\\tO\\nAustralian\\tO\\npopulation\\tO\\n.\\tO\\n\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nFRDA\\tB-Disease\\ngene\\tO\\nthat\\tO\\nencodes\\tO\\na\\tO\\n210\\tO\\n-\\tO\\namino\\tO\\nacid\\tO\\nprotein\\tO\\ncalled\\tO\\nfrataxin\\tO\\n.\\tO\\n\\nAn\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nGAA\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nin\\tO\\nintron\\tO\\n1\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nis\\tO\\npresent\\tO\\nin\\tO\\nmore\\tO\\nthan\\tO\\n95\\tO\\n%\\tO\\nof\\tO\\nmutant\\tO\\nalleles\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\n83\\tO\\npeople\\tO\\nwe\\tO\\nstudied\\tO\\nwho\\tO\\nhave\\tO\\nmutations\\tO\\nin\\tO\\nFRDA\\tO\\n,\\tO\\n78\\tO\\nare\\tO\\nhomozygous\\tO\\nfor\\tO\\nan\\tO\\nexpanded\\tO\\nGAA\\tO\\nrepeat\\tO\\n;\\tO\\nthe\\tO\\nother\\tO\\nfive\\tO\\npatients\\tO\\nhave\\tO\\nan\\tO\\nexpansion\\tO\\nin\\tO\\none\\tO\\nallele\\tO\\nand\\tO\\na\\tO\\npoint\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nother\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\npresent\\tO\\na\\tO\\ndetailed\\tO\\nclinical\\tO\\nand\\tO\\ngenetic\\tO\\nstudy\\tO\\nof\\tO\\na\\tO\\nsubset\\tO\\nof\\tO\\n51\\tO\\npatients\\tO\\nhomozygous\\tO\\nfor\\tO\\nan\\tO\\nexpansion\\tO\\nof\\tO\\nthe\\tO\\nGAA\\tO\\nrepeat\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\na\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\nsmaller\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nexpanded\\tO\\nalleles\\tO\\nand\\tO\\nage\\tO\\nat\\tO\\nonset\\tO\\n,\\tO\\nage\\tO\\ninto\\tO\\nwheelchair\\tO\\n,\\tO\\nscoliosis\\tB-Disease\\n,\\tO\\nimpaired\\tO\\nvibration\\tO\\nsense\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nfoot\\tB-Disease\\ndeformity\\tI-Disease\\n.\\tO\\n\\nThere\\tO\\nwas\\tO\\nno\\tO\\nsignificant\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\nsmaller\\tO\\nallele\\tO\\nand\\tO\\ncardiomyopathy\\tB-Disease\\n,\\tO\\ndiabetes\\tB-Disease\\nmellitus\\tI-Disease\\n,\\tO\\nloss\\tB-Disease\\nof\\tI-Disease\\nproprioception\\tI-Disease\\n,\\tO\\nor\\tO\\nbladder\\tB-Disease\\nsymptoms\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nlarger\\tO\\nallele\\tO\\nsize\\tO\\ncorrelated\\tO\\nwith\\tO\\nbladder\\tB-Disease\\nsymptoms\\tI-Disease\\nand\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nfoot\\tB-Disease\\ndeformity\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nduration\\tO\\nof\\tO\\ndisease\\tO\\nis\\tO\\ncorrelated\\tO\\nwith\\tO\\nwheelchair\\tO\\nuse\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\ndiabetes\\tB-Disease\\n,\\tO\\nscoliosis\\tB-Disease\\n,\\tO\\nbladder\\tB-Disease\\nsymptoms\\tI-Disease\\nand\\tO\\nimpaired\\tB-Disease\\nproprioception\\tI-Disease\\n,\\tO\\nand\\tO\\nvibration\\tO\\nsense\\tO\\nbut\\tO\\nno\\tO\\nother\\tO\\ncomplications\\tO\\nstudied\\tO\\n.\\tO\\n.\\tO\\n\\nNovel\\tO\\nmutations\\tO\\nin\\tO\\nXLRS1\\tO\\ncausing\\tO\\nretinoschisis\\tB-Disease\\n,\\tO\\nincluding\\tO\\nfirst\\tO\\nevidence\\tO\\nof\\tO\\nputative\\tO\\nleader\\tO\\nsequence\\tO\\nchange\\tO\\n.\\tO\\n\\nJuvenile\\tB-Disease\\nretinoschisis\\tI-Disease\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\ndisease\\tI-Disease\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nXLRS1\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nscreened\\tO\\n31\\tO\\nnew\\tO\\nunrelated\\tO\\npatients\\tO\\nand\\tO\\nfamilies\\tO\\nfor\\tO\\nXLRS1\\tO\\nmutations\\tO\\nin\\tO\\naddition\\tO\\nto\\tO\\npreviously\\tO\\nreported\\tO\\nmutations\\tO\\nfor\\tO\\n60\\tO\\nof\\tO\\nour\\tO\\nfamilies\\tO\\n(\\tO\\nRetinoschisis\\tB-Disease\\nConsortium\\tO\\n,\\tO\\nHum\\tO\\nMol\\tO\\nGenet\\tO\\n1998\\tO\\n;\\tO\\n7\\tO\\n1185\\tO\\n-\\tO\\n1192\\tO\\n)\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\nthree\\tO\\ndifferent\\tO\\nmutations\\tO\\nincluding\\tO\\n12\\tO\\nnovel\\tO\\nones\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\n28\\tO\\npatients\\tO\\n.\\tO\\n\\nMutations\\tO\\nidentified\\tO\\nin\\tO\\nthis\\tO\\nstudy\\tO\\ninclude\\tO\\n19\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\ntwo\\tO\\nnonsense\\tO\\nmutations\\tO\\n,\\tO\\none\\tO\\nintragenic\\tO\\ndeletion\\tO\\n,\\tO\\nfour\\tO\\nmicrodeletions\\tO\\n,\\tO\\none\\tO\\ninsertion\\tO\\n,\\tO\\nand\\tO\\none\\tO\\nintronic\\tO\\nsequence\\tO\\nsubstitution\\tO\\nthat\\tO\\nis\\tO\\nlikely\\tO\\nto\\tO\\nresult\\tO\\nin\\tO\\na\\tO\\nsplice\\tO\\nsite\\tO\\ndefect\\tO\\n.\\tO\\n\\nTwo\\tO\\nnovel\\tO\\nmutations\\tO\\n,\\tO\\nc\\tO\\n.\\tO\\n\\n38T\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\n(\\tO\\nL13P\\tO\\n)\\tO\\nand\\tO\\nc\\tO\\n.\\tO\\n\\n667T\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\n(\\tO\\nC223R\\tO\\n)\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\npresent\\tO\\nthe\\tO\\nfirst\\tO\\ngenetic\\tO\\nevidence\\tO\\nfor\\tO\\nthe\\tO\\nfunctional\\tO\\nsignificance\\tO\\nof\\tO\\nthe\\tO\\nputative\\tO\\nleader\\tO\\npeptide\\tO\\nsequence\\tO\\nand\\tO\\nfor\\tO\\nthe\\tO\\nfunctional\\tO\\nsignificance\\tO\\nat\\tO\\nthe\\tO\\ncarboxyl\\tO\\nterminal\\tO\\nof\\tO\\nthe\\tO\\nXLRS1\\tO\\nprotein\\tO\\nbeyond\\tO\\nthe\\tO\\ndiscoidin\\tO\\ndomain\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\n25\\tO\\nof\\tO\\nthe\\tO\\nfamilies\\tO\\nwere\\tO\\nlocalized\\tO\\nto\\tO\\nexons\\tO\\n4\\tO\\n-\\tO\\n6\\tO\\n,\\tO\\nemphasizing\\tO\\nthe\\tO\\ncritical\\tO\\nfunctional\\tO\\nsignificance\\tO\\nof\\tO\\nthe\\tO\\ndiscoidin\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nXLRS1\\tO\\nprotein\\tO\\n\\nGrowth\\tO\\nhormone\\tO\\ntreatment\\tO\\nincreases\\tO\\nCO\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nresponse\\tO\\n,\\tO\\nventilation\\tO\\nand\\tO\\ncentral\\tO\\ninspiratory\\tO\\ndrive\\tO\\nin\\tO\\nchildren\\tO\\nwith\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\nwhether\\tO\\nthe\\tO\\nbeneficial\\tO\\neffects\\tO\\nof\\tO\\ngrowth\\tO\\nhormone\\tO\\n(\\tO\\nGH\\tO\\n)\\tO\\ntreatment\\tO\\non\\tO\\ngrowth\\tO\\nand\\tO\\nbody\\tO\\ncomposition\\tO\\nin\\tO\\nPWS\\tB-Disease\\nare\\tO\\naccompanied\\tO\\nby\\tO\\nan\\tO\\nimprovement\\tO\\nin\\tO\\nrespiratory\\tO\\nfunction\\tO\\n.\\tO\\n\\nWe\\tO\\nmeasured\\tO\\nresting\\tO\\nventilation\\tO\\n,\\tO\\nairway\\tO\\nocclusion\\tO\\npressure\\tO\\n(\\tO\\nP\\tO\\n(\\tO\\n0\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\n)\\tO\\nand\\tO\\nventilatory\\tO\\nresponse\\tO\\nto\\tO\\nCO\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nin\\tO\\nnine\\tO\\nchildren\\tO\\n,\\tO\\naged\\tO\\n7\\tO\\n-\\tO\\n14\\tO\\nyears\\tO\\n,\\tO\\nbefore\\tO\\nand\\tO\\n6\\tO\\n-\\tO\\n9\\tO\\nmonths\\tO\\nafter\\tO\\nthe\\tO\\nstart\\tO\\nof\\tO\\nGH\\tO\\ntreatment\\tO\\n.\\tO\\n\\nDuring\\tO\\nGH\\tO\\ntreatment\\tO\\n,\\tO\\nresting\\tO\\nventilation\\tO\\nincreased\\tO\\nby\\tO\\n26\\tO\\n%\\tO\\n,\\tO\\nP\\tO\\n(\\tO\\n0\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\nby\\tO\\n72\\tO\\n%\\tO\\nand\\tO\\nthe\\tO\\nresponse\\tO\\nto\\tO\\nCO\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nby\\tO\\n65\\tO\\n%\\tO\\n(\\tO\\nP\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n002\\tO\\n,\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n04\\tO\\nand\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n02\\tO\\n,\\tO\\nrespectively\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nobserved\\tO\\nincrease\\tO\\nin\\tO\\nventilatory\\tO\\noutput\\tO\\nwas\\tO\\nnot\\tO\\ncorrelated\\tO\\nto\\tO\\nchanges\\tO\\nin\\tO\\nbody\\tO\\nmass\\tO\\nindex\\tO\\n.\\tO\\n\\nCONCLUSION\\tO\\nTreatment\\tO\\nof\\tO\\nchildren\\tO\\nwith\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\nseems\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nstimulatory\\tO\\neffect\\tO\\non\\tO\\ncentral\\tO\\nrespiratory\\tO\\nstructures\\tO\\n.\\tO\\n\\nThe\\tO\\nobserved\\tO\\nincrease\\tO\\nin\\tO\\nventilation\\tO\\nand\\tO\\ninspiratory\\tO\\ndrive\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\nthe\\tO\\nimproved\\tO\\nactivity\\tO\\nlevel\\tO\\nreported\\tO\\nby\\tO\\nparents\\tO\\nof\\tO\\nPWS\\tB-Disease\\nchildren\\tO\\nduring\\tO\\ngrowth\\tO\\nhormone\\tO\\ntherapy\\tO\\n\\nG130V\\tO\\n,\\tO\\na\\tO\\ncommon\\tO\\nFRDA\\tB-Disease\\npoint\\tO\\nmutation\\tO\\n,\\tO\\nappears\\tO\\nto\\tO\\nhave\\tO\\narisen\\tO\\nfrom\\tO\\na\\tO\\ncommon\\tO\\nfounder\\tO\\n.\\tO\\n\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n(\\tO\\nFRDA\\tB-Disease\\n)\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\ninherited\\tB-Disease\\nataxia\\tI-Disease\\n.\\tO\\n\\nAbout\\tO\\n98\\tO\\n%\\tO\\nof\\tO\\nmutant\\tO\\nalleles\\tO\\nhave\\tO\\nan\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nGAA\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nin\\tO\\nintron\\tO\\n1\\tO\\nof\\tO\\nthe\\tO\\naffected\\tO\\ngene\\tO\\n,\\tO\\nFRDA\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\n2\\tO\\n%\\tO\\nare\\tO\\npoint\\tO\\nmutations\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\n17\\tO\\npoint\\tO\\nmutations\\tO\\nso\\tO\\nfar\\tO\\ndescribed\\tO\\n,\\tO\\nthree\\tO\\nappear\\tO\\nto\\tO\\nbe\\tO\\nmore\\tO\\ncommon\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthese\\tO\\nis\\tO\\nthe\\tO\\nG130V\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n4\\tO\\nof\\tO\\nFRDA\\tO\\n.\\tO\\n\\nG130V\\tO\\n,\\tO\\nwhen\\tO\\npresent\\tO\\nwith\\tO\\nan\\tO\\nexpanded\\tO\\nGAA\\tO\\nrepeat\\tO\\non\\tO\\nthe\\tO\\nother\\tO\\nallele\\tO\\n,\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\natypical\\tO\\nFRDA\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nHaplotype\\tO\\nanalysis\\tO\\nwas\\tO\\nundertaken\\tO\\non\\tO\\nthe\\tO\\nfour\\tO\\nfamilies\\tO\\nwho\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\nwith\\tO\\nthis\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nsuggest\\tO\\na\\tO\\ncommon\\tO\\nfounder\\tO\\nfor\\tO\\nthis\\tO\\nmutation\\tO\\n.\\tO\\n\\nAlthough\\tO\\nmarked\\tO\\ndifferences\\tO\\nin\\tO\\nextragenic\\tO\\nmarker\\tO\\nhaplotypes\\tO\\nwere\\tO\\nseen\\tO\\nin\\tO\\none\\tO\\nfamily\\tO\\n,\\tO\\nsimilar\\tO\\nintragenic\\tO\\nhaplotyping\\tO\\nsuggests\\tO\\nthe\\tO\\nsame\\tO\\nmutation\\tO\\nfounder\\tO\\nfor\\tO\\nthis\\tO\\nfamily\\tO\\nwith\\tO\\nthe\\tO\\ndifferences\\tO\\nexplicable\\tO\\nby\\tO\\ntwo\\tO\\nrecombination\\tO\\nevents\\tO\\n.\\tO\\n.\\tO\\n\\nSynergistic\\tO\\neffect\\tO\\nof\\tO\\nhistone\\tO\\nhyperacetylation\\tO\\nand\\tO\\nDNA\\tO\\ndemethylation\\tO\\nin\\tO\\nthe\\tO\\nreactivation\\tO\\nof\\tO\\nthe\\tO\\nFMR1\\tO\\ngene\\tO\\n.\\tO\\n\\nMost\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\npatients\\tO\\nhave\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\n(\\tO\\nCGG\\tO\\n)\\tO\\n(\\tO\\nn\\tO\\n)\\tO\\nsequence\\tO\\nwith\\tO\\n>\\tO\\n200\\tO\\nrepeats\\tO\\n(\\tO\\nfull\\tO\\nmutation\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nFMR1\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nthis\\tO\\ncondition\\tO\\n.\\tO\\n\\nHypermethylation\\tO\\nof\\tO\\nthe\\tO\\nexpanded\\tO\\nrepeat\\tO\\nand\\tO\\nof\\tO\\nthe\\tO\\nFMR1\\tO\\npromoter\\tO\\nis\\tO\\nalmost\\tO\\nalways\\tO\\npresent\\tO\\nand\\tO\\napparently\\tO\\nsuppresses\\tO\\ntranscription\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nabsence\\tO\\nof\\tO\\nthe\\tO\\nFMR1\\tO\\nprotein\\tO\\n.\\tO\\n\\nWe\\tO\\nrecently\\tO\\nshowed\\tO\\nthat\\tO\\ntranscriptional\\tO\\nreactivation\\tO\\nof\\tO\\nFMR1\\tO\\nfull\\tO\\nmutations\\tO\\ncan\\tO\\nbe\\tO\\nachieved\\tO\\nby\\tO\\ninducing\\tO\\nDNA\\tO\\ndemethylation\\tO\\nwith\\tO\\n5\\tO\\n-\\tO\\nazadeoxycytidine\\tO\\n(\\tO\\n5\\tO\\n-\\tO\\nazadC\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nlevel\\tO\\nof\\tO\\nhistone\\tO\\nacetylation\\tO\\nis\\tO\\nanother\\tO\\nimportant\\tO\\nfactor\\tO\\nin\\tO\\nregulating\\tO\\ngene\\tO\\nexpression\\tO\\n;\\tO\\ntherefore\\tO\\n,\\tO\\nwe\\tO\\ntreated\\tO\\nlymphoblastoid\\tO\\ncell\\tO\\nlines\\tO\\nof\\tO\\nnon\\tO\\n-\\tO\\nmosaic\\tO\\nfull\\tO\\nmutation\\tO\\npatients\\tO\\nwith\\tO\\nthree\\tO\\ndrugs\\tO\\ncapable\\tO\\nof\\tO\\ninducing\\tO\\nhistone\\tO\\nhyperacetylation\\tO\\n.\\tO\\n\\nWe\\tO\\nobserved\\tO\\na\\tO\\nconsistent\\tO\\n,\\tO\\nalthough\\tO\\nmodest\\tO\\n,\\tO\\nreactivation\\tO\\nof\\tO\\nthe\\tO\\nFMR1\\tO\\ngene\\tO\\nwith\\tO\\n4\\tO\\n-\\tO\\nphenylbutyrate\\tO\\n,\\tO\\nsodium\\tO\\nbutyrate\\tO\\nand\\tO\\ntrichostatin\\tO\\nA\\tO\\n,\\tO\\nas\\tO\\nshown\\tO\\nby\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\ncombining\\tO\\nthese\\tO\\ndrugs\\tO\\nwith\\tO\\n5\\tO\\n-\\tO\\nazadC\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\n2\\tO\\n-\\tO\\nto\\tO\\n5\\tO\\n-\\tO\\nfold\\tO\\nincrease\\tO\\nin\\tO\\nFMR1\\tO\\nmRNA\\tO\\nlevels\\tO\\nobtained\\tO\\nwith\\tO\\n5\\tO\\n-\\tO\\nazadC\\tO\\nalone\\tO\\n,\\tO\\nthus\\tO\\nshowing\\tO\\na\\tO\\nmarked\\tO\\nsynergistic\\tO\\neffect\\tO\\nof\\tO\\nhistone\\tO\\nhyperacetylation\\tO\\nand\\tO\\nDNA\\tO\\ndemethylation\\tO\\nin\\tO\\nthe\\tO\\nreactivation\\tO\\nof\\tO\\nFMR1\\tO\\nfull\\tO\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nConstitutional\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\n(\\tO\\nVHL\\tB-Disease\\n)\\tO\\ngene\\tO\\ndeletions\\tO\\ndetected\\tO\\nin\\tO\\nVHL\\tB-Disease\\nfamilies\\tO\\nby\\tO\\nfluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n.\\tO\\n\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\n(\\tI-Disease\\nVHL\\tI-Disease\\n)\\tI-Disease\\ndisease\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominantly\\tI-Disease\\ninherited\\tI-Disease\\ncancer\\tI-Disease\\nsyndrome\\tI-Disease\\npredisposing\\tO\\nto\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\ntumor\\tB-Disease\\ntypes\\tO\\nthat\\tO\\ninclude\\tO\\nretinal\\tO\\nhemangioblastomas\\tB-Disease\\n,\\tO\\nhemangioblastomas\\tB-Disease\\nof\\tO\\nthe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n,\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\n,\\tO\\npancreatic\\tB-Disease\\ncysts\\tI-Disease\\nand\\tI-Disease\\ntumors\\tI-Disease\\n,\\tO\\npheochromocytomas\\tB-Disease\\n,\\tO\\nendolymphatic\\tB-Disease\\nsac\\tI-Disease\\ntumors\\tI-Disease\\n,\\tO\\nand\\tO\\nepididymal\\tB-Disease\\ncystadenomas\\tI-Disease\\n[\\tO\\nW\\tO\\n.\\tO\\n\\nM\\tO\\n.\\tO\\n\\nLinehan\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\nJ\\tO\\n.\\tO\\n\\nAm\\tO\\n.\\tO\\nMed\\tO\\n.\\tO\\nAssoc\\tO\\n.\\tO\\n,\\tO\\n273\\tO\\n564\\tO\\n-\\tO\\n570\\tO\\n,\\tO\\n1995\\tO\\n;\\tO\\nE\\tO\\n.\\tO\\nA\\tO\\n.\\tO\\nMaher\\tO\\nand\\tO\\nW\\tO\\n.\\tO\\nG\\tO\\n.\\tO\\nKaelin\\tO\\n,\\tO\\nJr\\tO\\n.\\tO\\n,\\tO\\nMedicine\\tO\\n(\\tO\\nBaltimore\\tO\\n)\\tO\\n,\\tO\\n76\\tO\\n381\\tO\\n-\\tO\\n391\\tO\\n,\\tO\\n1997\\tO\\n;\\tO\\nW\\tO\\n.\\tO\\nM\\tO\\n.\\tO\\nLinehan\\tO\\nand\\tO\\nR\\tO\\n.\\tO\\nD\\tO\\n.\\tO\\nKlausner\\tO\\n,\\tO\\nIn\\tO\\nB\\tO\\n.\\tO\\nVogelstein\\tO\\nand\\tO\\nK\\tO\\n.\\tO\\nKinzler\\tO\\n(\\tO\\neds\\tO\\n.\\tO\\n)\\tO\\n,\\tO\\nThe\\tO\\nGenetic\\tO\\nBasis\\tO\\nof\\tO\\nHuman\\tO\\nCancer\\tO\\n,\\tO\\npp\\tO\\n.\\tO\\n\\n455\\tO\\n-\\tO\\n473\\tO\\n,\\tO\\nMcGraw\\tO\\n-\\tO\\nHill\\tO\\n,\\tO\\n1998\\tO\\n]\\tO\\n.\\tO\\n\\nThe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nwas\\tO\\nlocalized\\tO\\nto\\tO\\nchromosome\\tO\\n3p25\\tO\\n-\\tO\\n26\\tO\\nand\\tO\\ncloned\\tO\\n[\\tO\\nF\\tO\\n.\\tO\\nLatif\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\nScience\\tO\\n(\\tO\\nWashington\\tO\\nDC\\tO\\n)\\tO\\n,\\tO\\n260\\tO\\n1317\\tO\\n-\\tO\\n1320\\tO\\n,\\tO\\n1993\\tO\\n]\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nVHL\\tB-Disease\\nkindreds\\tO\\n.\\tO\\n\\nThe\\tO\\nreported\\tO\\nfrequency\\tO\\nof\\tO\\ndetection\\tO\\nof\\tO\\nVHL\\tB-Disease\\ngermline\\tO\\nmutations\\tO\\nhas\\tO\\nvaried\\tO\\nfrom\\tO\\n39\\tO\\nto\\tO\\n80\\tO\\n%\\tO\\n(\\tO\\nJ\\tO\\n.\\tO\\nM\\tO\\n.\\tO\\nWhaley\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\nAm\\tO\\n.\\tO\\nJ\\tO\\n.\\tO\\nHum\\tO\\n.\\tO\\nGenet\\tO\\n.\\tO\\n,\\tO\\n55\\tO\\n1092\\tO\\n-\\tO\\n1102\\tO\\n,\\tO\\n1994\\tO\\n;\\tO\\nClinical\\tO\\nResearch\\tO\\nGroup\\tO\\nfor\\tO\\nJapan\\tO\\n,\\tO\\nHum\\tO\\n.\\tO\\nMol\\tO\\n.\\tO\\nGenet\\tO\\n.\\tO\\n,\\tO\\n4\\tO\\n2233\\tO\\n-\\tO\\n2237\\tO\\n,\\tO\\n1995\\tO\\n;\\tO\\nF\\tO\\n.\\tO\\nChen\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\nHum\\tO\\n.\\tO\\nMutat\\tO\\n.\\tO\\n,\\tO\\n5\\tO\\n66\\tO\\n-\\tO\\n75\\tO\\n,\\tO\\n1995\\tO\\n;\\tO\\nE\\tO\\n.\\tO\\nR\\tO\\n.\\tO\\nMaher\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\nJ\\tO\\n.\\tO\\nMed\\tO\\n.\\tO\\nGenet\\tO\\n.\\tO\\n,\\tO\\n33\\tO\\n328\\tO\\n-\\tO\\n332\\tO\\n,\\tO\\n1996\\tO\\n;\\tO\\nB\\tO\\n.\\tO\\nZbar\\tO\\n,\\tO\\nCancer\\tO\\nSurv\\tO\\n.\\tO\\n,\\tO\\n25\\tO\\n219\\tO\\n-\\tO\\n232\\tO\\n,\\tO\\n1995\\tO\\n)\\tO\\n.\\tO\\n\\nRecently\\tO\\na\\tO\\nquantitative\\tO\\nSouthern\\tO\\nblotting\\tO\\nprocedure\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nimprove\\tO\\nthis\\tO\\nfrequency\\tO\\n(\\tO\\nC\\tO\\n.\\tO\\nStolle\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\nHum\\tO\\n.\\tO\\nMutat\\tO\\n.\\tO\\n,\\tO\\n12\\tO\\n417\\tO\\n-\\tO\\n423\\tO\\n,\\tO\\n1998\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\nuse\\tO\\nof\\tO\\nfluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n(\\tO\\nFISH\\tO\\n)\\tO\\nas\\tO\\na\\tO\\nmethod\\tO\\nto\\tO\\ndetect\\tO\\nand\\tO\\ncharacterize\\tO\\nVHL\\tB-Disease\\ngermline\\tO\\ndeletions\\tO\\n.\\tO\\n\\nWe\\tO\\nreexamined\\tO\\na\\tO\\ngroup\\tO\\nof\\tO\\nVHL\\tB-Disease\\npatients\\tO\\nshown\\tO\\npreviously\\tO\\nby\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\nand\\tO\\nsequencing\\tO\\nanalysis\\tO\\nnot\\tO\\nto\\tO\\nharbor\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nVHL\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nconstitutional\\tO\\ndeletions\\tO\\nin\\tO\\n29\\tO\\nof\\tO\\n30\\tO\\nVHL\\tB-Disease\\npatients\\tO\\nin\\tO\\nthis\\tO\\ngroup\\tO\\nusing\\tO\\ncosmid\\tO\\nand\\tO\\nP1\\tO\\nprobes\\tO\\nthat\\tO\\ncover\\tO\\nthe\\tO\\nVHL\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nWe\\tO\\nthen\\tO\\ntested\\tO\\nsix\\tO\\nphenotypically\\tO\\nnormal\\tO\\noffspring\\tO\\nfrom\\tO\\nfour\\tO\\nof\\tO\\nthese\\tO\\nVHL\\tB-Disease\\nfamilies\\tO\\ntwo\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\ncarry\\tO\\nthe\\tO\\ndeletion\\tO\\nand\\tO\\nthe\\tO\\nother\\tO\\nfour\\tO\\nwere\\tO\\ndeletion\\tO\\n-\\tO\\nfree\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\ngermline\\tO\\nmosaicism\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\none\\tO\\nfamily\\tO\\n.\\tO\\n\\nIn\\tO\\nsum\\tO\\n,\\tO\\nFISH\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nsimple\\tO\\nand\\tO\\nreliable\\tO\\nmethod\\tO\\nto\\tO\\ndetect\\tO\\nVHL\\tB-Disease\\ngermline\\tO\\ndeletions\\tO\\nand\\tO\\npractically\\tO\\nuseful\\tO\\nin\\tO\\ncases\\tO\\nwhere\\tO\\nother\\tO\\nmethods\\tO\\nof\\tO\\nscreening\\tO\\nhave\\tO\\nfailed\\tO\\nto\\tO\\ndetect\\tO\\na\\tO\\nVHL\\tB-Disease\\ngene\\tI-Disease\\nabnormality\\tI-Disease\\n\\nSpectrum\\tO\\nof\\tO\\nhSNF5\\tO\\n/\\tO\\nINI1\\tO\\nsomatic\\tO\\nmutations\\tO\\nin\\tO\\nhuman\\tO\\ncancer\\tB-Disease\\nand\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\n.\\tO\\n\\nThe\\tO\\nhSNF5\\tO\\n/\\tO\\nINI1\\tO\\ngene\\tO\\nwhich\\tO\\nencodes\\tO\\na\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\nSWI\\tO\\n/\\tO\\nSNF\\tO\\nchromatin\\tO\\nATP\\tO\\n-\\tO\\ndependent\\tO\\nremodeling\\tO\\ncomplex\\tO\\n,\\tO\\nis\\tO\\na\\tO\\nnew\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\nlocalized\\tO\\non\\tO\\nchromosome\\tO\\n22q11\\tO\\n.\\tO\\n\\n2\\tO\\nand\\tO\\nrecently\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\nmutated\\tO\\nin\\tO\\nmalignant\\tB-Disease\\nrhabdoid\\tI-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nsearched\\tO\\nfor\\tO\\nhSNF5\\tO\\n/\\tO\\nINI1\\tO\\nmutations\\tO\\nin\\tO\\n229\\tO\\ntumors\\tB-Disease\\nof\\tO\\nvarious\\tO\\norigins\\tO\\nusing\\tO\\na\\tO\\nscreening\\tO\\nmethod\\tO\\nbased\\tO\\non\\tO\\ndenaturing\\tO\\nhigh\\tO\\n-\\tO\\nperformance\\tO\\nliquid\\tO\\nchromatography\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n31\\tO\\nhomozygous\\tO\\ndeletions\\tO\\nand\\tO\\n36\\tO\\npoint\\tO\\nalterations\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nPoint\\tO\\nmutations\\tO\\nwere\\tO\\nscattered\\tO\\nalong\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\nand\\tO\\nincluded\\tO\\n15\\tO\\nnonsense\\tO\\n,\\tO\\n15\\tO\\nframeshift\\tO\\n,\\tO\\nthree\\tO\\nsplice\\tO\\nsite\\tO\\n,\\tO\\ntwo\\tO\\nmissense\\tO\\nand\\tO\\none\\tO\\nediting\\tO\\nmutations\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\nretrieved\\tO\\nin\\tO\\nmost\\tO\\nrhabdoid\\tB-Disease\\ntumors\\tI-Disease\\n,\\tO\\nwhatever\\tO\\ntheir\\tO\\nsites\\tO\\nof\\tO\\noccurrence\\tO\\n,\\tO\\nindicating\\tO\\nthe\\tO\\ncommon\\tO\\npathogenetic\\tO\\norigin\\tO\\nof\\tO\\nthese\\tO\\ntumors\\tB-Disease\\n.\\tO\\n\\nRecurrent\\tO\\nhSNF5\\tO\\n/\\tO\\nINI1\\tO\\nalterations\\tO\\nwere\\tO\\nalso\\tO\\nobserved\\tO\\nin\\tO\\nchoroid\\tB-Disease\\nplexus\\tI-Disease\\ncarcinomas\\tI-Disease\\nand\\tO\\nin\\tO\\na\\tO\\nsubset\\tO\\nof\\tO\\ncentral\\tO\\nprimitive\\tO\\nneuroectodermal\\tB-Disease\\ntumors\\tI-Disease\\n(\\tO\\ncPNETs\\tO\\n)\\tO\\nand\\tO\\nmedulloblastomas\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nhSNF5\\tO\\n/\\tO\\nINI1\\tO\\npoint\\tO\\nmutations\\tO\\nwere\\tO\\nnot\\tO\\ndetected\\tO\\nin\\tO\\nbreast\\tB-Disease\\ncancers\\tI-Disease\\n,\\tO\\nWilms\\tB-Disease\\ntumors\\tI-Disease\\n,\\tO\\ngliomas\\tB-Disease\\n,\\tO\\nependymomas\\tB-Disease\\n,\\tO\\nsarcomas\\tB-Disease\\nand\\tO\\nother\\tO\\ntumor\\tB-Disease\\ntypes\\tO\\n,\\tO\\neven\\tO\\nthough\\tO\\nmost\\tO\\nanalyzed\\tO\\ncases\\tO\\nharbored\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\nat\\tO\\n22q11\\tO\\n.\\tO\\n\\n2\\tO\\nloci\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nrhabdoid\\tB-Disease\\ntumors\\tI-Disease\\n,\\tO\\nchoroid\\tB-Disease\\nplexus\\tI-Disease\\ncarcinomas\\tI-Disease\\nand\\tO\\na\\tO\\nsubset\\tO\\nof\\tO\\nmedulloblastomas\\tB-Disease\\nand\\tO\\ncPNETs\\tO\\nshare\\tO\\ncommon\\tO\\npathways\\tO\\nof\\tO\\noncogenesis\\tO\\nrelated\\tO\\nto\\tO\\nhSNF5\\tO\\n/\\tO\\nINI1\\tO\\nalteration\\tO\\nand\\tO\\nthat\\tO\\nhSNF5\\tO\\n/\\tO\\nINI1\\tO\\nmutations\\tO\\ndefine\\tO\\na\\tO\\ngenetically\\tO\\nhomogeneous\\tO\\nfamily\\tO\\nof\\tO\\nhighly\\tO\\naggressive\\tO\\ncancers\\tB-Disease\\nmainly\\tO\\noccurring\\tO\\nin\\tO\\nyoung\\tO\\nchildren\\tO\\nand\\tO\\nfrequently\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nalways\\tO\\n,\\tO\\nexhibiting\\tO\\na\\tO\\nrhabdoid\\tB-Disease\\nphenotype\\tO\\n\\nAtaxin\\tO\\n-\\tO\\n3\\tO\\nwith\\tO\\nan\\tO\\naltered\\tO\\nconformation\\tO\\nthat\\tO\\nexposes\\tO\\nthe\\tO\\npolyglutamine\\tO\\ndomain\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nnuclear\\tO\\nmatrix\\tO\\n.\\tO\\n\\nSpinocerebellar\\tB-Disease\\nataxia\\tI-Disease\\ntype\\tI-Disease\\n-\\tI-Disease\\n3\\tI-Disease\\nor\\tO\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nSCA3\\tB-Disease\\n/\\tO\\nMJD\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\nCAG\\tB-Disease\\n/\\tI-Disease\\npolyglutamine\\tI-Disease\\nrepeat\\tI-Disease\\ndisease\\tI-Disease\\nfamily\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nfamily\\tO\\nof\\tO\\ndisorders\\tO\\n,\\tO\\na\\tO\\nnormally\\tO\\npolymorphic\\tO\\nCAG\\tO\\nrepeat\\tO\\nbecomes\\tO\\nexpanded\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nexpression\\tO\\nof\\tO\\nan\\tO\\nexpanded\\tO\\npolyglutamine\\tO\\ndomain\\tO\\nin\\tO\\nthe\\tO\\ndisease\\tO\\ngene\\tO\\nproduct\\tO\\n.\\tO\\n\\nExperimental\\tO\\nmodels\\tO\\nof\\tO\\npolyglutamine\\tB-Disease\\ndisease\\tI-Disease\\nimplicate\\tO\\nthe\\tO\\nnucleus\\tO\\nin\\tO\\npathogenesis\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nthe\\tO\\nlink\\tO\\nbetween\\tO\\nintranuclear\\tO\\nexpression\\tO\\nof\\tO\\nexpanded\\tO\\npolyglutamine\\tO\\nand\\tO\\nneuronal\\tB-Disease\\ndysfunction\\tI-Disease\\nremains\\tO\\nunclear\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\ndemonstrate\\tO\\nthat\\tO\\nataxin\\tO\\n-\\tO\\n3\\tO\\n,\\tO\\nthe\\tO\\ndisease\\tO\\nprotein\\tO\\nin\\tO\\nSCA3\\tB-Disease\\n/\\tO\\nMJD\\tB-Disease\\n,\\tO\\nadopts\\tO\\na\\tO\\nunique\\tO\\nconformation\\tO\\nwhen\\tO\\nexpressed\\tO\\nwithin\\tO\\nthe\\tO\\nnucleus\\tO\\nof\\tO\\ntransfected\\tO\\ncells\\tO\\n.\\tO\\n\\nThe\\tO\\nmonoclonal\\tO\\nantibody\\tO\\n1C2\\tO\\nis\\tO\\nknown\\tO\\npreferentially\\tO\\nto\\tO\\nbind\\tO\\nexpanded\\tO\\npolyglutamine\\tO\\n,\\tO\\nbut\\tO\\nwe\\tO\\nfind\\tO\\nthat\\tO\\nit\\tO\\nalso\\tO\\nbinds\\tO\\na\\tO\\nfragment\\tO\\nof\\tO\\nataxin\\tO\\n-\\tO\\n3\\tO\\ncontaining\\tO\\na\\tO\\nnormal\\tO\\nglutamine\\tO\\nrepeat\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nexpression\\tO\\nof\\tO\\nataxin\\tO\\n-\\tO\\n3\\tO\\nwithin\\tO\\nthe\\tO\\nnucleus\\tO\\nexposes\\tO\\nthe\\tO\\nglutamine\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\nnon\\tO\\n-\\tO\\npathological\\tO\\nprotein\\tO\\n,\\tO\\nallowing\\tO\\nit\\tO\\nto\\tO\\nbind\\tO\\nthe\\tO\\nmonoclonal\\tO\\nantibody\\tO\\n1C2\\tO\\n.\\tO\\n\\nFractionation\\tO\\nand\\tO\\nimmunochemical\\tO\\nexperiments\\tO\\nindicate\\tO\\nthat\\tO\\nthis\\tO\\nnovel\\tO\\nconformation\\tO\\nof\\tO\\nintranuclear\\tO\\nataxin\\tO\\n-\\tO\\n3\\tO\\nis\\tO\\nnot\\tO\\ndue\\tO\\nto\\tO\\nproteolysis\\tO\\n,\\tO\\nsuggesting\\tO\\ninstead\\tO\\nthat\\tO\\nassociation\\tO\\nwith\\tO\\nnuclear\\tO\\nprotein\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\nalters\\tO\\nthe\\tO\\nstructure\\tO\\nof\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\nataxin\\tO\\n-\\tO\\n3\\tO\\nwhich\\tO\\nexposes\\tO\\nthe\\tO\\npolyglutamine\\tO\\ndomain\\tO\\n.\\tO\\n\\nThis\\tO\\nconformationally\\tO\\naltered\\tO\\nataxin\\tO\\n-\\tO\\n3\\tO\\nis\\tO\\nbound\\tO\\nto\\tO\\nthe\\tO\\nnuclear\\tO\\nmatrix\\tO\\n.\\tO\\n\\nThe\\tO\\npathological\\tO\\nform\\tO\\nof\\tO\\nataxin\\tO\\n-\\tO\\n3\\tO\\nwith\\tO\\nan\\tO\\nexpanded\\tO\\npolyglutamine\\tO\\ndomain\\tO\\nalso\\tO\\nassociates\\tO\\nwith\\tO\\nthe\\tO\\nnuclear\\tO\\nmatrix\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nan\\tO\\nearly\\tO\\nevent\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nSCA3\\tB-Disease\\n/\\tO\\nMJD\\tB-Disease\\nmay\\tO\\nbe\\tO\\nan\\tO\\naltered\\tO\\nconformation\\tO\\nof\\tO\\nataxin\\tO\\n-\\tO\\n3\\tO\\nwithin\\tO\\nthe\\tO\\nnucleus\\tO\\nthat\\tO\\nexposes\\tO\\nthe\\tO\\npolyglutamine\\tO\\ndomain\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\nMAGEL2\\tO\\ngene\\tO\\nand\\tO\\nits\\tO\\nmouse\\tO\\nhomologue\\tO\\nare\\tO\\npaternally\\tO\\nexpressed\\tO\\nand\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nregion\\tO\\n.\\tO\\n\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\ncomplex\\tO\\nneurogenetic\\tB-Disease\\ndisorder\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nphenotype\\tO\\nis\\tO\\nlikely\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\ncontiguous\\tB-Disease\\ngene\\tI-Disease\\nsyndrome\\tI-Disease\\ninvolving\\tO\\ngenes\\tO\\nwhich\\tO\\nare\\tO\\npaternally\\tO\\nexpressed\\tO\\nonly\\tO\\n,\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\nregion\\tO\\n.\\tO\\n\\nFour\\tO\\nmouse\\tO\\nmodels\\tO\\nof\\tO\\nPWS\\tB-Disease\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\nbut\\tO\\nthese\\tO\\ndo\\tO\\nnot\\tO\\ndefinitively\\tO\\nallow\\tO\\nthe\\tO\\ndelineation\\tO\\nof\\tO\\nthe\\tO\\ncritical\\tO\\nregion\\tO\\nand\\tO\\nthe\\tO\\nassociated\\tO\\ngenes\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\naetiology\\tO\\nof\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\ntargeted\\tO\\nmutagenesis\\tO\\nof\\tO\\nmouse\\tO\\nhomologues\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\ncandidate\\tO\\nPWS\\tB-Disease\\ngenes\\tO\\ndoes\\tO\\nnot\\tO\\nappear\\tO\\nto\\tO\\nresult\\tO\\nin\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\nfeatures\\tO\\nof\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\nthe\\tO\\nisolation\\tO\\nof\\tO\\nnew\\tO\\ngenes\\tO\\nin\\tO\\nthis\\tO\\nregion\\tO\\nremains\\tO\\ncrucial\\tO\\nfor\\tO\\na\\tO\\nbetter\\tO\\nunderstanding\\tO\\nof\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nmanuscript\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\ncharacterization\\tO\\nof\\tO\\nMAGEL2\\tO\\nand\\tO\\nits\\tO\\nmouse\\tO\\nhomologue\\tO\\nMagel2\\tO\\n.\\tO\\n\\nThese\\tO\\nare\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\nand\\tO\\nmouse\\tO\\n7C\\tO\\nregions\\tO\\n,\\tO\\nin\\tO\\nclose\\tO\\nproximity\\tO\\nto\\tO\\nNDN\\tO\\n/\\tO\\nNdn\\tO\\n.\\tO\\n\\nBy\\tO\\nnorthern\\tO\\nblot\\tO\\nanalysis\\tO\\nwe\\tO\\ndid\\tO\\nnot\\tO\\ndetect\\tO\\nany\\tO\\nexpression\\tO\\nof\\tO\\nMAGEL2\\tO\\n/\\tO\\nMagel2\\tO\\nbut\\tO\\nby\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nanalysis\\tO\\n,\\tO\\nspecific\\tO\\nexpression\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nfetal\\tO\\nand\\tO\\nadult\\tO\\nbrain\\tO\\nand\\tO\\nin\\tO\\nplacenta\\tO\\n.\\tO\\n\\nBoth\\tO\\ngenes\\tO\\nare\\tO\\nintronless\\tO\\nwith\\tO\\ntandem\\tO\\ndirect\\tO\\nrepeat\\tO\\nsequences\\tO\\ncontained\\tO\\nwithin\\tO\\na\\tO\\nCpG\\tO\\nisland\\tO\\nin\\tO\\nthe\\tO\\n5\\tO\\n-\\tO\\nuntranscribed\\tO\\nregion\\tO\\n.\\tO\\n\\nThe\\tO\\ntranscripts\\tO\\nencode\\tO\\nputative\\tO\\nproteins\\tO\\nthat\\tO\\nare\\tO\\nhomologous\\tO\\nto\\tO\\nthe\\tO\\nMAGE\\tO\\nproteins\\tO\\nand\\tO\\nNDN\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nMAGEL2\\tO\\n/\\tO\\nMagel2\\tO\\nare\\tO\\nexpressed\\tO\\nonly\\tO\\nfrom\\tO\\nthe\\tO\\npaternal\\tO\\nallele\\tO\\nin\\tO\\nbrain\\tO\\n,\\tO\\nsuggesting\\tO\\na\\tO\\npotential\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\naetiology\\tO\\nof\\tO\\nPWS\\tB-Disease\\nand\\tO\\nits\\tO\\nmouse\\tO\\nmodel\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n.\\tO\\n\\ncDNA\\tO\\nmicroarrays\\tO\\ndetect\\tO\\nactivation\\tO\\nof\\tO\\na\\tO\\nmyogenic\\tO\\ntranscription\\tO\\nprogram\\tO\\nby\\tO\\nthe\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nfusion\\tO\\noncogene\\tO\\n.\\tO\\n\\nAlveolar\\tB-Disease\\nrhabdomyosarcoma\\tI-Disease\\nis\\tO\\nan\\tO\\naggressive\\tO\\npediatric\\tB-Disease\\ncancer\\tI-Disease\\nof\\tI-Disease\\nstriated\\tI-Disease\\nmuscle\\tI-Disease\\ncharacterized\\tO\\nin\\tO\\n60\\tO\\n%\\tO\\nof\\tO\\ncases\\tO\\nby\\tO\\na\\tO\\nt\\tO\\n(\\tO\\n2\\tO\\n;\\tO\\n13\\tO\\n)\\tO\\n(\\tO\\nq35\\tO\\n;\\tO\\nq14\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nresults\\tO\\nin\\tO\\nthe\\tO\\nfusion\\tO\\nof\\tO\\nPAX3\\tO\\n,\\tO\\na\\tO\\ndevelopmental\\tO\\ntranscription\\tO\\nfactor\\tO\\nrequired\\tO\\nfor\\tO\\nlimb\\tO\\nmyogenesis\\tO\\n,\\tO\\nwith\\tO\\nFKHR\\tO\\n,\\tO\\na\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\nforkhead\\tO\\nfamily\\tO\\nof\\tO\\ntranscription\\tO\\nfactors\\tO\\n.\\tO\\n\\nThe\\tO\\nresultant\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\ngene\\tO\\npossesses\\tO\\ntransforming\\tO\\nproperties\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nthe\\tO\\neffects\\tO\\nof\\tO\\nthis\\tO\\nchimeric\\tO\\noncogene\\tO\\non\\tO\\ngene\\tO\\nexpression\\tO\\nare\\tO\\nlargely\\tO\\nunknown\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nthe\\tO\\nactions\\tO\\nof\\tO\\nthese\\tO\\ntranscription\\tO\\nfactors\\tO\\n,\\tO\\nboth\\tO\\nPax3\\tO\\nand\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nwere\\tO\\nintroduced\\tO\\ninto\\tO\\nNIH\\tO\\n3T3\\tO\\ncells\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nresultant\\tO\\ngene\\tO\\nexpression\\tO\\nchanges\\tO\\nwere\\tO\\nanalyzed\\tO\\nwith\\tO\\na\\tO\\nmurine\\tO\\ncDNA\\tO\\nmicroarray\\tO\\ncontaining\\tO\\n2\\tO\\n,\\tO\\n225\\tO\\nelements\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nthat\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nbut\\tO\\nnot\\tO\\nPAX3\\tO\\nactivated\\tO\\na\\tO\\nmyogenic\\tO\\ntranscription\\tO\\nprogram\\tO\\nincluding\\tO\\nthe\\tO\\ninduction\\tO\\nof\\tO\\ntranscription\\tO\\nfactors\\tO\\nMyoD\\tO\\n,\\tO\\nMyogenin\\tO\\n,\\tO\\nSix1\\tO\\n,\\tO\\nand\\tO\\nSlug\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\na\\tO\\nbattery\\tO\\nof\\tO\\ngenes\\tO\\ninvolved\\tO\\nin\\tO\\nseveral\\tO\\naspects\\tO\\nof\\tO\\nmuscle\\tO\\nfunction\\tO\\n.\\tO\\n\\nNotable\\tO\\namong\\tO\\nthis\\tO\\ngroup\\tO\\nwere\\tO\\nthe\\tO\\ngrowth\\tO\\nfactor\\tO\\ngene\\tO\\nIgf2\\tO\\nand\\tO\\nits\\tO\\nbinding\\tO\\nprotein\\tO\\nIgfbp5\\tO\\n.\\tO\\n\\nRelevance\\tO\\nof\\tO\\nthis\\tO\\nmodel\\tO\\nwas\\tO\\nsuggested\\tO\\nby\\tO\\nverification\\tO\\nthat\\tO\\nthree\\tO\\nof\\tO\\nthese\\tO\\ngenes\\tO\\n(\\tO\\nIGFBP5\\tO\\n,\\tO\\nHSIX1\\tO\\n,\\tO\\nand\\tO\\nSlug\\tO\\n)\\tO\\nwere\\tO\\nalso\\tO\\nexpressed\\tO\\nin\\tO\\nalveolar\\tB-Disease\\nrhabdomyosarcoma\\tI-Disease\\ncell\\tO\\nlines\\tO\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\nutilizes\\tO\\ncDNA\\tO\\nmicroarrays\\tO\\nto\\tO\\nelucidate\\tO\\nthe\\tO\\npattern\\tO\\nof\\tO\\ngene\\tO\\nexpression\\tO\\ninduced\\tO\\nby\\tO\\nan\\tO\\noncogenic\\tO\\ntranscription\\tO\\nfactor\\tO\\nand\\tO\\ndemonstrates\\tO\\nthe\\tO\\nprofound\\tO\\nmyogenic\\tO\\nproperties\\tO\\nof\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nin\\tO\\nNIH\\tO\\n3T3\\tO\\ncells\\tO\\n.\\tO\\n.\\tO\\n\\nExperimental\\tO\\nhemochromatosis\\tB-Disease\\ndue\\tO\\nto\\tO\\nMHC\\tO\\nclass\\tO\\nI\\tO\\nHFE\\tB-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\nimmune\\tO\\nstatus\\tO\\nand\\tO\\niron\\tO\\nmetabolism\\tO\\n.\\tO\\n\\nThe\\tO\\npuzzling\\tO\\nlinkage\\tO\\nbetween\\tO\\ngenetic\\tO\\nhemochromatosis\\tB-Disease\\nand\\tO\\nhistocompatibility\\tO\\nloci\\tO\\nbecame\\tO\\neven\\tO\\nmore\\tO\\nso\\tO\\nwhen\\tO\\nthe\\tO\\ngene\\tO\\ninvolved\\tO\\n,\\tO\\nHFE\\tO\\n,\\tO\\nwas\\tO\\nidentified\\tO\\n.\\tO\\n\\nIndeed\\tO\\n,\\tO\\nwithin\\tO\\nthe\\tO\\nwell\\tO\\ndefined\\tO\\n,\\tO\\nmainly\\tO\\npeptide\\tO\\n-\\tO\\nbinding\\tO\\n,\\tO\\nMHC\\tO\\nclass\\tO\\nI\\tO\\nfamily\\tO\\nof\\tO\\nmolecules\\tO\\n,\\tO\\nHFE\\tO\\nseems\\tO\\nto\\tO\\nperform\\tO\\nan\\tO\\nunusual\\tO\\nyet\\tO\\nessential\\tO\\nfunction\\tO\\n.\\tO\\n\\nAs\\tO\\nyet\\tO\\n,\\tO\\nour\\tO\\nunderstanding\\tO\\nof\\tO\\nHFE\\tO\\nfunction\\tO\\nin\\tO\\niron\\tO\\nhomeostasis\\tO\\nis\\tO\\nonly\\tO\\npartial\\tO\\n;\\tO\\nan\\tO\\neven\\tO\\nmore\\tO\\nopen\\tO\\nquestion\\tO\\nis\\tO\\nits\\tO\\npossible\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\nimmune\\tO\\nsystem\\tO\\n.\\tO\\n\\nTo\\tO\\nadvance\\tO\\non\\tO\\nboth\\tO\\nof\\tO\\nthese\\tO\\navenues\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\ndeletion\\tO\\nof\\tO\\nHFE\\tO\\nalpha1\\tO\\nand\\tO\\nalpha2\\tO\\nputative\\tO\\nligand\\tO\\nbinding\\tO\\ndomains\\tO\\nin\\tO\\nvivo\\tO\\n.\\tO\\n\\nHFE\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nanimals\\tO\\nwere\\tO\\nanalyzed\\tO\\nfor\\tO\\na\\tO\\ncomprehensive\\tO\\nset\\tO\\nof\\tO\\nmetabolic\\tO\\nand\\tO\\nimmune\\tO\\nparameters\\tO\\n.\\tO\\n\\nFaithfully\\tO\\nmimicking\\tO\\nhuman\\tO\\nhemochromatosis\\tB-Disease\\n,\\tO\\nmice\\tO\\nhomozygous\\tO\\nfor\\tO\\nthis\\tO\\ndeletion\\tO\\ndevelop\\tO\\niron\\tO\\noverload\\tO\\n,\\tO\\ncharacterized\\tO\\nby\\tO\\na\\tO\\nhigher\\tO\\nplasma\\tO\\niron\\tO\\ncontent\\tO\\nand\\tO\\na\\tO\\nraised\\tO\\ntransferrin\\tO\\nsaturation\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nan\\tO\\nelevated\\tO\\nhepatic\\tO\\niron\\tO\\nload\\tO\\n.\\tO\\n\\nThe\\tO\\nprimary\\tO\\ndefect\\tO\\ncould\\tO\\n,\\tO\\nindeed\\tO\\n,\\tO\\nbe\\tO\\ntraced\\tO\\nto\\tO\\nan\\tO\\naugmented\\tO\\nduodenal\\tO\\niron\\tO\\nabsorption\\tO\\n.\\tO\\n\\nIn\\tO\\nparallel\\tO\\n,\\tO\\nmeasurement\\tO\\nof\\tO\\nthe\\tO\\ngut\\tO\\nmucosal\\tO\\niron\\tO\\ncontent\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\niron\\tO\\nregulatory\\tO\\nproteins\\tO\\nallows\\tO\\na\\tO\\nmore\\tO\\ninformed\\tO\\nevaluation\\tO\\nof\\tO\\nvarious\\tO\\nhypotheses\\tO\\nregarding\\tO\\nthe\\tO\\nprecise\\tO\\nrole\\tO\\nof\\tO\\nHFE\\tO\\nin\\tO\\niron\\tO\\nhomeostasis\\tO\\n.\\tO\\n\\nFinally\\tO\\n,\\tO\\nan\\tO\\nextensive\\tO\\nphenotyping\\tO\\nof\\tO\\nprimary\\tO\\nand\\tO\\nsecondary\\tO\\nlymphoid\\tO\\norgans\\tO\\nincluding\\tO\\nthe\\tO\\ngut\\tO\\nprovides\\tO\\nno\\tO\\ncompelling\\tO\\nevidence\\tO\\nfor\\tO\\nan\\tO\\nobvious\\tO\\nimmune\\tO\\n-\\tO\\nlinked\\tO\\nfunction\\tO\\nfor\\tO\\nHFE\\tO\\n.\\tO\\n.\\tO\\n\\nSomatic\\tO\\nrearrangement\\tO\\nof\\tO\\nchromosome\\tO\\n14\\tO\\nin\\tO\\nhuman\\tO\\nlymphocytes\\tO\\n.\\tO\\n\\nAtaxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\ngenetic\\tB-Disease\\ndisorder\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nimmune\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nchromosome\\tB-Disease\\ninstability\\tI-Disease\\n,\\tO\\nand\\tO\\na\\tO\\npredisposition\\tO\\nto\\tO\\nlymphoid\\tB-Disease\\nmalignancy\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndetected\\tO\\nchromosomally\\tO\\nanomalous\\tO\\nclones\\tO\\nof\\tO\\nlymphocytes\\tO\\nin\\tO\\neight\\tO\\npatients\\tO\\nwith\\tO\\nthis\\tO\\ndisorder\\tO\\n.\\tO\\n\\nChromosome\\tO\\nbanding\\tO\\ndisclosed\\tO\\nthat\\tO\\nthe\\tO\\nclones\\tO\\nare\\tO\\nconsistently\\tO\\nmarked\\tO\\nby\\tO\\nstructural\\tO\\nrearrangement\\tO\\nof\\tO\\nthe\\tO\\nlong\\tO\\narm\\tO\\n(\\tO\\nq\\tO\\n)\\tO\\nof\\tO\\nchromosome\\tO\\n14\\tO\\n.\\tO\\n\\nA\\tO\\ntranslocation\\tO\\ninvolving\\tO\\n14q\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nclones\\tO\\nobtained\\tO\\nfrom\\tO\\nseven\\tO\\nof\\tO\\nthe\\tO\\neight\\tO\\npatients\\tO\\nwhereas\\tO\\na\\tO\\nring\\tO\\n14\\tO\\nchromosome\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\na\\tO\\nclone\\tO\\nobtained\\tO\\nfrom\\tO\\nthe\\tO\\nother\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\ndata\\tO\\nobtained\\tO\\nby\\tO\\nothers\\tO\\nfor\\tO\\npatients\\tO\\nwith\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nsuggest\\tO\\nthat\\tO\\nstructural\\tO\\nrearrangement\\tO\\nof\\tO\\n14q\\tO\\nis\\tO\\nthe\\tO\\ninitial\\tO\\nchromosomal\\tO\\nchange\\tO\\nin\\tO\\nlymphocyte\\tO\\nclones\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nthis\\tO\\ndisorder\\tO\\n.\\tO\\n\\nChromosomes\\tO\\nof\\tO\\nlymphocytes\\tO\\nfrom\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nwere\\tO\\nstudied\\tO\\nbefore\\tO\\nand\\tO\\nafter\\tO\\nthe\\tO\\nonset\\tO\\nof\\tO\\nchronic\\tB-Disease\\nlymphocytic\\tI-Disease\\nleukemia\\tI-Disease\\n.\\tO\\n\\nBefore\\tO\\nleukemia\\tB-Disease\\nwas\\tO\\ndiagnosed\\tO\\n,\\tO\\nthe\\tO\\npatient\\tO\\nhad\\tO\\na\\tO\\nlymphocyte\\tO\\nclone\\tO\\nwith\\tO\\na\\tO\\n14q\\tO\\ntranslocation\\tO\\n.\\tO\\n\\nThis\\tO\\nclone\\tO\\nappears\\tO\\nto\\tO\\nhave\\tO\\ngiven\\tO\\nrise\\tO\\nto\\tO\\nthe\\tO\\nleukemic\\tB-Disease\\ncells\\tO\\n.\\tO\\n\\nWe\\tO\\nhypothesize\\tO\\nthat\\tO\\nstructural\\tO\\nrearrangement\\tO\\nof\\tO\\n14q\\tO\\nis\\tO\\ndirectly\\tO\\nrelated\\tO\\nto\\tO\\nabnormal\\tO\\ngrowth\\tO\\nof\\tO\\nlymphocytes\\tO\\nand\\tO\\nthat\\tO\\nit\\tO\\nmay\\tO\\nbe\\tO\\na\\tO\\nstep\\tO\\ntoward\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nlymphoid\\tB-Disease\\nmalignancies\\tI-Disease\\n.\\tO\\n\\nIncreasing\\tO\\nevidence\\tO\\n,\\tO\\nprovided\\tO\\nby\\tO\\nothers\\tO\\n,\\tO\\nfor\\tO\\nthe\\tO\\nnonrandom\\tO\\ninvolvement\\tO\\nof\\tO\\n14q\\tO\\nin\\tO\\nAfrican\\tO\\n-\\tO\\ntype\\tO\\nBurkitts\\tB-Disease\\nlymphoma\\tI-Disease\\nand\\tO\\nother\\tO\\nlymphoid\\tB-Disease\\nneoplasms\\tI-Disease\\nfurther\\tO\\nstrengthens\\tO\\nthis\\tO\\nhypothesis\\tO\\n.\\tO\\n.\\tO\\n\\nExon\\tO\\n9\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nWT1\\tO\\ngene\\tO\\n,\\tO\\nwithout\\tO\\ninfluencing\\tO\\nKTS\\tO\\nsplice\\tO\\nisoforms\\tO\\n,\\tO\\nare\\tO\\nalso\\tO\\nresponsible\\tO\\nfor\\tO\\nFrasier\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nnew\\tO\\nmutations\\tO\\nin\\tO\\nexon\\tO\\n9\\tO\\nof\\tO\\nthe\\tO\\nWT1\\tO\\ngene\\tO\\nthat\\tO\\ndid\\tO\\nnot\\tO\\nalter\\tO\\nthe\\tO\\nratio\\tO\\nof\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\nKTS\\tO\\nsplice\\tO\\nisoforms\\tO\\nin\\tO\\ntwo\\tO\\nunrelated\\tO\\npatients\\tO\\nwith\\tO\\nFrasier\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nFS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nof\\tO\\nintron\\tO\\n9\\tO\\ninducing\\tO\\ndefective\\tO\\nalternative\\tO\\nsplicing\\tO\\nwas\\tO\\nreported\\tO\\nto\\tO\\nbe\\tO\\nresponsible\\tO\\nfor\\tO\\nthis\\tO\\nsyndrome\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\nfound\\tO\\nin\\tO\\nour\\tO\\ncases\\tO\\noccurred\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\nexon\\tO\\nof\\tO\\nthe\\tO\\nWT1\\tO\\ngene\\tO\\nas\\tO\\ndetected\\tO\\nin\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nDDS\\tB-Disease\\n)\\tO\\nand\\tO\\ncould\\tO\\nnot\\tO\\nbe\\tO\\nexplained\\tO\\nby\\tO\\nthe\\tO\\npreviously\\tO\\nproposed\\tO\\nmechanism\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\ntwo\\tO\\nsyndromes\\tO\\noriginate\\tO\\nfrom\\tO\\nthe\\tO\\nsame\\tO\\nWT1\\tB-Disease\\ngene\\tI-Disease\\nabnormality\\tI-Disease\\n.\\tO\\n\\nFrom\\tO\\na\\tO\\nmolecular\\tO\\nbiological\\tO\\npoint\\tO\\nof\\tO\\nview\\tO\\n,\\tO\\nwe\\tO\\nconcluded\\tO\\nthat\\tO\\nthe\\tO\\ntwo\\tO\\ndiseases\\tO\\nwere\\tO\\nnot\\tO\\nseparable\\tO\\n,\\tO\\nand\\tO\\nthat\\tO\\nFS\\tB-Disease\\nshould\\tO\\nbe\\tO\\nincluded\\tO\\nas\\tO\\nan\\tO\\natypical\\tO\\nform\\tO\\nof\\tO\\nDDS\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nSplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\nmay\\tO\\nresult\\tO\\nin\\tO\\nintrafamilial\\tO\\nvariability\\tO\\nfor\\tO\\ndeafness\\tB-Disease\\nin\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\nrecessive\\tB-Disease\\ninherited\\tI-Disease\\ndisorder\\tI-Disease\\nthat\\tO\\nconsists\\tO\\nof\\tO\\ndevelopmental\\tB-Disease\\nabnormalities\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\ncochlea\\tI-Disease\\n,\\tO\\nsensorineural\\tB-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\n,\\tO\\nand\\tO\\ndiffuse\\tB-Disease\\nthyroid\\tI-Disease\\nenlargement\\tI-Disease\\n(\\tO\\ngoiter\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\ndisorder\\tO\\nmay\\tO\\naccount\\tO\\nfor\\tO\\nup\\tO\\nto\\tO\\n10\\tO\\n%\\tO\\nof\\tO\\ncases\\tO\\nof\\tO\\nhereditary\\tB-Disease\\ndeafness\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ndisease\\tO\\ngene\\tO\\n(\\tO\\nPDS\\tB-Disease\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nchromosome\\tO\\n7q22\\tO\\n-\\tO\\nq31\\tO\\n,\\tO\\nand\\tO\\nencodes\\tO\\na\\tO\\nchloride\\tO\\n-\\tO\\niodide\\tO\\ntransport\\tO\\nprotein\\tO\\n.\\tO\\n\\nWe\\tO\\nperformed\\tO\\nmutation\\tO\\nanalysis\\tO\\nof\\tO\\nindividual\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\nin\\tO\\none\\tO\\nSpanish\\tO\\nfamily\\tO\\nthat\\tO\\nshows\\tO\\nintrafamilial\\tO\\nvariability\\tO\\nof\\tO\\nthe\\tO\\ndeafness\\tB-Disease\\nphenotype\\tO\\n(\\tO\\ntwo\\tO\\npatients\\tO\\nwith\\tO\\nprofound\\tO\\nand\\tO\\none\\tO\\nwith\\tO\\nmoderate\\tO\\n-\\tO\\nsevere\\tO\\ndeafness\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\na\\tO\\nnew\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\naffecting\\tO\\nintron\\tO\\n4\\tO\\nof\\tO\\nthe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\n,\\tO\\nat\\tO\\nnucleotide\\tO\\nposition\\tO\\n639\\tO\\n+\\tO\\n7\\tO\\n.\\tO\\n\\nRNA\\tO\\nanalysis\\tO\\nfrom\\tO\\nlymphocytes\\tO\\nof\\tO\\nthe\\tO\\naffected\\tO\\npatients\\tO\\nshowed\\tO\\nthat\\tO\\nmutation\\tO\\n639\\tO\\n+\\tO\\n7A\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\ngenerates\\tO\\na\\tO\\nnew\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\n,\\tO\\nleading\\tO\\nto\\tO\\nan\\tO\\nmRNA\\tO\\nwith\\tO\\nan\\tO\\ninsertion\\tO\\nof\\tO\\nsix\\tO\\nnucleotides\\tO\\nfrom\\tO\\nintron\\tO\\n4\\tO\\nof\\tO\\nPDS\\tO\\n.\\tO\\n\\nSince\\tO\\nthe\\tO\\nnewly\\tO\\ncreated\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\nis\\tO\\nlikely\\tO\\nto\\tO\\ncompete\\tO\\nwith\\tO\\nthe\\tO\\nnormal\\tO\\none\\tO\\n,\\tO\\nvariations\\tO\\nof\\tO\\nthe\\tO\\nlevels\\tO\\nof\\tO\\nnormal\\tO\\nand\\tO\\naberrant\\tO\\ntranscripts\\tO\\nof\\tO\\nthe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\nin\\tO\\nthe\\tO\\ncochlea\\tO\\nmay\\tO\\nexplain\\tO\\nthe\\tO\\nvariability\\tO\\nin\\tO\\nthe\\tO\\ndeafness\\tB-Disease\\npresentation\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nSjogren\\tB-Disease\\n-\\tI-Disease\\nLarsson\\tI-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\nmutation\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nfatty\\tO\\naldehyde\\tO\\ndehydrogenase\\tO\\ngene\\tO\\n.\\tO\\n\\nSjogren\\tB-Disease\\n-\\tI-Disease\\nLarsson\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nSLS\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nichthyosis\\tB-Disease\\n,\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\nspasticity\\tB-Disease\\n,\\tO\\nand\\tO\\ndeficient\\tB-Disease\\nactivity\\tI-Disease\\nof\\tI-Disease\\nfatty\\tI-Disease\\naldehyde\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tO\\nFALDH\\tO\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\ndefine\\tO\\nthe\\tO\\nmolecular\\tO\\ndefects\\tO\\ncausing\\tO\\nSLS\\tB-Disease\\n,\\tO\\nwe\\tO\\nperformed\\tO\\nmutation\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nFALDH\\tO\\ngene\\tO\\nin\\tO\\nprobands\\tO\\nfrom\\tO\\n63\\tO\\nkindreds\\tO\\nwith\\tO\\nSLS\\tB-Disease\\n.\\tO\\n\\nAmong\\tO\\nthese\\tO\\npatients\\tO\\n,\\tO\\n49\\tO\\ndifferent\\tO\\nmutations\\tO\\n-\\tO\\nincluding\\tO\\n10\\tO\\ndeletions\\tO\\n,\\tO\\n2\\tO\\ninsertions\\tO\\n,\\tO\\n22\\tO\\namino\\tO\\nacid\\tO\\nsubstitutions\\tO\\n,\\tO\\n3\\tO\\nnonsense\\tO\\nmutations\\tO\\n,\\tO\\n9\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\ndefects\\tO\\n,\\tO\\nand\\tO\\n3\\tO\\ncomplex\\tO\\nmutations\\tO\\n-\\tO\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nAll\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nwith\\tO\\nSLS\\tB-Disease\\nwere\\tO\\nfound\\tO\\nto\\tO\\ncarry\\tO\\nmutations\\tO\\n.\\tO\\n\\nNineteen\\tO\\nof\\tO\\nthe\\tO\\nmissense\\tO\\nmutations\\tO\\nresulted\\tO\\nin\\tO\\na\\tO\\nsevere\\tO\\nreduction\\tO\\nof\\tO\\nFALDH\\tO\\nenzyme\\tO\\ncatalytic\\tO\\nactivity\\tO\\nwhen\\tO\\nexpressed\\tO\\nin\\tO\\nmammalian\\tO\\ncells\\tO\\n,\\tO\\nbut\\tO\\none\\tO\\nmutation\\tO\\n(\\tO\\n798G\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\n[\\tO\\nK266N\\tO\\n]\\tO\\n)\\tO\\nseemed\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\ngreater\\tO\\neffect\\tO\\non\\tO\\nmRNA\\tO\\nstability\\tO\\n.\\tO\\n\\nThe\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutations\\tO\\nled\\tO\\nto\\tO\\nexon\\tO\\nskipping\\tO\\nor\\tO\\nutilization\\tO\\nof\\tO\\ncryptic\\tO\\nacceptor\\tO\\n-\\tO\\nsplice\\tO\\nsites\\tO\\n.\\tO\\n\\nThirty\\tO\\n-\\tO\\nseven\\tO\\nmutations\\tO\\nwere\\tO\\nprivate\\tO\\n,\\tO\\nand\\tO\\n12\\tO\\nmutations\\tO\\nwere\\tO\\nseen\\tO\\nin\\tO\\ntwo\\tO\\nor\\tO\\nmore\\tO\\nprobands\\tO\\nof\\tO\\nEuropean\\tO\\nor\\tO\\nMiddle\\tO\\nEastern\\tO\\ndescent\\tO\\n.\\tO\\n\\nFour\\tO\\nsingle\\tO\\n-\\tO\\nnucleotide\\tO\\npolymorphisms\\tO\\n(\\tO\\nSNPs\\tO\\n)\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nFALDH\\tO\\ngene\\tO\\n.\\tO\\n\\nAt\\tO\\nleast\\tO\\nfour\\tO\\nof\\tO\\nthe\\tO\\ncommon\\tO\\nmutations\\tO\\n(\\tO\\n551C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n,\\tO\\n682C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n,\\tO\\n733G\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n,\\tO\\nand\\tO\\n798\\tO\\n+\\tO\\n1delG\\tO\\n)\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\nmultiple\\tO\\nSNP\\tO\\nhaplotypes\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthese\\tO\\nmutations\\tO\\noriginated\\tO\\nindependently\\tO\\non\\tO\\nmore\\tO\\nthan\\tO\\none\\tO\\noccasion\\tO\\nor\\tO\\nwere\\tO\\nancient\\tO\\nSLS\\tB-Disease\\ngenes\\tO\\nthat\\tO\\nhad\\tO\\nundergone\\tO\\nintragenic\\tO\\nrecombination\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\ndemonstrate\\tO\\nthat\\tO\\nSLS\\tB-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\nstrikingly\\tO\\nheterogeneous\\tO\\ngroup\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nFALDH\\tO\\ngene\\tO\\nand\\tO\\nprovide\\tO\\na\\tO\\nframework\\tO\\nfor\\tO\\nunderstanding\\tO\\nthe\\tO\\ngenetic\\tO\\nbasis\\tO\\nof\\tO\\nSLS\\tB-Disease\\nand\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nDNA\\tO\\n-\\tO\\nbased\\tO\\ndiagnostic\\tO\\ntests\\tO\\n.\\tO\\n.\\tO\\n\\nLoss\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\nfunction\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ncathepsin\\tO\\nC\\tO\\ngene\\tO\\nresult\\tO\\nin\\tO\\nperiodontal\\tB-Disease\\ndisease\\tI-Disease\\nand\\tO\\npalmoplantar\\tB-Disease\\nkeratosis\\tI-Disease\\n.\\tO\\n\\nPapillon\\tB-Disease\\n-\\tI-Disease\\nLefevre\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nor\\tO\\nkeratosis\\tB-Disease\\npalmoplantaris\\tI-Disease\\nwith\\tO\\nperiodontopathia\\tB-Disease\\n(\\tO\\nPLS\\tB-Disease\\n,\\tO\\nMIM\\tO\\n245000\\tO\\n)\\tO\\n,\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\nthat\\tO\\nis\\tO\\nmainly\\tO\\nascertained\\tO\\nby\\tO\\ndentists\\tO\\nbecause\\tO\\nof\\tO\\nthe\\tO\\nsevere\\tO\\nperiodontitis\\tB-Disease\\nthat\\tO\\nafflicts\\tO\\npatients\\tO\\n.\\tO\\n\\nBoth\\tO\\nthe\\tO\\ndeciduous\\tO\\nand\\tO\\npermanent\\tO\\ndentitions\\tO\\nare\\tO\\naffected\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\npremature\\tO\\ntooth\\tB-Disease\\nloss\\tI-Disease\\n.\\tO\\n\\nPalmoplantar\\tB-Disease\\nkeratosis\\tI-Disease\\n,\\tO\\nvarying\\tO\\nfrom\\tO\\nmild\\tO\\npsoriasiform\\tO\\nscaly\\tO\\nskin\\tO\\nto\\tO\\novert\\tO\\nhyperkeratosis\\tB-Disease\\n,\\tO\\ntypically\\tO\\ndevelops\\tO\\nwithin\\tO\\nthe\\tO\\nfirst\\tO\\nthree\\tO\\nyears\\tO\\nof\\tO\\nlife\\tO\\n.\\tO\\n\\nKeratosis\\tB-Disease\\nalso\\tO\\naffects\\tO\\nother\\tO\\nsites\\tO\\nsuch\\tO\\nas\\tO\\nelbows\\tO\\nand\\tO\\nknees\\tO\\n.\\tO\\n\\nMost\\tO\\nPLS\\tB-Disease\\npatients\\tO\\ndisplay\\tO\\nboth\\tO\\nperiodontitis\\tB-Disease\\nand\\tO\\nhyperkeratosis\\tB-Disease\\n.\\tO\\n\\nSome\\tO\\npatients\\tO\\nhave\\tO\\nonly\\tO\\npalmoplantar\\tB-Disease\\nkeratosis\\tI-Disease\\nor\\tO\\nperiodontitis\\tB-Disease\\n,\\tO\\nand\\tO\\nin\\tO\\nrare\\tO\\nindividuals\\tO\\nthe\\tO\\nperiodontitis\\tB-Disease\\nis\\tO\\nmild\\tO\\nand\\tO\\nof\\tO\\nlate\\tO\\nonset\\tO\\n.\\tO\\n\\nThe\\tO\\nPLS\\tO\\nlocus\\tO\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nchromosome\\tO\\n11q14\\tO\\n-\\tO\\nq21\\tO\\n(\\tO\\nrefs\\tO\\n7\\tO\\n,\\tO\\n8\\tO\\n,\\tO\\n9\\tO\\n)\\tO\\n.\\tO\\n\\nUsing\\tO\\nhomozygosity\\tO\\nmapping\\tO\\nin\\tO\\neight\\tO\\nsmall\\tO\\nconsanguineous\\tO\\nfamilies\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nnarrowed\\tO\\nthe\\tO\\ncandidate\\tO\\nregion\\tO\\nto\\tO\\na\\tO\\n1\\tO\\n.\\tO\\n\\n2\\tO\\n-\\tO\\ncM\\tO\\ninterval\\tO\\nbetween\\tO\\nD11S4082\\tO\\nand\\tO\\nD11S931\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\n(\\tO\\nCTSC\\tO\\n)\\tO\\nencoding\\tO\\nthe\\tO\\nlysosomal\\tO\\nprotease\\tO\\ncathepsin\\tO\\nC\\tO\\n(\\tO\\nor\\tO\\ndipeptidyl\\tO\\naminopeptidase\\tO\\nI\\tO\\n)\\tO\\nlies\\tO\\nwithin\\tO\\nthis\\tO\\ninterval\\tO\\n.\\tO\\n\\nWe\\tO\\ndefined\\tO\\nthe\\tO\\ngenomic\\tO\\nstructure\\tO\\nof\\tO\\nCTSC\\tO\\nand\\tO\\nfound\\tO\\nmutations\\tO\\nin\\tO\\nall\\tO\\neight\\tO\\nfamilies\\tO\\n.\\tO\\n\\nIn\\tO\\ntwo\\tO\\nof\\tO\\nthese\\tO\\nfamilies\\tO\\nwe\\tO\\nused\\tO\\na\\tO\\nfunctional\\tO\\nassay\\tO\\nto\\tO\\ndemonstrate\\tO\\nan\\tO\\nalmost\\tO\\ntotal\\tO\\nloss\\tO\\nof\\tO\\ncathepsin\\tO\\nC\\tO\\nactivity\\tO\\nin\\tO\\nPLS\\tB-Disease\\npatients\\tO\\nand\\tO\\nreduced\\tO\\nactivity\\tO\\nin\\tO\\nobligate\\tO\\ncarriers\\tO\\n.\\tO\\n\\nConfirmation\\tO\\nof\\tO\\nlinkage\\tO\\nof\\tO\\nVan\\tB-Disease\\nder\\tI-Disease\\nWoude\\tI-Disease\\nsyndrome\\tI-Disease\\nto\\tO\\nchromosome\\tO\\n1q32\\tO\\n:\\tO\\nevidence\\tO\\nof\\tO\\nassociation\\tO\\nwith\\tO\\nSTR\\tO\\nalleles\\tO\\nsuggests\\tO\\npossible\\tO\\nunique\\tO\\norigin\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nmutation\\tO\\n.\\tO\\n\\nVan\\tB-Disease\\nder\\tI-Disease\\nWoude\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nVWS\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ncraniofacial\\tI-Disease\\ndisorder\\tI-Disease\\nwith\\tO\\nhigh\\tO\\npenetrance\\tO\\nand\\tO\\nvariable\\tO\\nexpression\\tO\\n.\\tO\\n\\nIts\\tO\\nclinical\\tO\\nfeatures\\tO\\nare\\tO\\nvariably\\tO\\nexpressed\\tO\\n,\\tO\\nbut\\tO\\ninclude\\tO\\ncleft\\tB-Disease\\nlip\\tI-Disease\\nand\\tO\\n/\\tO\\nor\\tO\\ncleft\\tB-Disease\\npalate\\tI-Disease\\n,\\tO\\nlip\\tB-Disease\\npits\\tI-Disease\\nand\\tO\\nhypodontia\\tB-Disease\\n.\\tO\\n\\nAll\\tO\\nVWS\\tB-Disease\\nfamilies\\tO\\nstudied\\tO\\nto\\tO\\ndate\\tO\\nmap\\tO\\nthe\\tO\\ndisease\\tO\\ngene\\tO\\nto\\tO\\na\\tO\\n<\\tO\\n2\\tO\\ncM\\tO\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n1q32\\tO\\n,\\tO\\nwith\\tO\\nno\\tO\\nevidence\\tO\\nof\\tO\\nlocus\\tO\\nheterogeneity\\tO\\n.\\tO\\n\\nThe\\tO\\naim\\tO\\nof\\tO\\nthis\\tO\\nstudy\\tO\\nis\\tO\\nto\\tO\\nrefine\\tO\\nthe\\tO\\nlocalization\\tO\\nof\\tO\\nthe\\tO\\nVWS\\tB-Disease\\ngene\\tO\\nand\\tO\\nto\\tO\\nfurther\\tO\\nassess\\tO\\npossible\\tO\\nheterogeneity\\tO\\n.\\tO\\n\\nWe\\tO\\nanalyzed\\tO\\nfour\\tO\\nmultiplex\\tO\\nVWS\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nAll\\tO\\navailable\\tO\\nmembers\\tO\\nwere\\tO\\nclinically\\tO\\nassessed\\tO\\nand\\tO\\ngenotyped\\tO\\nfor\\tO\\n19\\tO\\nshort\\tO\\ntandem\\tO\\nrepeat\\tO\\nmarkers\\tO\\non\\tO\\nchromosome\\tO\\n1\\tO\\nin\\tO\\nthe\\tO\\nVWS\\tB-Disease\\ncandidate\\tO\\ngene\\tO\\nregion\\tO\\n.\\tO\\n\\nWe\\tO\\nperformed\\tO\\ntwo\\tO\\n-\\tO\\npoint\\tO\\nand\\tO\\nmultipoint\\tO\\nlimit\\tO\\nof\\tO\\ndetection\\tO\\n(\\tO\\nLOD\\tO\\n)\\tO\\nscore\\tO\\nanalyses\\tO\\nusing\\tO\\na\\tO\\nhigh\\tO\\npenetrance\\tO\\nautosomal\\tO\\ndominant\\tO\\nmodel\\tO\\n.\\tO\\n\\nAll\\tO\\nfamilies\\tO\\nshowed\\tO\\npositive\\tO\\nLOD\\tO\\nscores\\tO\\nwithout\\tO\\nany\\tO\\nrecombination\\tO\\nin\\tO\\nthe\\tO\\ncandidate\\tO\\nregion\\tO\\n.\\tO\\n\\nThe\\tO\\nlargest\\tO\\ntwo\\tO\\n-\\tO\\npoint\\tO\\nLOD\\tO\\nscore\\tO\\nwas\\tO\\n5\\tO\\n.\\tO\\n\\n87\\tO\\n87\\tO\\n.\\tO\\n\\nOur\\tO\\nassay\\tO\\nmethod\\tO\\nfor\\tO\\nshort\\tO\\ntandem\\tO\\nrepeat\\tO\\n(\\tO\\nSTR\\tO\\n)\\tO\\nmarkers\\tO\\nprovided\\tO\\nhighly\\tO\\naccurate\\tO\\nsize\\tO\\nestimation\\tO\\nof\\tO\\nmarker\\tO\\nallele\\tO\\nfragment\\tO\\nsizes\\tO\\n,\\tO\\nand\\tO\\ntherefore\\tO\\nenabled\\tO\\nus\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\nspecific\\tO\\nalleles\\tO\\nsegregating\\tO\\nwith\\tO\\nthe\\tO\\nVWS\\tB-Disease\\ngene\\tO\\nin\\tO\\neach\\tO\\nof\\tO\\nour\\tO\\nfour\\tO\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nobserved\\tO\\na\\tO\\nstriking\\tO\\npattern\\tO\\nof\\tO\\nSTR\\tO\\nallele\\tO\\nsharing\\tO\\nat\\tO\\nseveral\\tO\\nclosely\\tO\\nlinked\\tO\\nloci\\tO\\namong\\tO\\nour\\tO\\nfour\\tO\\nCaucasian\\tO\\nVWS\\tB-Disease\\nfamilies\\tO\\nrecruited\\tO\\nat\\tO\\nthree\\tO\\ndifferent\\tO\\nlocations\\tO\\nin\\tO\\nthe\\tO\\nUS\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthe\\tO\\npossibility\\tO\\nof\\tO\\na\\tO\\nunique\\tO\\norigin\\tO\\nfor\\tO\\na\\tO\\nmutation\\tO\\nresponsible\\tO\\nfor\\tO\\nmany\\tO\\nor\\tO\\nmost\\tO\\ncases\\tO\\nof\\tO\\nVWS\\tB-Disease\\n.\\tO\\n\\nA\\tO\\npoint\\tO\\nmutation\\tO\\nThr\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nMet\\tO\\non\\tO\\nthe\\tO\\nalpha\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nintegrin\\tO\\nleads\\tO\\nto\\tO\\nthe\\tO\\nformation\\tO\\nof\\tO\\nnew\\tO\\nhuman\\tO\\nplatelet\\tO\\nalloantigen\\tO\\nSit\\tO\\n(\\tO\\na\\tO\\n)\\tO\\nand\\tO\\naffects\\tO\\ncollagen\\tO\\n-\\tO\\ninduced\\tO\\naggregation\\tO\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nplatelet\\tO\\n-\\tO\\nspecific\\tO\\nalloantigen\\tO\\n,\\tO\\ntermed\\tO\\nSit\\tO\\n(\\tO\\na\\tO\\n)\\tO\\n,\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\na\\tO\\nsevere\\tO\\ncase\\tO\\nof\\tO\\nneonatal\\tB-Disease\\nalloimmune\\tI-Disease\\nthrombocytopenia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nSit\\tO\\n(\\tO\\na\\tO\\n)\\tO\\nalloantigen\\tO\\nis\\tO\\nof\\tO\\nlow\\tO\\nfrequency\\tO\\n(\\tO\\n1\\tO\\n/\\tO\\n400\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nGerman\\tO\\npopulation\\tO\\n.\\tO\\n\\nImmunochemical\\tO\\nstudies\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nSit\\tO\\n(\\tO\\na\\tO\\n)\\tO\\nepitopes\\tO\\nreside\\tO\\non\\tO\\nplatelet\\tO\\nglycoprotein\\tO\\n(\\tO\\nGP\\tO\\n)\\tO\\nIa\\tO\\n.\\tO\\n\\nNucleotide\\tO\\nsequence\\tO\\nanalysis\\tO\\nof\\tO\\nGPIa\\tO\\ncDNA\\tO\\nderived\\tO\\nfrom\\tO\\nSit\\tO\\n(\\tO\\na\\tO\\n)\\tO\\n-\\tO\\npositive\\tO\\nplatelets\\tO\\nshowed\\tO\\nC\\tO\\n(\\tO\\n2531\\tO\\n)\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n(\\tO\\n2531\\tO\\n)\\tO\\npoint\\tO\\nmutation\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nThr\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nMet\\tO\\ndimorphism\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\ngenomic\\tO\\nDNA\\tO\\nfrom\\tO\\n22\\tO\\nSit\\tO\\n(\\tO\\na\\tO\\n)\\tO\\n-\\tO\\nnegative\\tO\\nnormal\\tO\\nindividuals\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nThr\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nis\\tO\\nencoded\\tO\\nby\\tO\\nACG\\tO\\n(\\tO\\n2532\\tO\\n)\\tO\\n(\\tO\\n90\\tO\\n.\\tO\\n9\\tO\\n%\\tO\\n)\\tO\\nor\\tO\\nACA\\tO\\n(\\tO\\n2532\\tO\\n)\\tO\\n(\\tO\\n9\\tO\\n.\\tO\\n1\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\nestablish\\tO\\na\\tO\\nDNA\\tO\\ntyping\\tO\\ntechnique\\tO\\n,\\tO\\nwe\\tO\\nelucidated\\tO\\nthe\\tO\\norganization\\tO\\nof\\tO\\nthe\\tO\\nGPIa\\tO\\ngene\\tO\\nadjacent\\tO\\nto\\tO\\nthe\\tO\\npolymorphic\\tO\\nbases\\tO\\n.\\tO\\n\\nThe\\tO\\nintrons\\tO\\n(\\tO\\n421\\tO\\nbp\\tO\\nand\\tO\\n1\\tO\\n.\\tO\\n2\\tO\\nkb\\tO\\n)\\tO\\nencompass\\tO\\na\\tO\\n142\\tO\\n-\\tO\\nbp\\tO\\nexon\\tO\\nwith\\tO\\nthe\\tO\\n2\\tO\\npolymorphic\\tO\\nbases\\tO\\n2531\\tO\\nand\\tO\\n2532\\tO\\n.\\tO\\n\\nPolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n-\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphism\\tO\\nanalysis\\tO\\non\\tO\\nDNA\\tO\\nderived\\tO\\nfrom\\tO\\n100\\tO\\ndonors\\tO\\nusing\\tO\\nthe\\tO\\nrestriction\\tO\\nenzyme\\tO\\nMae\\tO\\nIII\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nMet\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nform\\tO\\nof\\tO\\nGPIa\\tO\\nis\\tO\\nrestricted\\tO\\nto\\tO\\nSit\\tO\\n(\\tO\\na\\tO\\n)\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\nphenotype\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nstable\\tO\\nChinese\\tO\\nhamster\\tO\\novary\\tO\\ntransfectants\\tO\\nexpressing\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\nrecombinant\\tO\\nforms\\tO\\nof\\tO\\nGPIa\\tO\\nshowed\\tO\\nthat\\tO\\nanti\\tO\\n-\\tO\\nSit\\tO\\n(\\tO\\na\\tO\\n)\\tO\\nexclusively\\tO\\nreacted\\tO\\nwith\\tO\\nthe\\tO\\nGlu\\tO\\n(\\tO\\n505\\tO\\n)\\tO\\nMet\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nwith\\tO\\nthe\\tO\\nGlu\\tO\\n(\\tO\\n505\\tO\\n)\\tO\\nThr\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nLys\\tO\\n(\\tO\\n505\\tO\\n)\\tO\\nThr\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nisoforms\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nanti\\tO\\n-\\tO\\nBr\\tO\\n(\\tO\\na\\tO\\n)\\tO\\n(\\tO\\nHPA\\tO\\n-\\tO\\n5b\\tO\\n)\\tO\\nonly\\tO\\nrecognized\\tO\\nthe\\tO\\nLys\\tO\\n(\\tO\\n505\\tO\\n)\\tO\\nThr\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nform\\tO\\n,\\tO\\nwhereas\\tO\\nanti\\tO\\n-\\tO\\nBr\\tO\\n(\\tO\\nb\\tO\\n)\\tO\\n(\\tO\\nHPA\\tO\\n-\\tO\\n5a\\tO\\n)\\tO\\nreacted\\tO\\nwith\\tO\\nboth\\tO\\nGlu\\tO\\n(\\tO\\n505\\tO\\n)\\tO\\nThr\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nand\\tO\\nGlu\\tO\\n(\\tO\\n505\\tO\\n)\\tO\\nMet\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nisoforms\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nMet\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nformation\\tO\\nof\\tO\\nthe\\tO\\nSit\\tO\\n(\\tO\\na\\tO\\n)\\tO\\nalloantigenic\\tO\\ndeterminants\\tO\\n,\\tO\\nwhereas\\tO\\namino\\tO\\nacid\\tO\\n505\\tO\\n(\\tO\\nLys\\tO\\nor\\tO\\nGlu\\tO\\n)\\tO\\nspecifically\\tO\\ncontrols\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nBr\\tO\\n(\\tO\\na\\tO\\n)\\tO\\nand\\tO\\nBr\\tO\\n(\\tO\\nb\\tO\\n)\\tO\\nepitopes\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nPlatelet\\tO\\naggregation\\tO\\nresponses\\tO\\nof\\tO\\nSit\\tO\\n(\\tO\\na\\tO\\n)\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\nindividuals\\tO\\nwere\\tO\\ndiminished\\tO\\nin\\tO\\nresponse\\tO\\nto\\tO\\ncollagen\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nthe\\tO\\nThr\\tO\\n(\\tO\\n799\\tO\\n)\\tO\\nMet\\tO\\nmutation\\tO\\naffects\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\nGPIa\\tO\\n/\\tO\\nIIa\\tO\\ncomplex\\tO\\n\\nMutations\\tO\\nof\\tO\\nthe\\tO\\ncathepsin\\tO\\nC\\tO\\ngene\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nPapillon\\tB-Disease\\n-\\tI-Disease\\nLefevre\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nPapillon\\tB-Disease\\n-\\tI-Disease\\nLefevre\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPLS\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterised\\tO\\nby\\tO\\npalmoplantar\\tB-Disease\\nhyperkeratosis\\tI-Disease\\nand\\tO\\nsevere\\tO\\nearly\\tO\\nonset\\tO\\nperiodontitis\\tB-Disease\\nthat\\tO\\nresults\\tO\\nin\\tO\\nthe\\tO\\npremature\\tO\\nloss\\tO\\nof\\tO\\nthe\\tO\\nprimary\\tO\\nand\\tO\\nsecondary\\tO\\ndentitions\\tO\\n.\\tO\\n\\nA\\tO\\nmajor\\tO\\ngene\\tO\\nlocus\\tO\\nfor\\tO\\nPLS\\tB-Disease\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\na\\tO\\n2\\tO\\n.\\tO\\n\\n8\\tO\\ncM\\tO\\ninterval\\tO\\non\\tO\\nchromosome\\tO\\n11q14\\tO\\n.\\tO\\n\\nCorrelation\\tO\\nof\\tO\\nphysical\\tO\\nand\\tO\\ngenetic\\tO\\nmaps\\tO\\nof\\tO\\nthis\\tO\\ninterval\\tO\\nindicate\\tO\\nit\\tO\\nincludes\\tO\\nat\\tO\\nleast\\tO\\n40\\tO\\nESTs\\tO\\nand\\tO\\nsix\\tO\\nknown\\tO\\ngenes\\tO\\nincluding\\tO\\nthe\\tO\\nlysosomal\\tO\\nprotease\\tO\\ncathepsin\\tO\\nC\\tO\\ngene\\tO\\n(\\tO\\nCTSC\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nCTSC\\tO\\nmessage\\tO\\nis\\tO\\nexpressed\\tO\\nat\\tO\\nhigh\\tO\\nlevels\\tO\\nin\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nimmune\\tO\\ncells\\tO\\nincluding\\tO\\npolymorphonuclear\\tO\\nleucocytes\\tO\\n,\\tO\\nmacrophages\\tO\\n,\\tO\\nand\\tO\\ntheir\\tO\\nprecursors\\tO\\n.\\tO\\n\\nBy\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\n,\\tO\\nwe\\tO\\nfound\\tO\\nCTSC\\tO\\nis\\tO\\nalso\\tO\\nexpressed\\tO\\nin\\tO\\nepithelial\\tO\\nregions\\tO\\ncommonly\\tO\\naffected\\tO\\nby\\tO\\nPLS\\tB-Disease\\n,\\tO\\nincluding\\tO\\nthe\\tO\\npalms\\tO\\n,\\tO\\nsoles\\tO\\n,\\tO\\nknees\\tO\\n,\\tO\\nand\\tO\\noral\\tO\\nkeratinised\\tO\\ngingiva\\tO\\n.\\tO\\n\\nThe\\tO\\n4\\tO\\n.\\tO\\n\\n7\\tO\\nkb\\tO\\nCTSC\\tO\\ngene\\tO\\nconsists\\tO\\nof\\tO\\ntwo\\tO\\nexons\\tO\\n.\\tO\\n\\nSequence\\tO\\nanalysis\\tO\\nof\\tO\\nCTSC\\tO\\nfrom\\tO\\nsubjects\\tO\\naffected\\tO\\nwith\\tO\\nPLS\\tB-Disease\\nfrom\\tO\\nfive\\tO\\nconsanguineous\\tO\\nTurkish\\tO\\nfamilies\\tO\\nidentified\\tO\\nfour\\tO\\ndifferent\\tO\\nmutations\\tO\\n.\\tO\\n\\nAn\\tO\\nexon\\tO\\n1\\tO\\nnonsense\\tO\\nmutation\\tO\\n(\\tO\\n856C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n)\\tO\\nintroduces\\tO\\na\\tO\\npremature\\tO\\nstop\\tO\\ncodon\\tO\\nat\\tO\\namino\\tO\\nacid\\tO\\n286\\tO\\n.\\tO\\n\\nThree\\tO\\nexon\\tO\\n2\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\n,\\tO\\nincluding\\tO\\na\\tO\\nsingle\\tO\\nnucleotide\\tO\\ndeletion\\tO\\n(\\tO\\n2692delA\\tO\\n)\\tO\\nof\\tO\\ncodon\\tO\\n349\\tO\\nintroducing\\tO\\na\\tO\\nframeshift\\tO\\nand\\tO\\npremature\\tO\\ntermination\\tO\\ncodon\\tO\\n,\\tO\\na\\tO\\n2\\tO\\nbp\\tO\\ndeletion\\tO\\n(\\tO\\n2673\\tO\\n-\\tO\\n2674delCT\\tO\\n)\\tO\\nthat\\tO\\nresults\\tO\\nin\\tO\\nintroduction\\tO\\nof\\tO\\na\\tO\\nstop\\tO\\ncodon\\tO\\nat\\tO\\namino\\tO\\nacid\\tO\\n343\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\nsubstitution\\tO\\nin\\tO\\ncodon\\tO\\n429\\tO\\n(\\tO\\n2931G\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n)\\tO\\nintroducing\\tO\\na\\tO\\npremature\\tO\\ntermination\\tO\\ncodon\\tO\\n.\\tO\\n\\nAll\\tO\\nPLS\\tB-Disease\\npatients\\tO\\nwere\\tO\\nhomozygous\\tO\\nfor\\tO\\ncathepsin\\tO\\nC\\tO\\nmutations\\tO\\ninherited\\tO\\nfrom\\tO\\na\\tO\\ncommon\\tO\\nancestor\\tO\\n.\\tO\\n\\nParents\\tO\\nand\\tO\\nsibs\\tO\\nheterozygous\\tO\\nfor\\tO\\ncathepsin\\tO\\nC\\tO\\nmutations\\tO\\ndo\\tO\\nnot\\tO\\nshow\\tO\\neither\\tO\\nthe\\tO\\npalmoplantar\\tB-Disease\\nhyperkeratosis\\tI-Disease\\nor\\tO\\nsevere\\tO\\nearly\\tO\\nonset\\tO\\nperiodontitis\\tB-Disease\\ncharacteristic\\tO\\nof\\tO\\nPLS\\tB-Disease\\n.\\tO\\n\\nA\\tO\\nmore\\tO\\ncomplete\\tO\\nunderstanding\\tO\\nof\\tO\\nthe\\tO\\nfunctional\\tO\\nphysiology\\tO\\nof\\tO\\ncathepsin\\tO\\nC\\tO\\ncarries\\tO\\nsignificant\\tO\\nimplications\\tO\\nfor\\tO\\nunderstanding\\tO\\nnormal\\tO\\nand\\tO\\nabnormal\\tO\\nskin\\tO\\ndevelopment\\tO\\nand\\tO\\nperiodontal\\tB-Disease\\ndisease\\tI-Disease\\nsusceptibility\\tO\\n\\nMutational\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nHGO\\tO\\ngene\\tO\\nin\\tO\\nFinnish\\tO\\nalkaptonuria\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nAlkaptonuria\\tB-Disease\\n(\\tO\\nAKU\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nprototypic\\tO\\ninborn\\tB-Disease\\nerror\\tI-Disease\\nof\\tI-Disease\\nmetabolism\\tI-Disease\\n,\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\ncaused\\tO\\nby\\tO\\nloss\\tO\\nof\\tO\\nfunction\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhomogentisate\\tO\\n-\\tO\\n1\\tO\\n,\\tO\\n2\\tO\\n-\\tO\\ndioxygenase\\tO\\ngene\\tO\\n(\\tO\\nHGO\\tO\\n)\\tO\\n.\\tO\\n\\nSo\\tO\\nfar\\tO\\n17\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\ncharacterised\\tO\\nin\\tO\\nAKU\\tB-Disease\\npatients\\tO\\nof\\tO\\ndifferent\\tO\\nethnic\\tO\\norigin\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nthree\\tO\\nnovel\\tO\\nmutations\\tO\\n(\\tO\\nR58fs\\tO\\n,\\tO\\nR330S\\tO\\n,\\tO\\nand\\tO\\nH371R\\tO\\n)\\tO\\nand\\tO\\none\\tO\\ncommon\\tO\\nAKU\\tB-Disease\\nmutation\\tO\\n(\\tO\\nM368V\\tO\\n)\\tO\\n,\\tO\\ndetected\\tO\\nby\\tO\\nmutational\\tO\\nand\\tO\\npolymorphism\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nHGO\\tO\\ngene\\tO\\nin\\tO\\nfive\\tO\\nFinnish\\tO\\nAKU\\tB-Disease\\npedigrees\\tO\\n.\\tO\\n\\nThe\\tO\\nthree\\tO\\nnovel\\tO\\nAKU\\tB-Disease\\nmutations\\tO\\nare\\tO\\nmost\\tO\\nlikely\\tO\\nspecific\\tO\\nfor\\tO\\nthe\\tO\\nFinnish\\tO\\npopulation\\tO\\nand\\tO\\nhave\\tO\\noriginated\\tO\\nrecently\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nidentical\\tO\\n5\\tO\\n\\'\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nacceptor\\tO\\nmutation\\tO\\nin\\tO\\nfive\\tO\\nattenuated\\tB-Disease\\nAPC\\tI-Disease\\nfamilies\\tO\\nfrom\\tO\\nNewfoundland\\tO\\ndemonstrates\\tO\\na\\tO\\nfounder\\tO\\neffect\\tO\\n.\\tO\\n\\nInherited\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\npredispose\\tO\\ncarriers\\tO\\nto\\tO\\nmultiple\\tO\\nadenomatous\\tB-Disease\\npolyps\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\ncolon\\tI-Disease\\nand\\tI-Disease\\nrectum\\tI-Disease\\nand\\tO\\nto\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nlocated\\tO\\nat\\tO\\nthe\\tO\\nextreme\\tO\\n5\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nless\\tO\\nsevere\\tO\\ndisease\\tO\\nknown\\tO\\nas\\tO\\nattenuated\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAAPC\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nMany\\tO\\nindividuals\\tO\\nwith\\tO\\nAAPC\\tB-Disease\\ndevelop\\tO\\nrelatively\\tO\\nfew\\tO\\ncolorectal\\tB-Disease\\npolyps\\tI-Disease\\nbut\\tO\\nare\\tO\\nstill\\tO\\nat\\tO\\nhigh\\tO\\nrisk\\tO\\nfor\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\n5\\tO\\nAPC\\tB-Disease\\ngermline\\tO\\nmutation\\tO\\nin\\tO\\nfive\\tO\\nseparately\\tO\\nascertained\\tO\\nAAPC\\tB-Disease\\nfamilies\\tO\\nfrom\\tO\\nNewfoundland\\tO\\n,\\tO\\nCanada\\tO\\n.\\tO\\n\\nThis\\tO\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\nmutation\\tO\\nis\\tO\\na\\tO\\nsingle\\tO\\nbasepair\\tO\\nchange\\tO\\n(\\tO\\nG\\tO\\nto\\tO\\nA\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nsplice\\tO\\n-\\tO\\nacceptor\\tO\\nregion\\tO\\nof\\tO\\nAPC\\tB-Disease\\nintron\\tO\\n3\\tO\\nthat\\tO\\ncreates\\tO\\na\\tO\\nmutant\\tO\\nRNA\\tO\\nwithout\\tO\\nexon\\tO\\n4\\tO\\nof\\tO\\nAPC\\tO\\n.\\tO\\n\\nThe\\tO\\nobservation\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\nAPC\\tB-Disease\\nmutation\\tO\\nin\\tO\\nfive\\tO\\nfamilies\\tO\\nfrom\\tO\\nthe\\tO\\nsame\\tO\\ngeographic\\tO\\narea\\tO\\ndemonstrates\\tO\\na\\tO\\nfounder\\tO\\neffect\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\nthis\\tO\\ngermline\\tO\\nmutation\\tO\\nstrengthens\\tO\\nthe\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\n5\\tO\\nlocation\\tO\\nof\\tO\\nan\\tO\\nAPC\\tB-Disease\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\nmutation\\tO\\nand\\tO\\nthe\\tO\\nattenuated\\tB-Disease\\npolyposis\\tI-Disease\\nphenotype\\tO\\n.\\tO\\n.\\tO\\n\\nAlstrom\\tB-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\nfurther\\tO\\nevidence\\tO\\nfor\\tO\\nlinkage\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\n2p13\\tO\\n.\\tO\\n\\nAlstrom\\tB-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nretinal\\tB-Disease\\ndegeneration\\tI-Disease\\n,\\tO\\nsensorineural\\tB-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\n,\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nobesity\\tB-Disease\\n,\\tO\\nand\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\ninsulin\\tI-Disease\\n-\\tI-Disease\\ndependent\\tI-Disease\\ndiabetes\\tI-Disease\\nmellitus\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nfor\\tO\\nAlstrom\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nALMS1\\tO\\n)\\tO\\nhas\\tO\\nbeen\\tO\\npreviously\\tO\\nlocalized\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\n2p13\\tO\\nby\\tO\\nhomozygosity\\tO\\nmapping\\tO\\nin\\tO\\ntwo\\tO\\ndistinct\\tO\\nisolated\\tO\\npopulations\\tO\\n-\\tO\\nFrench\\tO\\nAcadian\\tO\\nand\\tO\\nNorth\\tO\\nAfrican\\tO\\n.\\tO\\n\\nPair\\tO\\n-\\tO\\nwise\\tO\\nanalyses\\tO\\nresulted\\tO\\nin\\tO\\nmaximum\\tO\\nlod\\tO\\n(\\tO\\nlogarithm\\tO\\nof\\tO\\nthe\\tO\\nodds\\tO\\nratio\\tO\\n)\\tO\\nscores\\tO\\nof\\tO\\n3\\tO\\n.\\tO\\n\\n84\\tO\\nand\\tO\\n2\\tO\\n.\\tO\\n\\n9\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nTo\\tO\\nconfirm\\tO\\nthese\\tO\\nfindings\\tO\\n,\\tO\\na\\tO\\nlarge\\tO\\nlinkage\\tO\\nstudy\\tO\\nwas\\tO\\nperformed\\tO\\nin\\tO\\ntwelve\\tO\\nadditional\\tO\\nfamilies\\tO\\nsegregating\\tO\\nfor\\tO\\nAlstrom\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nmaximum\\tO\\ntwo\\tO\\n-\\tO\\npoint\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\n7\\tO\\n.\\tO\\n\\n13\\tO\\n(\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n00\\tO\\n)\\tO\\nfor\\tO\\nmarker\\tO\\nD2S2110\\tO\\nand\\tO\\na\\tO\\nmaximum\\tO\\ncumulative\\tO\\nmultipoint\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\n9\\tO\\n.\\tO\\n\\n16\\tO\\nfor\\tO\\nmarker\\tO\\nD2S2110\\tO\\nwere\\tO\\nobserved\\tO\\n,\\tO\\nfurther\\tO\\nsupporting\\tO\\nlinkage\\tO\\nto\\tO\\nchromosome\\tO\\n2p13\\tO\\n.\\tO\\n\\nNo\\tO\\nevidence\\tO\\nof\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\nthese\\tO\\nfamilies\\tO\\n.\\tO\\n\\nMeiotic\\tO\\nrecombination\\tO\\nevents\\tO\\nhave\\tO\\nlocalized\\tO\\nthe\\tO\\ncritical\\tO\\nregion\\tO\\ncontaining\\tO\\nALMS1\\tO\\nto\\tO\\na\\tO\\n6\\tO\\n.\\tO\\n\\n1\\tO\\n-\\tO\\ncM\\tO\\ninterval\\tO\\nflanked\\tO\\nby\\tO\\nmarkers\\tO\\nD2S327\\tO\\nand\\tO\\nD2S286\\tO\\n.\\tO\\n\\nA\\tO\\nfine\\tO\\nresolution\\tO\\nradiation\\tO\\nhybrid\\tO\\nmap\\tO\\nof\\tO\\n31\\tO\\ngenes\\tO\\nand\\tO\\nmarkers\\tO\\nhas\\tO\\nbeen\\tO\\nconstructed\\tO\\n.\\tO\\n\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\nphenotypic\\tO\\nvariability\\tO\\nin\\tO\\ntwo\\tO\\nfamilies\\tO\\ncarrying\\tO\\nthe\\tO\\nsame\\tO\\nPDS\\tB-Disease\\nmissense\\tO\\nmutation\\tO\\n.\\tO\\n\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\ncomprises\\tO\\ncongenital\\tB-Disease\\nsensorineural\\tI-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\n,\\tO\\nthyroid\\tB-Disease\\ngoiter\\tI-Disease\\n,\\tO\\nand\\tO\\npositive\\tO\\nperchlorate\\tO\\ndischarge\\tO\\ntest\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nthis\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\nwas\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nencodes\\tO\\nan\\tO\\nanion\\tO\\ntransporter\\tO\\ncalled\\tO\\npendrin\\tO\\n.\\tO\\n\\nMolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\nwas\\tO\\nperformed\\tO\\nin\\tO\\ntwo\\tO\\nconsanguineous\\tO\\nlarge\\tO\\nfamilies\\tO\\nfrom\\tO\\nSouthern\\tO\\nTunisia\\tO\\ncomprising\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\n23\\tO\\nindividuals\\tO\\naffected\\tO\\nwith\\tO\\nprofound\\tO\\ncongenital\\tB-Disease\\ndeafness\\tI-Disease\\n;\\tO\\nthe\\tO\\nsame\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\nL445W\\tO\\n,\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\nall\\tO\\naffected\\tO\\nindividuals\\tO\\n.\\tO\\n\\nA\\tO\\nwidened\\tB-Disease\\nvestibular\\tI-Disease\\naqueduct\\tI-Disease\\nwas\\tO\\nfound\\tO\\nin\\tO\\nall\\tO\\npatients\\tO\\nwho\\tO\\nunderwent\\tO\\ncomputed\\tO\\ntomography\\tO\\n(\\tO\\nCT\\tO\\n)\\tO\\nscan\\tO\\nexploration\\tO\\nof\\tO\\nthe\\tO\\ninner\\tO\\near\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\ngoiter\\tB-Disease\\nwas\\tO\\npresent\\tO\\nin\\tO\\nonly\\tO\\n11\\tO\\naffected\\tO\\nindividuals\\tO\\n,\\tO\\nwho\\tO\\ninterestingly\\tO\\nhad\\tO\\na\\tO\\nnormal\\tO\\nresult\\tO\\nof\\tO\\nthe\\tO\\nperchlorate\\tO\\ndischarge\\tO\\ntest\\tO\\nwhenever\\tO\\nperformed\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nresults\\tO\\nquestion\\tO\\nthe\\tO\\nsensitivity\\tO\\nof\\tO\\nthe\\tO\\nperchlorate\\tO\\ntest\\tO\\nfor\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nsupport\\tO\\nthe\\tO\\nuse\\tO\\nof\\tO\\na\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\nin\\tO\\nthe\\tO\\nassessment\\tO\\nof\\tO\\nindividuals\\tO\\nwith\\tO\\nsevere\\tO\\nto\\tO\\nprofound\\tO\\ncongenital\\tB-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\nassociated\\tO\\nwith\\tO\\ninner\\tB-Disease\\near\\tI-Disease\\nmorphological\\tI-Disease\\nanomaly\\tI-Disease\\neven\\tO\\nin\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\na\\tO\\nthyroid\\tB-Disease\\ngoiter\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nKnobloch\\tB-Disease\\nsyndrome\\tI-Disease\\ninvolving\\tO\\nmidline\\tB-Disease\\nscalp\\tI-Disease\\ndefect\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfrontal\\tI-Disease\\nregion\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\na\\tO\\n4\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nboy\\tO\\nwith\\tO\\nKnobloch\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nHe\\tO\\nhas\\tO\\nvitreoretinal\\tB-Disease\\ndegeneration\\tI-Disease\\n,\\tO\\nhigh\\tB-Disease\\nmyopia\\tI-Disease\\n,\\tO\\ncataract\\tB-Disease\\n,\\tO\\ntelecanthus\\tB-Disease\\n,\\tO\\nhypertelorism\\tB-Disease\\n,\\tO\\nand\\tO\\na\\tO\\nhigh\\tB-Disease\\n-\\tI-Disease\\narched\\tI-Disease\\npalate\\tI-Disease\\n.\\tO\\n\\nHe\\tO\\nalso\\tO\\nhas\\tO\\na\\tO\\ndefect\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nanterior\\tI-Disease\\nmidline\\tI-Disease\\nscalp\\tI-Disease\\nwith\\tO\\ninvolvement\\tO\\nof\\tO\\nthe\\tO\\nfrontal\\tO\\nbone\\tO\\nas\\tO\\ndocumented\\tO\\nby\\tO\\na\\tO\\ncomputed\\tO\\ntomography\\tO\\n(\\tO\\nCT\\tO\\n)\\tO\\nscan\\tO\\n.\\tO\\n\\nThe\\tO\\nbrain\\tO\\nwas\\tO\\nnormal\\tO\\non\\tO\\nCT\\tO\\nscan\\tO\\nand\\tO\\nmagnetic\\tO\\nresonance\\tO\\nimaging\\tO\\n.\\tO\\n\\nWe\\tO\\npresent\\tO\\na\\tO\\nreview\\tO\\nof\\tO\\nthe\\tO\\n23\\tO\\npublished\\tO\\ncases\\tO\\nwith\\tO\\nthis\\tO\\nsyndrome\\tO\\n.\\tO\\n\\nOur\\tO\\npatient\\tO\\nillustrates\\tO\\nthe\\tO\\nimportance\\tO\\nof\\tO\\ninvestigating\\tO\\nfor\\tO\\nunderlying\\tO\\nocular\\tO\\nand\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\npathology\\tO\\nwhenever\\tO\\nmidline\\tB-Disease\\nscalp\\tI-Disease\\ndefects\\tI-Disease\\nare\\tO\\npresent\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nDNA\\tO\\ndouble\\tO\\n-\\tO\\nstrand\\tO\\nbreak\\tO\\nrepair\\tO\\ngene\\tO\\nhMRE11\\tO\\nis\\tO\\nmutated\\tO\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nan\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n-\\tI-Disease\\nlike\\tI-Disease\\ndisorder\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nhypomorphic\\tO\\nmutations\\tO\\nin\\tO\\nhMRE11\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nin\\tO\\nATM\\tO\\n,\\tO\\nare\\tO\\npresent\\tO\\nin\\tO\\ncertain\\tO\\nindividuals\\tO\\nwith\\tO\\nan\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n-\\tI-Disease\\nlike\\tI-Disease\\ndisorder\\tI-Disease\\n(\\tO\\nATLD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ncellular\\tO\\nfeatures\\tO\\nresulting\\tO\\nfrom\\tO\\nthese\\tO\\nhMRE11\\tO\\nmutations\\tO\\nare\\tO\\nsimilar\\tO\\nto\\tO\\nthose\\tO\\nseen\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nas\\tO\\nwell\\tO\\nas\\tO\\nNBS\\tB-Disease\\nand\\tO\\ninclude\\tO\\nhypersensitivity\\tB-Disease\\nto\\tI-Disease\\nionizing\\tI-Disease\\nradiation\\tI-Disease\\n,\\tO\\nradioresistant\\tO\\nDNA\\tO\\nsynthesis\\tO\\n,\\tO\\nand\\tO\\nabrogation\\tO\\nof\\tO\\nATM\\tO\\n-\\tO\\ndependent\\tO\\nevents\\tO\\n,\\tO\\nsuch\\tO\\nas\\tO\\nthe\\tO\\nactivation\\tO\\nof\\tO\\nJun\\tO\\nkinase\\tO\\nfollowing\\tO\\nexposure\\tO\\nto\\tO\\ngamma\\tO\\nirradiation\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\nmutant\\tO\\nhMre11\\tO\\nproteins\\tO\\nretain\\tO\\nsome\\tO\\nability\\tO\\nto\\tO\\ninteract\\tO\\nwith\\tO\\nhRad50\\tO\\nand\\tO\\nNbs1\\tO\\n,\\tO\\nformation\\tO\\nof\\tO\\nionizing\\tO\\nradiation\\tO\\n-\\tO\\ninduced\\tO\\nhMre11\\tO\\nand\\tO\\nNbs1\\tO\\nfoci\\tO\\nwas\\tO\\nabsent\\tO\\nin\\tO\\nhMRE11\\tO\\nmutant\\tO\\ncells\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\ndemonstrate\\tO\\nthat\\tO\\nATM\\tO\\nand\\tO\\nthe\\tO\\nhMre11\\tO\\n/\\tO\\nhRad50\\tO\\n/\\tO\\nNbs1\\tO\\nprotein\\tO\\ncomplex\\tO\\nact\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\nDNA\\tO\\ndamage\\tO\\nresponse\\tO\\npathway\\tO\\nand\\tO\\nlink\\tO\\nhMre11\\tO\\nto\\tO\\nthe\\tO\\ncomplex\\tO\\npathology\\tO\\nof\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nTNFRSF11A\\tO\\n,\\tO\\naffecting\\tO\\nthe\\tO\\nsignal\\tO\\npeptide\\tO\\nof\\tO\\nRANK\\tO\\n,\\tO\\ncause\\tO\\nfamilial\\tB-Disease\\nexpansile\\tI-Disease\\nosteolysis\\tI-Disease\\n.\\tO\\n\\nFamilial\\tB-Disease\\nexpansile\\tI-Disease\\nosteolysis\\tI-Disease\\n(\\tO\\nFEO\\tB-Disease\\n,\\tO\\nMIM\\tO\\n174810\\tO\\n)\\tO\\nis\\tO\\na\\tO\\nrare\\tO\\n,\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nbone\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nfocal\\tO\\nareas\\tO\\nof\\tO\\nincreased\\tB-Disease\\nbone\\tI-Disease\\nremodelling\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nosteolytic\\tB-Disease\\nlesions\\tI-Disease\\n,\\tO\\nwhich\\tO\\ndevelop\\tO\\nusually\\tO\\nin\\tO\\nthe\\tO\\nlong\\tO\\nbones\\tO\\nduring\\tO\\nearly\\tO\\nadulthood\\tO\\n,\\tO\\nshow\\tO\\nincreased\\tO\\nosteoblast\\tO\\nand\\tO\\nosteoclast\\tO\\nactivity\\tO\\n.\\tO\\n\\nOur\\tO\\nprevious\\tO\\nlinkage\\tO\\nstudies\\tO\\nmapped\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nFEO\\tB-Disease\\nto\\tO\\nan\\tO\\ninterval\\tO\\nof\\tO\\nless\\tO\\nthan\\tO\\n5\\tO\\ncM\\tO\\nbetween\\tO\\nD18S64\\tO\\nand\\tO\\nD18S51\\tO\\non\\tO\\nchromosome\\tO\\n18q21\\tO\\n.\\tO\\n\\n2\\tO\\n-\\tO\\n21\\tO\\n2\\tO\\n-\\tO\\n21\\tO\\n.\\tO\\n\\n3\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nNorthern\\tO\\nIrish\\tO\\nfamily\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nencoding\\tO\\nreceptor\\tO\\nactivator\\tO\\nof\\tO\\nnuclear\\tO\\nfactor\\tO\\n-\\tO\\nkappa\\tO\\nB\\tO\\n(\\tO\\nRANK\\tO\\n;\\tO\\nref\\tO\\n.\\tO\\n5\\tO\\n)\\tO\\n,\\tO\\nTNFRSF11A\\tO\\n,\\tO\\nmaps\\tO\\nto\\tO\\nthis\\tO\\nregion\\tO\\n.\\tO\\n\\nRANK\\tO\\nis\\tO\\nessential\\tO\\nin\\tO\\nosteoclast\\tO\\nformation\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\ntwo\\tO\\nheterozygous\\tO\\ninsertion\\tO\\nmutations\\tO\\nin\\tO\\nexon\\tO\\n1\\tO\\nof\\tO\\nTNFRSF11A\\tO\\nin\\tO\\naffected\\tO\\nmembers\\tO\\nof\\tO\\nfour\\tO\\nfamilies\\tO\\nwith\\tO\\nFEO\\tB-Disease\\nor\\tO\\nfamilial\\tB-Disease\\nPaget\\tI-Disease\\ndisease\\tI-Disease\\nof\\tI-Disease\\nbone\\tI-Disease\\n(\\tO\\nPDB\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nOne\\tO\\nwas\\tO\\na\\tO\\nduplication\\tO\\nof\\tO\\n18\\tO\\nbases\\tO\\nand\\tO\\nthe\\tO\\nother\\tO\\na\\tO\\nduplication\\tO\\nof\\tO\\n27\\tO\\nbases\\tO\\n,\\tO\\nboth\\tO\\nof\\tO\\nwhich\\tO\\naffected\\tO\\nthe\\tO\\nsignal\\tO\\npeptide\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nRANK\\tO\\nmolecule\\tO\\n.\\tO\\n\\nExpression\\tO\\nof\\tO\\nrecombinant\\tO\\nforms\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nRANK\\tO\\nproteins\\tO\\nrevealed\\tO\\nperturbations\\tO\\nin\\tO\\nexpression\\tO\\nlevels\\tO\\nand\\tO\\nlack\\tO\\nof\\tO\\nnormal\\tO\\ncleavage\\tO\\nof\\tO\\nthe\\tO\\nsignal\\tO\\npeptide\\tO\\n.\\tO\\n\\nBoth\\tO\\nmutations\\tO\\ncaused\\tO\\nan\\tO\\nincrease\\tO\\nin\\tO\\nRANK\\tO\\n-\\tO\\nmediated\\tO\\nnuclear\\tO\\nfactor\\tO\\n-\\tO\\nkappaB\\tO\\n(\\tO\\nNF\\tO\\n-\\tO\\nkappaB\\tO\\n)\\tO\\nsignalling\\tO\\nin\\tO\\nvitro\\tO\\n,\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nan\\tO\\nactivating\\tO\\nmutation\\tO\\n.\\tO\\n\\nCardiac\\tO\\nNa\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\nchannel\\tO\\ndysfunction\\tO\\nin\\tO\\nBrugada\\tB-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\naggravated\\tO\\nby\\tO\\nbeta\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\n-\\tO\\nsubunit\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\nMutations\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nencoding\\tO\\nthe\\tO\\nhuman\\tO\\ncardiac\\tO\\nNa\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\nchannel\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\n(\\tO\\nhH1\\tO\\n)\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nchromosome\\tO\\n3\\tO\\n-\\tO\\nlinked\\tO\\ncongenital\\tB-Disease\\nlong\\tI-Disease\\n-\\tI-Disease\\nQT\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nLQT3\\tB-Disease\\n)\\tO\\nand\\tO\\nidiopathic\\tB-Disease\\nventricular\\tI-Disease\\nfibrillation\\tI-Disease\\n(\\tO\\nIVF\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nAn\\tO\\nauxiliary\\tO\\nbeta\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\n-\\tO\\nsubunit\\tO\\n,\\tO\\nwidely\\tO\\nexpressed\\tO\\nin\\tO\\nexcitable\\tO\\ntissues\\tO\\n,\\tO\\nshifts\\tO\\nthe\\tO\\nvoltage\\tO\\ndependence\\tO\\nof\\tO\\nsteady\\tO\\n-\\tO\\nstate\\tO\\ninactivation\\tO\\ntoward\\tO\\nmore\\tO\\nnegative\\tO\\npotentials\\tO\\nand\\tO\\nrestores\\tO\\nnormal\\tO\\ngating\\tO\\nkinetics\\tO\\nof\\tO\\nbrain\\tO\\nand\\tO\\nskeletal\\tO\\nmuscle\\tO\\nNa\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\nchannels\\tO\\nexpressed\\tO\\nin\\tO\\nXenopus\\tO\\noocytes\\tO\\nbut\\tO\\nhas\\tO\\nlittle\\tO\\nif\\tO\\nany\\tO\\nfunctional\\tO\\neffect\\tO\\non\\tO\\nthe\\tO\\ncardiac\\tO\\nisoform\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\ncharacterize\\tO\\nthe\\tO\\naltered\\tO\\neffects\\tO\\nof\\tO\\na\\tO\\nhuman\\tO\\nbeta\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\n-\\tO\\nsubunit\\tO\\n(\\tO\\nhbeta\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\n)\\tO\\non\\tO\\nthe\\tO\\nheterologously\\tO\\nexpressed\\tO\\nhH1\\tO\\nmutation\\tO\\n(\\tO\\nT1620M\\tO\\n)\\tO\\npreviously\\tO\\nassociated\\tO\\nwith\\tO\\nIVF\\tB-Disease\\n.\\tO\\n\\nMETHODS\\tO\\nAND\\tO\\nRESULTS\\tO\\nWhen\\tO\\nexpressed\\tO\\nalone\\tO\\nin\\tO\\nXenopus\\tO\\noocytes\\tO\\n,\\tO\\nT1620M\\tO\\nexhibited\\tO\\nno\\tO\\npersistent\\tO\\ncurrents\\tO\\n,\\tO\\nin\\tO\\ncontrast\\tO\\nto\\tO\\nthe\\tO\\nLQT3\\tB-Disease\\nmutant\\tO\\nchannels\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nmidpoint\\tO\\nof\\tO\\nsteady\\tO\\n-\\tO\\nstate\\tO\\ninactivation\\tO\\n(\\tO\\nV\\tO\\n(\\tO\\n1\\tO\\n/\\tO\\n2\\tO\\n)\\tO\\n)\\tO\\nwas\\tO\\nsignificantly\\tO\\nshifted\\tO\\ntoward\\tO\\nmore\\tO\\npositive\\tO\\npotentials\\tO\\nthan\\tO\\nfor\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nhH1\\tO\\n.\\tO\\n\\nCoexpression\\tO\\nof\\tO\\nhbeta\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\ndid\\tO\\nnot\\tO\\nsignificantly\\tO\\nalter\\tO\\ncurrent\\tO\\ndecay\\tO\\nor\\tO\\nrecovery\\tO\\nfrom\\tO\\ninactivation\\tO\\nof\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nhH1\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nit\\tO\\nfurther\\tO\\nshifted\\tO\\nthe\\tO\\nV\\tO\\n(\\tO\\n1\\tO\\n/\\tO\\n2\\tO\\n)\\tO\\nand\\tO\\naccelerated\\tO\\nthe\\tO\\nrecovery\\tO\\nfrom\\tO\\ninactivation\\tO\\nof\\tO\\nT1620M\\tO\\n.\\tO\\n\\nOocyte\\tO\\nmacropatch\\tO\\nanalysis\\tO\\nrevealed\\tO\\nthat\\tO\\nthe\\tO\\nactivation\\tO\\nkinetics\\tO\\nof\\tO\\nT1620M\\tO\\nwere\\tO\\nnormal\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nIt\\tO\\nis\\tO\\nsuggested\\tO\\nthat\\tO\\ncoexpression\\tO\\nof\\tO\\nhbeta\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nexposes\\tO\\na\\tO\\nmore\\tO\\nsevere\\tO\\nfunctional\\tO\\ndefect\\tO\\nthat\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\ngreater\\tO\\noverlap\\tO\\nin\\tO\\nthe\\tO\\nrelationship\\tO\\nbetween\\tO\\nchannel\\tO\\ninactivation\\tO\\nand\\tO\\nactivation\\tO\\n(\\tO\\nwindow\\tO\\ncurrent\\tO\\n)\\tO\\nin\\tO\\nT1620M\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nproposed\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\npotential\\tO\\npathophysiological\\tO\\nmechanism\\tO\\nof\\tO\\nIVF\\tB-Disease\\nin\\tO\\nvivo\\tO\\n.\\tO\\n\\nOne\\tO\\npossible\\tO\\nexplanation\\tO\\nfor\\tO\\nour\\tO\\nfinding\\tO\\nis\\tO\\nan\\tO\\naltered\\tO\\nalpha\\tO\\n-\\tO\\n/\\tO\\nbeta\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\n-\\tO\\nsubunit\\tO\\nassociation\\tO\\nin\\tO\\nthe\\tO\\nmutant\\tO\\n.\\tO\\n.\\tO\\n\\nMeiotic\\tO\\nsegregation\\tO\\nanalysis\\tO\\nof\\tO\\nRB1\\tO\\nalleles\\tO\\nin\\tO\\nretinoblastoma\\tB-Disease\\npedigrees\\tO\\nby\\tO\\nuse\\tO\\nof\\tO\\nsingle\\tO\\n-\\tO\\nsperm\\tO\\ntyping\\tO\\n.\\tO\\n\\nIn\\tO\\nhereditary\\tB-Disease\\nretinoblastoma\\tI-Disease\\n,\\tO\\ndifferent\\tO\\nepidemiological\\tO\\nstudies\\tO\\nhave\\tO\\nindicated\\tO\\na\\tO\\npreferential\\tO\\npaternal\\tO\\ntransmission\\tO\\nof\\tO\\nmutant\\tO\\nretinoblastoma\\tB-Disease\\nalleles\\tO\\nto\\tO\\noffspring\\tO\\n,\\tO\\nsuggesting\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\na\\tO\\nmeiotic\\tO\\ndrive\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nthis\\tO\\nmechanism\\tO\\n,\\tO\\nwe\\tO\\nanalyzed\\tO\\nsperm\\tO\\nsamples\\tO\\nfrom\\tO\\nsix\\tO\\nindividuals\\tO\\nfrom\\tO\\nfive\\tO\\nunrelated\\tO\\nfamilies\\tO\\naffected\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nretinoblastoma\\tI-Disease\\n.\\tO\\n\\nSingle\\tO\\n-\\tO\\nsperm\\tO\\ntyping\\tO\\ntechniques\\tO\\nwere\\tO\\nperformed\\tO\\nfor\\tO\\neach\\tO\\nsample\\tO\\nby\\tO\\nstudy\\tO\\nof\\tO\\ntwo\\tO\\ninformative\\tO\\nshort\\tO\\ntandem\\tO\\nrepeats\\tO\\nlocated\\tO\\neither\\tO\\nin\\tO\\nor\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\nretinoblastoma\\tB-Disease\\ngene\\tO\\n(\\tO\\nRB1\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nsegregation\\tO\\nprobability\\tO\\nof\\tO\\nmutant\\tO\\nRB1\\tO\\nalleles\\tO\\nin\\tO\\nsperm\\tO\\nsamples\\tO\\nwas\\tO\\nassessed\\tO\\nby\\tO\\nuse\\tO\\nof\\tO\\nthe\\tO\\nSPERMSEG\\tO\\nprogram\\tO\\n,\\tO\\nwhich\\tO\\nincludes\\tO\\nexperimental\\tO\\nparameters\\tO\\n,\\tO\\nrecombination\\tO\\nfractions\\tO\\nbetween\\tO\\nthe\\tO\\nmarkers\\tO\\n,\\tO\\nand\\tO\\nsegregation\\tO\\nparameters\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n2\\tO\\n,\\tO\\n952\\tO\\nsingle\\tO\\nsperm\\tO\\nfrom\\tO\\nthe\\tO\\nsix\\tO\\ndonors\\tO\\nwere\\tO\\nanalyzed\\tO\\n.\\tO\\n\\nWe\\tO\\ndetected\\tO\\na\\tO\\nsignificant\\tO\\nsegregation\\tO\\ndistortion\\tO\\nin\\tO\\nthe\\tO\\ndata\\tO\\nas\\tO\\na\\tO\\nwhole\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n0099\\tO\\n)\\tO\\nand\\tO\\na\\tO\\nsignificant\\tO\\nheterogeneity\\tO\\nin\\tO\\nthe\\tO\\nsegregation\\tO\\nrate\\tO\\nacross\\tO\\ndonors\\tO\\n(\\tO\\n.\\tO\\n0092\\tO\\n)\\tO\\n.\\tO\\n\\nFurther\\tO\\nanalysis\\tO\\nshows\\tO\\nthat\\tO\\nthis\\tO\\nresult\\tO\\ncan\\tO\\nbe\\tO\\nexplained\\tO\\nby\\tO\\nsegregation\\tO\\ndistortion\\tO\\nin\\tO\\nfavor\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nallele\\tO\\nin\\tO\\none\\tO\\ndonor\\tO\\nonly\\tO\\nand\\tO\\nthat\\tO\\nit\\tO\\ndoes\\tO\\nnot\\tO\\nprovide\\tO\\nevidence\\tO\\nof\\tO\\na\\tO\\nsignificant\\tO\\nsegregation\\tO\\ndistortion\\tO\\nin\\tO\\nthe\\tO\\nother\\tO\\ndonors\\tO\\n.\\tO\\n\\nThe\\tO\\nsegregation\\tO\\ndistortion\\tO\\nfavoring\\tO\\nthe\\tO\\nmutant\\tO\\nRB1\\tO\\nallele\\tO\\ndoes\\tO\\nnot\\tO\\nseem\\tO\\nto\\tO\\noccur\\tO\\nduring\\tO\\nspermatogenesis\\tO\\n,\\tO\\nand\\tO\\n,\\tO\\nthus\\tO\\n,\\tO\\nmeiotic\\tO\\ndrive\\tO\\nmay\\tO\\nresult\\tO\\neither\\tO\\nfrom\\tO\\nvarious\\tO\\nmechanisms\\tO\\n,\\tO\\nincluding\\tO\\na\\tO\\nfertilization\\tO\\nadvantage\\tO\\nor\\tO\\na\\tO\\nbetter\\tO\\nmobility\\tO\\nin\\tO\\nsperm\\tO\\nbearing\\tO\\na\\tO\\nmutant\\tO\\nRB1\\tO\\ngene\\tO\\n,\\tO\\nor\\tO\\nfrom\\tO\\nthe\\tO\\nexistence\\tO\\nof\\tO\\na\\tO\\ndefectively\\tO\\nimprinted\\tO\\ngene\\tO\\nlocated\\tO\\non\\tO\\nthe\\tO\\nhuman\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n:\\tO\\nan\\tO\\noverview\\tO\\n.\\tO\\n\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n,\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nneurodegenerative\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nof\\tO\\nthe\\tO\\ninherited\\tB-Disease\\nataxias\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nrecent\\tO\\ndiscovery\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nthat\\tO\\nis\\tO\\nmutated\\tO\\nin\\tO\\nthis\\tO\\ncondition\\tO\\n,\\tO\\nFRDA\\tO\\n,\\tO\\nhas\\tO\\nled\\tO\\nto\\tO\\nrapid\\tO\\nadvances\\tO\\nin\\tO\\nthe\\tO\\nunderstanding\\tO\\nof\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n.\\tO\\n\\nAbout\\tO\\n98\\tO\\n%\\tO\\nof\\tO\\nmutant\\tO\\nalleles\\tO\\nhave\\tO\\nan\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nGAA\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nin\\tO\\nintron\\tO\\n1\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nThis\\tO\\nleads\\tO\\nto\\tO\\nreduced\\tO\\nlevels\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n,\\tO\\nfrataxin\\tO\\n.\\tO\\n\\nThere\\tO\\nis\\tO\\nmounting\\tO\\nevidence\\tO\\nto\\tO\\nsuggest\\tO\\nthat\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\nis\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\naccumulation\\tO\\nof\\tO\\niron\\tO\\nin\\tO\\nmitochondria\\tO\\nleading\\tO\\nto\\tO\\nexcess\\tO\\nproduction\\tO\\nof\\tO\\nfree\\tO\\nradicals\\tO\\n,\\tO\\nwhich\\tO\\nthen\\tO\\nresults\\tO\\nin\\tO\\ncellular\\tO\\ndamage\\tO\\nand\\tO\\ndeath\\tO\\n.\\tO\\n\\nCurrently\\tO\\nthere\\tO\\nis\\tO\\nno\\tO\\nknown\\tO\\ntreatment\\tO\\nthat\\tO\\nalters\\tO\\nthe\\tO\\nnatural\\tO\\ncourse\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\ndiscovery\\tO\\nof\\tO\\nthe\\tO\\nFRDA\\tB-Disease\\ngene\\tO\\nand\\tO\\nits\\tO\\npossible\\tO\\nfunction\\tO\\nhas\\tO\\nraised\\tO\\nhope\\tO\\nthat\\tO\\nrational\\tO\\ntherapeutic\\tO\\nstrategies\\tO\\nwill\\tO\\nbe\\tO\\ndeveloped\\tO\\n.\\tO\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nretinoschisis\\tI-Disease\\nwith\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nXLRS1\\tO\\ngene\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nretinoschisis\\tI-Disease\\n(\\tO\\nXLRS\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nrelatively\\tO\\nrare\\tO\\nvitreoretinal\\tB-Disease\\ndystrophy\\tI-Disease\\nthat\\tO\\ncauses\\tO\\nvisual\\tB-Disease\\nloss\\tI-Disease\\nin\\tO\\nyoung\\tO\\nmen\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\na\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nthis\\tO\\ndisease\\tO\\n,\\tO\\ndesignated\\tO\\nXLRS1\\tO\\n,\\tO\\nwas\\tO\\nidentified\\tO\\n,\\tO\\nand\\tO\\nseveral\\tO\\ndeleterious\\tO\\ngene\\tO\\nmutations\\tO\\nwere\\tO\\nreported\\tO\\n.\\tO\\n\\nOBJECTIVE\\tO\\nTo\\tO\\nanalyze\\tO\\nJapanese\\tO\\npatients\\tO\\nclinically\\tO\\ndiagnosed\\tO\\nas\\tO\\nhaving\\tO\\nXLRS\\tB-Disease\\nformutational\\tO\\nchanges\\tO\\nin\\tO\\nthe\\tO\\nXLRS1\\tO\\ngene\\tO\\n.\\tO\\n\\nMETHODS\\tO\\nTen\\tO\\npatients\\tO\\nwith\\tO\\nXLRS\\tB-Disease\\nunderwent\\tO\\nfull\\tO\\nophthalmologic\\tO\\nexamination\\tO\\n,\\tO\\nincluding\\tO\\nslitlamp\\tO\\nbiomicroscopy\\tO\\nand\\tO\\ndilated\\tO\\nfunduscopy\\tO\\n.\\tO\\n\\nGenomic\\tO\\nDNA\\tO\\nwas\\tO\\nisolated\\tO\\nfrom\\tO\\nleukocytes\\tO\\n,\\tO\\nand\\tO\\nall\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\nXLRS1\\tO\\ngene\\tO\\nwere\\tO\\namplified\\tO\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nand\\tO\\nanalyzed\\tO\\nusing\\tO\\na\\tO\\ndirect\\tO\\nsequencing\\tO\\nmethod\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nPoint\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nXLRS1\\tO\\ngene\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nall\\tO\\n10\\tO\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\nwere\\tO\\nidentical\\tO\\nin\\tO\\neach\\tO\\nof\\tO\\n2\\tO\\npairs\\tO\\nof\\tO\\nbrothers\\tO\\n.\\tO\\n\\nSix\\tO\\nof\\tO\\nthe\\tO\\npoint\\tO\\nmutations\\tO\\nrepresented\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\n1\\tO\\nwas\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\n1\\tO\\nwas\\tO\\na\\tO\\nframeshift\\tO\\nmutation\\tO\\n.\\tO\\n\\nFive\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nare\\tO\\nnewly\\tO\\nreported\\tO\\nherein\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nThe\\tO\\ndiscovery\\tO\\nof\\tO\\nnew\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nthis\\tO\\nstudy\\tO\\nincreases\\tO\\nthe\\tO\\navailable\\tO\\ninformation\\tO\\nregarding\\tO\\nthe\\tO\\nspectrum\\tO\\nof\\tO\\ngenetic\\tB-Disease\\nabnormalities\\tI-Disease\\nand\\tO\\nclinical\\tO\\nmanifestations\\tO\\nof\\tO\\nXLRS\\tB-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nlimited\\tO\\ndata\\tO\\nfailed\\tO\\nto\\tO\\nreveal\\tO\\na\\tO\\ncorrelation\\tO\\nbetween\\tO\\nmutation\\tO\\nand\\tO\\ndisease\\tO\\nphenotype\\tO\\n.\\tO\\n\\nCLINICAL\\tO\\nRELEVANCE\\tO\\nIdentification\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nXLRS1\\tO\\ngene\\tO\\nand\\tO\\nexpanded\\tO\\ninformation\\tO\\non\\tO\\nclinical\\tO\\nmanifestations\\tO\\nwill\\tO\\nfacilitate\\tO\\nearly\\tO\\ndiagnosis\\tO\\n,\\tO\\nappropriate\\tO\\nearly\\tO\\ntherapy\\tO\\n,\\tO\\nand\\tO\\ngenetic\\tO\\ncounseling\\tO\\nregarding\\tO\\nthe\\tO\\nprognosis\\tO\\nof\\tO\\nXLRS\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nAtm\\tO\\nand\\tO\\nBax\\tO\\ncooperate\\tO\\nin\\tO\\nionizing\\tO\\nradiation\\tO\\n-\\tO\\ninduced\\tO\\napoptosis\\tO\\nin\\tO\\nthe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n.\\tO\\n\\nAtaxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nis\\tO\\na\\tO\\nhereditary\\tB-Disease\\nmultisystemic\\tI-Disease\\ndisease\\tI-Disease\\nresulting\\tO\\nfrom\\tO\\nmutations\\tO\\nof\\tO\\nataxia\\tB-Disease\\ntelangiectasia\\tI-Disease\\n,\\tO\\nmutated\\tO\\n(\\tO\\nATM\\tO\\n)\\tO\\nand\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nneurodegeneration\\tB-Disease\\n,\\tO\\ncancer\\tB-Disease\\n,\\tO\\nimmune\\tB-Disease\\ndefects\\tI-Disease\\n,\\tO\\nand\\tO\\nhypersensitivity\\tB-Disease\\nto\\tI-Disease\\nionizing\\tI-Disease\\nradiation\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\ndetails\\tO\\nof\\tO\\nATM\\tO\\nfunction\\tO\\nin\\tO\\nthe\\tO\\nnervous\\tO\\nsystem\\tO\\nare\\tO\\nunclear\\tO\\n,\\tO\\nalthough\\tO\\nthe\\tO\\nneurological\\tB-Disease\\nlesion\\tI-Disease\\nin\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nbecomes\\tO\\napparent\\tO\\nearly\\tO\\nin\\tO\\nlife\\tO\\n,\\tO\\nsuggesting\\tO\\na\\tO\\ndevelopmental\\tO\\norigin\\tO\\n.\\tO\\n\\nThe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n(\\tO\\nCNS\\tO\\n)\\tO\\nof\\tO\\nAtm\\tO\\n-\\tO\\nnull\\tO\\nmice\\tO\\nshows\\tO\\na\\tO\\npronounced\\tO\\ndefect\\tO\\nin\\tO\\napoptosis\\tO\\ninduced\\tO\\nby\\tO\\ngenotoxic\\tO\\nstress\\tO\\n,\\tO\\nsuggesting\\tO\\nATM\\tO\\nfunctions\\tO\\nto\\tO\\neliminate\\tO\\nneurons\\tO\\nwith\\tO\\nexcessive\\tO\\ngenomic\\tO\\ndamage\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\nthe\\tO\\ndeath\\tO\\neffector\\tO\\nBax\\tO\\nis\\tO\\nrequired\\tO\\nfor\\tO\\na\\tO\\nlarge\\tO\\nproportion\\tO\\nof\\tO\\nAtm\\tO\\n-\\tO\\ndependent\\tO\\napoptosis\\tO\\nin\\tO\\nthe\\tO\\ndeveloping\\tO\\nCNS\\tO\\nafter\\tO\\nionizing\\tO\\nradiation\\tO\\n(\\tO\\nIR\\tO\\n)\\tO\\n.\\tO\\n\\nAlthough\\tO\\nmany\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\nCNS\\tO\\nin\\tO\\nboth\\tO\\nBax\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nand\\tO\\nAtm\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\nwere\\tO\\nradioresistant\\tO\\n,\\tO\\nmice\\tO\\nnullizygous\\tO\\nfor\\tO\\nboth\\tO\\nBax\\tO\\nand\\tO\\nAtm\\tO\\nshowed\\tO\\nadditional\\tO\\nreduction\\tO\\nin\\tO\\nIR\\tO\\n-\\tO\\ninduced\\tO\\napoptosis\\tO\\nin\\tO\\nthe\\tO\\nCNS\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\nalthough\\tO\\nthe\\tO\\nmajor\\tO\\nIR\\tO\\n-\\tO\\ninduced\\tO\\napoptotic\\tO\\npathway\\tO\\nin\\tO\\nthe\\tO\\nCNS\\tO\\nrequires\\tO\\nAtm\\tO\\nand\\tO\\nBax\\tO\\n,\\tO\\na\\tO\\np53\\tO\\n-\\tO\\ndependent\\tO\\ncollateral\\tO\\npathway\\tO\\nexists\\tO\\nthat\\tO\\nhas\\tO\\nboth\\tO\\nAtm\\tO\\n-\\tO\\nand\\tO\\nBax\\tO\\n-\\tO\\nindependent\\tO\\nbranches\\tO\\n.\\tO\\n\\nFurther\\tO\\n,\\tO\\nAtm\\tO\\n-\\tO\\nand\\tO\\nBax\\tO\\n-\\tO\\ndependent\\tO\\napoptosis\\tO\\nin\\tO\\nthe\\tO\\nCNS\\tO\\nalso\\tO\\nrequired\\tO\\ncaspase\\tO\\n-\\tO\\n3\\tO\\nactivation\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nimplicate\\tO\\nBax\\tO\\nand\\tO\\ncaspase\\tO\\n-\\tO\\n3\\tO\\nas\\tO\\ndeath\\tO\\neffectors\\tO\\nin\\tO\\nneurodegenerative\\tO\\npathways\\tO\\n.\\tO\\n.\\tO\\n\\nHaim\\tB-Disease\\n-\\tI-Disease\\nMunk\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nPapillon\\tB-Disease\\n-\\tI-Disease\\nLefevre\\tI-Disease\\nsyndrome\\tI-Disease\\nare\\tO\\nallelic\\tO\\nmutations\\tO\\nin\\tO\\ncathepsin\\tO\\nC\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\nmany\\tO\\npalmoplantar\\tB-Disease\\nkeratoderma\\tI-Disease\\n(\\tI-Disease\\nPPK\\tI-Disease\\n)\\tI-Disease\\nconditions\\tI-Disease\\n,\\tO\\nonly\\tO\\nPapillon\\tB-Disease\\n-\\tI-Disease\\nLefevre\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPLS\\tB-Disease\\n)\\tO\\nand\\tO\\nHaim\\tB-Disease\\n-\\tI-Disease\\nMunk\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nHMS\\tB-Disease\\n)\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\npremature\\tO\\nperiodontal\\tO\\ndestruction\\tO\\n.\\tO\\n\\nAlthough\\tO\\nboth\\tO\\nPLS\\tB-Disease\\nand\\tO\\nHMS\\tB-Disease\\nshare\\tO\\nthe\\tO\\ncardinal\\tO\\nfeatures\\tO\\nof\\tO\\nPPK\\tB-Disease\\nand\\tO\\nsevere\\tO\\nperiodontitis\\tB-Disease\\n,\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nadditional\\tO\\nfindings\\tO\\nare\\tO\\nreported\\tO\\nin\\tO\\nHMS\\tB-Disease\\nincluding\\tO\\narachnodactyly\\tB-Disease\\n,\\tO\\nacro\\tB-Disease\\n-\\tI-Disease\\nosteolysis\\tI-Disease\\n,\\tO\\natrophic\\tB-Disease\\nchanges\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nnails\\tI-Disease\\n,\\tO\\nand\\tO\\na\\tO\\nradiographic\\tB-Disease\\ndeformity\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfingers\\tI-Disease\\n.\\tO\\n\\nWhile\\tO\\nPLS\\tB-Disease\\ncases\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nthroughout\\tO\\nthe\\tO\\nworld\\tO\\n,\\tO\\nHMS\\tB-Disease\\nhas\\tO\\nonly\\tO\\nbeen\\tO\\ndescribed\\tO\\namong\\tO\\ndescendants\\tO\\nof\\tO\\na\\tO\\nreligious\\tO\\nisolate\\tO\\noriginally\\tO\\nfrom\\tO\\nCochin\\tO\\n,\\tO\\nIndia\\tO\\n.\\tO\\n\\nParental\\tO\\nconsanguinity\\tO\\nis\\tO\\na\\tO\\ncharacteristic\\tO\\nof\\tO\\nmany\\tO\\ncases\\tO\\nof\\tO\\nboth\\tO\\nconditions\\tO\\n.\\tO\\n\\nAlthough\\tO\\nautosomal\\tO\\nrecessive\\tO\\ntransmission\\tO\\nof\\tO\\nPLS\\tB-Disease\\nis\\tO\\nevident\\tO\\n,\\tO\\na\\tO\\nmore\\tO\\n\"\\tO\\ncomplex\\tO\\n\"\\tO\\nautosomal\\tO\\nrecessive\\tO\\npattern\\tO\\nof\\tO\\ninheritance\\tO\\nwith\\tO\\nphenotypic\\tO\\ninfluences\\tO\\nfrom\\tO\\na\\tO\\nclosely\\tO\\nlinked\\tO\\nmodifying\\tO\\nlocus\\tO\\nhas\\tO\\nbeen\\tO\\nhypothesised\\tO\\nfor\\tO\\nHMS\\tB-Disease\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\ncathepsin\\tO\\nC\\tO\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nas\\tO\\nthe\\tO\\nunderlying\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\nin\\tO\\nPLS\\tB-Disease\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nif\\tO\\na\\tO\\ncathepsin\\tO\\nC\\tO\\nmutation\\tO\\nis\\tO\\nalso\\tO\\nresponsible\\tO\\nfor\\tO\\nHMS\\tB-Disease\\n,\\tO\\nwe\\tO\\nsequenced\\tO\\nthe\\tO\\ngene\\tO\\nin\\tO\\naffected\\tO\\nand\\tO\\nunaffected\\tO\\nsubjects\\tO\\nfrom\\tO\\nthe\\tO\\nCochin\\tO\\nisolate\\tO\\nin\\tO\\nwhich\\tO\\nboth\\tO\\nthe\\tO\\nPLS\\tB-Disease\\nand\\tO\\nHMS\\tB-Disease\\nphenotypes\\tO\\nappear\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nmutation\\tO\\nof\\tO\\ncathepsin\\tO\\nC\\tO\\n(\\tO\\nexon\\tO\\n6\\tO\\n,\\tO\\n2127A\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\n)\\tO\\nthat\\tO\\nchanges\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\namino\\tO\\nacid\\tO\\nin\\tO\\nthe\\tO\\ncathepsin\\tO\\nC\\tO\\npeptide\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nsegregates\\tO\\nwith\\tO\\nHMS\\tB-Disease\\nin\\tO\\nfour\\tO\\nnuclear\\tO\\nfamilies\\tO\\n.\\tO\\n\\nAdditionally\\tO\\n,\\tO\\nthe\\tO\\nexistence\\tO\\nof\\tO\\na\\tO\\nshared\\tO\\ncommon\\tO\\nhaplotype\\tO\\nfor\\tO\\ngenetic\\tO\\nloci\\tO\\nflanking\\tO\\nthe\\tO\\ncathepsin\\tO\\nC\\tO\\ngene\\tO\\nsuggests\\tO\\nthat\\tO\\naffected\\tO\\nsubjects\\tO\\ndescended\\tO\\nfrom\\tO\\nthe\\tO\\nCochin\\tO\\nisolate\\tO\\nare\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nmutation\\tO\\ninherited\\tO\\n\"\\tO\\nidentical\\tO\\nby\\tO\\ndescent\\tO\\n\"\\tO\\nfrom\\tO\\na\\tO\\ncommon\\tO\\nancestor\\tO\\n.\\tO\\n\\nThis\\tO\\nfinding\\tO\\nsupports\\tO\\nsimple\\tO\\nautosomal\\tO\\nrecessive\\tO\\ninheritance\\tO\\nfor\\tO\\nHMS\\tB-Disease\\nin\\tO\\nthese\\tO\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nreport\\tO\\na\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\nexon\\tO\\n6\\tO\\nCTSC\\tO\\ncodon\\tO\\n(\\tO\\n2126C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n)\\tO\\nin\\tO\\na\\tO\\nTurkish\\tO\\nfamily\\tO\\nwith\\tO\\nclassical\\tO\\nPLS\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nprovide\\tO\\nevidence\\tO\\nthat\\tO\\nPLS\\tB-Disease\\nand\\tO\\nHMS\\tB-Disease\\nare\\tO\\nallelic\\tO\\nvariants\\tO\\nof\\tO\\ncathepsin\\tO\\nC\\tO\\ngene\\tO\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nATM\\tO\\n-\\tO\\nheterozygous\\tO\\ngermline\\tO\\nmutations\\tO\\ncontribute\\tO\\nto\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n-\\tO\\nsusceptibility\\tO\\n.\\tO\\n\\nApproximately\\tO\\n0\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\n-\\tO\\n1\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\nhas\\tO\\nbeen\\tO\\nestimated\\tO\\nto\\tO\\nbe\\tO\\nheterozygous\\tO\\nfor\\tO\\na\\tO\\ngermline\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\n(\\tO\\nMIM\\tO\\n208900\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nfinding\\tO\\nthat\\tO\\nATM\\tO\\n-\\tO\\nheterozygotes\\tO\\nhave\\tO\\nan\\tO\\nincreased\\tO\\nrelative\\tO\\nrisk\\tO\\nfor\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nwas\\tO\\nsupported\\tO\\nby\\tO\\nsome\\tO\\nstudies\\tO\\nbut\\tO\\nnot\\tO\\nconfirmed\\tO\\nby\\tO\\nothers\\tO\\n.\\tO\\n\\nIn\\tO\\nview\\tO\\nof\\tO\\nthis\\tO\\ndiscrepancy\\tO\\n,\\tO\\nwe\\tO\\nexamined\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nATM\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\nselected\\tO\\ngroup\\tO\\nof\\tO\\nDutch\\tO\\npatients\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nanalyzed\\tO\\nATM\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nnormal\\tO\\nblood\\tO\\nlymphocytes\\tO\\n,\\tO\\nusing\\tO\\nthe\\tO\\nprotein\\tO\\n-\\tO\\ntruncation\\tO\\ntest\\tO\\nfollowed\\tO\\nby\\tO\\ngenomic\\tO\\n-\\tO\\nsequence\\tO\\nanalysis\\tO\\n.\\tO\\n\\nA\\tO\\nhigh\\tO\\npercentage\\tO\\nof\\tO\\nATM\\tO\\ngermline\\tO\\nmutations\\tO\\nwas\\tO\\ndemonstrated\\tO\\namong\\tO\\npatients\\tO\\nwith\\tO\\nsporadic\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\n82\\tO\\npatients\\tO\\nincluded\\tO\\nin\\tO\\nthis\\tO\\nstudy\\tO\\nhad\\tO\\ndeveloped\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nat\\tO\\nage\\tO\\n<\\tO\\n45\\tO\\nand\\tO\\nhad\\tO\\nsurvived\\tO\\n>\\tO\\n/\\tO\\n=\\tO\\n5\\tO\\nyears\\tO\\n(\\tO\\nmean\\tO\\n15\\tO\\nyears\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\n33\\tO\\n(\\tO\\n40\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\na\\tO\\ncontralateral\\tO\\nbreast\\tO\\ntumor\\tO\\nhad\\tO\\nbeen\\tO\\ndiagnosed\\tO\\n.\\tO\\n\\nAmong\\tO\\nthese\\tO\\npatients\\tO\\nwe\\tO\\nidentified\\tO\\nseven\\tO\\n(\\tO\\n8\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\nATM\\tO\\ngermline\\tO\\nmutations\\tO\\n,\\tO\\nof\\tO\\nwhich\\tO\\nfive\\tO\\nare\\tO\\ndistinct\\tO\\n.\\tO\\n\\nOne\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\n(\\tO\\nIVS10\\tO\\n-\\tO\\n6T\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\n)\\tO\\nwas\\tO\\ndetected\\tO\\nthree\\tO\\ntimes\\tO\\nin\\tO\\nour\\tO\\nseries\\tO\\n.\\tO\\n\\nFour\\tO\\nheterozygous\\tO\\ncarriers\\tO\\nwere\\tO\\npatients\\tO\\nwith\\tO\\nbilateral\\tO\\nbreast\\tO\\ncancer\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nmutations\\tO\\nidentified\\tO\\nin\\tO\\nthis\\tO\\nstudy\\tO\\nare\\tO\\n\"\\tO\\nA\\tO\\n-\\tO\\nT\\tO\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\n\"\\tO\\nmutations\\tO\\nthat\\tO\\nmight\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tO\\ncancer\\tO\\nin\\tO\\nheterozygotes\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nATM\\tO\\nheterozygotes\\tO\\nhave\\tO\\nan\\tO\\napproximately\\tO\\nninefold\\tO\\n-\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\ndeveloping\\tO\\na\\tO\\ntype\\tO\\nof\\tO\\nbreast\\tO\\ncancer\\tO\\ncharacterized\\tO\\nby\\tO\\nfrequent\\tO\\nbilateral\\tO\\noccurrence\\tO\\n,\\tO\\nearly\\tO\\nage\\tO\\nat\\tO\\nonset\\tO\\n,\\tO\\nand\\tO\\nlong\\tO\\n-\\tO\\nterm\\tO\\nsurvival\\tO\\n.\\tO\\n\\nThe\\tO\\nspecific\\tO\\ncharacteristics\\tO\\nof\\tO\\nour\\tO\\npopulation\\tO\\nof\\tO\\npatients\\tO\\nmay\\tO\\nexplain\\tO\\nwhy\\tO\\nsuch\\tO\\na\\tO\\nhigh\\tO\\nfrequency\\tO\\nwas\\tO\\nnot\\tO\\nfound\\tO\\nin\\tO\\nother\\tO\\nseries\\tO\\n.\\tO\\n\\nHuman\\tO\\nmutations\\tO\\nin\\tO\\nglucose\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nreflect\\tO\\nevolutionary\\tO\\nhistory\\tO\\n.\\tO\\n\\nGlucose\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nis\\tO\\na\\tO\\ncytosolic\\tO\\nenzyme\\tO\\nencoded\\tO\\nby\\tO\\na\\tO\\nhousekeeping\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\ngene\\tO\\nwhose\\tO\\nmain\\tO\\nfunction\\tO\\nis\\tO\\nto\\tO\\nproduce\\tO\\nNADPH\\tO\\n,\\tO\\na\\tO\\nkey\\tO\\nelectron\\tO\\ndonor\\tO\\nin\\tO\\nthe\\tO\\ndefense\\tO\\nagainst\\tO\\noxidizing\\tO\\nagents\\tO\\nand\\tO\\nin\\tO\\nreductive\\tO\\nbiosynthetic\\tO\\nreactions\\tO\\n.\\tO\\n\\nInherited\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nassociated\\tO\\nwith\\tO\\neither\\tO\\nepisodic\\tB-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\n(\\tO\\ntriggered\\tO\\nby\\tO\\nfava\\tO\\nbeans\\tO\\nor\\tO\\nother\\tO\\nagents\\tO\\n)\\tO\\nor\\tO\\nlife\\tB-Disease\\n-\\tI-Disease\\nlong\\tI-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nhere\\tO\\nthat\\tO\\nan\\tO\\nevolutionary\\tO\\nanalysis\\tO\\nis\\tO\\na\\tO\\nkey\\tO\\nto\\tO\\nunderstanding\\tO\\nthe\\tO\\nbiology\\tO\\nof\\tO\\na\\tO\\nhousekeeping\\tO\\ngene\\tO\\n.\\tO\\n\\nFrom\\tO\\nthe\\tO\\nalignment\\tO\\nof\\tO\\nthe\\tO\\namino\\tO\\nacid\\tO\\n(\\tO\\naa\\tO\\n)\\tO\\nsequence\\tO\\nof\\tO\\n52\\tO\\nglucose\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nspecies\\tO\\nfrom\\tO\\n42\\tO\\ndifferent\\tO\\norganisms\\tO\\n,\\tO\\nwe\\tO\\nfound\\tO\\na\\tO\\nstriking\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\naa\\tO\\nreplacements\\tO\\nthat\\tO\\ncause\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nhumans\\tO\\nand\\tO\\nthe\\tO\\nsequence\\tO\\nconservation\\tO\\nof\\tO\\nG6PD\\tO\\ntwo\\tO\\n-\\tO\\nthirds\\tO\\nof\\tO\\nsuch\\tO\\nreplacements\\tO\\nare\\tO\\nin\\tO\\nhighly\\tO\\nand\\tO\\nmoderately\\tO\\nconserved\\tO\\n(\\tO\\n50\\tO\\n-\\tO\\n99\\tO\\n%\\tO\\n)\\tO\\naa\\tO\\n;\\tO\\nrelatively\\tO\\nfew\\tO\\nare\\tO\\nin\\tO\\nfully\\tO\\nconserved\\tO\\naa\\tO\\n(\\tO\\nwhere\\tO\\nthey\\tO\\nmight\\tO\\nbe\\tO\\nlethal\\tO\\n)\\tO\\nor\\tO\\nin\\tO\\npoorly\\tO\\nconserved\\tO\\naa\\tO\\n,\\tO\\nwhere\\tO\\npresumably\\tO\\nthey\\tO\\nsimply\\tO\\nwould\\tO\\nnot\\tO\\ncause\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nnotion\\tO\\nthat\\tO\\nall\\tO\\nhuman\\tO\\nmutants\\tO\\nhave\\tO\\nresidual\\tO\\nenzyme\\tO\\nactivity\\tO\\nand\\tO\\nthat\\tO\\nnull\\tO\\nmutations\\tO\\nare\\tO\\nlethal\\tO\\nat\\tO\\nsome\\tO\\nstage\\tO\\nof\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nComparing\\tO\\nthe\\tO\\ndistribution\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\nhuman\\tO\\nhousekeeping\\tO\\ngene\\tO\\nwith\\tO\\nevolutionary\\tO\\nconservation\\tO\\nis\\tO\\na\\tO\\nuseful\\tO\\ntool\\tO\\nfor\\tO\\npinpointing\\tO\\namino\\tO\\nacid\\tO\\nresidues\\tO\\nimportant\\tO\\nfor\\tO\\nthe\\tO\\nstability\\tO\\nor\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\ncorresponding\\tO\\nprotein\\tO\\n.\\tO\\n\\nIn\\tO\\nview\\tO\\nof\\tO\\nthe\\tO\\ncurrent\\tO\\nexplosive\\tO\\nincrease\\tO\\nin\\tO\\nfull\\tO\\ngenome\\tO\\nsequencing\\tO\\nprojects\\tO\\n,\\tO\\nthis\\tO\\ntool\\tO\\nwill\\tO\\nbecome\\tO\\nrapidly\\tO\\navailable\\tO\\nfor\\tO\\nnumerous\\tO\\nother\\tO\\ngenes\\tO\\n.\\tO\\n.\\tO\\n\\nConstitutive\\tO\\nand\\tO\\nregulated\\tO\\nmodes\\tO\\nof\\tO\\nsplicing\\tO\\nproduce\\tO\\nsix\\tO\\nmajor\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nprotein\\tO\\nkinase\\tO\\n(\\tO\\nDMPK\\tO\\n)\\tO\\nisoforms\\tO\\nwith\\tO\\ndistinct\\tO\\nproperties\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\nprevalent\\tO\\ninherited\\tB-Disease\\nneuromuscular\\tI-Disease\\ndisease\\tI-Disease\\nin\\tO\\nadults\\tO\\n.\\tO\\n\\nThe\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\nis\\tO\\na\\tO\\nCTG\\tO\\ntriplet\\tO\\nrepeat\\tO\\nexpansion\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\n-\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nprotein\\tO\\nkinase\\tO\\n(\\tO\\nDMPK\\tO\\n)\\tO\\ngene\\tO\\n,\\tO\\nconsisting\\tO\\nof\\tO\\n15\\tO\\nexons\\tO\\n.\\tO\\n\\nUsing\\tO\\na\\tO\\ntransgenic\\tO\\nDMPK\\tO\\n-\\tO\\noverexpressor\\tO\\nmouse\\tO\\nmodel\\tO\\n,\\tO\\nwe\\tO\\ndemonstrate\\tO\\nhere\\tO\\nthat\\tO\\nthe\\tO\\nendogenous\\tO\\nmouse\\tO\\nDMPK\\tO\\ngene\\tO\\nand\\tO\\nthe\\tO\\nhuman\\tO\\nDMPK\\tO\\ntransgene\\tO\\nproduce\\tO\\nsix\\tO\\nmajor\\tO\\nalternatively\\tO\\nspliced\\tO\\nmRNAs\\tO\\nwhich\\tO\\nhave\\tO\\nalmost\\tO\\nidentical\\tO\\ncell\\tO\\ntype\\tO\\n-\\tO\\ndependent\\tO\\ndistribution\\tO\\nfrequencies\\tO\\nand\\tO\\nexpression\\tO\\npatterns\\tO\\n.\\tO\\n\\nUse\\tO\\nof\\tO\\na\\tO\\ncryptic\\tO\\n5\\tO\\nsplice\\tO\\nsite\\tO\\nin\\tO\\nexon\\tO\\n8\\tO\\n,\\tO\\nwhich\\tO\\nresults\\tO\\nin\\tO\\nabsence\\tO\\nor\\tO\\npresence\\tO\\nof\\tO\\n15\\tO\\nnucleotides\\tO\\nspecifying\\tO\\na\\tO\\nVSGGG\\tO\\npeptide\\tO\\nmotif\\tO\\n,\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nuse\\tO\\nof\\tO\\na\\tO\\ncryptic\\tO\\n3\\tO\\nsplice\\tO\\nsite\\tO\\nin\\tO\\nexon\\tO\\n14\\tO\\n,\\tO\\nwhich\\tO\\nleads\\tO\\nto\\tO\\na\\tO\\nframeshift\\tO\\nin\\tO\\nthe\\tO\\nmRNA\\tO\\nreading\\tO\\nframe\\tO\\n,\\tO\\noccur\\tO\\nas\\tO\\nindependent\\tO\\nstochastic\\tO\\nevents\\tO\\nin\\tO\\nall\\tO\\ntissues\\tO\\nexamined\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nthe\\tO\\nexcision\\tO\\nof\\tO\\nexons\\tO\\n13\\tO\\n/\\tO\\n14\\tO\\nthat\\tO\\ncauses\\tO\\na\\tO\\nframeshift\\tO\\nand\\tO\\ncreates\\tO\\na\\tO\\nC\\tO\\n-\\tO\\nterminally\\tO\\ntruncated\\tO\\nprotein\\tO\\nis\\tO\\nclearly\\tO\\ncell\\tO\\ntype\\tO\\ndependent\\tO\\nand\\tO\\noccurs\\tO\\npredominantly\\tO\\nin\\tO\\nsmooth\\tO\\nmuscle\\tO\\n.\\tO\\n\\nWe\\tO\\ngenerated\\tO\\nall\\tO\\nsix\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\nmouse\\tO\\ncDNAs\\tO\\nthat\\tO\\nresult\\tO\\nfrom\\tO\\ncombinations\\tO\\nof\\tO\\nthese\\tO\\nthree\\tO\\nmajor\\tO\\nsplicing\\tO\\nevents\\tO\\nand\\tO\\nshow\\tO\\nthat\\tO\\ntheir\\tO\\ntransfection\\tO\\ninto\\tO\\ncells\\tO\\nin\\tO\\nculture\\tO\\nleads\\tO\\nto\\tO\\nproduction\\tO\\nof\\tO\\nfour\\tO\\ndifferent\\tO\\napproximately\\tO\\n74\\tO\\nkDa\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\n(\\tO\\nheart\\tO\\n-\\tO\\n,\\tO\\nskeletal\\tO\\nmuscle\\tO\\n-\\tO\\nor\\tO\\nbrain\\tO\\n-\\tO\\nspecific\\tO\\n)\\tO\\nand\\tO\\ntwo\\tO\\nC\\tO\\n-\\tO\\nterminally\\tO\\ntruncated\\tO\\napproximately\\tO\\n68\\tO\\nkDa\\tO\\n(\\tO\\nsmooth\\tO\\nmuscle\\tO\\n-\\tO\\nspecific\\tO\\n)\\tO\\nisoforms\\tO\\n.\\tO\\n\\nInformation\\tO\\non\\tO\\nDMPK\\tO\\nmRNA\\tO\\nand\\tO\\nprotein\\tO\\nisoform\\tO\\nexpression\\tO\\npatterns\\tO\\nwill\\tO\\nbe\\tO\\nuseful\\tO\\nfor\\tO\\nrecognizing\\tO\\ndifferential\\tO\\neffects\\tO\\nof\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\n(\\tO\\nn\\tO\\n)\\tO\\nexpansion\\tO\\nin\\tO\\nDM\\tB-Disease\\nmanifestation\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nanalysis\\tO\\n,\\tO\\nphenotypic\\tO\\ndiagnosis\\tO\\n,\\tO\\nand\\tO\\nrisk\\tO\\nof\\tO\\nvenous\\tB-Disease\\nthrombosis\\tI-Disease\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\ninherited\\tO\\ndeficiencies\\tB-Disease\\nof\\tI-Disease\\nprotein\\tI-Disease\\nS\\tI-Disease\\n.\\tO\\n\\nProtein\\tB-Disease\\nS\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\na\\tO\\nrecognized\\tO\\nrisk\\tO\\nfactor\\tO\\nfor\\tO\\nvenous\\tB-Disease\\nthrombosis\\tI-Disease\\n.\\tO\\n\\nOf\\tO\\nall\\tO\\nthe\\tO\\ninherited\\tO\\nthrombophilic\\tB-Disease\\nconditions\\tI-Disease\\n,\\tO\\nit\\tO\\nremains\\tO\\nthe\\tO\\nmost\\tO\\ndifficult\\tO\\nto\\tO\\ndiagnose\\tO\\nbecause\\tO\\nof\\tO\\nphenotypic\\tO\\nvariability\\tO\\n,\\tO\\nwhich\\tO\\ncan\\tO\\nlead\\tO\\nto\\tO\\ninconclusive\\tO\\nresults\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\novercome\\tO\\nthis\\tO\\nproblem\\tO\\nby\\tO\\nstudying\\tO\\na\\tO\\ncohort\\tO\\nof\\tO\\npatients\\tO\\nfrom\\tO\\na\\tO\\nsingle\\tO\\ncenter\\tO\\nwhere\\tO\\nthe\\tO\\ndiagnosis\\tO\\nwas\\tO\\nconfirmed\\tO\\nat\\tO\\nthe\\tO\\ngenetic\\tO\\nlevel\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\neight\\tO\\nindex\\tO\\npatients\\tO\\nwith\\tO\\nprotein\\tB-Disease\\nS\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\na\\tO\\nPROS1\\tB-Disease\\ngene\\tI-Disease\\ndefect\\tI-Disease\\nwere\\tO\\nstudied\\tO\\n,\\tO\\ntogether\\tO\\nwith\\tO\\n109\\tO\\nfirst\\tO\\n-\\tO\\ndegree\\tO\\nrelatives\\tO\\n.\\tO\\n\\nTo\\tO\\navoid\\tO\\nselection\\tO\\nbias\\tO\\n,\\tO\\nwe\\tO\\nconfined\\tO\\nanalysis\\tO\\nof\\tO\\ntotal\\tO\\nand\\tO\\nfree\\tO\\nprotein\\tO\\nS\\tO\\nlevels\\tO\\nand\\tO\\nthrombotic\\tO\\nrisk\\tO\\nto\\tO\\nthe\\tO\\npatients\\tO\\nrelatives\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\ngroup\\tO\\nof\\tO\\nrelatives\\tO\\n,\\tO\\na\\tO\\nlow\\tO\\nfree\\tO\\nprotein\\tO\\nS\\tO\\nlevel\\tO\\nwas\\tO\\nthe\\tO\\nmost\\tO\\nreliable\\tO\\npredictor\\tO\\nof\\tO\\na\\tO\\nPROS1\\tB-Disease\\ngene\\tI-Disease\\ndefect\\tI-Disease\\n(\\tO\\nsensitivity\\tO\\n97\\tO\\n.\\tO\\n7\\tO\\n%\\tO\\n,\\tO\\nspecificity\\tO\\n100\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nFirst\\tO\\n-\\tO\\ndegree\\tO\\nrelatives\\tO\\nwith\\tO\\na\\tO\\nPROS1\\tB-Disease\\ngene\\tI-Disease\\ndefect\\tI-Disease\\nhad\\tO\\na\\tO\\n5\\tO\\n.\\tO\\n\\n0\\tO\\n-\\tO\\nfold\\tO\\nhigher\\tO\\nrisk\\tO\\nof\\tO\\nthrombosis\\tB-Disease\\n(\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\n,\\tO\\n1\\tO\\n.\\tO\\n5\\tO\\n-\\tO\\n16\\tO\\n.\\tO\\n8\\tO\\n)\\tO\\nthan\\tO\\nthose\\tO\\nwith\\tO\\na\\tO\\nnormal\\tO\\nPROS1\\tO\\ngene\\tO\\nand\\tO\\nno\\tO\\nother\\tO\\nrecognized\\tO\\nthrombophilic\\tB-Disease\\ndefect\\tI-Disease\\n.\\tO\\n\\nAlthough\\tO\\npregnancy\\tO\\n/\\tO\\npuerperium\\tO\\nand\\tO\\nimmobility\\tO\\n/\\tO\\ntrauma\\tB-Disease\\nwere\\tO\\nimportant\\tO\\nprecipitating\\tO\\nfactors\\tO\\nfor\\tO\\nthrombosis\\tB-Disease\\n,\\tO\\nalmost\\tO\\nhalf\\tO\\nof\\tO\\nthe\\tO\\nevents\\tO\\nwere\\tO\\nspontaneous\\tO\\n.\\tO\\n\\nRelatives\\tO\\nwith\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nor\\tO\\nmajor\\tO\\nstructural\\tO\\ndefects\\tB-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\nPROS1\\tI-Disease\\ngene\\tI-Disease\\nwere\\tO\\nmore\\tO\\nlikely\\tO\\nto\\tO\\nhave\\tO\\nhad\\tO\\na\\tO\\nthrombotic\\tO\\nevent\\tO\\nand\\tO\\nhad\\tO\\nsignificantly\\tO\\nlower\\tO\\ntotal\\tO\\nand\\tO\\nfree\\tO\\nprotein\\tO\\nS\\tO\\nlevels\\tO\\nthan\\tO\\nthose\\tO\\nrelatives\\tO\\nhaving\\tO\\nmissense\\tO\\nmutations\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\npersons\\tO\\nwith\\tO\\nPROS1\\tB-Disease\\ngene\\tI-Disease\\ndefects\\tI-Disease\\nand\\tO\\nprotein\\tB-Disease\\nS\\tI-Disease\\ndeficiency\\tI-Disease\\nare\\tO\\nat\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\nthrombosis\\tB-Disease\\nand\\tO\\nthat\\tO\\nfree\\tO\\nprotein\\tO\\nS\\tO\\nestimation\\tO\\noffers\\tO\\nthe\\tO\\nmost\\tO\\nreliable\\tO\\nway\\tO\\nof\\tO\\ndiagnosing\\tO\\nthe\\tO\\ndeficiency\\tO\\n.\\tO\\n\\n(\\tO\\nBlood\\tO\\n.\\tO\\n2000\\tO\\n;\\tO\\n95\\tO\\n1935\\tO\\n-\\tO\\n1941\\tO\\n)\\tO\\n.\\tO\\n\\nAutoimmune\\tB-Disease\\nlymphoproliferative\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nALPS\\tB-Disease\\n)\\tO\\nin\\tO\\na\\tO\\nchild\\tO\\nfrom\\tO\\nconsanguineous\\tO\\nparents\\tO\\n:\\tO\\na\\tO\\ndominant\\tO\\nor\\tO\\nrecessive\\tO\\ndisease\\tO\\n?\\tO\\n\\nAutoimmune\\tB-Disease\\nlymphoproliferative\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nALPS\\tB-Disease\\n)\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nautoimmune\\tO\\nfeatures\\tO\\nand\\tO\\nlymphoproliferations\\tO\\nand\\tO\\nis\\tO\\ngenerally\\tO\\ncaused\\tO\\nby\\tO\\ndefective\\tO\\nFas\\tO\\n-\\tO\\nmediated\\tO\\napoptosis\\tO\\n.\\tO\\n\\nThis\\tO\\nreport\\tO\\ndescribes\\tO\\na\\tO\\nchild\\tO\\nwith\\tO\\nclinical\\tO\\nfeatures\\tO\\nof\\tO\\nALPS\\tB-Disease\\nwithout\\tO\\ndetectable\\tO\\nFas\\tO\\nexpression\\tO\\non\\tO\\nfreshly\\tO\\nisolated\\tO\\nblood\\tO\\nleukocytes\\tO\\n.\\tO\\n\\nDetection\\tO\\nof\\tO\\nFAS\\tO\\ntranscripts\\tO\\nvia\\tO\\nreal\\tO\\n-\\tO\\ntime\\tO\\nquantitative\\tO\\nPCR\\tO\\nmade\\tO\\na\\tO\\nsevere\\tO\\ntranscriptional\\tO\\ndefect\\tO\\nunlikely\\tO\\n.\\tO\\n\\nSequencing\\tO\\nof\\tO\\nthe\\tO\\nFAS\\tO\\ngene\\tO\\nrevealed\\tO\\na\\tO\\n20\\tO\\n-\\tO\\nnucleotide\\tO\\nduplication\\tO\\nin\\tO\\nthe\\tO\\nlast\\tO\\nexon\\tO\\naffecting\\tO\\nthe\\tO\\ncytoplasmic\\tO\\nsignaling\\tO\\ndomain\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\nwas\\tO\\nhomozygous\\tO\\nfor\\tO\\nthis\\tO\\nmutation\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nconsanguineous\\tO\\nparents\\tO\\nand\\tO\\nthe\\tO\\nsiblings\\tO\\nwere\\tO\\nheterozygous\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\nreported\\tO\\nhere\\tO\\nis\\tO\\na\\tO\\nhuman\\tO\\nhomologue\\tO\\nof\\tO\\nthe\\tO\\nFas\\tO\\n-\\tO\\nnull\\tO\\nmouse\\tO\\n,\\tO\\ninasmuch\\tO\\nas\\tO\\nshe\\tO\\ncarries\\tO\\nan\\tO\\nautosomal\\tO\\nhomozygous\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nFAS\\tO\\ngene\\tO\\nand\\tO\\nshe\\tO\\nshows\\tO\\nthe\\tO\\nsevere\\tO\\nand\\tO\\naccelerated\\tO\\nALPS\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nThe\\tO\\nheterozygous\\tO\\nfamily\\tO\\nmembers\\tO\\ndid\\tO\\nnot\\tO\\nhave\\tO\\nthe\\tO\\nALPS\\tB-Disease\\nphenotype\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nthe\\tO\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\nFAS\\tO\\nmutation\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nis\\tO\\nautosomal\\tO\\nrecessive\\tO\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nnovel\\tO\\nimprinted\\tO\\ntranscripts\\tO\\nin\\tO\\nthe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nAngelman\\tB-Disease\\nsyndrome\\tI-Disease\\ndeletion\\tO\\nregion\\tO\\n:\\tO\\nfurther\\tO\\nevidence\\tO\\nfor\\tO\\nregional\\tO\\nimprinting\\tO\\ncontrol\\tO\\n.\\tO\\n\\nDeletions\\tO\\nand\\tO\\nother\\tO\\nabnormalities\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\ntwo\\tO\\ndevelopmental\\tO\\ndisorders\\tO\\n,\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\nand\\tO\\nAngelman\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nAS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nLoss\\tO\\nof\\tO\\nexpression\\tO\\nof\\tO\\nimprinted\\tO\\n,\\tO\\npaternally\\tO\\nexpressed\\tO\\ngenes\\tO\\nhas\\tO\\nbeen\\tO\\nimplicated\\tO\\nin\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\nimprinted\\tO\\ngenes\\tO\\nthat\\tO\\ncontribute\\tO\\nto\\tO\\nPWS\\tB-Disease\\n,\\tO\\nand\\tO\\nthe\\tO\\nrange\\tO\\nover\\tO\\nwhich\\tO\\nthe\\tO\\nimprinting\\tO\\nsignal\\tO\\nacts\\tO\\nto\\tO\\nsilence\\tO\\none\\tO\\ncopy\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nparent\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\norigin\\tO\\n-\\tO\\nspecific\\tO\\nmanner\\tO\\n,\\tO\\nare\\tO\\nunknown\\tO\\n.\\tO\\n\\nTo\\tO\\nidentify\\tO\\nadditional\\tO\\nimprinted\\tO\\ngenes\\tO\\nthat\\tO\\ncould\\tO\\ncontribute\\tO\\nto\\tO\\nthe\\tO\\nPWS\\tB-Disease\\nphenotype\\tO\\nand\\tO\\nto\\tO\\nunderstand\\tO\\nthe\\tO\\nregional\\tO\\ncontrol\\tO\\nof\\tO\\nimprinting\\tO\\nin\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nconstructed\\tO\\nan\\tO\\nimprinted\\tO\\ntranscript\\tO\\nmap\\tO\\nof\\tO\\nthe\\tO\\nPWS\\tO\\n-\\tO\\nAS\\tO\\ndeletion\\tO\\ninterval\\tO\\n.\\tO\\n\\nThe\\tO\\nimprinting\\tO\\nstatus\\tO\\nof\\tO\\n22\\tO\\nexpressed\\tO\\nsequence\\tO\\ntags\\tO\\nderived\\tO\\nfrom\\tO\\nthe\\tO\\nradiation\\tO\\n-\\tO\\nhybrid\\tO\\nhuman\\tO\\ntranscript\\tO\\nmaps\\tO\\nor\\tO\\nphysical\\tO\\nmaps\\tO\\nwas\\tO\\ndetermined\\tO\\nin\\tO\\na\\tO\\nreverse\\tO\\ntranscriptase\\tO\\n-\\tO\\nPCR\\tO\\nassay\\tO\\nand\\tO\\ncorrelated\\tO\\nwith\\tO\\nthe\\tO\\nposition\\tO\\nof\\tO\\nthe\\tO\\ntranscripts\\tO\\non\\tO\\nthe\\tO\\nphysical\\tO\\nmap\\tO\\n.\\tO\\n\\nSeven\\tO\\nnew\\tO\\npaternally\\tO\\nexpressed\\tO\\ntranscripts\\tO\\nlocalize\\tO\\nto\\tO\\nan\\tO\\napproximately\\tO\\n1\\tO\\n.\\tO\\n\\n5\\tO\\n-\\tO\\nMb\\tO\\ndomain\\tO\\nsurrounding\\tO\\nthe\\tO\\nSNRPN\\tO\\n-\\tO\\nassociated\\tO\\nimprinting\\tO\\ncenter\\tO\\n,\\tO\\nwhich\\tO\\nalready\\tO\\nincludes\\tO\\nfour\\tO\\nimprinted\\tO\\n,\\tO\\npaternally\\tO\\nexpressed\\tO\\ngenes\\tO\\n.\\tO\\n\\nAll\\tO\\nother\\tO\\ntested\\tO\\nnew\\tO\\ntranscripts\\tO\\nin\\tO\\nthe\\tO\\ndeletion\\tO\\nregion\\tO\\nwere\\tO\\nexpressed\\tO\\nfrom\\tO\\nboth\\tO\\nalleles\\tO\\n.\\tO\\n\\nA\\tO\\ndomain\\tO\\nof\\tO\\nexclusive\\tO\\npaternal\\tO\\nexpression\\tO\\nsurrounding\\tO\\nthe\\tO\\nimprinting\\tO\\ncenter\\tO\\nsuggests\\tO\\nstrong\\tO\\nregional\\tO\\ncontrol\\tO\\nof\\tO\\nthe\\tO\\nimprinting\\tO\\nprocess\\tO\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\nprovides\\tO\\nthe\\tO\\nmeans\\tO\\nfor\\tO\\nfurther\\tO\\ninvestigation\\tO\\nof\\tO\\nadditional\\tO\\ngenes\\tO\\nthat\\tO\\ncause\\tO\\nor\\tO\\nmodify\\tO\\nthe\\tO\\nphenotypes\\tO\\nassociated\\tO\\nwith\\tO\\nrearrangements\\tO\\nof\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\n.\\tO\\n\\nCombined\\tO\\nanalysis\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\nlinkage\\tO\\nto\\tO\\n1q24\\tO\\n-\\tO\\n25\\tO\\n:\\tO\\nresults\\tO\\nfrom\\tO\\n772\\tO\\nhereditary\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nfrom\\tO\\nthe\\tO\\nInternational\\tO\\nConsortium\\tO\\nfor\\tO\\nProstate\\tB-Disease\\nCancer\\tI-Disease\\nGenetics\\tO\\n.\\tO\\n\\nA\\tO\\nprevious\\tO\\nlinkage\\tO\\nstudy\\tO\\nprovided\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\n-\\tO\\nsusceptibility\\tO\\nlocus\\tO\\nat\\tO\\n1q24\\tO\\n-\\tO\\n25\\tO\\n.\\tO\\n\\nSubsequent\\tO\\nreports\\tO\\nin\\tO\\nadditional\\tO\\ncollections\\tO\\nof\\tO\\nfamilies\\tO\\nhave\\tO\\nyielded\\tO\\nconflicting\\tO\\nresults\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nevidence\\tO\\nfor\\tO\\nlocus\\tO\\nheterogeneity\\tO\\nhas\\tO\\nbeen\\tO\\nprovided\\tO\\nby\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\nother\\tO\\nputative\\tO\\nhereditary\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\nloci\\tO\\non\\tO\\nXq27\\tO\\n-\\tO\\n28\\tO\\n,\\tO\\n1q42\\tO\\n-\\tO\\n43\\tO\\n,\\tO\\nand\\tO\\n1p36\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nstudy\\tO\\ndescribes\\tO\\na\\tO\\ncombined\\tO\\nanalysis\\tO\\nfor\\tO\\nsix\\tO\\nmarkers\\tO\\nin\\tO\\nthe\\tO\\n1q24\\tO\\n-\\tO\\n25\\tO\\nregion\\tO\\nin\\tO\\n772\\tO\\nfamilies\\tO\\naffected\\tO\\nby\\tO\\nhereditary\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\nascertained\\tO\\nby\\tO\\nthe\\tO\\nmembers\\tO\\nof\\tO\\nthe\\tO\\nInternational\\tO\\nConsortium\\tO\\nfor\\tO\\nProstate\\tB-Disease\\nCancer\\tI-Disease\\nGenetics\\tO\\n(\\tO\\nICPCG\\tO\\n)\\tO\\nfrom\\tO\\nNorth\\tO\\nAmerica\\tO\\n,\\tO\\nAustralia\\tO\\n,\\tO\\nFinland\\tO\\n,\\tO\\nNorway\\tO\\n,\\tO\\nSweden\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nUnited\\tO\\nKingdom\\tO\\n.\\tO\\n\\nOverall\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\nsome\\tO\\nevidence\\tO\\nfor\\tO\\nlinkage\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\npeak\\tO\\nparametric\\tO\\nmultipoint\\tO\\nLOD\\tO\\nscore\\tO\\nassuming\\tO\\nheterogeneity\\tO\\n(\\tO\\nHLOD\\tO\\n)\\tO\\nof\\tO\\n1\\tO\\n.\\tO\\n\\n40\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n01\\tO\\n)\\tO\\nat\\tO\\nD1S212\\tO\\n.\\tO\\n\\nThe\\tO\\nestimated\\tO\\nproportion\\tO\\nof\\tO\\nfamilies\\tO\\n(\\tO\\nalpha\\tO\\n)\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nlocus\\tO\\nwas\\tO\\n.\\tO\\n\\n06\\tO\\n(\\tO\\n1\\tO\\n-\\tO\\nLOD\\tO\\nsupport\\tO\\ninterval\\tO\\n.\\tO\\n01\\tO\\n-\\tO\\n.\\tO\\n12\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nevidence\\tO\\nwas\\tO\\nnot\\tO\\nobserved\\tO\\nby\\tO\\na\\tO\\nnonparametric\\tO\\napproach\\tO\\n,\\tO\\npresumably\\tO\\nbecause\\tO\\nof\\tO\\nthe\\tO\\nextensive\\tO\\nheterogeneity\\tO\\n.\\tO\\n\\nFurther\\tO\\nparametric\\tO\\nanalysis\\tO\\nrevealed\\tO\\na\\tO\\nsignificant\\tO\\neffect\\tO\\nof\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nmale\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nmale\\tO\\ndisease\\tO\\ntransmission\\tO\\nwithin\\tO\\nthe\\tO\\nfamilies\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nsubset\\tO\\nof\\tO\\n491\\tO\\nsuch\\tO\\nfamilies\\tO\\n,\\tO\\nthe\\tO\\npeak\\tO\\nHLOD\\tO\\nwas\\tO\\n2\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nsubset\\tO\\nof\\tO\\n491\\tO\\nsuch\\tO\\nfamilies\\tO\\n,\\tO\\nthe\\tO\\npeak\\tO\\nHLOD\\tO\\nwas\\tO\\n2\\tO\\n.\\tO\\n\\n56\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n0006\\tO\\n)\\tO\\nand\\tO\\nalpha\\tO\\n=\\tO\\n.\\tO\\n\\n11\\tO\\n(\\tO\\n1\\tO\\n-\\tO\\nLOD\\tO\\nsupport\\tO\\ninterval\\tO\\n.\\tO\\n04\\tO\\n-\\tO\\n.\\tO\\n19\\tO\\n)\\tO\\n,\\tO\\ncompared\\tO\\nwith\\tO\\nHLODs\\tO\\nof\\tO\\n0\\tO\\nin\\tO\\nthe\\tO\\nremaining\\tO\\n281\\tO\\nfamilies\\tO\\n.\\tO\\n\\nWithin\\tO\\nthe\\tO\\nfamilies\\tO\\nwith\\tO\\nmale\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nmale\\tO\\ndisease\\tO\\ntransmission\\tO\\n,\\tO\\nalpha\\tO\\nincreased\\tO\\nwith\\tO\\nthe\\tO\\nearly\\tO\\nmean\\tO\\nage\\tO\\nat\\tO\\ndiagnosis\\tO\\n(\\tO\\n<\\tO\\n65\\tO\\nyears\\tO\\n,\\tO\\nalpha\\tO\\n=\\tO\\n.\\tO\\n19\\tO\\n,\\tO\\nwith\\tO\\n1\\tO\\n-\\tO\\nLOD\\tO\\nsupport\\tO\\ninterval\\tO\\n.\\tO\\n06\\tO\\n-\\tO\\n.\\tO\\n34\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\naffected\\tO\\nfamily\\tO\\nmembers\\tO\\n(\\tO\\nfive\\tO\\nor\\tO\\nmore\\tO\\nfamily\\tO\\nmembers\\tO\\n,\\tO\\nalpha\\tO\\n=\\tO\\n.\\tO\\n15\\tO\\n,\\tO\\nwith\\tO\\n1\\tO\\n-\\tO\\nLOD\\tO\\nsupport\\tO\\ninterval\\tO\\n.\\tO\\n04\\tO\\n-\\tO\\n.\\tO\\n28\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nhighest\\tO\\nvalue\\tO\\nof\\tO\\nalpha\\tO\\nwas\\tO\\nobserved\\tO\\nfor\\tO\\nthe\\tO\\n48\\tO\\nfamilies\\tO\\nthat\\tO\\nmet\\tO\\nall\\tO\\nthree\\tO\\ncriteria\\tO\\n(\\tO\\npeak\\tO\\nHLOD\\tO\\n=\\tO\\n2\\tO\\n.\\tO\\n25\\tO\\n,\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n001\\tO\\n,\\tO\\nalpha\\tO\\n=\\tO\\n.\\tO\\n29\\tO\\n,\\tO\\nwith\\tO\\n1\\tO\\n-\\tO\\nLOD\\tO\\nsupport\\tO\\ninterval\\tO\\n.\\tO\\n08\\tO\\n-\\tO\\n.\\tO\\n53\\tO\\n)\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsupport\\tO\\nthe\\tO\\nfinding\\tO\\nof\\tO\\na\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\n-\\tO\\nsusceptibility\\tO\\ngene\\tO\\nlinked\\tO\\nto\\tO\\n1q24\\tO\\n-\\tO\\n25\\tO\\n,\\tO\\nalbeit\\tO\\nin\\tO\\na\\tO\\ndefined\\tO\\nsubset\\tO\\nof\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nAlthough\\tO\\nHPC1\\tO\\naccounts\\tO\\nfor\\tO\\nonly\\tO\\na\\tO\\nsmall\\tO\\nproportion\\tO\\nof\\tO\\nall\\tO\\nfamilies\\tO\\naffected\\tO\\nby\\tO\\nhereditary\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nit\\tO\\nappears\\tO\\nto\\tO\\nplay\\tO\\na\\tO\\nmore\\tO\\nprominent\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\nsubset\\tO\\nof\\tO\\nfamilies\\tO\\nwith\\tO\\nseveral\\tO\\nmembers\\tO\\naffected\\tO\\nat\\tO\\nan\\tO\\nearly\\tO\\nage\\tO\\nand\\tO\\nwith\\tO\\nmale\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nmale\\tO\\ndisease\\tO\\ntransmission\\tO\\n.\\tO\\n\\nA\\tO\\nrecurrent\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nmaternal\\tO\\nallele\\tO\\nwith\\tO\\n36\\tO\\nCAG\\tO\\nrepeats\\tO\\ncauses\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\nin\\tO\\ntwo\\tO\\nsisters\\tO\\n.\\tO\\n\\nLarge\\tO\\nintergenerational\\tO\\nrepeat\\tO\\nexpansions\\tO\\nof\\tO\\nthe\\tO\\nCAG\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nwell\\tO\\ndocumented\\tO\\nfor\\tO\\nthe\\tO\\nmale\\tO\\ngermline\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\na\\tO\\nrecurrent\\tO\\nlarge\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nmaternal\\tO\\nallele\\tO\\nwith\\tO\\n36\\tO\\nCAG\\tO\\nrepeats\\tO\\n(\\tO\\nto\\tO\\n66\\tO\\nand\\tO\\n57\\tO\\nrepeats\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nin\\tO\\ntwo\\tO\\ndaughters\\tO\\n)\\tO\\nassociated\\tO\\nwith\\tO\\nonset\\tO\\nof\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nin\\tO\\nthe\\tO\\nsecond\\tO\\nand\\tO\\nthird\\tO\\ndecade\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nwithout\\tO\\nhistory\\tO\\nof\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\ngive\\tO\\nevidence\\tO\\nof\\tO\\na\\tO\\ngonadal\\tO\\nmosaicism\\tO\\nin\\tO\\nthe\\tO\\nunaffected\\tO\\nmother\\tO\\n.\\tO\\n\\nWe\\tO\\nhypothesize\\tO\\nthat\\tO\\nlarge\\tO\\nexpansions\\tO\\nalso\\tO\\noccur\\tO\\nin\\tO\\nthe\\tO\\nfemale\\tO\\ngermline\\tO\\nand\\tO\\nthat\\tO\\na\\tO\\nnegative\\tO\\nselection\\tO\\nof\\tO\\noocytes\\tO\\nwith\\tO\\nlong\\tO\\nrepeats\\tO\\nmight\\tO\\nexplain\\tO\\nthe\\tO\\ndifferent\\tO\\ninstability\\tO\\nbehavior\\tO\\nof\\tO\\nthe\\tO\\nmale\\tO\\nand\\tO\\nthe\\tO\\nfemale\\tO\\ngermlines\\tO\\n.\\tO\\n.\\tO\\n\\nAbnormal\\tO\\ndevelopment\\tO\\nof\\tO\\nPurkinje\\tO\\ncells\\tO\\nand\\tO\\nlymphocytes\\tO\\nin\\tO\\nAtm\\tO\\nmutant\\tO\\nmice\\tO\\n.\\tO\\n\\nMotor\\tB-Disease\\nincoordination\\tI-Disease\\n,\\tO\\nimmune\\tB-Disease\\ndeficiencies\\tI-Disease\\n,\\tO\\nand\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\ncancer\\tB-Disease\\nare\\tO\\nthe\\tO\\ncharacteristic\\tO\\nfeatures\\tO\\nof\\tO\\nthe\\tO\\nhereditary\\tB-Disease\\ndisease\\tI-Disease\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\n.\\tO\\n\\nThrough\\tO\\ngene\\tO\\ntargeting\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ngenerated\\tO\\na\\tO\\nline\\tO\\nof\\tO\\nAtm\\tO\\nmutant\\tO\\nmice\\tO\\n,\\tO\\nAtm\\tO\\n(\\tO\\ny\\tO\\n/\\tO\\ny\\tO\\n)\\tO\\nmice\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\nto\\tO\\nother\\tO\\nAtm\\tO\\nmutant\\tO\\nmice\\tO\\n,\\tO\\nAtm\\tO\\n(\\tO\\ny\\tO\\n/\\tO\\ny\\tO\\n)\\tO\\nmice\\tO\\nshow\\tO\\na\\tO\\nlower\\tO\\nincidence\\tO\\nof\\tO\\nthymic\\tB-Disease\\nlymphoma\\tI-Disease\\nand\\tO\\nsurvive\\tO\\nbeyond\\tO\\na\\tO\\nfew\\tO\\nmonths\\tO\\nof\\tO\\nage\\tO\\n.\\tO\\n\\nAtm\\tO\\n(\\tO\\ny\\tO\\n/\\tO\\ny\\tO\\n)\\tO\\nmice\\tO\\nexhibit\\tO\\ndeficits\\tO\\nin\\tO\\nmotor\\tO\\nlearning\\tO\\nindicative\\tO\\nof\\tO\\ncerebellar\\tB-Disease\\ndysfunction\\tI-Disease\\n.\\tO\\n\\nEven\\tO\\nthough\\tO\\nwe\\tO\\nfound\\tO\\nno\\tO\\ngross\\tO\\ncerebellar\\tB-Disease\\ndegeneration\\tI-Disease\\nin\\tO\\nolder\\tO\\nAtm\\tO\\n(\\tO\\ny\\tO\\n/\\tO\\ny\\tO\\n)\\tO\\nanimals\\tO\\n,\\tO\\nectopic\\tO\\nand\\tO\\nabnormally\\tO\\ndifferentiated\\tO\\nPurkinje\\tO\\ncells\\tO\\nwere\\tO\\napparent\\tO\\nin\\tO\\nmutant\\tO\\nmice\\tO\\nof\\tO\\nall\\tO\\nages\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nestablish\\tO\\nthat\\tO\\nsome\\tO\\nneuropathological\\tB-Disease\\nabnormalities\\tI-Disease\\nseen\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\nalso\\tO\\nare\\tO\\npresent\\tO\\nin\\tO\\nAtm\\tO\\nmutant\\tO\\nmice\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\na\\tO\\npreviously\\tO\\nunrecognized\\tO\\neffect\\tO\\nof\\tO\\nAtm\\tB-Disease\\ndeficiency\\tI-Disease\\non\\tO\\ndevelopment\\tO\\nor\\tO\\nmaintenance\\tO\\nof\\tO\\nCD4\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\n8\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\nthymocytes\\tO\\n.\\tO\\n\\nWe\\tO\\ndiscuss\\tO\\nthese\\tO\\nfindings\\tO\\nin\\tO\\nthe\\tO\\ncontext\\tO\\nof\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nabnormal\\tO\\ndevelopment\\tO\\nof\\tO\\nPurkinje\\tO\\ncells\\tO\\nand\\tO\\nlymphocytes\\tO\\ncontributes\\tO\\nto\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nNovel\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nATP7B\\tO\\ngene\\tO\\nin\\tO\\nJapanese\\tO\\npatients\\tO\\nwith\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nWD\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\ncopper\\tO\\naccumulation\\tO\\nin\\tO\\nthe\\tO\\nliver\\tO\\n,\\tO\\nbrain\\tO\\n,\\tO\\nkidneys\\tO\\n,\\tO\\nand\\tO\\ncorneas\\tO\\n,\\tO\\nand\\tO\\nculminating\\tO\\nin\\tO\\ncopper\\tO\\ntoxication\\tO\\nin\\tO\\nthese\\tO\\norgans\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nanalyzed\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nresponsible\\tO\\ngene\\tO\\n,\\tO\\nATP7B\\tO\\n,\\tO\\nin\\tO\\nfour\\tO\\nJapanese\\tO\\npatients\\tO\\nwith\\tO\\nWD\\tB-Disease\\n.\\tO\\n\\nBy\\tO\\ndirect\\tO\\nsequencing\\tO\\n,\\tO\\nwe\\tO\\nidentified\\tO\\nfive\\tO\\nmutations\\tO\\n,\\tO\\nof\\tO\\nwhich\\tO\\ntwo\\tO\\nwere\\tO\\nnovel\\tO\\n,\\tO\\nand\\tO\\n16\\tO\\npolymorphisms\\tO\\n,\\tO\\nof\\tO\\nwhich\\tO\\n6\\tO\\nwere\\tO\\nnovel\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\n2871delC\\tO\\nand\\tO\\n2513delA\\tO\\nshift\\tO\\nthe\\tO\\nreading\\tO\\nframe\\tO\\nso\\tO\\nthat\\tO\\ntruncated\\tO\\nabnormal\\tO\\nprotein\\tO\\nis\\tO\\nexpected\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\nto\\tO\\nthese\\tO\\nmutations\\tO\\nfound\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nhepatic\\tO\\n-\\tO\\ntype\\tO\\nof\\tO\\nearly\\tO\\nonset\\tO\\n,\\tO\\nthe\\tO\\nmutations\\tO\\nA874V\\tO\\n,\\tO\\nR778L\\tO\\n,\\tO\\nand\\tO\\n3892delGTC\\tO\\nwere\\tO\\neither\\tO\\nmissense\\tO\\nmutations\\tO\\nor\\tO\\nin\\tO\\nframe\\tO\\n1\\tO\\n-\\tO\\namino\\tO\\nacid\\tO\\ndeletion\\tO\\n,\\tO\\nand\\tO\\noccurred\\tO\\nin\\tO\\nthe\\tO\\npatients\\tO\\nwith\\tO\\nhepato\\tO\\n-\\tO\\nneurologic\\tO\\ntype\\tO\\nof\\tO\\nlate\\tO\\nonset\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\n2871delC\\tO\\nand\\tO\\nR778L\\tO\\nhave\\tO\\nbeen\\tO\\npreviously\\tO\\nreported\\tO\\nin\\tO\\na\\tO\\nrelatively\\tO\\nlarge\\tO\\nnumber\\tO\\nof\\tO\\nJapanese\\tO\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\nparticular\\tO\\n,\\tO\\nR778L\\tO\\nis\\tO\\nknown\\tO\\nto\\tO\\nbe\\tO\\nmore\\tO\\nprevalent\\tO\\nin\\tO\\nAsian\\tO\\ncountries\\tO\\nthan\\tO\\nin\\tO\\nother\\tO\\ncountries\\tO\\nof\\tO\\nthe\\tO\\nworld\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nare\\tO\\ncompatible\\tO\\nwith\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nthe\\tO\\nmutations\\tO\\ntend\\tO\\nto\\tO\\noccur\\tO\\nin\\tO\\na\\tO\\npopulation\\tO\\n-\\tO\\nspecific\\tO\\nmanner\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\nthe\\tO\\naccumulation\\tO\\nof\\tO\\nthe\\tO\\ntypes\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nJapanese\\tO\\npatients\\tO\\nwith\\tO\\nWD\\tB-Disease\\nwill\\tO\\nfacilitate\\tO\\nthe\\tO\\nfast\\tO\\nand\\tO\\neffective\\tO\\ngenetic\\tO\\ndiagnosis\\tO\\nof\\tO\\nWD\\tB-Disease\\nin\\tO\\nJapanese\\tO\\npatients\\tO\\n.\\tO\\n.\\tO\\n\\nAutoinhibition\\tO\\nand\\tO\\nactivation\\tO\\nmechanisms\\tO\\nof\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nprotein\\tO\\n.\\tO\\n\\nThe\\tO\\nRho\\tO\\n-\\tO\\nfamily\\tO\\nGTPase\\tO\\n,\\tO\\nCdc42\\tO\\n,\\tO\\ncan\\tO\\nregulate\\tO\\nthe\\tO\\nactin\\tO\\ncytoskeleton\\tO\\nthrough\\tO\\nactivation\\tO\\nof\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nprotein\\tO\\n(\\tO\\nWASP\\tO\\n)\\tO\\nfamily\\tO\\nmembers\\tO\\n.\\tO\\n\\nActivation\\tO\\nrelieves\\tO\\nan\\tO\\nautoinhibitory\\tO\\ncontact\\tO\\nbetween\\tO\\nthe\\tO\\nGTPase\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\nand\\tO\\nthe\\tO\\ncarboxy\\tO\\n-\\tO\\nterminal\\tO\\nregion\\tO\\nof\\tO\\nWASP\\tO\\nproteins\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\nautoinhibited\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\nGTPase\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\nof\\tO\\nWASP\\tO\\n,\\tO\\nwhich\\tO\\ncan\\tO\\nbe\\tO\\ninduced\\tO\\nby\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nregion\\tO\\nor\\tO\\nby\\tO\\norganic\\tO\\nco\\tO\\n-\\tO\\nsolvents\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nautoinhibited\\tO\\ncomplex\\tO\\n,\\tO\\nintramolecular\\tO\\ninteractions\\tO\\nwith\\tO\\nthe\\tO\\nGTPase\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\nocclude\\tO\\nresidues\\tO\\nof\\tO\\nthe\\tO\\nC\\tO\\nterminus\\tO\\nthat\\tO\\nregulate\\tO\\nthe\\tO\\nArp2\\tO\\n/\\tO\\n3\\tO\\nactin\\tO\\n-\\tO\\nnucleating\\tO\\ncomplex\\tO\\n.\\tO\\n\\nBinding\\tO\\nof\\tO\\nCdc42\\tO\\nto\\tO\\nthe\\tO\\nGTPase\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\ncauses\\tO\\na\\tO\\ndramatic\\tO\\nconformational\\tO\\nchange\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\ndisruption\\tO\\nof\\tO\\nthe\\tO\\nhydrophobic\\tO\\ncore\\tO\\nand\\tO\\nrelease\\tO\\nof\\tO\\nthe\\tO\\nC\\tO\\nterminus\\tO\\n,\\tO\\nenabling\\tO\\nits\\tO\\ninteraction\\tO\\nwith\\tO\\nthe\\tO\\nactin\\tO\\nregulatory\\tO\\nmachinery\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nshow\\tO\\nthat\\tO\\nintrinsically\\tO\\nunstructured\\tO\\npeptides\\tO\\nsuch\\tO\\nas\\tO\\nthe\\tO\\nGTPase\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\nof\\tO\\nWASP\\tO\\ncan\\tO\\nbe\\tO\\ninduced\\tO\\ninto\\tO\\ndistinct\\tO\\nstructural\\tO\\nand\\tO\\nfunctional\\tO\\nstates\\tO\\ndepending\\tO\\non\\tO\\ncontext\\tO\\n.\\tO\\n.\\tO\\n\\nhCds1\\tO\\n-\\tO\\nmediated\\tO\\nphosphorylation\\tO\\nof\\tO\\nBRCA1\\tO\\nregulates\\tO\\nthe\\tO\\nDNA\\tO\\ndamage\\tO\\nresponse\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\nare\\tO\\nfound\\tO\\nin\\tO\\nalmost\\tO\\nall\\tO\\nof\\tO\\nthe\\tO\\nfamilies\\tO\\nwith\\tO\\ninherited\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\nand\\tO\\nabout\\tO\\nhalf\\tO\\nof\\tO\\nthe\\tO\\nfamilies\\tO\\nwith\\tO\\nonly\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\nbiochemical\\tO\\nfunction\\tO\\nof\\tO\\nBRCA1\\tO\\nis\\tO\\nnot\\tO\\nwell\\tO\\nunderstood\\tO\\n,\\tO\\nit\\tO\\nis\\tO\\nimportant\\tO\\nfor\\tO\\nDNA\\tO\\ndamage\\tO\\nrepair\\tO\\nand\\tO\\ncell\\tO\\n-\\tO\\ncycle\\tO\\ncheckpoint\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nexists\\tO\\nin\\tO\\nnuclear\\tO\\nfoci\\tO\\nbut\\tO\\nis\\tO\\nhyperphosphorylated\\tO\\nand\\tO\\ndisperses\\tO\\nafter\\tO\\nDNA\\tO\\ndamage\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nnot\\tO\\nknown\\tO\\nwhether\\tO\\nBRCA1\\tO\\nphosphorylation\\tO\\nand\\tO\\ndispersion\\tO\\nand\\tO\\nits\\tO\\nfunction\\tO\\nin\\tO\\nDNA\\tO\\ndamage\\tO\\nresponse\\tO\\nare\\tO\\nrelated\\tO\\n.\\tO\\n\\nIn\\tO\\nyeast\\tO\\nthe\\tO\\nDNA\\tO\\ndamage\\tO\\nresponse\\tO\\nand\\tO\\nthe\\tO\\nreplication\\tO\\n-\\tO\\nblock\\tO\\ncheckpoint\\tO\\nare\\tO\\nmediated\\tO\\npartly\\tO\\nthrough\\tO\\nthe\\tO\\nCds1\\tO\\nkinase\\tO\\nfamily\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\nthe\\tO\\nhuman\\tO\\nCds1\\tO\\nkinase\\tO\\n(\\tO\\nhCds1\\tO\\n/\\tO\\nChk2\\tO\\n)\\tO\\nregulates\\tO\\nBRCA1\\tO\\nfunction\\tO\\nafter\\tO\\nDNA\\tO\\ndamage\\tO\\nby\\tO\\nphosphorylating\\tO\\nserine\\tO\\n988\\tO\\nof\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nhCds1\\tO\\nand\\tO\\nBRCA1\\tO\\ninteract\\tO\\nand\\tO\\nco\\tO\\n-\\tO\\nlocalize\\tO\\nwithin\\tO\\ndiscrete\\tO\\nnuclear\\tO\\nfoci\\tO\\nbut\\tO\\nseparate\\tO\\nafter\\tO\\ngamma\\tO\\nirradiation\\tO\\n.\\tO\\n\\nPhosphorylation\\tO\\nof\\tO\\nBRCA1\\tO\\nat\\tO\\nserine\\tO\\n988\\tO\\nis\\tO\\nrequired\\tO\\nfor\\tO\\nthe\\tO\\nrelease\\tO\\nof\\tO\\nBRCA1\\tO\\nfrom\\tO\\nhCds1\\tO\\n.\\tO\\n\\nThis\\tO\\nphosphorylation\\tO\\nis\\tO\\nalso\\tO\\nimportant\\tO\\nfor\\tO\\nthe\\tO\\nability\\tO\\nof\\tO\\nBRCA1\\tO\\nto\\tO\\nrestore\\tO\\nsurvival\\tO\\nafter\\tO\\nDNA\\tO\\ndamage\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\n-\\tO\\nmutated\\tO\\ncell\\tO\\nline\\tO\\nHCC1937\\tO\\n.\\tO\\n.\\tO\\n\\nCharacterization\\tO\\nof\\tO\\nthe\\tO\\nrat\\tO\\nspinocerebellar\\tO\\nataxia\\tO\\ntype\\tO\\n3\\tO\\ngene\\tO\\n.\\tO\\n\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nMJD\\tB-Disease\\n)\\tO\\nbelongs\\tO\\nto\\tO\\na\\tO\\ngroup\\tO\\nof\\tO\\nclinically\\tO\\nand\\tO\\ngenetically\\tO\\nheterogeneous\\tO\\nneurodegenerative\\tB-Disease\\ndisorders\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nprogressive\\tB-Disease\\ncerebellar\\tI-Disease\\nataxia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\nmutation\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nidentified\\tO\\nas\\tO\\nan\\tO\\nunstable\\tO\\nand\\tO\\nexpanded\\tO\\n(\\tO\\nCAG\\tO\\n)\\tO\\nn\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nin\\tO\\na\\tO\\nnovel\\tO\\ngene\\tO\\nof\\tO\\nunknown\\tO\\nfunction\\tO\\n.\\tO\\n\\nIn\\tO\\nCaucasians\\tO\\n,\\tO\\nrepeat\\tO\\nexpansions\\tO\\nin\\tO\\nthe\\tO\\nMJD1\\tO\\ngene\\tO\\nhave\\tO\\nalso\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nclinically\\tO\\ndistinct\\tO\\nautosomal\\tO\\ndominant\\tO\\nspinocerebellar\\tB-Disease\\nataxia\\tI-Disease\\ntype\\tI-Disease\\n3\\tI-Disease\\n(\\tO\\nSCA3\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\ngain\\tO\\ninsight\\tO\\ninto\\tO\\nthe\\tO\\nbiology\\tO\\nof\\tO\\nthe\\tO\\nMJD1\\tO\\n/\\tO\\nSCA3\\tO\\ngene\\tO\\nwe\\tO\\ncloned\\tO\\nthe\\tO\\nrat\\tO\\nhomologue\\tO\\nand\\tO\\nstudied\\tO\\nits\\tO\\nexpression\\tO\\n.\\tO\\n\\nThe\\tO\\nrat\\tO\\nand\\tO\\nhuman\\tO\\nataxin\\tO\\n-\\tO\\n3\\tO\\ngenes\\tO\\nare\\tO\\nhighly\\tO\\nhomologous\\tO\\nwith\\tO\\nan\\tO\\noverall\\tO\\nsequence\\tO\\nidentity\\tO\\nof\\tO\\napproximately\\tO\\n88\\tO\\n%\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\nputative\\tO\\nprotein\\tO\\ndiffers\\tO\\nstrongly\\tO\\nfrom\\tO\\nthe\\tO\\npublished\\tO\\nhuman\\tO\\nsequence\\tO\\n.\\tO\\n\\nThe\\tO\\n(\\tO\\nCAG\\tO\\n)\\tO\\nn\\tO\\nblock\\tO\\nin\\tO\\nthe\\tO\\nrat\\tO\\ncDNA\\tO\\nconsists\\tO\\nof\\tO\\njust\\tO\\nthree\\tO\\ninterrupted\\tO\\nunits\\tO\\nsuggesting\\tO\\nthat\\tO\\na\\tO\\nlong\\tO\\npolyglutamine\\tO\\nstretch\\tO\\nis\\tO\\nnot\\tO\\nessential\\tO\\nfor\\tO\\nthe\\tO\\nnormal\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\nataxin\\tO\\n-\\tO\\n3\\tO\\nprotein\\tO\\nin\\tO\\nrodents\\tO\\n.\\tO\\n\\nThe\\tO\\nexpression\\tO\\npattern\\tO\\nof\\tO\\nthe\\tO\\nSCA3\\tO\\ngene\\tO\\nin\\tO\\nvarious\\tO\\nrat\\tO\\nand\\tO\\nhuman\\tO\\ntissues\\tO\\nwas\\tO\\ninvestigated\\tO\\nby\\tO\\nNorthern\\tO\\nblot\\tO\\nanalyses\\tO\\n.\\tO\\n\\nThe\\tO\\nmature\\tO\\ntranscript\\tO\\nis\\tO\\napproximately\\tO\\n6\\tO\\nkb\\tO\\nin\\tO\\nlength\\tO\\n.\\tO\\n\\nIn\\tO\\nrat\\tO\\ntestis\\tO\\n,\\tO\\na\\tO\\nsmaller\\tO\\ntranscript\\tO\\nof\\tO\\n1\\tO\\n.\\tO\\n\\n3\\tO\\nkb\\tO\\nwas\\tO\\nidentified\\tO\\n.\\tO\\n\\nTranscription\\tO\\nof\\tO\\nrsca3\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nmost\\tO\\nrat\\tO\\ntissues\\tO\\nincluding\\tO\\nbrain\\tO\\n.\\tO\\n\\nAnalyzing\\tO\\nthe\\tO\\nexpression\\tO\\nlevel\\tO\\nof\\tO\\nthe\\tO\\nSCA3\\tO\\ngene\\tO\\nin\\tO\\nseveral\\tO\\nhuman\\tO\\nbrain\\tO\\nsections\\tO\\nrevealed\\tO\\nno\\tO\\nsignificant\\tO\\nhigher\\tO\\nmRNA\\tO\\nlevel\\tO\\nin\\tO\\nregions\\tO\\npredominantly\\tO\\naffected\\tO\\nin\\tO\\nMJD\\tB-Disease\\n.\\tO\\n\\nThus\\tO\\nadditional\\tO\\nmolecules\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nregulatory\\tO\\nevents\\tO\\nare\\tO\\nnecessary\\tO\\nto\\tO\\nexplain\\tO\\nthe\\tO\\nexclusive\\tO\\ndegeneration\\tB-Disease\\nof\\tI-Disease\\ncertain\\tI-Disease\\nbrain\\tI-Disease\\nareas\\tI-Disease\\n.\\tO\\n\\nEmerin\\tB-Disease\\n,\\tI-Disease\\ndeficiency\\tI-Disease\\nof\\tO\\nwhich\\tO\\ncauses\\tO\\nEmery\\tB-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nis\\tO\\nlocalized\\tO\\nat\\tO\\nthe\\tO\\ninner\\tO\\nnuclear\\tO\\nmembrane\\tO\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\nEmery\\tI-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nEDMD\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\ninherited\\tB-Disease\\nmuscle\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nthe\\tO\\nclinical\\tO\\ntriad\\tO\\nof\\tO\\nprogressive\\tO\\nwasting\\tB-Disease\\nof\\tI-Disease\\nhumero\\tI-Disease\\n-\\tI-Disease\\nperoneal\\tI-Disease\\nmuscles\\tI-Disease\\n,\\tO\\nearly\\tO\\ncontractures\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nelbows\\tI-Disease\\n,\\tI-Disease\\nAchilles\\tI-Disease\\ntendons\\tI-Disease\\nand\\tI-Disease\\npostcervical\\tI-Disease\\nmuscles\\tI-Disease\\n,\\tO\\nand\\tO\\ncardiac\\tB-Disease\\nconduction\\tI-Disease\\nblock\\tI-Disease\\nwith\\tO\\na\\tO\\nhigh\\tO\\nrisk\\tO\\nof\\tO\\nsudden\\tB-Disease\\ndeath\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nfor\\tO\\nEDMD\\tB-Disease\\non\\tO\\nXq28\\tO\\nencodes\\tO\\na\\tO\\nnovel\\tO\\nprotein\\tO\\nnamed\\tO\\nemerin\\tO\\nthat\\tO\\nlocalizes\\tO\\nat\\tO\\nthe\\tO\\nnuclear\\tO\\nmembrane\\tO\\nof\\tO\\nskeletal\\tO\\n,\\tO\\ncardiac\\tO\\nand\\tO\\nsmooth\\tO\\nmuscles\\tO\\nand\\tO\\nsome\\tO\\nother\\tO\\nnon\\tO\\n-\\tO\\nmuscle\\tO\\ntissues\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\na\\tO\\npossible\\tO\\nphysiological\\tO\\nrole\\tO\\nfor\\tO\\nemerin\\tO\\n,\\tO\\nwe\\tO\\nexamined\\tO\\nthe\\tO\\nultrastructural\\tO\\nlocalization\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\nin\\tO\\nhuman\\tO\\nskeletal\\tO\\nmuscle\\tO\\nand\\tO\\nHeLa\\tO\\ncells\\tO\\n,\\tO\\nusing\\tO\\nultrathin\\tO\\ncryosections\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nthat\\tO\\nthe\\tO\\nimmune\\tO\\n-\\tO\\nlabeled\\tO\\ncolloidal\\tO\\ngold\\tO\\nparticles\\tO\\nwere\\tO\\nlocalized\\tO\\non\\tO\\nthe\\tO\\nnucleoplasmic\\tO\\nsurface\\tO\\nof\\tO\\nthe\\tO\\ninner\\tO\\nnuclear\\tO\\nmembrane\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\non\\tO\\nthe\\tO\\nnuclear\\tO\\npore\\tO\\n.\\tO\\n\\nEmerin\\tO\\nstayed\\tO\\non\\tO\\nthe\\tO\\ncytoplasmic\\tO\\nsurface\\tO\\nof\\tO\\nthe\\tO\\nnuclear\\tO\\nlamina\\tO\\n,\\tO\\neven\\tO\\nafter\\tO\\ndetergent\\tO\\ntreatment\\tO\\nthat\\tO\\nsolubilizes\\tO\\nmembrane\\tO\\nlipids\\tO\\nand\\tO\\nwashes\\tO\\nout\\tO\\nmembrane\\tO\\nproteins\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nemerin\\tO\\nanchors\\tO\\nat\\tO\\nthe\\tO\\ninner\\tO\\nnuclear\\tO\\nmembrane\\tO\\nthrough\\tO\\nthe\\tO\\nhydrophobic\\tO\\nstretch\\tO\\n,\\tO\\nand\\tO\\nprotrudes\\tO\\nfrom\\tO\\nthe\\tO\\nhydrophilic\\tO\\nregion\\tO\\nto\\tO\\nthe\\tO\\nnucleoplasm\\tO\\nwhere\\tO\\nit\\tO\\ninteracts\\tO\\nwith\\tO\\nthe\\tO\\nnuclear\\tO\\nlamina\\tO\\n.\\tO\\n\\nWe\\tO\\nspeculate\\tO\\nthat\\tO\\nemerin\\tO\\ncontributes\\tO\\nto\\tO\\nmaintain\\tO\\nthe\\tO\\nnuclear\\tO\\nstructure\\tO\\nand\\tO\\nstability\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nnuclear\\tO\\nfunctions\\tO\\n,\\tO\\nparticularly\\tO\\nin\\tO\\nmuscle\\tO\\ntissues\\tO\\nthat\\tO\\nhave\\tO\\nsevere\\tO\\nstress\\tO\\nwith\\tO\\nrigorous\\tO\\ncontraction\\tO\\n-\\tO\\nrelaxation\\tO\\nmovements\\tO\\nand\\tO\\ncalcium\\tO\\nflux\\tO\\n.\\tO\\n.\\tO\\n\\nLocus\\tO\\nheterogeneity\\tO\\nin\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n.\\tO\\n\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n(\\tO\\nFRDA\\tB-Disease\\n)\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nform\\tO\\nof\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nataxia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ndisease\\tO\\nlocus\\tO\\nwas\\tO\\nassigned\\tO\\nto\\tO\\nchromosome\\tO\\n9\\tO\\nand\\tO\\nthe\\tO\\ndisease\\tO\\ngene\\tO\\n,\\tO\\nSTM7\\tO\\n/\\tO\\nX25\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nisolated\\tO\\n.\\tO\\n\\nTo\\tO\\ndate\\tO\\nmost\\tO\\ndata\\tO\\nsuggest\\tO\\nlocus\\tO\\nhomogeneity\\tO\\nin\\tO\\nFRDA\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nnow\\tO\\nprovide\\tO\\nstrong\\tO\\nevidence\\tO\\nof\\tO\\na\\tO\\nsecond\\tO\\nFRDA\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nStudying\\tO\\ntwo\\tO\\nsiblings\\tO\\nwith\\tO\\nFRDA\\tB-Disease\\nfrom\\tO\\ntwo\\tO\\nfamilies\\tO\\nwe\\tO\\ndid\\tO\\nnot\\tO\\ndetect\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nSTM7\\tO\\n/\\tO\\nX25\\tO\\n.\\tO\\n\\nHaplotype\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nSTM7\\tO\\n/\\tO\\nX25\\tO\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n9\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nrelevant\\tO\\nportion\\tO\\nof\\tO\\nchromosome\\tO\\n9\\tO\\ndiffers\\tO\\nin\\tO\\nthe\\tO\\npatients\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\npatients\\tO\\nstudied\\tO\\nhad\\tO\\ntypical\\tO\\nFRDA\\tB-Disease\\n,\\tO\\none\\tO\\nsibpair\\tO\\nhad\\tO\\nthe\\tO\\nuncommon\\tO\\nsymptom\\tO\\nof\\tO\\nretained\\tO\\ntendon\\tO\\nreflexes\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\ninvestigate\\tO\\nwhether\\tO\\nretained\\tO\\ntendon\\tO\\nreflexes\\tO\\nare\\tO\\ncharacteristic\\tO\\nof\\tO\\nFRDA\\tB-Disease\\ncaused\\tO\\nby\\tO\\nthe\\tO\\nsecond\\tO\\nlocus\\tO\\n,\\tO\\nFRDA2\\tO\\n,\\tO\\nwe\\tO\\nstudied\\tO\\nan\\tO\\nunrelated\\tO\\nFRDA\\tB-Disease\\npatient\\tO\\nwith\\tO\\nretained\\tO\\ntendon\\tO\\nreflexes\\tO\\n.\\tO\\n\\nThe\\tO\\nobservation\\tO\\nof\\tO\\ntypical\\tO\\nmutations\\tO\\nin\\tO\\nSTM7\\tO\\n/\\tO\\nX25\\tO\\n(\\tO\\nGAA\\tO\\nexpansions\\tO\\n)\\tO\\nin\\tO\\nthis\\tO\\npatient\\tO\\ndemonstrates\\tO\\nthat\\tO\\nthe\\tO\\ntwo\\tO\\ngenetically\\tO\\ndifferent\\tO\\nforms\\tO\\nof\\tO\\nFRDA\\tB-Disease\\ncannot\\tO\\nbe\\tO\\ndistinguished\\tO\\nclinically\\tO\\n.\\tO\\n.\\tO\\n\\nGlycerol\\tO\\nas\\tO\\na\\tO\\ncorrelate\\tO\\nof\\tO\\nimpaired\\tB-Disease\\nglucose\\tI-Disease\\ntolerance\\tI-Disease\\n:\\tO\\ndissection\\tO\\nof\\tO\\na\\tO\\ncomplex\\tO\\nsystem\\tO\\nby\\tO\\nuse\\tO\\nof\\tO\\na\\tO\\nsimple\\tO\\ngenetic\\tO\\ntrait\\tO\\n.\\tO\\n\\nGlycerol\\tO\\nkinase\\tO\\n(\\tO\\nGK\\tO\\n)\\tO\\nrepresents\\tO\\nthe\\tO\\nprimary\\tO\\nentry\\tO\\nof\\tO\\nglycerol\\tO\\ninto\\tO\\nglucose\\tO\\nand\\tO\\ntriglyceride\\tO\\nmetabolism\\tO\\n.\\tO\\n\\nImpaired\\tB-Disease\\nglucose\\tI-Disease\\ntolerance\\tI-Disease\\n(\\tO\\nIGT\\tB-Disease\\n)\\tO\\nand\\tO\\nhypertriglyceridemia\\tB-Disease\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\ndiabetes\\tB-Disease\\nmellitus\\tI-Disease\\nand\\tO\\ncardiovascular\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nrelationship\\tO\\nbetween\\tO\\nglycerol\\tO\\nand\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\nIGT\\tB-Disease\\n,\\tO\\nhowever\\tO\\n,\\tO\\nis\\tO\\npoorly\\tO\\nunderstood\\tO\\n.\\tO\\n\\nWe\\tO\\ntherefore\\tO\\nundertook\\tO\\nthe\\tO\\nstudy\\tO\\nof\\tO\\nfasting\\tO\\nplasma\\tO\\nglycerol\\tO\\nlevels\\tO\\nin\\tO\\na\\tO\\ncohort\\tO\\nof\\tO\\n1\\tO\\n,\\tO\\n056\\tO\\nunrelated\\tO\\nmen\\tO\\nand\\tO\\nwomen\\tO\\nof\\tO\\nFrench\\tO\\n-\\tO\\nCanadian\\tO\\ndescent\\tO\\n.\\tO\\n\\nFamily\\tO\\nscreening\\tO\\nin\\tO\\nthe\\tO\\ninitial\\tO\\ncohort\\tO\\nidentified\\tO\\n18\\tO\\nmen\\tO\\nfrom\\tO\\nfive\\tO\\nfamilies\\tO\\nwith\\tO\\nsevere\\tO\\nhyperglycerolemia\\tB-Disease\\n(\\tO\\nvalues\\tO\\nabove\\tO\\n2\\tO\\n.\\tO\\n0\\tO\\nmmol\\tO\\n/\\tO\\nliter\\tO\\n)\\tO\\nand\\tO\\ndemonstrated\\tO\\nan\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\npattern\\tO\\nof\\tO\\ninheritance\\tO\\n.\\tO\\n\\nLinkage\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\ndata\\tO\\nfrom\\tO\\n12\\tO\\nmicrosatellite\\tO\\nmarkers\\tO\\nsurrounding\\tO\\nthe\\tO\\nXp21\\tO\\n.\\tO\\n\\n3\\tO\\nGK\\tO\\ngene\\tO\\nresulted\\tO\\nin\\tO\\na\\tO\\npeak\\tO\\nLOD\\tO\\nscore\\tO\\nof\\tO\\n3\\tO\\n.\\tO\\n\\n46\\tO\\n,\\tO\\ncentered\\tO\\naround\\tO\\nmarker\\tO\\nDXS8039\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nsince\\tO\\nall\\tO\\nof\\tO\\nthe\\tO\\nfamilies\\tO\\noriginated\\tO\\nin\\tO\\na\\tO\\npopulation\\tO\\nwith\\tO\\na\\tO\\nproven\\tO\\nfounder\\tO\\neffect\\tO\\n-\\tO\\nthe\\tO\\nSaguenay\\tO\\nLac\\tO\\n-\\tO\\nSt\\tO\\n.\\tO\\n\\n-\\tO\\nJean\\tO\\nregion\\tO\\nof\\tO\\nQuebec\\tO\\n-\\tO\\na\\tO\\ncommon\\tO\\ndisease\\tO\\nhaplotype\\tO\\nwas\\tO\\nsought\\tO\\n.\\tO\\n\\nIndeed\\tO\\n,\\tO\\na\\tO\\nsix\\tO\\n-\\tO\\nmarker\\tO\\nhaplotype\\tO\\nextending\\tO\\nover\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\n5\\tO\\n.\\tO\\n\\n5\\tO\\ncM\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\nall\\tO\\nfamilies\\tO\\n.\\tO\\n\\nResequencing\\tO\\nof\\tO\\nthe\\tO\\nGK\\tO\\ngene\\tO\\nin\\tO\\nfamily\\tO\\nmembers\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\ndiscovery\\tO\\nof\\tO\\na\\tO\\nN288D\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n10\\tO\\n,\\tO\\nwhich\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\nsubstitution\\tO\\nof\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\nasparagine\\tO\\nresidue\\tO\\nby\\tO\\na\\tO\\nnegatively\\tO\\ncharged\\tO\\naspartic\\tO\\nacid\\tO\\n.\\tO\\n\\nClinical\\tO\\nand\\tO\\nmolecular\\tO\\ngenetics\\tO\\nof\\tO\\nprimary\\tB-Disease\\ndystonias\\tI-Disease\\n.\\tO\\n\\nPrimary\\tB-Disease\\ndystonias\\tI-Disease\\nare\\tO\\nmovement\\tB-Disease\\ndisorders\\tI-Disease\\nwith\\tO\\ndystonia\\tB-Disease\\nas\\tO\\na\\tO\\nmajor\\tO\\nsymptom\\tO\\n.\\tO\\n\\nThey\\tO\\nare\\tO\\nfrequently\\tO\\ninherited\\tO\\nas\\tO\\nMendelian\\tO\\ntraits\\tO\\n.\\tO\\n\\nThere\\tO\\nare\\tO\\nat\\tO\\nleast\\tO\\neight\\tO\\nclinically\\tO\\ndistinct\\tO\\nautosomal\\tO\\ndominant\\tO\\nand\\tO\\ntwo\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nrecessive\\tO\\nforms\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\npedigree\\tO\\nanalyses\\tO\\nsuggest\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nan\\tO\\nautosomal\\tO\\nrecessive\\tO\\nvariant\\tO\\n.\\tO\\n\\nThe\\tO\\nclinical\\tO\\nclassification\\tO\\nis\\tO\\nincreasingly\\tO\\nbeing\\tO\\nreplaced\\tO\\nby\\tO\\na\\tO\\ngenetic\\tO\\none\\tO\\n.\\tO\\n\\nTo\\tO\\ndate\\tO\\ngene\\tO\\nloci\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\nat\\tO\\nleast\\tO\\nsix\\tO\\nautosomal\\tO\\ndominant\\tO\\nforms\\tO\\n,\\tO\\ni\\tO\\n.\\tO\\ne\\tO\\n.\\tO\\n,\\tO\\nin\\tO\\nidiopathic\\tB-Disease\\ntorsion\\tI-Disease\\ndystonia\\tI-Disease\\n(\\tO\\n9q34\\tO\\n)\\tO\\n,\\tO\\nfocal\\tB-Disease\\ndystonia\\tI-Disease\\n(\\tO\\n18p\\tO\\n)\\tO\\n,\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\nidiopathic\\tB-Disease\\ntorsion\\tI-Disease\\ndystonia\\tI-Disease\\nof\\tO\\nmixed\\tO\\ntype\\tO\\n(\\tO\\n8p21\\tO\\n-\\tO\\nq22\\tO\\n)\\tO\\n,\\tO\\ndopa\\tB-Disease\\n-\\tI-Disease\\nresponsive\\tI-Disease\\ndystonia\\tI-Disease\\n(\\tO\\n14q22\\tO\\n.\\tO\\n1\\tO\\n-\\tO\\nq22\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nparoxysmal\\tB-Disease\\ndystonic\\tI-Disease\\nchoreoathetosis\\tI-Disease\\n(\\tO\\n2q25\\tO\\n-\\tO\\nq33\\tO\\n;\\tO\\n1p21\\tO\\n-\\tO\\np13\\tO\\n.\\tO\\n3\\tO\\n)\\tO\\n.\\tO\\n\\nGene\\tO\\nloci\\tO\\nin\\tO\\nthe\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nrecessive\\tO\\nforms\\tO\\nhave\\tO\\nbeen\\tO\\nassigned\\tO\\nto\\tO\\nXq13\\tO\\n.\\tO\\n\\n1\\tO\\nin\\tO\\nthe\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndystonia\\tI-Disease\\nparkinsonism\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nto\\tO\\nXq22\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nsensorineural\\tI-Disease\\ndeafness\\tI-Disease\\n,\\tO\\ndystonia\\tB-Disease\\n,\\tO\\nand\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ndisease\\tO\\ngenes\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\ntwo\\tO\\nautosomal\\tO\\ndominant\\tO\\nforms\\tO\\nand\\tO\\nin\\tO\\none\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nrecessive\\tO\\nform\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\na\\tO\\ngene\\tO\\ncoding\\tO\\nfor\\tO\\nan\\tO\\nATP\\tO\\n-\\tO\\nbinding\\tO\\nprotein\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nidiopathic\\tB-Disease\\ntorsion\\tI-Disease\\ndystonia\\tI-Disease\\n(\\tO\\nDYT1\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nGTP\\tO\\ncyclohydrolase\\tO\\n1\\tO\\ngene\\tO\\nis\\tO\\nmutated\\tO\\nin\\tO\\ndopa\\tB-Disease\\n-\\tI-Disease\\nresponsive\\tI-Disease\\ndystonia\\tI-Disease\\n(\\tO\\nDYT5\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nsensorineural\\tB-Disease\\ndeafness\\tI-Disease\\n,\\tO\\ndystonia\\tB-Disease\\n,\\tO\\nand\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nDDP\\tO\\ncoding\\tO\\nfor\\tO\\na\\tO\\npolypeptide\\tO\\nof\\tO\\nunknown\\tO\\nfunction\\tO\\n.\\tO\\n\\nThis\\tO\\narticle\\tO\\nreviews\\tO\\nthe\\tO\\nclinical\\tO\\nand\\tO\\nmolecular\\tO\\ngenetics\\tO\\nof\\tO\\nprimary\\tB-Disease\\ndystonias\\tI-Disease\\n,\\tO\\ncritically\\tO\\ndiscusses\\tO\\npresent\\tO\\nfindings\\tO\\n,\\tO\\nand\\tO\\nproposes\\tO\\nreferring\\tO\\nto\\tO\\nthe\\tO\\nknown\\tO\\nforms\\tO\\n,\\tO\\nmost\\tO\\nof\\tO\\nwhich\\tO\\ncan\\tO\\nbe\\tO\\ndistinguished\\tO\\nby\\tO\\ngenetic\\tO\\ncriteria\\tO\\n,\\tO\\nas\\tO\\ndystonias\\tB-Disease\\n1\\tI-Disease\\n-\\tI-Disease\\n12\\tI-Disease\\n.\\tO\\n\\nDetermination\\tO\\nof\\tO\\n30\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\nmutations\\tO\\n,\\tO\\nincluding\\tO\\n15\\tO\\nnot\\tO\\npreviously\\tO\\ndescribed\\tO\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nAdrenoleukodystrophy\\tI-Disease\\n(\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\n)\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\nfrequent\\tO\\nperoxisomal\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nIt\\tO\\nmainly\\tO\\ninvolves\\tO\\nthe\\tO\\nnervous\\tO\\nsystem\\tO\\nwhite\\tO\\nmatter\\tO\\n,\\tO\\nadrenal\\tO\\ncortex\\tO\\nand\\tO\\ntestes\\tO\\n.\\tO\\n\\nSeveral\\tO\\ndistinct\\tO\\nclinical\\tO\\nphenotypes\\tO\\nare\\tO\\nknown\\tO\\n.\\tO\\n\\nThe\\tO\\nprincipal\\tO\\nbiochemical\\tO\\nabnormality\\tO\\nis\\tO\\nthe\\tO\\naccumulation\\tO\\nof\\tO\\nsaturated\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\n(\\tO\\nVLCFAs\\tO\\n>\\tO\\nC22\\tO\\n0\\tO\\n,\\tO\\nmainly\\tO\\nC26\\tO\\n0\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\ndue\\tO\\nto\\tO\\nimpaired\\tO\\ncapacity\\tO\\nfor\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\nin\\tO\\nperoxisomes\\tO\\n.\\tO\\n\\nDiagnosis\\tO\\nis\\tO\\nusually\\tO\\nbased\\tO\\non\\tO\\nthe\\tO\\nVLCFA\\tO\\nlevels\\tO\\nin\\tO\\nplasma\\tO\\nor\\tO\\ncultured\\tO\\nskin\\tO\\nfibroblasts\\tO\\nin\\tO\\nboth\\tO\\npatients\\tO\\nand\\tO\\ncarriers\\tO\\n.\\tO\\n\\nIn\\tO\\n0\\tO\\n.\\tO\\n\\n1\\tO\\n%\\tO\\nof\\tO\\naffected\\tO\\nmales\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nthe\\tO\\nplasma\\tO\\nC26\\tO\\n0\\tO\\nlevel\\tO\\nis\\tO\\nborderline\\tO\\nnormal\\tO\\n,\\tO\\nand\\tO\\n15\\tO\\n%\\tO\\nof\\tO\\nobligate\\tO\\nfemale\\tO\\ncarriers\\tO\\nhave\\tO\\nnormal\\tO\\nresults\\tO\\n.\\tO\\n\\nEffective\\tO\\nmutation\\tO\\ndetection\\tO\\nin\\tO\\nthese\\tO\\nfamilies\\tO\\nis\\tO\\ntherefore\\tO\\nfundamental\\tO\\nto\\tO\\nunambiguously\\tO\\ndetermine\\tO\\nthe\\tO\\ngenetic\\tO\\nstatus\\tO\\nof\\tO\\neach\\tO\\nindividual\\tO\\nat\\tO\\nrisk\\tO\\n.\\tO\\n\\nOf\\tO\\nparticular\\tO\\nconcern\\tO\\nare\\tO\\nfemale\\tO\\nmembers\\tO\\nof\\tO\\nkindreds\\tO\\nsegregating\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\nmutations\\tO\\n,\\tO\\nbecause\\tO\\nnormal\\tO\\nVLCFA\\tO\\nlevels\\tO\\ndo\\tO\\nnot\\tO\\nguarantee\\tO\\nlack\\tO\\nof\\tO\\ncarrier\\tO\\nstatus\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\na\\tO\\nfast\\tO\\nmethod\\tO\\nfor\\tO\\ndetection\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nmethod\\tO\\nis\\tO\\nbased\\tO\\non\\tO\\nSSCP\\tO\\nanalysis\\tO\\nof\\tO\\nnested\\tO\\nPCR\\tO\\nfragments\\tO\\nfollowed\\tO\\nby\\tO\\nsequence\\tO\\n-\\tO\\ndetermination\\tO\\nreactions\\tO\\n.\\tO\\n\\nUsing\\tO\\nthis\\tO\\nmethodology\\tO\\nwe\\tO\\nhave\\tO\\nfound\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\nmutations\\tO\\nin\\tO\\n30\\tO\\nkindreds\\tO\\n,\\tO\\nincluding\\tO\\n15\\tO\\nnot\\tO\\npreviously\\tO\\nreported\\tO\\n.\\tO\\n\\nbeta\\tO\\n-\\tO\\ngalactosidase\\tO\\ngene\\tO\\nmutations\\tO\\naffecting\\tO\\nthe\\tO\\nlysosomal\\tO\\nenzyme\\tO\\nand\\tO\\nthe\\tO\\nelastin\\tO\\n-\\tO\\nbinding\\tO\\nprotein\\tO\\nin\\tO\\nGM1\\tB-Disease\\n-\\tI-Disease\\ngangliosidosis\\tI-Disease\\npatients\\tO\\nwith\\tO\\ncardiac\\tB-Disease\\ninvolvement\\tI-Disease\\n.\\tO\\n\\nGM1\\tB-Disease\\n-\\tI-Disease\\ngangliosidosis\\tI-Disease\\nis\\tO\\na\\tO\\nlysosomal\\tB-Disease\\nstorage\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nacid\\tI-Disease\\nbeta\\tI-Disease\\n-\\tI-Disease\\ngalactosidase\\tI-Disease\\n(\\tO\\nGLB1\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nfive\\tO\\nnew\\tO\\nbeta\\tO\\n-\\tO\\ngalactosidase\\tO\\ngene\\tO\\nmutations\\tO\\nin\\tO\\nnine\\tO\\nItalian\\tO\\npatients\\tO\\nand\\tO\\none\\tO\\nfetus\\tO\\n,\\tO\\nsegregating\\tO\\nin\\tO\\nseven\\tO\\nunrelated\\tO\\nfamilies\\tO\\n.\\tO\\n\\nSix\\tO\\nof\\tO\\nthe\\tO\\neight\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\ninfantile\\tO\\n,\\tO\\nsevere\\tO\\nform\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\npresented\\tO\\ncardiac\\tB-Disease\\ninvolvement\\tI-Disease\\n,\\tO\\na\\tO\\nfeature\\tO\\nrarely\\tO\\nassociated\\tO\\nwith\\tO\\nGM1\\tB-Disease\\n-\\tI-Disease\\ngangliosidosis\\tI-Disease\\n.\\tO\\n\\nMolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nRNA\\tO\\nand\\tO\\nDNA\\tO\\nidentified\\tO\\ntwo\\tO\\nnew\\tO\\nRNA\\tO\\nsplicing\\tO\\ndefects\\tO\\n,\\tO\\nthree\\tO\\nnew\\tO\\nand\\tO\\nthree\\tO\\npreviously\\tO\\ndescribed\\tO\\namino\\tO\\nacid\\tO\\nsubstitutions\\tO\\n.\\tO\\n\\nInterestingly\\tO\\n,\\tO\\nall\\tO\\npatients\\tO\\nwith\\tO\\ncardiac\\tB-Disease\\ninvolvement\\tI-Disease\\nwere\\tO\\nhomozygous\\tO\\nfor\\tO\\none\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nR59H\\tO\\n,\\tO\\nY591C\\tO\\n,\\tO\\nY591N\\tO\\n,\\tO\\nor\\tO\\nIVS14\\tO\\n-\\tO\\n2A\\tO\\n>\\tO\\nG\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nall\\tO\\nother\\tO\\npatients\\tO\\nwere\\tO\\ncompound\\tO\\nheterozygous\\tO\\nfor\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nfollowing\\tO\\nmutations\\tO\\nR201H\\tO\\n,\\tO\\nR482H\\tO\\n,\\tO\\nG579D\\tO\\n,\\tO\\nIVS8\\tO\\n+\\tO\\n2T\\tO\\n>\\tO\\nC\\tO\\n.\\tO\\n\\nAlthough\\tO\\nwe\\tO\\ncould\\tO\\nnot\\tO\\ndirectly\\tO\\ncorrelate\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\ncardiac\\tB-Disease\\nabnormalities\\tI-Disease\\nwith\\tO\\nspecific\\tO\\ngenetic\\tB-Disease\\nlesions\\tI-Disease\\n,\\tO\\nthe\\tO\\nmutations\\tO\\nidentified\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\ncardiomyopathy\\tB-Disease\\nfell\\tO\\nin\\tO\\nthe\\tO\\nGLB1\\tO\\ncDNA\\tO\\nregion\\tO\\ncommon\\tO\\nto\\tO\\nthe\\tO\\nlysosomal\\tO\\nenzyme\\tO\\nand\\tO\\nthe\\tO\\nHbeta\\tO\\n-\\tO\\nGal\\tO\\n-\\tO\\nrelated\\tO\\nprotein\\tO\\n,\\tO\\nalso\\tO\\nknown\\tO\\nas\\tO\\nthe\\tO\\nelastin\\tO\\nbinding\\tO\\nprotein\\tO\\n(\\tO\\nEBP\\tO\\n)\\tO\\n.\\tO\\n\\nConsequently\\tO\\n,\\tO\\nboth\\tO\\nmolecules\\tO\\nare\\tO\\naffected\\tO\\nby\\tO\\nthe\\tO\\nmutations\\tO\\n,\\tO\\nand\\tO\\nthey\\tO\\nmay\\tO\\ncontribute\\tO\\ndifferently\\tO\\nto\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nspecific\\tO\\nclinical\\tO\\nmanifestations\\tO\\n.\\tO\\n.\\tO\\n\\nIn\\tO\\nvivo\\tO\\nmodulation\\tO\\nof\\tO\\nHmgic\\tO\\nreduces\\tO\\nobesity\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nHMGI\\tO\\nfamily\\tO\\nof\\tO\\nproteins\\tO\\nconsists\\tO\\nof\\tO\\nthree\\tO\\nmembers\\tO\\n,\\tO\\nHMGIC\\tO\\n,\\tO\\nHMGI\\tO\\nand\\tO\\nHMGI\\tO\\n(\\tO\\nY\\tO\\n)\\tO\\n,\\tO\\nthat\\tO\\nfunction\\tO\\nas\\tO\\narchitectural\\tO\\nfactors\\tO\\nand\\tO\\nare\\tO\\nessential\\tO\\ncomponents\\tO\\nof\\tO\\nthe\\tO\\nenhancesome\\tO\\n.\\tO\\n\\nHMGIC\\tO\\nis\\tO\\npredominantly\\tO\\nexpressed\\tO\\nin\\tO\\nproliferating\\tO\\n,\\tO\\nundifferentiated\\tO\\nmesenchymal\\tO\\ncells\\tO\\nand\\tO\\nis\\tO\\nnot\\tO\\ndetected\\tO\\nin\\tO\\nadult\\tO\\ntissues\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\ndisrupted\\tO\\nand\\tO\\nmisexpressed\\tO\\nin\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nmesenchymal\\tB-Disease\\ntumour\\tI-Disease\\ncell\\tO\\ntypes\\tO\\n,\\tO\\nincluding\\tO\\nfat\\tB-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\ntumours\\tI-Disease\\n(\\tO\\nlipomas\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\nHmgic\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\nhave\\tO\\na\\tO\\ndeficiency\\tO\\nin\\tO\\nfat\\tO\\ntissue\\tO\\n.\\tO\\n\\nTo\\tO\\nstudy\\tO\\nits\\tO\\nrole\\tO\\nin\\tO\\nadipogenesis\\tO\\nand\\tO\\nobesity\\tB-Disease\\n,\\tO\\nwe\\tO\\nexamined\\tO\\nHmgic\\tO\\nexpression\\tO\\nin\\tO\\nthe\\tO\\nadipose\\tO\\ntissue\\tO\\nof\\tO\\nadult\\tO\\n,\\tO\\nobese\\tB-Disease\\nmice\\tO\\n.\\tO\\n\\nMice\\tO\\nwith\\tO\\na\\tO\\npartial\\tB-Disease\\nor\\tI-Disease\\ncomplete\\tI-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nHmgic\\tI-Disease\\nresisted\\tO\\ndiet\\tO\\n-\\tO\\ninduced\\tO\\nobesity\\tB-Disease\\n.\\tO\\n\\nDisruption\\tO\\nof\\tO\\nHmgic\\tO\\ncaused\\tO\\na\\tO\\nreduction\\tO\\nin\\tO\\nthe\\tO\\nobesity\\tB-Disease\\ninduced\\tO\\nby\\tO\\nleptin\\tB-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nLepob\\tO\\n/\\tO\\nLepob\\tO\\n)\\tO\\nin\\tO\\na\\tO\\ngene\\tO\\n-\\tO\\ndose\\tO\\n-\\tO\\ndependent\\tO\\nmanner\\tO\\n.\\tO\\n\\nOur\\tO\\nstudies\\tO\\nimplicate\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nHMGIC\\tO\\nin\\tO\\nfat\\tO\\n-\\tO\\ncell\\tO\\nproliferation\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nit\\tO\\nmay\\tO\\nbe\\tO\\nan\\tO\\nadipose\\tO\\n-\\tO\\nspecific\\tO\\ntarget\\tO\\nfor\\tO\\nthe\\tO\\ntreatment\\tO\\nof\\tO\\nobesity\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\nrelationship\\tO\\nin\\tO\\nfactor\\tB-Disease\\nX\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nFactor\\tB-Disease\\nX\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\nhaemorrhagic\\tB-Disease\\ncondition\\tI-Disease\\n,\\tO\\nnormally\\tO\\ninherited\\tO\\nas\\tO\\nan\\tO\\nautosomal\\tO\\nrecessive\\tO\\ntrait\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\na\\tO\\nvariable\\tO\\nclinical\\tO\\npresentation\\tO\\ncorrelates\\tO\\npoorly\\tO\\nwith\\tO\\nlaboratory\\tO\\nphenotype\\tO\\n.\\tO\\n\\nThe\\tO\\nfactor\\tO\\nX\\tO\\n(\\tO\\nF10\\tO\\n)\\tO\\ngenes\\tO\\nof\\tO\\n14\\tO\\nunrelated\\tO\\nindividuals\\tO\\nwith\\tO\\nfactor\\tB-Disease\\nX\\tI-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\n12\\tO\\nfamilial\\tO\\nand\\tO\\ntwo\\tO\\nsporadic\\tO\\ncases\\tO\\n)\\tO\\nwere\\tO\\nsequenced\\tO\\nyielding\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\n13\\tO\\nnovel\\tO\\nmutations\\tO\\n.\\tO\\n\\nFamily\\tO\\nstudies\\tO\\nwere\\tO\\nperformed\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\ndistinguish\\tO\\nthe\\tO\\ncontributions\\tO\\nof\\tO\\nindividual\\tO\\nmutant\\tO\\nF10\\tO\\nalleles\\tO\\nto\\tO\\nthe\\tO\\nclinical\\tO\\nand\\tO\\nlaboratory\\tO\\nphenotypes\\tO\\n.\\tO\\n\\nMissense\\tO\\nmutations\\tO\\nwere\\tO\\nstudied\\tO\\nby\\tO\\nmeans\\tO\\nof\\tO\\nmolecular\\tO\\nmodelling\\tO\\n,\\tO\\nwhereas\\tO\\nsingle\\tO\\nbasepair\\tO\\nsubstitutions\\tO\\nin\\tO\\nsplice\\tO\\nsites\\tO\\nand\\tO\\nthe\\tO\\n5\\tO\\nflanking\\tO\\nregion\\tO\\nwere\\tO\\nexamined\\tO\\nby\\tO\\nin\\tO\\nvitro\\tO\\nsplicing\\tO\\nassay\\tO\\nand\\tO\\nluciferase\\tO\\nreporter\\tO\\ngene\\tO\\nassay\\tO\\nrespectively\\tO\\n.\\tO\\n\\nThe\\tO\\ndeletion\\tO\\nallele\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\nhexanucleotide\\tO\\ninsertion\\tO\\n/\\tO\\ndeletion\\tO\\npolymorphism\\tO\\nin\\tO\\nthe\\tO\\nF10\\tO\\ngene\\tO\\npromoter\\tO\\nregion\\tO\\nwas\\tO\\nshown\\tO\\nby\\tO\\nreporter\\tO\\ngene\\tO\\nassay\\tO\\n,\\tO\\nto\\tO\\nreduce\\tO\\npromoter\\tO\\nactivity\\tO\\nby\\tO\\napproximately\\tO\\n20\\tO\\n%\\tO\\n.\\tO\\n\\nOne\\tO\\nfamily\\tO\\nmanifesting\\tO\\nan\\tO\\nautosomal\\tO\\ndominant\\tO\\npattern\\tO\\nof\\tO\\ninheritance\\tO\\npossessed\\tO\\nthree\\tO\\nclinically\\tO\\naffected\\tO\\nmembers\\tO\\nwho\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\na\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\nthat\\tO\\nwas\\tO\\npredicted\\tO\\nto\\tO\\nlead\\tO\\nto\\tO\\nthe\\tO\\nproduction\\tO\\nof\\tO\\na\\tO\\ntruncated\\tO\\nprotein\\tO\\nproduct\\tO\\n.\\tO\\n\\nA\\tO\\nmodel\\tO\\nwhich\\tO\\naccounts\\tO\\nfor\\tO\\nthe\\tO\\ndominant\\tO\\nnegative\\tO\\neffect\\tO\\nof\\tO\\nthis\\tO\\nlesion\\tO\\nis\\tO\\npresented\\tO\\n.\\tO\\n\\nVariation\\tO\\nin\\tO\\nthe\\tO\\nantigen\\tO\\nlevel\\tO\\nof\\tO\\nheterozygous\\tO\\nrelatives\\tO\\nof\\tO\\nprobands\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nsignificantly\\tO\\nhigher\\tO\\nbetween\\tO\\nfamilies\\tO\\nthan\\tO\\nwithin\\tO\\nfamilies\\tO\\n,\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nview\\tO\\nthat\\tO\\nthe\\tO\\nnature\\tO\\nof\\tO\\nthe\\tO\\nF10\\tO\\nlesion\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\nsegregating\\tO\\nin\\tO\\na\\tO\\ngiven\\tO\\nfamily\\tO\\nis\\tO\\na\\tO\\nprime\\tO\\ndeterminant\\tO\\nof\\tO\\nthe\\tO\\nlaboratory\\tO\\nphenotype\\tO\\n.\\tO\\n\\nBy\\tO\\ncontrast\\tO\\n,\\tO\\nno\\tO\\nsuch\\tO\\nrelationship\\tO\\ncould\\tO\\nbe\\tO\\ndiscerned\\tO\\nbetween\\tO\\nlaboratory\\tO\\nphenotype\\tO\\nand\\tO\\npolymorphism\\tO\\ngenotype\\tO\\n.\\tO\\n.\\tO\\n\\nTransgenic\\tO\\nmice\\tO\\nexpressing\\tO\\na\\tO\\ntruncated\\tO\\nform\\tO\\nof\\tO\\nthe\\tO\\nhigh\\tO\\nmobility\\tO\\ngroup\\tO\\nI\\tO\\n-\\tO\\nC\\tO\\nprotein\\tO\\ndevelop\\tO\\nadiposity\\tO\\nand\\tO\\nan\\tO\\nabnormally\\tO\\nhigh\\tO\\nprevalence\\tO\\nof\\tO\\nlipomas\\tB-Disease\\n.\\tO\\n\\nChromosomal\\tO\\ntranslocations\\tO\\nin\\tO\\nhuman\\tO\\nlipomas\\tB-Disease\\nfrequently\\tO\\ncreate\\tO\\nfusion\\tO\\ntranscripts\\tO\\nencoding\\tO\\nhigh\\tO\\nmobility\\tO\\ngroup\\tO\\n(\\tO\\nHMG\\tO\\n)\\tO\\nI\\tO\\n-\\tO\\nC\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\ndomains\\tO\\nand\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nsequences\\tO\\nfrom\\tO\\ndifferent\\tO\\npresumed\\tO\\ntranscription\\tO\\nfactors\\tO\\n,\\tO\\nsuggesting\\tO\\na\\tO\\npotential\\tO\\nrole\\tO\\nfor\\tO\\nHMG\\tO\\nI\\tO\\n-\\tO\\nC\\tO\\nin\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nlipomas\\tB-Disease\\n.\\tO\\n\\nTo\\tO\\nevaluate\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nthe\\tO\\nHMG\\tO\\nI\\tO\\n-\\tO\\nC\\tO\\ncomponent\\tO\\n,\\tO\\nthe\\tO\\nthree\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\ndomains\\tO\\nof\\tO\\nHMG\\tO\\nI\\tO\\n-\\tO\\nC\\tO\\nhave\\tO\\nnow\\tO\\nbeen\\tO\\nexpressed\\tO\\nin\\tO\\ntransgenic\\tO\\nmice\\tO\\n.\\tO\\n\\nDespite\\tO\\nthe\\tO\\nubiquitous\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\ntruncated\\tO\\nHMG\\tO\\nI\\tO\\n-\\tO\\nC\\tO\\nprotein\\tO\\n,\\tO\\nthe\\tO\\ntransgenic\\tO\\nmice\\tO\\ndevelop\\tO\\na\\tO\\nselective\\tO\\nabundance\\tO\\nof\\tO\\nfat\\tO\\ntissue\\tO\\nearly\\tO\\nin\\tO\\nlife\\tO\\n,\\tO\\nshow\\tO\\nmarked\\tO\\nadipose\\tB-Disease\\ntissue\\tI-Disease\\ninflammation\\tI-Disease\\n,\\tO\\nand\\tO\\nhave\\tO\\nan\\tO\\nabnormally\\tO\\nhigh\\tO\\nincidence\\tO\\nof\\tO\\nlipomas\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\ndemonstrate\\tO\\nthat\\tO\\nthe\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\ndomains\\tO\\nof\\tO\\nHMG\\tO\\nI\\tO\\n-\\tO\\nC\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\na\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nfusion\\tO\\npartner\\tO\\n,\\tO\\nare\\tO\\nsufficient\\tO\\nto\\tO\\nperturb\\tO\\nadipogenesis\\tO\\nand\\tO\\npredispose\\tO\\nto\\tO\\nlipomas\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nprovide\\tO\\ndata\\tO\\nsupporting\\tO\\nthe\\tO\\ncentral\\tO\\nutility\\tO\\nof\\tO\\nthis\\tO\\nanimal\\tO\\nmodel\\tO\\nas\\tO\\na\\tO\\ntool\\tO\\nto\\tO\\nunderstand\\tO\\nthe\\tO\\nmolecular\\tO\\nmechanisms\\tO\\nunderlying\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nkind\\tO\\nof\\tO\\nhuman\\tO\\nbenign\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nATM\\tO\\nphosphorylates\\tO\\np95\\tO\\n/\\tO\\nnbs1\\tO\\nin\\tO\\nan\\tO\\nS\\tO\\n-\\tO\\nphase\\tO\\ncheckpoint\\tO\\npathway\\tO\\n.\\tO\\n\\nThe\\tO\\nrare\\tB-Disease\\ndiseases\\tI-Disease\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nAT\\tB-Disease\\n)\\tO\\n,\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nNijmegen\\tB-Disease\\nbreakage\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nNBS\\tB-Disease\\n)\\tO\\n,\\tO\\nwith\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\np95\\tO\\n/\\tO\\nnbs1\\tO\\ngene\\tO\\n,\\tO\\nshare\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nphenotypic\\tB-Disease\\nabnormalities\\tI-Disease\\nsuch\\tO\\nas\\tO\\nchromosomal\\tB-Disease\\ninstability\\tI-Disease\\n,\\tO\\nradiation\\tO\\nsensitivity\\tO\\nand\\tO\\ndefects\\tO\\nin\\tO\\ncell\\tO\\n-\\tO\\ncycle\\tO\\ncheckpoints\\tO\\nin\\tO\\nresponse\\tO\\nto\\tO\\nionizing\\tO\\nradiation\\tO\\n.\\tO\\n\\nThe\\tO\\nATM\\tO\\ngene\\tO\\nencodes\\tO\\na\\tO\\nprotein\\tO\\nkinase\\tO\\nthat\\tO\\nis\\tO\\nactivated\\tO\\nby\\tO\\nionizing\\tO\\nradiation\\tO\\nor\\tO\\nradiomimetic\\tO\\ndrugs\\tO\\n,\\tO\\nwhereas\\tO\\np95\\tO\\n/\\tO\\nnbs1\\tO\\nis\\tO\\npart\\tO\\nof\\tO\\na\\tO\\nprotein\\tO\\ncomplex\\tO\\nthat\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nresponses\\tO\\nto\\tO\\nDNA\\tO\\ndouble\\tO\\n-\\tO\\nstrand\\tO\\nbreaks\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nbecause\\tO\\nof\\tO\\nthe\\tO\\nsimilarities\\tO\\nbetween\\tO\\nAT\\tB-Disease\\nand\\tO\\nNBS\\tB-Disease\\n,\\tO\\nwe\\tO\\nevaluated\\tO\\nthe\\tO\\nfunctional\\tO\\ninteractions\\tO\\nbetween\\tO\\nATM\\tO\\nand\\tO\\np95\\tO\\n/\\tO\\nnbs1\\tO\\n.\\tO\\n\\nActivation\\tO\\nof\\tO\\nthe\\tO\\nATM\\tO\\nkinase\\tO\\nby\\tO\\nionizing\\tO\\nradiation\\tO\\nand\\tO\\ninduction\\tO\\nof\\tO\\nATM\\tO\\n-\\tO\\ndependent\\tO\\nresponses\\tO\\nin\\tO\\nNBS\\tB-Disease\\ncells\\tO\\nindicated\\tO\\nthat\\tO\\np95\\tO\\n/\\tO\\nnbs1\\tO\\nmay\\tO\\nnot\\tO\\nbe\\tO\\nrequired\\tO\\nfor\\tO\\nsignalling\\tO\\nto\\tO\\nATM\\tO\\nafter\\tO\\nionizing\\tO\\nradiation\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\np95\\tO\\n/\\tO\\nnbs1\\tO\\nwas\\tO\\nphosphorylated\\tO\\non\\tO\\nserine\\tO\\n343\\tO\\nin\\tO\\nan\\tO\\nATM\\tO\\n-\\tO\\ndependent\\tO\\nmanner\\tO\\nin\\tO\\nvitro\\tO\\nand\\tO\\nin\\tO\\nvivo\\tO\\nafter\\tO\\nionizing\\tO\\nradiation\\tO\\n.\\tO\\n\\nA\\tO\\np95\\tO\\n/\\tO\\nnbs1\\tO\\nconstruct\\tO\\nmutated\\tO\\nat\\tO\\nthe\\tO\\nATM\\tO\\nphosphorylation\\tO\\nsite\\tO\\nabrogated\\tO\\nan\\tO\\nS\\tO\\n-\\tO\\nphase\\tO\\ncheckpoint\\tO\\ninduced\\tO\\nby\\tO\\nionizing\\tO\\nradiation\\tO\\nin\\tO\\nnormal\\tO\\ncells\\tO\\nand\\tO\\nfailed\\tO\\nto\\tO\\ncompensate\\tO\\nfor\\tO\\nthis\\tO\\nfunctional\\tO\\ndeficiency\\tO\\nin\\tO\\nNBS\\tB-Disease\\ncells\\tO\\n.\\tO\\n\\nThese\\tO\\nobservations\\tO\\nlink\\tO\\nATM\\tO\\nand\\tO\\np95\\tO\\n/\\tO\\nnbs1\\tO\\nin\\tO\\na\\tO\\ncommon\\tO\\nsignalling\\tO\\npathway\\tO\\nand\\tO\\nprovide\\tO\\nan\\tO\\nexplanation\\tO\\nfor\\tO\\nphenotypic\\tO\\nsimilarities\\tO\\nin\\tO\\nthese\\tO\\ntwo\\tO\\ndiseases\\tO\\n.\\tO\\n.\\tO\\n\\nUnderstanding\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nFragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\na\\tO\\ncommon\\tO\\nform\\tO\\nof\\tO\\ninherited\\tB-Disease\\nmental\\tI-Disease\\nretardation\\tI-Disease\\n,\\tO\\nis\\tO\\nmainly\\tO\\ncaused\\tO\\nby\\tO\\nmassive\\tO\\nexpansion\\tO\\nof\\tO\\nCGG\\tO\\ntriplet\\tO\\nrepeats\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\n5\\tO\\n-\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nmental\\tI-Disease\\nretardation\\tI-Disease\\n-\\tO\\n1\\tO\\n(\\tO\\nFMR1\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nIn\\tO\\npatients\\tO\\nwith\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nthe\\tO\\nexpanded\\tO\\nCGG\\tO\\ntriplet\\tO\\nrepeats\\tO\\nare\\tO\\nhypermethylated\\tO\\nand\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nFMR1\\tO\\ngene\\tO\\nis\\tO\\nrepressed\\tO\\n,\\tO\\nwhich\\tO\\nleads\\tO\\nto\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nFMR1\\tO\\nprotein\\tO\\n(\\tO\\nFMRP\\tO\\n)\\tO\\nand\\tO\\nsubsequent\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n.\\tO\\n\\nFMRP\\tO\\nis\\tO\\nan\\tO\\nRNA\\tO\\n-\\tO\\nbinding\\tO\\nprotein\\tO\\nthat\\tO\\nshuttles\\tO\\nbetween\\tO\\nthe\\tO\\nnucleus\\tO\\nand\\tO\\ncytoplasm\\tO\\n.\\tO\\n\\nThis\\tO\\nprotein\\tO\\nhas\\tO\\nbeen\\tO\\nimplicated\\tO\\nin\\tO\\nprotein\\tO\\ntranslation\\tO\\nas\\tO\\nit\\tO\\nis\\tO\\nfound\\tO\\nassociated\\tO\\nwith\\tO\\npolyribosomes\\tO\\nand\\tO\\nthe\\tO\\nrough\\tO\\nendoplasmic\\tO\\nreticulum\\tO\\n.\\tO\\n\\nWe\\tO\\ndiscuss\\tO\\nhere\\tO\\nthe\\tO\\nrecent\\tO\\nprogress\\tO\\nmade\\tO\\ntowards\\tO\\nunderstanding\\tO\\nthe\\tO\\nmolecular\\tO\\nmechanism\\tO\\nof\\tO\\nCGG\\tO\\nrepeat\\tO\\nexpansion\\tO\\nand\\tO\\nphysiological\\tO\\nfunction\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\nof\\tO\\nFMRP\\tO\\n.\\tO\\n\\nThese\\tO\\nstudies\\tO\\nwill\\tO\\nnot\\tO\\nonly\\tO\\nhelp\\tO\\nto\\tO\\nilluminate\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\ngeneral\\tO\\nclass\\tO\\nof\\tO\\nhuman\\tO\\ndiseases\\tO\\nwith\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nexpansion\\tO\\nbut\\tO\\nalso\\tO\\nprovide\\tO\\nan\\tO\\navenue\\tO\\nto\\tO\\nunderstand\\tO\\naspects\\tO\\nof\\tO\\nhuman\\tO\\ncognition\\tO\\nand\\tO\\nintelligence\\tO\\n.\\tO\\n.\\tO\\n\\nHaploinsufficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\ntranscription\\tI-Disease\\nfactors\\tI-Disease\\nFOXC1\\tI-Disease\\nand\\tI-Disease\\nFOXC2\\tI-Disease\\nresults\\tO\\nin\\tO\\naberrant\\tO\\nocular\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nAnterior\\tB-Disease\\nsegment\\tI-Disease\\ndevelopmental\\tI-Disease\\ndisorders\\tI-Disease\\n,\\tO\\nincluding\\tO\\nAxenfeld\\tB-Disease\\n-\\tI-Disease\\nRieger\\tI-Disease\\nanomaly\\tI-Disease\\n(\\tO\\nARA\\tB-Disease\\n)\\tO\\n,\\tO\\nvariably\\tO\\nassociate\\tO\\nwith\\tO\\nharmfully\\tO\\nelevated\\tO\\nintraocular\\tO\\npressure\\tO\\n(\\tO\\nIOP\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\ncauses\\tO\\nglaucoma\\tB-Disease\\n.\\tO\\n\\nClinically\\tO\\nobserved\\tO\\ndysgenesis\\tO\\ndoes\\tO\\nnot\\tO\\ncorrelate\\tO\\nwith\\tO\\nIOP\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\netiology\\tO\\nof\\tO\\nglaucoma\\tB-Disease\\ndevelopment\\tO\\nis\\tO\\nnot\\tO\\nunderstood\\tO\\n.\\tO\\n\\nThe\\tO\\nforkhead\\tO\\ntranscription\\tO\\nfactor\\tO\\ngenes\\tO\\nFoxc1\\tO\\n(\\tO\\nformerly\\tO\\nMf1\\tO\\n)\\tO\\nand\\tO\\nFoxc2\\tO\\n(\\tO\\nformerly\\tO\\nMfh1\\tO\\n)\\tO\\nare\\tO\\nexpressed\\tO\\nin\\tO\\nthe\\tO\\nmesenchyme\\tO\\nfrom\\tO\\nwhich\\tO\\nthe\\tO\\nocular\\tO\\ndrainage\\tO\\nstructures\\tO\\nderive\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nhomolog\\tO\\nof\\tO\\nFoxc1\\tO\\n,\\tO\\nFKHL7\\tO\\n,\\tO\\ncause\\tO\\ndominant\\tO\\nanterior\\tB-Disease\\nsegment\\tI-Disease\\ndefects\\tI-Disease\\nand\\tO\\nglaucoma\\tB-Disease\\nin\\tO\\nvarious\\tO\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nFoxc1\\tO\\n(\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n)\\tO\\nmice\\tO\\nhave\\tO\\nanterior\\tB-Disease\\nsegment\\tI-Disease\\nabnormalities\\tI-Disease\\nsimilar\\tO\\nto\\tO\\nthose\\tO\\nreported\\tO\\nin\\tO\\nhuman\\tO\\npatients\\tO\\n.\\tO\\n\\nThese\\tO\\nabnormalities\\tO\\ninclude\\tO\\nsmall\\tO\\nor\\tO\\nabsent\\tO\\nSchlemms\\tO\\ncanal\\tO\\n,\\tO\\naberrantly\\tO\\ndeveloped\\tO\\ntrabecular\\tO\\nmeshwork\\tO\\n,\\tO\\niris\\tB-Disease\\nhypoplasia\\tI-Disease\\n,\\tO\\nseverely\\tO\\neccentric\\tO\\npupils\\tO\\nand\\tO\\ndisplaced\\tO\\nSchwalbes\\tO\\nline\\tO\\n.\\tO\\n\\nThe\\tO\\npenetrance\\tO\\nof\\tO\\nclinically\\tO\\nobvious\\tO\\nabnormalities\\tO\\nvaries\\tO\\nwith\\tO\\ngenetic\\tO\\nbackground\\tO\\n.\\tO\\n\\nIn\\tO\\nsome\\tO\\naffected\\tO\\neyes\\tO\\n,\\tO\\ncollagen\\tO\\nbundles\\tO\\nwere\\tO\\nhalf\\tO\\nnormal\\tO\\ndiameter\\tO\\n,\\tO\\nor\\tO\\ncollagen\\tO\\nand\\tO\\nelastic\\tO\\ntissue\\tO\\nwere\\tO\\nvery\\tO\\nsparse\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nabnormalities\\tO\\nin\\tO\\nextracellular\\tO\\nmatrix\\tO\\nsynthesis\\tO\\nor\\tO\\norganization\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\ndevelopment\\tO\\nof\\tO\\nthe\\tO\\nocular\\tO\\nphenotypes\\tO\\n.\\tO\\n\\nDespite\\tO\\nthe\\tO\\nabnormalities\\tO\\nin\\tO\\nocular\\tO\\ndrainage\\tO\\nstructures\\tO\\nin\\tO\\nFoxc1\\tO\\n(\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n)\\tO\\nmice\\tO\\n,\\tO\\nIOP\\tO\\nwas\\tO\\nnormal\\tO\\nin\\tO\\nalmost\\tO\\nall\\tO\\nmice\\tO\\nanalyzed\\tO\\n,\\tO\\non\\tO\\nall\\tO\\ngenetic\\tO\\nbackgrounds\\tO\\nand\\tO\\nat\\tO\\nall\\tO\\nages\\tO\\n.\\tO\\n\\nSimilar\\tO\\nabnormalities\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nFoxc2\\tO\\n(\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n)\\tO\\nmice\\tO\\n,\\tO\\nbut\\tO\\nno\\tO\\ndisease\\tO\\n-\\tO\\nassociated\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nhomolog\\tO\\nFKHL14\\tO\\nin\\tO\\n32\\tO\\nARA\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nFoxc1\\tO\\n(\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n)\\tO\\nand\\tO\\nFoxc2\\tO\\n(\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n)\\tO\\nmice\\tO\\nare\\tO\\nuseful\\tO\\nmodels\\tO\\nfor\\tO\\nstudying\\tO\\nanterior\\tO\\nsegment\\tO\\ndevelopment\\tO\\nand\\tO\\nits\\tO\\nanomalies\\tO\\n,\\tO\\nand\\tO\\nmay\\tO\\nallow\\tO\\nidentification\\tO\\nof\\tO\\ngenes\\tO\\nthat\\tO\\ninteract\\tO\\nwith\\tO\\nFoxc1\\tO\\nand\\tO\\nFoxc2\\tO\\n(\\tO\\nor\\tO\\nFKHL7\\tO\\nand\\tO\\nFKHL14\\tO\\n)\\tO\\nto\\tO\\nproduce\\tO\\na\\tO\\nphenotype\\tO\\nwith\\tO\\nelevated\\tO\\nIOP\\tO\\nand\\tO\\nglaucoma\\tB-Disease\\n.\\tO\\n.\\tO\\n\\n(\\tO\\nOver\\tO\\n)\\tO\\ncorrection\\tO\\nof\\tO\\nFMR1\\tB-Disease\\ndeficiency\\tI-Disease\\nwith\\tO\\nYAC\\tO\\ntransgenics\\tO\\n:\\tO\\nbehavioral\\tO\\nand\\tO\\nphysical\\tO\\nfeatures\\tO\\n.\\tO\\n\\nFragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\ncommon\\tO\\ncause\\tO\\nof\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\ninvolving\\tO\\nloss\\tO\\nof\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nFMR1\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nrole\\tO\\nof\\tO\\nFMR1\\tO\\nremains\\tO\\nundetermined\\tO\\nbut\\tO\\nthe\\tO\\nprotein\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\nRNA\\tO\\nmetabolism\\tO\\n.\\tO\\n\\nFmr1\\tO\\nknockout\\tO\\nmice\\tO\\nexhibit\\tO\\na\\tO\\nphenotype\\tO\\nwith\\tO\\nsome\\tO\\nsimilarities\\tO\\nto\\tO\\nhumans\\tO\\n,\\tO\\nsuch\\tO\\nas\\tO\\nmacroorchidism\\tB-Disease\\nand\\tO\\nbehavioral\\tO\\nabnormalities\\tO\\n.\\tO\\n\\nAs\\tO\\na\\tO\\nstep\\tO\\ntoward\\tO\\nunderstanding\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\nFMR1\\tO\\nand\\tO\\nthe\\tO\\ndetermination\\tO\\nof\\tO\\nthe\\tO\\npotential\\tO\\nfor\\tO\\ntherapeutic\\tO\\napproaches\\tO\\nto\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nyeast\\tO\\nartificial\\tO\\nchromosome\\tO\\n(\\tO\\nYAC\\tO\\n)\\tO\\ntransgenic\\tO\\nmice\\tO\\nwere\\tO\\ngenerated\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\ndetermine\\tO\\nwhether\\tO\\nthe\\tO\\nFmr1\\tO\\nknockout\\tO\\nmouse\\tO\\nphenotype\\tO\\ncould\\tO\\nbe\\tO\\nrescued\\tO\\n.\\tO\\n\\nSeveral\\tO\\ntransgenic\\tO\\nlines\\tO\\nwere\\tO\\ngenerated\\tO\\nthat\\tO\\ncarried\\tO\\nthe\\tO\\nentire\\tO\\nFMR1\\tO\\nlocus\\tO\\nwith\\tO\\nextensive\\tO\\namounts\\tO\\nof\\tO\\nflanking\\tO\\nsequence\\tO\\n.\\tO\\n\\nWe\\tO\\nobserved\\tO\\nthat\\tO\\nthe\\tO\\nYAC\\tO\\ntransgene\\tO\\nsupported\\tO\\nproduction\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nprotein\\tO\\n(\\tO\\nFMRP\\tO\\n)\\tO\\nwhich\\tO\\nwas\\tO\\npresent\\tO\\nat\\tO\\nlevels\\tO\\n10\\tO\\nto\\tO\\n15\\tO\\ntimes\\tO\\nthat\\tO\\nof\\tO\\nendogenous\\tO\\nprotein\\tO\\nand\\tO\\nwas\\tO\\nexpressed\\tO\\nin\\tO\\na\\tO\\ncell\\tO\\n-\\tO\\nand\\tO\\ntissue\\tO\\n-\\tO\\nspecific\\tO\\nmanner\\tO\\n.\\tO\\n\\nMacro\\tO\\n-\\tO\\norchidism\\tO\\nwas\\tO\\nabsent\\tO\\nin\\tO\\nknockout\\tO\\nmice\\tO\\ncarrying\\tO\\nthe\\tO\\nYAC\\tO\\ntransgene\\tO\\nindicating\\tO\\nfunctional\\tO\\nrescue\\tO\\nby\\tO\\nthe\\tO\\nhuman\\tO\\nprotein\\tO\\n.\\tO\\n\\nGiven\\tO\\nthe\\tO\\ncomplex\\tO\\nbehavioral\\tO\\nphenotype\\tO\\nin\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\npatients\\tO\\nand\\tO\\nthe\\tO\\nmild\\tO\\nphenotype\\tO\\npreviously\\tO\\nreported\\tO\\nfor\\tO\\nthe\\tO\\nFmr1\\tO\\nknockout\\tO\\nmouse\\tO\\n,\\tO\\nwe\\tO\\nperformed\\tO\\na\\tO\\nmore\\tO\\nthorough\\tO\\nevaluation\\tO\\nof\\tO\\nthe\\tO\\nFmr1\\tO\\nknockout\\tO\\nphenotype\\tO\\nusing\\tO\\nadditional\\tO\\nbehavioral\\tO\\nassays\\tO\\nthat\\tO\\nhad\\tO\\nnot\\tO\\npreviously\\tO\\nbeen\\tO\\nreported\\tO\\nfor\\tO\\nthis\\tO\\nanimal\\tO\\nmodel\\tO\\n.\\tO\\n\\nThe\\tO\\nmouse\\tO\\ndisplayed\\tO\\nreduced\\tO\\nanxiety\\tB-Disease\\n-\\tO\\nrelated\\tO\\nresponses\\tO\\nwith\\tO\\nincreased\\tO\\nexploratory\\tO\\nbehavior\\tO\\n.\\tO\\n\\nFMR1\\tO\\nYAC\\tO\\ntransgenic\\tO\\nmice\\tO\\noverexpressing\\tO\\nthe\\tO\\nhuman\\tO\\nprotein\\tO\\ndid\\tO\\nproduce\\tO\\nopposing\\tO\\nbehavioral\\tO\\nresponses\\tO\\nand\\tO\\nadditional\\tO\\nabnormal\\tO\\nbehaviors\\tO\\nwere\\tO\\nalso\\tO\\nobserved\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nhave\\tO\\nsignificant\\tO\\nimplications\\tO\\nfor\\tO\\ngene\\tO\\ntherapy\\tO\\nfor\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\nsince\\tO\\noverexpression\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nmay\\tO\\nharbor\\tO\\nits\\tO\\nown\\tO\\nphenotype\\tO\\n.\\tO\\n.\\tO\\n\\nTransgenic\\tO\\nmice\\tO\\ncarrying\\tO\\nlarge\\tO\\nhuman\\tO\\ngenomic\\tO\\nsequences\\tO\\nwith\\tO\\nexpanded\\tO\\nCTG\\tO\\nrepeat\\tO\\nmimic\\tO\\nclosely\\tO\\nthe\\tO\\nDM\\tB-Disease\\nCTG\\tO\\nrepeat\\tO\\nintergenerational\\tO\\nand\\tO\\nsomatic\\tO\\ninstability\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\nCTG\\tO\\nrepeat\\tO\\nexpansion\\tO\\nin\\tO\\nthe\\tO\\n3UTR\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nprotein\\tO\\nkinase\\tO\\n(\\tO\\nDMPK\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nA\\tO\\nvery\\tO\\nhigh\\tO\\nlevel\\tO\\nof\\tO\\ninstability\\tO\\nis\\tO\\nobserved\\tO\\nthrough\\tO\\nsuccessive\\tO\\ngenerations\\tO\\nand\\tO\\nthe\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\nis\\tO\\ngenerally\\tO\\ncorrelated\\tO\\nwith\\tO\\nthe\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nand\\tO\\nwith\\tO\\nage\\tO\\nat\\tO\\nonset\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\ntissues\\tO\\nfrom\\tO\\nDM\\tB-Disease\\npatients\\tO\\nexhibit\\tO\\nsomatic\\tO\\nmosaicism\\tO\\nthat\\tO\\nincreases\\tO\\nwith\\tO\\nage\\tO\\n.\\tO\\n\\nWe\\tO\\ngenerated\\tO\\ntransgenic\\tO\\nmice\\tO\\ncarrying\\tO\\nlarge\\tO\\nhuman\\tO\\ngenomic\\tO\\nsequences\\tO\\nwith\\tO\\n20\\tO\\n,\\tO\\n55\\tO\\nor\\tO\\n>\\tO\\n300\\tO\\nCTG\\tO\\n,\\tO\\ncloned\\tO\\nfrom\\tO\\npatients\\tO\\nfrom\\tO\\nthe\\tO\\nsame\\tO\\naffected\\tO\\nDM\\tB-Disease\\nfamily\\tO\\n.\\tO\\n\\nUsing\\tO\\nlarge\\tO\\nhuman\\tO\\nflanking\\tO\\nsequences\\tO\\nand\\tO\\na\\tO\\nlarge\\tO\\namplification\\tO\\n,\\tO\\nwe\\tO\\ndemonstrate\\tO\\nthat\\tO\\nthe\\tO\\nintergenerational\\tO\\nCTG\\tO\\nrepeat\\tO\\ninstability\\tO\\nis\\tO\\nreproduced\\tO\\nin\\tO\\nmice\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\nstrong\\tO\\nbias\\tO\\ntowards\\tO\\nexpansions\\tO\\nand\\tO\\nwith\\tO\\nthe\\tO\\nsame\\tO\\nsex\\tO\\n-\\tO\\nand\\tO\\nsize\\tO\\n-\\tO\\ndependent\\tO\\ncharacteristics\\tO\\nas\\tO\\nin\\tO\\nhumans\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\na\\tO\\nhigh\\tO\\nlevel\\tO\\nof\\tO\\ninstability\\tO\\n,\\tO\\nincreasing\\tO\\nwith\\tO\\nage\\tO\\n,\\tO\\ncan\\tO\\nbe\\tO\\nobserved\\tO\\nin\\tO\\ntissues\\tO\\nand\\tO\\nin\\tO\\nsperm\\tO\\n.\\tO\\n\\nAlthough\\tO\\nwe\\tO\\ndid\\tO\\nnot\\tO\\nobserve\\tO\\ndramatic\\tO\\nexpansions\\tO\\n(\\tO\\nor\\tO\\nbig\\tO\\njumps\\tO\\nover\\tO\\nseveral\\tO\\nhundred\\tO\\nCTG\\tO\\nrepeats\\tO\\n)\\tO\\nas\\tO\\nin\\tO\\ncongenital\\tO\\nforms\\tO\\nof\\tO\\nDM\\tB-Disease\\n,\\tO\\nour\\tO\\nmodel\\tO\\ncarrying\\tO\\n>\\tO\\n300\\tO\\nCTG\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nto\\tO\\nshow\\tO\\ninstability\\tO\\nso\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\nhuman\\tO\\nDM\\tB-Disease\\nsituation\\tO\\n.\\tO\\n\\nOur\\tO\\nthree\\tO\\nmodels\\tO\\ncarrying\\tO\\ndifferent\\tO\\nsizes\\tO\\nof\\tO\\nCTG\\tO\\nrepeat\\tO\\nprovide\\tO\\ninsight\\tO\\non\\tO\\nthe\\tO\\ndifferent\\tO\\nfactors\\tO\\nmodulating\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\ninstability\\tO\\n.\\tO\\n.\\tO\\n\\nInactivation\\tO\\nof\\tO\\nthe\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\nmouse\\tO\\ngene\\tO\\nleads\\tO\\nto\\tO\\nearly\\tO\\nembryonic\\tB-Disease\\nlethality\\tI-Disease\\nwithout\\tO\\niron\\tO\\naccumulation\\tO\\n.\\tO\\n\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n(\\tO\\nFRDA\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nataxia\\tI-Disease\\n,\\tO\\nis\\tO\\ncaused\\tO\\nin\\tO\\nalmost\\tO\\nall\\tO\\ncases\\tO\\nby\\tO\\nhomozygous\\tO\\nintronic\\tO\\nexpansions\\tO\\nresulting\\tO\\nin\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\nfrataxin\\tO\\n,\\tO\\na\\tO\\nmitochondrial\\tO\\nprotein\\tO\\nconserved\\tO\\nthrough\\tO\\nevolution\\tO\\n,\\tO\\nand\\tO\\ninvolved\\tO\\nin\\tO\\nmitochondrial\\tO\\niron\\tO\\nhomeostasis\\tO\\n.\\tO\\n\\nYeast\\tO\\nknockout\\tO\\nmodels\\tO\\n,\\tO\\nand\\tO\\nhistological\\tO\\nand\\tO\\nbiochemical\\tO\\ndata\\tO\\nfrom\\tO\\npatient\\tO\\nheart\\tO\\nbiopsies\\tO\\nor\\tO\\nautopsies\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nfrataxin\\tO\\ndefect\\tO\\ncauses\\tO\\na\\tO\\nspecific\\tO\\niron\\tB-Disease\\n-\\tI-Disease\\nsulfur\\tI-Disease\\nprotein\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nmitochondrial\\tO\\niron\\tO\\naccumulation\\tO\\nleading\\tO\\nto\\tO\\nthe\\tO\\npathological\\tO\\nchanges\\tO\\n.\\tO\\n\\nAffected\\tO\\nhuman\\tO\\ntissues\\tO\\nare\\tO\\nrarely\\tO\\navailable\\tO\\nto\\tO\\nfurther\\tO\\nexamine\\tO\\nthis\\tO\\nhypothesis\\tO\\n.\\tO\\n\\nTo\\tO\\nstudy\\tO\\nthe\\tO\\nmechanism\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n,\\tO\\nwe\\tO\\ngenerated\\tO\\na\\tO\\nmouse\\tO\\nmodel\\tO\\nby\\tO\\ndeletion\\tO\\nof\\tO\\nexon\\tO\\n4\\tO\\nleading\\tO\\nto\\tO\\ninactivation\\tO\\nof\\tO\\nthe\\tO\\nFrda\\tB-Disease\\ngene\\tO\\nproduct\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nhomozygous\\tO\\ndeletions\\tO\\ncause\\tO\\nembryonic\\tB-Disease\\nlethality\\tI-Disease\\na\\tO\\nfew\\tO\\ndays\\tO\\nafter\\tO\\nimplantation\\tO\\n,\\tO\\ndemonstrating\\tO\\nan\\tO\\nimportant\\tO\\nrole\\tO\\nfor\\tO\\nfrataxin\\tO\\nduring\\tO\\nearly\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nmilder\\tO\\nphenotype\\tO\\nin\\tO\\nhumans\\tO\\nis\\tO\\ndue\\tO\\nto\\tO\\nresidual\\tO\\nfrataxin\\tO\\nexpression\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nexpansion\\tO\\nmutations\\tO\\n.\\tO\\n\\nSurprisingly\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nfrataxin\\tO\\nknockout\\tO\\nmouse\\tO\\n,\\tO\\nno\\tO\\niron\\tO\\naccumulation\\tO\\nwas\\tO\\nobserved\\tO\\nduring\\tO\\nembryonic\\tO\\nresorption\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\ncell\\tO\\ndeath\\tO\\ncould\\tO\\nbe\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nmechanism\\tO\\nindependent\\tO\\nof\\tO\\niron\\tO\\naccumulation\\tO\\n.\\tO\\n.\\tO\\n\\nGaucher\\tB-Disease\\ndisease\\tI-Disease\\n:\\tO\\nthe\\tO\\norigins\\tO\\nof\\tO\\nthe\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nN370S\\tO\\nand\\tO\\n84GG\\tO\\nacid\\tO\\nbeta\\tO\\n-\\tO\\nglucosidase\\tO\\nmutations\\tO\\n.\\tO\\n\\nType\\tO\\n1\\tO\\nGaucher\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nGD\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nnon\\tO\\n-\\tO\\nneuronopathic\\tO\\nlysosomal\\tB-Disease\\nstorage\\tI-Disease\\ndisorder\\tI-Disease\\n,\\tO\\nresults\\tO\\nfrom\\tO\\nthe\\tO\\ndeficient\\tO\\nactivity\\tO\\nof\\tO\\nacid\\tO\\nbeta\\tO\\n-\\tO\\nglucosidase\\tO\\n(\\tO\\nGBA\\tO\\n)\\tO\\n.\\tO\\n\\nType\\tO\\n1\\tO\\ndisease\\tO\\nis\\tO\\npanethnic\\tO\\nbut\\tO\\nis\\tO\\nmore\\tO\\nprevalent\\tO\\nin\\tO\\nindividuals\\tO\\nof\\tO\\nAshkenazi\\tO\\nJewish\\tO\\n(\\tO\\nAJ\\tO\\n)\\tO\\ndescent\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\ncausative\\tO\\nGBA\\tO\\nmutations\\tO\\n,\\tO\\nN370S\\tO\\nis\\tO\\nparticularly\\tO\\nfrequent\\tO\\nin\\tO\\nthe\\tO\\nAJ\\tO\\npopulation\\tO\\n,\\tO\\n(\\tO\\nq\\tO\\napproximately\\tO\\n.\\tO\\n03\\tO\\n)\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\n84GG\\tO\\ninsertion\\tO\\n(\\tO\\nq\\tO\\napproximately\\tO\\n.\\tO\\n003\\tO\\n)\\tO\\noccurs\\tO\\nexclusively\\tO\\nin\\tO\\nthe\\tO\\nAshkenazim\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nthe\\tO\\ngenetic\\tO\\nhistory\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nAJ\\tO\\npopulation\\tO\\n,\\tO\\nshort\\tO\\ntandem\\tO\\nrepeat\\tO\\n(\\tO\\nSTR\\tO\\n)\\tO\\nmarkers\\tO\\nwere\\tO\\nused\\tO\\nto\\tO\\nmap\\tO\\na\\tO\\n9\\tO\\n.\\tO\\n\\n3\\tO\\n-\\tO\\ncM\\tO\\nregion\\tO\\ncontaining\\tO\\nthe\\tO\\nGBA\\tO\\nlocus\\tO\\nand\\tO\\nto\\tO\\ngenotype\\tO\\n261\\tO\\nAJ\\tO\\nN370S\\tO\\nchromosomes\\tO\\n,\\tO\\n60\\tO\\nEuropean\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nN370S\\tO\\nchromosomes\\tO\\n,\\tO\\nand\\tO\\n62\\tO\\nAJ\\tO\\n84GG\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nA\\tO\\nhighly\\tO\\nconserved\\tO\\nhaplotype\\tO\\nat\\tO\\nfour\\tO\\nmarkers\\tO\\nflanking\\tO\\nGBA\\tO\\n(\\tO\\nPKLR\\tO\\n,\\tO\\nD1S1595\\tO\\n,\\tO\\nD1S2721\\tO\\n,\\tO\\nand\\tO\\nD1S2777\\tO\\n)\\tO\\nwas\\tO\\nobserved\\tO\\non\\tO\\nboth\\tO\\nthe\\tO\\nAJ\\tO\\nchromosomes\\tO\\nand\\tO\\nthe\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nN370S\\tO\\nchromosomes\\tO\\n,\\tO\\nsuggesting\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\na\\tO\\nfounder\\tO\\ncommon\\tO\\nto\\tO\\nboth\\tO\\npopulations\\tO\\n.\\tO\\n\\nOf\\tO\\nnote\\tO\\n,\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\ndifferent\\tO\\ndivergent\\tO\\nhaplotypes\\tO\\nsuggested\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nde\\tO\\nnovo\\tO\\n,\\tO\\nrecurrent\\tO\\nN370S\\tO\\nmutations\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\na\\tO\\ndifferent\\tO\\nconserved\\tO\\nhaplotype\\tO\\nat\\tO\\nthese\\tO\\nmarkers\\tO\\nwas\\tO\\nidentified\\tO\\non\\tO\\nthe\\tO\\n84GG\\tO\\nchromosomes\\tO\\n,\\tO\\nwhich\\tO\\nwas\\tO\\nunique\\tO\\nto\\tO\\nthe\\tO\\nAJ\\tO\\npopulation\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\n(\\tO\\nLD\\tO\\n)\\tO\\ndelta\\tO\\nvalues\\tO\\n,\\tO\\nthe\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nEuropean\\tO\\nN370S\\tO\\nchromosomes\\tO\\nhad\\tO\\ngreater\\tO\\nhaplotype\\tO\\ndiversity\\tO\\nand\\tO\\nless\\tO\\nLD\\tO\\nat\\tO\\nthe\\tO\\nmarkers\\tO\\nflanking\\tO\\nthe\\tO\\nconserved\\tO\\nhaplotype\\tO\\nthan\\tO\\ndid\\tO\\nthe\\tO\\nAJ\\tO\\nN370S\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nThis\\tO\\nfinding\\tO\\nis\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nN370S\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nEuropean\\tO\\npopulation\\tO\\nprior\\tO\\nto\\tO\\nthe\\tO\\nfounding\\tO\\nof\\tO\\nthe\\tO\\nAJ\\tO\\npopulation\\tO\\n.\\tO\\n\\nCoalescence\\tO\\nanalyses\\tO\\nfor\\tO\\nthe\\tO\\nN370S\\tO\\nand\\tO\\n84GG\\tO\\nmutations\\tO\\nestimated\\tO\\nsimilar\\tO\\ncoalescence\\tO\\ntimes\\tO\\n,\\tO\\nof\\tO\\n48\\tO\\nand\\tO\\n55\\tO\\n.\\tO\\n5\\tO\\ngenerations\\tO\\nago\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nof\\tO\\nthese\\tO\\nstudies\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\na\\tO\\nsignificant\\tO\\nbottleneck\\tO\\noccurring\\tO\\nin\\tO\\nthe\\tO\\nAJ\\tO\\npopulation\\tO\\nduring\\tO\\nthe\\tO\\nfirst\\tO\\nmillennium\\tO\\n,\\tO\\nwhen\\tO\\nthe\\tO\\npopulation\\tO\\nbecame\\tO\\nestablished\\tO\\nin\\tO\\nEurope\\tO\\n.\\tO\\n\\nHLA\\tO\\nB27\\tO\\nand\\tO\\nthe\\tO\\ngenetics\\tO\\nof\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\n.\\tO\\n\\nOne\\tO\\nhundred\\tO\\nand\\tO\\ntwenty\\tO\\n-\\tO\\neight\\tO\\nof\\tO\\n145\\tO\\npatients\\tO\\nwith\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\n(\\tO\\nAS\\tB-Disease\\n)\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nHLA\\tO\\nB27\\tO\\npositive\\tO\\n.\\tO\\n\\nFive\\tO\\npatients\\tO\\nhad\\tO\\nevidence\\tO\\nof\\tO\\na\\tO\\nsero\\tO\\n-\\tO\\nnegative\\tO\\nperipheral\\tB-Disease\\narthritis\\tI-Disease\\nresembling\\tO\\nperipheral\\tB-Disease\\npsoriatic\\tI-Disease\\narthritis\\tI-Disease\\nand\\tO\\n3\\tO\\nof\\tO\\nthese\\tO\\nwere\\tO\\nB27\\tO\\nnegative\\tO\\n.\\tO\\n\\nOne\\tO\\nfurther\\tO\\nB27\\tO\\nnegative\\tO\\npatients\\tO\\nhad\\tO\\na\\tO\\nsister\\tO\\nwith\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\nand\\tO\\nulcerative\\tB-Disease\\ncolitis\\tI-Disease\\nand\\tO\\na\\tO\\nmother\\tO\\nwith\\tO\\nulcerative\\tB-Disease\\ncolitis\\tI-Disease\\n.\\tO\\n\\nThere\\tO\\nwas\\tO\\nevidence\\tO\\nof\\tO\\na\\tO\\nsomewhat\\tO\\nlater\\tO\\nage\\tO\\nof\\tO\\nonset\\tO\\nof\\tO\\nsymptoms\\tO\\nin\\tO\\nB27\\tO\\nnegative\\tO\\npatients\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nare\\tO\\ninterpreted\\tO\\nas\\tO\\nsuggesting\\tO\\nsome\\tO\\ndegree\\tO\\nof\\tO\\nclinical\\tO\\nand\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\nin\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\nwith\\tO\\ngenes\\tO\\nfor\\tO\\npsoriasis\\tB-Disease\\nand\\tO\\ninflammatory\\tB-Disease\\nbowel\\tI-Disease\\ndisease\\tI-Disease\\nbeing\\tO\\nimportant\\tO\\nin\\tO\\nsome\\tO\\nindividuals\\tO\\n,\\tO\\nparticularly\\tO\\nthose\\tO\\nwho\\tO\\nare\\tO\\nB27\\tO\\nnegative\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\nfive\\tO\\nfirst\\tO\\n-\\tO\\ndegree\\tO\\nrelatives\\tO\\nwith\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\nwere\\tO\\nall\\tO\\nB27\\tO\\npositive\\tO\\n.\\tO\\n\\nThe\\tO\\nonly\\tO\\ninstance\\tO\\nof\\tO\\ndisassociation\\tO\\nof\\tO\\nB27\\tO\\nand\\tO\\nspondylitis\\tB-Disease\\nin\\tO\\na\\tO\\nfamily\\tO\\nwas\\tO\\nwhere\\tO\\nthe\\tO\\nproband\\tO\\nhad\\tO\\nulcerative\\tB-Disease\\ncolitis\\tI-Disease\\nas\\tO\\nwell\\tO\\nas\\tO\\nspondylitis\\tB-Disease\\n.\\tO\\n\\nOf\\tO\\n13\\tO\\nB27\\tO\\npositive\\tO\\nfathers\\tO\\n3\\tO\\ncould\\tO\\nbe\\tO\\ndiagnosed\\tO\\nas\\tO\\nhaving\\tO\\ndefinite\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\n(\\tO\\n23\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nare\\tO\\nthought\\tO\\nto\\tO\\nprovide\\tO\\nevidence\\tO\\nagainst\\tO\\nthe\\tO\\nconcept\\tO\\nthat\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\nis\\tO\\nnot\\tO\\nB27\\tO\\nbut\\tO\\na\\tO\\nclosely\\tO\\nlinked\\tO\\ngene\\tO\\nand\\tO\\nfavour\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nan\\tO\\nenvironmental\\tO\\nevent\\tO\\naffecting\\tO\\napproximately\\tO\\none\\tO\\n-\\tO\\nfifth\\tO\\nof\\tO\\nB27\\tO\\npositive\\tO\\nmales\\tO\\nto\\tO\\nresult\\tO\\nin\\tO\\ndisease\\tO\\n.\\tO\\n.\\tO\\n\\nFounder\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nin\\tO\\nPolish\\tO\\nfamilies\\tO\\nwith\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nundertaken\\tO\\na\\tO\\nhospital\\tO\\n-\\tO\\nbased\\tO\\nstudy\\tO\\n,\\tO\\nto\\tO\\nidentify\\tO\\npossible\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nfounder\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nPolish\\tO\\npopulation\\tO\\n.\\tO\\n\\nThe\\tO\\nstudy\\tO\\ngroup\\tO\\nconsisted\\tO\\nof\\tO\\n66\\tO\\nPolish\\tO\\nfamilies\\tO\\nwith\\tO\\ncancer\\tB-Disease\\nwho\\tO\\nhave\\tO\\nat\\tO\\nleast\\tO\\nthree\\tO\\nrelated\\tO\\nfemales\\tO\\naffected\\tO\\nwith\\tO\\nbreast\\tB-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\nwho\\tO\\nhad\\tO\\ncancer\\tB-Disease\\ndiagnosed\\tO\\n,\\tO\\nin\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nthree\\tO\\naffected\\tO\\nfemales\\tO\\n,\\tO\\nat\\tO\\nage\\tO\\n<\\tO\\n50\\tO\\nyears\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n26\\tO\\nfamilies\\tO\\nhad\\tO\\nboth\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\n,\\tO\\n4\\tO\\nfamilies\\tO\\nhad\\tO\\novarian\\tB-Disease\\ncancers\\tI-Disease\\nonly\\tO\\n,\\tO\\nand\\tO\\n36\\tO\\nfamilies\\tO\\nhad\\tO\\nbreast\\tB-Disease\\ncancers\\tI-Disease\\nonly\\tO\\n.\\tO\\n\\nGenomic\\tO\\nDNA\\tO\\nwas\\tO\\nprepared\\tO\\nfrom\\tO\\nthe\\tO\\nperipheral\\tO\\nblood\\tO\\nleukocytes\\tO\\nof\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\naffected\\tO\\nwoman\\tO\\nfrom\\tO\\neach\\tO\\nfamily\\tO\\n.\\tO\\n\\nThe\\tO\\nentire\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nwas\\tO\\nscreened\\tO\\nfor\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\ngermline\\tO\\nmutations\\tO\\n,\\tO\\nby\\tO\\nuse\\tO\\nof\\tO\\nSSCP\\tO\\nfollowed\\tO\\nby\\tO\\ndirect\\tO\\nsequencing\\tO\\nof\\tO\\nobserved\\tO\\nvariants\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\n35\\tO\\n(\\tO\\n53\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\n66\\tO\\nfamilies\\tO\\nstudied\\tO\\n.\\tO\\n\\nAll\\tO\\nbut\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nwithin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\n.\\tO\\n\\nBRCA1\\tB-Disease\\nabnormalities\\tI-Disease\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nall\\tO\\nfour\\tO\\nfamilies\\tO\\nwith\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nonly\\tO\\n,\\tO\\nin\\tO\\n67\\tO\\n%\\tO\\nof\\tO\\n27\\tO\\nfamilies\\tO\\nwith\\tO\\nboth\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nand\\tO\\nin\\tO\\n34\\tO\\n%\\tO\\nof\\tO\\n35\\tO\\nfamilies\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nonly\\tO\\n.\\tO\\n\\nThe\\tO\\nsingle\\tO\\nfamily\\tO\\nwith\\tO\\na\\tO\\nBRCA2\\tO\\nmutation\\tO\\nhad\\tO\\nthe\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nSeven\\tO\\ndistinct\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\n;\\tO\\nfive\\tO\\nof\\tO\\nthese\\tO\\noccurred\\tO\\nin\\tO\\ntwo\\tO\\nor\\tO\\nmore\\tO\\nfamilies\\tO\\n.\\tO\\n\\nIn\\tO\\ntotal\\tO\\n,\\tO\\nrecurrent\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\n33\\tO\\n(\\tO\\n94\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\n35\\tO\\nfamilies\\tO\\nwith\\tO\\ndetected\\tO\\nmutations\\tO\\n.\\tO\\n\\nThree\\tO\\nBRCA1\\tB-Disease\\nabnormalities\\tI-Disease\\n-\\tO\\n5382insC\\tO\\n,\\tO\\nC61G\\tO\\n,\\tO\\nand\\tO\\n4153delA\\tO\\n-\\tO\\naccounted\\tO\\nfor\\tO\\n51\\tO\\n%\\tO\\n,\\tO\\n20\\tO\\n%\\tO\\n,\\tO\\nand\\tO\\n11\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nidentified\\tO\\nmutations\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbasis\\tO\\nof\\tO\\nvery\\tB-Disease\\nlong\\tI-Disease\\nchain\\tI-Disease\\nacyl\\tI-Disease\\n-\\tI-Disease\\nCoA\\tI-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthree\\tO\\nIsraeli\\tO\\npatients\\tO\\n:\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\ncomplex\\tO\\nmutant\\tO\\nallele\\tO\\nwith\\tO\\nP65L\\tO\\nand\\tO\\nK247Q\\tO\\nmutations\\tO\\n,\\tO\\nthe\\tO\\nformer\\tO\\nbeing\\tO\\nan\\tO\\nexonic\\tO\\nmutation\\tO\\ncausing\\tO\\nexon\\tO\\n3\\tO\\nskipping\\tO\\n.\\tO\\n\\nVery\\tB-Disease\\nlong\\tI-Disease\\nchain\\tI-Disease\\nacyl\\tI-Disease\\n-\\tI-Disease\\nCoA\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nVLCAD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\na\\tO\\nlife\\tO\\n-\\tO\\nthreatening\\tO\\ndisorder\\tO\\nof\\tO\\nmitochondrial\\tO\\nfatty\\tO\\nacid\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\nfour\\tO\\nnovel\\tO\\nmutations\\tO\\nin\\tO\\nthree\\tO\\nunrelated\\tO\\npatients\\tO\\n.\\tO\\n\\nAll\\tO\\npatients\\tO\\nhad\\tO\\nthe\\tO\\nsevere\\tO\\nchildhood\\tO\\nform\\tO\\nof\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\nwith\\tO\\nearly\\tO\\nonset\\tO\\nand\\tO\\nhigh\\tO\\nmortality\\tO\\n.\\tO\\n\\nImmunoblot\\tO\\nanalysis\\tO\\nrevealed\\tO\\nthat\\tO\\nVLCAD\\tO\\nprotein\\tO\\nwas\\tO\\nundetectable\\tO\\nin\\tO\\npatients\\tO\\n2\\tO\\nand\\tO\\n3\\tO\\n,\\tO\\nwhereas\\tO\\nnormal\\tO\\n-\\tO\\nsize\\tO\\nVLCAD\\tO\\nprotein\\tO\\nand\\tO\\nan\\tO\\naberrant\\tO\\nform\\tO\\nof\\tO\\nVLCAD\\tO\\n(\\tO\\n4kDa\\tO\\nsmaller\\tO\\n)\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\npatient\\tO\\n1\\tO\\n.\\tO\\n\\nAs\\tO\\nexpected\\tO\\n,\\tO\\nnull\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\npatients\\tO\\n2\\tO\\nand\\tO\\n3\\tO\\npatient\\tO\\n2\\tO\\nis\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nframeshift\\tO\\nmutation\\tO\\n,\\tO\\ndel\\tO\\n4\\tO\\nbp\\tO\\nat\\tO\\n798\\tO\\n-\\tO\\n801\\tO\\n,\\tO\\nand\\tO\\npatient\\tO\\n3\\tO\\nis\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\n65C\\tO\\n>\\tO\\nA\\tO\\n(\\tO\\nS22X\\tO\\n)\\tO\\n.\\tO\\n\\nPatient\\tO\\n1\\tO\\nwas\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\ncomplex\\tO\\nmutant\\tO\\nallele\\tO\\ncontaining\\tO\\ntwo\\tO\\nalterations\\tO\\n,\\tO\\nincluding\\tO\\na\\tO\\n194C\\tO\\n>\\tO\\nT\\tO\\ntransition\\tO\\n(\\tO\\nP65L\\tO\\n)\\tO\\nand\\tO\\n739A\\tO\\n>\\tO\\nC\\tO\\ntransversion\\tO\\n(\\tO\\nK247Q\\tO\\n)\\tO\\n;\\tO\\nin\\tO\\nthe\\tO\\ncase\\tO\\nof\\tO\\nP65L\\tO\\n,\\tO\\nthe\\tO\\namino\\tO\\nacid\\tO\\nchange\\tO\\ndoes\\tO\\nnot\\tO\\nreduce\\tO\\nenzyme\\tO\\nactivity\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nnucleotide\\tO\\nchange\\tO\\nresulted\\tO\\nin\\tO\\nexon\\tO\\n3\\tO\\nskipping\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nlatter\\tO\\nK247Q\\tO\\nmutation\\tO\\nhad\\tO\\na\\tO\\ndrastic\\tO\\neffect\\tO\\non\\tO\\nenzyme\\tO\\nactivity\\tO\\n.\\tO\\n\\nWe\\tO\\nverified\\tO\\nthese\\tO\\nevents\\tO\\nby\\tO\\nin\\tO\\nvivo\\tO\\nsplicing\\tO\\nexperiments\\tO\\nand\\tO\\ntransient\\tO\\nexpression\\tO\\nanalysis\\tO\\nof\\tO\\nmutant\\tO\\ncDNAs\\tO\\n.\\tO\\n\\nThe\\tO\\nP65L\\tO\\nmutation\\tO\\nlocates\\tO\\n11\\tO\\nbases\\tO\\nupstream\\tO\\nof\\tO\\na\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n3\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nan\\tO\\nexample\\tO\\nof\\tO\\nan\\tO\\nexonic\\tO\\nmutation\\tO\\nwhich\\tO\\naffects\\tO\\nexon\\tO\\n-\\tO\\nsplicing\\tO\\n.\\tO\\n.\\tO\\n\\nSubmicroscopic\\tO\\ndeletion\\tO\\nin\\tO\\ncousins\\tO\\nwith\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\ncauses\\tO\\na\\tO\\ngrandmatrilineal\\tO\\ninheritance\\tO\\npattern\\tO\\n:\\tO\\neffects\\tO\\nof\\tO\\nimprinting\\tO\\n.\\tO\\n\\nThe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\ncritical\\tO\\nregion\\tO\\non\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\nis\\tO\\nsubject\\tO\\nto\\tO\\nimprinting\\tO\\n.\\tO\\n\\nPWS\\tB-Disease\\nbecomes\\tO\\napparent\\tO\\nwhen\\tO\\ngenes\\tO\\non\\tO\\nthe\\tO\\npaternally\\tO\\ninherited\\tO\\nchromosome\\tO\\nare\\tO\\nnot\\tO\\nexpressed\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\nPWS\\tI-Disease\\nis\\tO\\nrare\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\na\\tO\\nfamily\\tO\\nin\\tO\\nwhich\\tO\\na\\tO\\nmale\\tO\\nand\\tO\\na\\tO\\nfemale\\tO\\npaternal\\tO\\nfirst\\tO\\ncousin\\tO\\nboth\\tO\\nhave\\tO\\nPWS\\tB-Disease\\nwith\\tO\\ncytogenetically\\tO\\nnormal\\tO\\nkaryotypes\\tO\\n.\\tO\\n\\nFluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n(\\tO\\nFISH\\tO\\n)\\tO\\nanalysis\\tO\\nshows\\tO\\na\\tO\\nsubmicroscopic\\tO\\ndeletion\\tO\\nof\\tO\\nSNRPN\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nthe\\tO\\nclosely\\tO\\nassociated\\tO\\nloci\\tO\\nD15S10\\tO\\n,\\tO\\nD15S11\\tO\\n,\\tO\\nD15S63\\tO\\n,\\tO\\nand\\tO\\nGABRB3\\tO\\n.\\tO\\n\\nThe\\tO\\ncousins\\tO\\nfathers\\tO\\nand\\tO\\ntwo\\tO\\npaternal\\tO\\naunts\\tO\\nhave\\tO\\nthe\\tO\\nsame\\tO\\ndeletion\\tO\\nand\\tO\\nare\\tO\\nclinically\\tO\\nnormal\\tO\\n.\\tO\\n\\nThe\\tO\\ngrandmother\\tO\\nof\\tO\\nthe\\tO\\ncousins\\tO\\nis\\tO\\ndeceased\\tO\\nand\\tO\\nnot\\tO\\navailable\\tO\\nfor\\tO\\nstudy\\tO\\n,\\tO\\nand\\tO\\ntheir\\tO\\ngrandfather\\tO\\nis\\tO\\nnot\\tO\\ndeleted\\tO\\nfor\\tO\\nSNRPN\\tO\\n.\\tO\\n\\nDNA\\tO\\nmethylation\\tO\\nanalysis\\tO\\nof\\tO\\nD15S63\\tO\\nis\\tO\\nconsistent\\tO\\nwith\\tO\\nan\\tO\\nabnormality\\tO\\nof\\tO\\nthe\\tO\\nimprinting\\tO\\ncenter\\tO\\nassociated\\tO\\nwith\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\n\"\\tO\\nGrandmatrilineal\\tO\\n\"\\tO\\ninheritance\\tO\\noccurs\\tO\\nwhen\\tO\\na\\tO\\nwoman\\tO\\nwith\\tO\\ndeletion\\tO\\nof\\tO\\nan\\tO\\nimprinted\\tO\\n,\\tO\\npaternally\\tO\\nexpressed\\tO\\ngene\\tO\\nis\\tO\\nat\\tO\\nrisk\\tO\\nof\\tO\\nhaving\\tO\\naffected\\tO\\ngrandchildren\\tO\\nthrough\\tO\\nher\\tO\\nsons\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\ncase\\tO\\n,\\tO\\nPWS\\tB-Disease\\ndoes\\tO\\nnot\\tO\\nbecome\\tO\\nevident\\tO\\nas\\tO\\nlong\\tO\\nas\\tO\\nthe\\tO\\ndeletion\\tO\\nis\\tO\\npassed\\tO\\nthrough\\tO\\nthe\\tO\\nmatrilineal\\tO\\nline\\tO\\n.\\tO\\n\\nThis\\tO\\nrepresents\\tO\\na\\tO\\nunique\\tO\\ninheritance\\tO\\npattern\\tO\\ndue\\tO\\nto\\tO\\nimprinting\\tO\\n.\\tO\\n.\\tO\\n\\nHuman\\tO\\nglycine\\tO\\ndecarboxylase\\tO\\ngene\\tO\\n(\\tO\\nGLDC\\tO\\n)\\tO\\nand\\tO\\nits\\tO\\nhighly\\tO\\nconserved\\tO\\nprocessed\\tO\\npseudogene\\tO\\n(\\tO\\npsiGLDC\\tO\\n)\\tO\\n:\\tO\\ntheir\\tO\\nstructure\\tO\\nand\\tO\\nexpression\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nlarge\\tO\\ndeletion\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nnonketotic\\tB-Disease\\nhyperglycinemia\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nglycine\\tO\\ndecarboxylase\\tO\\ngene\\tO\\n(\\tO\\nGLDC\\tO\\n)\\tO\\ncause\\tO\\nnonketotic\\tB-Disease\\nhyperglycinemia\\tI-Disease\\n(\\tO\\nNKH\\tB-Disease\\n)\\tO\\n,\\tO\\nan\\tO\\nin\\tB-Disease\\n-\\tI-Disease\\nborn\\tI-Disease\\nerror\\tI-Disease\\nof\\tI-Disease\\nmetabolism\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nsevere\\tO\\nneurological\\tB-Disease\\ndisturbance\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndetermined\\tO\\nthe\\tO\\nstructure\\tO\\nof\\tO\\nGLDC\\tO\\nand\\tO\\nof\\tO\\nits\\tO\\npseudogene\\tO\\n(\\tO\\npsiGLDC\\tO\\n)\\tO\\nand\\tO\\nstudied\\tO\\ntheir\\tO\\nexpression\\tO\\nfor\\tO\\na\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\nNKH\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nGLDC\\tO\\ngene\\tO\\nspans\\tO\\nat\\tO\\nleast\\tO\\n135\\tO\\nkb\\tO\\nand\\tO\\nconsists\\tO\\nof\\tO\\n25\\tO\\nexons\\tO\\n.\\tO\\n\\nAll\\tO\\ndonor\\tO\\nand\\tO\\nacceptor\\tO\\nsites\\tO\\nadhere\\tO\\nto\\tO\\nthe\\tO\\ncanonical\\tO\\nGT\\tO\\n-\\tO\\nAG\\tO\\nrule\\tO\\n,\\tO\\nexcept\\tO\\nfor\\tO\\nthe\\tO\\ndonor\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n21\\tO\\n,\\tO\\nwhere\\tO\\na\\tO\\nvariant\\tO\\nform\\tO\\nGC\\tO\\nis\\tO\\nused\\tO\\ninstead\\tO\\nof\\tO\\nGT\\tO\\n.\\tO\\n\\nThe\\tO\\ntranscription\\tO\\ninitiation\\tO\\nsite\\tO\\nhas\\tO\\nbeen\\tO\\nassigned\\tO\\nto\\tO\\na\\tO\\nresidue\\tO\\n163\\tO\\nbp\\tO\\nupstream\\tO\\nfrom\\tO\\nthe\\tO\\ntranslation\\tO\\ninitiation\\tO\\ntriplet\\tO\\nby\\tO\\nprimer\\tO\\nextension\\tO\\nanalysis\\tO\\n.\\tO\\n\\nThe\\tO\\npsiGLDC\\tO\\ngene\\tO\\nhas\\tO\\nno\\tO\\nintron\\tO\\nand\\tO\\nshares\\tO\\n97\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\nhomology\\tO\\nwith\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nfunctional\\tO\\nGLDC\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\npsiGLDC\\tO\\nis\\tO\\na\\tO\\nprocessed\\tO\\npseudogene\\tO\\nthat\\tO\\narose\\tO\\nfrom\\tO\\nthe\\tO\\nGLDC\\tO\\ntranscript\\tO\\nabout\\tO\\n4\\tO\\n-\\tO\\n8\\tO\\nmillion\\tO\\nyears\\tO\\nago\\tO\\n.\\tO\\n\\nRNA\\tO\\nblotting\\tO\\nanalysis\\tO\\nhas\\tO\\nrevealed\\tO\\nthat\\tO\\nGLDC\\tO\\nis\\tO\\nexpressed\\tO\\nin\\tO\\nhuman\\tO\\nliver\\tO\\n,\\tO\\nkidney\\tO\\n,\\tO\\nbrain\\tO\\n,\\tO\\nand\\tO\\nplacenta\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nalso\\tO\\nexamined\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nNKH\\tB-Disease\\nwith\\tO\\nno\\tO\\ndetectable\\tO\\nGLDC\\tO\\nmRNA\\tO\\nin\\tO\\nhis\\tO\\nlymphoblasts\\tO\\n.\\tO\\n\\nExons\\tO\\n1\\tO\\n-\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\nfunctional\\tO\\nGLDC\\tO\\ngene\\tO\\nfrom\\tO\\nthis\\tO\\npatient\\tO\\nare\\tO\\nnot\\tO\\namplified\\tO\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\n,\\tO\\nwhereas\\tO\\nthose\\tO\\nfrom\\tO\\ncontrol\\tO\\nsubjects\\tO\\nare\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\na\\tO\\nlarge\\tO\\nhomozygous\\tO\\ndeletion\\tO\\n(\\tO\\nat\\tO\\nleast\\tO\\n30\\tO\\nkb\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ndevised\\tO\\na\\tO\\nsemi\\tO\\n-\\tO\\nquantitative\\tO\\nPCR\\tO\\nto\\tO\\nestimate\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\nGLDC\\tO\\nalleles\\tO\\nby\\tO\\nusing\\tO\\npsiGLDC\\tO\\nas\\tO\\nan\\tO\\ninternal\\tO\\ncontrol\\tO\\nand\\tO\\nhave\\tO\\nconfirmed\\tO\\nthe\\tO\\nhomozygosity\\tO\\nand\\tO\\nheterozygosity\\tO\\nof\\tO\\nthe\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\nand\\tO\\nhis\\tO\\nparents\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nStructural\\tO\\ninformation\\tO\\nof\\tO\\nGLDC\\tO\\nand\\tO\\npsiGLDC\\tO\\nshould\\tO\\nfacilitate\\tO\\nthe\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\nNKH\\tB-Disease\\n.\\tO\\n\\nDe\\tO\\nnovo\\tO\\ndeletions\\tO\\nof\\tO\\nSNRPN\\tO\\nexon\\tO\\n1\\tO\\nin\\tO\\nearly\\tO\\nhuman\\tO\\nand\\tO\\nmouse\\tO\\nembryos\\tO\\nresult\\tO\\nin\\tO\\na\\tO\\npaternal\\tO\\nto\\tO\\nmaternal\\tO\\nimprint\\tO\\nswitch\\tO\\n.\\tO\\n\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nneurogenetic\\tB-Disease\\ndisease\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\ninfantile\\tB-Disease\\nhypotonia\\tI-Disease\\n,\\tO\\ngonadal\\tB-Disease\\nhypoplasia\\tI-Disease\\n,\\tO\\nobsessive\\tO\\nbehaviour\\tO\\nand\\tO\\nneonatal\\tO\\nfeeding\\tO\\ndifficulties\\tO\\nfollowed\\tO\\nby\\tO\\nhyperphagia\\tB-Disease\\n,\\tO\\nleading\\tO\\nto\\tO\\nprofound\\tO\\nobesity\\tB-Disease\\n.\\tO\\n\\nPWS\\tB-Disease\\nis\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nlack\\tO\\nof\\tO\\npaternal\\tO\\ngenetic\\tO\\ninformation\\tO\\nat\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\n.\\tO\\n\\nFive\\tO\\nimprinted\\tO\\n,\\tO\\npaternally\\tO\\nexpressed\\tO\\ngenes\\tO\\nmap\\tO\\nto\\tO\\nthe\\tO\\nPWS\\tB-Disease\\nregion\\tO\\n,\\tO\\nMKRN3\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n3\\tO\\n)\\tO\\n,\\tO\\nNDN\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n4\\tO\\n)\\tO\\n,\\tO\\nNDNL1\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n5\\tO\\n)\\tO\\n,\\tO\\nSNRPN\\tO\\n(\\tO\\nrefs\\tO\\n6\\tO\\n-\\tO\\n8\\tO\\n)\\tO\\nand\\tO\\nIPW\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n9\\tO\\n)\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\ntwo\\tO\\npoorly\\tO\\ncharacterized\\tO\\nframents\\tO\\ndesignated\\tO\\nPAR\\tO\\n-\\tO\\n1\\tO\\nand\\tO\\nPAR\\tO\\n-\\tO\\n5\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n10\\tO\\n)\\tO\\n.\\tO\\n\\nImprinting\\tO\\nof\\tO\\nthis\\tO\\nregion\\tO\\ninvolves\\tO\\na\\tO\\nbipartite\\tO\\nimprinting\\tO\\ncentre\\tO\\n(\\tO\\nIC\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\noverlaps\\tO\\nSNRPN\\tO\\n(\\tO\\nrefs\\tO\\n10\\tO\\n,\\tO\\n11\\tO\\n)\\tO\\n.\\tO\\n\\nDeletion\\tO\\nof\\tO\\nthe\\tO\\nSNRPN\\tO\\npromoter\\tO\\n/\\tO\\nexon\\tO\\n1\\tO\\nregion\\tO\\n(\\tO\\nthe\\tO\\nPWS\\tB-Disease\\nIC\\tO\\nelement\\tO\\n)\\tO\\nappears\\tO\\nto\\tO\\nimpair\\tO\\nthe\\tO\\nestablishment\\tO\\nof\\tO\\nthe\\tO\\npaternal\\tO\\nimprint\\tO\\nin\\tO\\nthe\\tO\\nmale\\tO\\ngerm\\tO\\nline\\tO\\nand\\tO\\nleads\\tO\\nto\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\na\\tO\\nPWS\\tB-Disease\\nfamily\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nfather\\tO\\nis\\tO\\nmosaic\\tO\\nfor\\tO\\nan\\tO\\nIC\\tO\\ndeletion\\tO\\non\\tO\\nhis\\tO\\npaternal\\tO\\nchromosome\\tO\\n.\\tO\\n\\nThe\\tO\\ndeletion\\tO\\nchromosome\\tO\\nhas\\tO\\nacquired\\tO\\na\\tO\\nmaternal\\tO\\nmethylation\\tO\\nimprint\\tO\\nin\\tO\\nhis\\tO\\nsomatic\\tO\\ncells\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nmade\\tO\\nidentical\\tO\\nfindings\\tO\\nin\\tO\\nchimaeric\\tO\\nmice\\tO\\ngenerated\\tO\\nfrom\\tO\\ntwo\\tO\\nindependent\\tO\\nembryonic\\tO\\nstem\\tO\\n(\\tO\\nES\\tO\\n)\\tO\\ncell\\tO\\nlines\\tO\\nharbouring\\tO\\na\\tO\\nsimilar\\tO\\ndeletion\\tO\\n.\\tO\\n\\nOur\\tO\\nstudies\\tO\\ndemonstrate\\tO\\nthat\\tO\\nthe\\tO\\nPWS\\tB-Disease\\nIC\\tO\\nelement\\tO\\nis\\tO\\nnot\\tO\\nonly\\tO\\nrequired\\tO\\nfor\\tO\\nthe\\tO\\nestablishment\\tO\\nof\\tO\\nthe\\tO\\npaternal\\tO\\nimprint\\tO\\n,\\tO\\nbut\\tO\\nalso\\tO\\nfor\\tO\\nits\\tO\\npostzygotic\\tO\\nmaintenance\\tO\\n.\\tO\\n.\\tO\\n\\nMice\\tO\\ndeficient\\tB-Disease\\nin\\tI-Disease\\nSix5\\tI-Disease\\ndevelop\\tO\\ncataracts\\tB-Disease\\n:\\tO\\nimplications\\tO\\nfor\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nExpansion\\tO\\nof\\tO\\na\\tO\\nCTG\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nUTR\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nDMPK\\tO\\nat\\tO\\nthe\\tO\\nDM1\\tO\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n19\\tO\\ncauses\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\na\\tO\\ndominantly\\tB-Disease\\ninherited\\tI-Disease\\ndisease\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nskeletal\\tO\\nmuscle\\tB-Disease\\ndystrophy\\tI-Disease\\nand\\tO\\nmyotonia\\tB-Disease\\n,\\tO\\ncataracts\\tB-Disease\\nand\\tO\\ncardiac\\tB-Disease\\nconduction\\tI-Disease\\ndefects\\tI-Disease\\n.\\tO\\n\\nTargeted\\tO\\ndeletion\\tO\\nof\\tO\\nDm15\\tO\\n,\\tO\\nthe\\tO\\nmouse\\tO\\northologue\\tO\\nof\\tO\\nhuman\\tO\\nDMPK\\tO\\n,\\tO\\nproduced\\tO\\nmice\\tO\\nwith\\tO\\na\\tO\\nmild\\tO\\nmyopathy\\tB-Disease\\nand\\tO\\ncardiac\\tB-Disease\\nconduction\\tI-Disease\\nabnormalities\\tI-Disease\\n,\\tO\\nbut\\tO\\nwithout\\tO\\nother\\tO\\nfeatures\\tO\\nof\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nsuch\\tO\\nas\\tO\\nmyotonia\\tB-Disease\\nand\\tO\\ncataracts\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\n,\\tO\\nand\\tO\\nothers\\tO\\n,\\tO\\nhave\\tO\\ndemonstrated\\tO\\nthat\\tO\\nrepeat\\tO\\nexpansion\\tO\\ndecreases\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nadjacent\\tO\\ngene\\tO\\nSIX5\\tO\\n(\\tO\\nrefs\\tO\\n7\\tO\\n,\\tO\\n8\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nencodes\\tO\\na\\tO\\nhomeodomain\\tO\\ntranscription\\tO\\nfactor\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nwhether\\tO\\nSIX5\\tB-Disease\\ndeficiency\\tI-Disease\\ncontributes\\tO\\nto\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nphenotype\\tO\\n,\\tO\\nwe\\tO\\ndisrupted\\tO\\nmouse\\tO\\nSix5\\tO\\nby\\tO\\nreplacing\\tO\\nthe\\tO\\nfirst\\tO\\nexon\\tO\\nwith\\tO\\na\\tO\\nbeta\\tO\\n-\\tO\\ngalactosidase\\tO\\nreporter\\tO\\n.\\tO\\n\\nSix5\\tO\\n-\\tO\\nmutant\\tO\\nmice\\tO\\nshowed\\tO\\nreporter\\tO\\nexpression\\tO\\nin\\tO\\nmultiple\\tO\\ntissues\\tO\\n,\\tO\\nincluding\\tO\\nthe\\tO\\ndeveloping\\tO\\nlens\\tO\\n.\\tO\\n\\nHomozygous\\tO\\nmutant\\tO\\nmice\\tO\\nhad\\tO\\nno\\tO\\napparent\\tO\\nabnormalities\\tB-Disease\\nof\\tI-Disease\\nskeletal\\tI-Disease\\nmuscle\\tI-Disease\\nfunction\\tI-Disease\\n,\\tO\\nbut\\tO\\ndeveloped\\tO\\nlenticular\\tB-Disease\\nopacities\\tI-Disease\\nat\\tO\\na\\tO\\nhigher\\tO\\nrate\\tO\\nthan\\tO\\ncontrols\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nSIX5\\tB-Disease\\ndeficiency\\tI-Disease\\ncontributes\\tO\\nto\\tO\\nthe\\tO\\ncataract\\tB-Disease\\nphenotype\\tO\\nin\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nand\\tO\\nthat\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nrepresents\\tO\\na\\tO\\nmultigenic\\tB-Disease\\ndisorder\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nHeterozygous\\tO\\nloss\\tO\\nof\\tO\\nSix5\\tO\\nin\\tO\\nmice\\tO\\nis\\tO\\nsufficient\\tO\\nto\\tO\\ncause\\tO\\nocular\\tO\\ncataracts\\tB-Disease\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nskeletal\\tO\\nmuscle\\tB-Disease\\nwasting\\tI-Disease\\n,\\tO\\nmyotonia\\tB-Disease\\n,\\tO\\ncardiac\\tB-Disease\\narrhythmia\\tI-Disease\\n,\\tO\\nhyperinsulinaemia\\tB-Disease\\n,\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\nand\\tO\\nocular\\tO\\ncataracts\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\nin\\tO\\nDM\\tB-Disease\\nis\\tO\\na\\tO\\nCTG\\tO\\nrepeat\\tO\\nexpansion\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\nDMPK\\tO\\nand\\tO\\n5\\tO\\nof\\tO\\na\\tO\\nhomeodomain\\tO\\n-\\tO\\nencoding\\tO\\ngene\\tO\\n,\\tO\\nSIX5\\tO\\n(\\tO\\nformerly\\tO\\nDMAHP\\tO\\n;\\tO\\nrefs\\tO\\n2\\tO\\n-\\tO\\n5\\tO\\n)\\tO\\n.\\tO\\n\\nThere\\tO\\nare\\tO\\nthree\\tO\\nmechanisms\\tO\\nby\\tO\\nwhich\\tO\\nCTG\\tO\\nexpansion\\tO\\ncan\\tO\\nresult\\tO\\nin\\tO\\nDM\\tB-Disease\\n.\\tO\\n\\nFirst\\tO\\n,\\tO\\nrepeat\\tO\\nexpansion\\tO\\nmay\\tO\\nalter\\tO\\nthe\\tO\\nprocessing\\tO\\nor\\tO\\ntransport\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nDMPK\\tO\\nmRNA\\tO\\nand\\tO\\nconsequently\\tO\\nreduce\\tO\\nDMPK\\tO\\nlevels\\tO\\n.\\tO\\n\\nSecond\\tO\\n,\\tO\\nCTG\\tO\\nexpansion\\tO\\nmay\\tO\\nestablish\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\nheterochromatin\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\nsequence\\tO\\nand\\tO\\ndecrease\\tO\\nSIX5\\tO\\ntranscription\\tO\\n.\\tO\\n\\nThird\\tO\\n,\\tO\\ntoxic\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\nexpansion\\tO\\nmay\\tO\\nbe\\tO\\nintrinsic\\tO\\nto\\tO\\nthe\\tO\\nrepeated\\tO\\nelements\\tO\\nat\\tO\\nthe\\tO\\nlevel\\tO\\nof\\tO\\nDNA\\tO\\nor\\tO\\nRNA\\tO\\n(\\tO\\nrefs\\tO\\n10\\tO\\n,\\tO\\n11\\tO\\n)\\tO\\n.\\tO\\n\\nPrevious\\tO\\nstudies\\tO\\nhave\\tO\\ndemonstrated\\tO\\nthat\\tO\\na\\tO\\ndose\\tO\\n-\\tO\\ndependent\\tO\\nloss\\tO\\nof\\tO\\nDm15\\tO\\n(\\tO\\nthe\\tO\\nmouse\\tO\\nDMPK\\tO\\nhomologue\\tO\\n)\\tO\\nin\\tO\\nmice\\tO\\nproduces\\tO\\na\\tO\\npartial\\tO\\nDM\\tB-Disease\\nphenotype\\tO\\ncharacterized\\tO\\nby\\tO\\ndecreased\\tO\\ndevelopment\\tO\\nof\\tO\\nskeletal\\tO\\nmuscle\\tO\\nforce\\tO\\nand\\tO\\ncardiac\\tB-Disease\\nconduction\\tI-Disease\\ndisorders\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\ntest\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nSix5\\tO\\nloss\\tO\\nin\\tO\\nDM\\tB-Disease\\n,\\tO\\nwe\\tO\\nhave\\tO\\nanalysed\\tO\\na\\tO\\nstrain\\tO\\nof\\tO\\nmice\\tO\\nin\\tO\\nwhich\\tO\\nSix5\\tO\\nwas\\tO\\ndeleted\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\ndemonstrate\\tO\\nthat\\tO\\nthe\\tO\\nrate\\tO\\nand\\tO\\nseverity\\tO\\nof\\tO\\ncataract\\tB-Disease\\nformation\\tO\\nis\\tO\\ninversely\\tO\\nrelated\\tO\\nto\\tO\\nSix5\\tO\\ndosage\\tO\\nand\\tO\\nis\\tO\\ntemporally\\tO\\nprogressive\\tO\\n.\\tO\\n\\nSix5\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\nand\\tO\\nSix5\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\nshow\\tO\\nincreased\\tO\\nsteady\\tO\\n-\\tO\\nstate\\tO\\nlevels\\tO\\nof\\tO\\nthe\\tO\\nNa\\tO\\n+\\tO\\n/\\tO\\nK\\tO\\n+\\tO\\n-\\tO\\nATPase\\tO\\nalpha\\tO\\n-\\tO\\n1\\tO\\nsubunit\\tO\\nand\\tO\\ndecreased\\tO\\nDm15\\tO\\nmRNA\\tO\\nlevels\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\naltered\\tO\\nion\\tO\\nhomeostasis\\tO\\nwithin\\tO\\nthe\\tO\\nlens\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\ncataract\\tB-Disease\\nformation\\tO\\n.\\tO\\n\\nAs\\tO\\nocular\\tO\\ncataracts\\tB-Disease\\nare\\tO\\na\\tO\\ncharacteristic\\tO\\nfeature\\tO\\nof\\tO\\nDM\\tB-Disease\\n,\\tO\\nthese\\tO\\nresults\\tO\\ndemonstrate\\tO\\nthat\\tO\\ndecreased\\tO\\nSIX5\\tO\\ntranscription\\tO\\nis\\tO\\nimportant\\tO\\nin\\tO\\nthe\\tO\\naetiology\\tO\\nof\\tO\\nDM\\tB-Disease\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nsupport\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nDM\\tB-Disease\\nis\\tO\\na\\tO\\ncontiguous\\tO\\ngene\\tO\\nsyndrome\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\npartial\\tO\\nloss\\tO\\nof\\tO\\nboth\\tO\\nDMPK\\tO\\nand\\tO\\nSIX5\\tO\\n.\\tO\\n.\\tO\\n\\nATM\\tO\\n-\\tO\\ndependent\\tO\\nphosphorylation\\tO\\nof\\tO\\nnibrin\\tO\\nin\\tO\\nresponse\\tO\\nto\\tO\\nradiation\\tO\\nexposure\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nATM\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\ngenetic\\tB-Disease\\ndisorder\\tI-Disease\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\ncerebellar\\tB-Disease\\ndysfunction\\tI-Disease\\n,\\tO\\nradiosensitivity\\tO\\n,\\tO\\nchromosomal\\tO\\ninstability\\tO\\nand\\tO\\ncancer\\tB-Disease\\npredisposition\\tO\\n.\\tO\\n\\nBoth\\tO\\nthe\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nphenotype\\tO\\nand\\tO\\nthe\\tO\\nsimilarity\\tO\\nof\\tO\\nthe\\tO\\nATM\\tO\\nprotein\\tO\\nto\\tO\\nother\\tO\\nDNA\\tO\\n-\\tO\\ndamage\\tO\\nsensors\\tO\\nsuggests\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nATM\\tO\\nin\\tO\\nbiochemical\\tO\\npathways\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nrecognition\\tO\\n,\\tO\\nsignalling\\tO\\nand\\tO\\nrepair\\tO\\nof\\tO\\nDNA\\tO\\ndouble\\tO\\n-\\tO\\nstrand\\tO\\nbreaks\\tO\\n(\\tO\\nDSBs\\tO\\n)\\tO\\n.\\tO\\n\\nThere\\tO\\nare\\tO\\nstrong\\tO\\nparallels\\tO\\nbetween\\tO\\nthe\\tO\\npattern\\tO\\nof\\tO\\nradiosensitivity\\tO\\n,\\tO\\nchromosomal\\tO\\ninstability\\tO\\nand\\tO\\ncancer\\tB-Disease\\npredisposition\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\nand\\tO\\nthat\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nNijmegen\\tB-Disease\\nbreakage\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nNBS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nprotein\\tO\\ndefective\\tO\\nin\\tO\\nNBS\\tB-Disease\\n,\\tO\\nnibrin\\tO\\n(\\tO\\nencoded\\tO\\nby\\tO\\nNBS1\\tO\\n)\\tO\\n,\\tO\\nforms\\tO\\na\\tO\\ncomplex\\tO\\nwith\\tO\\nMRE11\\tO\\nand\\tO\\nRAD50\\tO\\n(\\tO\\nrefs\\tO\\n1\\tO\\n,\\tO\\n2\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\ncomplex\\tO\\nlocalizes\\tO\\nto\\tO\\nDSBs\\tO\\nwithin\\tO\\n30\\tO\\nminutes\\tO\\nafter\\tO\\ncellular\\tO\\nexposure\\tO\\nto\\tO\\nionizing\\tO\\nradiation\\tO\\n(\\tO\\nIR\\tO\\n)\\tO\\nand\\tO\\nis\\tO\\nobserved\\tO\\nin\\tO\\nbrightly\\tO\\nstaining\\tO\\nnuclear\\tO\\nfoci\\tO\\nafter\\tO\\na\\tO\\nlonger\\tO\\nperiod\\tO\\nof\\tO\\ntime\\tO\\n.\\tO\\n\\nThe\\tO\\noverlap\\tO\\nbetween\\tO\\nclinical\\tO\\nand\\tO\\ncellular\\tO\\nphenotypes\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nand\\tO\\nNBS\\tB-Disease\\nsuggests\\tO\\nthat\\tO\\nATM\\tO\\nand\\tO\\nnibrin\\tO\\nmay\\tO\\nfunction\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\nbiochemical\\tO\\npathway\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\ndemonstrate\\tO\\nthat\\tO\\nnibrin\\tO\\nis\\tO\\nphosphorylated\\tO\\nwithin\\tO\\none\\tO\\nhour\\tO\\nof\\tO\\ntreatment\\tO\\nof\\tO\\ncells\\tO\\nwith\\tO\\nIR\\tO\\n.\\tO\\n\\nThis\\tO\\nresponse\\tO\\nis\\tO\\nabrogated\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\ncells\\tO\\nthat\\tO\\neither\\tO\\ndo\\tO\\nnot\\tO\\nexpress\\tO\\nATM\\tO\\nprotein\\tO\\nor\\tO\\nexpress\\tO\\nnear\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\nmutant\\tO\\nprotein\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nshow\\tO\\nthat\\tO\\nATM\\tO\\nphysically\\tO\\ninteracts\\tO\\nwith\\tO\\nand\\tO\\nphosphorylates\\tO\\nnibrin\\tO\\non\\tO\\nserine\\tO\\n343\\tO\\nboth\\tO\\nin\\tO\\nvivo\\tO\\nand\\tO\\nin\\tO\\nvitro\\tO\\n.\\tO\\n\\nPhosphorylation\\tO\\nof\\tO\\nthis\\tO\\nsite\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\nfunctionally\\tO\\nimportant\\tO\\nbecause\\tO\\nmutated\\tO\\nnibrin\\tO\\n(\\tO\\nS343A\\tO\\n)\\tO\\ndoes\\tO\\nnot\\tO\\ncompletely\\tO\\ncomplement\\tO\\nradiosensitivity\\tO\\nin\\tO\\nNBS\\tB-Disease\\ncells\\tO\\n.\\tO\\n\\nATM\\tO\\nphosphorylation\\tO\\nof\\tO\\nnibrin\\tO\\ndoes\\tO\\nnot\\tO\\naffect\\tO\\nnibrin\\tO\\n-\\tO\\nMRE11\\tO\\n-\\tO\\nRAD50\\tO\\nassociation\\tO\\nas\\tO\\nrevealed\\tO\\nby\\tO\\nradiation\\tO\\n-\\tO\\ninduced\\tO\\nfoci\\tO\\nformation\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nprovide\\tO\\na\\tO\\nbiochemical\\tO\\nexplanation\\tO\\nfor\\tO\\nthe\\tO\\nsimilarity\\tO\\nin\\tO\\nphenotype\\tO\\nbetween\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nand\\tO\\nNBS\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nClinicopathologic\\tO\\nfeatures\\tO\\nof\\tO\\nBRCA\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nand\\tI-Disease\\nsporadic\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nCONTEXT\\tO\\nMost\\tO\\nhereditary\\tB-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\nare\\tO\\nassociated\\tO\\nwith\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nAttempts\\tO\\nto\\tO\\ndefine\\tO\\nthe\\tO\\nclinical\\tO\\nsignificance\\tO\\nof\\tO\\nBRCA\\tO\\nmutation\\tO\\nstatus\\tO\\nin\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nhave\\tO\\nproduced\\tO\\nconflicting\\tO\\nresults\\tO\\n,\\tO\\nespecially\\tO\\nregarding\\tO\\nsurvival\\tO\\n.\\tO\\n\\nOBJECTIVE\\tO\\nTo\\tO\\ndetermine\\tO\\nwhether\\tO\\nhereditary\\tB-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\nhave\\tO\\ndistinct\\tO\\nclinical\\tO\\nand\\tO\\npathological\\tO\\nfeatures\\tO\\ncompared\\tO\\nwith\\tO\\nsporadic\\tB-Disease\\n(\\tI-Disease\\nnonhereditary\\tI-Disease\\n)\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nDESIGN\\tO\\nAND\\tO\\nSETTING\\tO\\nRetrospective\\tO\\ncohort\\tO\\nstudy\\tO\\nof\\tO\\na\\tO\\nconsecutive\\tO\\nseries\\tO\\nof\\tO\\n933\\tO\\novarian\\tB-Disease\\ncancers\\tI-Disease\\ndiagnosed\\tO\\nand\\tO\\ntreated\\tO\\nat\\tO\\nour\\tO\\ninstitution\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\na\\tO\\ncomprehensive\\tO\\ncancer\\tB-Disease\\ncenter\\tO\\nas\\tO\\ndesignated\\tO\\nby\\tO\\nthe\\tO\\nNational\\tO\\nCancer\\tB-Disease\\nInstitute\\tO\\n,\\tO\\nover\\tO\\na\\tO\\n12\\tO\\n-\\tO\\nyear\\tO\\nperiod\\tO\\n(\\tO\\nDecember\\tO\\n1986\\tO\\nto\\tO\\nAugust\\tO\\n1998\\tO\\n)\\tO\\n.\\tO\\n\\nPATIENTS\\tO\\nThe\\tO\\nstudy\\tO\\nwas\\tO\\nrestricted\\tO\\nto\\tO\\npatients\\tO\\nof\\tO\\nJewish\\tO\\norigin\\tO\\nbecause\\tO\\nof\\tO\\nthe\\tO\\nease\\tO\\nof\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\ngenotyping\\tO\\nin\\tO\\nthis\\tO\\nethnic\\tO\\ngroup\\tO\\n.\\tO\\n\\nFrom\\tO\\nthe\\tO\\n189\\tO\\npatients\\tO\\nwho\\tO\\nidentified\\tO\\nthemselves\\tO\\nas\\tO\\nJewish\\tO\\n,\\tO\\n88\\tO\\nhereditary\\tO\\ncases\\tO\\nwere\\tO\\nidentified\\tO\\nwith\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\ngermline\\tO\\nfounder\\tO\\nmutation\\tO\\nin\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nThe\\tO\\nremaining\\tO\\n101\\tO\\ncases\\tO\\nfrom\\tO\\nthe\\tO\\nsame\\tO\\nseries\\tO\\nnot\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nBRCA\\tO\\nmutation\\tO\\nand\\tO\\n2\\tO\\nadditional\\tO\\ngroups\\tO\\n(\\tO\\nGynecologic\\tO\\nOncology\\tO\\nGroup\\tO\\nprotocols\\tO\\n52\\tO\\nand\\tO\\n111\\tO\\n)\\tO\\nwith\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nfrom\\tO\\nclinical\\tO\\ntrials\\tO\\n(\\tO\\nfor\\tO\\nthe\\tO\\nsurvival\\tO\\nanalysis\\tO\\n)\\tO\\nwere\\tO\\nincluded\\tO\\nfor\\tO\\ncomparison\\tO\\n.\\tO\\n\\nMAIN\\tO\\nOUTCOME\\tO\\nMEASURES\\tO\\nAge\\tO\\nat\\tO\\ndiagnosis\\tO\\n,\\tO\\nsurgical\\tO\\nstage\\tO\\n,\\tO\\nhistologic\\tO\\ncell\\tO\\ntype\\tO\\nand\\tO\\ngrade\\tO\\n,\\tO\\nand\\tO\\nsurgical\\tO\\noutcome\\tO\\n;\\tO\\nand\\tO\\nresponse\\tO\\nto\\tO\\nchemotherapy\\tO\\nand\\tO\\nsurvival\\tO\\nfor\\tO\\nadvanced\\tO\\n-\\tO\\nstage\\tO\\n(\\tO\\nII\\tO\\nand\\tO\\nIV\\tO\\n)\\tO\\ncases\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nHereditary\\tB-Disease\\ncancers\\tI-Disease\\nwere\\tO\\nrarely\\tO\\ndiagnosed\\tO\\nbefore\\tO\\nage\\tO\\n40\\tO\\nyears\\tO\\nand\\tO\\nwere\\tO\\ncommon\\tO\\nafter\\tO\\nage\\tO\\n60\\tO\\nyears\\tO\\n,\\tO\\nwith\\tO\\nmean\\tO\\nage\\tO\\nat\\tO\\ndiagnosis\\tO\\nbeing\\tO\\nsignificantly\\tO\\nyounger\\tO\\nfor\\tO\\nBRCA1\\tO\\n-\\tO\\nvs\\tO\\nBRCA2\\tO\\n-\\tO\\nlinked\\tO\\npatients\\tO\\n(\\tO\\n54\\tO\\nvs\\tO\\n62\\tO\\nyears\\tO\\n;\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n04\\tO\\n)\\tO\\n.\\tO\\n\\nHistology\\tO\\n,\\tO\\ngrade\\tO\\n,\\tO\\nstage\\tO\\n,\\tO\\nand\\tO\\nsuccess\\tO\\nof\\tO\\ncytoreductive\\tO\\nsurgery\\tO\\nwere\\tO\\nsimilar\\tO\\nfor\\tO\\nhereditary\\tO\\nand\\tO\\nsporadic\\tO\\ncases\\tO\\n.\\tO\\n\\nThe\\tO\\nhereditary\\tO\\ngroup\\tO\\nhad\\tO\\na\\tO\\nlonger\\tO\\ndisease\\tO\\n-\\tO\\nfree\\tO\\ninterval\\tO\\nfollowing\\tO\\nprimary\\tO\\nchemotherapy\\tO\\nin\\tO\\ncomparison\\tO\\nwith\\tO\\nthe\\tO\\nnonhereditary\\tO\\ngroup\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\nmedian\\tO\\ntime\\tO\\nto\\tO\\nrecurrence\\tO\\nof\\tO\\n14\\tO\\nmonths\\tO\\nand\\tO\\n7\\tO\\nmonths\\tO\\n,\\tO\\nrespectively\\tO\\n(\\tO\\nP\\tO\\n<\\tO\\n.\\tO\\n001\\tO\\n)\\tO\\n.\\tO\\n\\nThose\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\ncancers\\tI-Disease\\nhad\\tO\\nimproved\\tO\\nsurvival\\tO\\ncompared\\tO\\nwith\\tO\\nthe\\tO\\nnonhereditary\\tO\\ngroup\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n004\\tO\\n)\\tO\\n.\\tO\\n\\nFor\\tO\\nstage\\tB-Disease\\nIII\\tI-Disease\\ncancers\\tI-Disease\\n,\\tO\\nBRCA\\tO\\nmutation\\tO\\nstatus\\tO\\nwas\\tO\\nan\\tO\\nindependent\\tO\\nprognostic\\tO\\nvariable\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n03\\tO\\n)\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nAlthough\\tO\\nBRCA\\tB-Disease\\n-\\tI-Disease\\nassociated\\tI-Disease\\nhereditary\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\nin\\tO\\nthis\\tO\\npopulation\\tO\\nhave\\tO\\nsurgical\\tO\\nand\\tO\\npathological\\tO\\ncharacteristics\\tO\\nsimilar\\tO\\nto\\tO\\nthose\\tO\\nof\\tO\\nsporadic\\tB-Disease\\ncancers\\tI-Disease\\n,\\tO\\nadvanced\\tB-Disease\\n-\\tI-Disease\\nstage\\tI-Disease\\nhereditary\\tI-Disease\\ncancer\\tI-Disease\\npatients\\tO\\nsurvive\\tO\\nlonger\\tO\\nthan\\tO\\nnonhereditary\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nAge\\tO\\npenetrance\\tO\\nis\\tO\\ngreater\\tO\\nfor\\tO\\nBRCA1\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nthan\\tI-Disease\\nfor\\tI-Disease\\nBRCA2\\tI-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ncancers\\tI-Disease\\nin\\tO\\nthis\\tO\\npopulation\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nfor\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n,\\tO\\nMEFV\\tO\\n,\\tO\\nis\\tO\\nexpressed\\tO\\nin\\tO\\nearly\\tO\\nleukocyte\\tO\\ndevelopment\\tO\\nand\\tO\\nis\\tO\\nregulated\\tO\\nin\\tO\\nresponse\\tO\\nto\\tO\\ninflammatory\\tO\\nmediators\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n(\\tO\\nFMF\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nrecessive\\tB-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nepisodes\\tO\\nof\\tO\\nfever\\tB-Disease\\nand\\tO\\nneutrophil\\tB-Disease\\n-\\tI-Disease\\nmediated\\tI-Disease\\nserosal\\tI-Disease\\ninflammation\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nrecently\\tO\\nidentified\\tO\\nthe\\tO\\ngene\\tO\\ncausing\\tO\\nFMF\\tB-Disease\\n,\\tO\\ndesignated\\tO\\nMEFV\\tO\\n,\\tO\\nand\\tO\\nfound\\tO\\nit\\tO\\nto\\tO\\nbe\\tO\\nexpressed\\tO\\nin\\tO\\nmature\\tO\\nneutrophils\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nit\\tO\\nfunctions\\tO\\nas\\tO\\nan\\tO\\ninflammatory\\tO\\nregulator\\tO\\n.\\tO\\n\\nTo\\tO\\nfacilitate\\tO\\nour\\tO\\nunderstanding\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nfunction\\tO\\nof\\tO\\nMEFV\\tO\\n,\\tO\\nwe\\tO\\nextended\\tO\\nour\\tO\\nprevious\\tO\\nstudies\\tO\\n.\\tO\\n\\nMEFV\\tO\\nmessenger\\tO\\nRNA\\tO\\nwas\\tO\\ndetected\\tO\\nby\\tO\\nreverse\\tO\\ntranscriptase\\tO\\n-\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nin\\tO\\nbone\\tO\\nmarrow\\tO\\nleukocytes\\tO\\n,\\tO\\nwith\\tO\\ndifferential\\tO\\nexpression\\tO\\nobserved\\tO\\namong\\tO\\ncells\\tO\\nby\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n.\\tO\\n\\nCD34\\tO\\nhematopoietic\\tO\\nstem\\tO\\n-\\tO\\ncell\\tO\\ncultures\\tO\\ninduced\\tO\\ntoward\\tO\\nthe\\tO\\ngranulocytic\\tO\\nlineage\\tO\\nexpressed\\tO\\nMEFV\\tO\\nat\\tO\\nthe\\tO\\nmyelocyte\\tO\\nstage\\tO\\n,\\tO\\nconcurrently\\tO\\nwith\\tO\\nlineage\\tO\\ncommitment\\tO\\n.\\tO\\n\\nThe\\tO\\nprepromyelocytic\\tO\\ncell\\tO\\nline\\tO\\nHL60\\tO\\nexpressed\\tO\\nMEFV\\tO\\nonly\\tO\\nat\\tO\\ngranulocytic\\tO\\nand\\tO\\nmonocytic\\tO\\ndifferentiation\\tO\\n.\\tO\\n\\nMEFV\\tO\\nwas\\tO\\nalso\\tO\\nexpressed\\tO\\nin\\tO\\nthe\\tO\\nmonocytic\\tO\\ncell\\tO\\nlines\\tO\\nU937\\tO\\nand\\tO\\nTHP\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n\\nAmong\\tO\\nperipheral\\tO\\nblood\\tO\\nleukocytes\\tO\\n,\\tO\\nMEFV\\tO\\nexpression\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nneutrophils\\tO\\n,\\tO\\neosinophils\\tO\\n,\\tO\\nand\\tO\\nto\\tO\\nvarying\\tO\\ndegrees\\tO\\n,\\tO\\nmonocytes\\tO\\n.\\tO\\n\\nConsistent\\tO\\nwith\\tO\\nthe\\tO\\ntissue\\tO\\nspecificity\\tO\\nof\\tO\\nexpression\\tO\\n,\\tO\\ncomplete\\tO\\nsequencing\\tO\\nand\\tO\\nanalysis\\tO\\nof\\tO\\nupstream\\tO\\nregulatory\\tO\\nregions\\tO\\nof\\tO\\nMEFV\\tO\\nrevealed\\tO\\nhomology\\tO\\nto\\tO\\nmyeloid\\tO\\n-\\tO\\nspecific\\tO\\npromoters\\tO\\nand\\tO\\nto\\tO\\nmore\\tO\\nbroadly\\tO\\nexpressed\\tO\\ninflammatory\\tO\\npromoter\\tO\\nelements\\tO\\n.\\tO\\n\\nIn\\tO\\nvitro\\tO\\nstimulation\\tO\\nof\\tO\\nmonocytes\\tO\\nwith\\tO\\nthe\\tO\\nproinflammatory\\tO\\nagents\\tO\\ninterferon\\tO\\n(\\tO\\nIFN\\tO\\n)\\tO\\ngamma\\tO\\n,\\tO\\ntumor\\tB-Disease\\nnecrosis\\tO\\nfactor\\tO\\n,\\tO\\nand\\tO\\nlipopolysaccharide\\tO\\ninduced\\tO\\nMEFV\\tO\\nexpression\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nantiinflammatory\\tO\\ncytokines\\tO\\ninterleukin\\tO\\n(\\tO\\nIL\\tO\\n)\\tO\\n4\\tO\\n,\\tO\\nIL\\tO\\n-\\tO\\n10\\tO\\n,\\tO\\nand\\tO\\ntransforming\\tO\\ngrowth\\tO\\nfactor\\tO\\nbeta\\tO\\ninhibited\\tO\\nsuch\\tO\\nexpression\\tO\\n.\\tO\\n\\nInduction\\tO\\nby\\tO\\nIFN\\tO\\n-\\tO\\ngamma\\tO\\noccurred\\tO\\nrapidly\\tO\\nand\\tO\\nwas\\tO\\nresistant\\tO\\nto\\tO\\ncycloheximide\\tO\\n.\\tO\\n\\nIFN\\tO\\n-\\tO\\nalpha\\tO\\nalso\\tO\\ninduced\\tO\\nMEFV\\tO\\nexpression\\tO\\n.\\tO\\n\\nIn\\tO\\ngranulocytes\\tO\\n,\\tO\\nMEFV\\tO\\nwas\\tO\\nup\\tO\\n-\\tO\\nregulated\\tO\\nby\\tO\\nIFN\\tO\\n-\\tO\\ngamma\\tO\\nand\\tO\\nthe\\tO\\ncombination\\tO\\nof\\tO\\nIFN\\tO\\n-\\tO\\nalpha\\tO\\nand\\tO\\ncolchicine\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nrefine\\tO\\nunderstanding\\tO\\nof\\tO\\nMEFV\\tO\\nby\\tO\\nplacing\\tO\\nthe\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\nmyelomonocytic\\tO\\n-\\tO\\nspecific\\tO\\nproinflammatory\\tO\\npathway\\tO\\nand\\tO\\nidentifying\\tO\\nit\\tO\\nas\\tO\\nan\\tO\\nIFN\\tO\\n-\\tO\\ngamma\\tO\\nimmediate\\tO\\nearly\\tO\\ngene\\tO\\n.\\tO\\n.\\tO\\n\\nBiochemical\\tO\\nand\\tO\\nstructural\\tO\\nanalysis\\tO\\nof\\tO\\nmissense\\tO\\nmutations\\tO\\nin\\tO\\nN\\tO\\n-\\tO\\nacetylgalactosamine\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nsulfate\\tO\\nsulfatase\\tO\\ncausing\\tO\\nmucopolysaccharidosis\\tB-Disease\\nIVA\\tI-Disease\\nphenotypes\\tO\\n.\\tO\\n\\nMucopolysaccharidosis\\tB-Disease\\nIVA\\tI-Disease\\n(\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\n;\\tO\\nOMIM\\tO\\n#\\tO\\n253000\\tO\\n)\\tO\\n,\\tO\\na\\tO\\nlysosomal\\tB-Disease\\nstorage\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nN\\tI-Disease\\n-\\tI-Disease\\nacetylgalactosamine\\tI-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nsulfate\\tI-Disease\\nsulfatase\\tI-Disease\\n(\\tO\\nGALNS\\tO\\n)\\tO\\n,\\tO\\nhas\\tO\\nvariable\\tO\\nclinical\\tO\\nphenotypes\\tO\\n.\\tO\\n\\nTo\\tO\\ndate\\tO\\nwe\\tO\\nhave\\tO\\nidentified\\tO\\n65\\tO\\nmissense\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nGALNS\\tO\\ngene\\tO\\nfrom\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\npatients\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\ncorrelation\\tO\\nbetween\\tO\\ngenotype\\tO\\nand\\tO\\nphenotype\\tO\\nhas\\tO\\nremained\\tO\\nunclear\\tO\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\n17\\tO\\nmissense\\tO\\nmutations\\tO\\nusing\\tO\\nbiochemical\\tO\\napproaches\\tO\\nand\\tO\\n32\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\nusing\\tO\\nstructural\\tO\\nanalyses\\tO\\n.\\tO\\n\\nFifteen\\tO\\nmissense\\tO\\nmutations\\tO\\nand\\tO\\ntwo\\tO\\nnewly\\tO\\nengineered\\tO\\nactive\\tO\\nsite\\tO\\nmutations\\tO\\n(\\tO\\nC79S\\tO\\n,\\tO\\nC79T\\tO\\n)\\tO\\nwere\\tO\\ncharacterized\\tO\\nby\\tO\\ntransient\\tO\\nexpression\\tO\\nanalysis\\tO\\n.\\tO\\n\\nMutant\\tO\\nproteins\\tO\\n,\\tO\\nexcept\\tO\\nfor\\tO\\nC79S\\tO\\nand\\tO\\nC79T\\tO\\n,\\tO\\nwere\\tO\\ndestabilized\\tO\\nand\\tO\\ndetected\\tO\\nas\\tO\\ninsoluble\\tO\\nprecursor\\tO\\nforms\\tO\\nwhile\\tO\\nthe\\tO\\nC79S\\tO\\nand\\tO\\nC79T\\tO\\nmutants\\tO\\nwere\\tO\\nof\\tO\\na\\tO\\nsoluble\\tO\\nmature\\tO\\nsize\\tO\\n.\\tO\\n\\nMutants\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nsevere\\tO\\nphenotype\\tO\\nhad\\tO\\nno\\tO\\nactivity\\tO\\n.\\tO\\n\\nMutants\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nmild\\tO\\nphenotype\\tO\\nhad\\tO\\na\\tO\\nconsiderable\\tO\\nresidual\\tO\\nactivity\\tO\\n(\\tO\\n1\\tO\\n.\\tO\\n3\\tO\\n-\\tO\\n13\\tO\\n.\\tO\\n3\\tO\\n%\\tO\\nof\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nGALNS\\tO\\nactivity\\tO\\n)\\tO\\n.\\tO\\n\\nSulfatases\\tO\\n,\\tO\\nincluding\\tO\\nGALNS\\tO\\n,\\tO\\nare\\tO\\nmembers\\tO\\nof\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\ngene\\tO\\nfamily\\tO\\nsharing\\tO\\nan\\tO\\nextensive\\tO\\nsequence\\tO\\nhomology\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\na\\tO\\ntertiary\\tO\\nstructural\\tO\\nmodel\\tO\\nof\\tO\\nhuman\\tO\\nGALNS\\tO\\nwas\\tO\\nconstructed\\tO\\nfrom\\tO\\nthe\\tO\\nX\\tO\\n-\\tO\\nray\\tO\\ncrystal\\tO\\nstructure\\tO\\nof\\tO\\nN\\tO\\n-\\tO\\nacetylgalacto\\tO\\n-\\tO\\nsamine\\tO\\n-\\tO\\n4\\tO\\n-\\tO\\nsulfatase\\tO\\nand\\tO\\narylsulfatase\\tO\\nA\\tO\\n,\\tO\\nusing\\tO\\nhomology\\tO\\nmodeling\\tO\\n,\\tO\\nand\\tO\\n32\\tO\\nmissense\\tO\\nmutations\\tO\\nwere\\tO\\ninvestigated\\tO\\n.\\tO\\n\\nConsequently\\tO\\n,\\tO\\nwe\\tO\\npropose\\tO\\nthat\\tO\\nthere\\tO\\nare\\tO\\nat\\tO\\nleast\\tO\\nthree\\tO\\ndifferent\\tO\\nreasons\\tO\\nfor\\tO\\nthe\\tO\\nsevere\\tO\\nphenotype\\tO\\n(\\tO\\ni\\tO\\n)\\tO\\ndestruction\\tO\\nof\\tO\\nthe\\tO\\nhydrophobic\\tO\\ncore\\tO\\nor\\tO\\nmodification\\tO\\nof\\tO\\nthe\\tO\\npacking\\tO\\n;\\tO\\n(\\tO\\nii\\tO\\n)\\tO\\nremoval\\tO\\nof\\tO\\na\\tO\\nsalt\\tO\\nbridge\\tO\\nto\\tO\\ndestabilize\\tO\\nthe\\tO\\nentire\\tO\\nconformation\\tO\\n;\\tO\\n(\\tO\\niii\\tO\\n)\\tO\\nmodification\\tO\\nof\\tO\\nthe\\tO\\nactive\\tO\\nsite\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nmild\\tO\\nmutations\\tO\\nwere\\tO\\nmostly\\tO\\nlocated\\tO\\non\\tO\\nthe\\tO\\nsurface\\tO\\nof\\tO\\nthe\\tO\\nGALNS\\tO\\nprotein\\tO\\n.\\tO\\n\\nThese\\tO\\nstudies\\tO\\nshed\\tO\\nfurther\\tO\\nlight\\tO\\non\\tO\\nthe\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelation\\tO\\nof\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\nand\\tO\\nstructure\\tO\\n-\\tO\\nfunction\\tO\\nrelationship\\tO\\nin\\tO\\nthe\\tO\\nsulfatase\\tO\\nfamily\\tO\\n.\\tO\\n\\nMutations\\tO\\nat\\tO\\nthe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nlocus\\tO\\nand\\tO\\nclinical\\tO\\nphenotypes\\tO\\nof\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nMutations\\tO\\nat\\tO\\nthe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\nband\\tO\\n11q22\\tO\\ncause\\tO\\na\\tO\\ndistinctive\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nsyndrome\\tI-Disease\\nin\\tO\\nhomozygotes\\tO\\nand\\tO\\npredispose\\tO\\nheterozygotes\\tO\\nto\\tO\\ncancer\\tB-Disease\\n,\\tO\\nischemic\\tB-Disease\\nheart\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nand\\tO\\nearly\\tO\\nmortality\\tO\\n.\\tO\\n\\nPCR\\tO\\namplification\\tO\\nfrom\\tO\\ngenomic\\tO\\nDNA\\tO\\nand\\tO\\nautomated\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\nentire\\tO\\ncoding\\tO\\nregion\\tO\\n(\\tO\\n66\\tO\\nexons\\tO\\n)\\tO\\nand\\tO\\nsplice\\tO\\njunctions\\tO\\ndetected\\tO\\n77\\tO\\nmutations\\tO\\n(\\tO\\n85\\tO\\n%\\tO\\n)\\tO\\nin\\tO\\n90\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nchromosomes\\tO\\n.\\tO\\n\\nHeteroduplex\\tO\\nanalysis\\tO\\ndetected\\tO\\nanother\\tO\\n42\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nlocus\\tO\\n.\\tO\\n\\nOut\\tO\\nof\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\n71\\tO\\nunique\\tO\\nmutations\\tO\\n,\\tO\\n50\\tO\\nwere\\tO\\nfound\\tO\\nonly\\tO\\nin\\tO\\na\\tO\\nsingle\\tO\\nfamily\\tO\\n,\\tO\\nand\\tO\\n51\\tO\\nhad\\tO\\nnot\\tO\\nbeen\\tO\\nreported\\tO\\npreviously\\tO\\n.\\tO\\n\\nMost\\tO\\n(\\tO\\n58\\tO\\n/\\tO\\n71\\tO\\n,\\tO\\n82\\tO\\n%\\tO\\n)\\tO\\nmutations\\tO\\nwere\\tO\\nframeshift\\tO\\nand\\tO\\nnonsense\\tO\\nmutations\\tO\\nthat\\tO\\nare\\tO\\npredicted\\tO\\nto\\tO\\ncause\\tO\\ntruncation\\tO\\nof\\tO\\nthe\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nprotein\\tO\\n;\\tO\\nthe\\tO\\nless\\tO\\ncommon\\tO\\nmutation\\tO\\ntypes\\tO\\nwere\\tO\\nmissense\\tO\\n(\\tO\\n9\\tO\\n/\\tO\\n71\\tO\\n,\\tO\\n13\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nsplicing\\tO\\n(\\tO\\n3\\tO\\n/\\tO\\n71\\tO\\n,\\tO\\n4\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\none\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletion\\tO\\n,\\tO\\n2546\\tO\\n3\\tO\\n(\\tO\\n1\\tO\\n/\\tO\\n71\\tO\\n,\\tO\\n1\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmean\\tO\\nsurvival\\tO\\nand\\tO\\nheight\\tO\\ndistribution\\tO\\nof\\tO\\n134\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\ncorrelated\\tO\\nsignificantly\\tO\\nwith\\tO\\nthe\\tO\\nspecific\\tO\\nmutations\\tO\\npresent\\tO\\nin\\tO\\nthe\\tO\\npatients\\tO\\n.\\tO\\n\\nPatients\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nsingle\\tO\\ntruncating\\tO\\nmutation\\tO\\n,\\tO\\ntypically\\tO\\nnear\\tO\\nthe\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nor\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletion\\tO\\n2546\\tO\\n3\\tO\\n,\\tO\\nwere\\tO\\nshorter\\tO\\nand\\tO\\nhad\\tO\\nsignificantly\\tO\\nshorter\\tO\\nsurvival\\tO\\nthan\\tO\\nthose\\tO\\nheterozygous\\tO\\nfor\\tO\\na\\tO\\nsplice\\tO\\nsite\\tO\\nor\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\nor\\tO\\nheterozygous\\tO\\nfor\\tO\\ntwo\\tO\\ntruncating\\tO\\nmutations\\tO\\n.\\tO\\n\\nAlterations\\tO\\nof\\tO\\nthe\\tO\\nlength\\tO\\nor\\tO\\namino\\tO\\nacid\\tO\\ncomposition\\tO\\nof\\tO\\nthe\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\ngene\\tO\\nproduct\\tO\\naffect\\tO\\nthe\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nclinical\\tO\\nphenotype\\tO\\nin\\tO\\ndifferent\\tO\\nways\\tO\\n.\\tO\\n\\nMutation\\tO\\nanalysis\\tO\\nat\\tO\\nthe\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nlocus\\tO\\nmay\\tO\\nhelp\\tO\\nestimate\\tO\\nthe\\tO\\nprognosis\\tO\\nof\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\n.\\tO\\n.\\tO\\n\\nIsolation\\tO\\n,\\tO\\ngenomic\\tO\\norganization\\tO\\n,\\tO\\nand\\tO\\nexpression\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nand\\tO\\nrat\\tO\\nhomologs\\tO\\nof\\tO\\nMEFV\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nfamilial\\tB-Disease\\nmediterranean\\tI-Disease\\nfever\\tI-Disease\\n.\\tO\\n\\nFamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n(\\tO\\nFMF\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nrecessive\\tB-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nepisodes\\tO\\nof\\tO\\nfever\\tB-Disease\\nwith\\tO\\nserositis\\tB-Disease\\nor\\tO\\nsynovitis\\tB-Disease\\n.\\tO\\n\\nRecently\\tO\\nthe\\tO\\nFMF\\tB-Disease\\ngene\\tO\\n(\\tO\\nMEFV\\tO\\n)\\tO\\nwas\\tO\\ncloned\\tO\\n;\\tO\\nthe\\tO\\nprotein\\tO\\nproduct\\tO\\n,\\tO\\npyrin\\tO\\n/\\tO\\nmarenostrin\\tO\\n,\\tO\\nis\\tO\\nthought\\tO\\nto\\tO\\nregulate\\tO\\ninflammation\\tO\\nin\\tO\\nmyeloid\\tO\\ncells\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nmanuscript\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\nmouse\\tO\\nand\\tO\\nrat\\tO\\nhomologs\\tO\\nof\\tO\\nMEFV\\tO\\n.\\tO\\n\\nThe\\tO\\nmurine\\tO\\ngene\\tO\\ncontains\\tO\\nten\\tO\\nexons\\tO\\nwith\\tO\\na\\tO\\ncoding\\tO\\nsequence\\tO\\nof\\tO\\n2304\\tO\\nbp\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\nrat\\tO\\nhomolog\\tO\\nhas\\tO\\nnine\\tO\\nexons\\tO\\nwith\\tO\\na\\tO\\ncoding\\tO\\nsequence\\tO\\nof\\tO\\n2253\\tO\\nbp\\tO\\n.\\tO\\n\\nA\\tO\\nconsiderable\\tO\\namino\\tO\\nacid\\tO\\nsequence\\tO\\nhomology\\tO\\nwas\\tO\\nobserved\\tO\\nbetween\\tO\\nthe\\tO\\nmouse\\tO\\nand\\tO\\nhuman\\tO\\n(\\tO\\n47\\tO\\n.\\tO\\n6\\tO\\n%\\tO\\nidentity\\tO\\nand\\tO\\n65\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\nsimilarity\\tO\\n)\\tO\\nand\\tO\\nbetween\\tO\\nthe\\tO\\nmouse\\tO\\nand\\tO\\nrat\\tO\\ngenes\\tO\\n(\\tO\\n73\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\nidentity\\tO\\nand\\tO\\n82\\tO\\n.\\tO\\n1\\tO\\n%\\tO\\nsimilarity\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\npredicted\\tO\\nrodent\\tO\\nproteins\\tO\\nhave\\tO\\nseveral\\tO\\nimportant\\tO\\ndomains\\tO\\nand\\tO\\nsignals\\tO\\nfound\\tO\\nin\\tO\\nhuman\\tO\\npyrin\\tO\\n,\\tO\\nincluding\\tO\\na\\tO\\nB\\tO\\n-\\tO\\nbox\\tO\\nzinc\\tO\\nfinger\\tO\\ndomain\\tO\\n,\\tO\\nRobbins\\tO\\n-\\tO\\nDingwall\\tO\\nnuclear\\tO\\nlocalization\\tO\\nsignal\\tO\\n,\\tO\\nand\\tO\\ncoiled\\tO\\n-\\tO\\ncoil\\tO\\ndomain\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nperhaps\\tO\\nbecause\\tO\\nof\\tO\\nan\\tO\\nancient\\tO\\nframe\\tO\\n-\\tO\\nshift\\tO\\nmutation\\tO\\n,\\tO\\nneither\\tO\\nthe\\tO\\nmouse\\tO\\nnor\\tO\\nthe\\tO\\nrat\\tO\\nprotein\\tO\\nhas\\tO\\nan\\tO\\nintact\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nB30\\tO\\n.\\tO\\n\\n2\\tO\\ndomain\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\nmost\\tO\\nFMF\\tB-Disease\\n-\\tO\\nassociated\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\nhuman\\tO\\nMEFV\\tO\\n.\\tO\\n\\nNevertheless\\tO\\n,\\tO\\nlike\\tO\\nthe\\tO\\nhuman\\tO\\ngene\\tO\\n,\\tO\\nmouse\\tO\\nMefv\\tO\\nis\\tO\\nexpressed\\tO\\nin\\tO\\nperipheral\\tO\\nblood\\tO\\ngranulocytes\\tO\\nbut\\tO\\nnot\\tO\\nlymphocytes\\tO\\n.\\tO\\n\\nConsistent\\tO\\nwith\\tO\\nits\\tO\\nexpression\\tO\\nin\\tO\\ngranulocytes\\tO\\n,\\tO\\nMefv\\tO\\nwas\\tO\\ndetected\\tO\\nat\\tO\\nhigh\\tO\\nlevels\\tO\\nin\\tO\\nthe\\tO\\nprimary\\tO\\nfollicles\\tO\\nand\\tO\\nmarginal\\tO\\nzones\\tO\\nof\\tO\\nthe\\tO\\nsplenic\\tO\\nwhite\\tO\\npulp\\tO\\n.\\tO\\n\\nMefv\\tO\\nis\\tO\\nlocalized\\tO\\non\\tO\\nmouse\\tO\\nChromosome\\tO\\n(\\tO\\nChr\\tO\\n)\\tO\\n16\\tO\\n,\\tO\\nregion\\tO\\nA3\\tO\\n-\\tO\\nB1\\tO\\n,\\tO\\nextending\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\nsynteny\\tO\\nwith\\tO\\nhuman\\tO\\nChr\\tO\\n16p13\\tO\\n.\\tO\\n\\n3\\tO\\n.\\tO\\n\\nDevelopment\\tO\\nof\\tO\\nknockout\\tO\\nand\\tO\\nknockin\\tO\\nmouse\\tO\\nmodels\\tO\\nmay\\tO\\nprovide\\tO\\nfurther\\tO\\ninsights\\tO\\ninto\\tO\\nthe\\tO\\nfunctional\\tO\\nevolution\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\n.\\tO\\n\\nAdditional\\tO\\ncopies\\tO\\nof\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\ngene\\tO\\ncausing\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\narise\\tO\\nby\\tO\\nseparate\\tO\\nintegration\\tO\\ninto\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nThe\\tO\\nproteolipid\\tO\\nprotein\\tO\\ngene\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\nis\\tO\\nnormally\\tO\\npresent\\tO\\nat\\tO\\nchromosome\\tO\\nXq22\\tO\\n.\\tO\\n\\nMutations\\tO\\nand\\tO\\nduplications\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nPMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\ndescribe\\tO\\ntwo\\tO\\nnew\\tO\\nfamilies\\tO\\nin\\tO\\nwhich\\tO\\nmales\\tO\\naffected\\tO\\nwith\\tO\\nPMD\\tB-Disease\\nwere\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\ncopy\\tO\\nof\\tO\\nPLP\\tO\\non\\tO\\nthe\\tO\\nshort\\tO\\narm\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n,\\tO\\nin\\tO\\naddition\\tO\\nto\\tO\\na\\tO\\nnormal\\tO\\ncopy\\tO\\non\\tO\\nXq22\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nfirst\\tO\\nfamily\\tO\\n,\\tO\\nthe\\tO\\nextra\\tO\\ncopy\\tO\\nwas\\tO\\nfirst\\tO\\ndetected\\tO\\nby\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nheterozygosity\\tO\\nof\\tO\\nthe\\tO\\nAhaII\\tO\\ndimorphism\\tO\\nwithin\\tO\\nthe\\tO\\nPLP\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nof\\tO\\nFISH\\tO\\nanalysis\\tO\\nshowed\\tO\\nan\\tO\\nadditional\\tO\\ncopy\\tO\\nof\\tO\\nPLP\\tO\\nin\\tO\\nXp22\\tO\\n.\\tO\\n\\n1\\tO\\n,\\tO\\nalthough\\tO\\nno\\tO\\nchromosomal\\tO\\nrearrangements\\tO\\ncould\\tO\\nbe\\tO\\ndetected\\tO\\nby\\tO\\nstandard\\tO\\nkaryotype\\tO\\nanalysis\\tO\\n.\\tO\\n\\nAnother\\tO\\nthree\\tO\\naffected\\tO\\nmales\\tO\\nfrom\\tO\\nthe\\tO\\nfamily\\tO\\nhad\\tO\\nsimilar\\tO\\nfindings\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nsecond\\tO\\nunrelated\\tO\\nfamily\\tO\\nwith\\tO\\nsigns\\tO\\nof\\tO\\nPMD\\tB-Disease\\n,\\tO\\ncytogenetic\\tO\\nanalysis\\tO\\nshowed\\tO\\na\\tO\\npericentric\\tO\\ninversion\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\ninv\\tO\\n(\\tO\\nX\\tO\\n)\\tO\\ncarried\\tO\\nby\\tO\\nseveral\\tO\\naffected\\tO\\nfamily\\tO\\nmembers\\tO\\n,\\tO\\nFISH\\tO\\nshowed\\tO\\nPLP\\tO\\nsignals\\tO\\nat\\tO\\nXp11\\tO\\n.\\tO\\n\\n4\\tO\\nand\\tO\\nXq22\\tO\\n.\\tO\\n\\nA\\tO\\nthird\\tO\\nfamily\\tO\\nhas\\tO\\npreviously\\tO\\nbeen\\tO\\nreported\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\naffected\\tO\\nmembers\\tO\\nhad\\tO\\nan\\tO\\nextra\\tO\\ncopy\\tO\\nof\\tO\\nthe\\tO\\nPLP\\tO\\ngene\\tO\\ndetected\\tO\\nat\\tO\\nXq26\\tO\\nin\\tO\\na\\tO\\nchromosome\\tO\\nwith\\tO\\nan\\tO\\notherwise\\tO\\nnormal\\tO\\nbanding\\tO\\npattern\\tO\\n.\\tO\\n\\nThe\\tO\\nidentification\\tO\\nof\\tO\\nthree\\tO\\nseparate\\tO\\nfamilies\\tO\\nin\\tO\\nwhich\\tO\\nPLP\\tO\\nis\\tO\\nduplicated\\tO\\nat\\tO\\na\\tO\\nnoncontiguous\\tO\\nsite\\tO\\nsuggests\\tO\\nthat\\tO\\nsuch\\tO\\nduplications\\tO\\ncould\\tO\\nbe\\tO\\na\\tO\\nrelatively\\tO\\ncommon\\tO\\nbut\\tO\\npreviously\\tO\\nundetected\\tO\\ncause\\tO\\nof\\tO\\ngenetic\\tB-Disease\\ndisorders\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nexon\\tO\\n13\\tO\\nduplication\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nis\\tO\\na\\tO\\nfounder\\tO\\nmutation\\tO\\npresent\\tO\\nin\\tO\\ngeographically\\tO\\ndiverse\\tO\\npopulations\\tO\\n.\\tO\\n\\nThe\\tO\\nBRCA1\\tO\\nExon\\tO\\n13\\tO\\nDuplication\\tO\\nScreening\\tO\\nGroup\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\na\\tO\\n6\\tO\\n-\\tO\\nkb\\tO\\nduplication\\tO\\nof\\tO\\nexon\\tO\\n13\\tO\\n,\\tO\\nwhich\\tO\\ncreates\\tO\\na\\tO\\nframeshift\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\ndescribed\\tO\\nin\\tO\\nthree\\tO\\nunrelated\\tO\\nU\\tO\\n.\\tO\\n\\nS\\tO\\nS\\tO\\n.\\tO\\nfamilies\\tO\\nof\\tO\\nEuropean\\tO\\nancestry\\tO\\nand\\tO\\nin\\tO\\none\\tO\\nPortuguese\\tO\\nfamily\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nour\\tO\\ngoal\\tO\\nwas\\tO\\nto\\tO\\nestimate\\tO\\nthe\\tO\\nfrequency\\tO\\nand\\tO\\ngeographic\\tO\\ndiversity\\tO\\nof\\tO\\ncarriers\\tO\\nof\\tO\\nthis\\tO\\nduplication\\tO\\n.\\tO\\n\\nTo\\tO\\ndo\\tO\\nthis\\tO\\n,\\tO\\na\\tO\\ncollaborative\\tO\\nscreening\\tO\\nstudy\\tO\\nwas\\tO\\nset\\tO\\nup\\tO\\nthat\\tO\\ninvolved\\tO\\n39\\tO\\ninstitutions\\tO\\nfrom\\tO\\n19\\tO\\ncountries\\tO\\nand\\tO\\nincluded\\tO\\n3\\tO\\n,\\tO\\n580\\tO\\nunrelated\\tO\\nindividuals\\tO\\nwith\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nand\\tO\\n934\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ncases\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n11\\tO\\nadditional\\tO\\nfamilies\\tO\\ncarrying\\tO\\nthis\\tO\\nmutation\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nAustralia\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\n,\\tO\\nBelgium\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\n,\\tO\\nCanada\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\n,\\tO\\nGreat\\tO\\nBritain\\tO\\n(\\tO\\n6\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nUnited\\tO\\nStates\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\n.\\tO\\n\\nHaplotyping\\tO\\nshowed\\tO\\nthat\\tO\\nthey\\tO\\nare\\tO\\nlikely\\tO\\nto\\tO\\nderive\\tO\\nfrom\\tO\\na\\tO\\ncommon\\tO\\nancestor\\tO\\n,\\tO\\npossibly\\tO\\nof\\tO\\nnorthern\\tO\\nBritish\\tO\\norigin\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\ndemonstrate\\tO\\nthat\\tO\\nit\\tO\\nis\\tO\\nstrongly\\tO\\nadvisable\\tO\\n,\\tO\\nfor\\tO\\nlaboratories\\tO\\ncarrying\\tO\\nout\\tO\\nscreening\\tO\\neither\\tO\\nin\\tO\\nEnglish\\tO\\n-\\tO\\nspeaking\\tO\\ncountries\\tO\\nor\\tO\\nin\\tO\\ncountries\\tO\\nwith\\tO\\nhistorical\\tO\\nlinks\\tO\\nwith\\tO\\nBritain\\tO\\n,\\tO\\nto\\tO\\ninclude\\tO\\nwithin\\tO\\ntheir\\tO\\nBRCA1\\tO\\nscreening\\tO\\nprotocols\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n-\\tO\\nbased\\tO\\nassay\\tO\\ndescribed\\tO\\nin\\tO\\nthis\\tO\\nreport\\tO\\n.\\tO\\n\\nGenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\ndeletions\\tO\\nin\\tO\\nthe\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\n(\\tO\\nVHL\\tB-Disease\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nVon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\n(\\tI-Disease\\nVHL\\tI-Disease\\n)\\tI-Disease\\ndisease\\tI-Disease\\nis\\tO\\na\\tO\\nhereditary\\tB-Disease\\ntumor\\tI-Disease\\nsyndrome\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\npredisposition\\tO\\nfor\\tO\\nbilateral\\tB-Disease\\nand\\tI-Disease\\nmulti\\tI-Disease\\n-\\tI-Disease\\ncentric\\tI-Disease\\nhemangioblastoma\\tI-Disease\\nin\\tO\\nthe\\tO\\nretina\\tO\\nand\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n,\\tO\\npheochromocytoma\\tB-Disease\\n,\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\n,\\tO\\nand\\tO\\ncysts\\tB-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\nkidney\\tI-Disease\\n,\\tI-Disease\\npancreas\\tI-Disease\\n,\\tI-Disease\\nand\\tI-Disease\\nepididymis\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nfive\\tO\\nfamilies\\tO\\nfor\\tO\\nwhich\\tO\\ndirect\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nhad\\tO\\nfailed\\tO\\nto\\tO\\nidentify\\tO\\nthe\\tO\\nfamily\\tO\\n-\\tO\\nspecific\\tO\\nmutation\\tO\\n.\\tO\\n\\nFurther\\tO\\nmolecular\\tO\\nanalysis\\tO\\nrevealed\\tO\\ndeletions\\tO\\ninvolving\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nin\\tO\\neach\\tO\\nof\\tO\\nthese\\tO\\nfamilies\\tO\\n.\\tO\\n\\nIn\\tO\\nfour\\tO\\nfamilies\\tO\\n,\\tO\\npartial\\tO\\ndeletions\\tO\\nof\\tO\\none\\tO\\nor\\tO\\nmore\\tO\\nexons\\tO\\nwere\\tO\\ndetected\\tO\\nby\\tO\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nfifth\\tO\\nfamily\\tO\\n,\\tO\\nFISH\\tO\\nanalysis\\tO\\ndemonstrated\\tO\\nthe\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nentire\\tO\\nVHL\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nshow\\tO\\nthat\\tO\\n(\\tO\\nquantitative\\tO\\n)\\tO\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\nis\\tO\\na\\tO\\nsensitive\\tO\\nmethod\\tO\\nfor\\tO\\ndetecting\\tO\\ngermline\\tO\\ndeletions\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nand\\tO\\nshould\\tO\\nbe\\tO\\nimplemented\\tO\\nin\\tO\\nroutine\\tO\\nDNA\\tO\\ndiagnosis\\tO\\nfor\\tO\\nVHL\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nsupport\\tO\\nthe\\tO\\npreviously\\tO\\nestablished\\tO\\nobservation\\tO\\nthat\\tO\\nfamilies\\tO\\nwith\\tO\\na\\tO\\ngermline\\tO\\ndeletion\\tO\\nhave\\tO\\na\\tO\\nlow\\tO\\nrisk\\tO\\nfor\\tO\\npheochromocytoma\\tB-Disease\\n.\\tO\\n\\nFurther\\tO\\nunraveling\\tO\\nof\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nin\\tO\\nVHL\\tB-Disease\\ndisease\\tI-Disease\\nhas\\tO\\nrevealed\\tO\\nthat\\tO\\nfamilies\\tO\\nwith\\tO\\na\\tO\\nfull\\tO\\nor\\tO\\npartial\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nexhibit\\tO\\na\\tO\\nphenotype\\tO\\nwith\\tO\\na\\tO\\npreponderance\\tO\\nof\\tO\\ncentral\\tB-Disease\\nnervous\\tI-Disease\\nsystem\\tI-Disease\\nhemangioblastoma\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nAge\\tO\\nof\\tO\\nthe\\tO\\nintronic\\tO\\nGAA\\tO\\ntriplet\\tO\\nrepeat\\tO\\nexpansion\\tO\\nmutation\\tO\\nin\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n.\\tO\\n\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n(\\tO\\nFRDA\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nmost\\tO\\nfrequently\\tO\\ninherited\\tB-Disease\\nataxia\\tI-Disease\\n,\\tO\\nis\\tO\\ndue\\tO\\nin\\tO\\nthe\\tO\\nvast\\tO\\nmajority\\tO\\nof\\tO\\ncases\\tO\\nto\\tO\\na\\tO\\nlarge\\tO\\nexpansion\\tO\\nof\\tO\\nan\\tO\\nintronic\\tO\\nGAA\\tO\\nrepeat\\tO\\n.\\tO\\n\\nUsing\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nanalysis\\tO\\nbased\\tO\\non\\tO\\nhaplotype\\tO\\ndata\\tO\\nof\\tO\\nseven\\tO\\npolymorphic\\tO\\nmarkers\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\nfrataxin\\tO\\ngene\\tO\\n,\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\nFRDA\\tB-Disease\\nfounding\\tO\\nmutational\\tO\\nevent\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\nis\\tO\\nestimated\\tO\\nto\\tO\\nbe\\tO\\nat\\tO\\nleast\\tO\\n682\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n203\\tO\\ngenerations\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\n564\\tO\\n-\\tO\\n801\\tO\\ng\\tO\\n)\\tO\\n,\\tO\\na\\tO\\ndating\\tO\\nwhich\\tO\\nis\\tO\\nconsistent\\tO\\nwith\\tO\\nlittle\\tO\\nor\\tO\\nno\\tO\\nnegative\\tO\\nselection\\tO\\nand\\tO\\nprovides\\tO\\nfurther\\tO\\nevidence\\tO\\nfor\\tO\\nan\\tO\\nancient\\tO\\nspread\\tO\\nof\\tO\\na\\tO\\npre\\tO\\n-\\tO\\nmutation\\tO\\n(\\tO\\nat\\tO\\n-\\tO\\nrisk\\tO\\nalleles\\tO\\n)\\tO\\nin\\tO\\nwestern\\tO\\nEurope\\tO\\n.\\tO\\n.\\tO\\n\\nFunctional\\tO\\nlink\\tO\\nbetween\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nand\\tO\\nNijmegen\\tB-Disease\\nbreakage\\tI-Disease\\nsyndrome\\tI-Disease\\ngene\\tO\\nproducts\\tO\\n.\\tO\\n\\nAtaxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\nand\\tO\\nNijmegen\\tB-Disease\\nbreakage\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nNBS\\tB-Disease\\n)\\tO\\nare\\tO\\nrecessive\\tB-Disease\\ngenetic\\tI-Disease\\ndisorders\\tI-Disease\\nwith\\tO\\nsusceptibility\\tO\\nto\\tO\\ncancer\\tB-Disease\\nand\\tO\\nsimilar\\tO\\ncellular\\tO\\nphenotypes\\tO\\n.\\tO\\n\\nThe\\tO\\nprotein\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n,\\tO\\ndesignated\\tO\\nATM\\tO\\n,\\tO\\nis\\tO\\na\\tO\\nmember\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\nof\\tO\\nkinases\\tO\\ncharacterized\\tO\\nby\\tO\\na\\tO\\ncarboxy\\tO\\n-\\tO\\nterminal\\tO\\nphosphatidylinositol\\tO\\n3\\tO\\n-\\tO\\nkinase\\tO\\n-\\tO\\nlike\\tO\\ndomain\\tO\\n.\\tO\\n\\nThe\\tO\\nNBS1\\tO\\nprotein\\tO\\nis\\tO\\nspecifically\\tO\\nmutated\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nNijmegen\\tB-Disease\\nbreakage\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nforms\\tO\\na\\tO\\ncomplex\\tO\\nwith\\tO\\nthe\\tO\\nDNA\\tO\\nrepair\\tO\\nproteins\\tO\\nRad50\\tO\\nand\\tO\\nMrel1\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nshow\\tO\\nthat\\tO\\nphosphorylation\\tO\\nof\\tO\\nNBS1\\tO\\n,\\tO\\ninduced\\tO\\nby\\tO\\nionizing\\tO\\nradiation\\tO\\n,\\tO\\nrequires\\tO\\ncatalytically\\tO\\nactive\\tO\\nATM\\tO\\n.\\tO\\n\\nComplexes\\tO\\ncontaining\\tO\\nATM\\tO\\nand\\tO\\nNBS1\\tO\\nexist\\tO\\nin\\tO\\nvivo\\tO\\nin\\tO\\nboth\\tO\\nuntreated\\tO\\ncells\\tO\\nand\\tO\\ncells\\tO\\ntreated\\tO\\nwith\\tO\\nionizing\\tO\\nradiation\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\ntwo\\tO\\nresidues\\tO\\nof\\tO\\nNBS1\\tO\\n,\\tO\\nSer\\tO\\n278\\tO\\nand\\tO\\nSer\\tO\\n343\\tO\\nthat\\tO\\nare\\tO\\nphosphorylated\\tO\\nin\\tO\\nvitro\\tO\\nby\\tO\\nATM\\tO\\nand\\tO\\nwhose\\tO\\nmodification\\tO\\nin\\tO\\nvivo\\tO\\nis\\tO\\nessential\\tO\\nfor\\tO\\nthe\\tO\\ncellular\\tO\\nresponse\\tO\\nto\\tO\\nDNA\\tO\\ndamage\\tO\\n.\\tO\\n\\nThis\\tO\\nresponse\\tO\\nincludes\\tO\\nS\\tO\\n-\\tO\\nphase\\tO\\ncheckpoint\\tO\\nactivation\\tO\\n,\\tO\\nformation\\tO\\nof\\tO\\nthe\\tO\\nNBS1\\tO\\n/\\tO\\nMrel1\\tO\\n/\\tO\\nRad50\\tO\\nnuclear\\tO\\nfoci\\tO\\nand\\tO\\nrescue\\tO\\nof\\tO\\nhypersensitivity\\tB-Disease\\nto\\tI-Disease\\nionizing\\tI-Disease\\nradiation\\tI-Disease\\n.\\tO\\n\\nTogether\\tO\\n,\\tO\\nthese\\tO\\nresults\\tO\\ndemonstrate\\tO\\na\\tO\\nbiochemical\\tO\\nlink\\tO\\nbetween\\tO\\ncell\\tO\\n-\\tO\\ncycle\\tO\\ncheckpoints\\tO\\nactivated\\tO\\nby\\tO\\nDNA\\tO\\ndamage\\tO\\nand\\tO\\nDNA\\tO\\nrepair\\tO\\nin\\tO\\ntwo\\tO\\ngenetic\\tB-Disease\\ndiseases\\tI-Disease\\nwith\\tO\\noverlapping\\tO\\nphenotypes\\tO\\n.\\tO\\n.\\tO\\n\\nHomozygosity\\tO\\nmapping\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nmicrocephaly\\tB-Disease\\n,\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\nand\\tO\\nshort\\tB-Disease\\nstature\\tI-Disease\\nto\\tO\\na\\tO\\nCohen\\tB-Disease\\nsyndrome\\tI-Disease\\nregion\\tO\\non\\tO\\n8q21\\tO\\n.\\tO\\n3\\tO\\n-\\tO\\n8q22\\tO\\n.\\tO\\n1\\tO\\n:\\tO\\nredefining\\tO\\na\\tO\\nclinical\\tO\\nentity\\tO\\n.\\tO\\n\\nA\\tO\\nsyndrome\\tO\\nof\\tO\\nmicrocephaly\\tB-Disease\\n,\\tO\\nprogressive\\tO\\npostnatal\\tB-Disease\\ngrowth\\tI-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nand\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\nwas\\tO\\nobserved\\tO\\nin\\tO\\ntwo\\tO\\nbrothers\\tO\\nand\\tO\\ntheir\\tO\\ncousin\\tO\\nfrom\\tO\\na\\tO\\nmultiply\\tO\\nconsanguineous\\tO\\nkindred\\tO\\nof\\tO\\nLebanese\\tO\\ndescent\\tO\\n.\\tO\\n\\nHypotonia\\tB-Disease\\n,\\tO\\nchorioretinal\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nand\\tO\\nmyopia\\tB-Disease\\nwere\\tO\\nalso\\tO\\nidentified\\tO\\n.\\tO\\n\\nThe\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\ncondition\\tO\\nvaried\\tO\\namong\\tO\\nthe\\tO\\nclosely\\tO\\nrelated\\tO\\npatients\\tO\\n.\\tO\\n\\nBecause\\tO\\nof\\tO\\nabsence\\tO\\nof\\tO\\na\\tO\\ndistinctive\\tO\\nfacial\\tO\\nappearance\\tO\\n,\\tO\\nthe\\tO\\ndegree\\tO\\nof\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\nand\\tO\\nshort\\tB-Disease\\nstature\\tI-Disease\\n,\\tO\\nthe\\tO\\ninitially\\tO\\nconsidered\\tO\\nclinical\\tO\\ndiagnosis\\tO\\nof\\tO\\nCohen\\tB-Disease\\nsyndrome\\tI-Disease\\nwas\\tO\\nwithdrawn\\tO\\nand\\tO\\na\\tO\\nnovel\\tO\\ngenetic\\tO\\nentity\\tO\\nwas\\tO\\nassumed\\tO\\n.\\tO\\n\\nHomozygosity\\tO\\nmapping\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nassigned\\tO\\nthe\\tO\\ngene\\tO\\nto\\tO\\na\\tO\\n26\\tO\\n.\\tO\\n\\n8\\tO\\n-\\tO\\ncM\\tO\\nregion\\tO\\non\\tO\\nthe\\tO\\nchromosome\\tO\\nband\\tO\\n8q21\\tO\\n.\\tO\\n\\n3\\tO\\n-\\tO\\n22\\tO\\n.\\tO\\n\\n1\\tO\\n,\\tO\\nbetween\\tO\\nthe\\tO\\nmicrosatellites\\tO\\nat\\tO\\nD8S270\\tO\\nand\\tO\\nD8S514\\tO\\n.\\tO\\n\\nThe\\tO\\nmaximum\\tO\\ntwo\\tO\\n-\\tO\\npoint\\tO\\nLOD\\tO\\nscore\\tO\\nwas\\tO\\nfound\\tO\\nfor\\tO\\nmarker\\tO\\nat\\tO\\nD8S267\\tO\\n(\\tO\\nZmax\\tO\\n=\\tO\\n3\\tO\\n.\\tO\\n.\\tO\\n237\\tO\\nat\\tO\\nOmax\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n00\\tO\\n)\\tO\\n.\\tO\\n\\nIntriguingly\\tO\\nenough\\tO\\n,\\tO\\nthe\\tO\\nidentified\\tO\\ngene\\tO\\nregion\\tO\\noverlaps\\tO\\nthe\\tO\\nrefined\\tO\\ngene\\tO\\nregion\\tO\\nfor\\tO\\nCohen\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nCOH1\\tO\\n)\\tO\\n[\\tO\\nKolehmainen\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1997\\tO\\nEuro\\tO\\nJ\\tO\\nHum\\tO\\nGenet\\tO\\n5\\tO\\n206\\tO\\n-\\tO\\n213\\tO\\n]\\tO\\n.\\tO\\n\\nThis\\tO\\nfact\\tO\\nencourages\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nthe\\tO\\ndescribed\\tO\\nkindred\\tO\\nsegregates\\tO\\nfor\\tO\\na\\tO\\nvariant\\tO\\nof\\tO\\nCohen\\tB-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nsuggests\\tO\\na\\tO\\nredefinition\\tO\\nof\\tO\\nits\\tO\\nphenotype\\tO\\n\\nPolymorphisms\\tO\\nof\\tO\\nthe\\tO\\nCYP2D6\\tO\\ngene\\tO\\nincrease\\tO\\nsusceptibility\\tO\\nto\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\n.\\tO\\n\\nAnkylosing\\tB-Disease\\nspondylitis\\tI-Disease\\n(\\tO\\nAS\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\ncommon\\tO\\nand\\tO\\nhighly\\tO\\nfamilial\\tO\\nrheumatic\\tB-Disease\\ndisorder\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nsibling\\tO\\nrecurrence\\tO\\nrisk\\tO\\nratio\\tO\\nfor\\tO\\nthe\\tO\\ndisease\\tO\\nis\\tO\\n63\\tO\\nand\\tO\\nheritability\\tO\\nassessed\\tO\\nin\\tO\\ntwins\\tO\\n>\\tO\\n90\\tO\\n%\\tO\\n.\\tO\\n\\nAlthough\\tO\\nMHC\\tO\\ngenes\\tO\\n,\\tO\\nincluding\\tO\\nHLA\\tO\\n-\\tO\\nB27\\tO\\n,\\tO\\ncontribute\\tO\\nonly\\tO\\n20\\tO\\n-\\tO\\n50\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ngenetic\\tO\\nrisk\\tO\\nfor\\tO\\nthe\\tO\\ndisease\\tO\\n,\\tO\\nno\\tO\\nnon\\tO\\n-\\tO\\nMHC\\tO\\ngene\\tO\\nhas\\tO\\nyet\\tO\\nbeen\\tO\\nconvincingly\\tO\\ndemonstrated\\tO\\nto\\tO\\ninfluence\\tO\\neither\\tO\\nsusceptibility\\tO\\nto\\tO\\nthe\\tO\\ndisease\\tO\\nor\\tO\\nits\\tO\\nphenotypic\\tO\\nexpression\\tO\\n.\\tO\\n\\nPrevious\\tO\\nlinkage\\tO\\nand\\tO\\nassociation\\tO\\nstudies\\tO\\nhave\\tO\\nsuggested\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nsusceptibility\\tO\\ngene\\tO\\nfor\\tO\\nAS\\tB-Disease\\nclose\\tO\\nto\\tO\\n,\\tO\\nor\\tO\\nwithin\\tO\\n,\\tO\\nthe\\tO\\ncytochrome\\tO\\nP450\\tO\\n2D6\\tO\\ngene\\tO\\n(\\tO\\nCYP2D6\\tO\\n,\\tO\\ndebrisoquine\\tO\\nhydroxylase\\tO\\n)\\tO\\nlocated\\tO\\nat\\tO\\nchromosome\\tO\\n22q13\\tO\\n.\\tO\\n1\\tO\\n.\\tO\\n\\nWe\\tO\\nperformed\\tO\\na\\tO\\nlinkage\\tO\\nstudy\\tO\\nof\\tO\\nchromosome\\tO\\n22\\tO\\nin\\tO\\n200\\tO\\nfamilies\\tO\\nwith\\tO\\nAS\\tB-Disease\\naffected\\tO\\nsibling\\tO\\n-\\tO\\npairs\\tO\\n.\\tO\\n\\nAssociation\\tO\\nof\\tO\\nalleles\\tO\\nof\\tO\\nthe\\tO\\nCYP2D6\\tO\\ngene\\tO\\nwas\\tO\\nexamined\\tO\\nby\\tO\\nboth\\tO\\ncase\\tO\\n-\\tO\\ncontrol\\tO\\nand\\tO\\nwithin\\tO\\n-\\tO\\nfamily\\tO\\nmeans\\tO\\n.\\tO\\n\\nFor\\tO\\ncase\\tO\\n-\\tO\\ncontrol\\tO\\nstudies\\tO\\n,\\tO\\n617\\tO\\nunrelated\\tO\\nindividuals\\tO\\nwith\\tO\\nAS\\tB-Disease\\n(\\tO\\n361\\tO\\nprobands\\tO\\nfrom\\tO\\nsibling\\tO\\n-\\tO\\npair\\tO\\nand\\tO\\nparent\\tO\\n-\\tO\\ncase\\tO\\ntrio\\tO\\nfamilies\\tO\\nand\\tO\\n256\\tO\\nunrelated\\tO\\nnon\\tO\\n-\\tO\\nfamilial\\tO\\nsporadic\\tO\\ncases\\tO\\n)\\tO\\nand\\tO\\n402\\tO\\nhealthy\\tO\\nethnically\\tO\\nmatched\\tO\\ncontrols\\tO\\nwere\\tO\\nemployed\\tO\\n.\\tO\\n\\nFor\\tO\\nwithin\\tO\\n-\\tO\\nfamily\\tO\\nassociation\\tO\\nstudies\\tO\\n,\\tO\\n361\\tO\\nfamilies\\tO\\nincluding\\tO\\n161\\tO\\nparent\\tO\\n-\\tO\\ncase\\tO\\ntrios\\tO\\nand\\tO\\n200\\tO\\naffected\\tO\\nsibling\\tO\\n-\\tO\\npair\\tO\\nfamilies\\tO\\nwere\\tO\\nemployed\\tO\\n.\\tO\\n\\nHomozygosity\\tO\\nfor\\tO\\npoor\\tO\\nmetabolizer\\tO\\nalleles\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nAS\\tB-Disease\\n.\\tO\\n\\nHeterozygosity\\tO\\nfor\\tO\\nthe\\tO\\nmost\\tO\\nfrequent\\tO\\npoor\\tO\\nmetabolizer\\tO\\nallele\\tO\\n(\\tO\\nCYP2D6\\tO\\n*\\tO\\n4\\tO\\n)\\tO\\nwas\\tO\\nnot\\tO\\nassociated\\tO\\nwith\\tO\\nincreased\\tO\\nsusceptibility\\tO\\nto\\tO\\nAS\\tB-Disease\\n.\\tO\\n\\nSignificant\\tO\\nwithin\\tO\\n-\\tO\\nfamily\\tO\\nassociation\\tO\\nof\\tO\\nCYP2D6\\tO\\n*\\tO\\n4\\tO\\nalleles\\tO\\nand\\tO\\nAS\\tB-Disease\\nwas\\tO\\ndemonstrated\\tO\\n.\\tO\\n\\nWeak\\tO\\nlinkage\\tO\\nwas\\tO\\nalso\\tO\\ndemonstrated\\tO\\nbetween\\tO\\nCYP2D6\\tO\\nand\\tO\\nAS\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\npostulate\\tO\\nthat\\tO\\naltered\\tO\\nmetabolism\\tO\\nof\\tO\\na\\tO\\nnatural\\tO\\ntoxin\\tO\\nor\\tO\\nantigen\\tO\\nby\\tO\\nthe\\tO\\nCYP2D6\\tO\\ngene\\tO\\nmay\\tO\\nincrease\\tO\\nsusceptibility\\tO\\nto\\tO\\nAS\\tB-Disease\\n.\\tO\\n\\nFunctional\\tO\\ndifferences\\tO\\nof\\tO\\nthe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\nproduct\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nphenotypic\\tO\\nvariation\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nsyndromic\\tI-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\n(\\tO\\nDFNB4\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\nencodes\\tO\\na\\tO\\ntransmembrane\\tO\\nprotein\\tO\\n,\\tO\\nknown\\tO\\nas\\tO\\npendrin\\tO\\n,\\tO\\nwhich\\tO\\nfunctions\\tO\\nas\\tO\\na\\tO\\ntransporter\\tO\\nof\\tO\\niodide\\tO\\nand\\tO\\nchloride\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthis\\tO\\ngene\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nnon\\tI-Disease\\n-\\tI-Disease\\nsyndromic\\tI-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\nat\\tO\\nthe\\tO\\nDFNB4\\tB-Disease\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n7q31\\tO\\n.\\tO\\n\\nA\\tO\\nscreen\\tO\\nof\\tO\\n20\\tO\\nindividuals\\tO\\nfrom\\tO\\nthe\\tO\\nmidwestern\\tO\\nUSA\\tO\\nwith\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nsyndromic\\tI-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\nand\\tO\\ndilated\\tO\\nvestibular\\tO\\naqueducts\\tO\\nidentified\\tO\\nthree\\tO\\npeople\\tO\\n(\\tO\\n15\\tO\\n%\\tO\\n)\\tO\\nwith\\tO\\nPDS\\tB-Disease\\nmutations\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nwhether\\tO\\nPDS\\tB-Disease\\nmutations\\tO\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\ndiffer\\tO\\nfunctionally\\tO\\nfrom\\tO\\nPDS\\tB-Disease\\nmutations\\tO\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nsyndromic\\tI-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\n,\\tO\\nwe\\tO\\ncompared\\tO\\nthree\\tO\\ncommon\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\nallele\\tO\\nvariants\\tO\\n(\\tO\\nL236P\\tO\\n,\\tO\\nT416P\\tO\\nand\\tO\\nE384G\\tO\\n)\\tO\\n,\\tO\\nwith\\tO\\nthree\\tO\\nPDS\\tB-Disease\\nmutations\\tO\\nreported\\tO\\nonly\\tO\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nsyndromic\\tI-Disease\\nhearing\\tI-Disease\\nloss\\tI-Disease\\n(\\tO\\nV480D\\tO\\n,\\tO\\nV653A\\tO\\nand\\tO\\nI490L\\tO\\n/\\tO\\nG497S\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\nassociated\\tO\\nwith\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\nhave\\tO\\ncomplete\\tO\\nloss\\tO\\nof\\tO\\npendrin\\tO\\n-\\tO\\ninduced\\tO\\nchloride\\tO\\nand\\tO\\niodide\\tO\\ntransport\\tO\\n,\\tO\\nwhile\\tO\\nalleles\\tO\\nunique\\tO\\nto\\tO\\npeople\\tO\\nwith\\tO\\nDFNB4\\tB-Disease\\nare\\tO\\nable\\tO\\nto\\tO\\ntransport\\tO\\nboth\\tO\\niodide\\tO\\nand\\tO\\nchloride\\tO\\n,\\tO\\nalbeit\\tO\\nat\\tO\\na\\tO\\nmuch\\tO\\nlower\\tO\\nlevel\\tO\\nthan\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\npendrin\\tO\\n.\\tO\\n\\nWe\\tO\\nhypothesize\\tO\\nthat\\tO\\nthis\\tO\\nresidual\\tO\\nlevel\\tO\\nof\\tO\\nanion\\tO\\ntransport\\tO\\nis\\tO\\nsufficient\\tO\\nto\\tO\\neliminate\\tO\\nor\\tO\\npostpone\\tO\\nthe\\tO\\nonset\\tO\\nof\\tO\\ngoiter\\tB-Disease\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nDFNB4\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\npropose\\tO\\na\\tO\\nmodel\\tO\\nfor\\tO\\npendrin\\tO\\nfunction\\tO\\nin\\tO\\nthe\\tO\\nthyroid\\tO\\nin\\tO\\nwhich\\tO\\npendrin\\tO\\ntransports\\tO\\niodide\\tO\\nacross\\tO\\nthe\\tO\\napical\\tO\\nmembrane\\tO\\nof\\tO\\nthe\\tO\\nthyrocyte\\tO\\ninto\\tO\\nthe\\tO\\ncolloid\\tO\\nspace\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\nfactor\\tO\\nIX\\tO\\ngene\\tO\\nas\\tO\\ngermline\\tO\\nmutagen\\tO\\ntest\\tO\\n:\\tO\\nsamples\\tO\\nfrom\\tO\\nMainland\\tO\\nChina\\tO\\nhave\\tO\\nthe\\tO\\nputatively\\tO\\nendogenous\\tO\\npattern\\tO\\nof\\tO\\nmutation\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nare\\tO\\nthe\\tO\\nmajor\\tO\\nsource\\tO\\nof\\tO\\ngenetic\\tO\\nvariation\\tO\\nthat\\tO\\nallows\\tO\\na\\tO\\nspecies\\tO\\nto\\tO\\nevolve\\tO\\nover\\tO\\ntime\\tO\\nbut\\tO\\nat\\tO\\nthe\\tO\\ncost\\tO\\nof\\tO\\nMendelian\\tB-Disease\\ndisease\\tI-Disease\\nand\\tO\\ngenetic\\tO\\npredisposition\\tO\\nto\\tO\\nmultifactorial\\tB-Disease\\ndiseases\\tI-Disease\\n.\\tO\\n\\nPrevious\\tO\\nanalyses\\tO\\nhave\\tO\\nrevealed\\tO\\nthat\\tO\\nthe\\tO\\npattern\\tO\\nof\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nfactor\\tO\\nIX\\tO\\ngene\\tO\\n(\\tO\\nF9\\tO\\n)\\tO\\nis\\tO\\nsimilar\\tO\\namong\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nethnically\\tO\\nand\\tO\\ngeographically\\tO\\ndiverse\\tO\\npopulations\\tO\\nand\\tO\\ncompatible\\tO\\nwith\\tO\\nthe\\tO\\nancient\\tO\\npattern\\tO\\nthat\\tO\\nhas\\tO\\nshaped\\tO\\nthe\\tO\\nmammalian\\tO\\ngenome\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\ncompare\\tO\\nthe\\tO\\npattern\\tO\\nof\\tO\\ngermline\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\npopulation\\tO\\nof\\tO\\nhemophilia\\tB-Disease\\nB\\tI-Disease\\npatients\\tO\\nfrom\\tO\\nMainland\\tO\\nChina\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n66\\tO\\n)\\tO\\nto\\tO\\nthat\\tO\\nin\\tO\\nU\\tO\\n.\\tO\\n\\nS\\tO\\n.\\tO\\n\\nCaucasians\\tO\\n,\\tO\\nBlacks\\tO\\n,\\tO\\nand\\tO\\nMexican\\tO\\nHispanics\\tO\\nand\\tO\\nstratify\\tO\\nby\\tO\\ndisease\\tO\\nseverity\\tO\\nand\\tO\\nethnicity\\tO\\n.\\tO\\n\\nThe\\tO\\nsimilar\\tO\\npattern\\tO\\nof\\tO\\ngermline\\tO\\nmutation\\tO\\nin\\tO\\nall\\tO\\nethnic\\tO\\ngroups\\tO\\nstudied\\tO\\nto\\tO\\ndate\\tO\\nprovides\\tO\\nadditional\\tO\\ndata\\tO\\ncompatible\\tO\\nwith\\tO\\nthe\\tO\\ninference\\tO\\nthat\\tO\\nendogenous\\tO\\nprocesses\\tO\\npredominate\\tO\\nin\\tO\\ngermline\\tO\\nmutations\\tO\\n.\\tO\\n\\nFas\\tO\\npreassociation\\tO\\nrequired\\tO\\nfor\\tO\\napoptosis\\tO\\nsignaling\\tO\\nand\\tO\\ndominant\\tO\\ninhibition\\tO\\nby\\tO\\npathogenic\\tO\\nmutations\\tO\\n.\\tO\\n\\nHeterozygous\\tO\\nmutations\\tO\\nencoding\\tO\\nabnormal\\tO\\nforms\\tO\\nof\\tO\\nthe\\tO\\ndeath\\tO\\nreceptor\\tO\\nFas\\tO\\ndominantly\\tO\\ninterfere\\tO\\nwith\\tO\\nFas\\tO\\n-\\tO\\ninduced\\tO\\nlymphocyte\\tO\\napoptosis\\tO\\nin\\tO\\nhuman\\tO\\nautoimmune\\tB-Disease\\nlymphoproliferative\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\neffect\\tO\\n,\\tO\\nrather\\tO\\nthan\\tO\\ndepending\\tO\\non\\tO\\nligand\\tO\\n-\\tO\\ninduced\\tO\\nreceptor\\tO\\noligomerization\\tO\\n,\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nstem\\tO\\nfrom\\tO\\nligand\\tO\\n-\\tO\\nindependent\\tO\\ninteraction\\tO\\nof\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nand\\tO\\nmutant\\tO\\nFas\\tO\\nreceptors\\tO\\nthrough\\tO\\na\\tO\\nspecific\\tO\\nregion\\tO\\nin\\tO\\nthe\\tO\\nextracellular\\tO\\ndomain\\tO\\n.\\tO\\n\\nPreassociated\\tO\\nFas\\tO\\ncomplexes\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nliving\\tO\\ncells\\tO\\nby\\tO\\nmeans\\tO\\nof\\tO\\nfluorescence\\tO\\nresonance\\tO\\nenergy\\tO\\ntransfer\\tO\\nbetween\\tO\\nvariants\\tO\\nof\\tO\\ngreen\\tO\\nfluorescent\\tO\\nprotein\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nshow\\tO\\nthat\\tO\\nformation\\tO\\nof\\tO\\npreassociated\\tO\\nreceptor\\tO\\ncomplexes\\tO\\nis\\tO\\nnecessary\\tO\\nfor\\tO\\nFas\\tO\\nsignaling\\tO\\nand\\tO\\ndominant\\tO\\ninterference\\tO\\nin\\tO\\nhuman\\tO\\ndisease\\tO\\n.\\tO\\n.\\tO\\n\\nDetermination\\tO\\nof\\tO\\ncarrier\\tO\\nstatus\\tO\\nfor\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nby\\tO\\nflow\\tO\\ncytometric\\tO\\nanalysis\\tO\\nof\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nprotein\\tO\\nexpression\\tO\\nin\\tO\\nperipheral\\tO\\nblood\\tO\\nmononuclear\\tO\\ncells\\tO\\n.\\tO\\n\\nThe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\ndefects\\tO\\nin\\tO\\nthe\\tO\\nWAS\\tB-Disease\\nprotein\\tO\\n(\\tO\\nWASP\\tO\\n)\\tO\\ngene\\tO\\non\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nPrevious\\tO\\nstudy\\tO\\ndisclosed\\tO\\nthat\\tO\\nflow\\tO\\ncytometric\\tO\\nanalysis\\tO\\nof\\tO\\nintracellular\\tO\\nWASP\\tO\\nexpression\\tO\\n(\\tO\\nFCM\\tO\\n-\\tO\\nWASP\\tO\\nanalysis\\tO\\n)\\tO\\nin\\tO\\nlymphocytes\\tO\\nwas\\tO\\nuseful\\tO\\nfor\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nWAS\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nLymphocytes\\tO\\nfrom\\tO\\nall\\tO\\nWAS\\tB-Disease\\npatients\\tO\\nshowed\\tO\\nWASPdim\\tO\\ninstead\\tO\\nof\\tO\\nWASPbright\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\nFCM\\tO\\n-\\tO\\nWASP\\tO\\nanalysis\\tO\\nin\\tO\\nmonocytes\\tO\\ncould\\tO\\nbe\\tO\\na\\tO\\nuseful\\tO\\ntool\\tO\\nfor\\tO\\nthe\\tO\\nWAS\\tB-Disease\\ncarrier\\tO\\ndiagnosis\\tO\\n.\\tO\\n\\nMonocytes\\tO\\nfrom\\tO\\nall\\tO\\nnine\\tO\\nWAS\\tB-Disease\\ncarriers\\tO\\nshowed\\tO\\nvaried\\tO\\npopulation\\tO\\nof\\tO\\nWASPdim\\tO\\ntogether\\tO\\nwith\\tO\\nWASPbright\\tO\\n.\\tO\\n\\nNone\\tO\\nof\\tO\\ncontrol\\tO\\nindividuals\\tO\\npossessed\\tO\\nthe\\tO\\nWASPdim\\tO\\npopulation\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nlymphocytes\\tO\\nfrom\\tO\\nall\\tO\\nthe\\tO\\ncarriers\\tO\\nexcept\\tO\\ntwo\\tO\\nlacked\\tO\\nthe\\tO\\nWASPdim\\tO\\npopulation\\tO\\n.\\tO\\n\\nThe\\tO\\ndifference\\tO\\nof\\tO\\nthe\\tO\\nWASPdim\\tO\\npopulation\\tO\\nin\\tO\\nmonocytes\\tO\\nand\\tO\\nlymphocytes\\tO\\nobserved\\tO\\nin\\tO\\nWAS\\tB-Disease\\ncarriers\\tO\\nsuggests\\tO\\nthat\\tO\\nWASP\\tO\\nplays\\tO\\na\\tO\\nmore\\tO\\ncritical\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nlymphocytes\\tO\\nthan\\tO\\nin\\tO\\nthat\\tO\\nof\\tO\\nmonocytes\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nstudies\\tO\\nsuggest\\tO\\nthat\\tO\\na\\tO\\nskewed\\tO\\nX\\tO\\n-\\tO\\nchromosomal\\tO\\ninactivation\\tO\\npattern\\tO\\nobserved\\tO\\nin\\tO\\nWAS\\tB-Disease\\ncarrier\\tO\\nperipheral\\tO\\nblood\\tO\\ncells\\tO\\nis\\tO\\nnot\\tO\\nfixed\\tO\\nat\\tO\\nthe\\tO\\nhemopoietic\\tO\\nstem\\tO\\ncell\\tO\\nlevel\\tO\\nbut\\tO\\nprogresses\\tO\\nafter\\tO\\nthe\\tO\\nlineage\\tO\\ncommitment\\tO\\n.\\tO\\n.\\tO\\n\\nRestoration\\tO\\nof\\tO\\nphotoreceptor\\tO\\nultrastructure\\tO\\nand\\tO\\nfunction\\tO\\nin\\tO\\nretinal\\tB-Disease\\ndegeneration\\tI-Disease\\nslow\\tO\\nmice\\tO\\nby\\tO\\ngene\\tO\\ntherapy\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nPrph2\\tO\\nencodes\\tO\\na\\tO\\nphotoreceptor\\tO\\n-\\tO\\nspecific\\tO\\nmembrane\\tO\\nglycoprotein\\tO\\n,\\tO\\nperipherin\\tO\\n-\\tO\\n2\\tO\\n(\\tO\\nalso\\tO\\nknown\\tO\\nas\\tO\\nperipherin\\tO\\n/\\tO\\nrds\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\ninserted\\tO\\ninto\\tO\\nthe\\tO\\nrims\\tO\\nof\\tO\\nphotoreceptor\\tO\\nouter\\tO\\nsegment\\tO\\ndiscs\\tO\\nin\\tO\\na\\tO\\ncomplex\\tO\\nwith\\tO\\nrom\\tO\\n-\\tO\\n1\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ncomplex\\tO\\nis\\tO\\nnecessary\\tO\\nfor\\tO\\nthe\\tO\\nstabilization\\tO\\nof\\tO\\nthe\\tO\\ndiscs\\tO\\n,\\tO\\nwhich\\tO\\nare\\tO\\nrenewed\\tO\\nconstantly\\tO\\nthroughout\\tO\\nlife\\tO\\n,\\tO\\nand\\tO\\nwhich\\tO\\ncontain\\tO\\nthe\\tO\\nvisual\\tO\\npigments\\tO\\nnecessary\\tO\\nfor\\tO\\nphoton\\tO\\ncapture\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nPrph2\\tO\\nhave\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nresult\\tO\\nin\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nphotoreceptor\\tB-Disease\\ndystrophies\\tI-Disease\\n,\\tO\\nincluding\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nretinitis\\tI-Disease\\npigmentosa\\tI-Disease\\nand\\tO\\nmacular\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nA\\tO\\ncommon\\tO\\nfeature\\tO\\nof\\tO\\nthese\\tO\\ndiseases\\tO\\nis\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\nphotoreceptor\\tO\\nfunction\\tO\\n,\\tO\\nalso\\tO\\nseen\\tO\\nin\\tO\\nthe\\tO\\nretinal\\tB-Disease\\ndegeneration\\tI-Disease\\nslow\\tO\\n(\\tO\\nrds\\tO\\nor\\tO\\nPrph2\\tO\\nRd2\\tO\\n/\\tO\\nRd2\\tO\\n)\\tO\\nmouse\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nnull\\tO\\nmutation\\tO\\nin\\tO\\nPrph2\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\na\\tO\\ncomplete\\tO\\nfailure\\tO\\nto\\tO\\ndevelop\\tO\\nphotoreceptor\\tO\\ndiscs\\tO\\nand\\tO\\nouter\\tO\\nsegments\\tO\\n,\\tO\\ndownregulation\\tO\\nof\\tO\\nrhodopsin\\tO\\nand\\tO\\napoptotic\\tO\\nloss\\tO\\nof\\tO\\nphotoreceptor\\tO\\ncells\\tO\\n.\\tO\\n\\nThe\\tO\\nelectroretinograms\\tO\\n(\\tO\\nERGs\\tO\\n)\\tO\\nof\\tO\\nPrph2Rd2\\tO\\n/\\tO\\nRd2\\tO\\nmice\\tO\\nhave\\tO\\ngreatly\\tO\\ndiminished\\tO\\na\\tO\\n-\\tO\\nwave\\tO\\nand\\tO\\nb\\tO\\n-\\tO\\nwave\\tO\\namplitudes\\tO\\n,\\tO\\nwhich\\tO\\ndecline\\tO\\nto\\tO\\nvirtually\\tO\\nundetectable\\tO\\nconcentrations\\tO\\nby\\tO\\ntwo\\tO\\nmonths\\tO\\n.\\tO\\n\\nSubretinal\\tO\\ninjection\\tO\\nof\\tO\\nrecombinant\\tO\\nadeno\\tO\\n-\\tO\\nassociated\\tO\\nvirus\\tO\\n(\\tO\\nAAV\\tO\\n)\\tO\\nencoding\\tO\\na\\tO\\nPrph2\\tO\\ntransgene\\tO\\nresults\\tO\\nin\\tO\\nstable\\tO\\ngeneration\\tO\\nof\\tO\\nouter\\tO\\nsegment\\tO\\nstructures\\tO\\nand\\tO\\nformation\\tO\\nof\\tO\\nnew\\tO\\nstacks\\tO\\nof\\tO\\ndiscs\\tO\\ncontaining\\tO\\nboth\\tO\\nperpherin\\tO\\n-\\tO\\n2\\tO\\nand\\tO\\nrhodopsin\\tO\\n,\\tO\\nwhich\\tO\\nin\\tO\\nmany\\tO\\ncases\\tO\\nare\\tO\\nmorphologically\\tO\\nsimilar\\tO\\nto\\tO\\nnormal\\tO\\nouter\\tO\\nsegments\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nthe\\tO\\nre\\tO\\n-\\tO\\nestablishment\\tO\\nof\\tO\\nthe\\tO\\nstructural\\tO\\nintegrity\\tO\\nof\\tO\\nthe\\tO\\nphotoreceptor\\tO\\nlayer\\tO\\nalso\\tO\\nresults\\tO\\nin\\tO\\nelectrophysiological\\tO\\ncorrection\\tO\\n.\\tO\\n\\nThese\\tO\\nstudies\\tO\\ndemonstrate\\tO\\nfor\\tO\\nthe\\tO\\nfirst\\tO\\ntime\\tO\\nthat\\tO\\na\\tO\\ncomplex\\tO\\nultrastructural\\tO\\ncell\\tO\\ndefect\\tO\\ncan\\tO\\nbe\\tO\\ncorrected\\tO\\nboth\\tO\\nmorphologically\\tO\\nand\\tO\\nfunctionally\\tO\\nby\\tO\\nin\\tO\\nvivo\\tO\\ngene\\tO\\ntransfer\\tO\\n.\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nfibrinogen\\tO\\naalpha\\tO\\ngene\\tO\\naccount\\tO\\nfor\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\ncases\\tO\\nof\\tO\\ncongenital\\tB-Disease\\nafibrinogenemia\\tI-Disease\\n.\\tO\\n\\nCongenital\\tB-Disease\\nafibrinogenemia\\tI-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\n,\\tO\\nautosomal\\tB-Disease\\n,\\tI-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nthe\\tO\\ncomplete\\tO\\nabsence\\tO\\nof\\tO\\ndetectable\\tO\\nfibrinogen\\tO\\n.\\tO\\n\\nWe\\tO\\npreviously\\tO\\nidentified\\tO\\nthe\\tO\\nfirst\\tO\\ncausative\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\nnonconsanguineous\\tO\\nSwiss\\tO\\nfamily\\tO\\n;\\tO\\nthe\\tO\\n4\\tO\\naffected\\tO\\npersons\\tO\\nhave\\tO\\nhomozygous\\tO\\ndeletions\\tO\\nof\\tO\\napproximately\\tO\\n11\\tO\\nkb\\tO\\nof\\tO\\nthe\\tO\\nfibrinogen\\tO\\nalpha\\tO\\n(\\tO\\nFGA\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nHaplotype\\tO\\ndata\\tO\\nimplied\\tO\\nthat\\tO\\nthese\\tO\\ndeletions\\tO\\noccurred\\tO\\non\\tO\\ndistinct\\tO\\nancestral\\tO\\nchromosomes\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthis\\tO\\nregion\\tO\\nmay\\tO\\nbe\\tO\\nsusceptible\\tO\\nto\\tO\\ndeletion\\tO\\nby\\tO\\na\\tO\\ncommon\\tO\\nmechanism\\tO\\n.\\tO\\n\\nWe\\tO\\nsubsequently\\tO\\nshowed\\tO\\nthat\\tO\\nall\\tO\\nthe\\tO\\ndeletions\\tO\\nwere\\tO\\nidentical\\tO\\nto\\tO\\nthe\\tO\\nbase\\tO\\npair\\tO\\nand\\tO\\nprobably\\tO\\nresulted\\tO\\nfrom\\tO\\na\\tO\\nnonhomologous\\tO\\nrecombination\\tO\\nmediated\\tO\\nby\\tO\\n7\\tO\\n-\\tO\\nbp\\tO\\ndirect\\tO\\nrepeats\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ncollected\\tO\\ndata\\tO\\non\\tO\\n13\\tO\\nadditional\\tO\\nunrelated\\tO\\npatients\\tO\\nto\\tO\\nidentify\\tO\\nthe\\tO\\ncausative\\tO\\nmutations\\tO\\nand\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\nprevalence\\tO\\nof\\tO\\nthe\\tO\\n11\\tO\\n-\\tO\\nkb\\tO\\ndeletion\\tO\\n.\\tO\\n\\nA\\tO\\ncommon\\tO\\nrecurrent\\tO\\nmutation\\tO\\n,\\tO\\nat\\tO\\nthe\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\nof\\tO\\nFGA\\tO\\nintron\\tO\\n4\\tO\\n(\\tO\\nIVS4\\tO\\n+\\tO\\n1\\tO\\nG\\tO\\n>\\tO\\nT\\tO\\n)\\tO\\n,\\tO\\naccounted\\tO\\nfor\\tO\\n14\\tO\\nof\\tO\\nthe\\tO\\n26\\tO\\n(\\tO\\n54\\tO\\n%\\tO\\n)\\tO\\nalleles\\tO\\n.\\tO\\n\\nOne\\tO\\npatient\\tO\\nwas\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\npreviously\\tO\\nidentified\\tO\\ndeletion\\tO\\n.\\tO\\n\\nThree\\tO\\nmore\\tO\\nframeshift\\tO\\nmutations\\tO\\n,\\tO\\n2\\tO\\nnonsense\\tO\\nmutations\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nsecond\\tO\\nsplice\\tO\\nsite\\tO\\nmutation\\tO\\nwere\\tO\\nalso\\tO\\nidentified\\tO\\n.\\tO\\n\\nConsequently\\tO\\n,\\tO\\n86\\tO\\n%\\tO\\nof\\tO\\nafibrinogenemia\\tB-Disease\\nalleles\\tO\\nanalyzed\\tO\\nto\\tO\\ndate\\tO\\nhave\\tO\\ntruncating\\tO\\nmutations\\tO\\nof\\tO\\nFGA\\tO\\n,\\tO\\nthough\\tO\\nmutations\\tO\\nin\\tO\\nall\\tO\\n3\\tO\\nfibrinogen\\tO\\ngenes\\tO\\n,\\tO\\nFGG\\tO\\n,\\tO\\nFGA\\tO\\n,\\tO\\nand\\tO\\nFGB\\tO\\n,\\tO\\nmight\\tO\\nbe\\tO\\npredicted\\tO\\nto\\tO\\ncause\\tO\\ncongenital\\tB-Disease\\nafibrinogenemia\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n:\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nthe\\tO\\nCUG\\tO\\ntriplet\\tO\\nrepeats\\tO\\nin\\tO\\nsplicing\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\nDMPK\\tO\\nexon\\tO\\nand\\tO\\naltered\\tO\\ncytoplasmic\\tO\\nDMPK\\tO\\nmRNA\\tO\\nisoform\\tO\\nratios\\tO\\n.\\tO\\n\\nThe\\tO\\nmechanism\\tO\\nby\\tO\\nwhich\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nexpansion\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nUTR\\tO\\nof\\tO\\nthe\\tO\\nDMPK\\tO\\ngene\\tO\\ncauses\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\nunknown\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\nfour\\tO\\nRNA\\tO\\nsplicing\\tO\\nfactors\\tO\\n-\\tO\\n-\\tO\\nhnRNP\\tO\\nC\\tO\\n,\\tO\\nU2AF\\tO\\n(\\tO\\nU2\\tO\\nauxiliary\\tO\\nfactor\\tO\\n)\\tO\\n,\\tO\\nPTB\\tO\\n(\\tO\\npolypyrimidine\\tO\\ntract\\tO\\nbinding\\tO\\nprotein\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nPSF\\tO\\n(\\tO\\nPTB\\tO\\nassociated\\tO\\nsplicing\\tO\\nfactor\\tO\\n)\\tO\\n-\\tO\\n-\\tO\\nthat\\tO\\nbind\\tO\\nto\\tO\\ntwo\\tO\\nshort\\tO\\nregions\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\n(\\tO\\nCUG\\tO\\n)\\tO\\nn\\tO\\n,\\tO\\nand\\tO\\nfound\\tO\\na\\tO\\nnovel\\tO\\n3\\tO\\nDMPK\\tO\\nexon\\tO\\nresulting\\tO\\nin\\tO\\nan\\tO\\nmRNA\\tO\\nlacking\\tO\\nthe\\tO\\nrepeats\\tO\\n.\\tO\\n\\nWe\\tO\\npropose\\tO\\nthat\\tO\\nthe\\tO\\n(\\tO\\nCUG\\tO\\n)\\tO\\nn\\tO\\nis\\tO\\nan\\tO\\nessential\\tO\\ncis\\tO\\nacting\\tO\\nelement\\tO\\nfor\\tO\\nthis\\tO\\nsplicing\\tO\\nevent\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\nto\\tO\\n(\\tO\\nCUG\\tO\\n)\\tO\\nn\\tO\\ncontaining\\tO\\nmRNAs\\tO\\n,\\tO\\nthe\\tO\\nnovel\\tO\\nisoform\\tO\\nis\\tO\\nnot\\tO\\nretained\\tO\\nin\\tO\\nthe\\tO\\nnucleus\\tO\\nin\\tO\\nDM\\tB-Disease\\ncells\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nimbalances\\tO\\nin\\tO\\nrelative\\tO\\nlevels\\tO\\nof\\tO\\ncytoplasmic\\tO\\nDMPK\\tO\\nmRNA\\tO\\nisoforms\\tO\\nand\\tO\\na\\tO\\nnew\\tO\\ndominant\\tO\\neffect\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\non\\tO\\nDMPK\\tO\\n.\\tO\\n.\\tO\\n\\nExpression\\tO\\nand\\tO\\nimprinting\\tO\\nof\\tO\\nMAGEL2\\tO\\nsuggest\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nwilli\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nthe\\tO\\nhomologous\\tO\\nmurine\\tO\\nimprinting\\tO\\nphenotype\\tO\\n.\\tO\\n\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\nexpression\\tO\\nof\\tO\\nimprinted\\tO\\ngenes\\tO\\nin\\tO\\nchromosome\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\n.\\tO\\n\\nAffected\\tO\\nindividuals\\tO\\nexhibit\\tO\\nneonatal\\tB-Disease\\nhypotonia\\tI-Disease\\n,\\tO\\ndevelopmental\\tB-Disease\\ndelay\\tI-Disease\\nand\\tO\\nchildhood\\tB-Disease\\n-\\tI-Disease\\nonset\\tI-Disease\\nobesity\\tI-Disease\\n.\\tO\\n\\nNecdin\\tO\\n,\\tO\\na\\tO\\nprotein\\tO\\nimplicated\\tO\\nin\\tO\\nthe\\tO\\nterminal\\tO\\ndifferentiation\\tO\\nof\\tO\\nneurons\\tO\\n,\\tO\\nis\\tO\\nthe\\tO\\nonly\\tO\\nPWS\\tB-Disease\\ncandidate\\tO\\ngene\\tO\\nto\\tO\\nreduce\\tO\\nviability\\tO\\nwhen\\tO\\ndisrupted\\tO\\nin\\tO\\na\\tO\\nmouse\\tO\\nmodel\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ncharacterized\\tO\\nMAGEL2\\tO\\n(\\tO\\nalso\\tO\\nknown\\tO\\nas\\tO\\nNDNL1\\tO\\n)\\tO\\n,\\tO\\na\\tO\\ngene\\tO\\nwith\\tO\\n51\\tO\\n%\\tO\\namino\\tO\\nacid\\tO\\nsequence\\tO\\nsimilarity\\tO\\nto\\tO\\nnecdin\\tO\\nand\\tO\\nlocated\\tO\\n41\\tO\\nkb\\tO\\ndistal\\tO\\nto\\tO\\nNDN\\tO\\nin\\tO\\nthe\\tO\\nPWS\\tB-Disease\\ndeletion\\tO\\nregion\\tO\\n.\\tO\\n\\nMAGEL2\\tO\\nis\\tO\\nexpressed\\tO\\npredominantly\\tO\\nin\\tO\\nbrain\\tO\\n,\\tO\\nthe\\tO\\nprimary\\tO\\ntissue\\tO\\naffected\\tO\\nin\\tO\\nPWS\\tB-Disease\\nand\\tO\\nin\\tO\\nseveral\\tO\\nfetal\\tO\\ntissues\\tO\\nas\\tO\\nshown\\tO\\nby\\tO\\nnorthern\\tO\\nblot\\tO\\nanalysis\\tO\\n.\\tO\\n\\nMAGEL2\\tO\\nis\\tO\\nimprinted\\tO\\nwith\\tO\\nmonoallelic\\tO\\nexpression\\tO\\nin\\tO\\ncontrol\\tO\\nbrain\\tO\\n,\\tO\\nand\\tO\\npaternal\\tO\\n-\\tO\\nonly\\tO\\nexpression\\tO\\nin\\tO\\nthe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\nas\\tO\\ndemonstrated\\tO\\nby\\tO\\nits\\tO\\nlack\\tO\\nof\\tO\\nexpression\\tO\\nin\\tO\\nbrain\\tO\\nfrom\\tO\\na\\tO\\nPWS\\tB-Disease\\n-\\tO\\naffected\\tO\\nindividual\\tO\\n.\\tO\\n\\nThe\\tO\\northologous\\tO\\nmouse\\tO\\ngene\\tO\\n(\\tO\\nMagel2\\tO\\n)\\tO\\nis\\tO\\nlocated\\tO\\nwithin\\tO\\n150\\tO\\nkb\\tO\\nof\\tO\\nNDN\\tO\\n,\\tO\\nis\\tO\\nimprinted\\tO\\nwith\\tO\\npaternal\\tO\\n-\\tO\\nonly\\tO\\nexpression\\tO\\nand\\tO\\nis\\tO\\nexpressed\\tO\\npredominantly\\tO\\nin\\tO\\nlate\\tO\\ndevelopmental\\tO\\nstages\\tO\\nand\\tO\\nadult\\tO\\nbrain\\tO\\nas\\tO\\nshown\\tO\\nby\\tO\\nnorthern\\tO\\nblotting\\tO\\n,\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nand\\tO\\nwhole\\tO\\n-\\tO\\nmount\\tO\\nRNA\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n.\\tO\\n\\nMagel2\\tO\\ndistribution\\tO\\npartially\\tO\\noverlaps\\tO\\nthat\\tO\\nof\\tO\\nNDN\\tO\\n,\\tO\\nwith\\tO\\nstrong\\tO\\nexpression\\tO\\nbeing\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\nin\\tO\\nmid\\tO\\n-\\tO\\ngestation\\tO\\nmouse\\tO\\nembryos\\tO\\nby\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n.\\tO\\n\\nWe\\tO\\nhypothesize\\tO\\nthat\\tO\\n,\\tO\\nalthough\\tO\\nloss\\tO\\nof\\tO\\nnecdin\\tO\\nexpression\\tO\\nmay\\tO\\nbe\\tO\\nimportant\\tO\\nin\\tO\\nthe\\tO\\nneonatal\\tO\\npresentation\\tO\\nof\\tO\\nPWS\\tB-Disease\\n,\\tO\\nloss\\tO\\nof\\tO\\nMAGEL2\\tO\\nmay\\tO\\nbe\\tO\\ncritical\\tO\\nto\\tO\\nabnormalities\\tB-Disease\\nin\\tI-Disease\\nbrain\\tI-Disease\\ndevelopment\\tI-Disease\\nand\\tO\\ndysmorphic\\tB-Disease\\nfeatures\\tI-Disease\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nPWS\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nRetinoschisin\\tO\\n,\\tO\\nthe\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nretinoschisis\\tI-Disease\\nprotein\\tO\\n,\\tO\\nis\\tO\\na\\tO\\nsecreted\\tO\\nphotoreceptor\\tO\\nprotein\\tO\\n,\\tO\\nand\\tO\\nis\\tO\\nexpressed\\tO\\nand\\tO\\nreleased\\tO\\nby\\tO\\nWeri\\tO\\n-\\tO\\nRb1\\tO\\ncells\\tO\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nretinoschisis\\tI-Disease\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nmicrocystic\\tO\\n-\\tO\\nlike\\tO\\nchanges\\tO\\nof\\tO\\nthe\\tO\\nmacular\\tO\\nregion\\tO\\nand\\tO\\nschisis\\tO\\nwithin\\tO\\nthe\\tO\\ninner\\tO\\nretinal\\tO\\nlayers\\tO\\n,\\tO\\nleading\\tO\\nto\\tO\\nvisual\\tB-Disease\\ndeterioration\\tI-Disease\\nin\\tO\\nmales\\tO\\n.\\tO\\n\\nMany\\tO\\nmissense\\tO\\nand\\tO\\nprotein\\tO\\n-\\tO\\ntruncating\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\ncausative\\tO\\ngene\\tO\\nRS1\\tO\\nhave\\tO\\nnow\\tO\\nbeen\\tO\\nidentified\\tO\\nand\\tO\\nare\\tO\\nthought\\tO\\nto\\tO\\nbe\\tO\\ninactivating\\tO\\n.\\tO\\n\\nRS1\\tO\\nencodes\\tO\\na\\tO\\n224\\tO\\namino\\tO\\nacid\\tO\\nprotein\\tO\\n,\\tO\\nretinoschisin\\tO\\n,\\tO\\nwhich\\tO\\ncontains\\tO\\na\\tO\\ndiscoidin\\tO\\ndomain\\tO\\nbut\\tO\\nis\\tO\\nof\\tO\\nunknown\\tO\\nfunction\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ngenerated\\tO\\na\\tO\\npolyclonal\\tO\\nantibody\\tO\\nagainst\\tO\\na\\tO\\npeptide\\tO\\nfrom\\tO\\na\\tO\\nunique\\tO\\nregion\\tO\\nwithin\\tO\\nretinoschisin\\tO\\n,\\tO\\nwhich\\tO\\ndetects\\tO\\na\\tO\\nprotein\\tO\\nof\\tO\\napproximately\\tO\\n28\\tO\\nkDa\\tO\\nin\\tO\\nretinal\\tO\\nsamples\\tO\\nreduced\\tO\\nwith\\tO\\ndithiothreitol\\tO\\n,\\tO\\nbut\\tO\\nmultimers\\tO\\nsized\\tO\\n>\\tO\\n40\\tO\\nkDa\\tO\\nunder\\tO\\nnon\\tO\\n-\\tO\\nreducing\\tO\\nconditions\\tO\\n.\\tO\\n\\nA\\tO\\nscreen\\tO\\nof\\tO\\nhuman\\tO\\ntissues\\tO\\nwith\\tO\\nthis\\tO\\nantibody\\tO\\nreveals\\tO\\nretinoschisin\\tO\\nto\\tO\\nbe\\tO\\nretina\\tO\\nspecific\\tO\\nand\\tO\\nthe\\tO\\nantibody\\tO\\ndetects\\tO\\na\\tO\\nprotein\\tO\\nof\\tO\\nsimilar\\tO\\nsize\\tO\\nin\\tO\\nbovine\\tO\\nand\\tO\\nmurine\\tO\\nretinae\\tO\\n.\\tO\\n\\nWe\\tO\\ninvestigated\\tO\\nthe\\tO\\nexpression\\tO\\npattern\\tO\\nin\\tO\\nthe\\tO\\nretina\\tO\\nof\\tO\\nboth\\tO\\nRS1\\tO\\nmRNA\\tO\\n(\\tO\\nusing\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\nwith\\tO\\nriboprobes\\tO\\n)\\tO\\nand\\tO\\nretinoschisin\\tO\\n(\\tO\\nusing\\tO\\nimmunohistochemistry\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nantisense\\tO\\nriboprobe\\tO\\ndetected\\tO\\nRS1\\tO\\nmRNA\\tO\\nonly\\tO\\nin\\tO\\nthe\\tO\\nphotoreceptor\\tO\\nlayer\\tO\\nbut\\tO\\nthe\\tO\\nprotein\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nwas\\tO\\npresent\\tO\\nboth\\tO\\nin\\tO\\nthe\\tO\\nphotoreceptors\\tO\\nand\\tO\\nwithin\\tO\\nthe\\tO\\ninner\\tO\\nportions\\tO\\nof\\tO\\nthe\\tO\\nretina\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\ndifferentiated\\tO\\nretinoblastoma\\tB-Disease\\ncells\\tO\\n(\\tO\\nWeri\\tO\\n-\\tO\\nRb1\\tO\\ncells\\tO\\n)\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nexpress\\tO\\nRS1\\tO\\nmRNA\\tO\\nand\\tO\\nto\\tO\\nrelease\\tO\\nretinoschisin\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nretinoschisin\\tO\\nis\\tO\\nreleased\\tO\\nby\\tO\\nphoto\\tO\\n-\\tO\\nreceptors\\tO\\nand\\tO\\nhas\\tO\\nfunctions\\tO\\nwithin\\tO\\nthe\\tO\\ninner\\tO\\nretinal\\tO\\nlayers\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nretinoschisis\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\nabnormalities\\tO\\nin\\tO\\na\\tO\\nputative\\tO\\nsecreted\\tO\\nphotoreceptor\\tO\\nprotein\\tO\\nand\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nexample\\tO\\nof\\tO\\na\\tO\\nsecreted\\tO\\nphoto\\tO\\n-\\tO\\nreceptor\\tO\\nprotein\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nretinal\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nStudy\\tO\\nof\\tO\\nthe\\tO\\nvoltage\\tO\\n-\\tO\\ngated\\tO\\nsodium\\tO\\nchannel\\tO\\nbeta\\tO\\n1\\tO\\nsubunit\\tO\\ngene\\tO\\n(\\tO\\nSCN1B\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nbenign\\tB-Disease\\nfamilial\\tI-Disease\\ninfantile\\tI-Disease\\nconvulsions\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nBFIC\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nBenign\\tB-Disease\\nfamilial\\tI-Disease\\ninfantile\\tI-Disease\\nconvulsions\\tI-Disease\\n(\\tO\\nBFIC\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nrare\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nepilepsy\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nsyndrome\\tO\\nhas\\tO\\nbeen\\tO\\nrecently\\tO\\ndescribed\\tO\\nin\\tO\\nItalian\\tO\\nand\\tO\\nFrench\\tO\\npedigrees\\tO\\n.\\tO\\n\\nPatients\\tO\\npresent\\tO\\nwith\\tO\\npartial\\tO\\n,\\tO\\nthen\\tO\\ngeneralized\\tO\\nseizures\\tO\\n,\\tO\\nwith\\tO\\nonset\\tO\\nat\\tO\\nage\\tO\\nthree\\tO\\nmonths\\tO\\n.\\tO\\n\\nThe\\tO\\nseizures\\tO\\nusually\\tO\\nspontaneously\\tO\\ncease\\tO\\nafter\\tO\\none\\tO\\nyear\\tO\\nwithout\\tO\\ntreatment\\tO\\n,\\tO\\nleaving\\tO\\nno\\tO\\nneurological\\tB-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nmapped\\tO\\nBFIC\\tB-Disease\\nto\\tO\\nchromosome\\tO\\n19q\\tO\\nin\\tO\\nfive\\tO\\nItalian\\tO\\npedigrees\\tO\\n.\\tO\\n\\nThe\\tO\\nsodium\\tO\\nchannel\\tO\\nbeta1\\tO\\nsubunit\\tO\\ngene\\tO\\n(\\tO\\nSCN1B\\tO\\n)\\tO\\nmaps\\tO\\nto\\tO\\nthis\\tO\\ncandidate\\tO\\nregion\\tO\\nand\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\none\\tO\\nAustralian\\tO\\npedigree\\tO\\nwith\\tO\\ngeneralized\\tB-Disease\\nepilepsy\\tI-Disease\\nand\\tI-Disease\\nfebrile\\tI-Disease\\nseizures\\tI-Disease\\n\"\\tI-Disease\\nplus\\tI-Disease\\n\"\\tI-Disease\\n(\\tO\\nGEFS\\tO\\n+\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nfamily\\tO\\n,\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nSCN1B\\tO\\ncosegregates\\tO\\nwith\\tO\\nthe\\tO\\nGEFS\\tO\\n+\\tO\\nphenotype\\tO\\n.\\tO\\n\\nBFIC\\tB-Disease\\nand\\tO\\nGEFS\\tO\\n+\\tO\\nhave\\tO\\nclinical\\tO\\nfeatures\\tO\\nin\\tO\\ncommon\\tO\\n,\\tO\\ntherefore\\tO\\nSCN1B\\tO\\nis\\tO\\na\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nBFIC\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\nSCN1B\\tO\\nexons\\tO\\n1\\tO\\n,\\tO\\n2\\tO\\n,\\tO\\n3\\tO\\n,\\tO\\n4\\tO\\n,\\tO\\nand\\tO\\n5\\tO\\n,\\tO\\nusing\\tO\\nfour\\tO\\nSSCP\\tO\\nmethods\\tO\\nin\\tO\\n10\\tO\\nCaucasian\\tO\\nBFIC\\tB-Disease\\nprobands\\tO\\nof\\tO\\nWestern\\tO\\nEurope\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nno\\tO\\nexon\\tO\\nvariants\\tO\\n.\\tO\\n\\nOne\\tO\\nvariant\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\nintron\\tO\\n5\\tO\\n(\\tO\\nIVS5\\tO\\n-\\tO\\n10C\\tO\\n>\\tO\\nG\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\ndid\\tO\\nnot\\tO\\nsegregate\\tO\\nwith\\tO\\nBFIC\\tB-Disease\\nand\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\n9\\tO\\n.\\tO\\n\\n2\\tO\\n%\\tO\\ncontrols\\tO\\n.\\tO\\n\\nA\\tO\\nsecond\\tO\\nvariant\\tO\\nin\\tO\\nintron\\tO\\n5\\tO\\nwas\\tO\\nidentified\\tO\\n(\\tO\\nIVS5\\tO\\n+\\tO\\n30G\\tO\\n>\\tO\\nA\\tO\\n)\\tO\\n.\\tO\\n\\nIt\\tO\\nwas\\tO\\nrare\\tO\\n,\\tO\\nas\\tO\\nnot\\tO\\nobserved\\tO\\nin\\tO\\ncontrols\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nsegregating\\tO\\nwith\\tO\\nthe\\tO\\nBFIC\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nInactivation\\tO\\nof\\tO\\ngermline\\tO\\nmutant\\tO\\nAPC\\tB-Disease\\nalleles\\tO\\nby\\tO\\nattenuated\\tO\\nsomatic\\tO\\nmutations\\tO\\n:\\tO\\na\\tO\\nmolecular\\tO\\ngenetic\\tO\\nmechanism\\tO\\nfor\\tO\\nattenuated\\tB-Disease\\nfamilial\\tI-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tI-Disease\\nAPC\\tI-Disease\\n)\\tI-Disease\\ntumor\\tI-Disease\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\nresult\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nPatients\\tO\\nwith\\tO\\nFAP\\tB-Disease\\ntypically\\tO\\ndevelop\\tO\\nhundreds\\tO\\nto\\tO\\nthousands\\tO\\nof\\tO\\nbenign\\tB-Disease\\ncolorectal\\tI-Disease\\ntumors\\tI-Disease\\nand\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nsubset\\tO\\nof\\tO\\ngermline\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\nresults\\tO\\nin\\tO\\nan\\tO\\nattenuated\\tB-Disease\\nFAP\\tI-Disease\\n(\\tO\\nAFAP\\tB-Disease\\n)\\tO\\nphenotype\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\npatients\\tO\\ndevelop\\tO\\nfewer\\tO\\ntumors\\tB-Disease\\nand\\tO\\ndevelop\\tO\\nthem\\tO\\nat\\tO\\nan\\tO\\nolder\\tO\\nage\\tO\\n.\\tO\\n\\nAlthough\\tO\\na\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\nlocations\\tO\\nof\\tO\\nAPC\\tB-Disease\\ngermline\\tO\\nmutations\\tO\\nand\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nAFAP\\tB-Disease\\nhas\\tO\\nbeen\\tO\\nwell\\tO\\ndocumented\\tO\\n,\\tO\\nthe\\tO\\nmechanism\\tO\\nfor\\tO\\nAFAP\\tB-Disease\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\nwell\\tO\\ndefined\\tO\\n.\\tO\\n\\nWe\\tO\\ninvestigated\\tO\\nthe\\tO\\nmechanism\\tO\\nfor\\tO\\nAFAP\\tB-Disease\\nin\\tO\\npatients\\tO\\ncarrying\\tO\\na\\tO\\nmutant\\tO\\nAPC\\tB-Disease\\nallele\\tO\\n(\\tO\\nAPC\\tO\\n(\\tO\\nAS9\\tO\\n)\\tO\\n)\\tO\\nthat\\tO\\nhas\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nalternatively\\tO\\nspliced\\tO\\nregion\\tO\\nof\\tO\\nexon\\tO\\n9\\tO\\n.\\tO\\n\\nAPC\\tO\\n(\\tO\\nAS9\\tO\\n)\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\ndown\\tO\\n-\\tO\\nregulate\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n-\\tO\\nregulated\\tO\\ntranscription\\tO\\n,\\tO\\nthe\\tO\\nmajor\\tO\\ntumor\\tB-Disease\\n-\\tO\\nsuppressor\\tO\\nfunction\\tO\\nof\\tO\\nAPC\\tO\\n,\\tO\\nas\\tO\\ndid\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nAPC\\tO\\n.\\tO\\n\\nMutation\\tO\\nanalysis\\tO\\nshowed\\tO\\nthat\\tO\\nboth\\tO\\nAPC\\tO\\n(\\tO\\nAS9\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nAPC\\tB-Disease\\nalleles\\tO\\nwere\\tO\\nsomatically\\tO\\nmutated\\tO\\nin\\tO\\nmost\\tO\\ncolorectal\\tB-Disease\\ntumors\\tI-Disease\\nfrom\\tO\\nthese\\tO\\npatients\\tO\\n.\\tO\\n\\nFunctional\\tO\\nanalysis\\tO\\nshowed\\tO\\nthat\\tO\\n4666insA\\tO\\n,\\tO\\na\\tO\\ncommon\\tO\\nsomatic\\tO\\nmutation\\tO\\nin\\tO\\nAPC\\tO\\n(\\tO\\nAS9\\tO\\n)\\tO\\nin\\tO\\nthese\\tO\\ntumors\\tB-Disease\\n,\\tO\\ndid\\tO\\nnot\\tO\\ninactivate\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nAPC\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\ncarriers\\tO\\nof\\tO\\nAPC\\tO\\n(\\tO\\nAS9\\tO\\n)\\tO\\ndevelop\\tO\\nfewer\\tO\\ncolorectal\\tB-Disease\\ntumors\\tI-Disease\\nthan\\tO\\ndo\\tO\\ntypical\\tO\\npatients\\tO\\nwith\\tO\\nFAP\\tB-Disease\\nbecause\\tO\\nsomatic\\tO\\ninactivation\\tO\\nof\\tO\\nboth\\tO\\nAPC\\tB-Disease\\nalleles\\tO\\nis\\tO\\nnecessary\\tO\\nfor\\tO\\ncolorectal\\tO\\ntumorigenesis\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthese\\tO\\npatients\\tO\\ndevelop\\tO\\ncolorectal\\tB-Disease\\ntumors\\tI-Disease\\nmore\\tO\\nfrequently\\tO\\nthan\\tO\\ndoes\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\nbecause\\tO\\nAPC\\tO\\n(\\tO\\nAS9\\tO\\n)\\tO\\nis\\tO\\ninactivated\\tO\\nby\\tO\\nmutations\\tO\\nthat\\tO\\ndo\\tO\\nnot\\tO\\ninactivate\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nAPC\\tO\\n.\\tO\\n.\\tO\\n\\nIron\\tO\\n-\\tO\\ndependent\\tO\\nself\\tO\\n-\\tO\\nassembly\\tO\\nof\\tO\\nrecombinant\\tO\\nyeast\\tO\\nfrataxin\\tO\\n:\\tO\\nimplications\\tO\\nfor\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n.\\tO\\n\\nFrataxin\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nthe\\tO\\nprimary\\tO\\ncause\\tO\\nof\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n(\\tO\\nFRDA\\tB-Disease\\n)\\tO\\n,\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ncardiodegenerative\\tI-Disease\\nand\\tI-Disease\\nneurodegenerative\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nFrataxin\\tO\\nis\\tO\\na\\tO\\nnuclear\\tO\\n-\\tO\\nencoded\\tO\\nmitochondrial\\tO\\nprotein\\tO\\nthat\\tO\\nis\\tO\\nwidely\\tO\\nconserved\\tO\\namong\\tO\\neukaryotes\\tO\\n.\\tO\\n\\nGenetic\\tO\\ninactivation\\tO\\nof\\tO\\nthe\\tO\\nyeast\\tO\\nfrataxin\\tO\\nhomologue\\tO\\n(\\tO\\nYfh1p\\tO\\n)\\tO\\nresults\\tO\\nin\\tO\\nmitochondrial\\tB-Disease\\niron\\tI-Disease\\naccumulation\\tI-Disease\\nand\\tO\\nhypersensitivity\\tB-Disease\\nto\\tI-Disease\\noxidative\\tI-Disease\\nstress\\tI-Disease\\n.\\tO\\n\\nIncreased\\tO\\niron\\tO\\ndeposition\\tO\\nand\\tO\\nevidence\\tO\\nof\\tO\\noxidative\\tO\\ndamage\\tO\\nhave\\tO\\nalso\\tO\\nbeen\\tO\\nobserved\\tO\\nin\\tO\\ncardiac\\tO\\ntissue\\tO\\nand\\tO\\ncultured\\tO\\nfibroblasts\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nFRDA\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nindicate\\tO\\nthat\\tO\\nfrataxin\\tO\\nis\\tO\\nessential\\tO\\nfor\\tO\\nmitochondrial\\tO\\niron\\tO\\nhomeostasis\\tO\\nand\\tO\\nprotection\\tO\\nfrom\\tO\\niron\\tO\\n-\\tO\\ninduced\\tO\\nformation\\tO\\nof\\tO\\nfree\\tO\\nradicals\\tO\\n.\\tO\\n\\nThe\\tO\\nfunctional\\tO\\nmechanism\\tO\\nof\\tO\\nfrataxin\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nis\\tO\\nstill\\tO\\nunknown\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexpressed\\tO\\nthe\\tO\\nmature\\tO\\nform\\tO\\nof\\tO\\nYfh1p\\tO\\n(\\tO\\nmYfh1p\\tO\\n)\\tO\\nin\\tO\\nEscherichia\\tO\\ncoli\\tO\\nand\\tO\\nhave\\tO\\nanalyzed\\tO\\nits\\tO\\nfunction\\tO\\nin\\tO\\nvitro\\tO\\n.\\tO\\n\\nIsolated\\tO\\nmYfh1p\\tO\\nis\\tO\\na\\tO\\nsoluble\\tO\\nmonomer\\tO\\n(\\tO\\n13\\tO\\n,\\tO\\n783\\tO\\nDa\\tO\\n)\\tO\\nthat\\tO\\ncontains\\tO\\nno\\tO\\niron\\tO\\nand\\tO\\nshows\\tO\\nno\\tO\\nsignificant\\tO\\ntendency\\tO\\nto\\tO\\nself\\tO\\n-\\tO\\nassociate\\tO\\n.\\tO\\n\\nAerobic\\tO\\naddition\\tO\\nof\\tO\\nferrous\\tO\\niron\\tO\\nto\\tO\\nmYfh1p\\tO\\nresults\\tO\\nin\\tO\\nassembly\\tO\\nof\\tO\\nregular\\tO\\nspherical\\tO\\nmultimers\\tO\\nwith\\tO\\na\\tO\\nmolecular\\tO\\nmass\\tO\\nof\\tO\\napproximately\\tO\\n1\\tO\\n.\\tO\\n\\n1\\tO\\nMDa\\tO\\n(\\tO\\nmegadaltons\\tO\\n)\\tO\\nand\\tO\\na\\tO\\ndiameter\\tO\\nof\\tO\\n13\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n2\\tO\\nnm\\tO\\n.\\tO\\n\\nEach\\tO\\nmultimer\\tO\\nconsists\\tO\\nof\\tO\\napproximately\\tO\\n60\\tO\\nsubunits\\tO\\nand\\tO\\ncan\\tO\\nsequester\\tO\\n>\\tO\\n3\\tO\\n,\\tO\\n000\\tO\\natoms\\tO\\nof\\tO\\niron\\tO\\n.\\tO\\n\\nTitration\\tO\\nof\\tO\\nmYfh1p\\tO\\nwith\\tO\\nincreasing\\tO\\niron\\tO\\nconcentrations\\tO\\nsupports\\tO\\na\\tO\\nstepwise\\tO\\nmechanism\\tO\\nof\\tO\\nmultimer\\tO\\nassembly\\tO\\n.\\tO\\n\\nSequential\\tO\\naddition\\tO\\nof\\tO\\nan\\tO\\niron\\tO\\nchelator\\tO\\nand\\tO\\na\\tO\\nreducing\\tO\\nagent\\tO\\nresults\\tO\\nin\\tO\\nquantitative\\tO\\niron\\tO\\nrelease\\tO\\nwith\\tO\\nconcomitant\\tO\\ndisassembly\\tO\\nof\\tO\\nthe\\tO\\nmultimer\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nmYfh1p\\tO\\nsequesters\\tO\\niron\\tO\\nin\\tO\\nan\\tO\\navailable\\tO\\nform\\tO\\n.\\tO\\n\\nIn\\tO\\nyeast\\tO\\nmitochondria\\tO\\n,\\tO\\nnative\\tO\\nmYfh1p\\tO\\nexists\\tO\\nas\\tO\\nmonomer\\tO\\nand\\tO\\na\\tO\\nhigher\\tO\\n-\\tO\\norder\\tO\\nspecies\\tO\\nwith\\tO\\na\\tO\\nmolecular\\tO\\nweight\\tO\\n>\\tO\\n600\\tO\\n,\\tO\\n000\\tO\\n.\\tO\\n\\nAfter\\tO\\naddition\\tO\\nof\\tO\\n(\\tO\\n55\\tO\\n)\\tO\\nFe\\tO\\nto\\tO\\nthe\\tO\\nmedium\\tO\\n,\\tO\\nimmunoprecipitates\\tO\\nof\\tO\\nthis\\tO\\nspecies\\tO\\ncontain\\tO\\n>\\tO\\n16\\tO\\natoms\\tO\\nof\\tO\\n(\\tO\\n55\\tO\\n)\\tO\\nFe\\tO\\nper\\tO\\nmolecule\\tO\\nof\\tO\\nmYfh1p\\tO\\n.\\tO\\n\\nWe\\tO\\npropose\\tO\\nthat\\tO\\niron\\tO\\n-\\tO\\ndependent\\tO\\nself\\tO\\n-\\tO\\nassembly\\tO\\nof\\tO\\nrecombinant\\tO\\nmYfh1p\\tO\\nreflects\\tO\\na\\tO\\nphysiological\\tO\\nrole\\tO\\nfor\\tO\\nfrataxin\\tO\\nin\\tO\\nmitochondrial\\tO\\niron\\tO\\nsequestration\\tO\\nand\\tO\\nbioavailability\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\npleckstrin\\tO\\nhomology\\tO\\n(\\tO\\nPH\\tO\\n)\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nFGD1\\tO\\ngene\\tO\\nin\\tO\\nan\\tO\\nItalian\\tO\\nfamily\\tO\\nwith\\tO\\nfaciogenital\\tB-Disease\\ndysplasia\\tI-Disease\\n(\\tO\\nAarskog\\tB-Disease\\n-\\tI-Disease\\nScott\\tI-Disease\\nsyndrome\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nAarskog\\tB-Disease\\n-\\tI-Disease\\nScott\\tI-Disease\\nSyndrome\\tI-Disease\\n(\\tO\\nAAS\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterised\\tO\\nby\\tO\\nshort\\tB-Disease\\nstature\\tI-Disease\\nand\\tO\\nmultiple\\tO\\nfacial\\tB-Disease\\n,\\tI-Disease\\nlimb\\tI-Disease\\nand\\tI-Disease\\ngenital\\tI-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nA\\tO\\ngene\\tO\\n,\\tO\\nFGD1\\tO\\n,\\tO\\naltered\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nAAS\\tB-Disease\\nphenotype\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nand\\tO\\nfound\\tO\\nto\\tO\\nencode\\tO\\na\\tO\\nprotein\\tO\\nwith\\tO\\nhomology\\tO\\nto\\tO\\nRho\\tO\\n/\\tO\\nRac\\tO\\nguanine\\tO\\nnucleotide\\tO\\nexchange\\tO\\nfactors\\tO\\n(\\tO\\nRho\\tO\\n/\\tO\\nRac\\tO\\nGEF\\tO\\n)\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nsince\\tO\\nthis\\tO\\noriginal\\tO\\nreport\\tO\\non\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nmutated\\tO\\nFGD1\\tO\\ngene\\tO\\nin\\tO\\nan\\tO\\nAAS\\tB-Disease\\npatient\\tO\\n,\\tO\\nno\\tO\\nadditional\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nFGD1\\tO\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\n.\\tO\\n\\nWe\\tO\\nanalysed\\tO\\n13\\tO\\nindependent\\tO\\npatients\\tO\\nwith\\tO\\nclinical\\tO\\ndiagnosis\\tO\\nof\\tO\\nAAS\\tB-Disease\\n.\\tO\\n\\nOne\\tO\\npatient\\tO\\npresented\\tO\\na\\tO\\nmutation\\tO\\nthat\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nnucleotide\\tO\\nchange\\tO\\nin\\tO\\nexon\\tO\\n10\\tO\\nof\\tO\\nthe\\tO\\nFGD1\\tO\\ngene\\tO\\n(\\tO\\nG2559\\tO\\n>\\tO\\nA\\tO\\n)\\tO\\nsubstituting\\tO\\na\\tO\\nGln\\tO\\nfor\\tO\\nArg\\tO\\nin\\tO\\nposition\\tO\\n610\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nsegregate\\tO\\nwith\\tO\\nthe\\tO\\nAAS\\tB-Disease\\nphenotype\\tO\\nin\\tO\\naffected\\tO\\nmales\\tO\\nand\\tO\\ncarrier\\tO\\nfemales\\tO\\nin\\tO\\nthe\\tO\\nfamily\\tO\\nof\\tO\\nthis\\tO\\npatient\\tO\\n.\\tO\\n\\nInterestingly\\tO\\n,\\tO\\nArg\\tO\\n-\\tO\\n610\\tO\\nis\\tO\\nlocated\\tO\\nwithin\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\npleckstrin\\tO\\nhomology\\tO\\n(\\tO\\nPH\\tO\\n)\\tO\\ndomains\\tO\\nof\\tO\\nthe\\tO\\nFGD1\\tO\\ngene\\tO\\nand\\tO\\nit\\tO\\ncorresponds\\tO\\nto\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\nresidue\\tO\\nwhich\\tO\\nhas\\tO\\nbeen\\tO\\ninvolved\\tO\\nin\\tO\\nInsP\\tO\\nbinding\\tO\\nin\\tO\\nPH\\tO\\ndomains\\tO\\nof\\tO\\nother\\tO\\nproteins\\tO\\n.\\tO\\n\\nThe\\tO\\nsame\\tO\\nresidue\\tO\\nis\\tO\\noften\\tO\\nmutated\\tO\\nin\\tO\\nthe\\tO\\nBrutons\\tO\\ntyrosine\\tO\\nkinase\\tO\\n(\\tO\\nBtk\\tO\\n)\\tO\\ngene\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nagammaglobulinemia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nArg610Gln\\tO\\nmutation\\tO\\nrepresents\\tO\\nthe\\tO\\nfirst\\tO\\ncase\\tO\\nof\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nPH\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nFGD1\\tO\\ngene\\tO\\nand\\tO\\nadditional\\tO\\nevidence\\tO\\nthat\\tO\\nmutations\\tO\\nin\\tO\\nPH\\tO\\ndomains\\tO\\ncan\\tO\\nbe\\tO\\nassociated\\tO\\nto\\tO\\nhuman\\tO\\ndiseases\\tO\\n.\\tO\\n.\\tO\\n\\nAmino\\tO\\n-\\tO\\nterminal\\tO\\nfragments\\tO\\nof\\tO\\nmutant\\tO\\nhuntingtin\\tO\\nshow\\tO\\nselective\\tO\\naccumulation\\tO\\nin\\tO\\nstriatal\\tO\\nneurons\\tO\\nand\\tO\\nsynaptic\\tO\\ntoxicity\\tO\\n.\\tO\\n\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nglutamine\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\namino\\tO\\n-\\tO\\nterminal\\tO\\nregion\\tO\\nof\\tO\\nhuntingtin\\tO\\n.\\tO\\n\\nDespite\\tO\\nits\\tO\\nwidespread\\tO\\nexpression\\tO\\n,\\tO\\nmutant\\tO\\nhuntingtin\\tO\\ninduces\\tO\\nselective\\tO\\nneuronal\\tO\\nloss\\tO\\nin\\tO\\nstriatal\\tO\\nneurons\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\n,\\tO\\nin\\tO\\nmutant\\tO\\nmice\\tO\\nexpressing\\tO\\nHD\\tB-Disease\\nrepeats\\tO\\n,\\tO\\nthe\\tO\\nproduction\\tO\\nand\\tO\\naggregation\\tO\\nof\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\nhuntingtin\\tO\\nfragments\\tO\\npreferentially\\tO\\noccur\\tO\\nin\\tO\\nHD\\tB-Disease\\n-\\tO\\naffected\\tO\\nneurons\\tO\\nand\\tO\\ntheir\\tO\\nprocesses\\tO\\nand\\tO\\naxonal\\tO\\nterminals\\tO\\n.\\tO\\n\\nN\\tO\\n-\\tO\\nterminal\\tO\\nfragments\\tO\\nof\\tO\\nmutant\\tO\\nhuntingtin\\tO\\nform\\tO\\naggregates\\tO\\nand\\tO\\ninduce\\tO\\nneuritic\\tB-Disease\\ndegeneration\\tI-Disease\\nin\\tO\\ncultured\\tO\\nstriatal\\tO\\nneurons\\tO\\n.\\tO\\n\\nN\\tO\\n-\\tO\\nterminal\\tO\\nmutant\\tO\\nhuntingtin\\tO\\nalso\\tO\\nbinds\\tO\\nto\\tO\\nsynaptic\\tO\\nvesicles\\tO\\nand\\tO\\ninhibits\\tO\\ntheir\\tO\\nglutamate\\tO\\nuptake\\tO\\nin\\tO\\nvitro\\tO\\n.\\tO\\n\\nThe\\tO\\nspecific\\tO\\nprocessing\\tO\\nand\\tO\\naccumulation\\tO\\nof\\tO\\ntoxic\\tO\\nfragments\\tO\\nof\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\nhuntingtin\\tO\\nin\\tO\\nHD\\tB-Disease\\n-\\tO\\naffected\\tO\\nstriatal\\tO\\nneurons\\tO\\n,\\tO\\nespecially\\tO\\nin\\tO\\ntheir\\tO\\nneuronal\\tO\\nprocesses\\tO\\nand\\tO\\naxonal\\tO\\nterminals\\tO\\n,\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\nthe\\tO\\nselective\\tO\\nneuropathology\\tO\\nof\\tO\\nHD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nhuman\\tO\\nSWI\\tO\\n/\\tO\\nSNF\\tO\\n-\\tO\\nrelated\\tO\\ncomplex\\tO\\n:\\tO\\nlinking\\tO\\nchromatin\\tO\\nremodeling\\tO\\nto\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n,\\tO\\nBRCA1\\tO\\n,\\tO\\npredispose\\tO\\nindividuals\\tO\\nto\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nUsing\\tO\\na\\tO\\ncombination\\tO\\nof\\tO\\naffinity\\tO\\n-\\tO\\nand\\tO\\nconventional\\tO\\nchromatographic\\tO\\ntechniques\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nisolated\\tO\\na\\tO\\npredominant\\tO\\nform\\tO\\nof\\tO\\na\\tO\\nmultiprotein\\tO\\nBRCA1\\tO\\n-\\tO\\ncontaining\\tO\\ncomplex\\tO\\nfrom\\tO\\nhuman\\tO\\ncells\\tO\\ndisplaying\\tO\\nchromatin\\tO\\n-\\tO\\nremodeling\\tO\\nactivity\\tO\\n.\\tO\\n\\nMass\\tO\\nspectrometric\\tO\\nsequencing\\tO\\nof\\tO\\ncomponents\\tO\\nof\\tO\\nthis\\tO\\ncomplex\\tO\\nindicated\\tO\\nthat\\tO\\nBRCA1\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nSWI\\tO\\n/\\tO\\nSNF\\tO\\n-\\tO\\nrelated\\tO\\ncomplex\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nBRCA1\\tO\\ncan\\tO\\ndirectly\\tO\\ninteract\\tO\\nwith\\tO\\nthe\\tO\\nBRG1\\tO\\nsubunit\\tO\\nof\\tO\\nthe\\tO\\nSWI\\tO\\n/\\tO\\nSNF\\tO\\ncomplex\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\np53\\tO\\n-\\tO\\nmediated\\tO\\nstimulation\\tO\\nof\\tO\\ntranscription\\tO\\nby\\tO\\nBRCA1\\tO\\nwas\\tO\\ncompletely\\tO\\nabrogated\\tO\\nby\\tO\\neither\\tO\\na\\tO\\ndominant\\tO\\n-\\tO\\nnegative\\tO\\nmutant\\tO\\nof\\tO\\nBRG1\\tO\\nor\\tO\\nthe\\tO\\ncancer\\tB-Disease\\n-\\tO\\ncausing\\tO\\ndeletion\\tO\\nin\\tO\\nexon\\tO\\n11\\tO\\nof\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nreveal\\tO\\na\\tO\\ndirect\\tO\\nfunction\\tO\\nfor\\tO\\nBRCA1\\tO\\nin\\tO\\ntranscriptional\\tO\\ncontrol\\tO\\nthrough\\tO\\nmodulation\\tO\\nof\\tO\\nchromatin\\tO\\nstructure\\tO\\n.\\tO\\n.\\tO\\n\\nAsef\\tO\\n,\\tO\\na\\tO\\nlink\\tO\\nbetween\\tO\\nthe\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\nAPC\\tO\\nand\\tO\\nG\\tO\\n-\\tO\\nprotein\\tO\\nsignaling\\tO\\n.\\tO\\n\\nThe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\ngene\\tO\\n(\\tO\\nAPC\\tO\\n)\\tO\\nis\\tO\\nmutated\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\nand\\tO\\nin\\tO\\nsporadic\\tO\\ncolorectal\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nHere\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nproduct\\tO\\nis\\tO\\nshown\\tO\\nto\\tO\\nbind\\tO\\nthrough\\tO\\nits\\tO\\narmadillo\\tO\\nrepeat\\tO\\ndomain\\tO\\nto\\tO\\na\\tO\\nRac\\tO\\n-\\tO\\nspecific\\tO\\nguanine\\tO\\nnucleotide\\tO\\nexchange\\tO\\nfactor\\tO\\n(\\tO\\nGEF\\tO\\n)\\tO\\n,\\tO\\ntermed\\tO\\nAsef\\tO\\n.\\tO\\n\\nEndogenous\\tO\\nAPC\\tO\\ncolocalized\\tO\\nwith\\tO\\nAsef\\tO\\nin\\tO\\nmouse\\tO\\ncolon\\tO\\nepithelial\\tO\\ncells\\tO\\nand\\tO\\nneuronal\\tO\\ncells\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nAPC\\tO\\nenhanced\\tO\\nthe\\tO\\nGEF\\tO\\nactivity\\tO\\nof\\tO\\nAsef\\tO\\nand\\tO\\nstimulated\\tO\\nAsef\\tO\\n-\\tO\\nmediated\\tO\\ncell\\tO\\nflattening\\tO\\n,\\tO\\nmembrane\\tO\\nruffling\\tO\\n,\\tO\\nand\\tO\\nlamellipodia\\tO\\nformation\\tO\\nin\\tO\\nMDCK\\tO\\ncells\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nAPC\\tO\\n-\\tO\\nAsef\\tO\\ncomplex\\tO\\nmay\\tO\\nregulate\\tO\\nthe\\tO\\nactin\\tO\\ncytoskeletal\\tO\\nnetwork\\tO\\n,\\tO\\ncell\\tO\\nmorphology\\tO\\nand\\tO\\nmigration\\tO\\n,\\tO\\nand\\tO\\nneuronal\\tO\\nfunction\\tO\\n.\\tO\\n.\\tO\\n\\nFunction\\tO\\nof\\tO\\nan\\tO\\naxonal\\tO\\nchemoattractant\\tO\\nmodulated\\tO\\nby\\tO\\nmetalloprotease\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\naxonal\\tO\\nchemoattractant\\tO\\nnetrin\\tO\\n-\\tO\\n1\\tO\\nguides\\tO\\nspinal\\tO\\ncommissural\\tO\\naxons\\tO\\nby\\tO\\nactivating\\tO\\nits\\tO\\nreceptor\\tO\\nDCC\\tO\\n(\\tO\\nDeleted\\tO\\nin\\tO\\nColorectal\\tB-Disease\\nCancer\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nfound\\tO\\nthat\\tO\\nchemical\\tO\\ninhibitors\\tO\\nof\\tO\\nmetalloproteases\\tO\\npotentiate\\tO\\nnetrin\\tO\\n-\\tO\\nmediated\\tO\\naxon\\tO\\noutgrowth\\tO\\nin\\tO\\nvitro\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nalso\\tO\\nfound\\tO\\nthat\\tO\\nDCC\\tO\\nis\\tO\\na\\tO\\nsubstrate\\tO\\nfor\\tO\\nmetalloprotease\\tO\\n-\\tO\\ndependent\\tO\\nectodomain\\tO\\nshedding\\tO\\n,\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\ninhibitors\\tO\\nblock\\tO\\nproteolytic\\tO\\nprocessing\\tO\\nof\\tO\\nDCC\\tO\\nand\\tO\\ncause\\tO\\nan\\tO\\nincrease\\tO\\nin\\tO\\nDCC\\tO\\nprotein\\tO\\nlevels\\tO\\non\\tO\\naxons\\tO\\nwithin\\tO\\nspinal\\tO\\ncord\\tO\\nexplants\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\npotentiation\\tO\\nof\\tO\\nnetrin\\tO\\nactivity\\tO\\nby\\tO\\ninhibitors\\tO\\nmay\\tO\\nresult\\tO\\nfrom\\tO\\nstabilization\\tO\\nof\\tO\\nDCC\\tO\\non\\tO\\nthe\\tO\\naxons\\tO\\n,\\tO\\nand\\tO\\nproteolytic\\tO\\nactivity\\tO\\nmay\\tO\\nregulate\\tO\\naxon\\tO\\nmigration\\tO\\nby\\tO\\ncontrolling\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\nfunctional\\tO\\nextracellular\\tO\\naxon\\tO\\nguidance\\tO\\nreceptors\\tO\\n.\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nin\\tO\\ntransgenic\\tO\\nmice\\tO\\nexpressing\\tO\\nan\\tO\\nexpanded\\tO\\nCUG\\tO\\nrepeat\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nform\\tO\\nof\\tO\\nmuscular\\tB-Disease\\ndystrophy\\tI-Disease\\nin\\tO\\nadult\\tO\\nhumans\\tO\\n,\\tO\\nresults\\tO\\nfrom\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nCTG\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nDMPK\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nmutant\\tO\\nDMPK\\tO\\nmessenger\\tO\\nRNA\\tO\\n(\\tO\\nmRNA\\tO\\n)\\tO\\ncontains\\tO\\nan\\tO\\nexpanded\\tO\\nCUG\\tO\\nrepeat\\tO\\nand\\tO\\nis\\tO\\nretained\\tO\\nin\\tO\\nthe\\tO\\nnucleus\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexpressed\\tO\\nan\\tO\\nuntranslated\\tO\\nCUG\\tO\\nrepeat\\tO\\nin\\tO\\nan\\tO\\nunrelated\\tO\\nmRNA\\tO\\nin\\tO\\ntransgenic\\tO\\nmice\\tO\\n.\\tO\\n\\nMice\\tO\\nthat\\tO\\nexpressed\\tO\\nexpanded\\tO\\nCUG\\tO\\nrepeats\\tO\\ndeveloped\\tO\\nmyotonia\\tB-Disease\\nand\\tO\\nmyopathy\\tB-Disease\\n,\\tO\\nwhereas\\tO\\nmice\\tO\\nexpressing\\tO\\na\\tO\\nnonexpanded\\tO\\nrepeat\\tO\\ndid\\tO\\nnot\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\ntranscripts\\tO\\nwith\\tO\\nexpanded\\tO\\nCUG\\tO\\nrepeats\\tO\\nare\\tO\\nsufficient\\tO\\nto\\tO\\ngenerate\\tO\\na\\tO\\nDM\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nThis\\tO\\nresult\\tO\\nsupports\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nRNA\\tO\\ngain\\tO\\nof\\tO\\nfunction\\tO\\nin\\tO\\ndisease\\tO\\npathogenesis\\tO\\n.\\tO\\n.\\tO\\n\\nGenomic\\tO\\nrearrangements\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ntumor\\tI-Disease\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tI-Disease\\nAPC\\tI-Disease\\n)\\tI-Disease\\ntumor\\tI-Disease\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\nresult\\tO\\nin\\tO\\nthe\\tO\\nhereditary\\tB-Disease\\ncolorectal\\tI-Disease\\ncancer\\tI-Disease\\nsyndrome\\tI-Disease\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nAlmost\\tO\\nall\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\nthat\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nare\\tO\\nsingle\\tO\\n-\\tO\\nnucleotide\\tO\\nalterations\\tO\\n,\\tO\\nsmall\\tO\\ninsertions\\tO\\n,\\tO\\nor\\tO\\nsmall\\tO\\ndeletions\\tO\\nthat\\tO\\nwould\\tO\\ntruncate\\tO\\nthe\\tO\\nprotein\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nNo\\tO\\nwell\\tO\\n-\\tO\\ncharacterized\\tO\\nintragenic\\tO\\nrearrangement\\tO\\nof\\tO\\nAPC\\tO\\nhas\\tO\\nbeen\\tO\\ndescribed\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nprevalence\\tO\\nof\\tO\\nthis\\tO\\ntype\\tO\\nof\\tO\\nmutation\\tO\\nin\\tO\\nFAP\\tB-Disease\\npatients\\tO\\nis\\tO\\nnot\\tO\\nclear\\tO\\n.\\tO\\n\\nWe\\tO\\nscreened\\tO\\n49\\tO\\npotential\\tO\\nFAP\\tB-Disease\\nfamilies\\tO\\nand\\tO\\nidentified\\tO\\n26\\tO\\ndifferent\\tO\\ngermline\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\nin\\tO\\n30\\tO\\nfamilies\\tO\\n.\\tO\\n\\nFour\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nwere\\tO\\ngenomic\\tO\\nrearrangements\\tO\\nresulting\\tO\\nfrom\\tO\\nhomologous\\tO\\nand\\tO\\nnonhomologous\\tO\\nrecombinations\\tO\\nmediated\\tO\\nby\\tO\\nAlu\\tO\\nelements\\tO\\n.\\tO\\n\\nTwo\\tO\\nof\\tO\\nthese\\tO\\nfour\\tO\\nrearrangements\\tO\\nwere\\tO\\ncomplex\\tO\\n,\\tO\\ninvolving\\tO\\ndeletion\\tO\\nand\\tO\\ninsertion\\tO\\nof\\tO\\nnucleotides\\tO\\n.\\tO\\n\\nOf\\tO\\nthese\\tO\\nfour\\tO\\nrearrangements\\tO\\n,\\tO\\none\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\ndeletion\\tO\\nof\\tO\\nexons\\tO\\n11\\tO\\nand\\tO\\n12\\tO\\nand\\tO\\ntwo\\tO\\nothers\\tO\\nresulted\\tO\\nin\\tO\\neither\\tO\\ncomplete\\tO\\nor\\tO\\npartial\\tO\\ndeletion\\tO\\nof\\tO\\nexon\\tO\\n14\\tO\\n.\\tO\\n\\nThe\\tO\\nfourth\\tO\\nrearrangement\\tO\\ngrossly\\tO\\naltered\\tO\\nthe\\tO\\nsequence\\tO\\nwithin\\tO\\nintron\\tO\\n14\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthis\\tO\\nrearrangement\\tO\\ndid\\tO\\nnot\\tO\\naffect\\tO\\nany\\tO\\ncoding\\tO\\nsequence\\tO\\nof\\tO\\nAPC\\tO\\nat\\tO\\nthe\\tO\\ngenomic\\tO\\nDNA\\tO\\nlevel\\tO\\n,\\tO\\nit\\tO\\ncaused\\tO\\ninappropriate\\tO\\nsplicing\\tO\\nof\\tO\\nexon\\tO\\n14\\tO\\n.\\tO\\n\\nThese\\tO\\nrearrangements\\tO\\nwere\\tO\\ninitially\\tO\\nrevealed\\tO\\nby\\tO\\nanalyzing\\tO\\ncDNAs\\tO\\nand\\tO\\ncould\\tO\\nnot\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nby\\tO\\nusing\\tO\\nmutation\\tO\\ndetection\\tO\\nmethods\\tO\\nthat\\tO\\nscreened\\tO\\neach\\tO\\nexon\\tO\\nindividually\\tO\\n.\\tO\\n\\nThe\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nrearrangement\\tO\\nthat\\tO\\ndid\\tO\\nnot\\tO\\nalter\\tO\\nany\\tO\\ncoding\\tO\\nexons\\tO\\nyet\\tO\\naffected\\tO\\nthe\\tO\\nsplicing\\tO\\nfurther\\tO\\nunderscores\\tO\\nthe\\tO\\nimportance\\tO\\nof\\tO\\nusing\\tO\\ncDNA\\tO\\nfor\\tO\\nmutation\\tO\\nanalysis\\tO\\n.\\tO\\n\\nThe\\tO\\nidentification\\tO\\nof\\tO\\nfour\\tO\\ngenomic\\tO\\nrearrangements\\tO\\namong\\tO\\n30\\tO\\nmutations\\tO\\nsuggests\\tO\\nthat\\tO\\ngenomic\\tO\\nrearrangements\\tO\\nare\\tO\\nfrequent\\tO\\ngermline\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nDetection\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\nmissense\\tO\\nmutation\\tO\\nand\\tO\\nsecond\\tO\\nrecurrent\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nCACNA1A\\tO\\ngene\\tO\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nEA\\tB-Disease\\n-\\tI-Disease\\n2\\tI-Disease\\nand\\tO\\nFHM\\tB-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nbrain\\tO\\nspecific\\tO\\nP\\tO\\n/\\tO\\nQ\\tO\\ntype\\tO\\nCa2\\tO\\n+\\tO\\nchannel\\tO\\nalpha1\\tO\\nsubunit\\tO\\ngene\\tO\\n,\\tO\\nCACNA1A\\tO\\n,\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\nthree\\tO\\nclinically\\tO\\ndistinct\\tO\\ndisorders\\tO\\n,\\tO\\nviz\\tO\\n.\\tO\\nepisodic\\tB-Disease\\nataxia\\tI-Disease\\ntype\\tI-Disease\\n2\\tI-Disease\\n(\\tO\\nEA\\tB-Disease\\n-\\tI-Disease\\n2\\tI-Disease\\n)\\tO\\n,\\tO\\nfamilial\\tB-Disease\\nhemiplegic\\tI-Disease\\nmigraine\\tI-Disease\\n(\\tO\\nFHM\\tB-Disease\\n)\\tO\\nand\\tO\\nspinocerebellar\\tB-Disease\\nataxia\\tI-Disease\\n6\\tI-Disease\\n(\\tO\\nSCA6\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nFor\\tO\\nindividuals\\tO\\nwith\\tO\\nEA\\tB-Disease\\n-\\tI-Disease\\n2\\tI-Disease\\n,\\tO\\nthe\\tO\\nmutations\\tO\\ndescribed\\tO\\nthus\\tO\\nfar\\tO\\nare\\tO\\npresumed\\tO\\nto\\tO\\nresult\\tO\\nin\\tO\\na\\tO\\ntruncated\\tO\\nprotein\\tO\\nproduct\\tO\\n.\\tO\\n\\nSeveral\\tO\\ndifferent\\tO\\nmissense\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nFHM\\tB-Disease\\n.\\tO\\n\\nAt\\tO\\nleast\\tO\\ntwo\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\non\\tO\\ntwo\\tO\\ndifferent\\tO\\nchromosome\\tO\\n19p13\\tO\\nhaplotypes\\tO\\nand\\tO\\nthus\\tO\\nrepresent\\tO\\nrecurrent\\tO\\nmutations\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nscreened\\tO\\nseveral\\tO\\nindividuals\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nall\\tO\\n47\\tO\\nexons\\tO\\nin\\tO\\nthe\\tO\\nCACNA1A\\tO\\ngene\\tO\\nby\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\nanalysis\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ncharacterised\\tO\\na\\tO\\nnovel\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\nG5260A\\tO\\n,\\tO\\nin\\tO\\nexon\\tO\\n32\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nsegregating\\tO\\nfor\\tO\\nEA\\tB-Disease\\n-\\tI-Disease\\n2\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nconsequence\\tO\\nof\\tO\\nthis\\tO\\nmutation\\tO\\nis\\tO\\nan\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\nat\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\nposition\\tO\\nwithin\\tO\\nthe\\tO\\nCACNA1A\\tO\\ngene\\tO\\n.\\tO\\n\\nThis\\tO\\nrepresents\\tO\\nthe\\tO\\nfirst\\tO\\npoint\\tO\\nmutation\\tO\\nnot\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\nproposed\\tO\\ntruncated\\tO\\nprotein\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nthis\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nmember\\tO\\nwith\\tO\\nmild\\tO\\nclinical\\tO\\nsigns\\tO\\nincluding\\tO\\nonly\\tO\\nmigraine\\tB-Disease\\n.\\tO\\n\\nAdditionally\\tO\\n,\\tO\\na\\tO\\nsecond\\tO\\npreviously\\tO\\nidentified\\tO\\nrecurrent\\tO\\nmuta\\tO\\ntion\\tO\\n,\\tO\\nC2272T\\tO\\n,\\tO\\nin\\tO\\nexon\\tO\\n16\\tO\\nhas\\tO\\nbeen\\tO\\ndiscovered\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nFHM\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nAnalbuminemia\\tB-Disease\\nin\\tO\\na\\tO\\nneonate\\tO\\n.\\tO\\n\\nA\\tO\\nsmall\\tO\\n-\\tO\\nfor\\tO\\n-\\tO\\ngestational\\tO\\n-\\tO\\nage\\tO\\ninfant\\tO\\n,\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nanalbuminemia\\tB-Disease\\nin\\tO\\nthe\\tO\\nneonatal\\tO\\nperiod\\tO\\n,\\tO\\nis\\tO\\nreported\\tO\\nand\\tO\\nthe\\tO\\ntwelve\\tO\\ncases\\tO\\nrecorded\\tO\\nin\\tO\\nthe\\tO\\nworld\\tO\\nliterature\\tO\\nare\\tO\\nreviewed\\tO\\n.\\tO\\n\\nPatients\\tO\\nlacking\\tO\\nthis\\tO\\nserum\\tO\\nprotein\\tO\\nare\\tO\\nessentially\\tO\\nasymptomatic\\tO\\n,\\tO\\napart\\tO\\nfrom\\tO\\nminimal\\tO\\nankle\\tB-Disease\\nedema\\tI-Disease\\nand\\tO\\nease\\tB-Disease\\nof\\tI-Disease\\nfatigue\\tI-Disease\\n.\\tO\\n\\nApparent\\tO\\ncompensatory\\tO\\nmechanisms\\tO\\nwhich\\tO\\ncome\\tO\\ninto\\tO\\nplay\\tO\\nwhen\\tO\\nserum\\tO\\nalbumin\\tO\\nis\\tO\\nlow\\tO\\ninclude\\tO\\nprolonged\\tO\\nhalf\\tO\\n-\\tO\\nlife\\tO\\nof\\tO\\nalbumin\\tO\\nand\\tO\\ntransferrin\\tO\\n,\\tO\\nan\\tO\\nincrease\\tO\\nin\\tO\\nserum\\tO\\nglobulins\\tO\\n,\\tO\\nbeta\\tO\\nlipoprotein\\tO\\n,\\tO\\nand\\tO\\nglycoproteins\\tO\\n,\\tO\\narterial\\tB-Disease\\nhypotension\\tI-Disease\\nwith\\tO\\nreduced\\tO\\ncapillary\\tO\\nhydrostatic\\tO\\npressure\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nability\\tO\\nto\\tO\\nrespond\\tO\\nwith\\tO\\nrapid\\tO\\nsodium\\tO\\nand\\tO\\nchloride\\tO\\ndiuresis\\tO\\nin\\tO\\nresponse\\tO\\nto\\tO\\nsmall\\tO\\nvolume\\tO\\nchanges\\tO\\n.\\tO\\n\\nExamination\\tO\\nof\\tO\\nplasma\\tO\\namino\\tO\\nacids\\tO\\n,\\tO\\nan\\tO\\ninvestigation\\tO\\nnot\\tO\\npreviously\\tO\\nreported\\tO\\n,\\tO\\nrevealed\\tO\\nan\\tO\\nextremely\\tO\\nlow\\tO\\nplasma\\tO\\ntryptophan\\tO\\nlevel\\tO\\n,\\tO\\na\\tO\\nfinding\\tO\\nwhich\\tO\\nmay\\tO\\nbe\\tO\\nimportant\\tO\\nin\\tO\\nview\\tO\\nof\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\ntryptophan\\tO\\nin\\tO\\nalbumin\\tO\\nsynthesis\\tO\\n.\\tO\\n.\\tO\\n\\nHistidinemia\\tB-Disease\\n.\\tO\\n\\nClassical\\tO\\nand\\tO\\natypical\\tO\\nform\\tO\\nin\\tO\\nsiblings\\tO\\n.\\tO\\n\\nTwo\\tO\\nbrothers\\tO\\n,\\tO\\n6\\tO\\nand\\tO\\n13\\tO\\nyears\\tO\\nold\\tO\\n,\\tO\\nhad\\tO\\nhistidinemia\\tB-Disease\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nclinical\\tO\\nand\\tO\\nbiochemical\\tO\\nobservations\\tO\\n,\\tO\\nthe\\tO\\nyounger\\tO\\nboy\\tO\\nwas\\tO\\nconsidered\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nclassical\\tO\\ntype\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\nolder\\tO\\nboy\\tO\\nhad\\tO\\nan\\tO\\natypical\\tO\\nform\\tO\\ncharacterized\\tO\\nby\\tO\\npartial\\tO\\nimpairment\\tO\\nof\\tO\\nthe\\tO\\nskin\\tO\\nhistidase\\tO\\nactivity\\tO\\nand\\tO\\na\\tO\\nmoderately\\tO\\nprolonged\\tO\\nhalf\\tO\\n-\\tO\\nlife\\tO\\nof\\tO\\nblood\\tO\\nhistidine\\tO\\n.\\tO\\n\\nThe\\tO\\nmother\\tO\\nis\\tO\\na\\tO\\nheterozygous\\tO\\ncarrier\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\nfather\\tO\\nand\\tO\\nsister\\tO\\nseem\\tO\\nto\\tO\\nbe\\tO\\nnormal\\tO\\n.\\tO\\n.\\tO\\n\\nCarrier\\tO\\ndetection\\tO\\nof\\tO\\npyruvate\\tB-Disease\\ncarboxylase\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nfibroblasts\\tO\\nand\\tO\\nlymphocytes\\tO\\n.\\tO\\n\\nPyruvate\\tO\\ncarboxylase\\tO\\n(\\tO\\nE\\tO\\n.\\tO\\nC\\tO\\n.\\tO\\n6\\tO\\n.\\tO\\n4\\tO\\n.\\tO\\n1\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\nactivity\\tO\\nwas\\tO\\ndetermined\\tO\\nin\\tO\\nthe\\tO\\ncirculating\\tO\\nperipheral\\tO\\nlymphocytes\\tO\\nand\\tO\\ncultured\\tO\\nskin\\tO\\nfibroblasts\\tO\\nfrom\\tO\\nthe\\tO\\nfamily\\tO\\nof\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nhepatic\\tO\\n,\\tO\\ncerebral\\tO\\n,\\tO\\nrenal\\tO\\ncortical\\tO\\n,\\tO\\nleukocyte\\tO\\n,\\tO\\nand\\tO\\nfibroblast\\tO\\npyruvate\\tB-Disease\\ncarboxylase\\tI-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nPC\\tB-Disease\\nPortland\\tI-Disease\\ndeficiency\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nLymphocyte\\tO\\nactivities\\tO\\nwere\\tO\\nmother\\tO\\n,\\tO\\n33\\tO\\n-\\tO\\n-\\tO\\n39\\tO\\n%\\tO\\n;\\tO\\nfather\\tO\\n,\\tO\\n11\\tO\\n-\\tO\\n-\\tO\\n29\\tO\\n%\\tO\\n;\\tO\\nbrother\\tO\\n,\\tO\\n82\\tO\\n-\\tO\\n-\\tO\\n103\\tO\\n%\\tO\\n;\\tO\\nand\\tO\\nsister\\tO\\n,\\tO\\n38\\tO\\n-\\tO\\n-\\tO\\n48\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nlowest\\tO\\nnormal\\tO\\n.\\tO\\n\\nFibroblasts\\tO\\nfrom\\tO\\nthe\\tO\\npatients\\tO\\nmother\\tO\\nand\\tO\\nfather\\tO\\nhad\\tO\\n42\\tO\\nand\\tO\\n34\\tO\\n%\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nof\\tO\\nthe\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nlowest\\tO\\nnormal\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\ndemonstrate\\tO\\nthat\\tO\\nthe\\tO\\ndisease\\tO\\nis\\tO\\ninherited\\tO\\nin\\tO\\nan\\tO\\nautosomal\\tO\\nrecessive\\tO\\nmanner\\tO\\nand\\tO\\nthat\\tO\\nlymphocytes\\tO\\nand\\tO\\nfibroblasts\\tO\\ncan\\tO\\nbe\\tO\\nused\\tO\\nto\\tO\\ndetect\\tO\\ncarriers\\tO\\n.\\tO\\n\\nNeither\\tO\\npyruvate\\tO\\ncarboxylase\\tO\\nnor\\tO\\nmitochondrial\\tO\\nPEPCK\\tO\\nactivity\\tO\\nin\\tO\\nlymphocytes\\tO\\nwas\\tO\\nincreased\\tO\\nby\\tO\\na\\tO\\n21\\tO\\n-\\tO\\nhr\\tO\\nfast\\tO\\n.\\tO\\n\\nGlucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nvariants\\tO\\nfrom\\tO\\nItalian\\tO\\nsubjects\\tO\\nassociated\\tO\\nwith\\tO\\nsevere\\tB-Disease\\nneonatal\\tI-Disease\\njaundice\\tI-Disease\\n.\\tO\\n\\nScreening\\tO\\nfor\\tO\\nthe\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\ncarried\\tO\\nout\\tO\\nat\\tO\\nthe\\tO\\nMaternity\\tO\\nDivision\\tO\\nof\\tO\\nthe\\tO\\nGalliera\\tO\\nHospital\\tO\\nin\\tO\\nGenoa\\tO\\n,\\tO\\nItaly\\tO\\n.\\tO\\n\\nTwo\\tO\\ngroups\\tO\\nof\\tO\\nsubjects\\tO\\nwith\\tO\\nhyperbilirubinaemia\\tB-Disease\\nof\\tO\\nnon\\tO\\n-\\tO\\nimmunological\\tO\\norigin\\tO\\nwere\\tO\\nexamined\\tO\\n(\\tO\\na\\tO\\n)\\tO\\n302\\tO\\nnewborn\\tO\\nbabies\\tO\\nof\\tO\\nSardinian\\tO\\nextraction\\tO\\n(\\tO\\non\\tO\\ncord\\tO\\nblood\\tO\\n)\\tO\\nand\\tO\\n(\\tO\\nb\\tO\\n)\\tO\\n201\\tO\\nnewborn\\tO\\nbabies\\tO\\nof\\tO\\nsouth\\tO\\nItalian\\tO\\nancestry\\tO\\n(\\tO\\non\\tO\\nperipheral\\tO\\nblood\\tO\\n)\\tO\\n.\\tO\\n\\nAmong\\tO\\n503\\tO\\nsubjects\\tO\\n,\\tO\\n43\\tO\\nshowed\\tO\\nan\\tO\\nenzyme\\tO\\ndeficiency\\tO\\n;\\tO\\nin\\tO\\n39\\tO\\nthe\\tO\\ndefect\\tO\\nwas\\tO\\nof\\tO\\nthe\\tO\\nMediterranean\\tO\\ntype\\tO\\n.\\tO\\n\\nIn\\tO\\none\\tO\\ncase\\tO\\n,\\tO\\npreviously\\tO\\ndescribed\\tO\\n,\\tO\\nthe\\tO\\nenzyme\\tO\\nwas\\tO\\nof\\tO\\nthe\\tO\\nA\\tO\\n-\\tO\\ntype\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nremaining\\tO\\ncases\\tO\\nthree\\tO\\ndifferent\\tO\\nvariants\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nwork\\tO\\nthese\\tO\\nthree\\tO\\ncases\\tO\\n,\\tO\\neach\\tO\\nwith\\tO\\nsevere\\tB-Disease\\nneonatal\\tI-Disease\\njaundice\\tI-Disease\\n,\\tO\\nare\\tO\\nreported\\tO\\n.\\tO\\n\\nTheir\\tO\\nparents\\tO\\noriginated\\tO\\nfrom\\tO\\nCalabria\\tO\\n,\\tO\\nfrom\\tO\\nSardinia\\tO\\nand\\tO\\nfrom\\tO\\nSicily\\tO\\n.\\tO\\n\\nThe\\tO\\nabnormal\\tO\\nenzymes\\tO\\nare\\tO\\nrespectively\\tO\\ndesignated\\tO\\nas\\tO\\nGdDcbrousse\\tO\\n-\\tO\\nlike\\tO\\n,\\tO\\nGdGallura\\tO\\nand\\tO\\nGdAgrigento\\tO\\n.\\tO\\n.\\tO\\n\\nCytogenetic\\tO\\ninvestigations\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n.\\tO\\n\\nChromosomal\\tO\\nstudies\\tO\\nwere\\tO\\nperformed\\tO\\non\\tO\\nperipheral\\tO\\nblood\\tO\\nlymphocytes\\tO\\nand\\tO\\ncultured\\tO\\nskin\\tO\\nfibroblasts\\tO\\nfrom\\tO\\nfive\\tO\\nIsraeli\\tO\\n-\\tO\\nMoroccan\\tO\\nfamilies\\tO\\nwith\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n24\\tO\\nindividuals\\tO\\n,\\tO\\nincluding\\tO\\nseven\\tO\\npropositi\\tO\\n,\\tO\\nwas\\tO\\ninvestigated\\tO\\n.\\tO\\n\\nAmong\\tO\\nthe\\tO\\nprobands\\tO\\n,\\tO\\nsignificantly\\tO\\nelevated\\tO\\nrates\\tO\\nof\\tO\\nchromosome\\tO\\ndamage\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nboth\\tO\\nblood\\tO\\nand\\tO\\nskin\\tO\\n.\\tO\\n\\nSkin\\tO\\nfibroblasts\\tO\\nof\\tO\\naffected\\tO\\nindividuals\\tO\\nshowed\\tO\\nseveral\\tO\\norders\\tO\\nof\\tO\\nmagnitude\\tO\\nmore\\tO\\nchromosome\\tO\\nbreakage\\tO\\nthan\\tO\\nlymphocytes\\tO\\n.\\tO\\n\\nIncreased\\tO\\nrates\\tO\\nof\\tO\\nchromosome\\tO\\ndamage\\tO\\nwere\\tO\\nalso\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\nfibroblasts\\tO\\nof\\tO\\nsome\\tO\\nphenotypically\\tO\\nnormal\\tO\\nfamily\\tO\\nmembers\\tO\\n(\\tO\\nobligate\\tO\\nheterozygotes\\tO\\nand\\tO\\nsibs\\tO\\n)\\tO\\nwhen\\tO\\ncompared\\tO\\nto\\tO\\nnormal\\tO\\ncontrols\\tO\\n.\\tO\\n\\nAn\\tO\\napparent\\tO\\nabnormal\\tO\\nclone\\tO\\nof\\tO\\ncells\\tO\\n,\\tO\\npossessing\\tO\\na\\tO\\nlarge\\tO\\nacrocentric\\tO\\nmarker\\tO\\nchromosome\\tO\\n(\\tO\\n14q\\tO\\n+\\tO\\n)\\tO\\n,\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\nvarying\\tO\\nproportions\\tO\\namong\\tO\\ncells\\tO\\nof\\tO\\nall\\tO\\nthe\\tO\\npropositi\\tO\\n(\\tO\\n2\\tO\\n-\\tO\\n5\\tO\\n%\\tO\\nof\\tO\\nlymphocytes\\tO\\n;\\tO\\n1\\tO\\n-\\tO\\n9\\tO\\n%\\tO\\nof\\tO\\nfibroblasts\\tO\\n)\\tO\\n.\\tO\\n.\\tO\\n\\nPrenatal\\tO\\ndiagnosis\\tO\\nof\\tO\\nWolman\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nTwo\\tO\\npregnancies\\tO\\nat\\tO\\nrisk\\tO\\nfor\\tO\\nWolman\\tB-Disease\\ndisease\\tI-Disease\\nwere\\tO\\nmonitored\\tO\\nby\\tO\\nassay\\tO\\nand\\tO\\nelectrophoresis\\tO\\nof\\tO\\nacid\\tO\\nlipase\\tO\\nin\\tO\\ncultured\\tO\\namniotic\\tO\\n-\\tO\\nfluid\\tO\\ncells\\tO\\n.\\tO\\n\\nCells\\tO\\nfrom\\tO\\npatient\\tO\\n1\\tO\\nhad\\tO\\n5\\tO\\n%\\tO\\nof\\tO\\ncontrol\\tO\\nlevels\\tO\\nof\\tO\\nacid\\tO\\nlipase\\tO\\n,\\tO\\nusing\\tO\\n14C\\tO\\n-\\tO\\ntriolein\\tO\\nas\\tO\\nsubstrate\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nwhen\\tO\\nartificial\\tO\\nsubstrates\\tO\\n(\\tO\\nesters\\tO\\nof\\tO\\n4\\tO\\n-\\tO\\nmethylumbelliferone\\tO\\nand\\tO\\np\\tO\\n-\\tO\\nnitrophenol\\tO\\n)\\tO\\nwere\\tO\\nused\\tO\\nto\\tO\\nmeasure\\tO\\nacid\\tO\\nlipase\\tO\\n,\\tO\\nthese\\tO\\ncells\\tO\\nhad\\tO\\n30\\tO\\n%\\tO\\nof\\tO\\ncontrol\\tO\\nlevels\\tO\\n.\\tO\\n\\nElectrophoresis\\tO\\nof\\tO\\ncell\\tO\\nextracts\\tO\\nrevealed\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nthe\\tO\\nA\\tO\\nform\\tO\\nof\\tO\\nacid\\tO\\nlipase\\tO\\n,\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nWolman\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nfetal\\tO\\ntissues\\tO\\nfollowing\\tO\\nprostaglandin\\tO\\ntermination\\tO\\nof\\tO\\nthis\\tO\\npregnancy\\tO\\nconfirmed\\tO\\nthe\\tO\\ndiagnosis\\tO\\n.\\tO\\n\\nAssay\\tO\\nof\\tO\\nfetal\\tO\\n-\\tO\\nskin\\tO\\nfibroblasts\\tO\\nwith\\tO\\n14C\\tO\\n-\\tO\\ntriolein\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nwith\\tO\\nartificial\\tO\\nsubstrates\\tO\\n,\\tO\\nshowed\\tO\\nmarked\\tO\\ndeficiency\\tO\\nof\\tO\\nacid\\tO\\nlipase\\tO\\nactivity\\tO\\n.\\tO\\n\\nElectrophoresis\\tO\\nof\\tO\\nfetal\\tO\\n-\\tO\\ntissue\\tO\\nextracts\\tO\\nalso\\tO\\ndemonstrated\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nthe\\tO\\nA\\tO\\nform\\tO\\nof\\tO\\nacid\\tO\\nlipase\\tO\\n.\\tO\\n\\nAmniotic\\tO\\n-\\tO\\nfluid\\tO\\ncells\\tO\\nfrom\\tO\\npatient\\tO\\n2\\tO\\nshowed\\tO\\nnormal\\tO\\nlevels\\tO\\nof\\tO\\nacid\\tO\\nlipase\\tO\\nwith\\tO\\nall\\tO\\nsubstrates\\tO\\ntested\\tO\\n;\\tO\\nthe\\tO\\nelectrophoretic\\tO\\npattern\\tO\\nof\\tO\\nacid\\tO\\nlipase\\tO\\nwas\\tO\\nnormal\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\nof\\tO\\nWolman\\tB-Disease\\ndisease\\tI-Disease\\nbe\\tO\\nmade\\tO\\nusing\\tO\\nthe\\tO\\nradioassay\\tO\\nof\\tO\\nacid\\tO\\nlipase\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nelectrophoresis\\tO\\n.\\tO\\n.\\tO\\n\\nMalignant\\tB-Disease\\nneoplasms\\tI-Disease\\nin\\tO\\nthe\\tO\\nfamilies\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n.\\tO\\n\\nAtaxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nsyndrome\\tI-Disease\\nassociated\\tO\\nwith\\tO\\na\\tO\\ngreatly\\tO\\nincreased\\tO\\nincidence\\tO\\nof\\tO\\nmalignant\\tB-Disease\\nneoplasms\\tI-Disease\\nin\\tO\\nhomozygous\\tO\\naffected\\tO\\nindividuals\\tO\\n.\\tO\\n\\nHeterozygotes\\tO\\nfor\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nare\\tO\\nthought\\tO\\nto\\tO\\ncomprise\\tO\\nabout\\tO\\n1\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\nand\\tO\\n,\\tO\\ntherefore\\tO\\n,\\tO\\nit\\tO\\nis\\tO\\nimportant\\tO\\nto\\tO\\nknow\\tO\\nwhether\\tO\\nthis\\tO\\ngene\\tO\\nalso\\tO\\npredisposes\\tO\\nthe\\tO\\nheterozygous\\tO\\ncarrier\\tO\\nto\\tO\\ncancers\\tB-Disease\\n.\\tO\\n\\nHeterozygous\\tO\\ncarriers\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\nare\\tO\\ncommon\\tO\\namong\\tO\\nthe\\tO\\nclose\\tO\\nrelatives\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n,\\tO\\nalthough\\tO\\nindividual\\tO\\ncarriers\\tO\\ncannot\\tO\\nbe\\tO\\nidentified\\tO\\nby\\tO\\nany\\tO\\nclinical\\tO\\ncriterion\\tO\\nor\\tO\\nlaboratory\\tO\\ntest\\tO\\n.\\tO\\n\\nFor\\tO\\nthis\\tO\\nreason\\tO\\n,\\tO\\nwe\\tO\\ncompared\\tO\\nthe\\tO\\nincidence\\tO\\nof\\tO\\ndeath\\tO\\nfrom\\tO\\nmalignant\\tB-Disease\\nneoplasms\\tI-Disease\\nin\\tO\\n2\\tO\\nfamilies\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nto\\tO\\nthat\\tO\\nexpected\\tO\\nin\\tO\\na\\tO\\nrandom\\tO\\nsample\\tO\\nof\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\n.\\tO\\n\\nThere\\tO\\nwere\\tO\\n59\\tO\\ndeaths\\tO\\nfrom\\tO\\nmalignant\\tB-Disease\\nneoplasms\\tI-Disease\\nin\\tO\\nrelatives\\tO\\ndying\\tO\\nbefore\\tO\\nage\\tO\\n75\\tO\\n,\\tO\\ncompared\\tO\\nto\\tO\\n42\\tO\\n.\\tO\\n\\n6\\tO\\nexpected\\tO\\n(\\tO\\np\\tO\\nless\\tO\\nthan\\tO\\n0\\tO\\n.\\tO\\n02\\tO\\n)\\tO\\n.\\tO\\n\\nFor\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nheterozygotes\\tO\\nyounger\\tO\\nthan\\tO\\nage\\tO\\n45\\tO\\n,\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\ndying\\tO\\nfrom\\tO\\na\\tO\\nmalignant\\tB-Disease\\nneoplasm\\tI-Disease\\nwas\\tO\\nestimated\\tO\\nto\\tO\\nbe\\tO\\ngreater\\tO\\nthan\\tO\\n5\\tO\\ntimes\\tO\\nthe\\tO\\nrisk\\tO\\nfor\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\n.\\tO\\n\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nheterozygotes\\tO\\nmay\\tO\\ncomprise\\tO\\nmore\\tO\\nthan\\tO\\n5\\tO\\n%\\tO\\nof\\tO\\nall\\tO\\npersons\\tO\\ndying\\tO\\nfrom\\tO\\na\\tO\\ncancer\\tB-Disease\\nbefore\\tO\\nage\\tO\\n45\\tO\\n.\\tO\\n\\nThe\\tO\\nincidence\\tO\\nof\\tO\\novarian\\tB-Disease\\n,\\tI-Disease\\ngastric\\tI-Disease\\n,\\tI-Disease\\nand\\tI-Disease\\nbiliary\\tI-Disease\\nsystem\\tI-Disease\\ncarcinomas\\tI-Disease\\nand\\tO\\nof\\tO\\nleukemia\\tB-Disease\\nand\\tO\\nlymphoma\\tB-Disease\\nwas\\tO\\nincreased\\tO\\nin\\tO\\nthese\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nOther\\tO\\nneoplasms\\tB-Disease\\nthat\\tO\\nmay\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nthis\\tO\\ngene\\tO\\nin\\tO\\nheterozygotes\\tO\\ninclude\\tO\\npancreatic\\tB-Disease\\n,\\tI-Disease\\nbasal\\tI-Disease\\ncell\\tI-Disease\\n,\\tI-Disease\\ncolonic\\tI-Disease\\n,\\tI-Disease\\nbreast\\tI-Disease\\n,\\tI-Disease\\nand\\tI-Disease\\ncervical\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n\\nStriking\\tO\\nprevalence\\tO\\nof\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\nin\\tO\\n\"\\tO\\nhealthy\\tO\\n\"\\tO\\nw27\\tO\\npositive\\tO\\nmales\\tO\\nand\\tO\\nfemales\\tO\\n.\\tO\\n\\nAnkylosing\\tB-Disease\\nspondylitis\\tI-Disease\\nis\\tO\\ndiagnosed\\tO\\nonce\\tO\\nor\\tO\\ntwice\\tO\\nin\\tO\\neach\\tO\\n1000\\tO\\nmales\\tO\\nand\\tO\\none\\tO\\ntenth\\tO\\nas\\tO\\nfrequently\\tO\\nin\\tO\\nfemales\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\ntrue\\tO\\nprevalence\\tO\\nis\\tO\\nunknown\\tO\\n.\\tO\\n\\nIndentification\\tO\\nof\\tO\\ngenetic\\tO\\nmarker\\tO\\n,\\tO\\nHL\\tO\\n-\\tO\\nA\\tO\\nW27\\tO\\n,\\tO\\nfor\\tO\\nsusceptible\\tO\\npersons\\tO\\nhas\\tO\\nprovided\\tO\\na\\tO\\ntool\\tO\\nfacilitating\\tO\\nepidemiologic\\tO\\nstudies\\tO\\nand\\tO\\nallowing\\tO\\nidentification\\tO\\nof\\tO\\n\"\\tO\\ncontrol\\tO\\n\"\\tO\\npopulations\\tO\\nwithout\\tO\\nthe\\tO\\nmarker\\tO\\n.\\tO\\n\\nEvaluation\\tO\\nby\\tO\\npostal\\tO\\nquestionnaires\\tO\\n,\\tO\\nand\\tO\\npelvic\\tO\\nradiography\\tO\\nof\\tO\\n78\\tO\\nHL\\tO\\n-\\tO\\nA\\tO\\n27W\\tO\\n-\\tO\\npositive\\tO\\nblood\\tO\\ndonors\\tO\\nselected\\tO\\nfrom\\tO\\na\\tO\\ngroup\\tO\\nof\\tO\\napparently\\tO\\nhealthy\\tO\\nsubjects\\tO\\nrevealed\\tO\\n14\\tO\\nwho\\tO\\nsatisfied\\tO\\nthe\\tO\\ncriteria\\tO\\nfor\\tO\\ndefinite\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nprevalence\\tO\\nwas\\tO\\nsimilar\\tO\\nin\\tO\\nboth\\tO\\nsexes\\tO\\n.\\tO\\n\\nOne\\tO\\nhundred\\tO\\nand\\tO\\ntwenty\\tO\\n-\\tO\\nsix\\tO\\nW27\\tO\\n-\\tO\\nnegative\\tO\\ncontrols\\tO\\nmatched\\tO\\nfor\\tO\\nrace\\tO\\n,\\tO\\nsex\\tO\\n,\\tO\\nand\\tO\\nage\\tO\\nfailed\\tO\\nto\\tO\\nyield\\tO\\na\\tO\\nsingle\\tO\\ncase\\tO\\n.\\tO\\n\\nFor\\tO\\na\\tO\\nperson\\tO\\nof\\tO\\neither\\tO\\nsex\\tO\\nwith\\tO\\nHL\\tO\\n-\\tO\\nA\\tO\\nW27\\tO\\n,\\tO\\nthere\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\nabout\\tO\\na\\tO\\n20\\tO\\nper\\tO\\ncent\\tO\\nchance\\tO\\nthat\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\nwill\\tO\\ndevelop\\tO\\n,\\tO\\nsuggesting\\tO\\na\\tO\\nprevalence\\tO\\nof\\tO\\n10\\tO\\nto\\tO\\n15\\tO\\nper\\tO\\nthousand\\tO\\n.\\tO\\n\\nHitherto\\tO\\naccepted\\tO\\nfigures\\tO\\nmay\\tO\\nunderestimate\\tO\\nthe\\tO\\nfrequency\\tO\\nby\\tO\\na\\tO\\nfactor\\tO\\nof\\tO\\n10\\tO\\nto\\tO\\n20\\tO\\n.\\tO\\n.\\tO\\n\\nAnalbuminemia\\tB-Disease\\nin\\tO\\nan\\tO\\nAmerican\\tO\\nIndian\\tO\\ngirl\\tO\\n.\\tO\\n\\nAnalbuminemia\\tB-Disease\\nwas\\tO\\nfortuitously\\tO\\ndetected\\tO\\nin\\tO\\na\\tO\\nnonedematous\\tO\\n12\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nAmerican\\tO\\nIndian\\tO\\ngirl\\tO\\nwith\\tO\\natopic\\tB-Disease\\ndermatitis\\tI-Disease\\n,\\tO\\nmild\\tO\\nbronchial\\tB-Disease\\nasthma\\tI-Disease\\n,\\tO\\na\\tO\\nmild\\tO\\nseizure\\tB-Disease\\ndisorder\\tI-Disease\\n,\\tO\\nand\\tO\\nhyperlipoproteinemia\\tB-Disease\\nwith\\tO\\na\\tO\\ncorneal\\tB-Disease\\narcus\\tI-Disease\\n.\\tO\\n\\nImmunologic\\tO\\nmethods\\tO\\nrevealed\\tO\\ntrace\\tO\\namounts\\tO\\n(\\tO\\n17\\tO\\nmg\\tO\\n/\\tO\\n100\\tO\\nml\\tO\\n)\\tO\\nof\\tO\\napparently\\tO\\nnormal\\tO\\nserum\\tO\\nalbumin\\tO\\n.\\tO\\n\\nThe\\tO\\npatients\\tO\\nparents\\tO\\nwere\\tO\\nremotely\\tO\\nrelated\\tO\\n.\\tO\\n\\nThe\\tO\\npedigree\\tO\\nand\\tO\\nclinical\\tO\\nfindings\\tO\\nwere\\tO\\ncompatible\\tO\\nwith\\tO\\nautosomal\\tO\\nrecessive\\tO\\ntransmission\\tO\\nof\\tO\\nanalbuminemia\\tB-Disease\\n.\\tO\\n\\nHeterozygotes\\tO\\nhad\\tO\\nsubnormal\\tO\\nlevels\\tO\\nof\\tO\\nserum\\tO\\nalbumin\\tO\\n.\\tO\\n\\nThe\\tO\\nGc\\tO\\n-\\tO\\nlocus\\tO\\nis\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nstructural\\tO\\nalbumin\\tO\\nlocus\\tO\\n.\\tO\\n\\nGc\\tO\\n-\\tO\\nprotein\\tO\\nlevels\\tO\\nwere\\tO\\nnormal\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\nand\\tO\\ntogether\\tO\\nwith\\tO\\nnormal\\tO\\nchromosomal\\tO\\nbanding\\tO\\nstudies\\tO\\nmake\\tO\\nit\\tO\\nunlikely\\tO\\nthat\\tO\\na\\tO\\nchromosomal\\tO\\ndeletion\\tO\\ncaused\\tO\\nanalbuminemia\\tB-Disease\\n.\\tO\\n\\nGc\\tO\\n-\\tO\\ntypes\\tO\\nin\\tO\\nthe\\tO\\nfamily\\tO\\nwere\\tO\\ncompatible\\tO\\nwith\\tO\\n,\\tO\\nbut\\tO\\ndid\\tO\\nnot\\tO\\nprove\\tO\\n,\\tO\\nlinkage\\tO\\nof\\tO\\nanalbuminemia\\tB-Disease\\nto\\tO\\nthe\\tO\\nGc\\tO\\n-\\tO\\nlocus\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggest\\tO\\na\\tO\\n\"\\tO\\nthalassemia\\tB-Disease\\n\"\\tO\\n-\\tO\\nlike\\tO\\nmutation\\tO\\nfor\\tO\\nthis\\tO\\ndisorder\\tO\\n.\\tO\\n.\\tO\\n\\nDeletion\\tO\\nof\\tO\\nthe\\tO\\nKIT\\tO\\nand\\tO\\nPDGFRA\\tO\\ngenes\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\npiebaldism\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\npreviously\\tO\\nshown\\tO\\nthat\\tO\\nhuman\\tO\\npiebaldism\\tB-Disease\\nresults\\tO\\nfrom\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nKIT\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nencodes\\tO\\nthe\\tO\\nreceptor\\tO\\nfor\\tO\\nthe\\tO\\nmast\\tO\\n/\\tO\\nstem\\tO\\ncell\\tO\\ngrowth\\tO\\nfactor\\tO\\nand\\tO\\nis\\tO\\nlocated\\tO\\nin\\tO\\nchromosome\\tO\\nsegment\\tO\\n4q12\\tO\\n.\\tO\\n\\nUsing\\tO\\nDNA\\tO\\nof\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\npiebaldism\\tB-Disease\\n,\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\nand\\tO\\nmultiple\\tB-Disease\\ncongenital\\tI-Disease\\nanomalies\\tI-Disease\\nassociated\\tO\\nwith\\tO\\na\\tO\\n46\\tO\\n,\\tO\\nXY\\tO\\n,\\tO\\ndel\\tO\\n(\\tO\\n4\\tO\\n)\\tO\\n(\\tO\\nq12q21\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\nkaryotype\\tO\\n,\\tO\\nwe\\tO\\ncarried\\tO\\nout\\tO\\nquantitative\\tO\\nSouthern\\tO\\nblot\\tO\\nhybridization\\tO\\nanalyses\\tO\\nof\\tO\\nthe\\tO\\nKIT\\tO\\ngene\\tO\\nand\\tO\\nthe\\tO\\nadjacent\\tO\\nPDGFRA\\tO\\n(\\tO\\nplatelet\\tO\\n-\\tO\\nderived\\tO\\ngrowth\\tO\\nfactor\\tO\\nreceptor\\tO\\nalpha\\tO\\nsubunit\\tO\\n)\\tO\\ngenes\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\nwas\\tO\\nhemizygous\\tO\\nfor\\tO\\nboth\\tO\\nthe\\tO\\nKIT\\tO\\nand\\tO\\nPDGFRA\\tO\\ngenes\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nboth\\tO\\nof\\tO\\nthese\\tO\\ngenes\\tO\\nare\\tO\\nincluded\\tO\\nwithin\\tO\\nthe\\tO\\ndeleted\\tO\\nregion\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nKIT\\tO\\nand\\tO\\nPDGFRA\\tO\\ngenes\\tO\\nmay\\tO\\naccount\\tO\\nfor\\tO\\nthe\\tO\\npiebald\\tB-Disease\\nphenotype\\tO\\nin\\tO\\nthis\\tO\\npatient\\tO\\n.\\tO\\n\\nA\\tO\\ngerm\\tO\\nline\\tO\\nmutation\\tO\\nwithin\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\nfor\\tO\\nthe\\tO\\nputative\\tO\\n5\\tO\\n-\\tO\\nphosphoribosyl\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\npyrophosphate\\tO\\nbinding\\tO\\nsite\\tO\\nof\\tO\\nhypoxanthine\\tO\\n-\\tO\\nguanine\\tO\\nphosphoribosyltransferase\\tO\\n(\\tO\\nHPRT\\tO\\n)\\tO\\nin\\tO\\na\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\npatient\\tO\\n:\\tO\\nmissense\\tO\\nmutations\\tO\\nwithin\\tO\\na\\tO\\nfunctionally\\tO\\nimportant\\tO\\nregion\\tO\\nprobably\\tO\\ncause\\tO\\ndisease\\tO\\n.\\tO\\n\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ncomplete\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nhypoxanthine\\tI-Disease\\nguanine\\tI-Disease\\nphosphoribosyltransferase\\tI-Disease\\n(\\tO\\nHPRT\\tO\\n)\\tO\\nis\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\na\\tO\\nheterogeneous\\tO\\ngroup\\tO\\nof\\tO\\ngerm\\tO\\nline\\tO\\nmutations\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\neach\\tO\\nmutant\\tO\\ngene\\tO\\nprovides\\tO\\nvaluable\\tO\\ninformation\\tO\\nas\\tO\\nto\\tO\\nthe\\tO\\ntype\\tO\\nof\\tO\\nmutation\\tO\\nthat\\tO\\noccurs\\tO\\nspontaneously\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\na\\tO\\nnewly\\tO\\nidentified\\tO\\nHPRT\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nJapanese\\tO\\npatient\\tO\\nwith\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\ngene\\tO\\n,\\tO\\ndesignated\\tO\\nHPRT\\tO\\nTokyo\\tO\\n,\\tO\\nhad\\tO\\na\\tO\\nsingle\\tO\\nnucleotide\\tO\\nchange\\tO\\nfrom\\tO\\nG\\tO\\nto\\tO\\nA\\tO\\n,\\tO\\nas\\tO\\nidentified\\tO\\nby\\tO\\nsequencing\\tO\\ncDNA\\tO\\namplified\\tO\\nby\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n.\\tO\\n\\nAllele\\tO\\nspecific\\tO\\noligonucleotide\\tO\\nhybridization\\tO\\nanalysis\\tO\\nusing\\tO\\namplified\\tO\\ngenomic\\tO\\nDNA\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nmutant\\tO\\ngene\\tO\\nwas\\tO\\ntransmitted\\tO\\nfrom\\tO\\nthe\\tO\\nmaternal\\tO\\ngerm\\tO\\nline\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nwould\\tO\\nlead\\tO\\nto\\tO\\nan\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\nof\\tO\\nAsp\\tO\\nfor\\tO\\nGly\\tO\\nat\\tO\\nthe\\tO\\namino\\tO\\nacid\\tO\\nposition\\tO\\n140\\tO\\nlocated\\tO\\nwithin\\tO\\nthe\\tO\\nputative\\tO\\n5\\tO\\n-\\tO\\nphosphoribosyl\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\npyrophosphate\\tO\\n(\\tO\\nPRPP\\tO\\n)\\tO\\nbinding\\tO\\nregion\\tO\\n.\\tO\\n\\nMissense\\tO\\nmutations\\tO\\nin\\tO\\nhuman\\tO\\nHPRT\\tB-Disease\\ndeficient\\tI-Disease\\npatients\\tO\\nthus\\tO\\nfar\\tO\\nreported\\tO\\ntend\\tO\\nto\\tO\\naccumulate\\tO\\nin\\tO\\nthis\\tO\\nfunctionally\\tO\\nactive\\tO\\nregion\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\na\\tO\\ncomparison\\tO\\nof\\tO\\nthe\\tO\\ndata\\tO\\nsuggested\\tO\\nthat\\tO\\nboth\\tO\\nmissense\\tO\\nand\\tO\\nsynonymous\\tO\\nmutations\\tO\\ncan\\tO\\noccur\\tO\\nat\\tO\\nany\\tO\\ncoding\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\ngerm\\tO\\nline\\tO\\nHPRT\\tO\\ngene\\tO\\n,\\tO\\nbut\\tO\\nthat\\tO\\na\\tO\\nlimited\\tO\\npercentage\\tO\\nof\\tO\\nall\\tO\\nthe\\tO\\nmissense\\tO\\nmutations\\tO\\ncause\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\nprobability\\tO\\nthat\\tO\\na\\tO\\nmutation\\tO\\nwill\\tO\\ncause\\tO\\ndisease\\tO\\ntends\\tO\\nto\\tO\\nbe\\tO\\nhigher\\tO\\nwhen\\tO\\nthe\\tO\\nmissense\\tO\\nmutation\\tO\\nis\\tO\\nwithin\\tO\\na\\tO\\nfunctionally\\tO\\nimportant\\tO\\nsequence\\tO\\n.\\tO\\n.\\tO\\n\\nCharacterisation\\tO\\nof\\tO\\na\\tO\\nnew\\tO\\nrare\\tO\\nfragile\\tO\\nsite\\tO\\neasily\\tO\\nconfused\\tO\\nwith\\tO\\nthe\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nfragile\\tO\\nsite\\tO\\n(\\tO\\nFRAXE\\tO\\n)\\tO\\nin\\tO\\nXq28\\tO\\nis\\tO\\ndescribed\\tO\\n.\\tO\\n\\nIt\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\ntypical\\tO\\nfolate\\tO\\nsensitive\\tO\\nfragile\\tO\\nsite\\tO\\n.\\tO\\n\\nThe\\tO\\nfragile\\tO\\nsite\\tO\\nis\\tO\\nnot\\tO\\nassociated\\tO\\nwith\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\nit\\tO\\ndoes\\tO\\nnot\\tO\\ngive\\tO\\nabnormal\\tO\\nresults\\tO\\nwhen\\tO\\nsubjected\\tO\\nto\\tO\\nSouthern\\tO\\nanalysis\\tO\\nwith\\tO\\nprobe\\tO\\npfxa3\\tO\\nwhich\\tO\\ndetects\\tO\\nthe\\tO\\nunstable\\tO\\nDNA\\tO\\nsequence\\tO\\ncharacteristic\\tO\\nof\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nsitu\\tO\\nhybridization\\tO\\nmapping\\tO\\nlocates\\tO\\nthe\\tO\\nfragile\\tO\\nsite\\tO\\nbetween\\tO\\n150\\tO\\nkb\\tO\\nand\\tO\\n600\\tO\\nkb\\tO\\ndistal\\tO\\nto\\tO\\nFRAXA\\tO\\n.\\tO\\n\\nThe\\tO\\ndistinction\\tO\\nbetween\\tO\\nthe\\tO\\ntwo\\tO\\nfragile\\tO\\nsites\\tO\\nis\\tO\\nimportant\\tO\\nclinically\\tO\\nsince\\tO\\ncytogenetic\\tO\\ndetection\\tO\\nof\\tO\\nFRAXE\\tO\\n,\\tO\\nwithout\\tO\\nmolecular\\tO\\nanalysis\\tO\\n,\\tO\\ncould\\tO\\nresult\\tO\\nin\\tO\\nmisdiagnosis\\tO\\nof\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\nmaps\\tO\\nto\\tO\\na\\tO\\n150\\tO\\nkb\\tO\\nregion\\tO\\non\\tO\\nchromosome\\tO\\nXp11\\tO\\n.\\tO\\n3\\tO\\n.\\tO\\n\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\nis\\tO\\na\\tO\\nhuman\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\nof\\tO\\nunknown\\tO\\netiology\\tO\\ncharacterized\\tO\\nby\\tO\\ncongenital\\tB-Disease\\nblindness\\tI-Disease\\n,\\tO\\nsensory\\tB-Disease\\nneural\\tI-Disease\\ndeafness\\tI-Disease\\nand\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\ndisease\\tO\\ngene\\tO\\nwas\\tO\\npreviously\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nDXS7\\tO\\n(\\tO\\nL1\\tO\\n.\\tO\\n28\\tO\\n)\\tO\\nlocus\\tO\\nand\\tO\\nthe\\tO\\nMAO\\tO\\ngenes\\tO\\nin\\tO\\nband\\tO\\nXp11\\tO\\n.\\tO\\n\\n3\\tO\\n3\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nfine\\tO\\nphysical\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\nobligate\\tO\\nregion\\tO\\ncontaining\\tO\\nthe\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\n(\\tO\\nNDP\\tO\\n)\\tO\\ndefined\\tO\\nby\\tO\\na\\tO\\nrecombination\\tO\\nand\\tO\\nby\\tO\\nthe\\tO\\nsmallest\\tO\\nsubmicroscopic\\tO\\nchromosomal\\tO\\ndeletion\\tO\\nassociated\\tO\\nwith\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\nidentified\\tO\\nto\\tO\\ndate\\tO\\n.\\tO\\n\\nAnalysis\\tO\\n,\\tO\\nusing\\tO\\nin\\tO\\naddition\\tO\\ntwo\\tO\\noverlapping\\tO\\nYAC\\tO\\nclones\\tO\\nfrom\\tO\\nthis\\tO\\nregion\\tO\\n,\\tO\\nallowed\\tO\\norientation\\tO\\nof\\tO\\nthe\\tO\\nMAOA\\tO\\nand\\tO\\nMAOB\\tO\\ngenes\\tO\\nin\\tO\\na\\tO\\n5\\tO\\n-\\tO\\n3\\tO\\n-\\tO\\n3\\tO\\n-\\tO\\n5\\tO\\nconfiguration\\tO\\n.\\tO\\n\\nA\\tO\\nrecombination\\tO\\nevent\\tO\\nbetween\\tO\\na\\tO\\n(\\tO\\nGT\\tO\\n)\\tO\\nn\\tO\\npolymorphism\\tO\\nin\\tO\\nintron\\tO\\n2\\tO\\nof\\tO\\nthe\\tO\\nMAOB\\tO\\ngene\\tO\\nand\\tO\\nthe\\tO\\nNDP\\tO\\nlocus\\tO\\n,\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\npreviously\\tO\\nreported\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nrecombination\\tO\\nbetween\\tO\\nDXS7\\tO\\nand\\tO\\nNDP\\tO\\n,\\tO\\ndelineates\\tO\\na\\tO\\nflanking\\tO\\nmarker\\tO\\ntelomeric\\tO\\nto\\tO\\nthis\\tO\\ndisease\\tO\\ngene\\tO\\n.\\tO\\n\\nAn\\tO\\nanonymous\\tO\\nDNA\\tO\\nprobe\\tO\\n,\\tO\\ndc12\\tO\\n,\\tO\\npresent\\tO\\nin\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nYACs\\tO\\nand\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\na\\tO\\nsubmicroscopic\\tO\\ndeletion\\tO\\nwhich\\tO\\nincludes\\tO\\nMAOA\\tO\\nand\\tO\\nMAOB\\tO\\nbut\\tO\\nnot\\tO\\nL1\\tO\\n.\\tO\\n\\n28\\tO\\n,\\tO\\nserves\\tO\\nas\\tO\\na\\tO\\nflanking\\tO\\nmarker\\tO\\ncentromeric\\tO\\nto\\tO\\nthe\\tO\\ndisease\\tO\\ngene\\tO\\n.\\tO\\n\\nAn\\tO\\nAlu\\tO\\n-\\tO\\nPCR\\tO\\nfragment\\tO\\nfrom\\tO\\nthe\\tO\\nright\\tO\\narm\\tO\\nof\\tO\\nthe\\tO\\nMAO\\tO\\nYAC\\tO\\n(\\tO\\nYMAO\\tO\\n.\\tO\\nAluR\\tO\\n)\\tO\\nis\\tO\\nnot\\tO\\ndeleted\\tO\\nin\\tO\\nthis\\tO\\npatient\\tO\\nand\\tO\\nalso\\tO\\ndelineates\\tO\\nthe\\tO\\ncentromeric\\tO\\nextent\\tO\\nof\\tO\\nthe\\tO\\nobligate\\tO\\ndisease\\tO\\nregion\\tO\\n.\\tO\\n\\nThe\\tO\\napparent\\tO\\norder\\tO\\nof\\tO\\nthese\\tO\\nloci\\tO\\nis\\tO\\ntelomere\\tO\\n.\\tO\\n\\nDXS7\\tO\\n-\\tO\\nMAOA\\tO\\n-\\tO\\nMAOB\\tO\\n-\\tO\\nNDP\\tO\\n-\\tO\\ndc12\\tO\\n-\\tO\\nYMAO\\tO\\nDXS7\\tO\\n-\\tO\\nMAOA\\tO\\n-\\tO\\nMAOB\\tO\\n-\\tO\\nNDP\\tO\\n-\\tO\\ndc12\\tO\\n-\\tO\\nYMAO\\tO\\n.\\tO\\n\\nAluR\\tO\\n.\\tO\\ncentromere\\tO\\n.\\tO\\n\\nTogether\\tO\\nthese\\tO\\ndata\\tO\\ndefine\\tO\\nthe\\tO\\nobligate\\tO\\nregion\\tO\\ncontaining\\tO\\nthe\\tO\\nNDP\\tO\\ngene\\tO\\nto\\tO\\na\\tO\\nchromosomal\\tO\\nsegment\\tO\\nless\\tO\\nthan\\tO\\n150\\tO\\nkb\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbasis\\tO\\nof\\tO\\nphenylketonuria\\tB-Disease\\nand\\tO\\nrelated\\tO\\nhyperphenylalaninemias\\tB-Disease\\n:\\tO\\nmutations\\tO\\nand\\tO\\npolymorphisms\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\ngene\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\ngene\\tO\\nproducing\\tO\\nphenylketonuria\\tB-Disease\\nor\\tO\\nhyperphenylalaninemia\\tB-Disease\\nhave\\tO\\nnow\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\nmany\\tO\\npatients\\tO\\nfrom\\tO\\nvarious\\tO\\nethnic\\tO\\ngroups\\tO\\n.\\tO\\n\\nThese\\tO\\nmutations\\tO\\nall\\tO\\nexhibit\\tO\\na\\tO\\nhigh\\tO\\ndegree\\tO\\nof\\tO\\nassociation\\tO\\nwith\\tO\\nspecific\\tO\\nrestriction\\tO\\nfragment\\tO\\n-\\tO\\nlength\\tO\\npolymorphism\\tO\\nhaplotypes\\tO\\nat\\tO\\nthe\\tO\\nPAH\\tO\\nlocus\\tO\\n.\\tO\\n\\nAbout\\tO\\n50\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nare\\tO\\nsingle\\tO\\n-\\tO\\nbase\\tO\\nsubstitutions\\tO\\n,\\tO\\nincluding\\tO\\nsix\\tO\\nnonsense\\tO\\nmutations\\tO\\nand\\tO\\neight\\tO\\nsplicing\\tO\\nmutations\\tO\\n,\\tO\\nwith\\tO\\nthe\\tO\\nremainder\\tO\\nbeing\\tO\\nmissense\\tO\\nmutations\\tO\\n.\\tO\\n\\nOne\\tO\\nsplicing\\tO\\nmutation\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\n3\\tO\\namino\\tO\\nacid\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ninsertion\\tO\\n.\\tO\\n\\nTwo\\tO\\nor\\tO\\n3\\tO\\nlarge\\tO\\ndeletions\\tO\\n,\\tO\\n2\\tO\\nsingle\\tO\\ncodon\\tO\\ndeletions\\tO\\n,\\tO\\nand\\tO\\n2\\tO\\nsingle\\tO\\nbase\\tO\\ndeletions\\tO\\nhave\\tO\\nbeen\\tO\\nfound\\tO\\n.\\tO\\n\\nTwelve\\tO\\nof\\tO\\nthe\\tO\\nmissense\\tO\\nmutations\\tO\\napparently\\tO\\nresult\\tO\\nfrom\\tO\\nthe\\tO\\nmethylation\\tO\\nand\\tO\\nsubsequent\\tO\\ndeamination\\tO\\nof\\tO\\nhighly\\tO\\nmutagenic\\tO\\nCpG\\tO\\ndinucleotides\\tO\\n.\\tO\\n\\nRecurrent\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\nobserved\\tO\\nat\\tO\\nseveral\\tO\\nof\\tO\\nthese\\tO\\nsites\\tO\\n,\\tO\\nproducing\\tO\\nassociations\\tO\\nwith\\tO\\ndifferent\\tO\\nhaplotypes\\tO\\nin\\tO\\ndifferent\\tO\\npopulations\\tO\\n.\\tO\\n\\nAbout\\tO\\nhalf\\tO\\nof\\tO\\nall\\tO\\nmissense\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nexamined\\tO\\nby\\tO\\nin\\tO\\nvitro\\tO\\nexpression\\tO\\nanalysis\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nsignificant\\tO\\ncorrelation\\tO\\nhas\\tO\\nbeen\\tO\\nobserved\\tO\\nbetween\\tO\\nresidual\\tO\\nPAH\\tO\\nactivity\\tO\\nand\\tO\\ndisease\\tO\\nphenotype\\tO\\n.\\tO\\n\\nSince\\tO\\ncontinuing\\tO\\nadvances\\tO\\nin\\tO\\nmolecular\\tO\\nmethodologies\\tO\\nhave\\tO\\ndramatically\\tO\\naccelerated\\tO\\nthe\\tO\\nrate\\tO\\nin\\tO\\nwhich\\tO\\nnew\\tO\\nmutations\\tO\\nare\\tO\\nbeing\\tO\\nidentified\\tO\\nand\\tO\\ncharacterized\\tO\\n,\\tO\\nthis\\tO\\nregister\\tO\\nof\\tO\\nmutations\\tO\\nwill\\tO\\nbe\\tO\\nupdated\\tO\\nperiodically\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nglycine250\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\naspartate\\tO\\nsubstitution\\tO\\nin\\tO\\nthe\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nof\\tO\\nhexosaminidase\\tO\\nA\\tO\\ncauses\\tO\\njuvenile\\tO\\n-\\tO\\nonset\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nin\\tO\\na\\tO\\nLebanese\\tO\\n-\\tO\\nCanadian\\tO\\nfamily\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\ncausing\\tO\\njuvenile\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\nin\\tO\\ntwo\\tO\\nsibs\\tO\\nof\\tO\\nLebanese\\tO\\n-\\tO\\nMaronite\\tO\\norigin\\tO\\nis\\tO\\ndescribed\\tO\\n.\\tO\\n\\nAn\\tO\\nmRNA\\tO\\n-\\tO\\ncontaining\\tO\\nextract\\tO\\nof\\tO\\ncultured\\tO\\nfibroblasts\\tO\\nobtained\\tO\\nfrom\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nprobands\\tO\\nwas\\tO\\nused\\tO\\nas\\tO\\na\\tO\\ntemplate\\tO\\nto\\tO\\namplify\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\nhexosaminidase\\tO\\nA\\tO\\n(\\tO\\nHex\\tO\\nA\\tO\\n)\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\n.\\tO\\n\\nSequencing\\tO\\nof\\tO\\namplified\\tO\\ncDNA\\tO\\nfragments\\tO\\nrevealed\\tO\\na\\tO\\nsingle\\tO\\nalteration\\tO\\n,\\tO\\nguanine\\tO\\nto\\tO\\nadenine\\tO\\nat\\tO\\nnt\\tO\\n749\\tO\\ncreating\\tO\\na\\tO\\nG250D\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nintroduces\\tO\\na\\tO\\nnew\\tO\\nrecognition\\tO\\nsite\\tO\\nfor\\tO\\nthe\\tO\\nrestriction\\tO\\nenzyme\\tO\\nEco\\tO\\nRV\\tO\\n,\\tO\\npermitting\\tO\\nidentification\\tO\\nof\\tO\\nheterozygotes\\tO\\nfor\\tO\\nthis\\tO\\nallele\\tO\\nfollowing\\tO\\nPCR\\tO\\namplification\\tO\\nand\\tO\\nEco\\tO\\nRV\\tO\\ndigestion\\tO\\nof\\tO\\nexon\\tO\\n7\\tO\\nsequences\\tO\\nfrom\\tO\\ngenomic\\tO\\nDNA\\tO\\ntemplates\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\ntest\\tO\\nthe\\tO\\neffect\\tO\\nof\\tO\\nthis\\tO\\nsubstitution\\tO\\n,\\tO\\nan\\tO\\nin\\tO\\nvitro\\tO\\nmutagenized\\tO\\ncDNA\\tO\\nconstruct\\tO\\nwas\\tO\\nintroduced\\tO\\ninto\\tO\\na\\tO\\nmammalian\\tO\\nexpression\\tO\\nvector\\tO\\nand\\tO\\ntransfected\\tO\\ninto\\tO\\nmonkey\\tO\\nCos\\tO\\n-\\tO\\n1\\tO\\ncells\\tO\\nseparately\\tO\\nor\\tO\\nalong\\tO\\nwith\\tO\\na\\tO\\nbeta\\tO\\n-\\tO\\ncDNA\\tO\\nexpression\\tO\\nvector\\tO\\n.\\tO\\n\\nWhen\\tO\\nthe\\tO\\nmutant\\tO\\nalpha\\tO\\n-\\tO\\ncDNA\\tO\\nwas\\tO\\nthe\\tO\\nonly\\tO\\ngene\\tO\\nintroduced\\tO\\ninto\\tO\\nCOS\\tO\\ncells\\tO\\nno\\tO\\nenzymatic\\tO\\nactivity\\tO\\nabove\\tO\\nendogenous\\tO\\nCOS\\tO\\ncell\\tO\\nactivity\\tO\\nwas\\tO\\ndetected\\tO\\n.\\tO\\n\\nCotransfection\\tO\\nof\\tO\\nnormal\\tO\\nalpha\\tO\\n-\\tO\\ncDNA\\tO\\nand\\tO\\nbeta\\tO\\n-\\tO\\ncDNA\\tO\\nfollowed\\tO\\nby\\tO\\nimmunoprecipitation\\tO\\nof\\tO\\nhuman\\tO\\nHex\\tO\\nA\\tO\\nresulted\\tO\\nin\\tO\\n20\\tO\\n-\\tO\\nfold\\tO\\nincrease\\tO\\nin\\tO\\nthe\\tO\\nratio\\tO\\nbetween\\tO\\npositive\\tO\\nand\\tO\\nnegative\\tO\\n(\\tO\\nmock\\tO\\ntransfection\\tO\\n)\\tO\\ncontrol\\tO\\nvalues\\tO\\n.\\tO\\n\\nThis\\tO\\nallowed\\tO\\nthe\\tO\\ndetection\\tO\\nof\\tO\\nsome\\tO\\nresidual\\tO\\nactivity\\tO\\n(\\tO\\n12\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\npositive\\tO\\ncontrol\\tO\\n)\\tO\\nwhen\\tO\\nthe\\tO\\nmutant\\tO\\nalpha\\tO\\n-\\tO\\ncDNA\\tO\\nreplaced\\tO\\nits\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\ncounterpart\\tO\\n.\\tO\\n\\nThe\\tO\\npredicted\\tO\\nprotein\\tO\\nenvironment\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nmutation\\tO\\noccurs\\tO\\nis\\tO\\ncompared\\tO\\nto\\tO\\nthat\\tO\\nof\\tO\\nthe\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nmutation\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\nGly269\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nSer\\tO\\nsubstitution\\tO\\nin\\tO\\nexon\\tO\\n7\\tO\\n.\\tO\\n\\n(\\tO\\nABSTRACT\\tO\\nTRUNCATED\\tO\\nAT\\tO\\n250\\tO\\nWORDS\\tO\\n)\\tO\\n.\\tO\\n\\nNovel\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nmutations\\tO\\nfrom\\tO\\nChina\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nthree\\tO\\nHEXA\\tO\\nmutations\\tO\\nassociated\\tO\\nwith\\tO\\ninfantile\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\nin\\tO\\nthree\\tO\\nunrelated\\tO\\nnonconsanguineous\\tO\\nChinese\\tO\\nfamilies\\tO\\n.\\tO\\n\\nNovel\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\ntwo\\tO\\nof\\tO\\nthese\\tO\\nfamilies\\tO\\n.\\tO\\n\\nThe\\tO\\nthird\\tO\\nis\\tO\\na\\tO\\npreviously\\tO\\nreported\\tO\\nmutation\\tO\\n(\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nnt\\tO\\n1444\\tO\\n)\\tO\\n(\\tO\\nNakano\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1988\\tO\\n)\\tO\\n.\\tO\\n\\nDirect\\tO\\nsequencing\\tO\\nof\\tO\\nPCR\\tO\\nproducts\\tO\\nidentified\\tO\\na\\tO\\nnovel\\tO\\ninsertion\\tO\\nof\\tO\\nan\\tO\\nA\\tO\\nafter\\tO\\nnt\\tO\\n547\\tO\\nin\\tO\\nfamily\\tO\\n1\\tO\\n.\\tO\\n\\nThis\\tO\\nchange\\tO\\ngenerates\\tO\\nan\\tO\\nearly\\tO\\ntermination\\tO\\ncodon\\tO\\n6\\tO\\nbp\\tO\\ndownstream\\tO\\nfrom\\tO\\nthe\\tO\\ninsertion\\tO\\nsite\\tO\\n.\\tO\\n\\nAllele\\tO\\n-\\tO\\nspecific\\tO\\noligonucleotide\\tO\\nhybridization\\tO\\nconfirmed\\tO\\nhomozygosity\\tO\\nin\\tO\\nthe\\tO\\nproband\\tO\\n.\\tO\\n\\nSingle\\tO\\nstrand\\tO\\nconformational\\tO\\npolymorphism\\tO\\nanalysis\\tO\\nand\\tO\\ndirect\\tO\\nsequencing\\tO\\nof\\tO\\namplified\\tO\\nexon\\tO\\n13\\tO\\nrevealed\\tO\\na\\tO\\nT\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\ntransition\\tO\\nat\\tO\\nnt\\tO\\n1453\\tO\\nwith\\tO\\nthe\\tO\\ncorresponding\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\nW485R\\tO\\nin\\tO\\nthe\\tO\\nsecond\\tO\\nfamily\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\ncreates\\tO\\nan\\tO\\nFnu4HI\\tO\\nrestriction\\tO\\nsite\\tO\\n.\\tO\\n\\nThe\\tO\\nproband\\tO\\nis\\tO\\nhomozygous\\tO\\nfor\\tO\\nthis\\tO\\nallele\\tO\\n.\\tO\\n\\nWhen\\tO\\nthe\\tO\\nsite\\tO\\n-\\tO\\nspecific\\tO\\nmutagenized\\tO\\nalpha\\tO\\ncDNA\\tO\\ncarrying\\tO\\nthe\\tO\\nT\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\ntransition\\tO\\nat\\tO\\nnt\\tO\\n1453\\tO\\nwas\\tO\\nexpressed\\tO\\nin\\tO\\nCOS\\tO\\n1\\tO\\ncells\\tO\\nhexosaminidase\\tO\\nS\\tO\\nactivity\\tO\\nwas\\tO\\nnot\\tO\\ndetectable\\tO\\nabove\\tO\\nbackground\\tO\\n.\\tO\\n\\nA\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nnt\\tO\\n1444\\tO\\n(\\tO\\nexon\\tO\\n13\\tO\\n)\\tO\\ncorresponding\\tO\\nto\\tO\\nthe\\tO\\nE482K\\tO\\nsubstitution\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nthird\\tO\\nfamily\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\noccurs\\tO\\nat\\tO\\na\\tO\\nCpG\\tO\\ndinucleotide\\tO\\n.\\tO\\n\\nIt\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\nan\\tO\\nItalian\\tO\\nTSD\\tB-Disease\\nproband\\tO\\nand\\tO\\ncauses\\tO\\ndefective\\tO\\nintracellular\\tO\\ntransport\\tO\\nof\\tO\\nthe\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nfrom\\tO\\nthe\\tO\\nrough\\tO\\nendoplasmic\\tO\\nreticulum\\tO\\nto\\tO\\nthe\\tO\\nGolgi\\tO\\napparatus\\tO\\n.\\tO\\n\\nTwo\\tO\\nmissense\\tO\\nmutations\\tO\\ncausing\\tO\\nmild\\tO\\nhyperphenylalaninemia\\tB-Disease\\nassociated\\tO\\nwith\\tO\\nDNA\\tO\\nhaplotype\\tO\\n12\\tO\\n.\\tO\\n\\nThe\\tO\\ngenetic\\tB-Disease\\ndefects\\tI-Disease\\nresponsible\\tO\\nfor\\tO\\nmost\\tO\\nphenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nand\\tO\\nhyperphenylalaninemia\\tB-Disease\\n(\\tO\\nHPA\\tB-Disease\\n)\\tO\\ncases\\tO\\nare\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n(\\tO\\nPAH\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nApproximately\\tO\\n50\\tO\\n-\\tO\\n60\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\nCaucasians\\tO\\nand\\tO\\nare\\tO\\nreflected\\tO\\nin\\tO\\na\\tO\\nwide\\tO\\nrange\\tO\\nof\\tO\\nclinical\\tO\\nseverities\\tO\\n.\\tO\\n\\nMost\\tO\\nmutations\\tO\\nare\\tO\\nlinked\\tO\\nto\\tO\\nspecific\\tO\\nhaplotypes\\tO\\n,\\tO\\nas\\tO\\ndefined\\tO\\nby\\tO\\neight\\tO\\npolymorphic\\tO\\nrestriction\\tO\\nsites\\tO\\nin\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nhypothesized\\tO\\nthat\\tO\\nthere\\tO\\nis\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\nmild\\tO\\nmutation\\tO\\nlinked\\tO\\nto\\tO\\nhaplotype\\tO\\n12\\tO\\nin\\tO\\nthe\\tO\\nSwedish\\tO\\nPKU\\tB-Disease\\n/\\tO\\nHPA\\tB-Disease\\npopulation\\tO\\n,\\tO\\nsince\\tO\\n7\\tO\\nof\\tO\\n8\\tO\\npatients\\tO\\ncarrying\\tO\\nhaplotype\\tO\\n12\\tO\\nhad\\tO\\nmild\\tO\\nHPA\\tB-Disease\\n.\\tO\\n\\nSequence\\tO\\nanalysis\\tO\\nrevealed\\tO\\na\\tO\\nC\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nG\\tO\\ntransversion\\tO\\nat\\tO\\nthe\\tO\\nsecond\\tO\\nbase\\tO\\nof\\tO\\ncodon\\tO\\n322\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\nsubstitution\\tO\\nof\\tO\\nglycine\\tO\\nfor\\tO\\nalanine\\tO\\n,\\tO\\nin\\tO\\nfour\\tO\\nmutant\\tO\\nhaplotype\\tO\\n12\\tO\\ngenes\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nG\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nthe\\tO\\nsecond\\tO\\nbase\\tO\\nof\\tO\\ncodon\\tO\\n408\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\nsubstitution\\tO\\nof\\tO\\nglutamine\\tO\\nfor\\tO\\narginine\\tO\\n,\\tO\\nin\\tO\\nanother\\tO\\nthree\\tO\\nmutant\\tO\\nhaplotype\\tO\\n12\\tO\\ngenes\\tO\\n.\\tO\\n\\nThese\\tO\\nmutations\\tO\\nsegregated\\tO\\nwith\\tO\\nmutant\\tO\\nhaplotype\\tO\\n12\\tO\\nalleles\\tO\\nin\\tO\\nnuclear\\tO\\nfamilies\\tO\\nbut\\tO\\nwere\\tO\\nnot\\tO\\npresent\\tO\\non\\tO\\nnormal\\tO\\nor\\tO\\nother\\tO\\nmutant\\tO\\nalleles\\tO\\n.\\tO\\n\\nBoth\\tO\\nmutations\\tO\\nwere\\tO\\ntested\\tO\\nin\\tO\\na\\tO\\neukaryotic\\tO\\nexpression\\tO\\nsystem\\tO\\nin\\tO\\nwhich\\tO\\nenzyme\\tO\\nactivities\\tO\\nof\\tO\\ndifferent\\tO\\nmutant\\tO\\nPAH\\tO\\nenzymes\\tO\\nreflect\\tO\\nthe\\tO\\nrelative\\tO\\nseverities\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\n,\\tO\\nalthough\\tO\\nthese\\tO\\nin\\tO\\nvitro\\tO\\nactivities\\tO\\ncannot\\tO\\nbe\\tO\\ntranslated\\tO\\ndirectly\\tO\\ninto\\tO\\nin\\tO\\nvivo\\tO\\nhepatic\\tO\\nactivities\\tO\\n.\\tO\\n\\nThe\\tO\\nA322G\\tO\\nmutant\\tO\\nPAH\\tO\\nhad\\tO\\nabout\\tO\\n75\\tO\\n%\\tO\\nand\\tO\\nthe\\tO\\nR408Q\\tO\\nmutant\\tO\\nPAH\\tO\\nabout\\tO\\n55\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nPAH\\tO\\nenzyme\\tO\\nactivity\\tO\\n.\\tO\\n\\nThese\\tO\\nin\\tO\\nvitro\\tO\\nactivities\\tO\\nare\\tO\\nthe\\tO\\nhighest\\tO\\nreported\\tO\\nfor\\tO\\nmutant\\tO\\nPAH\\tO\\nenzymes\\tO\\nproduced\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\nexpression\\tO\\nsystem\\tO\\n.\\tO\\n\\n(\\tO\\nABSTRACT\\tO\\nTRUNCATED\\tO\\nAT\\tO\\n250\\tO\\nWORDS\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nvitro\\tO\\nand\\tO\\nin\\tO\\nvivo\\tO\\ncorrelations\\tO\\nfor\\tO\\nI65T\\tO\\nand\\tO\\nM1V\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\nlocus\\tO\\n.\\tO\\n\\nMutations\\tO\\nat\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n(\\tO\\nPAH\\tO\\n)\\tO\\nlocus\\tO\\nare\\tO\\nthe\\tO\\nmajor\\tO\\ncause\\tO\\nof\\tO\\nhyperphenylalaninemia\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\npreviously\\tO\\ndescribed\\tO\\nfour\\tO\\nmutations\\tO\\n(\\tO\\nM1V\\tO\\n,\\tO\\nIVS12nt1\\tO\\n,\\tO\\nR408W\\tO\\n,\\tO\\nand\\tO\\nS349P\\tO\\n)\\tO\\nat\\tO\\nthe\\tO\\nPAH\\tO\\nlocus\\tO\\nin\\tO\\nFrench\\tO\\nCanadians\\tO\\nwith\\tO\\nancestry\\tO\\nin\\tO\\neastern\\tO\\nQuebec\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nidentification\\tO\\nof\\tO\\nanother\\tO\\nmutation\\tO\\n,\\tO\\non\\tO\\na\\tO\\nhaplotype\\tO\\n9\\tO\\nchromosome\\tO\\n,\\tO\\nwhich\\tO\\nconverts\\tO\\ncodon\\tO\\n65\\tO\\nfrom\\tO\\nisoleucine\\tO\\n(\\tO\\nATT\\tO\\n)\\tO\\nto\\tO\\nthreonine\\tO\\n(\\tO\\nACT\\tO\\n)\\tO\\n,\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nexpression\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nI65T\\tO\\nmutation\\tO\\nin\\tO\\nCOS\\tO\\ncells\\tO\\ndemonstrating\\tO\\n75\\tO\\n%\\tO\\nloss\\tO\\nof\\tO\\nboth\\tO\\nimmunoreactive\\tO\\nprotein\\tO\\nand\\tO\\nenzyme\\tO\\nactivity\\tO\\n,\\tO\\nand\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\nexpression\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nmost\\tO\\nprevalent\\tO\\nPKU\\tB-Disease\\nallele\\tO\\n(\\tO\\nM1V\\tO\\n)\\tO\\nin\\tO\\neastern\\tO\\nQuebec\\tO\\n,\\tO\\nshowing\\tO\\nnondetectable\\tO\\nlevels\\tO\\nof\\tO\\nPAH\\tO\\nprotein\\tO\\nand\\tO\\nactivity\\tO\\n,\\tO\\na\\tO\\nfinding\\tO\\ncompatible\\tO\\nwith\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ntranslation\\tO\\ninitiation\\tO\\ncodon\\tO\\n.\\tO\\n\\nHomozygosity\\tO\\nfor\\tO\\nM1V\\tO\\nand\\tO\\ncodominant\\tO\\ninheritance\\tO\\nof\\tO\\nI65T\\tO\\n/\\tO\\nR408W\\tO\\nwere\\tO\\nboth\\tO\\nassociated\\tO\\nwith\\tO\\nclassical\\tB-Disease\\nphenylketonuria\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbasis\\tO\\nof\\tO\\nhexosaminidase\\tB-Disease\\nA\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\npseudodeficiency\\tO\\nin\\tO\\nthe\\tO\\nBerks\\tO\\nCounty\\tO\\nPennsylvania\\tO\\nDutch\\tO\\n.\\tO\\n\\nFollowing\\tO\\nthe\\tO\\nbirth\\tO\\nof\\tO\\ntwo\\tO\\ninfants\\tO\\nwith\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\n,\\tO\\nPennsylvania\\tO\\nDutch\\tO\\nkindred\\tO\\nwas\\tO\\nscreened\\tO\\nfor\\tO\\nTSD\\tB-Disease\\ncarriers\\tO\\nusing\\tO\\nthe\\tO\\nbiochemical\\tO\\nassay\\tO\\n.\\tO\\n\\nA\\tO\\nhigh\\tO\\nfrequency\\tO\\nof\\tO\\nindividuals\\tO\\nwho\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\nTSD\\tB-Disease\\nheterozygotes\\tO\\nwas\\tO\\ndetected\\tO\\n(\\tO\\nKelly\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1975\\tO\\n)\\tO\\n.\\tO\\n\\nClinical\\tO\\nand\\tO\\nbiochemical\\tO\\nevidence\\tO\\nsuggested\\tO\\nthat\\tO\\nthe\\tO\\nincreased\\tO\\ncarrier\\tO\\nfrequency\\tO\\nwas\\tO\\ndue\\tO\\nto\\tO\\nat\\tO\\nleast\\tO\\ntwo\\tO\\naltered\\tO\\nalleles\\tO\\nfor\\tO\\nthe\\tO\\nhexosaminidase\\tO\\nA\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\n.\\tO\\n\\nWe\\tO\\nnow\\tO\\nreport\\tO\\ntwo\\tO\\nmutant\\tO\\nalleles\\tO\\nin\\tO\\nthis\\tO\\nPennsylvania\\tO\\nDutch\\tO\\nkindred\\tO\\n,\\tO\\nand\\tO\\none\\tO\\npolymorphism\\tO\\n.\\tO\\n\\nOne\\tO\\nallele\\tO\\n,\\tO\\nreported\\tO\\noriginally\\tO\\nin\\tO\\na\\tO\\nFrench\\tO\\nTSD\\tB-Disease\\npatient\\tO\\n(\\tO\\nAkli\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1991\\tO\\n)\\tO\\n,\\tO\\nis\\tO\\na\\tO\\nGT\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nAT\\tO\\ntransition\\tO\\nat\\tO\\nthe\\tO\\ndonor\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n9\\tO\\n.\\tO\\n\\nThe\\tO\\nsecond\\tO\\n,\\tO\\na\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransition\\tO\\nat\\tO\\nnucleotide\\tO\\n739\\tO\\n(\\tO\\nArg247Trp\\tO\\n)\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nby\\tO\\nTriggs\\tO\\n-\\tO\\nRaine\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n\\n(\\tO\\n1992\\tO\\n)\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nclinically\\tO\\nbenign\\tO\\n\"\\tO\\npseudodeficient\\tO\\n\"\\tO\\nallele\\tO\\nassociated\\tO\\nwith\\tO\\nreduced\\tO\\nenzyme\\tO\\nactivity\\tO\\nagainst\\tO\\nartificial\\tO\\nsubstrate\\tO\\n.\\tO\\n\\nFinally\\tO\\n,\\tO\\na\\tO\\npolymorphism\\tO\\n[\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n(\\tO\\n759\\tO\\n)\\tO\\n]\\tO\\n,\\tO\\nwhich\\tO\\nleaves\\tO\\nvaline\\tO\\nat\\tO\\ncodon\\tO\\n253\\tO\\nunchanged\\tO\\n,\\tO\\nis\\tO\\ndescribed\\tO\\n.\\tO\\n\\nA\\tO\\nmutation\\tO\\ncommon\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n:\\tO\\nfrequency\\tO\\nand\\tO\\nRNA\\tO\\nstudies\\tO\\n.\\tO\\n\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ngenetic\\tI-Disease\\ndisorder\\tI-Disease\\nresulting\\tO\\nfrom\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\nencoding\\tO\\nthe\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nof\\tO\\nthe\\tO\\nlysosomal\\tO\\nenzyme\\tO\\n,\\tO\\nbeta\\tO\\n-\\tO\\nN\\tO\\n-\\tO\\nacetylhexosaminidase\\tO\\nA\\tO\\n(\\tO\\nHex\\tO\\nA\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndiscovered\\tO\\nthat\\tO\\na\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\nmutation\\tO\\n,\\tO\\nIVS\\tO\\n-\\tO\\n9\\tO\\n+\\tO\\n1\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n,\\tO\\nfirst\\tO\\ndetected\\tO\\nby\\tO\\nAkli\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n\\n(\\tO\\nGenomics\\tO\\n11\\tO\\n124\\tO\\n-\\tO\\n134\\tO\\n,\\tO\\n1991\\tO\\n)\\tO\\n,\\tO\\nis\\tO\\na\\tO\\ncommon\\tO\\ndisease\\tO\\nallele\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nCaucasians\\tO\\n(\\tO\\n10\\tO\\n/\\tO\\n58\\tO\\nalleles\\tO\\nexamined\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nPCR\\tO\\n-\\tO\\nbased\\tO\\ndiagnostic\\tO\\ntest\\tO\\n,\\tO\\nwhich\\tO\\ndetects\\tO\\nan\\tO\\nNlaIII\\tO\\nsite\\tO\\ngenerated\\tO\\nby\\tO\\nthe\\tO\\nmutation\\tO\\n,\\tO\\nrevealed\\tO\\na\\tO\\nfrequency\\tO\\namong\\tO\\nenzyme\\tO\\n-\\tO\\ndefined\\tO\\ncarriers\\tO\\nof\\tO\\n9\\tO\\n/\\tO\\n64\\tO\\n(\\tO\\n14\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nMost\\tO\\nof\\tO\\nthose\\tO\\ncarrying\\tO\\nthe\\tO\\nallele\\tO\\ntrace\\tO\\ntheir\\tO\\norigins\\tO\\nto\\tO\\nthe\\tO\\nUnited\\tO\\nKingdom\\tO\\n,\\tO\\nIreland\\tO\\n,\\tO\\nor\\tO\\nWestern\\tO\\nEurope\\tO\\n.\\tO\\n\\nIt\\tO\\nwas\\tO\\nnot\\tO\\nidentified\\tO\\namong\\tO\\n12\\tO\\nBlack\\tO\\nAmerican\\tO\\nTSD\\tB-Disease\\nalleles\\tO\\nor\\tO\\nin\\tO\\nany\\tO\\nof\\tO\\n18\\tO\\nAshkenazi\\tO\\nJewish\\tO\\n,\\tO\\nenzyme\\tO\\n-\\tO\\ndefined\\tO\\ncarriers\\tO\\nwho\\tO\\ndid\\tO\\nnot\\tO\\ncarry\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\ncommon\\tO\\nto\\tO\\nthis\\tO\\npopulation\\tO\\n.\\tO\\n\\nNo\\tO\\nnormally\\tO\\nspliced\\tO\\nRNA\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nPCR\\tO\\nproducts\\tO\\ngenerated\\tO\\nfrom\\tO\\nreverse\\tO\\ntranscription\\tO\\nof\\tO\\nRNA\\tO\\ncarrying\\tO\\nthe\\tO\\nIVS\\tO\\n-\\tO\\n9\\tO\\nmutation\\tO\\n.\\tO\\n\\nInstead\\tO\\n,\\tO\\nthe\\tO\\nlow\\tO\\nlevels\\tO\\nof\\tO\\nmRNA\\tO\\nfrom\\tO\\nthis\\tO\\nallele\\tO\\nwere\\tO\\ncomprised\\tO\\nof\\tO\\naberrant\\tO\\nspecies\\tO\\nresulting\\tO\\nfrom\\tO\\nthe\\tO\\nuse\\tO\\nof\\tO\\neither\\tO\\nof\\tO\\ntwo\\tO\\ncryptic\\tO\\ndonor\\tO\\nsites\\tO\\n,\\tO\\none\\tO\\ntruncating\\tO\\nexon\\tO\\n9\\tO\\nand\\tO\\nthe\\tO\\nother\\tO\\nwithin\\tO\\nIVS\\tO\\n-\\tO\\n9\\tO\\n,\\tO\\nspliced\\tO\\nto\\tO\\nexon\\tO\\n10\\tO\\n.\\tO\\n\\nNumerous\\tO\\nadditional\\tO\\nsplice\\tO\\nproducts\\tO\\nwere\\tO\\ndetected\\tO\\n,\\tO\\nmost\\tO\\ninvolving\\tO\\nskipping\\tO\\nof\\tO\\none\\tO\\nor\\tO\\nmore\\tO\\nsurrounding\\tO\\nexons\\tO\\n.\\tO\\n\\nTogether\\tO\\nwith\\tO\\na\\tO\\nrecently\\tO\\nidentified\\tO\\nallele\\tO\\nresponsible\\tO\\nfor\\tO\\nHex\\tO\\nA\\tO\\npseudodeficiency\\tO\\n(\\tO\\nTriggs\\tO\\n-\\tO\\nRaine\\tO\\net\\tO\\nal\\tO\\n.\\tO\\nAm\\tO\\nJ\\tO\\nHum\\tO\\nGenet\\tO\\n,\\tO\\n1992\\tO\\n)\\tO\\n,\\tO\\nthese\\tO\\ntwo\\tO\\nalleles\\tO\\naccounted\\tO\\nfor\\tO\\nalmost\\tO\\n50\\tO\\n%\\tO\\n(\\tO\\n29\\tO\\n/\\tO\\n64\\tO\\n)\\tO\\nof\\tO\\nTSD\\tB-Disease\\nor\\tO\\ncarrier\\tO\\nalleles\\tO\\nascertained\\tO\\nby\\tO\\nenzyme\\tO\\nscreening\\tO\\ntests\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nCaucasians\\tO\\n.\\tO\\n.\\tO\\n\\nAberrant\\tO\\nsplicing\\tO\\nof\\tO\\nthe\\tO\\nCHM\\tB-Disease\\ngene\\tO\\nis\\tO\\na\\tO\\nsignificant\\tO\\ncause\\tO\\nof\\tO\\nchoroideremia\\tB-Disease\\n.\\tO\\n\\nChoroideremia\\tB-Disease\\n(\\tO\\nCHM\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nprogressive\\tI-Disease\\ndegeneration\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nchoroid\\tI-Disease\\nand\\tI-Disease\\nretina\\tI-Disease\\n.\\tO\\n\\n12\\tO\\n%\\tO\\nof\\tO\\nunrelated\\tO\\nmale\\tO\\npatients\\tO\\ncarry\\tO\\ndeletions\\tO\\nof\\tO\\nthe\\tO\\npartially\\tO\\ncloned\\tO\\nCHM\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nIn\\tO\\nFinland\\tO\\n,\\tO\\nthere\\tO\\nare\\tO\\nmore\\tO\\nthan\\tO\\n120\\tO\\nliving\\tO\\nCHM\\tB-Disease\\npatients\\tO\\nbelonging\\tO\\nto\\tO\\neight\\tO\\napparently\\tO\\nunrelated\\tO\\npedigrees\\tO\\n.\\tO\\n\\nMolecular\\tO\\ndeletions\\tO\\ninvolving\\tO\\nthe\\tO\\nCHM\\tB-Disease\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\nthree\\tO\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nscreened\\tO\\nthe\\tO\\nremaining\\tO\\nfive\\tO\\nfamilies\\tO\\nfor\\tO\\npoint\\tO\\nmutations\\tO\\n.\\tO\\n\\nIn\\tO\\none\\tO\\nlarge\\tO\\nfamily\\tO\\na\\tO\\nsingle\\tO\\nnucleotide\\tO\\n(\\tO\\nT\\tO\\n)\\tO\\ninsertion\\tO\\ninto\\tO\\nthe\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\nof\\tO\\nexon\\tO\\nC\\tO\\nleads\\tO\\nto\\tO\\ntwo\\tO\\naberrantly\\tO\\nspliced\\tO\\nmRNAs\\tO\\nboth\\tO\\nproducing\\tO\\na\\tO\\npremature\\tO\\nstop\\tO\\ncodon\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\ncan\\tO\\nbe\\tO\\nassayed\\tO\\neasily\\tO\\nby\\tO\\namplification\\tO\\nand\\tO\\ndigestion\\tO\\nwith\\tO\\nMsel\\tO\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nprovide\\tO\\nadditional\\tO\\nevidence\\tO\\nfor\\tO\\nthe\\tO\\npathogenetic\\tO\\nrole\\tO\\nof\\tO\\nCHM\\tB-Disease\\nmutations\\tO\\nand\\tO\\nprovide\\tO\\na\\tO\\ndiagnostic\\tO\\ntool\\tO\\nfor\\tO\\none\\tO\\nfifth\\tO\\nof\\tO\\nthe\\tO\\nworlds\\tO\\nknown\\tO\\nCHM\\tB-Disease\\npatients\\tO\\n.\\tO\\n.\\tO\\n\\nGermline\\tO\\nintronic\\tO\\nand\\tO\\nexonic\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nWilms\\tB-Disease\\n\\'\\tI-Disease\\ntumour\\tI-Disease\\ngene\\tO\\n(\\tO\\nWT1\\tO\\n)\\tO\\naffecting\\tO\\nurogenital\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\nhuman\\tO\\ndevelopmental\\tB-Disease\\ndisorder\\tI-Disease\\naffecting\\tO\\nthe\\tO\\nurogenital\\tO\\nsystem\\tO\\nand\\tO\\nleading\\tO\\nto\\tO\\nrenal\\tB-Disease\\nfailure\\tI-Disease\\n,\\tO\\nintersex\\tB-Disease\\ndisorders\\tI-Disease\\nand\\tO\\nWilms\\tB-Disease\\ntumour\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nreport\\tO\\n,\\tO\\nfour\\tO\\nindividuals\\tO\\nwith\\tO\\nthis\\tO\\nsyndrome\\tO\\nare\\tO\\ndescribed\\tO\\ncarrying\\tO\\ngermline\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nWilms\\tB-Disease\\ntumour\\tI-Disease\\nsuppressor\\tO\\ngene\\tO\\n,\\tO\\nWT1\\tO\\n.\\tO\\n\\nThree\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nwere\\tO\\nin\\tO\\nthe\\tO\\nzinc\\tO\\nfinger\\tO\\ndomains\\tO\\nof\\tO\\nWT1\\tO\\n.\\tO\\n\\nThe\\tO\\nfourth\\tO\\noccurred\\tO\\nwithin\\tO\\nintron\\tO\\n9\\tO\\n,\\tO\\npreventing\\tO\\nsplicing\\tO\\nat\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nalternatively\\tO\\nchosen\\tO\\nsplice\\tO\\ndonor\\tO\\nsites\\tO\\nof\\tO\\nexon\\tO\\n9\\tO\\nwhen\\tO\\nassayed\\tO\\nin\\tO\\nvitro\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nprovide\\tO\\ngenetic\\tO\\nevidence\\tO\\nfor\\tO\\ndistinct\\tO\\nfunctional\\tO\\nroles\\tO\\nof\\tO\\nthe\\tO\\nWT1\\tO\\nisoforms\\tO\\nin\\tO\\nurogenital\\tO\\ndevelopment\\tO\\n.\\tO\\n.\\tO\\n\\nCharacterization\\tO\\nof\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nregion\\tO\\npredicts\\tO\\nmultiple\\tO\\nprotein\\tO\\nisoform\\tO\\n-\\tO\\nencoding\\tO\\nmRNAs\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nunderlying\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nas\\tO\\nan\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\npolymorphic\\tO\\nCTG\\tO\\n-\\tO\\nrepeat\\tO\\nin\\tO\\na\\tO\\ngene\\tO\\nencoding\\tO\\nprotein\\tO\\nkinase\\tO\\nactivity\\tO\\n.\\tO\\n\\nBrain\\tO\\nand\\tO\\nheart\\tO\\ntranscripts\\tO\\nof\\tO\\nthe\\tO\\nDM\\tO\\n-\\tO\\nkinase\\tO\\n(\\tO\\nDMR\\tO\\n-\\tO\\nB15\\tO\\n)\\tO\\ngene\\tO\\nare\\tO\\nsubject\\tO\\nto\\tO\\nalternative\\tO\\nRNA\\tO\\nsplicing\\tO\\nin\\tO\\nboth\\tO\\nhuman\\tO\\nand\\tO\\nmouse\\tO\\n.\\tO\\n\\nThe\\tO\\nunstable\\tO\\n[\\tO\\nCTG\\tO\\n]\\tO\\n5\\tO\\n-\\tO\\n30\\tO\\nmotif\\tO\\nis\\tO\\nfound\\tO\\nuniquely\\tO\\nin\\tO\\nhumans\\tO\\n,\\tO\\nalthough\\tO\\nthe\\tO\\nflanking\\tO\\nnucleotides\\tO\\nare\\tO\\nalso\\tO\\npresent\\tO\\nin\\tO\\nmouse\\tO\\n.\\tO\\n\\nCharacterization\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nregion\\tO\\nof\\tO\\nboth\\tO\\nspecies\\tO\\nreveals\\tO\\nanother\\tO\\nactive\\tO\\ngene\\tO\\n(\\tO\\nDMR\\tO\\n-\\tO\\nN9\\tO\\n)\\tO\\nin\\tO\\nclose\\tO\\nproximity\\tO\\nto\\tO\\nthe\\tO\\nkinase\\tO\\ngene\\tO\\n.\\tO\\n\\nDMR\\tO\\n-\\tO\\nN9\\tO\\ntranscripts\\tO\\n,\\tO\\nmainly\\tO\\nexpressed\\tO\\nin\\tO\\nbrain\\tO\\nand\\tO\\ntestis\\tO\\n,\\tO\\npossess\\tO\\na\\tO\\nsingle\\tO\\n,\\tO\\nlarge\\tO\\nopen\\tO\\nreading\\tO\\nframe\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\nits\\tO\\nprotein\\tO\\nproduct\\tO\\nis\\tO\\nunknown\\tO\\n.\\tO\\n\\nClinical\\tO\\nmanifestation\\tO\\nof\\tO\\nDM\\tB-Disease\\nmay\\tO\\nbe\\tO\\ncaused\\tO\\nby\\tO\\nthe\\tO\\nexpanded\\tO\\nCTG\\tO\\n-\\tO\\nrepeat\\tO\\ncompromising\\tO\\nthe\\tO\\n(\\tO\\nalternative\\tO\\n)\\tO\\nexpression\\tO\\nof\\tO\\nDM\\tO\\n-\\tO\\nkinase\\tO\\nor\\tO\\nDMR\\tO\\n-\\tO\\nN9\\tO\\nproteins\\tO\\n.\\tO\\n.\\tO\\n\\nFragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\nwithout\\tO\\nCCG\\tO\\namplification\\tO\\nhas\\tO\\nan\\tO\\nFMR1\\tO\\ndeletion\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\ntypical\\tO\\nclinical\\tO\\nfeatures\\tO\\nof\\tO\\nthe\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nbut\\tO\\nwithout\\tO\\ncytogenetic\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nor\\tO\\nan\\tO\\namplified\\tO\\nCCG\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nfragment\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\nhas\\tO\\na\\tO\\npreviously\\tO\\nuncharacterized\\tO\\nsubmicroscopic\\tO\\ndeletion\\tO\\nencompassing\\tO\\nthe\\tO\\nCCG\\tO\\nrepeat\\tO\\n,\\tO\\nthe\\tO\\nentire\\tO\\nFMR1\\tO\\ngene\\tO\\nand\\tO\\nabout\\tO\\n2\\tO\\n.\\tO\\n\\n5\\tO\\nmegabases\\tO\\nof\\tO\\nflanking\\tO\\nsequences\\tO\\n.\\tO\\n\\nThis\\tO\\nfinding\\tO\\nconfirms\\tO\\nthat\\tO\\nthe\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nphenotype\\tO\\ncan\\tO\\nexist\\tO\\n,\\tO\\nwithout\\tO\\namplification\\tO\\nof\\tO\\nthe\\tO\\nCCG\\tO\\nrepeat\\tO\\nor\\tO\\ncytogenetic\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\n,\\tO\\nand\\tO\\nthat\\tO\\nfragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\ngenetically\\tO\\nhomogeneous\\tO\\ndisorder\\tO\\ninvolving\\tO\\nFMR1\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nfound\\tO\\nrandom\\tO\\nX\\tO\\n-\\tO\\ninactivation\\tO\\nin\\tO\\nthe\\tO\\nmother\\tO\\nof\\tO\\nthe\\tO\\npatient\\tO\\nwho\\tO\\nwas\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\ncarrier\\tO\\nof\\tO\\nthis\\tO\\ndeletion\\tO\\n.\\tO\\n\\nCloning\\tO\\nof\\tO\\nthe\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\nregion\\tO\\nin\\tO\\nyeast\\tO\\nartificial\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\nhas\\tO\\nbeen\\tO\\nlocalized\\tO\\nto\\tO\\na\\tO\\n2\\tO\\n.\\tO\\n\\n5\\tO\\nmillion\\tO\\nbase\\tO\\npair\\tO\\n(\\tO\\nMb\\tO\\n)\\tO\\nregion\\tO\\nbetween\\tO\\nthe\\tO\\nloci\\tO\\nD4S10\\tO\\nand\\tO\\nD4S168\\tO\\non\\tO\\nthe\\tO\\nshort\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n4\\tO\\n.\\tO\\n\\nAs\\tO\\npart\\tO\\nof\\tO\\na\\tO\\nstrategy\\tO\\nto\\tO\\nclone\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nits\\tO\\nchromosomal\\tO\\nlocation\\tO\\n,\\tO\\nwe\\tO\\nisolated\\tO\\ngenomic\\tO\\nDNA\\tO\\nfrom\\tO\\nthe\\tO\\nHD\\tB-Disease\\nregion\\tO\\nas\\tO\\na\\tO\\nset\\tO\\nof\\tO\\noverlapping\\tO\\nyeast\\tO\\nartificial\\tO\\nchromosome\\tO\\n(\\tO\\nYAC\\tO\\n)\\tO\\nclones\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\neight\\tO\\nYAC\\tO\\nclones\\tO\\nwere\\tO\\nidentified\\tO\\nby\\tO\\nscreening\\tO\\nhuman\\tO\\nYAC\\tO\\nlibraries\\tO\\nwith\\tO\\ntwelve\\tO\\nPCR\\tO\\n-\\tO\\nbased\\tO\\nsequence\\tO\\n-\\tO\\ntagged\\tO\\nsites\\tO\\n(\\tO\\nSTSs\\tO\\n)\\tO\\nfrom\\tO\\nthe\\tO\\nregion\\tO\\n.\\tO\\n\\nWe\\tO\\nassembled\\tO\\nthe\\tO\\nYAC\\tO\\nclones\\tO\\ninto\\tO\\noverlapping\\tO\\nsets\\tO\\nby\\tO\\nhybridizing\\tO\\nthem\\tO\\nto\\tO\\na\\tO\\nlarge\\tO\\nnumber\\tO\\nof\\tO\\nDNA\\tO\\nprobes\\tO\\nfrom\\tO\\nthe\\tO\\nHD\\tB-Disease\\nregion\\tO\\n,\\tO\\nincluding\\tO\\nthe\\tO\\nSTSs\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nisolated\\tO\\nthe\\tO\\nends\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nDNA\\tO\\ninserts\\tO\\nof\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\nYAC\\tO\\nclones\\tO\\nto\\tO\\nassist\\tO\\nin\\tO\\nthe\\tO\\nconstruction\\tO\\nof\\tO\\nthe\\tO\\ncontig\\tO\\n.\\tO\\n\\nAlthough\\tO\\nalmost\\tO\\nhalf\\tO\\nof\\tO\\nthe\\tO\\nYACs\\tO\\nappear\\tO\\nto\\tO\\ncontain\\tO\\nchimeric\\tO\\ninserts\\tO\\nand\\tO\\nseveral\\tO\\ncontain\\tO\\ninternal\\tO\\ndeletions\\tO\\nor\\tO\\nother\\tO\\nrearrangements\\tO\\n,\\tO\\nwe\\tO\\nwere\\tO\\nable\\tO\\nto\\tO\\nobtain\\tO\\nover\\tO\\n2\\tO\\n.\\tO\\n\\n2\\tO\\nMb\\tO\\nof\\tO\\nthe\\tO\\nHD\\tB-Disease\\nregion\\tO\\nin\\tO\\nYACs\\tO\\n,\\tO\\nincluding\\tO\\none\\tO\\ncontinuous\\tO\\nsegment\\tO\\nof\\tO\\n2\\tO\\n.\\tO\\n\\n0\\tO\\nMb\\tO\\ncovering\\tO\\nthe\\tO\\nregion\\tO\\nthat\\tO\\nmost\\tO\\nlikely\\tO\\ncontains\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nTen\\tO\\nof\\tO\\nthe\\tO\\ntwenty\\tO\\neight\\tO\\nYAC\\tO\\nclones\\tO\\ncomprise\\tO\\na\\tO\\nminimal\\tO\\nset\\tO\\nspanning\\tO\\nthe\\tO\\n2\\tO\\n.\\tO\\n\\n2\\tO\\nMb\\tO\\n.\\tO\\n\\nThese\\tO\\nclones\\tO\\nprovide\\tO\\nreagents\\tO\\nfor\\tO\\nthe\\tO\\ncomplete\\tO\\ncharacterization\\tO\\nof\\tO\\nthis\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\ngenome\\tO\\nand\\tO\\nfor\\tO\\nthe\\tO\\neventual\\tO\\nisolation\\tO\\nof\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nCharacterization\\tO\\nof\\tO\\na\\tO\\nYAC\\tO\\ncontaining\\tO\\npart\\tO\\nor\\tO\\nall\\tO\\nof\\tO\\nthe\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\nlocus\\tO\\n.\\tO\\n\\nIt\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nfrom\\tO\\npulsed\\tO\\n-\\tO\\nfield\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n(\\tO\\nPFGE\\tO\\n)\\tO\\nthat\\tO\\nthe\\tO\\nmonoamine\\tO\\noxidase\\tO\\ngenes\\tO\\nA\\tO\\nand\\tO\\nB\\tO\\n(\\tO\\nMAOA\\tO\\n&\\tO\\nMAOB\\tO\\n)\\tO\\nand\\tO\\nDXS7\\tO\\nloci\\tO\\nare\\tO\\nphysically\\tO\\nvery\\tO\\nclose\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ntherefore\\tO\\nextended\\tO\\nstudies\\tO\\non\\tO\\ntheir\\tO\\nrelationship\\tO\\nthrough\\tO\\nthe\\tO\\ncharacterisation\\tO\\nof\\tO\\na\\tO\\n650\\tO\\nkb\\tO\\nYAC\\tO\\nisolated\\tO\\nusing\\tO\\nL1\\tO\\n.\\tO\\n\\n28\\tO\\n(\\tO\\nrecognising\\tO\\nthe\\tO\\nDXS7\\tO\\nlocus\\tO\\n)\\tO\\nas\\tO\\na\\tO\\nprobe\\tO\\n.\\tO\\n\\nRestriction\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\nYAC\\tO\\nindicates\\tO\\nthat\\tO\\nit\\tO\\ncontains\\tO\\nboth\\tO\\nMAOA\\tO\\nand\\tO\\nMAOB\\tO\\ngenes\\tO\\nin\\tO\\naddition\\tO\\nto\\tO\\nthe\\tO\\nDXS7\\tO\\nlocus\\tO\\n.\\tO\\n\\nThe\\tO\\nmap\\tO\\nderived\\tO\\nfrom\\tO\\nthe\\tO\\nYL1\\tO\\n.\\tO\\n\\n28\\tO\\n-\\tO\\nYAC\\tO\\nis\\tO\\ncompatible\\tO\\nboth\\tO\\nwith\\tO\\nthe\\tO\\nmap\\tO\\nfrom\\tO\\nan\\tO\\nindependently\\tO\\nderived\\tO\\nYAC\\tO\\ncarrying\\tO\\nMAOA\\tO\\nand\\tO\\nB\\tO\\ngenes\\tO\\nand\\tO\\nwith\\tO\\nthe\\tO\\nlong\\tO\\nrange\\tO\\ngenomic\\tO\\nmap\\tO\\nfor\\tO\\nthe\\tO\\nregion\\tO\\n.\\tO\\n\\nA\\tO\\nseries\\tO\\nof\\tO\\nsubclones\\tO\\nprepared\\tO\\nfrom\\tO\\na\\tO\\nphage\\tO\\nlibrary\\tO\\n(\\tO\\nlambda\\tO\\nDASH\\tO\\nII\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nYAC\\tO\\nhave\\tO\\nbeen\\tO\\ncharacterised\\tO\\nand\\tO\\nhave\\tO\\nbeen\\tO\\nemployed\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\nend\\tO\\npoint\\tO\\nof\\tO\\nthe\\tO\\ndeletion\\tO\\nof\\tO\\na\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nNDP\\tB-Disease\\n)\\tO\\npatient\\tO\\nwho\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nlack\\tO\\nboth\\tO\\nDXS7\\tO\\nand\\tO\\nMAO\\tO\\ncoding\\tO\\nsequences\\tO\\n.\\tO\\n\\nThe\\tO\\npattern\\tO\\nof\\tO\\nretention\\tO\\nof\\tO\\nsubclones\\tO\\nin\\tO\\nthe\\tO\\ndeletion\\tO\\npatient\\tO\\nplace\\tO\\nthe\\tO\\nend\\tO\\npoint\\tO\\nof\\tO\\nthe\\tO\\ndeletion\\tO\\nwithin\\tO\\n30\\tO\\n-\\tO\\n130\\tO\\nkb\\tO\\nof\\tO\\nthe\\tO\\nproximal\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\nYAC\\tO\\n.\\tO\\n\\nBy\\tO\\ncombining\\tO\\nthe\\tO\\ndata\\tO\\nwith\\tO\\nestablished\\tO\\nrecombination\\tO\\nanalysis\\tO\\n,\\tO\\nwe\\tO\\nprovide\\tO\\nevidence\\tO\\nthat\\tO\\nall\\tO\\nor\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nNDP\\tO\\nlies\\tO\\nin\\tO\\nthe\\tO\\ninterval\\tO\\nof\\tO\\napproximately\\tO\\n250kb\\tO\\nwithin\\tO\\nthe\\tO\\nYAC\\tO\\n.\\tO\\n\\nBoth\\tO\\nmutations\\tO\\nin\\tO\\nG6PD\\tO\\nA\\tO\\n-\\tO\\nare\\tO\\nnecessary\\tO\\nto\\tO\\nproduce\\tO\\nthe\\tO\\nG6PD\\tB-Disease\\ndeficient\\tI-Disease\\nphenotype\\tO\\n.\\tO\\n\\nThe\\tO\\nhigh\\tO\\nprevalence\\tO\\nof\\tO\\nglucose\\tB-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nAfrican\\tO\\npopulations\\tO\\nis\\tO\\ndue\\tO\\nalmost\\tO\\nentirely\\tO\\nto\\tO\\nthe\\tO\\nenzyme\\tO\\nvariant\\tO\\nA\\tO\\n-\\tO\\n,\\tO\\nwhich\\tO\\ndiffers\\tO\\nfrom\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nG6PD\\tO\\nB\\tO\\nby\\tO\\ntwo\\tO\\namino\\tO\\nacid\\tO\\nreplacements\\tO\\n,\\tO\\n68\\tO\\nVal\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nMet\\tO\\nand\\tO\\n126\\tO\\nAsn\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nAsp\\tO\\n.\\tO\\n\\nThe\\tO\\nnon\\tO\\n-\\tO\\ndeficient\\tO\\npolymorphic\\tO\\nvariant\\tO\\nG6PD\\tO\\nA\\tO\\ncontains\\tO\\nonly\\tO\\nthe\\tO\\nmutation\\tO\\n126\\tO\\nAsn\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nAsp\\tO\\n.\\tO\\n\\nThe\\tO\\nfrequencies\\tO\\nof\\tO\\nthe\\tO\\nG6PD\\tO\\nA\\tO\\nand\\tO\\nof\\tO\\nthe\\tO\\nG6PD\\tO\\nA\\tO\\n-\\tO\\ngenes\\tO\\nin\\tO\\nparts\\tO\\nof\\tO\\nAfrica\\tO\\nare\\tO\\nboth\\tO\\nabout\\tO\\n0\\tO\\n.\\tO\\n\\n2\\tO\\n.\\tO\\n\\nThe\\tO\\n68\\tO\\nVal\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nMet\\tO\\nmutation\\tO\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\na\\tO\\nB\\tO\\nbackground\\tO\\n.\\tO\\n\\nThis\\tO\\ncould\\tO\\nbe\\tO\\nbecause\\tO\\nthe\\tO\\n68\\tO\\nVal\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nMet\\tO\\nmutation\\tO\\nhappened\\tO\\nto\\tO\\narise\\tO\\nin\\tO\\nan\\tO\\nA\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\nfirst\\tO\\ninstance\\tO\\n,\\tO\\nor\\tO\\nbecause\\tO\\nthe\\tO\\n68\\tO\\nVal\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nMet\\tO\\nmutation\\tO\\nalone\\tO\\nis\\tO\\nnot\\tO\\nsufficient\\tO\\nto\\tO\\ncause\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\napproached\\tO\\nthis\\tO\\nquestion\\tO\\nby\\tO\\nproducing\\tO\\nG6PD\\tO\\nB\\tO\\n,\\tO\\nA\\tO\\n,\\tO\\nA\\tO\\n-\\tO\\n,\\tO\\nand\\tO\\nG6PD\\tO\\n68\\tO\\nVal\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nMet\\tO\\nin\\tO\\na\\tO\\nbacterial\\tO\\nexpression\\tO\\nsystem\\tO\\nand\\tO\\nanalysing\\tO\\ntheir\\tO\\nbiochemical\\tO\\nproperties\\tO\\n.\\tO\\n\\nWith\\tO\\neach\\tO\\nsingle\\tO\\nmutation\\tO\\nwe\\tO\\nfound\\tO\\na\\tO\\nslight\\tO\\ndecrease\\tO\\nin\\tO\\nboth\\tO\\nthe\\tO\\nspecific\\tO\\nactivity\\tO\\nand\\tO\\nthe\\tO\\nyield\\tO\\nof\\tO\\nenzyme\\tO\\nwhen\\tO\\ncompared\\tO\\nto\\tO\\nG6PD\\tO\\nB\\tO\\n.\\tO\\n\\nWhen\\tO\\nboth\\tO\\nmutations\\tO\\nwere\\tO\\nintroduced\\tO\\ntogether\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\na\\tO\\nroughly\\tO\\nadditive\\tO\\neffect\\tO\\non\\tO\\nspecific\\tO\\nactivity\\tO\\n,\\tO\\nbut\\tO\\na\\tO\\nmuch\\tO\\nmore\\tO\\ndrastic\\tO\\neffect\\tO\\non\\tO\\nenzyme\\tO\\nyield\\tO\\n(\\tO\\n4\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nsynergistic\\tO\\neffect\\tO\\nwas\\tO\\nalso\\tO\\ndemonstrated\\tO\\non\\tO\\nthermal\\tO\\nstability\\tO\\n,\\tO\\nespecially\\tO\\nat\\tO\\nlow\\tO\\nNADP\\tO\\nconcentrations\\tO\\n.\\tO\\n\\nComparable\\tO\\nresults\\tO\\nwere\\tO\\nproduced\\tO\\nwhen\\tO\\nthe\\tO\\nreplacement\\tO\\n119\\tO\\nGln\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nGlu\\tO\\nwas\\tO\\nstudied\\tO\\ninstead\\tO\\nof\\tO\\n126\\tO\\nAsn\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nAsp\\tO\\n.\\tO\\n\\nWe\\tO\\ninfer\\tO\\nthat\\tO\\nthe\\tO\\ncoexistence\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nmutations\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nenzyme\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tI-Disease\\nG6PD\\tI-Disease\\nA\\tO\\n-\\tO\\nbecause\\tO\\nthey\\tO\\nact\\tO\\nsynergistically\\tO\\nin\\tO\\ncausing\\tO\\ninstability\\tO\\nof\\tO\\nthe\\tO\\nenzyme\\tO\\n.\\tO\\n\\nSmall\\tO\\nnuclear\\tO\\nribonucleoprotein\\tO\\npolypeptide\\tO\\nN\\tO\\n(\\tO\\nSNRPN\\tO\\n)\\tO\\n,\\tO\\nan\\tO\\nexpressed\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\ncritical\\tO\\nregion\\tO\\n.\\tO\\n\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\npaternally\\tO\\nderived\\tO\\nchromosomal\\tO\\ndeletions\\tO\\nin\\tO\\nregion\\tO\\n15q11\\tO\\n-\\tO\\n13\\tO\\nor\\tO\\nwith\\tO\\nmaternal\\tB-Disease\\ndisomy\\tI-Disease\\nfor\\tI-Disease\\nchromosome\\tI-Disease\\n15\\tI-Disease\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\nloss\\tO\\nof\\tO\\nthe\\tO\\nexpressed\\tO\\npaternal\\tO\\nalleles\\tO\\nof\\tO\\nmaternally\\tO\\nimprinted\\tO\\ngenes\\tO\\nmust\\tO\\nbe\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nPWS\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nmapped\\tO\\nthe\\tO\\ngene\\tO\\nencoding\\tO\\nthe\\tO\\nsmall\\tO\\nnuclear\\tO\\nRNA\\tO\\nassociated\\tO\\npolypeptide\\tO\\nSmN\\tO\\n(\\tO\\nSNRPN\\tO\\n)\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\n15q12\\tO\\nand\\tO\\na\\tO\\nprocessed\\tO\\npseudogene\\tO\\nSNRPNP1\\tO\\nto\\tO\\nchromosome\\tO\\nregion\\tO\\n6pter\\tO\\n-\\tO\\np21\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nSNRPN\\tO\\nwas\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\nminimal\\tO\\ndeletion\\tO\\ninterval\\tO\\nthat\\tO\\nis\\tO\\ncritical\\tO\\nfor\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nfact\\tO\\nthat\\tO\\nthe\\tO\\nmouse\\tO\\nSnrpn\\tO\\ngene\\tO\\nis\\tO\\nmaternally\\tO\\nimprinted\\tO\\nin\\tO\\nbrain\\tO\\nsuggests\\tO\\nthat\\tO\\nloss\\tO\\nof\\tO\\nthe\\tO\\npaternally\\tO\\nderived\\tO\\nSNRPN\\tO\\nallele\\tO\\nmay\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nPWS\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\npresence\\tO\\nof\\tO\\ntwo\\tO\\ndifferent\\tO\\ninfantile\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nmutations\\tO\\nin\\tO\\na\\tO\\nCajun\\tO\\npopulation\\tO\\n.\\tO\\n\\nA\\tO\\nstudy\\tO\\nwas\\tO\\nundertaken\\tO\\nto\\tO\\ncharacterize\\tO\\nthe\\tO\\nmutation\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\nresponsible\\tO\\nfor\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\nin\\tO\\na\\tO\\nCajun\\tO\\npopulation\\tO\\nin\\tO\\nsouthwest\\tO\\nLouisiana\\tO\\nand\\tO\\nto\\tO\\nidentify\\tO\\nthe\\tO\\norigins\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\n.\\tO\\n\\nEleven\\tO\\nof\\tO\\n12\\tO\\ninfantile\\tO\\nTSD\\tB-Disease\\nalleles\\tO\\nexamined\\tO\\nin\\tO\\nsix\\tO\\nfamilies\\tO\\nhad\\tO\\nthe\\tO\\nbeta\\tO\\n-\\tO\\nhexosaminidase\\tO\\nA\\tO\\n(\\tO\\nHex\\tO\\nA\\tO\\n)\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nexon\\tO\\n11\\tO\\ninsertion\\tO\\nmutation\\tO\\nthat\\tO\\nis\\tO\\npresent\\tO\\nin\\tO\\napproximately\\tO\\n70\\tO\\n%\\tO\\nof\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nTSD\\tB-Disease\\nheterozygotes\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nremaining\\tO\\nallele\\tO\\nwas\\tO\\na\\tO\\nsingle\\tO\\n-\\tO\\nbase\\tO\\ntransition\\tO\\nin\\tO\\nthe\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\nof\\tO\\nthe\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nintron\\tO\\n9\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\norigins\\tO\\nof\\tO\\nthese\\tO\\ntwo\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nCajun\\tO\\npopulation\\tO\\n,\\tO\\nthe\\tO\\nTSD\\tB-Disease\\ncarrier\\tO\\nstatus\\tO\\nwas\\tO\\nenzymatically\\tO\\ndetermined\\tO\\nfor\\tO\\n90\\tO\\nmembers\\tO\\nof\\tO\\nfour\\tO\\nof\\tO\\nthe\\tO\\nsix\\tO\\nfamilies\\tO\\n,\\tO\\nand\\tO\\nextensive\\tO\\npedigrees\\tO\\nwere\\tO\\nconstructed\\tO\\nfor\\tO\\nall\\tO\\ncarriers\\tO\\n.\\tO\\n\\nA\\tO\\nsingle\\tO\\nancestral\\tO\\ncouple\\tO\\nfrom\\tO\\nFrance\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ncommon\\tO\\nto\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\ncarriers\\tO\\nof\\tO\\nthe\\tO\\nexon\\tO\\n11\\tO\\ninsertion\\tO\\n.\\tO\\n\\nPedigree\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nthis\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\nin\\tO\\nthe\\tO\\nCajun\\tO\\npopulation\\tO\\nsince\\tO\\nits\\tO\\nfounding\\tO\\nover\\tO\\n2\\tO\\ncenturies\\tO\\nago\\tO\\nand\\tO\\nthat\\tO\\nit\\tO\\nmay\\tO\\nbe\\tO\\nwidely\\tO\\ndistributed\\tO\\nwithin\\tO\\nthe\\tO\\npopulation\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nthe\\tO\\nintron\\tO\\n9\\tO\\nmutation\\tO\\napparently\\tO\\nwas\\tO\\nintroduced\\tO\\nwithin\\tO\\nthe\\tO\\nlast\\tO\\ncentury\\tO\\nand\\tO\\nprobably\\tO\\nis\\tO\\nlimited\\tO\\nto\\tO\\na\\tO\\nfew\\tO\\nLouisiana\\tO\\nfamilies\\tO\\n.\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nwe\\tO\\nand\\tO\\nothers\\tO\\nhave\\tO\\nisolated\\tO\\na\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nX\\tB-Disease\\nlinked\\tI-Disease\\nNorrie\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nND\\tB-Disease\\n)\\tO\\nwhich\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ndeleted\\tO\\nor\\tO\\ndisrupted\\tO\\nin\\tO\\nseveral\\tO\\npatients\\tO\\n.\\tO\\n\\nAs\\tO\\na\\tO\\nprerequisite\\tO\\nfor\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nND\\tB-Disease\\ngene\\tO\\nwe\\tO\\nhave\\tO\\nestablished\\tO\\nthe\\tO\\nexon\\tO\\n-\\tO\\nintron\\tO\\nstructure\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\n.\\tO\\n\\nIn\\tO\\n17\\tO\\nunrelated\\tO\\npatients\\tO\\nand\\tO\\n15\\tO\\ncontrols\\tO\\n,\\tO\\nPCR\\tO\\nproducts\\tO\\nderived\\tO\\nfrom\\tO\\nthe\\tO\\npromoter\\tO\\nregion\\tO\\n,\\tO\\nexons\\tO\\n1\\tO\\nand\\tO\\n2\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nthe\\tO\\ncoding\\tO\\npart\\tO\\nof\\tO\\nexon\\tO\\n3\\tO\\nwere\\tO\\nanalysed\\tO\\nwith\\tO\\nthe\\tO\\nsingle\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\ntechnique\\tO\\n.\\tO\\n\\nIn\\tO\\n12\\tO\\npatients\\tO\\naltered\\tO\\nPCR\\tO\\nfragments\\tO\\nwere\\tO\\ndetected\\tO\\nwhich\\tO\\nwere\\tO\\nstudied\\tO\\nin\\tO\\ndetail\\tO\\nby\\tO\\ndirect\\tO\\nsequencing\\tO\\n.\\tO\\n\\nEleven\\tO\\ndifferent\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\n,\\tO\\nand\\tO\\nall\\tO\\nbut\\tO\\none\\tO\\nare\\tO\\nlikely\\tO\\nto\\tO\\ngive\\tO\\nrise\\tO\\nto\\tO\\nsignificant\\tO\\nstructural\\tO\\nchanges\\tO\\nin\\tO\\nthe\\tO\\npredicted\\tO\\nprotein\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nfunctionally\\tO\\nrelevant\\tO\\nbase\\tO\\nchanges\\tO\\nin\\tO\\nhealthy\\tO\\ncontrols\\tO\\n,\\tO\\nemphasize\\tO\\nthe\\tO\\ncausal\\tO\\nrole\\tO\\nof\\tO\\nthis\\tO\\ncandidate\\tO\\ngene\\tO\\nin\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\nand\\tO\\npave\\tO\\nthe\\tO\\nway\\tO\\nfor\\tO\\nreliable\\tO\\ndiagnosis\\tO\\nand\\tO\\ncarrier\\tO\\ndetection\\tO\\n.\\tO\\n.\\tO\\n\\nDetection\\tO\\nof\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ndystrophin\\tO\\ngene\\tO\\nby\\tO\\nmultiple\\tO\\nSSCP\\tO\\n.\\tO\\n\\nA\\tO\\ncombination\\tO\\nof\\tO\\nmultiplex\\tO\\nPCR\\tO\\nwith\\tO\\nthe\\tO\\nsingle\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\ntechnique\\tO\\nwas\\tO\\nemployed\\tO\\nto\\tO\\nscreen\\tO\\nfor\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\ndystrophin\\tO\\ngene\\tO\\n.\\tO\\n\\nCo\\tO\\n-\\tO\\namplification\\tO\\nof\\tO\\n11\\tO\\nexons\\tO\\nfrom\\tO\\ngenomic\\tO\\nDNA\\tO\\nof\\tO\\nDuchenne\\tB-Disease\\nand\\tI-Disease\\nBecker\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n/\\tO\\nBMD\\tB-Disease\\n)\\tO\\npatients\\tO\\nwith\\tO\\nno\\tO\\ndeletion\\tO\\nor\\tO\\nduplication\\tO\\nwas\\tO\\nperformed\\tO\\nand\\tO\\nthe\\tO\\nsamples\\tO\\nsubjected\\tO\\nto\\tO\\nmultiple\\tO\\nSSCP\\tO\\nanalysis\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nthe\\tO\\ncase\\tO\\nof\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nDuchenne\\tB-Disease\\npatient\\tO\\nidentified\\tO\\nby\\tO\\nthis\\tO\\napproach\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nintroduces\\tO\\na\\tO\\ntermination\\tO\\ncodon\\tO\\nwithin\\tO\\nexon\\tO\\n8\\tO\\nof\\tO\\nthe\\tO\\ndystrophin\\tO\\ngene\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\npredicted\\tO\\nto\\tO\\ncause\\tO\\na\\tO\\nvery\\tO\\npremature\\tO\\ntranslational\\tO\\ntermination\\tO\\naccounting\\tO\\nfor\\tO\\nthe\\tO\\nsevere\\tO\\nphenotype\\tO\\nobserved\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\ninherited\\tO\\nthis\\tO\\nmutation\\tO\\nfrom\\tO\\nhis\\tO\\nmother\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\nthe\\tO\\nanalysis\\tO\\nrevealed\\tO\\n5\\tO\\npolymorphisms\\tO\\nuseful\\tO\\nfor\\tO\\ninternal\\tO\\ncontrol\\tO\\n.\\tO\\n.\\tO\\n\\nProliferation\\tO\\n-\\tO\\nrelated\\tO\\nexpression\\tO\\nof\\tO\\np19\\tO\\n/\\tO\\nnm23\\tO\\nnucleoside\\tO\\ndiphosphate\\tO\\nkinase\\tO\\n.\\tO\\n\\nHigh\\tO\\nlevel\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nnm23\\tO\\n-\\tO\\nH1\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nencodes\\tO\\nfor\\tO\\na\\tO\\nnucleoside\\tO\\ndiphosphate\\tO\\nkinase\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nfound\\tO\\nto\\tO\\ncorrelate\\tO\\nwith\\tO\\ndiminished\\tO\\nmetastasis\\tO\\nin\\tO\\nsome\\tO\\ntumors\\tB-Disease\\nbut\\tO\\nnot\\tO\\nin\\tO\\nothers\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\npreviously\\tO\\nidentified\\tO\\nthe\\tO\\nprotein\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\nnm23\\tO\\n-\\tO\\nH1\\tO\\ngene\\tO\\nin\\tO\\ntwo\\tO\\n-\\tO\\ndimensional\\tO\\nelectrophoretic\\tO\\ngels\\tO\\nand\\tO\\nhave\\tO\\ndesignated\\tO\\nit\\tO\\np19\\tO\\n/\\tO\\nnm23\\tO\\n.\\tO\\n\\nIn\\tO\\nneuroblastoma\\tB-Disease\\n,\\tO\\nhigher\\tO\\nlevels\\tO\\nof\\tO\\np19\\tO\\n/\\tO\\nnm23\\tO\\n,\\tO\\nwhich\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\namplification\\tO\\nof\\tO\\nthe\\tO\\nN\\tO\\n-\\tO\\nmyc\\tO\\noncogene\\tO\\n,\\tO\\nlarge\\tO\\ntumor\\tB-Disease\\nmass\\tO\\n,\\tO\\nand\\tO\\nmetastasis\\tO\\n,\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nadvanced\\tO\\nstage\\tO\\ntumors\\tB-Disease\\ncompared\\tO\\nwith\\tO\\nlimited\\tO\\nstage\\tO\\ndisease\\tO\\n.\\tO\\n\\nBecause\\tO\\nof\\tO\\nthe\\tO\\nvariable\\tO\\nexpression\\tO\\nof\\tO\\nnm23\\tO\\n-\\tO\\nH1\\tO\\nin\\tO\\ndifferent\\tO\\ntumors\\tB-Disease\\n,\\tO\\nwe\\tO\\nhave\\tO\\ninvestigated\\tO\\nthe\\tO\\nrelationship\\tO\\nbetween\\tO\\namounts\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\nand\\tO\\ncell\\tO\\nproliferation\\tO\\n.\\tO\\n\\nThe\\tO\\nlevels\\tO\\nof\\tO\\np19\\tO\\n/\\tO\\nnm23\\tO\\nwere\\tO\\ncompared\\tO\\nbetween\\tO\\nresting\\tO\\nand\\tO\\nmitotically\\tO\\nstimulated\\tO\\nnormal\\tO\\nhuman\\tO\\nPBLs\\tO\\nand\\tO\\nin\\tO\\nleukemia\\tB-Disease\\ncells\\tO\\n.\\tO\\n\\nThe\\tO\\namount\\tO\\nof\\tO\\np19\\tO\\n/\\tO\\nnm23\\tO\\nincreased\\tO\\nin\\tO\\nnormal\\tO\\nlymphocytes\\tO\\nin\\tO\\nresponse\\tO\\nto\\tO\\nmitotic\\tO\\nstimulation\\tO\\nand\\tO\\nparalleled\\tO\\nthe\\tO\\nincrease\\tO\\nin\\tO\\nDNA\\tO\\nsynthesis\\tO\\n.\\tO\\n\\nIn\\tO\\nleukemia\\tB-Disease\\ncells\\tO\\nobtained\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\ndifferent\\tO\\nsubtypes\\tO\\nof\\tO\\nacute\\tB-Disease\\nleukemia\\tI-Disease\\n,\\tO\\np19\\tO\\n/\\tO\\nnm23\\tO\\nlevels\\tO\\nwere\\tO\\nalso\\tO\\nincreased\\tO\\nrelative\\tO\\nto\\tO\\nresting\\tO\\nnormal\\tO\\nlymphocytes\\tO\\n.\\tO\\n\\nTreatment\\tO\\nof\\tO\\nmitotically\\tO\\nstimulated\\tO\\nlymphocytes\\tO\\nwith\\tO\\ncyclosporin\\tO\\n,\\tO\\nwhich\\tO\\ninhibits\\tO\\nproliferation\\tO\\n,\\tO\\nblocked\\tO\\nthe\\tO\\nincrease\\tO\\nin\\tO\\np19\\tO\\n/\\tO\\nnm23\\tO\\n;\\tO\\ntreatment\\tO\\nof\\tO\\nthe\\tO\\nleukemia\\tB-Disease\\ncell\\tO\\nline\\tO\\nHL\\tO\\n-\\tO\\n60\\tO\\nwith\\tO\\ndimethylsulfoxide\\tO\\n,\\tO\\nwhich\\tO\\ninduces\\tO\\nterminal\\tO\\ndifferentiation\\tO\\n,\\tO\\nresulted\\tO\\nin\\tO\\ndiminished\\tO\\nlevels\\tO\\nof\\tO\\np19\\tO\\n/\\tO\\nnm23\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\ntherefore\\tO\\nprovide\\tO\\nevidence\\tO\\nthat\\tO\\nnm23\\tO\\n-\\tO\\nH1\\tO\\nexpression\\tO\\nis\\tO\\nrelated\\tO\\nto\\tO\\ncell\\tO\\nproliferative\\tO\\nactivity\\tO\\n.\\tO\\n.\\tO\\n\\nAn\\tO\\nintrachromosomal\\tO\\ninsertion\\tO\\ncausing\\tO\\n5q22\\tO\\ndeletion\\tO\\nand\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\nin\\tO\\ntwo\\tO\\ngenerations\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nFAPC\\tB-Disease\\n)\\tO\\nwith\\tO\\nepidermoid\\tB-Disease\\ncysts\\tI-Disease\\n,\\tO\\nosteomata\\tB-Disease\\n,\\tO\\nand\\tO\\nareas\\tO\\nof\\tO\\ncongenital\\tB-Disease\\nhypertrophy\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nretinal\\tI-Disease\\npigment\\tI-Disease\\nepithelium\\tI-Disease\\n(\\tO\\nCHRPEs\\tB-Disease\\n)\\tO\\nin\\tO\\na\\tO\\nmale\\tO\\npatient\\tO\\nand\\tO\\nhis\\tO\\nmaternal\\tO\\naunt\\tO\\n,\\tO\\nboth\\tO\\nof\\tO\\nwhom\\tO\\nsuffered\\tO\\na\\tO\\nmild\\tO\\nto\\tO\\nmoderate\\tO\\ndegree\\tO\\nof\\tO\\nmental\\tB-Disease\\nhandicap\\tI-Disease\\n.\\tO\\n\\nBoth\\tO\\nhad\\tO\\nan\\tO\\ninterstitial\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n5\\tO\\n(\\tO\\ndel\\tO\\n(\\tO\\n5\\tO\\n)\\tO\\n(\\tO\\nq22q23\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\n)\\tO\\n.\\tO\\n\\nTwo\\tO\\nother\\tO\\nnormal\\tO\\nfamily\\tO\\nmembers\\tO\\nhad\\tO\\nthe\\tO\\nunderlying\\tO\\ndirect\\tO\\ninsertion\\tO\\nof\\tO\\nchromosome\\tO\\n5\\tO\\n(\\tO\\ndir\\tO\\nins\\tO\\n(\\tO\\n5\\tO\\n)\\tO\\n(\\tO\\nq31\\tO\\n.\\tO\\n3q22q23\\tO\\n3q22q23\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\n)\\tO\\n.\\tO\\n\\nMolecular\\tO\\ngenetic\\tO\\nand\\tO\\nfluorescent\\tO\\nhybridisation\\tO\\nstudies\\tO\\nhave\\tO\\nshown\\tO\\nthat\\tO\\nloci\\tO\\nD5S37\\tO\\nand\\tO\\nD5S98\\tO\\nare\\tO\\noutside\\tO\\nthe\\tO\\ndeletion\\tO\\nwhereas\\tO\\nloci\\tO\\ndetected\\tO\\nby\\tO\\nprobes\\tO\\nEF5\\tO\\n.\\tO\\n\\n44\\tO\\nand\\tO\\nYN5\\tO\\n.\\tO\\n\\n48\\tO\\nare\\tO\\nlost\\tO\\n.\\tO\\n\\nAs\\tO\\nexpected\\tO\\n,\\tO\\nthe\\tO\\nmolecular\\tO\\nanalyses\\tO\\nindicate\\tO\\nloss\\tO\\nof\\tO\\none\\tO\\nallele\\tO\\nat\\tO\\nthe\\tO\\nMCC\\tO\\nand\\tO\\nAPC\\tB-Disease\\nloci\\tO\\n.\\tO\\n\\nThe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nis\\tO\\nlocated\\tO\\nwithin\\tO\\nband\\tO\\n5q22\\tO\\n.\\tO\\n\\nFamilial\\tO\\ndirect\\tO\\ninsertions\\tO\\nshould\\tO\\nbe\\tO\\nconsidered\\tO\\nas\\tO\\na\\tO\\ncause\\tO\\nof\\tO\\nrecurrent\\tO\\nmicrodeletion\\tO\\nsyndromes\\tO\\n.\\tO\\n\\nChromosome\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\nrod\\tO\\nphotoreceptor\\tO\\ncGMP\\tO\\nphosphodiesterase\\tO\\nbeta\\tO\\n-\\tO\\nsubunit\\tO\\ngene\\tO\\nin\\tO\\nmouse\\tO\\nand\\tO\\nhuman\\tO\\n:\\tO\\ntight\\tO\\nlinkage\\tO\\nto\\tO\\nthe\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\nregion\\tO\\n(\\tO\\n4p16\\tO\\n.\\tO\\n3\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nretinal\\tB-Disease\\ndegeneration\\tI-Disease\\nmouse\\tO\\n(\\tO\\ngene\\tO\\nsymbol\\tO\\n,\\tO\\nrd\\tO\\n)\\tO\\nis\\tO\\nan\\tO\\nanimal\\tO\\nmodel\\tO\\nfor\\tO\\ncertain\\tO\\nforms\\tO\\nof\\tO\\nhuman\\tO\\nhereditary\\tB-Disease\\nretinopathies\\tI-Disease\\n.\\tO\\n\\nRecent\\tO\\nfindings\\tO\\nof\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nrd\\tO\\nmouse\\tO\\nPDE\\tO\\nbeta\\tO\\n-\\tO\\nsubunit\\tO\\ngene\\tO\\n(\\tO\\nPdeb\\tO\\n)\\tO\\nprompted\\tO\\nus\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\nchromosome\\tO\\nlocations\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nand\\tO\\nhuman\\tO\\ngenes\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nutilized\\tO\\nbackcross\\tO\\nanalysis\\tO\\nin\\tO\\nmice\\tO\\nto\\tO\\nverify\\tO\\nand\\tO\\ndefine\\tO\\nmore\\tO\\nprecisely\\tO\\nthe\\tO\\nlocation\\tO\\nof\\tO\\nthe\\tO\\nPdeb\\tO\\nlocus\\tO\\n6\\tO\\n.\\tO\\n\\n1\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n2\\tO\\n.\\tO\\n\\n3\\tO\\ncM\\tO\\ndistal\\tO\\nof\\tO\\nMgsa\\tO\\non\\tO\\nmouse\\tO\\nchromosome\\tO\\n5\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndetermined\\tO\\nthat\\tO\\nthe\\tO\\nhuman\\tO\\ngene\\tO\\n(\\tO\\nPDEB\\tO\\n)\\tO\\nmaps\\tO\\nto\\tO\\n4p16\\tO\\n.\\tO\\n\\n3\\tO\\n,\\tO\\nvery\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nregion\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nthe\\tO\\ncomparative\\tO\\nmap\\tO\\nfor\\tO\\nmice\\tO\\nand\\tO\\nhumans\\tO\\nshows\\tO\\nthat\\tO\\nthe\\tO\\nmouse\\tO\\nhomologue\\tO\\nof\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\nwill\\tO\\nreside\\tO\\non\\tO\\nchromosome\\tO\\n5\\tO\\n.\\tO\\n\\nLinkage\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nPdeb\\tO\\nlocus\\tO\\nwith\\tO\\nother\\tO\\nhomologues\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\n4p16\\tO\\n.\\tO\\n\\n3\\tO\\nregion\\tO\\nis\\tO\\nmaintained\\tO\\nbut\\tO\\ngene\\tO\\norder\\tO\\nis\\tO\\nnot\\tO\\n,\\tO\\nsuggesting\\tO\\nat\\tO\\nleast\\tO\\nthree\\tO\\npossible\\tO\\nsites\\tO\\nfor\\tO\\nthe\\tO\\ncorresponding\\tO\\nmouse\\tO\\nHD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nCoincident\\tO\\nKaposi\\tB-Disease\\nsarcoma\\tI-Disease\\nand\\tO\\nT\\tB-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\nlymphoma\\tI-Disease\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nA\\tO\\n24\\tO\\nyear\\tO\\nold\\tO\\nmale\\tO\\nwith\\tO\\na\\tO\\nhistory\\tO\\nof\\tO\\neczema\\tB-Disease\\n,\\tO\\nrecurrent\\tO\\nmild\\tO\\ninfections\\tO\\n,\\tO\\nand\\tO\\nthrombocytopenia\\tB-Disease\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\npresented\\tO\\nwith\\tO\\na\\tO\\nmediastinal\\tO\\nmass\\tO\\n,\\tO\\ngeneralized\\tO\\nlymphadenopathy\\tB-Disease\\n,\\tO\\nsplenomegaly\\tB-Disease\\n,\\tO\\nand\\tO\\nsevere\\tO\\nthrombocytopenia\\tB-Disease\\n.\\tO\\n\\nStudies\\tO\\nof\\tO\\nimmune\\tO\\nfunction\\tO\\nincluding\\tO\\nimmunoglobulin\\tO\\nlevels\\tO\\nand\\tO\\nT\\tO\\n-\\tO\\ncell\\tO\\nsubsets\\tO\\nwere\\tO\\nnormal\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nhis\\tO\\nT\\tO\\nlymphocytes\\tO\\nproliferated\\tO\\nnormally\\tO\\nin\\tO\\nresponse\\tO\\nto\\tO\\nphytohemagglutinin\\tO\\n,\\tO\\nconcanavalin\\tO\\nA\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\ncombination\\tO\\nof\\tO\\nneuraminidase\\tO\\n/\\tO\\ngalactose\\tO\\noxidase\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\ntheir\\tO\\nproliferative\\tO\\nresponses\\tO\\nto\\tO\\nanti\\tO\\n-\\tO\\nCD43\\tO\\nantibody\\tO\\nand\\tO\\nperiodate\\tO\\nwere\\tO\\ndiminished\\tO\\n,\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nclinical\\tO\\ndiagnosis\\tO\\nof\\tO\\nWAS\\tB-Disease\\n.\\tO\\n\\nAn\\tO\\ninitial\\tO\\ninguinal\\tO\\nlymph\\tO\\nnode\\tO\\nbiopsy\\tO\\nsurprisingly\\tO\\nrevealed\\tO\\nKaposi\\tB-Disease\\nsarcoma\\tI-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nfollowing\\tO\\nsplenectomy\\tO\\nto\\tO\\nincrease\\tO\\nthe\\tO\\nplatelet\\tO\\ncount\\tO\\n,\\tO\\nbiopsy\\tO\\nof\\tO\\nthe\\tO\\nmediastinal\\tO\\nmass\\tO\\nrevealed\\tO\\nT\\tB-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\nlarge\\tI-Disease\\ncell\\tI-Disease\\nlymphoma\\tI-Disease\\n.\\tO\\n\\nStudies\\tO\\nof\\tO\\nbiopsied\\tO\\ntissue\\tO\\nfor\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nEpstein\\tB-Disease\\n-\\tI-Disease\\nBarr\\tI-Disease\\nvirus\\tI-Disease\\nand\\tO\\ncytomegalovirus\\tB-Disease\\nwere\\tO\\nnegative\\tO\\n,\\tO\\nas\\tO\\nwere\\tO\\nstudies\\tO\\nof\\tO\\nblood\\tO\\n,\\tO\\nincluding\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n,\\tO\\nfor\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tB-Disease\\nimmunodeficiency\\tI-Disease\\nvirus\\tI-Disease\\n(\\tO\\nHIV\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nreport\\tO\\nof\\tO\\nKaposi\\tB-Disease\\nsarcoma\\tI-Disease\\narising\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\na\\tO\\ncongenital\\tB-Disease\\nimmunodeficiency\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nAlthough\\tO\\nKaposi\\tB-Disease\\nsarcoma\\tI-Disease\\ncan\\tO\\narise\\tO\\nin\\tO\\nthe\\tO\\nface\\tO\\nof\\tO\\nthe\\tO\\nsevere\\tO\\nimmunosuppression\\tO\\nthat\\tO\\nfollows\\tO\\nallograft\\tO\\ntransplantation\\tO\\nand\\tO\\nin\\tO\\npatients\\tO\\ninfected\\tO\\nwith\\tO\\nHIV\\tB-Disease\\n,\\tO\\nwe\\tO\\npostulate\\tO\\nthat\\tO\\nlongevity\\tO\\nin\\tO\\nthe\\tO\\nface\\tO\\nof\\tO\\nmild\\tO\\nimmunosuppression\\tO\\nwas\\tO\\nthe\\tO\\nmajor\\tO\\nfactor\\tO\\nin\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nKaposi\\tB-Disease\\nsarcoma\\tI-Disease\\nin\\tO\\nthis\\tO\\npatient\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n,\\tO\\nresponsible\\tO\\nfor\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n,\\tO\\nis\\tO\\nmutated\\tO\\nin\\tO\\nhuman\\tO\\ngastric\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nAlthough\\tO\\ngastric\\tB-Disease\\ncancer\\tI-Disease\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\ncancer\\tB-Disease\\nin\\tO\\nthe\\tO\\nworld\\tO\\n,\\tO\\ngenetic\\tO\\nchanges\\tO\\nduring\\tO\\nits\\tO\\ncarcinogenesis\\tO\\nare\\tO\\nnot\\tO\\nwell\\tO\\nunderstood\\tO\\n.\\tO\\n\\nSince\\tO\\nsome\\tO\\ngastric\\tB-Disease\\ncancers\\tI-Disease\\nare\\tO\\nconsidered\\tO\\nto\\tO\\noriginate\\tO\\nfrom\\tO\\nthe\\tO\\nintestinal\\tO\\nmetaplasia\\tO\\n,\\tO\\nit\\tO\\nis\\tO\\nlikely\\tO\\nthat\\tO\\nthe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\ngene\\tO\\n,\\tO\\nthe\\tO\\nmutation\\tO\\nof\\tO\\nwhich\\tO\\ncauses\\tO\\nadenomatous\\tB-Disease\\npolyps\\tI-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\ncolon\\tI-Disease\\n,\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\ncarcinogenesis\\tO\\nof\\tO\\ngastric\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nBased\\tO\\non\\tO\\nthis\\tO\\nidea\\tO\\n,\\tO\\nDNAs\\tO\\nisolated\\tO\\nfrom\\tO\\ngastric\\tB-Disease\\ncancers\\tI-Disease\\nwere\\tO\\nexamined\\tO\\nby\\tO\\nmeans\\tO\\nof\\tO\\na\\tO\\nRNase\\tO\\nprotection\\tO\\nanalysis\\tO\\ncoupled\\tO\\nwith\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nfollowed\\tO\\nby\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nproducts\\tO\\n.\\tO\\n\\nBy\\tO\\nscreening\\tO\\nnearly\\tO\\none\\tO\\n-\\tO\\nhalf\\tO\\nof\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nin\\tO\\n44\\tO\\ntumors\\tB-Disease\\n,\\tO\\nsomatic\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nthree\\tO\\ntumors\\tB-Disease\\na\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\na\\tO\\n5\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\nframe\\tO\\nshift\\tO\\nwhich\\tO\\ncauses\\tO\\ntruncation\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nproduct\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nalso\\tO\\nplays\\tO\\nan\\tO\\nimportant\\tO\\nrole\\tO\\nduring\\tO\\nthe\\tO\\ncarcinogenesis\\tO\\nof\\tO\\nat\\tO\\nleast\\tO\\nsome\\tO\\ngastric\\tB-Disease\\ncancers\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nA\\tO\\n71\\tO\\n-\\tO\\nkilodalton\\tO\\nprotein\\tO\\nis\\tO\\na\\tO\\nmajor\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ngene\\tO\\nin\\tO\\nbrain\\tO\\nand\\tO\\nother\\tO\\nnonmuscle\\tO\\ntissues\\tO\\n.\\tO\\n\\nThe\\tO\\nknown\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\ngene\\tO\\nproducts\\tO\\n,\\tO\\nthe\\tO\\nmuscle\\tO\\n-\\tO\\nand\\tO\\nbrain\\tO\\n-\\tO\\ntype\\tO\\ndystrophin\\tO\\nisoforms\\tO\\n,\\tO\\nare\\tO\\n427\\tO\\n-\\tO\\nkDa\\tO\\nproteins\\tO\\ntranslated\\tO\\nfrom\\tO\\n14\\tO\\n-\\tO\\nkilobase\\tO\\n(\\tO\\nkb\\tO\\n)\\tO\\nmRNAs\\tO\\n.\\tO\\n\\nRecently\\tO\\nwe\\tO\\ndescribed\\tO\\na\\tO\\n6\\tO\\n.\\tO\\n\\n5\\tO\\n-\\tO\\nkb\\tO\\nmRNA\\tO\\nthat\\tO\\nalso\\tO\\nis\\tO\\ntranscribed\\tO\\nfrom\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nCloning\\tO\\nand\\tO\\nin\\tO\\nvitro\\tO\\ntranscription\\tO\\nand\\tO\\ntranslation\\tO\\nof\\tO\\nthe\\tO\\nentire\\tO\\ncoding\\tO\\nregion\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\n6\\tO\\n.\\tO\\n\\n5\\tO\\n-\\tO\\nkb\\tO\\nmRNA\\tO\\nencodes\\tO\\na\\tO\\n70\\tO\\n.\\tO\\n\\n8\\tO\\n-\\tO\\nkDa\\tO\\nprotein\\tO\\nthat\\tO\\nis\\tO\\na\\tO\\nmajor\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nIt\\tO\\ncontains\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nand\\tO\\nthe\\tO\\ncysteine\\tO\\n-\\tO\\nrich\\tO\\ndomains\\tO\\nof\\tO\\ndystrophin\\tO\\n,\\tO\\nseven\\tO\\nadditional\\tO\\namino\\tO\\nacids\\tO\\nat\\tO\\nthe\\tO\\nN\\tO\\nterminus\\tO\\n,\\tO\\nand\\tO\\nsome\\tO\\nmodifications\\tO\\nformed\\tO\\nby\\tO\\nalternative\\tO\\nsplicing\\tO\\nin\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\ndomain\\tO\\n.\\tO\\n\\nIt\\tO\\nlacks\\tO\\nthe\\tO\\nentire\\tO\\nlarge\\tO\\ndomain\\tO\\nof\\tO\\nspectrin\\tO\\n-\\tO\\nlike\\tO\\nrepeats\\tO\\nand\\tO\\nthe\\tO\\nactin\\tO\\n-\\tO\\nbinding\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\ndomain\\tO\\nof\\tO\\ndystrophin\\tO\\n.\\tO\\n\\nThis\\tO\\nprotein\\tO\\nis\\tO\\nthe\\tO\\nmajor\\tO\\nDMD\\tB-Disease\\ngene\\tO\\nproduct\\tO\\nin\\tO\\nbrain\\tO\\nand\\tO\\nother\\tO\\nnonmuscle\\tO\\ntissues\\tO\\nbut\\tO\\nis\\tO\\nundetectable\\tO\\nin\\tO\\nskeletal\\tO\\nmuscle\\tO\\nextracts\\tO\\n.\\tO\\n\\nCorrelation\\tO\\nbetween\\tO\\nthe\\tO\\nlocation\\tO\\nof\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nand\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\npolyps\\tI-Disease\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nRecently\\tO\\nwe\\tO\\nhave\\tO\\nisolated\\tO\\nthe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\ngene\\tO\\nwhich\\tO\\ncauses\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\n,\\tO\\nand\\tO\\nits\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\nsubstantial\\tO\\nnumber\\tO\\nof\\tO\\nFAP\\tB-Disease\\npatients\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthis\\tO\\ninformation\\tO\\n,\\tO\\nwe\\tO\\ncompared\\tO\\nthe\\tO\\nlocation\\tO\\nof\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nin\\tO\\n22\\tO\\nunrelated\\tO\\npatients\\tO\\n(\\tO\\n12\\tO\\nof\\tO\\nwhom\\tO\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\npreviously\\tO\\n)\\tO\\nwith\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\npolyps\\tI-Disease\\ndeveloped\\tO\\nin\\tO\\nFAP\\tB-Disease\\npatients\\tO\\n;\\tO\\n17\\tO\\nwere\\tO\\nsparse\\tO\\ntypes\\tO\\nand\\tO\\nfive\\tO\\nwere\\tO\\nprofuse\\tO\\ntypes\\tO\\n.\\tO\\n\\nAll\\tO\\nbut\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nwere\\tO\\nconsidered\\tO\\nto\\tO\\ncause\\tO\\ntruncation\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nproduct\\tO\\nby\\tO\\nframe\\tO\\n-\\tO\\nshift\\tO\\ndue\\tO\\nto\\tO\\ndeletion\\tO\\n(\\tO\\n14\\tO\\ncases\\tO\\n)\\tO\\nor\\tO\\nnonsense\\tO\\nmutation\\tO\\n(\\tO\\nseven\\tO\\ncases\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nlocation\\tO\\nof\\tO\\nthe\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nseems\\tO\\nto\\tO\\ncorrelate\\tO\\nwith\\tO\\nthe\\tO\\ntwo\\tO\\nclinical\\tO\\ntypes\\tO\\n;\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nfive\\tO\\nFAP\\tB-Disease\\npatients\\tO\\nwith\\tO\\nprofuse\\tO\\npolyps\\tB-Disease\\nwere\\tO\\nobserved\\tO\\nbetween\\tO\\ncodon\\tO\\n1250\\tO\\nand\\tO\\ncodon\\tO\\n1464\\tO\\n,\\tO\\nwhereas\\tO\\nmutations\\tO\\nin\\tO\\n17\\tO\\nFAP\\tB-Disease\\npatients\\tO\\nwith\\tO\\nfewer\\tO\\npolyps\\tB-Disease\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\nother\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nresult\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\npolyps\\tI-Disease\\nin\\tO\\nFAP\\tB-Disease\\npatients\\tO\\nmay\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\ndifference\\tO\\nin\\tO\\nthe\\tO\\nstability\\tO\\nor\\tO\\nbiological\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\ntruncated\\tO\\nAPC\\tB-Disease\\nprotein\\tO\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nand\\tO\\nrapid\\tO\\ndetection\\tO\\nof\\tO\\nthree\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nMoroccan\\tO\\nJewish\\tO\\npopulation\\tO\\n.\\tO\\n\\nInfantile\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\nthat\\tO\\nresult\\tO\\nin\\tO\\nthe\\tO\\ncomplete\\tO\\nabsence\\tO\\nof\\tO\\nbeta\\tO\\n-\\tO\\nhexosaminidase\\tO\\nA\\tO\\nactivity\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nwell\\tO\\nknown\\tO\\nthat\\tO\\nan\\tO\\nelevated\\tO\\nfrequency\\tO\\nof\\tO\\nTSD\\tB-Disease\\nmutations\\tO\\nexists\\tO\\namong\\tO\\nAshkenazi\\tO\\nJews\\tO\\n.\\tO\\n\\nMore\\tO\\nrecently\\tO\\nit\\tO\\nhas\\tO\\nbecome\\tO\\napparent\\tO\\nthat\\tO\\nelevated\\tO\\ncarrier\\tO\\nfrequencies\\tO\\nfor\\tO\\nTSD\\tB-Disease\\nalso\\tO\\noccur\\tO\\nin\\tO\\nseveral\\tO\\nother\\tO\\nethnic\\tO\\ngroups\\tO\\n,\\tO\\nincluding\\tO\\nMoroccan\\tO\\nJews\\tO\\n,\\tO\\na\\tO\\nsubgroup\\tO\\nof\\tO\\nSephardic\\tO\\nJews\\tO\\n.\\tO\\n\\nElsewhere\\tO\\nwe\\tO\\nreported\\tO\\nan\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletion\\tO\\nof\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nadjacent\\tO\\nphenylalanine\\tO\\ncodons\\tO\\nat\\tO\\nposition\\tO\\n304\\tO\\nor\\tO\\n305\\tO\\n(\\tO\\ndelta\\tO\\nF304\\tO\\n/\\tO\\n305\\tO\\n)\\tO\\nin\\tO\\none\\tO\\nHEXA\\tO\\nallele\\tO\\nof\\tO\\na\\tO\\nMoroccan\\tO\\nJewish\\tO\\nTSD\\tB-Disease\\npatient\\tO\\nand\\tO\\nin\\tO\\nthree\\tO\\nobligate\\tO\\ncarriers\\tO\\nfrom\\tO\\nsix\\tO\\nunrelated\\tO\\nMoroccan\\tO\\nJewish\\tO\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nnow\\tO\\nidentified\\tO\\ntwo\\tO\\nadditional\\tO\\nmutations\\tO\\nwithin\\tO\\nexon\\tO\\n5\\tO\\nof\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\nthat\\tO\\naccount\\tO\\nfor\\tO\\nthe\\tO\\nremaining\\tO\\nTSD\\tB-Disease\\nalleles\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\nand\\tO\\ncarriers\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nis\\tO\\na\\tO\\nnovel\\tO\\nC\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nG\\tO\\ntransversion\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\nreplacement\\tO\\nof\\tO\\nTyr180\\tO\\nby\\tO\\na\\tO\\nstop\\tO\\ncodon\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nmutation\\tO\\nis\\tO\\na\\tO\\nG\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nA\\tO\\ntransition\\tO\\nresulting\\tO\\nin\\tO\\nan\\tO\\nArg170\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nGln\\tO\\nsubstitution\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nis\\tO\\nat\\tO\\na\\tO\\nCpG\\tO\\nsite\\tO\\nin\\tO\\na\\tO\\nJapanese\\tO\\ninfant\\tO\\nwith\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nand\\tO\\nwas\\tO\\ndescribed\\tO\\nelsewhere\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nnine\\tO\\nobligate\\tO\\ncarriers\\tO\\nfrom\\tO\\nseven\\tO\\nunrelated\\tO\\nfamilies\\tO\\nshowed\\tO\\nthat\\tO\\nfour\\tO\\nharbor\\tO\\nthe\\tO\\ndelta\\tO\\nF304\\tO\\n/\\tO\\n305\\tO\\nmutation\\tO\\n,\\tO\\ntwo\\tO\\nthe\\tO\\nArg170\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nGln\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\none\\tO\\nthe\\tO\\nTyr180\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nStop\\tO\\nmutation\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nhave\\tO\\ndeveloped\\tO\\nrapid\\tO\\n,\\tO\\nnonradioactive\\tO\\nassays\\tO\\nfor\\tO\\nthe\\tO\\ndetection\\tO\\nof\\tO\\neach\\tO\\nmutation\\tO\\n,\\tO\\nwhich\\tO\\nshould\\tO\\nbe\\tO\\nhelpful\\tO\\nfor\\tO\\ncarrier\\tO\\nscreening\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\ncharacterization\\tO\\nof\\tO\\nglucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nby\\tO\\nnatural\\tO\\nand\\tO\\namplification\\tO\\ncreated\\tO\\nrestriction\\tO\\nsites\\tO\\n:\\tO\\nfive\\tO\\nmutations\\tO\\naccount\\tO\\nfor\\tO\\nmost\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\ncases\\tO\\nin\\tO\\nTaiwan\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndeveloped\\tO\\na\\tO\\nrapid\\tO\\nand\\tO\\nsimple\\tO\\nmethod\\tO\\nto\\tO\\ndiagnose\\tO\\nthe\\tO\\nmolecular\\tO\\ndefects\\tO\\nof\\tO\\nglucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nChinese\\tO\\nin\\tO\\nTaiwan\\tO\\n.\\tO\\n\\nThis\\tO\\nmethod\\tO\\ninvolves\\tO\\nthe\\tO\\nselective\\tO\\namplification\\tO\\nof\\tO\\na\\tO\\nDNA\\tO\\nfragment\\tO\\nfrom\\tO\\nhuman\\tO\\nG6PD\\tO\\ngene\\tO\\nwith\\tO\\nspecific\\tO\\noligonucleotide\\tO\\nprimers\\tO\\nfollowed\\tO\\nby\\tO\\ndigestion\\tO\\nwith\\tO\\nrestriction\\tO\\nenzymes\\tO\\nthat\\tO\\nrecognize\\tO\\nartificially\\tO\\ncreated\\tO\\nor\\tO\\nnaturally\\tO\\noccurring\\tO\\nrestriction\\tO\\nsites\\tO\\n.\\tO\\n\\nNinety\\tO\\n-\\tO\\nfour\\tO\\nChinese\\tO\\nmales\\tO\\nwith\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nwere\\tO\\nstudied\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nshow\\tO\\nthat\\tO\\n50\\tO\\n%\\tO\\n(\\tO\\n47\\tO\\nof\\tO\\n94\\tO\\n)\\tO\\nwere\\tO\\nG\\tO\\nto\\tO\\nT\\tO\\nmutation\\tO\\nat\\tO\\nnucleotide\\tO\\n(\\tO\\nnt\\tO\\n)\\tO\\n1376\\tO\\n,\\tO\\n21\\tO\\n.\\tO\\n\\n3\\tO\\n%\\tO\\n(\\tO\\n20\\tO\\nof\\tO\\n94\\tO\\n)\\tO\\nwere\\tO\\nG\\tO\\nto\\tO\\nA\\tO\\nmutation\\tO\\nat\\tO\\nnt\\tO\\n1388\\tO\\n,\\tO\\n7\\tO\\n.\\tO\\n\\n4\\tO\\n%\\tO\\n(\\tO\\n7\\tO\\nof\\tO\\n94\\tO\\n)\\tO\\nwere\\tO\\nA\\tO\\nto\\tO\\nG\\tO\\nmutation\\tO\\nat\\tO\\nnt\\tO\\n493\\tO\\n,\\tO\\n7\\tO\\n.\\tO\\n\\n4\\tO\\n%\\tO\\n(\\tO\\n7\\tO\\nof\\tO\\n94\\tO\\n)\\tO\\nwere\\tO\\nA\\tO\\nto\\tO\\nG\\tO\\nmutation\\tO\\nat\\tO\\nnt\\tO\\n95\\tO\\n,\\tO\\n4\\tO\\n.\\tO\\n\\n2\\tO\\n%\\tO\\n(\\tO\\n4\\tO\\nof\\tO\\n94\\tO\\n)\\tO\\nwere\\tO\\nC\\tO\\nto\\tO\\nT\\tO\\nmutation\\tO\\nat\\tO\\nnt\\tO\\n1024\\tO\\n,\\tO\\n1\\tO\\n.\\tO\\n\\n1\\tO\\n%\\tO\\n(\\tO\\n1\\tO\\nof\\tO\\n94\\tO\\n)\\tO\\nwas\\tO\\nG\\tO\\nto\\tO\\nT\\tO\\nmutation\\tO\\nat\\tO\\nnt\\tO\\n392\\tO\\n,\\tO\\nand\\tO\\n1\\tO\\n.\\tO\\n\\n1\\tO\\n%\\tO\\n(\\tO\\n1\\tO\\nof\\tO\\n94\\tO\\n)\\tO\\nwas\\tO\\nG\\tO\\nto\\tO\\nA\\tO\\nmutation\\tO\\nat\\tO\\nnt\\tO\\n487\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nformer\\tO\\nfive\\tO\\nmutations\\tO\\naccount\\tO\\nfor\\tO\\nmore\\tO\\nthan\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\ncases\\tO\\nin\\tO\\nTaiwan\\tO\\n.\\tO\\n\\nAside\\tO\\nfrom\\tO\\nshowing\\tO\\nthat\\tO\\nG\\tO\\nto\\tO\\nT\\tO\\nchange\\tO\\nat\\tO\\nnt\\tO\\n1376\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nmutation\\tO\\n,\\tO\\nour\\tO\\nresearch\\tO\\nindicates\\tO\\nthat\\tO\\nnt\\tO\\n493\\tO\\nmutation\\tO\\nis\\tO\\na\\tO\\nfrequent\\tO\\nmutation\\tO\\namong\\tO\\nChinese\\tO\\nin\\tO\\nTaiwan\\tO\\n.\\tO\\n\\nWe\\tO\\ncompared\\tO\\nG6PD\\tO\\nactivity\\tO\\namong\\tO\\ndifferent\\tO\\nmutations\\tO\\n,\\tO\\nwithout\\tO\\ndiscovering\\tO\\nsignificant\\tO\\ndifferences\\tO\\nbetween\\tO\\nthem\\tO\\n.\\tO\\n\\nEight\\tO\\nnovel\\tO\\ninactivating\\tO\\ngerm\\tO\\nline\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nidentified\\tO\\nby\\tO\\ndenaturing\\tO\\ngradient\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\ndominantly\\tO\\ninherited\\tO\\ncondition\\tO\\npredisposing\\tO\\nto\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nrecent\\tO\\nisolation\\tO\\nof\\tO\\nthe\\tO\\nresponsible\\tO\\ngene\\tO\\n(\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\nor\\tO\\nAPC\\tB-Disease\\n)\\tO\\nhas\\tO\\nfacilitated\\tO\\nthe\\tO\\nsearch\\tO\\nfor\\tO\\ngerm\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\naffected\\tO\\nindividuals\\tO\\n.\\tO\\n\\nPrevious\\tO\\nauthors\\tO\\nhave\\tO\\nused\\tO\\nthe\\tO\\nRNase\\tO\\nprotection\\tO\\nassay\\tO\\nand\\tO\\nthe\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphisms\\tO\\nprocedure\\tO\\nto\\tO\\nscreen\\tO\\nfor\\tO\\nmutations\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\nwe\\tO\\nused\\tO\\ndenaturing\\tO\\ngradient\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n(\\tO\\nDGGE\\tO\\n)\\tO\\n.\\tO\\n\\nDGGE\\tO\\nanalysis\\tO\\nof\\tO\\n10\\tO\\nAPC\\tB-Disease\\nexons\\tO\\n(\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n,\\tO\\n7\\tO\\n,\\tO\\n8\\tO\\n,\\tO\\n9\\tO\\n,\\tO\\n10\\tO\\n,\\tO\\n12\\tO\\n,\\tO\\n13\\tO\\n,\\tO\\n14\\tO\\n,\\tO\\nand\\tO\\npart\\tO\\nof\\tO\\n15\\tO\\n)\\tO\\nin\\tO\\n33\\tO\\nunrelated\\tO\\nDutch\\tO\\nFAP\\tB-Disease\\npatients\\tO\\nhas\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\neight\\tO\\nnovel\\tO\\ngerm\\tO\\nline\\tO\\nmutations\\tO\\nresulting\\tO\\nin\\tO\\nstop\\tO\\ncodons\\tO\\nor\\tO\\nframeshifts\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nreported\\tO\\nhere\\tO\\nindicate\\tO\\nthat\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\nan\\tO\\nextremely\\tO\\nheterogeneous\\tO\\nspectrum\\tO\\nof\\tO\\npoint\\tO\\nmutations\\tO\\n;\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nall\\tO\\nthe\\tO\\nmutations\\tO\\nfound\\tO\\nin\\tO\\nthis\\tO\\nstudy\\tO\\nare\\tO\\nchain\\tO\\nterminating\\tO\\n;\\tO\\nand\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\nDGGE\\tO\\nrepresents\\tO\\na\\tO\\nrapid\\tO\\nand\\tO\\nsensitive\\tO\\ntechnique\\tO\\nfor\\tO\\nthe\\tO\\ndetection\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nunusually\\tO\\nlarge\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nAn\\tO\\nextension\\tO\\nof\\tO\\nthe\\tO\\nDGGE\\tO\\nanalysis\\tO\\nto\\tO\\nthe\\tO\\nentire\\tO\\ncoding\\tO\\nregion\\tO\\nin\\tO\\na\\tO\\nsufficient\\tO\\nnumber\\tO\\nof\\tO\\nclinically\\tO\\nwell\\tO\\n-\\tO\\ncharacterized\\tO\\n,\\tO\\nunrelated\\tO\\npatients\\tO\\nwill\\tO\\nfacilitate\\tO\\nthe\\tO\\nestablishment\\tO\\nof\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nother\\tO\\nhand\\tO\\n,\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nan\\tO\\nextremely\\tO\\nheterogeneous\\tO\\nspectrum\\tO\\nof\\tO\\nmutations\\tO\\nspread\\tO\\nthroughout\\tO\\nthe\\tO\\nentire\\tO\\nlength\\tO\\nof\\tO\\nthe\\tO\\nlarge\\tO\\nAPC\\tB-Disease\\ngene\\tO\\namong\\tO\\nthe\\tO\\nFAP\\tB-Disease\\npatients\\tO\\nindicates\\tO\\nthat\\tO\\nthis\\tO\\napproach\\tO\\nmay\\tO\\nnot\\tO\\nbe\\tO\\nuseful\\tO\\nas\\tO\\na\\tO\\nrapid\\tO\\npresymptomatic\\tO\\ndiagnostic\\tO\\nprocedure\\tO\\nin\\tO\\na\\tO\\nroutine\\tO\\nlaboratory\\tO\\n.\\tO\\n\\nNevertheless\\tO\\n,\\tO\\nthe\\tO\\nabove\\tO\\nDGGE\\tO\\napproach\\tO\\nhas\\tO\\nincidentally\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\ncommon\\tO\\npolymorphism\\tO\\nin\\tO\\nexon\\tO\\n13\\tO\\n.\\tO\\n\\nSuch\\tO\\nintragenic\\tO\\npolymorphisms\\tO\\noffer\\tO\\na\\tO\\npractical\\tO\\napproach\\tO\\nto\\tO\\na\\tO\\nmore\\tO\\nrapid\\tO\\nprocedure\\tO\\nfor\\tO\\npresymptomatic\\tO\\ndiagnosis\\tO\\nof\\tO\\nFAP\\tB-Disease\\nby\\tO\\nlinkage\\tO\\nanalysis\\tO\\nin\\tO\\ninformative\\tO\\nfamilies\\tO\\n.\\tO\\n.\\tO\\n\\nYeast\\tO\\nartificial\\tO\\nchromosomes\\tO\\nfor\\tO\\nthe\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nfamilial\\tB-Disease\\npolyposis\\tI-Disease\\nAPC\\tI-Disease\\ngene\\tO\\nregion\\tO\\n.\\tO\\n\\nTwo\\tO\\nyeast\\tO\\nartificial\\tO\\nchromosomes\\tO\\n(\\tO\\nYACs\\tO\\n)\\tO\\nspanning\\tO\\na\\tO\\ntotal\\tO\\ndistance\\tO\\nof\\tO\\n1\\tO\\n.\\tO\\n\\n1\\tO\\nmegabase\\tO\\npairs\\tO\\nof\\tO\\nDNA\\tO\\naround\\tO\\nthe\\tO\\nMCC\\tO\\n(\\tO\\nfor\\tO\\nmutated\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncarcinoma\\tI-Disease\\n)\\tO\\nand\\tO\\nAPC\\tB-Disease\\n(\\tO\\nfor\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n)\\tO\\ngenes\\tO\\nat\\tO\\n5q21\\tO\\nhave\\tO\\nbeen\\tO\\nisolated\\tO\\nand\\tO\\ncharacterized\\tO\\n.\\tO\\n\\nStarting\\tO\\nfrom\\tO\\nthe\\tO\\nMCC\\tO\\ngene\\tO\\n,\\tO\\na\\tO\\nstrategy\\tO\\nwas\\tO\\nundertaken\\tO\\nto\\tO\\nidentify\\tO\\nconstitutional\\tO\\nsubmicroscopic\\tO\\ndeletions\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\npatients\\tO\\nthat\\tO\\nmight\\tO\\nconsiderably\\tO\\nnarrow\\tO\\ndown\\tO\\nthe\\tO\\nposition\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nTo\\tO\\nthis\\tO\\nend\\tO\\n,\\tO\\nYACs\\tO\\nidentified\\tO\\nby\\tO\\nthe\\tO\\nMCC\\tO\\ngene\\tO\\nwere\\tO\\nscreened\\tO\\nacross\\tO\\na\\tO\\nchromosome\\tO\\n5\\tO\\n-\\tO\\nspecific\\tO\\ncosmid\\tO\\nlibrary\\tO\\nto\\tO\\nprovide\\tO\\na\\tO\\nsource\\tO\\nof\\tO\\nDNA\\tO\\nprobes\\tO\\nfor\\tO\\ngenomic\\tO\\nscanning\\tO\\n.\\tO\\n\\nThe\\tO\\ncosmids\\tO\\nisolated\\tO\\nfrom\\tO\\nthese\\tO\\nexperiments\\tO\\nwere\\tO\\nused\\tO\\nto\\tO\\nscreen\\tO\\na\\tO\\npanel\\tO\\nof\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrids\\tO\\ncontaining\\tO\\nchromosome\\tO\\n5\\tO\\nsegregated\\tO\\nfrom\\tO\\npatients\\tO\\nsuspected\\tO\\nto\\tO\\ncarry\\tO\\nputative\\tO\\ninterstitial\\tO\\ndeletions\\tO\\n.\\tO\\n\\nThis\\tO\\nscreening\\tO\\napproach\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nconfirmation\\tO\\nof\\tO\\na\\tO\\nsmall\\tO\\nheterozygous\\tO\\ndeletion\\tO\\nin\\tO\\na\\tO\\npolyposis\\tB-Disease\\npatient\\tO\\nthat\\tO\\noverlaps\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nisolated\\tO\\nYACs\\tO\\n.\\tO\\n\\nThis\\tO\\nYAC\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\ncontain\\tO\\nthe\\tO\\nentire\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n,\\tO\\nin\\tO\\naddition\\tO\\nto\\tO\\na\\tO\\nsignificant\\tO\\nportion\\tO\\nof\\tO\\nDNA\\tO\\nflanking\\tO\\nthe\\tO\\n5\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nshould\\tO\\ntherefore\\tO\\nprove\\tO\\na\\tO\\nvaluable\\tO\\nresource\\tO\\nfor\\tO\\nfunctional\\tO\\nstudies\\tO\\nby\\tO\\ntransfer\\tO\\nto\\tO\\ncolorectal\\tB-Disease\\ntumor\\tI-Disease\\n-\\tO\\nderived\\tO\\ncell\\tO\\nlines\\tO\\n.\\tO\\n\\nInherited\\tO\\nWT1\\tO\\nmutation\\tO\\nin\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nPatients\\tO\\nwith\\tO\\nthe\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\n,\\tO\\ngenital\\tB-Disease\\nanomalies\\tI-Disease\\n,\\tO\\nand\\tO\\nnephropathy\\tB-Disease\\n)\\tO\\nhave\\tO\\nbeen\\tO\\ndemonstrated\\tO\\nto\\tO\\ncarry\\tO\\nde\\tO\\nnovo\\tO\\nconstitutional\\tO\\nmutations\\tO\\nin\\tO\\nWT1\\tO\\n,\\tO\\nthe\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\ngene\\tO\\nat\\tO\\nchromosome\\tO\\n11p13\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nthree\\tO\\nnew\\tO\\ncases\\tO\\n,\\tO\\ntwo\\tO\\ncarrying\\tO\\na\\tO\\npreviously\\tO\\ndescribed\\tO\\nWT1\\tO\\nexon\\tO\\n9\\tO\\nmutation\\tO\\nand\\tO\\none\\tO\\nwith\\tO\\na\\tO\\nnovel\\tO\\nWT1\\tO\\nexon\\tO\\n8\\tO\\nmutation\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nunlike\\tO\\npatients\\tO\\nin\\tO\\nprevious\\tO\\nreports\\tO\\n,\\tO\\none\\tO\\nof\\tO\\nour\\tO\\nthree\\tO\\npatients\\tO\\ninherited\\tO\\nthe\\tO\\naffected\\tO\\nallele\\tO\\nfrom\\tO\\nhis\\tO\\nphenotypically\\tO\\nunaffected\\tO\\nfather\\tO\\n.\\tO\\n\\nThis\\tO\\nobservation\\tO\\nindicates\\tO\\nthat\\tO\\nthe\\tO\\nWT1\\tO\\nexon\\tO\\n9\\tO\\nmutation\\tO\\naffecting\\tO\\n394Arg\\tO\\ndemonstrated\\tO\\nin\\tO\\nover\\tO\\none\\tO\\n-\\tO\\nhalf\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\nmay\\tO\\nexhibit\\tO\\nincomplete\\tO\\npenetrance\\tO\\n.\\tO\\n\\nConsequently\\tO\\n,\\tO\\nfamilial\\tO\\nstudies\\tO\\nin\\tO\\npatients\\tO\\naffected\\tO\\nby\\tO\\nthis\\tO\\nsyndrome\\tO\\nare\\tO\\nrecommended\\tO\\n.\\tO\\n.\\tO\\n\\nSubmicroscopic\\tO\\ndeletions\\tO\\nat\\tO\\nthe\\tO\\nWAGR\\tB-Disease\\nlocus\\tO\\n,\\tO\\nrevealed\\tO\\nby\\tO\\nnonradioactive\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n.\\tO\\n\\nFluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n(\\tO\\nFISH\\tO\\n)\\tO\\nwith\\tO\\nbiotin\\tO\\n-\\tO\\nlabeled\\tO\\nprobes\\tO\\nmapping\\tO\\nto\\tO\\n11p13\\tO\\nhas\\tO\\nbeen\\tO\\nused\\tO\\nfor\\tO\\nthe\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\ndeletions\\tO\\nof\\tO\\nthe\\tO\\nWAGR\\tB-Disease\\n(\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\n,\\tO\\naniridia\\tB-Disease\\n,\\tO\\ngenitourinary\\tB-Disease\\nabnormalities\\tI-Disease\\n,\\tO\\nand\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n)\\tO\\nlocus\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndetected\\tO\\na\\tO\\nsubmicroscopic\\tO\\n11p13\\tO\\ndeletion\\tO\\nin\\tO\\na\\tO\\nchild\\tO\\nwith\\tO\\ninherited\\tO\\naniridia\\tB-Disease\\nwho\\tO\\nsubsequently\\tO\\npresented\\tO\\nwith\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\nin\\tO\\na\\tO\\nhorseshoe\\tO\\nkidney\\tO\\n,\\tO\\nonly\\tO\\nrevealed\\tO\\nat\\tO\\nsurgery\\tO\\n.\\tO\\n\\nThe\\tO\\nmother\\tO\\n,\\tO\\nwho\\tO\\nhas\\tO\\naniridia\\tB-Disease\\n,\\tO\\nwas\\tO\\nalso\\tO\\nfound\\tO\\nto\\tO\\ncarry\\tO\\na\\tO\\ndeletion\\tO\\nincluding\\tO\\nboth\\tO\\nthe\\tO\\naniridia\\tB-Disease\\ncandidate\\tO\\ngene\\tO\\n(\\tO\\nAN2\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\npredisposition\\tO\\ngene\\tO\\n(\\tO\\nWT1\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\ntherefore\\tO\\na\\tO\\nrare\\tO\\ncase\\tO\\nof\\tO\\nan\\tO\\ninherited\\tO\\nWAGR\\tB-Disease\\ndeletion\\tO\\n.\\tO\\n\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\nhas\\tO\\nso\\tO\\nfar\\tO\\nonly\\tO\\nbeen\\tO\\nassociated\\tO\\nwith\\tO\\nsporadic\\tO\\nde\\tO\\nnovo\\tO\\naniridia\\tB-Disease\\ncases\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nshown\\tO\\nthat\\tO\\na\\tO\\ncosmid\\tO\\nprobe\\tO\\nfor\\tO\\na\\tO\\ncandidate\\tO\\naniridia\\tB-Disease\\ngene\\tO\\n,\\tO\\nhomologous\\tO\\nto\\tO\\nthe\\tO\\nmouse\\tO\\nPax\\tO\\n-\\tO\\n6\\tO\\ngene\\tO\\n,\\tO\\nis\\tO\\ndeleted\\tO\\nin\\tO\\ncell\\tO\\nlines\\tO\\nfrom\\tO\\naniridia\\tB-Disease\\npatients\\tO\\nwith\\tO\\npreviously\\tO\\ncharacterized\\tO\\ndeletions\\tO\\nat\\tO\\n11p13\\tO\\n,\\tO\\nwhile\\tO\\nanother\\tO\\ncosmid\\tO\\nmarker\\tO\\nmapping\\tO\\nbetween\\tO\\ntwo\\tO\\naniridia\\tB-Disease\\n-\\tO\\nassociated\\tO\\ntranslocation\\tO\\nbreakpoints\\tO\\n(\\tO\\nand\\tO\\nhence\\tO\\na\\tO\\nsecond\\tO\\ncandidate\\tO\\nmarker\\tO\\n)\\tO\\nis\\tO\\npresent\\tO\\non\\tO\\nboth\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsupport\\tO\\nthe\\tO\\nPax\\tO\\n-\\tO\\n6\\tO\\nhomologue\\tO\\nas\\tO\\na\\tO\\nstrong\\tO\\ncandidate\\tO\\nfor\\tO\\nthe\\tO\\nAN2\\tO\\ngene\\tO\\n.\\tO\\n\\nFISH\\tO\\nwith\\tO\\ncosmid\\tO\\nprobes\\tO\\nhas\\tO\\nproved\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nfast\\tO\\nand\\tO\\nreliable\\tO\\ntechnique\\tO\\nfor\\tO\\nthe\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\ndeletions\\tO\\n.\\tO\\n\\nIt\\tO\\ncan\\tO\\nbe\\tO\\nused\\tO\\nwith\\tO\\nlimited\\tO\\namounts\\tO\\nof\\tO\\nmaterial\\tO\\nand\\tO\\nhas\\tO\\nstrong\\tO\\npotential\\tO\\nfor\\tO\\nclinical\\tO\\napplications\\tO\\n.\\tO\\n.\\tO\\n\\nLinkage\\tO\\nof\\tO\\ngene\\tO\\nfor\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nthe\\tO\\nmajor\\tO\\nhistocompatibility\\tO\\ncomplex\\tO\\nMHC\\tO\\nin\\tO\\nman\\tO\\n.\\tO\\n\\nFamily\\tO\\nstudy\\tO\\nof\\tO\\na\\tO\\nfurther\\tO\\ncase\\tO\\n.\\tO\\n\\nClose\\tO\\nlinkage\\tO\\nbetween\\tO\\nHL\\tO\\n-\\tO\\nA\\tO\\nand\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\nfirst\\tO\\nreported\\tO\\nby\\tO\\nFU\\tO\\nand\\tO\\nco\\tO\\n-\\tO\\nworkers\\tO\\nin\\tO\\n1974\\tO\\n.\\tO\\n\\nWe\\tO\\npresent\\tO\\nhere\\tO\\na\\tO\\npedigree\\tO\\nof\\tO\\na\\tO\\n31\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nC2\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nindividual\\tO\\nwith\\tO\\nclinical\\tO\\nmanifestations\\tO\\nof\\tO\\nHodgkins\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nfollowing\\tO\\nmarkers\\tO\\nwere\\tO\\ntested\\tO\\nC2\\tO\\nlevels\\tO\\n,\\tO\\nfactor\\tO\\nB\\tO\\npolymorphism\\tO\\n,\\tO\\nblood\\tO\\ngroups\\tO\\n,\\tO\\nand\\tO\\nenzyme\\tO\\ntyping\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\nto\\tO\\nclose\\tO\\nlinkage\\tO\\nbetween\\tO\\nHL\\tO\\n-\\tO\\nA\\tO\\nand\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nboth\\tO\\nparents\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nBf\\tO\\n(\\tO\\nHL\\tO\\n-\\tO\\nA\\tO\\nlinked\\tO\\n,\\tO\\nelectrophoretic\\tO\\nvariation\\tO\\nof\\tO\\nB\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ntwo\\tO\\nHL\\tO\\n-\\tO\\nA\\tO\\nhaplotypes\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nare\\tO\\ndifferent\\tO\\n2\\tO\\n,\\tO\\nW18\\tO\\nand\\tO\\nW24\\tO\\n,\\tO\\nW18\\tO\\n.\\tO\\n\\nThey\\tO\\nshare\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nthe\\tO\\nSD2\\tO\\nantigen\\tO\\nW18\\tO\\nand\\tO\\nthe\\tO\\nLD\\tO\\ntype\\tO\\n7a\\tO\\n.\\tO\\n.\\tO\\n\\nScreening\\tO\\nfor\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\npatients\\tO\\n:\\tO\\n61\\tO\\nnew\\tO\\npatients\\tO\\nand\\tO\\na\\tO\\nsummary\\tO\\nof\\tO\\n150\\tO\\nunrelated\\tO\\npatients\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\na\\tO\\nscreening\\tO\\nfor\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\ngene\\tO\\nin\\tO\\n61\\tO\\nnew\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\npatients\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\na\\tO\\nsummary\\tO\\nof\\tO\\nthe\\tO\\nresults\\tO\\nof\\tO\\n150\\tO\\npatients\\tO\\n.\\tO\\n\\nExamination\\tO\\nof\\tO\\nthe\\tO\\nentire\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n,\\tO\\nbased\\tO\\non\\tO\\na\\tO\\nribonuclease\\tO\\nprotection\\tO\\nassay\\tO\\ncoupled\\tO\\nwith\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\n,\\tO\\ndisclosed\\tO\\nmutations\\tO\\nthat\\tO\\nwere\\tO\\nconsidered\\tO\\nto\\tO\\ncause\\tO\\nsignificant\\tO\\ndefects\\tO\\nin\\tO\\nthe\\tO\\nAPC\\tB-Disease\\nproduct\\tO\\nin\\tO\\n97\\tO\\nof\\tO\\n150\\tO\\nunrelated\\tO\\nFAP\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nrevealed\\tO\\nthe\\tO\\nfollowing\\tO\\ncharacteristics\\tO\\nof\\tO\\nthe\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nof\\tO\\nAPC\\tO\\n1\\tO\\n)\\tO\\nthe\\tO\\ngreat\\tO\\nmajority\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\ntruncate\\tO\\nthe\\tO\\nAPC\\tB-Disease\\nproduct\\tO\\n;\\tO\\n2\\tO\\n)\\tO\\nalmost\\tO\\nall\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nwere\\tO\\nlocated\\tO\\nwithin\\tO\\nthe\\tO\\nfirst\\tO\\nhalf\\tO\\nof\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\n;\\tO\\n3\\tO\\n)\\tO\\nno\\tO\\ncorrelation\\tO\\nwas\\tO\\nobserved\\tO\\nbetween\\tO\\nthe\\tO\\nlocations\\tO\\nof\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nand\\tO\\nextracolonic\\tO\\nmanifestations\\tO\\nin\\tO\\nFAP\\tB-Disease\\npatients\\tO\\n;\\tO\\n4\\tO\\n)\\tO\\nmore\\tO\\nthan\\tO\\n80\\tO\\n%\\tO\\nof\\tO\\nbase\\tO\\nsubstitutions\\tO\\nin\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nwere\\tO\\nfrom\\tO\\ncytosine\\tO\\nto\\tO\\nother\\tO\\nnucleotides\\tO\\n,\\tO\\nnearly\\tO\\none\\tO\\n-\\tO\\nthird\\tO\\nof\\tO\\nwhich\\tO\\noccurred\\tO\\nat\\tO\\nthe\\tO\\nGpG\\tO\\nsite\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nprovide\\tO\\ninformation\\tO\\nhelpful\\tO\\nto\\tO\\nan\\tO\\nunderstanding\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nand\\tO\\nwill\\tO\\nalso\\tO\\ncontribute\\tO\\nto\\tO\\npresymptomatic\\tO\\ndiagnosis\\tO\\nof\\tO\\nmembers\\tO\\nin\\tO\\nFAP\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n.\\tO\\n\\nSomatic\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ntumors\\tI-Disease\\n:\\tO\\nmutation\\tO\\ncluster\\tO\\nregion\\tO\\nin\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nexamined\\tO\\nsomatic\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\ngene\\tO\\nin\\tO\\n63\\tO\\ncolorectal\\tB-Disease\\ntumors\\tI-Disease\\n(\\tO\\n16\\tO\\nadenomas\\tB-Disease\\nand\\tO\\n47\\tO\\ncarcinomas\\tB-Disease\\n)\\tO\\ndeveloped\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\nand\\tO\\nnon\\tO\\n-\\tO\\nFAP\\tO\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\nto\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\n(\\tO\\nLOH\\tO\\n)\\tO\\nat\\tO\\nthe\\tO\\nAPC\\tB-Disease\\nlocus\\tO\\nin\\tO\\n30\\tO\\ntumors\\tB-Disease\\n,\\tO\\n43\\tO\\nother\\tO\\nsomatic\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\none\\tO\\nof\\tO\\nthem\\tO\\nwere\\tO\\npoint\\tO\\nmutations\\tO\\n;\\tO\\n16\\tO\\nnonsense\\tO\\nand\\tO\\ntwo\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\nand\\tO\\nthree\\tO\\noccurred\\tO\\nin\\tO\\nintrons\\tO\\nat\\tO\\nthe\\tO\\nsplicing\\tO\\nsite\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\ntwo\\tO\\ntumors\\tB-Disease\\nhad\\tO\\nframeshift\\tO\\nmutations\\tO\\ndue\\tO\\nto\\tO\\ndeletion\\tO\\nor\\tO\\ninsertion\\tO\\n;\\tO\\nnineteen\\tO\\nof\\tO\\nthem\\tO\\nwere\\tO\\ndeletions\\tO\\nof\\tO\\none\\tO\\nto\\tO\\n31\\tO\\nbp\\tO\\nand\\tO\\nthree\\tO\\nwere\\tO\\na\\tO\\n1\\tO\\n-\\tO\\nbp\\tO\\ninsertion\\tO\\n.\\tO\\n\\nOne\\tO\\ntumor\\tB-Disease\\nhad\\tO\\na\\tO\\n1\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nin\\tO\\nan\\tO\\nintron\\tO\\nnear\\tO\\nthe\\tO\\nsplicing\\tO\\nsite\\tO\\n.\\tO\\n\\nHence\\tO\\n,\\tO\\n41\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n43\\tO\\nmutations\\tO\\nresulted\\tO\\nin\\tO\\ntruncation\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\nprotein\\tO\\n.\\tO\\n\\nOver\\tO\\n60\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nsomatic\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nwere\\tO\\nclustered\\tO\\nwithin\\tO\\na\\tO\\nsmall\\tO\\nregion\\tO\\nof\\tO\\nexon\\tO\\n15\\tO\\n,\\tO\\ndesignated\\tO\\nas\\tO\\nMCR\\tO\\n(\\tO\\nmutation\\tO\\ncluster\\tO\\nregion\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\naccounted\\tO\\nfor\\tO\\nless\\tO\\nthan\\tO\\n10\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\n.\\tO\\n\\nCombining\\tO\\nthese\\tO\\ndata\\tO\\nand\\tO\\nthe\\tO\\nresults\\tO\\nof\\tO\\nLOH\\tO\\n,\\tO\\nmore\\tO\\nthan\\tO\\n80\\tO\\n%\\tO\\nof\\tO\\ntumors\\tB-Disease\\n(\\tO\\n14\\tO\\nadenomas\\tB-Disease\\nand\\tO\\n39\\tO\\ncarcinomas\\tB-Disease\\n)\\tO\\nhad\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n,\\tO\\nof\\tO\\nwhich\\tO\\nmore\\tO\\nthan\\tO\\n60\\tO\\n%\\tO\\n(\\tO\\n9\\tO\\nadenomas\\tB-Disease\\nand\\tO\\n23\\tO\\ncarcinomas\\tB-Disease\\n)\\tO\\nhad\\tO\\ntwo\\tO\\nmutations\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nstrongly\\tO\\nsuggest\\tO\\nthat\\tO\\nsomatic\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\ndevelopment\\tO\\nof\\tO\\na\\tO\\ngreat\\tO\\nmajority\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nConstitutional\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nWT1\\tO\\ngene\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\ncharacterised\\tO\\nby\\tO\\na\\tO\\ntypical\\tO\\nnephropathy\\tB-Disease\\n,\\tO\\ngenital\\tB-Disease\\nabnormalities\\tI-Disease\\nand\\tO\\nalso\\tO\\npredisposes\\tO\\nto\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\n.\\tO\\n\\nThese\\tO\\npatients\\tO\\neventually\\tO\\ngo\\tO\\ninto\\tO\\nend\\tO\\nstage\\tO\\nrenal\\tB-Disease\\nfailure\\tI-Disease\\n.\\tO\\n\\nA\\tO\\ncandidate\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\ngene\\tO\\n,\\tO\\nWT1\\tO\\n,\\tO\\nfrom\\tO\\nthe\\tO\\n11p13\\tO\\nchromosome\\tO\\nregion\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\ncloned\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nanalysed\\tO\\nthe\\tO\\nDNA\\tO\\nsequence\\tO\\nin\\tO\\nconstitutional\\tO\\ncells\\tO\\nfrom\\tO\\neight\\tO\\npatients\\tO\\nand\\tO\\nhave\\tO\\nshown\\tO\\nheterozygous\\tO\\nmutations\\tO\\nin\\tO\\nsix\\tO\\nof\\tO\\nthem\\tO\\n.\\tO\\n\\nFour\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nwere\\tO\\nin\\tO\\nexon\\tO\\n9\\tO\\n,\\tO\\nall\\tO\\nresulting\\tO\\nin\\tO\\nmissense\\tO\\nmutations\\tO\\n.\\tO\\n\\nThree\\tO\\nwere\\tO\\nat\\tO\\nnucleotide\\tO\\nposition\\tO\\n1180\\tO\\nresulting\\tO\\nin\\tO\\nan\\tO\\narg\\tO\\n>\\tO\\ntrp\\tO\\namino\\tO\\nacid\\tO\\nchange\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nwas\\tO\\nat\\tO\\nposition\\tO\\n1186\\tO\\nconverting\\tO\\nan\\tO\\nasp\\tO\\n>\\tO\\nasn\\tO\\nin\\tO\\nthe\\tO\\npredicted\\tO\\nresultant\\tO\\nprotein\\tO\\n.\\tO\\n\\nOne\\tO\\npatient\\tO\\nhad\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n8\\tO\\n,\\tO\\nconverting\\tO\\nan\\tO\\narg\\tO\\n>\\tO\\nhis\\tO\\n.\\tO\\n\\nA\\tO\\nsingle\\tO\\nbase\\tO\\npair\\tO\\ninsertion\\tO\\nat\\tO\\nnucleotide\\tO\\nposition\\tO\\n821\\tO\\nin\\tO\\nexon\\tO\\n6\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\ngeneration\\tO\\nof\\tO\\na\\tO\\npremature\\tO\\nstop\\tO\\ncodon\\tO\\nin\\tO\\nthe\\tO\\nlast\\tO\\npatient\\tO\\n.\\tO\\n\\nWe\\tO\\nwere\\tO\\nunable\\tO\\nto\\tO\\nfind\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\none\\tO\\npatient\\tO\\ndespite\\tO\\ncomplete\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\ngenomic\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nlast\\tO\\npatient\\tO\\ncarried\\tO\\na\\tO\\nconstitutional\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\n11p13\\tO\\nregion\\tO\\nand\\tO\\nno\\tO\\nadditional\\tO\\nmutation\\tO\\nwas\\tO\\nfound\\tO\\n.\\tO\\n\\nThere\\tO\\nwas\\tO\\nno\\tO\\nobvious\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\ntype\\tO\\nof\\tO\\nmutation\\tO\\nand\\tO\\nphenotypic\\tO\\nexpression\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nfurther\\tO\\ndemonstrate\\tO\\nthat\\tO\\nthe\\tO\\nWT1\\tO\\ngene\\tO\\nis\\tO\\nimportant\\tO\\nin\\tO\\nboth\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nthe\\tO\\nkidney\\tO\\nand\\tO\\nthe\\tO\\ngenito\\tO\\n-\\tO\\nurinary\\tO\\nsystem\\tO\\n.\\tO\\n.\\tO\\n\\nLinkage\\tO\\ndisequilibrium\\tO\\nmapping\\tO\\nin\\tO\\nisolated\\tO\\nfounder\\tO\\npopulations\\tO\\n:\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\nin\\tO\\nFinland\\tO\\n.\\tO\\n\\nLinkage\\tO\\ndisequilibrium\\tO\\nmapping\\tO\\nin\\tO\\nisolated\\tO\\npopulations\\tO\\nprovides\\tO\\na\\tO\\npowerful\\tO\\ntool\\tO\\nfor\\tO\\nfine\\tO\\nstructure\\tO\\nlocalization\\tO\\nof\\tO\\ndisease\\tO\\ngenes\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nLuria\\tO\\nand\\tO\\nDelbrucks\\tO\\nclassical\\tO\\nmethods\\tO\\nfor\\tO\\nanalysing\\tO\\nbacterial\\tO\\ncultures\\tO\\nare\\tO\\nadapted\\tO\\nto\\tO\\nthe\\tO\\nstudy\\tO\\nof\\tO\\nhuman\\tO\\nisolated\\tO\\nfounder\\tO\\npopulations\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\nestimate\\tO\\n(\\tO\\ni\\tO\\n)\\tO\\nthe\\tO\\nrecombination\\tO\\nfraction\\tO\\nbetween\\tO\\na\\tO\\ndisease\\tO\\nlocus\\tO\\nand\\tO\\na\\tO\\nmarker\\tO\\n;\\tO\\n(\\tO\\nii\\tO\\n)\\tO\\nthe\\tO\\nexpected\\tO\\ndegree\\tO\\nof\\tO\\nallelic\\tO\\nhomogeneity\\tO\\nin\\tO\\na\\tO\\npopulation\\tO\\n;\\tO\\nand\\tO\\n(\\tO\\niii\\tO\\n)\\tO\\nthe\\tO\\nmutation\\tO\\nrate\\tO\\nof\\tO\\nmarker\\tO\\nloci\\tO\\n.\\tO\\n\\nUsing\\tO\\nthese\\tO\\nmethods\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nstriking\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nfor\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\n(\\tO\\nDTD\\tB-Disease\\n)\\tO\\nin\\tO\\nFinland\\tO\\nindicating\\tO\\nthat\\tO\\nthe\\tO\\nDTD\\tB-Disease\\ngene\\tO\\nshould\\tO\\nlie\\tO\\nwithin\\tO\\n0\\tO\\n.\\tO\\n\\n06\\tO\\ncentimorgans\\tO\\n(\\tO\\nor\\tO\\nabout\\tO\\n60\\tO\\nkilobases\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nCSF1R\\tO\\ngene\\tO\\n.\\tO\\n\\nPredictions\\tO\\nabout\\tO\\nallelic\\tO\\nhomogeneity\\tO\\nin\\tO\\nFinland\\tO\\nand\\tO\\nmutation\\tO\\nrates\\tO\\nin\\tO\\nsimple\\tO\\nsequence\\tO\\nrepeats\\tO\\nare\\tO\\nconfirmed\\tO\\nby\\tO\\nindependent\\tO\\nobservations\\tO\\n.\\tO\\n\\nThe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\nrefinement\\tO\\nof\\tO\\nthe\\tO\\nlocalization\\tO\\non\\tO\\nXp\\tO\\nand\\tO\\nidentification\\tO\\nof\\tO\\nanother\\tO\\nclosely\\tO\\nlinked\\tO\\nmarker\\tO\\nlocus\\tO\\n,\\tO\\nOATL1\\tO\\n.\\tO\\n\\nThe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\nhas\\tO\\npreviously\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\nproximal\\tO\\nshort\\tO\\narm\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\nbetween\\tO\\nthe\\tO\\nDXS14\\tO\\nand\\tO\\nDXS7\\tO\\nloci\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\n,\\tO\\nfurther\\tO\\nsegregation\\tO\\nanalysis\\tO\\nhas\\tO\\nbeen\\tO\\nperformed\\tO\\nusing\\tO\\na\\tO\\nnewly\\tO\\nidentified\\tO\\nWAS\\tB-Disease\\nfamily\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nan\\tO\\nadditional\\tO\\nmarker\\tO\\nprobe\\tO\\n,\\tO\\nHOATL1\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nindicate\\tO\\nclose\\tO\\nlinkage\\tO\\nbetween\\tO\\nthe\\tO\\nWAS\\tB-Disease\\nand\\tO\\nOATL1\\tO\\nloci\\tO\\n(\\tO\\nZ\\tO\\n=\\tO\\n6\\tO\\n.\\tO\\n08\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n00\\tO\\n)\\tO\\nand\\tO\\nlocalize\\tO\\nthe\\tO\\nTIMP\\tO\\n,\\tO\\nOATL1\\tO\\n,\\tO\\nDXS255\\tO\\n,\\tO\\nand\\tO\\nWAS\\tB-Disease\\nloci\\tO\\ndistal\\tO\\nto\\tO\\nDXS146\\tO\\nand\\tO\\nthe\\tO\\nOATL1\\tO\\nand\\tO\\nWAS\\tB-Disease\\nloci\\tO\\nproximal\\tO\\nto\\tO\\nTIMP\\tO\\n.\\tO\\n\\nThese\\tO\\nlinkage\\tO\\ndata\\tO\\nnarrow\\tO\\nthe\\tO\\nboundaries\\tO\\nwithin\\tO\\nwhich\\tO\\nthe\\tO\\nWAS\\tB-Disease\\nlocus\\tO\\nmaps\\tO\\nto\\tO\\nthe\\tO\\nchromosomal\\tO\\nregion\\tO\\nbracketed\\tO\\nby\\tO\\nTIMP\\tO\\nand\\tO\\nDXS146\\tO\\nand\\tO\\nsupport\\tO\\nthe\\tO\\nloci\\tO\\norder\\tO\\nXpter\\tO\\n-\\tO\\nDXS7\\tO\\n-\\tO\\nTIMP\\tO\\n-\\tO\\n(\\tO\\nOATL1\\tO\\n,\\tO\\nWAS\\tO\\n,\\tO\\nDXS255\\tO\\n)\\tO\\n-\\tO\\nDXS146\\tO\\n.\\tO\\n\\nDetection\\tO\\nof\\tO\\nan\\tO\\nunstable\\tO\\nfragment\\tO\\nof\\tO\\nDNA\\tO\\nspecific\\tO\\nto\\tO\\nindividuals\\tO\\nwith\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nform\\tO\\nof\\tO\\nadult\\tO\\nmuscular\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nwith\\tO\\na\\tO\\nprevalence\\tO\\nof\\tO\\n2\\tO\\n-\\tO\\n14\\tO\\nper\\tO\\n100\\tO\\n,\\tO\\n000\\tO\\nindividuals\\tO\\n.\\tO\\n\\nThe\\tO\\ndisease\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nprogressive\\tO\\nmuscle\\tB-Disease\\nweakness\\tI-Disease\\nand\\tO\\nsustained\\tB-Disease\\nmuscle\\tI-Disease\\ncontraction\\tI-Disease\\n,\\tO\\noften\\tO\\nwith\\tO\\na\\tO\\nwide\\tO\\nrange\\tO\\nof\\tO\\naccompanying\\tO\\nsymptoms\\tO\\n.\\tO\\n\\nThe\\tO\\nage\\tO\\nat\\tO\\nonset\\tO\\nand\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nshow\\tO\\nextreme\\tO\\nvariation\\tO\\n,\\tO\\nboth\\tO\\nwithin\\tO\\nand\\tO\\nbetween\\tO\\nfamilies\\tO\\n.\\tO\\n\\nDespite\\tO\\nits\\tO\\nclinical\\tO\\nvariability\\tO\\n,\\tO\\nthis\\tO\\ndominant\\tO\\ncondition\\tO\\nsegregates\\tO\\nas\\tO\\na\\tO\\nsingle\\tO\\nlocus\\tO\\nat\\tO\\nchromosome\\tO\\n19q13\\tO\\n.\\tO\\n\\n3\\tO\\nin\\tO\\nevery\\tO\\npopulation\\tO\\nstudied\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nflanked\\tO\\nby\\tO\\nthe\\tO\\ntightly\\tO\\nlinked\\tO\\ngenetic\\tO\\nmarkers\\tO\\nERCC1\\tO\\nproximally\\tO\\nand\\tO\\nD19S51\\tO\\ndistally\\tO\\n;\\tO\\nthese\\tO\\ndefine\\tO\\nthe\\tO\\nDM\\tB-Disease\\ncritical\\tO\\nregion\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nthe\\tO\\nisolation\\tO\\nof\\tO\\nan\\tO\\nexpressed\\tO\\nsequence\\tO\\nfrom\\tO\\nthis\\tO\\nregion\\tO\\nwhich\\tO\\ndetects\\tO\\na\\tO\\nDNA\\tO\\nfragment\\tO\\nthat\\tO\\nis\\tO\\nlarger\\tO\\nin\\tO\\naffected\\tO\\nindividuals\\tO\\nthan\\tO\\nin\\tO\\nnormal\\tO\\nsiblings\\tO\\nor\\tO\\nunaffected\\tO\\ncontrols\\tO\\n.\\tO\\n\\nThe\\tO\\nsize\\tO\\nof\\tO\\nthis\\tO\\nfragment\\tO\\nvaries\\tO\\nbetween\\tO\\naffected\\tO\\nsiblings\\tO\\n,\\tO\\nand\\tO\\nincreases\\tO\\nin\\tO\\nsize\\tO\\nthrough\\tO\\ngenerations\\tO\\nin\\tO\\nparallel\\tO\\nwith\\tO\\nincreasing\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nWe\\tO\\npostulate\\tO\\nthat\\tO\\nthis\\tO\\nunstable\\tO\\nDNA\\tO\\nsequence\\tO\\nis\\tO\\nthe\\tO\\nmolecular\\tO\\nfeature\\tO\\nthat\\tO\\nunderlies\\tO\\nDM\\tB-Disease\\n.\\tO\\n\\nCommon\\tO\\nsequence\\tO\\nmotifs\\tO\\nat\\tO\\nthe\\tO\\nrearrangement\\tO\\nsites\\tO\\nof\\tO\\na\\tO\\nconstitutional\\tO\\nX\\tO\\n/\\tO\\nautosome\\tO\\ntranslocation\\tO\\nand\\tO\\nassociated\\tO\\ndeletion\\tO\\n.\\tO\\n\\nReciprocal\\tO\\nchromosome\\tO\\ntranslocations\\tO\\nare\\tO\\ncommon\\tO\\nde\\tO\\nnovo\\tO\\nrearrangements\\tO\\nthat\\tO\\noccur\\tO\\nrandomly\\tO\\nthroughout\\tO\\nthe\\tO\\nhuman\\tO\\ngenome\\tO\\n.\\tO\\n\\nTo\\tO\\nlearn\\tO\\nabout\\tO\\ncausative\\tO\\nmechanisms\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ncloned\\tO\\nand\\tO\\nsequenced\\tO\\nthe\\tO\\nbreakpoints\\tO\\nof\\tO\\na\\tO\\ncytologically\\tO\\nbalanced\\tO\\nconstitutional\\tO\\nreciprocal\\tO\\ntranslocation\\tO\\n,\\tO\\nt\\tO\\n(\\tO\\nX\\tO\\n;\\tO\\n4\\tO\\n)\\tO\\n(\\tO\\np21\\tO\\n.\\tO\\n2\\tO\\n;\\tO\\nq31\\tO\\n.\\tO\\n22\\tO\\n)\\tO\\n,\\tO\\npresent\\tO\\nin\\tO\\na\\tO\\ngirl\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nPhysical\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\nderivative\\tO\\nchromosomes\\tO\\n,\\tO\\nafter\\tO\\ntheir\\tO\\nseparation\\tO\\nin\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrids\\tO\\n,\\tO\\nreveals\\tO\\nthat\\tO\\nthe\\tO\\ntranslocation\\tO\\ndisrupts\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\nin\\tO\\nXp21\\tO\\nwithin\\tO\\nthe\\tO\\n18\\tO\\n-\\tO\\nkb\\tO\\nintron\\tO\\n16\\tO\\n.\\tO\\n\\nRestriction\\tO\\nmapping\\tO\\nand\\tO\\nsequencing\\tO\\nof\\tO\\nclones\\tO\\nthat\\tO\\nspan\\tO\\nboth\\tO\\ntranslocation\\tO\\nbreakpoints\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nthe\\tO\\ncorresponding\\tO\\nnormal\\tO\\nregions\\tO\\nindicate\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\napproximately\\tO\\n5\\tO\\nkb\\tO\\nin\\tO\\nthe\\tO\\nformation\\tO\\nof\\tO\\nthe\\tO\\nderivative\\tO\\nX\\tO\\nchromosome\\tO\\n,\\tO\\nwith\\tO\\n4\\tO\\n-\\tO\\n6\\tO\\nbp\\tO\\ndeleted\\tO\\nfrom\\tO\\nchromosome\\tO\\n4\\tO\\n.\\tO\\n\\nRFLP\\tO\\nand\\tO\\nSouthern\\tO\\nanalyses\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nde\\tO\\nnovo\\tO\\ntranslocation\\tO\\nis\\tO\\na\\tO\\npaternal\\tO\\norigin\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\nfathers\\tO\\nX\\tO\\nchromosome\\tO\\ncontains\\tO\\nthe\\tO\\nDNA\\tO\\nthat\\tO\\nis\\tO\\ndeleted\\tO\\nin\\tO\\nthe\\tO\\nderivative\\tO\\nX\\tO\\n.\\tO\\n\\nMost\\tO\\nlikely\\tO\\n,\\tO\\ndeletion\\tO\\nand\\tO\\ntranslation\\tO\\narose\\tO\\nsimultaneously\\tO\\nfrom\\tO\\na\\tO\\ncomplex\\tO\\nrearrangement\\tO\\nevent\\tO\\nthat\\tO\\ninvolves\\tO\\nthree\\tO\\nchromosomal\\tO\\nbreakpoints\\tO\\n.\\tO\\n\\nShort\\tO\\nregions\\tO\\nof\\tO\\nsequence\\tO\\nhomology\\tO\\nwere\\tO\\npresent\\tO\\nat\\tO\\nthe\\tO\\nthree\\tO\\nsites\\tO\\n.\\tO\\n\\nA\\tO\\n5\\tO\\n-\\tO\\nbp\\tO\\nsequence\\tO\\n,\\tO\\nGGAAT\\tO\\n,\\tO\\nfound\\tO\\nexactly\\tO\\nat\\tO\\nthe\\tO\\ntranslocation\\tO\\nbreakpoints\\tO\\non\\tO\\nboth\\tO\\nnormal\\tO\\nchromosomes\\tO\\nX\\tO\\nand\\tO\\n4\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\npreserved\\tO\\nonly\\tO\\non\\tO\\nthe\\tO\\nder\\tO\\n(\\tO\\n4\\tO\\n)\\tO\\nchromosome\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nlikely\\tO\\nthat\\tO\\nthe\\tO\\nX\\tO\\n-\\tO\\nderived\\tO\\nsequence\\tO\\nGGAATCA\\tO\\nhas\\tO\\nbeen\\tO\\nlost\\tO\\nin\\tO\\nthe\\tO\\nformation\\tO\\nof\\tO\\nthe\\tO\\nder\\tO\\n(\\tO\\nX\\tO\\n)\\tO\\nchromosome\\tO\\n,\\tO\\nas\\tO\\nit\\tO\\nmatches\\tO\\nan\\tO\\ninverted\\tO\\nGAATCA\\tO\\nsequence\\tO\\npresent\\tO\\non\\tO\\nthe\\tO\\nopposite\\tO\\nstrand\\tO\\nexactly\\tO\\nat\\tO\\nthe\\tO\\nother\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\ndeleted\\tO\\n5\\tO\\n-\\tO\\nkb\\tO\\nfragment\\tO\\n.\\tO\\n\\nA\\tO\\ngenetic\\tO\\netiology\\tO\\nfor\\tO\\nDiGeorge\\tB-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\nconsistent\\tO\\ndeletions\\tO\\nand\\tO\\nmicrodeletions\\tO\\nof\\tO\\n22q11\\tO\\n.\\tO\\n\\nDiGeorge\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nDGS\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\ndevelopmental\\tO\\nfield\\tO\\ndefect\\tO\\nof\\tO\\nthe\\tO\\nthird\\tO\\nand\\tO\\nfourth\\tO\\npharyngeal\\tO\\npouches\\tO\\n,\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\naplasia\\tB-Disease\\nor\\tI-Disease\\nhypoplasia\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nthymus\\tI-Disease\\nand\\tI-Disease\\nparathyroid\\tI-Disease\\nglands\\tI-Disease\\nand\\tO\\nby\\tO\\nconotruncal\\tB-Disease\\ncardiac\\tI-Disease\\nmalformations\\tI-Disease\\n.\\tO\\n\\nCytogenetic\\tO\\nstudies\\tO\\nsupport\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nDGS\\tB-Disease\\ncritical\\tO\\nregion\\tO\\nin\\tO\\nband\\tO\\n22q11\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\nresults\\tO\\nof\\tO\\nclinical\\tO\\n,\\tO\\ncytogenetic\\tO\\n,\\tO\\nand\\tO\\nmolecular\\tO\\nstudies\\tO\\nof\\tO\\n14\\tO\\npatients\\tO\\nwith\\tO\\nDGS\\tB-Disease\\n.\\tO\\n\\nChromosome\\tO\\nanalysis\\tO\\n,\\tO\\nutilizing\\tO\\nhigh\\tO\\n-\\tO\\nresolution\\tO\\nbanding\\tO\\ntechniques\\tO\\n,\\tO\\ndetected\\tO\\ninterstitial\\tO\\ndeletions\\tO\\nin\\tO\\nfive\\tO\\nprobands\\tO\\nand\\tO\\nwas\\tO\\ninconclusive\\tO\\nfor\\tO\\na\\tO\\ndeletion\\tO\\nin\\tO\\nthree\\tO\\nprobands\\tO\\n.\\tO\\n\\nThe\\tO\\nremaining\\tO\\nsix\\tO\\npatients\\tO\\nhad\\tO\\nnormal\\tO\\nkaryotypes\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nmolecular\\tO\\nanalysis\\tO\\ndetected\\tO\\nDNA\\tO\\ndeletions\\tO\\nin\\tO\\nall\\tO\\n14\\tO\\nprobands\\tO\\n.\\tO\\n\\nTwo\\tO\\nof\\tO\\n10\\tO\\nloci\\tO\\ntested\\tO\\n,\\tO\\nD22S75\\tO\\nand\\tO\\nD22S259\\tO\\n,\\tO\\nare\\tO\\ndeleted\\tO\\nin\\tO\\nall\\tO\\n14\\tO\\npatients\\tO\\n.\\tO\\n\\nA\\tO\\nthird\\tO\\nlocus\\tO\\n,\\tO\\nD22S66\\tO\\n,\\tO\\nis\\tO\\ndeleted\\tO\\nin\\tO\\nthe\\tO\\neight\\tO\\nDGS\\tB-Disease\\nprobands\\tO\\ntested\\tO\\n.\\tO\\n\\nPhysical\\tO\\nmapping\\tO\\nusing\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrids\\tO\\nplaces\\tO\\nD22S66\\tO\\nbetween\\tO\\nD22S75\\tO\\nand\\tO\\nD22S259\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nit\\tO\\nshould\\tO\\nbe\\tO\\ndeleted\\tO\\nin\\tO\\nthe\\tO\\nremaining\\tO\\nsix\\tO\\ncases\\tO\\n.\\tO\\n\\nParent\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\norigin\\tO\\nstudies\\tO\\nwere\\tO\\nperformed\\tO\\nin\\tO\\nfive\\tO\\nfamilies\\tO\\n.\\tO\\n\\nFour\\tO\\nprobands\\tO\\nfailed\\tO\\nto\\tO\\ninherit\\tO\\na\\tO\\nmaternal\\tO\\nallele\\tO\\n,\\tO\\nand\\tO\\none\\tO\\nfailed\\tO\\nto\\tO\\ninherit\\tO\\na\\tO\\npaternal\\tO\\nallele\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthese\\tO\\nfamilies\\tO\\n,\\tO\\nand\\tO\\nof\\tO\\nsix\\tO\\nmaternally\\tO\\nand\\tO\\nfive\\tO\\npaternally\\tO\\nderived\\tO\\nunbalanced\\tO\\n-\\tO\\ntranslocation\\tO\\nDGS\\tB-Disease\\nprobands\\tO\\nin\\tO\\nthe\\tO\\nliterature\\tO\\n,\\tO\\nparent\\tO\\nof\\tO\\norigin\\tO\\nor\\tO\\nimprinting\\tO\\ndoes\\tO\\nnot\\tO\\nappear\\tO\\nto\\tO\\nplay\\tO\\nan\\tO\\nimportant\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nDGS\\tB-Disease\\n.\\tO\\n\\nDeletion\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\nthree\\tO\\nloci\\tO\\nin\\tO\\nall\\tO\\n14\\tO\\nDGS\\tB-Disease\\nprobands\\tO\\nbegins\\tO\\nto\\tO\\ndelineate\\tO\\nthe\\tO\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n22\\tO\\ncritical\\tO\\nfor\\tO\\nDGS\\tB-Disease\\nand\\tO\\nconfirms\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nsubmicroscopic\\tO\\ndeletions\\tO\\nof\\tO\\n22q11\\tO\\nare\\tO\\netiologic\\tO\\nin\\tO\\nthe\\tO\\nvast\\tO\\nmajority\\tO\\nof\\tO\\ncases\\tO\\n.\\tO\\n.\\tO\\n\\nLoss\\tO\\nof\\tO\\nnormal\\tO\\nallele\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nin\\tO\\nan\\tO\\nadrenocortical\\tB-Disease\\ncarcinoma\\tI-Disease\\nfrom\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n.\\tO\\n\\nEndocrine\\tB-Disease\\nneoplasms\\tI-Disease\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\noccasionally\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nAn\\tO\\nadrenocorotical\\tB-Disease\\ncarcinoma\\tI-Disease\\nwas\\tO\\nstudied\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nFAP\\tB-Disease\\n.\\tO\\n\\nLoss\\tO\\nof\\tO\\nheterozygosity\\tO\\n(\\tO\\nLOH\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nregion\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\ngene\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nthis\\tO\\ncarcinoma\\tB-Disease\\n,\\tO\\nand\\tO\\nevidence\\tO\\nwas\\tO\\nobtained\\tO\\nthat\\tO\\nthere\\tO\\nwas\\tO\\na\\tO\\nloss\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nallele\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\ndemonstration\\tO\\nof\\tO\\nLOH\\tO\\nat\\tO\\nthe\\tO\\nAPC\\tB-Disease\\nlocus\\tO\\nin\\tO\\nadrenocortical\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nresults\\tO\\nand\\tO\\nour\\tO\\nprevious\\tO\\ndata\\tO\\non\\tO\\nLOH\\tO\\nin\\tO\\na\\tO\\nrecurring\\tO\\ndesmoid\\tB-Disease\\ntumor\\tI-Disease\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nheterozygous\\tO\\nmutant\\tO\\n/\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\ncondition\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nmay\\tO\\ngive\\tO\\nrise\\tO\\nto\\tO\\nbenign\\tB-Disease\\ntumors\\tI-Disease\\n,\\tO\\nand\\tO\\nthat\\tO\\nfunctional\\tO\\nloss\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\nleads\\tO\\nto\\tO\\ndevelopment\\tO\\nof\\tO\\ntumors\\tB-Disease\\nnot\\tO\\nonly\\tO\\nin\\tO\\nthe\\tO\\ncolon\\tO\\nbut\\tO\\nalso\\tO\\nin\\tO\\nother\\tO\\nvarious\\tO\\nparts\\tO\\nof\\tO\\nthe\\tO\\nbody\\tO\\nin\\tO\\nFAP\\tB-Disease\\npatients\\tO\\n.\\tO\\n.\\tO\\n\\nOncogenic\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nexon\\tO\\n20\\tO\\nof\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nin\\tO\\nfamilies\\tO\\nshowing\\tO\\nincomplete\\tO\\npenetrance\\tO\\nand\\tO\\nmild\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nretinoblastoma\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nThe\\tO\\nretinoblastoma\\tB-Disease\\n-\\tO\\npredisposition\\tO\\ngene\\tO\\n,\\tO\\nRB1\\tO\\n,\\tO\\nsegregates\\tO\\nas\\tO\\nan\\tO\\nautosomal\\tO\\ndominant\\tO\\ntrait\\tO\\nwith\\tO\\nhigh\\tO\\n(\\tO\\n90\\tO\\n%\\tO\\n)\\tO\\npenetrance\\tO\\n.\\tO\\n\\nCertain\\tO\\nfamilies\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nshow\\tO\\nan\\tO\\nunusual\\tO\\nlow\\tO\\n-\\tO\\npenetrance\\tO\\nphenotype\\tO\\nwith\\tO\\nmany\\tO\\nindividuals\\tO\\nbeing\\tO\\nunaffected\\tO\\n,\\tO\\nunilaterally\\tO\\naffected\\tO\\n,\\tO\\nor\\tO\\nwith\\tO\\nevidence\\tO\\nof\\tO\\nspontaneously\\tO\\nregressed\\tO\\ntumors\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nused\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\nanalysis\\tO\\nand\\tO\\nPCR\\tO\\nsequencing\\tO\\nto\\tO\\nstudy\\tO\\ntwo\\tO\\nsuch\\tO\\nfamilies\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nexon\\tO\\n20\\tO\\nof\\tO\\nRB1\\tO\\nin\\tO\\nboth\\tO\\ncases\\tO\\n.\\tO\\n\\nIn\\tO\\none\\tO\\nfamily\\tO\\na\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nT\\tO\\ntransition\\tO\\nin\\tO\\ncodon\\tO\\n661\\tO\\nconverts\\tO\\nan\\tO\\narginine\\tO\\n(\\tO\\nCGG\\tO\\n)\\tO\\nto\\tO\\na\\tO\\ntryptophan\\tO\\n(\\tO\\nTGG\\tO\\n)\\tO\\ncodon\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nfamily\\tO\\n,\\tO\\nincomplete\\tO\\npenetrance\\tO\\nand\\tO\\nmild\\tO\\nphenotypic\\tO\\nexpression\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nvirtually\\tO\\nall\\tO\\npatients\\tO\\n,\\tO\\npossibly\\tO\\nindicating\\tO\\nthat\\tO\\nsingle\\tO\\namino\\tO\\nacid\\tO\\nchanges\\tO\\nmay\\tO\\nmodify\\tO\\nprotein\\tO\\nstructure\\tO\\n/\\tO\\nfunction\\tO\\nsuch\\tO\\nthat\\tO\\ntumorigenesis\\tO\\nis\\tO\\nnot\\tO\\ninevitable\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nsecond\\tO\\nfamily\\tO\\nthe\\tO\\nmutation\\tO\\nin\\tO\\ncodon\\tO\\n675\\tO\\nis\\tO\\na\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nT\\tO\\ntransversion\\tO\\nthat\\tO\\nconverts\\tO\\na\\tO\\nglutamine\\tO\\n(\\tO\\nGAA\\tO\\n)\\tO\\nto\\tO\\na\\tO\\nstop\\tO\\n(\\tO\\nTAA\\tO\\n)\\tO\\ncodon\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthis\\tO\\nmutation\\tO\\nalso\\tO\\noccurs\\tO\\nnear\\tO\\na\\tO\\npotential\\tO\\ncryptic\\tO\\nsplice\\tO\\nacceptor\\tO\\nsite\\tO\\n,\\tO\\nraising\\tO\\nthe\\tO\\npossibility\\tO\\nof\\tO\\nalternative\\tO\\nsplicing\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\nless\\tO\\nseverely\\tO\\ndisrupted\\tO\\nprotein\\tO\\n.\\tO\\n.\\tO\\n\\nLate\\tO\\n-\\tO\\nonset\\tO\\nmetachromatic\\tB-Disease\\nleukodystrophy\\tI-Disease\\n:\\tO\\nmolecular\\tO\\npathology\\tO\\nin\\tO\\ntwo\\tO\\nsiblings\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\na\\tO\\nnew\\tO\\nallele\\tO\\nat\\tO\\nthe\\tO\\narylsulfatase\\tO\\nA\\tO\\n(\\tO\\nARSA\\tO\\n)\\tO\\nlocus\\tO\\ncausing\\tO\\nlate\\tO\\n-\\tO\\nonset\\tO\\nmetachromatic\\tB-Disease\\nleukodystrophy\\tI-Disease\\n(\\tO\\nMLD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nthat\\tO\\nallele\\tO\\narginine84\\tO\\n,\\tO\\na\\tO\\nresidue\\tO\\nthat\\tO\\nis\\tO\\nhighly\\tO\\nconserved\\tO\\nin\\tO\\nthe\\tO\\narylsulfatase\\tO\\ngene\\tO\\nfamily\\tO\\n,\\tO\\nis\\tO\\nreplaced\\tO\\nby\\tO\\nglutamine\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\nto\\tO\\nalleles\\tO\\nthat\\tO\\ncause\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nMLD\\tB-Disease\\n,\\tO\\nthe\\tO\\narginine84\\tO\\nto\\tO\\nglutamine\\tO\\nsubstitution\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nsome\\tO\\nresidual\\tO\\nARSA\\tO\\nactivity\\tO\\n.\\tO\\n\\nA\\tO\\ncomparison\\tO\\nof\\tO\\ngenotypes\\tO\\n,\\tO\\nARSA\\tO\\nactivities\\tO\\n,\\tO\\nand\\tO\\nclinical\\tO\\ndata\\tO\\non\\tO\\n4\\tO\\nindividuals\\tO\\ncarrying\\tO\\nthe\\tO\\nallele\\tO\\nof\\tO\\n81\\tO\\npatients\\tO\\nwith\\tO\\nMLD\\tB-Disease\\nexamined\\tO\\n,\\tO\\nfurther\\tO\\nvalidates\\tO\\nthe\\tO\\nconcept\\tO\\nthat\\tO\\ndifferent\\tO\\ndegrees\\tO\\nof\\tO\\nresidual\\tO\\nARSA\\tO\\nactivity\\tO\\nare\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nphenotypical\\tO\\nvariation\\tO\\nin\\tO\\nMLD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nTrisomy\\tB-Disease\\n15\\tI-Disease\\nwith\\tO\\nloss\\tO\\nof\\tO\\nthe\\tO\\npaternal\\tO\\n15\\tO\\nas\\tO\\na\\tO\\ncause\\tO\\nof\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\ndue\\tO\\nto\\tO\\nmaternal\\tB-Disease\\ndisomy\\tI-Disease\\n.\\tO\\n\\nUniparental\\tB-Disease\\ndisomy\\tI-Disease\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nrecognized\\tO\\nto\\tO\\ncause\\tO\\nhuman\\tO\\ndisorders\\tO\\n,\\tO\\nincluding\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\na\\tO\\nparticularly\\tO\\ninstructive\\tO\\ncase\\tO\\nwhich\\tO\\nraises\\tO\\nimportant\\tO\\nissues\\tO\\nconcerning\\tO\\nthe\\tO\\nmechanisms\\tO\\nproducing\\tO\\nuniparental\\tB-Disease\\ndisomy\\tI-Disease\\nand\\tO\\nwhose\\tO\\nevaluation\\tO\\nprovides\\tO\\nevidence\\tO\\nthat\\tO\\ntrisomy\\tO\\nmay\\tO\\nprecede\\tO\\nuniparental\\tB-Disease\\ndisomy\\tI-Disease\\nin\\tO\\na\\tO\\nfetus\\tO\\n.\\tO\\n\\nChorionic\\tO\\nvillus\\tO\\nsampling\\tO\\nperformed\\tO\\nfor\\tO\\nadvanced\\tO\\nmaternal\\tO\\nage\\tO\\nrevealed\\tO\\ntrisomy\\tB-Disease\\n15\\tI-Disease\\nin\\tO\\nall\\tO\\ndirect\\tO\\nand\\tO\\ncultured\\tO\\ncells\\tO\\n,\\tO\\nthough\\tO\\nthe\\tO\\nfetus\\tO\\nappeared\\tO\\nnormal\\tO\\n.\\tO\\n\\nChromosome\\tO\\nanalysis\\tO\\nof\\tO\\namniocytes\\tO\\nobtained\\tO\\nat\\tO\\n15\\tO\\nwk\\tO\\nwas\\tO\\nnormal\\tO\\nin\\tO\\nover\\tO\\n100\\tO\\ncells\\tO\\nstudied\\tO\\n.\\tO\\n\\nThe\\tO\\nchild\\tO\\nwas\\tO\\nhypotonic\\tB-Disease\\nat\\tO\\nbirth\\tO\\n,\\tO\\nand\\tO\\nhigh\\tO\\n-\\tO\\nresolution\\tO\\nbanding\\tO\\nfailed\\tO\\nto\\tO\\nreveal\\tO\\nthe\\tO\\ndeletion\\tO\\nof\\tO\\n15q11\\tO\\n-\\tO\\n13\\tO\\n,\\tO\\na\\tO\\ndeletion\\tO\\nwhich\\tO\\nis\\tO\\nfound\\tO\\nin\\tO\\n50\\tO\\n%\\tO\\n-\\tO\\n70\\tO\\n%\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nOver\\tO\\ntime\\tO\\n,\\tO\\ntypical\\tO\\nfeatures\\tO\\nof\\tO\\nPWS\\tB-Disease\\ndeveloped\\tO\\n.\\tO\\n\\nMolecular\\tO\\ngenetic\\tO\\nanalysis\\tO\\nusing\\tO\\nprobes\\tO\\nfor\\tO\\nchromosome\\tO\\n15\\tO\\nrevealed\\tO\\nmaternal\\tO\\ndisomy\\tO\\n.\\tO\\n\\nMaternal\\tO\\nnondisjunction\\tO\\nwith\\tO\\nfertilization\\tO\\nof\\tO\\na\\tO\\ndisomic\\tO\\negg\\tO\\nby\\tO\\na\\tO\\nnormal\\tO\\nsperm\\tO\\n,\\tO\\nfollowed\\tO\\nby\\tO\\nloss\\tO\\nof\\tO\\nthe\\tO\\npaternal\\tO\\n15\\tO\\n,\\tO\\nis\\tO\\na\\tO\\nlikely\\tO\\ncause\\tO\\nof\\tO\\nconfined\\tO\\nplacental\\tO\\nmosaicism\\tO\\nand\\tO\\nuniparental\\tB-Disease\\ndisomy\\tI-Disease\\nin\\tO\\nthis\\tO\\ncase\\tO\\nof\\tO\\nPWS\\tB-Disease\\n,\\tO\\nand\\tO\\nadvanced\\tO\\nmaternal\\tO\\nage\\tO\\nmay\\tO\\nbe\\tO\\na\\tO\\npredisposing\\tO\\nfactor\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nheterogeneity\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\namelogenesis\\tI-Disease\\nimperfecta\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nAMELX\\tO\\ngene\\tO\\nlocated\\tO\\nat\\tO\\nXp22\\tO\\n.\\tO\\n\\n1\\tO\\n-\\tO\\np22\\tO\\n.\\tO\\n\\n3\\tO\\nencodes\\tO\\nfor\\tO\\nthe\\tO\\nenamel\\tO\\nprotein\\tO\\namelogenin\\tO\\nand\\tO\\nhas\\tO\\nbeen\\tO\\nimplicated\\tO\\nas\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\ninherited\\tB-Disease\\ndental\\tI-Disease\\nabnormality\\tI-Disease\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\namelogenesis\\tI-Disease\\nimperfecta\\tI-Disease\\n(\\tO\\nXAI\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThree\\tO\\nfamilies\\tO\\nwith\\tO\\nXAI\\tB-Disease\\nhave\\tO\\nbeen\\tO\\ninvestigated\\tO\\nusing\\tO\\npolymorphic\\tO\\nDNA\\tO\\nmarkers\\tO\\nflanking\\tO\\nthe\\tO\\nposition\\tO\\nof\\tO\\nAMELX\\tO\\n.\\tO\\n\\nUsing\\tO\\ntwo\\tO\\n-\\tO\\npoint\\tO\\nlinkage\\tO\\nanalysis\\tO\\n,\\tO\\nlinkage\\tO\\nwas\\tO\\nestablished\\tO\\nbetween\\tO\\nXAI\\tB-Disease\\nand\\tO\\nseveral\\tO\\nof\\tO\\nthese\\tO\\nmarkers\\tO\\nin\\tO\\ntwo\\tO\\nfamilies\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\ncombined\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\n6\\tO\\n.\\tO\\n\\n05\\tO\\nfor\\tO\\nDXS16\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\n04\\tO\\n04\\tO\\n.\\tO\\n\\nThis\\tO\\nsupports\\tO\\nthe\\tO\\ninvolvement\\tO\\nof\\tO\\nAMELX\\tO\\n,\\tO\\nlocated\\tO\\nclose\\tO\\nto\\tO\\nDXS16\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nXAI\\tB-Disease\\ndisease\\tI-Disease\\nprocess\\tO\\n(\\tO\\nAIH1\\tO\\n)\\tO\\nin\\tO\\nthose\\tO\\nfamilies\\tO\\n.\\tO\\n\\nUsing\\tO\\nmultipoint\\tO\\nlinkage\\tO\\nanalysis\\tO\\n,\\tO\\nthe\\tO\\ncombined\\tO\\nmaximum\\tO\\nlod\\tO\\nscore\\tO\\nfor\\tO\\nthese\\tO\\ntwo\\tO\\nfamilies\\tO\\nwas\\tO\\n7\\tO\\n.\\tO\\n\\n30\\tO\\nfor\\tO\\na\\tO\\nlocation\\tO\\nof\\tO\\nAIH1\\tO\\nat\\tO\\n2\\tO\\ncM\\tO\\ndistal\\tO\\nto\\tO\\nDXS16\\tO\\n.\\tO\\n\\nThe\\tO\\nsupport\\tO\\ninterval\\tO\\naround\\tO\\nthis\\tO\\nlocation\\tO\\nextended\\tO\\nabout\\tO\\n8\\tO\\ncM\\tO\\nproximal\\tO\\nto\\tO\\nDXS92\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nAIH1\\tO\\nlocation\\tO\\ncould\\tO\\nnot\\tO\\nbe\\tO\\nprecisely\\tO\\ndefined\\tO\\nby\\tO\\nmultipoint\\tO\\nmapping\\tO\\n.\\tO\\n\\nStudy\\tO\\nof\\tO\\nrecombination\\tO\\nevents\\tO\\nindicated\\tO\\nthat\\tO\\nAIH1\\tO\\nlies\\tO\\nin\\tO\\nthe\\tO\\ninterval\\tO\\nbetween\\tO\\nDXS143\\tO\\nand\\tO\\nDXS85\\tO\\n.\\tO\\n\\nThere\\tO\\nwas\\tO\\nsignificant\\tO\\nevidence\\tO\\nagainst\\tO\\nlinkage\\tO\\nto\\tO\\nthis\\tO\\nregion\\tO\\nin\\tO\\nthe\\tO\\nthird\\tO\\nfamily\\tO\\n,\\tO\\nindicating\\tO\\nlocus\\tO\\nheterogeneity\\tO\\nin\\tO\\nXAI\\tB-Disease\\n.\\tO\\n\\nFurther\\tO\\nanalysis\\tO\\nwith\\tO\\nmarkers\\tO\\non\\tO\\nthe\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\nshowed\\tO\\nevidence\\tO\\nof\\tO\\nlinkage\\tO\\nto\\tO\\nDXS144E\\tO\\nand\\tO\\nF9\\tO\\nwith\\tO\\nno\\tO\\nrecombination\\tO\\nwith\\tO\\neither\\tO\\nof\\tO\\nthese\\tO\\nmarkers\\tO\\n.\\tO\\n\\nTwo\\tO\\n-\\tO\\npoint\\tO\\nanalysis\\tO\\ngave\\tO\\na\\tO\\npeak\\tO\\nlod\\tO\\nscore\\tO\\nat\\tO\\nDXS144E\\tO\\nwith\\tO\\na\\tO\\nmaximum\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\n2\\tO\\n.\\tO\\n\\n83\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\npeak\\tO\\nlod\\tO\\nscore\\tO\\nin\\tO\\nmultipoint\\tO\\nlinkage\\tO\\nanalysis\\tO\\nof\\tO\\n2\\tO\\n.\\tO\\n\\n84\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\nThe\\tO\\nsupport\\tO\\ninterval\\tO\\nextended\\tO\\n9\\tO\\ncM\\tO\\nproximal\\tO\\nto\\tO\\nDXS144E\\tO\\nand\\tO\\n14\\tO\\ncM\\tO\\ndistal\\tO\\nto\\tO\\nF9\\tO\\n.\\tO\\n\\n(\\tO\\nABSTRACT\\tO\\nTRUNCATED\\tO\\nAT\\tO\\n250\\tO\\nWORDS\\tO\\n)\\tO\\n.\\tO\\n\\nMultiple\\tO\\norigins\\tO\\nfor\\tO\\nphenylketonuria\\tB-Disease\\nin\\tO\\nEurope\\tO\\n.\\tO\\n\\nPhenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\ndisorder\\tB-Disease\\nof\\tI-Disease\\namino\\tI-Disease\\nacid\\tI-Disease\\nmetabolism\\tI-Disease\\nprevalent\\tO\\namong\\tO\\nCaucasians\\tO\\nand\\tO\\nother\\tO\\nethnic\\tO\\ngroups\\tO\\n,\\tO\\nis\\tO\\ncaused\\tO\\nprimarily\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nhepatic\\tI-Disease\\nenzyme\\tI-Disease\\nphenylalanine\\tI-Disease\\nhydroxylase\\tI-Disease\\n(\\tO\\nPAH\\tO\\n)\\tO\\n.\\tO\\n\\nPKU\\tB-Disease\\nis\\tO\\na\\tO\\nhighly\\tO\\nheterogeneous\\tO\\ndisorder\\tO\\n,\\tO\\nwith\\tO\\nmore\\tO\\nthan\\tO\\n60\\tO\\nmolecular\\tO\\nlesions\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nhaplotype\\tO\\nassociations\\tO\\n,\\tO\\nrelative\\tO\\nfrequencies\\tO\\n,\\tO\\nand\\tO\\ndistributions\\tO\\nof\\tO\\nfive\\tO\\nprevalent\\tO\\nPAH\\tO\\nmutations\\tO\\n(\\tO\\nR158Q\\tO\\n,\\tO\\nR261Q\\tO\\n,\\tO\\nIVS10nt546\\tO\\n,\\tO\\nR408W\\tO\\n,\\tO\\nand\\tO\\nIVS12n1\\tO\\n)\\tO\\nwere\\tO\\nestablished\\tO\\nin\\tO\\na\\tO\\ncomprehensive\\tO\\nEuropean\\tO\\nsample\\tO\\npopulation\\tO\\nand\\tO\\nsubsequently\\tO\\nwere\\tO\\nexamined\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\npotential\\tO\\nroles\\tO\\nof\\tO\\nseveral\\tO\\ngenetic\\tO\\nmechanisms\\tO\\nin\\tO\\nexplaining\\tO\\nthe\\tO\\npresent\\tO\\ndistribution\\tO\\nof\\tO\\nthe\\tO\\nmajor\\tO\\nPKU\\tB-Disease\\nalleles\\tO\\n.\\tO\\n\\nEach\\tO\\nof\\tO\\nthese\\tO\\nfive\\tO\\nmutations\\tO\\nwas\\tO\\nstrongly\\tO\\nassociated\\tO\\nwith\\tO\\nonly\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nmore\\tO\\nthan\\tO\\n70\\tO\\nchromosomal\\tO\\nhaplotypes\\tO\\ndefined\\tO\\nby\\tO\\neight\\tO\\nRFLPs\\tO\\nin\\tO\\nor\\tO\\nnear\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\neach\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\narose\\tO\\nthrough\\tO\\na\\tO\\nsingle\\tO\\nfounding\\tO\\nevent\\tO\\nthat\\tO\\noccurred\\tO\\nwithin\\tO\\ntime\\tO\\nperiods\\tO\\nranging\\tO\\nfrom\\tO\\nseveral\\tO\\nhundred\\tO\\nto\\tO\\nseveral\\tO\\nthousand\\tO\\nyears\\tO\\nago\\tO\\n.\\tO\\n\\nFrom\\tO\\nthe\\tO\\nsignificant\\tO\\ndifferences\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\nrelative\\tO\\nfrequencies\\tO\\nand\\tO\\ndistributions\\tO\\nof\\tO\\nthese\\tO\\nfive\\tO\\nalleles\\tO\\nthroughout\\tO\\nEurope\\tO\\n,\\tO\\nfour\\tO\\nof\\tO\\nthese\\tO\\nputative\\tO\\nfounding\\tO\\nevents\\tO\\ncould\\tO\\nbe\\tO\\nlocalized\\tO\\nto\\tO\\nspecific\\tO\\nethnic\\tO\\nsubgroups\\tO\\n.\\tO\\n\\nTogether\\tO\\n,\\tO\\nthese\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nthere\\tO\\nwere\\tO\\nmultiple\\tO\\n,\\tO\\ngeographically\\tO\\nand\\tO\\nethnically\\tO\\ndistinct\\tO\\norigins\\tO\\nfor\\tO\\nPKU\\tB-Disease\\nwithin\\tO\\nthe\\tO\\nEuropean\\tO\\npopulation\\tO\\n.\\tO\\n.\\tO\\n\\nComplement\\tB-Disease\\nfactor\\tI-Disease\\n2\\tI-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\na\\tO\\nclinical\\tO\\nand\\tO\\nserological\\tO\\nfamily\\tO\\nstudy\\tO\\n.\\tO\\n\\nInherited\\tB-Disease\\ncomplement\\tI-Disease\\ndeficiencies\\tI-Disease\\nare\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nconnective\\tO\\ntissue\\tO\\ndiseases\\tO\\n.\\tO\\n\\nA\\tO\\nfamily\\tO\\nwith\\tO\\ninherited\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nfactor\\tI-Disease\\n2\\tI-Disease\\n(\\tO\\nC2\\tO\\n)\\tO\\nis\\tO\\ndescribed\\tO\\nin\\tO\\nwhich\\tO\\ntwo\\tO\\nfamily\\tO\\nmembers\\tO\\nwith\\tO\\nhomozygous\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\ndeveloped\\tO\\ncutaneous\\tB-Disease\\nvasculitis\\tI-Disease\\nand\\tO\\nsicca\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nfamily\\tO\\nmembers\\tO\\nhad\\tO\\nheterozygous\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\neach\\tO\\nmember\\tO\\nhad\\tO\\nthe\\tO\\nHLA\\tO\\n-\\tO\\nA25\\tO\\n,\\tO\\nB18\\tO\\n,\\tO\\nDR2\\tO\\n(\\tO\\nw15\\tO\\n)\\tO\\nhaplotype\\tO\\n.\\tO\\n\\nThe\\tO\\nmother\\tO\\nhad\\tO\\nseropositive\\tB-Disease\\nrheumatoid\\tI-Disease\\narthritis\\tI-Disease\\n.\\tO\\n\\nFurther\\tO\\nstudies\\tO\\nshowed\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\ncryoglobulins\\tO\\n,\\tO\\nantibodies\\tO\\nagainst\\tO\\nendothelial\\tO\\ncells\\tO\\n,\\tO\\nand\\tO\\nanticardiolipin\\tO\\nantibodies\\tO\\n.\\tO\\n.\\tO\\n\\nNew\\tO\\nvariant\\tO\\nin\\tO\\nexon\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\ngreater\\tO\\nthan\\tO\\nG\\tO\\ntransversion\\tO\\nhas\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\nexon\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\nPLP\\tO\\ngene\\tO\\nof\\tO\\naffected\\tO\\nmales\\tO\\nand\\tO\\ntheir\\tO\\nmother\\tO\\nin\\tO\\na\\tO\\nsingle\\tO\\nsibship\\tO\\nwith\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nmerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nPMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ntransversion\\tO\\nshould\\tO\\nnot\\tO\\nresult\\tO\\nin\\tO\\nan\\tO\\namino\\tO\\nacid\\tO\\nchange\\tO\\nin\\tO\\nthe\\tO\\nprotein\\tO\\nbut\\tO\\nit\\tO\\ndoes\\tO\\nresult\\tO\\nin\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\na\\tO\\nHaeIII\\tO\\nrestriction\\tO\\nendonuclease\\tO\\ncleavage\\tO\\nsite\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nconcordant\\tO\\nwith\\tO\\nthe\\tO\\ndisease\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n.\\tO\\n\\nOne\\tO\\n-\\tO\\nhundred\\tO\\n-\\tO\\nten\\tO\\nunrelated\\tO\\nX\\tO\\nchromosomes\\tO\\nare\\tO\\nnegative\\tO\\nfor\\tO\\nthis\\tO\\nmutation\\tO\\n.\\tO\\n\\nNo\\tO\\nother\\tO\\nsequence\\tO\\ndefect\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nPLP\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\naffected\\tO\\nmales\\tO\\n.\\tO\\n\\nThe\\tO\\ncause\\tO\\nof\\tO\\ndisease\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nremains\\tO\\nunknown\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nassociation\\tO\\nbetween\\tO\\nthis\\tO\\nrare\\tO\\nmutation\\tO\\nand\\tO\\nPMD\\tB-Disease\\nis\\tO\\nintriguing\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\ncan\\tO\\nserve\\tO\\nas\\tO\\na\\tO\\nmarker\\tO\\nfor\\tO\\nfollowing\\tO\\nsegregation\\tO\\nof\\tO\\nthe\\tO\\nPLP\\tO\\ngene\\tO\\n.\\tO\\n.\\tO\\n\\nUncoupling\\tO\\nof\\tO\\nhypomyelination\\tB-Disease\\nand\\tO\\nglial\\tB-Disease\\ncell\\tI-Disease\\ndeath\\tI-Disease\\nby\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\ngene\\tO\\n.\\tO\\n\\nProteolipid\\tO\\nprotein\\tO\\n(\\tO\\nPLP\\tO\\n;\\tO\\nM\\tO\\n(\\tO\\nr\\tO\\n)\\tO\\n30\\tO\\n,\\tO\\n000\\tO\\n)\\tO\\nis\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\nmajor\\tO\\npolytopic\\tO\\nmembrane\\tO\\nprotein\\tO\\nin\\tO\\nmyelin\\tO\\nbut\\tO\\nits\\tO\\ncellular\\tO\\nfunction\\tO\\nremains\\tO\\nobscure\\tO\\n.\\tO\\n\\nNeurological\\tO\\nmutant\\tO\\nmice\\tO\\ncan\\tO\\noften\\tO\\nprovide\\tO\\nmodel\\tO\\nsystems\\tO\\nfor\\tO\\nhuman\\tO\\ngenetic\\tB-Disease\\ndisorders\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\n-\\tO\\nchromosome\\tO\\n-\\tO\\nlinked\\tO\\nPLP\\tO\\ngene\\tO\\nare\\tO\\nlethal\\tO\\n,\\tO\\nidentified\\tO\\nfirst\\tO\\nin\\tO\\nthe\\tO\\njimpy\\tO\\nmouse\\tO\\nand\\tO\\nsubsequently\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nunexplained\\tO\\nphenotype\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nincludes\\tO\\ndegeneration\\tB-Disease\\nand\\tI-Disease\\npremature\\tI-Disease\\ncell\\tI-Disease\\ndeath\\tI-Disease\\nof\\tI-Disease\\noligodendrocytes\\tI-Disease\\nwith\\tO\\nassociated\\tO\\nhypomyelination\\tB-Disease\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nshow\\tO\\nthat\\tO\\na\\tO\\nnew\\tO\\nmouse\\tO\\nmutant\\tO\\nrumpshaker\\tO\\nis\\tO\\ndefined\\tO\\nby\\tO\\nthe\\tO\\namino\\tO\\n-\\tO\\nacid\\tO\\nsubstitution\\tO\\nIle\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nThr\\tO\\nat\\tO\\nresidue\\tO\\n186\\tO\\nin\\tO\\na\\tO\\nmembrane\\tO\\n-\\tO\\nembedded\\tO\\ndomain\\tO\\nof\\tO\\nPLP\\tO\\n.\\tO\\n\\nSurprisingly\\tO\\n,\\tO\\nrumpshaker\\tO\\nmice\\tO\\n,\\tO\\nalthough\\tO\\nmyelin\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\n,\\tO\\nhave\\tO\\nnormal\\tO\\nlongevity\\tO\\nand\\tO\\na\\tO\\nfull\\tO\\ncomplement\\tO\\nof\\tO\\nmorphologically\\tO\\nnormal\\tO\\noligodendrocytes\\tO\\n.\\tO\\n\\nHypomyelination\\tB-Disease\\ncan\\tO\\nthus\\tO\\nbe\\tO\\ngenetically\\tO\\nseparated\\tO\\nfrom\\tO\\nthe\\tO\\nPLP\\tO\\n-\\tO\\ndependent\\tO\\noligodendrocyte\\tB-Disease\\ndegeneration\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nsuggest\\tO\\nthat\\tO\\nPLP\\tO\\nhas\\tO\\na\\tO\\nvital\\tO\\nfunction\\tO\\nin\\tO\\nglial\\tO\\ncell\\tO\\ndevelopment\\tO\\n,\\tO\\ndistinct\\tO\\nfrom\\tO\\nits\\tO\\nlater\\tO\\nrole\\tO\\nin\\tO\\nmyelin\\tO\\nassembly\\tO\\n,\\tO\\nand\\tO\\nthat\\tO\\nthis\\tO\\ndichotomy\\tO\\nof\\tO\\naction\\tO\\nmay\\tO\\nexplain\\tO\\nthe\\tO\\nclinical\\tO\\nspectrum\\tO\\nof\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nA\\tO\\npseudodeficiency\\tO\\nallele\\tO\\ncommon\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ncarriers\\tO\\n:\\tO\\nimplications\\tO\\nfor\\tO\\ncarrier\\tO\\nscreening\\tO\\n.\\tO\\n\\nDeficiency\\tB-Disease\\nof\\tI-Disease\\nbeta\\tI-Disease\\n-\\tI-Disease\\nhexosaminidase\\tI-Disease\\nA\\tI-Disease\\n(\\tO\\nHex\\tO\\nA\\tO\\n)\\tO\\nactivity\\tO\\ntypically\\tO\\nresults\\tO\\nin\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nhealthy\\tO\\nsubjects\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ndeficient\\tB-Disease\\nin\\tI-Disease\\nHex\\tI-Disease\\nA\\tI-Disease\\nactivity\\tO\\n(\\tO\\ni\\tO\\n.\\tO\\ne\\tO\\n.\\tO\\n,\\tO\\npseudodeficient\\tO\\n)\\tO\\nby\\tO\\nmeans\\tO\\nof\\tO\\nin\\tO\\nvitro\\tO\\nbiochemical\\tO\\ntests\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\n.\\tO\\n\\nWe\\tO\\nanalyzed\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\nof\\tO\\none\\tO\\npseudodeficient\\tO\\nsubject\\tO\\nand\\tO\\nidentified\\tO\\nboth\\tO\\na\\tO\\nC739\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nT\\tO\\nsubstitution\\tO\\nthat\\tO\\nchanges\\tO\\nArg247\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nTrp\\tO\\non\\tO\\none\\tO\\nallele\\tO\\nand\\tO\\na\\tO\\npreviously\\tO\\nidentified\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nmutation\\tO\\non\\tO\\nthe\\tO\\nsecond\\tO\\nallele\\tO\\n.\\tO\\n\\nSix\\tO\\nadditional\\tO\\npseudodeficient\\tO\\nsubjects\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nthe\\tO\\nC739\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nT\\tO\\nmutation\\tO\\n.\\tO\\n\\nThis\\tO\\nallele\\tO\\naccounted\\tO\\nfor\\tO\\n32\\tO\\n%\\tO\\n(\\tO\\n20\\tO\\n/\\tO\\n62\\tO\\n)\\tO\\nof\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nenzyme\\tO\\n-\\tO\\ndefined\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\ncarriers\\tO\\nbut\\tO\\nfor\\tO\\nnone\\tO\\nof\\tO\\n36\\tO\\nJewish\\tO\\nenzyme\\tO\\n-\\tO\\ndefined\\tO\\ncarriers\\tO\\nwho\\tO\\ndid\\tO\\nnot\\tO\\nhave\\tO\\none\\tO\\nof\\tO\\nthree\\tO\\nknown\\tO\\nmutations\\tO\\ncommon\\tO\\nto\\tO\\nthis\\tO\\ngroup\\tO\\n.\\tO\\n\\nThe\\tO\\nC739\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nT\\tO\\nallele\\tO\\n,\\tO\\ntogether\\tO\\nwith\\tO\\na\\tO\\n\"\\tO\\ntrue\\tO\\n\"\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nallele\\tO\\n,\\tO\\ncauses\\tO\\nHex\\tO\\nA\\tO\\npseudodeficiency\\tO\\n.\\tO\\n\\nGiven\\tO\\nboth\\tO\\nthe\\tO\\nlarge\\tO\\nproportion\\tO\\nof\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\ncarriers\\tO\\nwith\\tO\\nthis\\tO\\nallele\\tO\\nand\\tO\\nthat\\tO\\nstandard\\tO\\nbiochemical\\tO\\nscreening\\tO\\ncannot\\tO\\ndifferentiate\\tO\\nbetween\\tO\\nheterozygotes\\tO\\nfor\\tO\\nthe\\tO\\nC739\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nT\\tO\\nmutations\\tO\\nand\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\ncarriers\\tO\\n,\\tO\\nDNA\\tO\\ntesting\\tO\\nfor\\tO\\nthis\\tO\\nmutation\\tO\\nin\\tO\\nat\\tO\\n-\\tO\\nrisk\\tO\\ncouples\\tO\\nis\\tO\\nessential\\tO\\n.\\tO\\n\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n:\\tO\\ndetection\\tO\\nof\\tO\\nmutations\\tO\\nThr181\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nPro\\tO\\nand\\tO\\nLeu223\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nPro\\tO\\nin\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\n.\\tO\\n\\nA\\tO\\nfamily\\tO\\nwith\\tO\\nan\\tO\\napparent\\tO\\nhistory\\tO\\nof\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\npresented\\tO\\nfor\\tO\\ngenetic\\tO\\ncounseling\\tO\\n,\\tO\\nrequesting\\tO\\ncarrier\\tO\\ndetection\\tO\\nand\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\n.\\tO\\n\\nRFLP\\tO\\nanalysis\\tO\\nusing\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\ngene\\tO\\nprobe\\tO\\nwas\\tO\\nuninformative\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n.\\tO\\n\\nA\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\non\\tO\\na\\tO\\nchorionic\\tO\\nvillus\\tO\\nsample\\tO\\n(\\tO\\nCVS\\tO\\n)\\tO\\nwas\\tO\\ncarried\\tO\\nout\\tO\\nusing\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\nanalysis\\tO\\nof\\tO\\na\\tO\\nvariant\\tO\\nin\\tO\\nexon\\tO\\n4\\tO\\nof\\tO\\nthe\\tO\\nPLP\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nfetus\\tO\\nwas\\tO\\npredicted\\tO\\nto\\tO\\nbe\\tO\\nunaffected\\tO\\n.\\tO\\n\\nSequencing\\tO\\nof\\tO\\nthe\\tO\\nexon\\tO\\nfrom\\tO\\nthe\\tO\\nCVS\\tO\\n,\\tO\\nthe\\tO\\npredicted\\tO\\n-\\tO\\ncarrier\\tO\\nmother\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nobligate\\tO\\n-\\tO\\ncarrier\\tO\\ngrandmother\\tO\\nrevealed\\tO\\nan\\tO\\nA\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nC\\tO\\nchange\\tO\\nat\\tO\\nnucleotide\\tO\\n541\\tO\\nin\\tO\\nthe\\tO\\ntwo\\tO\\nwomen\\tO\\nbut\\tO\\nnot\\tO\\nin\\tO\\nthe\\tO\\nfetus\\tO\\n.\\tO\\n\\nAs\\tO\\nthis\\tO\\nchange\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nThr\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nPro\\tO\\nchange\\tO\\nat\\tO\\namino\\tO\\nacid\\tO\\n181\\tO\\nin\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\npredicted\\tO\\nto\\tO\\nbe\\tO\\npart\\tO\\nof\\tO\\na\\tO\\ntransmembrane\\tO\\nsegment\\tO\\n,\\tO\\nit\\tO\\nwas\\tO\\nconcluded\\tO\\nthat\\tO\\nthis\\tO\\nwas\\tO\\nthe\\tO\\nmutation\\tO\\ncausing\\tO\\nthe\\tO\\ndisease\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nin\\tO\\na\\tO\\nsecond\\tO\\nfamily\\tO\\n,\\tO\\nan\\tO\\nexon\\tO\\n5\\tO\\nvariant\\tO\\nband\\tO\\npattern\\tO\\non\\tO\\nSSCP\\tO\\nanalysis\\tO\\nwas\\tO\\nshown\\tO\\nby\\tO\\nsequencing\\tO\\nto\\tO\\nbe\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nT\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nC\\tO\\nchange\\tO\\nat\\tO\\nnucleotide\\tO\\n668\\tO\\n.\\tO\\n\\nThis\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nLeu\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nPro\\tO\\nchange\\tO\\nin\\tO\\na\\tO\\ncarrier\\tO\\nmother\\tO\\nand\\tO\\nin\\tO\\nher\\tO\\ntwo\\tO\\naffected\\tO\\nsons\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nprovide\\tO\\nfurther\\tO\\nexamples\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nPLP\\tO\\nthat\\tO\\ncause\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\nand\\tO\\nillustrate\\tO\\nthe\\tO\\nvalue\\tO\\nof\\tO\\nSSCP\\tO\\nin\\tO\\ngenetic\\tO\\nanalysis\\tO\\n.\\tO\\n.\\tO\\n\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\ntype\\tI-Disease\\nB\\tI-Disease\\n:\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nselectively\\tO\\nabolishes\\tO\\nristocetin\\tO\\n-\\tO\\ninduced\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\nbinding\\tO\\nto\\tO\\nplatelet\\tO\\nglycoprotein\\tO\\nIb\\tO\\n.\\tO\\n\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\n(\\tO\\nvWF\\tO\\n)\\tO\\nis\\tO\\na\\tO\\nmultimeric\\tO\\nglycoprotein\\tO\\nthat\\tO\\nmediates\\tO\\nthe\\tO\\nadhesion\\tO\\nof\\tO\\nplatelets\\tO\\nto\\tO\\nthe\\tO\\nsubendothelium\\tO\\nby\\tO\\nbinding\\tO\\nto\\tO\\nplatelet\\tO\\nglycoprotein\\tO\\nIb\\tO\\n.\\tO\\n\\nFor\\tO\\nhuman\\tO\\nvWF\\tO\\n,\\tO\\nthis\\tO\\ninteraction\\tO\\ncan\\tO\\nbe\\tO\\ninduced\\tO\\nin\\tO\\nvitro\\tO\\nby\\tO\\nthe\\tO\\nantibiotic\\tO\\nristocetin\\tO\\nor\\tO\\nthe\\tO\\nsnake\\tO\\nvenom\\tO\\nprotein\\tO\\nbotrocetin\\tO\\n.\\tO\\n\\nA\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\nGly\\tO\\n-\\tO\\n561\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nSer\\tO\\n,\\tO\\nwas\\tO\\nidentified\\tO\\nwithin\\tO\\nthe\\tO\\nproposed\\tO\\nglycoprotein\\tO\\nIb\\tO\\nbinding\\tO\\ndomain\\tO\\nof\\tO\\nvWF\\tO\\nin\\tO\\nthe\\tO\\nproband\\tO\\nwith\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\ntype\\tI-Disease\\nB\\tI-Disease\\n,\\tO\\na\\tO\\nunique\\tO\\nvariant\\tO\\ncharacterized\\tO\\nby\\tO\\nno\\tO\\nristocetin\\tO\\n-\\tO\\ninduced\\tO\\n,\\tO\\nbut\\tO\\nnormal\\tO\\nbotrocetin\\tO\\n-\\tO\\ninduced\\tO\\n,\\tO\\nbinding\\tO\\nto\\tO\\nglycoprotein\\tO\\nIb\\tO\\n.\\tO\\n\\nThe\\tO\\ncorresponding\\tO\\nmutant\\tO\\nrecombinant\\tO\\nprotein\\tO\\n,\\tO\\nrvWF\\tO\\n(\\tO\\nG561S\\tO\\n)\\tO\\n,\\tO\\nformed\\tO\\nnormal\\tO\\nmultimers\\tO\\nand\\tO\\nexhibited\\tO\\nthe\\tO\\nsame\\tO\\nfunctional\\tO\\ndefect\\tO\\nas\\tO\\nthe\\tO\\npatients\\tO\\nplasma\\tO\\nvWF\\tO\\n,\\tO\\nconfirming\\tO\\nthat\\tO\\nthis\\tO\\nmutation\\tO\\ncauses\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\ntype\\tI-Disease\\nB\\tI-Disease\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nshow\\tO\\nthat\\tO\\nbotrocetin\\tO\\nand\\tO\\nristocetin\\tO\\ncofactor\\tO\\nactivities\\tO\\nof\\tO\\nvWF\\tO\\ncan\\tO\\nbe\\tO\\ndissociated\\tO\\nby\\tO\\na\\tO\\npoint\\tO\\nmutation\\tO\\nand\\tO\\nconfirm\\tO\\nthat\\tO\\nthese\\tO\\nmediators\\tO\\npromote\\tO\\nvWF\\tO\\nbinding\\tO\\nto\\tO\\nplatelets\\tO\\nby\\tO\\ndifferent\\tO\\nmechanisms\\tO\\n.\\tO\\n\\nThe\\tO\\nnormal\\tO\\nbotrocetin\\tO\\n-\\tO\\ninduced\\tO\\nbinding\\tO\\nand\\tO\\nthe\\tO\\ndefective\\tO\\nristocetin\\tO\\n-\\tO\\ninduced\\tO\\nbinding\\tO\\nof\\tO\\nrvWF\\tO\\n(\\tO\\nG561S\\tO\\n)\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nprimary\\tO\\ndefect\\tO\\nin\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\ntype\\tI-Disease\\nB\\tI-Disease\\nmay\\tO\\nbe\\tO\\na\\tO\\nfailure\\tO\\nof\\tO\\nnormal\\tO\\nallosteric\\tO\\nregulation\\tO\\nof\\tO\\nthe\\tO\\nglycoprotein\\tO\\nIb\\tO\\nbinding\\tO\\nfunction\\tO\\nof\\tO\\nvWF\\tO\\n.\\tO\\n.\\tO\\n\\nTypical\\tO\\nand\\tO\\npartial\\tO\\ncat\\tB-Disease\\neye\\tI-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\nidentification\\tO\\nof\\tO\\nthe\\tO\\nmarker\\tO\\nchromosome\\tO\\nby\\tO\\nFISH\\tO\\n.\\tO\\n\\nThree\\tO\\nchildren\\tO\\nare\\tO\\nreported\\tO\\nwith\\tO\\ntypical\\tO\\ncat\\tB-Disease\\neye\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nCES\\tB-Disease\\n)\\tO\\nand\\tO\\nthree\\tO\\nmore\\tO\\nchildren\\tO\\nwith\\tO\\npartial\\tO\\nCES\\tB-Disease\\nbecause\\tO\\nof\\tO\\nabsence\\tO\\nof\\tO\\ncoloboma\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nsupernumerary\\tO\\nmarker\\tO\\nchromosome\\tO\\nwas\\tO\\nstudied\\tO\\nby\\tO\\nFISH\\tO\\n.\\tO\\n\\nUsing\\tO\\na\\tO\\ngenomic\\tO\\nlibrary\\tO\\n,\\tO\\nand\\tO\\nalso\\tO\\na\\tO\\ncentromeric\\tO\\nand\\tO\\nparticularly\\tO\\na\\tO\\ncosmid\\tO\\nprobe\\tO\\nof\\tO\\n22q11\\tO\\n,\\tO\\npartial\\tO\\ntetrasomy\\tB-Disease\\nwas\\tO\\nshown\\tO\\nin\\tO\\nall\\tO\\ncases\\tO\\n.\\tO\\n.\\tO\\n\\n[\\tO\\nGenetic\\tO\\nheterogeneity\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\nmutant\\tO\\nalleles\\tO\\nof\\tO\\nG6PD\\tO\\nin\\tO\\nthe\\tO\\nShekii\\tO\\ndistrict\\tO\\nof\\tO\\nAzerbaijan\\tO\\n]\\tO\\n\\nExamination\\tO\\non\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\n349\\tO\\npatients\\tO\\nof\\tO\\nShekii\\tO\\ndistrict\\tO\\nhospital\\tO\\n(\\tO\\nAzerbaijan\\tO\\n)\\tO\\nrevealed\\tO\\n16\\tO\\nhemi\\tO\\n-\\tO\\n,\\tO\\n4\\tO\\nhomo\\tO\\n-\\tO\\nand\\tO\\n9\\tO\\nheterozygotic\\tO\\ncarriers\\tO\\nof\\tO\\nthe\\tO\\ndefect\\tO\\n.\\tO\\n\\nGd\\tO\\n-\\tO\\nfrequency\\tO\\n,\\tO\\ncalculated\\tO\\nfrom\\tO\\nthe\\tO\\ndata\\tO\\nobtained\\tO\\n(\\tO\\n7\\tO\\n.\\tO\\n7\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nmay\\tO\\nbe\\tO\\ncompared\\tO\\nto\\tO\\nneighbouring\\tO\\nregions\\tO\\nfrequencies\\tO\\n(\\tO\\n6\\tO\\n-\\tO\\n30\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nCarriers\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nare\\tO\\nresidents\\tO\\nof\\tO\\n11\\tO\\nvillages\\tO\\nlocated\\tO\\nin\\tO\\nAlasani\\tO\\n-\\tO\\nAphtalan\\tO\\nvalley\\tO\\n,\\tO\\nhighly\\tO\\nendemic\\tO\\nwith\\tO\\nmalaria\\tB-Disease\\nin\\tO\\nthe\\tO\\npast\\tO\\n;\\tO\\nnearly\\tO\\nall\\tO\\nmarriages\\tO\\nare\\tO\\nendogamic\\tO\\n.\\tO\\n\\nPhysico\\tO\\n-\\tO\\nchemical\\tO\\nand\\tO\\nkinetic\\tO\\nstudy\\tO\\nof\\tO\\n10\\tO\\nmutant\\tO\\nforms\\tO\\nof\\tO\\nG6PD\\tO\\n,\\tO\\naccording\\tO\\nto\\tO\\nWHO\\tO\\nprogram\\tO\\n,\\tO\\nled\\tO\\nto\\tO\\nidentification\\tO\\nof\\tO\\n5\\tO\\nvariants\\tO\\nof\\tO\\nthe\\tO\\nII\\tO\\nclass\\tO\\n(\\tO\\nShekii\\tO\\n,\\tO\\nBideiz\\tO\\n,\\tO\\nShirin\\tO\\n-\\tO\\nBulakh\\tO\\n,\\tO\\nOkhut\\tO\\nI\\tO\\nand\\tO\\nZakataly\\tO\\n)\\tO\\nand\\tO\\n2\\tO\\nvariants\\tO\\nof\\tO\\nthe\\tO\\nIII\\tO\\nclass\\tO\\n(\\tO\\nOkhut\\tO\\nII\\tO\\nand\\tO\\nMartinique\\tO\\n-\\tO\\nlike\\tO\\n)\\tO\\n.\\tO\\n\\nResemblance\\tO\\nof\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nvariants\\tO\\nin\\tO\\nelectrophoretic\\tO\\nmobility\\tO\\nand\\tO\\nthe\\tO\\nlevel\\tO\\nof\\tO\\nerythrocyte\\tO\\nenzyme\\tO\\nactivity\\tO\\npermit\\tO\\nto\\tO\\nsuggest\\tO\\nthe\\tO\\nexistence\\tO\\nof\\tO\\na\\tO\\ncommon\\tO\\nparental\\tO\\nmutant\\tO\\nG6PD\\tO\\nallele\\tO\\ndistributed\\tO\\nin\\tO\\nthis\\tO\\narea\\tO\\n.\\tO\\n\\nCraniofrontonasal\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\nnine\\tO\\npatients\\tO\\nwith\\tO\\ncraniofrontonasal\\tB-Disease\\ndysplasia\\tI-Disease\\n(\\tO\\nCFND\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nSeven\\tO\\nclassical\\tO\\ncases\\tO\\nhad\\tO\\nfacial\\tO\\nfeatures\\tO\\nsuggestive\\tO\\nof\\tO\\nfrontonasal\\tB-Disease\\ndysplasia\\tI-Disease\\nand\\tO\\ncoronal\\tB-Disease\\ncraniosynostosis\\tI-Disease\\n.\\tO\\n\\nExtracranial\\tB-Disease\\nabnormalities\\tI-Disease\\nsuch\\tO\\nas\\tO\\nbrittle\\tB-Disease\\nnails\\tI-Disease\\nwith\\tI-Disease\\nprominent\\tI-Disease\\nlongitudinal\\tI-Disease\\ngrooves\\tI-Disease\\nor\\tO\\nsyndactyly\\tB-Disease\\nof\\tI-Disease\\nfingers\\tI-Disease\\nand\\tI-Disease\\ntoes\\tI-Disease\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nindividual\\tO\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\ntwo\\tO\\nfamilies\\tO\\nthe\\tO\\nfather\\tO\\nof\\tO\\nclassical\\tO\\ncases\\tO\\nshowed\\tO\\na\\tO\\nmilder\\tO\\npattern\\tO\\nof\\tO\\nabnormalities\\tO\\n,\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\ndiagnosis\\tO\\n.\\tO\\n\\nWe\\tO\\npresent\\tO\\na\\tO\\n2\\tO\\n-\\tO\\nto\\tO\\n13\\tO\\n-\\tO\\nyear\\tO\\nfollow\\tO\\n-\\tO\\nup\\tO\\non\\tO\\nour\\tO\\npatients\\tO\\n.\\tO\\n\\nHypotonia\\tB-Disease\\nand\\tO\\nlaxity\\tB-Disease\\nof\\tI-Disease\\njoints\\tI-Disease\\nare\\tO\\ncommon\\tO\\nand\\tO\\nmay\\tO\\nnecessitate\\tO\\nsupportive\\tO\\nmeasures\\tO\\n.\\tO\\n\\nMild\\tO\\ndevelopmental\\tB-Disease\\ndelay\\tI-Disease\\nwas\\tO\\nnoted\\tO\\nin\\tO\\nthree\\tO\\nout\\tO\\nof\\tO\\nsix\\tO\\nclassical\\tO\\ncases\\tO\\nstudied\\tO\\nin\\tO\\ndetail\\tO\\n.\\tO\\n\\nUnlike\\tO\\nalmost\\tO\\nall\\tO\\nother\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndisorders\\tI-Disease\\n,\\tO\\nclinical\\tO\\nexpression\\tO\\nin\\tO\\nCFND\\tB-Disease\\nis\\tO\\ngenerally\\tO\\nmuch\\tO\\nmore\\tO\\nsevere\\tO\\nin\\tO\\nfemales\\tO\\nthan\\tO\\nin\\tO\\nmales\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\nto\\tO\\nprevious\\tO\\nreports\\tO\\nof\\tO\\nthis\\tO\\ncondition\\tO\\n,\\tO\\none\\tO\\nof\\tO\\nour\\tO\\nseverely\\tO\\naffected\\tO\\ncases\\tO\\nis\\tO\\na\\tO\\nmale\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nintron\\tO\\n7\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\ntransition\\tO\\n:\\tO\\na\\tO\\nsecond\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nmutation\\tO\\nin\\tO\\nFrench\\tO\\nCanada\\tO\\n.\\tO\\n\\nMutations\\tO\\nat\\tO\\nthe\\tO\\nhexosaminidase\\tO\\nA\\tO\\n(\\tO\\nHEXA\\tO\\n)\\tO\\ngene\\tO\\nwhich\\tO\\ncause\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\nhave\\tO\\nelevated\\tO\\nfrequency\\tO\\nin\\tO\\nthe\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nand\\tO\\nFrench\\tO\\n-\\tO\\nCanadian\\tO\\npopulations\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\na\\tO\\nnovel\\tO\\nTSD\\tB-Disease\\nallele\\tO\\nin\\tO\\nthe\\tO\\nFrench\\tO\\n-\\tO\\nCanadian\\tO\\npopulation\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\ninfantile\\tO\\nform\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\n,\\tO\\na\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nthe\\tO\\n+\\tO\\n1\\tO\\nposition\\tO\\nof\\tO\\nintron\\tO\\n7\\tO\\n,\\tO\\nabolishes\\tO\\nthe\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\n.\\tO\\n\\nCultured\\tO\\nhuman\\tO\\nfibroblasts\\tO\\nfrom\\tO\\na\\tO\\ncompound\\tO\\nheterozygote\\tO\\nfor\\tO\\nthis\\tO\\ntransition\\tO\\n(\\tO\\nand\\tO\\nfor\\tO\\na\\tO\\ndeletion\\tO\\nmutation\\tO\\n)\\tO\\nproduce\\tO\\nno\\tO\\ndetectable\\tO\\nHEXA\\tO\\nmRNA\\tO\\n.\\tO\\n\\nThe\\tO\\nintron\\tO\\n7\\tO\\n+\\tO\\n1\\tO\\nmutation\\tO\\noccurs\\tO\\nin\\tO\\nthe\\tO\\nbase\\tO\\nadjacent\\tO\\nto\\tO\\nthe\\tO\\nsite\\tO\\nof\\tO\\nthe\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\nTSD\\tB-Disease\\nmutation\\tO\\n(\\tO\\nG805A\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nboth\\tO\\nmutations\\tO\\na\\tO\\nrestriction\\tO\\nsite\\tO\\nfor\\tO\\nthe\\tO\\nendonuclease\\tO\\nEcoRII\\tO\\nis\\tO\\nabolished\\tO\\n.\\tO\\n\\nUnambiguous\\tO\\ndiagnosis\\tO\\n,\\tO\\ntherefore\\tO\\n,\\tO\\nrequires\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\noligonucleotide\\tO\\nhybridization\\tO\\nto\\tO\\ndistinguish\\tO\\nbetween\\tO\\nthese\\tO\\ntwo\\tO\\nmutant\\tO\\nalleles\\tO\\n.\\tO\\n\\nThe\\tO\\nintron\\tO\\n7\\tO\\n+\\tO\\n1\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\nthree\\tO\\nunrelated\\tO\\nfamilies\\tO\\n.\\tO\\n\\nObligate\\tO\\nheterozygotes\\tO\\nfor\\tO\\nthe\\tO\\nintron\\tO\\n7\\tO\\n+\\tO\\n1\\tO\\nmutation\\tO\\nwere\\tO\\nborn\\tO\\nin\\tO\\nthe\\tO\\nSaguenay\\tO\\n-\\tO\\nLac\\tO\\n-\\tO\\nSt\\tO\\n-\\tO\\nJean\\tO\\nregion\\tO\\nof\\tO\\nQuebec\\tO\\n.\\tO\\n\\nThe\\tO\\nmost\\tO\\nrecent\\tO\\nancestors\\tO\\ncommon\\tO\\nto\\tO\\nobligate\\tO\\ncarriers\\tO\\nof\\tO\\nthis\\tO\\nmutation\\tO\\nwere\\tO\\nfrom\\tO\\nthe\\tO\\nCharlevoix\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nprovince\\tO\\nof\\tO\\nQuebec\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nthus\\tO\\nhas\\tO\\na\\tO\\ndifferent\\tO\\ngeographic\\tO\\ncentre\\tO\\nof\\tO\\ndiffusion\\tO\\nand\\tO\\nis\\tO\\nprobably\\tO\\nless\\tO\\ncommon\\tO\\nthan\\tO\\nthe\\tO\\nexon\\tO\\n1\\tO\\ndeletion\\tO\\nTSD\\tB-Disease\\nmutation\\tO\\nin\\tO\\nFrench\\tO\\nCanadians\\tO\\n.\\tO\\n\\nNeither\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\nFrance\\tO\\n,\\tO\\nthe\\tO\\nancestral\\tO\\nhomeland\\tO\\nof\\tO\\nFrench\\tO\\nCanada\\tO\\n.\\tO\\n.\\tO\\n\\nAssignment\\tO\\nof\\tO\\nthe\\tO\\naspartylglucosaminidase\\tO\\ngene\\tO\\n(\\tO\\nAGA\\tO\\n)\\tO\\nto\\tO\\n4q33\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nq35\\tO\\nbased\\tO\\non\\tO\\ndecreased\\tO\\nactivity\\tO\\nin\\tO\\na\\tO\\ngirl\\tO\\nwith\\tO\\na\\tO\\n46\\tO\\n,\\tO\\nXX\\tO\\n,\\tO\\ndel\\tO\\n(\\tO\\n4\\tO\\n)\\tO\\n(\\tO\\nq33\\tO\\n)\\tO\\nkaryotype\\tO\\n.\\tO\\n\\nAspartylglucosaminuria\\tB-Disease\\n(\\tO\\nAGU\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nrecessive\\tO\\nautosomally\\tO\\ninherited\\tO\\nlysosomal\\tB-Disease\\nstorage\\tI-Disease\\ndisorder\\tI-Disease\\ndue\\tO\\nto\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nenzyme\\tI-Disease\\naspartylglucosaminidase\\tI-Disease\\n(\\tO\\nAGA\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nstructural\\tO\\ngene\\tO\\nfor\\tO\\nthis\\tO\\nhuman\\tO\\nenzyme\\tO\\n(\\tO\\nAGA\\tO\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nassigned\\tO\\nto\\tO\\nthe\\tO\\nregion\\tO\\n4q21\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nqter\\tO\\n.\\tO\\n\\nWe\\tO\\ndetermined\\tO\\nthe\\tO\\nAGA\\tO\\nactivity\\tO\\nin\\tO\\ncultured\\tO\\nfibroblasts\\tO\\nof\\tO\\na\\tO\\ngirl\\tO\\nwith\\tO\\na\\tO\\n46\\tO\\n,\\tO\\nXX\\tO\\n,\\tO\\ndel\\tO\\n(\\tO\\n4\\tO\\n)\\tO\\n(\\tO\\nq33\\tO\\n)\\tO\\nkaryotype\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\ngirl\\tO\\nis\\tO\\na\\tO\\nhemizygote\\tO\\nfor\\tO\\nAGA\\tO\\n,\\tO\\npermitting\\tO\\nthe\\tO\\nassignment\\tO\\nof\\tO\\nhuman\\tO\\nAGA\\tO\\nto\\tO\\nthe\\tO\\nregion\\tO\\n4q33\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nqter\\tO\\n.\\tO\\n.\\tO\\n\\nResolution\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nloci\\tO\\nfor\\tO\\nautosomal\\tO\\ndominant\\tO\\naniridia\\tB-Disease\\n,\\tO\\nAN1\\tO\\nand\\tO\\nAN2\\tO\\n,\\tO\\nto\\tO\\na\\tO\\nsingle\\tO\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n11p13\\tO\\n.\\tO\\n\\nTwo\\tO\\ndistinct\\tO\\nloci\\tO\\nhave\\tO\\nbeen\\tO\\nproposed\\tO\\nfor\\tO\\naniridia\\tB-Disease\\n;\\tO\\nAN1\\tO\\nfor\\tO\\nautosomal\\tO\\ndominant\\tO\\naniridia\\tB-Disease\\non\\tO\\nchromosome\\tO\\n2p\\tO\\nand\\tO\\nAN2\\tO\\nfor\\tO\\nthe\\tO\\naniridia\\tB-Disease\\nin\\tO\\nthe\\tO\\nWAGR\\tB-Disease\\ncontiguous\\tI-Disease\\ngene\\tI-Disease\\nsyndrome\\tI-Disease\\non\\tO\\nchromosome\\tO\\n11p13\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nreport\\tO\\n,\\tO\\nthe\\tO\\nkindred\\tO\\nsegregating\\tO\\nfor\\tO\\nautosomal\\tO\\ndominant\\tO\\naniridia\\tB-Disease\\n,\\tO\\nwhich\\tO\\nsuggested\\tO\\nlinkage\\tO\\nto\\tO\\nacid\\tO\\nphosphatase\\tO\\n-\\tO\\n1\\tO\\n(\\tO\\nACP1\\tO\\n)\\tO\\nand\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nassignment\\tO\\nof\\tO\\nthe\\tO\\nAN1\\tO\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n2p\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nupdated\\tO\\nand\\tO\\nexpanded\\tO\\n.\\tO\\n\\nLinkage\\tO\\nanalysis\\tO\\nbetween\\tO\\nthe\\tO\\naniridia\\tB-Disease\\nphenotype\\tO\\nand\\tO\\nACP1\\tO\\ndoes\\tO\\nnot\\tO\\nsupport\\tO\\nthe\\tO\\noriginal\\tO\\nlinkage\\tO\\nresults\\tO\\n,\\tO\\nexcluding\\tO\\nlinkage\\tO\\nup\\tO\\nto\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\n17\\tO\\nwith\\tO\\nZ\\tO\\n=\\tO\\n-\\tO\\n2\\tO\\n.\\tO\\n\\nTests\\tO\\nfor\\tO\\nlinkage\\tO\\nto\\tO\\nother\\tO\\nchromosome\\tO\\n2p\\tO\\nmarkers\\tO\\n.\\tO\\n\\nAPOB\\tO\\n,\\tO\\nD2S71\\tO\\n,\\tO\\nD2S5\\tO\\n,\\tO\\nand\\tO\\nD2S1\\tO\\n,\\tO\\nalso\\tO\\nexcluded\\tO\\nlinkage\\tO\\nto\\tO\\naniridia\\tB-Disease\\n.\\tO\\n\\nMarkers\\tO\\nthat\\tO\\nhave\\tO\\nbeen\\tO\\nisolated\\tO\\nfrom\\tO\\nthe\\tO\\nchromosome\\tO\\n11p13\\tO\\nregion\\tO\\nwere\\tO\\nthen\\tO\\nanalyzed\\tO\\nin\\tO\\nthis\\tO\\naniridia\\tB-Disease\\nfamily\\tO\\n.\\tO\\n\\nTwo\\tO\\nRFLPs\\tO\\nat\\tO\\nthe\\tO\\nD11S323\\tO\\nlocus\\tO\\ngive\\tO\\nsignificant\\tO\\nevidence\\tO\\nfor\\tO\\nlinkage\\tO\\n.\\tO\\n\\nThe\\tO\\nPvuII\\tO\\npolymorphism\\tO\\ndetected\\tO\\nby\\tO\\nprobe\\tO\\np5S1\\tO\\n.\\tO\\n\\n6\\tO\\ndetects\\tO\\nno\\tO\\nrecombinants\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\nmaximum\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\nZ\\tO\\n=\\tO\\n6\\tO\\n.\\tO\\n\\n97\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\n00\\tO\\n00\\tO\\n.\\tO\\n\\nThe\\tO\\nHaeIII\\tO\\npolymorphism\\tO\\ndetected\\tO\\nby\\tO\\nthe\\tO\\nprobe\\tO\\np5BE1\\tO\\n.\\tO\\n\\n2\\tO\\ngives\\tO\\na\\tO\\nmaximum\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\nZ\\tO\\n=\\tO\\n2\\tO\\n.\\tO\\n\\n57\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\n00\\tO\\n00\\tO\\n.\\tO\\n\\nLocus\\tO\\nD11S325\\tO\\ngives\\tO\\na\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\nZ\\tO\\n=\\tO\\n1\\tO\\n.\\tO\\n\\n53\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\n00\\tO\\n00\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\na\\tO\\nlocus\\tO\\nfor\\tO\\naniridia\\tB-Disease\\n(\\tO\\nAN1\\tO\\n)\\tO\\non\\tO\\nchromosome\\tO\\n2p\\tO\\nhas\\tO\\nbeen\\tO\\nmisassigned\\tO\\nand\\tO\\nthat\\tO\\nthis\\tO\\nautosomal\\tO\\ndominant\\tO\\naniridia\\tB-Disease\\nfamily\\tO\\nis\\tO\\nsegregating\\tO\\nfor\\tO\\nan\\tO\\naniridia\\tB-Disease\\nmutation\\tO\\nlinked\\tO\\nto\\tO\\nmarkers\\tO\\nin\\tO\\nthe\\tO\\n11p13\\tO\\nregion\\tO\\n.\\tO\\n\\nFatal\\tO\\npyoderma\\tB-Disease\\ngangrenosum\\tI-Disease\\nin\\tO\\nassociation\\tO\\nwith\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nAlthough\\tO\\npyoderma\\tB-Disease\\ngangrenosum\\tI-Disease\\n(\\tO\\nPG\\tB-Disease\\n)\\tO\\nis\\tO\\noften\\tO\\nassociated\\tO\\nwith\\tO\\nsystemic\\tB-Disease\\ndiseases\\tI-Disease\\n,\\tO\\nit\\tO\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\ncomplement\\tI-Disease\\ndeficiencies\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nan\\tO\\naggressive\\tO\\nand\\tO\\nultimately\\tO\\nfatal\\tO\\ncase\\tO\\nof\\tO\\nPG\\tB-Disease\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\na\\tO\\ncongenital\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nDeficiencies\\tB-Disease\\nof\\tI-Disease\\nC7\\tI-Disease\\ncan\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\ndecreased\\tO\\nneutrophil\\tO\\nchemotaxis\\tO\\n,\\tO\\nphagocytosis\\tO\\n,\\tO\\nand\\tO\\nopsonization\\tO\\n,\\tO\\nsimilar\\tO\\nto\\tO\\nthe\\tO\\nimmunologic\\tB-Disease\\nabnormalities\\tI-Disease\\ndescribed\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nPG\\tB-Disease\\n.\\tO\\n\\nOur\\tO\\npatients\\tO\\ndecreased\\tO\\ncomplement\\tO\\nlevel\\tO\\n,\\tO\\nif\\tO\\nnot\\tO\\ndirectly\\tO\\nrelated\\tO\\nto\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nPG\\tB-Disease\\n,\\tO\\nmay\\tO\\nhave\\tO\\ncontributed\\tO\\nto\\tO\\nthe\\tO\\naggressive\\tO\\nnature\\tO\\nof\\tO\\nher\\tO\\ndisease\\tO\\n.\\tO\\n.\\tO\\n\\nDiverse\\tO\\npoint\\tO\\nmutations\\tO\\nresult\\tO\\nin\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\npolymorphism\\tO\\nin\\tO\\nTaiwan\\tO\\n.\\tO\\n\\nGlucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nPHOSPHATE\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n;\\tI-Disease\\nEC\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n49\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nhuman\\tO\\nenzymopathy\\tB-Disease\\n,\\tO\\naffecting\\tO\\nmore\\tO\\nthan\\tO\\n200\\tO\\nmillion\\tO\\npeople\\tO\\nworldwide\\tO\\n.\\tO\\n\\nAlthough\\tO\\ngreater\\tO\\nthan\\tO\\n400\\tO\\nvariants\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\nbased\\tO\\non\\tO\\nclinical\\tO\\nand\\tO\\nbiochemical\\tO\\ncriteria\\tO\\n,\\tO\\nlittle\\tO\\nis\\tO\\nknown\\tO\\nabout\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nthese\\tO\\nG6PD\\tB-Disease\\ndeficiencies\\tI-Disease\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nthat\\tO\\nencodes\\tO\\nhuman\\tO\\nG6PD\\tO\\nhas\\tO\\nbeen\\tO\\ncloned\\tO\\nand\\tO\\nsequenced\\tO\\n,\\tO\\nwhich\\tO\\nenables\\tO\\nus\\tO\\nto\\tO\\nexamine\\tO\\ndirectly\\tO\\nthe\\tO\\nheterogeneity\\tO\\nof\\tO\\nG6PD\\tO\\nat\\tO\\nthe\\tO\\nDNA\\tO\\nlevel\\tO\\n.\\tO\\n\\nDuring\\tO\\nthe\\tO\\npast\\tO\\n10\\tO\\nyears\\tO\\n,\\tO\\nwe\\tO\\nexamined\\tO\\nthe\\tO\\nG6PD\\tO\\nactivity\\tO\\nin\\tO\\n21\\tO\\n,\\tO\\n271\\tO\\nnewborn\\tO\\nChinese\\tO\\ninfants\\tO\\n(\\tO\\n11\\tO\\n,\\tO\\n400\\tO\\nmales\\tO\\nand\\tO\\n9\\tO\\n,\\tO\\n871\\tO\\nfemales\\tO\\n)\\tO\\nand\\tO\\nidentified\\tO\\n314\\tO\\n(\\tO\\n2\\tO\\n.\\tO\\n8\\tO\\n%\\tO\\n)\\tO\\nmales\\tO\\nand\\tO\\n246\\tO\\n(\\tO\\n2\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\nfemales\\tO\\nhaving\\tO\\nlow\\tO\\nG6PD\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\nG6PD\\tO\\ngene\\tO\\nfrom\\tO\\n10\\tO\\nrandomly\\tO\\nselected\\tO\\naffected\\tO\\nindividuals\\tO\\nand\\tO\\ntheir\\tO\\nrelatives\\tO\\nwas\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\namplified\\tO\\n,\\tO\\nsubcloned\\tO\\n,\\tO\\nand\\tO\\nsequenced\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nat\\tO\\nleast\\tO\\nfour\\tO\\ntypes\\tO\\nof\\tO\\nmutation\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nG6PD\\tO\\npolymorphism\\tO\\nin\\tO\\nTaiwan\\tO\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\ntype\\tO\\nof\\tO\\nmutation\\tO\\n(\\tO\\n487\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nA\\tO\\n)\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nan\\tO\\naffected\\tO\\nChinese\\tO\\nwith\\tO\\na\\tO\\nG\\tO\\nto\\tO\\nA\\tO\\nchange\\tO\\nat\\tO\\nnucleotide\\tO\\n487\\tO\\n,\\tO\\nwhich\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\n(\\tO\\n163\\tO\\n)\\tO\\nGly\\tO\\nto\\tO\\nSer\\tO\\nsubstitution\\tO\\n.\\tO\\n\\nThe\\tO\\nsecond\\tO\\ntype\\tO\\nof\\tO\\nmutation\\tO\\n(\\tO\\n493\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nG\\tO\\n)\\tO\\nis\\tO\\na\\tO\\nnovel\\tO\\nmutation\\tO\\nthat\\tO\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\nany\\tO\\nother\\tO\\nethnic\\tO\\ngroup\\tO\\nand\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\ntwo\\tO\\naffected\\tO\\nChinese\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\ncauses\\tO\\nan\\tO\\nA\\tO\\nto\\tO\\nG\\tO\\nchange\\tO\\nat\\tO\\nnucleotide\\tO\\nposition\\tO\\n493\\tO\\n,\\tO\\nproducing\\tO\\nan\\tO\\n(\\tO\\n165\\tO\\n)\\tO\\nAsn\\tO\\nto\\tO\\nAsp\\tO\\nsubstitution\\tO\\n.\\tO\\n\\nInterestingly\\tO\\n,\\tO\\nthe\\tO\\n487\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nA\\tO\\nand\\tO\\n493\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nG\\tO\\nmutations\\tO\\ncreate\\tO\\nAlu\\tO\\nI\\tO\\nand\\tO\\nAva\\tO\\nII\\tO\\nrecognition\\tO\\nsites\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nwhich\\tO\\nenabled\\tO\\nus\\tO\\nto\\tO\\nrapidly\\tO\\ndetect\\tO\\nthese\\tO\\ntwo\\tO\\nmutations\\tO\\nby\\tO\\nPCR\\tO\\n/\\tO\\nrestriction\\tO\\nenzyme\\tO\\n(\\tO\\nRE\\tO\\n)\\tO\\ndigestion\\tO\\nmethod\\tO\\n.\\tO\\n\\nThe\\tO\\nthird\\tO\\nmutation\\tO\\n(\\tO\\n1376\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nT\\tO\\n)\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nfour\\tO\\naffected\\tO\\nChinese\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\ncauses\\tO\\na\\tO\\nG\\tO\\nto\\tO\\nT\\tO\\nchange\\tO\\nat\\tO\\nnucleotide\\tO\\nposition\\tO\\n1376\\tO\\nthat\\tO\\nresults\\tO\\nin\\tO\\nan\\tO\\n(\\tO\\n459\\tO\\n)\\tO\\nArg\\tO\\nto\\tO\\nLeu\\tO\\nsubstitution\\tO\\n.\\tO\\n\\nThe\\tO\\n1376\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nT\\tO\\nmutation\\tO\\nseems\\tO\\nto\\tO\\nbe\\tO\\nthe\\tO\\ndominant\\tO\\nallele\\tO\\nthat\\tO\\ncauses\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nTaiwan\\tO\\n.\\tO\\n\\nFinally\\tO\\n,\\tO\\ntwo\\tO\\naffected\\tO\\nChinese\\tO\\nwere\\tO\\nidentified\\tO\\nas\\tO\\nhaving\\tO\\nthe\\tO\\nfourth\\tO\\nmutation\\tO\\n(\\tO\\n1388\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nA\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\ncauses\\tO\\na\\tO\\nG\\tO\\nto\\tO\\nA\\tO\\nchange\\tO\\nat\\tO\\nnucleotide\\tO\\n1388\\tO\\nthat\\tO\\nproduces\\tO\\nan\\tO\\n(\\tO\\n463\\tO\\n)\\tO\\nArg\\tO\\nto\\tO\\nHis\\tO\\nsubstitution\\tO\\n.\\tO\\n\\nOur\\tO\\nstudies\\tO\\nprovide\\tO\\nthe\\tO\\ndirect\\tO\\nproof\\tO\\nof\\tO\\nthe\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthe\\tO\\nChinese\\tO\\npopulations\\tO\\nof\\tO\\nTaiwan\\tO\\nand\\tO\\nthe\\tO\\nPCR\\tO\\n/\\tO\\nRE\\tO\\ndigestion\\tO\\nmethod\\tO\\nis\\tO\\nsuitable\\tO\\nfor\\tO\\nsimultaneous\\tO\\ndetection\\tO\\nof\\tO\\nthe\\tO\\n487\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nA\\tO\\nand\\tO\\n493\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nG\\tO\\nmutations\\tO\\n.\\tO\\n\\nAn\\tO\\nerror\\tO\\nin\\tO\\ndystrophin\\tO\\nmRNA\\tO\\nprocessing\\tO\\nin\\tO\\ngolden\\tB-Disease\\nretriever\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nan\\tO\\nanimal\\tO\\nhomologue\\tO\\nof\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nGolden\\tB-Disease\\nretriever\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nGRMD\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nspontaneous\\tO\\n,\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\n,\\tO\\nprogressively\\tO\\nfatal\\tO\\ndisease\\tO\\nof\\tO\\ndogs\\tO\\nand\\tO\\nis\\tO\\nalso\\tO\\na\\tO\\nhomologue\\tO\\nof\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nTwo\\tO\\n-\\tO\\nthirds\\tO\\nof\\tO\\nDMD\\tB-Disease\\npatients\\tO\\ncarry\\tO\\ndetectable\\tO\\ndeletions\\tO\\nin\\tO\\ntheir\\tO\\ndystrophin\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\ndefect\\tO\\nunderlying\\tO\\nthe\\tO\\nremaining\\tO\\none\\tO\\n-\\tO\\nthird\\tO\\nof\\tO\\nDMD\\tB-Disease\\npatients\\tO\\nis\\tO\\nundetermined\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nthe\\tO\\ncanine\\tO\\ndystrophin\\tO\\ngene\\tO\\nin\\tO\\nnormal\\tO\\nand\\tO\\nGRMD\\tB-Disease\\ndogs\\tO\\nhas\\tO\\nfailed\\tO\\nto\\tO\\ndemonstrate\\tO\\nany\\tO\\ndetectable\\tO\\nloss\\tO\\nof\\tO\\nexons\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ndemonstrated\\tO\\na\\tO\\nRNA\\tO\\nprocessing\\tO\\nerror\\tO\\nin\\tO\\nGRMD\\tB-Disease\\nthat\\tO\\nresults\\tO\\nfrom\\tO\\na\\tO\\nsingle\\tO\\nbase\\tO\\nchange\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nconsensus\\tO\\nsplice\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n6\\tO\\n.\\tO\\n\\nThe\\tO\\nseventh\\tO\\nexon\\tO\\nis\\tO\\nthen\\tO\\nskipped\\tO\\n,\\tO\\nwhich\\tO\\npredicts\\tO\\na\\tO\\ntermination\\tO\\nof\\tO\\nthe\\tO\\ndystrophin\\tO\\nreading\\tO\\nframe\\tO\\nwithin\\tO\\nits\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\ndomain\\tO\\nin\\tO\\nexon\\tO\\n8\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nexample\\tO\\nof\\tO\\ndystrophin\\tB-Disease\\ndeficiency\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\n.\\tO\\n.\\tO\\n\\nType\\tB-Disease\\nI\\tI-Disease\\nhuman\\tI-Disease\\ncomplement\\tI-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nA\\tO\\n28\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ngene\\tO\\ndeletion\\tO\\ncauses\\tO\\nskipping\\tO\\nof\\tO\\nexon\\tO\\n6\\tO\\nduring\\tO\\nRNA\\tO\\nsplicing\\tO\\n.\\tO\\n\\nTwo\\tO\\nvariants\\tO\\nof\\tO\\na\\tO\\ngenetic\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nprotein\\tI-Disease\\nC2\\tI-Disease\\n(\\tO\\nC2D\\tO\\n)\\tO\\nhave\\tO\\nbeen\\tO\\npreviously\\tO\\nidentified\\tO\\n.\\tO\\n\\nNo\\tO\\nC2\\tO\\nprotein\\tO\\ntranslation\\tO\\nis\\tO\\ndetected\\tO\\nin\\tO\\ntype\\tO\\nI\\tO\\ndeficiency\\tO\\n,\\tO\\nwhile\\tO\\ntype\\tO\\nII\\tO\\ndeficiency\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\na\\tO\\nselective\\tO\\nblock\\tO\\nin\\tO\\nC2\\tO\\nsecretion\\tO\\n.\\tO\\n\\nType\\tB-Disease\\nI\\tI-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\ndescribed\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nC2\\tO\\nnull\\tO\\nallele\\tO\\n(\\tO\\nC2Q0\\tO\\n)\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nmajor\\tO\\nhistocompatibility\\tO\\nhaplotype\\tO\\n/\\tO\\ncomplotype\\tO\\nHLA\\tO\\n-\\tO\\nA25\\tO\\n,\\tO\\nB18\\tO\\n,\\tO\\nC2Q0\\tO\\n,\\tO\\nBfS\\tO\\n,\\tO\\nC4A4\\tO\\n,\\tO\\nC4B2\\tO\\n,\\tO\\nDrw2\\tO\\n;\\tO\\nthis\\tO\\nextended\\tO\\nhaplotype\\tO\\noccurs\\tO\\nin\\tO\\nover\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\nC2\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nindividuals\\tO\\n(\\tO\\ncommon\\tO\\ncomplotype\\tO\\n/\\tO\\nhaplotype\\tO\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\ntype\\tB-Disease\\nI\\tI-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nthe\\tO\\nC2\\tO\\ngene\\tO\\nand\\tO\\ncDNA\\tO\\nwere\\tO\\ncharacterized\\tO\\nfrom\\tO\\na\\tO\\nhomozygous\\tO\\ntype\\tB-Disease\\nI\\tI-Disease\\nC2\\tI-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nindividual\\tO\\nwith\\tO\\nthe\\tO\\ncommon\\tO\\nassociated\\tO\\nhaplotype\\tO\\n/\\tO\\ncomplotype\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\na\\tO\\n28\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\ntype\\tO\\nI\\tO\\nC2Q0\\tO\\ngene\\tO\\n,\\tO\\nbeginning\\tO\\n9\\tO\\nbase\\tO\\npairs\\tO\\nupstream\\tO\\nof\\tO\\nthe\\tO\\n3\\tO\\n-\\tO\\nend\\tO\\nof\\tO\\nexon\\tO\\n6\\tO\\n,\\tO\\nthat\\tO\\ngenerates\\tO\\na\\tO\\nC2\\tO\\ntranscript\\tO\\nwith\\tO\\na\\tO\\ncomplete\\tO\\ndeletion\\tO\\nof\\tO\\nexon\\tO\\n6\\tO\\n(\\tO\\n134\\tO\\nbase\\tO\\npair\\tO\\n)\\tO\\nand\\tO\\na\\tO\\npremature\\tO\\ntermination\\tO\\ncodon\\tO\\n.\\tO\\n\\nIn\\tO\\nstudies\\tO\\nof\\tO\\neight\\tO\\nkindred\\tO\\n,\\tO\\nthe\\tO\\n28\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\nall\\tO\\nC2Q0\\tO\\nalleles\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\ncommon\\tO\\ntype\\tO\\nI\\tO\\ndeficient\\tO\\ncomplotype\\tO\\n/\\tO\\nhaplotype\\tO\\n;\\tO\\nthis\\tO\\ndeletion\\tO\\nwas\\tO\\nnot\\tO\\npresent\\tO\\nin\\tO\\nnormal\\tO\\nC2\\tO\\nnor\\tO\\nin\\tO\\ntype\\tB-Disease\\nII\\tI-Disease\\nC2\\tI-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\ngenes\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\ndemonstrate\\tO\\nthat\\tO\\n1\\tO\\n)\\tO\\ntype\\tB-Disease\\nI\\tI-Disease\\nhuman\\tI-Disease\\ncomplement\\tI-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\n28\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ngenomic\\tO\\ndeletion\\tO\\nthat\\tO\\ncauses\\tO\\nskipping\\tO\\nof\\tO\\nexon\\tO\\n6\\tO\\nduring\\tO\\nRNA\\tO\\nsplicing\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\ngeneration\\tO\\nof\\tO\\na\\tO\\npremature\\tO\\ntermination\\tO\\ncodon\\tO\\n,\\tO\\n2\\tO\\n)\\tO\\nthe\\tO\\n28\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\ntype\\tO\\nI\\tO\\nC2Q0\\tO\\ngene\\tO\\nis\\tO\\nstrongly\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nHLA\\tO\\nhaplotype\\tO\\n/\\tO\\ncomplotype\\tO\\nA25\\tO\\n,\\tO\\nB18\\tO\\n,\\tO\\nC2Q0\\tO\\n,\\tO\\nBfS\\tO\\n,\\tO\\nC4A4\\tO\\n,\\tO\\nC4B2\\tO\\n,\\tO\\nDrw2\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nall\\tO\\nC2\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nindividuals\\tO\\nwith\\tO\\nthis\\tO\\nhaplotype\\tO\\n/\\tO\\ncomplotype\\tO\\nwill\\tO\\nharbor\\tO\\nthe\\tO\\n28\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\nC2\\tO\\ngene\\tO\\ndeletion\\tO\\n,\\tO\\nand\\tO\\n3\\tO\\n)\\tO\\ntype\\tB-Disease\\nII\\tI-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\ndifferent\\tO\\n,\\tO\\nas\\tO\\nyet\\tO\\nuncharacterized\\tO\\n,\\tO\\nmolecular\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\ncharacterization\\tO\\nof\\tO\\ntwo\\tO\\ngalactosemia\\tB-Disease\\nmutations\\tO\\nand\\tO\\none\\tO\\npolymorphism\\tO\\n:\\tO\\nimplications\\tO\\nfor\\tO\\nstructure\\tO\\n-\\tO\\nfunction\\tO\\nanalysis\\tO\\nof\\tO\\nhuman\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridyltransferase\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthe\\tO\\nmolecular\\tO\\ncharacterization\\tO\\nof\\tO\\ntwo\\tO\\ngalactosemia\\tB-Disease\\nmutations\\tO\\n,\\tO\\nL74P\\tO\\nand\\tO\\nF171S\\tO\\n,\\tO\\nand\\tO\\none\\tO\\npolymorphism\\tO\\n,\\tO\\nS135L\\tO\\n,\\tO\\nin\\tO\\nhuman\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridyltransferase\\tO\\n(\\tO\\nGALT\\tO\\n)\\tO\\n.\\tO\\n\\nBoth\\tO\\ngalactosemia\\tB-Disease\\nmutations\\tO\\nresult\\tO\\nin\\tO\\nreduced\\tO\\nenzymatic\\tO\\nactivity\\tO\\nwhen\\tO\\nreconstructed\\tO\\nin\\tO\\nthe\\tO\\ncDNA\\tO\\nand\\tO\\noverexpressed\\tO\\n.\\tO\\n\\nThe\\tO\\npolymorphism\\tO\\n,\\tO\\nin\\tO\\ncontrast\\tO\\n,\\tO\\nhas\\tO\\nnear\\tO\\nnormal\\tO\\nactivity\\tO\\n.\\tO\\n\\nBoth\\tO\\nmutations\\tO\\naffect\\tO\\nevolutionarily\\tO\\nconserved\\tO\\nresidues\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthey\\tO\\nare\\tO\\nfunctionally\\tO\\nimportant\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\npolymorphism\\tO\\noccurs\\tO\\nin\\tO\\na\\tO\\nnonconserved\\tO\\ndomain\\tO\\nwhich\\tO\\nis\\tO\\npresumably\\tO\\nnot\\tO\\ncritical\\tO\\nfor\\tO\\nenzymatic\\tO\\nfunction\\tO\\n.\\tO\\n\\nThe\\tO\\nF171S\\tO\\nmutation\\tO\\nis\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\nputative\\tO\\nactive\\tO\\n-\\tO\\nsite\\tO\\nnucleophile\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nfurther\\tO\\nsupport\\tO\\nthe\\tO\\nnotion\\tO\\nof\\tO\\nmolecular\\tO\\nheterogeneity\\tO\\nof\\tO\\ngalactosemia\\tB-Disease\\nand\\tO\\nsuggest\\tO\\nthat\\tO\\ngalactosemia\\tB-Disease\\nmutations\\tO\\nand\\tO\\nGALT\\tO\\npolymorphisms\\tO\\nmay\\tO\\nbe\\tO\\nuseful\\tO\\ntools\\tO\\nin\\tO\\nhighlighting\\tO\\ndifferent\\tO\\nfunctional\\tO\\ndomains\\tO\\nin\\tO\\nhuman\\tO\\nGALT\\tO\\n.\\tO\\n.\\tO\\n\\nLinkage\\tO\\nrelationship\\tO\\nof\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nHLA\\tO\\nand\\tO\\nglyoxalase\\tO\\nI\\tO\\nloci\\tO\\n.\\tO\\n\\nImmunogenetic\\tO\\nanalysis\\tO\\nof\\tO\\na\\tO\\nhomozygous\\tO\\nC2\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nindividual\\tO\\nand\\tO\\nfamily\\tO\\nmembers\\tO\\ndemonstrated\\tO\\nlinkage\\tO\\nof\\tO\\nHLA\\tO\\n-\\tO\\nA25\\tO\\n,\\tO\\nB18\\tO\\nand\\tO\\nC2o\\tO\\n.\\tO\\n\\nHLA\\tO\\n-\\tO\\nD\\tO\\ntyping\\tO\\nshowed\\tO\\nthat\\tO\\n5\\tO\\nmembers\\tO\\ntyped\\tO\\nwith\\tO\\nhomozygous\\tO\\nDw2\\tO\\ntyping\\tO\\ncells\\tO\\nfrom\\tO\\nan\\tO\\nindividual\\tO\\nwith\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nbut\\tO\\nnot\\tO\\nwith\\tO\\nDw2\\tO\\ntyping\\tO\\ncells\\tO\\nfrom\\tO\\n2\\tO\\nindividuals\\tO\\nwith\\tO\\nnormal\\tO\\nC2\\tO\\n.\\tO\\n\\nThe\\tO\\nhomozygous\\tO\\nC2\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\npropositus\\tO\\nand\\tO\\nbrother\\tO\\nwere\\tO\\nHLA\\tO\\n-\\tO\\nA\\tO\\nand\\tO\\nB\\tO\\nhomozygous\\tO\\nbut\\tO\\nheterozygous\\tO\\nat\\tO\\nthe\\tO\\nHLA\\tO\\n-\\tO\\nD\\tO\\nand\\tO\\nglyoxalase\\tO\\nI\\tO\\nloci\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n,\\tO\\nthe\\tO\\nC2o\\tO\\ngene\\tO\\nis\\tO\\nlinked\\tO\\nwith\\tO\\ntwo\\tO\\ndistinct\\tO\\nhaplotypes\\tO\\nHLA\\tO\\n-\\tO\\nA25\\tO\\n,\\tO\\nB18\\tO\\n,\\tO\\nDw2\\tO\\n,\\tO\\nGLO1\\tO\\nand\\tO\\nHLA\\tO\\n-\\tO\\nA25\\tO\\n,\\tO\\nB18\\tO\\n,\\tO\\nD\\tO\\nunknown\\tO\\n,\\tO\\nGL02\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\ncould\\tO\\nbe\\tO\\nexplained\\tO\\nby\\tO\\nan\\tO\\nancestral\\tO\\nrecombinant\\tO\\nevent\\tO\\n,\\tO\\nwhich\\tO\\noccurred\\tO\\nbetween\\tO\\nthe\\tO\\nC2o\\tO\\nlocus\\tO\\nand\\tO\\nHLA\\tO\\n-\\tO\\nD\\tO\\nlocus\\tO\\nin\\tO\\nwhich\\tO\\nC2o\\tO\\nsegregated\\tO\\nwith\\tO\\nHLA\\tO\\n-\\tO\\nB\\tO\\n.\\tO\\n\\nThis\\tO\\nwould\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nlocus\\tO\\nfor\\tO\\nthe\\tO\\nC2o\\tO\\ngene\\tO\\nmaps\\tO\\nbetween\\tO\\nHLA\\tO\\n-\\tO\\nB\\tO\\nand\\tO\\nHLA\\tO\\n-\\tO\\nD\\tO\\non\\tO\\nthe\\tO\\nsixth\\tO\\nchromosome\\tO\\n.\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nWilms\\tB-Disease\\n\\'\\tI-Disease\\ntumor\\tI-Disease\\nsuppressor\\tO\\ngene\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nabnormal\\tO\\nurogenital\\tO\\ndevelopment\\tO\\nin\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\nhuman\\tO\\ncondition\\tO\\nin\\tO\\nwhich\\tO\\nsevere\\tO\\nurogenital\\tB-Disease\\naberrations\\tI-Disease\\nresult\\tO\\nin\\tO\\nrenal\\tB-Disease\\nfailure\\tI-Disease\\n,\\tO\\npseudohermaphroditism\\tB-Disease\\n,\\tO\\nand\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\n(\\tO\\nnephroblastoma\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nits\\tO\\npossible\\tO\\nrole\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nanalyzed\\tO\\nthe\\tO\\ncoding\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\nsuppressor\\tO\\ngene\\tO\\n(\\tO\\nWT1\\tO\\n)\\tO\\nfor\\tO\\ngermline\\tO\\nmutations\\tO\\n.\\tO\\n\\nIn\\tO\\nten\\tO\\nindependent\\tO\\ncases\\tO\\nof\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nzinc\\tO\\nfinger\\tO\\ndomains\\tO\\nof\\tO\\none\\tO\\nWT1\\tO\\ngene\\tO\\ncopy\\tO\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nNine\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nare\\tO\\nfound\\tO\\nwithin\\tO\\nexon\\tO\\n9\\tO\\n(\\tO\\nzinc\\tO\\nfinger\\tO\\nIII\\tO\\n)\\tO\\n;\\tO\\nthe\\tO\\nremaining\\tO\\nmutation\\tO\\nis\\tO\\nin\\tO\\nexon\\tO\\n8\\tO\\n(\\tO\\nzinc\\tO\\nfinger\\tO\\nII\\tO\\n)\\tO\\n.\\tO\\n\\nThese\\tO\\nmutations\\tO\\ndirectly\\tO\\naffect\\tO\\nDNA\\tO\\nsequence\\tO\\nrecognition\\tO\\n.\\tO\\n\\nIn\\tO\\ntwo\\tO\\nfamilies\\tO\\nanalyzed\\tO\\n,\\tO\\nthe\\tO\\nmutations\\tO\\nwere\\tO\\nshown\\tO\\nto\\tO\\narise\\tO\\nde\\tO\\nnovo\\tO\\n.\\tO\\n\\nWilms\\tB-Disease\\ntumors\\tI-Disease\\nfrom\\tO\\nthree\\tO\\nindividuals\\tO\\nand\\tO\\none\\tO\\njuvenile\\tO\\ngranulosa\\tO\\ncell\\tO\\ntumor\\tB-Disease\\ndemonstrate\\tO\\nreduction\\tO\\nto\\tO\\nhomozygosity\\tO\\nfor\\tO\\nthe\\tO\\nmutated\\tO\\nWT1\\tO\\nallele\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nprovide\\tO\\nevidence\\tO\\nof\\tO\\na\\tO\\ndirect\\tO\\nrole\\tO\\nfor\\tO\\nWT1\\tO\\nin\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nthus\\tO\\nurogenital\\tO\\nsystem\\tO\\ndevelopment\\tO\\n.\\tO\\n.\\tO\\n\\nLinkage\\tO\\nanalysis\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\nand\\tO\\napplication\\tO\\nin\\tO\\npost\\tO\\n-\\tO\\nand\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nperformed\\tO\\nlinkage\\tO\\nanalysis\\tO\\nwith\\tO\\nthe\\tO\\nDNA\\tO\\nmarkers\\tO\\nDXS52\\tO\\nand\\tO\\nthe\\tO\\nclotting\\tO\\nfactor\\tO\\nVIII\\tO\\ngene\\tO\\n(\\tO\\nF8C\\tO\\n)\\tO\\n,\\tO\\nin\\tO\\nseveral\\tO\\nlarge\\tO\\nfamilies\\tO\\nwith\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ntight\\tO\\nlinkage\\tO\\nto\\tO\\nDXS52\\tO\\ncould\\tO\\nbe\\tO\\nextended\\tO\\ngiving\\tO\\na\\tO\\nmaximal\\tO\\nLOD\\tO\\nscore\\tO\\nof\\tO\\n22\\tO\\n.\\tO\\n\\n5\\tO\\nat\\tO\\n1\\tO\\ncM\\tO\\n.\\tO\\n\\nF8C\\tO\\nwas\\tO\\nalso\\tO\\ntightly\\tO\\nlinked\\tO\\nto\\tO\\nALD\\tB-Disease\\nwith\\tO\\na\\tO\\nmaximal\\tO\\nLOD\\tO\\nscore\\tO\\nof\\tO\\n7\\tO\\n.\\tO\\n\\n8\\tO\\nwithout\\tO\\nrecombination\\tO\\n.\\tO\\n\\nMultipoint\\tO\\nlinkage\\tO\\nanalysis\\tO\\nwith\\tO\\nthe\\tO\\nmarkers\\tO\\nDXS304\\tO\\n,\\tO\\nDXS52\\tO\\n,\\tO\\nand\\tO\\nF8C\\tO\\nindicated\\tO\\nthat\\tO\\nboth\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nALD\\tB-Disease\\nand\\tO\\nfor\\tO\\nF8C\\tO\\nare\\tO\\ndistal\\tO\\nto\\tO\\nDXS52\\tO\\n.\\tO\\n\\nIn\\tO\\nfour\\tO\\npatients\\tO\\nwith\\tO\\nALD\\tB-Disease\\n,\\tO\\nno\\tO\\nmajor\\tO\\nstructural\\tO\\nrearrangement\\tO\\nin\\tO\\nthe\\tO\\nXqter\\tO\\nregion\\tO\\nwas\\tO\\nobserved\\tO\\n;\\tO\\nin\\tO\\nparticular\\tO\\n,\\tO\\nthere\\tO\\nwere\\tO\\nno\\tO\\nabnormalities\\tB-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\nvision\\tI-Disease\\nblindness\\tI-Disease\\ngenes\\tI-Disease\\n.\\tO\\n\\nDNA\\tO\\nanalysis\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\nof\\tO\\nuse\\tO\\nin\\tO\\ndetermination\\tO\\nof\\tO\\nthe\\tO\\ncarrier\\tO\\nstatus\\tO\\nof\\tO\\nfemales\\tO\\nat\\tO\\nrisk\\tO\\n,\\tO\\nfor\\tO\\nthe\\tO\\ndetermination\\tO\\nof\\tO\\nthe\\tO\\norigin\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nparticular\\tO\\nfamily\\tO\\n,\\tO\\nand\\tO\\nfor\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\n.\\tO\\n\\nTwo\\tO\\ndistinct\\tO\\nmutations\\tO\\nat\\tO\\na\\tO\\nsingle\\tO\\nBamHI\\tO\\nsite\\tO\\nin\\tO\\nphenylketonuria\\tB-Disease\\n.\\tO\\n\\nClassical\\tB-Disease\\nphenylketonuria\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisease\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nhepatic\\tI-Disease\\nphenylalanine\\tI-Disease\\nhydroxylase\\tI-Disease\\n(\\tO\\nPAH\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nabolition\\tO\\nof\\tO\\nan\\tO\\ninvariant\\tO\\nBamHI\\tO\\nsite\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\n(\\tO\\nexon\\tO\\n7\\tO\\n)\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nrecognition\\tO\\nof\\tO\\ntwo\\tO\\nnew\\tO\\npoint\\tO\\nmutations\\tO\\nat\\tO\\ncodon\\tO\\n272\\tO\\nand\\tO\\n273\\tO\\n(\\tO\\n272gly\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nstop\\tO\\nand\\tO\\n273ser\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nphe\\tO\\n,\\tO\\nrespectively\\tO\\n)\\tO\\n.\\tO\\n\\nBoth\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nnorth\\tO\\neastern\\tO\\nFrance\\tO\\nor\\tO\\nBelgium\\tO\\nand\\tO\\noccurred\\tO\\non\\tO\\nthe\\tO\\nbackground\\tO\\nof\\tO\\nRFLP\\tO\\nhaplotype\\tO\\n7\\tO\\nalleles\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nstudy\\tO\\nsupports\\tO\\nthe\\tO\\nview\\tO\\nthat\\tO\\nthe\\tO\\nclinical\\tO\\nheterogeneity\\tO\\nin\\tO\\nPKU\\tB-Disease\\nis\\tO\\naccounted\\tO\\nfor\\tO\\nby\\tO\\nthe\\tO\\nlarge\\tO\\nvariety\\tO\\nof\\tO\\nmutant\\tO\\ngenotypes\\tO\\nassociated\\tO\\nwith\\tO\\nPAH\\tB-Disease\\ndeficiencies\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nA\\tO\\ndetailed\\tO\\nmultipoint\\tO\\nmap\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n4\\tO\\nprovides\\tO\\nevidence\\tO\\nfor\\tO\\nlinkage\\tO\\nheterogeneity\\tO\\nand\\tO\\nposition\\tO\\n-\\tO\\nspecific\\tO\\nrecombination\\tO\\nrates\\tO\\n.\\tO\\n\\nUtilizing\\tO\\nthe\\tO\\nCEPH\\tO\\nreference\\tO\\npanel\\tO\\nand\\tO\\ngenotypic\\tO\\ndata\\tO\\nfor\\tO\\n53\\tO\\nmarkers\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nconstructed\\tO\\na\\tO\\n20\\tO\\n-\\tO\\nlocus\\tO\\nmultipoint\\tO\\ngenetic\\tO\\nmap\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n4\\tO\\n.\\tO\\n\\nNew\\tO\\nRFLPs\\tO\\nare\\tO\\nreported\\tO\\nfor\\tO\\nfour\\tO\\nloci\\tO\\n.\\tO\\n\\nThe\\tO\\nmap\\tO\\nintegrates\\tO\\na\\tO\\nhigh\\tO\\n-\\tO\\nresolution\\tO\\ngenetic\\tO\\nmap\\tO\\nof\\tO\\n4p16\\tO\\ninto\\tO\\na\\tO\\ncontinuous\\tO\\nmap\\tO\\nextending\\tO\\nto\\tO\\n4q31\\tO\\nand\\tO\\nan\\tO\\nunlinked\\tO\\ncluster\\tO\\nof\\tO\\nthree\\tO\\nloci\\tO\\nat\\tO\\n4q35\\tO\\n.\\tO\\n\\nThe\\tO\\n20\\tO\\nlinked\\tO\\nmarkers\\tO\\nform\\tO\\na\\tO\\ncontinuous\\tO\\nlinkage\\tO\\ngroup\\tO\\nof\\tO\\n152\\tO\\ncM\\tO\\nin\\tO\\nmales\\tO\\nand\\tO\\n202\\tO\\ncM\\tO\\nin\\tO\\nfemales\\tO\\n.\\tO\\n\\nLikely\\tO\\ngenetic\\tO\\nlocations\\tO\\nare\\tO\\nprovided\\tO\\nfor\\tO\\n25\\tO\\npolymorphic\\tO\\nanonymous\\tO\\nsequences\\tO\\nand\\tO\\n28\\tO\\ngene\\tO\\n-\\tO\\nspecific\\tO\\nRFLPs\\tO\\n.\\tO\\n\\nThe\\tO\\nmap\\tO\\nwas\\tO\\nconstructed\\tO\\nemploying\\tO\\nthe\\tO\\nLINKAGE\\tO\\nand\\tO\\nCRIMAP\\tO\\ncomputational\\tO\\nmethodologies\\tO\\nto\\tO\\nbuild\\tO\\nthe\\tO\\nmultipoint\\tO\\nmap\\tO\\nvia\\tO\\na\\tO\\nstepwise\\tO\\nalgorithm\\tO\\n.\\tO\\n\\nA\\tO\\ndetailed\\tO\\n10\\tO\\n-\\tO\\npoint\\tO\\nmap\\tO\\nof\\tO\\nthe\\tO\\n4p16\\tO\\nregion\\tO\\nconstructed\\tO\\nfrom\\tO\\nthe\\tO\\nCEPH\\tO\\npanel\\tO\\nprovides\\tO\\nevidence\\tO\\nfor\\tO\\nheterogeneity\\tO\\nin\\tO\\nthe\\tO\\nlinkage\\tO\\nmaps\\tO\\nconstructed\\tO\\nfrom\\tO\\nfamilies\\tO\\nsegregating\\tO\\nfor\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIt\\tO\\nadditionally\\tO\\nprovides\\tO\\nevidence\\tO\\nfor\\tO\\nposition\\tO\\n-\\tO\\nspecific\\tO\\nrecombination\\tO\\nfrequencies\\tO\\nin\\tO\\nthe\\tO\\ntelomeric\\tO\\nregion\\tO\\nof\\tO\\n4p\\tO\\n.\\tO\\n.\\tO\\n\\nCarrier\\tO\\ndetection\\tO\\nand\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\nof\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\nusing\\tO\\na\\tO\\ncombination\\tO\\nof\\tO\\nanonymous\\tO\\nDNA\\tO\\npolymorphisms\\tO\\nand\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\ngene\\tO\\ncDNA\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\ncarrier\\tO\\nidentification\\tO\\nand\\tO\\na\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\nusing\\tO\\nDNA\\tO\\npolymorphisms\\tO\\nin\\tO\\n2\\tO\\nfamilies\\tO\\nwith\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nPelizaeus\\tI-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nPMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nboth\\tO\\nfamilies\\tO\\n,\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\nsingle\\tO\\naffected\\tO\\nmale\\tO\\ncould\\tO\\nbe\\tO\\ntraced\\tO\\nback\\tO\\nto\\tO\\nhis\\tO\\nunaffected\\tO\\nmaternal\\tO\\ngrandfather\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\neach\\tO\\nfamily\\tO\\ncontains\\tO\\na\\tO\\nnew\\tO\\nmutation\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\ncase\\tO\\nof\\tO\\nthe\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\n,\\tO\\nthe\\tO\\nfetus\\tO\\nwas\\tO\\nshown\\tO\\nby\\tO\\ncytogenetic\\tO\\nanalysis\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nfemale\\tO\\n,\\tO\\nwho\\tO\\nwe\\tO\\npredict\\tO\\nwill\\tO\\nbe\\tO\\na\\tO\\nnoncarrier\\tO\\nof\\tO\\nPMD\\tB-Disease\\nbased\\tO\\non\\tO\\nher\\tO\\ngenotype\\tO\\nwith\\tO\\nthe\\tO\\nPLP\\tO\\nintragenic\\tO\\npolymorphism\\tO\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\ndeletion\\tO\\nmutations\\tO\\nand\\tO\\nthree\\tO\\nnew\\tO\\ngenes\\tO\\nat\\tO\\nthe\\tO\\nfamilial\\tB-Disease\\npolyposis\\tI-Disease\\nlocus\\tO\\n.\\tO\\n\\nSmall\\tO\\n(\\tO\\n100\\tO\\n-\\tO\\n260\\tO\\nkb\\tO\\n)\\tO\\n,\\tO\\nnested\\tO\\ndeletions\\tO\\nwere\\tO\\ncharacterized\\tO\\nin\\tO\\nDNA\\tO\\nfrom\\tO\\ntwo\\tO\\nunrelated\\tO\\npatients\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThree\\tO\\ncandidate\\tO\\ngenes\\tO\\nlocated\\tO\\nwithin\\tO\\nthe\\tO\\ndeleted\\tO\\nregion\\tO\\nwere\\tO\\nascertained\\tO\\nand\\tO\\na\\tO\\nprevious\\tO\\ncandidate\\tO\\ngene\\tO\\n,\\tO\\nMCC\\tO\\n,\\tO\\nwas\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\nlocated\\tO\\noutside\\tO\\nthe\\tO\\ndeleted\\tO\\nregion\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthe\\tO\\nnew\\tO\\ngenes\\tO\\ncontained\\tO\\nsequence\\tO\\nidentical\\tO\\nto\\tO\\nSRP19\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\ncoding\\tO\\nfor\\tO\\nthe\\tO\\n19\\tO\\nkd\\tO\\ncomponent\\tO\\nof\\tO\\nthe\\tO\\nribosomal\\tO\\nsignal\\tO\\nrecognition\\tO\\nparticle\\tO\\n.\\tO\\n\\nThe\\tO\\nsecond\\tO\\n,\\tO\\nprovisionally\\tO\\ndesignated\\tO\\nDP1\\tO\\n(\\tO\\ndeleted\\tO\\nin\\tO\\npolyposis\\tO\\n1\\tO\\n)\\tO\\n,\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ntranscribed\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\norientation\\tO\\nas\\tO\\nMCC\\tO\\n.\\tO\\n\\nTwo\\tO\\nother\\tO\\ncDNAs\\tO\\n,\\tO\\nDP2\\tO\\nand\\tO\\nDP3\\tO\\n,\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\noverlap\\tO\\n,\\tO\\nforming\\tO\\na\\tO\\nsingle\\tO\\ngene\\tO\\n,\\tO\\nDP2\\tO\\n.\\tO\\n\\n5\\tO\\n,\\tO\\nthat\\tO\\nis\\tO\\ntranscribed\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\norientation\\tO\\nas\\tO\\nSRP19\\tO\\n.\\tO\\n\\nExclusion\\tO\\nof\\tO\\nlinkage\\tO\\nbetween\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\nand\\tO\\nthe\\tO\\nhuman\\tO\\nserum\\tO\\namyloid\\tO\\nA\\tO\\n(\\tO\\nSAA\\tO\\n)\\tO\\ngene\\tO\\ncluster\\tO\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\nthe\\tO\\nrelationship\\tO\\nbetween\\tO\\nthe\\tO\\nautosomal\\tO\\nrecessive\\tO\\ntrait\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n(\\tO\\nFMF\\tB-Disease\\n)\\tO\\nand\\tO\\nthe\\tO\\nserum\\tO\\namyloid\\tO\\nA\\tO\\n(\\tO\\nSAA\\tO\\n)\\tO\\ngenes\\tO\\nby\\tO\\ncomparing\\tO\\nalleles\\tO\\nof\\tO\\na\\tO\\nhighly\\tO\\npolymorphic\\tO\\ndinucleotide\\tO\\nrepeat\\tO\\nand\\tO\\na\\tO\\nconventional\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphism\\tO\\n(\\tO\\nRFLP\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nSAA\\tO\\ngene\\tO\\ncluster\\tO\\nin\\tO\\nIsraeli\\tO\\nFMF\\tB-Disease\\nkindreds\\tO\\n.\\tO\\n\\nBy\\tO\\nhaplotype\\tO\\nanalysis\\tO\\n,\\tO\\nour\\tO\\ndata\\tO\\nindicate\\tO\\na\\tO\\nminimum\\tO\\ncrossover\\tO\\nfrequency\\tO\\nof\\tO\\n22\\tO\\n%\\tO\\nbetween\\tO\\nthe\\tO\\nSAA\\tO\\ngene\\tO\\nmarker\\tO\\nand\\tO\\nFMF\\tB-Disease\\n.\\tO\\n\\nBy\\tO\\nconventional\\tO\\nlinkage\\tO\\nanalysis\\tO\\nthis\\tO\\neliminates\\tO\\na\\tO\\nminimum\\tO\\nof\\tO\\n10\\tO\\n.\\tO\\n\\n4\\tO\\ncM\\tO\\nincluding\\tO\\nand\\tO\\nsurrounding\\tO\\nthe\\tO\\nSAA\\tO\\ngene\\tO\\ncluster\\tO\\nas\\tO\\nthe\\tO\\nsite\\tO\\nof\\tO\\nthe\\tO\\nFMF\\tB-Disease\\nmutation\\tO\\nalthough\\tO\\nSAA\\tO\\nproteins\\tO\\nare\\tO\\nprominent\\tO\\nphysiologic\\tO\\nmarkers\\tO\\nof\\tO\\nthe\\tO\\nacute\\tO\\nattacks\\tO\\n.\\tO\\n\\nPRAD1\\tO\\n,\\tO\\na\\tO\\ncandidate\\tO\\nBCL1\\tO\\noncogene\\tO\\n:\\tO\\nmapping\\tO\\nand\\tO\\nexpression\\tO\\nin\\tO\\ncentrocytic\\tB-Disease\\nlymphoma\\tI-Disease\\n.\\tO\\n\\nRearrangement\\tO\\nof\\tO\\nthe\\tO\\nBCL1\\tO\\n(\\tO\\nB\\tO\\n-\\tO\\ncell\\tO\\nlymphoma\\tO\\n1\\tO\\n)\\tO\\nregion\\tO\\non\\tO\\nchromosome\\tO\\n11q13\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\nhighly\\tO\\ncharacteristic\\tO\\nof\\tO\\ncentrocytic\\tB-Disease\\nlymphoma\\tI-Disease\\nand\\tO\\nalso\\tO\\nis\\tO\\nfound\\tO\\ninfrequently\\tO\\nin\\tO\\nother\\tO\\nB\\tB-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\nneoplasms\\tI-Disease\\n.\\tO\\n\\nRearrangement\\tO\\nis\\tO\\nthought\\tO\\nto\\tO\\nderegulate\\tO\\na\\tO\\nnearby\\tO\\nprotooncogene\\tO\\n,\\tO\\nbut\\tO\\ntranscribed\\tO\\nsequences\\tO\\nin\\tO\\nthe\\tO\\nimmediate\\tO\\nvicinity\\tO\\nof\\tO\\nBCL1\\tO\\nbreakpoints\\tO\\nhad\\tO\\nnot\\tO\\nbeen\\tO\\nidentified\\tO\\n.\\tO\\n\\nPRAD1\\tO\\n,\\tO\\npreviously\\tO\\ndesignated\\tO\\nD11S287E\\tO\\n,\\tO\\nwas\\tO\\nidentified\\tO\\non\\tO\\n11q13\\tO\\nas\\tO\\na\\tO\\nchromosomal\\tO\\nbreakpoint\\tO\\nregion\\tO\\nrearranged\\tO\\nwith\\tO\\nthe\\tO\\nparathyroid\\tO\\nhormone\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nsubset\\tO\\nof\\tO\\nparathyroid\\tB-Disease\\nadenomas\\tI-Disease\\n;\\tO\\nthis\\tO\\nhighly\\tO\\nconserved\\tO\\nputative\\tO\\noncogene\\tO\\n,\\tO\\nwhich\\tO\\nencodes\\tO\\na\\tO\\nnovel\\tO\\ncyclin\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nlinked\\tO\\nto\\tO\\nBCL1\\tO\\nand\\tO\\nimplicated\\tO\\nalso\\tO\\nin\\tO\\nsubsets\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\nsquamous\\tI-Disease\\ncell\\tI-Disease\\nneoplasms\\tI-Disease\\nwith\\tO\\n11q13\\tO\\namplification\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\npulsed\\tO\\n-\\tO\\nfield\\tO\\ngel\\tO\\nelectrophoresis\\tO\\ndata\\tO\\nshowing\\tO\\nBCL1\\tO\\nand\\tO\\nPRAD1\\tO\\nto\\tO\\nbe\\tO\\nno\\tO\\nmore\\tO\\nthan\\tO\\n130\\tO\\nkilobases\\tO\\napart\\tO\\n.\\tO\\n\\nPRAD1\\tO\\nmRNA\\tO\\nis\\tO\\nabundantly\\tO\\nexpressed\\tO\\nin\\tO\\nseven\\tO\\nof\\tO\\nseven\\tO\\ncentrocytic\\tB-Disease\\nlymphomas\\tI-Disease\\n(\\tO\\nKiel\\tO\\nclassification\\tO\\n)\\tO\\n,\\tO\\nin\\tO\\ncontrast\\tO\\nto\\tO\\n13\\tO\\nclosely\\tO\\nrelated\\tO\\nbut\\tO\\nnoncentrocytic\\tB-Disease\\nlymphomas\\tI-Disease\\n.\\tO\\n\\nThree\\tO\\nof\\tO\\nthe\\tO\\nseven\\tO\\ncentrocytic\\tB-Disease\\nlymphomas\\tI-Disease\\nhad\\tO\\ndetectable\\tO\\nBCL1\\tO\\nDNA\\tO\\nrearrangement\\tO\\n.\\tO\\n\\nAlso\\tO\\n,\\tO\\ntwo\\tO\\nunusual\\tO\\ncases\\tO\\nof\\tO\\nCLL\\tO\\nwith\\tO\\nBCL1\\tO\\nrearrangement\\tO\\noverexpressed\\tO\\nPRAD1\\tO\\n,\\tO\\nin\\tO\\ncontrast\\tO\\nto\\tO\\nfive\\tO\\nCLL\\tO\\ncontrols\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nPRAD1\\tO\\nis\\tO\\nan\\tO\\nexcellent\\tO\\ncandidate\\tO\\n\"\\tO\\nBCL1\\tO\\noncogene\\tO\\n.\\tO\\n\\n\"\\tO\\nIts\\tO\\noverexpression\\tO\\nmay\\tO\\nbe\\tO\\na\\tO\\nkey\\tO\\nconsequence\\tO\\nof\\tO\\nrearrangement\\tO\\nof\\tO\\nthe\\tO\\nBCL1\\tO\\nvicinity\\tO\\nin\\tO\\nB\\tB-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\nneoplasms\\tI-Disease\\nand\\tO\\na\\tO\\nunifying\\tO\\npathogenetic\\tO\\nfeature\\tO\\nin\\tO\\ncentrocytic\\tB-Disease\\nlymphoma\\tI-Disease\\n.\\tO\\n\\nTwo\\tO\\nnew\\tO\\narylsulfatase\\tO\\nA\\tO\\n(\\tO\\nARSA\\tO\\n)\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\njuvenile\\tO\\nmetachromatic\\tB-Disease\\nleukodystrophy\\tI-Disease\\n(\\tO\\nMLD\\tB-Disease\\n)\\tO\\npatient\\tO\\n.\\tO\\n\\nFragments\\tO\\nof\\tO\\nthe\\tO\\narylsulfatase\\tO\\nA\\tO\\n(\\tO\\nARSA\\tO\\n)\\tO\\ngene\\tO\\nfrom\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\njuvenile\\tO\\n-\\tO\\nonset\\tO\\nmetachromatic\\tB-Disease\\nleukodystrophy\\tI-Disease\\n(\\tO\\nMLD\\tB-Disease\\n)\\tO\\nwere\\tO\\namplified\\tO\\nby\\tO\\nPCR\\tO\\nand\\tO\\nligated\\tO\\ninto\\tO\\nMP13\\tO\\ncloning\\tO\\nvectors\\tO\\n.\\tO\\n\\nClones\\tO\\nhybridizing\\tO\\nwith\\tO\\ncDNA\\tO\\nfor\\tO\\nhuman\\tO\\nARSA\\tO\\nwere\\tO\\nselected\\tO\\n,\\tO\\nexamined\\tO\\nfor\\tO\\nappropriate\\tO\\nsize\\tO\\ninserts\\tO\\n,\\tO\\nand\\tO\\nused\\tO\\nto\\tO\\nprepare\\tO\\nsingle\\tO\\n-\\tO\\nstranded\\tO\\nphage\\tO\\nDNA\\tO\\n.\\tO\\n\\nExamination\\tO\\nof\\tO\\nthe\\tO\\nentire\\tO\\ncoding\\tO\\nand\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\nintronic\\tO\\nsequence\\tO\\nrevealed\\tO\\ntwo\\tO\\nputative\\tO\\ndisease\\tO\\n-\\tO\\nrelated\\tO\\nmutations\\tO\\n.\\tO\\n\\nOne\\tO\\n,\\tO\\na\\tO\\npoint\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n3\\tO\\n,\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\nsubstitution\\tO\\nof\\tO\\nisoleucine\\tO\\nby\\tO\\nserine\\tO\\n.\\tO\\n\\nIntroduction\\tO\\nof\\tO\\nthis\\tO\\nalteration\\tO\\ninto\\tO\\nthe\\tO\\nnormal\\tO\\nARSA\\tO\\ncDNA\\tO\\nsequence\\tO\\nresulted\\tO\\nin\\tO\\na\\tO\\nsubstantial\\tO\\ndecrease\\tO\\nin\\tO\\nARSA\\tO\\nactivity\\tO\\non\\tO\\ntransient\\tO\\nexpression\\tO\\nin\\tO\\ncultured\\tO\\nbaby\\tO\\nhamster\\tO\\nkidney\\tO\\ncells\\tO\\n.\\tO\\n\\nAbout\\tO\\n5\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ncontrol\\tO\\nexpression\\tO\\nwas\\tO\\nobserved\\tO\\n,\\tO\\nsuggesting\\tO\\na\\tO\\nsmall\\tO\\nresidual\\tO\\nactivity\\tO\\nin\\tO\\nthe\\tO\\nmutated\\tO\\nARSA\\tO\\n.\\tO\\n\\nThe\\tO\\nsecond\\tO\\nmutation\\tO\\n,\\tO\\na\\tO\\nG\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nA\\tO\\ntransition\\tO\\n,\\tO\\noccurred\\tO\\nin\\tO\\nthe\\tO\\nother\\tO\\nallele\\tO\\nand\\tO\\nresulted\\tO\\nin\\tO\\nan\\tO\\naltered\\tO\\nsplice\\tO\\n-\\tO\\nrecognition\\tO\\nsequence\\tO\\nbetween\\tO\\nexon\\tO\\n7\\tO\\nand\\tO\\nthe\\tO\\nfollowing\\tO\\nintron\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nalso\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\na\\tO\\nrestriction\\tO\\nsite\\tO\\n.\\tO\\n\\nApparently\\tO\\nnormal\\tO\\nlevels\\tO\\nof\\tO\\nmRNA\\tO\\nwere\\tO\\ngenerated\\tO\\nfrom\\tO\\nthis\\tO\\nallele\\tO\\n,\\tO\\nbut\\tO\\nno\\tO\\nARSA\\tO\\nactivity\\tO\\nor\\tO\\nimmuno\\tO\\n-\\tO\\ncross\\tO\\n-\\tO\\nreactive\\tO\\nmaterial\\tO\\ncould\\tO\\nbe\\tO\\ndetected\\tO\\n.\\tO\\n\\nA\\tO\\ncollection\\tO\\nof\\tO\\nDNA\\tO\\nsamples\\tO\\nfrom\\tO\\nknown\\tO\\nor\\tO\\nsuspected\\tO\\nMLD\\tB-Disease\\npatients\\tO\\n,\\tO\\nmembers\\tO\\nof\\tO\\ntheir\\tO\\nfamilies\\tO\\n,\\tO\\nand\\tO\\nnormal\\tO\\ncontrols\\tO\\nwas\\tO\\nscreened\\tO\\nfor\\tO\\nthese\\tO\\nmutations\\tO\\n.\\tO\\n\\nFour\\tO\\nadditional\\tO\\nindividuals\\tO\\ncarrying\\tO\\neach\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\namong\\tO\\nthe\\tO\\nnearly\\tO\\n100\\tO\\nMLD\\tB-Disease\\npatients\\tO\\nin\\tO\\nthe\\tO\\nsample\\tO\\n.\\tO\\n\\nGene\\tO\\nsegregation\\tO\\nin\\tO\\nthe\\tO\\noriginal\\tO\\npatients\\tO\\nfamily\\tO\\nwas\\tO\\nconsistent\\tO\\nwith\\tO\\navailable\\tO\\nclinical\\tO\\nand\\tO\\nbiochemical\\tO\\ndata\\tO\\n.\\tO\\n\\nNo\\tO\\nindividuals\\tO\\nhomozygous\\tO\\nfor\\tO\\neither\\tO\\nof\\tO\\nthese\\tO\\ntwo\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\ncombinations\\tO\\nwith\\tO\\nother\\tO\\nMLD\\tB-Disease\\nmutations\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\npoint\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n3\\tO\\ndoes\\tO\\nresult\\tO\\nin\\tO\\nsome\\tO\\nresidual\\tO\\nenzyme\\tO\\nactivity\\tO\\nand\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nlate\\tO\\n-\\tO\\nonset\\tO\\nforms\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\nfollowing\\tO\\nexon\\tO\\n7\\tO\\nproduces\\tO\\nlate\\tO\\n-\\tO\\ninfantile\\tO\\nMLD\\tB-Disease\\nwhen\\tO\\ncombined\\tO\\nwith\\tO\\nother\\tO\\nenzyme\\tO\\n-\\tO\\nnull\\tO\\nmutations\\tO\\n,\\tO\\nimplying\\tO\\nthat\\tO\\nit\\tO\\nis\\tO\\ncompletely\\tO\\nsilent\\tO\\nenzymatically\\tO\\n.\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nX\\tO\\n-\\tO\\nchromosome\\tO\\ninactivation\\tO\\nand\\tO\\npresumptive\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\ngene\\tO\\nin\\tO\\nhematopoietic\\tO\\ncell\\tO\\nlineages\\tO\\nof\\tO\\na\\tO\\nthrombocytopenic\\tO\\ncarrier\\tO\\nfemale\\tO\\nof\\tO\\nWAS\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\na\\tO\\nthrombocytopenic\\tB-Disease\\nfemale\\tO\\nbelonging\\tO\\nto\\tO\\na\\tO\\npedigree\\tO\\nwith\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nRestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphism\\tO\\n(\\tO\\nRFLP\\tO\\n)\\tO\\nanalysis\\tO\\nwith\\tO\\nprobe\\tO\\nM27\\tO\\nbeta\\tO\\n,\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nWAS\\tB-Disease\\ngene\\tO\\n,\\tO\\ndemonstrated\\tO\\nthat\\tO\\nshe\\tO\\nis\\tO\\na\\tO\\ncarrier\\tO\\nof\\tO\\nWAS\\tB-Disease\\n.\\tO\\n\\nBoth\\tO\\nsmall\\tO\\n-\\tO\\nsized\\tO\\nand\\tO\\nnormal\\tO\\n-\\tO\\nsized\\tO\\nplatelets\\tO\\nwere\\tO\\npresent\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\n,\\tO\\nunlike\\tO\\nthe\\tO\\nvast\\tO\\nmajority\\tO\\nof\\tO\\nWAS\\tB-Disease\\ncarriers\\tO\\n,\\tO\\nshe\\tO\\ndoes\\tO\\nnot\\tO\\nmanifest\\tO\\nnonrandom\\tO\\nX\\tO\\n-\\tO\\nchromosome\\tO\\ninactivation\\tO\\nin\\tO\\nthe\\tO\\nthrombopoietic\\tO\\ncell\\tO\\nlineage\\tO\\n.\\tO\\n\\nStudy\\tO\\nof\\tO\\nX\\tO\\n-\\tO\\nchromosome\\tO\\ninactivation\\tO\\nby\\tO\\nmeans\\tO\\nof\\tO\\nRFLP\\tO\\nand\\tO\\nmethylation\\tO\\nanalysis\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\npattern\\tO\\nof\\tO\\nX\\tO\\n-\\tO\\nchromosome\\tO\\ninactivation\\tO\\nwas\\tO\\nnonrandom\\tO\\nin\\tO\\nT\\tO\\nlymphocytes\\tO\\n,\\tO\\nbut\\tO\\nrandom\\tO\\nin\\tO\\ngranulocytes\\tO\\n.\\tO\\n\\nWhile\\tO\\nthis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\ncomplete\\tO\\nreport\\tO\\non\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nthrombocytopenia\\tB-Disease\\nin\\tO\\na\\tO\\ncarrier\\tO\\nfemale\\tO\\nof\\tO\\nWAS\\tB-Disease\\nas\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\natypical\\tO\\nlyonization\\tO\\n,\\tO\\nit\\tO\\nalso\\tO\\nsuggests\\tO\\nthat\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nWAS\\tB-Disease\\ngene\\tO\\noccurs\\tO\\nat\\tO\\n(\\tO\\nor\\tO\\nextends\\tO\\nup\\tO\\nto\\tO\\n)\\tO\\na\\tO\\nlater\\tO\\nstage\\tO\\nthan\\tO\\nthe\\tO\\nmultipotent\\tO\\nstem\\tO\\ncell\\tO\\nalong\\tO\\nthe\\tO\\nhematopoietic\\tO\\ndifferentiation\\tO\\npathway\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nGerman\\tO\\nfamily\\tO\\nwith\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nC\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nT\\tO\\ntransition\\tO\\nin\\tO\\nexon\\tO\\n4\\tO\\nof\\tO\\nthe\\tO\\nPLP\\tO\\ngene\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\n2\\tO\\naffected\\tO\\nmales\\tO\\nand\\tO\\ntwo\\tO\\nobligate\\tO\\ncarriers\\tO\\nin\\tO\\na\\tO\\nGerman\\tO\\nfamily\\tO\\nwith\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\n,\\tO\\nwhich\\tO\\ncauses\\tO\\nloss\\tO\\nof\\tO\\nan\\tO\\nHphI\\tO\\nsite\\tO\\nand\\tO\\nchanges\\tO\\namino\\tO\\nacid\\tO\\n155\\tO\\nfrom\\tO\\nthreonine\\tO\\nto\\tO\\nisoleucine\\tO\\n,\\tO\\nwas\\tO\\nabsent\\tO\\nfrom\\tO\\n108\\tO\\nnormal\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nThere\\tO\\nare\\tO\\n5\\tO\\nconcordances\\tO\\nand\\tO\\n1\\tO\\ndiscrepancy\\tO\\nbetween\\tO\\nthese\\tO\\nresults\\tO\\nand\\tO\\nthose\\tO\\nobtained\\tO\\nby\\tO\\nmagnetic\\tO\\nresonance\\tO\\nimaging\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\n3\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\ngene\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nkinetic\\tO\\nvariant\\tO\\nof\\tO\\nphenylketonuria\\tB-Disease\\n.\\tO\\n\\nPhenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisease\\tI-Disease\\ndue\\tO\\nto\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\na\\tI-Disease\\nhepatic\\tI-Disease\\nenzyme\\tI-Disease\\n,\\tI-Disease\\nphenylalanine\\tI-Disease\\nhydroxylase\\tI-Disease\\n(\\tO\\nPAH\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nabsence\\tO\\nof\\tO\\nPAH\\tO\\nactivity\\tO\\nresults\\tO\\nin\\tO\\ntypical\\tO\\nPKU\\tB-Disease\\nwhile\\tO\\npersistence\\tO\\nof\\tO\\na\\tO\\nresidual\\tO\\nenzyme\\tO\\nactivity\\tO\\ngives\\tO\\nrise\\tO\\nto\\tO\\nvariant\\tO\\nforms\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\na\\tO\\n3\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\n(\\tO\\ndelta\\tO\\n194\\tO\\n)\\tO\\nin\\tO\\na\\tO\\nmild\\tO\\nvariant\\tO\\n,\\tO\\nwith\\tO\\nmarkedly\\tO\\nreduced\\tO\\naffinity\\tO\\nof\\tO\\nthe\\tO\\nenzyme\\tO\\nfor\\tO\\nphenylalanine\\tO\\n(\\tO\\nKm\\tO\\n=\\tO\\n160\\tO\\nnM\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nwe\\tO\\nprovide\\tO\\nfunctional\\tO\\nevidence\\tO\\nfor\\tO\\nresponsibility\\tO\\nof\\tO\\nthe\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\nmutant\\tO\\nphenotype\\tO\\n.\\tO\\n\\nSince\\tO\\nthe\\tO\\ndeletion\\tO\\nwas\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\nthird\\tO\\nexon\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\npresents\\tO\\nno\\tO\\nhomology\\tO\\nwith\\tO\\nother\\tO\\nhydroxylases\\tO\\n,\\tO\\nwe\\tO\\nsuggest\\tO\\nthat\\tO\\nexon\\tO\\n3\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nspecificity\\tO\\nof\\tO\\nthe\\tO\\nenzyme\\tO\\nfor\\tO\\nphenylalanine\\tO\\n.\\tO\\n\\nFinally\\tO\\n,\\tO\\nsince\\tO\\nnone\\tO\\nof\\tO\\nthe\\tO\\n98\\tO\\nPKU\\tB-Disease\\npatients\\tO\\ntested\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\ncarry\\tO\\nthis\\tO\\nparticular\\tO\\ndeletion\\tO\\n,\\tO\\nour\\tO\\nstudy\\tO\\nsuggests\\tO\\nthat\\tO\\nthis\\tO\\nmolecular\\tO\\nevent\\tO\\nprobably\\tO\\noccurred\\tO\\nrecently\\tO\\non\\tO\\nthe\\tO\\nbackground\\tO\\nof\\tO\\na\\tO\\nhaplotype\\tO\\n2\\tO\\ngene\\tO\\nin\\tO\\nPortugal\\tO\\n.\\tO\\n.\\tO\\n\\nMutation\\tO\\nof\\tO\\nthe\\tO\\nKIT\\tO\\n(\\tO\\nmast\\tO\\n/\\tO\\nstem\\tO\\ncell\\tO\\ngrowth\\tO\\nfactor\\tO\\nreceptor\\tO\\n)\\tO\\nprotooncogene\\tO\\nin\\tO\\nhuman\\tO\\npiebaldism\\tB-Disease\\n.\\tO\\n\\nPiebaldism\\tB-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ngenetic\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\ncogenital\\tO\\npatches\\tO\\nof\\tO\\nskin\\tO\\nand\\tO\\nhair\\tO\\nfrom\\tO\\nwhich\\tO\\nmelanocytes\\tO\\nare\\tO\\ncompletely\\tO\\nabsent\\tO\\n.\\tO\\n\\nA\\tO\\nsimilar\\tO\\ndisorder\\tO\\nof\\tO\\nmouse\\tO\\n,\\tO\\ndominant\\tO\\nwhite\\tO\\nspotting\\tO\\n(\\tO\\nW\\tO\\n)\\tO\\n,\\tO\\nresults\\tO\\nfrom\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nc\\tO\\n-\\tO\\nKit\\tO\\nprotooncogene\\tO\\n,\\tO\\nwhich\\tO\\nencodes\\tO\\nand\\tO\\nreceptor\\tO\\nfor\\tO\\nmast\\tO\\n/\\tO\\nstem\\tO\\ncell\\tO\\ngrowth\\tO\\nfactor\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\na\\tO\\nKIT\\tO\\ngene\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nproband\\tO\\nwith\\tO\\nclassic\\tO\\nautosomal\\tO\\ndominant\\tO\\npiebaldism\\tB-Disease\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nGly\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nArg\\tO\\nsubstitution\\tO\\nat\\tO\\ncodon\\tO\\n664\\tO\\n,\\tO\\nwithin\\tO\\nthe\\tO\\ntyrosine\\tO\\nkinase\\tO\\ndomain\\tO\\n.\\tO\\n\\nThis\\tO\\nsubstitution\\tO\\nwas\\tO\\nnot\\tO\\nseen\\tO\\nin\\tO\\nany\\tO\\nnormal\\tO\\nindividuals\\tO\\nand\\tO\\nwas\\tO\\ncompletely\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\npiebald\\tB-Disease\\nphenotype\\tO\\nin\\tO\\nthe\\tO\\nprobands\\tO\\nfamily\\tO\\n.\\tO\\n\\nPiebaldism\\tB-Disease\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nthus\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\nthe\\tO\\nhuman\\tO\\nhomologue\\tO\\nto\\tO\\ndominant\\tO\\nwhite\\tO\\nspotting\\tO\\n(\\tO\\nW\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nanalysis\\tO\\nof\\tO\\na\\tO\\nJapanese\\tO\\nfamily\\tO\\nwith\\tO\\nnormotriglyceridemic\\tB-Disease\\nabetalipoproteinemia\\tI-Disease\\nindicates\\tO\\na\\tO\\nlack\\tO\\nof\\tO\\nlinkage\\tO\\nto\\tO\\nthe\\tO\\napolipoprotein\\tO\\nB\\tO\\ngene\\tO\\n.\\tO\\n\\nNormotriglyceridemic\\tB-Disease\\nabetalipoproteinemia\\tI-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\nfamilial\\tB-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nan\\tO\\nisolated\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\napoB\\tI-Disease\\n-\\tI-Disease\\n100\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\npreviously\\tO\\nreported\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nthis\\tO\\ndisease\\tO\\n,\\tO\\nwho\\tO\\nhad\\tO\\nnormal\\tO\\napoB\\tO\\n-\\tO\\n48\\tO\\nbut\\tO\\nno\\tO\\napoB\\tO\\n-\\tO\\n100\\tO\\n.\\tO\\n\\nTo\\tO\\nelucidate\\tO\\nthe\\tO\\ngenetic\\tB-Disease\\nabnormalities\\tI-Disease\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n,\\tO\\nwe\\tO\\nstudied\\tO\\nthe\\tO\\nlinkage\\tO\\nof\\tO\\napoB\\tO\\ngene\\tO\\nusing\\tO\\nthree\\tO\\ngenetic\\tO\\nmarkers\\tO\\n.\\tO\\n\\nThe\\tO\\nproband\\tO\\nand\\tO\\nher\\tO\\naffected\\tO\\nbrother\\tO\\nshowed\\tO\\ncompletely\\tO\\ndifferent\\tO\\napoB\\tO\\ngene\\tO\\nalleles\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthe\\tO\\napoB\\tO\\ngene\\tO\\nitself\\tO\\nis\\tO\\nnot\\tO\\nrelated\\tO\\nto\\tO\\nthis\\tO\\ndisorder\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n.\\tO\\n\\nBy\\tO\\ncontrast\\tO\\n,\\tO\\nan\\tO\\nAmerican\\tO\\ncase\\tO\\nhad\\tO\\na\\tO\\npoint\\tO\\nsubstitution\\tO\\nin\\tO\\nthe\\tO\\napoB\\tO\\ngene\\tO\\ngenerating\\tO\\nan\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\nstop\\tO\\ncodon\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nthis\\tO\\ndisorder\\tO\\ncan\\tO\\nbe\\tO\\ncaused\\tO\\nby\\tO\\ndefect\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\nof\\tO\\neither\\tO\\nan\\tO\\napoB\\tO\\ngene\\tO\\nor\\tO\\nother\\tO\\ngenes\\tO\\n.\\tO\\n.\\tO\\n\\nLocalisation\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\nto\\tO\\nbetween\\tO\\nDXS7\\tO\\nand\\tO\\nDXS426\\tO\\non\\tO\\nXp\\tO\\n.\\tO\\n\\nA\\tO\\nhighly\\tO\\ninformative\\tO\\nmicrosatellite\\tO\\nmarker\\tO\\n,\\tO\\nDXS426\\tO\\n,\\tO\\nwhich\\tO\\nmaps\\tO\\nproximal\\tO\\nto\\tO\\nDXS7\\tO\\nin\\tO\\nthe\\tO\\ninterval\\tO\\nXp11\\tO\\n.\\tO\\n\\n4\\tO\\n-\\tO\\nXp11\\tO\\n4\\tO\\n-\\tO\\nXp11\\tO\\n.\\tO\\n\\n23\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nused\\tO\\nto\\tO\\nrefine\\tO\\nfurther\\tO\\nthe\\tO\\nlocalisation\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nNDP\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nfrom\\tO\\na\\tO\\nmultiply\\tO\\ninformative\\tO\\ncrossover\\tO\\nlocalize\\tO\\nthe\\tO\\nNDP\\tB-Disease\\ngene\\tO\\nproximal\\tO\\nto\\tO\\nDXS7\\tO\\n.\\tO\\n\\nIn\\tO\\nconjunction\\tO\\nwith\\tO\\ninformation\\tO\\nfrom\\tO\\n2\\tO\\nNDP\\tB-Disease\\npatients\\tO\\nwho\\tO\\nhave\\tO\\na\\tO\\ndeletion\\tO\\nfor\\tO\\nDXS7\\tO\\nbut\\tO\\nnot\\tO\\nfor\\tO\\nDSX426\\tO\\n,\\tO\\nour\\tO\\ndata\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nNDP\\tB-Disease\\ngene\\tO\\nlies\\tO\\nbetween\\tO\\nDXS7\\tO\\nand\\tO\\nDXS426\\tO\\non\\tO\\nproximal\\tO\\nXp\\tO\\n.\\tO\\n\\nAberrant\\tO\\nsplicing\\tO\\nof\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\nmRNA\\tO\\n:\\tO\\nthe\\tO\\nmajor\\tO\\ncause\\tO\\nfor\\tO\\nphenylketonuria\\tB-Disease\\nin\\tO\\nparts\\tO\\nof\\tO\\nsouthern\\tO\\nEurope\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\na\\tO\\nmutation\\tO\\nwithin\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n(\\tO\\nPAH\\tO\\n)\\tO\\ngene\\tO\\nthat\\tO\\ncauses\\tO\\naberrant\\tO\\nsplicing\\tO\\nof\\tO\\nthe\\tO\\nmRNA\\tO\\nand\\tO\\nthat\\tO\\nis\\tO\\nin\\tO\\ntight\\tO\\nassociation\\tO\\nwith\\tO\\nchromosomal\\tO\\nhaplotypes\\tO\\n6\\tO\\n,\\tO\\n10\\tO\\n,\\tO\\nand\\tO\\n36\\tO\\n.\\tO\\n\\nBecause\\tO\\nof\\tO\\nthe\\tO\\nhigh\\tO\\nfrequency\\tO\\nof\\tO\\nthese\\tO\\nparticular\\tO\\nhaplotypes\\tO\\nin\\tO\\nBulgaria\\tO\\n,\\tO\\nItaly\\tO\\n,\\tO\\nand\\tO\\nTurkey\\tO\\n,\\tO\\nit\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nmore\\tO\\nfrequent\\tO\\ndefects\\tO\\nin\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\ncausing\\tO\\nclassical\\tO\\nphenylketonuria\\tB-Disease\\nin\\tO\\nthis\\tO\\npart\\tO\\nof\\tO\\nEurope\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nis\\tO\\na\\tO\\nG\\tO\\nto\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nposition\\tO\\n546\\tO\\nin\\tO\\nintron\\tO\\n10\\tO\\nof\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\n,\\tO\\n11\\tO\\nbp\\tO\\nupstream\\tO\\nfrom\\tO\\nthe\\tO\\nintron\\tO\\n10\\tO\\n/\\tO\\nexon\\tO\\n11\\tO\\nboundary\\tO\\n.\\tO\\n\\nIt\\tO\\nactivates\\tO\\na\\tO\\ncryptic\\tO\\nsplice\\tO\\nsite\\tO\\nand\\tO\\nresults\\tO\\nin\\tO\\nan\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ninsertion\\tO\\nof\\tO\\n9\\tO\\nnucleotides\\tO\\nbetween\\tO\\nexon\\tO\\n10\\tO\\nand\\tO\\nexon\\tO\\n11\\tO\\nof\\tO\\nthe\\tO\\nprocessed\\tO\\nmRNA\\tO\\n.\\tO\\n\\nNormal\\tO\\namounts\\tO\\nof\\tO\\nliver\\tO\\nPAH\\tO\\nprotein\\tO\\nare\\tO\\npresent\\tO\\nin\\tO\\nhomozygous\\tO\\npatients\\tO\\n,\\tO\\nbut\\tO\\nno\\tO\\ncatalytic\\tO\\nactivity\\tO\\ncan\\tO\\nbe\\tO\\ndetected\\tO\\n.\\tO\\n\\nThis\\tO\\nloss\\tO\\nof\\tO\\nenzyme\\tO\\nactivity\\tO\\nis\\tO\\nprobably\\tO\\ncaused\\tO\\nby\\tO\\nconformational\\tO\\nchanges\\tO\\nresulting\\tO\\nfrom\\tO\\nthe\\tO\\ninsertion\\tO\\nof\\tO\\nthree\\tO\\nadditional\\tO\\namino\\tO\\nacids\\tO\\n(\\tO\\nGly\\tO\\n-\\tO\\nLeu\\tO\\n-\\tO\\nGln\\tO\\n)\\tO\\nbetween\\tO\\nthe\\tO\\nnormal\\tO\\nsequences\\tO\\nencoded\\tO\\nby\\tO\\nexon\\tO\\n10\\tO\\nand\\tO\\nexon\\tO\\n11\\tO\\n.\\tO\\n.\\tO\\n\\nGardner\\tB-Disease\\nsyndrome\\tI-Disease\\nin\\tO\\na\\tO\\nboy\\tO\\nwith\\tO\\ninterstitial\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n5\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribed\\tO\\na\\tO\\n15\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nboy\\tO\\nwith\\tO\\nGardner\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nGS\\tB-Disease\\n)\\tO\\n,\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\nand\\tO\\ncraniofacial\\tB-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nHigh\\tO\\n-\\tO\\nresolution\\tO\\nbanding\\tO\\nanalysis\\tO\\nshowed\\tO\\nan\\tO\\ninterstitial\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n5\\tO\\n(\\tO\\nq22\\tO\\n.\\tO\\n1\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nq31\\tO\\n1\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nq31\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nbreakpoints\\tO\\nin\\tO\\nthe\\tO\\npresent\\tO\\ncase\\tO\\nand\\tO\\nin\\tO\\n3\\tO\\npreviously\\tO\\nreported\\tO\\n5q\\tO\\n-\\tO\\npatients\\tO\\nwith\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nGS\\tB-Disease\\n/\\tO\\nor\\tO\\nfamilial\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nFPC\\tB-Disease\\n)\\tO\\nis\\tO\\nin\\tO\\nthe\\tO\\n5q22\\tO\\nregion\\tO\\n,\\tO\\na\\tO\\nresult\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nfindings\\tO\\nof\\tO\\nlinkage\\tO\\nstudies\\tO\\n\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\nand\\tO\\nchildhood\\tO\\n-\\tO\\nonset\\tO\\nTourette\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nA\\tO\\n40\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nman\\tO\\nwith\\tO\\nchildhood\\tO\\n-\\tO\\nonset\\tO\\nTourette\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nTS\\tB-Disease\\n)\\tO\\ndeveloped\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nbelieve\\tO\\nthis\\tO\\nto\\tO\\nbe\\tO\\nthe\\tO\\nfirst\\tO\\nreported\\tO\\ncase\\tO\\nof\\tO\\nchildhood\\tO\\n-\\tO\\nonset\\tO\\nTS\\tB-Disease\\nwith\\tO\\nadult\\tO\\nonset\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nDiscovery\\tO\\nof\\tO\\nother\\tO\\ncases\\tO\\nwith\\tO\\nboth\\tO\\ndisorders\\tO\\nmay\\tO\\nprovide\\tO\\nclues\\tO\\nto\\tO\\nthe\\tO\\npathophysiology\\tO\\nof\\tO\\nboth\\tO\\nconditions\\tO\\n.\\tO\\n.\\tO\\n\\nSequence\\tO\\nof\\tO\\nDNA\\tO\\nflanking\\tO\\nthe\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nidentification\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nrapid\\tO\\nidentification\\tO\\nof\\tO\\nmutations\\tO\\ncausing\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nrequires\\tO\\nthe\\tO\\ncapacity\\tO\\nto\\tO\\nreadily\\tO\\nscreen\\tO\\nthe\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\nmost\\tO\\nlikely\\tO\\nto\\tO\\nbe\\tO\\naffected\\tO\\nby\\tO\\nmutation\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nsequenced\\tO\\nthe\\tO\\nportions\\tO\\nof\\tO\\nthe\\tO\\nintrons\\tO\\nflanking\\tO\\neach\\tO\\nof\\tO\\nthe\\tO\\n14\\tO\\nHEXA\\tO\\nexons\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\nspecify\\tO\\noligonucleotide\\tO\\nprimers\\tO\\nfor\\tO\\nthe\\tO\\nPCR\\tO\\n-\\tO\\ndependent\\tO\\namplification\\tO\\nof\\tO\\neach\\tO\\nexon\\tO\\nand\\tO\\nsplice\\tO\\n-\\tO\\njunction\\tO\\nsequence\\tO\\n.\\tO\\n\\nThe\\tO\\namplified\\tO\\nproducts\\tO\\nwere\\tO\\nanalyzed\\tO\\n,\\tO\\nby\\tO\\nelectrophoresis\\tO\\nin\\tO\\nnondenaturing\\tO\\npolyacrylamide\\tO\\ngels\\tO\\n,\\tO\\nfor\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\neither\\tO\\nheteroduplexes\\tO\\n,\\tO\\nderived\\tO\\nfrom\\tO\\nthe\\tO\\nannealing\\tO\\nof\\tO\\nnormal\\tO\\nand\\tO\\nmutant\\tO\\nDNA\\tO\\nstrands\\tO\\n,\\tO\\nor\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformational\\tO\\npolymorphisms\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\n,\\tO\\nderived\\tO\\nfrom\\tO\\nthe\\tO\\nrenaturation\\tO\\nof\\tO\\nsingle\\tO\\n-\\tO\\nstranded\\tO\\nDNA\\tO\\n.\\tO\\n\\nFive\\tO\\nnovel\\tO\\nmutations\\tO\\nfrom\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\npatients\\tO\\nwere\\tO\\ndetected\\tO\\na\\tO\\n5\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nof\\tO\\nTCTCC\\tO\\nin\\tO\\nIVS\\tO\\n-\\tO\\n9\\tO\\n;\\tO\\na\\tO\\n2\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nof\\tO\\nTG\\tO\\nin\\tO\\nexon\\tO\\n5\\tO\\n;\\tO\\nG78\\tO\\nto\\tO\\nA\\tO\\n,\\tO\\ngiving\\tO\\na\\tO\\nstop\\tO\\ncodon\\tO\\nin\\tO\\nexon\\tO\\n1\\tO\\n;\\tO\\nG533\\tO\\nto\\tO\\nT\\tO\\nin\\tO\\nexon\\tO\\n5\\tO\\n,\\tO\\nproducing\\tO\\nthe\\tO\\nthird\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\ndetected\\tO\\nat\\tO\\nthis\\tO\\nsite\\tO\\n;\\tO\\nand\\tO\\nG\\tO\\nto\\tO\\nC\\tO\\nat\\tO\\nposition\\tO\\n1\\tO\\nof\\tO\\nIVS\\tO\\n-\\tO\\n2\\tO\\n,\\tO\\nexpected\\tO\\nto\\tO\\nproduce\\tO\\nabnormal\\tO\\nsplicing\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\ntwo\\tO\\nmutations\\tO\\n,\\tO\\n(\\tO\\nG1496\\tO\\nto\\tO\\nA\\tO\\nin\\tO\\nexon\\tO\\n13\\tO\\nand\\tO\\na\\tO\\n4\\tO\\n-\\tO\\nbp\\tO\\ninsertion\\tO\\nin\\tO\\nexon\\tO\\n11\\tO\\n)\\tO\\nthat\\tO\\nhave\\tO\\npreviously\\tO\\nbeen\\tO\\nreported\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\ncharacterization\\tO\\nof\\tO\\ntwo\\tO\\ngalactosemia\\tB-Disease\\nmutations\\tO\\n:\\tO\\ncorrelation\\tO\\nof\\tO\\nmutations\\tO\\nwith\\tO\\nhighly\\tO\\nconserved\\tO\\ndomains\\tO\\nin\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridyl\\tO\\ntransferase\\tO\\n.\\tO\\n\\nGalactosemia\\tB-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\nof\\tI-Disease\\nhuman\\tI-Disease\\ngalactose\\tI-Disease\\nmetabolism\\tI-Disease\\ncaused\\tO\\nby\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nenzyme\\tI-Disease\\ngalactose\\tI-Disease\\n-\\tI-Disease\\n1\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\nuridyl\\tI-Disease\\ntransferase\\tI-Disease\\n(\\tO\\nGALT\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nthis\\tO\\ndisorder\\tO\\nis\\tO\\nat\\tO\\npresent\\tO\\nnot\\tO\\nwell\\tO\\nunderstood\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\ntwo\\tO\\nmissense\\tO\\nmutations\\tO\\nwhich\\tO\\nresult\\tO\\nin\\tO\\nlow\\tO\\nor\\tO\\nundetectable\\tO\\nenzymatic\\tO\\nactivity\\tO\\n.\\tO\\n\\nFirst\\tO\\n,\\tO\\nwe\\tO\\nidentified\\tO\\nat\\tO\\nnucleotide\\tO\\n591\\tO\\na\\tO\\ntransition\\tO\\nwhich\\tO\\nsubstitutes\\tO\\nglutamine\\tO\\n188\\tO\\nby\\tO\\narginine\\tO\\n.\\tO\\n\\nThe\\tO\\nmutated\\tO\\nglutamine\\tO\\nis\\tO\\nnot\\tO\\nonly\\tO\\nhighly\\tO\\nconserved\\tO\\nin\\tO\\nevolution\\tO\\n(\\tO\\nconserved\\tO\\nalso\\tO\\nin\\tO\\nEscherichia\\tO\\ncoli\\tO\\nand\\tO\\nSaccharomyces\\tO\\ncerevisiae\\tO\\n)\\tO\\n,\\tO\\nbut\\tO\\nis\\tO\\nalso\\tO\\ntwo\\tO\\namino\\tO\\nacid\\tO\\nresidues\\tO\\ndownstream\\tO\\nfrom\\tO\\nthe\\tO\\nactive\\tO\\nsite\\tO\\nhistidine\\tO\\n-\\tO\\nproline\\tO\\n-\\tO\\nhistidine\\tO\\ntriad\\tO\\nand\\tO\\nresults\\tO\\nin\\tO\\nabout\\tO\\n10\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\nenzymatic\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\narginine\\tO\\n188\\tO\\nmutation\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\ngalactosemia\\tB-Disease\\nmutation\\tO\\ncharacterized\\tO\\nto\\tO\\ndate\\tO\\n.\\tO\\n\\nIt\\tO\\naccounts\\tO\\nfor\\tO\\none\\tO\\n-\\tO\\nfourth\\tO\\nof\\tO\\nthe\\tO\\ngalactosemia\\tB-Disease\\nalleles\\tO\\nstudied\\tO\\n.\\tO\\n\\nSecond\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\nsubstitution\\tO\\nof\\tO\\narginine\\tO\\n333\\tO\\nby\\tO\\ntryptophan\\tO\\n,\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\ntransition\\tO\\nat\\tO\\nnucleotide\\tO\\n1025\\tO\\n.\\tO\\n\\nThe\\tO\\narea\\tO\\nsurrounding\\tO\\nthis\\tO\\nmissense\\tO\\nmutation\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\nhighly\\tO\\nconserved\\tO\\ndomain\\tO\\nin\\tO\\nthe\\tO\\nhomologous\\tO\\nenzymes\\tO\\nfrom\\tO\\nE\\tO\\n.\\tO\\ncoli\\tO\\n,\\tO\\nyeast\\tO\\n,\\tO\\nand\\tO\\nhumans\\tO\\n,\\tO\\nand\\tO\\nthis\\tO\\nmutation\\tO\\nresults\\tO\\nin\\tO\\nundetectable\\tO\\nenzymatic\\tO\\nactivity\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthis\\tO\\nis\\tO\\na\\tO\\nsevere\\tO\\nmutation\\tO\\n.\\tO\\n\\nThis\\tO\\nsecond\\tO\\nmutation\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\nrare\\tO\\n,\\tO\\nsince\\tO\\nit\\tO\\nwas\\tO\\nfound\\tO\\nonly\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\nwe\\tO\\nsequenced\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nprovide\\tO\\nfurther\\tO\\nevidence\\tO\\nfor\\tO\\nthe\\tO\\nheterogeneity\\tO\\nof\\tO\\ngalactosemia\\tB-Disease\\nat\\tO\\nthe\\tO\\nmolecular\\tO\\nlevel\\tO\\n,\\tO\\nheterogeneity\\tO\\nwhich\\tO\\nmight\\tO\\nbe\\tO\\nrelated\\tO\\nto\\tO\\nthe\\tO\\nvariable\\tO\\nclinical\\tO\\noutcome\\tO\\nobserved\\tO\\nin\\tO\\nthis\\tO\\ndisorder\\tO\\n.\\tO\\n.\\tO\\n\\nHypoxanthine\\tB-Disease\\n-\\tI-Disease\\nguanine\\tI-Disease\\nphosphoribosyltransferase\\tI-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\nanalysis\\tO\\nof\\tO\\nHPRT\\tO\\nmutations\\tO\\nby\\tO\\ndirect\\tO\\nsequencing\\tO\\nand\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\namplification\\tO\\n.\\tO\\n\\nThe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\nsevere\\tO\\nX\\tB-Disease\\nchromosome\\tI-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nhuman\\tI-Disease\\ndisease\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\nvirtual\\tO\\nabsence\\tB-Disease\\nof\\tI-Disease\\nhypoxanthine\\tI-Disease\\n-\\tI-Disease\\nguanine\\tI-Disease\\nphosphoribosyltransferase\\tI-Disease\\n(\\tI-Disease\\nHPRT\\tI-Disease\\n)\\tI-Disease\\nactivity\\tI-Disease\\n.\\tO\\n\\nA\\tO\\npartial\\tO\\ndeficiency\\tO\\nin\\tO\\nthe\\tO\\nactivity\\tO\\nof\\tO\\nthis\\tO\\nenzyme\\tO\\ncan\\tO\\nresult\\tO\\nin\\tO\\ngouty\\tB-Disease\\narthritis\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\ngenetic\\tO\\nbasis\\tO\\nfor\\tO\\nreduction\\tO\\nor\\tO\\nloss\\tO\\nof\\tO\\nenzyme\\tO\\nactivity\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\namplified\\tO\\nand\\tO\\nsequenced\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nHPRT\\tO\\ncDNA\\tO\\nfrom\\tO\\nfour\\tO\\npatients\\tO\\none\\tO\\nwith\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nHPRTPerth\\tO\\n)\\tO\\nand\\tO\\nthree\\tO\\nwith\\tO\\npartial\\tB-Disease\\ndeficiencies\\tI-Disease\\nof\\tI-Disease\\nHPRT\\tI-Disease\\nactivity\\tI-Disease\\n,\\tO\\nwhich\\tO\\nhave\\tO\\nbeen\\tO\\ndesignated\\tO\\nHPRTUrangan\\tO\\n,\\tO\\nHPRTSwan\\tO\\nand\\tO\\nHPRTToowong\\tO\\n.\\tO\\n\\nIn\\tO\\nall\\tO\\nfour\\tO\\npatients\\tO\\n,\\tO\\nthe\\tO\\nonly\\tO\\nmutation\\tO\\nidentified\\tO\\nwas\\tO\\na\\tO\\nsingle\\tO\\nbase\\tO\\nsubstitution\\tO\\nin\\tO\\nexons\\tO\\n2\\tO\\nor\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\n,\\tO\\nwhich\\tO\\nin\\tO\\neach\\tO\\ncase\\tO\\npredicts\\tO\\na\\tO\\nsingle\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\nin\\tO\\nthe\\tO\\ntranslated\\tO\\nprotein\\tO\\n.\\tO\\n\\nEach\\tO\\nbase\\tO\\nchange\\tO\\nwas\\tO\\nconfirmed\\tO\\nby\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\namplification\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\ngenomic\\tO\\nDNA\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\ninteresting\\tO\\nto\\tO\\nnote\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\nfound\\tO\\nfor\\tO\\nHPRTPerth\\tO\\nis\\tO\\nidentical\\tO\\nto\\tO\\nthat\\tO\\nreported\\tO\\nfor\\tO\\nHPRTFlint\\tO\\n.\\tO\\n\\nIt\\tO\\nappears\\tO\\nthat\\tO\\nthe\\tO\\ntwo\\tO\\nmutations\\tO\\nare\\tO\\nde\\tO\\nnovo\\tO\\nevents\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nand\\tO\\nmetabolic\\tO\\nbasis\\tO\\nfor\\tO\\nthe\\tO\\nmetabolic\\tB-Disease\\ndisorder\\tI-Disease\\nnormotriglyceridemic\\tB-Disease\\nabetalipoproteinemia\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\npreviously\\tO\\ndescribed\\tO\\na\\tO\\ndisorder\\tO\\n,\\tO\\nnormotriglyceridemic\\tB-Disease\\nabetalipoproteinemia\\tI-Disease\\n,\\tO\\nthat\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nthe\\tO\\nvirtual\\tO\\nabsence\\tO\\nof\\tO\\nplasma\\tO\\nlow\\tO\\ndensity\\tO\\nlipoproteins\\tO\\nand\\tO\\ncomplete\\tO\\nabsence\\tO\\nof\\tO\\napoB\\tO\\n-\\tO\\n100\\tO\\n,\\tO\\nbut\\tO\\nwith\\tO\\napparently\\tO\\nnormal\\tO\\nsecretion\\tO\\nof\\tO\\ntriglyceride\\tO\\n-\\tO\\nrich\\tO\\nlipoproteins\\tO\\ncontaining\\tO\\napoB\\tO\\n-\\tO\\n48\\tO\\n.\\tO\\n\\nThe\\tO\\npatients\\tO\\nplasma\\tO\\nlipoproteins\\tO\\nwere\\tO\\nshown\\tO\\non\\tO\\npolyacrylamide\\tO\\ngels\\tO\\nand\\tO\\nby\\tO\\nantibody\\tO\\nmapping\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nnew\\tO\\ntruncated\\tO\\napoB\\tO\\nvariant\\tO\\n,\\tO\\napoB\\tO\\n-\\tO\\n50\\tO\\n,\\tO\\ncirculating\\tO\\nalong\\tO\\nwith\\tO\\nher\\tO\\napoB\\tO\\n-\\tO\\n48\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nfound\\tO\\nthis\\tO\\nindividual\\tO\\nto\\tO\\nbe\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nsingle\\tO\\nC\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nT\\tO\\nnucleotide\\tO\\nsubstitution\\tO\\nat\\tO\\napoB\\tO\\ncodon\\tO\\n2252\\tO\\n,\\tO\\nwhich\\tO\\nproduces\\tO\\na\\tO\\npremature\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\nstop\\tO\\ncodon\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthis\\tO\\nis\\tO\\na\\tO\\nrare\\tO\\nexample\\tO\\nof\\tO\\nhomozygous\\tB-Disease\\nhypobetalipoproteinemia\\tI-Disease\\n.\\tO\\n\\nElectron\\tO\\nphotomicrographs\\tO\\nrevealed\\tO\\nthat\\tO\\nthe\\tO\\ndiameters\\tO\\nof\\tO\\nparticles\\tO\\nin\\tO\\nthe\\tO\\nd\\tO\\nless\\tO\\nthan\\tO\\n1\\tO\\n.\\tO\\n\\n006\\tO\\ng\\tO\\n/\\tO\\nml\\tO\\nlipoprotein\\tO\\nfraction\\tO\\n,\\tO\\nin\\tO\\nboth\\tO\\nthe\\tO\\npostprandial\\tO\\nand\\tO\\npostabsorptive\\tO\\nstate\\tO\\n,\\tO\\nare\\tO\\nbimodally\\tO\\ndistributed\\tO\\n.\\tO\\n\\nThe\\tO\\nmolar\\tO\\nratio\\tO\\nof\\tO\\napoE\\tO\\nto\\tO\\napoB\\tO\\nin\\tO\\nthese\\tO\\nparticles\\tO\\nis\\tO\\n3\\tO\\n.\\tO\\n\\n5\\tO\\n1\\tO\\n,\\tO\\nsimilar\\tO\\nto\\tO\\nnormal\\tO\\nVLDL\\tO\\n.\\tO\\n\\nThe\\tO\\nplasma\\tO\\nLDL\\tO\\ninterval\\tO\\ncontains\\tO\\nboth\\tO\\nspherical\\tO\\nand\\tO\\ncuboidal\\tO\\nparticles\\tO\\n.\\tO\\n\\nAutologous\\tO\\nreinfusion\\tO\\nof\\tO\\nlabeled\\tO\\nd\\tO\\nless\\tO\\nthan\\tO\\n1\\tO\\n.\\tO\\n\\n006\\tO\\ng\\tO\\n/\\tO\\nml\\tO\\nlipoproteins\\tO\\nshowed\\tO\\nexponential\\tO\\ndisappearance\\tO\\nfrom\\tO\\nplasma\\tO\\n,\\tO\\nwith\\tO\\nan\\tO\\napparent\\tO\\nhalf\\tO\\n-\\tO\\nremoval\\tO\\ntime\\tO\\nof\\tO\\n50\\tO\\nmin\\tO\\n,\\tO\\nsomewhat\\tO\\nslower\\tO\\nthan\\tO\\nfor\\tO\\nnormal\\tO\\nchylomicrons\\tO\\nbut\\tO\\nwithin\\tO\\nthe\\tO\\nnormal\\tO\\nrange\\tO\\nfor\\tO\\nVLDL\\tO\\n.\\tO\\n\\nThe\\tO\\ncalculated\\tO\\nproduction\\tO\\nrate\\tO\\nfor\\tO\\napoB\\tO\\nwas\\tO\\nwithin\\tO\\nthe\\tO\\nnormal\\tO\\nrange\\tO\\nin\\tO\\nthis\\tO\\nsubject\\tO\\n.\\tO\\n\\nA\\tO\\nsingle\\tO\\norigin\\tO\\nof\\tO\\nphenylketonuria\\tB-Disease\\nin\\tO\\nYemenite\\tO\\nJews\\tO\\n.\\tO\\n\\nPhenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nmetabolic\\tB-Disease\\ndisease\\tI-Disease\\ncaused\\tO\\nby\\tO\\nrecessive\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nencoding\\tO\\nthe\\tO\\nhepatic\\tO\\nenzyme\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n(\\tO\\nPAH\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nincidence\\tO\\nof\\tO\\nPKU\\tB-Disease\\nvaries\\tO\\nwidely\\tO\\nacross\\tO\\ndifferent\\tO\\ngeographic\\tO\\nareas\\tO\\n,\\tO\\nand\\tO\\nis\\tO\\nhighest\\tO\\n(\\tO\\nabout\\tO\\n1\\tO\\nin\\tO\\n5\\tO\\n,\\tO\\n000\\tO\\nlive\\tO\\nbirths\\tO\\n)\\tO\\nin\\tO\\nIreland\\tO\\nand\\tO\\nwestern\\tO\\nScotland\\tO\\n,\\tO\\nand\\tO\\namong\\tO\\nYemenite\\tO\\nJews\\tO\\n.\\tO\\n\\nA\\tO\\nlimited\\tO\\nnumber\\tO\\nof\\tO\\npoint\\tO\\nmutations\\tO\\naccount\\tO\\nfor\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\nPKU\\tB-Disease\\ncases\\tO\\nin\\tO\\nthe\\tO\\nEuropean\\tO\\npopulation\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\na\\tO\\nsingle\\tO\\nmolecular\\tO\\ndefect\\tO\\n-\\tO\\n-\\tO\\na\\tO\\ndeletion\\tO\\nspanning\\tO\\nthe\\tO\\nthird\\tO\\nexon\\tO\\nof\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\n-\\tO\\n-\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nall\\tO\\nthe\\tO\\nPKU\\tB-Disease\\ncases\\tO\\namong\\tO\\nthe\\tO\\nYemenite\\tO\\nJews\\tO\\n.\\tO\\n\\nExamination\\tO\\nof\\tO\\na\\tO\\nrandom\\tO\\nsample\\tO\\nof\\tO\\nYemenite\\tO\\nJews\\tO\\nusing\\tO\\na\\tO\\nmolecular\\tO\\nprobe\\tO\\nthat\\tO\\ndetects\\tO\\nthe\\tO\\ncarriers\\tO\\nof\\tO\\nthis\\tO\\ndeletion\\tO\\nindicated\\tO\\na\\tO\\nhigh\\tO\\nfrequency\\tO\\nof\\tO\\nthe\\tO\\ndefective\\tO\\ngene\\tO\\nin\\tO\\nthis\\tO\\ncommunity\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\ndeleted\\tO\\nPAH\\tO\\ngene\\tO\\nwas\\tO\\ntraced\\tO\\nto\\tO\\n25\\tO\\ndifferent\\tO\\nlocations\\tO\\nthroughout\\tO\\nYemen\\tO\\n,\\tO\\nfamily\\tO\\nhistories\\tO\\nand\\tO\\nofficial\\tO\\ndocuments\\tO\\nof\\tO\\nthe\\tO\\nYemenite\\tO\\nJewish\\tO\\ncommunity\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\ncommon\\tO\\nancestor\\tO\\nof\\tO\\nall\\tO\\nthe\\tO\\ncarriers\\tO\\nof\\tO\\nthis\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\nlived\\tO\\nin\\tO\\nSana\\tO\\n,\\tO\\nthe\\tO\\ncapital\\tO\\nof\\tO\\nYemen\\tO\\n,\\tO\\nbefore\\tO\\nthe\\tO\\neighteenth\\tO\\ncentury\\tO\\n.\\tO\\n.\\tO\\n\\nLinkage\\tO\\nof\\tO\\naspartylglucosaminuria\\tB-Disease\\n(\\tO\\nAGU\\tB-Disease\\n)\\tO\\nto\\tO\\nmarker\\tO\\nloci\\tO\\non\\tO\\nthe\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n4\\tO\\n.\\tO\\n\\nAspartylglucosaminuria\\tB-Disease\\n(\\tO\\nAGU\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\ndeficient\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nenzyme\\tO\\naspartylglucosaminidase\\tO\\n(\\tO\\nAGA\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nstructural\\tO\\ngene\\tO\\nfor\\tO\\nAGA\\tO\\nhas\\tO\\nbeen\\tO\\nassigned\\tO\\nto\\tO\\nthe\\tO\\nregion\\tO\\n4q21\\tO\\n-\\tO\\nqter\\tO\\nof\\tO\\nchromosome\\tO\\n4\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nstudied\\tO\\nthe\\tO\\nmap\\tO\\nposition\\tO\\nof\\tO\\nthe\\tO\\nAGU\\tO\\nlocus\\tO\\nin\\tO\\nrelation\\tO\\nto\\tO\\nother\\tO\\nmarker\\tO\\nloci\\tO\\non\\tO\\nthe\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n4\\tO\\nusing\\tO\\nlinkage\\tO\\nanalyses\\tO\\n.\\tO\\n\\nRestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphism\\tO\\nalleles\\tO\\nfor\\tO\\nthe\\tO\\nADH2\\tO\\n,\\tO\\nADH3\\tO\\n,\\tO\\nEGF\\tO\\n,\\tO\\nFG\\tO\\nalpha\\tO\\nand\\tO\\nFG\\tO\\nbeta\\tO\\nloci\\tO\\nand\\tO\\nblood\\tO\\ngroup\\tO\\nantigens\\tO\\nfor\\tO\\nthe\\tO\\nMNS\\tO\\nlocus\\tO\\nwere\\tO\\ndetermined\\tO\\nin\\tO\\na\\tO\\npanel\\tO\\nof\\tO\\n12\\tO\\nFinnish\\tO\\nAGU\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nThe\\tO\\nheterozygous\\tO\\nfamily\\tO\\nmembers\\tO\\nwere\\tO\\nidentified\\tO\\nby\\tO\\nreduced\\tO\\nactivity\\tO\\nof\\tO\\nAGA\\tO\\nin\\tO\\nlymphocytes\\tO\\n.\\tO\\n\\nLinkage\\tO\\nstudies\\tO\\nwere\\tO\\nperformed\\tO\\nusing\\tO\\nboth\\tO\\npairwise\\tO\\nand\\tO\\nmultipoint\\tO\\nanalyses\\tO\\n.\\tO\\n\\nLoose\\tO\\nlinkage\\tO\\nof\\tO\\nthe\\tO\\nAGU\\tB-Disease\\nlocus\\tO\\nto\\tO\\nthe\\tO\\nFG\\tO\\nand\\tO\\nMNS\\tO\\nloci\\tO\\nwas\\tO\\nobserved\\tO\\n(\\tO\\nz\\tO\\n=\\tO\\n1\\tO\\n.\\tO\\n16\\tO\\n,\\tO\\nz\\tO\\n=\\tO\\n1\\tO\\n.\\tO\\n39\\tO\\n,\\tO\\nrespectively\\tO\\n)\\tO\\n.\\tO\\n\\nMultipoint\\tO\\nanalysis\\tO\\nto\\tO\\nthe\\tO\\nfixed\\tO\\nmap\\tO\\n[\\tO\\nADH\\tO\\n-\\tO\\n(\\tO\\n0\\tO\\n.\\tO\\n03\\tO\\n)\\tO\\n-\\tO\\nEGF\\tO\\n-\\tO\\n(\\tO\\n0\\tO\\n.\\tO\\n35\\tO\\n)\\tO\\n-\\tO\\nFG\\tO\\n-\\tO\\n(\\tO\\n0\\tO\\n.\\tO\\n11\\tO\\n)\\tO\\n-\\tO\\nMNS\\tO\\n]\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nlocation\\tO\\nof\\tO\\nthe\\tO\\nAGU\\tO\\nlocus\\tO\\nis\\tO\\n0\\tO\\n.\\tO\\n\\n05\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n\\n30\\tO\\nrecombination\\tO\\nunits\\tO\\ndistal\\tO\\nto\\tO\\nMNS\\tO\\n(\\tO\\nz\\tO\\n=\\tO\\n3\\tO\\n.\\tO\\n03\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\norder\\tO\\ncen\\tO\\n-\\tO\\nADH\\tO\\n-\\tO\\nEGF\\tO\\n-\\tO\\nFG\\tO\\n-\\tO\\nMNS\\tO\\n-\\tO\\nAGU\\tO\\nis\\tO\\n35\\tO\\ntimes\\tO\\nmore\\tO\\nlikely\\tO\\nthan\\tO\\nthe\\tO\\nnext\\tO\\nbest\\tO\\norder\\tO\\ncen\\tO\\n-\\tO\\nADH\\tO\\n-\\tO\\nEGF\\tO\\n-\\tO\\nAGU\\tO\\n-\\tO\\nFG\\tO\\n-\\tO\\nMNS\\tO\\n.\\tO\\n\\nLinkage\\tO\\nrelationships\\tO\\nof\\tO\\nthe\\tO\\napolipoprotein\\tO\\nC1\\tO\\ngene\\tO\\nand\\tO\\na\\tO\\ncytochrome\\tO\\nP450\\tO\\ngene\\tO\\n(\\tO\\nCYP2A\\tO\\n)\\tO\\nto\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nstudied\\tO\\nthe\\tO\\ngenetic\\tO\\nlinkage\\tO\\nof\\tO\\ntwo\\tO\\nmarkers\\tO\\n,\\tO\\nthe\\tO\\napolipoprotein\\tO\\nC1\\tO\\n(\\tO\\nAPOC1\\tO\\n)\\tO\\ngene\\tO\\nand\\tO\\na\\tO\\ncytochrome\\tO\\nP450\\tO\\n(\\tO\\nCYP2A\\tO\\n)\\tO\\ngene\\tO\\n,\\tO\\nin\\tO\\nrelation\\tO\\nto\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nA\\tO\\npeak\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\n9\\tO\\n.\\tO\\n\\n29\\tO\\nat\\tO\\n2\\tO\\ncM\\tO\\nwas\\tO\\nobserved\\tO\\nfor\\tO\\nAPOC1\\tO\\n-\\tO\\nDM\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\n8\\tO\\n.\\tO\\n\\n55\\tO\\nat\\tO\\n4\\tO\\ncM\\tO\\nfor\\tO\\nCYP2A\\tO\\n-\\tO\\nDM\\tO\\n.\\tO\\n\\nThese\\tO\\ntwo\\tO\\nmarkers\\tO\\nalso\\tO\\nshow\\tO\\nclose\\tO\\nlinkage\\tO\\nto\\tO\\neach\\tO\\nother\\tO\\n(\\tO\\ntheta\\tO\\nmax\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n05\\tO\\n,\\tO\\nZmax\\tO\\n=\\tO\\n9\\tO\\n.\\tO\\n09\\tO\\n)\\tO\\n.\\tO\\n\\nFrom\\tO\\nexamination\\tO\\nof\\tO\\nthe\\tO\\ngenotypes\\tO\\nof\\tO\\nthe\\tO\\nrecombinant\\tO\\nindividuals\\tO\\n,\\tO\\nCYP2A\\tO\\nappears\\tO\\nto\\tO\\nmap\\tO\\nproximal\\tO\\nto\\tO\\nDM\\tO\\nbecause\\tO\\nin\\tO\\none\\tO\\nrecombinant\\tO\\nindividual\\tO\\nCYP2A\\tO\\n,\\tO\\nAPOC2\\tO\\nand\\tO\\nCKMM\\tO\\nhad\\tO\\nall\\tO\\nrecombined\\tO\\nwith\\tO\\nDM\\tO\\n.\\tO\\n\\nEvidence\\tO\\nfrom\\tO\\nanother\\tO\\nCYP2A\\tO\\n-\\tO\\nDM\\tO\\nrecombinant\\tO\\nindividual\\tO\\nplaces\\tO\\nCYP2A\\tO\\nproximal\\tO\\nto\\tO\\nAPOC2\\tO\\nand\\tO\\nCKMM\\tO\\n.\\tO\\n\\nLocalisation\\tO\\nof\\tO\\nCYP2A\\tO\\non\\tO\\na\\tO\\npanel\\tO\\nof\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrids\\tO\\nalso\\tO\\nsuggests\\tO\\nthat\\tO\\nit\\tO\\nis\\tO\\nproximal\\tO\\nto\\tO\\nDM\\tO\\nand\\tO\\nAPOC2\\tO\\n/\\tO\\nC1\\tO\\n/\\tO\\nE\\tO\\ngene\\tO\\ncluster\\tO\\n.\\tO\\n\\nGenetic\\tO\\nlinkage\\tO\\nmap\\tO\\nof\\tO\\nsix\\tO\\npolymorphic\\tO\\nDNA\\tO\\nmarkers\\tO\\naround\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\non\\tO\\nchromosome\\tO\\n5\\tO\\n.\\tO\\n\\nA\\tO\\ngenetic\\tO\\nlinkage\\tO\\nmap\\tO\\nof\\tO\\nsix\\tO\\npolymorphic\\tO\\nDNA\\tO\\nmarkers\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\ngene\\tO\\n(\\tO\\nAPC\\tO\\n)\\tO\\nfor\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\non\\tO\\nchromosome\\tO\\n5q\\tO\\nis\\tO\\nreported\\tO\\n.\\tO\\n\\nOne\\tO\\nhundred\\tO\\nfifty\\tO\\n-\\tO\\nfive\\tO\\ntyped\\tO\\nmembers\\tO\\nof\\tO\\nnine\\tO\\nFAP\\tB-Disease\\nkindred\\tO\\nprovided\\tO\\nmore\\tO\\nthan\\tO\\n90\\tO\\nmeioses\\tO\\nfor\\tO\\nlinkage\\tO\\nanalysis\\tO\\n.\\tO\\n\\nA\\tO\\nnumber\\tO\\nof\\tO\\ncrucial\\tO\\nrecombination\\tO\\nevents\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nwhich\\tO\\nare\\tO\\ninformative\\tO\\nat\\tO\\nthree\\tO\\nor\\tO\\nmore\\tO\\nloci\\tO\\n,\\tO\\nallowing\\tO\\nconfident\\tO\\nordering\\tO\\nof\\tO\\nparts\\tO\\nof\\tO\\nthe\\tO\\nmap\\tO\\n.\\tO\\n\\nThere\\tO\\nwas\\tO\\nno\\tO\\nevidence\\tO\\nof\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\n,\\tO\\nwith\\tO\\nall\\tO\\nfamilies\\tO\\nshowing\\tO\\nlinkage\\tO\\nof\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\nchromosome\\tO\\n5\\tO\\nmarker\\tO\\nto\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nRecombination\\tO\\ndata\\tO\\nand\\tO\\ntwo\\tO\\n-\\tO\\npoint\\tO\\nlinkage\\tO\\nanalysis\\tO\\nsupport\\tO\\na\\tO\\nlocus\\tO\\norder\\tO\\nof\\tO\\ncentromere\\tO\\n-\\tO\\npi\\tO\\n227\\tO\\n-\\tO\\nC11P11\\tO\\n-\\tO\\nECB27\\tO\\n-\\tO\\nL5\\tO\\n.\\tO\\n\\n62\\tO\\n-\\tO\\nAPC\\tO\\n-\\tO\\nEF5\\tO\\n62\\tO\\n-\\tO\\nAPC\\tO\\n-\\tO\\nEF5\\tO\\n.\\tO\\n\\n44\\tO\\n-\\tO\\nYN5\\tO\\n44\\tO\\n-\\tO\\nYN5\\tO\\n.\\tO\\n\\n48\\tO\\n-\\tO\\ntelomer\\tO\\ne\\tO\\n,\\tO\\nalthough\\tO\\nEF5\\tO\\n.\\tO\\n\\n44\\tO\\ncould\\tO\\nlie\\tO\\nin\\tO\\nthe\\tO\\ninterval\\tO\\nL5\\tO\\n.\\tO\\n\\n62\\tO\\n-\\tO\\nAPC\\tO\\nor\\tO\\nECB27\\tO\\n-\\tO\\nL5\\tO\\n.\\tO\\n\\n62\\tO\\n.\\tO\\n\\nNo\\tO\\nrecombinants\\tO\\nwere\\tO\\nidentified\\tO\\nbetween\\tO\\nAPC\\tO\\nand\\tO\\neither\\tO\\nEF5\\tO\\n.\\tO\\n\\n44\\tO\\nor\\tO\\nYN5\\tO\\n.\\tO\\n\\n48\\tO\\n,\\tO\\nbut\\tO\\npublished\\tO\\ndeletion\\tO\\nmapping\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncarcinomas\\tI-Disease\\nand\\tO\\nlinkage\\tO\\nanalysis\\tO\\nin\\tO\\nFAP\\tB-Disease\\nsuggest\\tO\\nthat\\tO\\nYN5\\tO\\n.\\tO\\n\\n48\\tO\\nis\\tO\\n1\\tO\\n-\\tO\\n3\\tO\\ncM\\tO\\nfrom\\tO\\nAPC\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nstudy\\tO\\nsuggests\\tO\\nthat\\tO\\nYN5\\tO\\n.\\tO\\n\\n48\\tO\\nand\\tO\\nL5\\tO\\n.\\tO\\n\\n62\\tO\\ndelineate\\tO\\na\\tO\\nsmall\\tO\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n5\\tO\\nwithin\\tO\\nwhich\\tO\\nthe\\tO\\nEF5\\tO\\n.\\tO\\n\\n44\\tO\\nlocus\\tO\\nlies\\tO\\nvery\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nnot\\tO\\nonly\\tO\\nallow\\tO\\nuse\\tO\\nof\\tO\\nflanking\\tO\\nmarkers\\tO\\nfor\\tO\\npresymptomatic\\tO\\ndiagnosis\\tO\\nof\\tO\\nFAP\\tB-Disease\\nbut\\tO\\nalso\\tO\\nprovide\\tO\\na\\tO\\nhigh\\tO\\n-\\tO\\ndensity\\tO\\nmap\\tO\\nof\\tO\\nthe\\tO\\nregion\\tO\\nfor\\tO\\nisolation\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nitself\\tO\\nand\\tO\\nfor\\tO\\nfurther\\tO\\nassessment\\tO\\nof\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nchromosome\\tO\\n5\\tO\\ndeletions\\tO\\nin\\tO\\nthe\\tO\\nbiology\\tO\\nof\\tO\\nsporadic\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nSerum\\tO\\namyloid\\tO\\nA\\tO\\nand\\tO\\nP\\tO\\nprotein\\tO\\ngenes\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n.\\tO\\n\\nTwo\\tO\\nrecent\\tO\\nstudies\\tO\\nhave\\tO\\nsuggested\\tO\\nthe\\tO\\ninvolvement\\tO\\nof\\tO\\nserum\\tO\\namyloid\\tO\\nA\\tO\\n(\\tO\\nSAA\\tO\\n)\\tO\\nand\\tO\\nP\\tO\\n(\\tO\\nAPCS\\tO\\n)\\tO\\ngenes\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n(\\tO\\nMEF\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\ntest\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nSAA\\tO\\nand\\tO\\nAPCS\\tO\\nin\\tO\\nMEF\\tB-Disease\\nand\\tO\\nMEF\\tB-Disease\\n-\\tI-Disease\\namyloidosis\\tI-Disease\\n,\\tO\\nwe\\tO\\nstudied\\tO\\n17\\tO\\ninformative\\tO\\nfamilies\\tO\\n(\\tO\\n15\\tO\\nArmenians\\tO\\n,\\tO\\n2\\tO\\nnon\\tO\\n-\\tO\\nAshkenazi\\tO\\nJews\\tO\\n)\\tO\\nand\\tO\\n8\\tO\\nMEF\\tB-Disease\\npatients\\tO\\nwith\\tO\\namyloidosis\\tB-Disease\\nusing\\tO\\na\\tO\\ncandidate\\tO\\ngene\\tO\\napproach\\tO\\n.\\tO\\n\\nNo\\tO\\nevidence\\tO\\nfor\\tO\\nany\\tO\\nMEF\\tB-Disease\\n-\\tO\\nassociated\\tO\\npolymorphism\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\n41\\tO\\nArmenian\\tO\\nand\\tO\\nJewish\\tO\\nMEF\\tB-Disease\\npatients\\tO\\ntested\\tO\\n.\\tO\\n\\nOur\\tO\\nfamily\\tO\\nstudies\\tO\\nallowed\\tO\\nus\\tO\\nto\\tO\\nrule\\tO\\nout\\tO\\ntight\\tO\\nlinkage\\tO\\nbetween\\tO\\nSAA\\tO\\nand\\tO\\nMEF\\tB-Disease\\n(\\tO\\nlod\\tO\\nscore\\tO\\n=\\tO\\n-\\tO\\n2\\tO\\n.\\tO\\n16\\tO\\n,\\tO\\ntheta\\tO\\nless\\tO\\nthan\\tO\\nor\\tO\\nequal\\tO\\nto\\tO\\n0\\tO\\n.\\tO\\n06\\tO\\n)\\tO\\n.\\tO\\n\\nFor\\tO\\nAPCS\\tO\\nwe\\tO\\nfound\\tO\\nthat\\tO\\nthe\\tO\\nallele\\tO\\nfrequency\\tO\\nin\\tO\\nthe\\tO\\nMEF\\tB-Disease\\n-\\tI-Disease\\namyloidosis\\tI-Disease\\npatients\\tO\\nwas\\tO\\nsimilar\\tO\\nto\\tO\\nthat\\tO\\nin\\tO\\n18\\tO\\nunrelated\\tO\\nMEF\\tB-Disease\\npatients\\tO\\nwithout\\tO\\namyloidosis\\tB-Disease\\nand\\tO\\ntheir\\tO\\n33\\tO\\nhealthy\\tO\\nparents\\tO\\n.\\tO\\n\\nSome\\tO\\nMexican\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nvariants\\tO\\nrevisited\\tO\\n.\\tO\\n\\nGlucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nappears\\tO\\nto\\tO\\nbe\\tO\\nfairly\\tO\\ncommon\\tO\\nin\\tO\\nMexico\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nnow\\tO\\nexamined\\tO\\nthe\\tO\\nDNA\\tO\\nof\\tO\\nthree\\tO\\npreviously\\tO\\nreported\\tO\\nelectrophoretically\\tO\\nfast\\tO\\nMexican\\tO\\nG6PD\\tO\\nvariants\\tO\\n,\\tO\\n-\\tO\\nG6PD\\tO\\nDistrito\\tO\\nFederal\\tO\\n,\\tO\\nG6PD\\tO\\nTepic\\tO\\n,\\tO\\nand\\tO\\nG6PD\\tO\\nCastilla\\tO\\n.\\tO\\n\\nAll\\tO\\nthree\\tO\\nof\\tO\\nthese\\tO\\nvariants\\tO\\n,\\tO\\nbelieved\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nbiochemical\\tO\\ncharacterization\\tO\\nand\\tO\\npopulation\\tO\\norigin\\tO\\nto\\tO\\nbe\\tO\\nunique\\tO\\n,\\tO\\nhave\\tO\\nthe\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nnucleotide\\tO\\n202\\tO\\nand\\tO\\nthe\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nG\\tO\\ntransition\\tO\\nat\\tO\\nnucleotide\\tO\\n376\\tO\\n,\\tO\\nmutations\\tO\\nthat\\tO\\nwe\\tO\\nnow\\tO\\nrecognize\\tO\\nto\\tO\\nbe\\tO\\ncharacteristic\\tO\\nof\\tO\\nG6PD\\tO\\nA\\tO\\n-\\tO\\n.\\tO\\n\\nTwo\\tO\\nother\\tO\\nMexican\\tO\\nmales\\tO\\nwith\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nwere\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nthe\\tO\\nsame\\tO\\nmutation\\tO\\n.\\tO\\n\\nAll\\tO\\nfive\\tO\\nhave\\tO\\nthe\\tO\\n(\\tO\\nNlaIII\\tO\\n/\\tO\\nFokI\\tO\\n/\\tO\\nPvuII\\tO\\n/\\tO\\nPstI\\tO\\n)\\tO\\nhaplotype\\tO\\ncharacteristic\\tO\\nof\\tO\\nG6PD\\tO\\nA\\tO\\n-\\tO\\nin\\tO\\nAfrica\\tO\\n.\\tO\\n\\nSince\\tO\\nthe\\tO\\nPvuII\\tO\\n+\\tO\\ngenotype\\tO\\nseems\\tO\\nto\\tO\\nbe\\tO\\nrare\\tO\\nin\\tO\\nEurope\\tO\\n,\\tO\\nwe\\tO\\nconclude\\tO\\nthat\\tO\\nall\\tO\\nof\\tO\\nthese\\tO\\nG6PD\\tO\\nA\\tO\\n-\\tO\\ngenes\\tO\\nhad\\tO\\ntheir\\tO\\nancient\\tO\\norigin\\tO\\nin\\tO\\nAfrica\\tO\\n,\\tO\\nalthough\\tO\\nin\\tO\\nmany\\tO\\nof\\tO\\nthe\\tO\\nMexican\\tO\\npatients\\tO\\nwith\\tO\\nG6PD\\tO\\nA\\tO\\n-\\tO\\n202A\\tO\\n/\\tO\\n376G\\tO\\nthe\\tO\\ngene\\tO\\nmay\\tO\\nhave\\tO\\nbeen\\tO\\nimported\\tO\\nmore\\tO\\nrecently\\tO\\nfrom\\tO\\nSpain\\tO\\n,\\tO\\nwhere\\tO\\nthis\\tO\\nvariant\\tO\\n,\\tO\\nformerly\\tO\\nknown\\tO\\nas\\tO\\nG6PD\\tO\\nBetica\\tO\\n,\\tO\\nis\\tO\\nalso\\tO\\nprevalent\\tO\\n.\\tO\\n.\\tO\\n\\nHereditary\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nC5\\tI-Disease\\nin\\tO\\nassociation\\tO\\nwith\\tO\\ndiscoid\\tB-Disease\\nlupus\\tI-Disease\\nerythematosus\\tI-Disease\\n.\\tO\\n\\nA\\tO\\n29\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nwoman\\tO\\nwith\\tO\\ndiscoid\\tB-Disease\\nlupus\\tI-Disease\\nerythematosus\\tI-Disease\\nhad\\tO\\nundetectable\\tO\\nclassic\\tO\\npathway\\tO\\ncomplement\\tO\\nactivity\\tO\\n.\\tO\\n\\nHypocomplementemia\\tB-Disease\\nwas\\tO\\ndue\\tO\\nto\\tO\\nselective\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nC5\\tI-Disease\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nher\\tO\\nchildren\\tO\\nwas\\tO\\nalso\\tO\\ndeficient\\tO\\n.\\tO\\n\\nTo\\tO\\nour\\tO\\nknowledge\\tO\\nthis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\ndocumented\\tO\\ncase\\tO\\nof\\tO\\nan\\tO\\nassociation\\tO\\nbetween\\tO\\ndiscoid\\tB-Disease\\nlupus\\tI-Disease\\nerythematosus\\tI-Disease\\nand\\tO\\nC5\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nFounder\\tO\\neffect\\tO\\nof\\tO\\na\\tO\\nprevalent\\tO\\nphenylketonuria\\tB-Disease\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nOriental\\tO\\npopulation\\tO\\n.\\tO\\n\\nA\\tO\\nmissense\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n[\\tO\\nPAH\\tO\\n;\\tO\\nphenylalanine\\tO\\n4\\tO\\n-\\tO\\nmonooxygenase\\tO\\n;\\tO\\nL\\tO\\n-\\tO\\nphenylalanine\\tO\\n,\\tO\\ntetrahydrobiopterin\\tO\\noxygen\\tO\\noxidoreductase\\tO\\n(\\tO\\n4\\tO\\n-\\tO\\nhydroxylating\\tO\\n)\\tO\\n,\\tO\\nEC\\tO\\n1\\tO\\n.\\tO\\n14\\tO\\n.\\tO\\n16\\tO\\n.\\tO\\n1\\tO\\n]\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nChinese\\tO\\npatient\\tO\\nwith\\tO\\nclassic\\tO\\nphenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nG\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nC\\tO\\ntransition\\tO\\nat\\tO\\nthe\\tO\\nsecond\\tO\\nbase\\tO\\nof\\tO\\ncodon\\tO\\n413\\tO\\nin\\tO\\nexon\\tO\\n12\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nresults\\tO\\nin\\tO\\nthe\\tO\\nsubstitution\\tO\\nof\\tO\\nPro413\\tO\\nfor\\tO\\nArg413\\tO\\nin\\tO\\nthe\\tO\\nmutant\\tO\\nprotein\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\n(\\tO\\nR413P\\tO\\n)\\tO\\nresults\\tO\\nin\\tO\\nnegligible\\tO\\nenzymatic\\tO\\nactivity\\tO\\nwhen\\tO\\nexpressed\\tO\\nin\\tO\\nheterologous\\tO\\nmammalian\\tO\\ncells\\tO\\nand\\tO\\nis\\tO\\ncompatible\\tO\\nwith\\tO\\na\\tO\\nclassic\\tO\\nPKU\\tB-Disease\\nphenotype\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\n.\\tO\\n\\nPopulation\\tO\\ngenetic\\tO\\nstudies\\tO\\nreveal\\tO\\nthat\\tO\\nthis\\tO\\nmutation\\tO\\nis\\tO\\ntightly\\tO\\nlinked\\tO\\nto\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphism\\tO\\nhaplotype\\tO\\n4\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nthe\\tO\\npredominant\\tO\\nhaplotype\\tO\\nof\\tO\\nthe\\tO\\nPAH\\tO\\nlocus\\tO\\nin\\tO\\nthe\\tO\\nOriental\\tO\\npopulation\\tO\\n.\\tO\\n\\nIt\\tO\\naccounts\\tO\\nfor\\tO\\n13\\tO\\n.\\tO\\n\\n8\\tO\\n%\\tO\\nof\\tO\\nnorthern\\tO\\nChinese\\tO\\nand\\tO\\n27\\tO\\n%\\tO\\nof\\tO\\nJapanese\\tO\\nPKU\\tB-Disease\\nalleles\\tO\\n,\\tO\\nbut\\tO\\nit\\tO\\nis\\tO\\nrare\\tO\\nin\\tO\\nsouthern\\tO\\nChinese\\tO\\n(\\tO\\n2\\tO\\n.\\tO\\n2\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\nis\\tO\\nabsent\\tO\\nin\\tO\\nthe\\tO\\nCaucasian\\tO\\npopulation\\tO\\n.\\tO\\n\\nThe\\tO\\ndata\\tO\\ndemonstrate\\tO\\nunambiguously\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\noccurred\\tO\\nafter\\tO\\nracial\\tO\\ndivergence\\tO\\nof\\tO\\nOrientals\\tO\\nand\\tO\\nCaucasians\\tO\\nand\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nallele\\tO\\nhas\\tO\\nspread\\tO\\nthroughout\\tO\\nthe\\tO\\nOrient\\tO\\nby\\tO\\na\\tO\\nfounder\\tO\\neffect\\tO\\n.\\tO\\n\\nPrevious\\tO\\nprotein\\tO\\npolymorphism\\tO\\nstudies\\tO\\nin\\tO\\neastern\\tO\\nAsia\\tO\\nhave\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\n\"\\tO\\nnorthern\\tO\\nMongoloids\\tO\\n\"\\tO\\nrepresented\\tO\\na\\tO\\nfounding\\tO\\npopulation\\tO\\nin\\tO\\nAsia\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nare\\tO\\ncompatible\\tO\\nwith\\tO\\nthis\\tO\\nhypothesis\\tO\\nin\\tO\\nthat\\tO\\nthe\\tO\\nPKU\\tB-Disease\\nmutation\\tO\\nmight\\tO\\nhave\\tO\\noccurred\\tO\\nin\\tO\\nnorthern\\tO\\nMongoloids\\tO\\nand\\tO\\nsubsequently\\tO\\nspread\\tO\\nto\\tO\\nthe\\tO\\nChinese\\tO\\nand\\tO\\nJapanese\\tO\\npopulations\\tO\\n.\\tO\\n\\nGlucose\\tB-Disease\\n/\\tI-Disease\\ngalactose\\tI-Disease\\nmalabsorption\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ndefect\\tO\\nin\\tO\\nthe\\tO\\nNa\\tO\\n+\\tO\\n/\\tO\\nglucose\\tO\\ncotransporter\\tO\\n.\\tO\\n\\nGlucose\\tB-Disease\\n/\\tI-Disease\\ngalactose\\tI-Disease\\nmalabsorption\\tI-Disease\\n(\\tO\\nGGM\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisease\\tI-Disease\\nmanifesting\\tO\\nwithin\\tO\\nthe\\tO\\nfirst\\tO\\nweeks\\tO\\nof\\tO\\nlife\\tO\\nand\\tO\\ncharacterized\\tO\\nby\\tO\\na\\tO\\nselective\\tO\\nfailure\\tO\\nto\\tO\\nabsorb\\tO\\ndietary\\tO\\nglucose\\tO\\nand\\tO\\ngalactose\\tO\\nfrom\\tO\\nthe\\tO\\nintestine\\tO\\n.\\tO\\n\\nThe\\tO\\nconsequent\\tO\\nsevere\\tO\\ndiarrhoea\\tB-Disease\\nand\\tO\\ndehydration\\tB-Disease\\nare\\tO\\nusually\\tO\\nfatal\\tO\\nunless\\tO\\nthese\\tO\\nsugars\\tO\\nare\\tO\\neliminated\\tO\\nfrom\\tO\\nthe\\tO\\ndiet\\tO\\n.\\tO\\n\\nIntestinal\\tO\\nbiopsies\\tO\\nof\\tO\\nGGM\\tB-Disease\\npatients\\tO\\nhave\\tO\\nrevealed\\tO\\na\\tO\\nspecific\\tO\\ndefect\\tO\\nin\\tO\\nNa\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\n-\\tO\\ndependent\\tO\\nabsorption\\tO\\nof\\tO\\nglucose\\tO\\nin\\tO\\nthe\\tO\\nbrush\\tO\\nborder\\tO\\n.\\tO\\n\\nNormal\\tO\\nglucose\\tO\\nabsorption\\tO\\nis\\tO\\nmediated\\tO\\nby\\tO\\nthe\\tO\\nNa\\tO\\n+\\tO\\n/\\tO\\nglucose\\tO\\ncotransporter\\tO\\nin\\tO\\nthe\\tO\\nbrush\\tO\\nborder\\tO\\nmembrane\\tO\\nof\\tO\\nthe\\tO\\nintestinal\\tO\\nepithelium\\tO\\n.\\tO\\n\\nCellular\\tO\\ninflux\\tO\\nis\\tO\\ndriven\\tO\\nby\\tO\\nthe\\tO\\ntransmembrane\\tO\\nNa\\tO\\n+\\tO\\nelectrochemical\\tO\\npotential\\tO\\ngradient\\tO\\n;\\tO\\nthereafter\\tO\\nthe\\tO\\nsugar\\tO\\nmoves\\tO\\nto\\tO\\nthe\\tO\\nblood\\tO\\nacross\\tO\\nthe\\tO\\nbasolateral\\tO\\nmembrane\\tO\\nvia\\tO\\nthe\\tO\\nfacilitated\\tO\\nglucose\\tO\\ncarrier\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\npreviously\\tO\\ncloned\\tO\\nand\\tO\\nsequenced\\tO\\na\\tO\\nNa\\tO\\n+\\tO\\n/\\tO\\nglucose\\tO\\ncotransporter\\tO\\nfrom\\tO\\nnormal\\tO\\nhuman\\tO\\nileum\\tO\\nand\\tO\\nshown\\tO\\nthat\\tO\\nthis\\tO\\ngene\\tO\\n,\\tO\\nSGLT1\\tO\\n,\\tO\\nresides\\tO\\non\\tO\\nthe\\tO\\ndistal\\tO\\nq\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n22\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nnow\\tO\\namplified\\tO\\nSGLT1\\tO\\ncomplementary\\tO\\nDNA\\tO\\nand\\tO\\ngenomic\\tO\\nDNA\\tO\\nfrom\\tO\\nmembers\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\naffected\\tO\\nwith\\tO\\nGGM\\tB-Disease\\nby\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n.\\tO\\n\\nSequence\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\namplified\\tO\\nproducts\\tO\\nhas\\tO\\nrevealed\\tO\\na\\tO\\nsingle\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nSGLT1\\tO\\nwhich\\tO\\ncosegregates\\tO\\nwith\\tO\\nthe\\tO\\nGGM\\tB-Disease\\nphenotype\\tO\\nand\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\ncomplete\\tO\\nloss\\tO\\nof\\tO\\nNa\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\n-\\tO\\ndependent\\tO\\nglucose\\tO\\ntransport\\tO\\nin\\tO\\nXenopus\\tO\\noocytes\\tO\\ninjected\\tO\\nwith\\tO\\nthis\\tO\\ncomplementary\\tO\\nRNA\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nde\\tO\\nnovo\\tO\\nunbalanced\\tO\\nreciprocal\\tO\\ntranslocation\\tO\\nidentified\\tO\\nas\\tO\\npaternal\\tO\\nin\\tO\\norigin\\tO\\nin\\tO\\nthe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nInterstitial\\tO\\ncytogenetic\\tO\\ndeletions\\tO\\ninvolving\\tO\\nthe\\tO\\npaternally\\tO\\nderived\\tO\\nchromosome\\tO\\n15q11\\tO\\n-\\tO\\n13\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\na\\tO\\nchild\\tO\\nwith\\tO\\nPWS\\tB-Disease\\nand\\tO\\na\\tO\\nde\\tO\\nnovo\\tO\\nunbalanced\\tO\\nkaryotype\\tO\\n-\\tO\\n45\\tO\\n,\\tO\\nXY\\tO\\n,\\tO\\n-\\tO\\n9\\tO\\n,\\tO\\n-\\tO\\n15\\tO\\n,\\tO\\n+\\tO\\nder\\tO\\n(\\tO\\n9\\tO\\n)\\tO\\nt\\tO\\n(\\tO\\n9\\tO\\n;\\tO\\n15\\tO\\n)\\tO\\n(\\tO\\nq34\\tO\\n;\\tO\\nq13\\tO\\n)\\tO\\n.\\tO\\n\\nMolecular\\tO\\nstudies\\tO\\nwith\\tO\\nthe\\tO\\nDNA\\tO\\nprobe\\tO\\npML34\\tO\\nconfirmed\\tO\\nthat\\tO\\nonly\\tO\\na\\tO\\nsingle\\tO\\nPrader\\tB-Disease\\nWilli\\tI-Disease\\ncritical\\tO\\nregion\\tO\\n(\\tO\\nPWCR\\tO\\n15q11\\tO\\n.\\tO\\n2\\tO\\n-\\tO\\nq12\\tO\\n)\\tO\\ncopy\\tO\\nwas\\tO\\npresent\\tO\\n.\\tO\\n\\nHybridisation\\tO\\nof\\tO\\npatient\\tO\\nand\\tO\\nparental\\tO\\nDNA\\tO\\nwith\\tO\\nthe\\tO\\nmulti\\tO\\n-\\tO\\nallelic\\tO\\nprobe\\tO\\nCMW1\\tO\\n,\\tO\\nwhich\\tO\\nmaps\\tO\\nto\\tO\\npter\\tO\\n-\\tO\\n15q13\\tO\\n,\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nchromosome\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\ntranslocation\\tO\\nwas\\tO\\npaternal\\tO\\nin\\tO\\norigin\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nexample\\tO\\nof\\tO\\na\\tO\\npaternally\\tO\\n-\\tO\\nderived\\tO\\nPWCR\\tO\\nallele\\tO\\nloss\\tO\\ncaused\\tO\\nby\\tO\\nan\\tO\\nunbalanced\\tO\\ntranslocation\\tO\\nthat\\tO\\nhas\\tO\\narisen\\tO\\nde\\tO\\nnovo\\tO\\n.\\tO\\n\\nLocalisation\\tO\\nof\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nlocus\\tO\\nto\\tO\\n19q13\\tO\\n.\\tO\\n2\\tO\\n-\\tO\\n19q13\\tO\\n.\\tO\\n3\\tO\\nand\\tO\\nits\\tO\\nrelationship\\tO\\nto\\tO\\ntwelve\\tO\\npolymorphic\\tO\\nloci\\tO\\non\\tO\\n19q\\tO\\n.\\tO\\n\\nThe\\tO\\norder\\tO\\nof\\tO\\nfourteen\\tO\\npolymorphic\\tO\\nmarkers\\tO\\nlocalised\\tO\\nto\\tO\\nthe\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n19\\tO\\nhas\\tO\\nbeen\\tO\\nestablished\\tO\\nby\\tO\\nmultipoint\\tO\\nmapping\\tO\\nin\\tO\\na\\tO\\nset\\tO\\nof\\tO\\n40\\tO\\nCEPH\\tO\\n(\\tO\\nCentre\\tO\\ndEtude\\tO\\nde\\tO\\nPolymorphisme\\tO\\nHumain\\tO\\n,\\tO\\nParis\\tO\\n)\\tO\\nreference\\tO\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthe\\tO\\nlinkage\\tO\\nrelationship\\tO\\nof\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nlocus\\tO\\nto\\tO\\ntwelve\\tO\\nof\\tO\\nthese\\tO\\nmarkers\\tO\\nas\\tO\\nstudied\\tO\\nin\\tO\\n45\\tO\\nfamilies\\tO\\nwith\\tO\\nDM\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nresulting\\tO\\ngenetic\\tO\\nmap\\tO\\nis\\tO\\nsupported\\tO\\nby\\tO\\nthe\\tO\\nlocalisation\\tO\\nof\\tO\\nthe\\tO\\nDNA\\tO\\nmarkers\\tO\\nin\\tO\\na\\tO\\npanel\\tO\\nof\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrids\\tO\\n.\\tO\\n\\nTen\\tO\\nof\\tO\\nthe\\tO\\ntwelve\\tO\\nmarkers\\tO\\nhave\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\nproximal\\tO\\nto\\tO\\nthe\\tO\\nDM\\tB-Disease\\ngene\\tO\\nand\\tO\\ntwo\\tO\\n,\\tO\\nPRKCG\\tO\\nand\\tO\\nD19S22\\tO\\n,\\tO\\ndistal\\tO\\nbut\\tO\\nat\\tO\\ndistances\\tO\\nof\\tO\\napproximately\\tO\\n25\\tO\\ncM\\tO\\nand\\tO\\n15\\tO\\ncM\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nThe\\tO\\nclosest\\tO\\nproximal\\tO\\nmarkers\\tO\\nare\\tO\\nAPOC2\\tO\\n(\\tO\\napolipoprotein\\tO\\nC\\tO\\n-\\tO\\nII\\tO\\n)\\tO\\nand\\tO\\nCKM\\tO\\n(\\tO\\ncreatine\\tO\\nkinase\\tO\\n,\\tO\\nmuscle\\tO\\n)\\tO\\napproximately\\tO\\n3\\tO\\ncM\\tO\\nand\\tO\\n2\\tO\\ncM\\tO\\nfrom\\tO\\nthe\\tO\\nDM\\tB-Disease\\ngene\\tO\\nrespectively\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\norder\\tO\\nAPOC2\\tO\\n-\\tO\\nCKM\\tO\\n-\\tO\\nDM\\tO\\n.\\tO\\n\\nThe\\tO\\ndistance\\tO\\nbetween\\tO\\nAPOC2\\tO\\n,\\tO\\nCKM\\tO\\nand\\tO\\nDM\\tB-Disease\\n(\\tO\\nof\\tO\\nthe\\tO\\norder\\tO\\nof\\tO\\n2\\tO\\nmillion\\tO\\nbase\\tO\\npairs\\tO\\n)\\tO\\nand\\tO\\ntheir\\tO\\nknown\\tO\\norientation\\tO\\nshould\\tO\\npermit\\tO\\ndirectional\\tO\\nchromosome\\tO\\nwalking\\tO\\nand\\tO\\njumping\\tO\\n.\\tO\\n\\nThe\\tO\\ndata\\tO\\npresented\\tO\\nhere\\tO\\nshould\\tO\\nenable\\tO\\nus\\tO\\nto\\tO\\ndetermine\\tO\\nwhether\\tO\\nor\\tO\\nnot\\tO\\nnew\\tO\\nmarkers\\tO\\nare\\tO\\ndistal\\tO\\nto\\tO\\nAPOC2\\tO\\n/\\tO\\nCKM\\tO\\nand\\tO\\nthus\\tO\\npotentially\\tO\\nflank\\tO\\nthe\\tO\\nDM\\tB-Disease\\ngene\\tO\\n.\\tO\\n.\\tO\\n\\nLocalization\\tO\\nof\\tO\\nhistidase\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\nregion\\tO\\n12q22\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nq24\\tO\\n.\\tO\\n1\\tO\\nand\\tO\\nmouse\\tO\\nchromosome\\tO\\nregion\\tO\\n10C2\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nD1\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\ngene\\tO\\nfor\\tO\\nhistidase\\tO\\n(\\tO\\nhistidine\\tO\\nammonia\\tO\\n-\\tO\\nlyase\\tO\\n;\\tO\\nHAL\\tO\\n)\\tO\\n,\\tO\\nthe\\tO\\nenzyme\\tO\\ndeficient\\tO\\nin\\tO\\nhistidinemia\\tB-Disease\\n,\\tO\\nwas\\tO\\nassigned\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\n12\\tO\\nby\\tO\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\nof\\tO\\nhuman\\tO\\nX\\tO\\nmouse\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrid\\tO\\nDNA\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nwas\\tO\\nsublocalized\\tO\\nto\\tO\\nregion\\tO\\n12q22\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nq24\\tO\\n.\\tO\\n\\n1\\tO\\nby\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n,\\tO\\nusing\\tO\\na\\tO\\nhuman\\tO\\nhistidase\\tO\\ncDNA\\tO\\n.\\tO\\n\\nThe\\tO\\nhomologous\\tO\\nlocus\\tO\\nin\\tO\\nthe\\tO\\nmouse\\tO\\n(\\tO\\nHal\\tO\\n)\\tO\\nwas\\tO\\nmapped\\tO\\nto\\tO\\nregion\\tO\\n10C2\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nD1\\tO\\nby\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n,\\tO\\nusing\\tO\\na\\tO\\ncell\\tO\\nline\\tO\\nfrom\\tO\\na\\tO\\nmouse\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\n1\\tO\\n.\\tO\\n\\n10\\tO\\nRobertsonian\\tO\\ntranslocation\\tO\\n.\\tO\\n\\nThese\\tO\\nassignments\\tO\\nextend\\tO\\nthe\\tO\\nconserved\\tO\\nsyntenic\\tO\\nregion\\tO\\nbetween\\tO\\nhuman\\tO\\nchromosome\\tO\\n12\\tO\\nand\\tO\\nmouse\\tO\\nchromosome\\tO\\n10\\tO\\nthat\\tO\\nincludes\\tO\\nthe\\tO\\ngenes\\tO\\nfor\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n,\\tO\\ngamma\\tO\\ninterferon\\tO\\n,\\tO\\npeptidase\\tO\\n,\\tO\\nand\\tO\\ncitrate\\tO\\nsynthase\\tO\\n.\\tO\\n\\nThe\\tO\\nlocalization\\tO\\nof\\tO\\nhistidase\\tO\\nto\\tO\\nmouse\\tO\\nchromosome\\tO\\n10\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nhistidase\\tO\\nregulatory\\tO\\nlocus\\tO\\n(\\tO\\nHsd\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nhistidinemia\\tO\\nmutation\\tO\\n(\\tO\\nhis\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nare\\tO\\nboth\\tO\\nknown\\tO\\nto\\tO\\nbe\\tO\\non\\tO\\nchromosome\\tO\\n10\\tO\\n,\\tO\\nmay\\tO\\nbe\\tO\\nalleles\\tO\\nof\\tO\\nthe\\tO\\nhistidase\\tO\\nstructural\\tO\\ngene\\tO\\nlocus\\tO\\n.\\tO\\n\\nDetermination\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\nin\\tO\\n17\\tO\\nsubjects\\tO\\n.\\tO\\n\\nHypoxanthine\\tO\\n-\\tO\\n-\\tO\\nguanine\\tO\\nphosphoribosyltransferase\\tO\\n(\\tO\\nHPRT\\tO\\n)\\tO\\nis\\tO\\na\\tO\\npurine\\tO\\nsalvage\\tO\\nenzyme\\tO\\nthat\\tO\\ncatalyzes\\tO\\nthe\\tO\\nconversion\\tO\\nof\\tO\\nhypoxanthine\\tO\\nto\\tO\\ninosine\\tO\\nmonophosphate\\tO\\nand\\tO\\nguanine\\tO\\nto\\tO\\nguanosine\\tO\\nmonophosphate\\tO\\n.\\tO\\n\\nPrevious\\tO\\nstudies\\tO\\nof\\tO\\nmutant\\tO\\nHPRT\\tO\\nproteins\\tO\\nanalyzed\\tO\\nat\\tO\\nthe\\tO\\nmolecular\\tO\\nlevel\\tO\\nhave\\tO\\nshown\\tO\\na\\tO\\nsignificant\\tO\\nheterogeneity\\tO\\n.\\tO\\n\\nThis\\tO\\ninvestigation\\tO\\nfurther\\tO\\nverifies\\tO\\nthis\\tO\\nheterogeneity\\tO\\nand\\tO\\nidentifies\\tO\\ninsertions\\tO\\n,\\tO\\ndeletions\\tO\\n,\\tO\\nand\\tO\\npoint\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\ndirect\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n-\\tO\\namplified\\tO\\nproduct\\tO\\nof\\tO\\nreverse\\tO\\n-\\tO\\ntranscribed\\tO\\nHPRT\\tO\\nmRNA\\tO\\nenabled\\tO\\nthe\\tO\\nrapid\\tO\\nidentification\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nfound\\tO\\nin\\tO\\n17\\tO\\npreviously\\tO\\nuncharacterized\\tO\\ncell\\tO\\nlines\\tO\\nderived\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nLinkage\\tO\\nof\\tO\\nDNA\\tO\\nmarkers\\tO\\nat\\tO\\nXq28\\tO\\nto\\tO\\nadrenoleukodystrophy\\tB-Disease\\nand\\tO\\nadrenomyeloneuropathy\\tB-Disease\\npresent\\tO\\nwithin\\tO\\nthe\\tO\\nsame\\tO\\nfamily\\tO\\n.\\tO\\n\\nWe\\tO\\npresent\\tO\\na\\tO\\nlarge\\tO\\nkindred\\tO\\nthat\\tO\\ncontained\\tO\\npatients\\tO\\nwith\\tO\\neither\\tO\\nadrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\nor\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n(\\tO\\nAMN\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\npedigree\\tO\\nclearly\\tO\\nsupported\\tO\\nthe\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nmode\\tO\\nof\\tO\\ninheritance\\tO\\nof\\tO\\nthe\\tO\\nnonneonatal\\tO\\nform\\tO\\nof\\tO\\nALD\\tB-Disease\\n/\\tO\\nAMN\\tB-Disease\\n.\\tO\\n\\nAnalysis\\tO\\nwith\\tO\\nDNA\\tO\\nmarkers\\tO\\nat\\tO\\nXq28\\tO\\nsuggested\\tO\\nsegregation\\tO\\nof\\tO\\nboth\\tO\\nALD\\tB-Disease\\nand\\tO\\nAMN\\tB-Disease\\nwith\\tO\\nan\\tO\\nidentical\\tO\\nhaplotype\\tO\\n.\\tO\\n\\nThis\\tO\\nindicated\\tO\\nthat\\tO\\nnonneonatal\\tO\\nALD\\tB-Disease\\nand\\tO\\nAMN\\tB-Disease\\nare\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\ngene\\tO\\nat\\tO\\nXq28\\tO\\n.\\tO\\n\\nIt\\tO\\nshowed\\tO\\n,\\tO\\nfurthermore\\tO\\n,\\tO\\nthat\\tO\\nphenotypic\\tO\\ndifferences\\tO\\nbetween\\tO\\nALD\\tB-Disease\\nand\\tO\\nAMN\\tB-Disease\\nare\\tO\\nnot\\tO\\nnecessarily\\tO\\nthe\\tO\\nconsequence\\tO\\nof\\tO\\nallelic\\tO\\nheterogeneity\\tO\\ndue\\tO\\nto\\tO\\ndifferent\\tO\\nmutations\\tO\\nwithin\\tO\\nthe\\tO\\nsame\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nmaximal\\tO\\nlod\\tO\\nscore\\tO\\nfor\\tO\\nlinkage\\tO\\nof\\tO\\nthe\\tO\\nALD\\tB-Disease\\n/\\tO\\nAMN\\tB-Disease\\ngene\\tO\\nand\\tO\\nthe\\tO\\nmultiallelic\\tO\\nanonymous\\tO\\nDNA\\tO\\nmarker\\tO\\nat\\tO\\nDXS52\\tO\\nwas\\tO\\n3\\tO\\n.\\tO\\n\\n0\\tO\\nat\\tO\\na\\tO\\nrecombination\\tO\\nfraction\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n00\\tO\\n.\\tO\\n\\nThis\\tO\\nmade\\tO\\na\\tO\\nprenatal\\tO\\nor\\tO\\npresymptomatic\\tO\\ndiagnosis\\tO\\nand\\tO\\nheterozygote\\tO\\ndetection\\tO\\nby\\tO\\nDNA\\tO\\nanalysis\\tO\\nwith\\tO\\nthis\\tO\\nmarker\\tO\\nreliable\\tO\\n.\\tO\\n\\nSkewed\\tO\\nX\\tO\\ninactivation\\tO\\nin\\tO\\na\\tO\\nfemale\\tO\\nMZ\\tO\\ntwin\\tO\\nresults\\tO\\nin\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nfemale\\tO\\nMZ\\tO\\ntwins\\tO\\npresented\\tO\\nwith\\tO\\nmuscular\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nPhysical\\tO\\nexamination\\tO\\n,\\tO\\ncreatine\\tO\\nphosphokinase\\tO\\nlevels\\tO\\n,\\tO\\nand\\tO\\nmuscle\\tO\\nbiopsy\\tO\\nwere\\tO\\nconsistent\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nbecause\\tO\\nof\\tO\\nher\\tO\\nsex\\tO\\nshe\\tO\\nwas\\tO\\ndiagnosed\\tO\\nas\\tO\\nhaving\\tO\\nlimb\\tB-Disease\\n-\\tI-Disease\\ngirdle\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nWith\\tO\\ncDNA\\tO\\nprobes\\tO\\nto\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n,\\tO\\na\\tO\\ngene\\tO\\ndeletion\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\ntwins\\tO\\nand\\tO\\ntheir\\tO\\nmother\\tO\\n.\\tO\\n\\nThe\\tO\\nde\\tO\\nnovo\\tO\\nmutation\\tO\\nwhich\\tO\\narose\\tO\\nin\\tO\\nthe\\tO\\nmother\\tO\\nwas\\tO\\nshown\\tO\\nby\\tO\\nnovel\\tO\\njunction\\tO\\nfragments\\tO\\ngenerated\\tO\\nby\\tO\\nHindIII\\tO\\n,\\tO\\nPstI\\tO\\n,\\tO\\nor\\tO\\nTaqI\\tO\\nwhen\\tO\\nprobed\\tO\\nwith\\tO\\ncDNA8\\tO\\n.\\tO\\n\\nAdditional\\tO\\nevidence\\tO\\nof\\tO\\na\\tO\\nlarge\\tO\\ngene\\tO\\ndeletion\\tO\\nwas\\tO\\ngiven\\tO\\nby\\tO\\nnovel\\tO\\nSfiI\\tO\\njunction\\tO\\nfragments\\tO\\ndetected\\tO\\nby\\tO\\nprobes\\tO\\np20\\tO\\n,\\tO\\nJ\\tO\\n-\\tO\\nBir\\tO\\n,\\tO\\nand\\tO\\nJ\\tO\\n-\\tO\\n66\\tO\\non\\tO\\npulsed\\tO\\n-\\tO\\nfield\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n(\\tO\\nPFGE\\tO\\n)\\tO\\n.\\tO\\n\\nImmunoblot\\tO\\nanalysis\\tO\\nof\\tO\\nmuscle\\tO\\nfrom\\tO\\nthe\\tO\\naffected\\tO\\ntwin\\tO\\nshowed\\tO\\ndystrophin\\tO\\nof\\tO\\nnormal\\tO\\nsize\\tO\\nbut\\tO\\nof\\tO\\nreduced\\tO\\namount\\tO\\n.\\tO\\n\\nImmunofluorescent\\tO\\nvisualization\\tO\\nof\\tO\\ndystrophin\\tO\\nrevealed\\tO\\nfoci\\tO\\nof\\tO\\ndystrophin\\tO\\n-\\tO\\npositive\\tO\\nfibers\\tO\\nadjacent\\tO\\nto\\tO\\nfoci\\tO\\nof\\tO\\ndystrophin\\tO\\n-\\tO\\nnegative\\tO\\nfibers\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\naffected\\tO\\ntwin\\tO\\nis\\tO\\na\\tO\\nmanifesting\\tO\\ncarrier\\tO\\nof\\tO\\nan\\tO\\nabnormal\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n,\\tO\\nher\\tO\\nmyopathy\\tB-Disease\\nbeing\\tO\\na\\tO\\ndirect\\tO\\nresult\\tO\\nof\\tO\\nunderexpression\\tO\\nof\\tO\\ndystrophin\\tO\\n.\\tO\\n\\nCytogenetic\\tO\\nanalysis\\tO\\nrevealed\\tO\\nnormal\\tO\\nkaryotypes\\tO\\n,\\tO\\neliminating\\tO\\nthe\\tO\\npossibility\\tO\\nof\\tO\\na\\tO\\ntranslocation\\tO\\naffecting\\tO\\nDMD\\tB-Disease\\ngene\\tO\\nfunction\\tO\\n.\\tO\\n\\nBoth\\tO\\nlinkage\\tO\\nanalysis\\tO\\nand\\tO\\nDNA\\tO\\nfingerprint\\tO\\nanalysis\\tO\\nrevealed\\tO\\nthat\\tO\\neach\\tO\\ntwin\\tO\\nhas\\tO\\ntwo\\tO\\ndifferent\\tO\\nX\\tO\\nchromosomes\\tO\\n,\\tO\\neliminating\\tO\\nthe\\tO\\npossibility\\tO\\nof\\tO\\nuniparental\\tB-Disease\\ndisomy\\tI-Disease\\nas\\tO\\na\\tO\\nmechanism\\tO\\nfor\\tO\\nDMD\\tB-Disease\\nexpression\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nmethylation\\tO\\ndifferences\\tO\\nof\\tO\\nthe\\tO\\npaternal\\tO\\nand\\tO\\nmaternal\\tO\\nX\\tO\\nchromosomes\\tO\\nin\\tO\\nthese\\tO\\nMZ\\tO\\ntwins\\tO\\n,\\tO\\nwe\\tO\\npropose\\tO\\nuneven\\tO\\nlyonization\\tO\\n(\\tO\\nX\\tO\\nchromosome\\tO\\ninactivation\\tO\\n)\\tO\\nas\\tO\\nthe\\tO\\nunderlying\\tO\\nmechanism\\tO\\nfor\\tO\\ndisease\\tO\\nexpression\\tO\\nin\\tO\\nthe\\tO\\naffected\\tO\\nfemale\\tO\\n.\\tO\\n.\\tO\\n\\nAdrenoleukodystrophy\\tB-Disease\\nand\\tO\\nadrenomyeloneuropathy\\tB-Disease\\nassociated\\tO\\nwith\\tO\\npartial\\tO\\nadrenal\\tB-Disease\\ninsufficiency\\tI-Disease\\nin\\tO\\nthree\\tO\\ngenerations\\tO\\nof\\tO\\na\\tO\\nkindred\\tO\\n.\\tO\\n\\nFour\\tO\\ncases\\tO\\nof\\tO\\nadrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\nand\\tO\\none\\tO\\ncase\\tO\\nof\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n(\\tO\\nAMN\\tB-Disease\\n)\\tO\\nhave\\tO\\ndeveloped\\tO\\nin\\tO\\na\\tO\\nkindred\\tO\\nover\\tO\\nthree\\tO\\ngenerations\\tO\\ndemonstrating\\tO\\nthat\\tO\\nAMN\\tB-Disease\\nis\\tO\\na\\tO\\nclinical\\tO\\nvariant\\tO\\nof\\tO\\nALD\\tB-Disease\\n.\\tO\\n\\nPituitary\\tO\\n-\\tO\\nadrenal\\tO\\nfunction\\tO\\nstudies\\tO\\nwere\\tO\\nperformed\\tO\\nin\\tO\\n10\\tO\\nfamily\\tO\\nmembers\\tO\\n,\\tO\\nincluding\\tO\\ntwo\\tO\\naffected\\tO\\nmales\\tO\\nand\\tO\\nfour\\tO\\nfemales\\tO\\nidentified\\tO\\nas\\tO\\ncarriers\\tO\\nof\\tO\\nALD\\tB-Disease\\n/\\tO\\nAMN\\tB-Disease\\n.\\tO\\n\\nNo\\tO\\npituitary\\tB-Disease\\n-\\tI-Disease\\nadrenal\\tI-Disease\\nabnormality\\tI-Disease\\nwas\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\ncarriers\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nbasal\\tO\\nmorning\\tO\\nplasma\\tO\\nadrenocorticotropic\\tO\\nhormone\\tO\\n(\\tO\\nACTH\\tO\\n)\\tO\\nlevels\\tO\\nwere\\tO\\nmarkedly\\tO\\nelevated\\tO\\nin\\tO\\nthe\\tO\\ntwo\\tO\\nmales\\tO\\nwith\\tO\\nALD\\tB-Disease\\nand\\tO\\nAMN\\tB-Disease\\n,\\tO\\ndespite\\tO\\nthe\\tO\\nfact\\tO\\nthat\\tO\\nthey\\tO\\nhad\\tO\\nno\\tO\\nclinical\\tO\\nsigns\\tO\\nof\\tO\\nadrenal\\tB-Disease\\ninsufficiency\\tI-Disease\\nand\\tO\\nthat\\tO\\nmorning\\tO\\nplasma\\tO\\ncortisol\\tO\\nlevels\\tO\\nand\\tO\\ntheir\\tO\\nresponse\\tO\\nto\\tO\\nmaximal\\tO\\nexogenous\\tO\\nACTH\\tO\\nstimulation\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\nnormal\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nthe\\tO\\nintegrated\\tO\\n24\\tO\\n-\\tO\\nhour\\tO\\nresponse\\tO\\nto\\tO\\nthe\\tO\\nadministration\\tO\\nwere\\tO\\nalso\\tO\\nsubnormal\\tO\\nin\\tO\\nthese\\tO\\ntwo\\tO\\ncases\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\npeople\\tO\\nwith\\tO\\nALD\\tB-Disease\\nand\\tO\\nAMN\\tB-Disease\\nmay\\tO\\nhave\\tO\\nsubclinical\\tO\\npartial\\tO\\nadrenocrotical\\tB-Disease\\ninsufficiency\\tI-Disease\\n.\\tO\\n\\nNo\\tO\\nother\\tO\\nendocrinologic\\tB-Disease\\ndysfunction\\tI-Disease\\nwas\\tO\\nidentified\\tO\\n.\\tO\\n.\\tO\\n\\nRegional\\tO\\nlocalisation\\tO\\nof\\tO\\nthe\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\nlocus\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\n9q13\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nq21\\tO\\n.\\tO\\n1\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\npreviously\\tO\\nassigned\\tO\\nthe\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\nlocus\\tO\\n(\\tO\\nFRDA\\tO\\n)\\tO\\nto\\tO\\nchromosome\\tO\\n9\\tO\\n;\\tO\\nthe\\tO\\ncurrent\\tO\\nmaximal\\tO\\nlod\\tO\\nscore\\tO\\nbetween\\tO\\nFRDA\\tO\\nand\\tO\\nMCT112\\tO\\n(\\tO\\nD9S15\\tO\\n)\\tO\\nis\\tO\\ngreater\\tO\\nthan\\tO\\n50\\tO\\nat\\tO\\na\\tO\\nrecombination\\tO\\nfraction\\tO\\nof\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\nThe\\tO\\nphysical\\tO\\nassignment\\tO\\nof\\tO\\nthe\\tO\\nlocus\\tO\\ndefined\\tO\\nby\\tO\\nMCT112\\tO\\n,\\tO\\nand\\tO\\nhence\\tO\\nFRDA\\tO\\n,\\tO\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\ndetermined\\tO\\n,\\tO\\nalthough\\tO\\nlinkage\\tO\\nanalysis\\tO\\nof\\tO\\nMCT112\\tO\\nwith\\tO\\nother\\tO\\nchromosome\\tO\\n9\\tO\\nmarkers\\tO\\ninferred\\tO\\na\\tO\\nlocation\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\ncentromere\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nused\\tO\\nin\\tO\\nsitu\\tO\\nhybridisation\\tO\\nwith\\tO\\nMCT112\\tO\\n,\\tO\\na\\tO\\ncorresponding\\tO\\ncosmid\\tO\\nMJ1\\tO\\n,\\tO\\nand\\tO\\nDR47\\tO\\n(\\tO\\nD9S5\\tO\\n)\\tO\\n,\\tO\\ncoupled\\tO\\nwith\\tO\\nmapping\\tO\\nstudies\\tO\\non\\tO\\nhybrid\\tO\\ncell\\tO\\npanels\\tO\\n,\\tO\\nto\\tO\\ndefine\\tO\\nmore\\tO\\nprecisely\\tO\\nthe\\tO\\nlocation\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nlocus\\tO\\n.\\tO\\n\\nThe\\tO\\nin\\tO\\nsitu\\tO\\nlocation\\tO\\nof\\tO\\nall\\tO\\nthree\\tO\\nprobes\\tO\\nis\\tO\\n9q13\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nq21\\tO\\n.\\tO\\n\\n1\\tO\\n,\\tO\\ndistal\\tO\\nto\\tO\\nthe\\tO\\nvariable\\tO\\nheterochromatin\\tO\\nregion\\tO\\n.\\tO\\n\\nPhysical\\tO\\nassignment\\tO\\nof\\tO\\nFRDA\\tO\\nwill\\tO\\nallow\\tO\\nus\\tO\\nto\\tO\\nidentify\\tO\\nhybrid\\tO\\ncell\\tO\\nlines\\tO\\ncontaining\\tO\\nthe\\tO\\nmutated\\tO\\ngene\\tO\\n.\\tO\\n\\nIncreased\\tO\\nhigh\\tO\\n-\\tO\\ndensity\\tO\\nlipoprotein\\tO\\nlevels\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\ncommon\\tO\\ncholesteryl\\tO\\n-\\tO\\nester\\tO\\ntransfer\\tO\\nprotein\\tO\\ngene\\tO\\nmutation\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\nAND\\tO\\nMETHODS\\tO\\n.\\tO\\n\\nThe\\tO\\nplasma\\tO\\ncholesteryl\\tO\\n-\\tO\\nester\\tO\\ntransfer\\tO\\nprotein\\tO\\n(\\tO\\nCETP\\tO\\n)\\tO\\ncatalyzes\\tO\\nthe\\tO\\ntransfer\\tO\\nof\\tO\\ncholesteryl\\tO\\nesters\\tO\\nfrom\\tO\\nhigh\\tO\\n-\\tO\\ndensity\\tO\\nlipoprotein\\tO\\n(\\tO\\nHDL\\tO\\n)\\tO\\nto\\tO\\nother\\tO\\nlipoproteins\\tO\\n.\\tO\\n\\nWe\\tO\\nrecently\\tO\\ndescribed\\tO\\na\\tO\\nJapanese\\tO\\nfamily\\tO\\nwith\\tO\\nincreased\\tO\\nHDL\\tO\\nlevels\\tO\\nand\\tO\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\ndue\\tO\\nto\\tO\\na\\tO\\nsplicing\\tO\\ndefect\\tO\\nof\\tO\\nthe\\tO\\nCETP\\tO\\ngene\\tO\\n.\\tO\\n\\nTo\\tO\\nassess\\tO\\nthe\\tO\\nfrequency\\tO\\nand\\tO\\nphenotype\\tO\\nof\\tO\\nthis\\tO\\ncondition\\tO\\n,\\tO\\nwe\\tO\\nscreened\\tO\\n11\\tO\\nadditional\\tO\\nfamilies\\tO\\nwith\\tO\\nhigh\\tO\\nHDL\\tO\\nlevels\\tO\\nby\\tO\\nmeans\\tO\\nof\\tO\\na\\tO\\nradioimmunoassay\\tO\\nfor\\tO\\nCETP\\tO\\nand\\tO\\nDNA\\tO\\nanalysis\\tO\\n.\\tO\\n\\nRESULTS\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nthe\\tO\\nsame\\tO\\nCETP\\tO\\ngene\\tO\\nmutation\\tO\\nin\\tO\\nfour\\tO\\nfamilies\\tO\\nfrom\\tO\\nthree\\tO\\ndifferent\\tO\\nregions\\tO\\nof\\tO\\nJapan\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nrestriction\\tO\\n-\\tO\\nfragment\\tO\\n-\\tO\\nlength\\tO\\npolymorphisms\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nCETP\\tO\\nallele\\tO\\nshowed\\tO\\nthat\\tO\\nall\\tO\\nprobands\\tO\\nwere\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\nidentical\\tO\\nhaplotype\\tO\\n.\\tO\\n\\nFamily\\tO\\nmembers\\tO\\nhomozygous\\tO\\nfor\\tO\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nn\\tO\\n=\\tO\\n10\\tO\\n)\\tO\\nhad\\tO\\nmoderate\\tO\\nhypercholesterolemia\\tB-Disease\\n(\\tO\\nmean\\tO\\ntotal\\tO\\ncholesterol\\tO\\nlevel\\tO\\n[\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\nSD\\tO\\n]\\tO\\n,\\tO\\n7\\tO\\n.\\tO\\n01\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n83\\tO\\nmmol\\tO\\nper\\tO\\nliter\\tO\\n)\\tO\\n,\\tO\\nmarkedly\\tO\\nincreased\\tO\\nlevels\\tO\\nof\\tO\\nHDL\\tO\\ncholesterol\\tO\\n(\\tO\\n4\\tO\\n.\\tO\\n24\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n01\\tO\\nmmol\\tO\\nper\\tO\\nliter\\tO\\n)\\tO\\nand\\tO\\napolipoprotein\\tO\\nA\\tO\\n-\\tO\\nI\\tO\\n,\\tO\\nand\\tO\\ndecreased\\tO\\nlevels\\tO\\nof\\tO\\nlow\\tO\\n-\\tO\\ndensity\\tO\\nlipoprotein\\tO\\ncholesterol\\tO\\n(\\tO\\n1\\tO\\n.\\tO\\n99\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n80\\tO\\nmmol\\tO\\nper\\tO\\nliter\\tO\\n)\\tO\\nand\\tO\\napolipoprotein\\tO\\nB\\tO\\n.\\tO\\n\\nMembers\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\ndeficiency\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n20\\tO\\n)\\tO\\n,\\tO\\nwhose\\tO\\nCETP\\tO\\nlevels\\tO\\nwere\\tO\\nin\\tO\\nthe\\tO\\nlower\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nrange\\tO\\n,\\tO\\nhad\\tO\\nmoderately\\tO\\nincreased\\tO\\nlevels\\tO\\nof\\tO\\nHDL\\tO\\ncholesterol\\tO\\nand\\tO\\napolipoprotein\\tO\\nA\\tO\\n-\\tO\\nI\\tO\\nand\\tO\\nan\\tO\\nincreased\\tO\\nratio\\tO\\nof\\tO\\nHDL\\tO\\nsubclass\\tO\\n2\\tO\\nto\\tO\\nHDL\\tO\\nsubclass\\tO\\n3\\tO\\n,\\tO\\nas\\tO\\ncompared\\tO\\nwith\\tO\\nunaffected\\tO\\nfamily\\tO\\nmembers\\tO\\n(\\tO\\n1\\tO\\n.\\tO\\n5\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n8\\tO\\nvs\\tO\\n.\\tO\\n0\\tO\\n.\\tO\\n7\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n4\\tO\\n)\\tO\\n.\\tO\\n\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\nnot\\tO\\nfound\\tO\\nin\\tO\\nsix\\tO\\nunrelated\\tO\\nsubjects\\tO\\nwith\\tO\\nelevated\\tO\\nHDL\\tO\\ncholesterol\\tO\\nlevels\\tO\\nwho\\tO\\nwere\\tO\\nfrom\\tO\\ndifferent\\tO\\nparts\\tO\\nof\\tO\\nthe\\tO\\nUnited\\tO\\nStates\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\n.\\tO\\n\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\nappears\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nfrequent\\tO\\ncause\\tO\\nof\\tO\\nincreased\\tO\\nHDL\\tO\\nlevels\\tO\\nin\\tO\\nthe\\tO\\npopulation\\tO\\nof\\tO\\nJapan\\tO\\n,\\tO\\npossibly\\tO\\nbecause\\tO\\nof\\tO\\na\\tO\\nfounder\\tO\\neffect\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nthat\\tO\\nwe\\tO\\nobserved\\tO\\nin\\tO\\nheterozygotes\\tO\\nsuggest\\tO\\nthat\\tO\\nCETP\\tO\\nnormally\\tO\\nplays\\tO\\na\\tO\\npart\\tO\\nin\\tO\\nthe\\tO\\nregulation\\tO\\nof\\tO\\nlevels\\tO\\nof\\tO\\nHDL\\tO\\nsubclass\\tO\\n2\\tO\\n.\\tO\\n\\nThere\\tO\\nwas\\tO\\nno\\tO\\nevidence\\tO\\nof\\tO\\npremature\\tB-Disease\\natherosclerosis\\tI-Disease\\nin\\tO\\nthe\\tO\\nfamilies\\tO\\nwith\\tO\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nfact\\tO\\n,\\tO\\nthe\\tO\\nlipoprotein\\tO\\nprofile\\tO\\nof\\tO\\npersons\\tO\\nwith\\tO\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\npotentially\\tO\\nantiatherogenic\\tO\\nand\\tO\\nmay\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nincreased\\tO\\nlife\\tO\\nspan\\tO\\n.\\tO\\n\\nFurther\\tO\\nmapping\\tO\\nof\\tO\\nan\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nlocus\\tO\\nto\\tO\\nthe\\tO\\nchromosome\\tO\\n11q23\\tO\\nregion\\tO\\n.\\tO\\n\\nWe\\tO\\nrecently\\tO\\nmapped\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\ngroup\\tO\\nA\\tO\\n(\\tO\\nATA\\tO\\n)\\tO\\nto\\tO\\nchromosome\\tO\\n11q22\\tO\\n-\\tO\\n23\\tO\\nby\\tO\\nlinkage\\tO\\nanalysis\\tO\\n,\\tO\\nusing\\tO\\nthe\\tO\\ngenetic\\tO\\nmarkers\\tO\\nTHY1\\tO\\nand\\tO\\npYNB3\\tO\\n.\\tO\\n\\n12\\tO\\n(\\tO\\nD11S144\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmost\\tO\\nlikely\\tO\\norder\\tO\\nwas\\tO\\ncent\\tO\\n-\\tO\\nAT\\tO\\n-\\tO\\nS144\\tO\\n-\\tO\\nTHY1\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\npaper\\tO\\ndescribes\\tO\\nfurther\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\nAT\\tB-Disease\\nlocus\\tO\\nby\\tO\\nmeans\\tO\\nof\\tO\\na\\tO\\npanel\\tO\\nof\\tO\\n10\\tO\\nmarkers\\tO\\nthat\\tO\\nspan\\tO\\napproximately\\tO\\n60\\tO\\ncM\\tO\\nin\\tO\\nthe\\tO\\n11q22\\tO\\n-\\tO\\n23\\tO\\nregion\\tO\\ncentered\\tO\\naround\\tO\\nS144\\tO\\nand\\tO\\nTHY1\\tO\\n.\\tO\\n\\nLocation\\tO\\nscores\\tO\\nindicate\\tO\\nthat\\tO\\nthree\\tO\\ncontiguous\\tO\\nsubsegments\\tO\\nwithin\\tO\\nthe\\tO\\n[\\tO\\nS144\\tO\\n-\\tO\\nTHY1\\tO\\n]\\tO\\nsegment\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nthree\\tO\\ncontiguous\\tO\\nsegments\\tO\\ntelomeric\\tO\\nto\\tO\\nTHY1\\tO\\n,\\tO\\nare\\tO\\neach\\tO\\nunlikely\\tO\\nto\\tO\\ncontain\\tO\\nthe\\tO\\nAT\\tB-Disease\\nlocus\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\nmore\\tO\\ncentromeric\\tO\\n[\\tO\\nSTMY\\tO\\n-\\tO\\nS144\\tO\\n]\\tO\\nsegment\\tO\\nis\\tO\\nmost\\tO\\nlikely\\tO\\nto\\tO\\ncontain\\tO\\nthe\\tO\\nAT\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\n,\\tO\\ntogether\\tO\\nwith\\tO\\nrecent\\tO\\nrefinements\\tO\\nin\\tO\\nthe\\tO\\nlinkage\\tO\\nand\\tO\\nphysical\\tO\\nmaps\\tO\\nof\\tO\\n11q22\\tO\\n-\\tO\\n23\\tO\\n,\\tO\\nplace\\tO\\nthe\\tO\\nAT\\tB-Disease\\nlocus\\tO\\nat\\tO\\n11q23\\tO\\n.\\tO\\n\\nRecurrent\\tO\\nmeningitis\\tB-Disease\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nC9\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n.\\tO\\n\\nFirst\\tO\\ncase\\tO\\nof\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nEurope\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nthe\\tO\\nfirst\\tO\\ncases\\tO\\n,\\tO\\nto\\tO\\nour\\tO\\nknowledge\\tO\\n,\\tO\\nof\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nEurope\\tO\\nthat\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\na\\tO\\nSwiss\\tO\\nfamily\\tO\\n,\\tO\\nof\\tO\\nwhich\\tO\\ntwo\\tO\\nmembers\\tO\\n-\\tO\\n-\\tO\\none\\tO\\nwith\\tO\\na\\tO\\ncomplete\\tO\\ndeficiency\\tO\\nand\\tO\\nthe\\tO\\nother\\tO\\nwith\\tO\\napproximately\\tO\\nhalf\\tO\\n-\\tO\\nnormal\\tO\\nC9\\tO\\nlevels\\tO\\n-\\tO\\n-\\tO\\nexperienced\\tO\\nbacterial\\tB-Disease\\nmeningitis\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nindex\\tO\\npatient\\tO\\n,\\tO\\na\\tO\\n56\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nwhite\\tO\\nman\\tO\\nwith\\tO\\na\\tO\\nhistory\\tO\\nof\\tO\\npurulent\\tB-Disease\\nmeningitis\\tI-Disease\\nat\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\n23\\tO\\nyears\\tO\\n,\\tO\\npresented\\tO\\nwith\\tO\\nan\\tO\\nacute\\tB-Disease\\nmeningococcal\\tI-Disease\\nmeningitis\\tI-Disease\\n.\\tO\\n\\nNo\\tO\\nimpairment\\tB-Disease\\nof\\tI-Disease\\ncellular\\tI-Disease\\nimmunity\\tI-Disease\\nor\\tO\\nimmunoglobulin\\tB-Disease\\ndeficiency\\tI-Disease\\ncould\\tO\\nbe\\tO\\nfound\\tO\\n.\\tO\\n\\nComplement\\tO\\nassays\\tO\\nshowed\\tO\\na\\tO\\ncomplete\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nC9\\tI-Disease\\ncomponent\\tI-Disease\\n,\\tO\\nwhile\\tO\\nthe\\tO\\nother\\tO\\nindividual\\tO\\ncomponent\\tO\\nlevels\\tO\\nwere\\tO\\nnormal\\tO\\nand\\tO\\nthe\\tO\\nhemolytic\\tO\\nactivity\\tO\\n(\\tO\\nmeasured\\tO\\nusing\\tO\\nthe\\tO\\nCH50\\tO\\nassay\\tO\\n)\\tO\\nwas\\tO\\nonly\\tO\\nslightly\\tO\\nreduced\\tO\\n.\\tO\\n\\nA\\tO\\nfamily\\tO\\nstudy\\tO\\nrevealed\\tO\\ncomplete\\tB-Disease\\nC9\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthe\\tO\\npatients\\tO\\nhealthy\\tO\\nbrother\\tO\\nand\\tO\\nhalf\\tO\\n-\\tO\\nnormal\\tO\\nC9\\tO\\nconcentrations\\tO\\nin\\tO\\nhis\\tO\\nsister\\tO\\n,\\tO\\nhis\\tO\\nson\\tO\\n(\\tO\\nwho\\tO\\nalso\\tO\\nhad\\tO\\nexperienced\\tO\\nan\\tO\\nepisode\\tO\\nof\\tO\\nbacterial\\tB-Disease\\nmeningitis\\tI-Disease\\n)\\tO\\n,\\tO\\nand\\tO\\nhis\\tO\\nniece\\tO\\n,\\tO\\nconsistent\\tO\\nwith\\tO\\nan\\tO\\ninherited\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nfirst\\tO\\ncase\\tO\\nof\\tO\\nrecurrent\\tB-Disease\\nmeningitis\\tI-Disease\\nin\\tO\\na\\tO\\nwhite\\tO\\npatient\\tO\\nwith\\tO\\ncomplete\\tB-Disease\\nC9\\tI-Disease\\ndeficiency\\tI-Disease\\nsuggests\\tO\\nthat\\tO\\nthis\\tO\\ncomplement\\tB-Disease\\ndefect\\tI-Disease\\nmay\\tO\\nalso\\tO\\nbe\\tO\\na\\tO\\nrisk\\tO\\nfactor\\tO\\nfor\\tO\\nbacterial\\tB-Disease\\n,\\tI-Disease\\nespecially\\tI-Disease\\nneisserial\\tI-Disease\\n,\\tI-Disease\\ninfections\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nDetection\\tO\\nof\\tO\\n98\\tO\\n%\\tO\\nof\\tO\\nDMD\\tB-Disease\\n/\\tO\\nBMD\\tB-Disease\\ngene\\tO\\ndeletions\\tO\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\noligonucleotide\\tO\\nprimer\\tO\\nsequences\\tO\\nthat\\tO\\ncan\\tO\\nbe\\tO\\nused\\tO\\nto\\tO\\namplify\\tO\\neight\\tO\\nexons\\tO\\nplus\\tO\\nthe\\tO\\nmuscle\\tO\\npromoter\\tO\\nof\\tO\\nthe\\tO\\ndystrophin\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nsingle\\tO\\nmultiplex\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\n.\\tO\\n\\nWhen\\tO\\nused\\tO\\nin\\tO\\nconjunction\\tO\\nwith\\tO\\nan\\tO\\nexisting\\tO\\nprimer\\tO\\nset\\tO\\n,\\tO\\nthese\\tO\\ntwo\\tO\\nmultiplex\\tO\\nreactions\\tO\\ndetect\\tO\\nabout\\tO\\n98\\tO\\n%\\tO\\nof\\tO\\ndeletions\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nor\\tI-Disease\\nBecker\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n,\\tO\\nBMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nthese\\tO\\nprimers\\tO\\namplify\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\nexons\\tO\\nin\\tO\\nthe\\tO\\ndeletion\\tO\\nprone\\tO\\n\"\\tO\\nhot\\tO\\nspot\\tO\\n\"\\tO\\nregion\\tO\\naround\\tO\\nexons\\tO\\n44\\tO\\nto\\tO\\n53\\tO\\n,\\tO\\nallowing\\tO\\ndetermination\\tO\\nof\\tO\\ndeletion\\tO\\nendpoints\\tO\\nand\\tO\\nprediction\\tO\\nof\\tO\\nmutational\\tO\\neffects\\tO\\non\\tO\\nthe\\tO\\ntranslational\\tO\\nreading\\tO\\nframe\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nuse\\tO\\nof\\tO\\nthese\\tO\\nPCR\\tO\\n-\\tO\\nbased\\tO\\nassays\\tO\\nwill\\tO\\nallow\\tO\\ndeletion\\tO\\ndetection\\tO\\nand\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\nfor\\tO\\nmost\\tO\\nDMD\\tB-Disease\\n/\\tO\\nBMD\\tB-Disease\\npatients\\tO\\nin\\tO\\na\\tO\\nfraction\\tO\\nof\\tO\\nthe\\tO\\ntime\\tO\\nrequired\\tO\\nfor\\tO\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nheterogeneity\\tO\\nat\\tO\\nthe\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nlocus\\tO\\nin\\tO\\nsouthern\\tO\\nItaly\\tO\\n:\\tO\\na\\tO\\nstudy\\tO\\non\\tO\\na\\tO\\npopulation\\tO\\nfrom\\tO\\nthe\\tO\\nMatera\\tO\\ndistrict\\tO\\n.\\tO\\n\\nGlucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nanalyzed\\tO\\nby\\tO\\ngel\\tO\\nelectrophoresis\\tO\\nand\\tO\\nby\\tO\\nquantitative\\tO\\nassay\\tO\\nin\\tO\\nan\\tO\\nunselected\\tO\\nsample\\tO\\nof\\tO\\n1524\\tO\\nschoolboys\\tO\\nfrom\\tO\\nthe\\tO\\nprovince\\tO\\nof\\tO\\nMatera\\tO\\n(\\tO\\nLucania\\tO\\n)\\tO\\nin\\tO\\nsouthern\\tO\\nItaly\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\n43\\tO\\nsubjects\\tO\\nwith\\tO\\na\\tO\\nG6PD\\tO\\nvariant\\tO\\n.\\tO\\n\\nOf\\tO\\nthese\\tO\\n,\\tO\\n31\\tO\\nhad\\tO\\nsevere\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nnine\\tO\\nhad\\tO\\nmild\\tO\\nto\\tO\\nmoderate\\tO\\ndeficiency\\tO\\n,\\tO\\nand\\tO\\nthree\\tO\\nhad\\tO\\na\\tO\\nnon\\tO\\n-\\tO\\ndeficient\\tO\\nelectrophoretic\\tO\\nvariant\\tO\\n.\\tO\\n\\nThe\\tO\\noverall\\tO\\nrate\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\n2\\tO\\n.\\tO\\n\\n6\\tO\\n%\\tO\\n.\\tO\\n\\nThe\\tO\\nfrequency\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nranging\\tO\\nfrom\\tO\\n7\\tO\\n.\\tO\\n\\n2\\tO\\n%\\tO\\non\\tO\\nthe\\tO\\nIonian\\tO\\nCoast\\tO\\nto\\tO\\nzero\\tO\\non\\tO\\nthe\\tO\\neastern\\tO\\nside\\tO\\nof\\tO\\nthe\\tO\\nLucanian\\tO\\nApennines\\tO\\n,\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\ninversely\\tO\\nrelated\\tO\\nto\\tO\\nthe\\tO\\ndistance\\tO\\nof\\tO\\neach\\tO\\ntown\\tO\\nexamined\\tO\\nfrom\\tO\\nthe\\tO\\nIonian\\tO\\nCoast\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthis\\tO\\ngeographic\\tO\\ndistribution\\tO\\nmay\\tO\\nreflect\\tO\\n,\\tO\\nat\\tO\\nleast\\tO\\nin\\tO\\npart\\tO\\n,\\tO\\ngene\\tO\\nflow\\tO\\nfrom\\tO\\nGreek\\tO\\nsettlers\\tO\\n.\\tO\\n\\nBiochemical\\tO\\ncharacterization\\tO\\nhas\\tO\\nshown\\tO\\nthat\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthis\\tO\\npopulation\\tO\\nis\\tO\\naccounted\\tO\\nfor\\tO\\nby\\tO\\nG6PD\\tO\\nMediterranean\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nfound\\tO\\nseveral\\tO\\nexamples\\tO\\nof\\tO\\ntwo\\tO\\nother\\tO\\nknown\\tO\\npolymorphic\\tO\\nvariants\\tO\\n(\\tO\\nG6PD\\tO\\nCagliari\\tO\\nand\\tO\\nG6PD\\tO\\nA\\tO\\n-\\tO\\n)\\tO\\n;\\tO\\nthree\\tO\\nnew\\tO\\npolymorphic\\tO\\nvariants\\tO\\n,\\tO\\nG6PD\\tO\\nMetaponto\\tO\\n(\\tO\\nclass\\tO\\nIII\\tO\\n)\\tO\\n,\\tO\\nG6PD\\tO\\nMontalbano\\tO\\n(\\tO\\nclass\\tO\\nIII\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nG6PD\\tO\\nPisticci\\tO\\n(\\tO\\nclass\\tO\\nIV\\tO\\n)\\tO\\n;\\tO\\nand\\tO\\ntwo\\tO\\nsporadic\\tO\\nvariants\\tO\\n,\\tO\\nG6PD\\tO\\nTursi\\tO\\n(\\tO\\nclass\\tO\\nIII\\tO\\n)\\tO\\nand\\tO\\nG6PD\\tO\\nFerrandina\\tO\\n(\\tO\\nclass\\tO\\nII\\tO\\n)\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nprovide\\tO\\nfurther\\tO\\nevidence\\tO\\nfor\\tO\\nthe\\tO\\nmarked\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nwithin\\tO\\na\\tO\\nrelatively\\tO\\nnarrow\\tO\\ngeographic\\tO\\narea\\tO\\nand\\tO\\nthey\\tO\\nprove\\tO\\nthe\\tO\\npresence\\tO\\nin\\tO\\nthe\\tO\\nItalian\\tO\\npeninsula\\tO\\nof\\tO\\na\\tO\\ngene\\tO\\n(\\tO\\nGdA\\tO\\n-\\tO\\n)\\tO\\nregarded\\tO\\nas\\tO\\ncharacteristically\\tO\\nAfrican\\tO\\n.\\tO\\n\\nDeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nmurine\\tI-Disease\\nfifth\\tI-Disease\\ncomplement\\tI-Disease\\ncomponent\\tI-Disease\\n(\\tI-Disease\\nC5\\tI-Disease\\n)\\tI-Disease\\n.\\tO\\n\\nA\\tO\\n2\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ngene\\tO\\ndeletion\\tO\\nin\\tO\\na\\tO\\n5\\tO\\n\\'\\tO\\n-\\tO\\nexon\\tO\\n.\\tO\\n\\nTo\\tO\\nascertain\\tO\\nthe\\tO\\nmolecular\\tO\\nmechanism\\tO\\nthat\\tO\\ncauses\\tO\\nmurine\\tO\\nC5\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\ngenomic\\tO\\nand\\tO\\ncDNA\\tO\\nlibraries\\tO\\nwere\\tO\\nconstructed\\tO\\nfrom\\tO\\nmouse\\tO\\nliver\\tO\\nDNA\\tO\\nand\\tO\\nmRNA\\tO\\nemploying\\tO\\nthe\\tO\\ncongenic\\tO\\nstrains\\tO\\nB10\\tO\\n.\\tO\\n\\nD2\\tO\\n/\\tO\\nnSnJ\\tO\\nand\\tO\\nB10\\tO\\n.\\tO\\n\\nD2\\tO\\n/\\tO\\noSnJ\\tO\\nthat\\tO\\nare\\tO\\nsufficient\\tO\\nand\\tO\\ndeficient\\tB-Disease\\nfor\\tI-Disease\\nC5\\tI-Disease\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nGenomic\\tO\\nfragments\\tO\\nwere\\tO\\nisolated\\tO\\nwhich\\tO\\ncorrespond\\tO\\nto\\tO\\nPvuII\\tO\\nand\\tO\\nHindIII\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphisms\\tO\\nassociated\\tO\\nwith\\tO\\nC5\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nSequence\\tO\\nanalyses\\tO\\ndemonstrated\\tO\\nthat\\tO\\neach\\tO\\nof\\tO\\nthese\\tO\\npolymorphisms\\tO\\nresulted\\tO\\nfrom\\tO\\nsingle\\tO\\nbase\\tO\\npair\\tO\\nsubstitutions\\tO\\nand\\tO\\nthat\\tO\\nneither\\tO\\nsubstitution\\tO\\nwould\\tO\\nprobably\\tO\\ncause\\tO\\nor\\tO\\ncontribute\\tO\\nto\\tO\\nthe\\tO\\nC5\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nSequence\\tO\\nanalyses\\tO\\nof\\tO\\nC5\\tO\\nsufficient\\tO\\nand\\tO\\ndeficient\\tO\\ncDNAs\\tO\\nrevealed\\tO\\na\\tO\\n2\\tO\\nbase\\tO\\n-\\tO\\npair\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\ndeficient\\tO\\ncDNAs\\tO\\n.\\tO\\n\\nThe\\tO\\n\"\\tO\\nTA\\tO\\n\"\\tO\\ndeletion\\tO\\nwas\\tO\\nlocated\\tO\\nnear\\tO\\nthe\\tO\\n5\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\ncDNA\\tO\\n.\\tO\\n\\nThis\\tO\\ndeletion\\tO\\nshifts\\tO\\nthe\\tO\\nreading\\tO\\nframe\\tO\\nof\\tO\\nthe\\tO\\nC5\\tO\\nmRNA\\tO\\nso\\tO\\nthat\\tO\\nthe\\tO\\ntermination\\tO\\ncodon\\tO\\nUGA\\tO\\nis\\tO\\npresent\\tO\\n4\\tO\\nbase\\tO\\npairs\\tO\\ndownstream\\tO\\nfrom\\tO\\nthe\\tO\\ndeletion\\tO\\n.\\tO\\n\\nGenomic\\tO\\nDNA\\tO\\nwas\\tO\\namplified\\tO\\nand\\tO\\nsequenced\\tO\\ncorresponding\\tO\\nto\\tO\\nthe\\tO\\narea\\tO\\nsurrounding\\tO\\nthe\\tO\\n2\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\n.\\tO\\n\\nSix\\tO\\nC5\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nstrains\\tO\\n,\\tO\\nA\\tO\\n/\\tO\\nHeJ\\tO\\n,\\tO\\nAKR\\tO\\n/\\tO\\nJ\\tO\\n,\\tO\\nDBA\\tO\\n/\\tO\\n2J\\tO\\n,\\tO\\nNZB\\tO\\n/\\tO\\nB1NJ\\tO\\n,\\tO\\nSWR\\tO\\n/\\tO\\nJ\\tO\\n,\\tO\\nand\\tO\\nB10\\tO\\n.\\tO\\n\\nD2\\tO\\n/\\tO\\noSnJ\\tO\\n,\\tO\\nand\\tO\\nfour\\tO\\nC5\\tO\\n-\\tO\\nsufficient\\tO\\nstrains\\tO\\n,\\tO\\nBalb\\tO\\n/\\tO\\nCJ\\tO\\n,\\tO\\nC57Bl\\tO\\n/\\tO\\n6J\\tO\\n,\\tO\\nDBA\\tO\\n/\\tO\\n1J\\tO\\n,\\tO\\nand\\tO\\nB10\\tO\\n.\\tO\\n\\nD2\\tO\\n/\\tO\\nnSnJ\\tO\\n,\\tO\\nwere\\tO\\nanalyzed\\tO\\n.\\tO\\n\\nThe\\tO\\nsequencing\\tO\\ndata\\tO\\nrevealed\\tO\\nthat\\tO\\nthe\\tO\\n2\\tO\\nbase\\tO\\npairs\\tO\\nwere\\tO\\ndeleted\\tO\\nfrom\\tO\\nthe\\tO\\nC5\\tO\\ngene\\tO\\nof\\tO\\neach\\tO\\ndeficient\\tO\\nmouse\\tO\\ntested\\tO\\nbut\\tO\\nnot\\tO\\nfrom\\tO\\nthe\\tO\\nC5\\tO\\ngene\\tO\\nof\\tO\\nany\\tO\\nsufficient\\tO\\nmouse\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\ndemonstrate\\tO\\nthat\\tO\\n1\\tO\\n)\\tO\\nthere\\tO\\nis\\tO\\nan\\tO\\nidentical\\tO\\n2\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\nin\\tO\\nan\\tO\\nexon\\tO\\nof\\tO\\nthe\\tO\\nC5\\tO\\ngene\\tO\\nin\\tO\\nseveral\\tO\\ndifferent\\tO\\nC5\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nmouse\\tO\\nstrains\\tO\\n;\\tO\\n2\\tO\\n)\\tO\\nthe\\tO\\nmRNA\\tO\\ntranscribed\\tO\\nfrom\\tO\\nthe\\tO\\nC5D\\tO\\ngene\\tO\\nretains\\tO\\nthis\\tO\\ndeletion\\tO\\n;\\tO\\nand\\tO\\n3\\tO\\n)\\tO\\nthis\\tO\\nmutation\\tO\\nshould\\tO\\nresult\\tO\\nin\\tO\\nC5\\tB-Disease\\nprotein\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nMolecular\\tO\\ngenetics\\tO\\nof\\tO\\nPKU\\tB-Disease\\nin\\tO\\neastern\\tO\\nEurope\\tO\\n:\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\nassociated\\tO\\nwith\\tO\\nhaplotype\\tO\\n4\\tO\\nof\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\ngene\\tO\\n.\\tO\\n\\nPhenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\ngenetic\\tB-Disease\\ndisorder\\tI-Disease\\nsecondary\\tO\\nto\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nhepatic\\tI-Disease\\nphenylalanine\\tI-Disease\\nhydroxylase\\tI-Disease\\n(\\tO\\nPAH\\tO\\n)\\tO\\n.\\tO\\n\\nSeveral\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\nhave\\tO\\nrecently\\tO\\nbeen\\tO\\nreported\\tO\\n,\\tO\\nand\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nwas\\tO\\nobserved\\tO\\nbetween\\tO\\nRFLP\\tO\\nhaplotypes\\tO\\nand\\tO\\nspecific\\tO\\nmutations\\tO\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nmolecular\\tB-Disease\\nlesion\\tI-Disease\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\nexon\\tO\\n7\\tO\\nof\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nHungarian\\tO\\nPKU\\tB-Disease\\npatient\\tO\\nby\\tO\\ndirect\\tO\\nsequencing\\tO\\nof\\tO\\nPCR\\tO\\n-\\tO\\namplified\\tO\\nDNA\\tO\\n.\\tO\\n\\nThe\\tO\\nC\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nT\\tO\\ntransition\\tO\\ncauses\\tO\\nthe\\tO\\nsubstitution\\tO\\nof\\tO\\nArg243\\tO\\nto\\tO\\na\\tO\\ntermination\\tO\\ncodon\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nmutant\\tO\\nallele\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nhaplotype\\tO\\n4\\tO\\nof\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nis\\tO\\npresent\\tO\\nin\\tO\\ntwo\\tO\\nof\\tO\\nnine\\tO\\nmutant\\tO\\nhaplotype\\tO\\n4\\tO\\nalleles\\tO\\namong\\tO\\nEastern\\tO\\nEuropeans\\tO\\nand\\tO\\nis\\tO\\nnot\\tO\\npresent\\tO\\namong\\tO\\nWestern\\tO\\nEuropeans\\tO\\nand\\tO\\nAsians\\tO\\n.\\tO\\n\\nThe\\tO\\nrarity\\tO\\nof\\tO\\nthis\\tO\\nmutant\\tO\\nallele\\tO\\nand\\tO\\nits\\tO\\nrestricted\\tO\\ngeographic\\tO\\ndistribution\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nmutational\\tO\\nevent\\tO\\noccurred\\tO\\nrecently\\tO\\non\\tO\\na\\tO\\nnormal\\tO\\nhaplotype\\tO\\n4\\tO\\nbackground\\tO\\nin\\tO\\nEastern\\tO\\nEurope\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nred\\tO\\n-\\tO\\ngreen\\tO\\nvisual\\tO\\npigment\\tO\\ngene\\tO\\nregion\\tO\\nin\\tO\\nadrenoleukodystrophy\\tB-Disease\\n.\\tO\\n\\nAlthough\\tO\\nrecent\\tO\\ndata\\tO\\nestablished\\tO\\nthat\\tO\\na\\tO\\nspecific\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nfatty\\tO\\nacyl\\tO\\n-\\tO\\nCoA\\tO\\nsynthetase\\tO\\nis\\tO\\ndefective\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nALD\\tB-Disease\\ngene\\tO\\nis\\tO\\nstill\\tO\\nunidentified\\tO\\n.\\tO\\n\\nThe\\tO\\nALD\\tB-Disease\\nlocus\\tO\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nXq28\\tO\\n,\\tO\\nlike\\tO\\nthe\\tO\\nred\\tO\\nand\\tO\\ngreen\\tO\\ncolor\\tO\\npigment\\tO\\ngenes\\tO\\n.\\tO\\n\\nAbnormal\\tB-Disease\\ncolor\\tI-Disease\\nvision\\tI-Disease\\nhas\\tO\\nbeen\\tO\\nobserved\\tO\\nin\\tO\\n12\\tO\\nof\\tO\\n27\\tO\\npatients\\tO\\nwith\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n(\\tO\\nAMN\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nmilder\\tO\\nform\\tO\\nof\\tO\\nALD\\tB-Disease\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nrearrangements\\tO\\nof\\tO\\nthe\\tO\\ncolor\\tO\\nvision\\tO\\ngene\\tO\\ncluster\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nfour\\tO\\nof\\tO\\neight\\tO\\nALD\\tB-Disease\\nkindreds\\tO\\n.\\tO\\n\\nThis\\tO\\nled\\tO\\nus\\tO\\nto\\tO\\npropose\\tO\\nthat\\tO\\na\\tO\\nsingle\\tO\\nDNA\\tO\\nrearrangement\\tO\\ncould\\tO\\nunderlie\\tO\\nboth\\tO\\nALD\\tB-Disease\\nand\\tO\\nabnormal\\tB-Disease\\ncolor\\tI-Disease\\nvision\\tI-Disease\\nin\\tO\\nthese\\tO\\npatients\\tO\\n.\\tO\\n\\nStudy\\tO\\nof\\tO\\n34\\tO\\nFrench\\tO\\nALD\\tB-Disease\\npatients\\tO\\nfailed\\tO\\nto\\tO\\nreveal\\tO\\na\\tO\\nhigher\\tO\\nthan\\tO\\nexpected\\tO\\nfrequency\\tO\\nof\\tO\\ngreen\\tO\\n/\\tO\\nred\\tO\\nvisual\\tO\\npigment\\tO\\nrearrangements\\tO\\n3\\tO\\nto\\tO\\nthe\\tO\\nred\\tO\\n/\\tO\\ngreen\\tO\\ncolor\\tO\\nvision\\tO\\ngene\\tO\\ncomplex\\tO\\n.\\tO\\n\\nThe\\tO\\nprevious\\tO\\nreport\\tO\\nof\\tO\\nsuch\\tO\\nrearrangements\\tO\\nwas\\tO\\nbased\\tO\\non\\tO\\nsmall\\tO\\nnumbers\\tO\\nand\\tO\\nlack\\tO\\nof\\tO\\nknowledge\\tO\\nthat\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\n\"\\tO\\nabnormal\\tO\\n\"\\tO\\ncolor\\tO\\nvision\\tO\\narrays\\tO\\non\\tO\\nmolecular\\tO\\nanalysis\\tO\\nwas\\tO\\ntwice\\tO\\nas\\tO\\nhigh\\tO\\nas\\tO\\nexpected\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nphenotypic\\tB-Disease\\ncolor\\tI-Disease\\nvision\\tI-Disease\\ndefects\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nred\\tO\\n/\\tO\\ngreen\\tO\\ncolor\\tO\\npigment\\tO\\n(\\tO\\nR\\tO\\n/\\tO\\nGCP\\tO\\n)\\tO\\nregion\\tO\\nwas\\tO\\nstudied\\tO\\nby\\tO\\npulsed\\tO\\n-\\tO\\nfield\\tO\\ngel\\tO\\nelectrophoresis\\tO\\nin\\tO\\n14\\tO\\nof\\tO\\nthese\\tO\\npatients\\tO\\n,\\tO\\nand\\tO\\nwe\\tO\\ndid\\tO\\nnot\\tO\\nfind\\tO\\nany\\tO\\nfragment\\tO\\nsize\\tO\\ndifference\\tO\\nbetween\\tO\\nthe\\tO\\npatients\\tO\\nand\\tO\\nnormal\\tO\\nindividuals\\tO\\nwho\\tO\\nhave\\tO\\nthe\\tO\\nsame\\tO\\nnumber\\tO\\nof\\tO\\npigment\\tO\\ngenes\\tO\\n.\\tO\\n\\nThe\\tO\\nR\\tO\\n/\\tO\\nGCP\\tO\\nregion\\tO\\nwas\\tO\\nalso\\tO\\nanalyzed\\tO\\nin\\tO\\n29\\tO\\nFrench\\tO\\nand\\tO\\nseven\\tO\\nNorth\\tO\\nAmerican\\tO\\nALD\\tB-Disease\\npatients\\tO\\nby\\tO\\nusing\\tO\\nsix\\tO\\ngenomic\\tO\\nDNA\\tO\\nprobes\\tO\\n,\\tO\\nisolated\\tO\\nfrom\\tO\\na\\tO\\ncosmid\\tO\\nwalk\\tO\\n,\\tO\\nthat\\tO\\nflank\\tO\\nthe\\tO\\ncolor\\tO\\nvision\\tO\\ngenes\\tO\\n.\\tO\\n\\nNo\\tO\\ndeletions\\tO\\nwere\\tO\\nfound\\tO\\nwith\\tO\\nprobes\\tO\\nthat\\tO\\nlie\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\ngreen\\tO\\npigment\\tO\\ngenes\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthe\\tO\\neight\\tO\\npreviously\\tO\\nreported\\tO\\nALD\\tB-Disease\\nindividuals\\tO\\nhas\\tO\\na\\tO\\nlong\\tO\\ndeletion\\tO\\n5\\tO\\nof\\tO\\nthe\\tO\\nred\\tO\\npigment\\tO\\ngene\\tO\\n,\\tO\\na\\tO\\ndeletion\\tO\\ncausing\\tO\\nblue\\tO\\ncone\\tO\\nmonochromacy\\tO\\n.\\tO\\n\\nThis\\tO\\nfinding\\tO\\nand\\tO\\nthe\\tO\\nprevious\\tO\\nfindings\\tO\\nof\\tO\\na\\tO\\n45\\tO\\n%\\tO\\nfrequency\\tO\\nof\\tO\\nphenotypic\\tO\\ncolor\\tO\\nvision\\tO\\ndefects\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nAMN\\tB-Disease\\nmay\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nALD\\tB-Disease\\n/\\tO\\nAMN\\tB-Disease\\ngene\\tO\\nlies\\tO\\n5\\tO\\nto\\tO\\nthe\\tO\\nred\\tO\\npigment\\tO\\ngene\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\nfrequent\\tO\\nphenotypic\\tO\\ncolor\\tB-Disease\\nvision\\tI-Disease\\nanomalies\\tI-Disease\\nowe\\tO\\ntheir\\tO\\norigin\\tO\\nto\\tO\\ndeleted\\tO\\nDNA\\tO\\nthat\\tO\\nincludes\\tO\\nregulatory\\tO\\ngenes\\tO\\nfor\\tO\\ncolor\\tO\\nvision\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\npossible\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nthat\\tO\\nphenotypic\\tO\\ncolor\\tB-Disease\\nvision\\tI-Disease\\nanomalies\\tI-Disease\\nin\\tO\\nAMN\\tB-Disease\\nmay\\tO\\nbe\\tO\\nphenocopies\\tO\\nsecondary\\tO\\nto\\tO\\nretinal\\tO\\nor\\tO\\nneural\\tO\\ninvolvement\\tO\\nby\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\nsingle\\tO\\ncase\\tO\\nof\\tO\\nblue\\tO\\ncone\\tO\\nmonochromacy\\tO\\nmay\\tO\\ntherefore\\tO\\nbe\\tO\\na\\tO\\nfortuitous\\tO\\ncoincidence\\tO\\nof\\tO\\ntwo\\tO\\ndiseases\\tO\\n.\\tO\\n.\\tO\\n\\nParoxysmal\\tB-Disease\\nnocturnal\\tI-Disease\\nhaemoglobinuria\\tI-Disease\\nwith\\tO\\ncoexisting\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nninth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n:\\tO\\nlack\\tO\\nof\\tO\\nmassive\\tO\\nhaemolytic\\tB-Disease\\nattack\\tI-Disease\\n.\\tO\\n\\nA\\tO\\n47\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nwoman\\tO\\nwith\\tO\\nparoxysmal\\tB-Disease\\nnocturnal\\tI-Disease\\nhaemoglobinuria\\tI-Disease\\n(\\tO\\nPNH\\tB-Disease\\n)\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nan\\tO\\ninherited\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\nninth\\tI-Disease\\ncomplement\\tI-Disease\\ncomponent\\tI-Disease\\n(\\tO\\nC9\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\ncomplement\\tO\\n-\\tO\\nsensitivity\\tO\\nlysis\\tO\\ntests\\tO\\n,\\tO\\n80\\tO\\n%\\tO\\nof\\tO\\nher\\tO\\nerythrocytes\\tO\\nwere\\tO\\nmarkedly\\tO\\ncomplement\\tO\\n-\\tO\\nsensitive\\tO\\n(\\tO\\nPNH\\tO\\n-\\tO\\nIII\\tO\\n)\\tO\\n.\\tO\\n\\nLaser\\tO\\ncytofluorimetry\\tO\\nwith\\tO\\na\\tO\\nmonoclonal\\tO\\nantibody\\tO\\nagainst\\tO\\ndecay\\tO\\n-\\tO\\naccelerating\\tO\\nfactor\\tO\\n(\\tO\\nDAF\\tO\\n)\\tO\\nrevealed\\tO\\nthat\\tO\\n95\\tO\\n%\\tO\\nof\\tO\\nher\\tO\\nerythrocytes\\tO\\nwere\\tO\\nDAF\\tO\\n-\\tO\\nnegative\\tO\\n.\\tO\\n\\nSurprisingly\\tO\\n,\\tO\\nshe\\tO\\nhas\\tO\\nsuffered\\tO\\nonly\\tO\\nmild\\tO\\nhaemolysis\\tB-Disease\\nand\\tO\\nhas\\tO\\nnever\\tO\\nexperienced\\tO\\nmassive\\tO\\nspontaneous\\tO\\nhaemolysis\\tB-Disease\\n.\\tO\\n\\nGross\\tO\\nhaemoglobinuria\\tB-Disease\\nand\\tO\\njaundice\\tB-Disease\\noccurred\\tO\\nonly\\tO\\nafter\\tO\\nreceiving\\tO\\npostoperative\\tO\\ntransfusion\\tO\\nof\\tO\\nwhole\\tO\\nblood\\tO\\n.\\tO\\n\\nIn\\tO\\nher\\tO\\nserum\\tO\\n,\\tO\\nC9\\tO\\nwas\\tO\\nnot\\tO\\ndetectable\\tO\\neither\\tO\\nby\\tO\\nimmunological\\tO\\nor\\tO\\nby\\tO\\nfunctional\\tO\\nassays\\tO\\n.\\tO\\n\\nBoth\\tO\\nthe\\tO\\nHam\\tO\\ntest\\tO\\nand\\tO\\nthe\\tO\\nsugar\\tO\\nwater\\tO\\ntest\\tO\\nusing\\tO\\nnormal\\tO\\nhuman\\tO\\nserum\\tO\\nor\\tO\\nplasma\\tO\\nyielded\\tO\\nmarked\\tO\\nhaemolysis\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nerythrocytes\\tO\\n.\\tO\\n\\nWhen\\tO\\nthe\\tO\\npatients\\tO\\nserum\\tO\\nor\\tO\\nplasma\\tO\\nwas\\tO\\nused\\tO\\n,\\tO\\nonly\\tO\\na\\tO\\ntrace\\tO\\nof\\tO\\nlysis\\tO\\nwas\\tO\\ndetected\\tO\\n.\\tO\\n\\nAddition\\tO\\nof\\tO\\npurified\\tO\\nhuman\\tO\\nC9\\tO\\nto\\tO\\nher\\tO\\nplasma\\tO\\nfully\\tO\\nrestored\\tO\\nhaemolysis\\tO\\n.\\tO\\n\\nThese\\tO\\nobservations\\tO\\nindicated\\tO\\nthat\\tO\\nC9\\tO\\nmay\\tO\\nplay\\tO\\na\\tO\\ncritical\\tO\\nrole\\tO\\nin\\tO\\nhaemolytic\\tB-Disease\\nattacks\\tI-Disease\\nin\\tO\\npatients\\tO\\nwith\\tO\\nPNH\\tB-Disease\\nand\\tO\\nthat\\tO\\ncharacteristic\\tO\\nhaemolysis\\tB-Disease\\nin\\tO\\nPNH\\tB-Disease\\nmay\\tO\\nbe\\tO\\ntempered\\tO\\nby\\tO\\ncoexisting\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nDuplicational\\tO\\nmutation\\tO\\nat\\tO\\nthe\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nlocus\\tO\\n:\\tO\\nits\\tO\\nfrequency\\tO\\n,\\tO\\ndistribution\\tO\\n,\\tO\\norigin\\tO\\n,\\tO\\nand\\tO\\nphenotypegenotype\\tO\\ncorrelation\\tO\\n.\\tO\\n\\nPartial\\tO\\ngene\\tO\\ndeletion\\tO\\nis\\tO\\nthe\\tO\\nmajor\\tO\\ncause\\tO\\nof\\tO\\nmutation\\tO\\nleading\\tO\\nto\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\nand\\tO\\nBecker\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nBMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nPartial\\tO\\ngene\\tO\\nduplication\\tO\\nhas\\tO\\nalso\\tO\\nbeen\\tO\\nrecognized\\tO\\nin\\tO\\na\\tO\\nfew\\tO\\ncases\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nconducted\\tO\\na\\tO\\nsurvey\\tO\\nfor\\tO\\nduplication\\tO\\nin\\tO\\n72\\tO\\nunrelated\\tO\\nnondeletion\\tO\\npatients\\tO\\n,\\tO\\nanalyzed\\tO\\nby\\tO\\nSouthern\\tO\\nblot\\tO\\nhybridization\\tO\\nwith\\tO\\nclones\\tO\\nrepresenting\\tO\\nthe\\tO\\nentire\\tO\\nDMD\\tB-Disease\\ncDNA\\tO\\n.\\tO\\n\\nWith\\tO\\ncareful\\tO\\nquantitative\\tO\\nanalysis\\tO\\nof\\tO\\nhybridization\\tO\\nband\\tO\\nintensity\\tO\\n,\\tO\\n10\\tO\\ncases\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\ncarry\\tO\\na\\tO\\nduplication\\tO\\nof\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\na\\tO\\nfrequency\\tO\\nof\\tO\\n14\\tO\\n%\\tO\\nfor\\tO\\nnondeletion\\tO\\ncases\\tO\\n(\\tO\\n10\\tO\\n/\\tO\\n72\\tO\\n)\\tO\\n,\\tO\\nor\\tO\\n6\\tO\\n%\\tO\\nfor\\tO\\nall\\tO\\ncases\\tO\\n(\\tO\\n10\\tO\\n/\\tO\\n181\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nextent\\tO\\nof\\tO\\nthese\\tO\\nduplications\\tO\\nhas\\tO\\nbeen\\tO\\ncharacterized\\tO\\naccording\\tO\\nto\\tO\\nthe\\tO\\npublished\\tO\\nexon\\tO\\n-\\tO\\ncontaining\\tO\\nHindIII\\tO\\nfragment\\tO\\nmap\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\nsix\\tO\\nof\\tO\\nthe\\tO\\n10\\tO\\nduplications\\tO\\na\\tO\\nnovel\\tO\\nrestriction\\tO\\nfragment\\tO\\nthat\\tO\\nspanned\\tO\\nthe\\tO\\nduplication\\tO\\njunction\\tO\\nwas\\tO\\ndetected\\tO\\n.\\tO\\n\\nThe\\tO\\nresulting\\tO\\ntranslational\\tO\\nreading\\tO\\nframe\\tO\\nof\\tO\\nmRNA\\tO\\nhas\\tO\\nbeen\\tO\\npredicted\\tO\\nfor\\tO\\nnine\\tO\\nduplications\\tO\\n.\\tO\\n\\nA\\tO\\nshift\\tO\\nof\\tO\\nthe\\tO\\nreading\\tO\\nframe\\tO\\nwas\\tO\\npredicted\\tO\\nin\\tO\\nfour\\tO\\nof\\tO\\nthe\\tO\\nsix\\tO\\nDMD\\tB-Disease\\ncases\\tO\\nand\\tO\\nin\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nintermediate\\tO\\ncases\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\nreading\\tO\\nframe\\tO\\nremained\\tO\\nuninterrupted\\tO\\nin\\tO\\nboth\\tO\\nBMD\\tB-Disease\\ncases\\tO\\n.\\tO\\n\\nRFLP\\tO\\nand\\tO\\nquantitative\\tO\\nSouthern\\tO\\nblot\\tO\\nanalyses\\tO\\nrevealed\\tO\\na\\tO\\ngrandpaternal\\tO\\norigin\\tO\\nof\\tO\\nduplication\\tO\\nin\\tO\\nfour\\tO\\nfamilies\\tO\\nand\\tO\\ngrandmaternal\\tO\\norigin\\tO\\nin\\tO\\none\\tO\\nfamily\\tO\\n.\\tO\\n\\nIn\\tO\\nall\\tO\\nfive\\tO\\nfamilies\\tO\\n,\\tO\\nthe\\tO\\nduplication\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\noriginate\\tO\\nfrom\\tO\\na\\tO\\nsingle\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nUnequal\\tO\\nsister\\tO\\n-\\tO\\nchromatid\\tO\\nexchange\\tO\\nis\\tO\\nproposed\\tO\\nto\\tO\\nbe\\tO\\nthe\\tO\\nmechanism\\tO\\nfor\\tO\\nthe\\tO\\nformation\\tO\\nof\\tO\\nthese\\tO\\nduplications\\tO\\n.\\tO\\n.\\tO\\n\\nGlucose\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nvariants\\tO\\n:\\tO\\nGd\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\nAlexandra\\tO\\nassociated\\tO\\nwith\\tO\\nneonatal\\tB-Disease\\njaundice\\tI-Disease\\nand\\tO\\nGd\\tO\\n(\\tO\\n-\\tO\\n)\\tO\\nCamperdown\\tO\\nin\\tO\\na\\tO\\nyoung\\tO\\nman\\tO\\nwith\\tO\\nlamellar\\tB-Disease\\ncataracts\\tI-Disease\\n.\\tO\\n\\nTwo\\tO\\nmale\\tO\\nsubjects\\tO\\nare\\tO\\ndescribed\\tO\\n,\\tO\\nwith\\tO\\nunusual\\tO\\nclinical\\tO\\npresentations\\tO\\nand\\tO\\nwith\\tO\\nhitherto\\tO\\nundescribed\\tO\\nG6PD\\tO\\nvariants\\tO\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\n,\\tO\\nof\\tO\\nItalian\\tO\\nextraction\\tO\\n,\\tO\\nsuffered\\tO\\nfrom\\tO\\nsevere\\tO\\nneonatal\\tB-Disease\\njaundice\\tI-Disease\\nfollowing\\tO\\nmaternal\\tO\\ningestion\\tO\\nof\\tO\\nfresh\\tO\\nbroad\\tO\\nbeans\\tO\\n(\\tO\\nVicia\\tO\\nfava\\tO\\n)\\tO\\nboth\\tO\\nprenatally\\tO\\nand\\tO\\npostnatally\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nenzymatic\\tO\\ndefect\\tO\\nwas\\tO\\nmuch\\tO\\nmore\\tO\\nsevere\\tO\\nin\\tO\\nthe\\tO\\nneonatal\\tO\\nperiod\\tO\\nthan\\tO\\non\\tO\\nretesting\\tO\\nin\\tO\\nadolescence\\tO\\n,\\tO\\nwhen\\tO\\nbiochemical\\tO\\ncharacterization\\tO\\nshowed\\tO\\nunique\\tO\\nfeatures\\tO\\nwhich\\tO\\njustify\\tO\\ndesignation\\tO\\nas\\tO\\na\\tO\\nnew\\tO\\nvariant\\tO\\nGd\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\nAlexandra\\tO\\n.\\tO\\n\\nThe\\tO\\nsecond\\tO\\npatient\\tO\\n,\\tO\\na\\tO\\nboy\\tO\\nof\\tO\\nMaltese\\tO\\nextraction\\tO\\nwho\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nbilateral\\tB-Disease\\nlamellar\\tI-Disease\\ncataracts\\tI-Disease\\nat\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\n4\\tO\\nyears\\tO\\n,\\tO\\nwas\\tO\\nidentified\\tO\\nas\\tO\\nG6PD\\tB-Disease\\ndeficient\\tI-Disease\\nonly\\tO\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\na\\tO\\nsurvey\\tO\\nof\\tO\\nchildren\\tO\\nof\\tO\\nMediterranean\\tO\\norigin\\tO\\nwith\\tO\\nunexplained\\tO\\ncataract\\tB-Disease\\nformation\\tO\\n;\\tO\\nhe\\tO\\nhas\\tO\\napproximately\\tO\\n15\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\nenzyme\\tO\\nactivity\\tO\\n,\\tO\\nwith\\tO\\nanother\\tO\\nunique\\tO\\ncombination\\tO\\nof\\tO\\nbiochemical\\tO\\ncharacteristics\\tO\\nwhich\\tO\\nhas\\tO\\nled\\tO\\nto\\tO\\nits\\tO\\ndesignation\\tO\\nas\\tO\\nGd\\tO\\n(\\tO\\n-\\tO\\n)\\tO\\nCamperdown\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthis\\tO\\nassociation\\tO\\nmay\\tO\\nbe\\tO\\ncoincidental\\tO\\n,\\tO\\nit\\tO\\nprompts\\tO\\nfurther\\tO\\nattention\\tO\\nto\\tO\\nthe\\tO\\npossibility\\tO\\nthat\\tO\\nunder\\tO\\ncertain\\tO\\ncircumstances\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nmay\\tO\\nfavor\\tO\\ncataract\\tB-Disease\\nformation\\tO\\n.\\tO\\n\\nThe\\tO\\ntwo\\tO\\ncases\\tO\\nillustrate\\tO\\nthe\\tO\\nvalue\\tO\\nof\\tO\\ncharacterization\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nenzyme\\tO\\nwhenever\\tO\\nunexpected\\tO\\nclinical\\tO\\nor\\tO\\nlaboratory\\tO\\nresults\\tO\\nare\\tO\\nobtained\\tO\\n.\\tO\\n.\\tO\\n\\nStatistical\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nstage\\tO\\nmutation\\tO\\nmodel\\tO\\nin\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nand\\tO\\nin\\tO\\nsporadic\\tB-Disease\\ncerebellar\\tI-Disease\\nhaemangioblastoma\\tI-Disease\\nand\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nthe\\tO\\nage\\tO\\nincidence\\tO\\ncurves\\tO\\nfor\\tO\\nunilateral\\tB-Disease\\nand\\tI-Disease\\nbilateral\\tI-Disease\\nretinoblastoma\\tI-Disease\\nled\\tO\\nKnudson\\tO\\nto\\tO\\npropose\\tO\\nthat\\tO\\nhereditary\\tB-Disease\\ntumours\\tI-Disease\\nmay\\tO\\narise\\tO\\nby\\tO\\na\\tO\\nsingle\\tO\\nevent\\tO\\nand\\tO\\nsporadic\\tB-Disease\\ntumours\\tI-Disease\\nby\\tO\\na\\tO\\ntwo\\tO\\nstage\\tO\\nmutation\\tO\\nprocess\\tO\\n.\\tO\\n\\nIt\\tO\\nhas\\tO\\nbeen\\tO\\nsuggested\\tO\\nrecently\\tO\\nthat\\tO\\nsporadic\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\nmay\\tO\\narise\\tO\\nfrom\\tO\\na\\tO\\ntwo\\tO\\nstage\\tO\\nmutation\\tO\\nprocess\\tO\\n.\\tO\\n\\nWe\\tO\\nanalysed\\tO\\nthe\\tO\\nage\\tO\\nincidence\\tO\\ncurves\\tO\\nfor\\tO\\nsymptomatic\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\n(\\tO\\nn\\tO\\n=\\tO\\n26\\tO\\n)\\tO\\nand\\tO\\ncerebellar\\tB-Disease\\nhaemangioblastoma\\tI-Disease\\n(\\tO\\nn\\tO\\n=\\tO\\n68\\tO\\n)\\tO\\nin\\tO\\n109\\tO\\npatients\\tO\\nwith\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\n(\\tI-Disease\\nVHL\\tI-Disease\\n)\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nand\\tO\\ncompared\\tO\\nthem\\tO\\nto\\tO\\n104\\tO\\npatients\\tO\\nwith\\tO\\nsporadic\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\nand\\tO\\n43\\tO\\npatients\\tO\\nwith\\tO\\nsporadic\\tB-Disease\\ncerebellar\\tI-Disease\\nhaemangioblastoma\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nage\\tO\\nincidence\\tO\\ncurves\\tO\\nfor\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\nand\\tO\\ncerebellar\\tB-Disease\\nhaemangioblastoma\\tI-Disease\\nin\\tO\\nVHL\\tB-Disease\\ndisease\\tI-Disease\\nwere\\tO\\ncompatible\\tO\\nwith\\tO\\na\\tO\\nsingle\\tO\\nmutation\\tO\\nmodel\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nage\\tO\\nincidence\\tO\\ncurves\\tO\\nfor\\tO\\nsporadic\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\nand\\tO\\ncerebellar\\tB-Disease\\nhaemangioblastoma\\tI-Disease\\nsuggested\\tO\\na\\tO\\ntwo\\tO\\nstage\\tO\\nmutation\\tO\\nprocess\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nare\\tO\\ncompatible\\tO\\nwith\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nfunctioning\\tO\\nas\\tO\\na\\tO\\nrecessive\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n.\\tO\\n\\nSporadic\\tB-Disease\\ncerebellar\\tI-Disease\\nhaemangioblastoma\\tI-Disease\\nand\\tO\\nsome\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\nmay\\tO\\narise\\tO\\nfrom\\tO\\nsomatic\\tO\\nmutations\\tO\\ninactivating\\tO\\nboth\\tO\\nalleles\\tO\\nat\\tO\\nthe\\tO\\nVHL\\tB-Disease\\nlocus\\tO\\n.\\tO\\n.\\tO\\n\\nScreening\\tO\\nfor\\tO\\ncarriers\\tO\\nof\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\namong\\tO\\nAshkenazi\\tO\\nJews\\tO\\n.\\tO\\n\\nA\\tO\\ncomparison\\tO\\nof\\tO\\nDNA\\tO\\n-\\tO\\nbased\\tO\\nand\\tO\\nenzyme\\tO\\n-\\tO\\nbased\\tO\\ntests\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\nAND\\tO\\nMETHODS\\tO\\n.\\tO\\n\\nThe\\tO\\nprevention\\tO\\nof\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nGM2\\tB-Disease\\ngangliosidosis\\tI-Disease\\n,\\tI-Disease\\ntype\\tI-Disease\\n1\\tI-Disease\\n)\\tO\\ndepends\\tO\\non\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\ncarriers\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nthis\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\ncompared\\tO\\nthe\\tO\\nenzyme\\tO\\n-\\tO\\nbased\\tO\\ntest\\tO\\nwidely\\tO\\nused\\tO\\nin\\tO\\nscreening\\tO\\nfor\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nwith\\tO\\na\\tO\\ntest\\tO\\nbased\\tO\\non\\tO\\nanalysis\\tO\\nof\\tO\\nDNA\\tO\\n.\\tO\\n\\nWe\\tO\\ndeveloped\\tO\\nmethods\\tO\\nto\\tO\\ndetect\\tO\\nthe\\tO\\nthree\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\nthat\\tO\\noccur\\tO\\nwith\\tO\\nhigh\\tO\\nfrequency\\tO\\namong\\tO\\nAshkenazi\\tO\\nJews\\tO\\ntwo\\tO\\nmutations\\tO\\ncause\\tO\\ninfantile\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nand\\tO\\nthe\\tO\\nthird\\tO\\ncauses\\tO\\nthe\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\nform\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nDNA\\tO\\nsegments\\tO\\ncontaining\\tO\\nthese\\tO\\nmutation\\tO\\nsites\\tO\\nwere\\tO\\namplified\\tO\\nwith\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nand\\tO\\nanalyzed\\tO\\nfor\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\n.\\tO\\n\\nRESULTS\\tO\\n.\\tO\\n\\nAmong\\tO\\n62\\tO\\nAshkenazi\\tO\\nobligate\\tO\\ncarriers\\tO\\nof\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nthe\\tO\\nthree\\tO\\nspecific\\tO\\nmutations\\tO\\naccounted\\tO\\nfor\\tO\\nall\\tO\\nbut\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nalleles\\tO\\n(\\tO\\n98\\tO\\npercent\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\n216\\tO\\nAshkenazi\\tO\\ncarriers\\tO\\nidentified\\tO\\nby\\tO\\nthe\\tO\\nenzyme\\tO\\ntest\\tO\\n,\\tO\\nDNA\\tO\\nanalysis\\tO\\nshowed\\tO\\nthat\\tO\\n177\\tO\\n(\\tO\\n82\\tO\\npercent\\tO\\n)\\tO\\nhad\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nidentified\\tO\\nmutations\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\n177\\tO\\n,\\tO\\n79\\tO\\npercent\\tO\\nhad\\tO\\nthe\\tO\\nexon\\tO\\n11\\tO\\ninsertion\\tO\\nmutation\\tO\\n,\\tO\\n18\\tO\\npercent\\tO\\nhad\\tO\\nthe\\tO\\nintron\\tO\\n12\\tO\\nsplice\\tO\\n-\\tO\\njunction\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\n3\\tO\\npercent\\tO\\nhad\\tO\\nthe\\tO\\nless\\tO\\nsevere\\tO\\nexon\\tO\\n7\\tO\\nmutation\\tO\\nassociated\\tO\\nwith\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nof\\tO\\nthe\\tO\\nenzyme\\tO\\ntests\\tO\\nin\\tO\\nthe\\tO\\n39\\tO\\nsubjects\\tO\\n(\\tO\\n18\\tO\\npercent\\tO\\n)\\tO\\nwho\\tO\\nwere\\tO\\ndefined\\tO\\nas\\tO\\ncarriers\\tO\\nbut\\tO\\nin\\tO\\nwhom\\tO\\nDNA\\tO\\nanalysis\\tO\\ndid\\tO\\nnot\\tO\\nidentify\\tO\\na\\tO\\nmutant\\tO\\nallele\\tO\\nwere\\tO\\nprobably\\tO\\nfalse\\tO\\npositive\\tO\\n(\\tO\\nalthough\\tO\\nthere\\tO\\nremains\\tO\\nsome\\tO\\npossibility\\tO\\nof\\tO\\nunidentified\\tO\\nmutations\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nof\\tO\\n152\\tO\\npersons\\tO\\ndefined\\tO\\nas\\tO\\nnoncarriers\\tO\\nby\\tO\\nthe\\tO\\nenzyme\\tO\\n-\\tO\\nbased\\tO\\ntest\\tO\\n,\\tO\\n1\\tO\\nwas\\tO\\nidentified\\tO\\nas\\tO\\na\\tO\\ncarrier\\tO\\nby\\tO\\nDNA\\tO\\nanalysis\\tO\\n(\\tO\\ni\\tO\\n.\\tO\\ne\\tO\\ne\\tO\\n.\\tO\\n,\\tO\\na\\tO\\nfalse\\tO\\nnegative\\tO\\nenzyme\\tO\\n-\\tO\\ntest\\tO\\nresult\\tO\\n)\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\n.\\tO\\n\\nThe\\tO\\nincreased\\tO\\nspecificity\\tO\\nand\\tO\\npredictive\\tO\\nvalue\\tO\\nof\\tO\\nthe\\tO\\nDNA\\tO\\n-\\tO\\nbased\\tO\\ntest\\tO\\nmake\\tO\\nit\\tO\\na\\tO\\nuseful\\tO\\nadjunct\\tO\\nto\\tO\\nthe\\tO\\ndiagnostic\\tO\\ntests\\tO\\ncurrently\\tO\\nused\\tO\\nto\\tO\\nscreen\\tO\\nfor\\tO\\ncarriers\\tO\\nof\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nTotal\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nplasma\\tI-Disease\\ncholesteryl\\tI-Disease\\nester\\tI-Disease\\ntransfer\\tI-Disease\\nprotein\\tI-Disease\\nin\\tO\\nsubjects\\tO\\nhomozygous\\tO\\nand\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nintron\\tO\\n14\\tO\\nsplicing\\tO\\ndefect\\tO\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\ncholesteryl\\tB-Disease\\nester\\tI-Disease\\ntransfer\\tI-Disease\\nprotein\\tI-Disease\\n(\\tI-Disease\\nCETP\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\ninvestigated\\tO\\nin\\tO\\n4\\tO\\nunrelated\\tO\\nCETP\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nThe\\tO\\nhigh\\tO\\ndensity\\tO\\nlipoprotein\\tO\\n-\\tO\\ncholesterol\\tO\\nlevels\\tO\\nof\\tO\\nthe\\tO\\nprobands\\tO\\nexceeded\\tO\\n150\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n.\\tO\\n\\nThe\\tO\\nplasma\\tO\\nof\\tO\\nthe\\tO\\nprobands\\tO\\nwas\\tO\\ntotally\\tO\\ndeficient\\tO\\nin\\tO\\nCETP\\tO\\nactivity\\tO\\nand\\tO\\nmass\\tO\\n.\\tO\\n\\nThe\\tO\\ngenomic\\tO\\nDNA\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nwas\\tO\\namplified\\tO\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n,\\tO\\nusing\\tO\\ntwo\\tO\\noligonucleotide\\tO\\nprimers\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\nintron\\tO\\n12\\tO\\nand\\tO\\n14\\tO\\nof\\tO\\nthe\\tO\\nCETP\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\namplified\\tO\\nproducts\\tO\\nwere\\tO\\ndirectly\\tO\\nsequenced\\tO\\n.\\tO\\n\\nTwo\\tO\\npatients\\tO\\nwere\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nG\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nA\\tO\\nchange\\tO\\nat\\tO\\nthe\\tO\\n5\\tO\\n-\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nof\\tO\\nthe\\tO\\nintron\\tO\\n14\\tO\\n.\\tO\\n\\nThe\\tO\\nG\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nA\\tO\\nchange\\tO\\nwould\\tO\\ncause\\tO\\nimpaired\\tO\\nsplicing\\tO\\nof\\tO\\npre\\tO\\n-\\tO\\nmessenger\\tO\\nRNA\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\ntwo\\tO\\nprobands\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nmutation\\tO\\n,\\tO\\nbut\\tO\\ntotally\\tO\\nlacked\\tO\\nCETP\\tO\\n.\\tO\\n\\nTheir\\tO\\nlipoprotein\\tO\\npatterns\\tO\\nwere\\tO\\nalso\\tO\\nsimilar\\tO\\nto\\tO\\nthose\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nhomozygotes\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nother\\tO\\ngenetic\\tB-Disease\\ndefects\\tI-Disease\\nor\\tO\\nmetabolic\\tO\\nfactors\\tO\\ninfluencing\\tO\\nCETP\\tO\\nexpression\\tO\\nare\\tO\\nimplicated\\tO\\n.\\tO\\n\\nThe\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nG\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nA\\tO\\nmutation\\tO\\nmay\\tO\\nbe\\tO\\ncommon\\tO\\nin\\tO\\nhuman\\tO\\nplasma\\tO\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nthere\\tO\\ncould\\tO\\nbe\\tO\\ncompound\\tO\\nheterozygotes\\tO\\nwho\\tO\\ntotally\\tO\\nlack\\tO\\nplasma\\tO\\nCETP\\tO\\nand\\tO\\nhave\\tO\\nlipoprotein\\tO\\nprofiles\\tO\\nsimilar\\tO\\nto\\tO\\nthose\\tO\\nof\\tO\\nhomozygotes\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\ngenetics\\tO\\nof\\tO\\nthe\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nMediterranean\\tO\\nvariant\\tO\\nand\\tO\\ndescription\\tO\\nof\\tO\\na\\tO\\nnew\\tO\\nG6PD\\tO\\nmutant\\tO\\n,\\tO\\nG6PD\\tO\\nAndalus1361A\\tO\\n.\\tO\\n\\nGlucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n;\\tI-Disease\\nE\\tI-Disease\\n.\\tI-Disease\\nC\\tI-Disease\\n.\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n49\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nhuman\\tO\\nenzymopathy\\tB-Disease\\n;\\tO\\nmore\\tO\\nthan\\tO\\n300\\tO\\ndifferent\\tO\\nbiochemical\\tO\\nvariants\\tO\\nof\\tO\\nthe\\tO\\nenzyme\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\n.\\tO\\n\\nIn\\tO\\nmany\\tO\\nparts\\tO\\nof\\tO\\nthe\\tO\\nworld\\tO\\nthe\\tO\\nMediterranean\\tO\\ntype\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nprevalent\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nG6PD\\tO\\nMediterranean\\tO\\nhas\\tO\\ncome\\tO\\nto\\tO\\nbe\\tO\\nregarded\\tO\\nas\\tO\\na\\tO\\ngeneric\\tO\\nterm\\tO\\napplied\\tO\\nto\\tO\\nsimilar\\tO\\nG6PD\\tO\\nmutations\\tO\\nthought\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nto\\tO\\nrepresent\\tO\\na\\tO\\nsomewhat\\tO\\nheterogeneous\\tO\\ngroup\\tO\\n.\\tO\\n\\nA\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nT\\tO\\nmutation\\tO\\nat\\tO\\nnucleotide\\tO\\n563\\tO\\nof\\tO\\nG6PD\\tO\\nMediterranean\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nby\\tO\\nVulliamy\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nsame\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\nfound\\tO\\nby\\tO\\nDe\\tO\\nVita\\tO\\net\\tO\\nal\\tO\\n.\\tO\\nin\\tO\\nG6PD\\tO\\nMediterranean\\tO\\n,\\tO\\nG6PD\\tO\\nSassari\\tO\\n,\\tO\\nand\\tO\\nG6PD\\tO\\nCagliari\\tO\\n.\\tO\\n\\nThe\\tO\\nlatter\\tO\\nsubjects\\tO\\nhad\\tO\\nan\\tO\\nadditional\\tO\\nmutation\\tO\\n,\\tO\\nat\\tO\\nnucleotide\\tO\\n1311\\tO\\n,\\tO\\nthat\\tO\\ndid\\tO\\nnot\\tO\\nproduce\\tO\\na\\tO\\ncoding\\tO\\nchange\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexamined\\tO\\ngenomic\\tO\\nDNA\\tO\\nof\\tO\\nfive\\tO\\npatients\\tO\\n-\\tO\\n-\\tO\\nfour\\tO\\nof\\tO\\nSpanish\\tO\\norigin\\tO\\nand\\tO\\none\\tO\\nof\\tO\\nJewish\\tO\\norigin\\tO\\n-\\tO\\n-\\tO\\nhaving\\tO\\nenzymatically\\tO\\ndocumented\\tO\\nG6PD\\tO\\nMediterranean\\tO\\n.\\tO\\n\\nAll\\tO\\nhad\\tO\\nboth\\tO\\nthe\\tO\\nmutation\\tO\\nat\\tO\\nnucleotide\\tO\\n563\\tO\\nand\\tO\\nthat\\tO\\nat\\tO\\nnucleotide\\tO\\n1311\\tO\\n.\\tO\\n\\nA\\tO\\nsixth\\tO\\nsample\\tO\\n,\\tO\\nresembling\\tO\\nG6PD\\tO\\nMediterranean\\tO\\nkinetically\\tO\\nbut\\tO\\nwith\\tO\\na\\tO\\nslightly\\tO\\nrapid\\tO\\nelectrophoretic\\tO\\nmobility\\tO\\n,\\tO\\nwas\\tO\\ndesignated\\tO\\nG6PD\\tO\\nAndalus\\tO\\nand\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\ndifferent\\tO\\nmutation\\tO\\n,\\tO\\na\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nnucleotide\\tO\\n1361\\tO\\n,\\tO\\nproducing\\tO\\nan\\tO\\narginine\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nhistidine\\tO\\nsubstitution\\tO\\n.\\tO\\n\\nThese\\tO\\nstudies\\tO\\nsuggest\\tO\\nthat\\tO\\nG6PD\\tO\\nMediterranean\\tO\\nis\\tO\\n,\\tO\\nafter\\tO\\nall\\tO\\n,\\tO\\nrelatively\\tO\\nhomogeneous\\tO\\n.\\tO\\n\\nA\\tO\\nnormal\\tO\\nmale\\tO\\nwith\\tO\\nan\\tO\\ninherited\\tO\\ndeletion\\tO\\nof\\tO\\none\\tO\\nexon\\tO\\nwithin\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\ntwo\\tO\\nbrothers\\tO\\nwith\\tO\\nidentical\\tO\\ninherited\\tO\\ndeletions\\tO\\nof\\tO\\none\\tO\\nsingle\\tO\\nexon\\tO\\nwithin\\tO\\nthe\\tO\\nmiddle\\tO\\nof\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n;\\tO\\none\\tO\\nbrother\\tO\\nhas\\tO\\nBecker\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ndiagnosed\\tO\\nat\\tO\\n11\\tO\\nyears\\tO\\nof\\tO\\nage\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nolder\\tO\\nbrother\\tO\\nis\\tO\\nnormal\\tO\\nat\\tO\\n18\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nhave\\tO\\nimplications\\tO\\nfor\\tO\\ngenetic\\tO\\ncounselling\\tO\\nand\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\nBecker\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ngene\\tO\\nexpression\\tO\\nin\\tO\\nnormal\\tO\\nand\\tO\\ndiseased\\tO\\nhuman\\tO\\nmuscle\\tO\\n.\\tO\\n\\nA\\tO\\nprobe\\tO\\nfor\\tO\\nthe\\tO\\n5\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\ngene\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nstudy\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nin\\tO\\nnormal\\tO\\nhuman\\tO\\nmuscle\\tO\\n,\\tO\\nmyogenic\\tO\\ncell\\tO\\ncultures\\tO\\n,\\tO\\nand\\tO\\nmuscle\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nDMD\\tB-Disease\\n.\\tO\\n\\nExpression\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nRNA\\tO\\nfrom\\tO\\nnormal\\tO\\nfetal\\tO\\nmuscle\\tO\\n,\\tO\\nadult\\tO\\ncardiac\\tO\\nand\\tO\\nskeletal\\tO\\nmuscle\\tO\\n,\\tO\\nand\\tO\\ncultured\\tO\\nmuscle\\tO\\nafter\\tO\\nmyoblast\\tO\\nfusion\\tO\\n.\\tO\\n\\nIn\\tO\\nDMD\\tB-Disease\\nmuscle\\tO\\n,\\tO\\nexpression\\tO\\nof\\tO\\nthis\\tO\\nportion\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nwas\\tO\\nalso\\tO\\nrevealed\\tO\\nby\\tO\\nin\\tO\\nsitu\\tO\\nRNA\\tO\\nhybridization\\tO\\n,\\tO\\nparticularly\\tO\\nin\\tO\\nregenerating\\tO\\nmuscle\\tO\\nfibers\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nand\\tO\\nphenotypic\\tO\\nanalysis\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\ndeletions\\tO\\nwithin\\tO\\nthe\\tO\\ndeletion\\tO\\n-\\tO\\nrich\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nEighty\\tO\\nunrelated\\tO\\nindividuals\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\nor\\tO\\nBecker\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nBMD\\tB-Disease\\n)\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\ndeletions\\tO\\nin\\tO\\nthe\\tO\\nmajor\\tO\\ndeletion\\tO\\n-\\tO\\nrich\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nDMD\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nThis\\tO\\nregion\\tO\\nincludes\\tO\\nthe\\tO\\nlast\\tO\\nfive\\tO\\nexons\\tO\\ndetected\\tO\\nby\\tO\\ncDNA5b\\tO\\n-\\tO\\n7\\tO\\n,\\tO\\nall\\tO\\nexons\\tO\\ndetected\\tO\\nby\\tO\\ncDNA8\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nfirst\\tO\\ntwo\\tO\\nexons\\tO\\ndetected\\tO\\nby\\tO\\ncDNA9\\tO\\n.\\tO\\n\\nThese\\tO\\n80\\tO\\nindividuals\\tO\\naccount\\tO\\nfor\\tO\\napproximately\\tO\\n75\\tO\\n%\\tO\\nof\\tO\\n109\\tO\\ndeletions\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\ndetected\\tO\\namong\\tO\\n181\\tO\\npatients\\tO\\nanalyzed\\tO\\nwith\\tO\\nthe\\tO\\nentire\\tO\\ndystrophin\\tO\\ncDNA\\tO\\n.\\tO\\n\\nEndpoints\\tO\\nfor\\tO\\nmany\\tO\\nof\\tO\\nthese\\tO\\ndeletions\\tO\\nwere\\tO\\nfurther\\tO\\ncharacterized\\tO\\nusing\\tO\\ntwo\\tO\\ngenomic\\tO\\nprobes\\tO\\n,\\tO\\np20\\tO\\n(\\tO\\nDXS269\\tO\\n;\\tO\\nWapenaar\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n)\\tO\\nand\\tO\\nGMGX11\\tO\\n(\\tO\\nDXS239\\tO\\n;\\tO\\npresent\\tO\\npaper\\tO\\n)\\tO\\n.\\tO\\n\\nClinical\\tO\\nfindings\\tO\\nare\\tO\\npresented\\tO\\nfor\\tO\\nall\\tO\\n80\\tO\\npatients\\tO\\nallowing\\tO\\na\\tO\\ncorrelation\\tO\\nof\\tO\\nphenotypic\\tO\\nseverity\\tO\\nwith\\tO\\nthe\\tO\\ngenotype\\tO\\n.\\tO\\n\\nThirty\\tO\\n-\\tO\\neight\\tO\\nindependent\\tO\\npatients\\tO\\nwere\\tO\\nold\\tO\\nenough\\tO\\nto\\tO\\nbe\\tO\\nclassified\\tO\\nas\\tO\\nDMD\\tB-Disease\\n,\\tO\\nBMD\\tB-Disease\\n,\\tO\\nor\\tO\\nintermediate\\tO\\nphenotype\\tO\\nand\\tO\\nhad\\tO\\ndeletions\\tO\\nof\\tO\\nexons\\tO\\nwith\\tO\\nsequenced\\tO\\nintron\\tO\\n/\\tO\\nexon\\tO\\nboundaries\\tO\\n.\\tO\\n\\nOf\\tO\\nthese\\tO\\n,\\tO\\neight\\tO\\nBMD\\tB-Disease\\npatients\\tO\\nand\\tO\\none\\tO\\nintermediate\\tO\\npatient\\tO\\nhad\\tO\\ngene\\tO\\ndeletions\\tO\\npredicted\\tO\\nto\\tO\\nleave\\tO\\nthe\\tO\\nreading\\tO\\nframe\\tO\\nintact\\tO\\n,\\tO\\nwhile\\tO\\n21\\tO\\nDMD\\tB-Disease\\npatients\\tO\\n,\\tO\\n7\\tO\\nintermediate\\tO\\npatients\\tO\\n,\\tO\\nand\\tO\\n1\\tO\\nBMD\\tB-Disease\\npatient\\tO\\nhad\\tO\\ngene\\tO\\ndeletions\\tO\\npredicted\\tO\\nto\\tO\\ndisrupt\\tO\\nthe\\tO\\nreading\\tO\\nframe\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nwith\\tO\\ntwo\\tO\\nexceptions\\tO\\n,\\tO\\nframeshift\\tO\\ndeletions\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nresulted\\tO\\nin\\tO\\nmore\\tO\\nsevere\\tO\\nphenotype\\tO\\nthan\\tO\\ndid\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletions\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nin\\tO\\nagreement\\tO\\nwith\\tO\\nrecent\\tO\\nfindings\\tO\\nby\\tO\\nBaumbach\\tO\\net\\tO\\nal\\tO\\n.\\tO\\nand\\tO\\nKoenig\\tO\\net\\tO\\nal\\tO\\n.\\tO\\nbut\\tO\\nis\\tO\\nin\\tO\\ncontrast\\tO\\nto\\tO\\nfindings\\tO\\n,\\tO\\nby\\tO\\nMalhotra\\tO\\net\\tO\\nal\\tO\\n.\\tO\\nat\\tO\\nthe\\tO\\n5\\tO\\n\\'\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nCloning\\tO\\nof\\tO\\nbreakpoints\\tO\\nof\\tO\\na\\tO\\nchromosome\\tO\\ntranslocation\\tO\\nidentifies\\tO\\nthe\\tO\\nAN2\\tO\\nlocus\\tO\\n.\\tO\\n\\nChromosome\\tO\\ntranslocations\\tO\\ninvolving\\tO\\n11p13\\tO\\nhave\\tO\\nbeen\\tO\\nassociated\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\naniridia\\tI-Disease\\nin\\tO\\ntwo\\tO\\nkindreds\\tO\\nhighlighting\\tO\\nthe\\tO\\nchromosomal\\tO\\nlocalization\\tO\\nof\\tO\\nthe\\tO\\nAN2\\tO\\nlocus\\tO\\n.\\tO\\n\\nThis\\tO\\nlocus\\tO\\nis\\tO\\nalso\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nWAGR\\tB-Disease\\ncomplex\\tO\\n(\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\n,\\tO\\naniridia\\tB-Disease\\n,\\tO\\ngenitourinary\\tB-Disease\\nabnormalities\\tI-Disease\\n,\\tO\\nand\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\none\\tO\\nkindred\\tO\\n,\\tO\\nthe\\tO\\ntranslocation\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\ndeletion\\tO\\n,\\tO\\nand\\tO\\nprobes\\tO\\nfor\\tO\\nthis\\tO\\nregion\\tO\\nwere\\tO\\nused\\tO\\nto\\tO\\nidentify\\tO\\nand\\tO\\nclone\\tO\\nthe\\tO\\nbreakpoints\\tO\\nof\\tO\\nthe\\tO\\ntranslocation\\tO\\nin\\tO\\nthe\\tO\\nsecond\\tO\\nkindred\\tO\\n.\\tO\\n\\nComparison\\tO\\nof\\tO\\nphage\\tO\\nrestriction\\tO\\nmaps\\tO\\nexclude\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nany\\tO\\nsizable\\tO\\ndeletion\\tO\\nin\\tO\\nthis\\tO\\ncase\\tO\\n.\\tO\\n\\nSequences\\tO\\nat\\tO\\nthe\\tO\\nchromosome\\tO\\n11\\tO\\nbreakpoint\\tO\\nare\\tO\\nconserved\\tO\\nin\\tO\\nmultiple\\tO\\nspecies\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthe\\tO\\ntranslocation\\tO\\nfalls\\tO\\nwithin\\tO\\nthe\\tO\\nAN2\\tO\\ngene\\tO\\n.\\tO\\n.\\tO\\n\\nLinkage\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\napolipoprotein\\tO\\nC2\\tO\\ngene\\tO\\nand\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\non\\tO\\nhuman\\tO\\nchromosome\\tO\\n19\\tO\\nreveals\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nin\\tO\\na\\tO\\nFrench\\tO\\n-\\tO\\nCanadian\\tO\\npopulation\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nfor\\tO\\nhuman\\tO\\napolipoprotein\\tO\\nC2\\tO\\n(\\tO\\nAPOC2\\tO\\n)\\tO\\n,\\tO\\nsituated\\tO\\non\\tO\\nthe\\tO\\nproximal\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n19\\tO\\n,\\tO\\nis\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nform\\tO\\nof\\tO\\nadult\\tO\\nmuscular\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nSix\\tO\\nAPOC2\\tO\\nRFLPs\\tO\\n(\\tO\\nTaqI\\tO\\n,\\tO\\nBglI\\tO\\n,\\tO\\nBanI\\tO\\n,\\tO\\nBamHI\\tO\\n,\\tO\\nNcoI\\tO\\n,\\tO\\nand\\tO\\nAvaII\\tO\\n)\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nto\\tO\\ndate\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nconducted\\tO\\na\\tO\\ncomprehensive\\tO\\nDM\\tB-Disease\\nlinkage\\tO\\nstudy\\tO\\nutilizing\\tO\\nall\\tO\\nsix\\tO\\nRFLPs\\tO\\nand\\tO\\ninvolving\\tO\\n50\\tO\\nfamilies\\tO\\nand\\tO\\n372\\tO\\nindividuals\\tO\\n.\\tO\\n\\nThe\\tO\\nmost\\tO\\ninformative\\tO\\nRFLPs\\tO\\nare\\tO\\n,\\tO\\nin\\tO\\ndescending\\tO\\norder\\tO\\n,\\tO\\nNcoI\\tO\\n(\\tO\\nlod\\tO\\n=\\tO\\n6\\tO\\n.\\tO\\n64\\tO\\n,\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n05\\tO\\n)\\tO\\n,\\tO\\nBglI\\tO\\n(\\tO\\nlod\\tO\\n=\\tO\\n6\\tO\\n.\\tO\\n12\\tO\\n,\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n05\\tO\\n)\\tO\\n,\\tO\\nAvaII\\tO\\n(\\tO\\nlod\\tO\\n=\\tO\\n6\\tO\\n.\\tO\\n02\\tO\\n,\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n03\\tO\\n)\\tO\\n,\\tO\\nBanI\\tO\\n(\\tO\\nlod\\tO\\n=\\tO\\n5\\tO\\n.\\tO\\n76\\tO\\n,\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n04\\tO\\n)\\tO\\n,\\tO\\nTaqI\\tO\\n(\\tO\\nlod\\tO\\n=\\tO\\n4\\tO\\n.\\tO\\n29\\tO\\n,\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n06\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nBamHI\\tO\\n(\\tO\\nlod\\tO\\n=\\tO\\n1\\tO\\n.\\tO\\n75\\tO\\n,\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n01\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nsubstantial\\tO\\nincrease\\tO\\nin\\tO\\nthe\\tO\\nlod\\tO\\nscores\\tO\\nover\\tO\\nthose\\tO\\nseen\\tO\\nwith\\tO\\nthe\\tO\\nindividual\\tO\\nRFLPs\\tO\\nwas\\tO\\nobtained\\tO\\nwhen\\tO\\nthe\\tO\\nlinkage\\tO\\nof\\tO\\nthe\\tO\\nentire\\tO\\nAPOC2\\tO\\nhaplotype\\tO\\n(\\tO\\ncomposed\\tO\\nof\\tO\\nthe\\tO\\nsix\\tO\\nRFLPs\\tO\\n)\\tO\\nwas\\tO\\nstudied\\tO\\n(\\tO\\nlod\\tO\\n=\\tO\\n17\\tO\\n.\\tO\\n87\\tO\\n,\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n04\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nobserved\\tO\\nsignificant\\tO\\ninter\\tO\\n-\\tO\\nAPOC2\\tO\\nRFLP\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\n.\\tO\\n\\nConsequently\\tO\\n,\\tO\\nthe\\tO\\nthree\\tO\\nmost\\tO\\ninformative\\tO\\nRFLPs\\tO\\nhave\\tO\\nbeen\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nBanI\\tO\\n,\\tO\\nTaqI\\tO\\n,\\tO\\nand\\tO\\neither\\tO\\nBglI\\tO\\n,\\tO\\nAvaII\\tO\\n,\\tO\\nor\\tO\\nNcoI\\tO\\npolymorphisms\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\ndemonstrate\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nbetween\\tO\\nDM\\tO\\nand\\tO\\nAPOC2\\tO\\nin\\tO\\nour\\tO\\nFrench\\tO\\n-\\tO\\nCanadian\\tO\\npopulation\\tO\\n(\\tO\\nstandardized\\tO\\ndisequilibrium\\tO\\nconstant\\tO\\nphi\\tO\\n=\\tO\\n.\\tO\\n22\\tO\\n,\\tO\\nchi\\tO\\n2\\tO\\n=\\tO\\n5\\tO\\n.\\tO\\n12\\tO\\n,\\tO\\ndf\\tO\\n=\\tO\\n1\\tO\\n,\\tO\\nP\\tO\\nless\\tO\\nthan\\tO\\n0\\tO\\n.\\tO\\n04\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nrepresents\\tO\\nthe\\tO\\nfirst\\tO\\nevidence\\tO\\nof\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nbetween\\tO\\nAPOC2\\tO\\nand\\tO\\nthe\\tO\\nDM\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nPhenylalanine\\tO\\nhydroxylase\\tO\\ngene\\tO\\nhaplotypes\\tO\\nin\\tO\\nPolynesians\\tO\\n:\\tO\\nevolutionary\\tO\\norigins\\tO\\nand\\tO\\nabsence\\tO\\nof\\tO\\nalleles\\tO\\nassociated\\tO\\nwith\\tO\\nsevere\\tO\\nphenylketonuria\\tB-Disease\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n630\\tO\\nhaplotypes\\tO\\nfor\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n(\\tO\\nPAH\\tO\\n)\\tO\\ngene\\tO\\nlocus\\tO\\nwere\\tO\\nestablished\\tO\\nin\\tO\\nfive\\tO\\ngroups\\tO\\nof\\tO\\nPolynesians\\tO\\ncomprising\\tO\\nSamoans\\tO\\n,\\tO\\nTongans\\tO\\n,\\tO\\nCook\\tO\\nIslanders\\tO\\n,\\tO\\nMaori\\tO\\n,\\tO\\nand\\tO\\nNiueans\\tO\\n.\\tO\\n\\nConsiderable\\tO\\ngenetic\\tO\\ncontinuity\\tO\\nwas\\tO\\ndemonstrated\\tO\\nbetween\\tO\\nthese\\tO\\nwidely\\tO\\ndispersed\\tO\\npopulations\\tO\\n,\\tO\\nsince\\tO\\nthree\\tO\\ncommon\\tO\\nhaplotypes\\tO\\n(\\tO\\n4\\tO\\n,\\tO\\n1\\tO\\n,\\tO\\nand\\tO\\n7\\tO\\n)\\tO\\nconstituted\\tO\\nover\\tO\\n95\\tO\\n%\\tO\\nof\\tO\\nalleles\\tO\\n.\\tO\\n\\nA\\tO\\ncontrol\\tO\\ngroup\\tO\\nof\\tO\\nindividuals\\tO\\nfrom\\tO\\nSoutheast\\tO\\nAsia\\tO\\nshared\\tO\\nthe\\tO\\nsame\\tO\\nmajor\\tO\\nhaplotypes\\tO\\n,\\tO\\n4\\tO\\n,\\tO\\n1\\tO\\n,\\tO\\nand\\tO\\n7\\tO\\n,\\tO\\nwith\\tO\\nPolynesians\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nprovide\\tO\\nfurther\\tO\\nsupport\\tO\\nfor\\tO\\nthe\\tO\\ntheories\\tO\\nof\\tO\\ngenetic\\tO\\nhomogeneity\\tO\\nand\\tO\\nof\\tO\\nAsian\\tO\\naffinities\\tO\\nof\\tO\\nthe\\tO\\nPolynesian\\tO\\nprecursor\\tO\\npopulations\\tO\\n.\\tO\\n\\nThe\\tO\\nabsence\\tO\\nof\\tO\\nsevere\\tO\\nphenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nin\\tO\\nboth\\tO\\nPolynesians\\tO\\nand\\tO\\nSoutheast\\tO\\nAsians\\tO\\nis\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nlack\\tO\\nof\\tO\\nPAH\\tO\\nhaplotypes\\tO\\n2\\tO\\nand\\tO\\n3\\tO\\n,\\tO\\non\\tO\\nwhich\\tO\\nthe\\tO\\nsevere\\tO\\nPKU\\tB-Disease\\nmutants\\tO\\nhave\\tO\\narisen\\tO\\namong\\tO\\nCaucasians\\tO\\n.\\tO\\n.\\tO\\n\\nPreferential\\tO\\ngermline\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\npaternal\\tO\\nallele\\tO\\nin\\tO\\nretinoblastoma\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nevent\\tO\\ntriggering\\tO\\nmalignant\\tO\\nproliferation\\tO\\nin\\tO\\n70\\tO\\n%\\tO\\nof\\tO\\nretinoblastoma\\tB-Disease\\ntumours\\tI-Disease\\nis\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\nfor\\tO\\nchromosome\\tO\\n13q14\\tO\\n,\\tO\\nwhereby\\tO\\nthe\\tO\\nnormal\\tO\\nretinoblastoma\\tB-Disease\\ngene\\tO\\n(\\tO\\nRB1\\tO\\n)\\tO\\nallele\\tO\\nis\\tO\\nlost\\tO\\nand\\tO\\nan\\tO\\nalready\\tO\\nmutated\\tO\\nRB1\\tO\\nallele\\tO\\nremains\\tO\\nin\\tO\\nthe\\tO\\ntumour\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\nallele\\tO\\nsuffers\\tO\\na\\tO\\nmutational\\tO\\nevent\\tO\\n-\\tO\\n-\\tO\\ndeletion\\tO\\n,\\tO\\nduplication\\tO\\nor\\tO\\npoint\\tO\\nmutation\\tO\\n(\\tO\\nmanuscript\\tO\\nin\\tO\\npreparation\\tO\\n)\\tO\\n-\\tO\\n-\\tO\\neither\\tO\\nin\\tO\\nthe\\tO\\ngerm\\tO\\nline\\tO\\n(\\tO\\nall\\tO\\nbilateral\\tO\\npatients\\tO\\n)\\tO\\nor\\tO\\nin\\tO\\na\\tO\\nsomatic\\tO\\nretinal\\tO\\ncell\\tO\\n(\\tO\\nmost\\tO\\nunilateral\\tO\\npatients\\tO\\n)\\tO\\n.\\tO\\n\\nMost\\tO\\nbilateral\\tO\\npatients\\tO\\nhave\\tO\\nno\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nretinoblastoma\\tB-Disease\\nand\\tO\\nare\\tO\\npresumed\\tO\\nto\\tO\\nhave\\tO\\nnew\\tO\\ngermline\\tO\\nmutations\\tO\\nwhich\\tO\\narose\\tO\\nin\\tO\\nthe\\tO\\negg\\tO\\n,\\tO\\nsperm\\tO\\nor\\tO\\nearly\\tO\\nembryo\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndetermined\\tO\\nthe\\tO\\nparental\\tO\\norigin\\tO\\nof\\tO\\nthe\\tO\\nretained\\tO\\nallele\\tO\\nin\\tO\\nnine\\tO\\nretinoblastoma\\tB-Disease\\ntumours\\tI-Disease\\nfrom\\tO\\neight\\tO\\nunrelated\\tO\\nnon\\tO\\n-\\tO\\nfamilial\\tO\\ncases\\tO\\nby\\tO\\nusing\\tO\\nRB1\\tO\\n-\\tO\\nlinked\\tO\\ngenetic\\tO\\nmarkers\\tO\\n.\\tO\\n\\nSix\\tO\\ntumours\\tB-Disease\\nretained\\tO\\nthe\\tO\\npaternal\\tO\\nallele\\tO\\nand\\tO\\nthree\\tO\\nretained\\tO\\nthe\\tO\\nmaternal\\tO\\nallele\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\nthree\\tO\\nunilateral\\tB-Disease\\ntumours\\tI-Disease\\n,\\tO\\nonly\\tO\\none\\tO\\nretained\\tO\\nthe\\tO\\npaternal\\tO\\nRB1\\tO\\nallele\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthere\\tO\\nis\\tO\\nno\\tO\\nevidence\\tO\\nthat\\tO\\nthe\\tO\\npaternal\\tO\\nRB1\\tO\\nallele\\tO\\nis\\tO\\npreferentially\\tO\\nretained\\tO\\nin\\tO\\nretinoblastoma\\tB-Disease\\n,\\tO\\nas\\tO\\nhas\\tO\\nbeen\\tO\\nsuggested\\tO\\nto\\tO\\nbe\\tO\\nthe\\tO\\ncase\\tO\\nin\\tO\\nosteosarcoma\\tB-Disease\\n.\\tO\\n\\nBy\\tO\\ncontrast\\tO\\n,\\tO\\ntumours\\tB-Disease\\nfrom\\tO\\nfour\\tO\\nof\\tO\\nthe\\tO\\nfive\\tO\\nbilateral\\tO\\npatients\\tO\\nretained\\tO\\nthe\\tO\\npaternal\\tO\\nRB1\\tO\\nallele\\tO\\n.\\tO\\n\\nThis\\tO\\nsuggests\\tO\\neither\\tO\\nthat\\tO\\nnew\\tO\\ngermline\\tO\\nRB1\\tO\\nmutations\\tO\\narise\\tO\\nmore\\tO\\nfrequently\\tO\\nduring\\tO\\nspermatogenesis\\tO\\nthan\\tO\\nduring\\tO\\noogenesis\\tO\\n,\\tO\\nor\\tO\\nthat\\tO\\nimprinting\\tO\\nin\\tO\\nthe\\tO\\nearly\\tO\\nembryo\\tO\\naffects\\tO\\nchromosomal\\tO\\nsusceptibility\\tO\\nto\\tO\\nmutation\\tO\\n.\\tO\\n.\\tO\\n\\nHaplotype\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\ngene\\tO\\nin\\tO\\nTurkish\\tO\\nphenylketonuria\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nestimated\\tO\\nthe\\tO\\nhaplotype\\tO\\ndistribution\\tO\\nof\\tO\\nmutant\\tO\\nand\\tO\\nnormal\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n(\\tO\\nPAH\\tO\\n)\\tO\\nalleles\\tO\\nfor\\tO\\n17\\tO\\nTurkish\\tO\\nphenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nfamilies\\tO\\n20\\tO\\nnormal\\tO\\nand\\tO\\n27\\tO\\nmutated\\tO\\nPAH\\tO\\nalleles\\tO\\ncould\\tO\\nbe\\tO\\nidentified\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\nlatter\\tO\\n,\\tO\\nthe\\tO\\nmost\\tO\\nprevalent\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\nhaplotype\\tO\\n6\\tO\\n(\\tO\\n29\\tO\\n.\\tO\\n6\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\n1\\tO\\n(\\tO\\n18\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\n36\\tO\\n(\\tO\\n11\\tO\\n.\\tO\\n1\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\nnormal\\tO\\nalleles\\tO\\nwere\\tO\\npreferentially\\tO\\nassociated\\tO\\nwith\\tO\\nhaplotype\\tO\\n1\\tO\\n(\\tO\\n20\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\n19\\tO\\ndifferent\\tO\\nhaplotypes\\tO\\nobserved\\tO\\n,\\tO\\n5\\tO\\nhave\\tO\\nnot\\tO\\nbeen\\tO\\ndescribed\\tO\\npreviously\\tO\\n.\\tO\\n\\nThe\\tO\\nhaplotype\\tO\\ndistribution\\tO\\ndiffered\\tO\\nsignificantly\\tO\\nfrom\\tO\\nthat\\tO\\nof\\tO\\nthe\\tO\\nNorthern\\tO\\nEuropean\\tO\\npopulation\\tO\\n.\\tO\\n\\nTwo\\tO\\nof\\tO\\nthe\\tO\\neight\\tO\\npolymorphic\\tO\\nsites\\tO\\nwere\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\nPKU\\tB-Disease\\n.\\tO\\n\\nNo\\tO\\ndeletions\\tO\\nof\\tO\\nexon\\tO\\nsequences\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nfamilies\\tO\\nanalysed\\tO\\n.\\tO\\n\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n:\\tO\\nno\\tO\\nevidence\\tO\\nfor\\tO\\nlocus\\tO\\nheterogeneity\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n63\\tO\\nfamilies\\tO\\nwith\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nwere\\tO\\nexamined\\tO\\nfor\\tO\\nlinkage\\tO\\nbetween\\tO\\nHD\\tB-Disease\\nand\\tO\\nG8\\tO\\n(\\tO\\nD4S10\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nfamilies\\tO\\nincluded\\tO\\n57\\tO\\nCaucasian\\tO\\n,\\tO\\nfour\\tO\\nBlack\\tO\\nAmerican\\tO\\n,\\tO\\nand\\tO\\ntwo\\tO\\nJapanese\\tO\\n.\\tO\\n\\nThe\\tO\\ncombined\\tO\\nmaximum\\tO\\nlod\\tO\\nscore\\tO\\nwas\\tO\\n87\\tO\\n.\\tO\\n\\n69\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\n04\\tO\\n(\\tO\\n99\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\n0\\tO\\n.\\tO\\n018\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n071\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmaximum\\tO\\nfrequency\\tO\\nof\\tO\\nrecombination\\tO\\nwas\\tO\\n0\\tO\\n.\\tO\\n\\n03\\tO\\nin\\tO\\nmales\\tO\\nand\\tO\\n0\\tO\\n.\\tO\\n\\n05\\tO\\nin\\tO\\nfemales\\tO\\n.\\tO\\n\\nFifty\\tO\\n-\\tO\\nseven\\tO\\nfamilies\\tO\\ngave\\tO\\npositive\\tO\\nlod\\tO\\nscores\\tO\\n;\\tO\\nfive\\tO\\nsmall\\tO\\nfamilies\\tO\\ngave\\tO\\nmildly\\tO\\nnegative\\tO\\nlod\\tO\\nscores\\tO\\n.\\tO\\n\\nThe\\tO\\nmaximum\\tO\\nlikelihood\\tO\\nestimate\\tO\\nof\\tO\\nalpha\\tO\\n,\\tO\\nthe\\tO\\nproportion\\tO\\nof\\tO\\nlinked\\tO\\nloci\\tO\\n,\\tO\\nwas\\tO\\n1\\tO\\n.\\tO\\n\\n0\\tO\\nwith\\tO\\na\\tO\\nlower\\tO\\n99\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n88\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nthere\\tO\\nis\\tO\\nonly\\tO\\none\\tO\\nHD\\tB-Disease\\nlocus\\tO\\n,\\tO\\nalthough\\tO\\na\\tO\\nsecond\\tO\\nrare\\tO\\nlocus\\tO\\ncannot\\tO\\nbe\\tO\\nruled\\tO\\nout\\tO\\n.\\tO\\n\\nHaplotype\\tO\\nand\\tO\\nmultipoint\\tO\\nlinkage\\tO\\nanalysis\\tO\\nin\\tO\\nFinnish\\tO\\nchoroideremia\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nMultipoint\\tO\\nlinkage\\tO\\nanalysis\\tO\\nof\\tO\\nchoroideremia\\tB-Disease\\n(\\tO\\nTCD\\tB-Disease\\n)\\tO\\nand\\tO\\nseven\\tO\\nX\\tO\\nchromosomal\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphisms\\tO\\n(\\tO\\nRFLPs\\tO\\n)\\tO\\nwas\\tO\\ncarried\\tO\\nout\\tO\\nin\\tO\\n18\\tO\\nFinnish\\tO\\nTCD\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nThe\\tO\\ndata\\tO\\nplace\\tO\\nTCD\\tB-Disease\\ndistal\\tO\\nto\\tO\\nPGK\\tO\\nand\\tO\\nDXS72\\tO\\n,\\tO\\nvery\\tO\\nclose\\tO\\nto\\tO\\nDXYS1\\tO\\nand\\tO\\nDXYS5\\tO\\n(\\tO\\nZmax\\tO\\n=\\tO\\n24\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n)\\tO\\nand\\tO\\nproximal\\tO\\nto\\tO\\nDXYS4\\tO\\nand\\tO\\nDXYS12\\tO\\n.\\tO\\n\\nThis\\tO\\nagrees\\tO\\nwith\\tO\\nthe\\tO\\ndata\\tO\\nobtained\\tO\\nfrom\\tO\\nother\\tO\\nlinkage\\tO\\nstudies\\tO\\nand\\tO\\nfrom\\tO\\nphysical\\tO\\nmapping\\tO\\n.\\tO\\n\\nAll\\tO\\nthe\\tO\\nTCD\\tB-Disease\\nmales\\tO\\nand\\tO\\ncarrier\\tO\\nfemales\\tO\\nstudied\\tO\\nhave\\tO\\nthe\\tO\\nsame\\tO\\nDXYS1\\tO\\nallele\\tO\\nin\\tO\\ncoupling\\tO\\nwith\\tO\\nTCD\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\nNortheastern\\tO\\nFinland\\tO\\n,\\tO\\n66\\tO\\n/\\tO\\n69\\tO\\nchromosomes\\tO\\ncarrying\\tO\\nTCD\\tB-Disease\\nhad\\tO\\nthe\\tO\\nsame\\tO\\nhaplotype\\tO\\nat\\tO\\nloci\\tO\\nDXS72\\tO\\n,\\tO\\nDXYS1\\tO\\n,\\tO\\nDXYS4\\tO\\n,\\tO\\nand\\tO\\nDXYS12\\tO\\n.\\tO\\n\\nThe\\tO\\nsame\\tO\\nhaplotype\\tO\\nis\\tO\\nseen\\tO\\nin\\tO\\nonly\\tO\\n15\\tO\\n/\\tO\\n99\\tO\\nchromosomes\\tO\\nnot\\tO\\ncarrying\\tO\\nTCD\\tB-Disease\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nin\\tO\\n71\\tO\\n/\\tO\\n104\\tO\\nnon\\tO\\n-\\tO\\nTCD\\tO\\nchromosomes\\tO\\n,\\tO\\nthe\\tO\\nhaplotype\\tO\\nat\\tO\\nsix\\tO\\nmarker\\tO\\nloci\\tO\\nis\\tO\\ndifferent\\tO\\nfrom\\tO\\nthose\\tO\\nseen\\tO\\nin\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\n76\\tO\\nTCD\\tB-Disease\\nchromosomes\\tO\\n.\\tO\\n\\nThis\\tO\\nsupports\\tO\\nthe\\tO\\npreviously\\tO\\ndescribed\\tO\\nhypothesis\\tO\\nthat\\tO\\nthe\\tO\\nlarge\\tO\\nNorthern\\tO\\nFinnish\\tO\\nchoroideremia\\tB-Disease\\npedigrees\\tO\\n,\\tO\\ncomprising\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\nover\\tO\\n80\\tO\\nliving\\tO\\npatients\\tO\\nrepresenting\\tO\\nmore\\tO\\nthan\\tO\\na\\tO\\nfifth\\tO\\nof\\tO\\nall\\tO\\nTCD\\tB-Disease\\npatients\\tO\\ndescribed\\tO\\nworldwide\\tO\\n,\\tO\\ncarry\\tO\\nthe\\tO\\nsame\\tO\\nmutation\\tO\\n.\\tO\\n\\nThese\\tO\\nlinkage\\tO\\nand\\tO\\nhaplotype\\tO\\ndata\\tO\\nprovide\\tO\\nimproved\\tO\\nopportunities\\tO\\nfor\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\nbased\\tO\\non\\tO\\nRFLP\\tO\\nstudies\\tO\\n.\\tO\\n.\\tO\\n\\nAutosomal\\tO\\ndominant\\tO\\naniridia\\tB-Disease\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nchromosome\\tO\\n11p13\\tO\\nmarkers\\tO\\ncatalase\\tO\\nand\\tO\\nD11S151\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nDutch\\tO\\nfamily\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nlarge\\tO\\npedigree\\tO\\nwith\\tO\\nautosomal\\tO\\ndominant\\tO\\naniridia\\tB-Disease\\n,\\tO\\nwe\\tO\\nfound\\tO\\nclose\\tO\\nlinkage\\tO\\nbetween\\tO\\nthe\\tO\\naniridia\\tB-Disease\\nlocus\\tO\\nAN2\\tO\\nand\\tO\\nthe\\tO\\nmarkers\\tO\\ncatalase\\tO\\n(\\tO\\nCAT\\tO\\n)\\tO\\n(\\tO\\nzeta\\tO\\n=\\tO\\n7\\tO\\n.\\tO\\n27\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n00\\tO\\n)\\tO\\nand\\tO\\nD11S151\\tO\\n(\\tO\\nzeta\\tO\\n=\\tO\\n3\\tO\\n.\\tO\\n86\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n10\\tO\\n)\\tO\\nflanking\\tO\\nthe\\tO\\nAN2\\tO\\nlocus\\tO\\non\\tO\\n11p13\\tO\\n.\\tO\\n\\nPositive\\tO\\nlod\\tO\\nscores\\tO\\nwere\\tO\\nalso\\tO\\nobtained\\tO\\nfor\\tO\\nthe\\tO\\n11p13\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n11p14\\tO\\nmarkers\\tO\\nD11S16\\tO\\nand\\tO\\nFSHB\\tO\\nwith\\tO\\nthe\\tO\\nlinkage\\tO\\ngroup\\tO\\nCAT\\tO\\n/\\tO\\nAN2\\tO\\n/\\tO\\nD11S151\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\nautosomal\\tO\\ndominant\\tO\\naniridia\\tB-Disease\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nis\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nmutation\\tO\\nat\\tO\\nthe\\tO\\nAN2\\tO\\nlocus\\tO\\non\\tO\\n11p13\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexcluded\\tO\\nlinkage\\tO\\n(\\tO\\nzeta\\tO\\nless\\tO\\nthan\\tO\\n-\\tO\\n2\\tO\\nat\\tO\\ntheta\\tO\\nless\\tO\\nthan\\tO\\n0\\tO\\n.\\tO\\n18\\tO\\n)\\tO\\nbetween\\tO\\nthe\\tO\\naniridia\\tB-Disease\\nand\\tO\\nthe\\tO\\nchromosome\\tO\\n2p25\\tO\\nmarker\\tO\\nD2S1\\tO\\n(\\tO\\nlinked\\tO\\nto\\tO\\nACP1\\tO\\n)\\tO\\n.\\tO\\n\\nRecombination\\tO\\nevents\\tO\\nthat\\tO\\nlocate\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\ndistal\\tO\\nto\\tO\\nAPOC2\\tO\\non\\tO\\n19q\\tO\\n.\\tO\\n\\nWe\\tO\\npreviously\\tO\\nreported\\tO\\na\\tO\\nrecombination\\tO\\nin\\tO\\nan\\tO\\nindividual\\tO\\nwith\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nwhich\\tO\\nplaced\\tO\\nthe\\tO\\nmarkers\\tO\\nD19S19\\tO\\nand\\tO\\nAPOC2\\tO\\non\\tO\\nthe\\tO\\nsame\\tO\\nside\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nHaplotyping\\tO\\nof\\tO\\nthis\\tO\\nfamily\\tO\\nwith\\tO\\nmore\\tO\\nrecently\\tO\\ncharacterized\\tO\\nprobes\\tO\\nwhich\\tO\\nare\\tO\\neither\\tO\\ntightly\\tO\\nlinked\\tO\\nto\\tO\\nDM\\tB-Disease\\nor\\tO\\ndistal\\tO\\nto\\tO\\nthe\\tO\\nlinkage\\tO\\ngroup\\tO\\nat\\tO\\nq13\\tO\\n.\\tO\\n\\n2\\tO\\nshows\\tO\\nthat\\tO\\nthe\\tO\\nDM\\tB-Disease\\nlocus\\tO\\nis\\tO\\ndistal\\tO\\nto\\tO\\nAPOC2\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nconfirmed\\tO\\nby\\tO\\nother\\tO\\nrecombinants\\tO\\nwhere\\tO\\nDM\\tB-Disease\\nsegregates\\tO\\nwith\\tO\\ndistal\\tO\\nprobes\\tO\\n.\\tO\\n\\nAdditional\\tO\\nmarker\\tO\\nto\\tO\\nmarker\\tO\\nrecombinations\\tO\\nin\\tO\\nunaffected\\tO\\nindividuals\\tO\\nare\\tO\\nreported\\tO\\nand\\tO\\nsupport\\tO\\nthe\\tO\\norder\\tO\\nand\\tO\\norientation\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nlinkage\\tO\\ngroup\\tO\\nas\\tO\\npter\\tO\\n-\\tO\\n(\\tO\\nINSR\\tO\\n,\\tO\\nLDLR\\tO\\n,\\tO\\nS9\\tO\\n)\\tO\\n-\\tO\\n(\\tO\\nS19\\tO\\n,\\tO\\nBCL3\\tO\\n,\\tO\\nAPOC2\\tO\\n)\\tO\\n-\\tO\\n(\\tO\\nCKMM\\tO\\n,\\tO\\nDM\\tO\\n)\\tO\\n-\\tO\\n(\\tO\\nS22\\tO\\n,\\tO\\n+\\tO\\n+\\tO\\n+\\tO\\nPRKCG\\tO\\n)\\tO\\n-\\tO\\nqter\\tO\\n.\\tO\\n\\nThe\\tO\\ndata\\tO\\npresented\\tO\\nhere\\tO\\ncannot\\tO\\ndetermine\\tO\\nwhether\\tO\\nDM\\tB-Disease\\nis\\tO\\nproximal\\tO\\nor\\tO\\ndistal\\tO\\nto\\tO\\nCKMM\\tO\\n.\\tO\\n\\nThe\\tO\\nconsequences\\tO\\nof\\tO\\nthis\\tO\\nprobe\\tO\\norder\\tO\\nfor\\tO\\nantenatal\\tO\\ndiagnosis\\tO\\nand\\tO\\nfuture\\tO\\nresearch\\tO\\naiming\\tO\\nto\\tO\\nisolate\\tO\\nthe\\tO\\ngene\\tO\\nwhich\\tO\\nis\\tO\\naffected\\tO\\nin\\tO\\nDM\\tB-Disease\\nare\\tO\\ndiscussed\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nand\\tO\\ntheir\\tO\\neffects\\tO\\non\\tO\\ntranscription\\tO\\n.\\tO\\n\\nInactivation\\tO\\nof\\tO\\nboth\\tO\\nalleles\\tO\\nof\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nduring\\tO\\nnormal\\tO\\nretinal\\tO\\ndevelopment\\tO\\ninitiates\\tO\\nthe\\tO\\nformation\\tO\\nof\\tO\\na\\tO\\nretinoblastoma\\tB-Disease\\n(\\tI-Disease\\nRB\\tI-Disease\\n)\\tI-Disease\\ntumor\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\nidentify\\tO\\nthe\\tO\\nmutations\\tO\\nwhich\\tO\\ninactivate\\tO\\nRB1\\tO\\n,\\tO\\n21\\tO\\nRB\\tB-Disease\\ntumors\\tI-Disease\\nisolated\\tO\\nfrom\\tO\\n19\\tO\\npatients\\tO\\nwere\\tO\\nanalyzed\\tO\\nwith\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nor\\tO\\nan\\tO\\nRNase\\tO\\nprotection\\tO\\nassay\\tO\\nor\\tO\\nboth\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\n13\\tO\\nof\\tO\\n21\\tO\\nRB\\tB-Disease\\ntumors\\tI-Disease\\n;\\tO\\nin\\tO\\n8\\tO\\ntumors\\tB-Disease\\n,\\tO\\nthe\\tO\\nprecise\\tO\\nerrors\\tO\\nin\\tO\\nnucleotide\\tO\\nsequence\\tO\\nwere\\tO\\ncharacterized\\tO\\n.\\tO\\n\\nEach\\tO\\nof\\tO\\nfour\\tO\\ngerm\\tO\\nline\\tO\\nmutations\\tO\\ninvolved\\tO\\na\\tO\\nsmall\\tO\\ndeletion\\tO\\nor\\tO\\nduplication\\tO\\n,\\tO\\nwhile\\tO\\nthree\\tO\\nsomatic\\tO\\nmutations\\tO\\nwere\\tO\\npoint\\tO\\nmutations\\tO\\nleading\\tO\\nto\\tO\\nsplice\\tO\\nalterations\\tO\\nand\\tO\\nloss\\tO\\nof\\tO\\nan\\tO\\nexon\\tO\\nfrom\\tO\\nthe\\tO\\nmature\\tO\\nRB1\\tO\\nmRNA\\tO\\n.\\tO\\n\\nWe\\tO\\nwere\\tO\\nunable\\tO\\nto\\tO\\ndetect\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nallele\\tO\\nin\\tO\\nlymphoblasts\\tO\\nof\\tO\\nthree\\tO\\nbilaterally\\tO\\naffected\\tO\\npatients\\tO\\n,\\tO\\nalthough\\tO\\nthe\\tO\\nmutation\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\nthe\\tO\\ngenomic\\tO\\nDNA\\tO\\nand\\tO\\ntranscripts\\tO\\ncontaining\\tO\\nthe\\tO\\nmutations\\tO\\nwere\\tO\\nobvious\\tO\\nin\\tO\\nthe\\tO\\nRB\\tB-Disease\\ntumors\\tI-Disease\\nin\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\na\\tO\\nnormal\\tO\\nRB1\\tO\\nallele\\tO\\n.\\tO\\n\\nThe\\tO\\nvariations\\tO\\nin\\tO\\nthe\\tO\\nlevel\\tO\\nof\\tO\\nexpression\\tO\\nof\\tO\\nmutant\\tO\\ntranscripts\\tO\\nsuggest\\tO\\nderegulation\\tO\\nof\\tO\\nRB1\\tO\\ntranscription\\tO\\nin\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\na\\tO\\nfunctional\\tO\\nRB1\\tO\\ngene\\tO\\nproduct\\tO\\n.\\tO\\n.\\tO\\n\\nPartial\\tO\\ndeletion\\tO\\n8q\\tO\\nwithout\\tO\\nLanger\\tB-Disease\\n-\\tI-Disease\\nGiedion\\tI-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\na\\tO\\nrecognisable\\tO\\nsyndrome\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\ntwo\\tO\\nde\\tO\\nnovo\\tO\\ncases\\tO\\nof\\tO\\ndel\\tO\\n(\\tO\\n8\\tO\\n)\\tO\\n(\\tO\\npter\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nq24\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\nwith\\tO\\nbreakpoints\\tO\\ninvolving\\tO\\nthe\\tO\\ndistal\\tO\\npart\\tO\\nof\\tO\\nband\\tO\\n8q24\\tO\\n.\\tO\\n\\n1\\tO\\n1\\tO\\n.\\tO\\n\\nThe\\tO\\nclinical\\tO\\nfeatures\\tO\\nwere\\tO\\nsimilar\\tO\\nand\\tO\\nthere\\tO\\nwere\\tO\\nno\\tO\\nobvious\\tO\\nstigmata\\tO\\nof\\tO\\nLanger\\tB-Disease\\n-\\tI-Disease\\nGiedion\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nLGS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThere\\tO\\nare\\tO\\nthree\\tO\\nother\\tO\\ncases\\tO\\nreported\\tO\\nwith\\tO\\na\\tO\\ndeletion\\tO\\nof\\tO\\nchromosome\\tO\\n8\\tO\\nat\\tO\\napproximately\\tO\\nthe\\tO\\nsame\\tO\\nbreakpoint\\tO\\n,\\tO\\none\\tO\\nwithout\\tO\\nLGS\\tB-Disease\\nand\\tO\\nsome\\tO\\nsimilarities\\tO\\nto\\tO\\nour\\tO\\ncases\\tO\\n,\\tO\\nthe\\tO\\nother\\tO\\ntwo\\tO\\nwith\\tO\\nLGS\\tB-Disease\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nwould\\tO\\nsupport\\tO\\nthe\\tO\\nobservation\\tO\\nthat\\tO\\nthe\\tO\\ncritical\\tO\\nsegment\\tO\\nfor\\tO\\nthe\\tO\\nassignment\\tO\\nof\\tO\\nLGS\\tB-Disease\\nis\\tO\\nproximal\\tO\\nto\\tO\\nor\\tO\\ninvolves\\tO\\nthe\\tO\\nproximal\\tO\\npart\\tO\\nof\\tO\\n8q24\\tO\\n.\\tO\\n\\n1\\tO\\n,\\tO\\nbut\\tO\\na\\tO\\nreview\\tO\\nof\\tO\\npublished\\tO\\nreports\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\naetiology\\tO\\nof\\tO\\nLGS\\tB-Disease\\nmay\\tO\\nbe\\tO\\na\\tO\\nmore\\tO\\ncomplex\\tO\\nissue\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nis\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nmuscle\\tO\\n-\\tO\\ntype\\tO\\ncreatine\\tO\\nkinase\\tO\\n(\\tO\\nCKMM\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nstudied\\tO\\ngenetic\\tO\\nlinkage\\tO\\nbetween\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\ncreatine\\tO\\nkinase\\tO\\nmuscle\\tO\\ntype\\tO\\n(\\tO\\nCKMM\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\npanel\\tO\\nof\\tO\\n65\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nfamilies\\tO\\nfrom\\tO\\nCanada\\tO\\nand\\tO\\nthe\\tO\\nNetherlands\\tO\\n,\\tO\\na\\tO\\nmaximum\\tO\\nlod\\tO\\nscore\\tO\\n(\\tO\\nZmax\\tO\\n)\\tO\\nof\\tO\\n22\\tO\\n.\\tO\\n\\n8\\tO\\nat\\tO\\na\\tO\\nrecombination\\tO\\nfrequency\\tO\\n(\\tO\\ntheta\\tO\\n)\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n03\\tO\\nwas\\tO\\nobtained\\tO\\n.\\tO\\n\\nTight\\tO\\nlinkage\\tO\\nwas\\tO\\nalso\\tO\\ndemonstrated\\tO\\nfor\\tO\\nCKMM\\tO\\nand\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\napolipoprotein\\tO\\nC2\\tO\\n(\\tO\\nApoC2\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nestablishes\\tO\\nCKMM\\tO\\nas\\tO\\na\\tO\\nuseful\\tO\\nmarker\\tO\\nfor\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n\\nColor\\tB-Disease\\nvision\\tI-Disease\\ndefects\\tI-Disease\\nin\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nrelationship\\tO\\nbetween\\tO\\nabnormal\\tB-Disease\\ncolor\\tI-Disease\\nvision\\tI-Disease\\nand\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n(\\tO\\nAMN\\tB-Disease\\n)\\tO\\nwas\\tO\\ninvestigated\\tO\\nin\\tO\\n27\\tO\\nAMN\\tB-Disease\\npatients\\tO\\nand\\tO\\n31\\tO\\nage\\tO\\n-\\tO\\nmatched\\tO\\ncontrols\\tO\\nby\\tO\\nusing\\tO\\nthe\\tO\\nFarnsworth\\tO\\n-\\tO\\nMunsell\\tO\\n100\\tO\\nHue\\tO\\ntest\\tO\\n.\\tO\\n\\nTwelve\\tO\\n(\\tO\\n44\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n27\\tO\\npatients\\tO\\nshowed\\tO\\ntest\\tO\\nscores\\tO\\nsignificantly\\tO\\nabove\\tO\\nnormal\\tO\\n.\\tO\\n\\nThe\\tO\\naxes\\tO\\nof\\tO\\nbipolarity\\tO\\ndetermined\\tO\\nby\\tO\\nthe\\tO\\ntesting\\tO\\ndiffered\\tO\\nwidely\\tO\\nbetween\\tO\\nthe\\tO\\npatients\\tO\\nwith\\tO\\nabnormal\\tO\\nscores\\tO\\n,\\tO\\ncompatible\\tO\\nwith\\tO\\nthe\\tO\\nnotion\\tO\\nthat\\tO\\ndifferent\\tO\\nalterations\\tO\\nin\\tO\\nvisual\\tO\\npigment\\tO\\ngenes\\tO\\noccur\\tO\\nin\\tO\\ndifferent\\tO\\nAMN\\tB-Disease\\nkindreds\\tO\\n.\\tO\\n\\nThese\\tO\\nobservations\\tO\\nconfirm\\tO\\nour\\tO\\nearlier\\tO\\nimpression\\tO\\nthat\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nabnormal\\tB-Disease\\ncolor\\tI-Disease\\nvision\\tI-Disease\\nis\\tO\\nincreased\\tO\\nin\\tO\\nthese\\tO\\nkindreds\\tO\\n,\\tO\\nand\\tO\\nit\\tO\\nsupports\\tO\\nour\\tO\\ncontentions\\tO\\nthat\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nAMN\\tB-Disease\\n(\\tO\\nand\\tO\\nits\\tO\\ncompanion\\tO\\n,\\tO\\nadrenoleukodystrophy\\tB-Disease\\n)\\tO\\nare\\tO\\nvery\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nvisual\\tO\\npigment\\tO\\nloci\\tO\\nat\\tO\\nXq28\\tO\\nand\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nthis\\tO\\nproximity\\tO\\nmight\\tO\\nprovide\\tO\\nthe\\tO\\nopportunity\\tO\\nto\\tO\\nobserve\\tO\\ncontiguous\\tB-Disease\\ngene\\tI-Disease\\ndefects\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nanalysis\\tO\\nof\\tO\\na\\tO\\nfemale\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\npatient\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nfemale\\tO\\npatient\\tO\\nwith\\tO\\nthe\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nrecessive\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nhypoxanthine\\tB-Disease\\nphosphoribosyltransferase\\tI-Disease\\n[\\tI-Disease\\nHPRT\\tI-Disease\\n]\\tI-Disease\\ndeficiency\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nCytogenetic\\tO\\nand\\tO\\ncarrier\\tO\\nstudies\\tO\\nrevealed\\tO\\nstructurally\\tO\\nnormal\\tO\\nchromosomes\\tO\\nfor\\tO\\nthis\\tO\\npatient\\tO\\nand\\tO\\nher\\tO\\nparents\\tO\\nand\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthis\\tO\\nmutation\\tO\\narose\\tO\\nthrough\\tO\\na\\tO\\nde\\tO\\nnovo\\tO\\ngametic\\tO\\nevent\\tO\\n.\\tO\\n\\nComparison\\tO\\nof\\tO\\nthis\\tO\\npatients\\tO\\nDNA\\tO\\nwith\\tO\\nthe\\tO\\nDNA\\tO\\nof\\tO\\nher\\tO\\nparents\\tO\\nrevealed\\tO\\nthat\\tO\\na\\tO\\nmicrodeletion\\tO\\n,\\tO\\nwhich\\tO\\noccurred\\tO\\nwithin\\tO\\na\\tO\\nmaternal\\tO\\ngamete\\tO\\nand\\tO\\ninvolved\\tO\\nthe\\tO\\nentire\\tO\\nHPRT\\tO\\ngene\\tO\\n,\\tO\\nwas\\tO\\npartially\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\ndisease\\tO\\nin\\tO\\nthis\\tO\\npatient\\tO\\n.\\tO\\n\\nSomatic\\tO\\ncell\\tO\\nhybrids\\tO\\n,\\tO\\ngenerated\\tO\\nto\\tO\\nseparate\\tO\\nmaternal\\tO\\nand\\tO\\npaternal\\tO\\nX\\tO\\nchromosomes\\tO\\n,\\tO\\nshowed\\tO\\nthat\\tO\\nexpression\\tO\\nof\\tO\\ntwo\\tO\\nadditional\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nenzymes\\tO\\n,\\tO\\nphosphoglycerate\\tO\\nkinase\\tO\\nand\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n,\\tO\\nwere\\tO\\nexpressed\\tO\\nonly\\tO\\nin\\tO\\ncells\\tO\\nthat\\tO\\ncontained\\tO\\nthe\\tO\\nmaternal\\tO\\nX\\tO\\nchromosome\\tO\\n,\\tO\\nsuggesting\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nfunctionally\\tO\\ninactive\\tO\\npaternal\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\ncomparison\\tO\\nof\\tO\\nmethylation\\tO\\npatterns\\tO\\nwithin\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nHPRT\\tO\\ngene\\tO\\nknown\\tO\\nto\\tO\\nbe\\tO\\nimportant\\tO\\nin\\tO\\ngene\\tO\\nregulation\\tO\\nrevealed\\tO\\ndifferences\\tO\\nbetween\\tO\\nDNA\\tO\\nfrom\\tO\\nthe\\tO\\nfather\\tO\\nand\\tO\\nthe\\tO\\npatient\\tO\\n,\\tO\\nin\\tO\\nkeeping\\tO\\nwith\\tO\\nan\\tO\\nactive\\tO\\nHPRT\\tO\\nlocus\\tO\\nin\\tO\\nthe\\tO\\nfather\\tO\\nand\\tO\\nan\\tO\\ninactive\\tO\\nHPRT\\tO\\nlocus\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\n.\\tO\\n\\nTogether\\tO\\nthese\\tO\\ndata\\tO\\nindicate\\tO\\nthat\\tO\\nnonrandom\\tO\\ninactivation\\tO\\nof\\tO\\nthe\\tO\\ncytogenetically\\tO\\nnormal\\tO\\npaternal\\tO\\nX\\tO\\nchromosome\\tO\\nand\\tO\\na\\tO\\nmicrodeletion\\tO\\nof\\tO\\nthe\\tO\\nHPRT\\tO\\ngene\\tO\\non\\tO\\nan\\tO\\nactive\\tO\\nmaternal\\tO\\nX\\tO\\nchromosome\\tO\\nwere\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nHPRT\\tO\\nin\\tO\\nthis\\tO\\npatient\\tO\\n.\\tO\\n.\\tO\\n\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n:\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nneurologic\\tI-Disease\\ndisorder\\tI-Disease\\nof\\tI-Disease\\nmyelin\\tI-Disease\\nmetabolism\\tI-Disease\\nwith\\tO\\na\\tO\\nnovel\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nencoding\\tO\\nproteolipid\\tO\\nprotein\\tO\\n.\\tO\\n\\nThe\\tO\\nnosology\\tO\\nof\\tO\\nthe\\tO\\ninborn\\tB-Disease\\nerrors\\tI-Disease\\nof\\tI-Disease\\nmyelin\\tI-Disease\\nmetabolism\\tI-Disease\\nhas\\tO\\nbeen\\tO\\nstymied\\tO\\nby\\tO\\nthe\\tO\\nlack\\tO\\nof\\tO\\nmolecular\\tO\\ngenetic\\tO\\nanalysis\\tO\\n.\\tO\\n\\nHistorically\\tO\\n,\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\nhas\\tO\\nencompassed\\tO\\na\\tO\\nhost\\tO\\nof\\tO\\nneurologic\\tB-Disease\\ndisorders\\tI-Disease\\nthat\\tO\\npresent\\tO\\nwith\\tO\\na\\tO\\ndeficit\\tB-Disease\\nof\\tI-Disease\\nmyelin\\tI-Disease\\n,\\tO\\nthe\\tO\\nmembrane\\tO\\nelaborated\\tO\\nby\\tO\\nglial\\tO\\ncells\\tO\\nthat\\tO\\nencircles\\tO\\nand\\tO\\nsuccessively\\tO\\nenwraps\\tO\\naxons\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nhere\\tO\\na\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\npedigree\\tO\\nof\\tO\\nthe\\tO\\nclassical\\tO\\ntype\\tO\\n,\\tO\\nwith\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\ninheritance\\tO\\n,\\tO\\na\\tO\\ntypical\\tO\\nclinical\\tO\\nprogression\\tO\\n,\\tO\\nand\\tO\\na\\tO\\npathologic\\tO\\nloss\\tO\\nof\\tO\\nmyelinating\\tO\\ncells\\tO\\nand\\tO\\nmyelin\\tO\\nin\\tO\\nthe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n.\\tO\\n\\nTo\\tO\\ndiscriminate\\tO\\nvariants\\tO\\nof\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\na\\tO\\nset\\tO\\nof\\tO\\noligonucleotide\\tO\\nprimers\\tO\\nwas\\tO\\nconstructed\\tO\\nto\\tO\\npolymerase\\tO\\n-\\tO\\nchain\\tO\\n-\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\namplify\\tO\\nand\\tO\\nsequence\\tO\\nthe\\tO\\ngene\\tO\\nencoding\\tO\\nproteolipid\\tO\\nprotein\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\n,\\tO\\na\\tO\\nstructural\\tO\\nprotein\\tO\\nthat\\tO\\ncomprises\\tO\\nhalf\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\nof\\tO\\nthe\\tO\\nmyelin\\tO\\nsheath\\tO\\n.\\tO\\n\\nThe\\tO\\nPLP\\tO\\ngene\\tO\\nin\\tO\\none\\tO\\nof\\tO\\ntwo\\tO\\naffected\\tO\\nmales\\tO\\nand\\tO\\nthe\\tO\\ncarrier\\tO\\nmother\\tO\\nof\\tO\\nthis\\tO\\nfamily\\tO\\nexhibited\\tO\\na\\tO\\nsingle\\tO\\nbase\\tO\\ndifference\\tO\\nin\\tO\\nthe\\tO\\nmore\\tO\\nthan\\tO\\n2\\tO\\nkb\\tO\\nof\\tO\\nthe\\tO\\nPLP\\tO\\ngene\\tO\\nsequenced\\tO\\n,\\tO\\na\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nT\\tO\\ntransition\\tO\\nthat\\tO\\nwould\\tO\\ncreate\\tO\\na\\tO\\nserine\\tO\\nsubstitution\\tO\\nfor\\tO\\nproline\\tO\\nat\\tO\\nthe\\tO\\ncarboxy\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\ndelineate\\tO\\nthe\\tO\\nclinical\\tO\\nfeatures\\tO\\nof\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\ndefine\\tO\\nthe\\tO\\npossible\\tO\\nmolecular\\tO\\npathology\\tO\\nof\\tO\\nthis\\tO\\ndysmyelinating\\tB-Disease\\ndisorder\\tI-Disease\\n,\\tO\\nand\\tO\\naddress\\tO\\nthe\\tO\\nmolecular\\tO\\nclassification\\tO\\nof\\tO\\ninborn\\tB-Disease\\nerrors\\tI-Disease\\nof\\tI-Disease\\nmyelin\\tI-Disease\\nmetabolism\\tI-Disease\\n.\\tO\\n\\nPatients\\tO\\nwith\\tO\\nthe\\tO\\nclassical\\tO\\nform\\tO\\n(\\tO\\ntype\\tO\\nI\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nmore\\tO\\nseverely\\tO\\naffected\\tO\\n,\\tO\\nconnatal\\tO\\nvariant\\tO\\nof\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n(\\tI-Disease\\ntype\\tI-Disease\\nII\\tI-Disease\\n)\\tI-Disease\\nwould\\tO\\nbe\\tO\\npredicted\\tO\\nto\\tO\\ndisplay\\tO\\nmutation\\tO\\nat\\tO\\nthe\\tO\\nPLP\\tO\\nlocus\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nvariants\\tO\\n(\\tO\\ntypes\\tO\\nIII\\tO\\n-\\tO\\nVI\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nhave\\tO\\nsometimes\\tO\\nbeen\\tO\\ncategorized\\tO\\nas\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nmay\\tO\\nrepresent\\tO\\nmutations\\tO\\nin\\tO\\ngenes\\tO\\nencoding\\tO\\nother\\tO\\nstructural\\tO\\nmyelin\\tO\\nproteins\\tO\\nor\\tO\\nproteins\\tO\\ncritical\\tO\\nto\\tO\\nmyelination\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbasis\\tO\\nof\\tO\\nhuman\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\n:\\tO\\nanalysis\\tO\\nof\\tO\\nplatelet\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\nmRNA\\tO\\n.\\tO\\n\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nvWD\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\ninherited\\tB-Disease\\nbleeding\\tI-Disease\\ndisorder\\tI-Disease\\nin\\tO\\nhumans\\tO\\n,\\tO\\ncan\\tO\\nresult\\tO\\nfrom\\tO\\neither\\tO\\na\\tO\\nquantitative\\tO\\nor\\tO\\na\\tO\\nqualitative\\tO\\ndefect\\tO\\nin\\tO\\nthe\\tO\\nadhesive\\tO\\nglycoprotein\\tO\\n,\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\n(\\tO\\nvWF\\tO\\n)\\tO\\n.\\tO\\n\\nMolecular\\tO\\nstudies\\tO\\nof\\tO\\nvWD\\tB-Disease\\nhave\\tO\\nbeen\\tO\\nlimited\\tO\\nby\\tO\\nthe\\tO\\nlarge\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\nvWF\\tO\\ngene\\tO\\nand\\tO\\ndifficulty\\tO\\nin\\tO\\nobtaining\\tO\\nthe\\tO\\nvWF\\tO\\nmRNA\\tO\\nfrom\\tO\\npatients\\tO\\n.\\tO\\n\\nBy\\tO\\nuse\\tO\\nof\\tO\\nan\\tO\\nadaptation\\tO\\nof\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n,\\tO\\nvWF\\tO\\nmRNA\\tO\\nwas\\tO\\namplified\\tO\\nand\\tO\\nsequenced\\tO\\nfrom\\tO\\nperipheral\\tO\\nblood\\tO\\nplatelets\\tO\\n.\\tO\\n\\nA\\tO\\nsilent\\tO\\nvWF\\tO\\nallele\\tO\\nwas\\tO\\nidentified\\tO\\n,\\tO\\nresulting\\tO\\nfrom\\tO\\na\\tO\\ncis\\tO\\ndefect\\tO\\nin\\tO\\nvWF\\tO\\nmRNA\\tO\\ntranscription\\tO\\nor\\tO\\nprocessing\\tO\\n.\\tO\\n\\nIn\\tO\\ntwo\\tO\\ntype\\tB-Disease\\nIIA\\tI-Disease\\nvWD\\tI-Disease\\npatients\\tO\\n,\\tO\\ntwo\\tO\\ndifferent\\tO\\nbut\\tO\\nadjacent\\tO\\nmissense\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\n,\\tO\\nthe\\tO\\nlocations\\tO\\nof\\tO\\nwhich\\tO\\nmay\\tO\\nidentify\\tO\\nan\\tO\\nimportant\\tO\\nvWF\\tO\\nfunctional\\tO\\ndomain\\tO\\n.\\tO\\n\\nExpression\\tO\\nin\\tO\\nheterologous\\tO\\ncells\\tO\\nof\\tO\\nrecombinant\\tO\\nvWF\\tO\\ncontaining\\tO\\none\\tO\\nof\\tO\\nthese\\tO\\nlatter\\tO\\nmutations\\tO\\nreproduced\\tO\\nthe\\tO\\ncharacteristic\\tO\\nstructural\\tO\\nabnormality\\tO\\nseen\\tO\\nin\\tO\\ntype\\tB-Disease\\nIIA\\tI-Disease\\nvWD\\tI-Disease\\nplasma\\tO\\n.\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nseventh\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nrecurrent\\tO\\nmeningococcal\\tB-Disease\\ninfections\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nan\\tO\\n11\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\ngirl\\tO\\nsuffering\\tO\\nfrom\\tO\\nrecurrent\\tB-Disease\\nmeningitis\\tI-Disease\\nwith\\tO\\na\\tO\\ncomplete\\tO\\nabsence\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nseventh\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC7\\tO\\n)\\tO\\n.\\tO\\n\\nDiagnosis\\tO\\nwas\\tO\\nestablished\\tO\\nby\\tO\\nhaemolytic\\tO\\ntitration\\tO\\nand\\tO\\nwestern\\tO\\nblotting\\tO\\n.\\tO\\n\\nThe\\tO\\npatients\\tO\\nserum\\tO\\nlacked\\tO\\nthe\\tO\\n85\\tO\\nkDa\\tO\\nC7\\tO\\nchain\\tO\\n.\\tO\\n\\nHaemolytic\\tO\\nactivity\\tO\\nof\\tO\\nserum\\tO\\nwas\\tO\\nreconstituted\\tO\\nwith\\tO\\neither\\tO\\npooled\\tO\\nnormal\\tO\\nhuman\\tO\\nserum\\tO\\nor\\tO\\nwith\\tO\\npurified\\tO\\nC7\\tO\\n.\\tO\\n\\nThe\\tO\\nrelatives\\tO\\n(\\tO\\nparents\\tO\\nand\\tO\\none\\tO\\nsister\\tO\\n)\\tO\\nhad\\tO\\nhalf\\tO\\n-\\tO\\nnormal\\tO\\nlevels\\tO\\nof\\tO\\nboth\\tO\\nimmunochemically\\tO\\nand\\tO\\nfunctionally\\tO\\ndetermined\\tO\\nC7\\tO\\n,\\tO\\nindicating\\tO\\na\\tO\\nheterozygous\\tO\\nstate\\tO\\nfor\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nTranslocation\\tO\\nt\\tO\\n(\\tO\\n5\\tO\\n;\\tO\\n11\\tO\\n)\\tO\\n(\\tO\\nq13\\tO\\n.\\tO\\n1\\tO\\n;\\tO\\np13\\tO\\n)\\tO\\nassociated\\tO\\nwith\\tO\\nfamilial\\tO\\nisolated\\tB-Disease\\naniridia\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nfather\\tO\\nand\\tO\\ndaughter\\tO\\nwith\\tO\\nisolated\\tB-Disease\\naniridia\\tI-Disease\\nwere\\tO\\nobserved\\tO\\nto\\tO\\nhave\\tO\\nan\\tO\\napparently\\tO\\nbalanced\\tO\\n,\\tO\\nreciprocal\\tO\\ntranslocation\\tO\\ninvolving\\tO\\nchromosomes\\tO\\n5\\tO\\nand\\tO\\n11\\tO\\n[\\tO\\nt\\tO\\n(\\tO\\n5\\tO\\n;\\tO\\n11\\tO\\n)\\tO\\n(\\tO\\nq13\\tO\\n.\\tO\\n1\\tO\\n;\\tO\\np13\\tO\\n)\\tO\\n]\\tO\\n.\\tO\\n\\nNo\\tO\\nother\\tO\\nclinical\\tO\\ncharacteristics\\tO\\noften\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\ndeletion\\tO\\nof\\tO\\n11p13\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n.\\tO\\n\\nThis\\tO\\nfinding\\tO\\n,\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\n3\\tO\\nother\\tO\\ninstances\\tO\\nof\\tO\\nsingle\\tO\\nbreaks\\tO\\nat\\tO\\n11p13\\tO\\nand\\tO\\naniridia\\tB-Disease\\n,\\tO\\nsupports\\tO\\nthe\\tO\\nassignment\\tO\\nof\\tO\\nAN2\\tO\\nto\\tO\\n11p13\\tO\\n.\\tO\\n\\nHomozygous\\tB-Disease\\nhypobetalipoproteinemia\\tI-Disease\\n:\\tO\\na\\tO\\ndisease\\tO\\ndistinct\\tO\\nfrom\\tO\\nabetalipoproproteinemia\\tB-Disease\\nat\\tO\\nthe\\tO\\nmolecular\\tO\\nlevel\\tO\\n.\\tO\\n\\napoB\\tO\\nDNA\\tO\\n,\\tO\\nRNA\\tO\\n,\\tO\\nand\\tO\\nprotein\\tO\\nfrom\\tO\\ntwo\\tO\\npatients\\tO\\nwith\\tO\\nhomozygous\\tB-Disease\\nhypobetalipoproteinemia\\tI-Disease\\n(\\tO\\nHBL\\tB-Disease\\n)\\tO\\nwere\\tO\\nevaluated\\tO\\nand\\tO\\ncompared\\tO\\nwith\\tO\\nnormal\\tO\\nindividuals\\tO\\n.\\tO\\n\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\nwith\\tO\\n10\\tO\\ndifferent\\tO\\ncDNA\\tO\\nprobes\\tO\\nrevealed\\tO\\na\\tO\\nnormal\\tO\\ngene\\tO\\nwithout\\tO\\nmajor\\tO\\ninsertions\\tO\\n,\\tO\\ndeletions\\tO\\n,\\tO\\nor\\tO\\nrearrangements\\tO\\n.\\tO\\n\\nNorthern\\tO\\nand\\tO\\nslot\\tO\\nblot\\tO\\nanalyses\\tO\\nof\\tO\\ntotal\\tO\\nliver\\tO\\nmRNA\\tO\\nfrom\\tO\\nHBL\\tB-Disease\\npatients\\tO\\ndocumented\\tO\\na\\tO\\nnormal\\tO\\nsize\\tO\\napoB\\tO\\nmRNA\\tO\\nthat\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\ngreatly\\tO\\nreduced\\tO\\nquantities\\tO\\n.\\tO\\n\\nApoB\\tO\\nprotein\\tO\\nwas\\tO\\ndetected\\tO\\nwithin\\tO\\nHBL\\tB-Disease\\nhepatocytes\\tO\\nutilizing\\tO\\nimmunohistochemical\\tO\\ntechniques\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nit\\tO\\nwas\\tO\\nmarkedly\\tO\\nreduced\\tO\\nin\\tO\\nquantity\\tO\\nwhen\\tO\\ncompared\\tO\\nwith\\tO\\ncontrol\\tO\\nsamples\\tO\\n.\\tO\\n\\nNo\\tO\\napoB\\tO\\nwas\\tO\\ndetectable\\tO\\nin\\tO\\nthe\\tO\\nplasma\\tO\\nof\\tO\\nHBL\\tB-Disease\\nindividuals\\tO\\nwith\\tO\\nan\\tO\\nELISA\\tO\\nassay\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nare\\tO\\nmost\\tO\\nconsistent\\tO\\nwith\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nportion\\tO\\nof\\tO\\nthe\\tO\\napoB\\tO\\ngene\\tO\\nin\\tO\\nHBL\\tB-Disease\\npatients\\tO\\n,\\tO\\nleading\\tO\\nto\\tO\\nan\\tO\\nabnormal\\tO\\napoB\\tO\\nprotein\\tO\\nand\\tO\\napoB\\tO\\nmRNA\\tO\\ninstability\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nare\\tO\\ndistinct\\tO\\nfrom\\tO\\nthose\\tO\\npreviously\\tO\\nnoted\\tO\\nin\\tO\\nabetalipoproteinemia\\tB-Disease\\n,\\tO\\nwhich\\tO\\nwas\\tO\\ncharacterized\\tO\\nby\\tO\\nan\\tO\\nelevated\\tO\\nlevel\\tO\\nof\\tO\\nhepatic\\tO\\napoB\\tO\\nmRNA\\tO\\nand\\tO\\naccumulation\\tO\\nof\\tO\\nintracellular\\tO\\nhepatic\\tO\\napoB\\tO\\nprotein\\tO\\n.\\tO\\n.\\tO\\n\\nSpontaneous\\tO\\nreversion\\tO\\nof\\tO\\nnovel\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nmutation\\tO\\nby\\tO\\nHPRT\\tO\\ngene\\tO\\nrearrangement\\tO\\n.\\tO\\n\\nMolecular\\tO\\nanalysis\\tO\\nof\\tO\\nan\\tO\\nunusual\\tO\\npatient\\tO\\nwith\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\nhas\\tO\\nsuggested\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\nis\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\npartial\\tO\\nHPRT\\tO\\ngene\\tO\\nduplication\\tO\\n.\\tO\\n\\nWe\\tO\\nnow\\tO\\nreport\\tO\\nthe\\tO\\ncloning\\tO\\nand\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nHPRT\\tO\\ncDNA\\tO\\nwhich\\tO\\nshows\\tO\\nthe\\tO\\nprecise\\tO\\nduplication\\tO\\nof\\tO\\nexons\\tO\\n2\\tO\\nand\\tO\\n3\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nis\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\nan\\tO\\ninternal\\tO\\nduplication\\tO\\nof\\tO\\n16\\tO\\n-\\tO\\n20\\tO\\nkilobases\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\ngene\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nduplication\\tO\\nwas\\tO\\nnot\\tO\\ngenerated\\tO\\nby\\tO\\na\\tO\\nsingle\\tO\\nunequal\\tO\\ncrossing\\tO\\n-\\tO\\nover\\tO\\nevent\\tO\\nbetween\\tO\\ntwo\\tO\\nnormal\\tO\\nHPRT\\tO\\nalleles\\tO\\n.\\tO\\n\\nGrowth\\tO\\nof\\tO\\nEpstein\\tB-Disease\\n-\\tI-Disease\\nBarr\\tI-Disease\\nvirus\\tO\\n-\\tO\\ntransformed\\tO\\nlymphoblasts\\tO\\nfrom\\tO\\nthis\\tO\\npatient\\tO\\nin\\tO\\nselective\\tO\\nmedium\\tO\\nhas\\tO\\npermitted\\tO\\nisolation\\tO\\nof\\tO\\nspontaneous\\tO\\nHPRT\\tO\\n+\\tO\\nrevertants\\tO\\nof\\tO\\nthis\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nreversion\\tO\\nevent\\tO\\ninvolves\\tO\\na\\tO\\nsecond\\tO\\nmajor\\tO\\nHPRT\\tO\\ngene\\tO\\nrearrangement\\tO\\nwhere\\tO\\nmost\\tO\\nor\\tO\\nall\\tO\\nof\\tO\\nthe\\tO\\nduplicated\\tO\\nportion\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\ngene\\tO\\nis\\tO\\ndeleted\\tO\\n.\\tO\\n\\nThe\\tO\\noriginal\\tO\\nmutation\\tO\\ntherefore\\tO\\nhas\\tO\\nthe\\tO\\npotential\\tO\\nfor\\tO\\nspontaneous\\tO\\nsomatic\\tO\\nreversion\\tO\\n.\\tO\\n\\nThis\\tO\\nmay\\tO\\nexplain\\tO\\nthe\\tO\\nrelatively\\tO\\nmild\\tO\\nsymptoms\\tO\\nof\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\nexhibited\\tO\\nby\\tO\\nthis\\tO\\npatient\\tO\\n.\\tO\\n.\\tO\\n\\nComplex\\tB-Disease\\nglycerol\\tI-Disease\\nkinase\\tI-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\nmolecular\\tO\\n-\\tO\\ngenetic\\tO\\n,\\tO\\ncytogenetic\\tO\\n,\\tO\\nand\\tO\\nclinical\\tO\\nstudies\\tO\\nof\\tO\\nfive\\tO\\nJapanese\\tO\\npatients\\tO\\n.\\tO\\n\\nFive\\tO\\nmale\\tO\\nJapanese\\tO\\npatients\\tO\\nwith\\tO\\ncomplex\\tB-Disease\\nglycerol\\tI-Disease\\nkinase\\tI-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nCGKD\\tB-Disease\\n)\\tO\\nand\\tO\\ntheir\\tO\\nrelatives\\tO\\nwere\\tO\\nstudied\\tO\\nclinically\\tO\\n,\\tO\\ncytogenetically\\tO\\n,\\tO\\nand\\tO\\nmolecular\\tO\\n-\\tO\\ngenetically\\tO\\n.\\tO\\n\\nAll\\tO\\npatients\\tO\\nhad\\tO\\nmuscular\\tB-Disease\\ndystrophy\\tI-Disease\\nor\\tO\\nmuscle\\tB-Disease\\nweakness\\tI-Disease\\n,\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\ncongenital\\tB-Disease\\nadrenal\\tI-Disease\\nhypoplasia\\tI-Disease\\n,\\tO\\nand\\tO\\nglycerol\\tB-Disease\\nkinase\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nHigh\\tO\\n-\\tO\\nresolution\\tO\\nGTG\\tO\\n-\\tO\\nbanded\\tO\\nchromosomes\\tO\\nshowed\\tO\\na\\tO\\nmicrodeletion\\tO\\nin\\tO\\nthe\\tO\\nXp21\\tO\\nregion\\tO\\nin\\tO\\nall\\tO\\nfour\\tO\\npatients\\tO\\nexamined\\tO\\nand\\tO\\nin\\tO\\nall\\tO\\nfive\\tO\\nmothers\\tO\\n.\\tO\\n\\nSouthern\\tO\\nhybridizations\\tO\\n,\\tO\\nafter\\tO\\ndigestions\\tO\\nby\\tO\\nrestriction\\tO\\nendonucleases\\tO\\n,\\tO\\nwith\\tO\\nvarious\\tO\\ncloned\\tO\\nDNAs\\tO\\n(\\tO\\nD2\\tO\\n,\\tO\\n99\\tO\\n-\\tO\\n6\\tO\\n,\\tO\\nB24\\tO\\n,\\tO\\nC7\\tO\\n,\\tO\\nL1\\tO\\n-\\tO\\n4\\tO\\n,\\tO\\ncDMD13\\tO\\n-\\tO\\n14\\tO\\n,\\tO\\nJ66\\tO\\n-\\tO\\nHI\\tO\\n,\\tO\\nP20\\tO\\n,\\tO\\nJ\\tO\\n-\\tO\\nBir\\tO\\n,\\tO\\nERT87\\tO\\n-\\tO\\n30\\tO\\n,\\tO\\nERT87\\tO\\n-\\tO\\n15\\tO\\n,\\tO\\nERT87\\tO\\n-\\tO\\n8\\tO\\n,\\tO\\nERT87\\tO\\n-\\tO\\n1\\tO\\n,\\tO\\nXJ\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n1\\tO\\n,\\tO\\n754\\tO\\n,\\tO\\ncx5\\tO\\n.\\tO\\n7\\tO\\n,\\tO\\nand\\tO\\nOTC\\tO\\n-\\tO\\n1\\tO\\n)\\tO\\nthat\\tO\\nare\\tO\\nlocated\\tO\\naround\\tO\\nXp21\\tO\\nalso\\tO\\nshowed\\tO\\na\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\ngenome\\tO\\nof\\tO\\nall\\tO\\npatients\\tO\\nand\\tO\\nmothers\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\ndeletion\\tO\\ndiffered\\tO\\nin\\tO\\nsize\\tO\\namong\\tO\\npatients\\tO\\n,\\tO\\na\\tO\\nsegment\\tO\\ncommonly\\tO\\nabsent\\tO\\nwas\\tO\\nlocated\\tO\\nbetween\\tO\\nthe\\tO\\ngenomic\\tO\\nsequences\\tO\\ncorresponding\\tO\\nto\\tO\\nL1\\tO\\n-\\tO\\n4\\tO\\nand\\tO\\ncDMD13\\tO\\n-\\tO\\n14\\tO\\n.\\tO\\n\\nThis\\tO\\nfinding\\tO\\nindicated\\tO\\nthat\\tO\\nthe\\tO\\ngene\\tO\\ncoding\\tO\\nfor\\tO\\nglycerol\\tO\\nkinase\\tO\\n(\\tO\\nGK\\tO\\n)\\tO\\nis\\tO\\nlocated\\tO\\nwithin\\tO\\nthis\\tO\\nsegment\\tO\\n.\\tO\\n\\nA\\tO\\ncomparison\\tO\\nof\\tO\\nthe\\tO\\nclinical\\tO\\nmanifestations\\tO\\nof\\tO\\nthe\\tO\\npresent\\tO\\nfive\\tO\\npatients\\tO\\nand\\tO\\nreported\\tO\\nCGKD\\tB-Disease\\nor\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\npatients\\tO\\nwith\\tO\\nDNA\\tO\\ndeletion\\tO\\nsuggests\\tO\\nthe\\tO\\nexistence\\tO\\nof\\tO\\na\\tO\\ncertain\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\ngonadotropin\\tB-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nGTD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nresult\\tO\\nof\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\nand\\tO\\nresults\\tO\\nof\\tO\\nprevious\\tO\\nstudies\\tO\\nsuggest\\tO\\nthat\\tO\\ngenes\\tO\\nfor\\tO\\nornithine\\tO\\ntranscarbamylase\\tO\\n(\\tO\\nOTC\\tO\\n)\\tO\\n,\\tO\\nDMD\\tB-Disease\\n,\\tO\\nand\\tO\\nGK\\tO\\nand\\tO\\nputative\\tO\\ngenes\\tO\\nresponsible\\tO\\nfor\\tO\\ncongenital\\tB-Disease\\nadrenal\\tI-Disease\\nhypoplasia\\tI-Disease\\n(\\tO\\nAHC\\tB-Disease\\n)\\tO\\nand\\tO\\nGTD\\tB-Disease\\nare\\tO\\narranged\\tO\\nfrom\\tO\\ntelomere\\tO\\nto\\tO\\ncentromere\\tO\\nas\\tO\\npter\\tO\\n-\\tO\\n-\\tO\\nGTD\\tO\\n-\\tO\\n-\\tO\\nAHC\\tO\\n-\\tO\\n-\\tO\\nGK\\tO\\n-\\tO\\n-\\tO\\nDMD\\tO\\n-\\tO\\n-\\tO\\nOTC\\tO\\n-\\tO\\n-\\tO\\ncen\\tO\\n\\nGenetically\\tO\\ndetermined\\tO\\nlow\\tO\\nC4\\tO\\n:\\tO\\na\\tO\\npredisposing\\tO\\nfactor\\tO\\nto\\tO\\nautoimmune\\tB-Disease\\nchronic\\tI-Disease\\nactive\\tI-Disease\\nhepatitis\\tI-Disease\\n.\\tO\\n\\nOf\\tO\\n26\\tO\\npatients\\tO\\nwith\\tO\\nautoimmune\\tB-Disease\\nchronic\\tI-Disease\\nactive\\tI-Disease\\nhepatitis\\tI-Disease\\n(\\tO\\nCAH\\tB-Disease\\n)\\tO\\nstarting\\tO\\nin\\tO\\nchildhood\\tO\\n18\\tO\\n(\\tO\\n69\\tO\\n%\\tO\\n)\\tO\\nhad\\tO\\nlow\\tO\\nC4\\tO\\nand\\tO\\n5\\tO\\n(\\tO\\n19\\tO\\n%\\tO\\n)\\tO\\nhad\\tO\\nlow\\tO\\nC3\\tO\\nserum\\tO\\nlevels\\tO\\n.\\tO\\n\\nImpaired\\tO\\nhepatic\\tO\\nsynthesis\\tO\\nand\\tO\\nimmune\\tO\\n-\\tO\\nconsumption\\tO\\nwere\\tO\\nunlikely\\tO\\nsince\\tO\\ntransferrin\\tO\\nlevels\\tO\\nwere\\tO\\nnormal\\tO\\nin\\tO\\nall\\tO\\npatients\\tO\\n,\\tO\\nalbumin\\tO\\nlevels\\tO\\nwere\\tO\\npersistently\\tO\\nlow\\tO\\nin\\tO\\nonly\\tO\\n3\\tO\\n,\\tO\\nand\\tO\\nonly\\tO\\n3\\tO\\nhad\\tO\\nraised\\tO\\nlevels\\tO\\nof\\tO\\nactivation\\tO\\nfragment\\tO\\nC3d\\tO\\n.\\tO\\n\\nC4d\\tO\\nwas\\tO\\nnormal\\tO\\nin\\tO\\nall\\tO\\npatients\\tO\\nstudied\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nfamilies\\tO\\nof\\tO\\n12\\tO\\nprobands\\tO\\nwith\\tO\\nlow\\tO\\nC4\\tO\\n,\\tO\\n7\\tO\\nparents\\tO\\nhad\\tO\\nlow\\tO\\nC4\\tO\\nand\\tO\\n2\\tO\\nhad\\tO\\nlevels\\tO\\nwhich\\tO\\nwere\\tO\\nat\\tO\\nthe\\tO\\nlower\\tO\\nlimit\\tO\\nof\\tO\\nnormal\\tO\\n.\\tO\\n\\n5\\tO\\nof\\tO\\n10\\tO\\nsiblings\\tO\\nfrom\\tO\\n5\\tO\\nfamilies\\tO\\nhad\\tO\\nlow\\tO\\nC4\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nlow\\tO\\nC4\\tO\\nlevels\\tO\\nin\\tO\\nCAH\\tB-Disease\\nare\\tO\\ngenetically\\tO\\ndetermined\\tO\\n.\\tO\\n\\nC4\\tO\\nphenotyping\\tO\\nin\\tO\\n20\\tO\\npatients\\tO\\nand\\tO\\nin\\tO\\n26\\tO\\nparents\\tO\\nshowed\\tO\\nthat\\tO\\n90\\tO\\n%\\tO\\nand\\tO\\n81\\tO\\n%\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nhad\\tO\\nnull\\tO\\nallotypes\\tO\\nat\\tO\\neither\\tO\\nthe\\tO\\nC4A\\tO\\nor\\tO\\nC4B\\tO\\nlocus\\tO\\ncompared\\tO\\nwith\\tO\\n59\\tO\\n%\\tO\\nin\\tO\\ncontrols\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\ndefective\\tO\\nexpression\\tO\\nof\\tO\\nstructural\\tO\\ngenes\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\nthe\\tO\\nobserved\\tO\\nC4\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nAn\\tO\\namino\\tO\\n-\\tO\\nacid\\tO\\nsubstitution\\tO\\ninvolved\\tO\\nin\\tO\\nphenylketonuria\\tB-Disease\\nis\\tO\\nin\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nwith\\tO\\nDNA\\tO\\nhaplotype\\tO\\n2\\tO\\n.\\tO\\n\\nPhenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nhuman\\tI-Disease\\ngenetic\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nhepatic\\tI-Disease\\nphenylalanine\\tI-Disease\\nhydroxylase\\tI-Disease\\n(\\tO\\nPAH\\tO\\n,\\tO\\nphenylalanine\\tO\\n4\\tO\\n-\\tO\\nmonooxygenase\\tO\\n,\\tO\\nEC\\tO\\n1\\tO\\n.\\tO\\n14\\tO\\n.\\tO\\n16\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\n.\\tO\\n\\nPKU\\tB-Disease\\nis\\tO\\na\\tO\\ncommon\\tO\\ninborn\\tB-Disease\\nerror\\tI-Disease\\nof\\tI-Disease\\namino\\tI-Disease\\n-\\tI-Disease\\nacid\\tI-Disease\\nmetabolism\\tI-Disease\\nin\\tO\\ncaucasian\\tO\\npopulations\\tO\\nand\\tO\\napproximately\\tO\\n1\\tO\\nin\\tO\\n50\\tO\\nindividuals\\tO\\nare\\tO\\ncarriers\\tO\\nof\\tO\\na\\tO\\nPKU\\tB-Disease\\nallele\\tO\\n.\\tO\\n\\nTo\\tO\\ndefine\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nPKU\\tB-Disease\\n,\\tO\\nwe\\tO\\ncharacterized\\tO\\ntwelve\\tO\\nrestriction\\tO\\nfragment\\tO\\n-\\tO\\nlength\\tO\\npolymorphism\\tO\\n(\\tO\\nRFLP\\tO\\n)\\tO\\nhaplotypes\\tO\\nof\\tO\\nthe\\tO\\nPAH\\tO\\nlocus\\tO\\nin\\tO\\nthe\\tO\\nnorthern\\tO\\nEuropean\\tO\\npopulation\\tO\\nand\\tO\\nobserved\\tO\\nthat\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nPKU\\tB-Disease\\nalleles\\tO\\nin\\tO\\nthis\\tO\\npopulation\\tO\\nare\\tO\\nconfined\\tO\\nto\\tO\\nfour\\tO\\ncommon\\tO\\nRFLP\\tO\\nhaplotypes\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nrecently\\tO\\nreported\\tO\\na\\tO\\nsplicing\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\nthat\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nRFLP\\tO\\nhaplotype\\tO\\n3\\tO\\nwhich\\tO\\nis\\tO\\npresent\\tO\\nat\\tO\\nabout\\tO\\n40\\tO\\n%\\tO\\nof\\tO\\nmutant\\tO\\nalleles\\tO\\n.\\tO\\n\\nWe\\tO\\nnow\\tO\\nreport\\tO\\nthe\\tO\\nmolecular\\tB-Disease\\nlesion\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nRFLP\\tO\\nhaplotype\\tO\\n2\\tO\\nmutant\\tO\\nallele\\tO\\n.\\tO\\n\\nThis\\tO\\ndefect\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\nC\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nT\\tO\\ntransition\\tO\\nin\\tO\\nexon\\tO\\n12\\tO\\nresulting\\tO\\nin\\tO\\nan\\tO\\namino\\tO\\n-\\tO\\nacid\\tO\\nsubstitution\\tO\\n(\\tO\\nArg\\tO\\nto\\tO\\nTrp\\tO\\n)\\tO\\nat\\tO\\nresidue\\tO\\n408\\tO\\nof\\tO\\nPAH\\tO\\n.\\tO\\n\\nDirect\\tO\\nhybridization\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\npoint\\tO\\nmutation\\tO\\nusing\\tO\\na\\tO\\nspecific\\tO\\noligonucleotide\\tO\\nprobe\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthis\\tO\\nmutation\\tO\\nis\\tO\\nalso\\tO\\nin\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nwith\\tO\\nRFLP\\tO\\nhaplotype\\tO\\n2\\tO\\nalleles\\tO\\nthat\\tO\\nmake\\tO\\nup\\tO\\nabout\\tO\\n20\\tO\\n%\\tO\\nof\\tO\\nmutant\\tO\\nPAH\\tO\\ngenes\\tO\\n\\nChoroideremia\\tB-Disease\\n:\\tO\\nclose\\tO\\nlinkage\\tO\\nto\\tO\\nDXYS1\\tO\\nand\\tO\\nDXYS12\\tO\\ndemonstrated\\tO\\nby\\tO\\nsegregation\\tO\\nanalysis\\tO\\nand\\tO\\nhistorical\\tO\\n-\\tO\\ngenealogical\\tO\\nevidence\\tO\\n.\\tO\\n\\nLinkage\\tO\\nstudies\\tO\\nusing\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphisms\\tO\\nwere\\tO\\nconducted\\tO\\nin\\tO\\nthe\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndisorder\\tI-Disease\\n,\\tO\\nchoroideremia\\tB-Disease\\n,\\tO\\ndesignated\\tO\\nTCD\\tB-Disease\\nfor\\tO\\nProgressive\\tB-Disease\\nTapeto\\tI-Disease\\n-\\tI-Disease\\nChoroidal\\tI-Disease\\nDystrophy\\tI-Disease\\n.\\tO\\n\\nPreviously\\tO\\ndemonstrated\\tO\\nclose\\tO\\nlinkage\\tO\\nwith\\tO\\nlocus\\tO\\nDXYS1\\tO\\nwas\\tO\\nconfirmed\\tO\\n(\\tO\\nlod\\tO\\n11\\tO\\n.\\tO\\n44\\tO\\nat\\tO\\n0\\tO\\nrecombination\\tO\\ndistance\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nlocus\\tO\\nDXYS12\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nclosely\\tO\\nlinked\\tO\\nwith\\tO\\nTCD\\tB-Disease\\n(\\tO\\nlod\\tO\\n3\\tO\\n.\\tO\\n31\\tO\\nat\\tO\\n0\\tO\\nrecombination\\tO\\ndistance\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ndisease\\tO\\nmainly\\tO\\noccurs\\tO\\nin\\tO\\nthree\\tO\\nlarge\\tO\\nkindreds\\tO\\nin\\tO\\nremote\\tO\\nNorthern\\tO\\nFinland\\tO\\n.\\tO\\n\\nWhile\\tO\\nformal\\tO\\ngenealogical\\tO\\nproof\\tO\\nis\\tO\\nlacking\\tO\\n,\\tO\\nall\\tO\\npresently\\tO\\nliving\\tO\\n(\\tO\\nmore\\tO\\nthan\\tO\\n80\\tO\\naffected\\tO\\nmales\\tO\\nand\\tO\\n120\\tO\\ncarrier\\tO\\nfemales\\tO\\n)\\tO\\nprobably\\tO\\noriginate\\tO\\nfrom\\tO\\na\\tO\\ncommon\\tO\\nfounder\\tO\\ncouple\\tO\\nborn\\tO\\nin\\tO\\n1644\\tO\\nand\\tO\\n1646\\tO\\n,\\tO\\ntwelve\\tO\\ngenerations\\tO\\nago\\tO\\n.\\tO\\n\\nAll\\tO\\n36\\tO\\npatients\\tO\\nand\\tO\\n48\\tO\\ncarriers\\tO\\ntested\\tO\\nfrom\\tO\\nthe\\tO\\nthree\\tO\\nkindreds\\tO\\nhad\\tO\\nthe\\tO\\nsame\\tO\\nhaplotype\\tO\\n(\\tO\\nTCD\\tB-Disease\\n/\\tO\\nDXYS1\\tO\\n,\\tO\\n11kb\\tO\\n/\\tO\\nDXYS12\\tO\\n,\\tO\\n1\\tO\\n.\\tO\\n6kb\\tO\\n)\\tO\\n.\\tO\\n\\nGiven\\tO\\nthat\\tO\\nat\\tO\\nleast\\tO\\n105\\tO\\nfemale\\tO\\nmeioses\\tO\\ntransmitting\\tO\\nTCD\\tB-Disease\\nhave\\tO\\noccurred\\tO\\nsince\\tO\\n1650\\tO\\nin\\tO\\nthese\\tO\\nkindreds\\tO\\n,\\tO\\nextremely\\tO\\nclose\\tO\\nlinkage\\tO\\nbetween\\tO\\nTCD\\tB-Disease\\n,\\tO\\nDXYS1\\tO\\nand\\tO\\nDXYS12\\tO\\nis\\tO\\nsuggested\\tO\\n.\\tO\\n\\nThe\\tO\\nabove\\tO\\nhaplotype\\tO\\nis\\tO\\na\\tO\\nvery\\tO\\nuseful\\tO\\ndiagnostic\\tO\\ntool\\tO\\nin\\tO\\nthese\\tO\\nTCD\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nsuggest\\tO\\nthat\\tO\\nour\\tO\\nhistorical\\tO\\n-\\tO\\ngenealogical\\tO\\napproach\\tO\\nto\\tO\\nlinkage\\tO\\nanalysis\\tO\\nmay\\tO\\nbe\\tO\\npossible\\tO\\nelsewhere\\tO\\nin\\tO\\nsimilar\\tO\\nisolated\\tO\\npopulations\\tO\\n\\nVon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ndisease\\tI-Disease\\nmaps\\tO\\nto\\tO\\nthe\\tO\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n3\\tO\\nassociated\\tO\\nwith\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\n.\\tO\\n\\nVon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nVHL\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisorder\\tI-Disease\\nwith\\tO\\ninherited\\tO\\nsusceptibility\\tO\\nto\\tO\\nvarious\\tO\\nforms\\tO\\nof\\tO\\ncancer\\tB-Disease\\n,\\tO\\nincluding\\tO\\nhemangioblastomas\\tB-Disease\\nof\\tO\\nthe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n,\\tO\\nphaeochromocytomas\\tB-Disease\\n,\\tO\\npancreatic\\tB-Disease\\nmalignancies\\tI-Disease\\n,\\tO\\nand\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n\\nRenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\nconstitute\\tO\\na\\tO\\nparticularly\\tO\\nfrequent\\tO\\ncause\\tO\\nof\\tO\\ndeath\\tO\\nin\\tO\\nthis\\tO\\ndisorder\\tO\\n,\\tO\\noccurring\\tO\\nas\\tO\\nbilateral\\tB-Disease\\nand\\tI-Disease\\nmultifocal\\tI-Disease\\ntumours\\tI-Disease\\n,\\tO\\nand\\tO\\npresenting\\tO\\nat\\tO\\nan\\tO\\nearlier\\tO\\nage\\tO\\nthan\\tO\\nin\\tO\\nsporadic\\tO\\n,\\tO\\nnon\\tO\\n-\\tO\\nfamilial\\tO\\ncases\\tO\\nof\\tO\\nthis\\tO\\ntumour\\tB-Disease\\ntype\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthat\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nis\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nlocus\\tO\\nencoding\\tO\\nthe\\tO\\nhuman\\tO\\nhomologoue\\tO\\nof\\tO\\nthe\\tO\\nRAF1\\tO\\noncogene\\tO\\n,\\tO\\nwhich\\tO\\nmaps\\tO\\nto\\tO\\nchromosome\\tO\\n3p25\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n4\\tO\\n)\\tO\\n.\\tO\\n\\nCrossovers\\tO\\nwith\\tO\\nthe\\tO\\nVHL\\tB-Disease\\nlocus\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\ndefect\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nVHL\\tB-Disease\\nphenotype\\tO\\nis\\tO\\nnot\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nRAF1\\tO\\ngene\\tO\\nitself\\tO\\n.\\tO\\n\\nAn\\tO\\nalternative\\tO\\nor\\tO\\nprior\\tO\\nevent\\tO\\nto\\tO\\noncogene\\tO\\nactivation\\tO\\nin\\tO\\ntumour\\tB-Disease\\nformation\\tO\\nmay\\tO\\nbe\\tO\\nthe\\tO\\ninactivation\\tO\\nof\\tO\\na\\tO\\nputative\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\nwhich\\tO\\ncan\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nboth\\tO\\nthe\\tO\\ninherited\\tB-Disease\\nand\\tI-Disease\\nsporadic\\tI-Disease\\nforms\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nSporadic\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\nhave\\tO\\npreviously\\tO\\nbeen\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\nregions\\tO\\non\\tO\\nchromosome\\tO\\n3p\\tO\\n(\\tO\\nrefs\\tO\\n5\\tO\\n,\\tO\\n6\\tO\\n)\\tO\\n.\\tO\\n\\nConsequently\\tO\\n,\\tO\\nsporadic\\tO\\nand\\tO\\nVHL\\tO\\n-\\tO\\nassociated\\tO\\nforms\\tO\\nof\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\nmight\\tO\\nboth\\tO\\nresult\\tO\\nfrom\\tO\\nalterations\\tO\\ncausing\\tO\\nloss\\tO\\nof\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\non\\tO\\nthis\\tO\\nchromosome\\tO\\n.\\tO\\n.\\tO\\n\\nTightly\\tO\\nlinked\\tO\\nflanking\\tO\\nmarkers\\tO\\nfor\\tO\\nthe\\tO\\nLowe\\tB-Disease\\noculocerebrorenal\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nwith\\tO\\napplication\\tO\\nto\\tO\\ncarrier\\tO\\nassessment\\tO\\n.\\tO\\n\\nThe\\tO\\nLowe\\tB-Disease\\noculocerebrorenal\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nOCRL\\tB-Disease\\n)\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\ncongenital\\tO\\ncataract\\tB-Disease\\n,\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\nand\\tO\\ndefective\\tB-Disease\\nrenal\\tI-Disease\\ntubular\\tI-Disease\\nfunction\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nmap\\tO\\nassignment\\tO\\nof\\tO\\nOCRL\\tB-Disease\\nto\\tO\\nXq24\\tO\\n-\\tO\\nq26\\tO\\nhas\\tO\\nbeen\\tO\\nmade\\tO\\npreviously\\tO\\nby\\tO\\nlinkage\\tO\\nanalysis\\tO\\nwith\\tO\\nDXS42\\tO\\nat\\tO\\nXq24\\tO\\n-\\tO\\nq26\\tO\\n(\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n,\\tO\\nz\\tO\\n=\\tO\\n5\\tO\\n.\\tO\\n09\\tO\\n)\\tO\\nand\\tO\\nwith\\tO\\nDXS10\\tO\\nat\\tO\\nXq26\\tO\\n(\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n,\\tO\\nz\\tO\\n=\\tO\\n6\\tO\\n.\\tO\\n45\\tO\\n)\\tO\\n.\\tO\\n\\nTwo\\tO\\nadditional\\tO\\nfamilies\\tO\\nwere\\tO\\nstudied\\tO\\nand\\tO\\nthree\\tO\\nadditional\\tO\\npolymorphisms\\tO\\nwere\\tO\\nidentified\\tO\\nat\\tO\\nDXS42\\tO\\nby\\tO\\nusing\\tO\\na\\tO\\n35\\tO\\n-\\tO\\nkb\\tO\\nsequence\\tO\\nisolated\\tO\\nwith\\tO\\nthe\\tO\\nprobe\\tO\\ndetecting\\tO\\nthe\\tO\\noriginal\\tO\\npolymorphism\\tO\\nat\\tO\\nDXS42\\tO\\n.\\tO\\n\\nWith\\tO\\nadditional\\tO\\nOCRL\\tB-Disease\\nfamilies\\tO\\nmade\\tO\\ninformative\\tO\\nfor\\tO\\nDXS42\\tO\\n,\\tO\\ntheta\\tO\\nremained\\tO\\n0\\tO\\nwith\\tO\\nz\\tO\\n=\\tO\\n6\\tO\\n.\\tO\\n\\n63\\tO\\n;\\tO\\nand\\tO\\nfor\\tO\\nDXS10\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\n03\\tO\\nand\\tO\\nz\\tO\\n=\\tO\\n7\\tO\\n.\\tO\\n\\n07\\tO\\n.\\tO\\n\\nEvidence\\tO\\nfor\\tO\\nplacing\\tO\\nOCRL\\tO\\nat\\tO\\nXq25\\tO\\nalso\\tO\\ncomes\\tO\\nfrom\\tO\\na\\tO\\nfemale\\tO\\nwith\\tO\\nLowe\\tB-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nan\\tO\\nX\\tO\\n;\\tO\\n3\\tO\\ntranslocation\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nused\\tO\\nthe\\tO\\nXq25\\tO\\nbreakpoint\\tO\\nin\\tO\\nthis\\tO\\npatient\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\nposition\\tO\\nof\\tO\\nOCRL\\tO\\nrelative\\tO\\nto\\tO\\nthe\\tO\\ntwo\\tO\\nlinked\\tO\\nmarkers\\tO\\n.\\tO\\n\\nEach\\tO\\nderivative\\tO\\nchromosome\\tO\\nwas\\tO\\nisolated\\tO\\naway\\tO\\nfrom\\tO\\nits\\tO\\nnormal\\tO\\ncounterpart\\tO\\nin\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrids\\tO\\n.\\tO\\n\\nDXS42\\tO\\nwas\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\nderivative\\tO\\nchromosome\\tO\\nX\\tO\\ncontaining\\tO\\nXpterq25\\tO\\n,\\tO\\nand\\tO\\nDXS10\\tO\\nwas\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\nderivative\\tO\\nchromosome\\tO\\n3\\tO\\ncontaining\\tO\\nXq25\\tO\\n-\\tO\\nqter\\tO\\n.\\tO\\n\\nThe\\tO\\nmarkers\\tO\\nDXS10\\tO\\nand\\tO\\nDXS42\\tO\\ntherefore\\tO\\nshow\\tO\\ntight\\tO\\nlinkage\\tO\\nwith\\tO\\nOCRL\\tB-Disease\\nin\\tO\\nsix\\tO\\nfamilies\\tO\\nand\\tO\\nflank\\tO\\nthe\\tO\\nXq25\\tO\\nbreakpoint\\tO\\nin\\tO\\na\\tO\\nfemale\\tO\\npatient\\tO\\nwith\\tO\\nan\\tO\\nX\\tO\\n;\\tO\\n3\\tO\\ntranslocation\\tO\\n.\\tO\\n\\nLinkage\\tO\\nanalysis\\tO\\nwith\\tO\\nflanking\\tO\\nmarkers\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nassess\\tO\\nOCRL\\tB-Disease\\ncarrier\\tO\\nstatus\\tO\\nin\\tO\\nwomen\\tO\\nat\\tO\\nrisk\\tO\\n.\\tO\\n\\nResults\\tO\\n,\\tO\\nwhen\\tO\\ncompared\\tO\\nwith\\tO\\ncarrier\\tO\\ndetermination\\tO\\nby\\tO\\nophthalmologic\\tO\\nexamination\\tO\\n,\\tO\\nindicated\\tO\\nthat\\tO\\nthe\\tO\\nslit\\tO\\n-\\tO\\nlamp\\tO\\nexam\\tO\\ncan\\tO\\nbe\\tO\\na\\tO\\nsensitive\\tO\\nand\\tO\\nspecific\\tO\\nmethod\\tO\\nof\\tO\\ncarrier\\tO\\ndetermination\\tO\\nin\\tO\\nmany\\tO\\ncases\\tO\\n\\nIdentification\\tO\\nof\\tO\\na\\tO\\nsingle\\tO\\nnucleotide\\tO\\nchange\\tO\\nin\\tO\\nthe\\tO\\nhypoxanthine\\tO\\n-\\tO\\nguanine\\tO\\nphosphoribosyltransferase\\tO\\ngene\\tO\\n(\\tO\\nHPRTYale\\tO\\n)\\tO\\nresponsible\\tO\\nfor\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nComplete\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nhypoxanthine\\tI-Disease\\n-\\tI-Disease\\nguanine\\tI-Disease\\nphosphoribosyltransferase\\tI-Disease\\n(\\tO\\nHPRT\\tO\\n)\\tO\\ncauses\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nPrevious\\tO\\ncharacterization\\tO\\nof\\tO\\na\\tO\\nmutant\\tO\\nform\\tO\\nof\\tO\\nHPRT\\tO\\n,\\tO\\nHPRTYale\\tO\\n,\\tO\\nfrom\\tO\\na\\tO\\nsubject\\tO\\nwith\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\nrevealed\\tO\\nnormal\\tO\\nmRNA\\tO\\nand\\tO\\nprotein\\tO\\nconcentrations\\tO\\n,\\tO\\nno\\tO\\nresidual\\tO\\ncatalytic\\tO\\nactivity\\tO\\n,\\tO\\nand\\tO\\ncathodal\\tO\\nmigration\\tO\\nupon\\tO\\nPAGE\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ncloned\\tO\\nand\\tO\\nsequenced\\tO\\nHPRTYale\\tO\\ncDNA\\tO\\n.\\tO\\n\\nThe\\tO\\nnucleotide\\tO\\nsequence\\tO\\nof\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\nHPRTYale\\tO\\ncDNA\\tO\\nrevealed\\tO\\na\\tO\\nsingle\\tO\\nnucleotide\\tO\\nsubstitution\\tO\\ncompared\\tO\\nwith\\tO\\nnormal\\tO\\nHPRT\\tO\\ncDNA\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nC\\tO\\nat\\tO\\nnucleotide\\tO\\nposition\\tO\\n211\\tO\\n.\\tO\\n\\nThis\\tO\\ntransversion\\tO\\npredicts\\tO\\nsubstitution\\tO\\nof\\tO\\narginine\\tO\\nfor\\tO\\nglycine\\tO\\nat\\tO\\namino\\tO\\nacid\\tO\\nposition\\tO\\n71\\tO\\n,\\tO\\nexplaining\\tO\\nthe\\tO\\ncathodal\\tO\\nmigration\\tO\\nof\\tO\\nHPRTYale\\tO\\n.\\tO\\n\\nChou\\tO\\n-\\tO\\nFasman\\tO\\nsecondary\\tO\\nstructure\\tO\\nanalysis\\tO\\npredicts\\tO\\na\\tO\\nchange\\tO\\nin\\tO\\nthe\\tO\\nprobability\\tO\\nof\\tO\\nbeta\\tO\\n-\\tO\\nturn\\tO\\nformation\\tO\\nin\\tO\\nthe\\tO\\nregion\\tO\\ncontaining\\tO\\nthe\\tO\\nmutation\\tO\\n.\\tO\\n\\nInclusion\\tO\\nof\\tO\\nthe\\tO\\nbulky\\tO\\narginine\\tO\\nside\\tO\\nchain\\tO\\nin\\tO\\nplace\\tO\\nof\\tO\\nglycine\\tO\\nprobably\\tO\\ndisrupts\\tO\\nprotein\\tO\\nfolding\\tO\\nas\\tO\\nwell\\tO\\n.\\tO\\n\\nCloning\\tO\\nmutant\\tO\\nforms\\tO\\nof\\tO\\ncDNA\\tO\\nallows\\tO\\nidentification\\tO\\nof\\tO\\nspecific\\tO\\nmutations\\tO\\n,\\tO\\nprovides\\tO\\ninsight\\tO\\ninto\\tO\\nmutational\\tO\\nmechanisms\\tO\\n,\\tO\\nand\\tO\\nfacilitates\\tO\\nstructure\\tO\\n-\\tO\\nfunction\\tO\\nanalysis\\tO\\nof\\tO\\nmutant\\tO\\nproteins\\tO\\n.\\tO\\n.\\tO\\n\\nTwo\\tO\\npoint\\tO\\nmutations\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nG6PD\\tO\\npolymorphism\\tO\\nin\\tO\\nSardinia\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\ngene\\tO\\nencoding\\tO\\nglucose\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nis\\tO\\nhighly\\tO\\npolymorphic\\tO\\n;\\tO\\nmore\\tO\\nthan\\tO\\n300\\tO\\nG6PD\\tO\\nvariants\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\n.\\tO\\n\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\ndifferent\\tO\\ngeographical\\tO\\nareas\\tO\\nappears\\tO\\nto\\tO\\nhave\\tO\\narisen\\tO\\nthrough\\tO\\nindependent\\tO\\nmutational\\tO\\nevents\\tO\\n,\\tO\\nbut\\tO\\nwithin\\tO\\nthe\\tO\\nsame\\tO\\npopulation\\tO\\nit\\tO\\nmay\\tO\\nalso\\tO\\nbe\\tO\\nheterogeneous\\tO\\n.\\tO\\n\\nOne\\tO\\nexample\\tO\\nis\\tO\\nthe\\tO\\nisland\\tO\\nof\\tO\\nSardinia\\tO\\n,\\tO\\nwhere\\tO\\ncareful\\tO\\nclinical\\tO\\nand\\tO\\nbiochemical\\tO\\nstudies\\tO\\nhave\\tO\\nidentified\\tO\\nfour\\tO\\ndifferent\\tO\\nG6PD\\tO\\nvariants\\tO\\n.\\tO\\n\\nWe\\tO\\ncloned\\tO\\nand\\tO\\nsequenced\\tO\\nthe\\tO\\nfour\\tO\\nG6PD\\tO\\nvariants\\tO\\nfrom\\tO\\nSardinia\\tO\\nand\\tO\\nfound\\tO\\nthat\\tO\\nonly\\tO\\ntwo\\tO\\nmutations\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthis\\tO\\narea\\tO\\none\\tO\\nmutation\\tO\\nis\\tO\\nthe\\tO\\ncause\\tO\\nof\\tO\\nthe\\tO\\nG6PD\\tB-Disease\\nSeattle\\tI-Disease\\n-\\tI-Disease\\nlike\\tI-Disease\\nphenotype\\tI-Disease\\n,\\tO\\na\\tO\\nmilder\\tO\\nform\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n;\\tO\\nthe\\tO\\nother\\tO\\nmutation\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nall\\tO\\nforms\\tO\\nof\\tO\\nvery\\tO\\nsevere\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nSardinia\\tO\\nand\\tO\\n,\\tO\\npossibly\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nMediterranean\\tO\\n.\\tO\\n.\\tO\\n\\nChronic\\tB-Disease\\nnonspherocytic\\tI-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\n(\\tO\\nCNSHA\\tB-Disease\\n)\\tO\\nand\\tO\\nglucose\\tB-Disease\\n6\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\namyloidotic\\tI-Disease\\npolyneuropathy\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nMolecular\\tO\\nstudy\\tO\\nof\\tO\\na\\tO\\nnew\\tO\\nvariant\\tO\\n(\\tO\\nG6PD\\tO\\nClinic\\tO\\n)\\tO\\nwith\\tO\\nmarkedly\\tO\\nacidic\\tO\\npH\\tO\\noptimum\\tO\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nvariant\\tO\\nwith\\tO\\nsevere\\tO\\nerythrocytic\\tB-Disease\\nG6PD\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\na\\tO\\nunique\\tO\\npH\\tO\\noptimum\\tO\\nis\\tO\\ndescribed\\tO\\nin\\tO\\na\\tO\\nyoung\\tO\\npatient\\tO\\nwith\\tO\\nchronic\\tB-Disease\\nnonspherocytic\\tI-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\n(\\tO\\nCNSHA\\tB-Disease\\n)\\tO\\nand\\tO\\nfamilial\\tB-Disease\\namyloidotic\\tI-Disease\\npolyneuropathy\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nChronic\\tB-Disease\\nhemolysis\\tI-Disease\\nwas\\tO\\npresent\\tO\\nin\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\ninfections\\tO\\n,\\tO\\noxidant\\tO\\ndrugs\\tO\\nor\\tO\\ningestion\\tO\\nof\\tO\\nfaba\\tO\\nbeans\\tO\\n.\\tO\\n\\nResidual\\tO\\nenzyme\\tO\\nactivity\\tO\\nwas\\tO\\nabout\\tO\\n2\\tO\\n.\\tO\\n\\n6\\tO\\n%\\tO\\nand\\tO\\n63\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\nactivity\\tO\\nin\\tO\\nerythrocytes\\tO\\nand\\tO\\nleucocytes\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nA\\tO\\nmolecular\\tO\\nstudy\\tO\\nusing\\tO\\nstandard\\tO\\nmethods\\tO\\nshowed\\tO\\nG6PD\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\nto\\tO\\nhave\\tO\\nnormal\\tO\\nelectrophoretic\\tO\\nmobility\\tO\\n(\\tO\\nat\\tO\\npH\\tO\\n7\\tO\\n.\\tO\\n0\\tO\\n,\\tO\\n8\\tO\\n.\\tO\\n0\\tO\\nand\\tO\\n8\\tO\\n.\\tO\\n8\\tO\\n)\\tO\\n,\\tO\\nnormal\\tO\\napparent\\tO\\naffinity\\tO\\nfor\\tO\\nsubstrates\\tO\\n(\\tO\\nKm\\tO\\n,\\tO\\nG6P\\tO\\nand\\tO\\nNADP\\tO\\n)\\tO\\nand\\tO\\na\\tO\\nslightly\\tO\\nabnormal\\tO\\nutilization\\tO\\nof\\tO\\nsubstrate\\tO\\nanalogues\\tO\\n(\\tO\\ndecreased\\tO\\ndeamino\\tO\\n-\\tO\\nNADP\\tO\\nand\\tO\\nincreased\\tO\\n2\\tO\\n-\\tO\\ndeoxyglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\nutilization\\tO\\n)\\tO\\n.\\tO\\n\\nHeat\\tO\\nstability\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nmarkedly\\tO\\ndecreased\\tO\\n(\\tO\\n8\\tO\\n%\\tO\\nof\\tO\\nresidual\\tO\\nactivity\\tO\\nafter\\tO\\n20\\tO\\nmin\\tO\\nof\\tO\\nincubation\\tO\\nat\\tO\\n46\\tO\\ndegrees\\tO\\nC\\tO\\n)\\tO\\nand\\tO\\na\\tO\\nparticular\\tO\\ncharacteristic\\tO\\nof\\tO\\nthis\\tO\\nenzyme\\tO\\nwas\\tO\\na\\tO\\nbiphasic\\tO\\npH\\tO\\ncurve\\tO\\nwith\\tO\\na\\tO\\ngreatly\\tO\\nincreased\\tO\\nactivity\\tO\\nat\\tO\\nlow\\tO\\npH\\tO\\n.\\tO\\n\\nAlthough\\tO\\nmolecular\\tO\\ncharacteristics\\tO\\nof\\tO\\nthis\\tO\\nvariant\\tO\\nclosely\\tO\\nresemble\\tO\\nthose\\tO\\nof\\tO\\nG6PD\\tO\\nBangkok\\tO\\nand\\tO\\nG6PD\\tO\\nDuarte\\tO\\n,\\tO\\nit\\tO\\ncan\\tO\\nbe\\tO\\ndistinguished\\tO\\nfrom\\tO\\nthese\\tO\\nand\\tO\\nall\\tO\\nother\\tO\\npreviously\\tO\\nreported\\tO\\nvariants\\tO\\nby\\tO\\nvirtue\\tO\\nof\\tO\\nits\\tO\\nunusual\\tO\\npH\\tO\\ncurve\\tO\\n.\\tO\\n\\nTherefore\\tO\\nthe\\tO\\npresent\\tO\\nvariant\\tO\\nhas\\tO\\nbeen\\tO\\ndesignated\\tO\\nG6PD\\tO\\nClinic\\tO\\nto\\tO\\ndistinguish\\tO\\nit\\tO\\nfrom\\tO\\nother\\tO\\nG6PD\\tO\\nvariants\\tO\\npreviously\\tO\\ndescribed\\tO\\n\\nMolecular\\tO\\ndetection\\tO\\nof\\tO\\nchromosomal\\tO\\ntranslocations\\tO\\nthat\\tO\\ndisrupt\\tO\\nthe\\tO\\nputative\\tO\\nretinoblastoma\\tB-Disease\\nsusceptibility\\tO\\nlocus\\tO\\n.\\tO\\n\\nA\\tO\\ncandidate\\tO\\nDNA\\tO\\nsequence\\tO\\nwith\\tO\\nmany\\tO\\nof\\tO\\nthe\\tO\\nproperties\\tO\\npredicted\\tO\\nfor\\tO\\nthe\\tO\\nretinoblastoma\\tB-Disease\\nsusceptibility\\tO\\n(\\tO\\nRB1\\tO\\n)\\tO\\nlocus\\tO\\nhas\\tO\\nbeen\\tO\\ncloned\\tO\\n(\\tO\\nS\\tO\\n.\\tO\\nH\\tO\\n.\\tO\\nFriend\\tO\\n,\\tO\\nR\\tO\\n.\\tO\\nBernards\\tO\\n,\\tO\\nS\\tO\\n.\\tO\\nRogelj\\tO\\n,\\tO\\nR\\tO\\n.\\tO\\nA\\tO\\n.\\tO\\nWeinberg\\tO\\n,\\tO\\nJ\\tO\\n.\\tO\\nM\\tO\\n.\\tO\\nRapaport\\tO\\n,\\tO\\nD\\tO\\n.\\tO\\nM\\tO\\n.\\tO\\nAlbert\\tO\\n,\\tO\\nand\\tO\\nT\\tO\\n.\\tO\\nP\\tO\\n.\\tO\\nDryja\\tO\\n,\\tO\\nNature\\tO\\n[\\tO\\nLondon\\tO\\n]\\tO\\n323\\tO\\n643\\tO\\n-\\tO\\n645\\tO\\n,\\tO\\n1986\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nlarge\\tO\\nsize\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\n(\\tO\\nca\\tO\\n.\\tO\\n200\\tO\\nkilobases\\tO\\n[\\tO\\nkb\\tO\\n]\\tO\\n)\\tO\\nand\\tO\\nits\\tO\\nmultiple\\tO\\ndispersed\\tO\\nexons\\tO\\n(\\tO\\nWiggs\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\nN\\tO\\n.\\tO\\nEngl\\tO\\n.\\tO\\nJ\\tO\\n.\\tO\\nMed\\tO\\n.\\tO\\n318\\tO\\n151\\tO\\n-\\tO\\n157\\tO\\n,\\tO\\n1988\\tO\\n)\\tO\\ncomplicate\\tO\\nmolecular\\tO\\nscreening\\tO\\nstrategies\\tO\\nimportant\\tO\\nin\\tO\\nprenatal\\tO\\nand\\tO\\npresymptomatic\\tO\\ndiagnosis\\tO\\nand\\tO\\nin\\tO\\ncarrier\\tO\\ndetection\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nused\\tO\\nfield\\tO\\ninversion\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n(\\tO\\nFIGE\\tO\\n)\\tO\\nto\\tO\\nconstruct\\tO\\na\\tO\\nrestriction\\tO\\nmap\\tO\\nof\\tO\\napproximately\\tO\\n1\\tO\\n,\\tO\\n000\\tO\\nkb\\tO\\nof\\tO\\nDNA\\tO\\nsurrounding\\tO\\nthe\\tO\\nRB1\\tO\\nlocus\\tO\\nand\\tO\\nto\\tO\\ndetect\\tO\\nthe\\tO\\ntranslocation\\tO\\nbreakpoints\\tO\\nin\\tO\\nthree\\tO\\nretinoblastoma\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nDNA\\tO\\nprobes\\tO\\nfrom\\tO\\neither\\tO\\nthe\\tO\\n5\\tO\\nor\\tO\\n3\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nwere\\tO\\nused\\tO\\nto\\tO\\ndetect\\tO\\na\\tO\\n250\\tO\\n-\\tO\\nkb\\tO\\nEagI\\tO\\nrestriction\\tO\\nfragment\\tO\\nin\\tO\\nDNA\\tO\\nfrom\\tO\\nunaffected\\tO\\nindividuals\\tO\\n.\\tO\\n\\nBoth\\tO\\nprobes\\tO\\nidentified\\tO\\nan\\tO\\nadditional\\tO\\nhybridizing\\tO\\nfragment\\tO\\nin\\tO\\nthe\\tO\\nDNA\\tO\\nfrom\\tO\\neach\\tO\\npatient\\tO\\n,\\tO\\npermitting\\tO\\nthe\\tO\\nbreakpoints\\tO\\nin\\tO\\nall\\tO\\nthree\\tO\\nto\\tO\\nbe\\tO\\nmapped\\tO\\nwithin\\tO\\nthe\\tO\\ncloned\\tO\\nRB1\\tO\\ngene\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nthe\\tO\\nbreakpoint\\tO\\nin\\tO\\none\\tO\\ntranslocation\\tO\\ncell\\tO\\nline\\tO\\nallowed\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nto\\tO\\nbe\\tO\\noriented\\tO\\nwith\\tO\\nits\\tO\\n5\\tO\\nend\\tO\\ntoward\\tO\\nthe\\tO\\ncentromere\\tO\\n.\\tO\\n\\nThe\\tO\\n5\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nalso\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nclustering\\tO\\nof\\tO\\nsites\\tO\\nfor\\tO\\nseveral\\tO\\ninfrequently\\tO\\ncleaving\\tO\\nrestriction\\tO\\nenzymes\\tO\\n,\\tO\\nindicating\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nan\\tO\\nHpaII\\tO\\ntiny\\tO\\nfragment\\tO\\nisland\\tO\\n.\\tO\\n\\nThe\\tO\\ndetection\\tO\\nand\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\ntranslocation\\tO\\nbreakpoints\\tO\\nof\\tO\\nall\\tO\\nthree\\tO\\nretinoblastoma\\tB-Disease\\npatients\\tO\\nto\\tO\\nwithin\\tO\\nthe\\tO\\nputative\\tO\\nRB1\\tO\\ngene\\tO\\nsubstantiated\\tO\\nthe\\tO\\nauthenticity\\tO\\nof\\tO\\nthis\\tO\\ncandidate\\tO\\nsequence\\tO\\nand\\tO\\ndemonstrated\\tO\\nthe\\tO\\nutility\\tO\\nof\\tO\\nFIGE\\tO\\nin\\tO\\ndetecting\\tO\\nchromosomal\\tO\\nrearrangements\\tO\\naffecting\\tO\\nthis\\tO\\nlocus\\tO\\n.\\tO\\n\\nInherited\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\nwith\\tO\\nrecurrent\\tO\\ninfections\\tO\\nand\\tO\\nglomerulonephritis\\tB-Disease\\n.\\tO\\n\\nA\\tO\\n10\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nLaotian\\tO\\nboy\\tO\\nhad\\tO\\nhomozygous\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nthird\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nand\\tO\\nrecurrent\\tO\\nbacterial\\tB-Disease\\ninfections\\tI-Disease\\nbeginning\\tO\\nat\\tO\\nage\\tO\\n5\\tO\\nmonths\\tO\\n.\\tO\\n\\nCellular\\tO\\nand\\tO\\nhumoral\\tO\\nimmunity\\tO\\nwere\\tO\\nnormal\\tO\\n,\\tO\\nas\\tO\\nwere\\tO\\npolymorphonuclear\\tO\\nleukocyte\\tO\\nchemotaxis\\tO\\nand\\tO\\nbactericidal\\tO\\nactivities\\tO\\n.\\tO\\n\\nSerum\\tO\\ncomplement\\tO\\n-\\tO\\nmediated\\tO\\nhemolytic\\tO\\n,\\tO\\nchemotactic\\tO\\n,\\tO\\nand\\tO\\nopsonic\\tO\\nactivities\\tO\\nwere\\tO\\ndeficient\\tO\\n.\\tO\\n\\nIn\\tO\\nvitro\\tO\\naddition\\tO\\nof\\tO\\npurified\\tO\\nC3\\tO\\nto\\tO\\npatient\\tO\\nserum\\tO\\nrestored\\tO\\nhemolytic\\tO\\ncomplement\\tO\\nto\\tO\\nnormal\\tO\\nlevels\\tO\\n,\\tO\\nand\\tO\\nplasma\\tO\\ninfusion\\tO\\nduring\\tO\\neach\\tO\\nof\\tO\\nfour\\tO\\nepisodes\\tO\\nof\\tO\\npneumonia\\tB-Disease\\nsignificantly\\tO\\nenhanced\\tO\\nserum\\tO\\nopsonic\\tO\\nactivity\\tO\\nfor\\tO\\nas\\tO\\nlong\\tO\\nas\\tO\\n36\\tO\\nhours\\tO\\n.\\tO\\n\\nA\\tO\\nrenal\\tO\\nbiopsy\\tO\\nspecimen\\tO\\nrevealed\\tO\\nmesangiopathic\\tB-Disease\\nglomerulonephritis\\tI-Disease\\n,\\tO\\nalthough\\tO\\nsignificant\\tO\\nlevels\\tO\\nof\\tO\\ncirculating\\tO\\nIgG\\tO\\nimmune\\tO\\ncomplexes\\tO\\nwere\\tO\\nnot\\tO\\ndetected\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nfurther\\tO\\nsupport\\tO\\nthe\\tO\\nassociation\\tO\\nof\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\nwith\\tO\\nimmune\\tB-Disease\\n-\\tI-Disease\\ncomplex\\tI-Disease\\ndisease\\tI-Disease\\nand\\tO\\nsuggest\\tO\\nthat\\tO\\nplasma\\tO\\ninfusion\\tO\\nmay\\tO\\nbe\\tO\\nan\\tO\\nadjunct\\tO\\nto\\tO\\nantibiotic\\tO\\ntherapy\\tO\\nin\\tO\\nthe\\tO\\nmanagement\\tO\\nof\\tO\\nsevere\\tO\\npyogenic\\tB-Disease\\ninfections\\tI-Disease\\nin\\tO\\npatients\\tO\\nwith\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nDNA\\tO\\nrestriction\\tO\\nfragments\\tO\\nassociated\\tO\\nwith\\tO\\nalpha\\tO\\n1\\tO\\n-\\tO\\nantitrypsin\\tO\\nindicate\\tO\\na\\tO\\nsingle\\tO\\norigin\\tO\\nfor\\tO\\ndeficiency\\tO\\nallele\\tO\\nPI\\tO\\nZ\\tO\\n.\\tO\\n\\nThe\\tO\\nalpha\\tO\\n1\\tO\\n-\\tO\\nprotease\\tO\\ninhibitor\\tO\\n,\\tO\\nor\\tO\\nalpha\\tO\\n-\\tO\\nantitrypsin\\tO\\n(\\tO\\nAAT\\tO\\n)\\tO\\n,\\tO\\na\\tO\\nmajor\\tO\\nplasma\\tO\\ninhibitor\\tO\\nof\\tO\\nleukocyte\\tO\\nelastase\\tO\\nand\\tO\\nbacterial\\tO\\nproteases\\tO\\n,\\tO\\nis\\tO\\nencoded\\tO\\nat\\tO\\nthe\\tO\\nPI\\tO\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n14\\tO\\n(\\tO\\n14q24\\tO\\n.\\tO\\n3\\tO\\n-\\tO\\nq32\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nAAT\\tI-Disease\\nin\\tO\\nindividuals\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\nPI\\tO\\nZ\\tO\\nallele\\tO\\noccurs\\tO\\nin\\tO\\nabout\\tO\\n1\\tO\\nin\\tO\\n2\\tO\\n,\\tO\\n000\\tO\\n-\\tO\\n8\\tO\\n,\\tO\\n000\\tO\\ncaucasians\\tO\\nand\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\nearly\\tO\\nadult\\tO\\nonset\\tO\\nemphysema\\tB-Disease\\nand\\tO\\nliver\\tB-Disease\\ndisease\\tI-Disease\\nin\\tO\\nchildhood\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nnow\\tO\\nused\\tO\\nDNA\\tO\\npolymorphisms\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nAAT\\tO\\ngene\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\norigin\\tO\\nof\\tO\\nthe\\tO\\nPI\\tO\\nZ\\tO\\nallele\\tO\\n.\\tO\\n\\nUsing\\tO\\ntwo\\tO\\ngenomic\\tO\\nprobes\\tO\\nextending\\tO\\ninto\\tO\\nthe\\tO\\n5\\tO\\nand\\tO\\n3\\tO\\nflanking\\tO\\nregions\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nidentified\\tO\\neight\\tO\\npolymorphic\\tO\\nrestriction\\tO\\nsites\\tO\\n.\\tO\\n\\nExtensive\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\noccurs\\tO\\nthroughout\\tO\\nthe\\tO\\nprobed\\tO\\nregion\\tO\\nwith\\tO\\nthe\\tO\\nPI\\tO\\nZ\\tO\\nallele\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nwith\\tO\\nnormal\\tO\\nPI\\tO\\nM\\tO\\nalleles\\tO\\n.\\tO\\n\\nThe\\tO\\nZ\\tO\\nallele\\tO\\noccurs\\tO\\nmainly\\tO\\nwith\\tO\\none\\tO\\nhaplotype\\tO\\n,\\tO\\nindicating\\tO\\na\\tO\\nsingle\\tO\\n,\\tO\\nrelatively\\tO\\nrecent\\tO\\n,\\tO\\norigin\\tO\\nin\\tO\\ncaucasians\\tO\\n\\nSegregation\\tO\\nanalysis\\tO\\nof\\tO\\na\\tO\\nmarker\\tO\\nlocalised\\tO\\nXp21\\tO\\n.\\tO\\n2\\tO\\n-\\tO\\nXp21\\tO\\n.\\tO\\n3\\tO\\nin\\tO\\nDuchenne\\tB-Disease\\nand\\tI-Disease\\nBecker\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nA\\tO\\nDNA\\tO\\nmarker\\tO\\nC7\\tO\\n,\\tO\\nlocalised\\tO\\nXp21\\tO\\n.\\tO\\n\\n1\\tO\\n-\\tO\\nXp21\\tO\\n.\\tO\\n\\n3\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nstudied\\tO\\nin\\tO\\nkindreds\\tO\\nsegregating\\tO\\nfor\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\nand\\tO\\nBecker\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nBMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nDMD\\tB-Disease\\nfamilies\\tO\\nfour\\tO\\ncrossovers\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\n38\\tO\\ninformative\\tO\\nmeioses\\tO\\nbetween\\tO\\nC7\\tO\\nand\\tO\\nthe\\tO\\nDMD\\tB-Disease\\nlocus\\tO\\n(\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n12\\tO\\n,\\tO\\nz\\tO\\nmax\\tO\\n=\\tO\\n+\\tO\\n2\\tO\\n.\\tO\\n72\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nBMD\\tB-Disease\\nfamilies\\tO\\nno\\tO\\nrecombinants\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\n16\\tO\\ninformative\\tO\\nmeioses\\tO\\nstudied\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nlocalisation\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nin\\tO\\nthese\\tO\\ndisorders\\tO\\nbeing\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\nregion\\tO\\nof\\tO\\nXp21\\tO\\n.\\tO\\n\\nStudies\\tO\\nin\\tO\\nfamilies\\tO\\nalso\\tO\\nsegregating\\tO\\nfor\\tO\\nthe\\tO\\nDNA\\tO\\nmarker\\tO\\n754\\tO\\nsupport\\tO\\nthe\\tO\\npreviously\\tO\\nreported\\tO\\nphysical\\tO\\norder\\tO\\nof\\tO\\nthese\\tO\\nloci\\tO\\nas\\tO\\nX\\tO\\ncentromere\\tO\\n-\\tO\\n754\\tO\\n-\\tO\\nDMD\\tO\\n-\\tO\\nBMD\\tO\\n-\\tO\\nC7\\tO\\n-\\tO\\nX\\tO\\ntelomere\\tO\\n.\\tO\\n\\nA\\tO\\nrecombination\\tO\\nfraction\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n11\\tO\\n(\\tO\\nz\\tO\\nmax\\tO\\n=\\tO\\n+\\tO\\n5\\tO\\n.\\tO\\n58\\tO\\n)\\tO\\nwas\\tO\\nfound\\tO\\nbetween\\tO\\nDMD\\tO\\n-\\tO\\n754\\tO\\nby\\tO\\ncombining\\tO\\nour\\tO\\npreviously\\tO\\npublished\\tO\\ndata\\tO\\nwith\\tO\\nthe\\tO\\ndata\\tO\\npresented\\tO\\nhere\\tO\\n.\\tO\\n\\nC7\\tO\\nand\\tO\\n754\\tO\\nthus\\tO\\nprovide\\tO\\ngood\\tO\\nbridging\\tO\\nmarkers\\tO\\nfor\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nDMD\\tB-Disease\\nand\\tO\\nBMD\\tB-Disease\\n\\nIsolation\\tO\\nof\\tO\\nmolecular\\tO\\nprobes\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nchromosome\\tO\\n15\\tO\\ninstability\\tO\\nin\\tO\\nthe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nFlow\\tO\\ncytometry\\tO\\nand\\tO\\nrecombinant\\tO\\nDNA\\tO\\ntechniques\\tO\\nhave\\tO\\nbeen\\tO\\nused\\tO\\nto\\tO\\nobtain\\tO\\nreagents\\tO\\nfor\\tO\\na\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nHindIII\\tO\\ntotal\\tO\\n-\\tO\\ndigest\\tO\\nlibraries\\tO\\nwere\\tO\\nprepared\\tO\\nin\\tO\\nlambda\\tO\\nphage\\tO\\nCharon\\tO\\n21A\\tO\\nfrom\\tO\\nflow\\tO\\n-\\tO\\nsorted\\tO\\ninverted\\tO\\nduplicated\\tO\\nno\\tO\\n.\\tO\\n15\\tO\\nhuman\\tO\\nchromosomes\\tO\\nand\\tO\\npropagated\\tO\\non\\tO\\nrecombination\\tO\\n-\\tO\\nproficient\\tO\\n(\\tO\\nLE392\\tO\\n)\\tO\\nand\\tO\\nrecBC\\tO\\n-\\tO\\n,\\tO\\nsbcB\\tO\\n-\\tO\\n(\\tO\\nDB1257\\tO\\n)\\tO\\nbacteria\\tO\\n.\\tO\\n\\nTwelve\\tO\\ndistinct\\tO\\nchromosome\\tO\\n15\\tO\\n-\\tO\\nspecific\\tO\\nprobes\\tO\\nhave\\tO\\nbeen\\tO\\nisolated\\tO\\n.\\tO\\n\\nEight\\tO\\nlocalized\\tO\\nto\\tO\\nthe\\tO\\nregion\\tO\\n15q11\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n13\\tO\\n.\\tO\\n\\nFour\\tO\\nof\\tO\\nthese\\tO\\neight\\tO\\nsublocalized\\tO\\nto\\tO\\nband\\tO\\n15q11\\tO\\n.\\tO\\n\\n2\\tO\\nand\\tO\\nare\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\ndeleted\\tO\\nin\\tO\\nDNA\\tO\\nof\\tO\\none\\tO\\nof\\tO\\ntwo\\tO\\npatients\\tO\\nexamined\\tO\\nwith\\tO\\nthe\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nHeteroduplex\\tO\\nanalysis\\tO\\nof\\tO\\ntwo\\tO\\nof\\tO\\nthese\\tO\\nclones\\tO\\n,\\tO\\nwhich\\tO\\ngrew\\tO\\non\\tO\\nDB1257\\tO\\nbut\\tO\\nnot\\tO\\non\\tO\\nLE392\\tO\\n,\\tO\\nrevealed\\tO\\nstem\\tO\\n-\\tO\\nloop\\tO\\nstructures\\tO\\nin\\tO\\nthe\\tO\\ninserts\\tO\\n,\\tO\\nindicative\\tO\\nof\\tO\\ninverted\\tO\\n,\\tO\\nrepeated\\tO\\nDNA\\tO\\nelements\\tO\\n.\\tO\\n\\nSuch\\tO\\nDNA\\tO\\nrepeats\\tO\\nmight\\tO\\naccount\\tO\\nfor\\tO\\nsome\\tO\\nof\\tO\\nthe\\tO\\ncloning\\tO\\ninstability\\tO\\nof\\tO\\nDNA\\tO\\nsegments\\tO\\nfrom\\tO\\nproximal\\tO\\n15q\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nthe\\tO\\ngenetic\\tO\\nand\\tO\\nphysical\\tO\\ninstability\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nrepeated\\tO\\nsequences\\tO\\nwe\\tO\\nhave\\tO\\nisolated\\tO\\nfrom\\tO\\nband\\tO\\n15q11\\tO\\n.\\tO\\n\\n2\\tO\\nmay\\tO\\nelucidate\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nfor\\tO\\nthe\\tO\\ninstability\\tO\\nof\\tO\\nthis\\tO\\nchromosomal\\tO\\nregion\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nPWS\\tB-Disease\\nor\\tO\\nother\\tO\\ndiseases\\tO\\nassociated\\tO\\nwith\\tO\\nchromosomal\\tB-Disease\\nabnormalities\\tI-Disease\\nin\\tO\\nthe\\tO\\nproximal\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n15\\tO\\n\\nAnalysis\\tO\\nof\\tO\\ndeletions\\tO\\nin\\tO\\nDNA\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nBecker\\tB-Disease\\nand\\tI-Disease\\nDuchenne\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\ngenetic\\tI-Disease\\ndisorder\\tI-Disease\\nfor\\tO\\nwhich\\tO\\nthe\\tO\\nbiochemical\\tO\\ndefect\\tO\\nis\\tO\\nas\\tO\\nyet\\tO\\nunknown\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\ntwo\\tO\\ncloned\\tO\\nsegments\\tO\\nof\\tO\\nhuman\\tO\\nX\\tO\\n-\\tO\\nchromosome\\tO\\nDNA\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\nwhich\\tO\\ndetect\\tO\\nstructural\\tO\\nalterations\\tO\\nwithin\\tO\\nor\\tO\\nnear\\tO\\nthe\\tO\\ngenetic\\tO\\nlocus\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\ndisorder\\tO\\n.\\tO\\n\\nBoth\\tO\\nof\\tO\\nthese\\tO\\ncloned\\tO\\nsegments\\tO\\nwere\\tO\\ndescribed\\tO\\nas\\tO\\ntightly\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nlocus\\tO\\nand\\tO\\nwere\\tO\\ncapable\\tO\\nof\\tO\\ndetecting\\tO\\ndeletions\\tO\\nin\\tO\\nthe\\tO\\nDNA\\tO\\nof\\tO\\nboys\\tO\\naffected\\tO\\nwith\\tO\\nDMD\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\nan\\tO\\nattempt\\tO\\nto\\tO\\ndetermine\\tO\\nmore\\tO\\nprecisely\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nthese\\tO\\ndeletions\\tO\\nwithin\\tO\\na\\tO\\nlarge\\tO\\npopulation\\tO\\nof\\tO\\nDMD\\tB-Disease\\npatients\\tO\\nand\\tO\\nthe\\tO\\naccuracy\\tO\\nof\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nsegments\\tO\\n,\\tO\\nDXS164\\tO\\n(\\tO\\npERT87\\tO\\n)\\tO\\n,\\tO\\nin\\tO\\ndetermining\\tO\\nthe\\tO\\ninheritance\\tO\\nof\\tO\\nthe\\tO\\nDMD\\tB-Disease\\nX\\tO\\nchromosome\\tO\\n,\\tO\\nthe\\tO\\nsubclones\\tO\\n1\\tO\\n,\\tO\\n8\\tO\\nand\\tO\\n15\\tO\\nwere\\tO\\nmade\\tO\\navailable\\tO\\nto\\tO\\nmany\\tO\\ninvestigators\\tO\\nthroughout\\tO\\nthe\\tO\\nworld\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\ndescribe\\tO\\nthe\\tO\\ncombined\\tO\\nresults\\tO\\nof\\tO\\nmore\\tO\\nthan\\tO\\n20\\tO\\nresearch\\tO\\nlaboratories\\tO\\nwith\\tO\\nrespect\\tO\\nto\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\ndeletions\\tO\\nat\\tO\\nthe\\tO\\nDXS164\\tO\\nlocus\\tO\\nin\\tO\\nDNA\\tO\\nsamples\\tO\\nisolated\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nDMD\\tB-Disease\\nand\\tO\\nBecker\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nBMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nDXS164\\tO\\nlocus\\tO\\napparently\\tO\\nrecombines\\tO\\nwith\\tO\\nDMD\\tB-Disease\\n5\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ntime\\tO\\n,\\tO\\nbut\\tO\\nis\\tO\\nprobably\\tO\\nlocated\\tO\\nbetween\\tO\\nindependent\\tO\\nsites\\tO\\nof\\tO\\nmutation\\tO\\nwhich\\tO\\nyield\\tO\\nDMD\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nbreakpoints\\tO\\nof\\tO\\nsome\\tO\\ndeletions\\tO\\nare\\tO\\ndelineated\\tO\\nwithin\\tO\\nthe\\tO\\nDXS164\\tO\\nlocus\\tO\\n,\\tO\\nand\\tO\\nit\\tO\\nis\\tO\\nevident\\tO\\nthat\\tO\\nthe\\tO\\ndeletions\\tO\\nat\\tO\\nthe\\tO\\nDMD\\tB-Disease\\nlocus\\tO\\nare\\tO\\nfrequent\\tO\\nand\\tO\\nextremely\\tO\\nlarge\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\npotential\\tO\\nanimal\\tO\\nmodel\\tO\\nfor\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\nthrough\\tO\\nintroduction\\tO\\nof\\tO\\nHPRT\\tO\\nmutations\\tO\\ninto\\tO\\nmice\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\nneurological\\tB-Disease\\nand\\tI-Disease\\nbehavioural\\tI-Disease\\ndisorder\\tI-Disease\\n,\\tO\\naffecting\\tO\\nonly\\tO\\nmales\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nan\\tO\\ninherited\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthe\\tO\\nlevel\\tO\\nof\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\npurine\\tO\\nsalvage\\tO\\nenzyme\\tO\\nhypoxanthine\\tO\\n-\\tO\\nguanosine\\tO\\nphosphoribosyl\\tO\\ntransferase\\tO\\n(\\tO\\nHPRT\\tO\\n)\\tO\\n.\\tO\\n\\nHow\\tO\\nthe\\tO\\nresulting\\tO\\nalterations\\tO\\nin\\tO\\npurine\\tO\\nmetabolism\\tO\\nlead\\tO\\nto\\tO\\nthe\\tO\\nsevere\\tO\\nsymptoms\\tO\\ncharacteristic\\tO\\nof\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\npatients\\tO\\nis\\tO\\nstill\\tO\\nnot\\tO\\nunderstood\\tO\\n.\\tO\\n\\nNo\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nHprt\\tO\\nlocus\\tO\\nleading\\tO\\nto\\tO\\nloss\\tO\\nof\\tO\\nactivity\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\nin\\tO\\nlaboratory\\tO\\nanimals\\tO\\n.\\tO\\n\\nTo\\tO\\nderive\\tO\\nan\\tO\\nanimal\\tO\\nmodel\\tO\\nfor\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nwe\\tO\\nhave\\tO\\nused\\tO\\ncultured\\tO\\nmouse\\tO\\nembryonic\\tO\\nstem\\tO\\ncells\\tO\\n,\\tO\\nmutagenized\\tO\\nby\\tO\\nretroviral\\tO\\ninsertion\\tO\\nand\\tO\\nselected\\tO\\nfor\\tO\\nloss\\tO\\nof\\tO\\nHPRT\\tO\\nactivity\\tO\\n,\\tO\\nto\\tO\\nconstruct\\tO\\nchimaeric\\tO\\nmice\\tO\\n.\\tO\\n\\nTwo\\tO\\nclonal\\tO\\nlines\\tO\\ncarrying\\tO\\ndifferent\\tO\\nmutant\\tO\\nHprt\\tO\\nalleles\\tO\\nhave\\tO\\ngiven\\tO\\nrise\\tO\\nto\\tO\\ngerm\\tO\\ncells\\tO\\nin\\tO\\nchimaeras\\tO\\n,\\tO\\nallowing\\tO\\nthe\\tO\\nderivation\\tO\\nof\\tO\\nstrains\\tO\\nof\\tO\\nmutant\\tO\\nmice\\tO\\nhaving\\tO\\nthe\\tO\\nsame\\tO\\nbiochemical\\tO\\ndefect\\tO\\nas\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nMale\\tO\\nmice\\tO\\ncarrying\\tO\\nthe\\tO\\nmutant\\tO\\nalleles\\tO\\nare\\tO\\nviable\\tO\\nand\\tO\\nanalysis\\tO\\nof\\tO\\ntheir\\tO\\ncells\\tO\\nshows\\tO\\na\\tO\\ntotal\\tO\\nlack\\tO\\nof\\tO\\nHPRT\\tO\\nactivity\\tO\\n.\\tO\\n.\\tO\\n\\nRe\\tO\\n-\\tO\\nevaluation\\tO\\nof\\tO\\nthe\\tO\\nsublocalization\\tO\\nof\\tO\\nesterase\\tO\\nD\\tO\\nand\\tO\\nits\\tO\\nrelation\\tO\\nto\\tO\\nthe\\tO\\nretinoblastoma\\tB-Disease\\nlocus\\tO\\nby\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n.\\tO\\n\\nIn\\tO\\nsitu\\tO\\nhybridization\\tO\\nof\\tO\\na\\tO\\ncDNA\\tO\\nprobe\\tO\\nfor\\tO\\nthe\\tO\\nesterase\\tO\\nD\\tO\\ngene\\tO\\n(\\tO\\nESD\\tO\\n)\\tO\\nwas\\tO\\ncarried\\tO\\nout\\tO\\non\\tO\\nhuman\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nThe\\tO\\nprobe\\tO\\nhybridized\\tO\\nmost\\tO\\nstrongly\\tO\\nto\\tO\\n13q14\\tO\\n.\\tO\\n\\n2\\tO\\nand\\tO\\n13q14\\tO\\n.\\tO\\n\\n3\\tO\\n.\\tO\\n\\nThis\\tO\\nobservation\\tO\\nraises\\tO\\ndoubts\\tO\\nconcerning\\tO\\nthe\\tO\\nmost\\tO\\nrecently\\tO\\npublished\\tO\\nassignment\\tO\\nof\\tO\\nESD\\tO\\nto\\tO\\n13q14\\tO\\n.\\tO\\n\\n1\\tO\\n.\\tO\\n\\nA\\tO\\ndeletion\\tO\\nin\\tO\\nan\\tO\\nindividual\\tO\\nwith\\tO\\nretinoblastoma\\tB-Disease\\nwas\\tO\\nreported\\tO\\nto\\tO\\nseparate\\tO\\nthe\\tO\\nclosely\\tO\\nlinked\\tO\\nESD\\tO\\nand\\tO\\nretinoblastoma\\tB-Disease\\n(\\tO\\nRB1\\tO\\n)\\tO\\nloci\\tO\\n,\\tO\\nplacing\\tO\\nESD\\tO\\nproximal\\tO\\nto\\tO\\nRB1\\tO\\n.\\tO\\n\\nQuantitative\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\nstudies\\tO\\nof\\tO\\nthis\\tO\\ndeletion\\tO\\ndo\\tO\\nnot\\tO\\nconfirm\\tO\\nthis\\tO\\ninterpretation\\tO\\n.\\tO\\n\\nRather\\tO\\n,\\tO\\nthey\\tO\\nsuggest\\tO\\nthat\\tO\\nESD\\tO\\nis\\tO\\nmissing\\tO\\nfrom\\tO\\nthe\\tO\\ndeleted\\tO\\nchromosome\\tO\\n13\\tO\\nand\\tO\\nduplicated\\tO\\non\\tO\\nthe\\tO\\nnormal\\tO\\nhomolog\\tO\\n.\\tO\\n\\nFrom\\tO\\nthese\\tO\\nfindings\\tO\\n,\\tO\\nwe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\ndeletion\\tO\\nin\\tO\\nthis\\tO\\nindividual\\tO\\ncannot\\tO\\nbe\\tO\\nused\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\norientation\\tO\\nnor\\tO\\nthe\\tO\\nsublocalization\\tO\\nof\\tO\\nESD\\tO\\nand\\tO\\nRB1\\tO\\nwithin\\tO\\nthe\\tO\\n13q14\\tO\\nregion\\tO\\n.\\tO\\n\\nHereditary\\tB-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\nassociated\\tO\\nwith\\tO\\ncommon\\tO\\nvariable\\tO\\nimmunodeficiency\\tB-Disease\\n.\\tO\\n\\nHomozygous\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\na\\tO\\n19\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nboy\\tO\\nwas\\tO\\nassociated\\tO\\nwith\\tO\\nvariable\\tO\\nimmunodeficiency\\tB-Disease\\nmanifested\\tO\\nby\\tO\\nmarked\\tO\\nhypoimmunoglobulinemia\\tB-Disease\\nand\\tO\\nimpaired\\tO\\nantibody\\tO\\nresponses\\tO\\n,\\tO\\nnormal\\tO\\ncirculating\\tO\\nB\\tO\\nlymphocytes\\tO\\n,\\tO\\nand\\tO\\nsubnormal\\tO\\nT\\tO\\n-\\tO\\ncell\\tO\\nfunctions\\tO\\n.\\tO\\n\\nNeither\\tO\\nantilymphocytic\\tO\\nautoantibodies\\tO\\nnor\\tO\\nchromosomal\\tB-Disease\\nabnormalities\\tI-Disease\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nSerum\\tO\\nimmunoglobulin\\tO\\nlevels\\tO\\nwere\\tO\\nwithin\\tO\\nnormal\\tO\\nlimits\\tO\\nin\\tO\\nhis\\tO\\nparents\\tO\\nand\\tO\\nbrother\\tO\\nwho\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\npatients\\tO\\nlymphocytes\\tO\\nwere\\tO\\nhomozygous\\tO\\nat\\tO\\nthe\\tO\\nHLA\\tO\\n-\\tO\\nD\\tO\\nlocus\\tO\\nbut\\tO\\nexpressed\\tO\\nan\\tO\\nantigen\\tO\\ndifferent\\tO\\nfrom\\tO\\nDW2\\tO\\n.\\tO\\n.\\tO\\n\\nMild\\tO\\nand\\tO\\nsevere\\tO\\nmuscular\\tB-Disease\\ndystrophy\\tI-Disease\\nassociated\\tO\\nwith\\tO\\ndeletions\\tO\\nin\\tO\\nXp21\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nanalysed\\tO\\nover\\tO\\n300\\tO\\npatients\\tO\\nsuffering\\tO\\nfrom\\tO\\nDuchenne\\tB-Disease\\nor\\tI-Disease\\nBecker\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\nor\\tO\\nBMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nDeletions\\tO\\nhave\\tO\\nbeen\\tO\\ncharacterised\\tO\\nwhich\\tO\\nencompass\\tO\\neither\\tO\\nthe\\tO\\npERT87\\tO\\n(\\tO\\nDXS164\\tO\\n)\\tO\\nlocus\\tO\\nonly\\tO\\n,\\tO\\nthe\\tO\\nXJ1\\tO\\n.\\tO\\n\\n1\\tO\\n(\\tO\\nDXS206\\tO\\n)\\tO\\nand\\tO\\nHIP25\\tO\\nloci\\tO\\nonly\\tO\\n,\\tO\\nor\\tO\\nall\\tO\\nthree\\tO\\nloci\\tO\\n.\\tO\\n\\nThese\\tO\\nloci\\tO\\nhave\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nlie\\tO\\nwithin\\tO\\nthe\\tO\\nDMD\\tB-Disease\\nregion\\tO\\ncovering\\tO\\nseveral\\tO\\nhundred\\tO\\nkilobases\\tO\\n(\\tO\\nkb\\tO\\n)\\tO\\nof\\tO\\nDNA\\tO\\n.\\tO\\n\\nOne\\tO\\nmildly\\tO\\naffected\\tO\\nBMD\\tB-Disease\\npatient\\tO\\npossesses\\tO\\na\\tO\\ndeletion\\tO\\nof\\tO\\nat\\tO\\nleast\\tO\\n110\\tO\\nkb\\tO\\nincluding\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nOther\\tO\\npatients\\tO\\nwith\\tO\\nsimilar\\tO\\nexon\\tO\\ndeletions\\tO\\n,\\tO\\nor\\tO\\nsmaller\\tO\\ndeletions\\tO\\n,\\tO\\nshow\\tO\\nthe\\tO\\nmore\\tO\\nsevere\\tO\\nphenotype\\tO\\ntypical\\tO\\nof\\tO\\nDMD\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nfrom\\tO\\nthese\\tO\\nstudies\\tO\\nthat\\tO\\nthe\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\nclinical\\tO\\nphenotype\\tO\\ncannot\\tO\\nbe\\tO\\nexplained\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\ndeletion\\tO\\n.\\tO\\n\\nWe\\tO\\ndiscuss\\tO\\nthis\\tO\\nin\\tO\\nthe\\tO\\ncontext\\tO\\nof\\tO\\ncandidate\\tO\\ngene\\tO\\nsequences\\tO\\n.\\tO\\n\\nPatterns\\tO\\nof\\tO\\nexon\\tO\\ndeletions\\tO\\nin\\tO\\nDuchenne\\tB-Disease\\nand\\tI-Disease\\nBecker\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nA\\tO\\npanel\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nand\\tI-Disease\\nBecker\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\nand\\tO\\nBMD\\tB-Disease\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nscreened\\tO\\nwith\\tO\\nthe\\tO\\ncDNA\\tO\\nprobes\\tO\\nCf56a\\tO\\nand\\tO\\nCf23a\\tO\\n,\\tO\\nwhich\\tO\\ndetect\\tO\\nexons\\tO\\nin\\tO\\nthe\\tO\\ncentral\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nOne\\tO\\nor\\tO\\nmore\\tO\\nexons\\tO\\nwere\\tO\\ndeleted\\tO\\nin\\tO\\n60\\tO\\n%\\tO\\nof\\tO\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\ndeletions\\tO\\nwere\\tO\\nmapped\\tO\\nand\\tO\\nprove\\tO\\nto\\tO\\nbe\\tO\\nheterogeneous\\tO\\nin\\tO\\nsize\\tO\\nand\\tO\\nextent\\tO\\n,\\tO\\nparticularly\\tO\\nin\\tO\\nDMD\\tB-Disease\\n.\\tO\\n\\nDeletions\\tO\\nspecific\\tO\\nto\\tO\\nDMD\\tB-Disease\\nand\\tO\\nto\\tO\\nBMD\\tB-Disease\\nare\\tO\\ndescribed\\tO\\n.\\tO\\n\\nHalf\\tO\\nof\\tO\\nall\\tO\\nBMD\\tB-Disease\\npatients\\tO\\nhave\\tO\\na\\tO\\ndeletion\\tO\\nof\\tO\\none\\tO\\nparticular\\tO\\nsmall\\tO\\ngroup\\tO\\nof\\tO\\nexons\\tO\\n;\\tO\\nsmaller\\tO\\ndeletions\\tO\\nwithin\\tO\\nthis\\tO\\nsame\\tO\\ngroup\\tO\\nproduce\\tO\\nthe\\tO\\nmore\\tO\\nsevere\\tO\\nDMD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nHereditary\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nthird\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nin\\tO\\na\\tO\\nchild\\tO\\nwith\\tO\\nfever\\tB-Disease\\n,\\tO\\nskin\\tB-Disease\\nrash\\tI-Disease\\n,\\tO\\nand\\tO\\narthralgias\\tB-Disease\\n:\\tO\\nresponse\\tO\\nto\\tO\\ntransfusion\\tO\\nof\\tO\\nwhole\\tO\\nblood\\tO\\n.\\tO\\n\\nA\\tO\\npreviously\\tO\\nwell\\tO\\n34\\tO\\n-\\tO\\nmonth\\tO\\n-\\tO\\nold\\tO\\nmale\\tO\\npresenting\\tO\\nwith\\tO\\nfever\\tB-Disease\\n,\\tO\\nskin\\tB-Disease\\nrash\\tI-Disease\\n,\\tO\\nand\\tO\\narthralgias\\tB-Disease\\nwas\\tO\\nfound\\tO\\nto\\tO\\nlack\\tO\\nC3\\tO\\nby\\tO\\nimmunochemical\\tO\\n(\\tO\\nundetectable\\tO\\n)\\tO\\nand\\tO\\nhemolytic\\tO\\n(\\tO\\n1\\tO\\n%\\tO\\nnormal\\tO\\n)\\tO\\nassays\\tO\\n.\\tO\\n\\nNo\\tO\\ninfectious\\tO\\nagent\\tO\\ncould\\tO\\nbe\\tO\\ndemonstrated\\tO\\n.\\tO\\n\\nProtein\\tO\\nlevels\\tO\\nof\\tO\\nClq\\tO\\n.\\tO\\n\\nC4\\tO\\n,\\tO\\nC5\\tO\\n,\\tO\\nproperdin\\tO\\n,\\tO\\nand\\tO\\nC3b\\tO\\n-\\tO\\nINA\\tO\\nand\\tO\\nhemolytic\\tO\\nactivities\\tO\\nof\\tO\\ncomplement\\tO\\ncomponents\\tO\\nC1\\tO\\nto\\tO\\nC9\\tO\\nexcept\\tO\\nC3\\tO\\nwere\\tO\\nnormal\\tO\\nor\\tO\\nelevated\\tO\\n;\\tO\\ntotal\\tO\\nhemolytic\\tO\\ncomplement\\tO\\nactivity\\tO\\nwas\\tO\\n13\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\nand\\tO\\nwas\\tO\\nreconstituted\\tO\\nby\\tO\\npurified\\tO\\nC3\\tO\\n.\\tO\\n\\nProperdin\\tO\\nfactor\\tO\\nB\\tO\\nwas\\tO\\n702\\tO\\n(\\tO\\nnormal\\tO\\n175\\tO\\nto\\tO\\n275\\tO\\n)\\tO\\nmug\\tO\\n/\\tO\\nml\\tO\\n,\\tO\\nand\\tO\\nwas\\tO\\nnot\\tO\\ncleaver\\tO\\nupon\\tO\\naddition\\tO\\nof\\tO\\nzymosan\\tO\\nor\\tO\\ncobra\\tO\\nvenom\\tO\\nfactor\\tO\\n.\\tO\\n\\nThe\\tO\\nserum\\tO\\nhad\\tO\\nnormal\\tO\\nimmune\\tO\\nadherence\\tO\\nactivity\\tO\\n,\\tO\\nbut\\tO\\nwas\\tO\\ndeficient\\tO\\nin\\tO\\nability\\tO\\nto\\tO\\nopsonize\\tO\\nCandida\\tO\\nalbicans\\tO\\nfor\\tO\\nuptake\\tO\\nand\\tO\\nEscherichia\\tO\\ncoli\\tO\\nfor\\tO\\nkilling\\tO\\nby\\tO\\nneurophils\\tO\\n,\\tO\\ngenerate\\tO\\nneutrophil\\tO\\nchemotactic\\tO\\nfactors\\tO\\nand\\tO\\ninhibit\\tO\\nthe\\tO\\ngrowth\\tO\\nof\\tO\\nE\\tO\\n.\\tO\\ncoli\\tO\\n;\\tO\\nthese\\tO\\nactivities\\tO\\nwere\\tO\\nrestored\\tO\\nby\\tO\\npurified\\tO\\nC3\\tO\\n.\\tO\\n\\nA\\tO\\ntransfusion\\tO\\nof\\tO\\n320\\tO\\nml\\tO\\n1\\tO\\n-\\tO\\nhour\\tO\\n-\\tO\\nold\\tO\\nnormal\\tO\\nwhole\\tO\\nblood\\tO\\non\\tO\\nthe\\tO\\nfifty\\tO\\n-\\tO\\nsecond\\tO\\nday\\tO\\nresulted\\tO\\nin\\tO\\ntransitory\\tO\\nelevation\\tO\\nof\\tO\\nthe\\tO\\nC3\\tO\\nlevel\\tO\\nto\\tO\\n25\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\nwith\\tO\\na\\tO\\nfall\\tO\\n-\\tO\\noff\\tO\\n(\\tO\\napproximately\\tO\\n2\\tO\\n1\\tO\\n/\\tO\\n2\\tO\\n%\\tO\\nper\\tO\\nhour\\tO\\n)\\tO\\nto\\tO\\nundetectable\\tO\\nlevels\\tO\\nby\\tO\\n69\\tO\\nhours\\tO\\n;\\tO\\nit\\tO\\nwas\\tO\\nfollowed\\tO\\nby\\tO\\ndisappearance\\tO\\nof\\tO\\nthe\\tO\\nskin\\tB-Disease\\nrash\\tI-Disease\\nand\\tO\\narthralgias\\tB-Disease\\nand\\tO\\nreturn\\tO\\nto\\tO\\nnormal\\tO\\nof\\tO\\nthe\\tO\\npreviously\\tO\\nelevated\\tO\\ntemperature\\tO\\nand\\tO\\nCRP\\tO\\nlevels\\tO\\n.\\tO\\n\\nC3\\tO\\nlevels\\tO\\nin\\tO\\nfamily\\tO\\nmembers\\tO\\n(\\tO\\nseven\\tO\\nof\\tO\\n24\\tO\\nhalf\\tO\\n-\\tO\\nnormal\\tO\\n)\\tO\\n,\\tO\\nlack\\tO\\nof\\tO\\nanti\\tO\\n-\\tO\\nC3\\tO\\nactivity\\tO\\n,\\tO\\nnormal\\tO\\nC3b\\tO\\n-\\tO\\nINA\\tO\\nlevels\\tO\\nand\\tO\\na\\tO\\nnormal\\tO\\nrate\\tO\\nof\\tO\\ncatabolism\\tO\\nof\\tO\\ntransfused\\tO\\nC3\\tO\\nindicated\\tO\\nthat\\tO\\nthe\\tO\\ndeficiency\\tO\\nwas\\tO\\ninherited\\tO\\nwith\\tO\\nautosomal\\tO\\ncodominance\\tO\\nand\\tO\\ninvolved\\tO\\ndecreased\\tB-Disease\\nsynthesis\\tI-Disease\\nof\\tI-Disease\\nC3\\tI-Disease\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthis\\tO\\nchild\\tO\\nis\\tO\\na\\tO\\nunique\\tO\\nindividual\\tO\\nwith\\tO\\ninherited\\tB-Disease\\nC3\\tI-Disease\\ndeficiency\\tI-Disease\\npresenting\\tO\\nwith\\tO\\nabsence\\tO\\nof\\tO\\nrepeated\\tO\\ninfections\\tO\\n,\\tO\\nwhose\\tO\\nsymptoms\\tO\\nof\\tO\\nfever\\tB-Disease\\n,\\tO\\nskin\\tB-Disease\\nrash\\tI-Disease\\n,\\tO\\nand\\tO\\narthralgia\\tB-Disease\\nwere\\tO\\nabated\\tO\\nby\\tO\\nwhole\\tO\\nblood\\tO\\ntransfusion\\tO\\n.\\tO\\n.\\tO\\n\\nGlucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nvariants\\tO\\nand\\tO\\ntheir\\tO\\nfrequency\\tO\\nin\\tO\\nGuangdong\\tO\\n,\\tO\\nChina\\tO\\n.\\tO\\n\\nErythrocyte\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nwas\\tO\\ncharacterized\\tO\\nin\\tO\\nblood\\tO\\nsamples\\tO\\nobtained\\tO\\nfrom\\tO\\n97\\tO\\nrandomly\\tO\\nselected\\tO\\nmales\\tO\\nwith\\tO\\nenzyme\\tB-Disease\\ndeficiency\\tI-Disease\\nfrom\\tO\\nvarious\\tO\\nregions\\tO\\nof\\tO\\nGuangdong\\tO\\nProvince\\tO\\n,\\tO\\nChina\\tO\\n.\\tO\\n\\nNine\\tO\\nnew\\tO\\nvariants\\tO\\n(\\tO\\nGd\\tO\\nKaiping\\tO\\n,\\tO\\nGd\\tO\\nBoluo\\tO\\n,\\tO\\nGd\\tO\\nHuiyang\\tO\\n,\\tO\\nGd\\tO\\nGaomin\\tO\\n,\\tO\\nGd\\tO\\nQing\\tO\\n-\\tO\\nBaijiang\\tO\\n,\\tO\\nGd\\tO\\nGaozhou\\tO\\n,\\tO\\nGd\\tO\\nHuazhou\\tO\\n,\\tO\\nGd\\tO\\nNanhai\\tO\\n,\\tO\\nand\\tO\\nGd\\tO\\nGuangzhou\\tO\\n)\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\n31\\tO\\nvariants\\tO\\nfound\\tO\\nin\\tO\\nthis\\tO\\nprovince\\tO\\n,\\tO\\nGd\\tO\\nKaiping\\tO\\n,\\tO\\nGd\\tO\\nTaiwan\\tO\\n-\\tO\\nHakka\\tO\\n,\\tO\\nGd\\tO\\nHaad\\tO\\nYai\\tO\\n,\\tO\\nGd\\tO\\nHaad\\tO\\nYai\\tO\\n-\\tO\\nlike\\tO\\nand\\tO\\nGd\\tO\\nHuiyang\\tO\\noccurred\\tO\\nmost\\tO\\nfrequently\\tO\\n.\\tO\\n\\nThe\\tO\\nfrequency\\tO\\nof\\tO\\neach\\tO\\nvariant\\tO\\nwas\\tO\\ncalculated\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\nhigh\\tO\\nin\\tO\\nthis\\tO\\narea\\tO\\n.\\tO\\n.\\tO\\n\\nHomozygous\\tO\\nand\\tO\\nheterozygous\\tO\\ndeletions\\tO\\nof\\tO\\nthe\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\ngene\\tO\\nin\\tO\\npatients\\tO\\nand\\tO\\ncarriers\\tO\\nof\\tO\\nsevere\\tB-Disease\\nvon\\tI-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nSevere\\tB-Disease\\nvon\\tI-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nundetectable\\tO\\nor\\tO\\ntrace\\tO\\nquantities\\tO\\nof\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\nin\\tO\\nplasma\\tO\\nand\\tO\\ntissue\\tO\\nstores\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nstudied\\tO\\nthe\\tO\\ngenomic\\tO\\nDNA\\tO\\nof\\tO\\n10\\tO\\naffected\\tO\\nindividuals\\tO\\nfrom\\tO\\nsix\\tO\\nfamilies\\tO\\nwith\\tO\\nthis\\tO\\ndisorder\\tO\\nusing\\tO\\nprobes\\tO\\nfrom\\tO\\nthe\\tO\\n5\\tO\\nand\\tO\\n3\\tO\\nends\\tO\\nof\\tO\\nthe\\tO\\nvWF\\tO\\ncDNA\\tO\\nand\\tO\\nwith\\tO\\na\\tO\\nprobe\\tO\\nextending\\tO\\nfrom\\tO\\nthe\\tO\\n5\\tO\\nend\\tO\\ninto\\tO\\nthe\\tO\\ncentral\\tO\\nregion\\tO\\n.\\tO\\n\\nSouthern\\tO\\nblots\\tO\\nof\\tO\\nrestriction\\tO\\nendonuclease\\tO\\ndigests\\tO\\nand\\tO\\ngene\\tO\\ndosage\\tO\\nanalysis\\tO\\nmeasurements\\tO\\ncarried\\tO\\nout\\tO\\nwith\\tO\\nquantitative\\tO\\nslot\\tO\\nblots\\tO\\nof\\tO\\nundigested\\tO\\ngenomic\\tO\\nDNA\\tO\\nseparated\\tO\\nthese\\tO\\npatients\\tO\\ninto\\tO\\nthree\\tO\\ngroups\\tO\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\ngroup\\tO\\nconsisted\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\ncomplete\\tO\\nhomozygous\\tO\\ndeletions\\tO\\nof\\tO\\nthe\\tO\\nvWF\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\nfour\\tO\\nprobands\\tO\\n.\\tO\\n\\nGene\\tO\\ndosage\\tO\\nanalysis\\tO\\nwas\\tO\\nconsistent\\tO\\nwith\\tO\\nheterozygous\\tO\\ndeletions\\tO\\nin\\tO\\nboth\\tO\\nof\\tO\\nthe\\tO\\nasymptomatic\\tO\\nparents\\tO\\nand\\tO\\nfour\\tO\\nasymptomatic\\tO\\nsiblings\\tO\\nof\\tO\\nthis\\tO\\nkindred\\tO\\n(\\tO\\nP\\tO\\nless\\tO\\nthan\\tO\\n0\\tO\\n.\\tO\\n01\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nsecond\\tO\\ngroup\\tO\\nwas\\tO\\ncomprised\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\nin\\tO\\nwhich\\tO\\nthere\\tO\\nwas\\tO\\na\\tO\\ncomplete\\tO\\nheterozygous\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nvWF\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\nproband\\tO\\nand\\tO\\none\\tO\\nasymptomatic\\tO\\nparent\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\na\\tO\\ndifferent\\tO\\ntype\\tO\\nof\\tO\\ngenetic\\tB-Disease\\nabnormality\\tI-Disease\\nwas\\tO\\ninherited\\tO\\nfrom\\tO\\nthe\\tO\\nother\\tO\\nparent\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\npatient\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\ndoubly\\tO\\nheterozygous\\tO\\nfor\\tO\\ninteracting\\tO\\ngenetic\\tB-Disease\\nabnormalities\\tI-Disease\\naffecting\\tO\\nvWF\\tO\\nexpression\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nthird\\tO\\ngroup\\tO\\n,\\tO\\nno\\tO\\ngene\\tO\\ndeletions\\tO\\ncould\\tO\\nbe\\tO\\ndetected\\tO\\n.\\tO\\n\\nAlloantibodies\\tO\\ndeveloped\\tO\\nonly\\tO\\nin\\tO\\nthe\\tO\\nkindred\\tO\\nwith\\tO\\nhomozygous\\tO\\ndeletions\\tO\\n.\\tO\\n\\nThese\\tO\\ntechniques\\tO\\nshould\\tO\\nprove\\tO\\nuseful\\tO\\nin\\tO\\nidentifying\\tO\\ncarriers\\tO\\nof\\tO\\nsevere\\tB-Disease\\nvon\\tI-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\nand\\tO\\nalso\\tO\\nin\\tO\\ndefining\\tO\\npatients\\tO\\npredictably\\tO\\nat\\tO\\nrisk\\tO\\nof\\tO\\ndeveloping\\tO\\nalloantibodies\\tO\\nto\\tO\\nvWF\\tO\\n.\\tO\\n\\nSjogren\\tB-Disease\\n-\\tI-Disease\\nLarsson\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nImpaired\\tO\\nfatty\\tO\\nalcohol\\tO\\noxidation\\tO\\nin\\tO\\ncultured\\tO\\nfibroblasts\\tO\\ndue\\tO\\nto\\tO\\ndeficient\\tO\\nfatty\\tO\\nalcohol\\tO\\n:\\tO\\nnicotinamide\\tO\\nadenine\\tO\\ndinucleotide\\tO\\noxidoreductase\\tO\\nactivity\\tO\\n.\\tO\\n\\nLipid\\tO\\nmetabolism\\tO\\nwas\\tO\\nstudied\\tO\\nin\\tO\\ncultured\\tO\\nskin\\tO\\nfibroblasts\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\ninherited\\tB-Disease\\ndisorder\\tI-Disease\\n,\\tO\\nSjogren\\tB-Disease\\n-\\tI-Disease\\nLarsson\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nSLS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIntact\\tO\\nSLS\\tB-Disease\\nfibroblasts\\tO\\nincubated\\tO\\nin\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\n[\\tO\\n1\\tO\\n-\\tO\\n14C\\tO\\n]\\tO\\npalmitate\\tO\\naccumulated\\tO\\nmore\\tO\\nradioactive\\tO\\nhexadecanol\\tO\\nthan\\tO\\ndid\\tO\\nnormal\\tO\\ncells\\tO\\n,\\tO\\nwhereas\\tO\\nincorporation\\tO\\nof\\tO\\nradioactivity\\tO\\ninto\\tO\\nother\\tO\\ncellular\\tO\\nlipids\\tO\\nwas\\tO\\nunaltered\\tO\\n.\\tO\\n\\nThe\\tO\\nhexadecanol\\tO\\ncontent\\tO\\nof\\tO\\nSLS\\tB-Disease\\nfibroblasts\\tO\\nwas\\tO\\nabnormally\\tO\\nelevated\\tO\\n.\\tO\\n\\nHexadecanol\\tO\\naccumulation\\tO\\nwas\\tO\\nnot\\tO\\ndue\\tO\\nto\\tO\\nincreased\\tO\\nfatty\\tO\\nalcohol\\tO\\nsynthesis\\tO\\nnor\\tO\\nits\\tO\\ndeficient\\tO\\nutilization\\tO\\nfor\\tO\\nglycerol\\tO\\nether\\tO\\nsynthesis\\tO\\n.\\tO\\n\\nThe\\tO\\nhalf\\tO\\n-\\tO\\nlife\\tO\\nof\\tO\\nintracellular\\tO\\nhexadecanol\\tO\\nloaded\\tO\\ninto\\tO\\nSLS\\tB-Disease\\nfibroblasts\\tO\\nwas\\tO\\nincreased\\tO\\n(\\tO\\n70\\tO\\nmin\\tO\\n)\\tO\\ncompared\\tO\\nwith\\tO\\nnormal\\tO\\n(\\tO\\n15\\tO\\nmin\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nintact\\tO\\nSLS\\tB-Disease\\nfibroblasts\\tO\\nshowed\\tO\\nimpaired\\tO\\noxidation\\tO\\nof\\tO\\n[\\tO\\n14C\\tO\\n]\\tO\\n-\\tO\\nhexadecanol\\tO\\nto\\tO\\nfatty\\tO\\nacid\\tO\\n.\\tO\\n\\nFatty\\tO\\nalcohol\\tO\\nNAD\\tO\\n+\\tO\\noxidoreductase\\tO\\n,\\tO\\nthe\\tO\\nenzyme\\tO\\ncatalyzing\\tO\\nthis\\tO\\nreaction\\tO\\n,\\tO\\nwas\\tO\\ndeficient\\tO\\nin\\tO\\nSLS\\tB-Disease\\nfibroblasts\\tO\\n.\\tO\\n\\nMean\\tO\\ntotal\\tO\\nactivity\\tO\\nin\\tO\\nSLS\\tB-Disease\\nfibroblasts\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n5\\tO\\n)\\tO\\nwas\\tO\\n13\\tO\\n%\\tO\\nof\\tO\\nthat\\tO\\nin\\tO\\nnormal\\tO\\nfibroblasts\\tO\\n,\\tO\\nand\\tO\\npalmitoyl\\tO\\nCoA\\tO\\n-\\tO\\ninhibitable\\tO\\nactivity\\tO\\nwas\\tO\\n1\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\n.\\tO\\n\\nFibroblasts\\tO\\nfrom\\tO\\ntwo\\tO\\nobligate\\tO\\nSLS\\tB-Disease\\nheterozygotes\\tO\\nhad\\tO\\nenzyme\\tO\\nactivities\\tO\\nintermediate\\tO\\nbetween\\tO\\nthat\\tO\\nin\\tO\\nnormal\\tO\\nfibroblasts\\tO\\nand\\tO\\nindividuals\\tO\\nwith\\tO\\nSLS\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nprimary\\tO\\ndefect\\tO\\nin\\tO\\nSLS\\tB-Disease\\nis\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nfatty\\tI-Disease\\nalcohol\\tI-Disease\\nNAD\\tI-Disease\\n+\\tI-Disease\\noxidoreductase\\tI-Disease\\n.\\tO\\n\\nSLS\\tB-Disease\\nrepresents\\tO\\nthe\\tO\\nfirst\\tO\\ninherited\\tB-Disease\\ndisorder\\tI-Disease\\nin\\tO\\nman\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nisolated\\tO\\nabnormality\\tB-Disease\\nin\\tI-Disease\\nfatty\\tI-Disease\\nalcohol\\tI-Disease\\nmetabolism\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nGerminal\\tO\\nmosaicism\\tO\\nin\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\na\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\npedigree\\tO\\nwhere\\tO\\nthe\\tO\\ndisease\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nmolecular\\tO\\ndeletion\\tO\\nwithin\\tO\\nthe\\tO\\nDMD\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexamined\\tO\\nthe\\tO\\nmeiotic\\tO\\nsegregation\\tO\\nproducts\\tO\\nof\\tO\\nthe\\tO\\ncommon\\tO\\nfemale\\tO\\nancestor\\tO\\nusing\\tO\\nmarker\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphisms\\tO\\n(\\tO\\nRFLPs\\tO\\n)\\tO\\ndetected\\tO\\nby\\tO\\nprobes\\tO\\nthat\\tO\\nlie\\tO\\nwithin\\tO\\nthis\\tO\\ndeletion\\tO\\n.\\tO\\n\\nThese\\tO\\nstudies\\tO\\nshow\\tO\\nthat\\tO\\nthis\\tO\\nfemale\\tO\\nhas\\tO\\ntransmitted\\tO\\nthree\\tO\\ndistinct\\tO\\ntypes\\tO\\nof\\tO\\nX\\tO\\nchromosome\\tO\\nto\\tO\\nher\\tO\\noffspring\\tO\\n.\\tO\\n\\nThis\\tO\\nobservation\\tO\\nmay\\tO\\nbe\\tO\\nexplained\\tO\\nby\\tO\\npostulating\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\narose\\tO\\nas\\tO\\na\\tO\\npostzygotic\\tO\\ndeletion\\tO\\nwithin\\tO\\nthis\\tO\\ncommon\\tO\\nancestor\\tO\\n,\\tO\\nwho\\tO\\nwas\\tO\\nconsequently\\tO\\ngerminally\\tO\\nmosaic\\tO\\n.\\tO\\n.\\tO\\n\\nNebulin\\tO\\nseen\\tO\\nin\\tO\\nDMD\\tB-Disease\\nmales\\tO\\nincluding\\tO\\none\\tO\\npatient\\tO\\nwith\\tO\\na\\tO\\nlarge\\tO\\nDNA\\tO\\ndeletion\\tO\\nencompassing\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\npresence\\tO\\nof\\tO\\nnebulin\\tO\\nin\\tO\\na\\tO\\nmuscle\\tO\\nspecimen\\tO\\nfrom\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nlarge\\tO\\ndeletion\\tO\\nprecludes\\tO\\nthe\\tO\\npossibility\\tO\\nthat\\tO\\nthis\\tO\\nprotein\\tO\\nis\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\nproduct\\tO\\n.\\tO\\n.\\tO\\n\\nExpression\\tO\\nof\\tO\\nthe\\tO\\nmurine\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ngene\\tO\\nin\\tO\\nmuscle\\tO\\nand\\tO\\nbrain\\tO\\n.\\tO\\n\\nComplementary\\tO\\nDNA\\tO\\nclones\\tO\\nwere\\tO\\nisolated\\tO\\nthat\\tO\\nrepresent\\tO\\nthe\\tO\\n5\\tO\\nterminal\\tO\\n2\\tO\\n.\\tO\\n\\n5\\tO\\nkilobases\\tO\\nof\\tO\\nthe\\tO\\nmurine\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDmd\\tO\\n)\\tO\\nmessenger\\tO\\nRNA\\tO\\n(\\tO\\nmRNA\\tO\\n)\\tO\\n.\\tO\\n\\nMouse\\tO\\nDmd\\tO\\nmRNA\\tO\\nwas\\tO\\ndetectable\\tO\\nin\\tO\\nskeletal\\tO\\nand\\tO\\ncardiac\\tO\\nmuscle\\tO\\nand\\tO\\nat\\tO\\na\\tO\\nlevel\\tO\\napproximately\\tO\\n90\\tO\\npercent\\tO\\nlower\\tO\\nin\\tO\\nbrain\\tO\\n.\\tO\\n\\nDmd\\tO\\nmRNA\\tO\\nis\\tO\\nalso\\tO\\npresent\\tO\\n,\\tO\\nbut\\tO\\nat\\tO\\nmuch\\tO\\nlower\\tO\\nthan\\tO\\nnormal\\tO\\nlevels\\tO\\n,\\tO\\nin\\tO\\nboth\\tO\\nthe\\tO\\nmuscle\\tO\\nand\\tO\\nbrain\\tO\\nof\\tO\\nthree\\tO\\ndifferent\\tO\\nstrains\\tO\\nof\\tO\\ndystrophic\\tB-Disease\\nmdx\\tO\\nmice\\tO\\n.\\tO\\n\\nThe\\tO\\nidentification\\tO\\nof\\tO\\nDmd\\tO\\nmRNA\\tO\\nin\\tO\\nbrain\\tO\\nraises\\tO\\nthe\\tO\\npossibility\\tO\\nof\\tO\\na\\tO\\nrelation\\tO\\nbetween\\tO\\nhuman\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\ngene\\tO\\nexpression\\tO\\nand\\tO\\nthe\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\nfound\\tO\\nin\\tO\\nsome\\tO\\nDMD\\tB-Disease\\nmales\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nalso\\tO\\nprovide\\tO\\nevidence\\tO\\nthat\\tO\\nthe\\tO\\nmdx\\tO\\nmutations\\tO\\nare\\tO\\nallelic\\tO\\nvariants\\tO\\nof\\tO\\nmouse\\tO\\nDmd\\tO\\ngene\\tO\\nmutations\\tO\\n.\\tO\\n\\nGlucose\\tB-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nincidence\\tO\\nof\\tO\\nhematologic\\tB-Disease\\nmalignancy\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nevaluated\\tO\\nthe\\tO\\nhypothesis\\tO\\nof\\tO\\na\\tO\\nnegative\\tO\\nassociation\\tO\\nbetween\\tO\\nglucose\\tB-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\ncancer\\tB-Disease\\nin\\tO\\na\\tO\\ncohort\\tO\\nof\\tO\\n481\\tO\\nSardinian\\tO\\nmales\\tO\\nwith\\tO\\nhematological\\tB-Disease\\nmalignancies\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nfrequency\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthe\\tO\\npatients\\tO\\nwas\\tO\\nnot\\tO\\ndifferent\\tO\\nfrom\\tO\\nthe\\tO\\nincidence\\tO\\nin\\tO\\na\\tO\\ngroup\\tO\\nof\\tO\\n16\\tO\\n,\\tO\\n219\\tO\\ncontrols\\tO\\n.\\tO\\n\\nThe\\tO\\nsame\\tO\\nconclusion\\tO\\nresulted\\tO\\nfrom\\tO\\nthe\\tO\\ncomparison\\tO\\nof\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nGdB\\tO\\ngene\\tO\\nin\\tO\\n23\\tO\\nheterozygous\\tO\\nwomen\\tO\\nhaving\\tO\\na\\tO\\nclonal\\tO\\nhematologic\\tB-Disease\\ndisease\\tI-Disease\\nand\\tO\\na\\tO\\ncontrol\\tO\\ngroup\\tO\\nof\\tO\\n37\\tO\\nhealthy\\tO\\nheterozygotes\\tO\\n.\\tO\\n\\nTherefore\\tO\\nat\\tO\\npresent\\tO\\nthere\\tO\\nis\\tO\\nno\\tO\\nevidence\\tO\\nthat\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nhas\\tO\\na\\tO\\nprotective\\tO\\neffect\\tO\\nagainst\\tO\\ndevelopment\\tO\\nof\\tO\\nhematologic\\tB-Disease\\nneoplasms\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nHepatoblastoma\\tB-Disease\\n,\\tO\\npigmented\\tB-Disease\\nocular\\tI-Disease\\nfundus\\tI-Disease\\nlesions\\tI-Disease\\nand\\tO\\njaw\\tB-Disease\\nlesions\\tI-Disease\\nin\\tO\\nGardner\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nHepatoblastoma\\tB-Disease\\nis\\tO\\na\\tO\\nrare\\tO\\nneoplasm\\tB-Disease\\nof\\tO\\ninfants\\tO\\nand\\tO\\nchildren\\tO\\nonly\\tO\\nrecently\\tO\\ndocumented\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\ncolon\\tI-Disease\\n[\\tO\\nKingston\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1983\\tO\\n]\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nfour\\tO\\nchildren\\tO\\nwith\\tO\\nhepatoblastoma\\tB-Disease\\nfrom\\tO\\nfour\\tO\\nunrelated\\tO\\nfamilies\\tO\\nwith\\tO\\nGardner\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nGS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nOne\\tO\\nchild\\tO\\n,\\tO\\nnow\\tO\\n19\\tO\\nyears\\tO\\nold\\tO\\n,\\tO\\nsurvived\\tO\\nafter\\tO\\na\\tO\\nresection\\tO\\nof\\tO\\na\\tO\\nhepatoblastoma\\tB-Disease\\nin\\tO\\ninfancy\\tO\\nand\\tO\\nrecently\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nGS\\tB-Disease\\n.\\tO\\n\\nHe\\tO\\nhas\\tO\\nan\\tO\\nassociated\\tO\\nodontoma\\tB-Disease\\nand\\tO\\npigmented\\tB-Disease\\nocular\\tI-Disease\\nfundus\\tI-Disease\\nlesions\\tI-Disease\\n,\\tO\\nboth\\tO\\nof\\tO\\nwhich\\tO\\nhave\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\nclinical\\tO\\nmarkers\\tO\\nof\\tO\\nGS\\tB-Disease\\n.\\tO\\n\\nMany\\tO\\nindividuals\\tO\\nin\\tO\\nthese\\tO\\nfour\\tO\\nGS\\tB-Disease\\nfamilies\\tO\\n,\\tO\\nboth\\tO\\naffected\\tO\\nand\\tO\\nat\\tO\\nrisk\\tO\\n,\\tO\\nhave\\tO\\nosteomatous\\tB-Disease\\njaw\\tI-Disease\\nlesions\\tI-Disease\\nand\\tO\\npigmented\\tB-Disease\\nocular\\tI-Disease\\nfundus\\tI-Disease\\nlesions\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nsearch\\tO\\nfor\\tO\\ncolonic\\tB-Disease\\npolyps\\tI-Disease\\nshould\\tO\\nbe\\tO\\nmade\\tO\\nin\\tO\\nfamilies\\tO\\nof\\tO\\ninfants\\tO\\nand\\tO\\nchildren\\tO\\nwith\\tO\\nhepatoblastoma\\tB-Disease\\n.\\tO\\n\\nIf\\tO\\nthe\\tO\\nchild\\tO\\nsurvives\\tO\\n,\\tO\\nhe\\tO\\nor\\tO\\nshe\\tO\\nshould\\tO\\nbe\\tO\\nmonitored\\tO\\nfor\\tO\\nthe\\tO\\nlater\\tO\\nappearance\\tO\\nof\\tO\\ncolonic\\tB-Disease\\npolyps\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nfinding\\tO\\nof\\tO\\njaw\\tB-Disease\\nlesions\\tI-Disease\\nand\\tO\\n/\\tO\\nor\\tO\\npigmented\\tB-Disease\\nocular\\tI-Disease\\nfundus\\tI-Disease\\nlesions\\tI-Disease\\nin\\tO\\nrelatives\\tO\\nat\\tO\\nrisk\\tO\\nare\\tO\\nindications\\tO\\nof\\tO\\nthe\\tO\\npossible\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nGS\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nan\\tO\\naltered\\tO\\nsplice\\tO\\nsite\\tO\\nin\\tO\\nAshkenazi\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ngenetic\\tI-Disease\\ndisorder\\tI-Disease\\nresulting\\tO\\nfrom\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\nencoding\\tO\\nthe\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nof\\tO\\nthe\\tO\\nlysosomal\\tO\\nenzyme\\tO\\n,\\tO\\nbeta\\tO\\n-\\tO\\nN\\tO\\n-\\tO\\nacetylhexosaminidase\\tO\\nA\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nrelatively\\tO\\nhigh\\tO\\nfrequency\\tO\\nof\\tO\\ncarriers\\tO\\n(\\tO\\n1\\tO\\n/\\tO\\n27\\tO\\n)\\tO\\nof\\tO\\na\\tO\\nlethal\\tO\\n,\\tO\\ninfantile\\tO\\nform\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nis\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nAshkenazi\\tO\\nJewish\\tO\\npopulation\\tO\\n,\\tO\\nbut\\tO\\nit\\tO\\nis\\tO\\nnot\\tO\\nyet\\tO\\nevident\\tO\\nwhether\\tO\\nthis\\tO\\nhas\\tO\\nresulted\\tO\\nfrom\\tO\\na\\tO\\nfounder\\tO\\neffect\\tO\\nand\\tO\\nrandom\\tO\\ngenetic\\tO\\ndrift\\tO\\nor\\tO\\nfrom\\tO\\na\\tO\\nselective\\tO\\nadvantage\\tO\\nof\\tO\\nheterozygotes\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\na\\tO\\nsingle\\tO\\n-\\tO\\nbase\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\ncloned\\tO\\nfragment\\tO\\nof\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\nfrom\\tO\\nan\\tO\\nAshkenazi\\tO\\nJewish\\tO\\npatient\\tO\\n.\\tO\\n\\nThis\\tO\\nchange\\tO\\n,\\tO\\nthe\\tO\\nsubstitution\\tO\\nof\\tO\\na\\tO\\nC\\tO\\nfor\\tO\\nG\\tO\\nin\\tO\\nthe\\tO\\nfirst\\tO\\nnucleotide\\tO\\nof\\tO\\nintron\\tO\\n12\\tO\\nis\\tO\\nexpected\\tO\\nto\\tO\\nresult\\tO\\nin\\tO\\ndefective\\tO\\nsplicing\\tO\\nof\\tO\\nthe\\tO\\nmessenger\\tO\\nRNA\\tO\\n.\\tO\\n\\nA\\tO\\ntest\\tO\\nfor\\tO\\nthe\\tO\\nmutant\\tO\\nallele\\tO\\nbased\\tO\\non\\tO\\namplification\\tO\\nof\\tO\\nDNA\\tO\\nby\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nrection\\tO\\nand\\tO\\ncleavage\\tO\\nof\\tO\\na\\tO\\nDdeI\\tO\\nrestriction\\tO\\nsite\\tO\\ngenerated\\tO\\nby\\tO\\nthe\\tO\\nmutation\\tO\\nrevealed\\tO\\nthat\\tO\\nthis\\tO\\ncase\\tO\\nand\\tO\\ntwo\\tO\\nother\\tO\\ncases\\tO\\nof\\tO\\nthe\\tO\\nAshkenazi\\tO\\n,\\tO\\ninfantile\\tO\\nform\\tO\\nof\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\nare\\tO\\nheterozygous\\tO\\nfor\\tO\\ntwo\\tO\\ndifferent\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\noccurrence\\tO\\nof\\tO\\nmultiple\\tO\\nmutant\\tO\\nalleles\\tO\\nwarrants\\tO\\nfurther\\tO\\nexamination\\tO\\nof\\tO\\nthe\\tO\\nselective\\tO\\nadvantage\\tO\\nhypothesis\\tO\\n.\\tO\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nglucose\\tI-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nMus\\tO\\nmusculus\\tO\\n.\\tO\\n\\nA\\tO\\nmouse\\tO\\nwith\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nglucose\\tI-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nhas\\tO\\nbeen\\tO\\nrecovered\\tO\\nin\\tO\\noffspring\\tO\\nof\\tO\\n1\\tO\\n-\\tO\\nethyl\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nnitrosourea\\tO\\n-\\tO\\ntreated\\tO\\nmale\\tO\\nmice\\tO\\n.\\tO\\n\\nThe\\tO\\nactivity\\tO\\nalteration\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nblood\\tO\\nbut\\tO\\ncan\\tO\\nalso\\tO\\nbe\\tO\\nobserved\\tO\\nin\\tO\\nother\\tO\\ntissue\\tO\\nextracts\\tO\\n.\\tO\\n\\nHemizygous\\tO\\n,\\tO\\nheterozygous\\tO\\n,\\tO\\nand\\tO\\nhomozygous\\tO\\nmutants\\tO\\nhave\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nabout\\tO\\n15\\tO\\n,\\tO\\n60\\tO\\n,\\tO\\nand\\tO\\n15\\tO\\n%\\tO\\nG6PD\\tO\\nremaining\\tO\\nactivity\\tO\\nin\\tO\\nthe\\tO\\nblood\\tO\\nas\\tO\\ncompared\\tO\\nto\\tO\\nthe\\tO\\nwild\\tO\\ntype\\tO\\n.\\tO\\n\\nErythrocyte\\tO\\nindices\\tO\\ndid\\tO\\nnot\\tO\\nshow\\tO\\ndifferences\\tO\\nbetween\\tO\\nmutants\\tO\\nand\\tO\\nwild\\tO\\ntypes\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\ndoes\\tO\\nnot\\tO\\naffect\\tO\\nthe\\tO\\nelectrophoretic\\tO\\nmigration\\tO\\n,\\tO\\nthe\\tO\\nisoelectric\\tO\\npoint\\tO\\n,\\tO\\nor\\tO\\nthe\\tO\\nthermal\\tO\\nstability\\tO\\n.\\tO\\n\\nKinetic\\tO\\nproperties\\tO\\n,\\tO\\nsuch\\tO\\nas\\tO\\nthe\\tO\\nKm\\tO\\nfor\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\nor\\tO\\nfor\\tO\\nNADP\\tO\\nand\\tO\\nthe\\tO\\nrelative\\tO\\nutilization\\tO\\nof\\tO\\nsubstrate\\tO\\nanalogues\\tO\\n,\\tO\\nshowed\\tO\\nno\\tO\\ndifferences\\tO\\nbetween\\tO\\nwild\\tO\\ntypes\\tO\\nand\\tO\\nmutants\\tO\\nwith\\tO\\nthe\\tO\\nexception\\tO\\nof\\tO\\nthe\\tO\\nrelative\\tO\\nutilization\\tO\\nof\\tO\\ndeamino\\tO\\n-\\tO\\nNADP\\tO\\nwhich\\tO\\nwas\\tO\\nsignificantly\\tO\\nlower\\tO\\nin\\tO\\nmutants\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\npresently\\tO\\nthe\\tO\\nonly\\tO\\nanimal\\tO\\nmodel\\tO\\nfor\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nG6PD\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nhumans\\tO\\n.\\tO\\n.\\tO\\n\\nDiverse\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\ngene\\tO\\ncause\\tO\\nenzyme\\tB-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nmild\\tO\\nor\\tO\\nsevere\\tO\\nhemolytic\\tB-Disease\\nanemia\\tI-Disease\\n.\\tO\\n\\nGlucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n;\\tI-Disease\\nEC\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n49\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\na\\tO\\ncommon\\tO\\ngenetic\\tB-Disease\\nabnormality\\tI-Disease\\naffecting\\tO\\nan\\tO\\nestimated\\tO\\n400\\tO\\nmillion\\tO\\npeople\\tO\\nworldwide\\tO\\n.\\tO\\n\\nClinical\\tO\\nand\\tO\\nbiochemical\\tO\\nanalyses\\tO\\nhave\\tO\\nidentified\\tO\\nmany\\tO\\nvariants\\tO\\nexhibiting\\tO\\na\\tO\\nrange\\tO\\nof\\tO\\nphenotypes\\tO\\n,\\tO\\nwhich\\tO\\nhave\\tO\\nbeen\\tO\\nwell\\tO\\ncharacterized\\tO\\nfrom\\tO\\nthe\\tO\\nhematological\\tO\\npoint\\tO\\nof\\tO\\nview\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nuntil\\tO\\nnow\\tO\\n,\\tO\\ntheir\\tO\\nprecise\\tO\\nmolecular\\tO\\nbasis\\tO\\nhas\\tO\\nremained\\tO\\nunknown\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ncloned\\tO\\nand\\tO\\nsequenced\\tO\\nseven\\tO\\nmutant\\tO\\nG6PD\\tO\\nalleles\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nnondeficient\\tO\\npolymorphic\\tO\\nAfrican\\tO\\nvariant\\tO\\nG6PD\\tO\\nA\\tO\\nwe\\tO\\nhave\\tO\\nfound\\tO\\na\\tO\\nsingle\\tO\\npoint\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nsix\\tO\\nmutants\\tO\\ninvestigated\\tO\\nwere\\tO\\nall\\tO\\nassociated\\tO\\nwith\\tO\\nenzyme\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ncommonest\\tO\\n,\\tO\\nG6PD\\tO\\nMediterranean\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nfavism\\tB-Disease\\namong\\tO\\nother\\tO\\nclinical\\tO\\nmanifestations\\tO\\n,\\tO\\na\\tO\\nsingle\\tO\\namino\\tO\\nacid\\tO\\nreplacement\\tO\\nwas\\tO\\nfound\\tO\\n(\\tO\\nserine\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nphenylalanine\\tO\\n)\\tO\\nit\\tO\\nmust\\tO\\nbe\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\ndecreased\\tO\\nstability\\tO\\nand\\tO\\nthe\\tO\\nreduced\\tO\\ncatalytic\\tO\\nefficiency\\tO\\nof\\tO\\nthis\\tO\\nenzyme\\tO\\n.\\tO\\n\\nSingle\\tO\\npoint\\tO\\nmutations\\tO\\nwere\\tO\\nalso\\tO\\nfound\\tO\\nin\\tO\\nG6PD\\tO\\nMetaponto\\tO\\n(\\tO\\nSouthern\\tO\\nItaly\\tO\\n)\\tO\\nand\\tO\\nin\\tO\\nG6PD\\tO\\nIlesha\\tO\\n(\\tO\\nNigeria\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nare\\tO\\nasymptomatic\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\nG6PD\\tO\\nChatham\\tO\\n,\\tO\\nwhich\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\nan\\tO\\nIndian\\tO\\nboy\\tO\\nwith\\tO\\nneonatal\\tB-Disease\\njaundice\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nG6PD\\tO\\n\"\\tO\\nMatera\\tO\\n,\\tO\\n\"\\tO\\nwhich\\tO\\nis\\tO\\nnow\\tO\\nknown\\tO\\nto\\tO\\nbe\\tO\\nthe\\tO\\nsame\\tO\\nas\\tO\\nG6PD\\tO\\nA\\tO\\n-\\tO\\n,\\tO\\ntwo\\tO\\nseparate\\tO\\npoint\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\n,\\tO\\none\\tO\\nof\\tO\\nwhich\\tO\\nis\\tO\\nthe\\tO\\nsame\\tO\\nas\\tO\\nin\\tO\\nG6PD\\tO\\nA\\tO\\n.\\tO\\n\\nIn\\tO\\nG6PD\\tO\\nSantiago\\tO\\n,\\tO\\na\\tO\\nde\\tO\\nnovo\\tO\\nmutation\\tO\\n(\\tO\\nglycine\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\narginine\\tO\\n)\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nsevere\\tO\\nchronic\\tO\\nhemolytic\\tB-Disease\\nanemia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\nobserved\\tO\\nshow\\tO\\na\\tO\\nstriking\\tO\\npredominance\\tO\\nof\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nT\\tO\\ntransitions\\tO\\n,\\tO\\nwith\\tO\\nCG\\tO\\ndoublets\\tO\\ninvolved\\tO\\nin\\tO\\nfour\\tO\\nof\\tO\\nseven\\tO\\ncases\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\ndiverse\\tO\\npoint\\tO\\nmutations\\tO\\nmay\\tO\\naccount\\tO\\nlargely\\tO\\nfor\\tO\\nthe\\tO\\nphenotypic\\tO\\nheterogeneity\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nTight\\tO\\nlinkage\\tO\\nbetween\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nand\\tO\\napolipoprotein\\tO\\nE\\tO\\ngenes\\tO\\nrevealed\\tO\\nwith\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\noligonucleotides\\tO\\n.\\tO\\n\\nIn\\tO\\n16\\tO\\nfamilies\\tO\\nwith\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\na\\tO\\nnovel\\tO\\napproach\\tO\\nbased\\tO\\non\\tO\\nuse\\tO\\nof\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\noligonucleotides\\tO\\nhas\\tO\\nbeen\\tO\\nemployed\\tO\\nto\\tO\\nstudy\\tO\\nthe\\tO\\nlinkage\\tO\\nrelationship\\tO\\nbetween\\tO\\nthe\\tO\\napolipoprotein\\tO\\nE\\tO\\n(\\tO\\nAPOE\\tO\\n)\\tO\\ngene\\tO\\nand\\tO\\nDM\\tB-Disease\\n.\\tO\\n\\nSynthetic\\tO\\noligonucleotides\\tO\\n,\\tO\\ndesigned\\tO\\nto\\tO\\ndiscriminate\\tO\\nbetween\\tO\\nAPOE\\tO\\nalleles\\tO\\nepsilon\\tO\\n3\\tO\\nand\\tO\\nepsilon\\tO\\n4\\tO\\n,\\tO\\nenabled\\tO\\nus\\tO\\nto\\tO\\ndistinguish\\tO\\nheterozygous\\tO\\ncarriers\\tO\\nin\\tO\\na\\tO\\nhybridization\\tO\\nassay\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nsubset\\tO\\nof\\tO\\nfamilies\\tO\\n,\\tO\\nthe\\tO\\nrelevant\\tO\\nsegment\\tO\\nof\\tO\\nthe\\tO\\nAPOE\\tO\\ngene\\tO\\nwas\\tO\\nenzymatically\\tO\\namplified\\tO\\nto\\tO\\nincrease\\tO\\nthe\\tO\\nsensitivity\\tO\\nof\\tO\\nthe\\tO\\nmethod\\tO\\n.\\tO\\n\\nFor\\tO\\nDM\\tO\\nand\\tO\\nAPOE\\tO\\n,\\tO\\na\\tO\\nmaximum\\tO\\nlod\\tO\\nscore\\tO\\n(\\tO\\nzmax\\tO\\nof\\tO\\n7\\tO\\n.\\tO\\n\\n47\\tO\\nwas\\tO\\nobtained\\tO\\nat\\tO\\na\\tO\\nrecombination\\tO\\nfrequency\\tO\\n(\\tO\\ntheta\\tO\\n)\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n047\\tO\\n(\\tO\\nmale\\tO\\ntheta\\tO\\n=\\tO\\nfemale\\tO\\ntheta\\tO\\n)\\tO\\n.\\tO\\n\\nNo\\tO\\nrecombination\\tO\\n(\\tO\\nmaximum\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\n5\\tO\\n.\\tO\\n61\\tO\\nat\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n0\\tO\\n)\\tO\\nwas\\tO\\nfound\\tO\\nbetween\\tO\\nAPOE\\tO\\nand\\tO\\nthe\\tO\\napolipoprotein\\tO\\nCII\\tO\\n(\\tO\\nAPOC2\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\n,\\tO\\nin\\tO\\naddition\\tO\\nto\\tO\\nAPOC2\\tO\\n,\\tO\\nAPOE\\tO\\nis\\tO\\na\\tO\\nuseful\\tO\\nmarker\\tO\\nfor\\tO\\npresymptomatic\\tO\\nDM\\tB-Disease\\ndiagnosis\\tO\\n.\\tO\\n\\nRegional\\tO\\nlocalization\\tO\\nof\\tO\\npolymorphic\\tO\\nDNA\\tO\\nloci\\tO\\non\\tO\\nthe\\tO\\nproximal\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\nusing\\tO\\ndeletions\\tO\\nassociated\\tO\\nwith\\tO\\nchoroideremia\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\ntwo\\tO\\nunrelated\\tO\\nfamilies\\tO\\n,\\tO\\nmales\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nwho\\tO\\nsuffer\\tO\\nfrom\\tO\\nchoroideremia\\tB-Disease\\nand\\tO\\nat\\tO\\nthe\\tO\\nsame\\tO\\ntime\\tO\\nhave\\tO\\nan\\tO\\ninterstitial\\tO\\ndeletion\\tO\\non\\tO\\nthe\\tO\\nproximal\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nBy\\tO\\nhigh\\tO\\n-\\tO\\nresolution\\tO\\nbanding\\tO\\nwe\\tO\\nhave\\tO\\ncharacterized\\tO\\nthe\\tO\\ndeletion\\tO\\nchromosomes\\tO\\nas\\tO\\ndel\\tO\\n(\\tO\\nX\\tO\\n)\\tO\\n(\\tO\\nq21\\tO\\n.\\tO\\n1\\tO\\n-\\tO\\nq21\\tO\\n1\\tO\\n-\\tO\\nq21\\tO\\n.\\tO\\n33\\tO\\n)\\tO\\nand\\tO\\ndel\\tO\\n(\\tO\\nX\\tO\\n)\\tO\\n(\\tO\\nq21\\tO\\n.\\tO\\n2\\tO\\n-\\tO\\nq21\\tO\\n2\\tO\\n-\\tO\\nq21\\tO\\n.\\tO\\n31\\tO\\n)\\tO\\nrespectively\\tO\\n.\\tO\\n\\nBy\\tO\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\nwe\\tO\\nhave\\tO\\nmapped\\tO\\nten\\tO\\ndifferent\\tO\\npolymorphic\\tO\\nDNA\\tO\\nloci\\tO\\nrelative\\tO\\nto\\tO\\nthe\\tO\\nposition\\tO\\nof\\tO\\nthe\\tO\\ndeletion\\tO\\nand\\tO\\nthe\\tO\\nchoroideremia\\tB-Disease\\nlocus\\tO\\nTCD\\tO\\n.\\tO\\n\\nOne\\tO\\nprobe\\tO\\n,\\tO\\np31\\tO\\n,\\tO\\nwas\\tO\\nshown\\tO\\nto\\tO\\ncover\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nbreakpoints\\tO\\nof\\tO\\nthe\\tO\\nsmallest\\tO\\ndeletion\\tO\\n.\\tO\\n\\nThe\\tO\\nfollowing\\tO\\norder\\tO\\nof\\tO\\nthe\\tO\\nloci\\tO\\nwas\\tO\\nsuggested\\tO\\nby\\tO\\ndeletion\\tO\\nmapping\\tO\\ncen\\tO\\n-\\tO\\nDXS106\\tO\\n-\\tO\\nDXS72\\tO\\n-\\tO\\nTCD\\tO\\n-\\tO\\n(\\tO\\nDXYS1\\tO\\n/\\tO\\nDXYS23\\tO\\n/\\tO\\nDXYS5\\tO\\n)\\tO\\n-\\tO\\nDXYS2\\tO\\n-\\tO\\n(\\tO\\nDXYS12\\tO\\n/\\tO\\nDXS3\\tO\\n)\\tO\\n-\\tO\\n(\\tO\\nDXS17\\tO\\n/\\tO\\nDXS101\\tO\\n)\\tO\\n-\\tO\\nXqter\\tO\\n.\\tO\\n\\nRetroviral\\tO\\n-\\tO\\nmediated\\tO\\ngene\\tO\\ntransfer\\tO\\nof\\tO\\nhuman\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\ninto\\tO\\nNIH\\tO\\n3T3\\tO\\nand\\tO\\nhepatoma\\tB-Disease\\ncells\\tO\\n.\\tO\\n\\nPhenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nhepatic\\tI-Disease\\nenzyme\\tI-Disease\\nphenylalanine\\tI-Disease\\nhydroxylase\\tI-Disease\\n(\\tO\\nPAH\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\nhuman\\tO\\nPAH\\tO\\ncDNA\\tO\\nsequence\\tO\\nhas\\tO\\nbeen\\tO\\ninserted\\tO\\ninto\\tO\\npzip\\tO\\n-\\tO\\nneoSV\\tO\\n(\\tO\\nX\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\na\\tO\\nretroviral\\tO\\nvector\\tO\\ncontaining\\tO\\nthe\\tO\\nbacterial\\tO\\nneo\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nrecombinant\\tO\\nhas\\tO\\nbeen\\tO\\ntransfected\\tO\\ninto\\tO\\npsi\\tO\\n2\\tO\\ncells\\tO\\n,\\tO\\nwhich\\tO\\nprovide\\tO\\nsynthesis\\tO\\nof\\tO\\nthe\\tO\\nretroviral\\tO\\ncapsid\\tO\\n.\\tO\\n\\nRecombinant\\tO\\nvirus\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nculture\\tO\\nmedium\\tO\\nof\\tO\\nthe\\tO\\ntransfected\\tO\\npsi\\tO\\n2\\tO\\ncells\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\ncapable\\tO\\nof\\tO\\ntransmitting\\tO\\nthe\\tO\\nhuman\\tO\\nPAH\\tO\\ngene\\tO\\ninto\\tO\\nmouse\\tO\\nNIH\\tO\\n3T3\\tO\\ncells\\tO\\nby\\tO\\ninfection\\tO\\nleading\\tO\\nto\\tO\\nstable\\tO\\nincorporation\\tO\\nof\\tO\\nthe\\tO\\nrecombinant\\tO\\nprovirus\\tO\\n.\\tO\\n\\nInfected\\tO\\ncells\\tO\\nexpress\\tO\\nPAH\\tO\\nmRNA\\tO\\n,\\tO\\nimmunoreactive\\tO\\nPAH\\tO\\nprotein\\tO\\n,\\tO\\nand\\tO\\nexhibit\\tO\\npterin\\tO\\n-\\tO\\ndependent\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\nrecombinant\\tO\\nvirus\\tO\\nis\\tO\\nalso\\tO\\ncapable\\tO\\nof\\tO\\ninfecting\\tO\\na\\tO\\nmouse\\tO\\nhepatoma\\tB-Disease\\ncell\\tO\\nline\\tO\\nthat\\tO\\ndoes\\tO\\nnot\\tO\\nnormally\\tO\\nsynthesize\\tO\\nPAH\\tO\\n.\\tO\\n\\nPAH\\tO\\nactivity\\tO\\nis\\tO\\npresent\\tO\\nin\\tO\\nthe\\tO\\ncellular\\tO\\nextracts\\tO\\nand\\tO\\nthe\\tO\\nentire\\tO\\nhydroxylation\\tO\\nsystem\\tO\\nis\\tO\\nreconstituted\\tO\\nin\\tO\\nthe\\tO\\nhepatoma\\tB-Disease\\ncells\\tO\\ninfected\\tO\\nwith\\tO\\nthe\\tO\\nrecombinant\\tO\\nviruses\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nrecombinant\\tO\\nviruses\\tO\\ncontaining\\tO\\nhuman\\tO\\nPAH\\tO\\ncDNA\\tO\\nprovide\\tO\\na\\tO\\nmeans\\tO\\nfor\\tO\\nintroducing\\tO\\nfunctional\\tO\\nPAH\\tO\\ninto\\tO\\nmammalian\\tO\\ncells\\tO\\nof\\tO\\nhepatic\\tO\\norigin\\tO\\nand\\tO\\ncan\\tO\\npotentially\\tO\\nbe\\tO\\nintroduced\\tO\\ninto\\tO\\nwhole\\tO\\nanimals\\tO\\nas\\tO\\na\\tO\\nmodel\\tO\\nfor\\tO\\nsomatic\\tO\\ngene\\tO\\ntherapy\\tO\\nfor\\tO\\nPKU\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nEstimation\\tO\\nof\\tO\\nthe\\tO\\nmale\\tO\\nto\\tO\\nfemale\\tO\\nratio\\tO\\nof\\tO\\nmutation\\tO\\nrates\\tO\\nfrom\\tO\\nthe\\tO\\nsegregation\\tO\\nof\\tO\\nX\\tO\\n-\\tO\\nchromosomal\\tO\\nDNA\\tO\\nhaplotypes\\tO\\nin\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nA\\tO\\nnovel\\tO\\nprocedure\\tO\\nis\\tO\\npresented\\tO\\nto\\tO\\nestimate\\tO\\nthe\\tO\\nratio\\tO\\nof\\tO\\nmale\\tO\\nto\\tO\\nfemale\\tO\\nmutation\\tO\\nrates\\tO\\nfor\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nX\\tO\\n-\\tO\\nspecific\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphisms\\tO\\nare\\tO\\nused\\tO\\nto\\tO\\nestablish\\tO\\nDNA\\tO\\nhaplotypes\\tO\\nin\\tO\\nthree\\tO\\n-\\tO\\ngeneration\\tO\\nDMD\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nFrom\\tO\\nthe\\tO\\nproportion\\tO\\nof\\tO\\nDMD\\tB-Disease\\npatients\\tO\\nwho\\tO\\nhave\\tO\\ninherited\\tO\\ntheir\\tO\\nmaternal\\tO\\ngrandfathers\\tO\\nX\\tO\\nchromosome\\tO\\n,\\tO\\nthe\\tO\\nratio\\tO\\nof\\tO\\nmutation\\tO\\nrates\\tO\\ncan\\tO\\nbe\\tO\\ncalculated\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\nto\\tO\\nclassical\\tO\\nmethods\\tO\\n,\\tO\\nthe\\tO\\nproposed\\tO\\nprocedure\\tO\\nis\\tO\\nnot\\tO\\nrestricted\\tO\\nto\\tO\\nsporadic\\tO\\nor\\tO\\nfamiliar\\tO\\ncases\\tO\\nnor\\tO\\nis\\tO\\nany\\tO\\ninformation\\tO\\non\\tO\\nthe\\tO\\ncarrier\\tO\\nstatus\\tO\\nof\\tO\\nfemale\\tO\\nrelatives\\tO\\nrequired\\tO\\n.\\tO\\n.\\tO\\n\\nDeletions\\tO\\nof\\tO\\na\\tO\\nDNA\\tO\\nsequence\\tO\\nin\\tO\\nretinoblastomas\\tB-Disease\\nand\\tO\\nmesenchymal\\tB-Disease\\ntumors\\tI-Disease\\n:\\tO\\norganization\\tO\\nof\\tO\\nthe\\tO\\nsequence\\tO\\nand\\tO\\nits\\tO\\nencoded\\tO\\nprotein\\tO\\n.\\tO\\n\\nRetinoblastoma\\tB-Disease\\nis\\tO\\na\\tO\\nchildhood\\tB-Disease\\ntumor\\tI-Disease\\nthat\\tO\\ncan\\tO\\narise\\tO\\nbecause\\tO\\nof\\tO\\nmutant\\tO\\nalleles\\tO\\nacquired\\tO\\nas\\tO\\nsomatic\\tO\\nor\\tO\\ngerminal\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nmutant\\tO\\nallele\\tO\\ncan\\tO\\nbe\\tO\\ncarried\\tO\\nin\\tO\\nthe\\tO\\ngerm\\tO\\nline\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\ncreating\\tO\\nthese\\tO\\nalleles\\tO\\nact\\tO\\nby\\tO\\ninactivating\\tO\\ncopies\\tO\\nof\\tO\\na\\tO\\nrecessive\\tO\\noncogene\\tO\\nlocated\\tO\\nwithin\\tO\\nband\\tO\\nq14\\tO\\nof\\tO\\nchromosome\\tO\\n13\\tO\\nand\\tO\\ntermed\\tO\\nthe\\tO\\nRB1\\tO\\nlocus\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nreported\\tO\\nisolation\\tO\\nof\\tO\\na\\tO\\ncDNA\\tO\\nfragment\\tO\\nthat\\tO\\nrecognizes\\tO\\nchromosomal\\tO\\nsequences\\tO\\npossessing\\tO\\nmany\\tO\\nof\\tO\\nthe\\tO\\nattributes\\tO\\nof\\tO\\nthe\\tO\\nretinoblastoma\\tB-Disease\\ngene\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nRB1\\tO\\nlocus\\tO\\n.\\tO\\n\\nWe\\tO\\nnow\\tO\\nreport\\tO\\nthat\\tO\\nthis\\tO\\nsegment\\tO\\nis\\tO\\nadditionally\\tO\\nthe\\tO\\ntarget\\tO\\nof\\tO\\nsomatic\\tO\\nmutations\\tO\\nin\\tO\\nmesenchymal\\tB-Disease\\ntumors\\tI-Disease\\namong\\tO\\npatients\\tO\\nhaving\\tO\\nno\\tO\\napparent\\tO\\npredisposition\\tO\\nto\\tO\\nretinoblastoma\\tB-Disease\\nand\\tO\\nno\\tO\\nprevious\\tO\\nevidence\\tO\\nof\\tO\\nretinoblastoma\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\ntumors\\tB-Disease\\nprovide\\tO\\nadditional\\tO\\nevidence\\tO\\nthat\\tO\\nthe\\tO\\ncloned\\tO\\nsequences\\tO\\nare\\tO\\nrepresentative\\tO\\nof\\tO\\na\\tO\\ngene\\tO\\nthat\\tO\\nis\\tO\\na\\tO\\nfrequent\\tO\\ntarget\\tO\\nof\\tO\\ninactivation\\tO\\nduring\\tO\\ntumorigenesis\\tO\\n.\\tO\\n\\nSequence\\tO\\nanalysis\\tO\\nof\\tO\\nthis\\tO\\ncDNA\\tO\\nprovides\\tO\\nlittle\\tO\\ninsight\\tO\\ninto\\tO\\nits\\tO\\nnormal\\tO\\nfunctional\\tO\\nrole\\tO\\n.\\tO\\n.\\tO\\n\\nTreatment\\tO\\nof\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nwith\\tO\\ngrowth\\tO\\nhormone\\tO\\ninhibitors\\tO\\n.\\tO\\n\\nA\\tO\\ncontrolled\\tO\\n,\\tO\\ndouble\\tO\\n-\\tO\\nblind\\tO\\ntherapeutic\\tO\\ntrial\\tO\\nwith\\tO\\nthe\\tO\\ndrug\\tO\\nmazindol\\tO\\n,\\tO\\na\\tO\\ngrowth\\tO\\nhormone\\tO\\ninhibitor\\tO\\n,\\tO\\nwas\\tO\\nperformed\\tO\\nin\\tO\\na\\tO\\npair\\tO\\nof\\tO\\n7\\tO\\n1\\tO\\n/\\tO\\n2\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nmonozygotic\\tO\\ntwins\\tO\\n,\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nrationale\\tO\\nfor\\tO\\nthis\\tO\\ntrial\\tO\\nwas\\tO\\nbased\\tO\\non\\tO\\na\\tO\\npatient\\tO\\n(\\tO\\nreported\\tO\\npreviously\\tO\\n)\\tO\\naffected\\tO\\nsimultaneously\\tO\\nwith\\tO\\nDMD\\tB-Disease\\nand\\tO\\ngrowth\\tB-Disease\\nhormone\\tI-Disease\\n(\\tI-Disease\\nGH\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nwho\\tO\\nis\\tO\\nshowing\\tO\\na\\tO\\nbenign\\tO\\ncourse\\tO\\nof\\tO\\nthe\\tO\\ndystrophic\\tB-Disease\\nprocess\\tI-Disease\\nand\\tO\\nis\\tO\\nstill\\tO\\nwalking\\tO\\nat\\tO\\n18\\tO\\nyears\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthe\\tO\\ntwins\\tO\\nreceived\\tO\\n2\\tO\\nmg\\tO\\nof\\tO\\nmazindol\\tO\\ndaily\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\nother\\tO\\nreceived\\tO\\na\\tO\\nplacebo\\tO\\n.\\tO\\n\\nThe\\tO\\nassessment\\tO\\n,\\tO\\nrepeated\\tO\\nevery\\tO\\n2\\tO\\nmonths\\tO\\n,\\tO\\nincluded\\tO\\nweight\\tO\\nand\\tO\\nheight\\tO\\nmeasurements\\tO\\n,\\tO\\nfunctional\\tO\\nand\\tO\\nmotor\\tO\\nability\\tO\\ntests\\tO\\n,\\tO\\nergometry\\tO\\nand\\tO\\ndeterminations\\tO\\nof\\tO\\nserum\\tO\\nenzymes\\tO\\nand\\tO\\nGH\\tO\\nlevels\\tO\\n.\\tO\\n\\nAfter\\tO\\none\\tO\\nyear\\tO\\nof\\tO\\ntrial\\tO\\nthe\\tO\\ncode\\tO\\nwas\\tO\\nbroken\\tO\\nand\\tO\\nit\\tO\\nwas\\tO\\nseen\\tO\\nthat\\tO\\nthe\\tO\\ntwin\\tO\\nunder\\tO\\nplacebo\\tO\\ntreatment\\tO\\nwas\\tO\\nstrikingly\\tO\\nworse\\tO\\nthan\\tO\\nhis\\tO\\nbrother\\tO\\n,\\tO\\nthe\\tO\\nprogression\\tO\\nof\\tO\\nwhose\\tO\\ncondition\\tO\\nwas\\tO\\npractically\\tO\\narrested\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nstrongly\\tO\\nsuggest\\tO\\nthat\\tO\\ntreatment\\tO\\nwith\\tO\\na\\tO\\nGH\\tO\\ninhibitor\\tO\\nis\\tO\\nbeneficial\\tO\\nfor\\tO\\nDMD\\tB-Disease\\npatients\\tO\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nand\\tO\\nlocalization\\tO\\nof\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nlocus\\tO\\nby\\tO\\nribonuclease\\tO\\nA\\tO\\ncleavage\\tO\\n.\\tO\\n\\nMany\\tO\\nmutations\\tO\\nleading\\tO\\nto\\tO\\nhuman\\tO\\ndisease\\tO\\nare\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\nsingle\\tO\\nDNA\\tO\\nbase\\tO\\npair\\tO\\nchanges\\tO\\nthat\\tO\\ncannot\\tO\\nbe\\tO\\nidentified\\tO\\nby\\tO\\nSouthern\\tO\\nanalysis\\tO\\n.\\tO\\n\\nThis\\tO\\nhas\\tO\\nprompted\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nalternative\\tO\\nassays\\tO\\nfor\\tO\\npoint\\tO\\nmutation\\tO\\ndetection\\tO\\n.\\tO\\n\\nThe\\tO\\nrecently\\tO\\ndescribed\\tO\\nribonuclease\\tO\\nA\\tO\\ncleavage\\tO\\nprocedure\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\npolyuridylic\\tO\\nacid\\tO\\n-\\tO\\npaper\\tO\\naffinity\\tO\\nchromatography\\tO\\nstep\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nused\\tO\\nto\\tO\\nidentify\\tO\\nthe\\tO\\nmutational\\tO\\nlesions\\tO\\nin\\tO\\nthe\\tO\\nhypoxanthine\\tO\\nphosphoribosyltransferase\\tO\\n(\\tO\\nHPRT\\tO\\n)\\tO\\nmessenger\\tO\\nRNAs\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nDistinctive\\tO\\nribonuclease\\tO\\nA\\tO\\ncleavage\\tO\\npatterns\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nmessenger\\tO\\nRNA\\tO\\nfrom\\tO\\n5\\tO\\nof\\tO\\n14\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\npatients\\tO\\nwho\\tO\\nwere\\tO\\nchosen\\tO\\nbecause\\tO\\nno\\tO\\nHPRT\\tO\\nSouthern\\tO\\nor\\tO\\nNorthern\\tO\\nblotting\\tO\\npattern\\tO\\nchanges\\tO\\nhad\\tO\\nbeen\\tO\\nfound\\tO\\n.\\tO\\n\\nThis\\tO\\napproach\\tO\\nnow\\tO\\nallows\\tO\\nHPRT\\tO\\nmutation\\tO\\ndetection\\tO\\nin\\tO\\n50\\tO\\npercent\\tO\\nof\\tO\\nthe\\tO\\ncases\\tO\\nof\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\npolyuridylic\\tO\\nacid\\tO\\n-\\tO\\npaper\\tO\\naffinity\\tO\\nprocedure\\tO\\nprovides\\tO\\na\\tO\\ngeneral\\tO\\nmethod\\tO\\nfor\\tO\\nanalysis\\tO\\nof\\tO\\nlow\\tO\\nabundance\\tO\\nmessenger\\tO\\nRNAs\\tO\\n.\\tO\\n.\\tO\\n\\nTwo\\tO\\nnew\\tO\\nvariants\\tO\\nof\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nassociated\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nnon\\tI-Disease\\n-\\tI-Disease\\nspherocytic\\tI-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\n:\\tO\\nG6PD\\tO\\nWayne\\tO\\nand\\tO\\nG6PD\\tO\\nHuron\\tO\\n.\\tO\\n\\nTwo\\tO\\nnew\\tO\\ndeficient\\tO\\nvariants\\tO\\nof\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\ncausing\\tO\\nhereditary\\tB-Disease\\nnonspherocytic\\tI-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\n(\\tO\\nHNSHA\\tB-Disease\\n)\\tO\\nare\\tO\\ndescribed\\tO\\n.\\tO\\n\\nBoth\\tO\\nof\\tO\\nthese\\tO\\nare\\tO\\nunique\\tO\\nand\\tO\\nthey\\tO\\nhave\\tO\\nbeen\\tO\\nnamed\\tO\\nG6PD\\tO\\nWayne\\tO\\nand\\tO\\nG6PD\\tO\\nHuron\\tO\\n.\\tO\\n\\nPatients\\tO\\nwith\\tO\\nG6PD\\tO\\nWayne\\tO\\nunderwent\\tO\\nsplenectomy\\tO\\nand\\tO\\nno\\tO\\nobjective\\tO\\nimprovement\\tO\\nwas\\tO\\nnoted\\tO\\n.\\tO\\n\\nThe\\tO\\npatients\\tO\\nwith\\tO\\nG6PD\\tO\\nHuron\\tO\\nwere\\tO\\nunder\\tO\\nmedical\\tO\\nobservation\\tO\\nfor\\tO\\na\\tO\\nconsiderable\\tO\\nperiod\\tO\\nof\\tO\\ntime\\tO\\nwithout\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nbeing\\tO\\nentertained\\tO\\nbecause\\tO\\nthe\\tO\\nfamily\\tO\\nwas\\tO\\nof\\tO\\nNorthern\\tO\\nEuropean\\tO\\norigin\\tO\\n.\\tO\\n\\nSince\\tO\\nsporadic\\tO\\nvariants\\tO\\nof\\tO\\nG6PD\\tO\\ncausing\\tO\\nHNSHA\\tB-Disease\\nshow\\tO\\nno\\tO\\nspecial\\tO\\nracial\\tO\\npredilection\\tO\\n,\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nshould\\tO\\nalways\\tO\\nbe\\tO\\nconsidered\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nthis\\tO\\nsyndrome\\tO\\n.\\tO\\n.\\tO\\n\\nSialophorin\\tO\\n,\\tO\\na\\tO\\nsurface\\tO\\nsialoglycoprotein\\tO\\ndefective\\tO\\nin\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nhuman\\tO\\nT\\tO\\nlymphocyte\\tO\\nproliferation\\tO\\n.\\tO\\n\\nThe\\tO\\nmAb\\tO\\nL10\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\ndistribution\\tO\\nand\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\nsialophorin\\tO\\n,\\tO\\nthe\\tO\\nheavily\\tO\\nglycosylated\\tO\\nsurface\\tO\\nmolecule\\tO\\nthat\\tO\\nis\\tO\\ndeficient\\tO\\n/\\tO\\ndefective\\tO\\nin\\tO\\nlymphocytes\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nimmunodeficiency\\tI-Disease\\nWiskott\\tI-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nDual\\tO\\n-\\tO\\nparameter\\tO\\nFACS\\tO\\nanalysis\\tO\\nindicated\\tO\\nthat\\tO\\nsialophorin\\tO\\nis\\tO\\nexpressed\\tO\\non\\tO\\nCD4\\tO\\n+\\tO\\nand\\tO\\nCD8\\tO\\n+\\tO\\nlymphocytes\\tO\\n,\\tO\\non\\tO\\na\\tO\\nsubpopulation\\tO\\nof\\tO\\nperipheral\\tO\\nblood\\tO\\nB\\tO\\nlymphocytes\\tO\\n,\\tO\\non\\tO\\nall\\tO\\nthymocytes\\tO\\n,\\tO\\nand\\tO\\non\\tO\\na\\tO\\nsubpopulation\\tO\\nof\\tO\\nbone\\tO\\nmarrow\\tO\\ncells\\tO\\n.\\tO\\n\\nFunctional\\tO\\nstudies\\tO\\ndemonstrated\\tO\\nthat\\tO\\nL10\\tO\\nmAb\\tO\\nstimulates\\tO\\nthe\\tO\\nproliferation\\tO\\nof\\tO\\nperipheral\\tO\\nblood\\tO\\nT\\tO\\nlymphocytes\\tO\\nas\\tO\\nmeasured\\tO\\nby\\tO\\nstimulation\\tO\\nof\\tO\\n[\\tO\\n3H\\tO\\n]\\tO\\nthymidine\\tO\\nincorporation\\tO\\n.\\tO\\n\\nThe\\tO\\ntime\\tO\\ncourse\\tO\\nand\\tO\\nmagnitude\\tO\\nof\\tO\\nincreased\\tO\\n[\\tO\\n3H\\tO\\n]\\tO\\nthymidine\\tO\\nincorporation\\tO\\nby\\tO\\nT\\tO\\nlymphocytes\\tO\\nin\\tO\\nresponse\\tO\\nto\\tO\\nL10\\tO\\nmAb\\tO\\nparalleled\\tO\\nthat\\tO\\ninduced\\tO\\nby\\tO\\nanti\\tO\\n-\\tO\\nCD3\\tO\\nmAb\\tO\\n.\\tO\\n\\nEffective\\tO\\nstimulation\\tO\\nwas\\tO\\ndependent\\tO\\non\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nmonocytes\\tO\\nand\\tO\\nthe\\tO\\nFc\\tO\\nportion\\tO\\nof\\tO\\nL10\\tO\\nmAb\\tO\\n.\\tO\\n\\nStimulation\\tO\\nof\\tO\\nlymphocytes\\tO\\nby\\tO\\nL10\\tO\\n,\\tO\\nlike\\tO\\nstimulation\\tO\\nby\\tO\\nanti\\tO\\n-\\tO\\nCD3\\tO\\nmAb\\tO\\n,\\tO\\ninvolves\\tO\\nincreased\\tO\\nexpression\\tO\\nof\\tO\\n4F2\\tO\\n,\\tO\\nHLA\\tO\\n-\\tO\\nDR\\tO\\n,\\tO\\nand\\tO\\nIL\\tO\\n-\\tO\\n2\\tO\\n-\\tO\\nR\\tO\\n.\\tO\\n\\nThese\\tO\\nobservations\\tO\\nsuggest\\tO\\nthat\\tO\\nsialophorin\\tO\\nfunctions\\tO\\nin\\tO\\nT\\tO\\ncell\\tO\\nactivation\\tO\\n.\\tO\\n.\\tO\\n\\nHypopigmentation\\tB-Disease\\nin\\tO\\nthe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nCutaneous\\tB-Disease\\nand\\tI-Disease\\nocular\\tI-Disease\\npigmentation\\tI-Disease\\nwere\\tO\\nevaluated\\tO\\nin\\tO\\n29\\tO\\nindividuals\\tO\\nwith\\tO\\nthe\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nCriteria\\tO\\nfor\\tO\\nhypopigmentation\\tB-Disease\\nincluded\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\ntype\\tO\\nI\\tO\\nor\\tO\\nII\\tO\\nskin\\tO\\n,\\tO\\nthe\\tO\\nlightest\\tO\\nskin\\tO\\ntype\\tO\\nin\\tO\\nthe\\tO\\nfamily\\tO\\nby\\tO\\nhistory\\tO\\n,\\tO\\nand\\tO\\niris\\tO\\ntranslucency\\tO\\non\\tO\\nglobe\\tO\\ntransillumination\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthese\\tO\\ncriteria\\tO\\n,\\tO\\n48\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nPWS\\tB-Disease\\nindividuals\\tO\\nwere\\tO\\nhypopigmented\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\npresence\\tO\\nof\\tO\\nhypopigmentation\\tB-Disease\\ncorrelated\\tO\\nwith\\tO\\na\\tO\\nsmall\\tO\\ninterstitial\\tO\\ndeletion\\tO\\non\\tO\\nthe\\tO\\nproximal\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n15\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nthis\\tO\\ndeletion\\tO\\nwas\\tO\\nalso\\tO\\nfound\\tO\\nin\\tO\\nindividuals\\tO\\nwho\\tO\\ndid\\tO\\nnot\\tO\\nmeet\\tO\\nthe\\tO\\nfull\\tO\\ncriteria\\tO\\nfor\\tO\\nhypopigmentation\\tB-Disease\\n.\\tO\\n\\nHairbulb\\tO\\ntyrosinase\\tO\\nactivity\\tO\\nand\\tO\\nglutathione\\tO\\ncontent\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nurine\\tO\\ncysteinyldopa\\tO\\nexcretion\\tO\\n,\\tO\\nwere\\tO\\nlow\\tO\\nin\\tO\\nPWS\\tB-Disease\\nindividuals\\tO\\nwith\\tO\\nand\\tO\\nwithout\\tO\\nhypopigmentation\\tB-Disease\\nand\\tO\\ndid\\tO\\nnot\\tO\\nseparate\\tO\\nthese\\tO\\ntwo\\tO\\ngroups\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nhypopigmentation\\tB-Disease\\nis\\tO\\nfound\\tO\\nin\\tO\\na\\tO\\nsignificant\\tO\\nproportion\\tO\\nof\\tO\\nindividuals\\tO\\nwith\\tO\\nPWS\\tB-Disease\\nand\\tO\\nthat\\tO\\nthe\\tO\\nhypopigmentation\\tB-Disease\\nmay\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n15\\tO\\n.\\tO\\n\\nThe\\tO\\nmechanism\\tO\\nfor\\tO\\nthe\\tO\\nhypopigmentation\\tB-Disease\\nis\\tO\\nunknown\\tO\\n.\\tO\\n.\\tO\\n\\nPhenotype\\tO\\nheterogeneity\\tO\\namong\\tO\\nhemizygotes\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nbiochemically\\tO\\nscreened\\tO\\nfor\\tO\\nadrenoleukodystrophy\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\ntwo\\tO\\nclinically\\tO\\n,\\tO\\nneurologically\\tO\\nnormal\\tO\\nrelatives\\tO\\nof\\tO\\na\\tO\\nboy\\tO\\naffected\\tO\\nby\\tO\\nadrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\n;\\tO\\nthey\\tO\\nwere\\tO\\nfound\\tO\\nrepeatedly\\tO\\nto\\tO\\nhave\\tO\\nthe\\tO\\nbiochemical\\tO\\ndefect\\tO\\nof\\tO\\nan\\tO\\nALD\\tB-Disease\\nhemizygote\\tO\\n.\\tO\\n\\nThe\\tO\\nassay\\tO\\nconsisted\\tO\\nin\\tO\\nthe\\tO\\ndetermination\\tO\\nof\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\nin\\tO\\nlyophilized\\tO\\nand\\tO\\nreconstituted\\tO\\nplasma\\tO\\n.\\tO\\n\\nWhile\\tO\\nno\\tO\\nevidence\\tO\\nof\\tO\\nneurologic\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nleukodystrophy\\tB-Disease\\nor\\tO\\nmyeloneuropathy\\tB-Disease\\n)\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\nthese\\tO\\nhemizygotes\\tO\\n,\\tO\\nadrenocortical\\tB-Disease\\ninsufficiency\\tI-Disease\\nprovoking\\tO\\ncompensatory\\tO\\nhigh\\tO\\nACTH\\tO\\nrelease\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nboth\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nshould\\tO\\nbe\\tO\\ntaken\\tO\\ninto\\tO\\nconsideration\\tO\\nwhen\\tO\\ncounseling\\tO\\nfamilies\\tO\\nin\\tO\\nwhich\\tO\\ncases\\tO\\nwith\\tO\\nclinically\\tO\\nexpressed\\tO\\nALD\\tB-Disease\\nare\\tO\\nrepresented\\tO\\nin\\tO\\nseveral\\tO\\ngenerations\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nmapping\\tO\\nof\\tO\\na\\tO\\ncDNA\\tO\\nfrom\\tO\\nthe\\tO\\nhuman\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nDuchenne\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ngene\\tO\\nto\\tO\\nthe\\tO\\nmouse\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nThe\\tO\\nrecent\\tO\\ndiscovery\\tO\\nof\\tO\\nsequences\\tO\\nat\\tO\\nthe\\tO\\nsite\\tO\\nof\\tO\\nthe\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\ngene\\tO\\nin\\tO\\nhumans\\tO\\nhas\\tO\\nopened\\tO\\nup\\tO\\nthe\\tO\\npossibility\\tO\\nof\\tO\\na\\tO\\ndetailed\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\ngenes\\tO\\nin\\tO\\nhumans\\tO\\nand\\tO\\nin\\tO\\nrelated\\tO\\nmammalian\\tO\\nspecies\\tO\\n.\\tO\\n\\nUntil\\tO\\nrelatively\\tO\\nrecently\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\nno\\tO\\nobvious\\tO\\nmouse\\tO\\nmodel\\tO\\nof\\tO\\nthis\\tO\\ngenetic\\tB-Disease\\ndisease\\tI-Disease\\nfor\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\ntherapeutic\\tO\\nstrategies\\tO\\n.\\tO\\n\\nThe\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nmouse\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nmutant\\tO\\nshowing\\tO\\nmuscular\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nmdx\\tO\\n,\\tO\\nhas\\tO\\nprovided\\tO\\na\\tO\\ncandidate\\tO\\nmouse\\tO\\ngenetic\\tO\\nhomologue\\tO\\nto\\tO\\nthe\\tO\\nDMD\\tB-Disease\\nlocus\\tO\\n;\\tO\\nthe\\tO\\nrelatively\\tO\\nmild\\tO\\npathological\\tO\\nfeatures\\tO\\nof\\tO\\nmdx\\tO\\nsuggest\\tO\\nit\\tO\\nmay\\tO\\nhave\\tO\\nmore\\tO\\nin\\tO\\ncommon\\tO\\nwith\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nBecker\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ntype\\tO\\nat\\tO\\nthe\\tO\\nsame\\tO\\nhuman\\tO\\nlocus\\tO\\n,\\tO\\nhowever\\tO\\n.\\tO\\n\\nBut\\tO\\nthe\\tO\\nclose\\tO\\ngenetic\\tO\\nlinkage\\tO\\nof\\tO\\nmdx\\tO\\nto\\tO\\nG6PD\\tO\\nand\\tO\\nHprt\\tO\\non\\tO\\nthe\\tO\\nmouse\\tO\\nX\\tO\\nchromosome\\tO\\n,\\tO\\ncoupled\\tO\\nwith\\tO\\nits\\tO\\ncomparatively\\tO\\nmild\\tO\\npathology\\tO\\n,\\tO\\nhave\\tO\\nsuggested\\tO\\nthat\\tO\\nthe\\tO\\nmdx\\tO\\nmutation\\tO\\nmay\\tO\\ninstead\\tO\\ncorrespond\\tO\\nto\\tO\\nEmery\\tB-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nwhich\\tO\\nitself\\tO\\nis\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nDNA\\tO\\nmarkers\\tO\\nat\\tO\\nXq28\\tO\\n-\\tO\\nqter\\tO\\nin\\tO\\nthe\\tO\\nregion\\tO\\nof\\tO\\nG6PD\\tO\\non\\tO\\nthe\\tO\\nhuman\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nUsing\\tO\\nan\\tO\\ninterspecific\\tO\\nmouse\\tO\\ndomesticus\\tO\\n/\\tO\\nspretus\\tO\\ncross\\tO\\n,\\tO\\nsegregating\\tO\\nfor\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nmarkers\\tO\\non\\tO\\nthe\\tO\\nmouse\\tO\\nX\\tO\\nchromosome\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\npositioned\\tO\\non\\tO\\nthe\\tO\\nmouse\\tO\\nX\\tO\\nchromosome\\tO\\nsequences\\tO\\nhomologous\\tO\\nto\\tO\\na\\tO\\nDMD\\tB-Disease\\ncDNA\\tO\\nclone\\tO\\n.\\tO\\n\\nThese\\tO\\nsequences\\tO\\nmap\\tO\\nprovocatively\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\nmdx\\tO\\nmutation\\tO\\nand\\tO\\nunexpectedly\\tO\\ndistant\\tO\\nfrom\\tO\\nsparse\\tO\\nfur\\tO\\n,\\tO\\nspf\\tO\\n,\\tO\\nthe\\tO\\nmouse\\tO\\nhomologue\\tO\\nof\\tO\\nOTC\\tO\\n(\\tO\\nornithine\\tO\\ntranscarbamylase\\tO\\n)\\tO\\nwhich\\tO\\nis\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nDMD\\tB-Disease\\non\\tO\\nthe\\tO\\nhuman\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n.\\tO\\n\\nLocalization\\tO\\nof\\tO\\nthe\\tO\\nregion\\tO\\nhomologous\\tO\\nto\\tO\\nthe\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nlocus\\tO\\non\\tO\\nthe\\tO\\nmouse\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nRecent\\tO\\nprogress\\tO\\nhas\\tO\\nresulted\\tO\\nin\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nmutated\\tO\\nin\\tO\\nDuchenne\\tB-Disease\\nand\\tI-Disease\\nthe\\tI-Disease\\nmilder\\tI-Disease\\nBecker\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophies\\tI-Disease\\nbeing\\tO\\ncloned\\tO\\nand\\tO\\nhas\\tO\\nsuggested\\tO\\nthat\\tO\\nthe\\tO\\ngene\\tO\\nitself\\tO\\nextends\\tO\\nover\\tO\\n1\\tO\\n,\\tO\\n000\\tO\\nto\\tO\\n2\\tO\\n,\\tO\\n000\\tO\\nkilobases\\tO\\n(\\tO\\nkb\\tO\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\nstudy\\tO\\nhow\\tO\\nmutations\\tO\\nin\\tO\\nthis\\tO\\ngene\\tO\\naffect\\tO\\nmuscle\\tO\\ndevelopment\\tO\\nand\\tO\\nintegrity\\tO\\n,\\tO\\nit\\tO\\nwould\\tO\\nbe\\tO\\nof\\tO\\ninterest\\tO\\nto\\tO\\nhave\\tO\\navailable\\tO\\na\\tO\\nmouse\\tO\\nmodel\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\nmouse\\tO\\nmdx\\tO\\nmutation\\tO\\naffects\\tO\\nmuscle\\tO\\nand\\tO\\nconfers\\tO\\na\\tO\\nmild\\tO\\ndystrophic\\tB-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nbut\\tO\\nit\\tO\\nis\\tO\\nnot\\tO\\nclear\\tO\\nwhether\\tO\\nthis\\tO\\nmutation\\tO\\nis\\tO\\nequivalent\\tO\\nto\\tO\\nDuchenne\\tB-Disease\\n/\\tI-Disease\\nBecker\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nin\\tO\\nman\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\ndescribe\\tO\\nthe\\tO\\nuse\\tO\\nof\\tO\\ntwo\\tO\\nsequences\\tO\\nfrom\\tO\\nthe\\tO\\nhuman\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\ngene\\tO\\nthat\\tO\\ncross\\tO\\n-\\tO\\nhybridize\\tO\\nto\\tO\\nmouse\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nsequences\\tO\\nto\\tO\\nlocalize\\tO\\nthe\\tO\\ngene\\tO\\nhomologous\\tO\\nto\\tO\\nDMD\\tB-Disease\\nin\\tO\\nthe\\tO\\nmouse\\tO\\n.\\tO\\n\\nBoth\\tO\\nsequences\\tO\\nmap\\tO\\nto\\tO\\nthe\\tO\\nregion\\tO\\nof\\tO\\n10\\tO\\ncentimorgan\\tO\\nlying\\tO\\nbetween\\tO\\nthe\\tO\\nTabby\\tO\\n(\\tO\\nTa\\tO\\n)\\tO\\nand\\tO\\nSt14\\tO\\n-\\tO\\n1\\tO\\n(\\tO\\nDxPas8\\tO\\n)\\tO\\nloci\\tO\\n,\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\nphosphorylase\\tO\\nb\\tO\\nkinase\\tO\\nlocus\\tO\\n(\\tO\\nPhk\\tO\\n)\\tO\\n.\\tO\\n\\nBy\\tO\\nanalogy\\tO\\nwith\\tO\\nthe\\tO\\nhuman\\tO\\nX\\tO\\n-\\tO\\nchromosome\\tO\\n,\\tO\\nwe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\nregion\\tO\\nin\\tO\\nthe\\tO\\nmouse\\tO\\naround\\tO\\nthe\\tO\\nG6pd\\tO\\nand\\tO\\nSt14\\tO\\n-\\tO\\n1\\tO\\nloci\\tO\\nmay\\tO\\ncontain\\tO\\ntwo\\tO\\ngenes\\tO\\ncorresponding\\tO\\nto\\tO\\ndistinct\\tO\\nhuman\\tO\\nmyopathies\\tB-Disease\\nEmery\\tB-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nwhich\\tO\\nis\\tO\\nknown\\tO\\nto\\tO\\nbe\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nSt14\\tO\\n-\\tO\\n1\\tO\\nin\\tO\\nman\\tO\\nand\\tO\\nthe\\tO\\nDMD\\tB-Disease\\nhomologue\\tO\\ndescribed\\tO\\nhere\\tO\\n.\\tO\\n.\\tO\\n\\nGT\\tO\\nto\\tO\\nAT\\tO\\ntransition\\tO\\nat\\tO\\na\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\ncauses\\tO\\nskipping\\tO\\nof\\tO\\nthe\\tO\\npreceding\\tO\\nexon\\tO\\nin\\tO\\nphenylketonuria\\tB-Disease\\n.\\tO\\n\\nClassical\\tB-Disease\\nPhenylketonuria\\tI-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nhuman\\tI-Disease\\ngenetic\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nhepatic\\tI-Disease\\nphenylalanine\\tI-Disease\\nhydroxylase\\tI-Disease\\n(\\tO\\nPAH\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nisolated\\tO\\nseveral\\tO\\nmutant\\tO\\nPAH\\tO\\ncDNA\\tO\\nclones\\tO\\nfrom\\tO\\na\\tO\\nPKU\\tB-Disease\\ncarrier\\tO\\nindividual\\tO\\nand\\tO\\nshowed\\tO\\nthat\\tO\\nthey\\tO\\ncontained\\tO\\nan\\tO\\ninternal\\tO\\n116\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\n,\\tO\\ncorresponding\\tO\\nprecisely\\tO\\nto\\tO\\nexon\\tO\\n12\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nchromosomal\\tO\\nPAH\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\ndeletion\\tO\\ncauses\\tO\\nthe\\tO\\nsynthesis\\tO\\nof\\tO\\na\\tO\\ntruncated\\tO\\nprotein\\tO\\nlacking\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\n52\\tO\\namino\\tO\\nacids\\tO\\n.\\tO\\n\\nGene\\tO\\ntransfer\\tO\\nand\\tO\\nexpression\\tO\\nstudies\\tO\\nusing\\tO\\nthe\\tO\\nmutant\\tO\\nPAH\\tO\\ncDNA\\tO\\nindicated\\tO\\nthat\\tO\\nthe\\tO\\ndeletion\\tO\\nabolishes\\tO\\nPAH\\tO\\nactivity\\tO\\nin\\tO\\nthe\\tO\\ncell\\tO\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\nprotein\\tO\\ninstability\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\ndeletion\\tO\\n,\\tO\\nthe\\tO\\nmutant\\tO\\nchromosomal\\tO\\nPAH\\tO\\ngene\\tO\\nwas\\tO\\nisolated\\tO\\nfrom\\tO\\nthis\\tO\\nindividual\\tO\\nand\\tO\\nshown\\tO\\nto\\tO\\ncontain\\tO\\na\\tO\\nGT\\tO\\n-\\tO\\n-\\tO\\ngreater\\tO\\nthan\\tO\\nAT\\tO\\nsubstitution\\tO\\nat\\tO\\nthe\\tO\\n5\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n12\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\nconsequence\\tO\\nof\\tO\\nthe\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nliver\\tO\\nis\\tO\\nthe\\tO\\nskipping\\tO\\nof\\tO\\nthe\\tO\\npreceding\\tO\\nexon\\tO\\nduring\\tO\\nRNA\\tO\\nsplicing\\tO\\n.\\tO\\n.\\tO\\n\\nConservation\\tO\\nof\\tO\\nthe\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ngene\\tO\\nin\\tO\\nmice\\tO\\nand\\tO\\nhumans\\tO\\n.\\tO\\n\\nA\\tO\\nportion\\tO\\nof\\tO\\nthe\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\ngene\\tO\\ntranscript\\tO\\nfrom\\tO\\nhuman\\tO\\nfetal\\tO\\nskeletal\\tO\\nmuscle\\tO\\nand\\tO\\nmouse\\tO\\nadult\\tO\\nheart\\tO\\nwas\\tO\\nsequenced\\tO\\n,\\tO\\nrepresenting\\tO\\napproximately\\tO\\n25\\tO\\npercent\\tO\\nof\\tO\\nthe\\tO\\ntotal\\tO\\n,\\tO\\n14\\tO\\n-\\tO\\nkb\\tO\\nDMD\\tB-Disease\\ntranscript\\tO\\n.\\tO\\n\\nThe\\tO\\nnucleic\\tO\\nacid\\tO\\nand\\tO\\npredicted\\tO\\namino\\tO\\nacid\\tO\\nsequences\\tO\\nfrom\\tO\\nthe\\tO\\ntwo\\tO\\nspecies\\tO\\nare\\tO\\nnearly\\tO\\n90\\tO\\npercent\\tO\\nhomologous\\tO\\n.\\tO\\n\\nThe\\tO\\namino\\tO\\nacid\\tO\\nsequence\\tO\\nthat\\tO\\nis\\tO\\npredicted\\tO\\nfrom\\tO\\nthis\\tO\\nportion\\tO\\nof\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\nindicates\\tO\\nthat\\tO\\nthe\\tO\\nprotein\\tO\\nproduct\\tO\\nmight\\tO\\nserve\\tO\\na\\tO\\nstructural\\tO\\nrole\\tO\\nin\\tO\\nmuscle\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nabundance\\tO\\nand\\tO\\ntissue\\tO\\ndistribution\\tO\\nof\\tO\\nthe\\tO\\nmessenger\\tO\\nRNA\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nDMD\\tB-Disease\\nprotein\\tO\\nis\\tO\\nnot\\tO\\nnebulin\\tO\\n.\\tO\\n.\\tO\\n\\nFamilial\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\nwith\\tO\\napparently\\tO\\nnormal\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\n4\\tO\\nsibs\\tO\\n(\\tO\\n2F\\tO\\n,\\tO\\n2M\\tO\\n)\\tO\\nwith\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nDiagnosis\\tO\\nwas\\tO\\nmade\\tO\\nclinically\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nhistory\\tO\\n,\\tO\\nbehavior\\tO\\n,\\tO\\nand\\tO\\nphysical\\tO\\nfindings\\tO\\nin\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\nsibs\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nchild\\tO\\nhad\\tO\\ndied\\tO\\nat\\tO\\nage\\tO\\n10\\tO\\nmonths\\tO\\nwith\\tO\\na\\tO\\nhistory\\tO\\nand\\tO\\nclinical\\tO\\nfindings\\tO\\ntypical\\tO\\nof\\tO\\nfirst\\tO\\nphase\\tO\\nof\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nResults\\tO\\nof\\tO\\nchromosome\\tO\\nstudies\\tO\\non\\tO\\nthe\\tO\\nparents\\tO\\nand\\tO\\nsurviving\\tO\\nsibs\\tO\\nwere\\tO\\nnormal\\tO\\n.\\tO\\n\\nThe\\tO\\nimplications\\tO\\nof\\tO\\nthis\\tO\\nunusual\\tO\\nfamilial\\tO\\noccurrence\\tO\\nfor\\tO\\nour\\tO\\nunderstanding\\tO\\nof\\tO\\nPWS\\tB-Disease\\nare\\tO\\ndiscussed\\tO\\n.\\tO\\n.\\tO\\n\\nNebulin\\tO\\nand\\tO\\ntitin\\tO\\nexpression\\tO\\nin\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nappears\\tO\\nnormal\\tO\\n.\\tO\\n\\nMonoclonal\\tO\\nantibodies\\tO\\nwhich\\tO\\nrecognize\\tO\\ndifferent\\tO\\nepitopes\\tO\\non\\tO\\neither\\tO\\ntitin\\tO\\nor\\tO\\nnebulin\\tO\\nshow\\tO\\nnormal\\tO\\nstaining\\tO\\npatterns\\tO\\non\\tO\\nfrozen\\tO\\nsections\\tO\\nof\\tO\\nthree\\tO\\nmuscle\\tO\\nbiopsies\\tO\\nof\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nGel\\tO\\nelectrophoresis\\tO\\nand\\tO\\nimmunoblotting\\tO\\nperformed\\tO\\non\\tO\\ntwo\\tO\\nof\\tO\\nthese\\tO\\nmuscle\\tO\\nbiopsies\\tO\\nshow\\tO\\nthe\\tO\\nnormal\\tO\\npattern\\tO\\nof\\tO\\ntitin\\tO\\nand\\tO\\nnebulin\\tO\\npolypeptides\\tO\\n.\\tO\\n\\nSince\\tO\\nthe\\tO\\ndonor\\tO\\nof\\tO\\none\\tO\\nof\\tO\\nthese\\tO\\nbiopsies\\tO\\nhas\\tO\\na\\tO\\nlarge\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\n5\\tO\\n-\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n,\\tO\\nour\\tO\\nresults\\tO\\nargue\\tO\\nagainst\\tO\\nthe\\tO\\nrecent\\tO\\nproposal\\tO\\nthat\\tO\\nnebulin\\tO\\nis\\tO\\nthe\\tO\\ngene\\tO\\nmutated\\tO\\nin\\tO\\nDMD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nHeterozygous\\tB-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nangioedema\\tB-Disease\\n,\\tO\\nmyasthenia\\tB-Disease\\ngravis\\tI-Disease\\n,\\tO\\nand\\tO\\nsystemic\\tB-Disease\\nlupus\\tI-Disease\\nerythematosus\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nmyasthenia\\tB-Disease\\ngravis\\tI-Disease\\n,\\tO\\nsystemic\\tB-Disease\\nlupus\\tI-Disease\\nerythematosus\\tI-Disease\\n,\\tO\\nand\\tO\\nangioedema\\tB-Disease\\nassociated\\tO\\nwith\\tO\\nheterozygous\\tO\\ncomplement\\tB-Disease\\nfactor\\tI-Disease\\n2\\tI-Disease\\n(\\tI-Disease\\nC2\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nsignificance\\tO\\nof\\tO\\nthis\\tO\\nassociation\\tO\\nis\\tO\\ncontroversial\\tO\\n,\\tO\\nthough\\tO\\nthe\\tO\\nassociation\\tO\\nof\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nwith\\tO\\ncertain\\tO\\nhistocompatibility\\tO\\nantigens\\tO\\nsuggests\\tO\\npossible\\tO\\nlinkage\\tO\\nto\\tO\\nimmune\\tO\\nresponse\\tO\\ngenes\\tO\\n.\\tO\\n\\nTo\\tO\\nour\\tO\\nknowledge\\tO\\nthis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nreport\\tO\\nof\\tO\\nheterozygous\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nassociation\\tO\\nwith\\tO\\nthis\\tO\\ncombination\\tO\\nof\\tO\\nautoimmune\\tB-Disease\\ndisorders\\tI-Disease\\n,\\tO\\nand\\tO\\nwe\\tO\\ndiscuss\\tO\\nthe\\tO\\naetiological\\tO\\nimplications\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nanalysis\\tO\\nof\\tO\\nan\\tO\\ninherited\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nthird\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nin\\tO\\nBrittany\\tO\\nspaniel\\tO\\ndogs\\tO\\n.\\tO\\n\\nGenetically\\tO\\ndetermined\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nBrittany\\tO\\nspaniel\\tO\\ndogs\\tO\\nshares\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nbiochemical\\tO\\nand\\tO\\nclinical\\tO\\ncharacteristics\\tO\\nwith\\tO\\nthe\\tO\\nhuman\\tO\\ndisorder\\tO\\n.\\tO\\n\\nIn\\tO\\nhumans\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\na\\tO\\nnull\\tO\\ngene\\tO\\nthat\\tO\\nis\\tO\\nallelic\\tO\\nto\\tO\\nthe\\tO\\nstructural\\tO\\ngene\\tO\\nfor\\tO\\nC3\\tO\\nand\\tO\\nis\\tO\\nnot\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nmajor\\tO\\nhistocompatibility\\tO\\nlocus\\tO\\n.\\tO\\n\\nThe\\tO\\ncurrent\\tO\\nstudy\\tO\\nused\\tO\\nallotype\\tO\\nanalysis\\tO\\nof\\tO\\ncanine\\tO\\nC3\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\ndemonstrate\\tO\\nthat\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthese\\tO\\ndogs\\tO\\nis\\tO\\nalso\\tO\\na\\tO\\nnull\\tO\\ngene\\tO\\nallelic\\tO\\nto\\tO\\nthe\\tO\\nstructural\\tO\\ngene\\tO\\nfor\\tO\\nC3\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\npreliminary\\tO\\npedigree\\tO\\nanalysis\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\ncanine\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\napparently\\tO\\nnot\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nmajor\\tO\\nhistocompatibility\\tO\\ncomplex\\tO\\nof\\tO\\nthe\\tO\\ndog\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nit\\tO\\nappears\\tO\\nthat\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nBrittany\\tO\\nspaniel\\tO\\ndogs\\tO\\nnot\\tO\\nonly\\tO\\nshares\\tO\\nbiochemical\\tO\\nand\\tO\\nclinical\\tO\\nfeatures\\tO\\nwith\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nhumans\\tO\\n,\\tO\\nbut\\tO\\nalso\\tO\\nshares\\tO\\nsome\\tO\\ngenetic\\tO\\ncharacteristics\\tO\\nwith\\tO\\nthe\\tO\\nhuman\\tO\\ndisorder\\tO\\n.\\tO\\n.\\tO\\n\\nGene\\tO\\ntransfer\\tO\\nand\\tO\\nexpression\\tO\\nof\\tO\\nhuman\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n.\\tO\\n\\nPhenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\ngenetic\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nenzyme\\tI-Disease\\nphenylalanine\\tI-Disease\\nhydroxylase\\tI-Disease\\n(\\tO\\nPAH\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\ncomplementary\\tO\\nDNA\\tO\\nclone\\tO\\nof\\tO\\nhuman\\tO\\nPAH\\tO\\nwas\\tO\\ninserted\\tO\\ninto\\tO\\na\\tO\\neukaryotic\\tO\\nexpression\\tO\\nvector\\tO\\nand\\tO\\ntransferred\\tO\\ninto\\tO\\nmouse\\tO\\nNIH3T3\\tO\\ncells\\tO\\nwhich\\tO\\ndo\\tO\\nnot\\tO\\nnormally\\tO\\nexpress\\tO\\nPAH\\tO\\n.\\tO\\n\\nThe\\tO\\ntransformed\\tO\\nmouse\\tO\\ncells\\tO\\nexpressed\\tO\\nPAH\\tO\\nmessenger\\tO\\nRNA\\tO\\n,\\tO\\nimmunoreactive\\tO\\nprotein\\tO\\n,\\tO\\nand\\tO\\nenzymatic\\tO\\nactivity\\tO\\nthat\\tO\\nare\\tO\\ncharacteristic\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nhuman\\tO\\nliver\\tO\\nproducts\\tO\\n,\\tO\\ndemonstrating\\tO\\nthat\\tO\\na\\tO\\nsingle\\tO\\ngene\\tO\\ncontains\\tO\\nall\\tO\\nof\\tO\\nthe\\tO\\nnecessary\\tO\\ngenetic\\tO\\ninformation\\tO\\nto\\tO\\ncode\\tO\\nfor\\tO\\nfunctional\\tO\\nPAH\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsupport\\tO\\nthe\\tO\\nuse\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nPAH\\tO\\nprobe\\tO\\nin\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\nand\\tO\\ndetection\\tO\\nof\\tO\\ncarriers\\tO\\n,\\tO\\nto\\tO\\nprovide\\tO\\nnew\\tO\\nopportunities\\tO\\nfor\\tO\\nthe\\tO\\nbiochemical\\tO\\ncharacterization\\tO\\nof\\tO\\nnormal\\tO\\nand\\tO\\nmutant\\tO\\nenzymes\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\nthe\\tO\\ninvestigation\\tO\\nof\\tO\\nalternative\\tO\\ngenetic\\tO\\ntherapies\\tO\\nfor\\tO\\nPKU\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nRegional\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\ngene\\tO\\nand\\tO\\nthe\\tO\\nphenylketonuria\\tB-Disease\\nlocus\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\ngenome\\tO\\n.\\tO\\n\\nPhenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\nof\\tO\\namino\\tO\\nacid\\tO\\nmetabolism\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nhepatic\\tI-Disease\\nenzyme\\tI-Disease\\nphenylalanine\\tI-Disease\\nhydroxylase\\tI-Disease\\n(\\tO\\nPAH\\tO\\n;\\tO\\nphenylalanine\\tO\\n4\\tO\\n-\\tO\\nmonooxygenase\\tO\\n,\\tO\\nEC\\tO\\n1\\tO\\n.\\tO\\n14\\tO\\n.\\tO\\n16\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\ncDNA\\tO\\nclone\\tO\\nfor\\tO\\nhuman\\tO\\nPAH\\tO\\nhas\\tO\\npreviously\\tO\\nbeen\\tO\\nused\\tO\\nto\\tO\\nassign\\tO\\nthe\\tO\\ncorresponding\\tO\\ngene\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\n12\\tO\\n.\\tO\\n\\nTo\\tO\\ndefine\\tO\\nthe\\tO\\nregional\\tO\\nmap\\tO\\nposition\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nlocus\\tO\\nand\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\non\\tO\\nhuman\\tO\\nchromosome\\tO\\n12\\tO\\n,\\tO\\nDNA\\tO\\nwas\\tO\\nisolated\\tO\\nfrom\\tO\\nhuman\\tO\\n-\\tO\\nhamster\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrids\\tO\\nwith\\tO\\nvarious\\tO\\ndeletions\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n12\\tO\\nand\\tO\\nwas\\tO\\nanalyzed\\tO\\nby\\tO\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\nusing\\tO\\nthe\\tO\\nhuman\\tO\\ncDNA\\tO\\nPAH\\tO\\nclone\\tO\\nas\\tO\\na\\tO\\nhybridization\\tO\\nprobe\\tO\\n.\\tO\\n\\nFrom\\tO\\nthese\\tO\\nresults\\tO\\n,\\tO\\ntogether\\tO\\nwith\\tO\\ndetailed\\tO\\nbiochemical\\tO\\nand\\tO\\ncytogenetic\\tO\\ncharacterization\\tO\\nof\\tO\\nthe\\tO\\nhybrid\\tO\\ncells\\tO\\n,\\tO\\nthe\\tO\\nregion\\tO\\non\\tO\\nchromosome\\tO\\n12\\tO\\ncontaining\\tO\\nthe\\tO\\nhuman\\tO\\nPAH\\tO\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\ndefined\\tO\\nas\\tO\\n12q14\\tO\\n.\\tO\\n\\n3\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nqter\\tO\\n3\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\nqter\\tO\\n.\\tO\\n\\nThe\\tO\\nPAH\\tO\\nmap\\tO\\nposition\\tO\\non\\tO\\nchromosome\\tO\\n12\\tO\\nwas\\tO\\nfurther\\tO\\nlocalized\\tO\\nby\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\nof\\tO\\n125I\\tO\\n-\\tO\\nlabeled\\tO\\nhuman\\tO\\nPAH\\tO\\ncDNA\\tO\\nto\\tO\\nchromosomes\\tO\\nprepared\\tO\\nfrom\\tO\\na\\tO\\nhuman\\tO\\nlymphoblastoid\\tO\\ncell\\tO\\nline\\tO\\n.\\tO\\n\\nResults\\tO\\nof\\tO\\nthese\\tO\\nexperiments\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nregion\\tO\\non\\tO\\nchromosome\\tO\\n12\\tO\\ncontaining\\tO\\nthe\\tO\\nPAH\\tO\\ngene\\tO\\nand\\tO\\nthe\\tO\\nPKU\\tB-Disease\\nlocus\\tO\\nin\\tO\\nman\\tO\\nis\\tO\\n12q22\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n-\\tO\\n12q24\\tO\\n.\\tO\\n\\n1\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nnot\\tO\\nonly\\tO\\nprovide\\tO\\na\\tO\\nregionalized\\tO\\nmap\\tO\\nposition\\tO\\nfor\\tO\\na\\tO\\nmajor\\tO\\nhuman\\tO\\ndisease\\tO\\nlocus\\tO\\nbut\\tO\\nalso\\tO\\ncan\\tO\\nserve\\tO\\nas\\tO\\na\\tO\\nreference\\tO\\npoint\\tO\\nfor\\tO\\nlinkage\\tO\\nanalysis\\tO\\nwith\\tO\\nother\\tO\\nDNA\\tO\\nmarkers\\tO\\non\\tO\\nhuman\\tO\\nchromosome\\tO\\n12\\tO\\n\\nHeterogeneity\\tO\\nof\\tO\\ntype\\tB-Disease\\nI\\tI-Disease\\nvon\\tI-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\n:\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\nsubgroup\\tO\\nwith\\tO\\nan\\tO\\nabnormal\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\n.\\tO\\n\\nType\\tB-Disease\\nI\\tI-Disease\\nvon\\tI-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nvWD\\tB-Disease\\n)\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nequally\\tO\\nlow\\tO\\nplasma\\tO\\nconcentrations\\tO\\nof\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\nantigen\\tO\\n(\\tO\\nvWF\\tO\\nAg\\tO\\n)\\tO\\nand\\tO\\nristocetin\\tO\\ncofactor\\tO\\n(\\tO\\nRiCof\\tO\\n)\\tO\\nand\\tO\\nby\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nall\\tO\\nvWF\\tO\\nmultimers\\tO\\nin\\tO\\nsodium\\tO\\ndodecyl\\tO\\nsulfate\\tO\\n(\\tO\\nSDS\\tO\\n)\\tO\\n-\\tO\\nagarose\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n.\\tO\\n\\nFor\\tO\\n17\\tO\\npatients\\tO\\n(\\tO\\n13\\tO\\nkindreds\\tO\\n)\\tO\\ndiagnosed\\tO\\nwith\\tO\\nthese\\tO\\ncriteria\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nstudied\\tO\\nthe\\tO\\nplatelet\\tO\\ncontents\\tO\\nof\\tO\\nvWF\\tO\\nAg\\tO\\nand\\tO\\nRiCof\\tO\\nand\\tO\\nthe\\tO\\nchanges\\tO\\nof\\tO\\nthese\\tO\\nin\\tO\\nplasma\\tO\\nafter\\tO\\nDDAVP\\tO\\ninfusion\\tO\\n.\\tO\\n\\nPlatelet\\tO\\nvWF\\tO\\nAg\\tO\\nand\\tO\\nRiCof\\tO\\nwere\\tO\\nnormal\\tO\\nin\\tO\\nfour\\tO\\nkindreds\\tO\\n(\\tO\\ncalled\\tO\\n\"\\tO\\nplatelet\\tO\\nnormal\\tO\\n\"\\tO\\nsubgroup\\tO\\n)\\tO\\n;\\tO\\nfollowing\\tO\\n1\\tO\\n-\\tO\\ndeamino\\tO\\n-\\tO\\n8\\tO\\n-\\tO\\nD\\tO\\n-\\tO\\narginine\\tO\\nvasopressin\\tO\\n;\\tO\\nplasma\\tO\\nvWF\\tO\\nAg\\tO\\n,\\tO\\nRiCof\\tO\\nand\\tO\\nthe\\tO\\nbleeding\\tO\\ntime\\tO\\n(\\tO\\nBT\\tO\\n)\\tO\\nbecame\\tO\\nnormal\\tO\\n.\\tO\\n\\nIn\\tO\\nsix\\tO\\nkindreds\\tO\\n,\\tO\\nplatelet\\tO\\nvWF\\tO\\nAg\\tO\\nand\\tO\\nRiCof\\tO\\nwere\\tO\\nequally\\tO\\nlow\\tO\\n(\\tO\\nplatelet\\tO\\nlow\\tO\\n)\\tO\\n;\\tO\\nafter\\tO\\nDDAVP\\tO\\n,\\tO\\nplasma\\tO\\nvWF\\tO\\nAg\\tO\\nand\\tO\\nRiCof\\tO\\nremained\\tO\\nlow\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nBT\\tO\\nwas\\tO\\nprolonged\\tO\\n.\\tO\\n\\nIn\\tO\\nthree\\tO\\nadditional\\tO\\nkindreds\\tO\\n,\\tO\\nplatelets\\tO\\ncontained\\tO\\nnormal\\tO\\nconcentrations\\tO\\nof\\tO\\nvWF\\tO\\nAg\\tO\\n,\\tO\\nbut\\tO\\nRiCof\\tO\\nwas\\tO\\nvery\\tO\\nlow\\tO\\n(\\tO\\nplatelet\\tO\\ndiscordant\\tO\\n)\\tO\\n;\\tO\\neven\\tO\\nthough\\tO\\na\\tO\\ncomplete\\tO\\nset\\tO\\nof\\tO\\nmultimers\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nplasma\\tO\\nand\\tO\\nplatelets\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\na\\tO\\nrelatively\\tO\\nsmall\\tO\\namount\\tO\\nof\\tO\\nlarge\\tO\\nmultimers\\tO\\n.\\tO\\n\\nAfter\\tO\\nDDAVP\\tO\\n,\\tO\\nplasma\\tO\\nvWF\\tO\\nAg\\tO\\nbecame\\tO\\nnormal\\tO\\n,\\tO\\nbut\\tO\\nRiCof\\tO\\nremained\\tO\\nlow\\tO\\nand\\tO\\nthe\\tO\\nBT\\tO\\nwas\\tO\\nvery\\tO\\nprolonged\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthere\\tO\\ncan\\tO\\nbe\\tO\\nan\\tO\\nabnormal\\tO\\nvWF\\tO\\n(\\tO\\nRiCof\\tO\\nless\\tO\\nthan\\tO\\nvWF\\tO\\nAg\\tO\\n)\\tO\\neven\\tO\\nin\\tO\\ntype\\tB-Disease\\nI\\tI-Disease\\nvWD\\tI-Disease\\n,\\tO\\ncoexisting\\tO\\nwith\\tO\\na\\tO\\ncomplete\\tO\\nset\\tO\\nof\\tO\\nvWF\\tO\\nmultimers\\tO\\n(\\tO\\nplatelet\\tO\\ndiscordant\\tO\\n)\\tO\\n;\\tO\\nthat\\tO\\nthe\\tO\\nabnormal\\tO\\nvWF\\tO\\ncan\\tO\\nbe\\tO\\nshown\\tO\\nmore\\tO\\nclearly\\tO\\nin\\tO\\nplatelets\\tO\\nthan\\tO\\nin\\tO\\nplasma\\tO\\nor\\tO\\nelse\\tO\\nin\\tO\\nplasma\\tO\\nafter\\tO\\nDDAVP\\tO\\ninfusion\\tO\\n;\\tO\\nand\\tO\\nthat\\tO\\nDDAVP\\tO\\nnormalizes\\tO\\nthe\\tO\\nBT\\tO\\nonly\\tO\\nin\\tO\\nthose\\tO\\npatients\\tO\\nwith\\tO\\nnormal\\tO\\nplatelet\\tO\\nlevels\\tO\\nof\\tO\\nboth\\tO\\nvWF\\tO\\nAg\\tO\\nand\\tO\\nRiCof\\tO\\n(\\tO\\nplatelet\\tO\\nnormal\\tO\\n)\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nanalysis\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\nvan\\tB-Disease\\nder\\tI-Disease\\nWoude\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nbrought\\tO\\ntogether\\tO\\ninformation\\tO\\non\\tO\\n864\\tO\\naffected\\tO\\nindividuals\\tO\\nin\\tO\\n164\\tO\\nfamilies\\tO\\n(\\tO\\nincluding\\tO\\nthree\\tO\\nnew\\tO\\npedigrees\\tO\\n)\\tO\\nreported\\tO\\nin\\tO\\nthe\\tO\\n137\\tO\\nyear\\tO\\nperiod\\tO\\nsince\\tO\\n1845\\tO\\nwhen\\tO\\nDemarquay\\tO\\nfirst\\tO\\ndescribed\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nwhat\\tO\\nwas\\tO\\nlater\\tO\\ncalled\\tO\\nvan\\tB-Disease\\nder\\tI-Disease\\nWoude\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nVWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nBoth\\tO\\ntypes\\tO\\nof\\tO\\noral\\tB-Disease\\ncleft\\tI-Disease\\n,\\tO\\ncleft\\tB-Disease\\npalate\\tI-Disease\\n(\\tO\\nCP\\tB-Disease\\n)\\tO\\nand\\tO\\ncleft\\tB-Disease\\nlip\\tI-Disease\\nwith\\tO\\nor\\tO\\nwithout\\tO\\nCP\\tB-Disease\\n(\\tO\\nCLP\\tB-Disease\\n)\\tO\\n,\\tO\\nsegregate\\tO\\nin\\tO\\nthese\\tO\\nfamilies\\tO\\ntogether\\tO\\nwith\\tO\\nlower\\tO\\nlip\\tB-Disease\\npits\\tI-Disease\\nor\\tO\\nfistulae\\tB-Disease\\nin\\tO\\nan\\tO\\nautosomal\\tO\\ndominant\\tO\\nmode\\tO\\nwith\\tO\\nhigh\\tO\\npenetrance\\tO\\nestimated\\tO\\nto\\tO\\nbe\\tO\\nK\\tO\\n=\\tO\\n.\\tO\\n\\n89\\tO\\nand\\tO\\n.\\tO\\n\\n99\\tO\\nby\\tO\\ndifferent\\tO\\nmethods\\tO\\n.\\tO\\n\\nCleft\\tO\\ntypes\\tO\\n(\\tO\\nCLP\\tB-Disease\\nand\\tO\\nCP\\tB-Disease\\n)\\tO\\noccur\\tO\\nin\\tO\\nVWS\\tB-Disease\\nin\\tO\\nthe\\tO\\nsame\\tO\\nproportions\\tO\\nas\\tO\\nin\\tO\\nthe\\tO\\ngeneral\\tO\\nnon\\tO\\n-\\tO\\nVWS\\tO\\npopulation\\tO\\n,\\tO\\nie\\tO\\n,\\tO\\nabout\\tO\\ntwice\\tO\\nas\\tO\\nmany\\tO\\ncleft\\tO\\n-\\tO\\nbearing\\tO\\nindividuals\\tO\\nhave\\tO\\nCLP\\tB-Disease\\nas\\tO\\nhave\\tO\\nCP\\tB-Disease\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nother\\tO\\nhand\\tO\\n,\\tO\\nwe\\tO\\ndo\\tO\\nnot\\tO\\nfind\\tO\\nthe\\tO\\nusually\\tO\\nobserved\\tO\\nexcess\\tO\\nof\\tO\\nfemales\\tO\\nwith\\tO\\nCP\\tB-Disease\\nand\\tO\\nexcess\\tO\\nof\\tO\\nmales\\tO\\nwith\\tO\\nCLP\\tB-Disease\\n;\\tO\\nin\\tO\\nVWS\\tB-Disease\\nthe\\tO\\nsex\\tO\\nratios\\tO\\nare\\tO\\nmore\\tO\\nnearly\\tO\\nequal\\tO\\n.\\tO\\n\\nLip\\tB-Disease\\npits\\tI-Disease\\nalso\\tO\\nare\\tO\\nequally\\tO\\ndistributed\\tO\\nbetween\\tO\\nthe\\tO\\nsexes\\tO\\n.\\tO\\n\\nAffected\\tO\\nmales\\tO\\nand\\tO\\nfemales\\tO\\nare\\tO\\nequally\\tO\\nlikely\\tO\\nto\\tO\\ntransmit\\tO\\nVWS\\tB-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthere\\tO\\nis\\tO\\nan\\tO\\nexcess\\tO\\nof\\tO\\nless\\tO\\nseverely\\tO\\naffected\\tO\\nindividuals\\tO\\namong\\tO\\ntransmitters\\tO\\nand\\tO\\na\\tO\\ndeficiency\\tO\\nof\\tO\\nmore\\tO\\nseverely\\tO\\naffected\\tO\\n,\\tO\\nbrought\\tO\\nabout\\tO\\nby\\tO\\na\\tO\\nproband\\tO\\nbias\\tO\\nand\\tO\\ndifferential\\tO\\nfecundity\\tO\\n.\\tO\\n\\nThe\\tO\\nexpression\\tO\\nof\\tO\\nVWS\\tB-Disease\\nis\\tO\\nsignificantly\\tO\\nmodified\\tO\\nby\\tO\\nthe\\tO\\ngenetic\\tO\\nbackground\\tO\\nMore\\tO\\nextreme\\tO\\nphenotypes\\tO\\nin\\tO\\nparents\\tO\\ntend\\tO\\nto\\tO\\nproduce\\tO\\nmore\\tO\\nextreme\\tO\\nexpression\\tO\\nin\\tO\\ntheir\\tO\\nchildren\\tO\\n.\\tO\\n\\nFor\\tO\\na\\tO\\nVWS\\tB-Disease\\ngene\\tO\\ncarrier\\tO\\nthe\\tO\\nrelative\\tO\\nrisk\\tO\\nof\\tO\\ntransmitting\\tO\\na\\tO\\ncleft\\tO\\nis\\tO\\n26\\tO\\n.\\tO\\n\\n45\\tO\\n%\\tO\\n;\\tO\\nthat\\tO\\nof\\tO\\ntransmitting\\tO\\nlower\\tO\\nlip\\tB-Disease\\npits\\tI-Disease\\nis\\tO\\n23\\tO\\n.\\tO\\n\\n55\\tO\\n%\\tO\\n.\\tO\\n\\nThree\\tO\\npedigrees\\tO\\nof\\tO\\nlip\\tB-Disease\\npits\\tI-Disease\\nin\\tO\\nthe\\tO\\nliterature\\tO\\nshow\\tO\\nno\\tO\\nclefts\\tO\\namong\\tO\\na\\tO\\nsignificant\\tO\\nnumber\\tO\\nof\\tO\\naffected\\tO\\nindividuals\\tO\\n.\\tO\\n\\nControl\\tO\\nof\\tO\\ngene\\tO\\nexpression\\tO\\nin\\tO\\nVWS\\tB-Disease\\nin\\tO\\nthe\\tO\\nthree\\tO\\ntarget\\tO\\ntissues\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\nindependent\\tO\\nand\\tO\\nseparately\\tO\\ndesignated\\tO\\n.\\tO\\n\\nMutation\\tO\\nrate\\tO\\nof\\tO\\nthe\\tO\\nVWS\\tB-Disease\\ngene\\tO\\nis\\tO\\ncalculated\\tO\\nto\\tO\\nbe\\tO\\n1\\tO\\n.\\tO\\n\\n8\\tO\\nX\\tO\\n10\\tO\\n(\\tO\\n-\\tO\\n5\\tO\\n)\\tO\\n\\nHereditary\\tB-Disease\\nC7\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nDiagnosis\\tO\\nand\\tO\\nHLA\\tO\\nstudies\\tO\\nin\\tO\\na\\tO\\nFrench\\tO\\n-\\tO\\nCanadian\\tO\\nfamily\\tO\\n.\\tO\\n\\nThe\\tO\\nserum\\tO\\nof\\tO\\na\\tO\\n44\\tO\\n-\\tO\\nyr\\tO\\n-\\tO\\nold\\tO\\nwoman\\tO\\nof\\tO\\nFrench\\tO\\n-\\tO\\nCanadian\\tO\\ndescent\\tO\\nhaving\\tO\\na\\tO\\nB\\tO\\n-\\tO\\n27\\tO\\npositive\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\nwas\\tO\\ndeficient\\tB-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\nseventh\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC7\\tO\\n)\\tO\\nas\\tO\\ndetermined\\tO\\nby\\tO\\nhemolytic\\tO\\nand\\tO\\nimmunochemical\\tO\\nmethods\\tO\\n.\\tO\\n\\nNo\\tO\\ninhibitor\\tO\\nagainst\\tO\\nC7\\tO\\nwas\\tO\\ndetected\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nlevels\\tO\\nof\\tO\\nall\\tO\\nother\\tO\\ncomplement\\tO\\ncomponents\\tO\\nwere\\tO\\nnormal\\tO\\n.\\tO\\n\\nNo\\tO\\ndeficiency\\tO\\nin\\tO\\nthe\\tO\\nopsonic\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nserum\\tO\\nwas\\tO\\nfound\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nresults\\tO\\nof\\tO\\nbasic\\tO\\ncoagulation\\tO\\nstudies\\tO\\nof\\tO\\nthe\\tO\\nplasma\\tO\\nwere\\tO\\nnormal\\tO\\n.\\tO\\n\\nOn\\tO\\ninvestigation\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nfamily\\tO\\n,\\tO\\ntwo\\tO\\nsisters\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nthe\\tO\\nsame\\tO\\ndeficiency\\tO\\nbut\\tO\\nwere\\tO\\notherwise\\tO\\nin\\tO\\ngood\\tO\\nhealth\\tO\\n.\\tO\\n\\nThe\\tO\\nseven\\tO\\nother\\tO\\nsiblings\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nwhile\\tO\\nthe\\tO\\npaternal\\tO\\naunt\\tO\\nhad\\tO\\na\\tO\\nnormal\\tO\\nC7\\tO\\nlevel\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nthird\\tO\\ngeneration\\tO\\n,\\tO\\nsix\\tO\\nchildren\\tO\\nof\\tO\\nthe\\tO\\nthree\\tO\\nhomozygous\\tO\\nsisters\\tO\\nand\\tO\\nfive\\tO\\nchildren\\tO\\nof\\tO\\nheterozygotes\\tO\\nwere\\tO\\navailable\\tO\\nfor\\tO\\ntesting\\tO\\n.\\tO\\n\\nStudies\\tO\\nof\\tO\\nthe\\tO\\nHLA\\tO\\nantigens\\tO\\nin\\tO\\nall\\tO\\nthe\\tO\\n22\\tO\\nsubjects\\tO\\nand\\tO\\nin\\tO\\nthree\\tO\\nspouses\\tO\\nindicated\\tO\\nno\\tO\\nclose\\tO\\nlinkage\\tO\\nbetween\\tO\\nthe\\tO\\nCM\\tB-Disease\\ndeficienty\\tI-Disease\\nand\\tO\\nthe\\tO\\nHLA\\tO\\nsystem\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nthe\\tO\\nsimultaneous\\tO\\noccurrence\\tO\\nof\\tO\\ntwo\\tO\\nhereditary\\tO\\ncomplement\\tB-Disease\\ndeficiencies\\tI-Disease\\n(\\tI-Disease\\nC2\\tI-Disease\\nand\\tI-Disease\\nC7\\tI-Disease\\n)\\tI-Disease\\nwas\\tO\\ndiscovered\\tO\\nin\\tO\\none\\tO\\nfamily\\tO\\nof\\tO\\nthis\\tO\\nremarkable\\tO\\nkindred\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\ndefect\\tB-Disease\\nin\\tI-Disease\\nsecretion\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nC5\\tI-Disease\\nin\\tO\\nmice\\tO\\n.\\tO\\n\\nA\\tO\\ngenetic\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfifth\\tI-Disease\\n(\\tI-Disease\\nC5\\tI-Disease\\n)\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement1\\tI-Disease\\n-\\tI-Disease\\n3\\tI-Disease\\n,\\tO\\na\\tO\\nserum\\tO\\nglycoprotein\\tO\\nof\\tO\\nmolecular\\tO\\nweight\\tO\\n(\\tO\\nMW\\tO\\n)\\tO\\n220\\tO\\n,\\tO\\n000\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n4\\tO\\n)\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\n39\\tO\\n%\\tO\\nof\\tO\\ninbred\\tO\\nstrains\\tO\\nof\\tO\\nmice3\\tO\\n.\\tO\\n\\nSera\\tO\\nof\\tO\\ndeficient\\tO\\nmice\\tO\\nlack\\tO\\ndetectable\\tO\\nC5\\tO\\nactivity\\tO\\nand\\tO\\nprotein2\\tO\\n,\\tO\\n3\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\ndeficient\\tO\\nmice\\tO\\nproduce\\tO\\nantibody\\tO\\nto\\tO\\nmouse\\tO\\nC5\\tO\\nwhen\\tO\\ninjected\\tO\\nwith\\tO\\nsera\\tO\\nfrom\\tO\\nC5\\tO\\nsufficient\\tO\\n(\\tO\\nnormal\\tO\\n)\\tO\\nstrains\\tO\\n.\\tO\\n\\nLevy\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n\\n5\\tO\\nshowed\\tO\\nthat\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrids\\tO\\nbetween\\tO\\nC5\\tO\\ndeficient\\tO\\n(\\tO\\nB10\\tO\\n.\\tO\\nD2\\tO\\n/\\tO\\nold\\tO\\nline\\tO\\n)\\tO\\nmacrophages\\tO\\nand\\tO\\neither\\tO\\nC5\\tO\\nsufficient\\tO\\n(\\tO\\nB10\\tO\\n.\\tO\\nD2\\tO\\n/\\tO\\nnew\\tO\\nline\\tO\\n)\\tO\\nmouse\\tO\\nkidney\\tO\\nor\\tO\\nchicken\\tO\\nerythroblasts\\tO\\nsecreted\\tO\\nhaemolytically\\tO\\nactive\\tO\\nmouse\\tO\\nC5\\tO\\nin\\tO\\nvitro\\tO\\n.\\tO\\n\\nSeveral\\tO\\npossible\\tO\\nmolecular\\tO\\nmechanisms\\tO\\nto\\tO\\naccount\\tO\\nfor\\tO\\nthe\\tO\\nfindings\\tO\\nwere\\tO\\nconsidered\\tO\\n,\\tO\\nbut\\tO\\ninsufficient\\tO\\ndirect\\tO\\ndata\\tO\\nwere\\tO\\navailable\\tO\\nto\\tO\\nchoose\\tO\\namong\\tO\\nthem\\tO\\n.\\tO\\n\\nWe\\tO\\nrecently\\tO\\nreported\\tO\\nthat\\tO\\nmouse\\tO\\n(\\tO\\nCD\\tO\\n.\\tO\\n1\\tO\\nstrain\\tO\\n)\\tO\\nperitoneal\\tO\\ncells\\tO\\nin\\tO\\nculture\\tO\\nsynthesise\\tO\\nand\\tO\\nsecrete\\tO\\na\\tO\\nsingle\\tO\\nchain\\tO\\nprecursor\\tO\\n,\\tO\\npro\\tO\\n-\\tO\\nC5\\tO\\n(\\tO\\nMW\\tO\\napproximately\\tO\\n210\\tO\\n,\\tO\\n000\\tO\\n)\\tO\\n,\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\n-\\tO\\nchain\\tO\\n(\\tO\\nalpha\\tO\\nchain\\tO\\n,\\tO\\n125\\tO\\n,\\tO\\n000\\tO\\nand\\tO\\nbeta\\tO\\nchain\\tO\\n83\\tO\\n,\\tO\\n000\\tO\\nMW\\tO\\n)\\tO\\nC5\\tO\\nprotein6\\tO\\n.\\tO\\n\\nRadiolabelled\\tO\\nprecursor\\tO\\nC5\\tO\\nwas\\tO\\ncontained\\tO\\nwithin\\tO\\nthe\\tO\\ncells\\tO\\nand\\tO\\nwas\\tO\\nsecreted\\tO\\ninto\\tO\\nthe\\tO\\ntissue\\tO\\nculture\\tO\\nmedia\\tO\\n.\\tO\\n\\nUsing\\tO\\nsimilar\\tO\\nmethods\\tO\\n,\\tO\\nwe\\tO\\nnow\\tO\\nfind\\tO\\nthat\\tO\\nC5\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\neach\\tO\\nof\\tO\\nfive\\tO\\ndifferent\\tO\\nmouse\\tO\\nstrains\\tO\\n(\\tO\\nAKR\\tO\\n,\\tO\\nSWR\\tO\\n,\\tO\\nDBA\\tO\\n/\\tO\\n2J8\\tO\\nA\\tO\\n/\\tO\\nHeJ\\tO\\nand\\tO\\nB10\\tO\\n.\\tO\\nD2\\tO\\n/\\tO\\nold\\tO\\nline\\tO\\n)\\tO\\nis\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nfailure\\tO\\nin\\tO\\nsecretion\\tO\\nof\\tO\\nC5\\tO\\nprotein\\tO\\nand\\tO\\nnot\\tO\\nto\\tO\\na\\tO\\nfailure\\tO\\nin\\tO\\nbiosynthesis\\tO\\nof\\tO\\npro\\tO\\n-\\tO\\nC5\\tO\\n\\nRecurrent\\tO\\nmeningococcal\\tB-Disease\\nmeningitis\\tI-Disease\\nwith\\tO\\nabsence\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nsixth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n:\\tO\\nan\\tO\\nevaluation\\tO\\nof\\tO\\nunderlying\\tO\\nimmunologic\\tO\\nmechanisms\\tO\\n.\\tO\\n\\nA\\tO\\n51\\tO\\n/\\tO\\n2\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nblack\\tO\\ngirl\\tO\\nwith\\tO\\nrecurrent\\tO\\nmeningococcal\\tB-Disease\\nmeningitis\\tI-Disease\\nand\\tO\\nabsence\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nsixth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC6\\tO\\n)\\tO\\nis\\tO\\nreported\\tO\\n.\\tO\\n\\nTo\\tO\\nexplore\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nrecurrent\\tO\\nneisserial\\tB-Disease\\ninfections\\tI-Disease\\nin\\tO\\nC6\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\na\\tO\\ndetailed\\tO\\nanalysis\\tO\\nof\\tO\\nher\\tO\\nimmune\\tO\\ncompetence\\tO\\nwas\\tO\\nconducted\\tO\\n.\\tO\\n\\nHer\\tO\\nserum\\tO\\nhad\\tO\\nnormal\\tO\\nchemotactic\\tO\\n,\\tO\\nopsonic\\tO\\n,\\tO\\nalternative\\tO\\ncomplement\\tO\\npathway\\tO\\n,\\tO\\nand\\tO\\nspecific\\tO\\nantibody\\tO\\nactivity\\tO\\n,\\tO\\nbut\\tO\\nlacked\\tO\\ncomplement\\tO\\n-\\tO\\nmediated\\tO\\nbacteriolytic\\tO\\nactivity\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nher\\tO\\nC6\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nserum\\tO\\nwas\\tO\\nindistinguishable\\tO\\nfrom\\tO\\nnormal\\tO\\nserum\\tO\\nin\\tO\\na\\tO\\ncomplement\\tO\\n-\\tO\\ndependent\\tO\\nassay\\tO\\nof\\tO\\nphagocyte\\tO\\nbactericidal\\tO\\nactivity\\tO\\n.\\tO\\n\\nAbsent\\tO\\nbacteriolysis\\tO\\nremains\\tO\\nthe\\tO\\nonly\\tO\\nconsistent\\tO\\ndefect\\tO\\nassociated\\tO\\nwith\\tO\\nrecurrent\\tO\\nneisserial\\tB-Disease\\ninfections\\tI-Disease\\nand\\tO\\nabsence\\tO\\nof\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nlate\\tO\\n-\\tO\\nacting\\tO\\ncomplement\\tO\\ncomponents\\tO\\n.\\tO\\n.\\tO\\n\\nDeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfifth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nin\\tO\\nhuman\\tO\\nsubjects\\tO\\n.\\tO\\n\\nClinical\\tO\\n,\\tO\\ngenetic\\tO\\nand\\tO\\nimmunologic\\tO\\nstudies\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nkindred\\tO\\n.\\tO\\n\\nThe\\tO\\ndiscovery\\tO\\nof\\tO\\na\\tO\\nlarge\\tO\\nkindred\\tO\\nwith\\tO\\na\\tO\\nheritable\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfifth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC5\\tO\\n)\\tO\\nhas\\tO\\npermitted\\tO\\nthe\\tO\\naccumulation\\tO\\nof\\tO\\nnew\\tO\\nclinical\\tO\\n,\\tO\\ngenetic\\tO\\nand\\tO\\nimmunologic\\tO\\ndata\\tO\\nconcerning\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nC5\\tO\\nin\\tO\\nhuman\\tO\\nsubjects\\tO\\n.\\tO\\n\\nThe\\tO\\nproband\\tO\\n,\\tO\\nwho\\tO\\nhas\\tO\\nhad\\tO\\nnine\\tO\\nepisodes\\tO\\nof\\tO\\ndisseminated\\tO\\ngonococcal\\tB-Disease\\ninfection\\tI-Disease\\n,\\tO\\nhas\\tO\\na\\tO\\nhemolytic\\tO\\nC5\\tO\\nlevel\\tO\\nof\\tO\\napproximately\\tO\\n0\\tO\\n.\\tO\\n\\n5\\tO\\nper\\tO\\ncent\\tO\\nof\\tO\\nnormal\\tO\\n.\\tO\\n\\nNo\\tO\\nC5\\tO\\nprotein\\tO\\nwas\\tO\\ndetectable\\tO\\n,\\tO\\nbut\\tO\\nlow\\tO\\nlevels\\tO\\nof\\tO\\nfunctional\\tO\\nC5\\tO\\nactivity\\tO\\ncould\\tO\\nbe\\tO\\nfound\\tO\\nusing\\tO\\na\\tO\\nsensitive\\tO\\nbactericidal\\tO\\nassay\\tO\\n.\\tO\\n\\nThe\\tO\\nprobands\\tO\\ntwin\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nanother\\tO\\nsister\\tO\\nalso\\tO\\nhad\\tO\\nextremely\\tO\\nlow\\tO\\nlevels\\tO\\nof\\tO\\nhemolytic\\tO\\nC5\\tO\\n(\\tO\\napproximately\\tO\\n0\\tO\\n.\\tO\\n5\\tO\\nper\\tO\\ncent\\tO\\nnormal\\tO\\n)\\tO\\n,\\tO\\nbut\\tO\\nboth\\tO\\nthese\\tO\\nsubjects\\tO\\nhave\\tO\\nbeen\\tO\\nhealthy\\tO\\n.\\tO\\n\\nHemolytic\\tO\\ncomplement\\tO\\nand\\tO\\nbacteriolytic\\tO\\nactivity\\tO\\ncould\\tO\\nbe\\tO\\nrestored\\tO\\nby\\tO\\nthe\\tO\\naddition\\tO\\nof\\tO\\npurified\\tO\\nC5\\tO\\n.\\tO\\n\\nNo\\tO\\nchemotactic\\tO\\nactivity\\tO\\nfor\\tO\\npolymorphonuclear\\tO\\nleukocytes\\tO\\ncould\\tO\\nbe\\tO\\ngenerated\\tO\\nin\\tO\\nthe\\tO\\nC5\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nserums\\tO\\nupon\\tO\\nactivation\\tO\\nof\\tO\\neither\\tO\\nthe\\tO\\nclassic\\tO\\nor\\tO\\nalternative\\tO\\npathways\\tO\\n,\\tO\\nagain\\tO\\ndemonstrating\\tO\\nthe\\tO\\nimportance\\tO\\nof\\tO\\nC5\\tO\\nin\\tO\\nhuman\\tO\\nsubjects\\tO\\nfor\\tO\\nthe\\tO\\nproduction\\tO\\nof\\tO\\nchemotactic\\tO\\nfactors\\tO\\n.\\tO\\n\\nThe\\tO\\nchemotactic\\tO\\nresponsiveness\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\npolymorphonuclear\\tO\\nleukocytes\\tO\\nand\\tO\\nmonocytes\\tO\\nto\\tO\\npreformed\\tO\\nchemotactic\\tO\\nfactors\\tO\\nwas\\tO\\nnot\\tO\\ndepressed\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\ntwo\\tO\\nof\\tO\\n32\\tO\\nother\\tO\\nfamily\\tO\\nmembers\\tO\\nfrom\\tO\\nthree\\tO\\ngenerations\\tO\\nhad\\tO\\ndepressed\\tO\\nwhole\\tO\\nhemolytic\\tO\\ncomplement\\tO\\nlevels\\tO\\n.\\tO\\n\\nIn\\tO\\n19\\tO\\nof\\tO\\n30\\tO\\nfamily\\tO\\nmembers\\tO\\n,\\tO\\nlevels\\tO\\nof\\tO\\nhemolytic\\tO\\nC5\\tO\\nranged\\tO\\nfrom\\tO\\n13\\tO\\nto\\tO\\n64\\tO\\nper\\tO\\ncent\\tO\\nof\\tO\\nnormal\\tO\\n.\\tO\\n\\nNo\\tO\\nlinkage\\tO\\nfor\\tO\\nC5\\tB-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nthe\\tO\\nA\\tO\\nor\\tO\\nB\\tO\\nloci\\tO\\nof\\tO\\nthe\\tO\\nmajor\\tO\\nhistocompatibility\\tO\\ncomplex\\tO\\ncould\\tO\\nbe\\tO\\nfound\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsuggest\\tO\\nan\\tO\\nautosomal\\tO\\ncodominant\\tO\\nmode\\tO\\nof\\tO\\ninheritance\\tO\\nof\\tO\\nC5\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nDeficiency\\tB-Disease\\nof\\tI-Disease\\nC5\\tI-Disease\\nis\\tO\\ncompatible\\tO\\nwith\\tO\\ngood\\tO\\nhealth\\tO\\n,\\tO\\nbut\\tO\\nit\\tO\\ncan\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nrepeated\\tO\\ndisseminated\\tO\\ngonococcal\\tB-Disease\\ninfection\\tI-Disease\\n\\nIncidence\\tO\\nand\\tO\\ncharacteristics\\tO\\nof\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nvariants\\tO\\nin\\tO\\nJapan\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n3000\\tO\\nmen\\tO\\nliving\\tO\\nin\\tO\\nYamaguchi\\tO\\nwere\\tO\\nscreened\\tO\\nfor\\tO\\nglucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nusing\\tO\\nBeutlers\\tO\\nspot\\tO\\ntest\\tO\\nand\\tO\\nthree\\tO\\ntypes\\tO\\nof\\tO\\nstarch\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n.\\tO\\n\\nThese\\tO\\nelectrophoresis\\tO\\nused\\tO\\na\\tO\\nphosphate\\tO\\nbuffer\\tO\\nsystem\\tO\\nat\\tO\\npH\\tO\\n7\\tO\\n.\\tO\\n\\n0\\tO\\n,\\tO\\na\\tO\\nTRIS\\tO\\n-\\tO\\nEDTA\\tO\\n-\\tO\\nborate\\tO\\nbuffer\\tO\\nsystem\\tO\\nat\\tO\\npH\\tO\\n8\\tO\\n.\\tO\\n\\n6\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nTRIS\\tO\\n-\\tO\\nhydrochloride\\tO\\nbuffer\\tO\\nsystem\\tO\\nat\\tO\\npH\\tO\\n8\\tO\\n.\\tO\\n.\\tO\\n\\nFifteen\\tO\\nG6PD\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nvariants\\tO\\nwere\\tO\\nfound\\tO\\nat\\tO\\nthe\\tO\\nrate\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\nand\\tO\\nclassified\\tO\\ninto\\tO\\nfour\\tO\\ngroups\\tO\\n.\\tO\\n\\nAs\\tO\\nnew\\tO\\nvariants\\tO\\n,\\tO\\nG6PD\\tO\\nKonan\\tO\\n,\\tO\\nKamiube\\tO\\n,\\tO\\nand\\tO\\nKiwa\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nThese\\tO\\nthree\\tO\\nvariants\\tO\\nhad\\tO\\na\\tO\\nmild\\tO\\nto\\tO\\nmoderate\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nwere\\tO\\nnot\\tO\\nassociated\\tO\\nwith\\tO\\nany\\tO\\nclinical\\tO\\nsigns\\tO\\n.\\tO\\n\\nG6PD\\tO\\nKonan\\tO\\nhad\\tO\\nfast\\tO\\nelectrophoretic\\tO\\nmobility\\tO\\nas\\tO\\ncompared\\tO\\nwith\\tO\\nnormal\\tO\\nlevels\\tO\\n,\\tO\\nG6PD\\tO\\nKiwa\\tO\\nhad\\tO\\nslightly\\tO\\nelevated\\tO\\nelectrophoretic\\tO\\nmobility\\tO\\n,\\tO\\nand\\tO\\nG6PD\\tO\\nKamiube\\tO\\nhad\\tO\\nnormal\\tO\\nelectrophoretic\\tO\\nmobility\\tO\\n.\\tO\\n\\nThese\\tO\\nthree\\tO\\nvariants\\tO\\nhad\\tO\\nnormal\\tO\\nlevels\\tO\\nof\\tO\\nKm\\tO\\nG6P\\tO\\n,\\tO\\nKm\\tO\\nNADP\\tO\\n,\\tO\\nand\\tO\\nKi\\tO\\nNADPH\\tO\\n,\\tO\\nnormal\\tO\\nutilizations\\tO\\nof\\tO\\nboth\\tO\\n2\\tO\\n-\\tO\\ndeoxy\\tO\\n-\\tO\\nG6P\\tO\\nand\\tO\\ndeamino\\tO\\n-\\tO\\nNAPD\\tO\\n,\\tO\\nnormal\\tO\\nheat\\tO\\nstability\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nnormal\\tO\\npH\\tO\\ncurve\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nvariant\\tO\\nwas\\tO\\nG6PD\\tO\\nUbe\\tO\\n,\\tO\\nwhich\\tO\\nwe\\tO\\nhad\\tO\\npreviously\\tO\\nfound\\tO\\nin\\tO\\nYamaguchi\\tO\\n(\\tO\\nNakashima\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1977\\tO\\n)\\tO\\n.\\tO\\n\\nOne\\tO\\nboy\\tO\\nwith\\tO\\nG6PD\\tO\\nUbe\\tO\\nwas\\tO\\nKorean\\tO\\n\\nUtilization\\tO\\nof\\tO\\npurines\\tO\\nby\\tO\\nan\\tO\\nHPRT\\tO\\nvariant\\tO\\nin\\tO\\nan\\tO\\nintelligent\\tO\\n,\\tO\\nnonmutilative\\tO\\npatient\\tO\\nwith\\tO\\nfeatures\\tO\\nof\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\n,\\tO\\nH\\tO\\n.\\tO\\n\\nChr\\tO\\n.\\tO\\n\\nB\\tO\\n.\\tO\\n,\\tO\\nwas\\tO\\namong\\tO\\nthe\\tO\\nfirst\\tO\\nreported\\tO\\nwith\\tO\\nhyperuricemia\\tB-Disease\\nand\\tO\\ncentral\\tB-Disease\\nnervous\\tI-Disease\\nsystem\\tI-Disease\\nsymptoms\\tI-Disease\\n.\\tO\\n\\nHe\\tO\\nhas\\tO\\nbeen\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nvariant\\tO\\nof\\tO\\nhypoxanthine\\tO\\nguanine\\tO\\nphosphoribosyl\\tO\\ntransferase\\tO\\n(\\tO\\nHPRT\\tO\\n;\\tO\\nE\\tO\\n.\\tO\\nC\\tO\\n.\\tO\\n2\\tO\\n.\\tO\\n4\\tO\\n.\\tO\\n2\\tO\\n.\\tO\\n8\\tO\\n)\\tO\\ndistinct\\tO\\nfrom\\tO\\nthe\\tO\\nenzyme\\tO\\npresent\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\nhad\\tO\\nchroeoathetosis\\tB-Disease\\n,\\tO\\nspasticity\\tB-Disease\\n,\\tO\\ndysarthric\\tB-Disease\\nspeech\\tI-Disease\\n,\\tO\\nand\\tO\\nhyperuricemia\\tB-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nhis\\tO\\nintelligence\\tO\\nwas\\tO\\nnormal\\tO\\nand\\tO\\nhe\\tO\\nhad\\tO\\nno\\tO\\nevidence\\tO\\nof\\tO\\nself\\tO\\n-\\tO\\nmutilation\\tO\\n.\\tO\\n\\nThere\\tO\\nwas\\tO\\nno\\tO\\nactivity\\tO\\nof\\tO\\nHPRT\\tO\\nin\\tO\\nthe\\tO\\nlysates\\tO\\nof\\tO\\nerythrocytes\\tO\\nand\\tO\\ncultured\\tO\\nfibroblasts\\tO\\nwhen\\tO\\nanalyzed\\tO\\nin\\tO\\nthe\\tO\\nusual\\tO\\nmanner\\tO\\n.\\tO\\n\\nUsing\\tO\\na\\tO\\nnewly\\tO\\ndeveloped\\tO\\nmethod\\tO\\nfor\\tO\\nthe\\tO\\nstudy\\tO\\nof\\tO\\npurine\\tO\\nmetabolism\\tO\\nin\\tO\\nintact\\tO\\ncultured\\tO\\ncells\\tO\\n,\\tO\\nthis\\tO\\npatient\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nmetabolize\\tO\\nsome\\tO\\n9\\tO\\n%\\tO\\nof\\tO\\n8\\tO\\n-\\tO\\n14C\\tO\\n-\\tO\\nhypoxanthine\\tO\\n,\\tO\\nand\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nisotope\\tO\\nutilized\\tO\\nwas\\tO\\nconverted\\tO\\nto\\tO\\nadenine\\tO\\nand\\tO\\nguanine\\tO\\nnucleotides\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\ncells\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\nwere\\tO\\nvirtually\\tO\\ncompletely\\tO\\nunable\\tO\\nto\\tO\\nconvert\\tO\\nhypoxanthine\\tO\\nto\\tO\\nnucleotides\\tO\\n.\\tO\\n\\nThe\\tO\\npatients\\tO\\nfibroblasts\\tO\\nwere\\tO\\neven\\tO\\nmore\\tO\\nefficient\\tO\\nin\\tO\\nthe\\tO\\nmetabolism\\tO\\nof\\tO\\n8\\tO\\n-\\tO\\n14C\\tO\\n-\\tO\\nguanine\\tO\\n,\\tO\\nwhich\\tO\\nwas\\tO\\nutilized\\tO\\nto\\tO\\nthe\\tO\\nextent\\tO\\nof\\tO\\n27\\tO\\n%\\tO\\n,\\tO\\nover\\tO\\n80\\tO\\n%\\tO\\nof\\tO\\nwhich\\tO\\nwas\\tO\\nconverted\\tO\\nto\\tO\\nguanine\\tO\\nand\\tO\\nadenine\\tO\\nnucleotides\\tO\\n.\\tO\\n\\nThe\\tO\\ngrowth\\tO\\nof\\tO\\nthe\\tO\\ncultured\\tO\\nfibroblasts\\tO\\nof\\tO\\nthis\\tO\\npatient\\tO\\nwas\\tO\\nintermediate\\tO\\nin\\tO\\nmedia\\tO\\ncontaining\\tO\\nhypoxanthine\\tO\\naminopterin\\tO\\nthymidine\\tO\\n(\\tO\\nHAT\\tO\\n)\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\ngrowth\\tO\\nof\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\ncells\\tO\\nwas\\tO\\ninhibited\\tO\\nand\\tO\\nnormal\\tO\\ncells\\tO\\ngrew\\tO\\nnormally\\tO\\n.\\tO\\n\\nSimilarly\\tO\\nin\\tO\\n8\\tO\\n-\\tO\\nazaguanine\\tO\\n,\\tO\\n6\\tO\\n-\\tO\\nthioguanine\\tO\\n,\\tO\\nand\\tO\\n8\\tO\\n-\\tO\\nazahypoxanthine\\tO\\n,\\tO\\nthe\\tO\\ngrowth\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\ncells\\tO\\nwas\\tO\\nintermediate\\tO\\nbetween\\tO\\nnormal\\tO\\nand\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\ncells\\tO\\n.\\tO\\n\\nThese\\tO\\nobservations\\tO\\nprovide\\tO\\nfurther\\tO\\nevidence\\tO\\nfor\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\namong\\tO\\npatients\\tO\\nwith\\tO\\ndisorders\\tO\\nin\\tO\\npurine\\tO\\nmetabolism\\tO\\ninvolving\\tO\\nthe\\tO\\nHPRT\\tO\\ngene\\tO\\n.\\tO\\n\\nThey\\tO\\ndocument\\tO\\nthat\\tO\\nthis\\tO\\nfamous\\tO\\npatient\\tO\\ndid\\tO\\nnot\\tO\\nhave\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n\\nLocalisation\\tO\\nof\\tO\\nthe\\tO\\nBecker\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ngene\\tO\\non\\tO\\nthe\\tO\\nshort\\tO\\narm\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\nby\\tO\\nlinkage\\tO\\nto\\tO\\ncloned\\tO\\nDNA\\tO\\nsequences\\tO\\n.\\tO\\n\\nA\\tO\\nlinkage\\tO\\nstudy\\tO\\nin\\tO\\n30\\tO\\nBecker\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nBMD\\tB-Disease\\n)\\tO\\nkindreds\\tO\\nusing\\tO\\nthree\\tO\\ncloned\\tO\\nDNA\\tO\\nsequences\\tO\\nfrom\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\nwhich\\tO\\ndemonstrate\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphisms\\tO\\n(\\tO\\nRFLPs\\tO\\n)\\tO\\n,\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nBMD\\tB-Disease\\ngene\\tO\\nis\\tO\\nlocated\\tO\\non\\tO\\nthe\\tO\\nshort\\tO\\narm\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\np21\\tO\\nregion\\tO\\n.\\tO\\n\\nThe\\tO\\ngenes\\tO\\nfor\\tO\\nBecker\\tB-Disease\\nand\\tI-Disease\\nDuchenne\\tI-Disease\\ndystrophies\\tI-Disease\\nmust\\tO\\ntherefore\\tO\\nbe\\tO\\nclosely\\tO\\nlinked\\tO\\n,\\tO\\nif\\tO\\nnot\\tO\\nallelic\\tO\\n,\\tO\\nand\\tO\\nany\\tO\\nfuture\\tO\\nDNA\\tO\\nprobes\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nof\\tO\\npractical\\tO\\nuse\\tO\\nin\\tO\\none\\tO\\ndisorder\\tO\\nshould\\tO\\nbe\\tO\\nequally\\tO\\napplicable\\tO\\nto\\tO\\nthe\\tO\\nother\\tO\\n.\\tO\\n\\nThe\\tO\\nlinkage\\tO\\nanalysis\\tO\\nalso\\tO\\nprovides\\tO\\ndata\\tO\\non\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nrecombination\\tO\\nalong\\tO\\nthe\\tO\\nshort\\tO\\narm\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n,\\tO\\nand\\tO\\nacross\\tO\\nthe\\tO\\ncentromeric\\tO\\nregion\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nevidence\\tO\\nfor\\tO\\nnew\\tO\\nmutation\\tO\\nat\\tO\\nthe\\tO\\nhprt\\tO\\nlocus\\tO\\nin\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nHypoxanthine\\tO\\n-\\tO\\nguanine\\tO\\nphosphoribosyltransferase\\tO\\n(\\tO\\nHPRT\\tO\\n;\\tO\\nEC2\\tO\\n.\\tO\\n4\\tO\\n.\\tO\\n2\\tO\\n.\\tO\\n8\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nfunctions\\tO\\nin\\tO\\nthe\\tO\\nmetabolic\\tO\\nsalvage\\tO\\nof\\tO\\npurines\\tO\\n,\\tO\\nis\\tO\\nencoded\\tO\\nby\\tO\\nan\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\ngene\\tO\\nin\\tO\\nman\\tO\\n.\\tO\\n\\nPartial\\tO\\nHPRT\\tB-Disease\\ndeficiencies\\tI-Disease\\nare\\tO\\nassociated\\tO\\nwith\\tO\\ngouty\\tB-Disease\\narthritis\\tI-Disease\\n,\\tO\\nwhile\\tO\\nabsence\\tO\\nof\\tO\\nactivity\\tO\\nresults\\tO\\nin\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nL\\tB-Disease\\n-\\tI-Disease\\nN\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nL\\tB-Disease\\n-\\tI-Disease\\nN\\tI-Disease\\npatients\\tO\\nfail\\tO\\nto\\tO\\nreproduce\\tO\\nand\\tO\\nthe\\tO\\nheterozygous\\tO\\nstate\\tO\\nappears\\tO\\nto\\tO\\nconfer\\tO\\nno\\tO\\nselective\\tO\\nadvantage\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nHaldanes\\tO\\nprinciple\\tO\\npredicts\\tO\\nthat\\tO\\nnew\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nhprt\\tO\\nlocus\\tO\\nmust\\tO\\noccur\\tO\\nfrequently\\tO\\nin\\tO\\norder\\tO\\nfor\\tO\\nL\\tB-Disease\\n-\\tI-Disease\\nN\\tI-Disease\\nsyndrome\\tI-Disease\\nto\\tO\\nbe\\tO\\nmaintained\\tO\\nin\\tO\\nthe\\tO\\npopulation\\tO\\n.\\tO\\n\\nThis\\tO\\nconstant\\tO\\nintroduction\\tO\\nof\\tO\\nnew\\tO\\nmutations\\tO\\nwould\\tO\\nbe\\tO\\nexpected\\tO\\nto\\tO\\nresult\\tO\\nin\\tO\\na\\tO\\nheterogeneous\\tO\\ncollection\\tO\\nof\\tO\\ngenetic\\tB-Disease\\nlesions\\tI-Disease\\n,\\tO\\nsome\\tO\\nof\\tO\\nwhich\\tO\\nmay\\tO\\nbe\\tO\\nnovel\\tO\\n.\\tO\\n\\nAs\\tO\\nwe\\tO\\nreport\\tO\\nhere\\tO\\n,\\tO\\nthe\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhprt\\tO\\ngene\\tO\\nof\\tO\\nseven\\tO\\nL\\tB-Disease\\n-\\tI-Disease\\nN\\tI-Disease\\npatients\\tO\\n,\\tO\\nselected\\tO\\nfrom\\tO\\nan\\tO\\ninitial\\tO\\nsurvey\\tO\\nof\\tO\\n28\\tO\\npatients\\tO\\n,\\tO\\nhave\\tO\\nbeen\\tO\\ncharacterized\\tO\\nand\\tO\\nall\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ndistinctly\\tO\\ndifferent\\tO\\n,\\tO\\nas\\tO\\npredicted\\tO\\n.\\tO\\n\\nThe\\tO\\norigin\\tO\\nof\\tO\\none\\tO\\nunusual\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nby\\tO\\nanalysis\\tO\\nof\\tO\\nDNA\\tO\\nfrom\\tO\\nfour\\tO\\ngenerations\\tO\\nof\\tO\\nfamily\\tO\\nmembers\\tO\\n.\\tO\\n\\nFurther\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\norigin\\tO\\nof\\tO\\nnew\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nhprt\\tO\\nlocus\\tO\\nshould\\tO\\naid\\tO\\nin\\tO\\nresolving\\tO\\nthe\\tO\\nissue\\tO\\nof\\tO\\nan\\tO\\napparent\\tO\\ndifference\\tO\\nin\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nhprt\\tO\\nmutations\\tO\\nin\\tO\\nmales\\tO\\nand\\tO\\nfemales\\tO\\n\\nAllelic\\tO\\nexclusion\\tO\\nof\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nin\\tO\\nplatelets\\tO\\nand\\tO\\nT\\tO\\nlymphocytes\\tO\\nfrom\\tO\\na\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\ncarrier\\tO\\n.\\tO\\n\\nAn\\tO\\nobligate\\tO\\ncarrier\\tO\\nof\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\nwho\\tO\\nwas\\tO\\nalso\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nA\\tO\\nand\\tO\\nB\\tO\\ntypes\\tO\\nof\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nwas\\tO\\nfound\\tO\\n.\\tO\\n\\nWith\\tO\\nher\\tO\\nit\\tO\\nbecame\\tO\\npossible\\tO\\nto\\tO\\ndetermine\\tO\\nwhether\\tO\\nallelic\\tO\\nexclusion\\tO\\noccurs\\tO\\nin\\tO\\nparticular\\tO\\ncell\\tO\\n-\\tO\\ntypes\\tO\\nof\\tO\\nthe\\tO\\nWAS\\tB-Disease\\ncarrier\\tO\\n.\\tO\\n\\nIf\\tO\\nso\\tO\\n,\\tO\\nthe\\tO\\nremaining\\tO\\ncells\\tO\\nof\\tO\\na\\tO\\nparticular\\tO\\ncell\\tO\\n-\\tO\\ntype\\tO\\nwould\\tO\\nexpress\\tO\\nonly\\tO\\nthe\\tO\\nnormal\\tO\\nX\\tO\\nchromosome\\tO\\nand\\tO\\nonly\\tO\\none\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nisoenzyme\\tO\\nwould\\tO\\nbe\\tO\\ndemonstrable\\tO\\n.\\tO\\n\\nThis\\tO\\ncarrier\\tO\\nhad\\tO\\nonly\\tO\\nthe\\tO\\nB\\tO\\nisoenzyme\\tO\\nof\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nin\\tO\\nplatelets\\tO\\nand\\tO\\nthymus\\tO\\n-\\tO\\nderived\\tO\\nT\\tO\\nlymphocytes\\tO\\n,\\tO\\nalthough\\tO\\nboth\\tO\\nisoenzymes\\tO\\nA\\tO\\nand\\tO\\nB\\tO\\nwere\\tO\\npresent\\tO\\nin\\tO\\nerythrocytes\\tO\\nand\\tO\\nneutrophils\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nselection\\tO\\nagainst\\tO\\nthe\\tO\\nWAS\\tB-Disease\\ngene\\tO\\noccurs\\tO\\nin\\tO\\nplatelets\\tO\\nand\\tO\\nthymus\\tO\\n-\\tO\\nderived\\tO\\nT\\tO\\nlymphocytes\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\ndefects\\tO\\nassociated\\tO\\nwith\\tO\\nWAS\\tB-Disease\\nexpressed\\tO\\nin\\tO\\nthese\\tO\\ncell\\tO\\n-\\tO\\ntypes\\tO\\nmay\\tO\\nbe\\tO\\nimplicated\\tO\\nin\\tO\\nthe\\tO\\ngenesis\\tO\\nof\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nComplement\\tB-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nnephritis\\tB-Disease\\n.\\tO\\n\\nA\\tO\\nreport\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\n.\\tO\\n\\nA\\tO\\nfamily\\tO\\nis\\tO\\ndescribed\\tO\\nin\\tO\\nwhich\\tO\\nthree\\tO\\nchildren\\tO\\nhad\\tO\\nhomozygous\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nC3\\tI-Disease\\nand\\tO\\nin\\tO\\nwhich\\tO\\nboth\\tO\\nparents\\tO\\nand\\tO\\ntwo\\tO\\nother\\tO\\nchildren\\tO\\nwere\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nC3\\tO\\nnull\\tO\\ngene\\tO\\n.\\tO\\n\\nOne\\tO\\nchild\\tO\\nwith\\tO\\nheterozygous\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nmembranoproliferative\\tO\\nglomerulonephritis\\tB-Disease\\n;\\tO\\nproteinuria\\tB-Disease\\nand\\tO\\n/\\tO\\nor\\tO\\nmicroscopical\\tO\\nhaematuria\\tB-Disease\\nwas\\tO\\npresent\\tO\\nin\\tO\\nall\\tO\\nthree\\tO\\nhomozygous\\tO\\nC3\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nchildren\\tO\\n.\\tO\\n\\nAll\\tO\\nchildren\\tO\\nwith\\tO\\nhomozygous\\tO\\nor\\tO\\nheterozygous\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\nwere\\tO\\n,\\tO\\nto\\tO\\na\\tO\\nvarying\\tO\\ndegree\\tO\\n,\\tO\\nsusceptible\\tO\\nto\\tO\\ninfection\\tO\\n.\\tO\\n\\nThe\\tO\\nonly\\tO\\nchild\\tO\\nof\\tO\\nthe\\tO\\nfamily\\tO\\nwith\\tO\\nnormal\\tO\\ncomplement\\tO\\nhad\\tO\\nno\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\ninfection\\tO\\nand\\tO\\nno\\tO\\nrenal\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nfamily\\tO\\nstudy\\tO\\nprovides\\tO\\nfurther\\tO\\nsupport\\tO\\nfor\\tO\\nthe\\tO\\nproposal\\tO\\nthat\\tO\\nC3\\tB-Disease\\ndeficiency\\tI-Disease\\npredisposes\\tO\\nto\\tO\\nnephritis\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nHeterogeneity\\tO\\nof\\tO\\nglucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nAlgeria\\tO\\n.\\tO\\n\\nStudy\\tO\\nin\\tO\\nNorthern\\tO\\nAlgeria\\tO\\nwith\\tO\\ndescription\\tO\\nof\\tO\\nfive\\tO\\nnew\\tO\\nvariants\\tO\\n.\\tO\\n\\nGlucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\nfound\\tO\\nin\\tO\\n3\\tO\\n.\\tO\\n\\n2\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nmale\\tO\\npopulation\\tO\\nliving\\tO\\nin\\tO\\nthe\\tO\\nurban\\tO\\narea\\tO\\nof\\tO\\nAlgiers\\tO\\n.\\tO\\n\\nThe\\tO\\ndeficient\\tO\\nsubjects\\tO\\noriginated\\tO\\nfrom\\tO\\nmultiple\\tO\\ngeographic\\tO\\nregions\\tO\\nof\\tO\\nNorthern\\tO\\nAlgeria\\tO\\n,\\tO\\nwith\\tO\\nprevalence\\tO\\nof\\tO\\nindividuals\\tO\\nof\\tO\\nBerber\\tO\\n-\\tO\\nKabyle\\tO\\norigin\\tO\\n.\\tO\\n\\nRed\\tO\\nblood\\tO\\ncell\\tO\\nG6PD\\tO\\nwas\\tO\\npartially\\tO\\npurified\\tO\\nand\\tO\\ncharacterized\\tO\\nin\\tO\\ndeficient\\tO\\nmales\\tO\\nfrom\\tO\\n17\\tO\\nfamilies\\tO\\n,\\tO\\nand\\tO\\nsix\\tO\\ndifferent\\tO\\nvariants\\tO\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nAmong\\tO\\nthem\\tO\\n,\\tO\\nonly\\tO\\none\\tO\\n,\\tO\\nthe\\tO\\nGd\\tO\\n(\\tO\\n-\\tO\\n)\\tO\\nKabyle\\tO\\nvariant\\tO\\n,\\tO\\nhad\\tO\\nbeen\\tO\\npreviously\\tO\\ndescribed\\tO\\n.\\tO\\n\\nIt\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nnine\\tO\\nfamilies\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nfive\\tO\\nvariants\\tO\\nwere\\tO\\nnew\\tO\\nGd\\tO\\n(\\tO\\n-\\tO\\n)\\tO\\nLaghouat\\tO\\n(\\tO\\nfour\\tO\\ncases\\tO\\n)\\tO\\n,\\tO\\nGd\\tO\\n(\\tO\\n-\\tO\\n)\\tO\\nBlida\\tO\\n(\\tO\\none\\tO\\ncase\\tO\\n)\\tO\\n,\\tO\\nGd\\tO\\n(\\tO\\n-\\tO\\n)\\tO\\nThenia\\tO\\n(\\tO\\none\\tO\\ncase\\tO\\n)\\tO\\n,\\tO\\nGd\\tO\\n(\\tO\\n-\\tO\\n)\\tO\\nTitteri\\tO\\n(\\tO\\none\\tO\\ncase\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nGd\\tO\\n(\\tO\\n-\\tO\\n)\\tO\\nAlger\\tO\\n(\\tO\\ntwo\\tO\\nbrothers\\tO\\n)\\tO\\n.\\tO\\n\\nStrikingly\\tO\\n,\\tO\\nthe\\tO\\ncommon\\tO\\nMediterranean\\tO\\nvariant\\tO\\nwas\\tO\\nnot\\tO\\nfound\\tO\\n.\\tO\\n\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nheterogeneous\\tO\\nin\\tO\\nnorthern\\tO\\nAlgeria\\tO\\nwhere\\tO\\nautochtonous\\tO\\nvariants\\tO\\nseem\\tO\\nto\\tO\\nprevail\\tO\\n.\\tO\\n\\nThe\\tO\\nKabyle\\tO\\nvariant\\tO\\nmay\\tO\\nbe\\tO\\ncommon\\tO\\nin\\tO\\nthis\\tO\\ncountry\\tO\\n.\\tO\\n\\nGlucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\ninhibits\\tO\\nin\\tO\\nvitro\\tO\\ngrowth\\tO\\nof\\tO\\nPlasmodium\\tO\\nfalciparum\\tO\\n.\\tO\\n\\nGlucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n;\\tI-Disease\\nEC\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n1\\tI-Disease\\n.\\tI-Disease\\n49\\tI-Disease\\n)\\tI-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nred\\tO\\nblood\\tO\\ncells\\tO\\nfrom\\tO\\nmale\\tO\\nhemizygotes\\tO\\nand\\tO\\nfemale\\tO\\nheterozygotes\\tO\\nfrom\\tO\\nthe\\tO\\nisland\\tO\\nof\\tO\\nSardinia\\tO\\nwere\\tO\\nstudied\\tO\\nfor\\tO\\ntheir\\tO\\nability\\tO\\nto\\tO\\nsupport\\tO\\ngrowth\\tO\\nin\\tO\\nvitro\\tO\\nof\\tO\\nthe\\tO\\nmalaria\\tB-Disease\\n-\\tO\\ncausing\\tO\\norganism\\tO\\nPlasmodium\\tO\\nfalciparum\\tO\\n.\\tO\\n\\nParasite\\tO\\ngrowth\\tO\\nwas\\tO\\napproximately\\tO\\none\\tO\\n-\\tO\\nthird\\tO\\nof\\tO\\nnormal\\tO\\nin\\tO\\nboth\\tO\\nhemi\\tO\\n-\\tO\\nand\\tO\\nheterozygotes\\tO\\nfor\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nSardinians\\tO\\nwith\\tO\\nthe\\tO\\nbeta\\tO\\n0\\tO\\n-\\tO\\nthalassemia\\tO\\ntrait\\tO\\n,\\tO\\nparasite\\tO\\ngrowth\\tO\\nwas\\tO\\nnormal\\tO\\nexcept\\tO\\nwhen\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\noccurred\\tO\\ntogether\\tO\\nwith\\tO\\nthe\\tO\\nthalassemia\\tB-Disease\\ntrait\\tO\\n.\\tO\\n\\nThe\\tO\\ndata\\tO\\nsupport\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nmay\\tO\\nconfer\\tO\\na\\tO\\nselective\\tO\\nadvantage\\tO\\nin\\tO\\na\\tO\\nmalarious\\tB-Disease\\narea\\tO\\n;\\tO\\nthe\\tO\\nfemale\\tO\\nheterozygote\\tO\\nmay\\tO\\nbe\\tO\\nat\\tO\\na\\tO\\nparticular\\tO\\nadvantage\\tO\\nbecause\\tO\\nresistance\\tO\\nto\\tO\\nmalaria\\tB-Disease\\nequals\\tO\\nthat\\tO\\nof\\tO\\nmale\\tO\\nhemizygotes\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\nfatal\\tB-Disease\\nhemolysis\\tI-Disease\\nmay\\tO\\nbe\\tO\\nless\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nmore\\tO\\nfemale\\tO\\nheterozygotes\\tO\\nmust\\tO\\nbe\\tO\\nstudied\\tO\\nto\\tO\\nconfirm\\tO\\nthis\\tO\\nhypothesis\\tO\\n.\\tO\\n\\nNo\\tO\\nprotective\\tO\\neffect\\tO\\nof\\tO\\nbeta\\tO\\n0\\tO\\n-\\tO\\nthalassemia\\tO\\ntrait\\tO\\ncould\\tO\\nbe\\tO\\ndemonstrated\\tO\\nin\\tO\\nvitro\\tO\\n.\\tO\\n\\nBone\\tO\\nmarrow\\tO\\ntransplant\\tO\\nin\\tO\\nadrenoleukodystrophy\\tB-Disease\\n.\\tO\\n\\nAn\\tO\\nallogeneic\\tO\\nbone\\tO\\nmarrow\\tO\\ntransplant\\tO\\n(\\tO\\nBMT\\tO\\n)\\tO\\nfrom\\tO\\na\\tO\\nnormal\\tO\\nHLA\\tO\\nidentical\\tO\\nsibling\\tO\\ndonor\\tO\\nwas\\tO\\nperformed\\tO\\nin\\tO\\na\\tO\\n13\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nboy\\tO\\nwith\\tO\\nrapidly\\tO\\nprogressive\\tO\\nadrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nEngraftment\\tO\\nand\\tO\\ncomplete\\tO\\nhematologic\\tO\\nrecovery\\tO\\noccurred\\tO\\nwithin\\tO\\n4\\tO\\nweeks\\tO\\n,\\tO\\nbut\\tO\\nneurologic\\tB-Disease\\ndeterioration\\tI-Disease\\ncontinued\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\ndied\\tO\\nof\\tO\\nan\\tO\\nadenovirus\\tB-Disease\\ninfection\\tI-Disease\\n141\\tO\\ndays\\tO\\nafter\\tO\\nBMT\\tO\\n.\\tO\\n\\nALD\\tB-Disease\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nabnormally\\tO\\nhigh\\tO\\nplasma\\tO\\nlevels\\tO\\nof\\tO\\nvery\\tO\\nlong\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\n(\\tO\\nVLCFA\\tO\\n)\\tO\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\nimpaired\\tO\\ncapacity\\tO\\nto\\tO\\ndegrade\\tO\\nthem\\tO\\n.\\tO\\n\\nTen\\tO\\ndays\\tO\\nafter\\tO\\nBMT\\tO\\n,\\tO\\nthe\\tO\\nwhite\\tO\\nblood\\tO\\ncell\\tO\\nVLCFA\\tO\\nlevels\\tO\\nand\\tO\\nenzyme\\tO\\nactivity\\tO\\nbecame\\tO\\nnormal\\tO\\n;\\tO\\nafter\\tO\\n3\\tO\\nmonths\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\nprogressive\\tO\\nreduction\\tO\\nof\\tO\\nplasma\\tO\\nVLCFA\\tO\\nto\\tO\\nlevels\\tO\\nonly\\tO\\nslightly\\tO\\nabove\\tO\\nnormal\\tO\\n.\\tO\\n.\\tO\\n\\n[\\tO\\nGd\\tO\\n-\\tO\\nallele\\tO\\ndistribution\\tO\\npatterns\\tO\\nin\\tO\\nAzerbaijan\\tO\\n.\\tO\\nIII\\tO\\n.\\tO\\nThe\\tO\\nidentification\\tO\\nof\\tO\\nmutant\\tO\\nforms\\tO\\nof\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n]\\tO\\n\\nIn\\tO\\n28\\tO\\nfamilies\\tO\\nwith\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nliving\\tO\\nin\\tO\\n3\\tO\\nsettlements\\tO\\nof\\tO\\nShekii\\tO\\ndistrict\\tO\\nof\\tO\\nAzerbaijan\\tO\\n11\\tO\\nG6PD\\tO\\nvariants\\tO\\nof\\tO\\nII\\tO\\nand\\tO\\nIII\\tO\\nclasses\\tO\\ndiffering\\tO\\nby\\tO\\nkinetic\\tO\\nproperties\\tO\\nwere\\tO\\nidentified\\tO\\naccording\\tO\\nWHO\\tO\\nprogram\\tO\\n.\\tO\\n\\n9\\tO\\nof\\tO\\nthem\\tO\\nare\\tO\\ncharacterized\\tO\\nwith\\tO\\nthe\\tO\\nsame\\tO\\nelectrophoretic\\tO\\nmobility\\tO\\n.\\tO\\n\\nComparison\\tO\\nof\\tO\\nG6PD\\tO\\nspectra\\tO\\nin\\tO\\ntwo\\tO\\nsubpopulations\\tO\\nand\\tO\\nin\\tO\\na\\tO\\nmixed\\tO\\ngroup\\tO\\npermits\\tO\\nto\\tO\\nmake\\tO\\na\\tO\\nconclusion\\tO\\nabout\\tO\\nexistence\\tO\\nof\\tO\\ncommon\\tO\\nand\\tO\\nrare\\tO\\nG6PD\\tO\\nalleles\\tO\\nin\\tO\\nexamined\\tO\\npopulation\\tO\\n.\\tO\\n\\nThey\\tO\\ndistribute\\tO\\nby\\tO\\ngene\\tO\\ndrift\\tO\\nsupported\\tO\\nby\\tO\\nnatural\\tO\\nselection\\tO\\n.\\tO\\n\\nAmong\\tO\\n7\\tO\\nsamples\\tO\\nof\\tO\\nG6PD\\tO\\nwith\\tO\\nnormal\\tO\\nand\\tO\\nincreased\\tO\\nactivity\\tO\\ntwo\\tO\\nnew\\tO\\nvariants\\tO\\nof\\tO\\nIV\\tO\\nclass\\tO\\n-\\tO\\n-\\tO\\nNukha\\tO\\nand\\tO\\nBash\\tO\\n-\\tO\\nKungut\\tO\\n-\\tO\\n-\\tO\\nwere\\tO\\nfound\\tO\\n.\\tO\\n.\\tO\\n\\nAdrenoleukodystrophy\\tB-Disease\\n:\\tO\\nsurvey\\tO\\nof\\tO\\n303\\tO\\ncases\\tO\\n:\\tO\\nbiochemistry\\tO\\n,\\tO\\ndiagnosis\\tO\\n,\\tO\\nand\\tO\\ntherapy\\tO\\n.\\tO\\n\\nAdrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\ngenetically\\tO\\ndetermined\\tO\\ndisorder\\tO\\nassociated\\tO\\nwith\\tO\\nprogressive\\tB-Disease\\ncentral\\tI-Disease\\ndemyelination\\tI-Disease\\nand\\tO\\nadrenal\\tB-Disease\\ncortical\\tI-Disease\\ninsufficiency\\tI-Disease\\n.\\tO\\n\\nAll\\tO\\naffected\\tO\\npersons\\tO\\nshow\\tO\\nincreased\\tO\\nlevels\\tO\\nof\\tO\\nsaturated\\tO\\nunbranched\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\n,\\tO\\nparticularly\\tO\\nhexacosanoate\\tO\\n(\\tO\\nC26\\tO\\n0\\tO\\n)\\tO\\n,\\tO\\nbecause\\tO\\nof\\tO\\nimpaired\\tO\\ncapacity\\tO\\nto\\tO\\ndegrade\\tO\\nthese\\tO\\nacids\\tO\\n.\\tO\\n\\nThis\\tO\\ndegradation\\tO\\nnormally\\tO\\ntakes\\tO\\nplace\\tO\\nin\\tO\\na\\tO\\nsubcellular\\tO\\norganelle\\tO\\ncalled\\tO\\nthe\\tO\\nperoxisome\\tO\\n,\\tO\\nand\\tO\\nALD\\tB-Disease\\n,\\tO\\ntogether\\tO\\nwith\\tO\\nZellwegers\\tB-Disease\\ncerebrohepatorenal\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nis\\tO\\nnow\\tO\\nconsidered\\tO\\nto\\tO\\nbelong\\tO\\nto\\tO\\nthe\\tO\\nnewly\\tO\\nformed\\tO\\ncategory\\tO\\nof\\tO\\nperoxisomal\\tB-Disease\\ndisorders\\tI-Disease\\n.\\tO\\n\\nBiochemical\\tO\\nassays\\tO\\npermit\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nidentification\\tO\\nof\\tO\\nmost\\tO\\nheterozygotes\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\n303\\tO\\npatients\\tO\\nwith\\tO\\nALD\\tB-Disease\\nin\\tO\\n217\\tO\\nkindreds\\tO\\n.\\tO\\n\\nThese\\tO\\npatients\\tO\\nshow\\tO\\na\\tO\\nwide\\tO\\nphenotypic\\tO\\nvariation\\tO\\n.\\tO\\n\\nSixty\\tO\\npercent\\tO\\nof\\tO\\npatients\\tO\\nhad\\tO\\nchildhood\\tO\\nALD\\tB-Disease\\nand\\tO\\n17\\tO\\n%\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n,\\tO\\nboth\\tO\\nof\\tO\\nwhich\\tO\\nare\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\n,\\tO\\nwith\\tO\\nthe\\tO\\ngene\\tO\\nmapped\\tO\\nto\\tO\\nXq28\\tO\\n.\\tO\\n\\nNeonatal\\tB-Disease\\nALD\\tI-Disease\\n,\\tO\\na\\tO\\ndistinct\\tO\\nentity\\tO\\nwith\\tO\\nautosomal\\tO\\nrecessive\\tO\\ninheritance\\tO\\nand\\tO\\npoints\\tO\\nof\\tO\\nresemblance\\tO\\nto\\tO\\nZellwegers\\tB-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\naccounted\\tO\\nfor\\tO\\n7\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ncases\\tO\\n.\\tO\\n\\nAlthough\\tO\\nexcess\\tO\\nC26\\tO\\n0\\tO\\nin\\tO\\nthe\\tO\\nbrain\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nALD\\tB-Disease\\nis\\tO\\npartially\\tO\\nof\\tO\\ndietary\\tO\\norigin\\tO\\n,\\tO\\ndietary\\tO\\nC26\\tO\\n0\\tO\\nrestriction\\tO\\ndid\\tO\\nnot\\tO\\nproduce\\tO\\nclear\\tO\\nbenefit\\tO\\n.\\tO\\n\\nBone\\tO\\nmarrow\\tO\\ntransplant\\tO\\nlowered\\tO\\nthe\\tO\\nplasma\\tO\\nC26\\tO\\n0\\tO\\nlevel\\tO\\nbut\\tO\\nfailed\\tO\\nto\\tO\\narrest\\tO\\nneurological\\tO\\nprogression\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\npolymorphism\\tO\\nof\\tO\\nG6PD\\tO\\nin\\tO\\na\\tO\\nBulgarian\\tO\\npopulation\\tO\\n.\\tO\\n\\nConsiderable\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\nin\\tO\\nG6PD\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nBulgarian\\tO\\npopulation\\tO\\n-\\tO\\n14\\tO\\nG6PD\\tO\\nvariants\\tO\\nisolated\\tO\\nfrom\\tO\\n117\\tO\\nhemizygous\\tO\\ncarriers\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nOf\\tO\\nthese\\tO\\n,\\tO\\nG6PD\\tO\\nMediterranean\\tO\\ntype\\tO\\nwas\\tO\\na\\tO\\npolymorphic\\tO\\nvariant\\tO\\nand\\tO\\nG6PD\\tO\\nCorinth\\tO\\noccurred\\tO\\nwith\\tO\\nhigh\\tO\\nfrequency\\tO\\n.\\tO\\n\\nTwo\\tO\\nnew\\tO\\nvariants\\tO\\nwere\\tO\\nidentified\\tO\\n-\\tO\\nG6PD\\tO\\nRudosem\\tO\\nand\\tO\\nG6PD\\tO\\nNedelino\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nselected\\tO\\ngroup\\tO\\nof\\tO\\n78\\tO\\nsubjects\\tO\\nwith\\tO\\nclinical\\tO\\nmanifestations\\tO\\n,\\tO\\nfour\\tO\\nvariants\\tO\\nwere\\tO\\nestablished\\tO\\nG6PD\\tO\\nMediterranian\\tO\\n,\\tO\\nG6PD\\tO\\nCorinth\\tO\\n,\\tO\\nG6PD\\tO\\nSeattle\\tO\\nand\\tO\\nG6PD\\tO\\nOhut\\tO\\nII\\tO\\n.\\tO\\n.\\tO\\n\\nClinical\\tO\\nuse\\tO\\nof\\tO\\nDNA\\tO\\nmarkers\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nSeventy\\tO\\nfamilies\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\nknown\\tO\\nto\\tO\\nthe\\tO\\nInstitute\\tO\\nof\\tO\\nChild\\tO\\nHealth\\tO\\nfall\\tO\\ninto\\tO\\nthree\\tO\\ncategories\\tO\\nwith\\tO\\nrespect\\tO\\nto\\tO\\npotential\\tO\\nlinkage\\tO\\nanalysis\\tO\\nwith\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\nDNA\\tO\\nmarkers\\tO\\nRC8\\tO\\nand\\tO\\nL1\\tO\\n.\\tO\\n\\n28\\tO\\nthat\\tO\\nbridge\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nFamilies\\tO\\nin\\tO\\nwhich\\tO\\nthere\\tO\\nis\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\nobligatory\\tO\\nfemale\\tO\\nheterozygote\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n13\\tO\\n)\\tO\\n.\\tO\\n\\nHere\\tO\\nprediction\\tO\\nand\\tO\\nexclusion\\tO\\nof\\tO\\nDMD\\tB-Disease\\ngene\\tO\\ntransmission\\tO\\nmay\\tO\\nbe\\tO\\npossible\\tO\\n,\\tO\\nthe\\tO\\naccuracy\\tO\\nbeing\\tO\\ndependent\\tO\\non\\tO\\nthe\\tO\\ncloseness\\tO\\nof\\tO\\nthe\\tO\\nlinkage\\tO\\nof\\tO\\nthe\\tO\\nDNA\\tO\\nmarker\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\nto\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n;\\tO\\nan\\tO\\nillustrative\\tO\\ncase\\tO\\nis\\tO\\nreported\\tO\\n.\\tO\\n\\nFamilies\\tO\\nin\\tO\\nwhich\\tO\\nthere\\tO\\nis\\tO\\na\\tO\\nsingle\\tO\\naffected\\tO\\nboy\\tO\\n,\\tO\\nwho\\tO\\nalso\\tO\\nhas\\tO\\none\\tO\\nor\\tO\\nmore\\tO\\nhealthy\\tO\\nbrothers\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n26\\tO\\n)\\tO\\n.\\tO\\n\\nGiven\\tO\\nan\\tO\\ninformative\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphism\\tO\\n(\\tO\\nRFLP\\tO\\n)\\tO\\n,\\tO\\nthe\\tO\\nprobability\\tO\\nthat\\tO\\nthe\\tO\\nboy\\tO\\nrepresents\\tO\\na\\tO\\nnew\\tO\\nmutation\\tO\\ncan\\tO\\nbe\\tO\\nreassessed\\tO\\n;\\tO\\nit\\tO\\nis\\tO\\nalso\\tO\\npossible\\tO\\nto\\tO\\nexclude\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\nin\\tO\\na\\tO\\nsister\\tO\\n.\\tO\\n\\nFamilies\\tO\\nwith\\tO\\na\\tO\\nsingle\\tO\\naffected\\tO\\nboy\\tO\\nwith\\tO\\nno\\tO\\nbrother\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n30\\tO\\n)\\tO\\n.\\tO\\n\\nHere\\tO\\nexclusion\\tO\\nof\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\nin\\tO\\na\\tO\\nsister\\tO\\nmay\\tO\\nbe\\tO\\npossible\\tO\\n.\\tO\\n\\nOnly\\tO\\nin\\tO\\none\\tO\\nfamily\\tO\\nwas\\tO\\nthere\\tO\\nno\\tO\\npossibility\\tO\\nof\\tO\\nuseful\\tO\\nlinkage\\tO\\nanalysis\\tO\\n.\\tO\\n\\nThe\\tO\\nlinkage\\tO\\nanalysis\\tO\\nrequired\\tO\\nis\\tO\\ndescribed\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nneed\\tO\\nto\\tO\\ncheck\\tO\\nDMD\\tB-Disease\\nfamilies\\tO\\nfor\\tO\\ninformative\\tO\\nRFLPs\\tO\\nis\\tO\\nstressed\\tO\\n.\\tO\\n\\nFamily\\tO\\nstudies\\tO\\nin\\tO\\nBechterew\\tB-Disease\\n\\'\\tI-Disease\\ns\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\n)\\tO\\nIII\\tO\\n.\\tO\\n\\nGenetics\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nof\\tO\\nsegregation\\tO\\nanalyses\\tO\\nin\\tO\\n75\\tO\\nfamilies\\tO\\nwhere\\tO\\nthe\\tO\\nproband\\tO\\nhad\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\n,\\tO\\nare\\tO\\npresented\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\n278\\tO\\nadult\\tO\\n,\\tO\\nliving\\tO\\nfirst\\tO\\ndegree\\tO\\nrelatives\\tO\\n,\\tO\\napproximately\\tO\\n85\\tO\\n%\\tO\\ncooperated\\tO\\nin\\tO\\nthe\\tO\\nstudy\\tO\\n.\\tO\\n\\nClinical\\tO\\nand\\tO\\nradiographical\\tO\\nexaminations\\tO\\nwere\\tO\\nperformed\\tO\\nand\\tO\\nHLA\\tO\\ntyping\\tO\\nwas\\tO\\nconducted\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nwere\\tO\\nin\\tO\\nagreement\\tO\\nwith\\tO\\nour\\tO\\nhypothesis\\tO\\nthat\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\nis\\tO\\npart\\tO\\nof\\tO\\na\\tO\\nsyndrome\\tO\\nwhere\\tO\\ndifferent\\tO\\ngenetic\\tO\\nfactors\\tO\\ninteract\\tO\\n.\\tO\\n\\nSuch\\tO\\nknown\\tO\\nfactors\\tO\\nare\\tO\\nHLA\\tO\\nB27\\tO\\nassociated\\tO\\ndisease\\tO\\nsusceptibility\\tO\\n,\\tO\\nsusceptibility\\tO\\nto\\tO\\npsoriatic\\tB-Disease\\narthropathy\\tI-Disease\\nand\\tO\\nsusceptibility\\tO\\nto\\tO\\nentero\\tB-Disease\\n-\\tI-Disease\\narthropathy\\tI-Disease\\n.\\tO\\n\\nRadiographical\\tO\\nsacro\\tB-Disease\\n-\\tI-Disease\\niliitis\\tI-Disease\\nwas\\tO\\nrestricted\\tO\\nto\\tO\\nHLA\\tO\\nB27\\tO\\npositive\\tO\\nrelatives\\tO\\n,\\tO\\nand\\tO\\nwas\\tO\\nmore\\tO\\nfrequently\\tO\\nfound\\tO\\nin\\tO\\nrelatives\\tO\\nto\\tO\\nprobands\\tO\\nwith\\tO\\npsoriasis\\tB-Disease\\nthan\\tO\\nin\\tO\\nrelatives\\tO\\nto\\tO\\nprobands\\tO\\nwithout\\tO\\npsoriasis\\tB-Disease\\n.\\tO\\n\\nEnvironmental\\tO\\nfactors\\tO\\n(\\tO\\nintestinal\\tO\\nbacteria\\tO\\n)\\tO\\nare\\tO\\nknown\\tO\\nto\\tO\\ntrigger\\tO\\nthe\\tO\\ndisease\\tO\\nat\\tO\\nleast\\tO\\nin\\tO\\nsome\\tO\\npersons\\tO\\n,\\tO\\nand\\tO\\nwe\\tO\\nhave\\tO\\npostulated\\tO\\nthat\\tO\\nall\\tO\\nor\\tO\\nmost\\tO\\nof\\tO\\nthem\\tO\\nhave\\tO\\nthe\\tO\\npredisposition\\tO\\nto\\tO\\ndevelop\\tO\\ndisease\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\nsyndrome\\tO\\nhas\\tO\\na\\tO\\nmultifactorial\\tO\\netiology\\tO\\n.\\tO\\n\\nThe\\tO\\nphenotypic\\tO\\nexpressions\\tO\\nof\\tO\\nthe\\tO\\ndifferent\\tO\\ngenetic\\tO\\npredispositions\\tO\\ninvolved\\tO\\n,\\tO\\ninclude\\tO\\nsacro\\tB-Disease\\n-\\tI-Disease\\niliitis\\tI-Disease\\n,\\tO\\npsoriasis\\tB-Disease\\n,\\tO\\nacute\\tB-Disease\\nanterior\\tI-Disease\\nuveitis\\tI-Disease\\n,\\tO\\nperipheral\\tO\\narthropathy\\tB-Disease\\nand\\tO\\ninflammatory\\tB-Disease\\nbowel\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nsuggest\\tO\\nthe\\tO\\ndescriptive\\tO\\nname\\tO\\nHEREDITARY\\tB-Disease\\nMULTIFOCAL\\tI-Disease\\nRELAPSING\\tI-Disease\\nINFLAMMATION\\tI-Disease\\n(\\tO\\nHEMRI\\tB-Disease\\n)\\tO\\nfor\\tO\\nthis\\tO\\nsyndrome\\tO\\n.\\tO\\n\\nAnkylosing\\tB-Disease\\nspondylitis\\tI-Disease\\n,\\tO\\npsoriatic\\tB-Disease\\narthropathy\\tI-Disease\\nand\\tO\\nentero\\tB-Disease\\n-\\tI-Disease\\narthropathy\\tI-Disease\\nmay\\tO\\nbe\\tO\\nregarded\\tO\\nas\\tO\\nclinical\\tO\\nsub\\tO\\n-\\tO\\ntypes\\tO\\nof\\tO\\nthe\\tO\\nsyndrome\\tO\\n.\\tO\\n.\\tO\\n\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nchromosome\\tO\\n15\\tO\\n.\\tO\\n\\nA\\tO\\nclinical\\tO\\ndiscussion\\tO\\nof\\tO\\n20\\tO\\ncases\\tO\\n.\\tO\\n\\nA\\tO\\nchromosome\\tB-Disease\\n15\\tI-Disease\\nanomaly\\tI-Disease\\nwas\\tO\\nobserved\\tO\\nin\\tO\\n12\\tO\\nof\\tO\\n20\\tO\\npatients\\tO\\n,\\tO\\n17\\tO\\nof\\tO\\nwhom\\tO\\nwere\\tO\\nclinically\\tO\\nsuspected\\tO\\nof\\tO\\nhaving\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nclinical\\tO\\nfeatures\\tO\\nof\\tO\\neight\\tO\\ncases\\tO\\nwith\\tO\\n15q11\\tO\\n-\\tO\\n12\\tO\\ndeletion\\tO\\nwere\\tO\\nvery\\tO\\nsimilar\\tO\\nto\\tO\\nthose\\tO\\noriginally\\tO\\ndescribed\\tO\\nin\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nother\\tO\\nhand\\tO\\n,\\tO\\nthe\\tO\\ngroup\\tO\\nof\\tO\\nnormal\\tO\\nkaryotype\\tO\\npatients\\tO\\nis\\tO\\nheterogeneous\\tO\\n,\\tO\\nand\\tO\\ntheir\\tO\\nfeatures\\tO\\ndo\\tO\\nnot\\tO\\nstrictly\\tO\\ncorrespond\\tO\\nto\\tO\\nthe\\tO\\nclinical\\tO\\ndefinition\\tO\\nof\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nPWS\\tB-Disease\\nis\\tO\\nassociated\\tO\\nwith\\tO\\ndeletion\\tO\\nof\\tO\\n15q11\\tO\\n-\\tO\\n12\\tO\\ncan\\tO\\nneither\\tO\\nexplain\\tO\\nthe\\tO\\napparently\\tO\\nbalanced\\tO\\ntranslocations\\tO\\nof\\tO\\nchromosome\\tO\\n15\\tO\\nnor\\tO\\naccount\\tO\\nfor\\tO\\nthe\\tO\\nsmall\\tO\\nsupernumerary\\tO\\nmetacentric\\tO\\nchromosomes\\tO\\ncorresponding\\tO\\nto\\tO\\nan\\tO\\nisochromosome\\tO\\n15\\tO\\nfor\\tO\\nband\\tO\\n15q11\\tO\\nobserved\\tO\\nin\\tO\\nsome\\tO\\ncases\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\ngene\\tO\\nin\\tO\\nNorth\\tO\\nAmerican\\tO\\nJewish\\tO\\npopulations\\tO\\n:\\tO\\ngeographic\\tO\\nvariations\\tO\\nand\\tO\\norigin\\tO\\n.\\tO\\n\\nFrom\\tO\\ndata\\tO\\ncollected\\tO\\nin\\tO\\na\\tO\\nNorth\\tO\\nAmerican\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\nheterozygote\\tO\\nscreening\\tO\\nprogram\\tO\\n,\\tO\\nthe\\tO\\nTSD\\tB-Disease\\ncarrier\\tO\\nfrequency\\tO\\namong\\tO\\n46\\tO\\n,\\tO\\n304\\tO\\nJewish\\tO\\nindividuals\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\n.\\tO\\n\\n0324\\tO\\n(\\tO\\n1\\tO\\nin\\tO\\n31\\tO\\nindividuals\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nfrequency\\tO\\nis\\tO\\nconsistent\\tO\\nwith\\tO\\nearlier\\tO\\nestimates\\tO\\nbased\\tO\\non\\tO\\nTSD\\tB-Disease\\nincidence\\tO\\ndata\\tO\\n.\\tO\\n\\nTSD\\tB-Disease\\ncarrier\\tO\\nfrequencies\\tO\\nwere\\tO\\nthen\\tO\\nexamined\\tO\\nby\\tO\\nsingle\\tO\\ncountry\\tO\\nand\\tO\\nsingle\\tO\\nregion\\tO\\nof\\tO\\norigin\\tO\\nin\\tO\\n28\\tO\\n,\\tO\\n029\\tO\\nJews\\tO\\nwithin\\tO\\nthis\\tO\\nsample\\tO\\nfor\\tO\\nwhom\\tO\\nsuch\\tO\\ndata\\tO\\nwere\\tO\\navailable\\tO\\nfor\\tO\\nanalysis\\tO\\n.\\tO\\n\\nJews\\tO\\nwith\\tO\\nPolish\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nRussian\\tO\\nancestry\\tO\\nconstituted\\tO\\n88\\tO\\n%\\tO\\nof\\tO\\nthis\\tO\\nsample\\tO\\nand\\tO\\nhad\\tO\\na\\tO\\nTSD\\tB-Disease\\ncarrier\\tO\\nfrequency\\tO\\nof\\tO\\n.\\tO\\n\\n0327\\tO\\n.\\tO\\n\\nNo\\tO\\nTSD\\tB-Disease\\ncarriers\\tO\\nwere\\tO\\nobserved\\tO\\namong\\tO\\nthe\\tO\\n166\\tO\\nJews\\tO\\nof\\tO\\nNear\\tO\\nEastern\\tO\\norigins\\tO\\n.\\tO\\n\\nRelative\\tO\\nto\\tO\\nJews\\tO\\nof\\tO\\nPolish\\tO\\nand\\tO\\nRussian\\tO\\norigins\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\nat\\tO\\nleast\\tO\\na\\tO\\ntwofold\\tO\\nincrease\\tO\\nin\\tO\\nthe\\tO\\nTSD\\tB-Disease\\ncarrier\\tO\\nfrequency\\tO\\nin\\tO\\nJews\\tO\\nof\\tO\\nAustrian\\tO\\n,\\tO\\nHungarian\\tO\\n,\\tO\\nand\\tO\\nCzechoslovakian\\tO\\norigins\\tO\\n(\\tO\\nP\\tO\\nless\\tO\\nthan\\tO\\n.\\tO\\n005\\tO\\n)\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nTSD\\tB-Disease\\ngene\\tO\\nproliferated\\tO\\namong\\tO\\nthe\\tO\\nantecedents\\tO\\nof\\tO\\nmodern\\tO\\nAshkenazi\\tO\\nJewry\\tO\\nafter\\tO\\nthe\\tO\\nSecond\\tO\\nDiaspora\\tO\\n(\\tO\\n70\\tO\\nA\\tO\\n.\\tO\\nD\\tO\\n.\\tO\\n)\\tO\\nand\\tO\\nbefore\\tO\\ntheir\\tO\\nmajor\\tO\\nmigrations\\tO\\nto\\tO\\nregions\\tO\\nof\\tO\\nPoland\\tO\\nand\\tO\\nRussia\\tO\\n(\\tO\\nbefore\\tO\\n1100\\tO\\nA\\tO\\n.\\tO\\nD\\tO\\n.\\tO\\n)\\tO\\n.\\tO\\n\\nHuman\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nsixth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nmeningococcal\\tB-Disease\\nmeningitis\\tI-Disease\\nand\\tO\\nno\\tO\\nhaemostasis\\tB-Disease\\nabnormality\\tI-Disease\\n.\\tO\\n\\nA\\tO\\ncase\\tO\\nof\\tO\\nhuman\\tO\\ncomplete\\tO\\nC6\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nreported\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\n,\\tO\\na\\tO\\n31\\tO\\nyear\\tO\\nold\\tO\\nwhite\\tO\\nmale\\tO\\n,\\tO\\nwas\\tO\\nseen\\tO\\non\\tO\\nthe\\tO\\noccasion\\tO\\nof\\tO\\nan\\tO\\nisolated\\tO\\nepisode\\tO\\nof\\tO\\nmeningococcal\\tB-Disease\\nmeningitis\\tI-Disease\\n.\\tO\\n\\nSerum\\tO\\ncomplement\\tO\\nhemolytic\\tO\\nand\\tO\\nbactericidal\\tO\\nactivities\\tO\\nwere\\tO\\nlacking\\tO\\nand\\tO\\ncould\\tO\\nbe\\tO\\nrestored\\tO\\nto\\tO\\nnormal\\tO\\nby\\tO\\naddition\\tO\\nof\\tO\\nappropriate\\tO\\namounts\\tO\\nof\\tO\\npurified\\tO\\nC6\\tO\\n.\\tO\\n\\nNo\\tO\\nhemostatic\\tB-Disease\\nabnormalities\\tI-Disease\\nwere\\tO\\nobserved\\tO\\n.\\tO\\n.\\tO\\n\\nAbsence\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nseventh\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nchronic\\tB-Disease\\nmeningococcemia\\tI-Disease\\npresenting\\tO\\nas\\tO\\nvasculitis\\tB-Disease\\n.\\tO\\n\\nA\\tO\\npreviously\\tO\\nhealthy\\tO\\n40\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nman\\tO\\npresenting\\tO\\nwith\\tO\\nfever\\tB-Disease\\n,\\tO\\narthritis\\tB-Disease\\n,\\tO\\nand\\tO\\ncutaneous\\tB-Disease\\nvasculitis\\tI-Disease\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nchronic\\tB-Disease\\nmeningococcemia\\tI-Disease\\n.\\tO\\n\\nEvaluation\\tO\\nof\\tO\\nhis\\tO\\ncomplement\\tO\\nsystem\\tO\\nshowed\\tO\\nan\\tO\\nabsence\\tO\\nof\\tO\\nfunctional\\tO\\nand\\tO\\nantigenic\\tO\\nC7\\tO\\n,\\tO\\ncompatible\\tO\\nwith\\tO\\na\\tO\\ncomplete\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nseventh\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n.\\tO\\n\\nStudy\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nfamily\\tO\\nspanning\\tO\\nfour\\tO\\ngenerations\\tO\\nshowed\\tO\\nheterozygous\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nC7\\tI-Disease\\nin\\tO\\nfive\\tO\\nmembers\\tO\\n.\\tO\\n\\nChronic\\tB-Disease\\nneisserial\\tI-Disease\\ninfection\\tI-Disease\\ncan\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nmust\\tO\\nbe\\tO\\ndistinguished\\tO\\nfrom\\tO\\nother\\tO\\ncauses\\tO\\nof\\tO\\ncutaneous\\tB-Disease\\nvasculitis\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\ndiscoid\\tI-Disease\\nlupus\\tI-Disease\\nerythematosus\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nheterozygote\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nTwo\\tO\\nsiblings\\tO\\nwith\\tO\\nchronic\\tB-Disease\\ndiscoid\\tI-Disease\\nlupus\\tI-Disease\\nerythematosus\\tI-Disease\\nand\\tO\\nseveral\\tO\\nfamily\\tO\\nmembers\\tO\\nwere\\tO\\nfound\\tO\\nwith\\tO\\nheterozygous\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nAn\\tO\\nassociation\\tO\\nwith\\tO\\nhistocompatibility\\tO\\nmarkers\\tO\\nHLA\\tO\\n-\\tO\\nB18\\tO\\nand\\tO\\nHLA\\tO\\n-\\tO\\nDw2\\tO\\nwas\\tO\\ndemonstrated\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nslow\\tO\\nallotype\\tO\\nof\\tO\\nfactor\\tO\\nB\\tO\\nwas\\tO\\npresent\\tO\\n.\\tO\\n\\nLinkage\\tO\\nstudies\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nsuggested\\tO\\na\\tO\\nclose\\tO\\nlinkage\\tO\\nbetween\\tO\\nthe\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\ngene\\tO\\nand\\tO\\ngenes\\tO\\ncoding\\tO\\nfor\\tO\\nB18\\tO\\n,\\tO\\nDw2\\tO\\n,\\tO\\nand\\tO\\nBfS\\tO\\nantigens\\tO\\n.\\tO\\n\\nOne\\tO\\nHLA\\tO\\n-\\tO\\nACB\\tO\\n/\\tO\\nDBf\\tO\\nrecombinant\\tO\\nwas\\tO\\nobserved\\tO\\nshowing\\tO\\ncloser\\tO\\nlinkage\\tO\\nbetween\\tO\\nHLA\\tO\\n-\\tO\\nD\\tO\\nand\\tO\\nBf\\tO\\nthan\\tO\\nbetween\\tO\\nHLA\\tO\\n-\\tO\\nB\\tO\\nand\\tO\\nBf\\tO\\n.\\tO\\n.\\tO\\n\\nSevere\\tB-Disease\\n-\\tI-Disease\\nglucose\\tI-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nchronic\\tO\\nhemolytic\\tB-Disease\\nanemia\\tI-Disease\\n,\\tO\\ngranulocyte\\tB-Disease\\ndysfunction\\tI-Disease\\n,\\tO\\nand\\tO\\nincreased\\tO\\nsusceptibility\\tO\\nto\\tO\\ninfections\\tO\\n:\\tO\\ndescription\\tO\\nof\\tO\\na\\tO\\nnew\\tO\\nmolecular\\tO\\nvariant\\tO\\n(\\tO\\nG6PD\\tO\\nBarcelona\\tO\\n)\\tO\\n.\\tO\\n\\nMolecular\\tO\\n,\\tO\\nkinetic\\tO\\n,\\tO\\nand\\tO\\nfunctional\\tO\\nstudies\\tO\\nwere\\tO\\ncarried\\tO\\nout\\tO\\non\\tO\\nerythrocytes\\tO\\nand\\tO\\nleukocytes\\tO\\nin\\tO\\na\\tO\\nSpanish\\tO\\nmale\\tO\\nwith\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\ncongenital\\tB-Disease\\nnonspherocytic\\tI-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\n(\\tO\\nCNSHA\\tB-Disease\\n)\\tO\\n,\\tO\\nand\\tO\\nincreased\\tO\\nsusceptibility\\tO\\nto\\tO\\ninfections\\tO\\n.\\tO\\n\\nG6PD\\tO\\nactivity\\tO\\nwas\\tO\\nabsent\\tO\\nin\\tO\\npatients\\tO\\nred\\tO\\ncells\\tO\\nand\\tO\\nwas\\tO\\nabout\\tO\\n2\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\nin\\tO\\nleukocytes\\tO\\n.\\tO\\n\\nMolecular\\tO\\nstudies\\tO\\nusing\\tO\\nstandard\\tO\\nmethods\\tO\\n(\\tO\\nWHO\\tO\\n,\\tO\\n1967\\tO\\n)\\tO\\nshowed\\tO\\nG6PD\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nslightly\\tO\\nfast\\tO\\nelectrophoretic\\tO\\nmobility\\tO\\nat\\tO\\npH\\tO\\n8\\tO\\n.\\tO\\n\\n0\\tO\\nwith\\tO\\notherwise\\tO\\nnormal\\tO\\nproperties\\tO\\n(\\tO\\nheat\\tO\\nstability\\tO\\nat\\tO\\n46\\tO\\ndegrees\\tO\\nC\\tO\\n,\\tO\\napparent\\tO\\naffinity\\tO\\nfor\\tO\\nsubstrates\\tO\\n,\\tO\\noptimum\\tO\\npH\\tO\\n,\\tO\\nand\\tO\\nutilization\\tO\\nof\\tO\\nsubstrate\\tO\\nanalogues\\tO\\n)\\tO\\n.\\tO\\n\\nOther\\tO\\ntests\\tO\\nshowed\\tO\\nthe\\tO\\npatients\\tO\\ngranulocytes\\tO\\nto\\tO\\nengulf\\tO\\nlatex\\tO\\nparticles\\tO\\nnormally\\tO\\n,\\tO\\nbut\\tO\\nto\\tO\\nhave\\tO\\nimpaired\\tO\\nreduction\\tO\\nof\\tO\\nnitroblue\\tO\\ntetrazolium\\tO\\nand\\tO\\nferricytochrome\\tO\\n-\\tO\\nc\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nreduced\\tO\\niodination\\tO\\n.\\tO\\n\\nChemotaxis\\tO\\nand\\tO\\nrandom\\tO\\nmigration\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\ngranulocytes\\tO\\nwere\\tO\\nnormal\\tO\\nas\\tO\\nwere\\tO\\nmyeloperoxidase\\tO\\n,\\tO\\nleukocyte\\tO\\nalkaline\\tO\\nphosphatase\\tO\\n(\\tO\\nLAP\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nultrastructural\\tO\\nfeatures\\tO\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\ncharacteristics\\tO\\nof\\tO\\nG6PD\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\ndiffered\\tO\\nfrom\\tO\\nthose\\tO\\nof\\tO\\nall\\tO\\npreviously\\tO\\nreported\\tO\\nvariants\\tO\\nassociated\\tO\\nwith\\tO\\nCNSHA\\tB-Disease\\n,\\tO\\nso\\tO\\nthe\\tO\\npresent\\tO\\nvariant\\tO\\nwas\\tO\\nprovisionally\\tO\\ncalled\\tO\\nG6PD\\tO\\nBarcelona\\tO\\nto\\tO\\ndistinguish\\tO\\nit\\tO\\nfrom\\tO\\nother\\tO\\nG6PD\\tO\\nvariants\\tO\\npreviously\\tO\\ndescribed\\tO\\n.\\tO\\n\\nPossible\\tO\\nmechanisms\\tO\\nfor\\tO\\nthe\\tO\\nsevere\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nG6PD\\tI-Disease\\nin\\tO\\nerythrocytes\\tO\\nand\\tO\\ngranulocytes\\tO\\nwas\\tO\\ninvestigated\\tO\\nby\\tO\\nstudies\\tO\\non\\tO\\nthe\\tO\\nimmunologic\\tO\\nspecific\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nenzyme\\tO\\n.\\tO\\n\\nGlucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nPapua\\tO\\nNew\\tO\\nGuinea\\tO\\n.\\tO\\n\\nThe\\tO\\ndescription\\tO\\nof\\tO\\n13\\tO\\nnew\\tO\\nvariants\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n362\\tO\\nmales\\tO\\nfrom\\tO\\nvarious\\tO\\nregions\\tO\\nof\\tO\\nPapua\\tO\\nNew\\tO\\nGuinea\\tO\\nwere\\tO\\nscreened\\tO\\nfor\\tO\\nred\\tO\\ncell\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nactivity\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\nsix\\tO\\nG6PD\\tB-Disease\\ndeficient\\tI-Disease\\nindividuals\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nBiochemical\\tO\\ncharacterization\\tO\\nof\\tO\\nG6PD\\tO\\npurified\\tO\\nfrom\\tO\\nthese\\tO\\nsubjects\\tO\\nhas\\tO\\nrevealed\\tO\\n13\\tO\\nnew\\tO\\nvariants\\tO\\nand\\tO\\nseveral\\tO\\ncopies\\tO\\nof\\tO\\npreviously\\tO\\ndescribed\\tO\\nforms\\tO\\nof\\tO\\nG6PD\\tO\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\nillustrates\\tO\\nthe\\tO\\nextreme\\tO\\nheterogeneity\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\namong\\tO\\nthe\\tO\\npeople\\tO\\nof\\tO\\nPapua\\tO\\nNew\\tO\\nGuinea\\tO\\n.\\tO\\n.\\tO\\n\\nHeterogeneity\\tO\\nof\\tO\\n\"\\tO\\nMediterranean\\tO\\ntype\\tO\\n\"\\tO\\nglucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nSpain\\tO\\nand\\tO\\ndescription\\tO\\nof\\tO\\ntwo\\tO\\nnew\\tO\\nvariants\\tO\\nassociated\\tO\\nwith\\tO\\nfavism\\tB-Disease\\n.\\tO\\n\\nGlucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\n;\\tO\\nEC\\tO\\n1\\tO\\n.\\tO\\n\\n1\\tO\\n.\\tO\\n\\n1\\tO\\n.\\tO\\n\\n49\\tO\\nfrom\\tO\\nthirty\\tO\\n-\\tO\\nsix\\tO\\nunrelated\\tO\\nSpanish\\tO\\nmales\\tO\\nwas\\tO\\npartially\\tO\\npurified\\tO\\nfrom\\tO\\nblood\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nvariants\\tO\\nwere\\tO\\ncharacterized\\tO\\nbiochemically\\tO\\nand\\tO\\nelectrophoretically\\tO\\naccording\\tO\\nto\\tO\\nthe\\tO\\nmethods\\tO\\nrecommended\\tO\\nby\\tO\\nthe\\tO\\nworld\\tO\\nHealth\\tO\\nOrganization\\tO\\n.\\tO\\n\\nSubjects\\tO\\nwere\\tO\\nfrom\\tO\\nmultiple\\tO\\ngeographic\\tO\\nregions\\tO\\nwithin\\tO\\nSpain\\tO\\n,\\tO\\nand\\tO\\nall\\tO\\nsuffered\\tO\\nfrom\\tO\\nhemolytic\\tB-Disease\\nanemia\\tI-Disease\\n,\\tO\\neither\\tO\\nacute\\tO\\n(\\tO\\n34\\tO\\ncases\\tO\\n)\\tO\\nor\\tO\\nchronic\\tO\\nnonspherocytic\\tO\\n(\\tO\\n2\\tO\\ncases\\tO\\n)\\tO\\n.\\tO\\n\\nAlmost\\tO\\nall\\tO\\nthe\\tO\\nvariants\\tO\\nstudied\\tO\\npresented\\tO\\nresidual\\tO\\nerythrocyte\\tO\\nG6PD\\tO\\nactivity\\tO\\nranging\\tO\\nfrom\\tO\\n0\\tO\\nto\\tO\\n10\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\n,\\tO\\nand\\tO\\nfive\\tO\\ndifferent\\tO\\nmutants\\tO\\nwere\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\ndeficient\\tO\\nphenotype\\tO\\n.\\tO\\n\\nThree\\tO\\nvariants\\tO\\nwere\\tO\\nsimilar\\tO\\nto\\tO\\nothers\\tO\\npreviously\\tO\\ndescribed\\tO\\nG6PD\\tO\\nMediterranean\\tO\\n(\\tO\\n11\\tO\\ncases\\tO\\n)\\tO\\n,\\tO\\nG6PD\\tO\\nAthens\\tO\\n-\\tO\\nlike\\tO\\n(\\tO\\n3\\tO\\ncases\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nG6PD\\tO\\nUnion\\tO\\n(\\tO\\n2\\tO\\ncases\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nremaining\\tO\\nvariants\\tO\\nwere\\tO\\ndifferent\\tO\\nfrom\\tO\\nthe\\tO\\nnumerous\\tO\\nvariants\\tO\\nalready\\tO\\nreported\\tO\\nand\\tO\\nhave\\tO\\nbeen\\tO\\nconsidered\\tO\\nas\\tO\\nnew\\tO\\nmutants\\tO\\n.\\tO\\n\\nProvisionally\\tO\\nthey\\tO\\nare\\tO\\ncalled\\tO\\nG6PD\\tO\\nBetica\\tO\\n(\\tO\\n19\\tO\\ncases\\tO\\n)\\tO\\nand\\tO\\nG6PD\\tO\\nMenorca\\tO\\n(\\tO\\n1\\tO\\ncase\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nstudy\\tO\\nconstitutes\\tO\\nthe\\tO\\nfirst\\tO\\nattempt\\tO\\nto\\tO\\ncharacterize\\tO\\nthe\\tO\\ndeficient\\tB-Disease\\nG6PD\\tI-Disease\\nvariants\\tO\\nfound\\tO\\nin\\tO\\nSpain\\tO\\nand\\tO\\nsupplies\\tO\\nnew\\tO\\ndata\\tO\\non\\tO\\nthe\\tO\\nrelationship\\tO\\nbetween\\tO\\nmolecular\\tO\\ncharacteristics\\tO\\nof\\tO\\ndeficient\\tO\\nvariants\\tO\\nand\\tO\\ntheir\\tO\\nclinical\\tO\\nmanifestations\\tO\\n.\\tO\\n\\nThe\\tO\\nmost\\tO\\nimportant\\tO\\nfindings\\tO\\ncan\\tO\\nbe\\tO\\nsummarized\\tO\\nas\\tO\\nfollows\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nThe\\tO\\nSpanish\\tO\\npopulation\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nan\\tO\\nimportant\\tO\\nheterogeneity\\tO\\nin\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\n(\\tO\\n2\\tO\\n)\\tO\\nAlthough\\tO\\nG6PD\\tO\\nMediterranean\\tO\\nis\\tO\\nvery\\tO\\nfrequent\\tO\\n,\\tO\\nit\\tO\\npresents\\tO\\na\\tO\\nrelatively\\tO\\nhigh\\tO\\ndegree\\tO\\nof\\tO\\npolymorphism\\tO\\n.\\tO\\n\\n(\\tO\\n3\\tO\\n)\\tO\\nFavism\\tB-Disease\\nhas\\tO\\nbeen\\tO\\nobserved\\tO\\nassociated\\tO\\nwith\\tO\\nall\\tO\\nkinds\\tO\\nof\\tO\\nvariants\\tO\\ndescribed\\tO\\nhere\\tO\\n.\\tO\\n\\n(\\tO\\n4\\tO\\n)\\tO\\nG6PD\\tO\\nBetica\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\nfrequent\\tO\\nvariant\\tO\\nfound\\tO\\nin\\tO\\nsubjects\\tO\\nof\\tO\\nSouthern\\tO\\nSpanish\\tO\\norigin\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nobserved\\tO\\nassociated\\tO\\nwith\\tO\\nfavism\\tB-Disease\\nin\\tO\\nall\\tO\\ncases\\tO\\nexcept\\tO\\none\\tO\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nvariant\\tO\\n(\\tO\\nG6PD\\tO\\nNagano\\tO\\n)\\tO\\nassociated\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nvariant\\tO\\nassociated\\tO\\nwith\\tO\\nchronic\\tB-Disease\\nnonspherocytic\\tI-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\nwas\\tO\\nreported\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\n,\\tO\\na\\tO\\n6\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nJapanese\\tO\\nmale\\tO\\n,\\tO\\nwas\\tO\\nnoticed\\tO\\nto\\tO\\nhave\\tO\\nhemolytic\\tB-Disease\\nanemia\\tI-Disease\\nsoon\\tO\\nafter\\tO\\nbirth\\tO\\n,\\tO\\nand\\tO\\na\\tO\\ndiagnosis\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\nmade\\tO\\nat\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\n2\\tO\\n.\\tO\\n\\nHe\\tO\\nhad\\tO\\nepisodes\\tO\\nof\\tO\\nhemolytic\\tB-Disease\\ncrisis\\tI-Disease\\nseveral\\tO\\ntimes\\tO\\nafter\\tO\\nupper\\tB-Disease\\nrespiratory\\tI-Disease\\ninfection\\tI-Disease\\n.\\tO\\n\\nG6PD\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\npatient\\tO\\nwas\\tO\\n5\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\n.\\tO\\n\\nThe\\tO\\nenzymatic\\tO\\ncharacteristics\\tO\\nwere\\tO\\nexamined\\tO\\nwhen\\tO\\nhe\\tO\\nwas\\tO\\n5\\tO\\nyears\\tO\\nold\\tO\\n,\\tO\\nand\\tO\\nhis\\tO\\nG6PD\\tO\\nshowed\\tO\\nfaster\\tO\\n-\\tO\\nthan\\tO\\n-\\tO\\nnormal\\tO\\nelectrophoretic\\tO\\nmobility\\tO\\n,\\tO\\nlow\\tO\\nKm\\tO\\nG6P\\tO\\n,\\tO\\nhigh\\tO\\nKm\\tO\\nNADP\\tO\\n,\\tO\\nlow\\tO\\nKi\\tO\\nNADPH\\tO\\n,\\tO\\nnormal\\tO\\nutilization\\tO\\nof\\tO\\nsubstrate\\tO\\nanalogues\\tO\\n,\\tO\\nheat\\tO\\ninstability\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nnormal\\tO\\npH\\tO\\noptimum\\tO\\ncurve\\tO\\n.\\tO\\n\\nFrom\\tO\\nthese\\tO\\nresults\\tO\\n,\\tO\\nthis\\tO\\nwas\\tO\\nconsidered\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nnew\\tO\\nvariant\\tO\\nand\\tO\\nwas\\tO\\ndesignated\\tO\\nG6PD\\tO\\nNagano\\tO\\n.\\tO\\n\\nInfection\\tO\\n-\\tO\\ninduced\\tO\\nhemolysis\\tB-Disease\\nand\\tO\\nchronic\\tB-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\nseem\\tO\\nto\\tO\\nbe\\tO\\ndue\\tO\\nto\\tO\\nmarkedly\\tO\\nimpaired\\tO\\nenzyme\\tO\\nactivity\\tO\\nand\\tO\\nthermal\\tO\\ninstability\\tO\\n.\\tO\\n\\nHeterozygous\\tO\\nC2\\tB-Disease\\n-\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nmyasthenia\\tB-Disease\\ngravis\\tI-Disease\\n.\\tO\\n\\nComplement\\tB-Disease\\ndeficiency\\tI-Disease\\nstates\\tO\\nin\\tO\\nmyasthenia\\tB-Disease\\ngravis\\tI-Disease\\n(\\tO\\nMG\\tB-Disease\\n)\\tO\\nhave\\tO\\nnot\\tO\\nbeen\\tO\\nreported\\tO\\npreviously\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\na\\tO\\n19\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nwoman\\tO\\nwith\\tO\\ntypical\\tO\\nMG\\tB-Disease\\nand\\tO\\nheterozygous\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nalong\\tO\\nwith\\tO\\nHLA\\tO\\ntyping\\tO\\nof\\tO\\nthe\\tO\\npatient\\tO\\nand\\tO\\nher\\tO\\nimmediate\\tO\\nfamily\\tO\\n.\\tO\\n.\\tO\\n\\nAdrenoleukodystrophy\\tB-Disease\\n:\\tO\\nincreased\\tO\\nplasma\\tO\\ncontent\\tO\\nof\\tO\\nsaturated\\tO\\nvery\\tO\\nlong\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\n.\\tO\\n\\nWith\\tO\\na\\tO\\nnew\\tO\\nmethod\\tO\\nwe\\tO\\nmeasured\\tO\\nthe\\tO\\nsaturated\\tO\\nvery\\tO\\nlong\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\nin\\tO\\nthe\\tO\\nplasma\\tO\\nof\\tO\\nadrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\nhemizygotes\\tO\\n,\\tO\\nALD\\tB-Disease\\nheterozygotes\\tO\\n,\\tO\\nand\\tO\\ncontrols\\tO\\n.\\tO\\n\\nALD\\tB-Disease\\nhemizygotes\\tO\\nshowed\\tO\\nincreased\\tO\\nlevels\\tO\\nof\\tO\\nhexacosanoate\\tO\\n(\\tO\\nC26\\tO\\nfatty\\tO\\nacid\\tO\\n)\\tO\\nwhich\\tO\\nrepresented\\tO\\n0\\tO\\n.\\tO\\n\\n081\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n\\n0066\\tO\\n%\\tO\\n(\\tO\\nSEM\\tO\\n)\\tO\\nof\\tO\\ntotal\\tO\\nfatty\\tO\\nacids\\tO\\n,\\tO\\ncompared\\tO\\nto\\tO\\n0\\tO\\n.\\tO\\n\\n015\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n\\n0032\\tO\\n%\\tO\\nin\\tO\\nthe\\tO\\ncontrols\\tO\\n.\\tO\\n\\nC25\\tO\\n,\\tO\\nC24\\tO\\n,\\tO\\nand\\tO\\nC23\\tO\\nfatty\\tO\\nacids\\tO\\nwere\\tO\\nalso\\tO\\nincreased\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nC22\\tO\\nand\\tO\\nC20\\tO\\nfatty\\tO\\nacids\\tO\\nwere\\tO\\nnormal\\tO\\n.\\tO\\n\\nC26\\tO\\nlevels\\tO\\nwere\\tO\\nalso\\tO\\nincreased\\tO\\nin\\tO\\nmost\\tO\\nALD\\tB-Disease\\nheterozygotes\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\nmean\\tO\\nlevel\\tO\\n0\\tO\\n.\\tO\\n\\n057\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n\\n0063\\tO\\n%\\tO\\nof\\tO\\ntotal\\tO\\nfatty\\tO\\nacids\\tO\\n.\\tO\\n\\nThe\\tO\\ntechnique\\tO\\ncan\\tO\\nbe\\tO\\nused\\tO\\nfor\\tO\\ndiagnosis\\tO\\nand\\tO\\ncarrier\\tO\\nidentification\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\nthe\\tO\\nevaluation\\tO\\nof\\tO\\ntherapy\\tO\\n.\\tO\\n\\nAbnormal\\tO\\nhigh\\tO\\ndensity\\tO\\nlipoproteins\\tO\\nin\\tO\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nplasma\\tO\\nlipoprotein\\tO\\nprofiles\\tO\\nand\\tO\\nhigh\\tO\\ndensity\\tO\\nlipoproteins\\tO\\n(\\tO\\nHDL\\tO\\n)\\tO\\nwere\\tO\\ncharacterized\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\ngenetic\\tB-Disease\\ndisease\\tI-Disease\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n(\\tO\\nCTX\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nAbnormalities\\tB-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\nHDL\\tI-Disease\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\ntheir\\tO\\nincreased\\tO\\natherogenesis\\tO\\nand\\tO\\nexcessive\\tO\\ndeposits\\tO\\nof\\tO\\ntissue\\tO\\nsterols\\tO\\nin\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nlow\\tO\\nor\\tO\\nlow\\tO\\n-\\tO\\nnormal\\tO\\nconcentrations\\tO\\nof\\tO\\nplasma\\tO\\ncholesterol\\tO\\n(\\tO\\n165\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n25\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n)\\tO\\nand\\tO\\nlow\\tO\\ndensity\\tO\\nlipoproteins\\tO\\n(\\tO\\nLDL\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmean\\tO\\nHDL\\tO\\n-\\tO\\ncholesterol\\tO\\nconcentration\\tO\\nin\\tO\\nthe\\tO\\nCTX\\tB-Disease\\nplasmas\\tO\\nwas\\tO\\n14\\tO\\n.\\tO\\n\\n5\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n3\\tO\\n.\\tO\\n\\n2\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n,\\tO\\nabout\\tO\\none\\tO\\n-\\tO\\nthird\\tO\\nthe\\tO\\nnormal\\tO\\nvalue\\tO\\n.\\tO\\n\\nThe\\tO\\nlow\\tO\\nHDL\\tO\\n-\\tO\\ncholesterol\\tO\\nreflects\\tO\\na\\tO\\nlow\\tO\\nconcentration\\tO\\nand\\tO\\nan\\tO\\nabnormal\\tO\\nlipid\\tO\\ncomposition\\tO\\nof\\tO\\nthe\\tO\\nplasma\\tO\\nHDL\\tO\\n.\\tO\\n\\nRelative\\tO\\nto\\tO\\nnormal\\tO\\nHDL\\tO\\n,\\tO\\nthe\\tO\\ncholesteryl\\tO\\nesters\\tO\\nare\\tO\\nlow\\tO\\n,\\tO\\nfree\\tO\\ncholesterol\\tO\\nand\\tO\\nphospholipids\\tO\\nessentially\\tO\\nnormal\\tO\\n,\\tO\\nand\\tO\\ntriglycerides\\tO\\nincreased\\tO\\n.\\tO\\n\\nThe\\tO\\nratio\\tO\\nof\\tO\\napoprotein\\tO\\n(\\tO\\napo\\tO\\n)\\tO\\nto\\tO\\ntotal\\tO\\ncholesterol\\tO\\nin\\tO\\nthe\\tO\\nHDL\\tO\\nof\\tO\\nCTX\\tB-Disease\\nwas\\tO\\ntwo\\tO\\nto\\tO\\nthree\\tO\\ntimes\\tO\\ngreater\\tO\\nthan\\tO\\nnormal\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nCTX\\tB-Disease\\nHDL\\tO\\n,\\tO\\nthe\\tO\\nratio\\tO\\nof\\tO\\napoAI\\tO\\nto\\tO\\napoAII\\tO\\nwas\\tO\\nhigh\\tO\\n,\\tO\\nthe\\tO\\nproportion\\tO\\nof\\tO\\napoC\\tO\\nlow\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nnormally\\tO\\nminor\\tO\\nform\\tO\\nof\\tO\\napoAI\\tO\\nincreased\\tO\\nrelative\\tO\\nto\\tO\\nother\\tO\\nforms\\tO\\n.\\tO\\n\\nThe\\tO\\nHDL\\tO\\nin\\tO\\nelectron\\tO\\nmicrographs\\tO\\nappeared\\tO\\nnormal\\tO\\nmorphologically\\tO\\nand\\tO\\nin\\tO\\nparticle\\tO\\nsize\\tO\\n.\\tO\\n\\nThe\\tO\\nabnormalities\\tO\\nin\\tO\\nlipoprotein\\tO\\ndistribution\\tO\\nprofile\\tO\\nand\\tO\\ncomposition\\tO\\nof\\tO\\nthe\\tO\\nplasma\\tO\\nHDL\\tO\\nresult\\tO\\nfrom\\tO\\nmetabolic\\tO\\ndefects\\tO\\nthat\\tO\\nare\\tO\\nnot\\tO\\nunderstood\\tO\\nbut\\tO\\nmay\\tO\\nbe\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\nin\\tO\\nbile\\tO\\nacid\\tO\\nsynthesis\\tO\\nin\\tO\\nCTX\\tB-Disease\\n.\\tO\\n\\nAs\\tO\\na\\tO\\nconsequence\\tO\\n,\\tO\\nit\\tO\\nis\\tO\\nprobable\\tO\\nthat\\tO\\nthe\\tO\\nnormal\\tO\\nfunctions\\tO\\nof\\tO\\nthe\\tO\\nHDL\\tO\\n,\\tO\\npossibly\\tO\\nincluding\\tO\\nmodulation\\tO\\nof\\tO\\nLDL\\tO\\n-\\tO\\ncholesterol\\tO\\nuptake\\tO\\nand\\tO\\nthe\\tO\\nremoval\\tO\\nof\\tO\\nexcess\\tO\\ncholesterol\\tO\\nfrom\\tO\\nperipheral\\tO\\ntissues\\tO\\n,\\tO\\nare\\tO\\nperturbed\\tO\\nsignificantly\\tO\\nin\\tO\\nthis\\tO\\ndisease\\tO\\n.\\tO\\n\\nGenetics\\tO\\nof\\tO\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n(\\tO\\nCTX\\tB-Disease\\n)\\tO\\n:\\tO\\nan\\tO\\nautosomal\\tO\\nrecessive\\tO\\ntrait\\tO\\nwith\\tO\\nhigh\\tO\\ngene\\tO\\nfrequency\\tO\\nin\\tO\\nSephardim\\tO\\nof\\tO\\nMoroccan\\tO\\norigin\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribed\\tO\\n6\\tO\\npatients\\tO\\n(\\tO\\nfrom\\tO\\n3\\tO\\nfamilies\\tO\\n)\\tO\\naffected\\tO\\nwith\\tO\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n(\\tO\\nCTX\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nAll\\tO\\nare\\tO\\nSephardic\\tO\\nJews\\tO\\nof\\tO\\nMoroccan\\tO\\nextraction\\tO\\n.\\tO\\n\\nIn\\tO\\nview\\tO\\nof\\tO\\nthe\\tO\\nsmall\\tO\\nnumber\\tO\\nof\\tO\\nCTX\\tB-Disease\\npatients\\tO\\ndiagnosed\\tO\\nin\\tO\\nthe\\tO\\nworld\\tO\\n(\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\n50\\tO\\nincluding\\tO\\nour\\tO\\n6\\tO\\npatients\\tO\\n)\\tO\\n,\\tO\\nwe\\tO\\nare\\tO\\nprobably\\tO\\ndealing\\tO\\nwith\\tO\\nan\\tO\\nethnic\\tO\\nsubgroup\\tO\\nwith\\tO\\na\\tO\\nhigh\\tO\\nCTX\\tO\\ngene\\tO\\nfrequency\\tO\\n,\\tO\\nwhich\\tO\\nwe\\tO\\nhave\\tO\\nestimated\\tO\\nto\\tO\\nbe\\tO\\n1\\tO\\n/\\tO\\n108\\tO\\n.\\tO\\n\\nSince\\tO\\nthere\\tO\\nare\\tO\\ndifferences\\tO\\nin\\tO\\nexpression\\tO\\nin\\tO\\nthis\\tO\\ndisease\\tO\\n,\\tO\\nwe\\tO\\nrecommend\\tO\\ncholestanol\\tO\\nstudy\\tO\\nin\\tO\\ncases\\tO\\nof\\tO\\nundiagnosed\\tO\\ncataract\\tB-Disease\\nor\\tO\\ntendinous\\tB-Disease\\nxanthomas\\tI-Disease\\nin\\tO\\nchildhood\\tO\\nor\\tO\\nearly\\tO\\nadolescence\\tO\\n.\\tO\\n\\nThe\\tO\\ndiagnosis\\tO\\nin\\tO\\nCTX\\tB-Disease\\nis\\tO\\nimportant\\tO\\nnot\\tO\\nonly\\tO\\nfor\\tO\\ngenetic\\tO\\ncounseling\\tO\\n,\\tO\\nbut\\tO\\nalso\\tO\\nin\\tO\\nveiw\\tO\\nof\\tO\\npossible\\tO\\ntreatment\\tO\\n.\\tO\\n.\\tO\\n\\nNew\\tO\\ngenetic\\tO\\nvariants\\tO\\nof\\tO\\nglucose\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nin\\tO\\nItaly\\tO\\n.\\tO\\n\\nSix\\tO\\nnew\\tO\\nvariants\\tO\\nof\\tO\\nhuman\\tO\\nerythrocyte\\tO\\nG6PD\\tO\\nhave\\tO\\nbeen\\tO\\ncharacterized\\tO\\n.\\tO\\n\\nAll\\tO\\nof\\tO\\nthem\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nItalian\\tO\\nmales\\tO\\nand\\tO\\nall\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\nenzyme\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nbut\\tO\\nonly\\tO\\ntwo\\tO\\nwith\\tO\\nsigns\\tO\\nof\\tO\\nhaemolysis\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\nand\\tO\\nother\\tO\\nvariants\\tO\\nreported\\tO\\nin\\tO\\nthe\\tO\\nliterature\\tO\\n,\\tO\\nwhich\\tO\\nmust\\tO\\nthus\\tO\\nfar\\tO\\nbe\\tO\\nregarded\\tO\\nas\\tO\\nsporadic\\tO\\n,\\tO\\nare\\tO\\nfound\\tO\\nto\\tO\\nmap\\tO\\nin\\tO\\nparts\\tO\\nof\\tO\\nItaly\\tO\\nwhere\\tO\\ncommon\\tO\\ntypes\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nare\\tO\\nalso\\tO\\nprevalent\\tO\\n.\\tO\\n.\\tO\\n\\nVariants\\tO\\nof\\tO\\nerythrocyte\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nin\\tO\\nBulgarian\\tO\\npopulations\\tO\\n.\\tO\\n\\nTen\\tO\\nvariants\\tO\\nof\\tO\\nerythrocyte\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\n22\\tO\\npatients\\tO\\nwith\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nfrom\\tO\\nthree\\tO\\ndistricts\\tO\\nof\\tO\\nBulgaria\\tO\\n.\\tO\\n\\nCorinth\\tO\\n-\\tO\\nlike\\tO\\nand\\tO\\nFayoum\\tO\\n-\\tO\\nlike\\tO\\nvariants\\tO\\nwere\\tO\\nthe\\tO\\nmost\\tO\\nfrequent\\tO\\n;\\tO\\nMediterranean\\tO\\n,\\tO\\nOhut\\tO\\nII\\tO\\n,\\tO\\nKilgore\\tO\\n,\\tO\\nBoston\\tO\\n,\\tO\\nPoznan\\tO\\n,\\tO\\nand\\tO\\nPanay\\tO\\nvariants\\tO\\nand\\tO\\ntwo\\tO\\nnew\\tO\\nvariants\\tO\\n,\\tO\\nPetrich\\tO\\nand\\tO\\nGotze\\tO\\nDelchev\\tO\\n,\\tO\\nwere\\tO\\neach\\tO\\nfound\\tO\\nin\\tO\\none\\tO\\nor\\tO\\ntwo\\tO\\ncarriers\\tO\\n.\\tO\\n\\nNo\\tO\\ncorrelation\\tO\\nwas\\tO\\nrevealed\\tO\\nbetween\\tO\\nclinical\\tO\\nand\\tO\\nbiochemical\\tO\\npolymorphism\\tO\\n.\\tO\\n.\\tO\\n\\nNephropathy\\tB-Disease\\nin\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nNephropathy\\tB-Disease\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nfive\\tO\\nof\\tO\\n32\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nwho\\tO\\nwere\\tO\\nparticipating\\tO\\nin\\tO\\na\\tO\\nstudy\\tO\\nof\\tO\\ntransfer\\tO\\nfactor\\tO\\n(\\tO\\nTF\\tO\\n)\\tO\\ntherapy\\tO\\n.\\tO\\n\\nIn\\tO\\ntwo\\tO\\npatients\\tO\\n,\\tO\\nnephropathy\\tB-Disease\\nwas\\tO\\npresent\\tO\\nbefore\\tO\\nTF\\tO\\nand\\tO\\ndid\\tO\\nnot\\tO\\nappear\\tO\\nchanged\\tO\\nby\\tO\\nTF\\tO\\ntherapy\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthese\\tO\\npatients\\tO\\nsubsequently\\tO\\ndeveloped\\tO\\nprogressive\\tO\\nrenal\\tB-Disease\\nfailure\\tI-Disease\\nrequiring\\tO\\ndialysis\\tO\\nbeginning\\tO\\n5\\tO\\n1\\tO\\n/\\tO\\n2\\tO\\nyears\\tO\\nafter\\tO\\nTF\\tO\\ntherapy\\tO\\n.\\tO\\n\\nIn\\tO\\ntwo\\tO\\npatients\\tO\\n,\\tO\\ndecreased\\tO\\nrenal\\tO\\nfunction\\tO\\nappeared\\tO\\nvery\\tO\\nsoon\\tO\\nafter\\tO\\nthe\\tO\\nadministration\\tO\\nof\\tO\\nTF\\tO\\n.\\tO\\n\\nOne\\tO\\npatient\\tO\\nshowed\\tO\\ngradually\\tO\\ndecreasing\\tO\\nrenal\\tO\\nfunction\\tO\\nbeginning\\tO\\nafter\\tO\\ntwo\\tO\\nyears\\tO\\nof\\tO\\nTF\\tO\\ntherapy\\tO\\n.\\tO\\n\\nAn\\tO\\nadditional\\tO\\npatient\\tO\\nwas\\tO\\nidentified\\tO\\nwho\\tO\\ndied\\tO\\nwith\\tO\\nrenal\\tB-Disease\\nfailure\\tI-Disease\\nwithout\\tO\\nhaving\\tO\\nreceived\\tO\\nTF\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nrenal\\tB-Disease\\nfailure\\tI-Disease\\noccurs\\tO\\nin\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nmore\\tO\\nfrequently\\tO\\nthan\\tO\\ngenerally\\tO\\nrecognized\\tO\\nand\\tO\\nthat\\tO\\nadministration\\tO\\nof\\tO\\nTF\\tO\\nmay\\tO\\nprecipitate\\tO\\nor\\tO\\naccelerate\\tO\\nthe\\tO\\nrenal\\tB-Disease\\ndisease\\tI-Disease\\nin\\tO\\npatients\\tO\\nwith\\tO\\nthis\\tO\\nsyndrome\\tO\\n.\\tO\\n.\\tO\\n\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\ncellular\\tO\\nimpairments\\tO\\nand\\tO\\ntheir\\tO\\nimplication\\tO\\nfor\\tO\\ncarrier\\tO\\ndetection\\tO\\n.\\tO\\n\\nA\\tO\\nfamily\\tO\\nin\\tO\\nwhich\\tO\\ntwo\\tO\\nmale\\tO\\nsiblings\\tO\\nwere\\tO\\naffected\\tO\\nwith\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\nwas\\tO\\nstudied\\tO\\nusing\\tO\\nG\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nPD\\tO\\nisoenzymes\\tO\\nas\\tO\\nan\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\nmarker\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\nnature\\tO\\nof\\tO\\ncellular\\tO\\nabnormalities\\tO\\n.\\tO\\n\\nIsolated\\tO\\nperipheral\\tO\\nblood\\tO\\ncell\\tO\\ntypes\\tO\\nfrom\\tO\\nthe\\tO\\ndoubly\\tO\\nheterozygous\\tO\\nmother\\tO\\nof\\tO\\nthe\\tO\\naffected\\tO\\nmales\\tO\\nseemingly\\tO\\nfailed\\tO\\nto\\tO\\nexpress\\tO\\nthe\\tO\\nG\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nPD\\tO\\nallele\\tO\\nin\\tO\\ncis\\tO\\nposition\\tO\\nwith\\tO\\nthe\\tO\\nWAS\\tB-Disease\\nallele\\tO\\nwhile\\tO\\nher\\tO\\ncultured\\tO\\nskin\\tO\\nfibroblasts\\tO\\nexpressed\\tO\\nboth\\tO\\nG\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nPD\\tO\\nalleles\\tO\\n.\\tO\\n\\nAdditionally\\tO\\n,\\tO\\na\\tO\\nhistogram\\tO\\nanalysis\\tO\\nof\\tO\\nplatelet\\tO\\nsize\\tO\\nrevealed\\tO\\na\\tO\\nsingle\\tO\\npopulation\\tO\\nof\\tO\\nabnormally\\tO\\nsmall\\tO\\nplatelets\\tO\\nin\\tO\\nthe\\tO\\naffected\\tO\\npropositus\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nheterozygous\\tO\\nmother\\tO\\nhad\\tO\\nno\\tO\\nappreciable\\tO\\nsmall\\tO\\nplatelet\\tO\\nsubpopulation\\tO\\n.\\tO\\n\\nIn\\tO\\nvitro\\tO\\nculture\\tO\\nof\\tO\\nhemopoietic\\tO\\nprogenitor\\tO\\ncells\\tO\\nof\\tO\\nthe\\tO\\nheterozygous\\tO\\nmother\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nprogenitor\\tO\\ncells\\tO\\ndid\\tO\\nnot\\tO\\nexpress\\tO\\nthe\\tO\\nWAS\\tB-Disease\\nallele\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\na\\tO\\nsmall\\tO\\nnumber\\tO\\nof\\tO\\ncells\\tO\\nexpressing\\tO\\nthe\\tO\\nG\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nPD\\tO\\ntype\\tO\\nlinked\\tO\\nwith\\tO\\nthe\\tO\\nWAS\\tB-Disease\\nallele\\tO\\nwere\\tO\\ndetected\\tO\\n.\\tO\\n\\nThe\\tO\\nproportion\\tO\\nof\\tO\\nthe\\tO\\nlatter\\tO\\nprogenitors\\tO\\nwas\\tO\\nsignificantly\\tO\\nhigher\\tO\\namong\\tO\\nmore\\tO\\nprimitive\\tO\\nprogenitors\\tO\\n(\\tO\\nthose\\tO\\ngiving\\tO\\nrise\\tO\\nto\\tO\\nlater\\tO\\nappearing\\tO\\ncolonies\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nobservation\\tO\\nsuggests\\tO\\nthat\\tO\\nselection\\tO\\nagainst\\tO\\ncells\\tO\\nexpressing\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\ndefect\\tI-Disease\\ntakes\\tO\\nplace\\tO\\nin\\tO\\nthe\\tO\\nhemopoietic\\tO\\nsystem\\tO\\nof\\tO\\nthe\\tO\\nheterozygous\\tO\\nfemale\\tO\\nand\\tO\\noffers\\tO\\na\\tO\\npossible\\tO\\nmeans\\tO\\nof\\tO\\ncarrier\\tO\\ndetection\\tO\\nin\\tO\\nsome\\tO\\nwomen\\tO\\n.\\tO\\n\\nLinkage\\tO\\nstudies\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nrevealed\\tO\\none\\tO\\nexample\\tO\\nof\\tO\\nprobable\\tO\\nrecombination\\tO\\nbetween\\tO\\nthe\\tO\\nloci\\tO\\nfor\\tO\\nWAS\\tB-Disease\\nand\\tO\\nG\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nPD\\tO\\namong\\tO\\nthree\\tO\\ninformative\\tO\\nsubjects\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthese\\tO\\ntwo\\tO\\nloci\\tO\\nmay\\tO\\nnot\\tO\\nbe\\tO\\nclosely\\tO\\nlinked\\tO\\non\\tO\\nthe\\tO\\nX\\tO\\n-\\tO\\nchromosome\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nCT\\tO\\npattern\\tO\\nin\\tO\\nadrenoleukodystrophy\\tB-Disease\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nCT\\tO\\npattern\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\n2\\tO\\npatients\\tO\\nwith\\tO\\nadrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\npattern\\tO\\n,\\tO\\nwhich\\tO\\nthe\\tO\\nauthors\\tO\\ncall\\tO\\nType\\tO\\nII\\tO\\n,\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nposterior\\tO\\nperiventricular\\tO\\nareas\\tO\\nof\\tO\\ndecreased\\tO\\nattenuation\\tO\\naround\\tO\\nthe\\tO\\ntrigone\\tO\\non\\tO\\nnon\\tO\\n-\\tO\\ncontrast\\tO\\nscans\\tO\\nafter\\tO\\ncontrast\\tO\\ninfusion\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nthere\\tO\\nis\\tO\\nstriking\\tO\\nenhancement\\tO\\nof\\tO\\nvarious\\tO\\nwhite\\tO\\n-\\tO\\nmatter\\tO\\nstructures\\tO\\n(\\tO\\ntracts\\tO\\nor\\tO\\nfiber\\tO\\nsystems\\tO\\n)\\tO\\nsuch\\tO\\nas\\tO\\nthe\\tO\\ninternal\\tO\\ncapsules\\tO\\n,\\tO\\ncorpus\\tO\\ncallosum\\tO\\n,\\tO\\ncorona\\tO\\nradiata\\tO\\n,\\tO\\nforceps\\tO\\nmajor\\tO\\n,\\tO\\nand\\tO\\ncerebral\\tO\\npeduncles\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\ndifferent\\tO\\nfrom\\tO\\nnumerous\\tO\\nprevious\\tO\\ndescriptions\\tO\\nof\\tO\\nthe\\tO\\nCT\\tO\\npattern\\tO\\nin\\tO\\nALD\\tB-Disease\\n.\\tO\\n\\nType\\tB-Disease\\nII\\tI-Disease\\nALD\\tI-Disease\\ndoes\\tO\\nnot\\tO\\nappear\\tO\\nto\\tO\\nhave\\tO\\nbeen\\tO\\nseen\\tO\\nin\\tO\\nany\\tO\\nother\\tO\\nleukoencephalopathy\\tB-Disease\\nand\\tO\\nis\\tO\\nprobably\\tO\\nspecific\\tO\\nfor\\tO\\na\\tO\\nphenotypic\\tO\\nvariant\\tO\\nor\\tO\\nan\\tO\\nevolving\\tO\\nstage\\tO\\nof\\tO\\nALD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nFurther\\tO\\nevidence\\tO\\nfor\\tO\\nheterogeneity\\tO\\nof\\tO\\nglucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nPapua\\tO\\nNew\\tO\\nGuinea\\tO\\n.\\tO\\n\\nFour\\tO\\nnew\\tO\\nG6PD\\tO\\nvariants\\tO\\nhave\\tO\\nbeen\\tO\\ncharacterized\\tO\\nin\\tO\\nindividuals\\tO\\nfrom\\tO\\nPapua\\tO\\nNew\\tO\\nGuinea\\tO\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\ndemonstrates\\tO\\nthat\\tO\\nthe\\tO\\npreviously\\tO\\nreported\\tO\\nMarkham\\tO\\nvariant\\tO\\nand\\tO\\nthe\\tO\\nnewly\\tO\\ncharacterized\\tO\\nSalata\\tO\\nvariant\\tO\\nmay\\tO\\nbe\\tO\\nwidely\\tO\\ndistributed\\tO\\nin\\tO\\nPapua\\tO\\nNew\\tO\\nGuinea\\tO\\n.\\tO\\n\\nTh\\tO\\ndata\\tO\\npresented\\tO\\nhere\\tO\\ntogether\\tO\\nwith\\tO\\nthose\\tO\\nof\\tO\\npreviously\\tO\\npublished\\tO\\nstudies\\tO\\ndemonstrate\\tO\\na\\tO\\ndegree\\tO\\nof\\tO\\nheterogeneity\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nthat\\tO\\nis\\tO\\nmuch\\tO\\nhigher\\tO\\nthan\\tO\\nthat\\tO\\nin\\tO\\nother\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\nworld\\tO\\nwhere\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\ncommon\\tO\\n.\\tO\\n.\\tO\\n\\nIncreased\\tO\\nincidence\\tO\\nof\\tO\\ncataracts\\tB-Disease\\nin\\tO\\nmale\\tO\\nsubjects\\tO\\ndeficient\\tB-Disease\\nin\\tI-Disease\\nglucose\\tI-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n.\\tO\\n\\nGlucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nRBCs\\tO\\nwas\\tO\\nfound\\tO\\nsignificantly\\tO\\nmore\\tO\\nfrequently\\tO\\nin\\tO\\n210\\tO\\nmale\\tO\\ncataractous\\tB-Disease\\npatients\\tO\\nthan\\tO\\nin\\tO\\n672\\tO\\ncontrol\\tO\\nsubjects\\tO\\nof\\tO\\nSardinian\\tO\\norigin\\tO\\n.\\tO\\n\\nThe\\tO\\nfrequency\\tO\\nof\\tO\\nthe\\tO\\ndeficiency\\tO\\nwas\\tO\\nincreasingly\\tO\\nhigher\\tO\\nin\\tO\\npresenile\\tO\\ncataracts\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nG6PD\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\ngroup\\tO\\n,\\tO\\nthe\\tO\\nincidence\\tO\\nof\\tO\\ncortical\\tB-Disease\\nand\\tI-Disease\\ntotal\\tI-Disease\\ncataracts\\tI-Disease\\nwas\\tO\\nalso\\tO\\nincreased\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nsuggested\\tO\\nthat\\tO\\ndecrease\\tO\\nof\\tO\\nthe\\tO\\nG6PD\\tO\\nactivity\\tO\\nin\\tO\\nthe\\tO\\nlens\\tO\\n,\\tO\\nwhich\\tO\\naccompanies\\tO\\nits\\tO\\ndeficiency\\tO\\nin\\tO\\nthe\\tO\\nerythrocyte\\tO\\n,\\tO\\nmight\\tO\\nplay\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\ncataracto\\tO\\n-\\tO\\ngenesis\\tO\\nof\\tO\\nthese\\tO\\npatients\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nshould\\tO\\nbe\\tO\\nadded\\tO\\nto\\tO\\nother\\tO\\nconditions\\tO\\n,\\tO\\nsuch\\tO\\nas\\tO\\nthe\\tO\\ngalactosemic\\tB-Disease\\nstates\\tO\\nand\\tO\\nriboflavin\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nwhere\\tO\\ncataracts\\tB-Disease\\nrepresent\\tO\\na\\tO\\nsensitive\\tO\\nindicator\\tO\\nof\\tO\\nmetabolic\\tB-Disease\\nabnormalities\\tI-Disease\\nof\\tO\\nthe\\tO\\nRBC\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbasis\\tO\\nof\\tO\\nhuman\\tO\\nmitochondrial\\tO\\nvery\\tB-Disease\\n-\\tI-Disease\\nlong\\tI-Disease\\n-\\tI-Disease\\nchain\\tI-Disease\\nacyl\\tI-Disease\\n-\\tI-Disease\\nCoA\\tI-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\ncausing\\tO\\ncardiomyopathy\\tB-Disease\\nand\\tO\\nsudden\\tB-Disease\\ndeath\\tI-Disease\\nin\\tO\\nchildhood\\tO\\n.\\tO\\n\\nbeta\\tO\\n-\\tO\\nOxidation\\tO\\nof\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\nprovides\\tO\\nthe\\tO\\nmajor\\tO\\nsource\\tO\\nof\\tO\\nenergy\\tO\\nin\\tO\\nthe\\tO\\nheart\\tO\\n.\\tO\\n\\nDefects\\tO\\nin\\tO\\nenzymes\\tO\\nof\\tO\\nthe\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\npathway\\tO\\ncause\\tO\\nsudden\\tB-Disease\\n,\\tI-Disease\\nunexplained\\tI-Disease\\ndeath\\tI-Disease\\nin\\tO\\nchildhood\\tO\\n,\\tO\\nacute\\tO\\nhepatic\\tB-Disease\\nencephalopathy\\tI-Disease\\nor\\tO\\nliver\\tB-Disease\\nfailure\\tI-Disease\\n,\\tO\\nskeletal\\tB-Disease\\nmyopathy\\tI-Disease\\n,\\tO\\nand\\tO\\ncardiomyopathy\\tB-Disease\\n.\\tO\\n\\nVery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nacyl\\tO\\n-\\tO\\nCoA\\tO\\ndehydrogenase\\tO\\n[\\tO\\nVLCAD\\tO\\n;\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\n-\\tO\\nacyl\\tO\\n-\\tO\\nCoA\\tO\\n(\\tO\\nacceptor\\tO\\n)\\tO\\n2\\tO\\n,\\tO\\n3\\tO\\n-\\tO\\noxidoreductase\\tO\\n,\\tO\\nEC\\tO\\n1\\tO\\n.\\tO\\n3\\tO\\n3\\tO\\n.\\tO\\n99\\tO\\n99\\tO\\n.\\tO\\n13\\tO\\n]\\tO\\ncatalyzes\\tO\\nthe\\tO\\nfirst\\tO\\nstep\\tO\\nin\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nisolated\\tO\\nthe\\tO\\nhuman\\tO\\nVLCAD\\tO\\ncDNA\\tO\\nand\\tO\\ngene\\tO\\nand\\tO\\ndetermined\\tO\\nthe\\tO\\ncomplete\\tO\\nnucleotide\\tO\\nsequences\\tO\\n.\\tO\\n\\nPolymerase\\tO\\nchain\\tO\\nreaction\\tO\\namplification\\tO\\nof\\tO\\nVLCAD\\tO\\nmRNA\\tO\\nand\\tO\\ngenomic\\tO\\nexons\\tO\\ndefined\\tO\\nthe\\tO\\nmolecular\\tO\\ndefects\\tO\\nin\\tO\\ntwo\\tO\\npatients\\tO\\nwith\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\nwho\\tO\\npresented\\tO\\nwith\\tO\\nunexplained\\tO\\ncardiac\\tB-Disease\\narrest\\tI-Disease\\nand\\tO\\ncardiomyopathy\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\none\\tO\\n,\\tO\\na\\tO\\nhomozygous\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nconsensus\\tO\\ndinucleotide\\tO\\nof\\tO\\nthe\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\n(\\tO\\ng\\tO\\n+\\tO\\n1\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\na\\tO\\n)\\tO\\nwas\\tO\\nassociated\\tO\\nwith\\tO\\nuniversal\\tO\\nskipping\\tO\\nof\\tO\\nthe\\tO\\nprior\\tO\\nexon\\tO\\n(\\tO\\nexon\\tO\\n11\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nsecond\\tO\\npatient\\tO\\nwas\\tO\\na\\tO\\ncompound\\tO\\nheterozygote\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\nC1837\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n,\\tO\\nchanging\\tO\\nthe\\tO\\narginine\\tO\\nat\\tO\\nresidue\\tO\\n613\\tO\\nto\\tO\\ntryptophan\\tO\\non\\tO\\none\\tO\\nallele\\tO\\nand\\tO\\na\\tO\\nsingle\\tO\\nbase\\tO\\ndeletion\\tO\\nat\\tO\\nthe\\tO\\nintron\\tO\\n-\\tO\\nexon\\tO\\n6\\tO\\nboundary\\tO\\nas\\tO\\nthe\\tO\\nsecond\\tO\\nmutation\\tO\\n.\\tO\\n\\nThis\\tO\\ninitial\\tO\\ndelineation\\tO\\nof\\tO\\nhuman\\tO\\nmutations\\tO\\nin\\tO\\nVLCAD\\tO\\nsuggests\\tO\\nthat\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\nreduces\\tO\\nmyocardial\\tO\\nfatty\\tO\\nacid\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\nand\\tO\\nenergy\\tO\\nproduction\\tO\\nand\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\ncardiomyopathy\\tB-Disease\\nand\\tO\\nsudden\\tB-Disease\\ndeath\\tI-Disease\\nin\\tO\\nchildhood\\tO\\n.\\tO\\n\\nAberrant\\tO\\nsubcellular\\tO\\nlocalization\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nBRCA1\\tO\\ngene\\tO\\nproduct\\tO\\nwas\\tO\\nidentified\\tO\\nas\\tO\\na\\tO\\n220\\tO\\n-\\tO\\nkilodalton\\tO\\nnuclear\\tO\\nphosphoprotein\\tO\\nin\\tO\\nnormal\\tO\\ncells\\tO\\n,\\tO\\nincluding\\tO\\nbreast\\tO\\nductal\\tO\\nepithelial\\tO\\ncells\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\n18\\tO\\nof\\tO\\n20\\tO\\ntumor\\tB-Disease\\ncell\\tO\\nlines\\tO\\nderived\\tO\\nfrom\\tO\\ntissues\\tO\\nother\\tO\\nthan\\tO\\nbreast\\tO\\nand\\tO\\novary\\tO\\n.\\tO\\n\\nIn\\tO\\n16\\tO\\nof\\tO\\n17\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nlines\\tO\\nand\\tO\\n17\\tO\\nof\\tO\\n17\\tO\\nsamples\\tO\\nof\\tO\\ncells\\tO\\nobtained\\tO\\nfrom\\tO\\nmalignant\\tO\\neffusions\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nBRCA1\\tO\\nlocalized\\tO\\nmainly\\tO\\nin\\tO\\ncytoplasm\\tO\\n.\\tO\\n\\nAbsence\\tO\\nof\\tO\\nBRCA1\\tO\\nor\\tO\\naberrant\\tO\\nsubcellular\\tO\\nlocation\\tO\\nwas\\tO\\nalso\\tO\\nobserved\\tO\\nto\\tO\\na\\tO\\nvariable\\tO\\nextent\\tO\\nin\\tO\\nhistological\\tO\\nsections\\tO\\nof\\tO\\nmany\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nbiopsies\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nBRCA1\\tB-Disease\\nabnormalities\\tI-Disease\\nmay\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nmany\\tO\\nbreast\\tB-Disease\\ncancers\\tI-Disease\\n,\\tO\\nsporadic\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nfamilial\\tO\\n.\\tO\\n.\\tO\\n\\nMapping\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nhomologue\\tO\\nof\\tO\\nthe\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\nto\\tO\\nmouse\\tO\\nchromosome\\tO\\n8\\tO\\n.\\tO\\n\\nATP7B\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\naltered\\tO\\nin\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nWD\\tB-Disease\\n)\\tO\\npatients\\tO\\n,\\tO\\nlies\\tO\\nin\\tO\\na\\tO\\nblock\\tO\\nof\\tO\\nhomology\\tO\\nshared\\tO\\nbetween\\tO\\nhuman\\tO\\nchromosome\\tO\\n13q14\\tO\\nand\\tO\\nthe\\tO\\ncentral\\tO\\nregion\\tO\\nof\\tO\\nmouse\\tO\\nchromosome\\tO\\n14\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nmapped\\tO\\nthe\\tO\\nmurine\\tO\\nhomologue\\tO\\nof\\tO\\nATP7B\\tO\\n(\\tO\\nAtp7b\\tO\\n)\\tO\\nto\\tO\\nmouse\\tO\\nchromosome\\tO\\n8\\tO\\nby\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrid\\tO\\nanalysis\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\n80\\tO\\ninterspecific\\tO\\nbackcross\\tO\\noffspring\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nposition\\tO\\nAtp7b\\tO\\nclose\\tO\\nto\\tO\\nD8Mit3\\tO\\nand\\tO\\nanother\\tO\\nATPase\\tO\\nlocus\\tO\\n,\\tO\\nAtp4b\\tO\\n,\\tO\\non\\tO\\nmouse\\tO\\nchromosome\\tO\\n8\\tO\\n.\\tO\\n\\nATP4B\\tO\\nlies\\tO\\nin\\tO\\n13q34\\tO\\nand\\tO\\nis\\tO\\nseparated\\tO\\nfrom\\tO\\nATP7B\\tO\\nby\\tO\\nseveral\\tO\\nloci\\tO\\nwhose\\tO\\nmouse\\tO\\nhomologues\\tO\\nmap\\tO\\nto\\tO\\nmouse\\tO\\nchromosome\\tO\\n14\\tO\\n.\\tO\\n\\nThe\\tO\\nassignment\\tO\\nof\\tO\\nAtp7b\\tO\\nto\\tO\\nmouse\\tO\\nchromosome\\tO\\n8\\tO\\nidentifies\\tO\\na\\tO\\npreviously\\tO\\nunrecognized\\tO\\nregion\\tO\\nof\\tO\\nhomology\\tO\\nbetween\\tO\\nthis\\tO\\nchromosome\\tO\\nand\\tO\\nhuman\\tO\\nchromosome\\tO\\n13\\tO\\n.\\tO\\n\\nThis\\tO\\nassignment\\tO\\nsuggests\\tO\\na\\tO\\npossible\\tO\\nlocation\\tO\\nfor\\tO\\nthe\\tO\\ntoxic\\tO\\nmilk\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nmouse\\tO\\n,\\tO\\nwhich\\tO\\nhas\\tO\\nbeen\\tO\\nproposed\\tO\\nas\\tO\\na\\tO\\nhomologue\\tO\\nof\\tO\\nWD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nin\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nprovide\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelation\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\n,\\tO\\ndiscovered\\tO\\nin\\tO\\n1994\\tO\\n,\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\n80\\tO\\n-\\tO\\n90\\tO\\n%\\tO\\nlifetime\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nanalysed\\tO\\n60\\tO\\nfamilies\\tO\\nwith\\tO\\na\\tO\\nhistory\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfor\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\ntwo\\tO\\ndifferent\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\n32\\tO\\nfamilies\\tO\\n(\\tO\\n53\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nof\\tO\\nwhich\\tO\\n14\\tO\\nare\\tO\\npreviously\\tO\\nunreported\\tO\\n.\\tO\\n\\nWe\\tO\\nobserved\\tO\\na\\tO\\nsignificant\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\nlocation\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nand\\tO\\nthe\\tO\\nratio\\tO\\nof\\tO\\nbreast\\tB-Disease\\nto\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nincidence\\tO\\nwithin\\tO\\neach\\tO\\nfamily\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nsuggest\\tO\\na\\tO\\ntransition\\tO\\nin\\tO\\nrisk\\tO\\nsuch\\tO\\nthat\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nthird\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nlower\\tO\\nproportion\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nHaplotype\\tO\\nanalysis\\tO\\nsupports\\tO\\nprevious\\tO\\ndata\\tO\\nwhich\\tO\\nsuggest\\tO\\nsome\\tO\\nBRCA1\\tO\\nmutation\\tO\\ncarriers\\tO\\nhave\\tO\\ncommon\\tO\\nancestors\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nfound\\tO\\nat\\tO\\nleast\\tO\\ntwo\\tO\\nexamples\\tO\\nwhere\\tO\\nrecurrent\\tO\\nmutations\\tO\\nappear\\tO\\nto\\tO\\nhave\\tO\\narisen\\tO\\nindependently\\tO\\n.\\tO\\n.\\tO\\n\\nHereditary\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nseventh\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nand\\tO\\nrecurrent\\tO\\nmeningococcal\\tB-Disease\\ninfection\\tI-Disease\\n:\\tO\\ninvestigations\\tO\\nof\\tO\\nan\\tO\\nIrish\\tO\\nfamily\\tO\\nusing\\tO\\na\\tO\\nnovel\\tO\\nhaemolytic\\tO\\nscreening\\tO\\nassay\\tO\\nfor\\tO\\ncomplement\\tO\\nactivity\\tO\\nand\\tO\\nC7\\tO\\nM\\tO\\n/\\tO\\nN\\tO\\nallotyping\\tO\\n.\\tO\\n\\nTerminal\\tB-Disease\\ncomplement\\tI-Disease\\ncomponent\\tI-Disease\\ndeficiency\\tI-Disease\\npredisposes\\tO\\nto\\tO\\nmeningococcal\\tB-Disease\\ninfection\\tI-Disease\\nand\\tO\\nis\\tO\\ninherited\\tO\\nin\\tO\\nan\\tO\\nautosomal\\tO\\nco\\tO\\n-\\tO\\ndominant\\tO\\nmanner\\tO\\n.\\tO\\n\\nAn\\tO\\nIrish\\tO\\nfamily\\tO\\nis\\tO\\ndescribed\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\n2\\tO\\nof\\tO\\n3\\tO\\nbrothers\\tO\\nhad\\tO\\nrecurrent\\tO\\nmeningococcal\\tB-Disease\\ninfection\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nnovel\\tO\\nscreening\\tO\\nassay\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\ninvestigate\\tO\\nfor\\tO\\nterminal\\tB-Disease\\ncomplement\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nthe\\tO\\n2\\tO\\naffected\\tO\\nbrothers\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ncompletely\\tB-Disease\\ndeficient\\tI-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\nseventh\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC7\\tO\\n)\\tO\\n.\\tO\\n\\nEnzyme\\tO\\n-\\tO\\nlinked\\tO\\nimmunosorbent\\tO\\nassay\\tO\\nfor\\tO\\nC7\\tO\\nrevealed\\tO\\nlower\\tO\\nthan\\tO\\nnormal\\tO\\nlevels\\tO\\nin\\tO\\nthe\\tO\\nremaining\\tO\\nbrother\\tO\\nand\\tO\\nparents\\tO\\n.\\tO\\n\\nC7\\tO\\nM\\tO\\n/\\tO\\nN\\tO\\nprotein\\tO\\npolymorphism\\tO\\nallotyping\\tO\\n,\\tO\\nused\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\nsegregation\\tO\\nof\\tO\\nthe\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\ngenes\\tO\\n,\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\napparently\\tO\\ncomplement\\tO\\nsufficient\\tO\\nbrother\\tO\\nwas\\tO\\nheterozygous\\tO\\nC7\\tB-Disease\\ndeficient\\tI-Disease\\nand\\tO\\na\\tO\\ncarrier\\tO\\nof\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ndeficiency\\tO\\ngenes\\tO\\n.\\tO\\n\\nComplement\\tO\\nscreening\\tO\\nshould\\tO\\nbe\\tO\\ncarried\\tO\\nout\\tO\\nin\\tO\\nany\\tO\\nindividual\\tO\\nsuffering\\tO\\nrecurrent\\tO\\nmeningococcal\\tB-Disease\\ninfection\\tI-Disease\\nor\\tO\\ninfection\\tO\\nwith\\tO\\nan\\tO\\nuncommon\\tO\\nmeningococcal\\tB-Disease\\nserogroup\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\ncomplement\\tB-Disease\\ndeficient\\tI-Disease\\npatients\\tO\\nallows\\tO\\nthe\\tO\\nimplementation\\tO\\nof\\tO\\nstrategies\\tO\\nto\\tO\\nprevent\\tO\\nrecurrent\\tO\\ninfection\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbasis\\tO\\nof\\tO\\nsubtotal\\tB-Disease\\ncomplement\\tI-Disease\\nC6\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nA\\tO\\ncarboxy\\tO\\n-\\tO\\nterminally\\tO\\ntruncated\\tO\\nbut\\tO\\nfunctionally\\tO\\nactive\\tO\\nC6\\tO\\n.\\tO\\n\\nIndividuals\\tO\\nwith\\tO\\nsubtotal\\tB-Disease\\ncomplement\\tI-Disease\\nC6\\tI-Disease\\ndeficiency\\tI-Disease\\npossess\\tO\\na\\tO\\nC6\\tO\\nmolecule\\tO\\nthat\\tO\\nis\\tO\\n14\\tO\\n%\\tO\\nshorter\\tO\\nthan\\tO\\nnormal\\tO\\nC6\\tO\\nand\\tO\\npresent\\tO\\nin\\tO\\nlow\\tO\\nbut\\tO\\ndetectable\\tO\\nconcentrations\\tO\\n(\\tO\\n1\\tO\\n-\\tO\\n2\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nmean\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nnow\\tO\\nshow\\tO\\nthat\\tO\\nthis\\tO\\ndysmorphic\\tO\\nC6\\tO\\nis\\tO\\nbactericidally\\tO\\nactive\\tO\\nand\\tO\\nlacks\\tO\\nan\\tO\\nepitope\\tO\\nthat\\tO\\nwas\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\nmost\\tO\\ncarboxy\\tO\\n-\\tO\\nterminal\\tO\\npart\\tO\\nof\\tO\\nC6\\tO\\nusing\\tO\\nC6\\tO\\ncDNA\\tO\\nfragments\\tO\\nexpressed\\tO\\nas\\tO\\nfusion\\tO\\nproteins\\tO\\nin\\tO\\nthe\\tO\\npUEX\\tO\\nexpression\\tO\\nsystem\\tO\\n.\\tO\\n\\nWe\\tO\\nthus\\tO\\npredicted\\tO\\nthat\\tO\\nthe\\tO\\nabnormal\\tO\\nC6\\tO\\nmolecule\\tO\\nmight\\tO\\nbe\\tO\\ncarboxy\\tO\\n-\\tO\\nterminally\\tO\\ntruncated\\tO\\nand\\tO\\nsought\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nan\\tO\\narea\\tO\\napproximately\\tO\\n14\\tO\\n%\\tO\\nfrom\\tO\\nthe\\tO\\ncarboxy\\tO\\n-\\tO\\nterminal\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\n.\\tO\\n\\nBy\\tO\\nsequencing\\tO\\nPCR\\tO\\n-\\tO\\namplified\\tO\\nproducts\\tO\\nfrom\\tO\\nthis\\tO\\nregion\\tO\\n,\\tO\\nwe\\tO\\nfound\\tO\\n,\\tO\\nin\\tO\\nthree\\tO\\nindividuals\\tO\\nfrom\\tO\\ntwo\\tO\\nfamilies\\tO\\n,\\tO\\na\\tO\\nmutation\\tO\\nthat\\tO\\nmight\\tO\\nplausibly\\tO\\nbe\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\ndefect\\tO\\n.\\tO\\n\\nAll\\tO\\nthree\\tO\\nhave\\tO\\nan\\tO\\nabnormal\\tO\\n5\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n15\\tO\\n,\\tO\\nwhich\\tO\\nwould\\tO\\nprobably\\tO\\nprevent\\tO\\nsplicing\\tO\\n.\\tO\\n\\nAn\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\nstop\\tO\\ncodon\\tO\\nis\\tO\\nfound\\tO\\n17\\tO\\ncodons\\tO\\ndownstream\\tO\\nfrom\\tO\\nthe\\tO\\nintron\\tO\\nboundary\\tO\\n,\\tO\\nwhich\\tO\\nwould\\tO\\nlead\\tO\\nto\\tO\\na\\tO\\ntruncated\\tO\\npolypeptide\\tO\\n13\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\nsmaller\\tO\\nthan\\tO\\nnormal\\tO\\nC6\\tO\\n.\\tO\\n\\nThis\\tO\\nresult\\tO\\nwas\\tO\\nunexpected\\tO\\n,\\tO\\nas\\tO\\nearlier\\tO\\nstudies\\tO\\nmapped\\tO\\nthe\\tO\\nC5b\\tO\\nbinding\\tO\\nsite\\tO\\n,\\tO\\nor\\tO\\na\\tO\\nputative\\tO\\nenzymatic\\tO\\nregion\\tO\\n,\\tO\\nto\\tO\\nthis\\tO\\npart\\tO\\nof\\tO\\nC6\\tO\\n.\\tO\\n\\nInterestingly\\tO\\n,\\tO\\nall\\tO\\nthree\\tO\\nsubjects\\tO\\nwere\\tO\\nprobably\\tO\\nheterozygous\\tO\\nfor\\tO\\nboth\\tO\\nsubtotal\\tB-Disease\\nC6\\tI-Disease\\nand\\tI-Disease\\ncomplete\\tI-Disease\\nC6\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n:\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\npossible\\tO\\ndominant\\tO\\n-\\tO\\nnegative\\tO\\nRNA\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\ntrinucleotide\\tO\\nexpansion\\tO\\nmutation\\tO\\ncausing\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nis\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\na\\tO\\nprotein\\tO\\nkinase\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\nmechanisms\\tO\\nby\\tO\\nwhich\\tO\\nthe\\tO\\nexpanded\\tO\\nrepeat\\tO\\ncauses\\tO\\nthe\\tO\\nclinically\\tO\\nvariable\\tO\\nand\\tO\\nmultisystemic\\tB-Disease\\ndisease\\tI-Disease\\n,\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nare\\tO\\nnot\\tO\\nunderstood\\tO\\n.\\tO\\n\\nIt\\tO\\nhas\\tO\\nbeen\\tO\\nparticularly\\tO\\ndifficult\\tO\\nto\\tO\\nrationalize\\tO\\nthe\\tO\\ndominant\\tO\\ninheritance\\tO\\nwith\\tO\\nthe\\tO\\nfact\\tO\\nthat\\tO\\nthe\\tO\\nexpansion\\tO\\nmutation\\tO\\nlies\\tO\\noutside\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n-\\tO\\nencoding\\tO\\ngene\\tO\\nelements\\tO\\n,\\tO\\nand\\tO\\nshould\\tO\\nnot\\tO\\nbe\\tO\\ntranslated\\tO\\ninto\\tO\\nprotein\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nuse\\tO\\nmuscle\\tO\\nbiopsies\\tO\\nfrom\\tO\\nclassical\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\npatients\\tO\\nto\\tO\\nstudy\\tO\\nthe\\tO\\naccumulation\\tO\\nof\\tO\\ntranscripts\\tO\\nfrom\\tO\\nboth\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\nexpanded\\tO\\nDM\\tB-Disease\\nkinase\\tO\\ngenes\\tO\\nin\\tO\\npatient\\tO\\nmuscle\\tO\\n,\\tO\\nand\\tO\\ncompare\\tO\\nthe\\tO\\nresults\\tO\\nto\\tO\\nnormal\\tO\\nand\\tO\\nmyopathic\\tB-Disease\\ncontrols\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nrelatively\\tO\\nsmall\\tO\\ndecreases\\tO\\nof\\tO\\nDM\\tB-Disease\\nkinase\\tO\\nRNA\\tO\\nin\\tO\\nthe\\tO\\ntotal\\tO\\nRNA\\tO\\npool\\tO\\nfrom\\tO\\nmuscle\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nthese\\tO\\nreductions\\tO\\nwere\\tO\\nnot\\tO\\ndisease\\tO\\nspecific\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\npoly\\tO\\n(\\tO\\nA\\tO\\n)\\tO\\n+\\tO\\nRNA\\tO\\nshowed\\tO\\ndramatic\\tO\\ndecreases\\tO\\nof\\tO\\nboth\\tO\\nthe\\tO\\nmutant\\tO\\nand\\tO\\nnormal\\tO\\nDM\\tB-Disease\\nkinase\\tO\\nRNAs\\tO\\n,\\tO\\nand\\tO\\nthese\\tO\\nchanges\\tO\\nwere\\tO\\ndisease\\tO\\n-\\tO\\nspecific\\tO\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\na\\tO\\nnovel\\tO\\nmolecular\\tO\\npathogenetic\\tO\\nmechanism\\tO\\nfor\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nboth\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\nexpanded\\tO\\nDM\\tB-Disease\\nkinase\\tO\\ngenes\\tO\\nare\\tO\\ntranscribed\\tO\\nin\\tO\\npatient\\tO\\nmuscle\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nabnormal\\tO\\nexpansion\\tO\\n-\\tO\\ncontaining\\tO\\nRNA\\tO\\nhas\\tO\\na\\tO\\ndominant\\tO\\neffect\\tO\\non\\tO\\nRNA\\tO\\nmetabolism\\tO\\nby\\tO\\npreventing\\tO\\nthe\\tO\\naccumulation\\tO\\nof\\tO\\npoly\\tO\\n(\\tO\\nA\\tO\\n)\\tO\\n+\\tO\\nRNA\\tO\\n.\\tO\\n\\nThe\\tO\\nability\\tO\\nof\\tO\\nthe\\tO\\nexpansion\\tO\\nmutation\\tO\\nto\\tO\\nalter\\tO\\naccumulation\\tO\\nof\\tO\\npoly\\tO\\n(\\tO\\nA\\tO\\n)\\tO\\n+\\tO\\nRNA\\tO\\nin\\tO\\ntrans\\tO\\nsuggests\\tO\\nthat\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nmay\\tO\\nbe\\tO\\nthe\\tO\\nfirst\\tO\\nexample\\tO\\nof\\tO\\na\\tO\\ndominant\\tO\\n-\\tO\\nnegative\\tO\\nmutation\\tO\\nmanifested\\tO\\nat\\tO\\nthe\\tO\\nRNA\\tO\\nlevel\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nstrong\\tO\\ncandidate\\tO\\nfor\\tO\\nthe\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\ngene\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nA\\tO\\nstrong\\tO\\ncandidate\\tO\\nfor\\tO\\nthe\\tO\\n17q\\tO\\n-\\tO\\nlinked\\tO\\nBRCA1\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\ninfluences\\tO\\nsusceptibility\\tO\\nto\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nby\\tO\\npositional\\tO\\ncloning\\tO\\nmethods\\tO\\n.\\tO\\n\\nProbable\\tO\\npredisposing\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\nfive\\tO\\nof\\tO\\neight\\tO\\nkindreds\\tO\\npresumed\\tO\\nto\\tO\\nsegregate\\tO\\nBRCA1\\tO\\nsusceptibility\\tO\\nalleles\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\ninclude\\tO\\nan\\tO\\n11\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\n,\\tO\\na\\tO\\n1\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ninsertion\\tO\\n,\\tO\\na\\tO\\nstop\\tO\\ncodon\\tO\\n,\\tO\\na\\tO\\nmissense\\tO\\nsubstitution\\tO\\n,\\tO\\nand\\tO\\nan\\tO\\ninferred\\tO\\nregulatory\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nBRCA1\\tO\\ngene\\tO\\nis\\tO\\nexpressed\\tO\\nin\\tO\\nnumerous\\tO\\ntissues\\tO\\n,\\tO\\nincluding\\tO\\nbreast\\tO\\nand\\tO\\novary\\tO\\n,\\tO\\nand\\tO\\nencodes\\tO\\na\\tO\\npredicted\\tO\\nprotein\\tO\\nof\\tO\\n1863\\tO\\namino\\tO\\nacids\\tO\\n.\\tO\\n\\nThis\\tO\\nprotein\\tO\\ncontains\\tO\\na\\tO\\nzinc\\tO\\nfinger\\tO\\ndomain\\tO\\nin\\tO\\nits\\tO\\namino\\tO\\n-\\tO\\nterminal\\tO\\nregion\\tO\\n,\\tO\\nbut\\tO\\nis\\tO\\notherwise\\tO\\nunrelated\\tO\\nto\\tO\\npreviously\\tO\\ndescribed\\tO\\nproteins\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nBRCA1\\tO\\nshould\\tO\\nfacilitate\\tO\\nearly\\tO\\ndiagnosis\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\nin\\tO\\nsome\\tO\\nindividuals\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\na\\tO\\nbetter\\tO\\nunderstanding\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nbiology\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\ncharacterization\\tO\\nof\\tO\\ngalactosemia\\tB-Disease\\n(\\tO\\ntype\\tO\\n1\\tO\\n)\\tO\\nmutations\\tO\\nin\\tO\\nJapanese\\tO\\n.\\tO\\n\\nWe\\tO\\ncharacterized\\tO\\ntwo\\tO\\nnovel\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridyltransferase\\tO\\n(\\tO\\nGALT\\tO\\n)\\tO\\ngene\\tO\\nin\\tO\\ntwo\\tO\\nJapanese\\tO\\npatients\\tO\\nwith\\tO\\nGALT\\tB-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nidentified\\tO\\nN314D\\tO\\nand\\tO\\nR333W\\tO\\nmutations\\tO\\n,\\tO\\npreviously\\tO\\nfound\\tO\\nin\\tO\\nCaucasians\\tO\\n.\\tO\\n\\nOne\\tO\\nnovel\\tO\\nmissense\\tO\\nmutation\\tO\\nwas\\tO\\nan\\tO\\nG\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nA\\tO\\ntransition\\tO\\nin\\tO\\nexon\\tO\\n8\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nthe\\tO\\nsubstitution\\tO\\nof\\tO\\narginine\\tO\\nby\\tO\\nhistidine\\tO\\nat\\tO\\nthe\\tO\\ncodon\\tO\\n231\\tO\\n(\\tO\\nR231H\\tO\\n)\\tO\\n.\\tO\\n\\nGALT\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nR231H\\tO\\nmutant\\tO\\nconstruct\\tO\\nwas\\tO\\nreduced\\tO\\nto\\tO\\n15\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\ncontrols\\tO\\nin\\tO\\na\\tO\\nCOS\\tO\\ncell\\tO\\nexpression\\tO\\nsystem\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nwas\\tO\\na\\tO\\nsplicing\\tO\\nmutation\\tO\\n,\\tO\\nan\\tO\\nA\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nG\\tO\\ntransition\\tO\\nat\\tO\\nthe\\tO\\n38th\\tO\\nnucleotide\\tO\\nin\\tO\\nexon\\tO\\n3\\tO\\n(\\tO\\n318A\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\n)\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\n38\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\nGALT\\tO\\ncDNA\\tO\\nby\\tO\\nactivating\\tO\\na\\tO\\ncryptic\\tO\\nsplice\\tO\\nacceptor\\tO\\nsite\\tO\\n.\\tO\\n\\nIn\\tO\\nseven\\tO\\nJapanese\\tO\\nfamilies\\tO\\n(\\tO\\n14\\tO\\nalleles\\tO\\nfor\\tO\\nclassic\\tO\\nform\\tO\\nand\\tO\\none\\tO\\nallele\\tO\\nfor\\tO\\nDuarte\\tO\\nvariant\\tO\\n)\\tO\\nwith\\tO\\nGALT\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nthe\\tO\\nR231H\\tO\\nand\\tO\\n318A\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nonly\\tO\\non\\tO\\nboth\\tO\\nalleles\\tO\\nof\\tO\\nthe\\tO\\nproband\\tO\\n.\\tO\\n\\nThe\\tO\\nN314D\\tO\\nand\\tO\\nR333W\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\non\\tO\\none\\tO\\nallele\\tO\\neach\\tO\\n.\\tO\\n\\nThe\\tO\\nQ188R\\tO\\nwas\\tO\\nprevalent\\tO\\nin\\tO\\nthe\\tO\\nUnited\\tO\\nStates\\tO\\nbut\\tO\\nnot\\tO\\nin\\tO\\nJapanese\\tO\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\nN314D\\tO\\nmutation\\tO\\nwas\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nDuarte\\tO\\nvariant\\tO\\nin\\tO\\nJapanese\\tO\\npersons\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nin\\tO\\nthe\\tO\\nUnited\\tO\\nStates\\tO\\n.\\tO\\n\\nWe\\tO\\nspeculate\\tO\\nthat\\tO\\nclassic\\tB-Disease\\ngalactosemia\\tI-Disease\\nmutations\\tO\\nappear\\tO\\nto\\tO\\ndiffer\\tO\\nbetween\\tO\\nJapanese\\tO\\nand\\tO\\nCaucasian\\tO\\npatients\\tO\\n.\\tO\\n\\nOur\\tO\\nlimited\\tO\\ndata\\tO\\nset\\tO\\non\\tO\\ngalactosemia\\tB-Disease\\nmutations\\tO\\nin\\tO\\nJapanese\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nN314D\\tO\\nGALT\\tO\\nmutation\\tO\\nencoding\\tO\\nthe\\tO\\nDuarte\\tO\\nvariant\\tO\\narose\\tO\\nbefore\\tO\\nAsian\\tO\\nand\\tO\\nCaucasian\\tO\\npeople\\tO\\ndiverged\\tO\\nand\\tO\\nthat\\tO\\nclassic\\tB-Disease\\ngalactosemia\\tI-Disease\\nmutations\\tO\\narose\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\naccumulated\\tO\\nafter\\tO\\nthe\\tO\\ndivergence\\tO\\nof\\tO\\nAsian\\tO\\nand\\tO\\nCaucasian\\tO\\npopulations\\tO\\n.\\tO\\n.\\tO\\n\\nThree\\tO\\nnovel\\tO\\naniridia\\tB-Disease\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nPAX6\\tO\\ngene\\tO\\n.\\tO\\n\\nAniridia\\tB-Disease\\n(\\tO\\niris\\tB-Disease\\nhypoplasia\\tI-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ncongenital\\tI-Disease\\ndisorder\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\neye\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\naniridia\\tB-Disease\\n(\\tO\\nPAX6\\tO\\n)\\tO\\ngene\\tO\\nhave\\tO\\nnow\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\nmany\\tO\\npatients\\tO\\nfrom\\tO\\nvarious\\tO\\nethnic\\tO\\ngroups\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nstudy\\tO\\nreported\\tO\\nhere\\tO\\nwe\\tO\\ndescribe\\tO\\nPAX6\\tO\\nmutations\\tO\\nin\\tO\\none\\tO\\nsporadic\\tO\\nand\\tO\\nfive\\tO\\nfamilial\\tO\\ncases\\tO\\nwith\\tO\\naniridia\\tB-Disease\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\nfour\\tO\\ndifferent\\tO\\nmutations\\tO\\nidentified\\tO\\n,\\tO\\none\\tO\\nwas\\tO\\nidentical\\tO\\nto\\tO\\na\\tO\\npreviously\\tO\\nreported\\tO\\nmutation\\tO\\n(\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransition\\tO\\nat\\tO\\ncodon\\tO\\n240\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nthree\\tO\\nwere\\tO\\nnovel\\tO\\ntwo\\tO\\nin\\tO\\nthe\\tO\\nglycine\\tO\\n-\\tO\\nrich\\tO\\nregion\\tO\\nand\\tO\\none\\tO\\nin\\tO\\nthe\\tO\\nproline\\tO\\n/\\tO\\nserine\\tO\\n/\\tO\\nthreonine\\tO\\n-\\tO\\nrich\\tO\\n(\\tO\\nPST\\tO\\n)\\tO\\nregion\\tO\\n.\\tO\\n\\nOne\\tO\\nPAX6\\tO\\nmutation\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nPST\\tO\\nregion\\tO\\nwas\\tO\\nassociated\\tO\\nwith\\tO\\ncataracts\\tB-Disease\\nin\\tO\\nan\\tO\\naniridia\\tB-Disease\\nfamily\\tO\\n.\\tO\\n\\nAnother\\tO\\nsplice\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nPST\\tO\\ndomain\\tO\\noccurred\\tO\\nin\\tO\\nan\\tO\\naniridia\\tB-Disease\\npatient\\tO\\nwith\\tO\\nanosmia\\tB-Disease\\n(\\tO\\ninability\\tO\\nto\\tO\\nsmell\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nsix\\tO\\nnew\\tO\\naniridia\\tB-Disease\\ncases\\tO\\nreported\\tO\\nhere\\tO\\nhave\\tO\\nmutations\\tO\\npredicted\\tO\\nto\\tO\\ngenerate\\tO\\nincomplete\\tO\\nPAX6\\tO\\nproteins\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsupport\\tO\\nthe\\tO\\ntheory\\tO\\nthat\\tO\\nhuman\\tO\\naniridia\\tB-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\nhaploinsufficiency\\tB-Disease\\nof\\tI-Disease\\nPAX6\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\ncarrier\\tO\\nfrequency\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\n185delAG\\tO\\nmutation\\tO\\nis\\tO\\napproximately\\tO\\n1\\tO\\npercent\\tO\\nin\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nindividuals\\tO\\n.\\tO\\n\\nSince\\tO\\nBRCA1\\tO\\n,\\tO\\nthe\\tO\\nfirst\\tO\\nmajor\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\ninherited\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nwas\\tO\\ncloned\\tO\\n,\\tO\\nmore\\tO\\nthan\\tO\\n50\\tO\\nunique\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\ngermline\\tO\\nof\\tO\\nindividuals\\tO\\nwith\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nhigh\\tO\\n-\\tO\\nrisk\\tO\\npedigrees\\tO\\n,\\tO\\nfemale\\tO\\ncarriers\\tO\\nof\\tO\\nBRCA1\\tO\\nmutations\\tO\\nhave\\tO\\nan\\tO\\n80\\tO\\n-\\tO\\n90\\tO\\n%\\tO\\nlifetime\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nand\\tO\\na\\tO\\n40\\tO\\n-\\tO\\n50\\tO\\n%\\tO\\nrisk\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nmutation\\tO\\nstats\\tO\\nof\\tO\\nindividuals\\tO\\nunselected\\tO\\nfor\\tO\\nbreast\\tB-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\ndetermined\\tO\\n,\\tO\\nand\\tO\\nit\\tO\\nis\\tO\\nnot\\tO\\nknown\\tO\\nwhether\\tO\\nmutations\\tO\\nin\\tO\\nsuch\\tO\\nindividuals\\tO\\nconfer\\tO\\nthe\\tO\\nsame\\tO\\nrisk\\tO\\nof\\tO\\ncancer\\tB-Disease\\nas\\tO\\nin\\tO\\nindividuals\\tO\\nfrom\\tO\\nthe\\tO\\nhigh\\tO\\n-\\tO\\nrisk\\tO\\nfamilies\\tO\\nstudied\\tO\\nso\\tO\\nfar\\tO\\n.\\tO\\n\\nFollowing\\tO\\nthe\\tO\\nfinding\\tO\\nof\\tO\\na\\tO\\n185delAG\\tO\\nframeshift\\tO\\nmutation\\tO\\nin\\tO\\nseveral\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nbreast\\tO\\n/\\tO\\novarian\\tO\\nfamilies\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ndetermined\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nthis\\tO\\nmutation\\tO\\nin\\tO\\n858\\tO\\nAshkenazim\\tO\\nseeking\\tO\\ngenetic\\tO\\ntesting\\tO\\nfor\\tO\\nconditions\\tO\\nunrelated\\tO\\nto\\tO\\ncancer\\tB-Disease\\n,\\tO\\nand\\tO\\nin\\tO\\n815\\tO\\nreference\\tO\\nindividuals\\tO\\nnot\\tO\\nselected\\tO\\nfor\\tO\\nethnic\\tO\\norigin\\tO\\n.\\tO\\n\\nWe\\tO\\nobserved\\tO\\nthe\\tO\\n185delAG\\tO\\nmutation\\tO\\nin\\tO\\n0\\tO\\n.\\tO\\n\\n9\\tO\\n%\\tO\\nof\\tO\\nAshkenazim\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\nlimit\\tO\\n,\\tO\\n0\\tO\\n.\\tO\\n4\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n8\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\nin\\tO\\nnone\\tO\\nof\\tO\\nthe\\tO\\nreference\\tO\\nsamples\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\none\\tO\\nin\\tO\\na\\tO\\nhundred\\tO\\nwomen\\tO\\nof\\tO\\nAshkenazi\\tO\\ndescent\\tO\\nmay\\tO\\nbe\\tO\\nat\\tO\\nespecially\\tO\\nhigh\\tO\\nrisk\\tO\\nof\\tO\\ndeveloping\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nIdentification\\tO\\nand\\tO\\nlocalization\\tO\\nof\\tO\\nhuntingtin\\tO\\nin\\tO\\nbrain\\tO\\nand\\tO\\nhuman\\tO\\nlymphoblastoid\\tO\\ncell\\tO\\nlines\\tO\\nwith\\tO\\nanti\\tO\\n-\\tO\\nfusion\\tO\\nprotein\\tO\\nantibodies\\tO\\n.\\tO\\n\\nThe\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nphenotype\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\nIT15\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\npredicted\\tO\\nto\\tO\\nencode\\tO\\na\\tO\\n348\\tO\\n-\\tO\\nkDa\\tO\\nprotein\\tO\\nnamed\\tO\\nhuntington\\tO\\n.\\tO\\n\\nWe\\tO\\nused\\tO\\npolyclonal\\tO\\nand\\tO\\nmonoclonal\\tO\\nanti\\tO\\n-\\tO\\nfusion\\tO\\nprotein\\tO\\nantibodies\\tO\\nto\\tO\\nidentify\\tO\\nnative\\tO\\nhuntingtin\\tO\\nin\\tO\\nrat\\tO\\n,\\tO\\nmonkey\\tO\\n,\\tO\\nand\\tO\\nhuman\\tO\\n.\\tO\\n\\nWestern\\tO\\nblots\\tO\\nrevealed\\tO\\na\\tO\\nprotein\\tO\\nwith\\tO\\nthe\\tO\\nexpected\\tO\\nmolecular\\tO\\nweight\\tO\\nwhich\\tO\\nis\\tO\\npresent\\tO\\nin\\tO\\nthe\\tO\\nsoluble\\tO\\nfraction\\tO\\nof\\tO\\nrat\\tO\\nand\\tO\\nmonkey\\tO\\nbrain\\tO\\ntissues\\tO\\nand\\tO\\nlymphoblastoid\\tO\\ncells\\tO\\nfrom\\tO\\ncontrol\\tO\\ncases\\tO\\n.\\tO\\n\\nIn\\tO\\nlymphoblastoid\\tO\\ncell\\tO\\nlines\\tO\\nfrom\\tO\\njuvenile\\tO\\n-\\tO\\nonset\\tO\\nheterozygote\\tO\\nHD\\tB-Disease\\ncases\\tO\\n,\\tO\\nboth\\tO\\nnormal\\tO\\nand\\tO\\nmutant\\tO\\nhuntingtin\\tO\\nare\\tO\\nexpressed\\tO\\n,\\tO\\nand\\tO\\nincreasing\\tO\\nrepeat\\tO\\nexpansion\\tO\\nleads\\tO\\nto\\tO\\nlower\\tO\\nlevels\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nprotein\\tO\\n.\\tO\\n\\nImmunocytochemistry\\tO\\nindicates\\tO\\nthat\\tO\\nhuntingtin\\tO\\nis\\tO\\nlocated\\tO\\nin\\tO\\nneurons\\tO\\nthroughout\\tO\\nthe\\tO\\nbrain\\tO\\n,\\tO\\nwith\\tO\\nthe\\tO\\nhighest\\tO\\nlevels\\tO\\nevident\\tO\\nin\\tO\\nlarger\\tO\\nneurons\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nhuman\\tO\\nstriatum\\tO\\n,\\tO\\nhuntingtin\\tO\\nis\\tO\\nenriched\\tO\\nin\\tO\\na\\tO\\npatch\\tO\\n-\\tO\\nlike\\tO\\ndistribution\\tO\\n,\\tO\\npotentially\\tO\\ncorresponding\\tO\\nto\\tO\\nthe\\tO\\nfirst\\tO\\nareas\\tO\\naffected\\tO\\nin\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nSubcellular\\tO\\nlocalization\\tO\\nof\\tO\\nhuntingtin\\tO\\nis\\tO\\nconsistent\\tO\\nwith\\tO\\na\\tO\\ncytosolic\\tO\\nprotein\\tO\\nprimarily\\tO\\nfound\\tO\\nin\\tO\\nsomatodendritic\\tO\\nregions\\tO\\n.\\tO\\n\\nHuntingtin\\tO\\nappears\\tO\\nto\\tO\\nparticularly\\tO\\nassociate\\tO\\nwith\\tO\\nmicrotubules\\tO\\n,\\tO\\nalthough\\tO\\nsome\\tO\\nis\\tO\\nalso\\tO\\nassociated\\tO\\nwith\\tO\\nsynaptic\\tO\\nvesicles\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\nlocalization\\tO\\nof\\tO\\nhuntingtin\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\nmicrotubules\\tO\\n,\\tO\\nwe\\tO\\nspeculate\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\nimpairs\\tO\\nthe\\tO\\ncytoskeletal\\tO\\nanchoring\\tO\\nor\\tO\\ntransport\\tO\\nof\\tO\\nmitochondria\\tO\\n,\\tO\\nvesicles\\tO\\n,\\tO\\nor\\tO\\nother\\tO\\norganelles\\tO\\nor\\tO\\nmolecules\\tO\\n.\\tO\\n.\\tO\\n\\nMarked\\tO\\nphenotypic\\tO\\nheterogeneity\\tO\\nassociated\\tO\\nwith\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nCAG\\tO\\nrepeat\\tO\\nsequence\\tO\\nat\\tO\\nthe\\tO\\nspinocerebellar\\tB-Disease\\nataxia\\tI-Disease\\n3\\tI-Disease\\n/\\tI-Disease\\nMachado\\tI-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\nlocus\\tO\\n.\\tO\\n\\nThe\\tO\\nspinocerebellar\\tB-Disease\\nataxia\\tI-Disease\\n3\\tI-Disease\\nlocus\\tO\\n(\\tO\\nSCA3\\tB-Disease\\n)\\tO\\nfor\\tO\\ntype\\tB-Disease\\nI\\tI-Disease\\nautosomal\\tI-Disease\\ndominant\\tI-Disease\\ncerebellar\\tI-Disease\\nataxia\\tI-Disease\\n(\\tO\\nADCA\\tB-Disease\\ntype\\tI-Disease\\nI\\tI-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nclinically\\tO\\nand\\tO\\ngenetically\\tO\\nheterogeneous\\tO\\ngroup\\tO\\nof\\tO\\nneurodegenerative\\tB-Disease\\ndisorders\\tI-Disease\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nchromosome\\tO\\n14q32\\tO\\n.\\tO\\n\\n1\\tO\\n1\\tO\\n.\\tO\\n\\nADCA\\tB-Disease\\ntype\\tI-Disease\\nI\\tI-Disease\\npatients\\tO\\nfrom\\tO\\nfamilies\\tO\\nsegregating\\tO\\nSCA3\\tB-Disease\\nshare\\tO\\nclinical\\tO\\nfeatures\\tO\\nin\\tO\\ncommon\\tO\\nwith\\tO\\nthose\\tO\\nwith\\tO\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nMJD\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nof\\tO\\nwhich\\tO\\nmaps\\tO\\nto\\tO\\nthe\\tO\\nsame\\tO\\nregion\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nhere\\tO\\nthat\\tO\\nthe\\tO\\ndisease\\tO\\ngene\\tO\\nsegregating\\tO\\nin\\tO\\neach\\tO\\nof\\tO\\nthree\\tO\\nFrench\\tO\\nADCA\\tB-Disease\\ntype\\tI-Disease\\nI\\tI-Disease\\nkindreds\\tO\\nand\\tO\\nin\\tO\\na\\tO\\nFrench\\tO\\nfamily\\tO\\nwith\\tO\\nneuropathological\\tO\\nfindings\\tO\\nsuggesting\\tO\\nthe\\tO\\nataxochoreic\\tO\\nform\\tO\\nof\\tO\\ndentatorubropallidoluysian\\tB-Disease\\natrophy\\tI-Disease\\ncarries\\tO\\nan\\tO\\nexpanded\\tO\\nCAG\\tO\\nrepeat\\tO\\nsequence\\tO\\nlocated\\tO\\nat\\tO\\nthe\\tO\\nsame\\tO\\nlocus\\tO\\nas\\tO\\nthat\\tO\\nfor\\tO\\nMJD\\tB-Disease\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\nin\\tO\\nthese\\tO\\nfamilies\\tO\\nshows\\tO\\na\\tO\\nstrong\\tO\\nnegative\\tO\\ncorrelation\\tO\\nbetween\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\nexpanded\\tO\\nCAG\\tO\\nrepeat\\tO\\nand\\tO\\nage\\tO\\nat\\tO\\nonset\\tO\\nof\\tO\\nclinical\\tO\\ndisease\\tO\\n.\\tO\\n\\nInstability\\tO\\nof\\tO\\nthe\\tO\\nexpanded\\tO\\ntriplet\\tO\\nrepeat\\tO\\nwas\\tO\\nnot\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\naffected\\tO\\nby\\tO\\nsex\\tO\\nof\\tO\\nthe\\tO\\nparent\\tO\\ntransmitting\\tO\\nthe\\tO\\nmutation\\tO\\n.\\tO\\n\\nEvidence\\tO\\nwas\\tO\\nfound\\tO\\nfor\\tO\\nsomatic\\tO\\nand\\tO\\ngonadal\\tO\\nmosaicism\\tO\\nfor\\tO\\nalleles\\tO\\ncarrying\\tO\\nexpanded\\tO\\ntrinucleotide\\tO\\nrepeats\\tO\\n.\\tO\\n\\nOverexpression\\tO\\nof\\tO\\nDM20\\tO\\nmessenger\\tO\\nRNA\\tO\\nin\\tO\\ntwo\\tO\\nbrothers\\tO\\nwith\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\nis\\tO\\na\\tO\\nrare\\tB-Disease\\n,\\tI-Disease\\nsex\\tI-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\n,\\tI-Disease\\ndysmyelinating\\tI-Disease\\ndisease\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\ncentral\\tI-Disease\\nnervous\\tI-Disease\\nsystem\\tI-Disease\\nthat\\tO\\nhas\\tO\\nbeen\\tO\\nassociated\\tO\\nwith\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nmyelin\\tO\\nproteolipid\\tO\\nprotein\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nOnly\\tO\\n25\\tO\\n%\\tO\\nof\\tO\\npatients\\tO\\nstudied\\tO\\nwith\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\nhave\\tO\\nexonic\\tO\\nmutations\\tO\\nin\\tO\\nthis\\tO\\ngene\\tO\\n,\\tO\\nthe\\tO\\nunderlying\\tO\\ncause\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nin\\tO\\nthe\\tO\\nremaining\\tO\\npatients\\tO\\nis\\tO\\nunknown\\tO\\n.\\tO\\n\\nThe\\tO\\nPLP\\tO\\ngene\\tO\\nencodes\\tO\\ntwo\\tO\\nmajor\\tO\\nalternatively\\tO\\nspliced\\tO\\ntranscripts\\tO\\ncalled\\tO\\nPLP\\tO\\nand\\tO\\nDM20\\tO\\n.\\tO\\n\\nPLP\\tO\\nmessenger\\tO\\nRNA\\tO\\nis\\tO\\nspecifically\\tO\\nexpressed\\tO\\nin\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\ntissue\\tO\\n,\\tO\\nwhereas\\tO\\nDM20\\tO\\nmessenger\\tO\\nRNA\\tO\\nis\\tO\\nfound\\tO\\nin\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n,\\tO\\ncardiac\\tO\\n,\\tO\\nand\\tO\\nother\\tO\\ntissues\\tO\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\ncultured\\tO\\nskin\\tO\\nfibroblasts\\tO\\nfrom\\tO\\n2\\tO\\nbrothers\\tO\\nwith\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\nwho\\tO\\nexhibited\\tO\\nno\\tO\\ndetectable\\tO\\nexonic\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nPLP\\tO\\ngene\\tO\\n.\\tO\\n\\nExamination\\tO\\nof\\tO\\nRNA\\tO\\nfrom\\tO\\nthese\\tO\\ncells\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nlevel\\tO\\nof\\tO\\nDM20\\tO\\nmessenger\\tO\\nRNA\\tO\\nis\\tO\\nelevated\\tO\\nsixfold\\tO\\nrelative\\tO\\nto\\tO\\nmale\\tO\\ncontrol\\tO\\nskin\\tO\\nfibroblasts\\tO\\n.\\tO\\n\\nAn\\tO\\nunrelated\\tO\\nfemale\\tO\\ncarrier\\tO\\n,\\tO\\nalso\\tO\\nwith\\tO\\nno\\tO\\ndetectable\\tO\\nexonic\\tO\\nmutation\\tO\\n,\\tO\\nshowed\\tO\\na\\tO\\nthreefold\\tO\\nincrease\\tO\\nin\\tO\\nDM20\\tO\\nmessenger\\tO\\nRNA\\tO\\nin\\tO\\ncultured\\tO\\nskin\\tO\\nfibroblasts\\tO\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nin\\tO\\nsome\\tO\\npatients\\tO\\n,\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\noverexpression\\tO\\nof\\tO\\nPLP\\tO\\ngene\\tO\\ntranscripts\\tO\\n,\\tO\\nand\\tO\\nthat\\tO\\nin\\tO\\nthese\\tO\\nfamilies\\tO\\na\\tO\\n50\\tO\\n%\\tO\\nincrease\\tO\\nof\\tO\\nDM20\\tO\\nmessenger\\tO\\nRNA\\tO\\nin\\tO\\nfemales\\tO\\n,\\tO\\nrelative\\tO\\nto\\tO\\nthe\\tO\\nincrease\\tO\\nin\\tO\\naffected\\tO\\nmales\\tO\\n,\\tO\\ncan\\tO\\nidentify\\tO\\na\\tO\\nfemale\\tO\\ncarrier\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ncongenital\\tI-Disease\\nthrombocytopenia\\tI-Disease\\nare\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nthrombocytopenia\\tB-Disease\\n,\\tO\\nsmall\\tO\\nplatelets\\tO\\n,\\tO\\neczema\\tB-Disease\\n,\\tO\\nrecurrent\\tO\\ninfections\\tO\\n,\\tO\\nand\\tO\\nimmunodeficiency\\tB-Disease\\n.\\tO\\n\\nBesides\\tO\\nthe\\tO\\nclassic\\tO\\nWAS\\tB-Disease\\nphenotype\\tO\\n,\\tO\\nthere\\tO\\nis\\tO\\na\\tO\\ngroup\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\nX\\tI-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nthrombocytopenia\\tI-Disease\\n(\\tO\\nXLT\\tB-Disease\\n)\\tO\\nwho\\tO\\nhave\\tO\\nsmall\\tO\\nplatelets\\tO\\nbut\\tO\\nonly\\tO\\ntransient\\tO\\neczema\\tB-Disease\\n,\\tO\\nif\\tO\\nany\\tO\\n,\\tO\\nand\\tO\\nminimal\\tO\\nimmune\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nBecause\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nWAS\\tB-Disease\\nhas\\tO\\nbeen\\tO\\nsequenced\\tO\\n,\\tO\\nit\\tO\\nwas\\tO\\npossible\\tO\\nto\\tO\\ncorrelate\\tO\\nthe\\tO\\nWAS\\tB-Disease\\nphenotypes\\tO\\nwith\\tO\\nWAS\\tB-Disease\\ngene\\tO\\nmutations\\tO\\n.\\tO\\n\\nUsing\\tO\\na\\tO\\nfingerprinting\\tO\\nscreening\\tO\\ntechnique\\tO\\n,\\tO\\nwe\\tO\\ndetermined\\tO\\nthe\\tO\\napproximate\\tO\\nlocation\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\nin\\tO\\n13\\tO\\nunrelated\\tO\\nWAS\\tB-Disease\\npatients\\tO\\nwith\\tO\\nmild\\tO\\nto\\tO\\nsevere\\tO\\nclinical\\tO\\nsymptoms\\tO\\n.\\tO\\n\\nDirect\\tO\\nsequence\\tO\\nanalysis\\tO\\nof\\tO\\ncDNA\\tO\\nand\\tO\\ngenomic\\tO\\nDNA\\tO\\nobtained\\tO\\nfrom\\tO\\npatient\\tO\\n-\\tO\\nderived\\tO\\ncell\\tO\\nlines\\tO\\nshowed\\tO\\n12\\tO\\nunique\\tO\\nmutations\\tO\\ndistributed\\tO\\nthroughout\\tO\\nthe\\tO\\nWAS\\tB-Disease\\ngene\\tO\\n,\\tO\\nincluding\\tO\\ninsertions\\tO\\n,\\tO\\ndeletions\\tO\\n,\\tO\\nand\\tO\\npoint\\tO\\nmutations\\tO\\nresulting\\tO\\nin\\tO\\namino\\tO\\nacid\\tO\\nsubstitutions\\tO\\n,\\tO\\ntermination\\tO\\n,\\tO\\nexon\\tO\\nskipping\\tO\\n,\\tO\\nor\\tO\\nsplicing\\tO\\ndefects\\tO\\n.\\tO\\n\\nOf\\tO\\n4\\tO\\nunrelated\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nXLT\\tB-Disease\\nphenotype\\tO\\n,\\tO\\n3\\tO\\nhad\\tO\\nmissense\\tO\\nmutations\\tO\\naffecting\\tO\\nexon\\tO\\n2\\tO\\nand\\tO\\n1\\tO\\nhad\\tO\\na\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\naffecting\\tO\\nexon\\tO\\n9\\tO\\n.\\tO\\n\\nPatients\\tO\\nwith\\tO\\nclassic\\tO\\nWAS\\tB-Disease\\nhad\\tO\\nmore\\tO\\ncomplex\\tO\\nmutations\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\ntermination\\tO\\ncodons\\tO\\n,\\tO\\nframeshift\\tO\\n,\\tO\\nand\\tO\\nearly\\tO\\ntermination\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nprovide\\tO\\ndirect\\tO\\nevidence\\tO\\nthat\\tO\\nXLT\\tB-Disease\\nand\\tO\\nWAS\\tB-Disease\\nare\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\ngene\\tO\\nand\\tO\\nsuggest\\tO\\nthat\\tO\\nsevere\\tO\\nclinical\\tO\\nphenotypes\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\ncomplex\\tO\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nMyotonia\\tB-Disease\\nlevior\\tI-Disease\\nis\\tO\\na\\tO\\nchloride\\tB-Disease\\nchannel\\tI-Disease\\ndisorder\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ngroup\\tO\\nof\\tO\\ndominant\\tB-Disease\\nnon\\tI-Disease\\n-\\tI-Disease\\ndystrophic\\tI-Disease\\nmyotonias\\tI-Disease\\n,\\tO\\ncomprising\\tO\\ndisorders\\tO\\ncharacterized\\tO\\nby\\tO\\nclinically\\tO\\nsimilar\\tO\\nforms\\tO\\nof\\tO\\nmyogenic\\tO\\nmuscle\\tO\\nstiffness\\tO\\n,\\tO\\nis\\tO\\ngenetically\\tO\\ninhomogeneous\\tO\\n.\\tO\\n\\nDominant\\tB-Disease\\nmyotonia\\tI-Disease\\ncongenita\\tI-Disease\\n(\\tO\\nThomsens\\tB-Disease\\ndisease\\tI-Disease\\n)\\tO\\nis\\tO\\nlinked\\tO\\nto\\tO\\nCLCN1\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nencoding\\tO\\nthe\\tO\\nmajor\\tO\\nmuscle\\tO\\nchloride\\tO\\nchannel\\tO\\n,\\tO\\nlocalized\\tO\\non\\tO\\nchromosome\\tO\\n7q35\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\ndominant\\tB-Disease\\nmyotonias\\tI-Disease\\nsensitive\\tO\\nto\\tO\\npotassium\\tO\\nare\\tO\\ncaused\\tO\\nby\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nSCN4A\\tO\\non\\tO\\nchromosome\\tO\\n17q\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nthe\\tO\\nalpha\\tO\\nsubunit\\tO\\nof\\tO\\nthe\\tO\\nadult\\tO\\nskeletal\\tO\\nmuscle\\tO\\nsodium\\tO\\nchannel\\tO\\n.\\tO\\n\\nNo\\tO\\nlinkage\\tO\\nor\\tO\\nmolecular\\tO\\ngenetic\\tO\\ndata\\tO\\nare\\tO\\nas\\tO\\nyet\\tO\\navailable\\tO\\non\\tO\\nmyotonia\\tB-Disease\\nlevior\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nmilder\\tO\\nsymptoms\\tO\\nand\\tO\\nlater\\tO\\nonset\\tO\\nof\\tO\\nmyotonia\\tB-Disease\\nthan\\tO\\nin\\tO\\nThomsens\\tB-Disease\\ndisease\\tI-Disease\\n,\\tO\\nand\\tO\\nabsence\\tO\\nof\\tO\\nmuscle\\tB-Disease\\nhypertrophy\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\na\\tO\\nCLCN1\\tO\\nGln\\tO\\n-\\tO\\n552\\tO\\n-\\tO\\nArg\\tO\\nsubstitution\\tO\\nfor\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\ndominant\\tO\\ninheritance\\tO\\npreviously\\tO\\ndiagnosed\\tO\\nto\\tO\\nhave\\tO\\nmyotonia\\tB-Disease\\nlevior\\tI-Disease\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthis\\tO\\ndisorder\\tO\\nappears\\tO\\nas\\tO\\na\\tO\\nvariant\\tO\\nof\\tO\\nThomsens\\tB-Disease\\ndisease\\tI-Disease\\ndue\\tO\\nto\\tO\\nmutations\\tO\\nleading\\tO\\nto\\tO\\nlow\\tO\\nclinical\\tO\\nexpressivity\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\na\\tO\\nnovel\\tO\\nIle\\tO\\n-\\tO\\n290\\tO\\n-\\tO\\nMet\\tO\\nCLCN1\\tO\\nmutation\\tO\\nfor\\tO\\na\\tO\\ntypical\\tO\\nThomsen\\tO\\npedigree\\tO\\n.\\tO\\n\\nIn\\tO\\nanother\\tO\\nfamily\\tO\\npreviously\\tO\\ndiagnosed\\tO\\nas\\tO\\nhaving\\tO\\nThomsens\\tB-Disease\\ndisease\\tI-Disease\\n,\\tO\\nwe\\tO\\nunexpectedly\\tO\\nfound\\tO\\na\\tO\\nCLCN1\\tO\\n14\\tO\\nbp\\tO\\ndeletion\\tO\\nknown\\tO\\nto\\tO\\ncause\\tO\\nrecessive\\tB-Disease\\nmyotonia\\tI-Disease\\n,\\tO\\nand\\tO\\na\\tO\\nrare\\tO\\nTrp\\tO\\n-\\tO\\n118\\tO\\n-\\tO\\nGly\\tO\\npolymorphism\\tO\\n.\\tO\\n.\\tO\\n\\nSouthern\\tO\\nanalysis\\tO\\nreveals\\tO\\na\\tO\\nlarge\\tO\\ndeletion\\tO\\nat\\tO\\nthe\\tO\\nhypoxanthine\\tO\\nphosphoribosyltransferase\\tO\\nlocus\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nWhole\\tO\\ngenomic\\tO\\nhprt\\tO\\nclones\\tO\\nwere\\tO\\nused\\tO\\nin\\tO\\nSouthern\\tO\\nanalysis\\tO\\nto\\tO\\nscreen\\tO\\nthe\\tO\\nintegrity\\tO\\nof\\tO\\nthe\\tO\\nhprt\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nthat\\tO\\nincludes\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nHPRT\\tB-Disease\\nenzyme\\tI-Disease\\ndeficiency\\tI-Disease\\ncausal\\tO\\nto\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nA\\tO\\n5\\tO\\nkb\\tO\\nDNA\\tO\\nsequence\\tO\\ndeletion\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nits\\tO\\nendpoints\\tO\\nin\\tO\\nthe\\tO\\nfirst\\tO\\nand\\tO\\nthird\\tO\\nintrons\\tO\\n.\\tO\\n\\nThe\\tO\\nprobes\\tO\\nidentified\\tO\\nthe\\tO\\ncarrier\\tO\\nstatus\\tO\\nof\\tO\\nfemale\\tO\\nfamily\\tO\\nmembers\\tO\\n,\\tO\\naided\\tO\\nby\\tO\\nan\\tO\\nRFLP\\tO\\ncarried\\tO\\nby\\tO\\nthe\\tO\\nmothers\\tO\\nnormal\\tO\\nX\\tO\\n-\\tO\\nchromosome\\tO\\n.\\tO\\n.\\tO\\n\\nCharacterisation\\tO\\nof\\tO\\nmolecular\\tO\\ndefects\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\namelogenesis\\tI-Disease\\nimperfecta\\tI-Disease\\n(\\tO\\nAIH1\\tO\\n)\\tO\\n.\\tO\\n\\nAmelogenins\\tO\\nare\\tO\\nan\\tO\\nheterogenous\\tO\\nfamily\\tO\\nof\\tO\\nproteins\\tO\\nproduced\\tO\\nby\\tO\\nameloblasts\\tO\\nof\\tO\\nthe\\tO\\nenamel\\tO\\norgan\\tO\\nduring\\tO\\ntooth\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nDisturbances\\tO\\nof\\tO\\nenamel\\tO\\nformation\\tO\\noccur\\tO\\nin\\tO\\namelogenesis\\tB-Disease\\nimperfecta\\tI-Disease\\n,\\tO\\na\\tO\\nclinically\\tO\\nheterogenous\\tO\\ngroup\\tO\\nof\\tO\\ninherited\\tB-Disease\\ndisorders\\tI-Disease\\ncharacterised\\tO\\nby\\tO\\ndefective\\tO\\nenamel\\tO\\nbiomineralisation\\tO\\n.\\tO\\n\\nAn\\tO\\namelogenin\\tO\\ngene\\tO\\n,\\tO\\nAMGX\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\nshort\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n(\\tO\\nXp22\\tO\\n.\\tO\\n1\\tO\\n-\\tO\\np22\\tO\\n.\\tO\\n3\\tO\\n)\\tO\\nand\\tO\\nhas\\tO\\nbeen\\tO\\nimplicated\\tO\\nin\\tO\\nthe\\tO\\nmolecular\\tO\\npathology\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\namelogenesis\\tI-Disease\\nimperfecta\\tI-Disease\\n(\\tO\\nAIH1\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\nthree\\tO\\nfamilies\\tO\\nexhibiting\\tO\\nAIH1\\tB-Disease\\nand\\tO\\nscreened\\tO\\nthe\\tO\\nAMGX\\tO\\ngene\\tO\\nfor\\tO\\nmutations\\tO\\nusing\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformational\\tO\\npolymorphism\\tO\\nanalysis\\tO\\nand\\tO\\nDNA\\tO\\nsequencing\\tO\\n.\\tO\\n\\nThree\\tO\\nnovel\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\na\\tO\\nC\\tO\\n-\\tO\\nT\\tO\\nsubstitution\\tO\\nin\\tO\\nexon\\tO\\n5\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nG\\tO\\n-\\tO\\nT\\tO\\nsubstitution\\tO\\nand\\tO\\nsingle\\tO\\ncytosine\\tO\\ndeletion\\tO\\nin\\tO\\nexon\\tO\\n6\\tO\\n,\\tO\\nconfirming\\tO\\nthe\\tO\\nexistence\\tO\\nof\\tO\\nextensive\\tO\\nallelic\\tO\\nheterogeneity\\tO\\nin\\tO\\nthis\\tO\\ncondition\\tO\\n.\\tO\\n\\nThe\\tO\\nidentification\\tO\\nof\\tO\\nfamily\\tO\\n-\\tO\\nspecific\\tO\\nmutations\\tO\\nwill\\tO\\nenable\\tO\\nearly\\tO\\nidentification\\tO\\nof\\tO\\naffected\\tO\\nindividuals\\tO\\nand\\tO\\ncorrelation\\tO\\nof\\tO\\nclinical\\tO\\nphenotype\\tO\\nwith\\tO\\ngenotype\\tO\\nwill\\tO\\nfacilitate\\tO\\nan\\tO\\nobjective\\tO\\nsystem\\tO\\nof\\tO\\ndisease\\tO\\nclassification\\tO\\n.\\tO\\n\\nFrequency\\tO\\nof\\tO\\nexon\\tO\\n15\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\n442D\\tO\\n:\\tO\\nG\\tO\\n)\\tO\\nin\\tO\\ncholesteryl\\tO\\nester\\tO\\ntransfer\\tO\\nprotein\\tO\\ngene\\tO\\nin\\tO\\nhyperalphalipoproteinemic\\tB-Disease\\nJapanese\\tO\\nsubjects\\tO\\n.\\tO\\n\\nCholesteryl\\tO\\nester\\tO\\ntransfer\\tO\\nprotein\\tO\\n(\\tO\\nCETP\\tO\\n)\\tO\\ntransfers\\tO\\ncholesteryl\\tO\\nester\\tO\\nfrom\\tO\\nhigh\\tO\\ndensity\\tO\\nlipoprotein\\tO\\n(\\tO\\nHDL\\tO\\n)\\tO\\nto\\tO\\napo\\tO\\nB\\tO\\n-\\tO\\ncontaining\\tO\\nlipoproteins\\tO\\n.\\tO\\n\\nThe\\tO\\nhyperalphalipoproteinemia\\tB-Disease\\ncaused\\tO\\nby\\tO\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nfairly\\tO\\ncommon\\tO\\nin\\tO\\nJapan\\tO\\nand\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nCETP\\tO\\ngene\\tO\\nis\\tO\\nthe\\tO\\nsplicing\\tO\\ndefect\\tO\\nof\\tO\\nthe\\tO\\nintron\\tO\\n14\\tO\\n,\\tO\\nthe\\tO\\nallelic\\tO\\nfrequency\\tO\\nof\\tO\\nwhich\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\n0\\tO\\n.\\tO\\n\\n0049\\tO\\nin\\tO\\nthe\\tO\\nJapanese\\tO\\ngeneral\\tO\\npopulation\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nreported\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n15\\tO\\nof\\tO\\nthe\\tO\\nCETP\\tO\\ngene\\tO\\n(\\tO\\n442D\\tO\\nG\\tO\\n)\\tO\\n,\\tO\\nshowing\\tO\\na\\tO\\ndominant\\tO\\neffect\\tO\\non\\tO\\nthe\\tO\\nCETP\\tO\\nactivity\\tO\\nand\\tO\\nHDL\\tO\\n-\\tO\\ncholesterol\\tO\\nlevel\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\ncurrent\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\ndetermined\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nthis\\tO\\nnew\\tO\\nmutation\\tO\\nin\\tO\\nJapanese\\tO\\nhyperalphalipoproteinemic\\tB-Disease\\n(\\tO\\nHDL\\tO\\n-\\tO\\ncholesterol\\tO\\n>\\tO\\nor\\tO\\n=\\tO\\n100\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n)\\tO\\nsubjects\\tO\\n.\\tO\\n\\nA\\tO\\nrapid\\tO\\nand\\tO\\neasy\\tO\\nscreening\\tO\\nmethod\\tO\\nfor\\tO\\nthis\\tO\\nnew\\tO\\nmutation\\tO\\nwas\\tO\\ndeveloped\\tO\\nusing\\tO\\na\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\n-\\tO\\nmediated\\tO\\nsite\\tO\\n-\\tO\\ndirected\\tO\\nmutagenesis\\tO\\n.\\tO\\n\\nAmong\\tO\\n117\\tO\\nJapanese\\tO\\nhyperalphalipoproteinemic\\tB-Disease\\nsubjects\\tO\\n(\\tO\\nHDL\\tO\\n-\\tO\\ncholesterol\\tO\\n;\\tO\\n116\\tO\\n.\\tO\\n7\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n16\\tO\\n.\\tO\\n5\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n,\\tO\\nmean\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\nS\\tO\\n.\\tO\\nD\\tO\\n.\\tO\\n)\\tO\\nwithout\\tO\\nthe\\tO\\nintron\\tO\\n14\\tO\\nsplice\\tO\\ndefect\\tO\\n,\\tO\\nthree\\tO\\nhomozygotes\\tO\\n(\\tO\\n2\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\n34\\tO\\nheterozygotes\\tO\\n(\\tO\\n29\\tO\\n.\\tO\\n1\\tO\\n%\\tO\\n)\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nthe\\tO\\n442D\\tO\\nG\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nrelative\\tO\\nallelic\\tO\\nfrequency\\tO\\nof\\tO\\nthis\\tO\\nmutation\\tO\\nwas\\tO\\ncalculated\\tO\\nto\\tO\\nbe\\tO\\n0\\tO\\n.\\tO\\n\\n17\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthe\\tO\\nhomozygotes\\tO\\nfor\\tO\\nthe\\tO\\n442D\\tO\\nG\\tO\\nmutation\\tO\\nwas\\tO\\nthe\\tO\\npatient\\tO\\npreviously\\tO\\ndescribed\\tO\\nby\\tO\\nus\\tO\\nas\\tO\\nhaving\\tO\\nhyperalphalipoproteinemia\\tB-Disease\\nwith\\tO\\ncorneal\\tB-Disease\\nopacity\\tI-Disease\\nand\\tO\\ncoronary\\tB-Disease\\nheart\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nwas\\tO\\nthe\\tO\\nfirst\\tO\\nreported\\tO\\nsubject\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\nwho\\tO\\nalso\\tO\\ndemonstrated\\tO\\natherosclerotic\\tB-Disease\\nsymptoms\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nhomozygous\\tO\\nsubjects\\tO\\n,\\tO\\nCETP\\tO\\nactivity\\tO\\nranged\\tO\\nfrom\\tO\\n37\\tO\\n%\\tO\\nto\\tO\\n62\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nvalue\\tO\\n,\\tO\\nwhich\\tO\\nwas\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nresults\\tO\\nobtained\\tO\\nfrom\\tO\\nthe\\tO\\ntransient\\tO\\nexpression\\tO\\nexperiment\\tO\\npreviously\\tO\\nreported\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nthe\\tO\\nspecific\\tO\\nactivity\\tO\\nof\\tO\\nCETP\\tO\\nwas\\tO\\nnot\\tO\\nas\\tO\\nlow\\tO\\nas\\tO\\nexpected\\tO\\n.\\tO\\n\\n(\\tO\\nABSTRACT\\tO\\nTRUNCATED\\tO\\nAT\\tO\\n250\\tO\\nWORDS\\tO\\n)\\tO\\n\\nMucopolysaccharidosis\\tB-Disease\\ntype\\tI-Disease\\nIVA\\tI-Disease\\n:\\tO\\ncommon\\tO\\ndouble\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\nN\\tO\\n-\\tO\\nacetylgalactosamine\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nsulfatase\\tO\\ngene\\tO\\n(\\tO\\nGALNS\\tO\\n)\\tO\\n.\\tO\\n\\nMucopolysaccharidosis\\tB-Disease\\nIVA\\tI-Disease\\n(\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nin\\tI-Disease\\nN\\tI-Disease\\n-\\tI-Disease\\nacetylgalactosamine\\tI-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nsulfatase\\tI-Disease\\n(\\tO\\nGALNS\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\ntwo\\tO\\nseparate\\tO\\ndeletions\\tO\\nof\\tO\\nnearly\\tO\\n8\\tO\\n.\\tO\\n\\n0\\tO\\nand\\tO\\n6\\tO\\n.\\tO\\n\\n0\\tO\\nkb\\tO\\nin\\tO\\nthe\\tO\\nGALNS\\tO\\ngene\\tO\\n,\\tO\\nincluding\\tO\\nsome\\tO\\nexons\\tO\\n.\\tO\\n\\nThere\\tO\\nare\\tO\\nAlu\\tO\\nrepetitive\\tO\\nelements\\tO\\nnear\\tO\\nthe\\tO\\nbreakpoints\\tO\\nof\\tO\\nthe\\tO\\n8\\tO\\n.\\tO\\n\\n0\\tO\\n-\\tO\\nkb\\tO\\ndeletion\\tO\\n,\\tO\\nand\\tO\\nthis\\tO\\ndeletion\\tO\\nresulted\\tO\\nfrom\\tO\\nan\\tO\\nAlu\\tO\\n-\\tO\\nAlu\\tO\\nrecombination\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\n6\\tO\\n.\\tO\\n\\n0\\tO\\n-\\tO\\nkb\\tO\\ndeletion\\tO\\ninvolved\\tO\\nillegitimate\\tO\\nrecombinational\\tO\\nevents\\tO\\nbetween\\tO\\nincomplete\\tO\\nshort\\tO\\ndirect\\tO\\nrepeats\\tO\\nof\\tO\\n8\\tO\\nbp\\tO\\nat\\tO\\ndeletion\\tO\\nbreakpoints\\tO\\n.\\tO\\n\\nThe\\tO\\nsame\\tO\\nrearrangement\\tO\\nhas\\tO\\nbeen\\tO\\nobserved\\tO\\nin\\tO\\na\\tO\\nheteroallelic\\tO\\nstate\\tO\\nin\\tO\\nfour\\tO\\nunrelated\\tO\\npatients\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\ndocumentation\\tO\\nof\\tO\\na\\tO\\ncommon\\tO\\ndouble\\tO\\ndeletion\\tO\\na\\tO\\ngene\\tO\\nthat\\tO\\nis\\tO\\nnot\\tO\\na\\tO\\nmember\\tO\\nof\\tO\\na\\tO\\ngene\\tO\\ncluster\\tO\\n.\\tO\\n\\nDetection\\tO\\nof\\tO\\neight\\tO\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\n10\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n,\\tO\\nincluding\\tO\\n1\\tO\\nfamily\\tO\\nwith\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nGenetic\\tO\\nepidemiological\\tO\\nevidence\\tO\\nsuggests\\tO\\nthat\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\nmay\\tO\\nbe\\tO\\nresponsible\\tO\\nfor\\tO\\napproximately\\tO\\none\\tO\\nhalf\\tO\\nof\\tO\\nearly\\tO\\nonset\\tO\\nfamilial\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nfamilial\\tB-Disease\\nbreast\\tI-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nrecent\\tO\\ncloning\\tO\\nof\\tO\\nBRCA1\\tO\\nallows\\tO\\nfor\\tO\\nthe\\tO\\ndirect\\tO\\ndetection\\tO\\nof\\tO\\nmutations\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nfeasibility\\tO\\nof\\tO\\npresymptomatic\\tO\\nscreening\\tO\\nfor\\tO\\ncancer\\tB-Disease\\nsusceptibility\\tO\\nis\\tO\\nunknown\\tO\\n.\\tO\\n\\nWe\\tO\\nanalyzed\\tO\\ngenomic\\tO\\nDNA\\tO\\nfrom\\tO\\none\\tO\\naffected\\tO\\nindividual\\tO\\nfrom\\tO\\neach\\tO\\nof\\tO\\n24\\tO\\nfamilies\\tO\\nwith\\tO\\nat\\tO\\nleast\\tO\\nthree\\tO\\ncases\\tO\\nof\\tO\\novarian\\tB-Disease\\nor\\tI-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nusing\\tO\\nSSCP\\tO\\nassays\\tO\\n.\\tO\\n\\nVariant\\tO\\nSSCP\\tO\\nbands\\tO\\nwere\\tO\\nsubcloned\\tO\\nand\\tO\\nsequenced\\tO\\n.\\tO\\n\\nAllele\\tO\\n-\\tO\\nspecific\\tO\\noligonucleotide\\tO\\nhybridization\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nverify\\tO\\nsequence\\tO\\nchanges\\tO\\nand\\tO\\nto\\tO\\nscreen\\tO\\nDNA\\tO\\nfrom\\tO\\ncontrol\\tO\\nindividuals\\tO\\n.\\tO\\n\\nSix\\tO\\nframeshift\\tO\\nand\\tO\\ntwo\\tO\\nmissense\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\n10\\tO\\ndifferent\\tO\\nfamilies\\tO\\n.\\tO\\n\\nA\\tO\\nframeshift\\tO\\nmutation\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\na\\tO\\nmale\\tO\\nproband\\tO\\naffected\\tO\\nwith\\tO\\nboth\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nA\\tO\\n40\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwho\\tO\\ndeveloped\\tO\\nintra\\tB-Disease\\n-\\tI-Disease\\nabdominal\\tI-Disease\\ncarcinomatosis\\tI-Disease\\n1\\tO\\nyear\\tO\\nafter\\tO\\nprophylactic\\tO\\noophorectomy\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\ndetected\\tO\\nthroughout\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nonly\\tO\\none\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nmore\\tO\\nthan\\tO\\na\\tO\\nsingle\\tO\\nfamily\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nprovide\\tO\\nfurther\\tO\\nevidence\\tO\\nthat\\tO\\ninherited\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ncan\\tO\\noccur\\tO\\nas\\tO\\na\\tO\\nconsequence\\tO\\nof\\tO\\na\\tO\\nwide\\tO\\narray\\tO\\nof\\tO\\nBRCA1\\tO\\nmutations\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggests\\tO\\nthat\\tO\\ndevelopment\\tO\\nof\\tO\\na\\tO\\nscreening\\tO\\ntest\\tO\\nfor\\tO\\nBRCA1\\tO\\nmutations\\tO\\nwill\\tO\\nbe\\tO\\ntechnically\\tO\\nchallenging\\tO\\n.\\tO\\n\\nThe\\tO\\nfinding\\tO\\nof\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nnot\\tO\\npreviously\\tO\\nthought\\tO\\nto\\tO\\nbe\\tO\\nrelated\\tO\\nto\\tO\\nBRCA1\\tO\\n,\\tO\\nalso\\tO\\nillustrates\\tO\\nthe\\tO\\npotential\\tO\\ndifficulties\\tO\\nof\\tO\\ngenetic\\tO\\ncounseling\\tO\\nfor\\tO\\nindividuals\\tO\\nknown\\tO\\nto\\tO\\ncarry\\tO\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nNatural\\tO\\nselection\\tO\\nof\\tO\\nhemi\\tO\\n-\\tO\\nand\\tO\\nheterozygotes\\tO\\nfor\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nAfrica\\tO\\nby\\tO\\nresistance\\tO\\nto\\tO\\nsevere\\tO\\nmalaria\\tB-Disease\\n.\\tO\\n\\nGlucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nenzymopathy\\tB-Disease\\nof\\tO\\nhumans\\tO\\n,\\tO\\naffects\\tO\\nover\\tO\\n400\\tO\\nmillion\\tO\\npeople\\tO\\n.\\tO\\n\\nThe\\tO\\ngeographical\\tO\\ncorrelation\\tO\\nof\\tO\\nits\\tO\\ndistribution\\tO\\nwith\\tO\\nthe\\tO\\nhistorical\\tO\\nendemicity\\tO\\nof\\tO\\nmalaria\\tB-Disease\\nsuggests\\tO\\nthat\\tO\\nthis\\tO\\ndisorder\\tO\\nhas\\tO\\nrisen\\tO\\nin\\tO\\nfrequency\\tO\\nthrough\\tO\\nnatural\\tO\\nselection\\tO\\nby\\tO\\nmalaria\\tB-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nattempts\\tO\\nto\\tO\\nconfirm\\tO\\nthat\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nprotective\\tO\\nin\\tO\\ncase\\tO\\n-\\tO\\ncontrol\\tO\\nstudies\\tO\\nof\\tO\\nmalaria\\tB-Disease\\nhave\\tO\\nyielded\\tO\\nconflicting\\tO\\nresults\\tO\\n.\\tO\\n\\nHence\\tO\\n,\\tO\\nfor\\tO\\nthis\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndisorder\\tI-Disease\\n,\\tO\\nit\\tO\\nis\\tO\\nunclear\\tO\\nwhether\\tO\\nboth\\tO\\nmale\\tO\\nhemizygotes\\tO\\nand\\tO\\nfemale\\tO\\nheterozygotes\\tO\\nare\\tO\\nprotected\\tO\\nor\\tO\\n,\\tO\\nas\\tO\\nfrequently\\tO\\nsuggested\\tO\\n,\\tO\\nonly\\tO\\nfemales\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nhow\\tO\\nmuch\\tO\\nprotection\\tO\\nmay\\tO\\nbe\\tO\\nafforded\\tO\\nis\\tO\\nunknown\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\n,\\tO\\nin\\tO\\ntwo\\tO\\nlarge\\tO\\ncase\\tO\\n-\\tO\\ncontrol\\tO\\nstudies\\tO\\nof\\tO\\nover\\tO\\n2\\tO\\n,\\tO\\n000\\tO\\nAfrican\\tO\\nchildren\\tO\\n,\\tO\\nthe\\tO\\ncommon\\tO\\nAfrican\\tO\\nform\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nG6PD\\tB-Disease\\nA\\tI-Disease\\n-\\tI-Disease\\n)\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\n46\\tO\\n-\\tO\\n58\\tO\\n%\\tO\\nreduction\\tO\\nin\\tO\\nrisk\\tO\\nof\\tO\\nsevere\\tO\\nmalaria\\tB-Disease\\nfor\\tO\\nboth\\tO\\nfemale\\tO\\nheterozygotes\\tO\\nand\\tO\\nmale\\tO\\nhemizygotes\\tO\\n.\\tO\\n\\nA\\tO\\nmathematical\\tO\\nmodel\\tO\\nincorporating\\tO\\nthe\\tO\\nmeasured\\tO\\nselective\\tO\\nadvantage\\tO\\nagainst\\tO\\nmalaria\\tB-Disease\\nsuggests\\tO\\nthat\\tO\\na\\tO\\ncounterbalancing\\tO\\nselective\\tO\\ndisadvantage\\tO\\n,\\tO\\nassociated\\tO\\nwith\\tO\\nthis\\tO\\nenzyme\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nhas\\tO\\nretarded\\tO\\nits\\tO\\nrise\\tO\\nin\\tO\\nfrequency\\tO\\nin\\tO\\nmalaria\\tB-Disease\\n-\\tO\\nendemic\\tO\\nregions\\tO\\n.\\tO\\n\\nAlthough\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nnow\\tO\\nregarded\\tO\\nas\\tO\\na\\tO\\ngenerally\\tO\\nbenign\\tO\\ndisorder\\tO\\n,\\tO\\nin\\tO\\nearlier\\tO\\nenvironmental\\tO\\nconditions\\tO\\nit\\tO\\ncould\\tO\\nhave\\tO\\nbeen\\tO\\nsignificantly\\tO\\ndisadvantageous\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nalveolar\\tB-Disease\\nrhabdomyosarcoma\\tI-Disease\\nPAX3\\tO\\n/\\tO\\nFKHR\\tO\\nfusion\\tO\\nprotein\\tO\\nis\\tO\\na\\tO\\ntranscriptional\\tO\\nactivator\\tO\\n.\\tO\\n\\nChimeric\\tO\\ntranscription\\tO\\nfactors\\tO\\n,\\tO\\ncreated\\tO\\nby\\tO\\ngene\\tO\\nfusions\\tO\\nas\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\nchromosomal\\tO\\ntranslocations\\tO\\n,\\tO\\nhave\\tO\\nbeen\\tO\\nimplicated\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nseveral\\tO\\npathologically\\tO\\ndisparate\\tO\\nsolid\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nPAX3\\tO\\n/\\tO\\nFKHR\\tO\\nfusion\\tO\\ngene\\tO\\n,\\tO\\nformed\\tO\\nby\\tO\\na\\tO\\nt\\tO\\n(\\tO\\n2\\tO\\n;\\tO\\n13\\tO\\n)\\tO\\n(\\tO\\nq35\\tO\\n;\\tO\\nq14\\tO\\n)\\tO\\nin\\tO\\nalveolar\\tB-Disease\\nrhabdomyosarcoma\\tI-Disease\\n,\\tO\\nencodes\\tO\\na\\tO\\nhybrid\\tO\\nprotein\\tO\\nthat\\tO\\ncontains\\tO\\nboth\\tO\\nPAX3\\tO\\nDNA\\tO\\nbinding\\tO\\ndomains\\tO\\n,\\tO\\nthe\\tO\\npaired\\tO\\nbox\\tO\\nand\\tO\\nhomeodomain\\tO\\n,\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nbisected\\tO\\nDNA\\tO\\nbinding\\tO\\ndomain\\tO\\nof\\tO\\nFKHR\\tO\\n,\\tO\\na\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\nforkhead\\tO\\nfamily\\tO\\nof\\tO\\ntranscription\\tO\\nfactors\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\nPAX3\\tO\\nand\\tO\\nPAX3\\tO\\n/\\tO\\nFKHR\\tO\\ndisplay\\tO\\nsimilar\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nidentical\\tO\\ntransactivation\\tO\\nactivities\\tO\\nwhen\\tO\\ntested\\tO\\nwith\\tO\\nmodel\\tO\\nPax\\tO\\nrecognition\\tO\\nsequences\\tO\\n.\\tO\\n\\nNo\\tO\\nfunctional\\tO\\nrole\\tO\\ncould\\tO\\nbe\\tO\\nascribed\\tO\\nsolely\\tO\\nto\\tO\\nthe\\tO\\nresidual\\tO\\nFKHR\\tO\\nbinding\\tO\\ndomain\\tO\\npresent\\tO\\nin\\tO\\nthe\\tO\\nfusion\\tO\\nprotein\\tO\\n,\\tO\\nbut\\tO\\nFKHR\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\ncontribute\\tO\\na\\tO\\nstrong\\tO\\ncarboxyl\\tO\\nterminal\\tO\\nactivation\\tO\\ndomain\\tO\\nreplacing\\tO\\nthe\\tO\\none\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\nunrearranged\\tO\\nPAX3\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nnative\\tO\\nPAX3\\tO\\n/\\tO\\nFKHR\\tO\\nprotein\\tO\\npresent\\tO\\nin\\tO\\ntumor\\tB-Disease\\ncells\\tO\\nwith\\tO\\nthis\\tO\\ntranslocation\\tO\\nhas\\tO\\ntranscriptional\\tO\\ncharacteristics\\tO\\nsimilar\\tO\\nto\\tO\\nthe\\tO\\nin\\tO\\nvitro\\tO\\nexpressed\\tO\\nprotein\\tO\\n.\\tO\\n\\nThe\\tO\\nability\\tO\\nof\\tO\\nthe\\tO\\nPAX3\\tO\\n/\\tO\\nFKHR\\tO\\nhybrid\\tO\\nprotein\\tO\\nto\\tO\\nbind\\tO\\nDNA\\tO\\nin\\tO\\na\\tO\\nsequence\\tO\\nspecific\\tO\\nmanner\\tO\\nand\\tO\\nto\\tO\\ntransactivate\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nartificial\\tO\\nreporter\\tO\\ngenes\\tO\\nsuggests\\tO\\nthat\\tO\\nits\\tO\\naberrant\\tO\\nexpression\\tO\\ncould\\tO\\nsubvert\\tO\\nthe\\tO\\ntranscriptional\\tO\\nprograms\\tO\\nthat\\tO\\nnormally\\tO\\ncontrol\\tO\\nthe\\tO\\ngrowth\\tO\\n,\\tO\\ndifferentiation\\tO\\n,\\tO\\nand\\tO\\nsurvival\\tO\\nof\\tO\\nprimitive\\tO\\nmyogenic\\tO\\nprecursors\\tO\\nin\\tO\\nvivo\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\np16INK4a\\tO\\n-\\tO\\ninsensitive\\tO\\nCDK4\\tO\\nmutant\\tO\\ntargeted\\tO\\nby\\tO\\ncytolytic\\tO\\nT\\tO\\nlymphocytes\\tO\\nin\\tO\\na\\tO\\nhuman\\tO\\nmelanoma\\tB-Disease\\n.\\tO\\n\\nA\\tO\\nmutated\\tO\\ncyclin\\tO\\n-\\tO\\ndependent\\tO\\nkinase\\tO\\n4\\tO\\n(\\tO\\nCDK4\\tO\\n)\\tO\\nwas\\tO\\nidentified\\tO\\nas\\tO\\na\\tO\\ntumor\\tB-Disease\\n-\\tO\\nspecific\\tO\\nantigen\\tO\\nrecognized\\tO\\nby\\tO\\nHLA\\tO\\n-\\tO\\nA2\\tO\\n.\\tO\\n\\n1\\tO\\n-\\tO\\nrestricted\\tO\\nautologous\\tO\\ncytolytic\\tO\\nT\\tO\\nlymphocytes\\tO\\n(\\tO\\nCTLs\\tO\\n)\\tO\\nin\\tO\\na\\tO\\nhuman\\tO\\nmelanoma\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nmutated\\tO\\nCDK4\\tO\\nallele\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\nautologous\\tO\\ncultured\\tO\\nmelanoma\\tB-Disease\\ncells\\tO\\nand\\tO\\nmetastasis\\tO\\ntissue\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nin\\tO\\nthe\\tO\\npatients\\tO\\nlymphocytes\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\n,\\tO\\nan\\tO\\narginine\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\ncysteine\\tO\\nexchange\\tO\\nat\\tO\\nresidue\\tO\\n24\\tO\\n,\\tO\\nwas\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nCDK4\\tO\\npeptide\\tO\\nrecognized\\tO\\nby\\tO\\nCTLs\\tO\\nand\\tO\\nprevented\\tO\\nbinding\\tO\\nof\\tO\\nthe\\tO\\nCDK4\\tO\\ninhibitor\\tO\\np16INK4a\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nof\\tO\\np21\\tO\\nor\\tO\\nof\\tO\\np27KIP1\\tO\\n.\\tO\\n\\nThe\\tO\\nsame\\tO\\nmutation\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\none\\tO\\nadditional\\tO\\nmelanoma\\tB-Disease\\namong\\tO\\n28\\tO\\nmelanomas\\tB-Disease\\nanalyzed\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nmutation\\tO\\nof\\tO\\nCDK4\\tO\\ncan\\tO\\ncreate\\tO\\na\\tO\\ntumor\\tB-Disease\\n-\\tO\\nspecific\\tO\\nantigen\\tO\\nand\\tO\\ncan\\tO\\ndisrupt\\tO\\nthe\\tO\\ncell\\tO\\n-\\tO\\ncycle\\tO\\nregulation\\tO\\nexerted\\tO\\nby\\tO\\nthe\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\np16INK4a\\tO\\n.\\tO\\n.\\tO\\n\\nRapid\\tO\\ndetection\\tO\\nof\\tO\\nBRCA1\\tO\\nmutations\\tO\\nby\\tO\\nthe\\tO\\nprotein\\tO\\ntruncation\\tO\\ntest\\tO\\n.\\tO\\n\\nMore\\tO\\nthan\\tO\\n75\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nreported\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ngene\\tO\\n,\\tO\\nBRCA1\\tO\\n,\\tO\\nresult\\tO\\nin\\tO\\ntruncated\\tO\\nproteins\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nused\\tO\\nthe\\tO\\nprotein\\tO\\ntruncation\\tO\\ntest\\tO\\n(\\tO\\nPTT\\tO\\n)\\tO\\nto\\tO\\nscreen\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nexon\\tO\\n11\\tO\\n,\\tO\\nwhich\\tO\\nencodes\\tO\\n61\\tO\\n%\\tO\\nof\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nIn\\tO\\n45\\tO\\npatients\\tO\\nfrom\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nwe\\tO\\nfound\\tO\\nsix\\tO\\nnovel\\tO\\nmutations\\tO\\ntwo\\tO\\nsingle\\tO\\nnucleotide\\tO\\ninsertions\\tO\\n,\\tO\\nthree\\tO\\nsmall\\tO\\ndeletions\\tO\\n(\\tO\\n1\\tO\\n-\\tO\\n5\\tO\\nbp\\tO\\n)\\tO\\nand\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\nidentified\\tO\\ntwo\\tO\\nunrelated\\tO\\nfamilies\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nwe\\tO\\nwere\\tO\\nable\\tO\\nto\\tO\\namplify\\tO\\nthe\\tO\\nremaining\\tO\\ncoding\\tO\\nregion\\tO\\nby\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nusing\\tO\\nlymphocyte\\tO\\nRNA\\tO\\n.\\tO\\n\\nCombined\\tO\\nwith\\tO\\nPTT\\tO\\n,\\tO\\nwe\\tO\\ndetected\\tO\\naberrantly\\tO\\nspliced\\tO\\nproducts\\tO\\naffecting\\tO\\nexons\\tO\\n5\\tO\\nand\\tO\\n6\\tO\\nin\\tO\\none\\tO\\nof\\tO\\ntwo\\tO\\nBRCA1\\tO\\n-\\tO\\nlinked\\tO\\nfamilies\\tO\\nexamined\\tO\\n.\\tO\\n\\nThe\\tO\\nprotein\\tO\\ntruncation\\tO\\ntest\\tO\\npromises\\tO\\nto\\tO\\nbecome\\tO\\na\\tO\\nvaluable\\tO\\ntechnique\\tO\\nin\\tO\\ndetecting\\tO\\nBRCA1\\tO\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nCloning\\tO\\nof\\tO\\nhuman\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nacyl\\tO\\n-\\tO\\ncoenzyme\\tO\\nA\\tO\\ndehydrogenase\\tO\\nand\\tO\\nmolecular\\tO\\ncharacterization\\tO\\nof\\tO\\nits\\tO\\ndeficiency\\tO\\nin\\tO\\ntwo\\tO\\npatients\\tO\\n.\\tO\\n\\nTwo\\tO\\noverlapping\\tO\\ncDNA\\tO\\nclones\\tO\\n(\\tO\\n1\\tO\\n,\\tO\\n991\\tO\\nbp\\tO\\nand\\tO\\n736\\tO\\nbp\\tO\\n,\\tO\\nrespectively\\tO\\n)\\tO\\nencoding\\tO\\nthe\\tO\\nprecursor\\tO\\nof\\tO\\nhuman\\tO\\nmitochondrial\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nacyl\\tO\\n-\\tO\\ncoenzyme\\tO\\nA\\tO\\ndehydrogenase\\tO\\n(\\tO\\nVLCAD\\tO\\n)\\tO\\nwere\\tO\\ncloned\\tO\\nand\\tO\\nsequenced\\tO\\n.\\tO\\n\\nThe\\tO\\ncDNA\\tO\\ninserts\\tO\\nof\\tO\\nthese\\tO\\nclones\\tO\\ntogether\\tO\\nencompass\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\n2\\tO\\n,\\tO\\n177\\tO\\nbases\\tO\\n,\\tO\\nencoding\\tO\\nthe\\tO\\nentire\\tO\\nprotein\\tO\\nof\\tO\\n655\\tO\\namino\\tO\\nacids\\tO\\n,\\tO\\nincluding\\tO\\na\\tO\\n40\\tO\\n-\\tO\\namino\\tO\\nacid\\tO\\nleader\\tO\\npeptide\\tO\\nand\\tO\\na\\tO\\n615\\tO\\n-\\tO\\namino\\tO\\nacid\\tO\\nmature\\tO\\npolypeptide\\tO\\n.\\tO\\n\\nPCR\\tO\\n-\\tO\\namplified\\tO\\nVLCAD\\tO\\ncDNAs\\tO\\nwere\\tO\\nsequenced\\tO\\nin\\tO\\ncultured\\tO\\nfibroblasts\\tO\\nfrom\\tO\\ntwo\\tO\\nVLCAD\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\nboth\\tO\\npatients\\tO\\n,\\tO\\na\\tO\\n105\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nencompassing\\tO\\nbases\\tO\\n1078\\tO\\n-\\tO\\n1182\\tO\\nin\\tO\\nVLCAD\\tO\\ncDNA\\tO\\nwas\\tO\\nidentified\\tO\\n.\\tO\\n\\nThe\\tO\\ndeletion\\tO\\nseems\\tO\\nto\\tO\\noccur\\tO\\ndue\\tO\\nto\\tO\\nexon\\tO\\nskipping\\tO\\nduring\\tO\\nprocessing\\tO\\nof\\tO\\nVLCAD\\tO\\npre\\tO\\n-\\tO\\nmRNA\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\ndemonstration\\tO\\nof\\tO\\na\\tO\\nmutation\\tO\\ncausing\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nQuantitative\\tO\\ncDNA\\tO\\nexpression\\tO\\nof\\tO\\nnormal\\tO\\nhuman\\tO\\nVLCAD\\tO\\nwas\\tO\\nperformed\\tO\\nin\\tO\\nthe\\tO\\npatients\\tO\\nfibroblasts\\tO\\n,\\tO\\nusing\\tO\\nvaccinia\\tO\\nviral\\tO\\nsystem\\tO\\n,\\tO\\nwhich\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nnormal\\tI-Disease\\nVLCAD\\tI-Disease\\nprotein\\tI-Disease\\ncauses\\tO\\nimpaired\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nfatty\\tO\\nacid\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\nactivity\\tO\\nin\\tO\\nthe\\tO\\npatients\\tO\\nfibroblasts\\tO\\n.\\tO\\n\\nIn\\tO\\npatient\\tO\\nfibroblasts\\tO\\n,\\tO\\nraising\\tO\\nVLCAD\\tO\\nactivity\\tO\\nto\\tO\\napproximately\\tO\\n20\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\ncontrol\\tO\\nfibroblast\\tO\\nactivity\\tO\\nraised\\tO\\npalmitic\\tO\\nacid\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\nflux\\tO\\nto\\tO\\nthe\\tO\\nlevel\\tO\\nfound\\tO\\nin\\tO\\ncontrol\\tO\\nfibroblasts\\tO\\n,\\tO\\nwhich\\tO\\nmay\\tO\\noffer\\tO\\nimportant\\tO\\ninformation\\tO\\nfor\\tO\\nthe\\tO\\nrational\\tO\\ndesign\\tO\\nof\\tO\\nfuture\\tO\\nsomatic\\tO\\ngene\\tO\\ntherapy\\tO\\nfor\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nBrain\\tB-Disease\\ndisease\\tI-Disease\\nand\\tO\\nmolecular\\tO\\nanalysis\\tO\\nin\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nAbnormal\\tO\\namplification\\tO\\nof\\tO\\na\\tO\\nCTG\\tO\\nrepeat\\tO\\non\\tO\\nchromosome\\tO\\n19\\tO\\nis\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nExpansion\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\nhas\\tO\\nbeen\\tO\\ncorrelated\\tO\\nwith\\tO\\nseverity\\tO\\nof\\tO\\nseveral\\tO\\nclinical\\tO\\nfeatures\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nWe\\tO\\nperformed\\tO\\nextensive\\tO\\ncognitive\\tO\\ntesting\\tO\\n,\\tO\\ncerebral\\tO\\nmagnetic\\tO\\nresonance\\tO\\nimaging\\tO\\n(\\tO\\nMRI\\tO\\n)\\tO\\nand\\tO\\na\\tO\\nmolecular\\tO\\nanalysis\\tO\\nin\\tO\\n28\\tO\\ncases\\tO\\nof\\tO\\nDM\\tB-Disease\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\nrelationship\\tO\\nbetween\\tO\\nthe\\tO\\nmolecular\\tO\\ndefect\\tO\\nand\\tO\\nbrain\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nPerformance\\tO\\nin\\tO\\ntwo\\tO\\nor\\tO\\nmore\\tO\\ncognitive\\tO\\ntests\\tO\\nwas\\tO\\npathological\\tO\\nin\\tO\\n10\\tO\\ncases\\tO\\n.\\tO\\n\\nFourteen\\tO\\npatients\\tO\\nhad\\tO\\nsubcortical\\tO\\nwhite\\tB-Disease\\nmatter\\tI-Disease\\nlesions\\tI-Disease\\non\\tO\\nMRI\\tO\\n,\\tO\\n14\\tO\\nhad\\tO\\ncerebral\\tB-Disease\\natrophy\\tI-Disease\\n.\\tO\\n\\nAmplification\\tO\\nof\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nshowed\\tO\\na\\tO\\nstrong\\tO\\ncorrelation\\tO\\nwith\\tO\\ncognitive\\tO\\ntest\\tO\\ndeficits\\tO\\nwhen\\tO\\nexceeding\\tO\\na\\tO\\nlength\\tO\\nof\\tO\\nover\\tO\\n1000\\tO\\ntrinucleotides\\tO\\n.\\tO\\n\\nMRI\\tO\\nlesions\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\nimpaired\\tO\\npsychometric\\tO\\nperformance\\tO\\n,\\tO\\nbut\\tO\\nMRI\\tO\\nand\\tO\\nmolecular\\tO\\nfindings\\tO\\nwere\\tO\\nonly\\tO\\nweakly\\tO\\nrelated\\tO\\n.\\tO\\n\\nDisease\\tO\\nduration\\tO\\ninfluenced\\tO\\nthe\\tO\\nappearance\\tO\\nand\\tO\\namount\\tO\\nof\\tO\\nwhite\\tB-Disease\\nmatter\\tI-Disease\\nlesions\\tI-Disease\\non\\tO\\nMRI\\tO\\n.\\tO\\n\\nQuantification\\tO\\nof\\tO\\nCTG\\tO\\nrepeat\\tO\\nsize\\tO\\nmay\\tO\\nallow\\tO\\nan\\tO\\nearly\\tO\\nestimate\\tO\\non\\tO\\nthe\\tO\\nprobability\\tO\\nof\\tO\\nbrain\\tO\\ninvolvement\\tO\\nin\\tO\\nDM\\tB-Disease\\n;\\tO\\ncognitive\\tB-Disease\\ndysfunction\\tI-Disease\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nwhite\\tB-Disease\\nmatter\\tI-Disease\\nlesions\\tI-Disease\\nand\\tO\\ncerebral\\tB-Disease\\natrophy\\tI-Disease\\nlater\\tO\\non\\tO\\nin\\tO\\nthe\\tO\\ncourse\\tO\\n.\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\nin\\tO\\npatients\\tO\\nwith\\tO\\ndifferent\\tO\\nclinical\\tO\\nphenotypes\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nperoxisomal\\tB-Disease\\ndisorder\\tI-Disease\\n,\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\n(\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\n)\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\ndescribed\\tO\\nencoding\\tO\\na\\tO\\nperoxisomal\\tO\\nmembrane\\tO\\ntransporter\\tO\\nprotein\\tO\\n.\\tO\\n\\nWe\\tO\\nanalyzed\\tO\\nthe\\tO\\nentire\\tO\\nprotein\\tO\\n-\\tO\\ncoding\\tO\\nsequence\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\nby\\tO\\nreverse\\tO\\n-\\tO\\ntranscription\\tO\\nPCR\\tO\\n,\\tO\\nSSCP\\tO\\n,\\tO\\nand\\tO\\nDNA\\tO\\nsequencing\\tO\\nin\\tO\\nfive\\tO\\npatients\\tO\\nwith\\tO\\ndifferent\\tO\\nclinical\\tO\\nexpression\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\nand\\tO\\nin\\tO\\ntheir\\tO\\nfemale\\tO\\nrelatives\\tO\\n;\\tO\\nthese\\tO\\nclinical\\tO\\nexpressions\\tO\\nwere\\tO\\ncerebral\\tO\\nchildhood\\tO\\nALD\\tB-Disease\\n,\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n(\\tO\\nAMN\\tB-Disease\\n)\\tO\\n,\\tO\\nand\\tO\\n\"\\tO\\nAddison\\tB-Disease\\ndisease\\tI-Disease\\nonly\\tI-Disease\\n\"\\tO\\n(\\tO\\nADO\\tB-Disease\\n)\\tO\\nphenotype\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nthree\\tO\\npatients\\tO\\nexhibiting\\tO\\nthe\\tO\\nclassical\\tO\\npicture\\tO\\nof\\tO\\nsevere\\tO\\nchildhood\\tO\\nALD\\tB-Disease\\nwe\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\n5\\tO\\nportion\\tO\\nof\\tO\\nthe\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\ngene\\tO\\na\\tO\\n38\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nthat\\tO\\ncauses\\tO\\na\\tO\\nframeshift\\tO\\nmutation\\tO\\n,\\tO\\na\\tO\\n3\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\nleading\\tO\\nto\\tO\\na\\tO\\ndeletion\\tO\\nof\\tO\\nan\\tO\\namino\\tO\\nacid\\tO\\nin\\tO\\nthe\\tO\\nATP\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nALD\\tB-Disease\\nprotein\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npatient\\tO\\nwith\\tO\\nthe\\tO\\nclinical\\tO\\nphenotype\\tO\\nof\\tO\\nAMN\\tB-Disease\\n,\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\nin\\tO\\ncodon\\tO\\n212\\tO\\n,\\tO\\nalong\\tO\\nwith\\tO\\na\\tO\\nsecond\\tO\\nsite\\tO\\nmutation\\tO\\nat\\tO\\ncodon\\tO\\n178\\tO\\n,\\tO\\nwas\\tO\\nobserved\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nthe\\tO\\npatient\\tO\\nwith\\tO\\nthe\\tO\\nADO\\tB-Disease\\nphenotype\\tO\\nrevealed\\tO\\na\\tO\\nfurther\\tO\\nmissense\\tO\\nmutation\\tO\\nat\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\nposition\\tO\\nin\\tO\\nthe\\tO\\nALDP\\tO\\n/\\tO\\nPMP70\\tO\\ncomparison\\tO\\n.\\tO\\n\\nThe\\tO\\ndisruptive\\tO\\nnature\\tO\\nof\\tO\\ntwo\\tO\\nmutations\\tO\\n(\\tO\\ni\\tO\\n.\\tO\\ne\\tO\\n.\\tO\\n,\\tO\\nthe\\tO\\nframeshift\\tO\\nand\\tO\\nthe\\tO\\nnonsense\\tO\\nmutation\\tO\\n)\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nbiochemically\\tO\\nproved\\tO\\nchildhood\\tO\\nALD\\tB-Disease\\nand\\tO\\nAMN\\tB-Disease\\nfurther\\tO\\nstrongly\\tO\\nsupports\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nalterations\\tO\\nin\\tO\\nthis\\tO\\ngene\\tO\\nplay\\tO\\na\\tO\\ncrucial\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\n.\\tO\\n\\nSince\\tO\\nthe\\tO\\ncurrent\\tO\\nbiochemical\\tO\\ntechniques\\tO\\nfor\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\ncarrier\\tO\\ndetection\\tO\\nin\\tO\\naffected\\tO\\nfamilies\\tO\\nlack\\tO\\nsufficient\\tO\\nreliability\\tO\\n,\\tO\\nour\\tO\\nprocedure\\tO\\ndescribed\\tO\\nfor\\tO\\nsystematic\\tO\\nmutation\\tO\\nscanning\\tO\\nis\\tO\\nalso\\tO\\ncapable\\tO\\nof\\tO\\nimproving\\tO\\ngenetic\\tO\\ncounseling\\tO\\nand\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\n\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nand\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nin\\tO\\nthe\\tO\\nsame\\tO\\npatient\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\nthe\\tO\\nfirst\\tO\\npatient\\tO\\nidentified\\tO\\nwith\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nand\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nfamily\\tO\\nof\\tO\\nthe\\tO\\npropositus\\tO\\nhad\\tO\\na\\tO\\nstrong\\tO\\nhistory\\tO\\nof\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nand\\tO\\nthere\\tO\\nwas\\tO\\nan\\tO\\nintrafamilial\\tO\\npathological\\tO\\nexpansion\\tO\\nof\\tO\\nthe\\tO\\nresponsible\\tO\\nCTG\\tO\\nrepeat\\tO\\nbetween\\tO\\nthe\\tO\\nmildly\\tO\\naffected\\tO\\nmother\\tO\\n(\\tO\\n160\\tO\\nrepeats\\tO\\n;\\tO\\nnormal\\tO\\n27\\tO\\nrepeats\\tO\\n)\\tO\\nand\\tO\\nher\\tO\\nmore\\tO\\nseverely\\tO\\naffected\\tO\\nson\\tO\\n(\\tO\\n650\\tO\\nrepeats\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nhis\\tO\\nsister\\tO\\n(\\tO\\n650\\tO\\nrepeats\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\npropositus\\tO\\nwas\\tO\\nan\\tO\\nisolated\\tO\\ncase\\tO\\nof\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nwith\\tO\\nmarked\\tO\\ndystrophin\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nmuscle\\tO\\nbiopsy\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\nwas\\tO\\nstill\\tO\\nambulatory\\tO\\npost\\tO\\nage\\tO\\n16\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\ncould\\tO\\ninterfere\\tO\\nto\\tO\\nsome\\tO\\nextent\\tO\\nwith\\tO\\nthe\\tO\\nprogression\\tO\\nof\\tO\\nDuchenne\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nother\\tO\\ninterpretations\\tO\\nare\\tO\\npossible\\tO\\n.\\tO\\n\\nTwelve\\tO\\npercent\\tO\\nof\\tO\\ndystrophin\\tO\\nrevertant\\tO\\nfibers\\tO\\nas\\tO\\nobserved\\tO\\nby\\tO\\nimmunohistochemistry\\tO\\ncould\\tO\\nbe\\tO\\nsufficient\\tO\\nto\\tO\\nameliorate\\tO\\ntypical\\tO\\nDMD\\tB-Disease\\nclinical\\tO\\nseverity\\tO\\n,\\tO\\nor\\tO\\nthe\\tO\\npatient\\tO\\nmay\\tO\\npresent\\tO\\na\\tO\\nsomatic\\tO\\nmosaic\\tO\\n.\\tO\\n\\nThe\\tO\\npathophysiological\\tO\\ninteractions\\tO\\nof\\tO\\nthese\\tO\\ntwo\\tO\\nunlinked\\tO\\ndisorders\\tO\\nare\\tO\\ndiscussed\\tO\\nat\\tO\\nthe\\tO\\nclinical\\tO\\nand\\tO\\nhistopathological\\tO\\nlevels\\tO\\n.\\tO\\n.\\tO\\n\\nAge\\tO\\nat\\tO\\ndiagnosis\\tO\\nas\\tO\\nan\\tO\\nindicator\\tO\\nof\\tO\\neligibility\\tO\\nfor\\tO\\nBRCA1\\tO\\nDNA\\tO\\ntesting\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nsearched\\tO\\nfor\\tO\\ncriteria\\tO\\nthat\\tO\\ncould\\tO\\nindicate\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nwith\\tO\\na\\tO\\nhigh\\tO\\nprior\\tO\\nprobability\\tO\\nof\\tO\\nbeing\\tO\\ncaused\\tO\\nby\\tO\\nthe\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\nlocus\\tO\\nBRCA1\\tO\\non\\tO\\nchromosome\\tO\\n17\\tO\\n.\\tO\\n\\nTo\\tO\\nthis\\tO\\nend\\tO\\n,\\tO\\nwe\\tO\\nperformed\\tO\\na\\tO\\nlinkage\\tO\\nstudy\\tO\\nwith\\tO\\n59\\tO\\nconsecutively\\tO\\ncollected\\tO\\nDutch\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n,\\tO\\nincluding\\tO\\n16\\tO\\nwith\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\ncase\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nused\\tO\\nan\\tO\\nintake\\tO\\ncut\\tO\\n-\\tO\\noff\\tO\\nof\\tO\\nat\\tO\\nleast\\tO\\nthree\\tO\\nfirst\\tO\\n-\\tO\\ndegree\\tO\\nrelatives\\tO\\nwith\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nat\\tO\\nany\\tO\\nage\\tO\\n.\\tO\\n\\nSignificant\\tO\\nevidence\\tO\\nfor\\tO\\nlinkage\\tO\\nwas\\tO\\nfound\\tO\\nonly\\tO\\namong\\tO\\nthe\\tO\\n13\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nwith\\tO\\na\\tO\\nmean\\tO\\nage\\tO\\nat\\tO\\ndiagnosis\\tO\\nof\\tO\\nless\\tO\\nthan\\tO\\n45\\tO\\nyears\\tO\\n.\\tO\\n\\nAn\\tO\\nunexpectedly\\tO\\nlow\\tO\\nproportion\\tO\\nof\\tO\\nthe\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nwere\\tO\\nestimated\\tO\\nto\\tO\\nbe\\tO\\nlinked\\tO\\nto\\tO\\nBRCA1\\tO\\n,\\tO\\nwhich\\tO\\ncould\\tO\\nbe\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nfounder\\tO\\neffect\\tO\\nin\\tO\\nthe\\tO\\nDutch\\tO\\npopulation\\tO\\n.\\tO\\n\\nGiven\\tO\\nthe\\tO\\nexpected\\tO\\nlogistical\\tO\\nproblems\\tO\\nin\\tO\\nclinical\\tO\\nmanagement\\tO\\nnow\\tO\\nthat\\tO\\nBRCA1\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\n,\\tO\\nwe\\tO\\npropose\\tO\\nan\\tO\\ninterim\\tO\\nperiod\\tO\\nin\\tO\\nwhich\\tO\\nonly\\tO\\nfamilies\\tO\\nwith\\tO\\na\\tO\\nstrong\\tO\\npositive\\tO\\nfamily\\tO\\nhistory\\tO\\nfor\\tO\\nearly\\tO\\nonset\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nwill\\tO\\nbe\\tO\\noffered\\tO\\nBRCA1\\tO\\nmutation\\tO\\ntesting\\tO\\n.\\tO\\n.\\tO\\n\\nLinkage\\tO\\nanalysis\\tO\\nof\\tO\\n26\\tO\\nCanadian\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\nbreast\\tI-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexamined\\tO\\n26\\tO\\nCanadian\\tO\\nfamilies\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfor\\tO\\nlinkage\\tO\\nto\\tO\\nmarkers\\tO\\nflanking\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\non\\tO\\nchromosome\\tO\\n17q12\\tO\\n-\\tO\\nq21\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\n15\\tO\\nfamilies\\tO\\nthat\\tO\\ncontain\\tO\\ncases\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\n94\\tO\\n%\\tO\\nwere\\tO\\nestimated\\tO\\nto\\tO\\nbe\\tO\\nlinked\\tO\\nto\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\nno\\tO\\noverall\\tO\\nevidence\\tO\\nof\\tO\\nlinkage\\tO\\nin\\tO\\nthe\\tO\\ngroup\\tO\\nof\\tO\\n10\\tO\\nfamilies\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nwithout\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nA\\tO\\ngenetic\\tO\\nrecombinant\\tO\\nin\\tO\\na\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamily\\tO\\nindicates\\tO\\na\\tO\\nplacement\\tO\\nof\\tO\\nBRCA1\\tO\\ntelomeric\\tO\\nto\\tO\\nD17S776\\tO\\n,\\tO\\nand\\tO\\nhelps\\tO\\nto\\tO\\ndefine\\tO\\nthe\\tO\\nregion\\tO\\nof\\tO\\nassignment\\tO\\nof\\tO\\nthe\\tO\\ncancer\\tB-Disease\\nsusceptibility\\tO\\ngene\\tO\\n.\\tO\\n\\nOther\\tO\\ncancers\\tB-Disease\\nof\\tO\\ninterest\\tO\\nthat\\tO\\nappeared\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\n-\\tO\\nlinked\\tO\\nfamilies\\tO\\nincluded\\tO\\nprimary\\tB-Disease\\nperitoneal\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\ncancer\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfallopian\\tI-Disease\\ntube\\tI-Disease\\n,\\tO\\nand\\tO\\nmalignant\\tB-Disease\\nmelanoma\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nStructural\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\n5\\tO\\n\\'\\tO\\nregion\\tO\\nof\\tO\\nmouse\\tO\\nand\\tO\\nhuman\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\ngenes\\tO\\nreveals\\tO\\nconservation\\tO\\nof\\tO\\nputative\\tO\\npromoter\\tO\\nregion\\tO\\nand\\tO\\ndi\\tO\\n-\\tO\\nand\\tO\\ntrinucleotide\\tO\\npolymorphisms\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\npreviously\\tO\\ncloned\\tO\\nand\\tO\\ncharacterized\\tO\\nthe\\tO\\nmurine\\tO\\nhomologue\\tO\\nof\\tO\\nthe\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\ngene\\tO\\nand\\tO\\nshown\\tO\\nthat\\tO\\nit\\tO\\nmaps\\tO\\nto\\tO\\nmouse\\tO\\nchromosome\\tO\\n5\\tO\\nwithin\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\nconserved\\tO\\nsynteny\\tO\\nwith\\tO\\nhuman\\tO\\nchromosome\\tO\\n4p16\\tO\\n.\\tO\\n\\n3\\tO\\n3\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\npresent\\tO\\na\\tO\\ndetailed\\tO\\ncomparison\\tO\\nof\\tO\\nthe\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\nputative\\tO\\npromoter\\tO\\nand\\tO\\nthe\\tO\\norganization\\tO\\nof\\tO\\nthe\\tO\\n5\\tO\\ngenomic\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nmurine\\tO\\n(\\tO\\nHdh\\tO\\n)\\tO\\nand\\tO\\nhuman\\tO\\nHD\\tB-Disease\\ngenes\\tO\\nencompassing\\tO\\nthe\\tO\\nfirst\\tO\\nfive\\tO\\nexons\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nin\\tO\\nthis\\tO\\nregion\\tO\\nthese\\tO\\ntwo\\tO\\ngenes\\tO\\nshare\\tO\\nidentical\\tO\\nexon\\tO\\nboundaries\\tO\\n,\\tO\\nbut\\tO\\nhave\\tO\\ndifferent\\tO\\n-\\tO\\nsize\\tO\\nintrons\\tO\\n.\\tO\\n\\nTwo\\tO\\ndinucleotide\\tO\\n(\\tO\\nCT\\tO\\n)\\tO\\nand\\tO\\none\\tO\\ntrinucleotide\\tO\\nintronic\\tO\\npolymorphism\\tO\\nin\\tO\\nHdh\\tO\\nand\\tO\\nan\\tO\\nintronic\\tO\\nCA\\tO\\npolymorphism\\tO\\nin\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\nwere\\tO\\nidentified\\tO\\n.\\tO\\n\\nComparison\\tO\\nof\\tO\\n940\\tO\\n-\\tO\\nbp\\tO\\nsequence\\tO\\n5\\tO\\nto\\tO\\nthe\\tO\\nputative\\tO\\ntranslation\\tO\\nstart\\tO\\nsite\\tO\\nreveals\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\nregion\\tO\\n(\\tO\\n78\\tO\\n.\\tO\\n8\\tO\\n%\\tO\\nnucleotide\\tO\\nidentity\\tO\\n)\\tO\\nbetween\\tO\\nHdh\\tO\\nand\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\nfrom\\tO\\nnucleotide\\tO\\n-\\tO\\n56\\tO\\nto\\tO\\n-\\tO\\n206\\tO\\n(\\tO\\nof\\tO\\nHdh\\tO\\n)\\tO\\n.\\tO\\n\\nNeither\\tO\\nHdh\\tO\\nnor\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\nhave\\tO\\ntypical\\tO\\nTATA\\tO\\nor\\tO\\nCCAAT\\tO\\nelements\\tO\\n,\\tO\\nbut\\tO\\nboth\\tO\\nshow\\tO\\none\\tO\\nputative\\tO\\nAP2\\tO\\nbinding\\tO\\nsite\\tO\\nand\\tO\\nnumerous\\tO\\npotential\\tO\\nSp1\\tO\\nbinding\\tO\\nsites\\tO\\n.\\tO\\n\\nThe\\tO\\nhigh\\tO\\nsequence\\tO\\nidentity\\tO\\nbetween\\tO\\nHdh\\tO\\nand\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\nfor\\tO\\napproximately\\tO\\n200\\tO\\nbp\\tO\\n5\\tO\\nto\\tO\\nthe\\tO\\nputative\\tO\\ntranslation\\tO\\nstart\\tO\\nsite\\tO\\nindicates\\tO\\nthat\\tO\\nthese\\tO\\nsequences\\tO\\nmay\\tO\\nplay\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\nregulating\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\n\\nThe\\tO\\nprotein\\tO\\ndeficient\\tO\\nin\\tO\\nLowe\\tB-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\nphosphatidylinositol\\tO\\n-\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n-\\tO\\nbisphosphate\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\n.\\tO\\n\\nLowe\\tB-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nalso\\tO\\nknown\\tO\\nas\\tO\\noculocerebrorenal\\tB-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n-\\tO\\nencoded\\tO\\nOCRL\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nOCRL\\tO\\nprotein\\tO\\nis\\tO\\n51\\tO\\n%\\tO\\nidentical\\tO\\nto\\tO\\ninositol\\tO\\npolyphosphate\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\nII\\tO\\n(\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\nII\\tO\\n)\\tO\\nfrom\\tO\\nhuman\\tO\\nplatelets\\tO\\nover\\tO\\na\\tO\\nspan\\tO\\nof\\tO\\n744\\tO\\naa\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nOCRL\\tO\\nmay\\tO\\nbe\\tO\\na\\tO\\nsimilar\\tO\\nenzyme\\tO\\n.\\tO\\n\\nWe\\tO\\nengineered\\tO\\na\\tO\\nconstruct\\tO\\nof\\tO\\nthe\\tO\\nOCRL\\tO\\ncDNA\\tO\\nthat\\tO\\nencodes\\tO\\namino\\tO\\nacids\\tO\\nhomologous\\tO\\nto\\tO\\nthe\\tO\\nplatelet\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\nfor\\tO\\nexpression\\tO\\nin\\tO\\nbaculovirus\\tO\\n-\\tO\\ninfected\\tO\\nSf9\\tO\\ninsect\\tO\\ncells\\tO\\n.\\tO\\n\\nThis\\tO\\ncDNA\\tO\\nencodes\\tO\\naa\\tO\\n264\\tO\\n-\\tO\\n968\\tO\\nof\\tO\\nthe\\tO\\nOCRL\\tO\\nprotein\\tO\\n.\\tO\\n\\nThe\\tO\\nrecombinant\\tO\\nprotein\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\ncatalyze\\tO\\nthe\\tO\\nreactions\\tO\\nalso\\tO\\ncarried\\tO\\nout\\tO\\nby\\tO\\nplatelet\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\nII\\tO\\n.\\tO\\n\\nThus\\tO\\nOCRL\\tO\\nconverts\\tO\\ninositol\\tO\\n1\\tO\\n,\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n-\\tO\\ntrisphosphate\\tO\\nto\\tO\\ninositol\\tO\\n1\\tO\\n,\\tO\\n4\\tO\\n-\\tO\\nbisphosphate\\tO\\n,\\tO\\nand\\tO\\nit\\tO\\nconverts\\tO\\ninositol\\tO\\n1\\tO\\n,\\tO\\n3\\tO\\n,\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n-\\tO\\ntetrakisphosphate\\tO\\nto\\tO\\ninositol\\tO\\n1\\tO\\n,\\tO\\n3\\tO\\n,\\tO\\n4\\tO\\n-\\tO\\ntrisphosphate\\tO\\n.\\tO\\n\\nMost\\tO\\nimportant\\tO\\n,\\tO\\nthe\\tO\\nenzyme\\tO\\nconverts\\tO\\nphosphatidylinositol\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n-\\tO\\nbisphosphate\\tO\\nto\\tO\\nphosphatidylinositol\\tO\\n4\\tO\\n-\\tO\\nphosphate\\tO\\n.\\tO\\n\\nThe\\tO\\nrelative\\tO\\nability\\tO\\nof\\tO\\nOCRL\\tO\\nto\\tO\\ncatalyze\\tO\\nthe\\tO\\nthree\\tO\\nreactions\\tO\\nis\\tO\\ndifferent\\tO\\nfrom\\tO\\nthat\\tO\\nof\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\nII\\tO\\nand\\tO\\nfrom\\tO\\nthat\\tO\\nof\\tO\\nanother\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\nisoenzyme\\tO\\nfrom\\tO\\nplatelets\\tO\\n,\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\nI\\tO\\n.\\tO\\n\\nThe\\tO\\nrecombinant\\tO\\nOCRL\\tO\\nprotein\\tO\\nhydrolyzes\\tO\\nthe\\tO\\nphospholipid\\tO\\nsubstrate\\tO\\n10\\tO\\n-\\tO\\nto\\tO\\n30\\tO\\n-\\tO\\nfold\\tO\\nbetter\\tO\\nthan\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\nII\\tO\\n,\\tO\\nand\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\nI\\tO\\ndoes\\tO\\nnot\\tO\\ncleave\\tO\\nthe\\tO\\nlipid\\tO\\nat\\tO\\nall\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nshow\\tO\\nthat\\tO\\nOCRL\\tO\\nfunctions\\tO\\nas\\tO\\na\\tO\\nphosphatidylinositol\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n-\\tO\\nbisphosphate\\tO\\n5\\tO\\n-\\tO\\nphosphatase\\tO\\nin\\tO\\nOCRL\\tO\\n-\\tO\\nexpressing\\tO\\nSf9\\tO\\ncells\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nOCRL\\tO\\nis\\tO\\nmainly\\tO\\na\\tO\\nlipid\\tO\\nphosphatase\\tO\\nthat\\tO\\nmay\\tO\\ncontrol\\tO\\ncellular\\tO\\nlevels\\tO\\nof\\tO\\na\\tO\\ncritical\\tO\\nmetabolite\\tO\\n,\\tO\\nphosphatidylinositol\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n-\\tO\\nbisphosphate\\tO\\n.\\tO\\n\\nDeficiency\\tO\\nof\\tO\\nthis\\tO\\nenzyme\\tO\\napparently\\tO\\ncauses\\tO\\nthe\\tO\\nprotean\\tO\\nmanifestations\\tO\\nof\\tO\\nLowe\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nNew\\tO\\nfounder\\tO\\nhaplotypes\\tO\\nat\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nlocus\\tO\\nin\\tO\\nsouthern\\tO\\nAfrica\\tO\\n.\\tO\\n\\nThe\\tO\\nassociation\\tO\\nbetween\\tO\\nnormal\\tO\\nalleles\\tO\\nat\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nand\\tO\\ntwo\\tO\\nnearby\\tO\\npolymorphisms\\tO\\nin\\tO\\nthe\\tO\\nmyotonin\\tO\\nprotein\\tO\\nkinase\\tO\\ngene\\tO\\n,\\tO\\nthe\\tO\\nAlu\\tO\\ninsertion\\tO\\n/\\tO\\ndeletion\\tO\\npolymorphism\\tO\\nand\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nkinase\\tO\\n(\\tO\\nDMK\\tO\\n)\\tO\\n(\\tO\\nG\\tO\\n/\\tO\\nT\\tO\\n)\\tO\\nintron\\tO\\n9\\tO\\n/\\tO\\nHinfI\\tO\\npolymorphism\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nanalyzed\\tO\\nin\\tO\\nSouth\\tO\\nAfrican\\tO\\nNegroids\\tO\\n,\\tO\\na\\tO\\npopulation\\tO\\nin\\tO\\nwhich\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\ndescribed\\tO\\n.\\tO\\n\\nSouth\\tO\\nAfrican\\tO\\nNegroids\\tO\\nhave\\tO\\na\\tO\\nCTG\\tO\\nallelic\\tO\\ndistribution\\tO\\nthat\\tO\\nis\\tO\\nsignificantly\\tO\\ndifferent\\tO\\nfrom\\tO\\nthat\\tO\\nin\\tO\\nCaucasoids\\tO\\nand\\tO\\nJapanese\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nlengths\\tO\\nof\\tO\\n>\\tO\\nor\\tO\\n=\\tO\\n19\\tO\\nare\\tO\\nvery\\tO\\nrare\\tO\\n.\\tO\\n\\nThe\\tO\\nstriking\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nbetween\\tO\\nspecific\\tO\\nalleles\\tO\\nat\\tO\\nthe\\tO\\nAlu\\tO\\npolymorphism\\tO\\n(\\tO\\nAlu\\tO\\n(\\tO\\nins\\tO\\n)\\tO\\nand\\tO\\nAlu\\tO\\n(\\tO\\ndel\\tO\\n)\\tO\\n)\\tO\\n,\\tO\\nthe\\tO\\nHinfI\\tO\\npolymorphism\\tO\\n(\\tO\\nHinfI\\tO\\n-\\tO\\n1\\tO\\nand\\tO\\nHinfI\\tO\\n-\\tO\\n2\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\npolymorphism\\tO\\nseen\\tO\\nin\\tO\\nCaucasoid\\tO\\n(\\tO\\nEuropeans\\tO\\nand\\tO\\nCanadians\\tO\\n)\\tO\\npopulations\\tO\\nwas\\tO\\nalso\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nSouth\\tO\\nAfrican\\tO\\nNegroid\\tO\\npopulation\\tO\\n.\\tO\\n\\nNumerous\\tO\\nhaplotypes\\tO\\n,\\tO\\nnot\\tO\\npreviously\\tO\\ndescribed\\tO\\nin\\tO\\nEuropeans\\tO\\n,\\tO\\nwere\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nfound\\tO\\n.\\tO\\n\\nIt\\tO\\nthus\\tO\\nseems\\tO\\nlikely\\tO\\nthat\\tO\\nonly\\tO\\na\\tO\\nsmall\\tO\\nnumber\\tO\\nof\\tO\\nthese\\tO\\n\"\\tO\\nAfrican\\tO\\n\"\\tO\\nchromosomes\\tO\\nwere\\tO\\npresent\\tO\\nin\\tO\\nthe\\tO\\nprogenitors\\tO\\nof\\tO\\nall\\tO\\nnon\\tO\\n-\\tO\\nAfrican\\tO\\npeoples\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nprovide\\tO\\nsupport\\tO\\nfor\\tO\\nthe\\tO\\n\"\\tO\\nout\\tO\\nof\\tO\\nAfrica\\tO\\n\"\\tO\\nmodel\\tO\\nfor\\tO\\nthe\\tO\\norigin\\tO\\nof\\tO\\nmodern\\tO\\nhumans\\tO\\nand\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nrare\\tO\\nancestral\\tO\\nDM\\tB-Disease\\nmutation\\tO\\nevent\\tO\\nmay\\tO\\nhave\\tO\\noccurred\\tO\\nafter\\tO\\nthe\\tO\\nmigration\\tO\\nfrom\\tO\\nAfrica\\tO\\n,\\tO\\nhence\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nDM\\tB-Disease\\nin\\tO\\nsub\\tO\\n-\\tO\\nSaharan\\tO\\nNegroid\\tO\\npeoples\\tO\\n.\\tO\\n.\\tO\\n\\nDiscordant\\tO\\nclinical\\tO\\noutcome\\tO\\nin\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nrelatives\\tO\\nshowing\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\n>\\tO\\n700\\tO\\nrepeats\\tO\\n.\\tO\\n\\nA\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nfamily\\tO\\nis\\tO\\ndescribed\\tO\\nin\\tO\\nwhich\\tO\\ndiscordant\\tO\\nDM\\tB-Disease\\nphenotypes\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nchildren\\tO\\nof\\tO\\ntwo\\tO\\naffected\\tO\\nsisters\\tO\\nwith\\tO\\nsimilar\\tO\\nCTG\\tO\\nexpansion\\tO\\nand\\tO\\nclinical\\tO\\nmanifestations\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nfamily\\tO\\n,\\tO\\ncongenital\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nearly\\tO\\nsevere\\tO\\nchildhood\\tO\\nand\\tO\\nlater\\tO\\nchildhood\\tO\\nonset\\tO\\nDM\\tB-Disease\\ncoexist\\tO\\n.\\tO\\n\\nThis\\tO\\nobservation\\tO\\nstrengthens\\tO\\nthe\\tO\\nlimited\\tO\\nability\\tO\\nof\\tO\\nlymphocytes\\tO\\nCTG\\tO\\nrepeat\\tO\\nnumber\\tO\\nanalysis\\tO\\nin\\tO\\npredicting\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nin\\tO\\nDM\\tB-Disease\\npatients\\tO\\n.\\tO\\n.\\tO\\n\\nPurification\\tO\\nof\\tO\\nhuman\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nacyl\\tO\\n-\\tO\\ncoenzyme\\tO\\nA\\tO\\ndehydrogenase\\tO\\nand\\tO\\ncharacterization\\tO\\nof\\tO\\nits\\tO\\ndeficiency\\tO\\nin\\tO\\nseven\\tO\\npatients\\tO\\n.\\tO\\n\\nMitochondrial\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nacyl\\tO\\n-\\tO\\ncoenzyme\\tO\\nA\\tO\\ndehydrogenase\\tO\\n(\\tO\\nVLCAD\\tO\\n)\\tO\\nwas\\tO\\npurified\\tO\\nfrom\\tO\\nhuman\\tO\\nliver\\tO\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\nmasses\\tO\\nof\\tO\\nthe\\tO\\nnative\\tO\\nenzyme\\tO\\nand\\tO\\nthe\\tO\\nsubunit\\tO\\nwere\\tO\\nestimated\\tO\\nto\\tO\\nbe\\tO\\n154\\tO\\nand\\tO\\n70\\tO\\nkD\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nThe\\tO\\nenzyme\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\ncatalyze\\tO\\nthe\\tO\\nmajor\\tO\\npart\\tO\\nof\\tO\\nmitochondrial\\tO\\npalmitoylcoenzyme\\tO\\nA\\tO\\ndehydrogenation\\tO\\nin\\tO\\nliver\\tO\\n,\\tO\\nheart\\tO\\n,\\tO\\nskeletal\\tO\\nmuscle\\tO\\n,\\tO\\nand\\tO\\nskin\\tO\\nfibroblasts\\tO\\n(\\tO\\n89\\tO\\n-\\tO\\n97\\tO\\n,\\tO\\n86\\tO\\n-\\tO\\n99\\tO\\n,\\tO\\n96\\tO\\n-\\tO\\n99\\tO\\n,\\tO\\nand\\tO\\n78\\tO\\n-\\tO\\n87\\tO\\n%\\tO\\n,\\tO\\nrespectively\\tO\\n)\\tO\\n.\\tO\\n\\nSkin\\tO\\nfibroblasts\\tO\\nfrom\\tO\\n26\\tO\\npatients\\tO\\nsuspected\\tO\\nof\\tO\\nhaving\\tO\\na\\tO\\ndisorder\\tO\\nof\\tO\\nmitochondrial\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\nwere\\tO\\nanalyzed\\tO\\nfor\\tO\\nVLCAD\\tO\\nprotein\\tO\\nusing\\tO\\nimmunoblotting\\tO\\n,\\tO\\nand\\tO\\n7\\tO\\nof\\tO\\nthem\\tO\\ncontained\\tO\\nundetectable\\tO\\nor\\tO\\ntrace\\tO\\nlevels\\tO\\nof\\tO\\nthe\\tO\\nenzyme\\tO\\n.\\tO\\n\\nThe\\tO\\nseven\\tO\\ndeficient\\tO\\nfibroblast\\tO\\nlines\\tO\\nwere\\tO\\ncharacterized\\tO\\nby\\tO\\nmeasuring\\tO\\nacyl\\tO\\n-\\tO\\ncoenzyme\\tO\\nA\\tO\\ndehydrogenation\\tO\\nactivities\\tO\\n,\\tO\\noverall\\tO\\npalmitic\\tO\\nacid\\tO\\noxidation\\tO\\n,\\tO\\nand\\tO\\nVLCAD\\tO\\nprotein\\tO\\nsynthesis\\tO\\nusing\\tO\\npulse\\tO\\n-\\tO\\nchase\\tO\\n,\\tO\\nfurther\\tO\\nconfirming\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggested\\tO\\nthe\\tO\\nheterogenous\\tO\\nnature\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\ncausing\\tO\\nthe\\tO\\ndeficiency\\tO\\nin\\tO\\nthe\\tO\\nseven\\tO\\npatients\\tO\\n.\\tO\\n\\nClinically\\tO\\n,\\tO\\nall\\tO\\npatients\\tO\\nwith\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\nexhibited\\tO\\ncardiac\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nAt\\tO\\nleast\\tO\\nfour\\tO\\nof\\tO\\nthem\\tO\\npresented\\tO\\nwith\\tO\\nhypertrophic\\tB-Disease\\ncardiomyopathy\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nfrequency\\tO\\n(\\tO\\n>\\tO\\n57\\tO\\n%\\tO\\n)\\tO\\nwas\\tO\\nmuch\\tO\\nhigher\\tO\\nthan\\tO\\nthat\\tO\\nobserved\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nother\\tO\\ndisorders\\tO\\nof\\tO\\nmitochondrial\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nfatty\\tO\\nacid\\tO\\noxidation\\tO\\nthat\\tO\\nmay\\tO\\nbe\\tO\\naccompanied\\tO\\nby\\tO\\ncardiac\\tB-Disease\\ndisease\\tI-Disease\\nin\\tO\\ninfants\\tO\\n.\\tO\\n.\\tO\\n\\nHereditary\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfifth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nin\\tO\\nman\\tO\\n.\\tO\\n\\nII\\tO\\n.\\tO\\n\\nBiological\\tO\\nproperties\\tO\\nof\\tO\\nC5\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nhuman\\tO\\nserum\\tO\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\nknown\\tO\\nhuman\\tO\\nkindred\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfifth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC5\\tO\\n)\\tO\\nwas\\tO\\ndocumented\\tO\\nin\\tO\\nthe\\tO\\naccompanying\\tO\\nreport\\tO\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\nexamines\\tO\\nseveral\\tO\\nbiological\\tO\\nproperties\\tO\\nof\\tO\\nC5\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\n(\\tO\\nC5D\\tB-Disease\\n)\\tO\\nhuman\\tO\\nserum\\tO\\n,\\tO\\nparticularly\\tO\\nsera\\tO\\nobtained\\tO\\nfrom\\tO\\ntwo\\tO\\nC5D\\tB-Disease\\nhomozygotes\\tO\\n.\\tO\\n\\nThe\\tO\\nproband\\tO\\n,\\tO\\nwho\\tO\\nhas\\tO\\ninactive\\tO\\nsystemic\\tB-Disease\\nlupus\\tI-Disease\\nerythematosus\\tI-Disease\\nis\\tO\\ncompletely\\tO\\nlacking\\tO\\nC5\\tO\\n,\\tO\\nwhile\\tO\\nher\\tO\\nhealthy\\tO\\nhalf\\tO\\n-\\tO\\nsister\\tO\\nhas\\tO\\n1\\tO\\n-\\tO\\n2\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\nlevels\\tO\\n.\\tO\\n\\nBoth\\tO\\nsera\\tO\\nwere\\tO\\nseverely\\tO\\nimpaired\\tO\\nin\\tO\\ntheir\\tO\\nability\\tO\\nto\\tO\\ngenerate\\tO\\nchemotactic\\tO\\nactivity\\tO\\nfor\\tO\\nnormal\\tO\\nhuman\\tO\\nneutrophils\\tO\\nupon\\tO\\nincubation\\tO\\nwith\\tO\\naggregated\\tO\\nhuman\\tO\\ngamma\\tO\\n-\\tO\\nglobulin\\tO\\nor\\tO\\nEscherichia\\tO\\ncoli\\tO\\nendotoxin\\tO\\n.\\tO\\n\\nThis\\tO\\nfunction\\tO\\nwas\\tO\\nfully\\tO\\nrestored\\tO\\nin\\tO\\nthe\\tO\\nsiblings\\tO\\nserum\\tO\\n,\\tO\\nand\\tO\\nsubstantially\\tO\\nimproved\\tO\\nin\\tO\\nthe\\tO\\nprobands\\tO\\nserum\\tO\\n,\\tO\\nby\\tO\\naddition\\tO\\nof\\tO\\nhighly\\tO\\npurified\\tO\\nhuman\\tO\\nC5\\tO\\nto\\tO\\nnormal\\tO\\nserum\\tO\\nconcentrations\\tO\\n.\\tO\\n\\nSera\\tO\\nfrom\\tO\\neight\\tO\\nfamily\\tO\\nmembers\\tO\\nwho\\tO\\nwere\\tO\\napparently\\tO\\nheterozygous\\tO\\nfor\\tO\\nC5\\tB-Disease\\ndeficiency\\tI-Disease\\ngave\\tO\\nnormal\\tO\\nchemotactic\\tO\\nscores\\tO\\n.\\tO\\n\\nThe\\tO\\nability\\tO\\nof\\tO\\nC5D\\tB-Disease\\nserum\\tO\\nto\\tO\\nopsonize\\tO\\nSaccharomyces\\tO\\ncerevisiae\\tO\\n(\\tO\\nbakers\\tO\\nyeast\\tO\\n)\\tO\\nor\\tO\\nCandida\\tO\\nalbicans\\tO\\nfor\\tO\\ningestion\\tO\\nby\\tO\\nnormal\\tO\\nneutrophils\\tO\\nwas\\tO\\ncompletely\\tO\\nnormal\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nC5D\\tB-Disease\\nserum\\tO\\nwas\\tO\\ncapable\\tO\\nof\\tO\\npromoting\\tO\\nnormal\\tO\\nphagocytosis\\tO\\nand\\tO\\nintracellular\\tO\\nkilling\\tO\\nof\\tO\\nStaphylococcus\\tO\\naureus\\tO\\n.\\tO\\n\\nThe\\tO\\nprobands\\tO\\nserum\\tO\\nwas\\tO\\nincapable\\tO\\nof\\tO\\nmediating\\tO\\nlysis\\tO\\nof\\tO\\nerythrocytes\\tO\\nfrom\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nparoxysmal\\tB-Disease\\nnocturnal\\tI-Disease\\nhemoglobinuria\\tI-Disease\\nin\\tO\\nboth\\tO\\nthe\\tO\\nsucrose\\tO\\nhemolysia\\tO\\nand\\tO\\nacid\\tO\\nhemolysis\\tO\\ntests\\tO\\n,\\tO\\nand\\tO\\nalso\\tO\\nlacked\\tO\\nbactericidal\\tO\\nactivity\\tO\\nagainst\\tO\\nsensitized\\tO\\nor\\tO\\nunsensitized\\tO\\nSalmonella\\tO\\ntyphi\\tO\\n.\\tO\\n\\nThe\\tO\\nsiblings\\tO\\nserum\\tO\\n,\\tO\\ncontaining\\tO\\nonly\\tO\\n1\\tO\\n-\\tO\\n2\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\nC5\\tO\\n,\\tO\\neffectively\\tO\\nlysed\\tO\\nS\\tO\\n.\\tO\\ntyphi\\tO\\n,\\tO\\nbut\\tO\\nonly\\tO\\nat\\tO\\neightfold\\tO\\nlower\\tO\\nserum\\tO\\ndilutions\\tO\\nas\\tO\\ncompared\\tO\\nto\\tO\\nnormals\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nunderscore\\tO\\nthe\\tO\\ncritical\\tO\\nrole\\tO\\nof\\tO\\nC5\\tO\\nin\\tO\\nthe\\tO\\ngeneration\\tO\\nof\\tO\\nchemotactic\\tO\\nactivity\\tO\\nand\\tO\\nin\\tO\\ncytolytic\\tO\\nreactions\\tO\\n,\\tO\\nas\\tO\\nopposed\\tO\\nto\\tO\\na\\tO\\nnonobligatory\\tO\\nor\\tO\\nminimal\\tO\\nrole\\tO\\nin\\tO\\nopsonization\\tO\\n,\\tO\\nat\\tO\\nleast\\tO\\nfor\\tO\\nthe\\tO\\norganisms\\tO\\nunder\\tO\\nstudy\\tO\\n.\\tO\\n.\\tO\\n\\nHuman\\tO\\nperoxisomal\\tO\\ntargeting\\tO\\nsignal\\tO\\n-\\tO\\n1\\tO\\nreceptor\\tO\\nrestores\\tO\\nperoxisomal\\tO\\nprotein\\tO\\nimport\\tO\\nin\\tO\\ncells\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nfatal\\tO\\nperoxisomal\\tB-Disease\\ndisorders\\tI-Disease\\n.\\tO\\n\\nTwo\\tO\\nperoxisomal\\tO\\ntargeting\\tO\\nsignals\\tO\\n,\\tO\\nPTS1\\tO\\nand\\tO\\nPTS2\\tO\\n,\\tO\\nare\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nimport\\tO\\nof\\tO\\nproteins\\tO\\ninto\\tO\\nthe\\tO\\nperoxisome\\tO\\nmatrix\\tO\\n.\\tO\\n\\nHuman\\tO\\npatients\\tO\\nwith\\tO\\nfatal\\tO\\ngeneralized\\tO\\nperoxisomal\\tB-Disease\\ndeficiency\\tI-Disease\\ndisorders\\tI-Disease\\nfall\\tO\\ninto\\tO\\nat\\tO\\nleast\\tO\\nnine\\tO\\ngenetic\\tO\\ncomplementation\\tO\\ngroups\\tO\\n.\\tO\\n\\nCells\\tO\\nfrom\\tO\\nmany\\tO\\nof\\tO\\nthese\\tO\\npatients\\tO\\nare\\tO\\ndeficient\\tO\\nin\\tO\\nthe\\tO\\nimport\\tO\\nof\\tO\\nPTS1\\tO\\n-\\tO\\ncontaining\\tO\\nproteins\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\ncauses\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n-\\tO\\nimport\\tO\\ndefect\\tO\\nin\\tO\\nthese\\tO\\npatients\\tO\\nare\\tO\\nunknown\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ncloned\\tO\\nand\\tO\\nsequenced\\tO\\nthe\\tO\\nhuman\\tO\\ncDNA\\tO\\nhomologue\\tO\\n(\\tO\\nPTS1R\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nPichia\\tO\\npastoris\\tO\\nPAS8\\tO\\ngene\\tO\\n,\\tO\\nthe\\tO\\nPTS1\\tO\\nreceptor\\tO\\n(\\tO\\nMcCollum\\tO\\n,\\tO\\nD\\tO\\n.\\tO\\n,\\tO\\nE\\tO\\n.\\tO\\nMonosov\\tO\\n,\\tO\\nand\\tO\\nS\\tO\\n.\\tO\\nSubramani\\tO\\n.\\tO\\n1993\\tO\\n.\\tO\\nJ\\tO\\n.\\tO\\nCell\\tO\\nBiol\\tO\\n.\\tO\\n121\\tO\\n761\\tO\\n-\\tO\\n774\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nPTS1R\\tO\\nmRNA\\tO\\nis\\tO\\nexpressed\\tO\\nin\\tO\\nall\\tO\\nhuman\\tO\\ntissues\\tO\\nexamined\\tO\\n.\\tO\\n\\nAntibodies\\tO\\nto\\tO\\nthe\\tO\\nhuman\\tO\\nPTS1R\\tO\\nrecognize\\tO\\nthis\\tO\\nprotein\\tO\\nin\\tO\\nhuman\\tO\\n,\\tO\\nmonkey\\tO\\n,\\tO\\nrat\\tO\\n,\\tO\\nand\\tO\\nhamster\\tO\\ncells\\tO\\n.\\tO\\n\\nThe\\tO\\nprotein\\tO\\nis\\tO\\nlocalized\\tO\\nmainly\\tO\\nin\\tO\\nthe\\tO\\ncytosol\\tO\\nbut\\tO\\nis\\tO\\nalso\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nperoxisomes\\tO\\n.\\tO\\n\\nPart\\tO\\nof\\tO\\nthe\\tO\\nperoxisomal\\tO\\nPTS1R\\tO\\nprotein\\tO\\nis\\tO\\ntightly\\tO\\nbound\\tO\\nto\\tO\\nthe\\tO\\nperoxisomal\\tO\\nmembrane\\tO\\n.\\tO\\n\\nAntibodies\\tO\\nto\\tO\\nPTS1R\\tO\\ninhibit\\tO\\nperoxisomal\\tO\\nprotein\\tO\\n-\\tO\\nimport\\tO\\nof\\tO\\nPTS1\\tO\\n-\\tO\\ncontaining\\tO\\nproteins\\tO\\nin\\tO\\na\\tO\\npermeabilized\\tO\\nCHO\\tO\\ncell\\tO\\nsystem\\tO\\n.\\tO\\n\\nIn\\tO\\nvitro\\tO\\n-\\tO\\ntranslated\\tO\\nPTS1R\\tO\\nprotein\\tO\\nspecifically\\tO\\nbinds\\tO\\na\\tO\\nserine\\tO\\n-\\tO\\nlysine\\tO\\n-\\tO\\nleucine\\tO\\n-\\tO\\npeptide\\tO\\n.\\tO\\n\\nA\\tO\\nPAS8\\tO\\n-\\tO\\nPTS1R\\tO\\nfusion\\tO\\nprotein\\tO\\ncomplements\\tO\\nthe\\tO\\nP\\tO\\n.\\tO\\npastoris\\tO\\npas8\\tO\\nmutant\\tO\\n.\\tO\\n\\nThe\\tO\\nPTS1R\\tO\\ncDNA\\tO\\nalso\\tO\\ncomplements\\tO\\nthe\\tO\\nPTS1\\tB-Disease\\nprotein\\tI-Disease\\n-\\tI-Disease\\nimport\\tI-Disease\\ndefect\\tI-Disease\\nin\\tO\\nskin\\tO\\nfibroblasts\\tO\\nfrom\\tO\\npatients\\tO\\n-\\tO\\n-\\tO\\nbelonging\\tO\\nto\\tO\\ncomplementation\\tO\\ngroup\\tO\\ntwo\\tO\\n-\\tO\\n-\\tO\\ndiagnosed\\tO\\nas\\tO\\nhaving\\tO\\nneonatal\\tB-Disease\\nadrenoleukodystrophy\\tI-Disease\\nor\\tO\\nZellweger\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nPTS1R\\tO\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nlocalized\\tO\\nto\\tO\\na\\tO\\nchromosomal\\tO\\nlocation\\tO\\nwhere\\tO\\nno\\tO\\nother\\tO\\nperoxisomal\\tB-Disease\\ndisorder\\tI-Disease\\ngenes\\tO\\nare\\tO\\nknown\\tO\\nto\\tO\\nmap\\tO\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nrepresent\\tO\\nthe\\tO\\nonly\\tO\\ncase\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tB-Disease\\n-\\tI-Disease\\nimport\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nhuman\\tO\\nperoxisomal\\tB-Disease\\ndisorders\\tI-Disease\\nis\\tO\\nunderstood\\tO\\n.\\tO\\n\\nSpectrum\\tO\\nof\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\n:\\tO\\na\\tO\\nstudy\\tO\\nof\\tO\\n232\\tO\\npatients\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nand\\tI-Disease\\nnon\\tI-Disease\\nhereditary\\tI-Disease\\nretinoblastoma\\tI-Disease\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nconfer\\tO\\nhereditary\\tO\\npredisposition\\tO\\nto\\tO\\nretinoblastoma\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nperformed\\tO\\na\\tO\\nmutation\\tO\\nsurvey\\tO\\nof\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nin\\tO\\n232\\tO\\npatients\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nor\\tI-Disease\\nnon\\tI-Disease\\nhereditary\\tI-Disease\\nretinoblastoma\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nsystematically\\tO\\nexplored\\tO\\nall\\tO\\n27\\tO\\nexons\\tO\\nand\\tO\\nflanking\\tO\\nsequences\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nthe\\tO\\npromotor\\tO\\n.\\tO\\n\\nAll\\tO\\ntypes\\tO\\nof\\tO\\npoint\\tO\\nmutations\\tO\\nare\\tO\\nrepresented\\tO\\nand\\tO\\nare\\tO\\nfound\\tO\\nunequally\\tO\\ndistributed\\tO\\nalong\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nsequence\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npopulation\\tO\\nwe\\tO\\nstudied\\tO\\n,\\tO\\nexons\\tO\\n3\\tO\\n,\\tO\\n8\\tO\\n,\\tO\\n18\\tO\\nand\\tO\\n19\\tO\\nare\\tO\\npreferentially\\tO\\naltered\\tO\\n.\\tO\\n\\nThe\\tO\\nrange\\tO\\nof\\tO\\nfrequency\\tO\\nof\\tO\\ndetection\\tO\\nof\\tO\\ngermline\\tO\\nmutations\\tO\\nis\\tO\\nabout\\tO\\n20\\tO\\n%\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nother\\tO\\nmechanisms\\tO\\nof\\tO\\ninactivation\\tO\\nof\\tO\\nRB1\\tO\\nshould\\tO\\nbe\\tO\\ninvolved\\tO\\n.\\tO\\n\\nThe\\tO\\nspectrum\\tO\\nof\\tO\\nmutations\\tO\\npresented\\tO\\nhere\\tO\\nshould\\tO\\nhelp\\tO\\nto\\tO\\nimprove\\tO\\nthe\\tO\\nclinical\\tO\\nmanagement\\tO\\nof\\tO\\nretinoblastoma\\tB-Disease\\nand\\tO\\nto\\tO\\nunderstand\\tO\\nthe\\tO\\nmolecular\\tO\\nmechanisms\\tO\\nleading\\tO\\nto\\tO\\ntumorigenesis\\tO\\n.\\tO\\n.\\tO\\n\\nAniridia\\tB-Disease\\n-\\tO\\nassociated\\tO\\ncytogenetic\\tO\\nrearrangements\\tO\\nsuggest\\tO\\nthat\\tO\\na\\tO\\nposition\\tO\\neffect\\tO\\nmay\\tO\\ncause\\tO\\nthe\\tO\\nmutant\\tO\\nphenotype\\tO\\n.\\tO\\n\\nCurrent\\tO\\nevidence\\tO\\nsuggests\\tO\\nthat\\tO\\naniridia\\tB-Disease\\n(\\tO\\nabsence\\tB-Disease\\nof\\tI-Disease\\niris\\tI-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nloss\\tO\\nof\\tO\\nfunction\\tO\\nof\\tO\\none\\tO\\ncopy\\tO\\nof\\tO\\nthe\\tO\\nPAX6\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nmaps\\tO\\nto\\tO\\n11p13\\tO\\n.\\tO\\n\\nWe\\tO\\npresent\\tO\\nthe\\tO\\nfurther\\tO\\ncharacterisation\\tO\\nof\\tO\\ntwo\\tO\\naniridia\\tB-Disease\\npedigrees\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\ndisease\\tO\\nsegregates\\tO\\nwith\\tO\\nchromosomal\\tO\\nrearrangements\\tO\\nwhich\\tO\\ninvolve\\tO\\n11p13\\tO\\nbut\\tO\\ndo\\tO\\nnot\\tO\\ndisrupt\\tO\\nthe\\tO\\nPAX6\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nisolated\\tO\\nthree\\tO\\nhuman\\tO\\nYAC\\tO\\nclones\\tO\\nwhich\\tO\\nencompass\\tO\\nthe\\tO\\nPAX6\\tO\\nlocus\\tO\\nand\\tO\\nwe\\tO\\nhave\\tO\\nused\\tO\\nthese\\tO\\nto\\tO\\nshow\\tO\\nthat\\tO\\nin\\tO\\nboth\\tO\\ncases\\tO\\nthe\\tO\\nchromosomal\\tO\\nbreakpoint\\tO\\nis\\tO\\nat\\tO\\nleast\\tO\\n85\\tO\\nkb\\tO\\ndistal\\tO\\nof\\tO\\nthe\\tO\\n3\\tO\\nend\\tO\\nof\\tO\\nPAX6\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nthe\\tO\\nopen\\tO\\nreading\\tO\\nframe\\tO\\nof\\tO\\nPAX6\\tO\\nis\\tO\\napparently\\tO\\nfree\\tO\\nof\\tO\\nmutations\\tO\\n.\\tO\\n\\nWe\\tO\\npropose\\tO\\nthat\\tO\\nthe\\tO\\nPAX6\\tO\\ngene\\tO\\non\\tO\\nthe\\tO\\nrearranged\\tO\\nchromosome\\tO\\n11\\tO\\nis\\tO\\nin\\tO\\nan\\tO\\ninappropriate\\tO\\nchromatin\\tO\\nenvironment\\tO\\nfor\\tO\\nnormal\\tO\\nexpression\\tO\\nand\\tO\\ntherefore\\tO\\nthat\\tO\\na\\tO\\nposition\\tO\\neffect\\tO\\nis\\tO\\nthe\\tO\\nunderlying\\tO\\nmechanism\\tO\\nof\\tO\\ndisease\\tO\\nin\\tO\\nthese\\tO\\nfamilies\\tO\\n.\\tO\\n.\\tO\\n\\nSomatic\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nin\\tO\\nsporadic\\tB-Disease\\novarian\\tI-Disease\\ntumours\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nBRCA1\\tO\\ngene\\tO\\non\\tO\\nchromosome\\tO\\n17q21\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nsyndrome\\tI-Disease\\nof\\tO\\nincreased\\tO\\nsusceptibility\\tO\\nto\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nbut\\tO\\nno\\tO\\nsomatic\\tO\\nmutations\\tO\\nin\\tO\\ntumours\\tB-Disease\\nhave\\tO\\nyet\\tO\\nbeen\\tO\\ndescribed\\tO\\n.\\tO\\n\\nTo\\tO\\nstudy\\tO\\nthe\\tO\\npotential\\tO\\nrole\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\nsporadic\\tO\\ncarcinogenesis\\tO\\n,\\tO\\nwe\\tO\\nanalysed\\tO\\nthe\\tO\\ngenomic\\tO\\nDNA\\tO\\nof\\tO\\ntumour\\tB-Disease\\nand\\tO\\nnormal\\tO\\nfractions\\tO\\nof\\tO\\n47\\tO\\novarian\\tB-Disease\\ncancers\\tI-Disease\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\nusing\\tO\\nthe\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\ntechnique\\tO\\n.\\tO\\n\\nWe\\tO\\nnow\\tO\\ndescribe\\tO\\nsomatic\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nDNA\\tO\\nof\\tO\\nfour\\tO\\ntumours\\tB-Disease\\nwhich\\tO\\nalso\\tO\\nhad\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\n(\\tO\\nLOH\\tO\\n)\\tO\\nat\\tO\\na\\tO\\nBRCA1\\tO\\nintragenic\\tO\\nmarker\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nsupport\\tO\\na\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\nmechanism\\tO\\nfor\\tO\\nBRCA1\\tO\\n;\\tO\\nsomatic\\tO\\nmutations\\tO\\nand\\tO\\nLOH\\tO\\nmay\\tO\\nresult\\tO\\nin\\tO\\ninactivation\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\nat\\tO\\nleast\\tO\\na\\tO\\nsmall\\tO\\nnumber\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancers\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nDecreased\\tO\\nexpression\\tO\\nof\\tO\\nBRCA1\\tO\\naccelerates\\tO\\ngrowth\\tO\\nand\\tO\\nis\\tO\\noften\\tO\\npresent\\tO\\nduring\\tO\\nsporadic\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nprogression\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ncharacterized\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nfamilial\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ngene\\tO\\n,\\tO\\nBRCA1\\tO\\n,\\tO\\nin\\tO\\ncases\\tO\\nof\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nhereditary\\tI-Disease\\n(\\tI-Disease\\nsporadic\\tI-Disease\\n)\\tI-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\nanalyzed\\tO\\nthe\\tO\\neffect\\tO\\nof\\tO\\nantisense\\tO\\ninhibition\\tO\\nof\\tO\\nBRCA1\\tO\\non\\tO\\nthe\\tO\\nproliferative\\tO\\nrate\\tO\\nof\\tO\\nmammary\\tO\\nepithelial\\tO\\ncells\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nmRNA\\tO\\nlevels\\tO\\nare\\tO\\nmarkedly\\tO\\ndecreased\\tO\\nduring\\tO\\nthe\\tO\\ntransition\\tO\\nfrom\\tO\\ncarcinoma\\tB-Disease\\nin\\tI-Disease\\nsitu\\tI-Disease\\nto\\tO\\ninvasive\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nExperimental\\tO\\ninhibition\\tO\\nof\\tO\\nBRCA1\\tO\\nexpression\\tO\\nwith\\tO\\nantisense\\tO\\noligonucleotides\\tO\\nproduced\\tO\\naccelerated\\tO\\ngrowth\\tO\\nof\\tO\\nnormal\\tO\\nand\\tO\\nmalignant\\tO\\nmammary\\tO\\ncells\\tO\\n,\\tO\\nbut\\tO\\nhad\\tO\\nno\\tO\\neffect\\tO\\non\\tO\\nnon\\tO\\n-\\tO\\nmammary\\tO\\nepithelial\\tO\\ncells\\tO\\n.\\tO\\n\\nThese\\tO\\nstudies\\tO\\nsuggest\\tO\\nthat\\tO\\nBRCA1\\tO\\nmay\\tO\\nnormally\\tO\\nserve\\tO\\nas\\tO\\na\\tO\\nnegative\\tO\\nregulator\\tO\\nof\\tO\\nmammary\\tO\\nepithelial\\tO\\ncell\\tO\\ngrowth\\tO\\nwhose\\tO\\nfunction\\tO\\nis\\tO\\ncompromised\\tO\\nin\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\neither\\tO\\nby\\tO\\ndirect\\tO\\nmutation\\tO\\nor\\tO\\nalterations\\tO\\nin\\tO\\ngene\\tO\\nexpression\\tO\\n.\\tO\\n.\\tO\\n\\nAdditional\\tO\\ncase\\tO\\nof\\tO\\nfemale\\tO\\nmonozygotic\\tO\\ntwins\\tO\\ndiscordant\\tO\\nfor\\tO\\nthe\\tO\\nclinical\\tO\\nmanifestations\\tO\\nof\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ndue\\tO\\nto\\tO\\nopposite\\tO\\nX\\tO\\n-\\tO\\nchromosome\\tO\\ninactivation\\tO\\n.\\tO\\n\\nA\\tO\\npair\\tO\\nof\\tO\\nfemale\\tO\\nmonozygotic\\tO\\n(\\tO\\nMZ\\tO\\n)\\tO\\ntwins\\tO\\n,\\tO\\nheterozygous\\tO\\ncarriers\\tO\\nfor\\tO\\na\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\nand\\tO\\ndiscordant\\tO\\nfor\\tO\\nthe\\tO\\nclinical\\tO\\nmanifestations\\tO\\nof\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nwere\\tO\\nanalyzed\\tO\\nby\\tO\\nmolecular\\tO\\nstudies\\tO\\n,\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n,\\tO\\nand\\tO\\nmethylation\\tO\\npattern\\tO\\nof\\tO\\nX\\tO\\nchromosomes\\tO\\nto\\tO\\nsearch\\tO\\nfor\\tO\\nopposite\\tO\\nX\\tO\\ninactivation\\tO\\nas\\tO\\nan\\tO\\nexplanation\\tO\\nof\\tO\\ntheir\\tO\\nclinical\\tO\\ndiscordance\\tO\\n.\\tO\\n\\nResults\\tO\\nin\\tO\\nlymphocytes\\tO\\nand\\tO\\nskin\\tO\\nfibroblast\\tO\\ncell\\tO\\nlines\\tO\\nsuggest\\tO\\na\\tO\\npartial\\tO\\nmirror\\tO\\ninactivation\\tO\\nwith\\tO\\nthe\\tO\\nnormal\\tO\\nX\\tO\\nchromosome\\tO\\npreferentially\\tO\\nactive\\tO\\nin\\tO\\nthe\\tO\\nunaffected\\tO\\ntwin\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nmaternal\\tO\\ndeleted\\tO\\nX\\tO\\nchromosome\\tO\\npreferentially\\tO\\nactive\\tO\\nin\\tO\\nthe\\tO\\naffected\\tO\\ntwin\\tO\\n.\\tO\\n\\nA\\tO\\nreview\\tO\\nshows\\tO\\nthat\\tO\\nMZ\\tO\\nfemale\\tO\\ntwins\\tO\\ndiscordant\\tO\\nfor\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndiseases\\tI-Disease\\nare\\tO\\nnot\\tO\\nuncommon\\tO\\n.\\tO\\n\\nTwinning\\tO\\nand\\tO\\nX\\tO\\ninactivation\\tO\\nmay\\tO\\nbe\\tO\\ninterrelated\\tO\\nand\\tO\\ncould\\tO\\nexplain\\tO\\nthe\\tO\\nfemale\\tO\\ntwins\\tO\\ndiscordant\\tO\\nfor\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\ntraits\\tO\\n.\\tO\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\n:\\tO\\na\\tO\\nnovel\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nALD\\tB-Disease\\ngene\\tO\\nin\\tO\\n6\\tO\\nmembers\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\npresenting\\tO\\nwith\\tO\\n5\\tO\\ndifferent\\tO\\nphenotypes\\tO\\n.\\tO\\n\\nFragments\\tO\\nof\\tO\\nthe\\tO\\nadrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\ncDNA\\tO\\nfrom\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nadolescent\\tB-Disease\\nALD\\tI-Disease\\nwere\\tO\\namplified\\tO\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nand\\tO\\nsubcloned\\tO\\n.\\tO\\n\\nBidirectional\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\nentire\\tO\\ncoding\\tO\\nALD\\tB-Disease\\ngene\\tO\\ndisclosed\\tO\\na\\tO\\ncytosine\\tO\\nto\\tO\\nguanine\\tO\\ntransversion\\tO\\nat\\tO\\nnucleotide\\tO\\n1451\\tO\\nin\\tO\\nexon\\tO\\nfive\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nsubstitution\\tO\\nof\\tO\\nproline\\tO\\n484\\tO\\nby\\tO\\narginine\\tO\\n.\\tO\\n\\nFive\\tO\\nof\\tO\\nnine\\tO\\nsiblings\\tO\\nof\\tO\\nthe\\tO\\npatient\\tO\\n,\\tO\\ncomprising\\tO\\ntwo\\tO\\ncerebral\\tB-Disease\\nALD\\tI-Disease\\n,\\tO\\none\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n,\\tO\\none\\tO\\nAddison\\tB-Disease\\nonly\\tI-Disease\\nas\\tO\\nwell\\tO\\nas\\tO\\nthe\\tO\\nsymptomatic\\tO\\nmother\\tO\\n(\\tO\\nall\\tO\\naccumulating\\tO\\nvery\\tO\\nlong\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\n)\\tO\\ncarried\\tO\\nthis\\tO\\nmutation\\tO\\n,\\tO\\nwhich\\tO\\nwas\\tO\\nnot\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nunaffected\\tO\\npersons\\tO\\n,\\tO\\nin\\tO\\nfive\\tO\\nunrelated\\tO\\nALD\\tB-Disease\\npatients\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\ntwenty\\tO\\ncontrols\\tO\\n.\\tO\\n\\nWe\\tO\\npropose\\tO\\nthat\\tO\\nthis\\tO\\nmissense\\tO\\nmutation\\tO\\ngenerated\\tO\\nthe\\tO\\ndisease\\tO\\nper\\tO\\nse\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nthe\\tO\\nmetabolic\\tO\\ndefect\\tO\\n;\\tO\\nthe\\tO\\ndifferent\\tO\\nphenotypes\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nmust\\tO\\nhave\\tO\\noriginated\\tO\\nby\\tO\\nmeans\\tO\\nof\\tO\\nadditional\\tO\\npathogenetic\\tO\\nfactors\\tO\\n.\\tO\\n.\\tO\\n\\nNovel\\tO\\nmutation\\tO\\nat\\tO\\nthe\\tO\\ninitiation\\tO\\ncodon\\tO\\nin\\tO\\nthe\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\nin\\tO\\ntwo\\tO\\nJapanese\\tO\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\na\\tO\\nnew\\tO\\nmutation\\tO\\nof\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nND\\tB-Disease\\n)\\tO\\ngene\\tO\\nin\\tO\\ntwo\\tO\\nJapanese\\tO\\nmales\\tO\\nfrom\\tO\\nunrelated\\tO\\nfamilies\\tO\\n;\\tO\\nthey\\tO\\nshowed\\tO\\ntypical\\tO\\nocular\\tO\\nfeatures\\tO\\nof\\tO\\nND\\tB-Disease\\nbut\\tO\\nno\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\nor\\tO\\nhearing\\tB-Disease\\nimpairment\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nmutation\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nboth\\tO\\npatients\\tO\\nat\\tO\\nthe\\tO\\ninitiation\\tO\\ncodon\\tO\\nof\\tO\\nexon\\tO\\n2\\tO\\nof\\tO\\nthe\\tO\\nND\\tB-Disease\\ngene\\tO\\n(\\tO\\nATG\\tO\\nto\\tO\\nGTG\\tO\\n)\\tO\\n,\\tO\\nwith\\tO\\notherwise\\tO\\nnormal\\tO\\nnucleotide\\tO\\nsequences\\tO\\n.\\tO\\n\\nTheir\\tO\\nmothers\\tO\\nhad\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\nmutant\\tO\\ntypes\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nwas\\tO\\nexpected\\tO\\nfor\\tO\\nheterozygotes\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\ninitiation\\tO\\ncodon\\tO\\nwould\\tO\\ncause\\tO\\nthe\\tO\\nfailure\\tO\\nof\\tO\\nND\\tB-Disease\\ngene\\tO\\nexpression\\tO\\nor\\tO\\na\\tO\\ndefect\\tO\\nin\\tO\\ntranslation\\tO\\nthereby\\tO\\ntruncating\\tO\\nthe\\tO\\namino\\tO\\nterminus\\tO\\nof\\tO\\nND\\tB-Disease\\nprotein\\tO\\n.\\tO\\n\\nIn\\tO\\nview\\tO\\nof\\tO\\nthe\\tO\\nrarity\\tO\\nand\\tO\\nmarked\\tO\\nheterogeneity\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nND\\tB-Disease\\ngene\\tO\\n,\\tO\\nthe\\tO\\npresent\\tO\\napparently\\tO\\nunrelated\\tO\\nJapanese\\tO\\nfamilies\\tO\\nwho\\tO\\nhave\\tO\\nlived\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\narea\\tO\\nfor\\tO\\nover\\tO\\ntwo\\tO\\ncenturies\\tO\\npresumably\\tO\\nshare\\tO\\nthe\\tO\\norigin\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\n.\\tO\\n.\\tO\\n\\nAnticipation\\tO\\nresulting\\tO\\nin\\tO\\nelimination\\tO\\nof\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\ngene\\tO\\n:\\tO\\na\\tO\\nfollow\\tO\\nup\\tO\\nstudy\\tO\\nof\\tO\\none\\tO\\nextended\\tO\\nfamily\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nre\\tO\\n-\\tO\\nexamined\\tO\\nan\\tO\\nextended\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nfamily\\tO\\n,\\tO\\npreviously\\tO\\ndescribed\\tO\\nin\\tO\\n1955\\tO\\n,\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\nstudy\\tO\\nthe\\tO\\nlong\\tO\\nterm\\tO\\neffects\\tO\\nof\\tO\\nanticipation\\tO\\nin\\tO\\nDM\\tB-Disease\\nand\\tO\\nin\\tO\\nparticular\\tO\\nthe\\tO\\nimplications\\tO\\nfor\\tO\\nfamilies\\tO\\naffected\\tO\\nby\\tO\\nthis\\tO\\ndisease\\tO\\n.\\tO\\n\\nThis\\tO\\nfollow\\tO\\nup\\tO\\nstudy\\tO\\nprovides\\tO\\ndata\\tO\\non\\tO\\n35\\tO\\ngene\\tO\\ncarriers\\tO\\nand\\tO\\n46\\tO\\nasymptomatic\\tO\\nat\\tO\\nrisk\\tO\\nfamily\\tO\\nmembers\\tO\\nin\\tO\\nfive\\tO\\ngenerations\\tO\\n.\\tO\\n\\nClinical\\tO\\nanticipation\\tO\\n,\\tO\\ndefined\\tO\\nas\\tO\\nthe\\tO\\ncascade\\tO\\nof\\tO\\nmild\\tO\\n,\\tO\\nadult\\tO\\n,\\tO\\nchildhood\\tO\\n,\\tO\\nor\\tO\\ncongenital\\tB-Disease\\ndisease\\tI-Disease\\nin\\tO\\nsubsequent\\tO\\ngenerations\\tO\\n,\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nrelentless\\tO\\nprocess\\tO\\n,\\tO\\noccurring\\tO\\nin\\tO\\nall\\tO\\naffected\\tO\\nbranches\\tO\\nof\\tO\\nthe\\tO\\nfamily\\tO\\n.\\tO\\n\\nThe\\tO\\ncascade\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nproceed\\tO\\nasynchronously\\tO\\nin\\tO\\nthe\\tO\\ndifferent\\tO\\nbranches\\tO\\n,\\tO\\nmainly\\tO\\nbecause\\tO\\nof\\tO\\nan\\tO\\nunequal\\tO\\nnumber\\tO\\nof\\tO\\ngenerations\\tO\\nwith\\tO\\nmild\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\ntransition\\tO\\nfrom\\tO\\nthe\\tO\\nmild\\tO\\nto\\tO\\nthe\\tO\\nadult\\tO\\ntype\\tO\\nwas\\tO\\nassociated\\tO\\nwith\\tO\\ntransmission\\tO\\nthrough\\tO\\na\\tO\\nmale\\tO\\nparent\\tO\\n.\\tO\\n\\nStable\\tO\\ntransmission\\tO\\nof\\tO\\nthe\\tO\\nasymptomatic\\tO\\n/\\tO\\nmild\\tO\\nphenotype\\tO\\nshowed\\tO\\na\\tO\\nfemale\\tO\\ntransmission\\tO\\nbias\\tO\\n.\\tO\\n\\nWe\\tO\\nfurther\\tO\\nexamined\\tO\\nthe\\tO\\nextent\\tO\\nand\\tO\\ncauses\\tO\\nof\\tO\\ngene\\tO\\nloss\\tO\\nin\\tO\\nthis\\tO\\npedigree\\tO\\n.\\tO\\n\\nGene\\tO\\nloss\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\ngroup\\tO\\nwas\\tO\\ncomplete\\tO\\n,\\tO\\nowing\\tO\\nto\\tO\\ninfertility\\tB-Disease\\nof\\tO\\nthe\\tO\\nmale\\tO\\npatients\\tO\\nwith\\tO\\nadult\\tO\\nonset\\tO\\ndisease\\tO\\nand\\tO\\nthe\\tO\\nfact\\tO\\nthat\\tO\\nmentally\\tB-Disease\\nretarded\\tI-Disease\\npatients\\tO\\ndid\\tO\\nnot\\tO\\nprocreate\\tO\\n.\\tO\\n\\nOut\\tO\\nof\\tO\\nthe\\tO\\n46\\tO\\nat\\tO\\nrisk\\tO\\nsubjects\\tO\\nin\\tO\\nthe\\tO\\ntwo\\tO\\nyoungest\\tO\\ngenerations\\tO\\n,\\tO\\nonly\\tO\\none\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nfull\\tO\\nmutation\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nonly\\tO\\nsubject\\tO\\nwho\\tO\\nmay\\tO\\ntransmit\\tO\\nthe\\tO\\ngene\\tO\\nto\\tO\\nthe\\tO\\nsixth\\tO\\ngeneration\\tO\\n.\\tO\\n\\nNo\\tO\\nprotomutation\\tO\\ncarriers\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nfourth\\tO\\nand\\tO\\nfifth\\tO\\ngenerations\\tO\\n.\\tO\\n\\nTherefore\\tO\\nit\\tO\\nis\\tO\\nhighly\\tO\\nprobable\\tO\\nthat\\tO\\nthe\\tO\\nDM\\tB-Disease\\ngene\\tO\\nwill\\tO\\nbe\\tO\\neliminated\\tO\\nfrom\\tO\\nthis\\tO\\npedigree\\tO\\nwithin\\tO\\none\\tO\\ngeneration\\tO\\n.\\tO\\n\\nThe\\tO\\nhigh\\tO\\npopulation\\tO\\nfrequency\\tO\\nof\\tO\\nDM\\tB-Disease\\ncan\\tO\\nat\\tO\\npresent\\tO\\nnot\\tO\\nbe\\tO\\nexplained\\tO\\nby\\tO\\nthe\\tO\\ncontribution\\tO\\nof\\tO\\nasymptomatic\\tO\\ncases\\tO\\nin\\tO\\nthe\\tO\\nyounger\\tO\\ngenerations\\tO\\nof\\tO\\nknown\\tO\\nfamilies\\tO\\n,\\tO\\nbut\\tO\\nis\\tO\\nprobably\\tO\\ncaused\\tO\\nby\\tO\\nthe\\tO\\nevents\\tO\\nin\\tO\\nthe\\tO\\nancestral\\tO\\ngenerations\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nfor\\tO\\nspinal\\tB-Disease\\ncerebellar\\tI-Disease\\nataxia\\tI-Disease\\n3\\tO\\n(\\tO\\nSCA3\\tO\\n)\\tO\\nis\\tO\\nlocated\\tO\\nin\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\napproximately\\tO\\n3\\tO\\ncM\\tO\\non\\tO\\nchromosome\\tO\\n14q24\\tO\\n.\\tO\\n3\\tO\\n-\\tO\\nq32\\tO\\n.\\tO\\n2\\tO\\n.\\tO\\n\\nSCA3\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nspinal\\tB-Disease\\ncerebellar\\tI-Disease\\nataxia\\tI-Disease\\n3\\tO\\n,\\tO\\nwas\\tO\\nrecently\\tO\\nmapped\\tO\\nto\\tO\\na\\tO\\n15\\tO\\n-\\tO\\ncM\\tO\\ninterval\\tO\\nbetween\\tO\\nD14S67\\tO\\nand\\tO\\nD14S81\\tO\\non\\tO\\nchromosome\\tO\\n14q\\tO\\n,\\tO\\nby\\tO\\nlinkage\\tO\\nanalysis\\tO\\nin\\tO\\ntwo\\tO\\nfamilies\\tO\\nof\\tO\\nFrench\\tO\\nancestry\\tO\\n.\\tO\\n\\nThe\\tO\\nSCA3\\tO\\ncandidate\\tO\\nregion\\tO\\nhas\\tO\\nnow\\tO\\nbeen\\tO\\nrefined\\tO\\nby\\tO\\nlinkage\\tO\\nanalysis\\tO\\nwith\\tO\\nfour\\tO\\nnew\\tO\\nmicrosatellite\\tO\\nmarkers\\tO\\n(\\tO\\nD14S256\\tO\\n,\\tO\\nD14S291\\tO\\n,\\tO\\nD14S280\\tO\\n,\\tO\\nand\\tO\\nAFM343vf1\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\ntwo\\tO\\nfamilies\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\n19\\tO\\nadditional\\tO\\nindividuals\\tO\\nwere\\tO\\ngenotyped\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\na\\tO\\nthird\\tO\\nFrench\\tO\\nfamily\\tO\\n.\\tO\\n\\nCombined\\tO\\ntwo\\tO\\n-\\tO\\npoint\\tO\\nlinkage\\tO\\nanalyses\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nnew\\tO\\nmarkers\\tO\\n,\\tO\\nD14S280\\tO\\nand\\tO\\nAFM343vf1\\tO\\n,\\tO\\nare\\tO\\ntightly\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nSCA3\\tO\\nlocus\\tO\\n,\\tO\\nwith\\tO\\nmaximal\\tO\\nlod\\tO\\nscores\\tO\\n,\\tO\\nat\\tO\\nrecombination\\tO\\nfraction\\tO\\n,\\tO\\n(\\tO\\ntheta\\tO\\n)\\tO\\n=\\tO\\n.\\tO\\n\\n00\\tO\\n,\\tO\\nof\\tO\\n7\\tO\\n.\\tO\\n\\n05\\tO\\nand\\tO\\n13\\tO\\n.\\tO\\n\\n70\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nCombined\\tO\\nmultipoint\\tO\\nand\\tO\\nrecombinant\\tO\\nhaplotype\\tO\\nanalyses\\tO\\nlocalize\\tO\\nthe\\tO\\nSCA3\\tO\\nlocus\\tO\\nto\\tO\\na\\tO\\n3\\tO\\n-\\tO\\ncM\\tO\\ninterval\\tO\\nflanked\\tO\\nby\\tO\\nD14S291\\tO\\nand\\tO\\nD14S81\\tO\\n.\\tO\\n\\nThe\\tO\\nsame\\tO\\nallele\\tO\\nfor\\tO\\nD14S280\\tO\\nsegregates\\tO\\nwith\\tO\\nthe\\tO\\ndisease\\tO\\nlocus\\tO\\nin\\tO\\nthe\\tO\\nthree\\tO\\nkindreds\\tO\\n.\\tO\\n\\nThis\\tO\\nallele\\tO\\nis\\tO\\nfrequent\\tO\\nin\\tO\\nthe\\tO\\nFrench\\tO\\npopulation\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nand\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nis\\tO\\nnot\\tO\\nclearly\\tO\\nestablished\\tO\\n.\\tO\\n\\nThe\\tO\\nSCA3\\tO\\nlocus\\tO\\nremains\\tO\\nwithin\\tO\\nthe\\tO\\n29\\tO\\n-\\tO\\ncM\\tO\\nregion\\tO\\non\\tO\\n14q24\\tO\\n.\\tO\\n\\n3\\tO\\n-\\tO\\nq32\\tO\\n.\\tO\\n\\n2\\tO\\ncontaining\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nthe\\tO\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nwhich\\tO\\nis\\tO\\nclinically\\tO\\nrelated\\tO\\nto\\tO\\nthe\\tO\\nphenotype\\tO\\ndetermined\\tO\\nby\\tO\\nSCA3\\tO\\n,\\tO\\nbut\\tO\\nit\\tO\\ncannot\\tO\\nyet\\tO\\nbe\\tO\\nconcluded\\tO\\nthat\\tO\\nboth\\tO\\ndiseases\\tO\\nresult\\tO\\nfrom\\tO\\nalterations\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\ngene\\tO\\n\\nAn\\tO\\nevaluation\\tO\\nof\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\nin\\tO\\n145\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nBreast\\tB-Disease\\nCancer\\tI-Disease\\nLinkage\\tO\\nConsortium\\tO\\n.\\tO\\n\\nThe\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novary\\tI-Disease\\ncancer\\tI-Disease\\n-\\tI-Disease\\nfamily\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\ndominant\\tO\\npredisposition\\tO\\nto\\tO\\ncancer\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novaries\\tI-Disease\\nwhich\\tO\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nchromosome\\tO\\nregion\\tO\\n17q12\\tO\\n-\\tO\\nq21\\tO\\n.\\tO\\n\\nThe\\tO\\nmajority\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nall\\tO\\n,\\tO\\nof\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novary\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nshow\\tO\\nlinkage\\tO\\nto\\tO\\nthis\\tO\\nsusceptibility\\tO\\nlocus\\tO\\n,\\tO\\ndesignated\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthe\\tO\\nresults\\tO\\nof\\tO\\na\\tO\\nlinkage\\tO\\nanalysis\\tO\\nof\\tO\\n145\\tO\\nfamilies\\tO\\nwith\\tO\\nboth\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThese\\tO\\nfamilies\\tO\\ncontain\\tO\\neither\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\nthree\\tO\\nor\\tO\\nmore\\tO\\ncases\\tO\\nof\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\n(\\tO\\nbefore\\tO\\nage\\tO\\n60\\tO\\nyears\\tO\\n)\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nor\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nAll\\tO\\nfamilies\\tO\\ncontained\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\ncase\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nOverall\\tO\\n,\\tO\\nan\\tO\\nestimated\\tO\\n76\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\n145\\tO\\nfamilies\\tO\\nare\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nBRCA1\\tO\\nlocus\\tO\\n.\\tO\\n\\nNone\\tO\\nof\\tO\\nthe\\tO\\n13\\tO\\nfamilies\\tO\\nwith\\tO\\ncases\\tO\\nof\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nappear\\tO\\nto\\tO\\nbe\\tO\\nlinked\\tO\\n,\\tO\\nbut\\tO\\nit\\tO\\nis\\tO\\nestimated\\tO\\nthat\\tO\\n92\\tO\\n%\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\n76\\tO\\n%\\tO\\n-\\tO\\n100\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nfamilies\\tO\\nwith\\tO\\nno\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\nwith\\tO\\ntwo\\tO\\nor\\tO\\nmore\\tO\\novarian\\tB-Disease\\ncancers\\tI-Disease\\nare\\tO\\nlinked\\tO\\nto\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n-\\tI-Disease\\nfamily\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\ngenetically\\tO\\nheterogeneous\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nlarge\\tO\\nmajority\\tO\\nof\\tO\\nfamilies\\tO\\nwith\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\nwith\\tO\\ntwo\\tO\\nor\\tO\\nmore\\tO\\ncases\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nare\\tO\\nlikely\\tO\\nto\\tO\\nbe\\tO\\ndue\\tO\\nto\\tO\\nBRCA1\\tO\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbasis\\tO\\nof\\tO\\nessential\\tB-Disease\\nfructosuria\\tI-Disease\\n:\\tO\\nmolecular\\tO\\ncloning\\tO\\nand\\tO\\nmutational\\tO\\nanalysis\\tO\\nof\\tO\\nhuman\\tO\\nketohexokinase\\tO\\n(\\tO\\nfructokinase\\tO\\n)\\tO\\n.\\tO\\n\\nEssential\\tB-Disease\\nfructosuria\\tI-Disease\\nis\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\noldest\\tO\\nknown\\tO\\ninborn\\tB-Disease\\nerrors\\tI-Disease\\nof\\tI-Disease\\nmetabolism\\tI-Disease\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\na\\tO\\nbenign\\tO\\ncondition\\tO\\nwhich\\tO\\nis\\tO\\nbelieved\\tO\\nto\\tO\\nresult\\tO\\nfrom\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nhepatic\\tI-Disease\\nfructokinase\\tI-Disease\\n(\\tO\\nketohexokinase\\tO\\n,\\tO\\nKHK\\tO\\n,\\tO\\nE\\tO\\n.\\tO\\nC\\tO\\n.\\tO\\n2\\tO\\n.\\tO\\n7\\tO\\n.\\tO\\n1\\tO\\n.\\tO\\n3\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nenzyme\\tO\\ncatalyses\\tO\\nthe\\tO\\nfirst\\tO\\nstep\\tO\\nof\\tO\\nmetabolism\\tO\\nof\\tO\\ndietary\\tO\\nfructose\\tO\\n,\\tO\\nconversion\\tO\\nof\\tO\\nfructose\\tO\\nto\\tO\\nfructose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\n.\\tO\\n\\nDespite\\tO\\nthe\\tO\\nearly\\tO\\nrecognition\\tO\\nof\\tO\\nthis\\tO\\ndisorder\\tO\\n,\\tO\\nthe\\tO\\nprimary\\tO\\nstructure\\tO\\nof\\tO\\nhuman\\tO\\nKHK\\tO\\nand\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nessential\\tB-Disease\\nfructosuria\\tI-Disease\\nhave\\tO\\nnot\\tO\\nbeen\\tO\\npreviously\\tO\\ndefined\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nreport\\tO\\n,\\tO\\nthe\\tO\\nisolation\\tO\\nand\\tO\\nsequencing\\tO\\nof\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\ncDNA\\tO\\nclones\\tO\\nencoding\\tO\\nhuman\\tO\\nketohexokinase\\tO\\nare\\tO\\ndescribed\\tO\\n.\\tO\\n\\nAlternative\\tO\\nmRNA\\tO\\nspecies\\tO\\nand\\tO\\nalternative\\tO\\nKHK\\tO\\nisozymes\\tO\\nare\\tO\\nproduced\\tO\\nby\\tO\\nalternative\\tO\\npolyadenylation\\tO\\nand\\tO\\nsplicing\\tO\\nof\\tO\\nthe\\tO\\nKHK\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nKHK\\tO\\nproteins\\tO\\nshow\\tO\\na\\tO\\nhigh\\tO\\nlevel\\tO\\nof\\tO\\nsequence\\tO\\nconservation\\tO\\nrelative\\tO\\nto\\tO\\nrat\\tO\\nKHK\\tO\\n.\\tO\\n\\nDirect\\tO\\nevidence\\tO\\nthat\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nKHK\\tO\\nstructural\\tO\\ngene\\tO\\nis\\tO\\nthe\\tO\\ncause\\tO\\nof\\tO\\nessential\\tB-Disease\\nfructosuria\\tI-Disease\\nwas\\tO\\nalso\\tO\\nobtained\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nwell\\tO\\n-\\tO\\ncharacterized\\tO\\nfamily\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\nthree\\tO\\nof\\tO\\neight\\tO\\nsiblings\\tO\\nhave\\tO\\nfructosuria\\tB-Disease\\n,\\tO\\nall\\tO\\naffected\\tO\\nindividuals\\tO\\nare\\tO\\ncompound\\tO\\nheterozygotes\\tO\\nfor\\tO\\ntwo\\tO\\nmutations\\tO\\nGly40Arg\\tO\\nand\\tO\\nAla43Thr\\tO\\n.\\tO\\n\\nBoth\\tO\\nmutations\\tO\\nresult\\tO\\nfrom\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\ntransitions\\tO\\n,\\tO\\nand\\tO\\neach\\tO\\nalters\\tO\\nthe\\tO\\nsame\\tO\\nconserved\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nKHK\\tO\\nprotein\\tO\\n.\\tO\\n\\nNeither\\tO\\nmutation\\tO\\nwas\\tO\\nseen\\tO\\nin\\tO\\na\\tO\\nsample\\tO\\nof\\tO\\n52\\tO\\nunrelated\\tO\\ncontrol\\tO\\nindividuals\\tO\\n.\\tO\\n\\nAn\\tO\\nadditional\\tO\\nconservative\\tO\\namino\\tO\\nacid\\tO\\nchange\\tO\\n(\\tO\\nVal49IIe\\tO\\n)\\tO\\nwas\\tO\\npresent\\tO\\non\\tO\\nthe\\tO\\nKHK\\tO\\nallele\\tO\\nbearing\\tO\\nAla43Thr\\tO\\n\\nHomozygous\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\ncrossover\\tO\\n(\\tO\\nfusion\\tO\\ngene\\tO\\n)\\tO\\nmutation\\tO\\nidentified\\tO\\nin\\tO\\na\\tO\\ntype\\tB-Disease\\nII\\tI-Disease\\nGaucher\\tI-Disease\\ndisease\\tI-Disease\\nfetus\\tO\\n:\\tO\\nis\\tO\\nthis\\tO\\nanalogous\\tO\\nto\\tO\\nthe\\tO\\nGaucher\\tO\\nknock\\tO\\n-\\tO\\nout\\tO\\nmouse\\tO\\nmodel\\tO\\n?\\tO\\n\\nGaucher\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nGD\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\ninherited\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nbeta\\tI-Disease\\n-\\tI-Disease\\nglucocerebrosidase\\tI-Disease\\n(\\tO\\nEC\\tO\\n3\\tO\\n.\\tO\\n1\\tO\\n.\\tO\\n2\\tO\\n.\\tO\\n45\\tO\\n,\\tO\\ngene\\tO\\nsymbol\\tO\\nGBA\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\ntype\\tB-Disease\\nI\\tI-Disease\\nGD\\tI-Disease\\n,\\tO\\nthe\\tO\\nCNS\\tO\\nis\\tO\\nnot\\tO\\ninvolved\\tO\\n(\\tO\\nnonneuronopathic\\tO\\n)\\tO\\n,\\tO\\nwhereas\\tO\\nin\\tO\\ntype\\tB-Disease\\nII\\tI-Disease\\nGD\\tI-Disease\\n(\\tO\\nacute\\tO\\nneuronopathic\\tO\\n)\\tO\\nCNS\\tO\\ninvolvement\\tO\\nis\\tO\\nearly\\tO\\nand\\tO\\nrapidly\\tO\\nprogressive\\tO\\n,\\tO\\nwhile\\tO\\nin\\tO\\ntype\\tB-Disease\\nIII\\tI-Disease\\nGD\\tI-Disease\\n(\\tO\\nsubacute\\tO\\nneuronopathic\\tO\\n)\\tO\\nCNS\\tO\\ninvolvement\\tO\\noccurs\\tO\\nlater\\tO\\nand\\tO\\nis\\tO\\nslowly\\tO\\nprogressive\\tO\\n.\\tO\\n\\nThe\\tO\\nT6433C\\tO\\n(\\tO\\nL444P\\tO\\n)\\tO\\nsubstitution\\tO\\nis\\tO\\nprevalent\\tO\\nin\\tO\\ntype\\tB-Disease\\nGD\\tI-Disease\\nII\\tI-Disease\\n.\\tO\\n\\nIt\\tO\\nmay\\tO\\noccur\\tO\\nalone\\tO\\nas\\tO\\na\\tO\\nsingle\\tO\\nbase\\tO\\n-\\tO\\npair\\tO\\nmutation\\tO\\nbut\\tO\\noften\\tO\\nis\\tO\\nfound\\tO\\nas\\tO\\npart\\tO\\nof\\tO\\na\\tO\\ncomplex\\tO\\nallele\\tO\\ncontaining\\tO\\nadditional\\tO\\nGBA\\tO\\nnucleotide\\tO\\nsubstitutions\\tO\\n,\\tO\\nG6468C\\tO\\n(\\tO\\nA456P\\tO\\n)\\tO\\nand\\tO\\nG6482C\\tO\\n(\\tO\\nV460V\\tO\\n)\\tO\\n,\\tO\\nwithout\\tO\\n(\\tO\\nrecNciI\\tO\\n)\\tO\\nor\\tO\\nwith\\tO\\n(\\tO\\nrecTL\\tO\\n)\\tO\\nG5957C\\tO\\n(\\tO\\nD409H\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\ncomplex\\tO\\nallele\\tO\\nis\\tO\\npresumed\\tO\\nto\\tO\\nhave\\tO\\nformed\\tO\\nby\\tO\\nrecombination\\tO\\n(\\tO\\ncrossover\\tO\\n,\\tO\\nfusion\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nstructural\\tO\\ngene\\tO\\nwith\\tO\\nthe\\tO\\npseudogene\\tO\\n,\\tO\\nwhich\\tO\\ncontains\\tO\\nthe\\tO\\nmutated\\tO\\nsequences\\tO\\n.\\tO\\n\\nTwo\\tO\\ncomplex\\tO\\nalleles\\tO\\nhave\\tO\\nnever\\tO\\nbeen\\tO\\ndemonstrated\\tO\\nto\\tO\\ncoexist\\tO\\nin\\tO\\nany\\tO\\nindividual\\tO\\n.\\tO\\n\\nWe\\tO\\ndevised\\tO\\na\\tO\\nselective\\tO\\nPCR\\tO\\nmethod\\tO\\nfor\\tO\\nthe\\tO\\nspecific\\tO\\namplification\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nfusion\\tO\\ngene\\tO\\n.\\tO\\n\\nUsing\\tO\\nthis\\tO\\nprocedure\\tO\\nwe\\tO\\ndemonstrated\\tO\\nthe\\tO\\nfusion\\tO\\ngene\\tO\\nin\\tO\\nhomozygous\\tO\\nform\\tO\\nfor\\tO\\nthe\\tO\\nfirst\\tO\\ntime\\tO\\n,\\tO\\nin\\tO\\na\\tO\\nMacedonian\\tO\\n/\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nGD\\tB-Disease\\ntype\\tI-Disease\\nII\\tI-Disease\\nfetus\\tO\\n.\\tO\\n\\nBoth\\tO\\nparents\\tO\\nwere\\tO\\ncarriers\\tO\\nof\\tO\\nthe\\tO\\nrecombination\\tO\\n.\\tO\\n\\nThis\\tO\\nwas\\tO\\nconfirmed\\tO\\nby\\tO\\ndirect\\tO\\nsequence\\tO\\nanalysis\\tO\\n.\\tO\\n\\nA\\tO\\nprevious\\tO\\nconceptus\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nwas\\tO\\nstillborn\\tB-Disease\\nat\\tO\\n36\\tO\\nweeks\\tO\\n,\\tO\\nwith\\tO\\nfeatures\\tO\\nof\\tO\\nsevere\\tO\\ntype\\tB-Disease\\nII\\tI-Disease\\nGD\\tI-Disease\\n.\\tO\\n\\nNeonates\\tO\\nshowing\\tO\\na\\tO\\nsevere\\tO\\nclinical\\tO\\nphenotype\\tO\\n,\\tO\\nanalogous\\tO\\nto\\tO\\nthe\\tO\\nearly\\tO\\nneonatal\\tO\\nlethal\\tO\\ndisease\\tO\\noccurring\\tO\\nin\\tO\\nmice\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nnull\\tO\\nallele\\tO\\nproduced\\tO\\nby\\tO\\ntargeted\\tO\\ndisruption\\tO\\nof\\tO\\nGBA\\tO\\n,\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\nelsewhere\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nspecific\\tO\\nmutations\\tO\\nin\\tO\\nthese\\tO\\ncases\\tO\\nhave\\tO\\nnot\\tO\\nyet\\tO\\nbeen\\tO\\ncharacterized\\tO\\n.\\tO\\n\\n(\\tO\\nABSTRACT\\tO\\nTRUNCATED\\tO\\nAT\\tO\\n250\\tO\\nWORDS\\tO\\n)\\tO\\n\\nLate\\tO\\ninfantile\\tO\\nmetachromatic\\tB-Disease\\nleukodystrophy\\tI-Disease\\nin\\tO\\nIsrael\\tO\\n.\\tO\\n\\nMetachromatic\\tB-Disease\\nLeukodystrophy\\tI-Disease\\n(\\tO\\nMLD\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nneurodegenerative\\tB-Disease\\ndisease\\tI-Disease\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nlysosomal\\tO\\nenzyme\\tO\\n,\\tO\\nAryl\\tO\\nsulfatase\\tO\\nA\\tO\\n(\\tO\\nARSA\\tO\\n)\\tO\\nis\\tO\\ndeficient\\tO\\n.\\tO\\n\\nThe\\tO\\ndisease\\tO\\nis\\tO\\ninherited\\tO\\nas\\tO\\nan\\tO\\nautosomal\\tO\\nrecessive\\tO\\ntrait\\tO\\nand\\tO\\nits\\tO\\nfrequency\\tO\\nis\\tO\\nestimated\\tO\\nto\\tO\\nbe\\tO\\n1\\tO\\n/\\tO\\n40\\tO\\n,\\tO\\n000\\tO\\nlive\\tO\\nbirths\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nof\\tO\\nARSA\\tO\\nhas\\tO\\nbeen\\tO\\ncloned\\tO\\nand\\tO\\nup\\tO\\nto\\tO\\nnow\\tO\\neight\\tO\\nmutations\\tO\\ncausing\\tO\\nMLD\\tB-Disease\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\n.\\tO\\n\\nAnother\\tO\\nmutation\\tO\\n,\\tO\\nPD\\tO\\n,\\tO\\nleads\\tO\\nto\\tO\\nthe\\tO\\ndeficiency\\tO\\nof\\tO\\nthe\\tO\\nenzyme\\tO\\nin\\tO\\nvitro\\tO\\n(\\tO\\npseudodeficiency\\tO\\n)\\tO\\nwithout\\tO\\nany\\tO\\nknown\\tO\\nclinical\\tO\\neffect\\tO\\n.\\tO\\n\\nThe\\tO\\nPD\\tO\\nmutation\\tO\\nis\\tO\\nfrequent\\tO\\nin\\tO\\nall\\tO\\npopulations\\tO\\n.\\tO\\n\\nIn\\tO\\nIsrael\\tO\\n,\\tO\\nlate\\tO\\ninfantile\\tO\\nMLD\\tB-Disease\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nvery\\tO\\nfrequent\\tO\\nin\\tO\\na\\tO\\nsmall\\tO\\nJewish\\tO\\nisolate\\tO\\n,\\tO\\nthe\\tO\\nHabbanite\\tO\\nJews\\tO\\n(\\tO\\n1\\tO\\n/\\tO\\n75\\tO\\nlive\\tO\\nbirths\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\nanalysis\\tO\\ndemonstrated\\tO\\nthat\\tO\\nin\\tO\\nthe\\tO\\nHabbanite\\tO\\npopulation\\tO\\n,\\tO\\nthe\\tO\\nmutation\\tO\\noccurred\\tO\\non\\tO\\nan\\tO\\nallele\\tO\\nwith\\tO\\nthe\\tO\\nPD\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nloss\\tO\\nof\\tO\\nARSA\\tO\\nactivity\\tO\\nis\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\npoint\\tO\\nmutation\\tO\\nC\\tO\\n>\\tO\\nT\\tO\\nleading\\tO\\nto\\tO\\na\\tO\\nchange\\tO\\nof\\tO\\nproline\\tO\\nto\\tO\\nleucine\\tO\\n.\\tO\\n\\nMLD\\tB-Disease\\nis\\tO\\nalso\\tO\\nfrequent\\tO\\namong\\tO\\nMoslem\\tO\\nArabs\\tO\\nin\\tO\\nJerusalem\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nis\\tO\\na\\tO\\ntransition\\tO\\nG\\tO\\n>\\tO\\nA\\tO\\ndestroying\\tO\\nthe\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nof\\tO\\nexon\\tO\\n2\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nlate\\tO\\ninfantile\\tO\\nMLD\\tB-Disease\\nfrom\\tO\\ndifferent\\tO\\nethnic\\tO\\ngroups\\tO\\n.\\tO\\n\\nThe\\tO\\nChristian\\tO\\nArabs\\tO\\nin\\tO\\nIsrael\\tO\\nalso\\tO\\nhave\\tO\\na\\tO\\nhigh\\tO\\nincidence\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n(\\tO\\n1\\tO\\n/\\tO\\n10\\tO\\n,\\tO\\n000\\tO\\nlive\\tO\\nbirths\\tO\\n)\\tO\\n;\\tO\\nthe\\tO\\nmutation\\tO\\nin\\tO\\nthis\\tO\\npopulation\\tO\\nis\\tO\\nstill\\tO\\nunknown\\tO\\n.\\tO\\n\\nKnowledge\\tO\\nof\\tO\\nthe\\tO\\ndifferent\\tO\\nmutations\\tO\\ncausing\\tO\\nMLD\\tB-Disease\\nin\\tO\\nthese\\tO\\ndefined\\tO\\npopulations\\tO\\nwill\\tO\\nallow\\tO\\na\\tO\\ncarrier\\tO\\nscreening\\tO\\nprogram\\tO\\nto\\tO\\nbe\\tO\\ncarried\\tO\\nout\\tO\\nand\\tO\\nprevent\\tO\\nthe\\tO\\nbirth\\tO\\nof\\tO\\nadditional\\tO\\naffected\\tO\\nchildren\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nsingle\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\n(\\tO\\nG103D\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\ntype\\tO\\nII\\tO\\ncollagen\\tO\\ntriple\\tO\\nhelix\\tO\\nproduces\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\nis\\tO\\na\\tO\\nmoderately\\tO\\nsevere\\tO\\nchondrodysplasia\\tB-Disease\\nphenotype\\tO\\nthat\\tO\\nresults\\tO\\nfrom\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\ntype\\tO\\nII\\tO\\ncollagen\\tO\\n,\\tO\\nCOL2A1\\tO\\n.\\tO\\n\\nCharacteristics\\tO\\nof\\tO\\nthe\\tO\\ndisorder\\tO\\ninclude\\tO\\na\\tO\\nshort\\tB-Disease\\ntrunk\\tI-Disease\\nand\\tI-Disease\\nextremities\\tI-Disease\\n,\\tO\\nmid\\tB-Disease\\n-\\tI-Disease\\nface\\tI-Disease\\nhypoplasia\\tI-Disease\\n,\\tO\\ncleft\\tB-Disease\\npalate\\tI-Disease\\n,\\tO\\nmyopia\\tB-Disease\\n,\\tO\\nretinal\\tB-Disease\\ndetachment\\tI-Disease\\n,\\tO\\nand\\tO\\nhearing\\tB-Disease\\nloss\\tI-Disease\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\ndeletions\\tO\\nof\\tO\\nall\\tO\\nor\\tO\\npart\\tO\\nof\\tO\\nexon\\tO\\n12\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nmutations\\tO\\nwithin\\tO\\nthis\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\nmay\\tO\\nprimarily\\tO\\nresult\\tO\\nin\\tO\\nthe\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\nphenotype\\tO\\n.\\tO\\n\\nWe\\tO\\nused\\tO\\nSSCP\\tO\\nto\\tO\\nanalyze\\tO\\nan\\tO\\namplified\\tO\\ngenomic\\tO\\nDNA\\tO\\nfragment\\tO\\ncontaining\\tO\\nexon\\tO\\n12\\tO\\nfrom\\tO\\nseven\\tO\\nindividuals\\tO\\nwith\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nAn\\tO\\nabnormality\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\none\\tO\\npatient\\tO\\n.\\tO\\n\\nDNA\\tO\\nsequence\\tO\\nanalysis\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\npatient\\tO\\nwas\\tO\\nheterozygous\\tO\\nfor\\tO\\na\\tO\\nG\\tO\\nto\\tO\\nA\\tO\\ntransition\\tO\\nthat\\tO\\nimplied\\tO\\nsubstitution\\tO\\nof\\tO\\nglycine103\\tO\\nof\\tO\\nthe\\tO\\ntriple\\tO\\nhelical\\tO\\ndomain\\tO\\nby\\tO\\naspartate\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nwas\\tO\\nnot\\tO\\nobserved\\tO\\nin\\tO\\nDNA\\tO\\nfrom\\tO\\neither\\tO\\nof\\tO\\nthe\\tO\\nclinically\\tO\\nunaffected\\tO\\nparents\\tO\\nof\\tO\\nthe\\tO\\nproband\\tO\\n.\\tO\\n\\nProtein\\tO\\nmicrosequencing\\tO\\ndemonstrated\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nabnormal\\tO\\nallele\\tO\\nin\\tO\\ncartilage\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\ndemonstrate\\tO\\nthat\\tO\\npoint\\tO\\nmutations\\tO\\nwhich\\tO\\nresult\\tO\\nin\\tO\\nsingle\\tO\\namino\\tO\\nacid\\tO\\nsubstitutions\\tO\\ncan\\tO\\nproduce\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\nand\\tO\\nfurther\\tO\\nsupport\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nalteration\\tO\\nof\\tO\\na\\tO\\ndomain\\tO\\n,\\tO\\nwhich\\tO\\nincludes\\tO\\nthe\\tO\\nregion\\tO\\nencoded\\tO\\nby\\tO\\nexon\\tO\\n12\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\ntype\\tO\\nII\\tO\\ncollagen\\tO\\nprotein\\tO\\nleads\\tO\\nto\\tO\\nthis\\tO\\ndisorder\\tO\\n.\\tO\\n.\\tO\\n\\nCAG\\tO\\nexpansions\\tO\\nin\\tO\\na\\tO\\nnovel\\tO\\ngene\\tO\\nfor\\tO\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\nat\\tO\\nchromosome\\tO\\n14q32\\tO\\n.\\tO\\n1\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\na\\tO\\nnovel\\tO\\ngene\\tO\\ncontaining\\tO\\nCAG\\tO\\nrepeats\\tO\\nand\\tO\\nmapped\\tO\\nit\\tO\\nto\\tO\\nchromosome\\tO\\n14q32\\tO\\n.\\tO\\n\\n1\\tO\\n,\\tO\\nthe\\tO\\ngenetic\\tO\\nlocus\\tO\\nfor\\tO\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nMJD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nnormal\\tO\\nindividuals\\tO\\nthe\\tO\\ngene\\tO\\ncontains\\tO\\nbetween\\tO\\n13\\tO\\nand\\tO\\n36\\tO\\nCAG\\tO\\nrepeats\\tO\\n,\\tO\\nwhereas\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\nclinically\\tO\\ndiagnosed\\tO\\npatients\\tO\\nand\\tO\\nall\\tO\\nof\\tO\\nthe\\tO\\naffected\\tO\\nmembers\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nthe\\tO\\nclinical\\tO\\nand\\tO\\npathological\\tO\\ndiagnosis\\tO\\nof\\tO\\nMJD\\tB-Disease\\nshow\\tO\\nexpansion\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\n-\\tO\\nnumber\\tO\\n(\\tO\\nfrom\\tO\\n68\\tO\\n-\\tO\\n79\\tO\\n)\\tO\\n.\\tO\\n\\nSouthern\\tO\\nblot\\tO\\nanalyses\\tO\\nand\\tO\\ngenomic\\tO\\ncloning\\tO\\ndemonstrates\\tO\\nthe\\tO\\nexistence\\tO\\nof\\tO\\nrelated\\tO\\ngenes\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nraise\\tO\\nthe\\tO\\npossibility\\tO\\nthat\\tO\\nsimilar\\tO\\nabnormalities\\tO\\nin\\tO\\nrelated\\tO\\ngenes\\tO\\nmay\\tO\\ngive\\tO\\nrise\\tO\\nto\\tO\\ndiseases\\tO\\nsimilar\\tO\\nto\\tO\\nMJD\\tB-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nanalysed\\tO\\n50\\tO\\nprobands\\tO\\nwith\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfor\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ncandidate\\tO\\ngene\\tO\\n,\\tO\\nusing\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\nanalysis\\tO\\non\\tO\\nPCR\\tO\\n-\\tO\\namplified\\tO\\ngenomic\\tO\\nDNA\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\neight\\tO\\nputative\\tO\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\nalterations\\tO\\nwere\\tO\\nidentified\\tO\\nfour\\tO\\nof\\tO\\nthese\\tO\\nare\\tO\\nframeshifts\\tO\\nand\\tO\\ntwo\\tO\\nare\\tO\\nnonsense\\tO\\nmutations\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nfound\\tO\\ntwo\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\none\\tO\\nof\\tO\\nwhich\\tO\\nchanges\\tO\\nthe\\tO\\nfinal\\tO\\ncysteine\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\nzinc\\tO\\nfinger\\tO\\nmotif\\tO\\nto\\tO\\nglycine\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\na\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\nmodel\\tO\\n,\\tO\\nand\\tO\\nsupport\\tO\\nthe\\tO\\nnotion\\tO\\nthat\\tO\\nthis\\tO\\ncandidate\\tO\\ngene\\tO\\nis\\tO\\nin\\tO\\nfact\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nThe\\tO\\nheterogeneity\\tO\\nof\\tO\\nmutations\\tO\\n,\\tO\\ncoupled\\tO\\nwith\\tO\\nthe\\tO\\nlarge\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nindicates\\tO\\nthat\\tO\\nclinical\\tO\\napplication\\tO\\nof\\tO\\nBRCA1\\tO\\nmutation\\tO\\ntesting\\tO\\nwill\\tO\\nbe\\tO\\ntechnically\\tO\\nchallenging\\tO\\n.\\tO\\n.\\tO\\n\\nConfirmation\\tO\\nof\\tO\\nBRCA1\\tO\\nby\\tO\\nanalysis\\tO\\nof\\tO\\ngermline\\tO\\nmutations\\tO\\nlinked\\tO\\nto\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nin\\tO\\nten\\tO\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nprovide\\tO\\ngenetic\\tO\\nevidence\\tO\\nsupporting\\tO\\nthe\\tO\\nidentity\\tO\\nof\\tO\\nthe\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nBRCA1\\tO\\nthrough\\tO\\nthe\\tO\\ncharacterization\\tO\\nof\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\n63\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\nand\\tO\\n10\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\nin\\tO\\nten\\tO\\nfamilies\\tO\\nwith\\tO\\ncancer\\tB-Disease\\nlinked\\tO\\nto\\tO\\nchromosome\\tO\\n17q21\\tO\\n.\\tO\\n\\nNine\\tO\\ndifferent\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nby\\tO\\nscreening\\tO\\nBRCA1\\tO\\nDNA\\tO\\nand\\tO\\nRNA\\tO\\nby\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\nanalysis\\tO\\nand\\tO\\ndirect\\tO\\nsequencing\\tO\\n.\\tO\\n\\nSeven\\tO\\nmutations\\tO\\nlead\\tO\\nto\\tO\\nprotein\\tO\\ntruncations\\tO\\nat\\tO\\nsites\\tO\\nthroughout\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nOne\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nwhich\\tO\\noccurred\\tO\\nindependently\\tO\\nin\\tO\\ntwo\\tO\\nfamilies\\tO\\n)\\tO\\nleads\\tO\\nto\\tO\\nloss\\tO\\nof\\tO\\na\\tO\\ncysteine\\tO\\nin\\tO\\nthe\\tO\\nzinc\\tO\\nbinding\\tO\\ndomain\\tO\\n.\\tO\\n\\nAn\\tO\\nintronic\\tO\\nsingle\\tO\\nbasepair\\tO\\nsubstitution\\tO\\ndestroys\\tO\\nan\\tO\\nacceptor\\tO\\nsite\\tO\\nand\\tO\\nactivates\\tO\\na\\tO\\ncryptic\\tO\\nsplice\\tO\\nsite\\tO\\n,\\tO\\nleading\\tO\\nto\\tO\\na\\tO\\n59\\tO\\nbasepair\\tO\\ninsertion\\tO\\nand\\tO\\nchain\\tO\\ntermination\\tO\\n.\\tO\\n\\nThe\\tO\\nfour\\tO\\nfamilies\\tO\\nwith\\tO\\nboth\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nhad\\tO\\nchain\\tO\\ntermination\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\nhalf\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n.\\tO\\n.\\tO\\n\\nHigh\\tO\\nresolution\\tO\\ngenetic\\tO\\nanalysis\\tO\\nsuggests\\tO\\none\\tO\\nancestral\\tO\\npredisposing\\tO\\nhaplotype\\tO\\nfor\\tO\\nthe\\tO\\norigin\\tO\\nof\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\ncausing\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nas\\tO\\nan\\tO\\namplification\\tO\\nof\\tO\\nan\\tO\\nunstable\\tO\\ntrinucleotide\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\nin\\tO\\nover\\tO\\n99\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nglobal\\tO\\nDM\\tB-Disease\\npopulation\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nin\\tO\\ncomplete\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nwith\\tO\\nan\\tO\\nAlu\\tO\\nelement\\tO\\npolymorphism\\tO\\nwithin\\tO\\nthe\\tO\\nDM\\tB-Disease\\nkinase\\tO\\ngene\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nDM\\tB-Disease\\nis\\tO\\na\\tO\\nconsequence\\tO\\nof\\tO\\none\\tO\\nor\\tO\\nfew\\tO\\nancestral\\tO\\nmutations\\tO\\n.\\tO\\n\\nA\\tO\\nrecent\\tO\\nanalysis\\tO\\nutilizing\\tO\\nthis\\tO\\npolymorphism\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\na\\tO\\nflanking\\tO\\ndinucleotide\\tO\\nmarker\\tO\\n,\\tO\\nsuggested\\tO\\nthat\\tO\\nsimilar\\tO\\nto\\tO\\nFragile\\tB-Disease\\nX\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nDM\\tB-Disease\\nexhibited\\tO\\na\\tO\\nfounder\\tO\\neffect\\tO\\n(\\tO\\nImbert\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1993\\tO\\nNature\\tO\\nGenet\\tO\\n.\\tO\\n4\\tO\\n,\\tO\\n72\\tO\\n-\\tO\\n76\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nthe\\tO\\nlow\\tO\\nreproductive\\tO\\nfitness\\tO\\nof\\tO\\nindividuals\\tO\\nwith\\tO\\ncongenital\\tO\\nDM\\tB-Disease\\n(\\tO\\nthe\\tO\\nendpoint\\tO\\nof\\tO\\ngenetic\\tO\\nanticipation\\tO\\nin\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n)\\tO\\nsuggests\\tO\\na\\tO\\nhigher\\tO\\nrate\\tO\\nof\\tO\\nnew\\tO\\nmutations\\tO\\n.\\tO\\n\\nWe\\tO\\npresent\\tO\\na\\tO\\nhigh\\tO\\nresolution\\tO\\ngenetic\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nlocus\\tO\\nusing\\tO\\nPCR\\tO\\nbased\\tO\\nassays\\tO\\nof\\tO\\nnine\\tO\\npolymorphisms\\tO\\n,\\tO\\nspanning\\tO\\na\\tO\\nphysical\\tO\\ndistance\\tO\\nof\\tO\\n30\\tO\\nkb\\tO\\n,\\tO\\nwithin\\tO\\nand\\tO\\nimmediately\\tO\\nflanking\\tO\\nthe\\tO\\nDM\\tB-Disease\\nkinase\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\npersistent\\tO\\ncomplete\\tO\\nallelic\\tO\\nassociation\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nmutation\\tO\\nwith\\tO\\nall\\tO\\nthese\\tO\\npolymorphisms\\tO\\nprovides\\tO\\nfurther\\tO\\nsupport\\tO\\nto\\tO\\nprevious\\tO\\nobservations\\tO\\nand\\tO\\nsuggests\\tO\\nmore\\tO\\nstrongly\\tO\\nthat\\tO\\nthe\\tO\\nDM\\tB-Disease\\nmutation\\tO\\noccurred\\tO\\non\\tO\\nthe\\tO\\nbackground\\tO\\nof\\tO\\na\\tO\\nparticular\\tO\\nhaplotype\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\nbecame\\tO\\ninherently\\tO\\nunstable\\tO\\nand\\tO\\ntherefore\\tO\\npredisposed\\tO\\nto\\tO\\namplification\\tO\\n.\\tO\\n\\nGenetic\\tO\\ninstability\\tO\\nin\\tO\\nhuman\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\ncell\\tO\\nlines\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nanalyzed\\tO\\nthe\\tO\\nstability\\tO\\nof\\tO\\nmicrosatellites\\tO\\nin\\tO\\ncell\\tO\\nlines\\tO\\nderived\\tO\\nfrom\\tO\\nhuman\\tO\\novarian\\tB-Disease\\ncancers\\tI-Disease\\nand\\tO\\nfound\\tO\\nthat\\tO\\n5\\tO\\nout\\tO\\nof\\tO\\n10\\tO\\nof\\tO\\nthe\\tO\\novarian\\tB-Disease\\ntumor\\tI-Disease\\ncell\\tO\\nlines\\tO\\nare\\tO\\ngenetically\\tO\\nunstable\\tO\\nat\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nthe\\tO\\nloci\\tO\\nanalyzed\\tO\\n.\\tO\\n\\nIn\\tO\\nclones\\tO\\nand\\tO\\nsubclones\\tO\\nderived\\tO\\nserially\\tO\\nfrom\\tO\\none\\tO\\nof\\tO\\nthese\\tO\\ncell\\tO\\nlines\\tO\\n(\\tO\\n2774\\tO\\n;\\tO\\nserous\\tB-Disease\\ncystadenocarcinoma\\tI-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nvery\\tO\\nhigh\\tO\\nproportion\\tO\\nof\\tO\\nmicrosatellites\\tO\\ndistributed\\tO\\nin\\tO\\nmany\\tO\\ndifferent\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\ngenome\\tO\\nchange\\tO\\ntheir\\tO\\nsize\\tO\\nin\\tO\\na\\tO\\nmercurial\\tO\\nfashion\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\ngenomic\\tO\\ninstability\\tO\\nin\\tO\\novarian\\tB-Disease\\ntumors\\tI-Disease\\nis\\tO\\na\\tO\\ndynamic\\tO\\nand\\tO\\nongoing\\tO\\nprocess\\tO\\nwhose\\tO\\nhigh\\tO\\nfrequency\\tO\\nmay\\tO\\nhave\\tO\\nbeen\\tO\\npreviously\\tO\\nunderestimated\\tO\\nby\\tO\\nPCR\\tO\\n-\\tO\\nbased\\tO\\nallelotyping\\tO\\nof\\tO\\nbulk\\tO\\ntumor\\tB-Disease\\ntissue\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\nthe\\tO\\nsource\\tO\\nof\\tO\\nthe\\tO\\ngenetic\\tO\\ninstability\\tO\\nin\\tO\\none\\tO\\novarian\\tB-Disease\\ntumor\\tI-Disease\\nas\\tO\\na\\tO\\npoint\\tO\\nmutation\\tO\\n(\\tO\\nR524P\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nmismatch\\tO\\n-\\tO\\nrepair\\tO\\ngene\\tO\\nMSH2\\tO\\n(\\tO\\nSalmonella\\tO\\nMutS\\tO\\nhomologue\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\nhereditary\\tB-Disease\\nnonpolyposis\\tI-Disease\\ncolorectal\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nPatient\\tO\\n2774\\tO\\nwas\\tO\\na\\tO\\n38\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nheterozygote\\tO\\n,\\tO\\nand\\tO\\nher\\tO\\nnormal\\tO\\ntissue\\tO\\ncarried\\tO\\nboth\\tO\\nmutant\\tO\\nand\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nalleles\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nMSH2\\tO\\ngene\\tO\\n.\\tO\\n\\nHowever\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nallele\\tO\\nwas\\tO\\nlost\\tO\\nat\\tO\\nsome\\tO\\npoint\\tO\\nearly\\tO\\nduring\\tO\\ntumorigenesis\\tO\\nso\\tO\\nthat\\tO\\nDNA\\tO\\nisolated\\tO\\neither\\tO\\nfrom\\tO\\nthe\\tO\\npatients\\tO\\novarian\\tB-Disease\\ntumor\\tI-Disease\\nor\\tO\\nfrom\\tO\\nthe\\tO\\n2774\\tO\\ncell\\tO\\nline\\tO\\ncarries\\tO\\nonly\\tO\\nthe\\tO\\nmutant\\tO\\nallele\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nMSH2\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\ngenetic\\tO\\ninstability\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\ntumor\\tB-Disease\\nand\\tO\\ncell\\tO\\nline\\tO\\nDNA\\tO\\n,\\tO\\ntogether\\tO\\nwith\\tO\\nthe\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nmismatch\\tO\\n-\\tO\\nrepair\\tO\\ngene\\tO\\n,\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nMSH2\\tO\\ngene\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nonset\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nprogression\\tO\\nin\\tO\\na\\tO\\nsubset\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\nprimary\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n\\nLoss\\tO\\nof\\tO\\nheterozygosity\\tO\\ndata\\tO\\nfrom\\tO\\nfamilial\\tB-Disease\\ntumors\\tI-Disease\\nsuggest\\tO\\nthat\\tO\\nBRCA1\\tO\\n,\\tO\\na\\tO\\ngene\\tO\\nthat\\tO\\nconfers\\tO\\nsusceptibility\\tO\\nto\\tO\\novarian\\tB-Disease\\nand\\tI-Disease\\nearly\\tI-Disease\\n-\\tI-Disease\\nonset\\tI-Disease\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nencodes\\tO\\na\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\n.\\tO\\n\\nThe\\tO\\nBRCA1\\tO\\nregion\\tO\\nis\\tO\\nalso\\tO\\nsubject\\tO\\nto\\tO\\nallelic\\tO\\nloss\\tO\\nin\\tO\\nsporadic\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\n,\\tO\\nan\\tO\\nindication\\tO\\nthat\\tO\\nBRCA1\\tO\\nmutations\\tO\\nmay\\tO\\noccur\\tO\\nsomatically\\tO\\nin\\tO\\nthese\\tO\\ntumors\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nBRCA1\\tO\\ncoding\\tO\\nregion\\tO\\nwas\\tO\\nexamined\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nprimary\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ntumors\\tI-Disease\\nthat\\tO\\nshow\\tO\\nallele\\tO\\nloss\\tO\\nat\\tO\\nthe\\tO\\nBRCA1\\tO\\nlocus\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\n3\\tO\\nof\\tO\\n32\\tO\\nbreast\\tO\\nand\\tO\\n1\\tO\\nof\\tO\\n12\\tO\\novarian\\tB-Disease\\ncarcinomas\\tI-Disease\\n;\\tO\\nall\\tO\\nfour\\tO\\nmutations\\tO\\nwere\\tO\\ngermline\\tO\\nalterations\\tO\\nand\\tO\\noccurred\\tO\\nin\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\ncancers\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nmutation\\tO\\nof\\tO\\nBRCA1\\tO\\nmay\\tO\\nnot\\tO\\nbe\\tO\\ncritical\\tO\\nin\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\nthat\\tO\\narise\\tO\\nin\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\na\\tO\\nmutant\\tO\\ngermline\\tO\\nallele\\tO\\n.\\tO\\n.\\tO\\n\\nPAX6\\tO\\ngene\\tO\\ndosage\\tO\\neffect\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\ncataracts\\tI-Disease\\n,\\tO\\naniridia\\tB-Disease\\n,\\tO\\nanophthalmia\\tB-Disease\\nand\\tO\\ncentral\\tB-Disease\\nnervous\\tI-Disease\\nsystem\\tI-Disease\\ndefects\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\neye\\tO\\nmalformation\\tO\\naniridia\\tB-Disease\\nresults\\tO\\nfrom\\tO\\nhaploinsufficiency\\tB-Disease\\nof\\tI-Disease\\nPAX6\\tI-Disease\\n,\\tO\\na\\tO\\npaired\\tO\\nbox\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\nprotein\\tO\\n.\\tO\\n\\nTo\\tO\\nstudy\\tO\\nthis\\tO\\ndosage\\tO\\neffect\\tO\\n,\\tO\\nwe\\tO\\ncharacterized\\tO\\ntwo\\tO\\nPAX6\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nsegregating\\tO\\naniridia\\tB-Disease\\nand\\tO\\na\\tO\\nmilder\\tO\\nsyndrome\\tO\\nconsisting\\tO\\nof\\tO\\ncongenital\\tB-Disease\\ncataracts\\tI-Disease\\nand\\tO\\nlate\\tO\\nonset\\tO\\ncorneal\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nnonsense\\tO\\nmutations\\tO\\n,\\tO\\nat\\tO\\ncodons\\tO\\n103\\tO\\nand\\tO\\n353\\tO\\n,\\tO\\ntruncate\\tO\\nPAX6\\tO\\nwithin\\tO\\nthe\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\npaired\\tO\\nand\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nPST\\tO\\ndomains\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nThe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nPST\\tO\\ndomain\\tO\\nactivates\\tO\\ntranscription\\tO\\nautonomously\\tO\\nand\\tO\\nthe\\tO\\nmutant\\tO\\nform\\tO\\nhas\\tO\\npartial\\tO\\nactivity\\tO\\n.\\tO\\n\\nA\\tO\\ncompound\\tO\\nheterozygote\\tO\\nhad\\tO\\nsevere\\tO\\ncraniofacial\\tB-Disease\\nand\\tI-Disease\\ncentral\\tI-Disease\\nnervous\\tI-Disease\\nsystem\\tI-Disease\\ndefects\\tI-Disease\\nand\\tO\\nno\\tB-Disease\\neyes\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\npattern\\tO\\nof\\tO\\nmalformations\\tO\\nis\\tO\\nsimilar\\tO\\nto\\tO\\nthat\\tO\\nin\\tO\\nhomozygous\\tO\\nSey\\tO\\nmice\\tO\\nand\\tO\\nsuggests\\tO\\na\\tO\\ncritical\\tO\\nrole\\tO\\nfor\\tO\\nPAX6\\tO\\nin\\tO\\ncontrolling\\tO\\nthe\\tO\\nmigration\\tO\\nand\\tO\\ndifferentiation\\tO\\nof\\tO\\nspecific\\tO\\nneuronal\\tO\\nprogenitor\\tO\\ncells\\tO\\nin\\tO\\nthe\\tO\\nbrain\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nphysical\\tO\\nmap\\tO\\nand\\tO\\ncandidate\\tO\\ngenes\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\nregion\\tO\\non\\tO\\nchromosome\\tO\\n17q12\\tO\\n-\\tO\\n21\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nconstructed\\tO\\na\\tO\\nphysical\\tO\\nmap\\tO\\nof\\tO\\na\\tO\\n4\\tO\\ncM\\tO\\nregion\\tO\\non\\tO\\nchromosome\\tO\\n17q12\\tO\\n-\\tO\\n21\\tO\\nthat\\tO\\ncontains\\tO\\nthe\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ngene\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nThe\\tO\\nmap\\tO\\ncomprises\\tO\\na\\tO\\ncontig\\tO\\nof\\tO\\n137\\tO\\noverlapping\\tO\\nyeast\\tO\\nartificial\\tO\\nchromosomes\\tO\\nand\\tO\\nP1\\tO\\nclones\\tO\\n,\\tO\\nonto\\tO\\nwhich\\tO\\nwe\\tO\\nhave\\tO\\nplaced\\tO\\n112\\tO\\nPCR\\tO\\nmarkers\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nlocalized\\tO\\nmore\\tO\\nthan\\tO\\n20\\tO\\ngenes\\tO\\non\\tO\\nthis\\tO\\nmap\\tO\\n,\\tO\\nten\\tO\\nof\\tO\\nwhich\\tO\\nhad\\tO\\nnot\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\nregion\\tO\\npreviously\\tO\\n,\\tO\\nand\\tO\\nhave\\tO\\nisolated\\tO\\n30\\tO\\ncDNA\\tO\\nclones\\tO\\nrepresenting\\tO\\npartial\\tO\\nsequences\\tO\\nof\\tO\\nas\\tO\\nyet\\tO\\nunidentified\\tO\\ngenes\\tO\\n.\\tO\\n\\nTwo\\tO\\ngenes\\tO\\nthat\\tO\\nlie\\tO\\nwithin\\tO\\na\\tO\\nnarrow\\tO\\nregion\\tO\\ndefined\\tO\\nby\\tO\\nmeiotic\\tO\\nbreakpoints\\tO\\nin\\tO\\nBRCA1\\tO\\npatients\\tO\\nhave\\tO\\nbeen\\tO\\nsequenced\\tO\\nin\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\nwithout\\tO\\nrevealing\\tO\\nany\\tO\\ndeleterious\\tO\\nmutations\\tO\\n.\\tO\\n\\nThese\\tO\\nnew\\tO\\nreagents\\tO\\nshould\\tO\\nfacilitate\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\nBRCA1\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nLEC\\tO\\nrat\\tO\\nhas\\tO\\na\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\ncopper\\tO\\ntransporting\\tO\\nATPase\\tO\\ngene\\tO\\nhomologous\\tO\\nto\\tO\\nthe\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nLong\\tO\\n-\\tO\\nEvans\\tO\\nCinnamon\\tO\\n(\\tO\\nLEC\\tO\\n)\\tO\\nrat\\tO\\nshows\\tO\\nsimilarity\\tO\\nto\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\nin\\tO\\nmany\\tO\\nclinical\\tO\\nand\\tO\\nbiochemical\\tO\\nfeatures\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ncloned\\tO\\ncDNAs\\tO\\nfor\\tO\\nthe\\tO\\nrat\\tO\\ngene\\tO\\n(\\tO\\nAtp7b\\tO\\n)\\tO\\nhomologous\\tO\\nto\\tO\\nthe\\tO\\nhuman\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\n(\\tO\\nATP7B\\tO\\n)\\tO\\nand\\tO\\nhave\\tO\\nused\\tO\\nthem\\tO\\nto\\tO\\nidentify\\tO\\na\\tO\\npartial\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\nAtp7b\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\nLEC\\tO\\nrat\\tO\\n.\\tO\\n\\nThe\\tO\\ndeletion\\tO\\nremoves\\tO\\nat\\tO\\nleast\\tO\\n900\\tO\\nbp\\tO\\nof\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nat\\tO\\nthe\\tO\\n3\\tO\\nend\\tO\\n,\\tO\\nincludes\\tO\\nthe\\tO\\ncrucial\\tO\\nATP\\tO\\nbinding\\tO\\ndomain\\tO\\nand\\tO\\nextends\\tO\\ndownstream\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nprovide\\tO\\nconvincing\\tO\\nevidence\\tO\\nfor\\tO\\ndefining\\tO\\nthe\\tO\\nLEC\\tO\\nrat\\tO\\nas\\tO\\nan\\tO\\nanimal\\tO\\nmodel\\tO\\nfor\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nmodel\\tO\\nwill\\tO\\nbe\\tO\\nimportant\\tO\\nfor\\tO\\nstudying\\tO\\nliver\\tO\\npathophysiology\\tO\\n,\\tO\\nfor\\tO\\ndeveloping\\tO\\ntherapy\\tO\\nfor\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\nand\\tO\\nfor\\tO\\nstudying\\tO\\nthe\\tO\\npathway\\tO\\nof\\tO\\ncopper\\tO\\ntransport\\tO\\nand\\tO\\nits\\tO\\npossible\\tO\\ninteraction\\tO\\nwith\\tO\\nother\\tO\\nheavy\\tO\\nmetals\\tO\\n.\\tO\\n.\\tO\\n\\nGenomic\\tO\\norganization\\tO\\nof\\tO\\nthe\\tO\\nadrenoleukodystrophy\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nAdrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nmost\\tO\\nfrequent\\tO\\nperoxisomal\\tB-Disease\\ndisorder\\tI-Disease\\n,\\tO\\nis\\tO\\na\\tO\\nsevere\\tO\\nneurodegenerative\\tB-Disease\\ndisease\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nimpairment\\tB-Disease\\nof\\tI-Disease\\nvery\\tI-Disease\\nlong\\tI-Disease\\nchain\\tI-Disease\\nfatty\\tI-Disease\\nacids\\tI-Disease\\nbeta\\tI-Disease\\n-\\tI-Disease\\noxidation\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nrecently\\tO\\nidentified\\tO\\nby\\tO\\npositional\\tO\\ncloning\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nALD\\tB-Disease\\n,\\tO\\nlocated\\tO\\nin\\tO\\nXq28\\tO\\n.\\tO\\n\\nIt\\tO\\nencodes\\tO\\na\\tO\\nnew\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\n\"\\tO\\nABC\\tO\\n\"\\tO\\nsuperfamily\\tO\\nof\\tO\\nmembrane\\tO\\n-\\tO\\nassociated\\tO\\ntransporters\\tO\\nthat\\tO\\nshows\\tO\\n,\\tO\\nin\\tO\\nparticular\\tO\\n,\\tO\\nsignificant\\tO\\nhomology\\tO\\nto\\tO\\nthe\\tO\\n70\\tO\\n-\\tO\\nkDa\\tO\\nperoxisomal\\tO\\nmembrane\\tO\\nprotein\\tO\\n(\\tO\\nPMP70\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\na\\tO\\ndetailed\\tO\\ncharacterization\\tO\\nof\\tO\\nthe\\tO\\nALD\\tB-Disease\\ngene\\tO\\nstructure\\tO\\n.\\tO\\n\\nIt\\tO\\nextends\\tO\\nover\\tO\\n21\\tO\\nkb\\tO\\nand\\tO\\nconsists\\tO\\nof\\tO\\n10\\tO\\nexons\\tO\\n.\\tO\\n\\nTo\\tO\\nfacilitate\\tO\\nthe\\tO\\ndetection\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nALD\\tB-Disease\\npatients\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ndetermined\\tO\\nthe\\tO\\nintronic\\tO\\nsequences\\tO\\nflanking\\tO\\nthe\\tO\\nexons\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nthe\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nregion\\tO\\nand\\tO\\nof\\tO\\nthe\\tO\\nimmediate\\tO\\n5\\tO\\npromoter\\tO\\nregion\\tO\\n.\\tO\\n\\nSequences\\tO\\npresent\\tO\\nin\\tO\\ndistal\\tO\\nexons\\tO\\ncross\\tO\\n-\\tO\\nhybridize\\tO\\nstrongly\\tO\\nto\\tO\\nadditional\\tO\\nsequences\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\ngenome\\tO\\n.\\tO\\n\\nThe\\tO\\nALD\\tB-Disease\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\npositioned\\tO\\non\\tO\\na\\tO\\npulsed\\tO\\n-\\tO\\nfield\\tO\\nmap\\tO\\nbetween\\tO\\nDXS15\\tO\\nand\\tO\\nthe\\tO\\nL1CAM\\tO\\ngene\\tO\\n,\\tO\\nabout\\tO\\n650\\tO\\nkb\\tO\\nupstream\\tO\\nfrom\\tO\\nthe\\tO\\ncolor\\tO\\npigment\\tO\\ngenes\\tO\\n.\\tO\\n\\nThe\\tO\\nfrequent\\tO\\noccurrence\\tO\\nof\\tO\\ncolor\\tO\\nvision\\tO\\nanomalies\\tO\\nobserved\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n(\\tO\\nthe\\tO\\nadult\\tO\\nonset\\tO\\nform\\tO\\nof\\tO\\nALD\\tB-Disease\\n)\\tO\\nthus\\tO\\ndoes\\tO\\nnot\\tO\\nrepresent\\tO\\na\\tO\\ncontiguous\\tB-Disease\\ngene\\tI-Disease\\nsyndrome\\tI-Disease\\nbut\\tO\\na\\tO\\nsecondary\\tO\\nmanifestation\\tO\\nof\\tO\\nALD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nmurine\\tO\\nhomologues\\tO\\nof\\tO\\nthe\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\n(\\tO\\nHdh\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nalpha\\tO\\n-\\tO\\nadducin\\tO\\ngene\\tO\\n(\\tO\\nAdd1\\tO\\n)\\tO\\nmap\\tO\\nto\\tO\\nmouse\\tO\\nchromosome\\tO\\n5\\tO\\nwithin\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\nconserved\\tO\\nsynteny\\tO\\nwith\\tO\\nhuman\\tO\\nchromosome\\tO\\n4p16\\tO\\n.\\tO\\n3\\tO\\n.\\tO\\n\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nsevere\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nneurodegenerative\\tI-Disease\\ndisorder\\tI-Disease\\nassociated\\tO\\nwith\\tO\\na\\tO\\nnovel\\tO\\ngene\\tO\\n(\\tO\\nIT15\\tO\\n)\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nwe\\tO\\nreported\\tO\\nthe\\tO\\ncloning\\tO\\nof\\tO\\nHdh\\tO\\n,\\tO\\nthe\\tO\\nmurine\\tO\\nhomologue\\tO\\nof\\tO\\nIT15\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nusing\\tO\\nan\\tO\\ninterspecific\\tO\\nbackcross\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nmapped\\tO\\nboth\\tO\\nHdh\\tO\\nand\\tO\\nthe\\tO\\nmouse\\tO\\nhomologue\\tO\\nof\\tO\\nhuman\\tO\\nalpha\\tO\\n-\\tO\\nadducin\\tO\\n(\\tO\\nAdd1\\tO\\n)\\tO\\n,\\tO\\na\\tO\\nmembrane\\tO\\n-\\tO\\nassociated\\tO\\ncytoskeletal\\tO\\nprotein\\tO\\ngene\\tO\\n.\\tO\\n\\nBoth\\tO\\nof\\tO\\nthese\\tO\\ngenes\\tO\\nmap\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\nposition\\tO\\non\\tO\\nmouse\\tO\\nchromosome\\tO\\n5\\tO\\nin\\tO\\na\\tO\\nregion\\tO\\nassociated\\tO\\nwith\\tO\\nancestral\\tO\\nchromosomal\\tO\\nrearrangements\\tO\\nand\\tO\\nshow\\tO\\nno\\tO\\nrecombination\\tO\\nwith\\tO\\nD5H4S43\\tO\\n,\\tO\\nD5H4S115\\tO\\n,\\tO\\nand\\tO\\nD5H4S62\\tO\\n,\\tO\\nthe\\tO\\nmurine\\tO\\nhomologues\\tO\\nof\\tO\\nD4S43\\tO\\n,\\tO\\nD4S115\\tO\\n,\\tO\\nand\\tO\\nD4S62\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nFurther\\tO\\nmapping\\tO\\nstudies\\tO\\nof\\tO\\nhumans\\tO\\n,\\tO\\nmice\\tO\\n,\\tO\\nand\\tO\\nother\\tO\\nmammalian\\tO\\nspecies\\tO\\nshould\\tO\\nreveal\\tO\\nthe\\tO\\nnature\\tO\\nof\\tO\\nthe\\tO\\nrearrangements\\tO\\naffecting\\tO\\nthis\\tO\\nchromosomal\\tO\\nsegment\\tO\\nduring\\tO\\nmammalian\\tO\\nevolution\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\ncholesteryl\\tB-Disease\\nester\\tI-Disease\\ntransfer\\tI-Disease\\nprotein\\tI-Disease\\ndeficiency\\tI-Disease\\ncaused\\tO\\nby\\tO\\ntwo\\tO\\nprevalent\\tO\\nmutations\\tO\\nas\\tO\\na\\tO\\nmajor\\tO\\ndeterminant\\tO\\nof\\tO\\nincreased\\tO\\nlevels\\tO\\nof\\tO\\nhigh\\tO\\ndensity\\tO\\nlipoprotein\\tO\\ncholesterol\\tO\\n.\\tO\\n\\nGenetic\\tO\\ndeterminants\\tO\\nof\\tO\\nHDL\\tO\\ncholesterol\\tO\\n(\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\n)\\tO\\nlevels\\tO\\nin\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\nare\\tO\\npoorly\\tO\\nunderstood\\tO\\n.\\tO\\n\\nWe\\tO\\npreviously\\tO\\ndescribed\\tO\\nplasma\\tO\\ncholesteryl\\tB-Disease\\nester\\tI-Disease\\ntransfer\\tI-Disease\\nprotein\\tI-Disease\\n(\\tI-Disease\\nCETP\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\ndue\\tO\\nto\\tO\\nan\\tO\\nintron\\tO\\n14\\tO\\nG\\tO\\n(\\tO\\n+\\tO\\n1\\tO\\n)\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nA\\tO\\nmutation\\tO\\n(\\tO\\nInt14\\tO\\nA\\tO\\n)\\tO\\nin\\tO\\nseveral\\tO\\nfamilies\\tO\\nwith\\tO\\nvery\\tO\\nhigh\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\nlevels\\tO\\nin\\tO\\nJapan\\tO\\n.\\tO\\n\\nSubjects\\tO\\nwith\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\n>\\tO\\nor\\tO\\n=\\tO\\n100\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n130\\tO\\n)\\tO\\nwere\\tO\\nscreened\\tO\\nby\\tO\\nPCR\\tO\\nsingle\\tO\\nstrand\\tO\\nconformational\\tO\\npolymorphism\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nCETP\\tO\\ngene\\tO\\n.\\tO\\n\\nTwo\\tO\\nother\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nby\\tO\\nDNA\\tO\\nsequencing\\tO\\nor\\tO\\nprimer\\tO\\n-\\tO\\nmediated\\tO\\nrestriction\\tO\\nmap\\tO\\nmodification\\tO\\nof\\tO\\nPCR\\tO\\nproducts\\tO\\na\\tO\\nnovel\\tO\\nintron\\tO\\n14\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nmutation\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\nT\\tO\\ninsertion\\tO\\nat\\tO\\nposition\\tO\\n+\\tO\\n3\\tO\\nfrom\\tO\\nthe\\tO\\nexon14\\tO\\n/\\tO\\nintron14\\tO\\nboundary\\tO\\n(\\tO\\nInt14\\tO\\nT\\tO\\n)\\tO\\nand\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nAsp442\\tO\\nto\\tO\\nGly\\tO\\n)\\tO\\nwithin\\tO\\nexon\\tO\\n15\\tO\\n(\\tO\\nD442G\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nInt14\\tO\\nT\\tO\\nmutation\\tO\\nwas\\tO\\nonly\\tO\\nfound\\tO\\nin\\tO\\none\\tO\\nfamily\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nD442G\\tO\\nand\\tO\\nInt14\\tO\\nA\\tO\\nmutations\\tO\\nwere\\tO\\nhighly\\tO\\nprevalent\\tO\\nin\\tO\\nsubjects\\tO\\nwith\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\n>\\tO\\nor\\tO\\n=\\tO\\n60\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n,\\tO\\nwith\\tO\\ncombined\\tO\\nallele\\tO\\nfrequencies\\tO\\nof\\tO\\n9\\tO\\n%\\tO\\n,\\tO\\n12\\tO\\n%\\tO\\n,\\tO\\n21\\tO\\n%\\tO\\nand\\tO\\n43\\tO\\n%\\tO\\nfor\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\n60\\tO\\n-\\tO\\n79\\tO\\n,\\tO\\n80\\tO\\n-\\tO\\n99\\tO\\n,\\tO\\n100\\tO\\n-\\tO\\n119\\tO\\n,\\tO\\nand\\tO\\n>\\tO\\nor\\tO\\n=\\tO\\n120\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nprevalences\\tO\\nof\\tO\\nthe\\tO\\nD442G\\tO\\nand\\tO\\nInt14\\tO\\nA\\tO\\nmutations\\tO\\nwere\\tO\\nextremely\\tO\\nhigh\\tO\\nin\\tO\\na\\tO\\ngeneral\\tO\\nsample\\tO\\nof\\tO\\nJapanese\\tO\\nmen\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n236\\tO\\n)\\tO\\n,\\tO\\nwith\\tO\\nheterozygote\\tO\\nfrequencies\\tO\\nof\\tO\\n7\\tO\\n%\\tO\\nand\\tO\\n2\\tO\\n%\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nThese\\tO\\ntwo\\tO\\nmutations\\tO\\naccounted\\tO\\nfor\\tO\\nabout\\tO\\n10\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ntotal\\tO\\nvariance\\tO\\nof\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\nin\\tO\\nthis\\tO\\npopulation\\tO\\n.\\tO\\n\\nThe\\tO\\nphenotype\\tO\\nin\\tO\\na\\tO\\ngenetic\\tO\\ncompound\\tO\\nheterozygote\\tO\\n(\\tO\\nInt14\\tO\\nT\\tO\\nand\\tO\\nInt14\\tO\\nA\\tO\\n)\\tO\\nwas\\tO\\nsimilar\\tO\\nto\\tO\\nthat\\tO\\nof\\tO\\nInt14\\tO\\nA\\tO\\nhomozygotes\\tO\\n(\\tO\\nno\\tO\\ndetectable\\tO\\nCETP\\tO\\nand\\tO\\nmarkedly\\tO\\nincreased\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\n)\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nthe\\tO\\nInt14\\tO\\nT\\tO\\nproduces\\tO\\na\\tO\\nnull\\tO\\nallele\\tO\\n.\\tO\\n\\nIn\\tO\\nfour\\tO\\nD442G\\tO\\nhomozygotes\\tO\\n,\\tO\\nmean\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\nlevels\\tO\\n(\\tO\\n86\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n26\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n)\\tO\\nwere\\tO\\nlower\\tO\\nthan\\tO\\nin\\tO\\nInt14\\tO\\nA\\tO\\nhomozygotes\\tO\\n(\\tO\\n158\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n35\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n)\\tO\\n,\\tO\\nreflecting\\tO\\nresidual\\tO\\nCETP\\tO\\nactivity\\tO\\nin\\tO\\nplasma\\tO\\n.\\tO\\n\\nIn\\tO\\n47\\tO\\nD442G\\tO\\nheterozygotes\\tO\\n,\\tO\\nmean\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\nlevels\\tO\\nwere\\tO\\n91\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n23\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n,\\tO\\nsimilar\\tO\\nto\\tO\\nthe\\tO\\nlevel\\tO\\nin\\tO\\nD442G\\tO\\nhomozygotes\\tO\\n,\\tO\\nand\\tO\\nsignificantly\\tO\\ngreater\\tO\\nthan\\tO\\nmean\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\nlevels\\tO\\nin\\tO\\nInt14\\tO\\nA\\tO\\nheterozygotes\\tO\\n(\\tO\\n69\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n15\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n)\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\nD442G\\tO\\nmutation\\tO\\nacts\\tO\\ndifferently\\tO\\nto\\tO\\nthe\\tO\\nnull\\tO\\nmutations\\tO\\nwith\\tO\\nweaker\\tO\\neffects\\tO\\non\\tO\\nHDL\\tO\\nin\\tO\\nthe\\tO\\nhomozygous\\tO\\nstate\\tO\\nand\\tO\\nstronger\\tO\\neffects\\tO\\nin\\tO\\nthe\\tO\\nheterozygotes\\tO\\n,\\tO\\nsuggesting\\tO\\ndominant\\tO\\nexpression\\tO\\nof\\tO\\na\\tO\\npartially\\tO\\ndefective\\tO\\nallele\\tO\\n.\\tO\\n\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nreflecting\\tO\\ntwo\\tO\\nprevalent\\tO\\nmutations\\tO\\n(\\tO\\nD442G\\tO\\nand\\tO\\nInt14\\tO\\nA\\tO\\n)\\tO\\n,\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nexample\\tO\\nof\\tO\\na\\tO\\ngenetic\\tB-Disease\\ndeficiency\\tI-Disease\\nstate\\tO\\nwhich\\tO\\nis\\tO\\nsufficiently\\tO\\ncommon\\tO\\nto\\tO\\nexplain\\tO\\na\\tO\\nsignificant\\tO\\nfraction\\tO\\nof\\tO\\nthe\\tO\\nvariation\\tO\\nin\\tO\\nHDL\\tO\\n-\\tO\\nC\\tO\\nin\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\n.\\tO\\n.\\tO\\n\\nTreatment\\tO\\nof\\tO\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n:\\tO\\neffects\\tO\\nof\\tO\\nchenodeoxycholic\\tO\\nacid\\tO\\n,\\tO\\npravastatin\\tO\\n,\\tO\\nand\\tO\\ncombined\\tO\\nuse\\tO\\n.\\tO\\n\\nTreatments\\tO\\nby\\tO\\noral\\tO\\nadministration\\tO\\nof\\tO\\nchenodeoxycholic\\tO\\nacid\\tO\\n(\\tO\\nCDCA\\tO\\n)\\tO\\nalone\\tO\\n,\\tO\\n3\\tO\\n-\\tO\\nhydroxy\\tO\\n-\\tO\\n3\\tO\\n-\\tO\\nmethylglutaryl\\tO\\n(\\tO\\nHMG\\tO\\n)\\tO\\nCoA\\tO\\nreductase\\tO\\ninhibitor\\tO\\n(\\tO\\npravastatin\\tO\\n)\\tO\\nalone\\tO\\n,\\tO\\nand\\tO\\ncombination\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\ndrugs\\tO\\nwere\\tO\\nattempted\\tO\\nfor\\tO\\n7\\tO\\npatients\\tO\\nwith\\tO\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n(\\tO\\nCTX\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nCDCA\\tO\\ntreatment\\tO\\nat\\tO\\na\\tO\\ndose\\tO\\nof\\tO\\n300\\tO\\nmg\\tO\\n/\\tO\\nday\\tO\\nreduced\\tO\\nserum\\tO\\ncholestanol\\tO\\n(\\tO\\n67\\tO\\n.\\tO\\n3\\tO\\n%\\tO\\nreduction\\tO\\n)\\tO\\n,\\tO\\nlathosterol\\tO\\n(\\tO\\n50\\tO\\n.\\tO\\n8\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\ncampesterol\\tO\\n(\\tO\\n61\\tO\\n.\\tO\\n7\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\nsitosterol\\tO\\n(\\tO\\n12\\tO\\n.\\tO\\n7\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nsera\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nchanged\\tO\\nto\\tO\\nbe\\tO\\n\"\\tO\\natherogenic\\tO\\n\"\\tO\\n;\\tO\\ntotal\\tO\\ncholesterol\\tO\\n,\\tO\\ntriglyceride\\tO\\nand\\tO\\nlow\\tO\\n-\\tO\\ndensity\\tO\\nlipoprotein\\tO\\n(\\tO\\nLDL\\tO\\n)\\tO\\n-\\tO\\ncholesterol\\tO\\nwere\\tO\\nincreased\\tO\\n,\\tO\\nwhile\\tO\\nhigh\\tO\\n-\\tO\\ndensity\\tO\\nlipoprotein\\tO\\n(\\tO\\nHDL\\tO\\n)\\tO\\n-\\tO\\ncholesterol\\tO\\nwas\\tO\\ndecreased\\tO\\n.\\tO\\n\\nContrarily\\tO\\n,\\tO\\npravastatin\\tO\\nat\\tO\\na\\tO\\ndose\\tO\\nof\\tO\\n10\\tO\\nmg\\tO\\n/\\tO\\nday\\tO\\nimproved\\tO\\nthe\\tO\\nsera\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nto\\tO\\nbe\\tO\\nmarkedly\\tO\\n\"\\tO\\nanti\\tO\\n-\\tO\\natherogenic\\tO\\n\"\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nreductions\\tO\\nof\\tO\\ncholestanol\\tO\\n(\\tO\\n30\\tO\\n.\\tO\\n4\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nlathosterol\\tO\\n(\\tO\\n44\\tO\\n.\\tO\\n0\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\ncampesterol\\tO\\n(\\tO\\n22\\tO\\n.\\tO\\n9\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\nsitosterol\\tO\\n(\\tO\\n9\\tO\\n.\\tO\\n6\\tO\\n%\\tO\\n)\\tO\\nwere\\tO\\ninadequate\\tO\\n.\\tO\\n\\nCombined\\tO\\ntreatment\\tO\\nwith\\tO\\nCDCA\\tO\\nand\\tO\\npravastatin\\tO\\nshowed\\tO\\ngood\\tO\\noverlapping\\tO\\nof\\tO\\nthe\\tO\\neffects\\tO\\nof\\tO\\neach\\tO\\ndrug\\tO\\nalone\\tO\\n.\\tO\\n\\nThe\\tO\\nsera\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nwere\\tO\\napparently\\tO\\nmore\\tO\\n\"\\tO\\nanti\\tO\\n-\\tO\\natherogenic\\tO\\n\"\\tO\\nthan\\tO\\nthose\\tO\\nafter\\tO\\nCDCA\\tO\\ntreatment\\tO\\n.\\tO\\n\\nSerum\\tO\\ncholestanol\\tO\\nconcentration\\tO\\nwas\\tO\\nstill\\tO\\n2\\tO\\n.\\tO\\n\\n7\\tO\\ntimes\\tO\\nhigher\\tO\\nthan\\tO\\nin\\tO\\ncontrols\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nserum\\tO\\nlathosterol\\tO\\nlevel\\tO\\nwas\\tO\\nwithin\\tO\\nthe\\tO\\nnormal\\tO\\nrange\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nthe\\tO\\nenhancement\\tO\\nof\\tO\\noverall\\tO\\ncholesterol\\tO\\nsynthesis\\tO\\nin\\tO\\nthe\\tO\\npatients\\tO\\nwas\\tO\\nsufficiently\\tO\\nsuppressed\\tO\\n.\\tO\\n\\nPlant\\tO\\nsterol\\tO\\nlevels\\tO\\nwere\\tO\\nalso\\tO\\nwithin\\tO\\nthe\\tO\\nnormal\\tO\\nrange\\tO\\n.\\tO\\n\\nThe\\tO\\ncombination\\tO\\nof\\tO\\nCDCA\\tO\\nand\\tO\\npravastatin\\tO\\nwas\\tO\\na\\tO\\ngood\\tO\\ntreatment\\tO\\nfor\\tO\\nCTX\\tB-Disease\\n,\\tO\\nbased\\tO\\non\\tO\\nthe\\tO\\nimprovement\\tO\\nof\\tO\\nserum\\tO\\nlipoprotein\\tO\\nmetabolism\\tO\\n,\\tO\\nthe\\tO\\nsuppression\\tO\\nof\\tO\\ncholesterol\\tO\\nsynthesis\\tO\\n,\\tO\\nand\\tO\\nreductions\\tO\\nof\\tO\\ncholestanol\\tO\\nand\\tO\\nplant\\tO\\nsterol\\tO\\nlevels\\tO\\n.\\tO\\n\\nIn\\tO\\nall\\tO\\nof\\tO\\n7\\tO\\npatients\\tO\\n,\\tO\\nthe\\tO\\nprogression\\tO\\nof\\tO\\ndisease\\tO\\nwas\\tO\\narrested\\tO\\n,\\tO\\nbut\\tO\\ndramatic\\tO\\neffects\\tO\\non\\tO\\nclinical\\tO\\nmanifestations\\tO\\n,\\tO\\nxanthoma\\tB-Disease\\n,\\tO\\nand\\tO\\nelectrophysiological\\tO\\nfindings\\tO\\ncould\\tO\\nnot\\tO\\nbe\\tO\\nfound\\tO\\nafter\\tO\\nthe\\tO\\ntreatment\\tO\\nof\\tO\\nthese\\tO\\ndrugs\\tO\\n\\nMutation\\tO\\nspectrum\\tO\\nin\\tO\\nthe\\tO\\nCHM\\tB-Disease\\ngene\\tO\\nof\\tO\\nDanish\\tO\\nand\\tO\\nSwedish\\tO\\nchoroideremia\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\nrecent\\tO\\nisolation\\tO\\nof\\tO\\nthe\\tO\\ncomplete\\tO\\nopen\\tO\\nreading\\tO\\nframe\\tO\\nof\\tO\\nthe\\tO\\nchoroideremia\\tB-Disease\\n(\\tO\\nCHM\\tB-Disease\\n)\\tO\\ngene\\tO\\nand\\tO\\nthe\\tO\\ncharacterization\\tO\\nof\\tO\\nthe\\tO\\nexon\\tO\\n-\\tO\\nintron\\tO\\nboundaries\\tO\\nhas\\tO\\npaved\\tO\\nthe\\tO\\nway\\tO\\nto\\tO\\nmutation\\tO\\ndetection\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nclassical\\tO\\nchoroideremia\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nperformed\\tO\\nmutation\\tO\\nscreening\\tO\\nin\\tO\\npatients\\tO\\nfrom\\tO\\n15\\tO\\nDanish\\tO\\nand\\tO\\nSwedish\\tO\\nfamilies\\tO\\nby\\tO\\nusing\\tO\\nSouthern\\tO\\nblot\\tO\\nhybridization\\tO\\nand\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nPCR\\tO\\n-\\tO\\nSSCP\\tO\\n)\\tO\\ntechnique\\tO\\n.\\tO\\n\\nCausative\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nCHM\\tB-Disease\\ngene\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nat\\tO\\nleast\\tO\\n12\\tO\\nfamilies\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\na\\tO\\nsubstantial\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\ncan\\tO\\nbe\\tO\\nidentified\\tO\\nby\\tO\\nthis\\tO\\napproach\\tO\\n.\\tO\\n\\nIn\\tO\\nfour\\tO\\nof\\tO\\nthese\\tO\\nfamilies\\tO\\ndeletions\\tO\\nof\\tO\\ndifferent\\tO\\nsizes\\tO\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nin\\tO\\none\\tO\\npatient\\tO\\n,\\tO\\nthe\\tO\\ndeletion\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nonly\\tO\\none\\tO\\nexon\\tO\\n,\\tO\\nwhile\\tO\\nin\\tO\\nanother\\tO\\nthe\\tO\\ndeletion\\tO\\ncomprised\\tO\\nthe\\tO\\nentire\\tO\\nCHM\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nMapping\\tO\\nof\\tO\\nthe\\tO\\ndeletion\\tO\\nendpoints\\tO\\nin\\tO\\nthese\\tO\\nfour\\tO\\npatients\\tO\\nand\\tO\\nin\\tO\\nanother\\tO\\n11\\tO\\nmale\\tO\\npatients\\tO\\nwith\\tO\\nsizeable\\tO\\ndeletions\\tO\\nenabled\\tO\\nus\\tO\\nto\\tO\\nconstruct\\tO\\na\\tO\\nvery\\tO\\ndetailed\\tO\\nmap\\tO\\nof\\tO\\nintervals\\tO\\n2\\tO\\nand\\tO\\n3\\tO\\nof\\tO\\nXq21\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nremaining\\tO\\n11\\tO\\nDanish\\tO\\nand\\tO\\nSwedish\\tO\\nfamilies\\tO\\nat\\tO\\nleast\\tO\\n8\\tO\\ncausative\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nby\\tO\\nPCR\\tO\\n-\\tO\\nSSCP\\tO\\nanalysis\\tO\\nand\\tO\\ndirect\\tO\\nsequencing\\tO\\n.\\tO\\n\\nInterestingly\\tO\\n,\\tO\\nall\\tO\\nCHM\\tB-Disease\\ngene\\tO\\nmutations\\tO\\ndetected\\tO\\nthus\\tO\\nfar\\tO\\nin\\tO\\nchoroideremia\\tB-Disease\\npatients\\tO\\ngive\\tO\\nrise\\tO\\nto\\tO\\nthe\\tO\\nintroduction\\tO\\nof\\tO\\na\\tO\\npremature\\tO\\nstop\\tO\\ncodon\\tO\\n.\\tO\\n.\\tO\\n\\nPredominance\\tO\\nof\\tO\\nthe\\tO\\nadrenomyeloneuropathy\\tB-Disease\\nphenotype\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\nin\\tO\\nThe\\tO\\nNetherlands\\tO\\n:\\tO\\na\\tO\\nsurvey\\tO\\nof\\tO\\n30\\tO\\nkindreds\\tO\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\n(\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\ninherited\\tB-Disease\\ndisorder\\tI-Disease\\nof\\tO\\nperoxisomal\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\nassociated\\tO\\nwith\\tO\\naccumulation\\tO\\nof\\tO\\nsaturated\\tO\\nvery\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\n,\\tO\\nwhich\\tO\\nresults\\tO\\nin\\tO\\ncentral\\tO\\nand\\tO\\nperipheral\\tO\\ndemyelination\\tB-Disease\\nand\\tO\\nin\\tO\\nimpaired\\tB-Disease\\nfunction\\tI-Disease\\nof\\tI-Disease\\nadrenal\\tI-Disease\\ncortex\\tI-Disease\\nand\\tI-Disease\\ntestes\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nphenotypic\\tO\\nexpression\\tO\\nis\\tO\\nhighly\\tO\\nvariable\\tO\\n,\\tO\\nchildhood\\tB-Disease\\ncerebral\\tI-Disease\\nALD\\tI-Disease\\n(\\tO\\nCCALD\\tB-Disease\\n)\\tO\\nand\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n(\\tO\\nAMN\\tB-Disease\\n)\\tO\\nbeing\\tO\\nthe\\tO\\nmain\\tO\\nvariants\\tO\\n.\\tO\\n\\nWe\\tO\\nexplored\\tO\\nthe\\tO\\n30\\tO\\nDutch\\tO\\nkindreds\\tO\\nwell\\tO\\nknown\\tO\\nto\\tO\\nthe\\tO\\nDutch\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\n/\\tO\\nAMN\\tB-Disease\\nStudy\\tO\\nGroup\\tO\\nand\\tO\\nphenotyped\\tO\\n77\\tO\\nmale\\tO\\npatients\\tO\\n35\\tO\\n(\\tO\\n46\\tO\\n%\\tO\\n)\\tO\\nhad\\tO\\nAMN\\tB-Disease\\nand\\tO\\n24\\tO\\n(\\tO\\n31\\tO\\n%\\tO\\n)\\tO\\nCCALD\\tB-Disease\\nor\\tO\\nadolescent\\tB-Disease\\ncerebral\\tI-Disease\\nALD\\tI-Disease\\n(\\tO\\nAdolCALD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThese\\tO\\npercentages\\tO\\ndiffer\\tO\\nsignificantly\\tO\\nfrom\\tO\\nprevious\\tO\\nreports\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\n25\\tO\\nto\\tO\\n28\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\ndeveloped\\tO\\nAMN\\tB-Disease\\nand\\tO\\n53\\tO\\nto\\tO\\n57\\tO\\n%\\tO\\nCCALD\\tB-Disease\\nor\\tO\\nAdolCALD\\tB-Disease\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nindicate\\tO\\nthat\\tO\\n-\\tO\\n-\\tO\\nat\\tO\\nleast\\tO\\nin\\tO\\nthe\\tO\\nNetherlands\\tO\\n-\\tO\\n-\\tO\\nAMN\\tB-Disease\\nmay\\tO\\nbe\\tO\\nthe\\tO\\nmost\\tO\\nfrequent\\tO\\nphenotype\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nALD\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nAdrenoleukodystrophy\\tB-Disease\\ngene\\tO\\nencodes\\tO\\nan\\tO\\n80\\tO\\nkDa\\tO\\nmembrane\\tO\\nprotein\\tO\\n.\\tO\\n\\nAn\\tO\\nantibody\\tO\\nagainst\\tO\\nthe\\tO\\nsynthetic\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\npeptides\\tO\\ndeduced\\tO\\nfrom\\tO\\nthe\\tO\\ncDNA\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\nwas\\tO\\nproduced\\tO\\nto\\tO\\ncharacterize\\tO\\nthe\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\nALD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nantibody\\tO\\nreacted\\tO\\nwith\\tO\\nthe\\tO\\n80\\tO\\nkDa\\tO\\nband\\tO\\nprotein\\tO\\nin\\tO\\ncontrol\\tO\\nfibroblasts\\tO\\n,\\tO\\nwhile\\tO\\nno\\tO\\nbands\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nfibroblasts\\tO\\nfrom\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nALD\\tB-Disease\\n(\\tO\\n#\\tO\\n163\\tO\\n)\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\nmRNA\\tO\\nof\\tO\\nthe\\tO\\nALD\\tB-Disease\\ngene\\tO\\nwas\\tO\\nundetectable\\tO\\nbased\\tO\\non\\tO\\nNorthern\\tO\\nblot\\tO\\nanalysis\\tO\\n.\\tO\\n\\nThe\\tO\\n293T\\tO\\ncells\\tO\\ntransfected\\tO\\nwith\\tO\\nthe\\tO\\nfull\\tO\\n-\\tO\\ncoding\\tO\\ncDNA\\tO\\ninserted\\tO\\nin\\tO\\nthe\\tO\\nexpression\\tO\\nvector\\tO\\nproduced\\tO\\na\\tO\\nnew\\tO\\n80\\tO\\nkDa\\tO\\nprotein\\tO\\n,\\tO\\nas\\tO\\ndetected\\tO\\nby\\tO\\nWestern\\tO\\nblot\\tO\\n.\\tO\\n\\nIn\\tO\\nan\\tO\\nimmunocytological\\tO\\nstudy\\tO\\n,\\tO\\nthe\\tO\\nstaining\\tO\\nwas\\tO\\nin\\tO\\na\\tO\\npunctate\\tO\\npattern\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nnormal\\tO\\nfibroblasts\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\nno\\tO\\npunctate\\tO\\nstaining\\tO\\nin\\tO\\nthe\\tO\\n#\\tO\\n163\\tO\\ncells\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nthus\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nALD\\tB-Disease\\ngene\\tO\\nencodes\\tO\\nan\\tO\\n80\\tO\\nkDa\\tO\\nmembrane\\tO\\nprotein\\tO\\n.\\tO\\n.\\tO\\n\\nIsolation\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nMcLeod\\tB-Disease\\nsyndrome\\tI-Disease\\nthat\\tO\\nencodes\\tO\\na\\tO\\nnovel\\tO\\nmembrane\\tO\\ntransport\\tO\\nprotein\\tO\\n.\\tO\\n\\nMcLeod\\tB-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nmultisystem\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nabnormalities\\tO\\nin\\tO\\nthe\\tO\\nneuromuscular\\tO\\nand\\tO\\nhematopoietic\\tO\\nsystems\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nassembled\\tO\\na\\tO\\ncosmid\\tO\\ncontig\\tO\\nof\\tO\\n360\\tO\\nkb\\tO\\nthat\\tO\\nencompasses\\tO\\nthe\\tO\\nMcLeod\\tB-Disease\\ngene\\tO\\nlocus\\tO\\n.\\tO\\n\\nA\\tO\\n50\\tO\\nkb\\tO\\ndeletion\\tO\\nwas\\tO\\ndetected\\tO\\nby\\tO\\nscreening\\tO\\nDNA\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nradiolabeled\\tO\\nwhole\\tO\\ncosmids\\tO\\n,\\tO\\nand\\tO\\ntwo\\tO\\ntranscription\\tO\\nunits\\tO\\nwere\\tO\\nidentified\\tO\\nwithin\\tO\\nthis\\tO\\ndeletion\\tO\\n.\\tO\\n\\nThe\\tO\\nmRNA\\tO\\nexpression\\tO\\npattern\\tO\\nof\\tO\\none\\tO\\nof\\tO\\nthem\\tO\\n,\\tO\\ndesignated\\tO\\nas\\tO\\nXK\\tO\\n,\\tO\\ncorrelates\\tO\\nclosely\\tO\\nto\\tO\\nthe\\tO\\nMcLeod\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nXK\\tO\\nencodes\\tO\\na\\tO\\nnovel\\tO\\nprotein\\tO\\nwith\\tO\\nstructural\\tO\\ncharacteristics\\tO\\nof\\tO\\nprokaryotic\\tO\\nand\\tO\\neukaryotic\\tO\\nmembrane\\tO\\ntransport\\tO\\nproteins\\tO\\n.\\tO\\n\\nNucleotide\\tO\\nsequence\\tO\\nanalysis\\tO\\nof\\tO\\nXK\\tO\\nfrom\\tO\\ntwo\\tO\\nunrelated\\tO\\nMcLeod\\tB-Disease\\npatients\\tO\\nhas\\tO\\nidentified\\tO\\npoint\\tO\\nmutations\\tO\\nat\\tO\\nconserved\\tO\\nsplice\\tO\\ndonor\\tO\\nand\\tO\\nacceptor\\tO\\nsites\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nprovide\\tO\\ndirect\\tO\\nevidence\\tO\\nthat\\tO\\nXK\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nMcLeod\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nspastic\\tI-Disease\\nparaplegia\\tI-Disease\\nand\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\nare\\tO\\nallelic\\tB-Disease\\ndisorders\\tI-Disease\\nat\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\nlocus\\tO\\n.\\tO\\n\\nThree\\tO\\nforms\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nspastic\\tI-Disease\\nparaplegia\\tI-Disease\\n(\\tO\\nSPG\\tB-Disease\\n)\\tO\\nhave\\tO\\nbeen\\tO\\ndefined\\tO\\n.\\tO\\n\\nOne\\tO\\nlocus\\tO\\n(\\tO\\nSPG\\tO\\n1\\tO\\n)\\tO\\nmaps\\tO\\nto\\tO\\nXq28\\tO\\nwhile\\tO\\ntwo\\tO\\nclinically\\tO\\ndistinct\\tO\\nforms\\tO\\nmap\\tO\\nto\\tO\\nXq22\\tO\\n(\\tO\\nSPG2\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nrare\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndysmyelinating\\tI-Disease\\ndisorder\\tI-Disease\\nof\\tO\\nthe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n,\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nPMD\\tB-Disease\\n)\\tO\\n,\\tO\\nhas\\tO\\nalso\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nXq21\\tO\\n-\\tO\\nq22\\tO\\n,\\tO\\nand\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\ngene\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\nwhich\\tO\\nencodes\\tO\\ntwo\\tO\\nmyelin\\tO\\nproteins\\tO\\n,\\tO\\nPLP\\tO\\nand\\tO\\nDM20\\tO\\n.\\tO\\n\\nWhile\\tO\\nnarrowing\\tO\\nthe\\tO\\ngenetic\\tO\\ninterval\\tO\\ncontaining\\tO\\nSPG2\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\npedigree\\tO\\n,\\tO\\nwe\\tO\\nfound\\tO\\nthat\\tO\\nPLP\\tO\\nwas\\tO\\nthe\\tO\\nclosest\\tO\\nmarker\\tO\\nto\\tO\\nthe\\tO\\ndisease\\tO\\nlocus\\tO\\n,\\tO\\nimplicating\\tO\\nPLP\\tO\\nas\\tO\\na\\tO\\npossible\\tO\\ncandidate\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nfound\\tO\\nthat\\tO\\na\\tO\\npoint\\tO\\nmutation\\tO\\n(\\tO\\nHis139Tyr\\tO\\n)\\tO\\nin\\tO\\nexon\\tO\\n3B\\tO\\nof\\tO\\nan\\tO\\naffected\\tO\\nmale\\tO\\nproduces\\tO\\na\\tO\\nmutant\\tO\\nPLP\\tO\\nbut\\tO\\na\\tO\\nnormal\\tO\\nDM20\\tO\\n,\\tO\\nand\\tO\\nsegregates\\tO\\nwith\\tO\\nthe\\tO\\ndisease\\tO\\n(\\tO\\nZmax\\tO\\n=\\tO\\n6\\tO\\n.\\tO\\n63\\tO\\n,\\tO\\ntheta\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n00\\tO\\n)\\tO\\n.\\tO\\n\\nIt\\tO\\nappears\\tO\\n,\\tO\\ntherefore\\tO\\n,\\tO\\nthat\\tO\\nSPG2\\tO\\nand\\tO\\nPMD\\tB-Disease\\nare\\tO\\nallelic\\tB-Disease\\ndisorders\\tI-Disease\\n\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\n:\\tO\\nmutations\\tO\\namong\\tO\\nJewish\\tO\\nand\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\npatients\\tO\\n.\\tO\\n\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nleukodystrophy\\tI-Disease\\ncaused\\tO\\nby\\tO\\nthe\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\naspartoacylase\\tI-Disease\\n(\\tO\\nASPA\\tO\\n)\\tO\\n.\\tO\\n\\nSixty\\tO\\n-\\tO\\nfour\\tO\\nprobands\\tO\\nwere\\tO\\nanalyzed\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nASPA\\tO\\ngene\\tO\\n.\\tO\\n\\nThree\\tO\\npoint\\tO\\nmutations\\tO\\n-\\tO\\n-\\tO\\n693C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n,\\tO\\n854A\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\n,\\tO\\nand\\tO\\n914C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\n.\\tO\\n\\nThe\\tO\\n693C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\nand\\tO\\n914C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\nbase\\tO\\nchanges\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nnonsense\\tO\\ntyr231\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nter\\tO\\nand\\tO\\nmissense\\tO\\nala305\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nglu\\tO\\nmutations\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nlead\\tO\\nto\\tO\\ncomplete\\tO\\nloss\\tO\\nof\\tO\\nASPA\\tO\\nactivity\\tO\\nin\\tO\\nin\\tO\\nvitro\\tO\\nexpression\\tO\\nstudies\\tO\\n.\\tO\\n\\nThe\\tO\\n854A\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\ntransversion\\tO\\nconverted\\tO\\nglu\\tO\\nto\\tO\\nala\\tO\\nin\\tO\\ncodon\\tO\\n285\\tO\\n.\\tO\\n\\nThe\\tO\\nglu285\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nala\\tO\\nmutant\\tO\\nASPA\\tO\\nhas\\tO\\n2\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nactivity\\tO\\nexpressed\\tO\\nby\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nenzyme\\tO\\n.\\tO\\n\\nA\\tO\\nfourth\\tO\\nmutation\\tO\\n,\\tO\\n433\\tO\\n-\\tO\\n-\\tO\\n2\\tO\\n(\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\n)\\tO\\ntransition\\tO\\n,\\tO\\nwas\\tO\\nidentified\\tO\\nat\\tO\\nthe\\tO\\nsplice\\tO\\n-\\tO\\nacceptor\\tO\\nsite\\tO\\nin\\tO\\nintron\\tO\\n2\\tO\\n.\\tO\\n\\nThe\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\nwould\\tO\\nlead\\tO\\nto\\tO\\nskipping\\tO\\nof\\tO\\nexon\\tO\\n3\\tO\\n,\\tO\\naccompanied\\tO\\nby\\tO\\na\\tO\\nframeshift\\tO\\n,\\tO\\nand\\tO\\nthus\\tO\\nwould\\tO\\nproduce\\tO\\naberrant\\tO\\nASPA\\tO\\n.\\tO\\n\\nOf\\tO\\nthe\\tO\\n128\\tO\\nunrelated\\tO\\nCanavan\\tB-Disease\\nchromosomes\\tO\\nanalyzed\\tO\\n,\\tO\\n88\\tO\\nwere\\tO\\nfrom\\tO\\nprobands\\tO\\nof\\tO\\nAshkenazi\\tO\\nJewish\\tO\\ndescent\\tO\\n.\\tO\\n\\nThe\\tO\\nglu285\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nala\\tO\\nmutation\\tO\\nwas\\tO\\npredominant\\tO\\n(\\tO\\n82\\tO\\n.\\tO\\n9\\tO\\n%\\tO\\n)\\tO\\nin\\tO\\nthis\\tO\\npopulation\\tO\\n,\\tO\\nfollowed\\tO\\nby\\tO\\nthe\\tO\\ntyr231\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nter\\tO\\n(\\tO\\n14\\tO\\n.\\tO\\n8\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\n433\\tO\\n-\\tO\\n-\\tO\\n2\\tO\\n(\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\n)\\tO\\n(\\tO\\n1\\tO\\n.\\tO\\n1\\tO\\n%\\tO\\n)\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nthree\\tO\\nmutations\\tO\\naccount\\tO\\nfor\\tO\\n98\\tO\\n.\\tO\\n\\n8\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nCanavan\\tB-Disease\\nchromosomes\\tO\\nof\\tO\\nAshkenazi\\tO\\nJewish\\tO\\norigin\\tO\\n.\\tO\\n\\nThe\\tO\\nala305\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nglu\\tO\\nmutation\\tO\\nwas\\tO\\nfound\\tO\\nexclusively\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nprobands\\tO\\nof\\tO\\nEuropean\\tO\\ndescent\\tO\\nand\\tO\\nconstituted\\tO\\n60\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\n40\\tO\\nmutant\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nPredominant\\tO\\noccurrence\\tO\\nof\\tO\\ncertain\\tO\\nmutations\\tO\\namong\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nand\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\npatients\\tO\\nwith\\tO\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\nwould\\tO\\nsuggest\\tO\\na\\tO\\nfounding\\tO\\n-\\tO\\nfather\\tO\\neffect\\tO\\nin\\tO\\npropagation\\tO\\nof\\tO\\nthese\\tO\\nmutant\\tO\\nchromosomes\\tO\\n\\nIntelligence\\tO\\nquotient\\tO\\nprofile\\tO\\nin\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nintergenerational\\tO\\ndeficit\\tO\\n,\\tO\\nand\\tO\\ncorrelation\\tO\\nwith\\tO\\nCTG\\tO\\namplification\\tO\\n.\\tO\\n\\nAn\\tO\\nabbreviated\\tO\\nWechsler\\tO\\nAdult\\tO\\nIntelligence\\tO\\nScale\\tO\\nRevised\\tO\\n(\\tO\\nWAIS\\tO\\n-\\tO\\nR\\tO\\n)\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nassess\\tO\\nverbal\\tO\\nand\\tO\\narithmetical\\tO\\ncognitive\\tO\\nperformance\\tO\\nin\\tO\\n55\\tO\\nsubjects\\tO\\nwith\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n,\\tO\\ncovering\\tO\\nall\\tO\\ngrades\\tO\\nof\\tO\\ndisease\\tO\\nseverity\\tO\\n,\\tO\\nand\\tO\\n31\\tO\\ncontrols\\tO\\nat\\tO\\n50\\tO\\n%\\tO\\nrisk\\tO\\nof\\tO\\ninheriting\\tO\\nDM\\tB-Disease\\n.\\tO\\n\\nScaled\\tO\\nscores\\tO\\nfrom\\tO\\nthe\\tO\\nassessment\\tO\\nwere\\tO\\nconverted\\tO\\ninto\\tO\\nan\\tO\\nintelligence\\tO\\nquotient\\tO\\n(\\tO\\nIQ\\tO\\n)\\tO\\nestimation\\tO\\non\\tO\\neach\\tO\\nperson\\tO\\n.\\tO\\n\\nSignificant\\tO\\nIQ\\tO\\ndifferences\\tO\\nwere\\tO\\nfound\\tO\\nbetween\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nall\\tO\\n55\\tO\\nDM\\tB-Disease\\nsubjects\\tO\\n(\\tO\\nmean\\tO\\n90\\tO\\n.\\tO\\n2\\tO\\n,\\tO\\nSD\\tO\\n16\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\nand\\tO\\n31\\tO\\ncontrols\\tO\\n(\\tO\\n102\\tO\\n.\\tO\\n6\\tO\\n,\\tO\\nSD\\tO\\n9\\tO\\n.\\tO\\n4\\tO\\n)\\tO\\n,\\tO\\nwith\\tO\\nno\\tO\\nsex\\tO\\ndifferences\\tO\\nin\\tO\\neither\\tO\\ngroup\\tO\\n;\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\n15\\tO\\naffected\\tO\\nparents\\tO\\n(\\tO\\n99\\tO\\n.\\tO\\n3\\tO\\n,\\tO\\nSD\\tO\\n12\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\nand\\tO\\ntheir\\tO\\naffected\\tO\\nchildren\\tO\\n(\\tO\\n88\\tO\\n.\\tO\\n1\\tO\\n,\\tO\\nSD\\tO\\n17\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\n,\\tO\\nwhere\\tO\\nsignificance\\tO\\nwas\\tO\\ndependent\\tO\\non\\tO\\nparental\\tO\\nsex\\tO\\nbeing\\tO\\nfemale\\tO\\n;\\tO\\nand\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\n15\\tO\\npairs\\tO\\nof\\tO\\naffected\\tO\\nsibs\\tO\\n(\\tO\\n89\\tO\\n.\\tO\\n6\\tO\\n,\\tO\\nSD\\tO\\n13\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\nand\\tO\\ntheir\\tO\\nnormal\\tO\\nsibs\\tO\\n(\\tO\\n100\\tO\\n.\\tO\\n2\\tO\\n,\\tO\\nSD\\tO\\n7\\tO\\n.\\tO\\n6\\tO\\n)\\tO\\n.\\tO\\n\\nIQ\\tO\\nsteadily\\tO\\ndeclined\\tO\\nas\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\nonset\\tO\\nof\\tO\\nsigns\\tO\\nand\\tO\\nsymptoms\\tO\\ndecreased\\tO\\n,\\tO\\nand\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nthe\\tO\\nCTG\\tO\\nexpansion\\tO\\nsize\\tO\\nincreased\\tO\\n.\\tO\\n\\nThe\\tO\\ncorrelation\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\nmore\\tO\\nlinear\\tO\\nwith\\tO\\nage\\tO\\nof\\tO\\nonset\\tO\\n.\\tO\\n\\nThe\\tO\\ncorrelation\\tO\\nof\\tO\\nIQ\\tO\\ndifference\\tO\\nand\\tO\\nCTG\\tO\\nexpansion\\tO\\ndifference\\tO\\nin\\tO\\nboth\\tO\\nthe\\tO\\nDM\\tB-Disease\\nparent\\tO\\n-\\tO\\nchild\\tO\\npairs\\tO\\nand\\tO\\nnormal\\tO\\nsib\\tO\\n-\\tO\\naffected\\tO\\nsib\\tO\\npairs\\tO\\nwas\\tO\\npoor\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nCTG\\tO\\nexpansion\\tO\\nis\\tO\\nnot\\tO\\na\\tO\\nreliable\\tO\\npredictor\\tO\\nof\\tO\\nIQ\\tO\\neither\\tO\\nin\\tO\\nindividual\\tO\\npersons\\tO\\nor\\tO\\nfamilies\\tO\\n.\\tO\\n\\nFurther\\tO\\nanalysis\\tO\\nof\\tO\\ncognitive\\tO\\nfunction\\tO\\nin\\tO\\nDM\\tB-Disease\\nis\\tO\\nrequired\\tO\\nto\\tO\\nclarify\\tO\\nspecific\\tO\\ndeficits\\tO\\ncharacteristic\\tO\\nof\\tO\\nthis\\tO\\npatient\\tO\\ngroup\\tO\\n\\nAdenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\nand\\tO\\na\\tO\\ncytogenetic\\tO\\ndeletion\\tO\\nof\\tO\\nchromosome\\tO\\n5\\tO\\nresulting\\tO\\nfrom\\tO\\na\\tO\\nmaternal\\tO\\nintrachromosomal\\tO\\ninsertion\\tO\\n.\\tO\\n\\nWe\\tO\\npresent\\tO\\nthe\\tO\\nclinical\\tO\\nand\\tO\\nlaboratory\\tO\\nfindings\\tO\\nin\\tO\\nan\\tO\\ninstitutionalised\\tO\\nadult\\tO\\npatient\\tO\\noriginally\\tO\\nreferred\\tO\\nfor\\tO\\nautism\\tB-Disease\\n.\\tO\\n\\nA\\tO\\nhigh\\tO\\nrisk\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nwas\\tO\\npredicted\\tO\\nwhen\\tO\\nan\\tO\\ninterstitial\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n5\\tO\\n,\\tO\\ndel\\tO\\n(\\tO\\n5\\tO\\n)\\tO\\n(\\tO\\nq15q22\\tO\\n.\\tO\\n3\\tO\\n)\\tO\\n,\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nher\\tO\\nlymphocytes\\tO\\nand\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nMCC\\tO\\nand\\tO\\nAPC\\tB-Disease\\ngenes\\tO\\nconfirmed\\tO\\nby\\tO\\nmolecular\\tO\\nanalysis\\tO\\n.\\tO\\n\\nAdenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\nand\\tO\\ncarcinoma\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nrectum\\tI-Disease\\nwere\\tO\\nsubsequently\\tO\\ndiagnosed\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\n.\\tO\\n\\nShe\\tO\\nwas\\tO\\nprofoundly\\tO\\nmentally\\tB-Disease\\nretarded\\tI-Disease\\n,\\tO\\nautistic\\tB-Disease\\n,\\tO\\nand\\tO\\nhad\\tO\\nminor\\tO\\ndysmorphic\\tB-Disease\\nfeatures\\tI-Disease\\nconsistent\\tO\\nwith\\tO\\nthose\\tO\\nof\\tO\\nprevious\\tO\\npatients\\tO\\nwith\\tO\\nsimilar\\tO\\ndeletions\\tO\\n.\\tO\\n\\nThe\\tO\\ndeletion\\tO\\narose\\tO\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\nrecombination\\tO\\nwithin\\tO\\nthe\\tO\\nsmall\\tO\\ninsertion\\tO\\nloop\\tO\\nformed\\tO\\nat\\tO\\nmeiosis\\tO\\nby\\tO\\nthe\\tO\\ndirect\\tO\\ninsertion\\tO\\n(\\tO\\ndir\\tO\\nins\\tO\\n(\\tO\\n5\\tO\\n)\\tO\\n(\\tO\\nq22\\tO\\n.\\tO\\n3q14\\tO\\n.\\tO\\n2q15\\tO\\n)\\tO\\n)\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\npatients\\tO\\nmother\\tO\\n.\\tO\\n\\nThis\\tO\\nfamily\\tO\\nfurther\\tO\\nconfirms\\tO\\nthe\\tO\\ncytogenetic\\tO\\nmapping\\tO\\nof\\tO\\nboth\\tO\\nMCC\\tO\\nand\\tO\\nAPC\\tB-Disease\\ngenes\\tO\\nto\\tO\\n5q22\\tO\\nand\\tO\\ncomparison\\tO\\nwith\\tO\\nother\\tO\\nrecent\\tO\\ncases\\tO\\nsuggests\\tO\\nthat\\tO\\nboth\\tO\\ngenes\\tO\\nand\\tO\\ntheir\\tO\\nclosely\\tO\\nlinked\\tO\\nmarkers\\tO\\nlie\\tO\\nwithin\\tO\\nthe\\tO\\n5q22\\tO\\n.\\tO\\n\\n1\\tO\\nsubband\\tO\\n\\nFamilial\\tB-Disease\\nmale\\tI-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nis\\tO\\nnot\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nBRCA1\\tO\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n17q\\tO\\n.\\tO\\n\\nBreast\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\nmen\\tO\\nis\\tO\\nabout\\tO\\na\\tO\\nhundredfold\\tO\\nless\\tO\\ncommon\\tO\\nthan\\tO\\nin\\tO\\nwomen\\tO\\nand\\tO\\nthis\\tO\\nhas\\tO\\nhindered\\tO\\nresearch\\tO\\ninto\\tO\\nits\\tO\\ngenetic\\tO\\nbasis\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexamined\\tO\\n22\\tO\\nfamilies\\tO\\nwith\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\ncase\\tO\\nof\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nfor\\tO\\nlinkage\\tO\\nto\\tO\\nthe\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nlocus\\tO\\n,\\tO\\nBRCA1\\tO\\n,\\tO\\non\\tO\\nchromosome\\tO\\n17q\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nstrong\\tO\\nevidence\\tO\\nagainst\\tO\\nlinkage\\tO\\nto\\tO\\nBRCA1\\tO\\n(\\tO\\nlod\\tO\\nscore\\tO\\n-\\tO\\n16\\tO\\n.\\tO\\n63\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nbest\\tO\\nestimate\\tO\\nof\\tO\\nthe\\tO\\nproportion\\tO\\nof\\tO\\nlinked\\tO\\nfamilies\\tO\\nwas\\tO\\n0\\tO\\n%\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nCI\\tO\\n0\\tO\\n-\\tO\\n18\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nthere\\tO\\nis\\tO\\na\\tO\\ngene\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\nother\\tO\\nthan\\tO\\nBRCA1\\tO\\nwhich\\tO\\npredisposes\\tO\\nto\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\nwomen\\tO\\nand\\tO\\nwhich\\tO\\nconfers\\tO\\na\\tO\\nhigher\\tO\\nrisk\\tO\\nof\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nadditional\\tO\\npedigrees\\tO\\nthat\\tO\\ninclude\\tO\\ncases\\tO\\nof\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nmay\\tO\\ntherefore\\tO\\nfacilitate\\tO\\nthe\\tO\\nmapping\\tO\\nand\\tO\\nisolation\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nEWS\\tO\\ngene\\tO\\n,\\tO\\ninvolved\\tO\\nin\\tO\\nEwing\\tB-Disease\\nfamily\\tI-Disease\\nof\\tI-Disease\\ntumors\\tI-Disease\\n,\\tO\\nmalignant\\tB-Disease\\nmelanoma\\tI-Disease\\nof\\tI-Disease\\nsoft\\tI-Disease\\nparts\\tI-Disease\\nand\\tO\\ndesmoplastic\\tB-Disease\\nsmall\\tI-Disease\\nround\\tI-Disease\\ncell\\tI-Disease\\ntumors\\tI-Disease\\n,\\tO\\ncodes\\tO\\nfor\\tO\\nan\\tO\\nRNA\\tO\\nbinding\\tO\\nprotein\\tO\\nwith\\tO\\nnovel\\tO\\nregulatory\\tO\\ndomains\\tO\\n.\\tO\\n\\nThe\\tO\\nEWS\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nmaps\\tO\\nto\\tO\\nband\\tO\\nq12\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n22\\tO\\n,\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\na\\tO\\nwide\\tO\\nvariety\\tO\\nof\\tO\\nhuman\\tO\\nsolid\\tB-Disease\\ntumors\\tI-Disease\\nincluding\\tO\\nEwing\\tB-Disease\\nsarcoma\\tI-Disease\\n,\\tO\\nrelated\\tO\\nprimitive\\tO\\nneuroectodermal\\tB-Disease\\ntumors\\tI-Disease\\n,\\tO\\nmalignant\\tB-Disease\\nmelanoma\\tI-Disease\\nof\\tI-Disease\\nsoft\\tI-Disease\\nparts\\tI-Disease\\nand\\tO\\ndesmoplastic\\tB-Disease\\nsmall\\tI-Disease\\nround\\tI-Disease\\ncell\\tI-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nthese\\tO\\ntumors\\tB-Disease\\n,\\tO\\nthe\\tO\\nEWS\\tO\\nis\\tO\\nfused\\tO\\nto\\tO\\ngenes\\tO\\nencoding\\tO\\ntranscriptional\\tO\\nactivators\\tO\\n/\\tO\\nrepressors\\tO\\n,\\tO\\nlike\\tO\\nFli\\tO\\n-\\tO\\n1\\tO\\nor\\tO\\nerg\\tO\\nor\\tO\\nATF\\tO\\n1\\tO\\nor\\tO\\nwt1\\tO\\n.\\tO\\n\\nTo\\tO\\nbetter\\tO\\nunderstand\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\nEWS\\tO\\nprotein\\tO\\n,\\tO\\nwe\\tO\\ncloned\\tO\\nthe\\tO\\nEWS\\tO\\ncDNA\\tO\\n.\\tO\\n\\nSequence\\tO\\nanalysis\\tO\\nof\\tO\\nthis\\tO\\ncDNA\\tO\\nrevealed\\tO\\ndifferential\\tO\\nsplicing\\tO\\ninvolving\\tO\\ntwo\\tO\\nexons\\tO\\nencoding\\tO\\n72\\tO\\namino\\tO\\nacids\\tO\\n.\\tO\\n\\nBoth\\tO\\nalternatively\\tO\\nspliced\\tO\\ntranscripts\\tO\\n,\\tO\\nEWS\\tO\\nand\\tO\\nEWS\\tO\\n-\\tO\\nb\\tO\\n,\\tO\\nare\\tO\\nexpressed\\tO\\nin\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\ncells\\tO\\n.\\tO\\n\\nBecause\\tO\\nEWS\\tO\\nproteins\\tO\\ncontain\\tO\\nputative\\tO\\nconserved\\tO\\nRNA\\tO\\nbinding\\tO\\nmotifs\\tO\\n,\\tO\\nwe\\tO\\nstudied\\tO\\nthe\\tO\\nRNA\\tO\\nbinding\\tO\\nproperties\\tO\\nof\\tO\\nthe\\tO\\nEWS\\tO\\nprotein\\tO\\n.\\tO\\n\\nThe\\tO\\nEWS\\tO\\n-\\tO\\nb\\tO\\nprotein\\tO\\nbinds\\tO\\nto\\tO\\nRNA\\tO\\nin\\tO\\nvitro\\tO\\nand\\tO\\n,\\tO\\nspecifically\\tO\\n,\\tO\\nto\\tO\\npoly\\tO\\nG\\tO\\nand\\tO\\npoly\\tO\\nU\\tO\\n.\\tO\\n\\nThe\\tO\\nRNA\\tO\\nbinding\\tO\\nactivity\\tO\\nwas\\tO\\nlocalized\\tO\\nto\\tO\\nthe\\tO\\ncarboxy\\tO\\nterminal\\tO\\n86\\tO\\namino\\tO\\nacids\\tO\\n,\\tO\\nwhich\\tO\\nconstitute\\tO\\nRGG\\tO\\nbox\\tO\\n.\\tO\\n\\nThus\\tO\\nthe\\tO\\namino\\tO\\nterminal\\tO\\ndomain\\tO\\nof\\tO\\nEWS\\tO\\n(\\tO\\nNTD\\tO\\n-\\tO\\nEWS\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nchromosome\\tO\\ntranslocation\\tO\\nmay\\tO\\nregulate\\tO\\nthe\\tO\\nspecificity\\tO\\nof\\tO\\nRNA\\tO\\nbinding\\tO\\nactivity\\tO\\nof\\tO\\nEWS\\tO\\n.\\tO\\n\\nAn\\tO\\nEWS\\tO\\n-\\tO\\nerg\\tO\\nchimeric\\tO\\nprotein\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nfound\\tO\\nin\\tO\\nEwings\\tB-Disease\\nsarcoma\\tI-Disease\\ncells\\tO\\n,\\tO\\nfunctions\\tO\\nas\\tO\\na\\tO\\ntranscriptional\\tO\\nactivator\\tO\\n.\\tO\\n\\nMutational\\tO\\nanalysis\\tO\\nof\\tO\\nEWS\\tO\\n-\\tO\\nerg\\tO\\nchimeric\\tO\\nprotein\\tO\\nrevealed\\tO\\nthat\\tO\\nNTD\\tO\\n-\\tO\\nEWS\\tO\\nfunctions\\tO\\nas\\tO\\na\\tO\\nregulatory\\tO\\ndomain\\tO\\nfor\\tO\\nthe\\tO\\ntranscriptional\\tO\\nactivation\\tO\\nproperties\\tO\\nof\\tO\\nEWS\\tO\\n-\\tO\\nerg\\tO\\nchimeric\\tO\\nprotein\\tO\\n.\\tO\\n.\\tO\\n\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\n:\\tO\\ngenomic\\tO\\norganization\\tO\\nand\\tO\\nlocalization\\tO\\nof\\tO\\nhuman\\tO\\nASPA\\tO\\nto\\tO\\n17p13\\tO\\n-\\tO\\nter\\tO\\nand\\tO\\nconservation\\tO\\nof\\tO\\nthe\\tO\\nASPA\\tO\\ngene\\tO\\nduring\\tO\\nevolution\\tO\\n.\\tO\\n\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\n,\\tO\\nor\\tO\\nspongy\\tB-Disease\\ndegeneration\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nbrain\\tI-Disease\\n,\\tO\\nis\\tO\\na\\tO\\nsevere\\tO\\nleukodystrophy\\tB-Disease\\ncaused\\tO\\nby\\tO\\nthe\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\naspartoacylase\\tI-Disease\\n(\\tO\\nASPA\\tO\\n)\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\nhuman\\tO\\nASPA\\tO\\ncoding\\tO\\nsequence\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\nASPA\\tO\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\ncloned\\tO\\nand\\tO\\nfound\\tO\\nto\\tO\\nspan\\tO\\n29\\tO\\nkb\\tO\\nof\\tO\\nthe\\tO\\ngenome\\tO\\n.\\tO\\n\\nHuman\\tO\\naspartoacylase\\tO\\nis\\tO\\ncoded\\tO\\nby\\tO\\nsix\\tO\\nexons\\tO\\nintervened\\tO\\nby\\tO\\nfive\\tO\\nintrons\\tO\\n.\\tO\\n\\nThe\\tO\\nexons\\tO\\nvary\\tO\\nfrom\\tO\\n94\\tO\\n(\\tO\\nexon\\tO\\nIII\\tO\\n)\\tO\\nto\\tO\\n514\\tO\\n(\\tO\\nexon\\tO\\nVI\\tO\\n)\\tO\\nbases\\tO\\n.\\tO\\n\\nThe\\tO\\nexon\\tO\\n/\\tO\\nintron\\tO\\nsplice\\tO\\njunction\\tO\\nsites\\tO\\nfollow\\tO\\nthe\\tO\\ngt\\tO\\n/\\tO\\nag\\tO\\nconsensus\\tO\\nsequence\\tO\\nrule\\tO\\n.\\tO\\n\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\nof\\tO\\ngenomic\\tO\\nDNA\\tO\\nfrom\\tO\\nhuman\\tO\\n/\\tO\\nmouse\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrid\\tO\\ncell\\tO\\nlines\\tO\\nlocalized\\tO\\nASPA\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\n17\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\nASPA\\tO\\nlocus\\tO\\nwas\\tO\\nfurther\\tO\\nmapped\\tO\\nin\\tO\\nthe\\tO\\n17p13\\tO\\n-\\tO\\nter\\tO\\nregion\\tO\\nby\\tO\\nfluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n.\\tO\\n\\nThe\\tO\\nbovine\\tO\\naspa\\tO\\ngene\\tO\\nhas\\tO\\nalso\\tO\\nbeen\\tO\\ncloned\\tO\\n,\\tO\\nand\\tO\\nits\\tO\\nexon\\tO\\n/\\tO\\nintron\\tO\\norganization\\tO\\nis\\tO\\nidentical\\tO\\nto\\tO\\nthat\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\n500\\tO\\n-\\tO\\nbase\\tO\\nsequence\\tO\\nupstream\\tO\\nof\\tO\\nthe\\tO\\ninitiator\\tO\\nATG\\tO\\ncodon\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\ngene\\tO\\nand\\tO\\nthat\\tO\\nin\\tO\\nthe\\tO\\nbovine\\tO\\ngene\\tO\\nare\\tO\\n77\\tO\\n%\\tO\\nidentical\\tO\\n.\\tO\\n\\nHuman\\tO\\nASPA\\tO\\ncoding\\tO\\nsequences\\tO\\ncross\\tO\\n-\\tO\\nhybridize\\tO\\nwith\\tO\\ngenomic\\tO\\nDNA\\tO\\nfrom\\tO\\nyeast\\tO\\n,\\tO\\nchicken\\tO\\n,\\tO\\nrabbit\\tO\\n,\\tO\\ncow\\tO\\n,\\tO\\ndog\\tO\\n,\\tO\\nmouse\\tO\\n,\\tO\\nrat\\tO\\n,\\tO\\nand\\tO\\nmonkey\\tO\\n.\\tO\\n\\nThe\\tO\\nspecificity\\tO\\nof\\tO\\ncross\\tO\\n-\\tO\\nspecies\\tO\\nhybridization\\tO\\nof\\tO\\ncoding\\tO\\nsequences\\tO\\nsuggests\\tO\\nthat\\tO\\naspartoacylase\\tO\\nhas\\tO\\nbeen\\tO\\nconserved\\tO\\nduring\\tO\\nevolution\\tO\\n.\\tO\\n\\nIt\\tO\\nshould\\tO\\nnow\\tO\\nbe\\tO\\npossible\\tO\\nto\\tO\\nidentify\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nnoncoding\\tO\\ngenomic\\tO\\nsequences\\tO\\nthat\\tO\\nlead\\tO\\nto\\tO\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\nand\\tO\\nto\\tO\\nstudy\\tO\\nthe\\tO\\nregulation\\tO\\nof\\tO\\nASPA\\tO\\n.\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n:\\tO\\nsize\\tO\\n-\\tO\\nand\\tO\\nsex\\tO\\n-\\tO\\ndependent\\tO\\ndynamics\\tO\\nof\\tO\\nCTG\\tO\\nmeiotic\\tO\\ninstability\\tO\\n,\\tO\\nand\\tO\\nsomatic\\tO\\nmosaicism\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nprogressive\\tO\\nneuromuscular\\tB-Disease\\ndisorder\\tI-Disease\\nwhich\\tO\\nresults\\tO\\nfrom\\tO\\nelongations\\tO\\nof\\tO\\nan\\tO\\nunstable\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\n,\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nA\\tO\\ncorrelation\\tO\\nhas\\tO\\nbeen\\tO\\ndemonstrated\\tO\\nbetween\\tO\\nthe\\tO\\nincrease\\tO\\nin\\tO\\nthe\\tO\\nrepeat\\tO\\nnumber\\tO\\nof\\tO\\nthis\\tO\\nsequence\\tO\\nand\\tO\\nthe\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nclinical\\tO\\nstatus\\tO\\nof\\tO\\npatients\\tO\\ncannot\\tO\\nbe\\tO\\nunambiguously\\tO\\nascertained\\tO\\nsolely\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\nCTG\\tO\\nrepeats\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nthe\\tO\\nexclusive\\tO\\nmaternal\\tO\\ninheritance\\tO\\nof\\tO\\nthe\\tO\\ncongenital\\tO\\nform\\tO\\nremains\\tO\\nunexplained\\tO\\n.\\tO\\n\\nOur\\tO\\nobservation\\tO\\nof\\tO\\ndifferently\\tO\\nsized\\tO\\nrepeats\\tO\\nin\\tO\\nvarious\\tO\\nDM\\tB-Disease\\ntissues\\tO\\nfrom\\tO\\nthe\\tO\\nsame\\tO\\nindividual\\tO\\nmay\\tO\\nexplain\\tO\\nwhy\\tO\\nthe\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\nobserved\\tO\\nin\\tO\\nlymphocytes\\tO\\ndoes\\tO\\nnot\\tO\\nnecessarily\\tO\\ncorrelate\\tO\\nwith\\tO\\nthe\\tO\\nseverity\\tO\\nand\\tO\\nnature\\tO\\nof\\tO\\nsymptoms\\tO\\n.\\tO\\n\\nThrough\\tO\\na\\tO\\nmolecular\\tO\\nand\\tO\\ngenetic\\tO\\nstudy\\tO\\nof\\tO\\n142\\tO\\nfamilies\\tO\\nincluding\\tO\\n418\\tO\\nDM\\tB-Disease\\npatients\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ninvestigated\\tO\\nthe\\tO\\ndynamics\\tO\\nof\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nmeiotic\\tO\\ninstability\\tO\\n.\\tO\\n\\nA\\tO\\npositive\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\nand\\tO\\nthe\\tO\\nintergenerational\\tO\\nenlargement\\tO\\nwas\\tO\\nobserved\\tO\\nsimilarly\\tO\\nthrough\\tO\\nmale\\tO\\nand\\tO\\nfemale\\tO\\nmeioses\\tO\\nfor\\tO\\n<\\tO\\nor\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\n5\\tO\\n-\\tO\\nkb\\tO\\nCTG\\tO\\nsequences\\tO\\n.\\tO\\n\\nBeyond\\tO\\n0\\tO\\n.\\tO\\n\\n5\\tO\\nkb\\tO\\n,\\tO\\nthe\\tO\\nintergenerational\\tO\\nvariation\\tO\\nwas\\tO\\nmore\\tO\\nimportant\\tO\\nthrough\\tO\\nfemale\\tO\\nmeioses\\tO\\n,\\tO\\nwhereas\\tO\\na\\tO\\ntendency\\tO\\nto\\tO\\ncompression\\tO\\nwas\\tO\\nobserved\\tO\\nalmost\\tO\\nexclusively\\tO\\nin\\tO\\nmale\\tO\\nmeioses\\tO\\n,\\tO\\nfor\\tO\\n>\\tO\\nor\\tO\\n=\\tO\\n1\\tO\\n.\\tO\\n\\n5\\tO\\n-\\tO\\nkb\\tO\\nfragments\\tO\\n.\\tO\\n\\nThis\\tO\\nimplies\\tO\\na\\tO\\nsize\\tO\\n-\\tO\\nand\\tO\\nsex\\tO\\n-\\tO\\ndependent\\tO\\nmeiotic\\tO\\ninstability\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nsegregation\\tO\\nanalysis\\tO\\nsupports\\tO\\nthe\\tO\\nhypothesis\\tO\\nof\\tO\\na\\tO\\nmaternal\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\na\\tO\\nfamilial\\tO\\npredisposition\\tO\\nfor\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nthe\\tO\\ncongenital\\tO\\nform\\tO\\n.\\tO\\n\\nFinally\\tO\\n,\\tO\\nthis\\tO\\nanalysis\\tO\\nreveals\\tO\\na\\tO\\nsignificant\\tO\\nexcess\\tO\\nof\\tO\\ntransmitting\\tO\\ngrandfathers\\tO\\npartially\\tO\\naccounted\\tO\\nfor\\tO\\nby\\tO\\nincreased\\tO\\nfertility\\tO\\nin\\tO\\naffected\\tO\\nmales\\tO\\n\\nIllegitimate\\tO\\ntranscription\\tO\\nof\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\ngene\\tO\\nin\\tO\\nlymphocytes\\tO\\nfor\\tO\\nidentification\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nphenylketonuria\\tB-Disease\\n.\\tO\\n\\nTaking\\tO\\nadvantage\\tO\\nof\\tO\\nthe\\tO\\nillegitimate\\tO\\ntranscription\\tO\\nof\\tO\\nthe\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n(\\tO\\nPAH\\tO\\n)\\tO\\ngene\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nbeen\\tO\\nable\\tO\\nto\\tO\\nanalyse\\tO\\nthe\\tO\\nPAH\\tO\\ncDNA\\tO\\nsequence\\tO\\nof\\tO\\nhyperphenylalaninemic\\tB-Disease\\nchildren\\tO\\nin\\tO\\ncirculating\\tO\\nlymphocytes\\tO\\n.\\tO\\n\\nUsing\\tO\\nthis\\tO\\napproach\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nalso\\tO\\nidentified\\tO\\n3\\tO\\nnovel\\tO\\nmutations\\tO\\nin\\tO\\ncDNA\\tO\\nfrom\\tO\\nliver\\tO\\nand\\tO\\nlymphocytes\\tO\\nof\\tO\\ntwo\\tO\\npatients\\tO\\n.\\tO\\n\\nOne\\tO\\nmutation\\tO\\n,\\tO\\ndetected\\tO\\nby\\tO\\nthe\\tO\\nabnormal\\tO\\npattern\\tO\\nof\\tO\\nmigration\\tO\\nof\\tO\\nan\\tO\\namplified\\tO\\nfragment\\tO\\n,\\tO\\nis\\tO\\na\\tO\\nC\\tO\\nto\\tO\\nT\\tO\\ntransition\\tO\\nin\\tO\\nthe\\tO\\nsplice\\tO\\nacceptor\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n10\\tO\\n,\\tO\\nwhich\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\nskipping\\tO\\nof\\tO\\nexon\\tO\\n11\\tO\\nwith\\tO\\nthe\\tO\\npremature\\tO\\ntermination\\tO\\nof\\tO\\nRNA\\tO\\ntranslation\\tO\\ndownstream\\tO\\nfrom\\tO\\nexon\\tO\\n12\\tO\\n(\\tO\\n-\\tO\\n3\\tO\\nIVS10\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\ntwo\\tO\\nmutations\\tO\\nare\\tO\\nmissense\\tO\\nmutations\\tO\\nin\\tO\\nexons\\tO\\n10\\tO\\nand\\tO\\n11\\tO\\n(\\tO\\nrespectively\\tO\\n,\\tO\\nL333F\\tO\\nand\\tO\\nE390G\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nstudy\\tO\\nsupports\\tO\\nthe\\tO\\nview\\tO\\nthat\\tO\\ncirculating\\tO\\nlymphocytes\\tO\\ngive\\tO\\neasy\\tO\\naccess\\tO\\nto\\tO\\nPAH\\tO\\ngene\\tO\\ntranscripts\\tO\\nwhose\\tO\\nnucleotide\\tO\\nsequence\\tO\\nis\\tO\\nidentical\\tO\\nto\\tO\\nthat\\tO\\nreported\\tO\\nin\\tO\\nliver\\tO\\nand\\tO\\ntherefore\\tO\\nrepresent\\tO\\na\\tO\\nuseful\\tO\\ntool\\tO\\nfor\\tO\\nmolecular\\tO\\ngenetic\\tO\\nstudies\\tO\\nin\\tO\\nphenylketonuria\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nHigh\\tO\\nresidual\\tO\\narylsulfatase\\tO\\nA\\tO\\n(\\tO\\nARSA\\tO\\n)\\tO\\nactivity\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nlate\\tB-Disease\\n-\\tI-Disease\\ninfantile\\tI-Disease\\nmetachromatic\\tI-Disease\\nleukodystrophy\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\na\\tO\\npatient\\tO\\nsuffering\\tO\\nfrom\\tO\\nlate\\tB-Disease\\n-\\tI-Disease\\ninfantile\\tI-Disease\\nmetachromatic\\tI-Disease\\nleukodystrophy\\tI-Disease\\n(\\tO\\nMLD\\tB-Disease\\n)\\tO\\nwho\\tO\\nhas\\tO\\na\\tO\\nresidual\\tO\\narylsulfatase\\tO\\nA\\tO\\n(\\tO\\nARSA\\tO\\n)\\tO\\nactivity\\tO\\nof\\tO\\nabout\\tO\\n10\\tO\\n%\\tO\\n.\\tO\\n\\nFibroblasts\\tO\\nof\\tO\\nthe\\tO\\npatient\\tO\\nshow\\tO\\nsignificant\\tO\\nsulfatide\\tO\\ndegradation\\tO\\nactivity\\tO\\nexceeding\\tO\\nthat\\tO\\nof\\tO\\nadult\\tB-Disease\\nMLD\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nthe\\tO\\nARSA\\tO\\ngene\\tO\\nin\\tO\\nthis\\tO\\npatient\\tO\\nrevealed\\tO\\nheterozygosity\\tO\\nfor\\tO\\ntwo\\tO\\nnew\\tO\\nmutant\\tO\\nalleles\\tO\\nin\\tO\\none\\tO\\nallele\\tO\\n,\\tO\\ndeletion\\tO\\nof\\tO\\nC\\tO\\n447\\tO\\nin\\tO\\nexon\\tO\\n2\\tO\\nleads\\tO\\nto\\tO\\na\\tO\\nframeshift\\tO\\nand\\tO\\nto\\tO\\na\\tO\\npremature\\tO\\nstop\\tO\\ncodon\\tO\\nat\\tO\\namino\\tO\\nacid\\tO\\nposition\\tO\\n105\\tO\\n;\\tO\\nin\\tO\\nthe\\tO\\nsecond\\tO\\nallele\\tO\\n,\\tO\\na\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\ntransition\\tO\\nin\\tO\\nexon\\tO\\n5\\tO\\ncauses\\tO\\na\\tO\\nGly309\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nSer\\tO\\nsubstitution\\tO\\n.\\tO\\n\\nTransient\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nSer309\\tO\\n-\\tO\\nARSA\\tO\\nresulted\\tO\\nin\\tO\\nonly\\tO\\n13\\tO\\n%\\tO\\nenzyme\\tO\\nactivity\\tO\\nof\\tO\\nthat\\tO\\nobserved\\tO\\nin\\tO\\ncells\\tO\\nexpressing\\tO\\nnormal\\tO\\nARSA\\tO\\n.\\tO\\n\\nThe\\tO\\nmutant\\tO\\nARSA\\tO\\nis\\tO\\ncorrectly\\tO\\ntargeted\\tO\\nto\\tO\\nthe\\tO\\nlysosomes\\tO\\nbut\\tO\\nis\\tO\\nunstable\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nare\\tO\\nin\\tO\\ncontrast\\tO\\nto\\tO\\nprevious\\tO\\nresults\\tO\\nshowing\\tO\\nthat\\tO\\nthe\\tO\\nlate\\tB-Disease\\n-\\tI-Disease\\ninfantile\\tI-Disease\\ntype\\tI-Disease\\nof\\tI-Disease\\nMLD\\tI-Disease\\nis\\tO\\nalways\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\ncomplete\\tO\\nabsence\\tO\\nof\\tO\\nARSA\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nARSA\\tO\\nprotein\\tO\\nmay\\tO\\nbe\\tO\\ninfluenced\\tO\\nby\\tO\\nparticular\\tO\\nfeatures\\tO\\nof\\tO\\noligodendrocytes\\tO\\n,\\tO\\nsuch\\tO\\nthat\\tO\\nthe\\tO\\nlevel\\tO\\nof\\tO\\nmutant\\tO\\nenzyme\\tO\\nis\\tO\\nlower\\tO\\nin\\tO\\nthese\\tO\\ncells\\tO\\nthan\\tO\\nin\\tO\\nothers\\tO\\n.\\tO\\n.\\tO\\n\\nAn\\tO\\narylsulfatase\\tO\\nA\\tO\\n(\\tO\\nARSA\\tO\\n)\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nT274M\\tO\\n)\\tO\\ncausing\\tO\\nlate\\tB-Disease\\n-\\tI-Disease\\ninfantile\\tI-Disease\\nmetachromatic\\tI-Disease\\nleukodystrophy\\tI-Disease\\n.\\tO\\n\\nMetachromatic\\tB-Disease\\nleukodystrophy\\tI-Disease\\n(\\tO\\nMLD\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nlysosomal\\tI-Disease\\nstorage\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\narylsulfatase\\tI-Disease\\nA\\tI-Disease\\n(\\tO\\nARSA\\tO\\n;\\tO\\nEC\\tO\\n3\\tO\\n.\\tO\\n1\\tO\\n.\\tO\\n6\\tO\\n.\\tO\\n8\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\n8\\tO\\nARSA\\tO\\nexons\\tO\\nand\\tO\\nadjacent\\tO\\nintron\\tO\\nboundaries\\tO\\nfrom\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nlate\\tB-Disease\\n-\\tI-Disease\\ninfantile\\tI-Disease\\nmetachromatic\\tI-Disease\\nleukodystrophy\\tI-Disease\\nwere\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\namplified\\tO\\nin\\tO\\nseven\\tO\\ndiscrete\\tO\\nreactions\\tO\\n.\\tO\\n\\nAmplified\\tO\\nARSA\\tO\\nexons\\tO\\nwere\\tO\\nanalysed\\tO\\nfor\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nsequence\\tO\\nalterations\\tO\\nby\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\nanalysis\\tO\\n,\\tO\\nfollowed\\tO\\nby\\tO\\ndirect\\tO\\nsequencing\\tO\\nof\\tO\\nPCR\\tO\\nproducts\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransition\\tO\\nin\\tO\\nexon\\tO\\nIV\\tO\\nthat\\tO\\nresults\\tO\\nin\\tO\\nthe\\tO\\nsubstitution\\tO\\nof\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\nthreonine\\tO\\nresidue\\tO\\nat\\tO\\namino\\tO\\nacid\\tO\\n274\\tO\\nwith\\tO\\na\\tO\\nmethionine\\tO\\n(\\tO\\nT274M\\tO\\n)\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\na\\tO\\nfurther\\tO\\n29\\tO\\nMLD\\tB-Disease\\npatients\\tO\\nrevealed\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nfive\\tO\\nadditional\\tO\\nhomozygotes\\tO\\nfor\\tO\\nT274M\\tO\\n.\\tO\\n\\nAll\\tO\\n6\\tO\\nT274M\\tO\\nhomozygotes\\tO\\n(\\tO\\nrepresenting\\tO\\nfour\\tO\\nfamilies\\tO\\n)\\tO\\nwere\\tO\\nof\\tO\\nLebanese\\tO\\ndescent\\tO\\n,\\tO\\nand\\tO\\nall\\tO\\nwere\\tO\\nknown\\tO\\nto\\tO\\nbe\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\nconsanguineous\\tO\\nmarriages\\tO\\n.\\tO\\n\\nThe\\tO\\naltered\\tO\\namino\\tO\\nacid\\tO\\nis\\tO\\nrigidly\\tO\\nconserved\\tO\\namong\\tO\\n10\\tO\\nsulfatases\\tO\\nfrom\\tO\\nEscherichia\\tO\\ncoli\\tO\\nto\\tO\\nhumans\\tO\\n;\\tO\\ntherefore\\tO\\n,\\tO\\nit\\tO\\nis\\tO\\nmost\\tO\\nlikely\\tO\\nthat\\tO\\nthe\\tO\\nresultant\\tO\\nmutant\\tO\\nprotein\\tO\\nwill\\tO\\nhave\\tO\\nlittle\\tO\\nor\\tO\\nno\\tO\\nenzyme\\tO\\nactivity\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nvery\\tO\\nlow\\tO\\nARSA\\tO\\nactivity\\tO\\nmeasured\\tO\\nin\\tO\\nthese\\tO\\npatients\\tO\\nand\\tO\\ntheir\\tO\\nuniformly\\tO\\nsevere\\tO\\nclinical\\tO\\npresentation\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nPAX6\\tO\\ngene\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nhereditary\\tO\\naniridia\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\n14\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\nPAX6\\tO\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nanalysed\\tO\\nexon\\tO\\n-\\tO\\nby\\tO\\n-\\tO\\nexon\\tO\\nusing\\tO\\nSSCP\\tO\\nin\\tO\\n6\\tO\\naniridia\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nIn\\tO\\neach\\tO\\nfamily\\tO\\nband\\tO\\nshifts\\tO\\nwere\\tO\\nobserved\\tO\\non\\tO\\nthe\\tO\\nSSCP\\tO\\ngels\\tO\\nfor\\tO\\nonly\\tO\\none\\tO\\nexon\\tO\\nand\\tO\\ndirect\\tO\\nPCR\\tO\\n-\\tO\\nsequencing\\tO\\nrevealed\\tO\\nmutations\\tO\\nin\\tO\\neach\\tO\\ncase\\tO\\n.\\tO\\n\\nTwo\\tO\\nmutations\\tO\\ninvolved\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransitions\\tO\\nin\\tO\\nCGAarg\\tO\\ncodons\\tO\\nin\\tO\\nexons\\tO\\n9\\tO\\nand\\tO\\n11\\tO\\n.\\tO\\n\\nAnother\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransition\\tO\\nconverted\\tO\\na\\tO\\nCAG\\tO\\n-\\tO\\nglutamine\\tO\\nto\\tO\\na\\tO\\nTAG\\tO\\n-\\tO\\nstop\\tO\\nin\\tO\\nexon\\tO\\n7\\tO\\n.\\tO\\n\\nSmall\\tO\\ninsertions\\tO\\ncreated\\tO\\nframeshifts\\tO\\nwhich\\tO\\nproduced\\tO\\ndownstream\\tO\\nstop\\tO\\ncodons\\tO\\nin\\tO\\nanother\\tO\\ntwo\\tO\\npatients\\tO\\nand\\tO\\nan\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\nmutation\\tO\\ndisrupted\\tO\\nthe\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nof\\tO\\nexon\\tO\\n5\\tO\\nin\\tO\\nthe\\tO\\nremaining\\tO\\nfamily\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\ncomplete\\tO\\ninactivation\\tO\\nof\\tO\\nthe\\tO\\nPAX6\\tO\\ngene\\tO\\nis\\tO\\npredicted\\tO\\nin\\tO\\nall\\tO\\ncases\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nother\\tO\\naffected\\tO\\nmembers\\tO\\nof\\tO\\nthe\\tO\\nfamilies\\tO\\nshowed\\tO\\nthat\\tO\\n,\\tO\\nin\\tO\\neach\\tO\\ncase\\tO\\n,\\tO\\nall\\tO\\naffected\\tO\\nindividuals\\tO\\ncarried\\tO\\nthe\\tO\\nsame\\tO\\nfamily\\tO\\n-\\tO\\nspecific\\tO\\nmutation\\tO\\n.\\tO\\n\\nOne\\tO\\npolymorphism\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nexon\\tO\\n7\\tO\\n.\\tO\\n\\nThis\\tO\\ndata\\tO\\nstrongly\\tO\\nsupports\\tO\\nthe\\tO\\ncandidature\\tO\\nof\\tO\\nPAX6\\tO\\nas\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nhereditary\\tO\\naniridia\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nThree\\tO\\nnovel\\tO\\nmutations\\tO\\nin\\tO\\nfive\\tO\\nunrelated\\tO\\nsubjects\\tO\\nwith\\tO\\nhereditary\\tO\\nprotein\\tB-Disease\\nS\\tI-Disease\\ndeficiency\\tI-Disease\\ntype\\tI-Disease\\nI\\tI-Disease\\n.\\tO\\n\\nA\\tO\\npanel\\tO\\nof\\tO\\neight\\tO\\nunrelated\\tO\\nsubjects\\tO\\nwith\\tO\\ninherited\\tO\\ntype\\tB-Disease\\nI\\tI-Disease\\nprotein\\tI-Disease\\nS\\tI-Disease\\ndeficiency\\tI-Disease\\nwas\\tO\\nscreened\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nPROS1\\tO\\ngene\\tO\\n.\\tO\\n\\nIn\\tO\\nfive\\tO\\nsubjects\\tO\\nan\\tO\\nabnormality\\tO\\nwas\\tO\\nfound\\tO\\nbut\\tO\\nmutations\\tO\\nwere\\tO\\nnot\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nremaining\\tO\\nthree\\tO\\nsubjects\\tO\\n.\\tO\\n\\nTwo\\tO\\nsubjects\\tO\\nshared\\tO\\na\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nposition\\tO\\n+\\tO\\n5\\tO\\nof\\tO\\nthe\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\nconsensus\\tO\\nsequence\\tO\\nof\\tO\\nintron\\tO\\n10\\tO\\n.\\tO\\n\\nAlso\\tO\\nin\\tO\\ntwo\\tO\\nsubjects\\tO\\nan\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransversion\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nstopcodon\\tO\\nof\\tO\\nthe\\tO\\nPROS1\\tO\\ngene\\tO\\n;\\tO\\nthis\\tO\\ntransversion\\tO\\npredicts\\tO\\na\\tO\\nprotein\\tO\\nS\\tO\\nmolecule\\tO\\nthat\\tO\\nis\\tO\\nextended\\tO\\nby\\tO\\n14\\tO\\namino\\tO\\nacids\\tO\\n.\\tO\\n\\nThe\\tO\\nfifth\\tO\\nsubject\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\npossess\\tO\\ntwo\\tO\\nsequence\\tO\\nabnormalities\\tO\\n.\\tO\\n\\nOne\\tO\\nallele\\tO\\ncarried\\tO\\na\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\ntransition\\tO\\nnear\\tO\\nthe\\tO\\ndonor\\tO\\nsplice\\tO\\njunction\\tO\\nof\\tO\\nintron\\tO\\n2\\tO\\n,\\tO\\nbut\\tO\\nthis\\tO\\nabnormality\\tO\\nis\\tO\\nprobably\\tO\\nneutral\\tO\\n,\\tO\\nsince\\tO\\nit\\tO\\nwas\\tO\\ninherited\\tO\\nfrom\\tO\\nthe\\tO\\nparent\\tO\\nwith\\tO\\nnormal\\tO\\nprotein\\tO\\nS\\tO\\nantigen\\tO\\nlevels\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nother\\tO\\nallele\\tO\\na\\tO\\nsingle\\tO\\nT\\tO\\ninsertion\\tO\\nin\\tO\\ncodon\\tO\\n-\\tO\\n25\\tO\\nwas\\tO\\nfound\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nplatelet\\tO\\nRNA\\tO\\nshowed\\tO\\nthat\\tO\\nonly\\tO\\nthe\\tO\\nmRNA\\tO\\nwith\\tO\\nthe\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nstopcodon\\tO\\nis\\tO\\npresent\\tO\\nin\\tO\\namounts\\tO\\ncomparable\\tO\\nto\\tO\\nwildtype\\tO\\nRNA\\tO\\n.\\tO\\n\\nmRNA\\tO\\nfrom\\tO\\nthe\\tO\\nalleles\\tO\\nwith\\tO\\nthe\\tO\\nother\\tO\\ntwo\\tO\\nmutations\\tO\\nwas\\tO\\neither\\tO\\nundetectable\\tO\\nor\\tO\\npresent\\tO\\nin\\tO\\ngreatly\\tO\\nreduced\\tO\\namounts\\tO\\n.\\tO\\n\\nThe\\tO\\nlatter\\tO\\nindicates\\tO\\nthat\\tO\\na\\tO\\nmRNA\\tO\\nbased\\tO\\napproach\\tO\\nis\\tO\\nnot\\tO\\nfeasible\\tO\\nfor\\tO\\nthe\\tO\\ngenetic\\tO\\nanalysis\\tO\\nof\\tO\\nprotein\\tB-Disease\\nS\\tI-Disease\\ndeficiency\\tI-Disease\\ntype\\tI-Disease\\nI\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nCharacteristics\\tO\\nof\\tO\\nintergenerational\\tO\\ncontractions\\tO\\nof\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nin\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nsize\\tO\\nof\\tO\\na\\tO\\nCTG\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\nDM\\tB-Disease\\nkinase\\tO\\ngene\\tO\\ngenerally\\tO\\nincreases\\tO\\nin\\tO\\nsuccessive\\tO\\ngenerations\\tO\\nwith\\tO\\nclinical\\tO\\nevidence\\tO\\nof\\tO\\nanticipation\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthere\\tO\\nhave\\tO\\nalso\\tO\\nbeen\\tO\\ncases\\tO\\nwith\\tO\\nan\\tO\\nintergenerational\\tO\\ncontraction\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\n.\\tO\\n\\nWe\\tO\\nexamined\\tO\\n1\\tO\\n,\\tO\\n489\\tO\\nDM\\tB-Disease\\nparent\\tO\\n-\\tO\\noffspring\\tO\\npairs\\tO\\n,\\tO\\nof\\tO\\nwhich\\tO\\n95\\tO\\n(\\tO\\n6\\tO\\n.\\tO\\n4\\tO\\n%\\tO\\n)\\tO\\nshowed\\tO\\nsuch\\tO\\ncontractions\\tO\\nin\\tO\\nperipheral\\tO\\nblood\\tO\\nleukocytes\\tO\\n(\\tO\\nPBL\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\n56\\tO\\nof\\tO\\nthe\\tO\\n95\\tO\\npairs\\tO\\n,\\tO\\nclinical\\tO\\ndata\\tO\\nallowed\\tO\\nan\\tO\\nanalysis\\tO\\nof\\tO\\ntheir\\tO\\nanticipation\\tO\\nstatus\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nsurprising\\tO\\nthat\\tO\\nanticipation\\tO\\noccurred\\tO\\nin\\tO\\n27\\tO\\n(\\tO\\n48\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthese\\tO\\n56\\tO\\npairs\\tO\\n,\\tO\\nwhile\\tO\\nnone\\tO\\nclearly\\tO\\nshowed\\tO\\na\\tO\\nlater\\tO\\nonset\\tO\\nof\\tO\\nDM\\tB-Disease\\nin\\tO\\nthe\\tO\\nsymptomatic\\tO\\noffspring\\tO\\n.\\tO\\n\\nThe\\tO\\ncontraction\\tO\\noccurred\\tO\\nin\\tO\\n76\\tO\\n(\\tO\\n10\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n753\\tO\\npaternal\\tO\\ntransmissions\\tO\\nand\\tO\\nin\\tO\\n19\\tO\\n(\\tO\\n3\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n736\\tO\\nmaternal\\tO\\ntransmissions\\tO\\n.\\tO\\n\\nAnticipation\\tO\\nwas\\tO\\nobserved\\tO\\nmore\\tO\\nfrequently\\tO\\nin\\tO\\nmaternal\\tO\\n(\\tO\\n85\\tO\\n%\\tO\\n)\\tO\\nthan\\tO\\nin\\tO\\npaternal\\tO\\n(\\tO\\n37\\tO\\n%\\tO\\n)\\tO\\ntransmissions\\tO\\n(\\tO\\nP\\tO\\n<\\tO\\n.\\tO\\n001\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nparental\\tO\\nrepeat\\tO\\nsize\\tO\\ncorrelated\\tO\\nwith\\tO\\nthe\\tO\\nsize\\tO\\nof\\tO\\nintergenerational\\tO\\ncontraction\\tO\\n(\\tO\\nr2\\tO\\n=\\tO\\n.\\tO\\n50\\tO\\n,\\tO\\nP\\tO\\n<\\tO\\n<\\tO\\n.\\tO\\n001\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nslope\\tO\\nof\\tO\\nlinear\\tO\\nregression\\tO\\nwas\\tO\\nsteeper\\tO\\nin\\tO\\npaternal\\tO\\n(\\tO\\n-\\tO\\n.\\tO\\n62\\tO\\n)\\tO\\nthan\\tO\\nin\\tO\\nmaternal\\tO\\n(\\tO\\n-\\tO\\n.\\tO\\n30\\tO\\n)\\tO\\ntransmissions\\tO\\n(\\tO\\nP\\tO\\n<\\tO\\n<\\tO\\n.\\tO\\n001\\tO\\n)\\tO\\n.\\tO\\n\\nSixteen\\tO\\nDM\\tB-Disease\\nparents\\tO\\nhad\\tO\\nmultiple\\tO\\nDM\\tB-Disease\\noffspring\\tO\\nwith\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\ncontractions\\tO\\n.\\tO\\n\\nThis\\tO\\nfrequency\\tO\\nwas\\tO\\nhigher\\tO\\nthan\\tO\\nthe\\tO\\nfrequency\\tO\\nexpected\\tO\\nfrom\\tO\\nthe\\tO\\nprobability\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\ncontractions\\tO\\n(\\tO\\n6\\tO\\n.\\tO\\n4\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nsize\\tO\\nof\\tO\\nDM\\tB-Disease\\nsib\\tO\\npopulation\\tO\\n(\\tO\\n1\\tO\\n.\\tO\\n54\\tO\\nDM\\tB-Disease\\noffspring\\tO\\nper\\tO\\nDM\\tB-Disease\\nparent\\tO\\n,\\tO\\nin\\tO\\n968\\tO\\nDM\\tB-Disease\\nparents\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nintergenerational\\tO\\ncontractions\\tO\\nof\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nin\\tO\\nleukocyte\\tO\\nDNA\\tO\\nfrequently\\tO\\naccompanies\\tO\\napparent\\tO\\nanticipation\\tO\\n,\\tO\\nespecially\\tO\\nwhen\\tO\\nDM\\tB-Disease\\nis\\tO\\nmaternally\\tO\\ntransmitted\\tO\\n,\\tO\\nand\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nthe\\tO\\npaternal\\tO\\norigin\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\ncontraction\\tO\\nin\\tO\\na\\tO\\nsibling\\tO\\nincrease\\tO\\nthe\\tO\\nprobability\\tO\\nof\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\ncontraction\\tO\\n\\nGonosomal\\tO\\nmosaicism\\tO\\nin\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\npatients\\tO\\n:\\tO\\ninvolvement\\tO\\nof\\tO\\nmitotic\\tO\\nevents\\tO\\nin\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\nvariation\\tO\\nand\\tO\\nselection\\tO\\nagainst\\tO\\nextreme\\tO\\nexpansion\\tO\\nin\\tO\\nsperm\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nabnormal\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\npolymorphic\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\n,\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\nDM\\tB-Disease\\nprotein\\tO\\nkinase\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\ndetermined\\tO\\nthe\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\nlengths\\tO\\nin\\tO\\na\\tO\\nbroad\\tO\\nrange\\tO\\nof\\tO\\ntissue\\tO\\nDNAs\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nmild\\tO\\n,\\tO\\nclassical\\tO\\n,\\tO\\nor\\tO\\ncongenital\\tO\\nmanifestation\\tO\\nof\\tO\\nDM\\tB-Disease\\n.\\tO\\n\\nDifferences\\tO\\nin\\tO\\nthe\\tO\\nrepeat\\tO\\nlength\\tO\\nwere\\tO\\nseen\\tO\\nin\\tO\\nsomatic\\tO\\ntissues\\tO\\nfrom\\tO\\nsingle\\tO\\nDM\\tB-Disease\\nindividuals\\tO\\nand\\tO\\ntwins\\tO\\n.\\tO\\n\\nRepeats\\tO\\nappeared\\tO\\nto\\tO\\nexpand\\tO\\nto\\tO\\na\\tO\\nsimilar\\tO\\nextent\\tO\\nin\\tO\\ntissues\\tO\\noriginating\\tO\\nfrom\\tO\\nthe\\tO\\nsame\\tO\\nembryonal\\tO\\norigin\\tO\\n.\\tO\\n\\nIn\\tO\\nmost\\tO\\nmale\\tO\\npatients\\tO\\ncarrying\\tO\\nintermediate\\tO\\n-\\tO\\nor\\tO\\nsmall\\tO\\n-\\tO\\nsized\\tO\\nexpansions\\tO\\nin\\tO\\nblood\\tO\\n,\\tO\\nthe\\tO\\nrepeat\\tO\\nlengths\\tO\\ncovered\\tO\\na\\tO\\nmarkedly\\tO\\nwider\\tO\\nrange\\tO\\nin\\tO\\nsperm\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nmale\\tO\\npatients\\tO\\nwith\\tO\\nlarge\\tO\\nallele\\tO\\nexpansions\\tO\\nin\\tO\\nblood\\tO\\n(\\tO\\n>\\tO\\n700\\tO\\nCTGs\\tO\\n)\\tO\\nhad\\tO\\nsimilar\\tO\\nor\\tO\\nsmaller\\tO\\nrepeats\\tO\\nin\\tO\\nsperm\\tO\\n,\\tO\\nwhen\\tO\\ndetectable\\tO\\n.\\tO\\n\\nSperm\\tO\\nalleles\\tO\\nwith\\tO\\n>\\tO\\n1\\tO\\n,\\tO\\n000\\tO\\nCTGs\\tO\\nwere\\tO\\nnot\\tO\\nseen\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nDM\\tB-Disease\\npatients\\tO\\ncan\\tO\\nbe\\tO\\nconsidered\\tO\\ngonosomal\\tO\\nmosaics\\tO\\n,\\tO\\ni\\tO\\n.\\tO\\n\\ne\\tO\\ne\\tO\\n.\\tO\\n,\\tO\\ncombined\\tO\\nsomatic\\tO\\nand\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\ntissue\\tO\\nmosaics\\tO\\n.\\tO\\n\\nMost\\tO\\nremarkably\\tO\\n,\\tO\\nwe\\tO\\nobserved\\tO\\nmultiple\\tO\\ncases\\tO\\nwhere\\tO\\nthe\\tO\\nlength\\tO\\ndistributions\\tO\\nof\\tO\\nintermediate\\tO\\n-\\tO\\nor\\tO\\nsmall\\tO\\n-\\tO\\nsized\\tO\\nalleles\\tO\\nin\\tO\\nfathers\\tO\\nsperm\\tO\\nwere\\tO\\nsignificantly\\tO\\ndifferent\\tO\\nfrom\\tO\\nthat\\tO\\nin\\tO\\ntheir\\tO\\noffsprings\\tO\\nblood\\tO\\n.\\tO\\n\\nOur\\tO\\ncombined\\tO\\nfindings\\tO\\nindicate\\tO\\nthat\\tO\\nintergenerational\\tO\\nlength\\tO\\nchanges\\tO\\nin\\tO\\nthe\\tO\\nunstable\\tO\\nCTG\\tO\\nrepeat\\tO\\nare\\tO\\nmost\\tO\\nlikely\\tO\\nto\\tO\\noccur\\tO\\nduring\\tO\\nearly\\tO\\nembryonic\\tO\\nmitotic\\tO\\ndivisions\\tO\\nin\\tO\\nboth\\tO\\nsomatic\\tO\\nand\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\ntissue\\tO\\nformation\\tO\\n.\\tO\\n\\nBoth\\tO\\nthe\\tO\\ninitial\\tO\\nCTG\\tO\\nlength\\tO\\n,\\tO\\nthe\\tO\\noverall\\tO\\nnumber\\tO\\nof\\tO\\ncell\\tO\\ndivisions\\tO\\ninvolved\\tO\\nin\\tO\\ntissue\\tO\\nformation\\tO\\n,\\tO\\nand\\tO\\nperhaps\\tO\\na\\tO\\nspecific\\tO\\nselection\\tO\\nprocess\\tO\\nin\\tO\\nspermatogenesis\\tO\\nmay\\tO\\ninfluence\\tO\\nthe\\tO\\ndynamics\\tO\\nof\\tO\\nthis\\tO\\nprocess\\tO\\n.\\tO\\n\\nA\\tO\\nmodel\\tO\\nexplaining\\tO\\nmitotic\\tO\\ninstability\\tO\\nand\\tO\\nsex\\tO\\n-\\tO\\ndependent\\tO\\nsegregation\\tO\\nphenomena\\tO\\nin\\tO\\nDM\\tB-Disease\\nmanifestation\\tO\\nis\\tO\\ndiscussed\\tO\\n\\nRegionally\\tO\\nclustered\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nsevere\\tO\\nphenotype\\tO\\nand\\tO\\noccur\\tO\\nat\\tO\\na\\tO\\nhigh\\tO\\nfrequency\\tO\\nin\\tO\\nnew\\tO\\nmutation\\tO\\ncases\\tO\\nof\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n.\\tO\\n\\nGermline\\tO\\nmutation\\tO\\nin\\tO\\nAPC\\tO\\nat\\tO\\n5q21\\tO\\n-\\tO\\n22\\tO\\nresults\\tO\\nin\\tO\\nthe\\tO\\ndominantly\\tO\\ninherited\\tO\\nsyndrome\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nSomatic\\tO\\nmutation\\tO\\nin\\tO\\nthis\\tO\\ngene\\tO\\nis\\tO\\nan\\tO\\nearly\\tO\\nevent\\tO\\nin\\tO\\ncolorectal\\tO\\ntumourigenesis\\tO\\n.\\tO\\n\\nBoth\\tO\\ntypes\\tO\\nof\\tO\\nmutation\\tO\\nare\\tO\\nconcentrated\\tO\\nin\\tO\\nthe\\tO\\n5\\tO\\nhalf\\tO\\nof\\tO\\nexon\\tO\\n15\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nused\\tO\\nsingle\\tO\\nstrand\\tO\\nconformational\\tO\\npolymorphism\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\nand\\tO\\nheteroduplex\\tO\\nanalysis\\tO\\nto\\tO\\nscreen\\tO\\nfor\\tO\\nvariants\\tO\\nin\\tO\\nthis\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\n45\\tO\\naffected\\tO\\nbut\\tO\\nunrelated\\tO\\nindividuals\\tO\\n.\\tO\\n\\nEighteen\\tO\\npatients\\tO\\nhad\\tO\\nno\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n;\\tO\\nof\\tO\\nthese\\tO\\n11\\tO\\nwere\\tO\\nclassified\\tO\\nas\\tO\\nhaving\\tO\\na\\tO\\nsevere\\tO\\nphenotype\\tO\\n,\\tO\\nbased\\tO\\non\\tO\\nan\\tO\\nearly\\tO\\nage\\tO\\nat\\tO\\npresentation\\tO\\nor\\tO\\ncancer\\tB-Disease\\ndevelopment\\tO\\n.\\tO\\n\\nThis\\tO\\ncompared\\tO\\nwith\\tO\\n6\\tO\\nof\\tO\\n27\\tO\\nfamilial\\tO\\ncases\\tO\\n.\\tO\\n\\nA\\tO\\n5\\tO\\nbp\\tO\\ndeletion\\tO\\nat\\tO\\ncodon\\tO\\n1309\\tO\\nreported\\tO\\nto\\tO\\noccur\\tO\\nin\\tO\\n10\\tO\\n-\\tO\\n15\\tO\\n%\\tO\\nof\\tO\\nunselected\\tO\\nAPC\\tB-Disease\\npatients\\tO\\nworldwide\\tO\\n,\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\n5\\tO\\nof\\tO\\nthe\\tO\\n18\\tO\\nnew\\tO\\nmutation\\tO\\ncases\\tO\\nand\\tO\\n4\\tO\\nof\\tO\\nthe\\tO\\n27\\tO\\nfamilial\\tO\\ncases\\tO\\nall\\tO\\nnine\\tO\\nwere\\tO\\nclassed\\tO\\nas\\tO\\nsevere\\tO\\n.\\tO\\n\\nA\\tO\\nfurther\\tO\\n3\\tO\\nnew\\tO\\nmutations\\tO\\nand\\tO\\n1\\tO\\nfamilial\\tO\\nmutation\\tO\\nwere\\tO\\nlocated\\tO\\ndownstream\\tO\\nfrom\\tO\\ncodon\\tO\\n1309\\tO\\n,\\tO\\nthese\\tO\\nindividuals\\tO\\nsimilarly\\tO\\nbeing\\tO\\nclassed\\tO\\nas\\tO\\nphenotypically\\tO\\nsevere\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\nall\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\ndetected\\tO\\nin\\tO\\naffected\\tO\\nindividuals\\tO\\nwith\\tO\\nan\\tO\\naverage\\tO\\nphenotype\\tO\\nwere\\tO\\nlocated\\tO\\nprior\\tO\\nto\\tO\\ncodon\\tO\\n1309\\tO\\n.\\tO\\n\\nThe\\tO\\nfrequent\\tO\\nassociation\\tO\\nof\\tO\\na\\tO\\nsevere\\tO\\nphenotype\\tO\\nwith\\tO\\nfresh\\tO\\nmutation\\tO\\nmay\\tO\\nexplain\\tO\\nthe\\tO\\napparent\\tO\\nconflict\\tO\\nof\\tO\\na\\tO\\nhigh\\tO\\nmutation\\tO\\nrate\\tO\\n(\\tO\\n20\\tO\\n-\\tO\\n30\\tO\\n%\\tO\\n)\\tO\\nin\\tO\\na\\tO\\ncondition\\tO\\n,\\tO\\nwhich\\tO\\non\\tO\\naverage\\tO\\n,\\tO\\nis\\tO\\nlethal\\tO\\nat\\tO\\na\\tO\\npost\\tO\\n-\\tO\\nreproductive\\tO\\nage\\tO\\n.\\tO\\n.\\tO\\n\\nMutations\\tO\\nat\\tO\\nthe\\tO\\nPAX6\\tO\\nlocus\\tO\\nare\\tO\\nfound\\tO\\nin\\tO\\nheterogeneous\\tO\\nanterior\\tB-Disease\\nsegment\\tI-Disease\\nmalformations\\tI-Disease\\nincluding\\tO\\nPeters\\tB-Disease\\n\\'\\tI-Disease\\nanomaly\\tI-Disease\\n.\\tO\\n\\nMutation\\tO\\nor\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nPAX6\\tO\\ngene\\tO\\nunderlies\\tO\\nmany\\tO\\ncases\\tO\\nof\\tO\\naniridia\\tB-Disease\\n.\\tO\\n\\nThree\\tO\\nlines\\tO\\nof\\tO\\nevidence\\tO\\nnow\\tO\\nconverge\\tO\\nto\\tO\\nimplicate\\tO\\nPAX6\\tO\\nmore\\tO\\nwidely\\tO\\nin\\tO\\nanterior\\tB-Disease\\nsegment\\tI-Disease\\nmalformations\\tI-Disease\\nincluding\\tO\\nPeters\\tB-Disease\\nanomaly\\tI-Disease\\n.\\tO\\n\\nFirst\\tO\\n,\\tO\\na\\tO\\nchild\\tO\\nwith\\tO\\nPeters\\tB-Disease\\nanomaly\\tI-Disease\\nis\\tO\\ndeleted\\tO\\nfor\\tO\\none\\tO\\ncopy\\tO\\nof\\tO\\nPAX6\\tO\\n.\\tO\\n\\nSecond\\tO\\n,\\tO\\naffected\\tO\\nmembers\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\ndominantly\\tO\\ninherited\\tO\\nanterior\\tB-Disease\\nsegment\\tI-Disease\\nmalformations\\tI-Disease\\n,\\tO\\nincluding\\tO\\nPeters\\tB-Disease\\nanomaly\\tI-Disease\\nare\\tO\\nheterozygous\\tO\\nfor\\tO\\nan\\tO\\nR26G\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nPAX6\\tO\\npaired\\tO\\nbox\\tO\\n.\\tO\\n\\nThird\\tO\\n,\\tO\\na\\tO\\nproportion\\tO\\nof\\tO\\nSey\\tO\\n/\\tO\\n+\\tO\\nSmalleye\\tO\\nmice\\tO\\n,\\tO\\nheterozygous\\tO\\nfor\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\nin\\tO\\nmurine\\tO\\nPax\\tO\\n-\\tO\\n6\\tO\\n,\\tO\\nhave\\tO\\nan\\tO\\nocular\\tO\\nphenotype\\tO\\nresembling\\tO\\nPeters\\tB-Disease\\nanomaly\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\ntherefore\\tO\\npropose\\tO\\nthat\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nanterior\\tB-Disease\\nsegment\\tI-Disease\\nanomalies\\tI-Disease\\nmay\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nPAX6\\tO\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\nwithout\\tO\\nCAG\\tO\\nexpansion\\tO\\n:\\tO\\nphenocopies\\tO\\nor\\tO\\nerrors\\tO\\nin\\tO\\nassignment\\tO\\n?\\tO\\n\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nexpanded\\tO\\nCAG\\tO\\nrepeat\\tO\\nwithin\\tO\\na\\tO\\nnovel\\tO\\ngene\\tO\\non\\tO\\n4p16\\tO\\n.\\tO\\n\\n3\\tO\\n(\\tO\\nIT15\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\n30\\tO\\nof\\tO\\n1\\tO\\n,\\tO\\n022\\tO\\naffected\\tO\\npersons\\tO\\n(\\tO\\n2\\tO\\n.\\tO\\n9\\tO\\n%\\tO\\nof\\tO\\nour\\tO\\ncohort\\tO\\n)\\tO\\ndid\\tO\\nnot\\tO\\nhave\\tO\\nan\\tO\\nexpanded\\tO\\nCAG\\tO\\nin\\tO\\nthe\\tO\\ndisease\\tO\\nrange\\tO\\n.\\tO\\n\\nThe\\tO\\nreasons\\tO\\nfor\\tO\\nnot\\tO\\nobserving\\tO\\nexpansion\\tO\\nin\\tO\\naffected\\tO\\nindividuals\\tO\\nare\\tO\\nimportant\\tO\\nfor\\tO\\ndetermining\\tO\\nthe\\tO\\nsensitivity\\tO\\nof\\tO\\nusing\\tO\\nrepeat\\tO\\nlength\\tO\\nboth\\tO\\nfor\\tO\\ndiagnosis\\tO\\nof\\tO\\naffected\\tO\\npatients\\tO\\nand\\tO\\nfor\\tO\\npredictive\\tO\\ntesting\\tO\\nprograms\\tO\\nand\\tO\\nmay\\tO\\nhave\\tO\\nbiological\\tO\\nrelevance\\tO\\nfor\\tO\\nthe\\tO\\nunderstanding\\tO\\nof\\tO\\nthe\\tO\\nmolecular\\tO\\nmechanism\\tO\\nunderlying\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nmajority\\tO\\n(\\tO\\n18\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nindividuals\\tO\\nwith\\tO\\nnormal\\tO\\nsized\\tO\\nalleles\\tO\\nrepresent\\tO\\nmisdiagnosis\\tO\\n,\\tO\\nsample\\tO\\nmix\\tO\\n-\\tO\\nup\\tO\\n,\\tO\\nor\\tO\\nclerical\\tO\\nerror\\tO\\n.\\tO\\n\\nThe\\tO\\nremaining\\tO\\n12\\tO\\npatients\\tO\\nrepresent\\tO\\npossible\\tO\\nphenocopies\\tO\\nfor\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\nat\\tO\\nleast\\tO\\nfour\\tO\\ncases\\tO\\n,\\tO\\nfamily\\tO\\nstudies\\tO\\nof\\tO\\nthese\\tO\\nphenocopies\\tO\\nexcluded\\tO\\n4p16\\tO\\n.\\tO\\n\\n3\\tO\\nas\\tO\\nthe\\tO\\nregion\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nphenotype\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\nthat\\tO\\nare\\tO\\nother\\tO\\nthan\\tO\\nCAG\\tO\\nexpansion\\tO\\nhave\\tO\\nnot\\tO\\nbeen\\tO\\nexcluded\\tO\\nfor\\tO\\nthe\\tO\\nremaining\\tO\\neight\\tO\\ncases\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nin\\tO\\nas\\tO\\nmany\\tO\\nas\\tO\\nseven\\tO\\nof\\tO\\nthese\\tO\\npersons\\tO\\n,\\tO\\nretrospective\\tO\\nreview\\tO\\nof\\tO\\nthese\\tO\\npatients\\tO\\nclinical\\tO\\nfeatures\\tO\\nidentified\\tO\\ncharacteristics\\tO\\nnot\\tO\\ntypical\\tO\\nfor\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\nshows\\tO\\nthat\\tO\\non\\tO\\nrare\\tO\\noccasions\\tO\\nmutations\\tO\\nin\\tO\\nother\\tO\\n,\\tO\\nas\\tO\\n-\\tO\\nyet\\tO\\n-\\tO\\nundefined\\tO\\ngenes\\tO\\ncan\\tO\\npresent\\tO\\nwith\\tO\\na\\tO\\nclinical\\tO\\nphenotype\\tO\\nvery\\tO\\nsimilar\\tO\\nto\\tO\\nthat\\tO\\nof\\tO\\nHD\\tB-Disease\\n\\nFrequent\\tO\\ndetection\\tO\\nof\\tO\\ncodon\\tO\\n877\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nandrogen\\tO\\nreceptor\\tO\\ngene\\tO\\nin\\tO\\nadvanced\\tB-Disease\\nprostate\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nProstatic\\tO\\ntissue\\tO\\nspecimens\\tO\\nderived\\tO\\nfrom\\tO\\ntransurethral\\tO\\nresections\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nmetastatic\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\nwere\\tO\\nanalyzed\\tO\\nfor\\tO\\ngenetic\\tO\\nalterations\\tO\\nin\\tO\\nthe\\tO\\nhormone\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nandrogen\\tO\\nreceptor\\tO\\n(\\tO\\nAR\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nDirect\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n-\\tO\\nderived\\tO\\nDNAs\\tO\\nof\\tO\\n6\\tO\\nof\\tO\\n24\\tO\\nspecimens\\tO\\nrevealed\\tO\\na\\tO\\ncodon\\tO\\n877\\tO\\nmutation\\tO\\n(\\tO\\nACT\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nGCT\\tO\\n,\\tO\\nThr\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nAla\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nhormone\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nAR\\tO\\ngene\\tO\\n.\\tO\\n\\nThis\\tO\\nsame\\tO\\nAR\\tO\\nmutation\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\npreviously\\tO\\nin\\tO\\na\\tO\\nmetastatic\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\ncell\\tO\\nline\\tO\\n,\\tO\\nLNCaP\\tO\\n,\\tO\\nwhere\\tO\\nthis\\tO\\nmutation\\tO\\nconfers\\tO\\nupon\\tO\\nthe\\tO\\nAR\\tO\\nan\\tO\\naltered\\tO\\nligand\\tO\\n-\\tO\\nbinding\\tO\\nspecificity\\tO\\nwhich\\tO\\nis\\tO\\nstimulated\\tO\\nby\\tO\\nestrogens\\tO\\n,\\tO\\nprogestagens\\tO\\n,\\tO\\nand\\tO\\nantiandrogens\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\npossible\\tO\\nthat\\tO\\nanalogous\\tO\\nto\\tO\\nan\\tO\\nactivated\\tO\\n/\\tO\\naltered\\tO\\ngrowth\\tO\\nfactor\\tO\\nreceptor\\tO\\noncogene\\tO\\n,\\tO\\ncodon\\tO\\n877\\tO\\nmutant\\tO\\nAR\\tO\\nwith\\tO\\naltered\\tO\\nligand\\tO\\nbinding\\tO\\nmay\\tO\\nprovide\\tO\\na\\tO\\nselective\\tO\\ngrowth\\tO\\nadvantage\\tO\\nin\\tO\\nthe\\tO\\ngenesis\\tO\\nof\\tO\\na\\tO\\nsubset\\tO\\nof\\tO\\nadvanced\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nAlthough\\tO\\nestrogens\\tO\\nare\\tO\\nused\\tO\\ninfrequently\\tO\\n,\\tO\\nantiandrogens\\tO\\nare\\tO\\nused\\tO\\nincreasingly\\tO\\nin\\tO\\nhormonal\\tO\\ntherapy\\tO\\nfor\\tO\\npatients\\tO\\nwith\\tO\\nadvanced\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nstimulatory\\tO\\neffect\\tO\\nof\\tO\\nthese\\tO\\ntherapeutic\\tO\\nagents\\tO\\non\\tO\\nthe\\tO\\ncodon\\tO\\n877\\tO\\nmutant\\tO\\nAR\\tO\\nfurther\\tO\\nsuggests\\tO\\nthat\\tO\\nthis\\tO\\nfrequently\\tO\\nobserved\\tO\\nAR\\tO\\nmutation\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\nthe\\tO\\ntreatment\\tO\\nrefractory\\tO\\ndisease\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\ngene\\tO\\nfor\\tO\\nalkaptonuria\\tB-Disease\\n(\\tO\\nAKU\\tB-Disease\\n)\\tO\\nmaps\\tO\\nto\\tO\\nchromosome\\tO\\n3q\\tO\\n.\\tO\\n\\nAlkaptonuria\\tB-Disease\\n(\\tO\\nAKU\\tB-Disease\\n;\\tO\\nMcKusick\\tO\\nno\\tO\\n.\\tO\\n203500\\tO\\n)\\tO\\nis\\tO\\na\\tO\\nrare\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\nthe\\tO\\nlack\\tO\\nof\\tO\\nhomogentisic\\tO\\nacid\\tO\\noxidase\\tO\\nactivity\\tO\\n.\\tO\\n\\nPatients\\tO\\nexcrete\\tO\\nlarge\\tO\\namounts\\tO\\nof\\tO\\nhomogentisic\\tO\\nacid\\tO\\nin\\tO\\ntheir\\tO\\nurine\\tO\\nand\\tO\\na\\tO\\nblack\\tO\\nochronotic\\tO\\npigment\\tO\\nis\\tO\\ndeposited\\tO\\nin\\tO\\ntheir\\tO\\ncartilage\\tO\\nand\\tO\\ncollagenous\\tO\\ntissues\\tO\\n.\\tO\\n\\nOchronosis\\tB-Disease\\nis\\tO\\nthe\\tO\\npredominant\\tO\\nclinical\\tO\\ncomplication\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nleading\\tO\\nto\\tO\\nochronotic\\tB-Disease\\narthropathy\\tI-Disease\\n,\\tO\\ndark\\tO\\nurine\\tO\\n,\\tO\\npigment\\tO\\nchanges\\tO\\nof\\tO\\nthe\\tO\\nskin\\tO\\n,\\tO\\nand\\tO\\nother\\tO\\nclinical\\tO\\nfeatures\\tO\\n.\\tO\\n\\nA\\tO\\nmutation\\tO\\ncausing\\tO\\nalkaptonuria\\tB-Disease\\nin\\tO\\nthe\\tO\\nmouse\\tO\\nhas\\tO\\nmapped\\tO\\nto\\tO\\nchromosome\\tO\\n16\\tO\\n.\\tO\\n\\nConsidering\\tO\\nconserved\\tO\\nsynteny\\tO\\n,\\tO\\nwe\\tO\\nwere\\tO\\nable\\tO\\nto\\tO\\nmap\\tO\\nthe\\tO\\nhuman\\tO\\ngene\\tO\\nto\\tO\\nchromosome\\tO\\n3q\\tO\\nin\\tO\\nsix\\tO\\nalkaptonuria\\tB-Disease\\npedigrees\\tO\\nof\\tO\\nSlovak\\tO\\norigin\\tO\\n.\\tO\\n.\\tO\\n\\nStructure\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nNa\\tO\\n+\\tO\\n/\\tO\\nglucose\\tO\\ncotransporter\\tO\\ngene\\tO\\nSGLT1\\tO\\n.\\tO\\n\\nIntestinal\\tO\\nuptake\\tO\\nof\\tO\\ndietary\\tO\\nglucose\\tO\\nand\\tO\\ngalactose\\tO\\nis\\tO\\nmediated\\tO\\nby\\tO\\nthe\\tO\\nSGLT1\\tO\\nNa\\tO\\n+\\tO\\n/\\tO\\nglucose\\tO\\ncotransporter\\tO\\nof\\tO\\nthe\\tO\\nbrush\\tO\\nborder\\tO\\n.\\tO\\n\\nAn\\tO\\nSGLT1\\tO\\nmissense\\tO\\nmutation\\tO\\nunderlies\\tO\\nhereditary\\tB-Disease\\nglucose\\tI-Disease\\n/\\tI-Disease\\ngalactose\\tI-Disease\\nmalabsorption\\tI-Disease\\n,\\tO\\ncharacterized\\tO\\nby\\tO\\npotentially\\tO\\nfatal\\tO\\ndiarrhea\\tB-Disease\\n;\\tO\\nconversely\\tO\\n,\\tO\\noral\\tO\\nrehydration\\tO\\ntherapy\\tO\\nexploits\\tO\\nnormal\\tO\\ntransport\\tO\\nto\\tO\\nalleviate\\tO\\nlife\\tO\\n-\\tO\\nthreatening\\tO\\ndiarrhea\\tB-Disease\\nof\\tO\\ninfectious\\tO\\norigin\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nmapped\\tO\\nthe\\tO\\nentire\\tO\\nhuman\\tO\\nSGLT1\\tO\\nNa\\tO\\n+\\tO\\n/\\tO\\nglucose\\tO\\ncotransporter\\tO\\ngene\\tO\\nfrom\\tO\\ncosmid\\tO\\nand\\tO\\nlambda\\tO\\nphage\\tO\\nclones\\tO\\nrepresenting\\tO\\na\\tO\\ngenomic\\tO\\nregion\\tO\\nof\\tO\\n112\\tO\\nkilobases\\tO\\n.\\tO\\n\\nTranscription\\tO\\ninitiation\\tO\\noccurred\\tO\\nfrom\\tO\\na\\tO\\nsite\\tO\\n27\\tO\\nbase\\tO\\npairs\\tO\\n3\\tO\\nof\\tO\\na\\tO\\nTATAA\\tO\\nsequence\\tO\\n.\\tO\\n\\nAll\\tO\\nexon\\tO\\n-\\tO\\nflanking\\tO\\nregions\\tO\\nwere\\tO\\nsequenced\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nentire\\tO\\n112\\tO\\n-\\tO\\nkilobase\\tO\\nregion\\tO\\nmapped\\tO\\nwith\\tO\\nfour\\tO\\nrestriction\\tO\\nenzymes\\tO\\n.\\tO\\n\\nSGLT1\\tO\\nis\\tO\\ncomprised\\tO\\nof\\tO\\n15\\tO\\nexons\\tO\\n(\\tO\\nspanning\\tO\\n72\\tO\\nkilobases\\tO\\n)\\tO\\n;\\tO\\na\\tO\\npossible\\tO\\nevolutionary\\tO\\norigin\\tO\\nfrom\\tO\\na\\tO\\nsix\\tO\\n-\\tO\\nmembrane\\tO\\n-\\tO\\nspan\\tO\\nancestral\\tO\\nprecursor\\tO\\nvia\\tO\\na\\tO\\ngene\\tO\\nduplication\\tO\\nevent\\tO\\nis\\tO\\nsuggested\\tO\\nfrom\\tO\\ncomparison\\tO\\nof\\tO\\nexons\\tO\\nagainst\\tO\\nprotein\\tO\\nsecondary\\tO\\nstructure\\tO\\nand\\tO\\nfrom\\tO\\nsequence\\tO\\nconsiderations\\tO\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n1\\tO\\ncausing\\tO\\nglucose\\tB-Disease\\n/\\tI-Disease\\ngalactose\\tI-Disease\\nmalabsorption\\tI-Disease\\nis\\tO\\nalso\\tO\\ndescribed\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nNa\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\n-\\tO\\ndependent\\tO\\ncotransporter\\tO\\ngene\\tO\\nstructure\\tO\\nreported\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nfacilitate\\tO\\nthe\\tO\\nsearch\\tO\\nfor\\tO\\nnew\\tO\\nglucose\\tB-Disease\\n/\\tI-Disease\\ngalactose\\tI-Disease\\nmalabsorption\\tI-Disease\\n-\\tO\\nrelated\\tO\\nmutations\\tO\\nin\\tO\\nthis\\tO\\nimportant\\tO\\ngene\\tO\\nand\\tO\\nprovide\\tO\\na\\tO\\nbasis\\tO\\nfor\\tO\\nfuture\\tO\\nevolutionary\\tO\\ncomparisons\\tO\\nwith\\tO\\nother\\tO\\nNa\\tO\\n(\\tO\\n+\\tO\\n)\\tO\\n-\\tO\\ndependent\\tO\\ncotransporters\\tO\\n.\\tO\\n.\\tO\\n\\nFour\\tO\\nnovel\\tO\\nPEPD\\tO\\nalleles\\tO\\ncausing\\tO\\nprolidase\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nat\\tO\\nthe\\tO\\nPEPD\\tO\\nlocus\\tO\\ncause\\tO\\nprolidase\\tB-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nMcKusick\\tO\\n170100\\tO\\n)\\tO\\n,\\tO\\na\\tO\\nrare\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\niminodipeptiduria\\tB-Disease\\n,\\tO\\nskin\\tB-Disease\\nulcers\\tI-Disease\\n,\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\nand\\tO\\nrecurrent\\tO\\ninfections\\tO\\n.\\tO\\n\\nFour\\tO\\nPEPD\\tO\\nmutations\\tO\\nfrom\\tO\\nfive\\tO\\nseverely\\tO\\naffected\\tO\\nindividuals\\tO\\nwere\\tO\\ncharacterized\\tO\\nby\\tO\\nanalysis\\tO\\nof\\tO\\nreverse\\tO\\n-\\tO\\ntranscribed\\tO\\n,\\tO\\nPCR\\tO\\n-\\tO\\namplified\\tO\\n(\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\n)\\tO\\ncDNA\\tO\\n.\\tO\\n\\nWe\\tO\\nused\\tO\\nSSCP\\tO\\nanalysis\\tO\\non\\tO\\nfour\\tO\\noverlapping\\tO\\ncDNA\\tO\\nfragments\\tO\\ncovering\\tO\\nthe\\tO\\nentire\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nPEPD\\tO\\ngene\\tO\\nand\\tO\\ndetected\\tO\\nabnormal\\tO\\nSSCP\\tO\\nbands\\tO\\nfor\\tO\\nthe\\tO\\nfragment\\tO\\nspanning\\tO\\nall\\tO\\nor\\tO\\npart\\tO\\nof\\tO\\nexons\\tO\\n13\\tO\\n-\\tO\\n15\\tO\\nin\\tO\\nthree\\tO\\nof\\tO\\nthe\\tO\\nprobands\\tO\\n.\\tO\\n\\nDirect\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\ncDNAs\\tO\\nshowed\\tO\\na\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n,\\tO\\n1342\\tO\\nsubstitution\\tO\\n(\\tO\\nG448R\\tO\\n)\\tO\\nin\\tO\\ntwo\\tO\\npatients\\tO\\nand\\tO\\na\\tO\\n3\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\n(\\tO\\ndelta\\tO\\nE452\\tO\\nor\\tO\\ndelta\\tO\\nE453\\tO\\n)\\tO\\nin\\tO\\nanother\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nother\\tO\\ntwo\\tO\\nprobands\\tO\\nthe\\tO\\namplified\\tO\\nproducts\\tO\\nwere\\tO\\nof\\tO\\nreduced\\tO\\nsize\\tO\\n.\\tO\\n\\nDirect\\tO\\nsequencing\\tO\\nof\\tO\\nthese\\tO\\nmutant\\tO\\ncDNAs\\tO\\nrevealed\\tO\\na\\tO\\ndeletion\\tO\\nof\\tO\\nexon\\tO\\n5\\tO\\nin\\tO\\none\\tO\\npatient\\tO\\nand\\tO\\nof\\tO\\nexon\\tO\\n7\\tO\\nin\\tO\\nthe\\tO\\nother\\tO\\n.\\tO\\n\\nIntronic\\tO\\nsequences\\tO\\nflanking\\tO\\nexons\\tO\\n5\\tO\\nand\\tO\\n7\\tO\\nwere\\tO\\nidentified\\tO\\nusing\\tO\\ninverse\\tO\\nPCR\\tO\\nfollowed\\tO\\nby\\tO\\ndirect\\tO\\nsequencing\\tO\\n.\\tO\\n\\nConventional\\tO\\nPCR\\tO\\nand\\tO\\ndirect\\tO\\nsequencing\\tO\\nthen\\tO\\nestablished\\tO\\nthe\\tO\\nintron\\tO\\n-\\tO\\nexon\\tO\\nborders\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\ngenomic\\tO\\nDNA\\tO\\nrevealing\\tO\\ntwo\\tO\\nsplice\\tO\\nacceptor\\tO\\nmutations\\tO\\na\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\nsubstitution\\tO\\nat\\tO\\nposition\\tO\\n-\\tO\\n1\\tO\\nof\\tO\\nintron\\tO\\n4\\tO\\nand\\tO\\nan\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\nsubstitution\\tO\\nat\\tO\\nposition\\tO\\n-\\tO\\n2\\tO\\nof\\tO\\nintron\\tO\\n6\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nsevere\\tO\\nform\\tO\\nof\\tO\\nprolidase\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmultiple\\tO\\nPEPD\\tO\\nalleles\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nreport\\tO\\nwe\\tO\\nattempt\\tO\\nto\\tO\\nbegin\\tO\\nthe\\tO\\nprocess\\tO\\nof\\tO\\ndescribing\\tO\\nthese\\tO\\nalleles\\tO\\nand\\tO\\ncataloging\\tO\\ntheir\\tO\\nphenotypic\\tO\\nexpression\\tO\\n.\\tO\\n.\\tO\\n\\nRecombinations\\tO\\nin\\tO\\nindividuals\\tO\\nhomozygous\\tO\\nby\\tO\\ndescent\\tO\\nlocalize\\tO\\nthe\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\nlocus\\tO\\nin\\tO\\na\\tO\\ncloned\\tO\\n450\\tO\\n-\\tO\\nkb\\tO\\ninterval\\tO\\n.\\tO\\n\\nThe\\tO\\nlocus\\tO\\nfor\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\n(\\tO\\nFRDA\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nsevere\\tO\\nneurodegenerative\\tB-Disease\\ndisease\\tI-Disease\\n,\\tO\\nis\\tO\\ntightly\\tO\\nlinked\\tO\\nto\\tO\\nmarkers\\tO\\nD9S5\\tO\\nand\\tO\\nD9S15\\tO\\n,\\tO\\nand\\tO\\nanalysis\\tO\\nof\\tO\\nrare\\tO\\nrecombination\\tO\\nevents\\tO\\nhas\\tO\\nsuggested\\tO\\nthe\\tO\\norder\\tO\\ncen\\tO\\n-\\tO\\nFRDA\\tO\\n-\\tO\\nD9S5\\tO\\n-\\tO\\nD9S15\\tO\\n-\\tO\\nqter\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthe\\tO\\nconstruction\\tO\\nof\\tO\\na\\tO\\nYAC\\tO\\ncontig\\tO\\nextending\\tO\\n800\\tO\\nkb\\tO\\ncentromeric\\tO\\nto\\tO\\nD9S5\\tO\\nand\\tO\\nthe\\tO\\nisolation\\tO\\nof\\tO\\nfive\\tO\\nnew\\tO\\nmicrosatellite\\tO\\nmarkers\\tO\\nfrom\\tO\\nthis\\tO\\nregion\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\nmap\\tO\\nthese\\tO\\nmarkers\\tO\\nwith\\tO\\nrespect\\tO\\nto\\tO\\nthe\\tO\\nFRDA\\tB-Disease\\nlocus\\tO\\n,\\tO\\nall\\tO\\nwithin\\tO\\na\\tO\\n1\\tO\\n-\\tO\\ncM\\tO\\nconfidence\\tO\\ninterval\\tO\\n,\\tO\\nwe\\tO\\nsought\\tO\\nto\\tO\\nincrease\\tO\\nthe\\tO\\ngenetic\\tO\\ninformation\\tO\\nof\\tO\\navailable\\tO\\nFRDA\\tB-Disease\\nfamilies\\tO\\nby\\tO\\nconsidering\\tO\\nhomozygosity\\tO\\nby\\tO\\ndescent\\tO\\nand\\tO\\nassociation\\tO\\nwith\\tO\\nfounder\\tO\\nhaplotypes\\tO\\nin\\tO\\nisolated\\tO\\npopulations\\tO\\n.\\tO\\n\\nThis\\tO\\napproach\\tO\\nallowed\\tO\\nus\\tO\\nto\\tO\\nidentify\\tO\\none\\tO\\nphase\\tO\\n-\\tO\\nknown\\tO\\nrecombination\\tO\\nand\\tO\\none\\tO\\nprobable\\tO\\nhistoric\\tO\\nrecombination\\tO\\non\\tO\\nhaplotypes\\tO\\nfrom\\tO\\nReunion\\tO\\nIsland\\tO\\npatients\\tO\\n,\\tO\\nboth\\tO\\nof\\tO\\nwhich\\tO\\nplace\\tO\\nthree\\tO\\nof\\tO\\nthe\\tO\\nfive\\tO\\nmarkers\\tO\\nproximal\\tO\\nto\\tO\\nFRDA\\tB-Disease\\n.\\tO\\n\\nThis\\tO\\nrepresents\\tO\\nthe\\tO\\nfirst\\tO\\nidentification\\tO\\nof\\tO\\nclose\\tO\\nFRDA\\tB-Disease\\nflanking\\tO\\nmarkers\\tO\\non\\tO\\nthe\\tO\\ncentromeric\\tO\\nside\\tO\\n.\\tO\\n\\nThe\\tO\\ntwo\\tO\\nother\\tO\\nmarkers\\tO\\nallowed\\tO\\nus\\tO\\nto\\tO\\nnarrow\\tO\\nthe\\tO\\nbreakpoint\\tO\\nof\\tO\\na\\tO\\npreviously\\tO\\nidentified\\tO\\ndistal\\tO\\nrecombination\\tO\\nthat\\tO\\nis\\tO\\n>\\tO\\n180\\tO\\nkb\\tO\\nfrom\\tO\\nD9S5\\tO\\n(\\tO\\n26P\\tO\\n)\\tO\\n.\\tO\\n\\nTaken\\tO\\ntogether\\tO\\n,\\tO\\nthe\\tO\\nresults\\tO\\nplace\\tO\\nthe\\tO\\nFRDA\\tB-Disease\\nlocus\\tO\\nin\\tO\\na\\tO\\n450\\tO\\n-\\tO\\nkb\\tO\\ninterval\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nsmall\\tO\\nenough\\tO\\nfor\\tO\\ndirect\\tO\\nsearch\\tO\\nof\\tO\\ncandidate\\tO\\ngenes\\tO\\n.\\tO\\n\\nA\\tO\\ndetailed\\tO\\nrare\\tO\\ncutter\\tO\\nrestriction\\tO\\nmap\\tO\\nand\\tO\\na\\tO\\ncosmid\\tO\\ncontig\\tO\\ncovering\\tO\\nthis\\tO\\ninterval\\tO\\nwere\\tO\\nconstructed\\tO\\nand\\tO\\nshould\\tO\\nfacilitate\\tO\\nthe\\tO\\nsearch\\tO\\nof\\tO\\ngenes\\tO\\nin\\tO\\nthis\\tO\\nregion\\tO\\n.\\tO\\n.\\tO\\n\\nInvestigation\\tO\\nof\\tO\\nthermoregulatory\\tO\\ncharacteristics\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nsurvey\\tO\\ninstrument\\tO\\nis\\tO\\nused\\tO\\nto\\tO\\nassess\\tO\\ntemperature\\tO\\nregulation\\tO\\ncharacteristics\\tO\\nin\\tO\\nchildren\\tO\\nwith\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\ncompared\\tO\\nto\\tO\\n3\\tO\\ncontrol\\tO\\ngroups\\tO\\nsibs\\tO\\nof\\tO\\nPWS\\tB-Disease\\npatients\\tO\\n(\\tO\\nSIB\\tO\\n)\\tO\\n,\\tO\\nneurodevelopmentally\\tB-Disease\\nhandicapped\\tI-Disease\\nchildren\\tO\\n(\\tO\\nND\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nage\\tO\\nand\\tO\\ngender\\tO\\nmatched\\tO\\nwell\\tO\\nchildren\\tO\\n(\\tO\\nWC\\tO\\n)\\tO\\n.\\tO\\n\\nSignificant\\tO\\ndifferences\\tO\\nwere\\tO\\nfound\\tO\\nbetween\\tO\\nPWS\\tB-Disease\\npatients\\tO\\n,\\tO\\nSIB\\tO\\ncontrols\\tO\\n,\\tO\\nand\\tO\\nWC\\tO\\ncontrols\\tO\\nin\\tO\\nthe\\tO\\nprevalence\\tO\\nof\\tO\\nfebrile\\tO\\nconvulsions\\tO\\n,\\tO\\nfever\\tO\\n-\\tO\\nassociated\\tO\\nsymptoms\\tO\\n,\\tO\\nand\\tO\\ntemperature\\tO\\nless\\tO\\nthan\\tO\\n94\\tO\\ndegrees\\tO\\nF\\tO\\n.\\tO\\n\\nNo\\tO\\ndifferences\\tO\\nwere\\tO\\nnoted\\tO\\nin\\tO\\nany\\tO\\nvariable\\tO\\nbetween\\tO\\nthe\\tO\\nPWS\\tB-Disease\\npatients\\tO\\nand\\tO\\nthe\\tO\\nND\\tO\\ncontrols\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthese\\tO\\nabnormalities\\tO\\nare\\tO\\nnot\\tO\\nunique\\tO\\nto\\tO\\nPWS\\tB-Disease\\n,\\tO\\nbut\\tO\\ncan\\tO\\noccur\\tO\\nin\\tO\\nany\\tO\\nneurodevelopmentally\\tB-Disease\\nhandicapped\\tI-Disease\\nindividual\\tO\\n,\\tO\\nfurther\\tO\\nsuggesting\\tO\\nthese\\tO\\ndo\\tO\\nnot\\tO\\nnecessarily\\tO\\nreflect\\tO\\nsyndrome\\tO\\n-\\tO\\nspecific\\tO\\nhypothalamic\\tB-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nPhenotypic\\tO\\nvariation\\tO\\nincluding\\tO\\nretinitis\\tB-Disease\\npigmentosa\\tI-Disease\\n,\\tO\\npattern\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nand\\tO\\nfundus\\tB-Disease\\nflavimaculatus\\tI-Disease\\nin\\tO\\na\\tO\\nsingle\\tO\\nfamily\\tO\\nwith\\tO\\na\\tO\\ndeletion\\tO\\nof\\tO\\ncodon\\tO\\n153\\tO\\nor\\tO\\n154\\tO\\nof\\tO\\nthe\\tO\\nperipherin\\tO\\n/\\tO\\nRDS\\tO\\ngene\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\nAND\\tO\\nOBJECTIVES\\tO\\nMutations\\tO\\nof\\tO\\nthe\\tO\\nperipherin\\tO\\n/\\tO\\nRDS\\tO\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nretinitis\\tI-Disease\\npigmentosa\\tI-Disease\\n,\\tO\\npattern\\tO\\nmacular\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nand\\tO\\nretinitis\\tB-Disease\\npunctata\\tI-Disease\\nalbescens\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nherein\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nthree\\tO\\nseparate\\tO\\nphenotypes\\tO\\nwithin\\tO\\na\\tO\\nsingle\\tO\\nfamily\\tO\\nwith\\tO\\na\\tO\\nnovel\\tO\\n3\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\nof\\tO\\ncodon\\tO\\n153\\tO\\nor\\tO\\n154\\tO\\nof\\tO\\nthe\\tO\\nperipherin\\tO\\n/\\tO\\nRDS\\tO\\ngene\\tO\\n.\\tO\\n\\nDESIGN\\tO\\nCase\\tO\\nreports\\tO\\nwith\\tO\\nclinical\\tO\\nfeatures\\tO\\n,\\tO\\nfluorescein\\tO\\nangiography\\tO\\n,\\tO\\nkinetic\\tO\\nperimetry\\tO\\n,\\tO\\nelectrophysiological\\tO\\nstudies\\tO\\n,\\tO\\nand\\tO\\nmolecular\\tO\\ngenetics\\tO\\n.\\tO\\n\\nSETTING\\tO\\nUniversity\\tO\\nmedical\\tO\\ncenters\\tO\\n.\\tO\\n\\nPATIENTS\\tO\\nA\\tO\\n75\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nwoman\\tO\\n,\\tO\\nher\\tO\\ntwo\\tO\\ndaughters\\tO\\n(\\tO\\naged\\tO\\n44\\tO\\nand\\tO\\n50\\tO\\nyears\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nher\\tO\\n49\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nson\\tO\\nwere\\tO\\nscreened\\tO\\nfor\\tO\\nperipherin\\tO\\n/\\tO\\nRDS\\tO\\nmutations\\tO\\nbecause\\tO\\nof\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nmultiple\\tO\\nphenotypes\\tO\\nwithin\\tO\\nthe\\tO\\nsame\\tO\\nfamily\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nThe\\tO\\nmother\\tO\\npresented\\tO\\nat\\tO\\nage\\tO\\n63\\tO\\nyears\\tO\\nwith\\tO\\na\\tO\\nprofoundly\\tO\\nabnormal\\tO\\nelectroretinogram\\tO\\n(\\tO\\nERG\\tO\\n)\\tO\\nand\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\nretinitis\\tB-Disease\\npigmentosa\\tI-Disease\\nthat\\tO\\nprogressed\\tO\\ndramatically\\tO\\nover\\tO\\n12\\tO\\nyears\\tO\\n,\\tO\\nwith\\tO\\nmarked\\tO\\nloss\\tO\\nof\\tO\\nperipheral\\tO\\nvisual\\tO\\nfield\\tO\\n.\\tO\\n\\nOne\\tO\\ndaughter\\tO\\ndeveloped\\tO\\npattern\\tB-Disease\\nmacular\\tI-Disease\\ndystrophy\\tI-Disease\\nat\\tO\\nage\\tO\\n31\\tO\\nyears\\tO\\n.\\tO\\n\\nAt\\tO\\nage\\tO\\n44\\tO\\nyears\\tO\\n,\\tO\\nher\\tO\\nERG\\tO\\nwas\\tO\\nmoderately\\tO\\nabnormal\\tO\\nbut\\tO\\nher\\tO\\nclinical\\tO\\ndisease\\tO\\nwas\\tO\\nlimited\\tO\\nto\\tO\\nthe\\tO\\nmacula\\tO\\n.\\tO\\n\\nAnother\\tO\\ndaughter\\tO\\npresented\\tO\\nat\\tO\\nage\\tO\\n42\\tO\\nyears\\tO\\nwith\\tO\\nmacular\\tB-Disease\\ndegeneration\\tI-Disease\\nand\\tO\\nover\\tO\\n10\\tO\\nyears\\tO\\ndeveloped\\tO\\nthe\\tO\\nclinical\\tO\\npicture\\tO\\nof\\tO\\nfundus\\tB-Disease\\nflavimaculatus\\tI-Disease\\n.\\tO\\n\\nHer\\tO\\nperipheral\\tO\\nvisual\\tO\\nfield\\tO\\nwas\\tO\\npreserved\\tO\\nbut\\tO\\nher\\tO\\nERG\\tO\\nwas\\tO\\nmoderately\\tO\\nabnormal\\tO\\n.\\tO\\n\\nThe\\tO\\nson\\tO\\nhad\\tO\\nonset\\tO\\nof\\tO\\nmacular\\tB-Disease\\ndegeneration\\tI-Disease\\nat\\tO\\nage\\tO\\n44\\tO\\nyears\\tO\\n.\\tO\\n\\nPericentral\\tB-Disease\\nscotomas\\tI-Disease\\nwere\\tO\\npresent\\tO\\nand\\tO\\nthe\\tO\\nERG\\tO\\nwas\\tO\\nmarkedly\\tO\\nabnormal\\tO\\n.\\tO\\n\\nFluorescein\\tO\\nangiography\\tO\\nrevealed\\tO\\npunctate\\tO\\npigment\\tO\\nepithelial\\tO\\ntransmission\\tO\\ndefects\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nA\\tO\\n3\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\nof\\tO\\ncodon\\tO\\n153\\tO\\nor\\tO\\n154\\tO\\nof\\tO\\nthe\\tO\\nperipherin\\tO\\n/\\tO\\nRDS\\tO\\ngene\\tO\\ncan\\tO\\nproduce\\tO\\nclinically\\tO\\ndisparate\\tO\\nphenotypes\\tO\\neven\\tO\\nwithin\\tO\\nthe\\tO\\nsame\\tO\\nfamily\\tO\\n.\\tO\\n.\\tO\\n\\nAssignment\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nNa\\tO\\n+\\tO\\n/\\tO\\nglucose\\tO\\ncotransporter\\tO\\ngene\\tO\\nSGLT1\\tO\\nto\\tO\\nchromosome\\tO\\n22q13\\tO\\n.\\tO\\n1\\tO\\n.\\tO\\n\\nThe\\tO\\nNa\\tO\\n+\\tO\\n/\\tO\\nglucose\\tO\\ncotransporter\\tO\\ngene\\tO\\nSGLT1\\tO\\nencodes\\tO\\nthe\\tO\\nprimary\\tO\\ncarrier\\tO\\nprotein\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nuptake\\tO\\nof\\tO\\nthe\\tO\\ndietary\\tO\\nsugars\\tO\\nglucose\\tO\\nand\\tO\\ngalactose\\tO\\nfrom\\tO\\nthe\\tO\\nintestinal\\tO\\nlumen\\tO\\n.\\tO\\n\\nSGLT1\\tO\\ntransport\\tO\\nactivity\\tO\\nis\\tO\\ncurrently\\tO\\nexploited\\tO\\nin\\tO\\noral\\tO\\nrehydration\\tO\\ntherapy\\tO\\n.\\tO\\n\\nThe\\tO\\n75\\tO\\n-\\tO\\nkDa\\tO\\nglycoprotein\\tO\\nis\\tO\\nlocalized\\tO\\nin\\tO\\nthe\\tO\\nbrush\\tO\\nborder\\tO\\nof\\tO\\nthe\\tO\\nintestinal\\tO\\nepithelium\\tO\\nand\\tO\\nis\\tO\\npredicted\\tO\\nto\\tO\\ncomprise\\tO\\n12\\tO\\nmembrane\\tO\\nspans\\tO\\n.\\tO\\n\\nIn\\tO\\ntwo\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisease\\tI-Disease\\nglucose\\tI-Disease\\n/\\tI-Disease\\ngalactose\\tI-Disease\\nmalabsorption\\tI-Disease\\n,\\tO\\nthe\\tO\\nunderlying\\tO\\ncause\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nSGLT1\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nAsp28\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nAsn\\tO\\nchange\\tO\\nwas\\tO\\ndemonstrated\\tO\\nin\\tO\\nvitro\\tO\\nto\\tO\\neliminate\\tO\\nSGLT1\\tO\\ntransport\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\nSGLT1\\tO\\ngene\\tO\\nwas\\tO\\npreviously\\tO\\nshown\\tO\\nto\\tO\\nreside\\tO\\non\\tO\\nthe\\tO\\ndistal\\tO\\nq\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n22\\tO\\n(\\tO\\n11\\tO\\n.\\tO\\n2\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nqter\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nused\\tO\\na\\tO\\ncosmid\\tO\\nprobe\\tO\\nfor\\tO\\nfluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n,\\tO\\nwhich\\tO\\nrefines\\tO\\nthe\\tO\\nlocalization\\tO\\nto\\tO\\n22q13\\tO\\n.\\tO\\n\\n1\\tO\\n,\\tO\\nand\\tO\\nprovide\\tO\\nan\\tO\\nexample\\tO\\nof\\tO\\nthe\\tO\\nutility\\tO\\nof\\tO\\nthe\\tO\\nSGLT1\\tO\\nprobe\\tO\\nas\\tO\\na\\tO\\ndiagnostic\\tO\\nfor\\tO\\ngenetic\\tB-Disease\\ndiseases\\tI-Disease\\nassociated\\tO\\nwith\\tO\\ntranslocations\\tO\\nof\\tO\\nchromosome\\tO\\n22\\tO\\n.\\tO\\n\\nRestriction\\tO\\nof\\tO\\nocular\\tO\\nfundus\\tO\\nlesions\\tO\\nto\\tO\\na\\tO\\nspecific\\tO\\nsubgroup\\tO\\nof\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\nin\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\nhumans\\tO\\n,\\tO\\nalteration\\tO\\nof\\tO\\nthe\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n,\\tO\\nAPC\\tB-Disease\\n,\\tO\\ncauses\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n,\\tO\\na\\tO\\ncondition\\tO\\ncausing\\tO\\npredisposition\\tO\\nto\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nsyndrome\\tO\\ninconsistently\\tO\\nassociates\\tO\\ncharacteristic\\tO\\npatches\\tO\\nof\\tO\\ncongenital\\tB-Disease\\nhypertrophy\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nretinal\\tI-Disease\\npigment\\tI-Disease\\nepithelium\\tI-Disease\\n(\\tO\\nCHRPE\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nOcular\\tO\\nexamination\\tO\\nrevealed\\tO\\nthat\\tO\\npatients\\tO\\nexpressing\\tO\\nCHRPE\\tB-Disease\\ntend\\tO\\nto\\tO\\ncluster\\tO\\nwithin\\tO\\nspecific\\tO\\nfamilies\\tO\\n.\\tO\\n\\nThe\\tO\\nexact\\tO\\nAPC\\tB-Disease\\nmutation\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\n42\\tO\\nunrelated\\tO\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\nall\\tO\\ncases\\tO\\nthese\\tO\\nmutations\\tO\\nwere\\tO\\npredicted\\tO\\nto\\tO\\nlead\\tO\\nto\\tO\\nthe\\tO\\nsynthesis\\tO\\nof\\tO\\na\\tO\\ntruncated\\tO\\nprotein\\tO\\n.\\tO\\n\\nThe\\tO\\nextent\\tO\\nof\\tO\\nCHRPE\\tB-Disease\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ndependent\\tO\\non\\tO\\nthe\\tO\\nposition\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\nalong\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\n.\\tO\\n\\nCHRPE\\tB-Disease\\nlesions\\tO\\nare\\tO\\nalmost\\tO\\nalways\\tO\\nabsent\\tO\\nif\\tO\\nthe\\tO\\nmutation\\tO\\noccurs\\tO\\nbefore\\tO\\nexon\\tO\\n9\\tO\\n,\\tO\\nbut\\tO\\nare\\tO\\nsystematically\\tO\\npresent\\tO\\nif\\tO\\nit\\tO\\noccurs\\tO\\nafter\\tO\\nthis\\tO\\nexon\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\nrange\\tO\\nof\\tO\\nphenotypic\\tO\\nexpression\\tO\\nobserved\\tO\\namong\\tO\\naffected\\tO\\npatients\\tO\\nmay\\tO\\nresult\\tO\\nin\\tO\\npart\\tO\\nfrom\\tO\\ndifferent\\tO\\nallelic\\tO\\nmanifestations\\tO\\nof\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\neffects\\tO\\nof\\tO\\ndystrophin\\tO\\ngene\\tO\\nmutations\\tO\\non\\tO\\nthe\\tO\\nERG\\tO\\nin\\tO\\nmice\\tO\\nand\\tO\\nhumans\\tO\\n.\\tO\\n\\nPURPOSE\\tO\\n.\\tO\\n\\nThe\\tO\\nauthors\\tO\\nearlier\\tO\\nfindings\\tO\\nof\\tO\\na\\tO\\nnegative\\tO\\nelectroretinogram\\tO\\n(\\tO\\nERG\\tO\\n)\\tO\\nin\\tO\\na\\tO\\nboy\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\nled\\tO\\nthem\\tO\\nto\\tO\\ninvestigate\\tO\\ndystrophin\\tO\\ngene\\tO\\ndeletions\\tO\\nand\\tO\\nERGs\\tO\\nin\\tO\\nfive\\tO\\nboys\\tO\\nwith\\tO\\nDMD\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nauthors\\tO\\nwanted\\tO\\nto\\tO\\ndetermined\\tO\\nwhether\\tO\\nthere\\tO\\nwere\\tO\\nsimilar\\tO\\nERG\\tO\\nfindings\\tO\\nin\\tO\\nan\\tO\\nanimal\\tO\\nmodel\\tO\\nfor\\tO\\nDMD\\tB-Disease\\n,\\tO\\nthe\\tO\\nmdx\\tO\\nmouse\\tO\\n.\\tO\\n\\nMETHODS\\tO\\n.\\tO\\n\\nGanzfeld\\tO\\nERGs\\tO\\nwere\\tO\\nrecorded\\tO\\nin\\tO\\nfive\\tO\\nboys\\tO\\nwith\\tO\\nDMD\\tB-Disease\\nafter\\tO\\na\\tO\\ncomplete\\tO\\nophthalmic\\tO\\nexamination\\tO\\n.\\tO\\n\\nThe\\tO\\ndystrophin\\tO\\ngene\\tO\\nwas\\tO\\nanalyzed\\tO\\nby\\tO\\nSouthern\\tO\\nblot\\tO\\nhybridization\\tO\\n.\\tO\\n\\nERGs\\tO\\nwere\\tO\\nrecorded\\tO\\nin\\tO\\nanesthetized\\tO\\nmdx\\tO\\nand\\tO\\ncontrol\\tO\\nmice\\tO\\nwith\\tO\\na\\tO\\nmodified\\tO\\nGrass\\tO\\nphotostimulator\\tO\\n(\\tO\\nGrass\\tO\\nInstrument\\tO\\nCompany\\tO\\n,\\tO\\nQuincy\\tO\\n,\\tO\\nMA\\tO\\n)\\tO\\n.\\tO\\n\\nRESULTS\\tO\\n.\\tO\\n\\nOphthalmic\\tO\\nexaminations\\tO\\nin\\tO\\nall\\tO\\nfive\\tO\\nboys\\tO\\nhad\\tO\\nnormal\\tO\\nfindings\\tO\\n,\\tO\\nyet\\tO\\nan\\tO\\nabnormal\\tO\\nnegative\\tO\\nERG\\tO\\nwas\\tO\\nrecorded\\tO\\nfor\\tO\\neach\\tO\\nsubject\\tO\\n.\\tO\\n\\nThe\\tO\\nsubjects\\tO\\ngene\\tO\\ndeletions\\tO\\nwere\\tO\\nvariable\\tO\\n,\\tO\\nranging\\tO\\nfrom\\tO\\nlarge\\tO\\ndeletions\\tO\\nto\\tO\\nno\\tO\\ndetectable\\tO\\ndeletions\\tO\\n.\\tO\\n\\nThe\\tO\\nERGs\\tO\\nof\\tO\\nthe\\tO\\nmdx\\tO\\nmice\\tO\\nwere\\tO\\nnormal\\tO\\nand\\tO\\ndid\\tO\\nnot\\tO\\ndiffer\\tO\\nsignificantly\\tO\\nfrom\\tO\\nthose\\tO\\nof\\tO\\nthe\\tO\\ncontrol\\tO\\nmice\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\n.\\tO\\n\\nThe\\tO\\nauthors\\tO\\nbelieve\\tO\\nthe\\tO\\nunique\\tO\\nERG\\tO\\nrecorded\\tO\\nfor\\tO\\nthe\\tO\\nhuman\\tO\\nsubjects\\tO\\nis\\tO\\na\\tO\\nmanifestation\\tO\\nof\\tO\\nDMD\\tB-Disease\\nassociated\\tO\\nwith\\tO\\ndefects\\tO\\nat\\tO\\nthe\\tO\\ndystrophin\\tO\\ngene\\tO\\nlocus\\tO\\nand\\tO\\nrepresents\\tO\\na\\tO\\nnew\\tO\\nclinical\\tO\\nentity\\tO\\n.\\tO\\n\\nThe\\tO\\nERG\\tO\\nof\\tO\\nthe\\tO\\nmdx\\tO\\nmouse\\tO\\nmay\\tO\\nbe\\tO\\nspared\\tO\\nfor\\tO\\nseveral\\tO\\nreasons\\tO\\n,\\tO\\nincluding\\tO\\nmilder\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\ngene\\tO\\ndefect\\tO\\n,\\tO\\ndifferences\\tO\\nin\\tO\\nmuscle\\tO\\nand\\tO\\nretinal\\tO\\ngene\\tO\\nproduct\\tO\\n,\\tO\\nor\\tO\\nspecies\\tO\\ndifferences\\tO\\nin\\tO\\nthe\\tO\\nbiochemical\\tO\\nrole\\tO\\nof\\tO\\ndystrophin\\tO\\n.\\tO\\n\\nThe\\tO\\nERG\\tO\\nshows\\tO\\npromise\\tO\\nof\\tO\\nbecoming\\tO\\na\\tO\\nnoninvasive\\tO\\ndiagnostic\\tO\\ntool\\tO\\nfor\\tO\\nDMD\\tB-Disease\\nand\\tO\\nits\\tO\\nmilder\\tO\\nallelic\\tO\\nforms\\tO\\n.\\tO\\n.\\tO\\n\\nAssociation\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ntumor\\tI-Disease\\nsuppressor\\tO\\nprotein\\tO\\nwith\\tO\\ncatenins\\tO\\n.\\tO\\n\\nMutations\\tO\\nof\\tO\\nAPC\\tO\\nappear\\tO\\nto\\tO\\ninitiate\\tO\\nsporadic\\tO\\nand\\tO\\ninherited\\tO\\nforms\\tO\\nof\\tO\\nhuman\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nAlthough\\tO\\nthese\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nwell\\tO\\ncharacterized\\tO\\n,\\tO\\nlittle\\tO\\nis\\tO\\nknown\\tO\\nabout\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nproduct\\tO\\n.\\tO\\n\\nTwo\\tO\\ncellular\\tO\\nproteins\\tO\\nthat\\tO\\nassociate\\tO\\nwith\\tO\\nAPC\\tB-Disease\\nwere\\tO\\nidentified\\tO\\nby\\tO\\nnucleotide\\tO\\nsequence\\tO\\nanalysis\\tO\\nand\\tO\\npeptide\\tO\\nmapping\\tO\\nas\\tO\\nthe\\tO\\nE\\tO\\n-\\tO\\ncadherin\\tO\\n-\\tO\\nassociated\\tO\\nproteins\\tO\\nalpha\\tO\\n-\\tO\\nand\\tO\\nbeta\\tO\\n-\\tO\\ncatenin\\tO\\n.\\tO\\n\\nA\\tO\\n27\\tO\\n-\\tO\\nresidue\\tO\\nfragment\\tO\\nof\\tO\\nAPC\\tO\\ncontaining\\tO\\na\\tO\\n15\\tO\\n-\\tO\\namino\\tO\\nacid\\tO\\nrepeat\\tO\\nwas\\tO\\nsufficient\\tO\\nfor\\tO\\nthe\\tO\\ninteraction\\tO\\nwith\\tO\\nthe\\tO\\ncatenins\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nan\\tO\\nimportant\\tO\\nlink\\tO\\nbetween\\tO\\ntumor\\tB-Disease\\ninitiation\\tO\\nand\\tO\\ncell\\tO\\nadhesion\\tO\\n.\\tO\\n.\\tO\\n\\nDifference\\tO\\nin\\tO\\nmethylation\\tO\\npatterns\\tO\\nwithin\\tO\\nthe\\tO\\nD15S9\\tO\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n15q11\\tO\\n-\\tO\\n13\\tO\\nin\\tO\\nfirst\\tO\\ncousins\\tO\\nwith\\tO\\nAngelman\\tB-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nAbnormalities\\tO\\nof\\tO\\nchromosome\\tO\\nregion\\tO\\n15q11\\tO\\n-\\tO\\n13\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nAngelman\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nAS\\tB-Disease\\n)\\tO\\nand\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nDifferences\\tO\\nbetween\\tO\\nthe\\tO\\nmethylation\\tO\\npatterns\\tO\\nof\\tO\\nthe\\tO\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n15q11\\tO\\n-\\tO\\n13\\tO\\nwhich\\tO\\nhybridizes\\tO\\nto\\tO\\nthe\\tO\\nhighly\\tO\\nconserved\\tO\\nDNA\\tO\\n,\\tO\\nDN34\\tO\\n,\\tO\\nin\\tO\\nnormal\\tO\\nindividuals\\tO\\nand\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nAS\\tB-Disease\\nand\\tO\\nPWS\\tB-Disease\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\na\\tO\\nfamily\\tO\\nin\\tO\\nwhich\\tO\\nfirst\\tO\\ncousins\\tO\\nare\\tO\\naffected\\tO\\nby\\tO\\nAS\\tB-Disease\\nand\\tO\\nPWS\\tB-Disease\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\na\\tO\\nfamilial\\tO\\nparacentric\\tO\\ninversion\\tO\\nof\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nof\\tO\\nthe\\tO\\nstudies\\tO\\non\\tO\\nthis\\tO\\nfamily\\tO\\ndemonstrate\\tO\\nthe\\tO\\ndifferences\\tO\\nin\\tO\\nthe\\tO\\nmethylation\\tO\\npatterns\\tO\\nin\\tO\\nthe\\tO\\n2\\tO\\nconditions\\tO\\nand\\tO\\nthe\\tO\\nphenomenon\\tO\\nof\\tO\\ngenomic\\tO\\nimprinting\\tO\\n,\\tO\\nwhereby\\tO\\ngenetic\\tO\\ninformation\\tO\\nis\\tO\\nexpressed\\tO\\ndifferently\\tO\\ndependent\\tO\\non\\tO\\nthe\\tO\\nparent\\tO\\nof\\tO\\norigin\\tO\\n.\\tO\\n.\\tO\\n\\nHaplotype\\tO\\nstudies\\tO\\nin\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\n51\\tO\\nfamilies\\tO\\nwith\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n,\\tO\\nwe\\tO\\nhave\\tO\\nstudied\\tO\\nDNA\\tO\\nhaplotypes\\tO\\nof\\tO\\ndinucleotide\\tO\\nrepeat\\tO\\npolymorphisms\\tO\\n(\\tO\\nCA\\tO\\nrepeats\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\n13q14\\tO\\n.\\tO\\n\\n3\\tO\\nregion\\tO\\n,\\tO\\nto\\tO\\nexamine\\tO\\nthese\\tO\\nmarkers\\tO\\nfor\\tO\\nassociation\\tO\\nwith\\tO\\nthe\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\n(\\tO\\nWND\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\nto\\tO\\na\\tO\\nmarker\\tO\\n(\\tO\\nD13S133\\tO\\n)\\tO\\ndescribed\\tO\\nelsewhere\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ndeveloped\\tO\\nthree\\tO\\nnew\\tO\\nhighly\\tO\\npolymorphic\\tO\\nmarkers\\tO\\n(\\tO\\nD13S314\\tO\\n,\\tO\\nD13S315\\tO\\n,\\tO\\nand\\tO\\nD13S316\\tO\\n)\\tO\\nclose\\tO\\nto\\tO\\nthe\\tO\\nWND\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexamined\\tO\\nthe\\tO\\ndistribution\\tO\\nof\\tO\\nmarker\\tO\\nalleles\\tO\\nat\\tO\\nthe\\tO\\nloci\\tO\\nstudied\\tO\\nand\\tO\\nhave\\tO\\nfound\\tO\\nthat\\tO\\nD13S314\\tO\\n,\\tO\\nD13S133\\tO\\n,\\tO\\nand\\tO\\nD13S316\\tO\\neach\\tO\\nshow\\tO\\nnonrandom\\tO\\ndistribution\\tO\\non\\tO\\nchromosomes\\tO\\ncarrying\\tO\\nthe\\tO\\nWND\\tB-Disease\\nmutation\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nstudied\\tO\\nhaplotypes\\tO\\nof\\tO\\nthese\\tO\\nthree\\tO\\nmarkers\\tO\\nand\\tO\\nhave\\tO\\nfound\\tO\\nthat\\tO\\nthere\\tO\\nare\\tO\\nhighly\\tO\\nsignificant\\tO\\ndifferences\\tO\\nbetween\\tO\\nWND\\tB-Disease\\nand\\tO\\nnormal\\tO\\nhaplotypes\\tO\\nin\\tO\\nnorthern\\tO\\nEuropean\\tO\\nfamilies\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nhave\\tO\\nimportant\\tO\\nimplications\\tO\\nfor\\tO\\nmutation\\tO\\ndetection\\tO\\nand\\tO\\nmolecular\\tO\\ndiagnosis\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nGenetic\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\nregion\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nbreast\\tO\\n/\\tO\\novarian\\tO\\nfamily\\tO\\n:\\tO\\nrefinement\\tO\\nof\\tO\\nthe\\tO\\nminimal\\tO\\nregion\\tO\\ncontaining\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nanalyzed\\tO\\na\\tO\\nsingle\\tO\\nmulti\\tO\\n-\\tO\\naffected\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\npedigree\\tO\\n(\\tO\\nBOV3\\tO\\n)\\tO\\nand\\tO\\nhave\\tO\\nshown\\tO\\nconsistent\\tO\\ninheritance\\tO\\nof\\tO\\nmarkers\\tO\\non\\tO\\nchromosome\\tO\\n17q\\tO\\nwith\\tO\\nthe\\tO\\ndisease\\tO\\nconfirming\\tO\\nthat\\tO\\nthis\\tO\\nfamily\\tO\\nis\\tO\\ndue\\tO\\nto\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\n17q\\tO\\nhaplotypes\\tO\\nshows\\tO\\na\\tO\\nrecombination\\tO\\nevent\\tO\\nin\\tO\\na\\tO\\nbilateral\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\ncase\\tO\\nwhich\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nlies\\tO\\ndistal\\tO\\nto\\tO\\nD17S857\\tO\\n;\\tO\\nD17S857\\tO\\nis\\tO\\nthus\\tO\\nthe\\tO\\nnew\\tO\\nproximal\\tO\\nboundary\\tO\\nfor\\tO\\nthe\\tO\\nregion\\tO\\ncontaining\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nCombining\\tO\\nthis\\tO\\ninformation\\tO\\nwith\\tO\\npreviously\\tO\\npublished\\tO\\nmapping\\tO\\ninformation\\tO\\nsuggests\\tO\\nthat\\tO\\nBRCA1\\tO\\nis\\tO\\ncontained\\tO\\nin\\tO\\na\\tO\\nregion\\tO\\nestimated\\tO\\nat\\tO\\n1\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n\\n5\\tO\\nMb\\tO\\nin\\tO\\nlength\\tO\\n.\\tO\\n\\nAll\\tO\\nseven\\tO\\nbreast\\tB-Disease\\ntumour\\tI-Disease\\n/\\tO\\nblood\\tO\\npairs\\tO\\nexamined\\tO\\nfrom\\tO\\nthis\\tO\\nfamily\\tO\\nshow\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\nin\\tO\\nthe\\tO\\ntumours\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nallel\\tO\\nretained\\tO\\nin\\tO\\neach\\tO\\ntumour\\tB-Disease\\nwas\\tO\\nfrom\\tO\\nthe\\tO\\ndisease\\tO\\n-\\tO\\nbearing\\tO\\nchromosome\\tO\\nimplicating\\tO\\nBRCA1\\tO\\nas\\tO\\na\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nsequenced\\tO\\nthe\\tO\\n17\\tO\\nbeta\\tO\\n-\\tO\\noestradiol\\tO\\ndehydrogenase\\tO\\ngenes\\tO\\n(\\tO\\nEDH17B1\\tO\\nand\\tO\\nEDH17B2\\tO\\n)\\tO\\nwhich\\tO\\nhave\\tO\\nbeen\\tO\\nsuggested\\tO\\nas\\tO\\ncandidate\\tO\\ngenes\\tO\\nfor\\tO\\nBRCA1\\tO\\nin\\tO\\nfour\\tO\\nmembers\\tO\\nof\\tO\\nthis\\tO\\nfamily\\tO\\n.\\tO\\n\\nNo\\tO\\ngermline\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nkinase\\tO\\nis\\tO\\na\\tO\\ncomponent\\tO\\nof\\tO\\nneuromuscular\\tO\\njunctions\\tO\\n.\\tO\\n\\nThe\\tO\\nclinical\\tO\\nmanifestation\\tO\\nof\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\ncorrelated\\tO\\nto\\tO\\nthe\\tO\\nextent\\tO\\nof\\tO\\nexpansion\\tO\\nof\\tO\\nan\\tO\\nunstable\\tO\\n[\\tO\\nCTG\\tO\\n]\\tO\\nn\\tO\\nDNA\\tO\\nmotif\\tO\\n.\\tO\\n\\nRecent\\tO\\nstudies\\tO\\nhave\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthis\\tO\\ntrinucleotide\\tO\\nmotif\\tO\\nforms\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nlast\\tO\\n,\\tO\\n3\\tO\\nuntranslated\\tO\\nexon\\tO\\nof\\tO\\na\\tO\\ngene\\tO\\nwhich\\tO\\npotentially\\tO\\nencodes\\tO\\nmultiple\\tO\\nprotein\\tO\\nisoforms\\tO\\nof\\tO\\na\\tO\\nserine\\tO\\n/\\tO\\nthreonine\\tO\\nprotein\\tO\\nkinase\\tO\\n(\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nprotein\\tO\\nkinase\\tO\\n,\\tO\\nDM\\tO\\n-\\tO\\nPK\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\non\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nantisera\\tO\\nagainst\\tO\\nsynthetic\\tO\\nDM\\tO\\n-\\tO\\nPK\\tO\\npeptide\\tO\\nantigens\\tO\\nand\\tO\\ntheir\\tO\\nuse\\tO\\nin\\tO\\nbiochemical\\tO\\nand\\tO\\nhistochemical\\tO\\nstudies\\tO\\n.\\tO\\n\\nImmunoreactive\\tO\\nDM\\tO\\n-\\tO\\nkinase\\tO\\nprotein\\tO\\nof\\tO\\n53\\tO\\nkD\\tO\\nis\\tO\\npresent\\tO\\nat\\tO\\nlow\\tO\\nlevels\\tO\\nin\\tO\\nskeletal\\tO\\nand\\tO\\ncardiac\\tO\\nmuscle\\tO\\nextracts\\tO\\nof\\tO\\nDM\\tB-Disease\\npatients\\tO\\nand\\tO\\nnormal\\tO\\ncontrols\\tO\\n.\\tO\\n\\nImmunohistochemical\\tO\\nstaining\\tO\\nrevealed\\tO\\nthat\\tO\\nDM\\tO\\n-\\tO\\nPK\\tO\\nis\\tO\\nlocalised\\tO\\nprominently\\tO\\nat\\tO\\nsites\\tO\\nof\\tO\\nneuromuscular\\tO\\nand\\tO\\nmyotendinous\\tO\\njunctions\\tO\\n(\\tO\\nNMJs\\tO\\nand\\tO\\nMTJs\\tO\\n)\\tO\\nof\\tO\\nhuman\\tO\\nand\\tO\\nrodent\\tO\\nskeletal\\tO\\nmuscles\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nvery\\tO\\nlow\\tO\\nlevels\\tO\\nof\\tO\\nimmunoreactive\\tO\\nDM\\tO\\n-\\tO\\nPK\\tO\\nprotein\\tO\\nare\\tO\\npresent\\tO\\nin\\tO\\nthe\\tO\\nsarcoplasm\\tO\\nof\\tO\\npredominantly\\tO\\ntype\\tO\\nI\\tO\\nfibres\\tO\\nin\\tO\\nvarious\\tO\\nmuscles\\tO\\n.\\tO\\n\\nStrikingly\\tO\\n,\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\ncan\\tO\\nalso\\tO\\nbe\\tO\\ndemonstrated\\tO\\nfor\\tO\\nNMJs\\tO\\nof\\tO\\nmuscular\\tO\\ntissues\\tO\\nof\\tO\\nadult\\tO\\nand\\tO\\ncongenital\\tO\\ncases\\tO\\nof\\tO\\nDM\\tB-Disease\\n,\\tO\\nwith\\tO\\nno\\tO\\ngross\\tO\\nchanges\\tO\\nin\\tO\\nstructural\\tO\\norganisation\\tO\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nprovide\\tO\\na\\tO\\nbasis\\tO\\nfor\\tO\\nfurther\\tO\\ncharacterisation\\tO\\nof\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nthe\\tO\\nkinase\\tO\\nin\\tO\\nprotein\\tO\\nassembly\\tO\\nprocesses\\tO\\nor\\tO\\nsignal\\tO\\nmediation\\tO\\nat\\tO\\nsynaptic\\tO\\nsites\\tO\\nand\\tO\\nultimately\\tO\\nfor\\tO\\nthe\\tO\\nunderstanding\\tO\\nof\\tO\\nthe\\tO\\ncomplex\\tO\\npathophysiology\\tO\\nof\\tO\\nDM\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nMarkedly\\tO\\naccelerated\\tO\\ncatabolism\\tO\\nof\\tO\\napolipoprotein\\tO\\nA\\tO\\n-\\tO\\nII\\tO\\n(\\tO\\nApoA\\tO\\n-\\tO\\nII\\tO\\n)\\tO\\nand\\tO\\nhigh\\tO\\ndensity\\tO\\nlipoproteins\\tO\\ncontaining\\tO\\nApoA\\tO\\n-\\tO\\nII\\tO\\nin\\tO\\nclassic\\tO\\nlecithin\\tO\\n:\\tO\\ncholesterol\\tB-Disease\\nacyltransferase\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nfish\\tB-Disease\\n-\\tI-Disease\\neye\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nClassic\\tB-Disease\\n(\\tI-Disease\\ncomplete\\tI-Disease\\n)\\tI-Disease\\nlecithin\\tI-Disease\\ncholesterol\\tI-Disease\\nacyltransferase\\tI-Disease\\n(\\tI-Disease\\nLCAT\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nFish\\tB-Disease\\n-\\tI-Disease\\neye\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\npartial\\tB-Disease\\nLCAT\\tI-Disease\\ndeficiency\\tI-Disease\\n)\\tO\\nare\\tO\\ngenetic\\tO\\nsyndromes\\tO\\nassociated\\tO\\nwith\\tO\\nmarkedly\\tO\\ndecreased\\tO\\nplasma\\tO\\nlevels\\tO\\nof\\tO\\nhigh\\tO\\ndensity\\tO\\nlipoprotein\\tO\\n(\\tO\\nHDL\\tO\\n)\\tO\\ncholesterol\\tO\\nbut\\tO\\nnot\\tO\\nwith\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\natherosclerotic\\tB-Disease\\ncardiovascular\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\ninvestigated\\tO\\nthe\\tO\\nmetabolism\\tO\\nof\\tO\\nthe\\tO\\nHDL\\tO\\napolipoproteins\\tO\\n(\\tO\\napo\\tO\\n)\\tO\\napoA\\tO\\n-\\tO\\nI\\tO\\nand\\tO\\napoA\\tO\\n-\\tO\\nII\\tO\\nin\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\nfive\\tO\\npatients\\tO\\nwith\\tO\\nLCAT\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\none\\tO\\nwith\\tO\\nclassic\\tB-Disease\\nLCAT\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nfour\\tO\\nwith\\tO\\nFish\\tB-Disease\\n-\\tI-Disease\\neye\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nPlasma\\tO\\nlevels\\tO\\nof\\tO\\napoA\\tO\\n-\\tO\\nII\\tO\\nwere\\tO\\ndecreased\\tO\\nto\\tO\\na\\tO\\nproportionately\\tO\\ngreater\\tO\\nextent\\tO\\n(\\tO\\n23\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\n)\\tO\\nthan\\tO\\napoA\\tO\\n-\\tO\\nI\\tO\\n(\\tO\\n30\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nplasma\\tO\\nconcentrations\\tO\\nof\\tO\\nHDL\\tO\\nparticles\\tO\\ncontaining\\tO\\nboth\\tO\\napoA\\tO\\n-\\tO\\nI\\tO\\nand\\tO\\napoA\\tO\\n-\\tO\\nII\\tO\\n(\\tO\\nLpA\\tO\\n-\\tO\\nI\\tO\\nA\\tO\\n-\\tO\\nII\\tO\\n)\\tO\\nwere\\tO\\nmuch\\tO\\nlower\\tO\\n(\\tO\\n18\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\n)\\tO\\nthan\\tO\\nthose\\tO\\nof\\tO\\nparticles\\tO\\ncontaining\\tO\\nonly\\tO\\napoA\\tO\\n-\\tO\\nI\\tO\\n(\\tO\\nLpA\\tO\\n-\\tO\\nI\\tO\\n)\\tO\\n(\\tO\\n51\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmetabolic\\tO\\nbasis\\tO\\nfor\\tO\\nthe\\tO\\nlow\\tO\\nlevels\\tO\\nof\\tO\\napoA\\tO\\n-\\tO\\nII\\tO\\nand\\tO\\nLpA\\tO\\n-\\tO\\nI\\tO\\nA\\tO\\n-\\tO\\nII\\tO\\nwas\\tO\\ninvestigated\\tO\\nin\\tO\\nall\\tO\\nfive\\tO\\npatients\\tO\\nusing\\tO\\nboth\\tO\\nexogenous\\tO\\nradiotracer\\tO\\nand\\tO\\nendogenous\\tO\\nstable\\tO\\nisotope\\tO\\nlabeling\\tO\\ntechniques\\tO\\n.\\tO\\n\\nThe\\tO\\nmean\\tO\\nplasma\\tO\\nresidence\\tO\\ntime\\tO\\nof\\tO\\napoA\\tO\\n-\\tO\\nI\\tO\\nwas\\tO\\ndecreased\\tO\\nat\\tO\\n2\\tO\\n.\\tO\\n\\n08\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n\\n27\\tO\\nd\\tO\\n(\\tO\\ncontrols\\tO\\n4\\tO\\n.\\tO\\n74\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n65\\tO\\ndays\\tO\\n)\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nthe\\tO\\nresidence\\tO\\ntime\\tO\\nof\\tO\\napoA\\tO\\n-\\tO\\nII\\tO\\nwas\\tO\\neven\\tO\\nshorter\\tO\\nat\\tO\\n1\\tO\\n.\\tO\\n\\n66\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n\\n24\\tO\\nd\\tO\\n(\\tO\\ncontrols\\tO\\n5\\tO\\n.\\tO\\n25\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n61\\tO\\nd\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nthe\\tO\\ncatabolism\\tO\\nof\\tO\\napoA\\tO\\n-\\tO\\nI\\tO\\nin\\tO\\nLpA\\tO\\n-\\tO\\nI\\tO\\nA\\tO\\n-\\tO\\nII\\tO\\nwas\\tO\\nsubstantially\\tO\\nfaster\\tO\\nthan\\tO\\nthat\\tO\\nof\\tO\\napoA\\tO\\n-\\tO\\nI\\tO\\nin\\tO\\nLpA\\tO\\n-\\tO\\nI\\tO\\n.\\tO\\n\\nIn\\tO\\nsummary\\tO\\n,\\tO\\ngenetic\\tO\\nsyndromes\\tO\\nof\\tO\\neither\\tO\\ncomplete\\tB-Disease\\nor\\tI-Disease\\npartial\\tI-Disease\\nLCAT\\tI-Disease\\ndeficiency\\tI-Disease\\nresult\\tO\\nin\\tO\\nlow\\tO\\nlevels\\tO\\nof\\tO\\nHDL\\tO\\nthrough\\tO\\npreferential\\tO\\nhypercatabolism\\tO\\nof\\tO\\napoA\\tO\\n-\\tO\\nII\\tO\\nand\\tO\\nHDL\\tO\\nparticles\\tO\\ncontaining\\tO\\napoA\\tO\\n-\\tO\\nII\\tO\\n.\\tO\\n\\nBecause\\tO\\nLpA\\tO\\n-\\tO\\nI\\tO\\nhas\\tO\\nbeen\\tO\\nproposed\\tO\\nto\\tO\\nbe\\tO\\nmore\\tO\\nprotective\\tO\\nthan\\tO\\nLpA\\tO\\n-\\tO\\nI\\tO\\nA\\tO\\n-\\tO\\nII\\tO\\nagainst\\tO\\natherosclerosis\\tB-Disease\\n,\\tO\\nthis\\tO\\nselective\\tO\\neffect\\tO\\non\\tO\\nthe\\tO\\nmetabolism\\tO\\nof\\tO\\nLpA\\tO\\n-\\tO\\nI\\tO\\nA\\tO\\n-\\tO\\nII\\tO\\nmay\\tO\\nprovide\\tO\\na\\tO\\npotential\\tO\\nexplanation\\tO\\nwhy\\tO\\npatients\\tO\\nwith\\tO\\nclassic\\tB-Disease\\nLCAT\\tI-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nFish\\tB-Disease\\n-\\tI-Disease\\neye\\tI-Disease\\ndisease\\tI-Disease\\nare\\tO\\nnot\\tO\\nat\\tO\\nincreased\\tO\\nrisk\\tO\\nfor\\tO\\npremature\\tO\\natherosclerosis\\tB-Disease\\ndespite\\tO\\nmarkedly\\tO\\ndecreased\\tO\\nlevels\\tO\\nof\\tO\\nHDL\\tO\\ncholesterol\\tO\\nand\\tO\\napoA\\tO\\n-\\tO\\nI\\tO\\n\\nX\\tB-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\nthrombocytopenia\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nSaudi\\tO\\nArab\\tO\\nboy\\tO\\npresented\\tO\\nin\\tO\\nearly\\tO\\nchildhood\\tO\\nwith\\tO\\nthrombocytopenia\\tB-Disease\\n,\\tO\\nmorphologically\\tO\\nlarge\\tO\\nand\\tO\\nnormal\\tO\\nsized\\tO\\nplatelets\\tO\\n,\\tO\\nincreased\\tO\\nmean\\tO\\nplatelet\\tO\\nvolume\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nhypermegakaryocytic\\tO\\nbone\\tO\\nmarrow\\tO\\n.\\tO\\n\\nThere\\tO\\nwas\\tO\\nno\\tO\\nclinical\\tO\\nand\\tO\\nlaboratory\\tO\\nevidence\\tO\\nof\\tO\\nany\\tO\\nsignificant\\tO\\nimmunological\\tB-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nSimilar\\tO\\nfindings\\tO\\nin\\tO\\ntwo\\tO\\nother\\tO\\nbrothers\\tO\\nsuggested\\tO\\nstrongly\\tO\\nthat\\tO\\nthey\\tO\\nwere\\tO\\nall\\tO\\nsuffering\\tO\\nfrom\\tO\\nan\\tO\\nX\\tB-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\nthrombocytopenic\\tI-Disease\\ndisorder\\tI-Disease\\n.\\tO\\n\\nResults\\tO\\nof\\tO\\nDNA\\tO\\nanalysis\\tO\\nwith\\tO\\nthe\\tO\\nprobe\\tO\\nM27\\tO\\nbeta\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\nX\\tO\\nlinkage\\tO\\nand\\tO\\nindicate\\tO\\nalso\\tO\\nthat\\tO\\nthe\\tO\\nlocus\\tO\\nof\\tO\\nthe\\tO\\nrelevant\\tO\\ngene\\tO\\nlies\\tO\\nclose\\tO\\nto\\tO\\nor\\tO\\nis\\tO\\nidentical\\tO\\nto\\tO\\nthe\\tO\\nlocus\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nBecause\\tO\\nof\\tO\\nvarious\\tO\\nfeatures\\tO\\nwhich\\tO\\ninclude\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nlarge\\tO\\nand\\tO\\nnormal\\tO\\nsized\\tO\\nplatelets\\tO\\n(\\tO\\nrather\\tO\\nthan\\tO\\nsmall\\tO\\nplatelets\\tO\\n)\\tO\\nand\\tO\\nfreedom\\tO\\nfrom\\tO\\nsignificant\\tO\\nimmune\\tB-Disease\\ndeficiencies\\tI-Disease\\n,\\tO\\nit\\tO\\nis\\tO\\nlikely\\tO\\nthat\\tO\\nthe\\tO\\nX\\tB-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\nthrombocytopenia\\tI-Disease\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nis\\tO\\nan\\tO\\nisolated\\tO\\nentity\\tO\\nquite\\tO\\ndistinct\\tO\\nfrom\\tO\\nthe\\tO\\nclassical\\tO\\nWAS\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\na\\tO\\nmodified\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nWAS\\tB-Disease\\ngene\\tO\\nproducing\\tO\\na\\tO\\nmild\\tO\\nphenotypic\\tO\\nvariant\\tO\\ncannot\\tO\\nbe\\tO\\nexcluded\\tO\\nentirely\\tO\\n.\\tO\\n.\\tO\\n\\nMacular\\tB-Disease\\ndystrophy\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nmutations\\tO\\nat\\tO\\ncodon\\tO\\n172\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nretinal\\tB-Disease\\ndegeneration\\tI-Disease\\nslow\\tO\\ngene\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\nRecently\\tO\\n,\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nretinal\\tB-Disease\\ndegeneration\\tI-Disease\\nslow\\tO\\n(\\tO\\nrds\\tO\\n)\\tO\\ngene\\tO\\nwhich\\tO\\ncodes\\tO\\nfor\\tO\\nperipherin\\tO\\n-\\tO\\nrds\\tO\\nhave\\tO\\nbeen\\tO\\nimplicated\\tO\\nas\\tO\\na\\tO\\ncause\\tO\\nof\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nretinitis\\tI-Disease\\npigmentosa\\tI-Disease\\n.\\tO\\n\\nBecause\\tO\\nthis\\tO\\ngene\\tO\\nis\\tO\\nexpressed\\tO\\nin\\tO\\nboth\\tO\\nrods\\tO\\nand\\tO\\ncones\\tO\\n,\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nrds\\tO\\ngene\\tO\\nmight\\tO\\nbe\\tO\\nexpected\\tO\\nto\\tO\\ncause\\tO\\ndegeneration\\tO\\naffecting\\tO\\neither\\tO\\nthe\\tO\\nscotopic\\tO\\nor\\tO\\nphotopic\\tO\\nsystems\\tO\\n.\\tO\\n\\nMutations\\tO\\nat\\tO\\ncodon\\tO\\n172\\tO\\nof\\tO\\nthe\\tO\\nrds\\tO\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\nthree\\tO\\nfamilies\\tO\\nwith\\tO\\nautosomal\\tO\\ndominantly\\tO\\ninherited\\tO\\n,\\tO\\nprogressive\\tO\\nmacular\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nMETHODS\\tO\\nAffected\\tO\\nindividuals\\tO\\nunderwent\\tO\\nophthalmic\\tO\\nexamination\\tO\\n,\\tO\\nscotopic\\tO\\nperimetry\\tO\\n,\\tO\\ndark\\tO\\nadaptometry\\tO\\n,\\tO\\nmeasurement\\tO\\nof\\tO\\ncolor\\tO\\n-\\tO\\ncontrast\\tO\\nsensitivity\\tO\\n,\\tO\\nand\\tO\\nelectroretinography\\tO\\nto\\tO\\ncharacterize\\tO\\nthe\\tO\\nphotoreceptor\\tO\\ndysfunction\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nIn\\tO\\nall\\tO\\nbut\\tO\\none\\tO\\naffected\\tO\\nmember\\tO\\n,\\tO\\nsymptoms\\tO\\nof\\tO\\nprogressive\\tO\\ncentral\\tO\\nvisual\\tB-Disease\\nloss\\tI-Disease\\ndeveloped\\tO\\nin\\tO\\nthe\\tO\\nthird\\tO\\nor\\tO\\nfourth\\tO\\ndecade\\tO\\nof\\tO\\nlife\\tO\\naccompanied\\tO\\nby\\tO\\ncentral\\tB-Disease\\nscotoma\\tI-Disease\\nand\\tO\\nwell\\tO\\n-\\tO\\ndemarcated\\tO\\natrophy\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nretinal\\tI-Disease\\npigment\\tI-Disease\\nepithelium\\tI-Disease\\nand\\tO\\nchoriocapillaris\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nmacula\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\ngeneral\\tO\\n,\\tO\\ncone\\tO\\nand\\tO\\nrod\\tO\\nthresholds\\tO\\nwere\\tO\\nelevated\\tO\\n,\\tO\\nand\\tO\\ncolor\\tO\\n-\\tO\\ncontrast\\tO\\nsensitivity\\tO\\nwas\\tO\\nabsent\\tO\\nin\\tO\\nthe\\tO\\ncentral\\tO\\nvisual\\tO\\nfield\\tO\\n.\\tO\\n\\nPeripherally\\tO\\n,\\tO\\nthe\\tO\\nscotopic\\tO\\nsensitivities\\tO\\nwere\\tO\\nnormal\\tO\\n,\\tO\\nas\\tO\\nwas\\tO\\nthe\\tO\\nrecovery\\tO\\nfrom\\tO\\nbleach\\tO\\n.\\tO\\n\\nCone\\tO\\nelectroretinograms\\tO\\nwere\\tO\\ndiminished\\tO\\nin\\tO\\namplitude\\tO\\n,\\tO\\nand\\tO\\ndelayed\\tO\\nin\\tO\\nall\\tO\\naffected\\tO\\nadults\\tO\\nexcept\\tO\\none\\tO\\n.\\tO\\n\\nRod\\tO\\nelectroretinograms\\tO\\nwere\\tO\\nnormal\\tO\\nor\\tO\\nnear\\tO\\nnormal\\tO\\nin\\tO\\namplitude\\tO\\n,\\tO\\nand\\tO\\nhad\\tO\\nnormal\\tO\\nimplicit\\tO\\ntimes\\tO\\n.\\tO\\n\\nAffected\\tO\\nasymptomatic\\tO\\nchildren\\tO\\nhad\\tO\\nmacular\\tO\\nchanges\\tO\\n,\\tO\\nabnormal\\tO\\ncolor\\tO\\n-\\tO\\ncontrast\\tO\\nsensitivity\\tO\\n,\\tO\\nand\\tO\\nreduced\\tO\\npattern\\tO\\nand\\tO\\ncone\\tO\\nelectroretinograms\\tO\\n.\\tO\\n\\nCONCLUSION\\tO\\nThese\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nrds\\tO\\ngene\\tO\\ncan\\tO\\nbe\\tO\\nexpressed\\tO\\nas\\tO\\na\\tO\\nmacular\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nwith\\tO\\nevidence\\tO\\nof\\tO\\nprimary\\tO\\ncone\\tB-Disease\\ndysfunction\\tI-Disease\\nand\\tO\\npreservation\\tO\\nof\\tO\\nperipheral\\tO\\nrod\\tO\\nfunction\\tO\\n.\\tO\\n.\\tO\\n\\nAnonymous\\tO\\nmarker\\tO\\nloci\\tO\\nwithin\\tO\\n400\\tO\\nkb\\tO\\nof\\tO\\nHLA\\tO\\n-\\tO\\nA\\tO\\ngenerate\\tO\\nhaplotypes\\tO\\nin\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nwith\\tO\\nthe\\tO\\nhemochromatosis\\tB-Disease\\ngene\\tO\\n(\\tO\\nHFE\\tO\\n)\\tO\\n\\nThe\\tO\\nhemochromatosis\\tB-Disease\\ngene\\tO\\n(\\tO\\nHFE\\tO\\n)\\tO\\nmaps\\tO\\nto\\tO\\n6p21\\tO\\n.\\tO\\n\\n3\\tO\\nand\\tO\\nis\\tO\\nless\\tO\\nthan\\tO\\n1\\tO\\ncM\\tO\\nfrom\\tO\\nthe\\tO\\nHLA\\tO\\nclass\\tO\\nI\\tO\\ngenes\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nthe\\tO\\nprecise\\tO\\nphysical\\tO\\nlocation\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nhas\\tO\\nremained\\tO\\nelusive\\tO\\nand\\tO\\ncontroversial\\tO\\n.\\tO\\n\\nThe\\tO\\nunambiguous\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\ncrossover\\tO\\nevent\\tO\\nwithin\\tO\\nhemochromatosis\\tB-Disease\\nfamilies\\tO\\nis\\tO\\nvery\\tO\\ndifficult\\tO\\n;\\tO\\nit\\tO\\nis\\tO\\nparticularly\\tO\\nhampered\\tO\\nby\\tO\\nthe\\tO\\nvariability\\tO\\nof\\tO\\nthe\\tO\\nphenotypic\\tO\\nexpression\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nby\\tO\\nthe\\tO\\nsex\\tO\\n-\\tO\\nand\\tO\\nage\\tO\\n-\\tO\\nrelated\\tO\\npenetrance\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nFor\\tO\\nthese\\tO\\npractical\\tO\\nconsiderations\\tO\\n,\\tO\\ntraditional\\tO\\nlinkage\\tO\\nanalysis\\tO\\ncould\\tO\\nprove\\tO\\nof\\tO\\nlimited\\tO\\nvalue\\tO\\nin\\tO\\nfurther\\tO\\nrefining\\tO\\nthe\\tO\\nextrapolated\\tO\\nphysical\\tO\\nposition\\tO\\nof\\tO\\nHFE\\tO\\n.\\tO\\n\\nWe\\tO\\ntherefore\\tO\\nembarked\\tO\\nupon\\tO\\na\\tO\\nlinkage\\tO\\n-\\tO\\ndisequilibrium\\tO\\nanalysis\\tO\\nof\\tO\\nHFE\\tO\\nand\\tO\\nnormal\\tO\\nchromosomes\\tO\\nfrom\\tO\\nthe\\tO\\nBrittany\\tO\\npopulation\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nreport\\tO\\n,\\tO\\n66\\tO\\nhemochromatosis\\tB-Disease\\nfamilies\\tO\\nyielding\\tO\\n151\\tO\\nhemochromatosis\\tB-Disease\\nchromosomes\\tO\\nand\\tO\\n182\\tO\\nnormal\\tO\\nchromosomes\\tO\\nwere\\tO\\nRFLP\\tO\\n-\\tO\\ntyped\\tO\\nwith\\tO\\na\\tO\\nbattery\\tO\\nof\\tO\\nprobes\\tO\\n,\\tO\\nincluding\\tO\\ntwo\\tO\\nnewly\\tO\\nderived\\tO\\npolymorphic\\tO\\nmarkers\\tO\\nfrom\\tO\\nthe\\tO\\n6\\tO\\n.\\tO\\n\\n7\\tO\\nand\\tO\\nHLA\\tO\\n-\\tO\\nF\\tO\\nloci\\tO\\nlocated\\tO\\n150\\tO\\nand\\tO\\n250\\tO\\nkb\\tO\\ntelomeric\\tO\\nto\\tO\\nHLA\\tO\\n-\\tO\\nA\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nsuggest\\tO\\na\\tO\\nstrong\\tO\\npeak\\tO\\nof\\tO\\nexisting\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nfocused\\tO\\nwithin\\tO\\nthe\\tO\\ni82\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\n6\\tO\\n.\\tO\\n\\n7\\tO\\ninterval\\tO\\n(\\tO\\napproximately\\tO\\n250\\tO\\nkb\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nzone\\tO\\nof\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nis\\tO\\nflanked\\tO\\nby\\tO\\nthe\\tO\\ni97\\tO\\nlocus\\tO\\n,\\tO\\npositioned\\tO\\n30\\tO\\nkb\\tO\\nproximal\\tO\\nto\\tO\\ni82\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nHLA\\tO\\n-\\tO\\nF\\tO\\ngene\\tO\\n,\\tO\\nfound\\tO\\n250\\tO\\nkb\\tO\\ndistal\\tO\\nto\\tO\\nHLA\\tO\\n-\\tO\\nA\\tO\\n,\\tO\\nmarkers\\tO\\nof\\tO\\nwhich\\tO\\ndisplay\\tO\\nno\\tO\\nsignificant\\tO\\nassociation\\tO\\nwith\\tO\\nHFE\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsupport\\tO\\nthe\\tO\\npossibility\\tO\\nthat\\tO\\nHFE\\tO\\nresides\\tO\\nwithin\\tO\\nthe\\tO\\n400\\tO\\n-\\tO\\nkb\\tO\\nexpanse\\tO\\nof\\tO\\nDNA\\tO\\nbetween\\tO\\ni97\\tO\\nand\\tO\\nHLA\\tO\\n-\\tO\\nF\\tO\\n.\\tO\\n\\nAlternatively\\tO\\n,\\tO\\nthe\\tO\\nvery\\tO\\ntight\\tO\\nassociation\\tO\\nof\\tO\\nHLA\\tO\\n-\\tO\\nA3\\tO\\nand\\tO\\nallele\\tO\\n1\\tO\\nof\\tO\\nthe\\tO\\n6\\tO\\n.\\tO\\n\\n7\\tO\\nlocus\\tO\\n,\\tO\\nboth\\tO\\nof\\tO\\nwhich\\tO\\nare\\tO\\ncomprised\\tO\\nby\\tO\\nthe\\tO\\nmajor\\tO\\nancestral\\tO\\nor\\tO\\nfounder\\tO\\nHFE\\tO\\nhaplotype\\tO\\nin\\tO\\nBrittany\\tO\\n,\\tO\\nsupports\\tO\\nthe\\tO\\npossibility\\tO\\nthat\\tO\\nthe\\tO\\ndisease\\tO\\ngene\\tO\\nmay\\tO\\nreside\\tO\\nimmediately\\tO\\ntelomeric\\tO\\nto\\tO\\nthe\\tO\\n6\\tO\\n.\\tO\\n\\n7\\tO\\nlocus\\tO\\nwithin\\tO\\nthe\\tO\\nlinkage\\tO\\n-\\tO\\ndisequilibrium\\tO\\nzone\\tO\\n.\\tO\\n\\nAdditionally\\tO\\n,\\tO\\nhemochromatosis\\tB-Disease\\nhaplotypes\\tO\\npossessing\\tO\\nHLA\\tO\\n-\\tO\\nA11\\tO\\nand\\tO\\nthe\\tO\\nlow\\tO\\n-\\tO\\nfrequency\\tO\\nHLA\\tO\\n-\\tO\\nF\\tO\\npolymorphism\\tO\\n(\\tO\\nallele\\tO\\n2\\tO\\n)\\tO\\nare\\tO\\nsupportive\\tO\\nof\\tO\\na\\tO\\nseparate\\tO\\nfounder\\tO\\nchromosome\\tO\\ncontaining\\tO\\na\\tO\\nsecond\\tO\\n,\\tO\\nindependently\\tO\\narising\\tO\\nmutant\\tO\\nallele\\tO\\n.\\tO\\n\\nOverall\\tO\\n,\\tO\\nthe\\tO\\nestablishment\\tO\\nof\\tO\\na\\tO\\nlikely\\tO\\n\"\\tO\\nhemochromatosis\\tB-Disease\\ncritical\\tO\\nregion\\tO\\n\"\\tO\\ncentromeric\\tO\\nboundary\\tO\\nand\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nlinkage\\tO\\n-\\tO\\ndisequilibrium\\tO\\nzone\\tO\\nboth\\tO\\nsignificantly\\tO\\ncontribute\\tO\\nto\\tO\\na\\tO\\nreduction\\tO\\nin\\tO\\nthe\\tO\\namount\\tO\\nof\\tO\\nDNA\\tO\\nrequired\\tO\\nto\\tO\\nbe\\tO\\nsearched\\tO\\nfor\\tO\\nnovel\\tO\\ncoding\\tO\\nsequences\\tO\\nconstituting\\tO\\nthe\\tO\\nHFE\\tB-Disease\\ndefect\\tI-Disease\\n\\nGenomic\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\nEWS\\tO\\ngene\\tO\\nand\\tO\\nits\\tO\\nrelationship\\tO\\nto\\tO\\nEWSR1\\tO\\n,\\tO\\na\\tO\\nsite\\tO\\nof\\tO\\ntumor\\tB-Disease\\n-\\tO\\nassociated\\tO\\nchromosome\\tO\\ntranslocation\\tO\\n.\\tO\\n\\nThe\\tO\\nEWS\\tO\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nbased\\tO\\non\\tO\\nits\\tO\\nlocation\\tO\\nat\\tO\\nthe\\tO\\nchromosome\\tO\\n22\\tO\\nbreakpoint\\tO\\nof\\tO\\nthe\\tO\\nt\\tO\\n(\\tO\\n11\\tO\\n;\\tO\\n22\\tO\\n)\\tO\\n(\\tO\\nq24\\tO\\n;\\tO\\nq12\\tO\\n)\\tO\\ntranslocation\\tO\\nthat\\tO\\ncharacterizes\\tO\\nEwing\\tB-Disease\\nsarcoma\\tI-Disease\\nand\\tO\\nrelated\\tO\\nneuroectodermal\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nEWS\\tO\\ngene\\tO\\nspans\\tO\\nabout\\tO\\n40\\tO\\nkb\\tO\\nof\\tO\\nDNA\\tO\\nand\\tO\\nis\\tO\\nencoded\\tO\\nby\\tO\\n17\\tO\\nexons\\tO\\n.\\tO\\n\\nThe\\tO\\nnucleotide\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\nexons\\tO\\nis\\tO\\nidentical\\tO\\nto\\tO\\nthat\\tO\\nof\\tO\\nthe\\tO\\npreviously\\tO\\ndescribed\\tO\\ncDNA\\tO\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\n7\\tO\\nexons\\tO\\nencode\\tO\\nthe\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\ndomain\\tO\\nof\\tO\\nEWS\\tO\\n,\\tO\\nwhich\\tO\\nconsists\\tO\\nof\\tO\\na\\tO\\nrepeated\\tO\\ndegenerated\\tO\\npolypeptide\\tO\\nof\\tO\\n7\\tO\\nto\\tO\\n12\\tO\\nresidues\\tO\\nrich\\tO\\nin\\tO\\ntyrosine\\tO\\n,\\tO\\nserine\\tO\\n,\\tO\\nthreonine\\tO\\n,\\tO\\nglycine\\tO\\n,\\tO\\nand\\tO\\nglutamine\\tO\\n.\\tO\\n\\nExons\\tO\\n11\\tO\\n,\\tO\\n12\\tO\\n,\\tO\\nand\\tO\\n13\\tO\\nencode\\tO\\nthe\\tO\\nputative\\tO\\nRNA\\tO\\nbinding\\tO\\ndomain\\tO\\n.\\tO\\n\\nThe\\tO\\nthree\\tO\\nglycine\\tO\\n-\\tO\\nand\\tO\\narginine\\tO\\n-\\tO\\nrich\\tO\\nmotifs\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nare\\tO\\nmainly\\tO\\nencoded\\tO\\nby\\tO\\nexons\\tO\\n8\\tO\\n-\\tO\\n9\\tO\\n,\\tO\\n14\\tO\\n,\\tO\\nand\\tO\\n16\\tO\\n.\\tO\\n\\nThe\\tO\\nDNA\\tO\\nsequence\\tO\\nin\\tO\\nthe\\tO\\n5\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nhas\\tO\\nfeatures\\tO\\nof\\tO\\na\\tO\\nCpG\\tO\\n-\\tO\\nrich\\tO\\nisland\\tO\\nand\\tO\\nlacks\\tO\\ncanonical\\tO\\npromoter\\tO\\nelements\\tO\\n,\\tO\\nsuch\\tO\\nas\\tO\\nTATA\\tO\\nand\\tO\\nCCAAT\\tO\\nconsensus\\tO\\nsequences\\tO\\n.\\tO\\n\\nPositions\\tO\\nof\\tO\\nthe\\tO\\nchromosome\\tO\\n22\\tO\\nbreakpoints\\tO\\nwere\\tO\\ndetermined\\tO\\nfor\\tO\\n19\\tO\\nEwing\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nThey\\tO\\nwere\\tO\\nlocalized\\tO\\nin\\tO\\nintrons\\tO\\n7\\tO\\nor\\tO\\n8\\tO\\nin\\tO\\n18\\tO\\ncases\\tO\\nand\\tO\\nin\\tO\\nintron\\tO\\n10\\tO\\nin\\tO\\n1\\tO\\ncase\\tO\\n.\\tO\\n.\\tO\\n\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\ngene\\tO\\n:\\tO\\ncharacterization\\tO\\nof\\tO\\ndeletions\\tO\\nand\\tO\\npossible\\tO\\nfunction\\tO\\n.\\tO\\n\\nPositional\\tO\\ncloning\\tO\\nexperiments\\tO\\nhave\\tO\\nresulted\\tO\\nrecently\\tO\\nin\\tO\\nthe\\tO\\nisolation\\tO\\nof\\tO\\na\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\npseudoglioma\\tB-Disease\\n;\\tO\\nNDP\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nsevere\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nneurodevelopmental\\tI-Disease\\ndisorder\\tI-Disease\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\nisolation\\tO\\nand\\tO\\nanalysis\\tO\\nof\\tO\\nhuman\\tO\\ngenomic\\tO\\nDNA\\tO\\nclones\\tO\\nencompassing\\tO\\nthe\\tO\\nNDP\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nspans\\tO\\n28\\tO\\nkb\\tO\\nand\\tO\\nconsists\\tO\\nof\\tO\\n3\\tO\\nexons\\tO\\n,\\tO\\nthe\\tO\\nfirst\\tO\\nof\\tO\\nwhich\\tO\\nis\\tO\\nentirely\\tO\\ncontained\\tO\\nwithin\\tO\\nthe\\tO\\n5\\tO\\nuntranslated\\tO\\nregion\\tO\\n.\\tO\\n\\nDetailed\\tO\\nanalysis\\tO\\nof\\tO\\ngenomic\\tO\\ndeletions\\tO\\nin\\tO\\nNorrie\\tB-Disease\\npatients\\tO\\nshows\\tO\\nthat\\tO\\nthey\\tO\\nare\\tO\\nheterogeneous\\tO\\n,\\tO\\nboth\\tO\\nin\\tO\\nsize\\tO\\nand\\tO\\nin\\tO\\nposition\\tO\\n.\\tO\\n\\nBy\\tO\\nPCR\\tO\\nanalysis\\tO\\n,\\tO\\nwe\\tO\\nfound\\tO\\nthat\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nNDP\\tB-Disease\\ngene\\tO\\nwas\\tO\\nnot\\tO\\nconfined\\tO\\nto\\tO\\nthe\\tO\\neye\\tO\\nor\\tO\\nto\\tO\\nthe\\tO\\nbrain\\tO\\n.\\tO\\n\\nAn\\tO\\nextensive\\tO\\nDNA\\tO\\nand\\tO\\nprotein\\tO\\nsequence\\tO\\ncomparison\\tO\\nbetween\\tO\\nthe\\tO\\nhuman\\tO\\nNDP\\tB-Disease\\ngene\\tO\\nand\\tO\\nrelated\\tO\\ngenes\\tO\\nfrom\\tO\\nthe\\tO\\ndatabase\\tO\\nrevealed\\tO\\nhomology\\tO\\nwith\\tO\\ncysteine\\tO\\n-\\tO\\nrich\\tO\\nprotein\\tO\\n-\\tO\\nbinding\\tO\\ndomains\\tO\\nof\\tO\\nimmediate\\tO\\n-\\tO\\n-\\tO\\nearly\\tO\\ngenes\\tO\\nimplicated\\tO\\nin\\tO\\nthe\\tO\\nregulation\\tO\\nof\\tO\\ncell\\tO\\nproliferation\\tO\\n.\\tO\\n\\nWe\\tO\\npropose\\tO\\nthat\\tO\\nNDP\\tO\\nis\\tO\\na\\tO\\nmolecule\\tO\\nrelated\\tO\\nin\\tO\\nfunction\\tO\\nto\\tO\\nthese\\tO\\ngenes\\tO\\nand\\tO\\nmay\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\na\\tO\\npathway\\tO\\nthat\\tO\\nregulates\\tO\\nneural\\tO\\ncell\\tO\\ndifferentiation\\tO\\nand\\tO\\nproliferation\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nnormal\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nallele\\tO\\n,\\tO\\nor\\tO\\na\\tO\\nclosely\\tO\\nlinked\\tO\\ngene\\tO\\n,\\tO\\ninfluences\\tO\\nage\\tO\\nat\\tO\\nonset\\tO\\nof\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nevaluated\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nis\\tO\\ninfluenced\\tO\\nby\\tO\\nthe\\tO\\nnormal\\tO\\nHD\\tB-Disease\\nallele\\tO\\nby\\tO\\ncomparing\\tO\\ntransmission\\tO\\npatterns\\tO\\nof\\tO\\ngenetically\\tO\\nlinked\\tO\\nmarkers\\tO\\nat\\tO\\nthe\\tO\\nD4S10\\tO\\nlocus\\tO\\nin\\tO\\nthe\\tO\\nnormal\\tO\\nparent\\tO\\nagainst\\tO\\nage\\tO\\nat\\tO\\nonset\\tO\\nin\\tO\\nthe\\tO\\naffected\\tO\\noffspring\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\ninformation\\tO\\nfrom\\tO\\n21\\tO\\nsibships\\tO\\nin\\tO\\n14\\tO\\nkindreds\\tO\\nshowed\\tO\\na\\tO\\nsignificant\\tO\\ntendency\\tO\\nfor\\tO\\nsibs\\tO\\nwho\\tO\\nhave\\tO\\nsimilar\\tO\\nonset\\tO\\nages\\tO\\nto\\tO\\nshare\\tO\\nthe\\tO\\nsame\\tO\\nD4S10\\tO\\nallele\\tO\\nfrom\\tO\\nthe\\tO\\nnormal\\tO\\nparent\\tO\\n.\\tO\\n\\nAffected\\tO\\nsibs\\tO\\nwho\\tO\\ninherited\\tO\\ndifferent\\tO\\nD4S10\\tO\\nalleles\\tO\\nfrom\\tO\\nthe\\tO\\nnormal\\tO\\nparent\\tO\\ntended\\tO\\nto\\tO\\nhave\\tO\\nmore\\tO\\nvariable\\tO\\nages\\tO\\nat\\tO\\nonset\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nHD\\tB-Disease\\nis\\tO\\nmodulated\\tO\\nby\\tO\\nthe\\tO\\nnormal\\tO\\nHD\\tB-Disease\\nallele\\tO\\nor\\tO\\nby\\tO\\na\\tO\\nclosely\\tO\\nlinked\\tO\\nlocus\\tO\\n.\\tO\\n.\\tO\\n\\nFurther\\tO\\ninvestigation\\tO\\nof\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\nintron\\tO\\n9\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\nmutation\\tO\\nfrequently\\tO\\nfound\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\npatients\\tO\\nfrom\\tO\\nthe\\tO\\nBritish\\tO\\nIsles\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nprevious\\tO\\nstudy\\tO\\nwe\\tO\\nfound\\tO\\nthat\\tO\\na\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\ncausing\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nintron\\tO\\n9\\tO\\ndonor\\tO\\nsplice\\tO\\nsite\\tO\\nof\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\noccurs\\tO\\nat\\tO\\nhigh\\tO\\nfrequency\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\npatients\\tO\\nand\\tO\\ncarriers\\tO\\nfrom\\tO\\nthe\\tO\\nBritish\\tO\\nIsles\\tO\\n.\\tO\\n\\nIt\\tO\\nwas\\tO\\nfound\\tO\\nmore\\tO\\nfrequently\\tO\\nin\\tO\\nsubjects\\tO\\nof\\tO\\nIrish\\tO\\n,\\tO\\nScottish\\tO\\n,\\tO\\nand\\tO\\nWelsh\\tO\\norigin\\tO\\ncompared\\tO\\nwith\\tO\\nEnglish\\tO\\norigin\\tO\\n(\\tO\\n63\\tO\\n%\\tO\\nand\\tO\\n31\\tO\\n%\\tO\\nrespectively\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nnow\\tO\\ntested\\tO\\n,\\tO\\nin\\tO\\na\\tO\\nblind\\tO\\nstudy\\tO\\n,\\tO\\n26\\tO\\nAmerican\\tO\\nTSD\\tB-Disease\\ncarriers\\tO\\nand\\tO\\n28\\tO\\nnon\\tO\\n-\\tO\\ncarriers\\tO\\nwho\\tO\\nhave\\tO\\nBritish\\tO\\nancestry\\tO\\nfor\\tO\\nthe\\tO\\nintron\\tO\\n9\\tO\\nsplice\\tO\\nsite\\tO\\nmutation\\tO\\n.\\tO\\n\\nSix\\tO\\nof\\tO\\nthe\\tO\\ncarriers\\tO\\nand\\tO\\nnone\\tO\\nof\\tO\\nthe\\tO\\ncontrols\\tO\\nwere\\tO\\npositive\\tO\\nfor\\tO\\nthe\\tO\\nmutation\\tO\\n.\\tO\\n\\nAll\\tO\\nsix\\tO\\nhad\\tO\\nIrish\\tO\\nancestry\\tO\\n,\\tO\\ncompared\\tO\\nwith\\tO\\nnine\\tO\\nof\\tO\\nthe\\tO\\n20\\tO\\nother\\tO\\n(\\tO\\nintron\\tO\\n9\\tO\\nmutation\\tO\\nnegative\\tO\\n)\\tO\\nTSD\\tB-Disease\\ncarriers\\tO\\n(\\tO\\np\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n05\\tO\\n)\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nconfirm\\tO\\nthe\\tO\\npreviously\\tO\\nfound\\tO\\nhigh\\tO\\nfrequency\\tO\\nof\\tO\\nthe\\tO\\nintron\\tO\\n9\\tO\\nmutation\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nTSD\\tB-Disease\\nfamilies\\tO\\nof\\tO\\nBritish\\tO\\nIsles\\tO\\n,\\tO\\nparticularly\\tO\\nIrish\\tO\\n,\\tO\\norigin\\tO\\n,\\tO\\nand\\tO\\nreinforce\\tO\\nthe\\tO\\nneed\\tO\\nto\\tO\\nscreen\\tO\\nsuch\\tO\\nfamilies\\tO\\nfor\\tO\\nthis\\tO\\nmutation\\tO\\n.\\tO\\n\\nMolecular\\tO\\nmechanisms\\tO\\nof\\tO\\noncogenic\\tO\\nmutations\\tO\\nin\\tO\\ntumors\\tB-Disease\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nbilateral\\tB-Disease\\nand\\tI-Disease\\nunilateral\\tI-Disease\\nretinoblastoma\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nRB1\\tO\\ngene\\tO\\nfrom\\tO\\n12\\tO\\nhuman\\tO\\nretinoblastoma\\tB-Disease\\ntumors\\tI-Disease\\nhas\\tO\\nbeen\\tO\\nanalyzed\\tO\\nexon\\tO\\n-\\tO\\nby\\tO\\n-\\tO\\nexon\\tO\\nwith\\tO\\nthe\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\ntechnique\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nall\\tO\\ntumors\\tB-Disease\\n,\\tO\\nand\\tO\\none\\tO\\n-\\tO\\nthird\\tO\\nof\\tO\\nthe\\tO\\ntumors\\tB-Disease\\nhad\\tO\\nindependent\\tO\\nmutations\\tO\\nin\\tO\\nboth\\tO\\nalleles\\tO\\nneither\\tO\\nof\\tO\\nwhich\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\ngerm\\tO\\nline\\tO\\n,\\tO\\nconfirming\\tO\\ntheir\\tO\\ntrue\\tO\\nsporadic\\tO\\nnature\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nremaining\\tO\\ntwo\\tO\\n-\\tO\\nthirds\\tO\\nof\\tO\\nthe\\tO\\ntumors\\tB-Disease\\nonly\\tO\\none\\tO\\nmutation\\tO\\nwas\\tO\\nfound\\tO\\n,\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nloss\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\nheterozygosity\\tO\\ntheory\\tO\\nof\\tO\\ntumorigenesis\\tO\\n.\\tO\\n\\nPoint\\tO\\nmutations\\tO\\n,\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nwhich\\tO\\nwere\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransitions\\tO\\n,\\tO\\nwere\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nabnormality\\tO\\nand\\tO\\nusually\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\nconversion\\tO\\nof\\tO\\nan\\tO\\narginine\\tO\\ncodon\\tO\\nto\\tO\\na\\tO\\nstop\\tO\\ncodon\\tO\\n.\\tO\\n\\nSmall\\tO\\ndeletions\\tO\\nwere\\tO\\nthe\\tO\\nsecond\\tO\\nmost\\tO\\ncommon\\tO\\nabnormality\\tO\\nand\\tO\\nmost\\tO\\noften\\tO\\ncreated\\tO\\na\\tO\\ndownstream\\tO\\nstop\\tO\\ncodon\\tO\\nas\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\na\\tO\\nreading\\tO\\nframeshift\\tO\\n.\\tO\\n\\nDeletions\\tO\\nand\\tO\\npoint\\tO\\nmutations\\tO\\nalso\\tO\\naffected\\tO\\nsplice\\tO\\njunctions\\tO\\n.\\tO\\n\\nDirect\\tO\\nrepeats\\tO\\nwere\\tO\\npresent\\tO\\nat\\tO\\nthe\\tO\\nbreakpoint\\tO\\njunctions\\tO\\nin\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\ndeletions\\tO\\n,\\tO\\nsupporting\\tO\\na\\tO\\nslipped\\tO\\n-\\tO\\nmispairing\\tO\\nmechanism\\tO\\n.\\tO\\n\\nPoint\\tO\\nmutations\\tO\\ngenerally\\tO\\nproduced\\tO\\nDNA\\tO\\nsequences\\tO\\nwhich\\tO\\nresulted\\tO\\nin\\tO\\nperfect\\tO\\nhomology\\tO\\nwith\\tO\\nendogenous\\tO\\nsequences\\tO\\nwhich\\tO\\nlay\\tO\\nwithin\\tO\\n14\\tO\\nbp\\tO\\n.\\tO\\n.\\tO\\n\\nPAX6\\tO\\nmutations\\tO\\nin\\tO\\naniridia\\tB-Disease\\n.\\tO\\n\\nAniridia\\tB-Disease\\nis\\tO\\na\\tO\\ncongenital\\tB-Disease\\nmalformation\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\neye\\tI-Disease\\n,\\tO\\nchiefly\\tO\\ncharacterised\\tO\\nby\\tO\\niris\\tB-Disease\\nhypoplasia\\tI-Disease\\n,\\tO\\nwhich\\tO\\ncan\\tO\\ncause\\tO\\nblindness\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nPAX6\\tO\\ngene\\tO\\nwas\\tO\\nisolated\\tO\\nas\\tO\\na\\tO\\ncandidate\\tO\\naniridia\\tB-Disease\\ngene\\tO\\nby\\tO\\npositional\\tO\\ncloning\\tO\\nfrom\\tO\\nthe\\tO\\nsmallest\\tO\\nregion\\tO\\nof\\tO\\noverlap\\tO\\nof\\tO\\naniridia\\tB-Disease\\n-\\tO\\nassociated\\tO\\ndeletions\\tO\\n.\\tO\\n\\nSubsequently\\tO\\nPAX6\\tO\\nintragenic\\tO\\nmutations\\tO\\nwere\\tO\\ndemonstrated\\tO\\nin\\tO\\nSmalleye\\tO\\n,\\tO\\na\\tO\\nmouse\\tO\\nmutant\\tO\\nwhich\\tO\\nis\\tO\\nan\\tO\\nanimal\\tO\\nmodel\\tO\\nfor\\tO\\naniridia\\tB-Disease\\n,\\tO\\nand\\tO\\nsix\\tO\\nhuman\\tO\\naniridia\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\npaper\\tO\\nwe\\tO\\ndescribe\\tO\\nfour\\tO\\nadditional\\tO\\nPAX6\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\naniridia\\tB-Disease\\npatients\\tO\\n,\\tO\\nboth\\tO\\nsporadic\\tO\\nand\\tO\\nfamilial\\tO\\n.\\tO\\n\\nThese\\tO\\nmutations\\tO\\nhighlight\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nwhich\\tO\\nare\\tO\\nessential\\tO\\nfor\\tO\\nnormal\\tO\\nPAX6\\tO\\nfunction\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nthe\\tO\\nfrequency\\tO\\nat\\tO\\nwhich\\tO\\nwe\\tO\\nhave\\tO\\nfound\\tO\\nPAX6\\tO\\nmutations\\tO\\nsuggests\\tO\\nthat\\tO\\nlesions\\tO\\nin\\tO\\nPAX6\\tO\\nwill\\tO\\naccount\\tO\\nfor\\tO\\nmost\\tO\\ncases\\tO\\nof\\tO\\naniridia\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nDetection\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\narginine\\tO\\nvasopressin\\tO\\ndefect\\tO\\nby\\tO\\ndideoxy\\tO\\nfingerprinting\\tO\\n.\\tO\\n\\nAutosomal\\tB-Disease\\ndominant\\tI-Disease\\nneurohypophyseal\\tI-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\nis\\tO\\na\\tO\\nfamilial\\tO\\nform\\tO\\nof\\tO\\ndiabetes\\tB-Disease\\ninsipidus\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\ndisorder\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nvariable\\tO\\nlevels\\tO\\nof\\tO\\narginine\\tO\\nvasopressin\\tO\\n(\\tO\\nAVP\\tO\\n)\\tO\\nand\\tO\\ndiabetes\\tB-Disease\\ninsipidus\\tI-Disease\\nof\\tO\\nvarying\\tO\\nseverity\\tO\\n,\\tO\\nwhich\\tO\\nresponds\\tO\\nto\\tO\\nexogenous\\tO\\nAVP\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nneurohypophyseal\\tI-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\n,\\tO\\nthe\\tO\\nAVP\\tO\\ngenes\\tO\\nof\\tO\\nmembers\\tO\\nof\\tO\\na\\tO\\nlarge\\tO\\nkindred\\tO\\nwere\\tO\\nanalyzed\\tO\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nmethod\\tO\\n,\\tO\\ncalled\\tO\\ndideoxy\\tO\\nfingerprinting\\tO\\n,\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\ndetect\\tO\\nan\\tO\\nAVP\\tO\\nmutation\\tO\\nthat\\tO\\nwas\\tO\\ncharacterized\\tO\\nby\\tO\\nDNA\\tO\\nsequencing\\tO\\n.\\tO\\n\\nThe\\tO\\nnovel\\tO\\ndefect\\tO\\nfound\\tO\\nchanges\\tO\\nthe\\tO\\nlast\\tO\\ncodon\\tO\\nof\\tO\\nthe\\tO\\nAVP\\tO\\nsignal\\tO\\npeptide\\tO\\nfrom\\tO\\nalanine\\tO\\nto\\tO\\nthreonine\\tO\\n,\\tO\\nwhich\\tO\\nshould\\tO\\nperturb\\tO\\ncleavage\\tO\\nof\\tO\\nmature\\tO\\nAVP\\tO\\nfrom\\tO\\nits\\tO\\nprecursor\\tO\\nprotein\\tO\\nand\\tO\\ninhibit\\tO\\nits\\tO\\nsecretion\\tO\\nor\\tO\\naction\\tO\\n.\\tO\\n.\\tO\\n\\nGerminal\\tO\\nmosaicism\\tO\\nin\\tO\\na\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nfamily\\tO\\n:\\tO\\nimplications\\tO\\nfor\\tO\\ngenetic\\tO\\ncounselling\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\nwe\\tO\\ndescribe\\tO\\na\\tO\\nthree\\tO\\n-\\tO\\ngeneration\\tO\\nfamily\\tO\\nin\\tO\\nwhich\\tO\\ntwo\\tO\\nsiblings\\tO\\nwere\\tO\\naffected\\tO\\nby\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nImmunohistochemical\\tO\\nanalysis\\tO\\nof\\tO\\nmuscle\\tO\\ndystrophin\\tO\\nand\\tO\\nhaplotype\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nDMD\\tB-Disease\\nlocus\\tO\\nrevealed\\tO\\nthat\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\ncarrying\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\nwas\\tO\\ntransmitted\\tO\\nfrom\\tO\\nthe\\tO\\nhealthy\\tO\\nmaternal\\tO\\ngrandfather\\tO\\nto\\tO\\nhis\\tO\\nthree\\tO\\ndaughters\\tO\\n,\\tO\\nincluding\\tO\\nthe\\tO\\nprobands\\tO\\nmother\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\ngrandfather\\tO\\nwas\\tO\\na\\tO\\ngerminal\\tO\\nmosaic\\tO\\nfor\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\ndefinition\\tO\\nof\\tO\\nthe\\tO\\ncarrier\\tO\\nstatus\\tO\\nin\\tO\\ntwo\\tO\\npossible\\tO\\ncarriers\\tO\\nled\\tO\\nus\\tO\\nto\\tO\\ngive\\tO\\naccurate\\tO\\ngenetic\\tO\\ncounselling\\tO\\nand\\tO\\nto\\tO\\nprevent\\tO\\nthe\\tO\\nbirth\\tO\\nof\\tO\\nan\\tO\\naffected\\tO\\nboy\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nof\\tO\\nthis\\tO\\nstudy\\tO\\ndemonstrate\\tO\\nthe\\tO\\nusefulness\\tO\\nof\\tO\\nhaplotype\\tO\\nanalysis\\tO\\nand\\tO\\nimmunohistochemical\\tO\\nmuscle\\tO\\ndystrophin\\tO\\nstudies\\tO\\nto\\tO\\ndetect\\tO\\nhidden\\tO\\ngerminal\\tO\\nmosaicism\\tO\\nand\\tO\\nto\\tO\\nimprove\\tO\\ngenetic\\tO\\ncounselling\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsyndrome\\tI-Disease\\nto\\tO\\na\\tO\\nsmall\\tO\\ninterval\\tO\\non\\tO\\nchromosome\\tO\\n17q12\\tO\\n-\\tO\\n21\\tO\\n:\\tO\\nexclusion\\tO\\nof\\tO\\ncandidate\\tO\\ngenes\\tO\\nEDH17B2\\tO\\nand\\tO\\nRARA\\tO\\n.\\tO\\n\\nA\\tO\\nsusceptibility\\tO\\ngene\\tO\\nfor\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nBRCA1\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nassigned\\tO\\nby\\tO\\nlinkage\\tO\\nanalysis\\tO\\nto\\tO\\nchromosome\\tO\\n17q21\\tO\\n.\\tO\\n\\nCandidate\\tO\\ngenes\\tO\\nin\\tO\\nthis\\tO\\nregion\\tO\\ninclude\\tO\\nEDH17B2\\tO\\n,\\tO\\nwhich\\tO\\nencodes\\tO\\nestradiol\\tO\\n17\\tO\\nbeta\\tO\\n-\\tO\\nhydroxysteroid\\tO\\ndehydrogenase\\tO\\nII\\tO\\n(\\tO\\n17\\tO\\nbeta\\tO\\n-\\tO\\nHSD\\tO\\nII\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nRARA\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nretinoic\\tO\\nacid\\tO\\nreceptor\\tO\\nalpha\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ntyped\\tO\\n22\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\nbreast\\tI-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nwith\\tO\\neight\\tO\\npolymorphisms\\tO\\nfrom\\tO\\nthe\\tO\\nchromosome\\tO\\n17q12\\tO\\n-\\tO\\n21\\tO\\nregion\\tO\\n,\\tO\\nincluding\\tO\\ntwo\\tO\\nin\\tO\\nthe\\tO\\nEDH17B2\\tO\\ngene\\tO\\n.\\tO\\n\\nGenetic\\tO\\nrecombination\\tO\\nwith\\tO\\nthe\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\ntrait\\tO\\nexcludes\\tO\\nRARA\\tO\\nfrom\\tO\\nfurther\\tO\\nconsideration\\tO\\nas\\tO\\na\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nBoth\\tO\\nBRCA1\\tO\\nand\\tO\\nEDH17B2\\tO\\nmap\\tO\\nto\\tO\\na\\tO\\n6\\tO\\ncM\\tO\\ninterval\\tO\\n(\\tO\\nbetween\\tO\\nTHRA1\\tO\\nand\\tO\\nD17S579\\tO\\n)\\tO\\nand\\tO\\nno\\tO\\nrecombination\\tO\\nwas\\tO\\nobserved\\tO\\nbetween\\tO\\nthe\\tO\\ntwo\\tO\\ngenes\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\ndirect\\tO\\nsequencing\\tO\\nof\\tO\\noverlapping\\tO\\nPCR\\tO\\nproducts\\tO\\ncontaining\\tO\\nthe\\tO\\nentire\\tO\\nEDH17B2\\tO\\ngene\\tO\\nin\\tO\\nfour\\tO\\nunrelated\\tO\\naffected\\tO\\nwomen\\tO\\ndid\\tO\\nnot\\tO\\nuncover\\tO\\nany\\tO\\nsequence\\tO\\nvariation\\tO\\n,\\tO\\nother\\tO\\nthan\\tO\\npreviously\\tO\\ndescribed\\tO\\npolymorphisms\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nEDH17B2\\tO\\ngene\\tO\\n,\\tO\\ntherefore\\tO\\ndo\\tO\\nnot\\tO\\nappear\\tO\\nto\\tO\\nbe\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nSingle\\tO\\nmeiotic\\tO\\ncrossovers\\tO\\nin\\tO\\naffected\\tO\\nwomen\\tO\\nsuggest\\tO\\nthat\\tO\\nBRCA1\\tO\\nis\\tO\\nflanked\\tO\\nby\\tO\\nthe\\tO\\nloci\\tO\\nRARA\\tO\\nand\\tO\\nD17S78\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ncholesteryl\\tO\\nester\\tO\\ntransfer\\tO\\nprotein\\tO\\ngene\\tO\\nwith\\tO\\npossible\\tO\\ndominant\\tO\\neffects\\tO\\non\\tO\\nplasma\\tO\\nhigh\\tO\\ndensity\\tO\\nlipoproteins\\tO\\n.\\tO\\n\\nPlasma\\tO\\nHDL\\tO\\nare\\tO\\na\\tO\\nnegative\\tO\\nrisk\\tO\\nfactor\\tO\\nfor\\tO\\natherosclerosis\\tB-Disease\\n.\\tO\\n\\nCholesteryl\\tO\\nester\\tO\\ntransfer\\tO\\nprotein\\tO\\n(\\tO\\nCETP\\tO\\n;\\tO\\n476\\tO\\namino\\tO\\nacids\\tO\\n)\\tO\\ntransfers\\tO\\ncholesteryl\\tO\\nester\\tO\\nfrom\\tO\\nHDL\\tO\\nto\\tO\\nother\\tO\\nlipoproteins\\tO\\n.\\tO\\n\\nSubjects\\tO\\nwith\\tO\\nhomozygous\\tO\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ngene\\tO\\nsplicing\\tO\\ndefect\\tO\\nhave\\tO\\nmarkedly\\tO\\nelevated\\tO\\nHDL\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nheterozygotes\\tO\\nhave\\tO\\nonly\\tO\\nmild\\tO\\nincreases\\tO\\nin\\tO\\nHDL\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\ntwo\\tO\\nprobands\\tO\\nwith\\tO\\na\\tO\\nCETP\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\n442\\tO\\nD\\tO\\nG\\tO\\n)\\tO\\n.\\tO\\n\\nAlthough\\tO\\nheterozygous\\tO\\n,\\tO\\nthey\\tO\\nhave\\tO\\nthreefold\\tO\\nincreases\\tO\\nin\\tO\\nHDL\\tO\\nconcentration\\tO\\nand\\tO\\nmarkedly\\tO\\ndecreased\\tO\\nplasma\\tO\\nCETP\\tO\\nmass\\tO\\nand\\tO\\nactivity\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\nhas\\tO\\ndominant\\tO\\neffects\\tO\\non\\tO\\nCETP\\tO\\nand\\tO\\nHDL\\tO\\nin\\tO\\nvivo\\tO\\n.\\tO\\n\\nCellular\\tO\\nexpression\\tO\\nof\\tO\\nmutant\\tO\\ncDNA\\tO\\nresults\\tO\\nin\\tO\\nsecretion\\tO\\nof\\tO\\nonly\\tO\\n30\\tO\\n%\\tO\\nof\\tO\\nwild\\tO\\ntype\\tO\\nCETP\\tO\\nactivity\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\ncoexpression\\tO\\nof\\tO\\nwild\\tO\\ntype\\tO\\nand\\tO\\nmutant\\tO\\ncDNAs\\tO\\nleads\\tO\\nto\\tO\\ninhibition\\tO\\nof\\tO\\nwild\\tO\\ntype\\tO\\nsecretion\\tO\\nand\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\ndominant\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\nCETP\\tO\\nmissense\\tO\\nmutation\\tO\\nduring\\tO\\ncellular\\tO\\nexpression\\tO\\nprobably\\tO\\nexplains\\tO\\nwhy\\tO\\nthe\\tO\\nprobands\\tO\\nhave\\tO\\nmarkedly\\tO\\nincreased\\tO\\nHDL\\tO\\nin\\tO\\nthe\\tO\\nheterozygous\\tO\\nstate\\tO\\n,\\tO\\nand\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nactive\\tO\\nmolecular\\tO\\nspecies\\tO\\nof\\tO\\nCETP\\tO\\nmay\\tO\\nbe\\tO\\nmultimeric\\tO\\n.\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\nin\\tO\\nthe\\tO\\ncolchicine\\tO\\nera\\tO\\n:\\tO\\nthe\\tO\\nfate\\tO\\nof\\tO\\none\\tO\\nfamily\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\ndemonstrate\\tO\\nthe\\tO\\neffect\\tO\\nof\\tO\\nprophylactic\\tO\\ncolchicine\\tO\\ntreatment\\tO\\non\\tO\\nthe\\tO\\nnatural\\tO\\nhistory\\tO\\nof\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n(\\tO\\nFMF\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nfamily\\tO\\nis\\tO\\npresented\\tO\\nwith\\tO\\n6\\tO\\nout\\tO\\nof\\tO\\n9\\tO\\nsiblings\\tO\\naffected\\tO\\nby\\tO\\nFMF\\tB-Disease\\n.\\tO\\n\\nEach\\tO\\npatient\\tO\\nrepresents\\tO\\na\\tO\\ndifferent\\tO\\nstage\\tO\\nof\\tO\\nthe\\tO\\namyloidotic\\tB-Disease\\nkidney\\tI-Disease\\ndisease\\tI-Disease\\nof\\tO\\nFMF\\tB-Disease\\nand\\tO\\nthe\\tO\\neffect\\tO\\nof\\tO\\ncontinuous\\tO\\ncolchicine\\tO\\ntreatment\\tO\\non\\tO\\nits\\tO\\ncourse\\tO\\n.\\tO\\n\\nConsidered\\tO\\ntogether\\tO\\n,\\tO\\nthe\\tO\\nmembers\\tO\\nof\\tO\\nthis\\tO\\nfamily\\tO\\npresent\\tO\\nan\\tO\\nalmost\\tO\\ncomplete\\tO\\nclinical\\tO\\n,\\tO\\ngenetic\\tO\\n,\\tO\\nand\\tO\\nbehavioral\\tO\\npicture\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n.\\tO\\n\\nDetection\\tO\\nof\\tO\\na\\tO\\nnew\\tO\\nsubmicroscopic\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\ndeletion\\tO\\ninterval\\tO\\nwith\\tO\\na\\tO\\nnovel\\tO\\nDNA\\tO\\nprobe\\tO\\nisolated\\tO\\nby\\tO\\ndifferential\\tO\\nAlu\\tO\\nPCR\\tO\\nfingerprint\\tO\\ncloning\\tO\\n.\\tO\\n\\nDifferential\\tO\\nAlu\\tO\\nPCR\\tO\\nfingerprint\\tO\\ncloning\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nisolate\\tO\\na\\tO\\nDNA\\tO\\nprobe\\tO\\nfrom\\tO\\nthe\\tO\\nXp11\\tO\\n.\\tO\\n\\n4\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\np11\\tO\\n.\\tO\\n\\n21\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nThis\\tO\\nnovel\\tO\\nsequence\\tO\\n,\\tO\\ncpXr318\\tO\\n(\\tO\\nDXS742\\tO\\n)\\tO\\n,\\tO\\ndetects\\tO\\na\\tO\\nnew\\tO\\nsubmicroscopic\\tO\\ndeletion\\tO\\ninterval\\tO\\nat\\tO\\nthe\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\nlocus\\tO\\n(\\tO\\nNDP\\tO\\n)\\tO\\n.\\tO\\n\\nCombining\\tO\\nour\\tO\\ndata\\tO\\nwith\\tO\\nthe\\tO\\nconsensus\\tO\\ngenetic\\tO\\nmap\\tO\\nof\\tO\\nthe\\tO\\nproximal\\tO\\nshort\\tO\\narm\\tO\\nof\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n,\\tO\\nwe\\tO\\npropose\\tO\\nthe\\tO\\nphysical\\tO\\norder\\tO\\nXcen\\tO\\n-\\tO\\nDXS14\\tO\\n-\\tO\\nDXS255\\tO\\n-\\tO\\n(\\tO\\nDXS426\\tO\\n,\\tO\\nTIMP\\tO\\n)\\tO\\n-\\tO\\n(\\tO\\nDXS742\\tO\\n-\\tO\\n(\\tO\\n[\\tO\\nMAOB\\tO\\n-\\tO\\nMAOA\\tO\\n-\\tO\\nDXS7\\tO\\n]\\tO\\n,\\tO\\nNDP\\tO\\n)\\tO\\n-\\tO\\nDXS77\\tO\\n-\\tO\\nDXS228\\tO\\n)\\tO\\n-\\tO\\nDXS209\\tO\\n-\\tO\\nDXS148\\tO\\n-\\tO\\nDXS196\\tO\\n-\\tO\\n+\\tO\\n+\\tO\\n+\\tO\\nXpter\\tO\\n.\\tO\\n\\nThe\\tO\\ncpXr318\\tO\\nprobe\\tO\\nand\\tO\\na\\tO\\nsubclone\\tO\\nfrom\\tO\\na\\tO\\ncosmid\\tO\\ncorresponding\\tO\\nto\\tO\\nthe\\tO\\nDXS7\\tO\\nlocus\\tO\\nwere\\tO\\nconverted\\tO\\ninto\\tO\\nsequence\\tO\\n-\\tO\\ntagged\\tO\\nsites\\tO\\n.\\tO\\n\\nFinally\\tO\\n,\\tO\\nDXS742\\tO\\n,\\tO\\nDSX7\\tO\\n,\\tO\\nDXS77\\tO\\n,\\tO\\nand\\tO\\nMAOA\\tO\\nwere\\tO\\nintegrated\\tO\\ninto\\tO\\na\\tO\\nphysical\\tO\\nmap\\tO\\nspanning\\tO\\nthe\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\nlocus\\tO\\n\\nPutative\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\ngene\\tO\\nshares\\tO\\nunexpected\\tO\\nhomology\\tO\\nwith\\tO\\nABC\\tO\\ntransporters\\tO\\n.\\tO\\n\\nAdrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndisease\\tI-Disease\\naffecting\\tO\\n1\\tO\\n/\\tO\\n20\\tO\\n,\\tO\\n000\\tO\\nmales\\tO\\neither\\tO\\nas\\tO\\ncerebral\\tB-Disease\\nALD\\tI-Disease\\nin\\tO\\nchildhood\\tO\\nor\\tO\\nas\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n(\\tO\\nAMN\\tB-Disease\\n)\\tO\\nin\\tO\\nadults\\tO\\n.\\tO\\n\\nChildhood\\tO\\nALD\\tB-Disease\\nis\\tO\\nthe\\tO\\nmore\\tO\\nsevere\\tO\\nform\\tO\\n,\\tO\\nwith\\tO\\nonset\\tO\\nof\\tO\\nneurological\\tO\\nsymptoms\\tO\\nbetween\\tO\\n5\\tO\\n-\\tO\\n12\\tO\\nyears\\tO\\nof\\tO\\nage\\tO\\n.\\tO\\n\\nCentral\\tB-Disease\\nnervous\\tI-Disease\\nsystem\\tI-Disease\\ndemyelination\\tI-Disease\\nprogresses\\tO\\nrapidly\\tO\\nand\\tO\\ndeath\\tO\\noccurs\\tO\\nwithin\\tO\\na\\tO\\nfew\\tO\\nyears\\tO\\n.\\tO\\n\\nAMN\\tB-Disease\\nis\\tO\\na\\tO\\nmilder\\tO\\nform\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nwith\\tO\\nonset\\tO\\nat\\tO\\n15\\tO\\n-\\tO\\n30\\tO\\nyears\\tO\\nof\\tO\\nage\\tO\\nand\\tO\\na\\tO\\nmore\\tO\\nprogressive\\tO\\ncourse\\tO\\n.\\tO\\n\\nAdrenal\\tB-Disease\\ninsufficiency\\tI-Disease\\n(\\tO\\nAddisons\\tB-Disease\\ndisease\\tI-Disease\\n)\\tO\\nmay\\tO\\nremain\\tO\\nthe\\tO\\nonly\\tO\\nclinical\\tO\\nmanifestation\\tO\\nof\\tO\\nALD\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nprincipal\\tO\\nbiochemical\\tO\\nabnormality\\tO\\nof\\tO\\nALD\\tB-Disease\\nis\\tO\\nthe\\tO\\naccumulation\\tO\\nof\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\n(\\tO\\nVLCFA\\tO\\n)\\tO\\nbecause\\tO\\nof\\tO\\nimpaired\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\nin\\tO\\nperoxisomes\\tO\\n.\\tO\\n\\nThe\\tO\\nnormal\\tO\\noxidation\\tO\\nof\\tO\\nVLCFA\\tO\\n-\\tO\\nCoA\\tO\\nin\\tO\\npatients\\tO\\nfibroblasts\\tO\\nsuggested\\tO\\nthat\\tO\\nthe\\tO\\ngene\\tO\\ncoding\\tO\\nfor\\tO\\nthe\\tO\\nVLCFA\\tO\\n-\\tO\\nCoA\\tO\\nsynthetase\\tO\\ncould\\tO\\nbe\\tO\\na\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nALD\\tB-Disease\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nuse\\tO\\npositional\\tO\\ncloning\\tO\\nto\\tO\\nidentify\\tO\\na\\tO\\ngene\\tO\\npartially\\tO\\ndeleted\\tO\\nin\\tO\\n6\\tO\\nof\\tO\\n85\\tO\\nindependent\\tO\\npatients\\tO\\nwith\\tO\\nALD\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\nfamilial\\tO\\ncases\\tO\\n,\\tO\\nthe\\tO\\ndeletions\\tO\\nsegregated\\tO\\nwith\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nAn\\tO\\nidentical\\tO\\ndeletion\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\ntwo\\tO\\nbrothers\\tO\\npresenting\\tO\\nwith\\tO\\ndifferent\\tO\\nclinical\\tO\\nALD\\tB-Disease\\nphenotypes\\tO\\n.\\tO\\n\\nCandidate\\tO\\nexons\\tO\\nwere\\tO\\nidentified\\tO\\nby\\tO\\ncomputer\\tO\\nanalysis\\tO\\nof\\tO\\ngenomic\\tO\\nsequences\\tO\\nand\\tO\\nused\\tO\\nto\\tO\\nisolate\\tO\\ncomplementary\\tO\\nDNAs\\tO\\nby\\tO\\nexon\\tO\\nconnection\\tO\\nand\\tO\\nscreening\\tO\\nof\\tO\\ncDNA\\tO\\nlibraries\\tO\\n.\\tO\\n\\nThe\\tO\\ndeduced\\tO\\nprotein\\tO\\nsequence\\tO\\nshows\\tO\\nsignificant\\tO\\nsequence\\tO\\nidentity\\tO\\nto\\tO\\na\\tO\\nperoxisomal\\tO\\nmembrane\\tO\\nprotein\\tO\\nof\\tO\\nM\\tO\\n(\\tO\\nr\\tO\\n)\\tO\\n70K\\tO\\nthat\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nperoxisome\\tO\\nbiogenesis\\tO\\nand\\tO\\nbelongs\\tO\\nto\\tO\\nthe\\tO\\nATP\\tO\\n-\\tO\\nbinding\\tO\\ncassette\\tO\\nsuperfamily\\tO\\nof\\tO\\ntransporters\\tO\\n.\\tO\\n.\\tO\\n\\nTargeted\\tO\\nmodification\\tO\\nof\\tO\\nthe\\tO\\napolipoprotein\\tO\\nB\\tO\\ngene\\tO\\nresults\\tO\\nin\\tO\\nhypobetalipoproteinemia\\tB-Disease\\nand\\tO\\ndevelopmental\\tB-Disease\\nabnormalities\\tI-Disease\\nin\\tO\\nmice\\tO\\n.\\tO\\n\\nFamilial\\tB-Disease\\nhypobetalipoproteinemia\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ncodominant\\tI-Disease\\ndisorder\\tI-Disease\\nresulting\\tO\\nin\\tO\\na\\tO\\ndramatic\\tO\\nreduction\\tO\\nin\\tO\\nplasma\\tO\\nconcentrations\\tO\\nof\\tO\\napolipoprotein\\tO\\n(\\tO\\napo\\tO\\n)\\tO\\nB\\tO\\n,\\tO\\ncholesterol\\tO\\n,\\tO\\nand\\tO\\nbeta\\tO\\n-\\tO\\nmigrating\\tO\\nlipoproteins\\tO\\n.\\tO\\n\\nA\\tO\\nbenefit\\tO\\nof\\tO\\nhypobetalipoproteinemia\\tB-Disease\\nis\\tO\\nthat\\tO\\nmildly\\tO\\naffected\\tO\\nindividuals\\tO\\nmay\\tO\\nbe\\tO\\nprotected\\tO\\nfrom\\tO\\ncoronary\\tB-Disease\\nvascular\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nused\\tO\\ngene\\tO\\ntargeting\\tO\\nto\\tO\\ngenerate\\tO\\nmice\\tO\\nwith\\tO\\na\\tO\\nmodified\\tO\\nApob\\tO\\nallele\\tO\\n.\\tO\\n\\nMice\\tO\\ncontaining\\tO\\nthis\\tO\\nallele\\tO\\ndisplay\\tO\\nall\\tO\\nof\\tO\\nthe\\tO\\nhallmarks\\tO\\nof\\tO\\nhuman\\tO\\nhypobetalipoproteinemia\\tB-Disease\\nthey\\tO\\nproduce\\tO\\na\\tO\\ntruncated\\tO\\napoB\\tO\\nprotein\\tO\\n,\\tO\\napoB70\\tO\\n,\\tO\\nand\\tO\\nhave\\tO\\nmarkedly\\tO\\ndecreased\\tO\\nplasma\\tO\\nconcentrations\\tO\\nof\\tO\\napoB\\tO\\n,\\tO\\nbeta\\tO\\n-\\tO\\nlipoproteins\\tO\\n,\\tO\\nand\\tO\\ntotal\\tO\\ncholesterol\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nthe\\tO\\nmice\\tO\\nmanifest\\tO\\nseveral\\tO\\ncharacteristics\\tO\\nthat\\tO\\nare\\tO\\noccasionally\\tO\\nobserved\\tO\\nin\\tO\\nhuman\\tO\\nhypobetalipoproteinemia\\tB-Disease\\n,\\tO\\nincluding\\tO\\nreduced\\tO\\nplasma\\tO\\ntriglyceride\\tO\\nconcentrations\\tO\\n,\\tO\\nfasting\\tO\\nchylomicronemia\\tB-Disease\\n,\\tO\\nand\\tO\\nreduced\\tO\\nhigh\\tO\\ndensity\\tO\\nlipoprotein\\tO\\ncholesterol\\tO\\n.\\tO\\n\\nAn\\tO\\nunexpected\\tO\\nfinding\\tO\\nis\\tO\\nthat\\tO\\nthe\\tO\\nmodified\\tO\\nApob\\tO\\nallele\\tO\\nis\\tO\\nstrongly\\tO\\nassociated\\tO\\nwith\\tO\\nexencephalus\\tB-Disease\\nand\\tO\\nhydrocephalus\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\nmice\\tO\\nshould\\tO\\nhelp\\tO\\nincrease\\tO\\nour\\tO\\nunderstanding\\tO\\nof\\tO\\nhypobetalipoproteinemia\\tB-Disease\\n,\\tO\\natherogenesis\\tB-Disease\\n,\\tO\\nand\\tO\\nthe\\tO\\netiology\\tO\\nof\\tO\\nexencephalus\\tB-Disease\\nand\\tO\\nhydrocephalus\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nnovel\\tO\\ndisease\\tO\\nwith\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nmitochondrial\\tI-Disease\\nvery\\tI-Disease\\n-\\tI-Disease\\nlong\\tI-Disease\\n-\\tI-Disease\\nchain\\tI-Disease\\nacyl\\tI-Disease\\n-\\tI-Disease\\nCoA\\tI-Disease\\ndehydrogenase\\tI-Disease\\n.\\tO\\n\\nPalmitoyl\\tO\\n-\\tO\\nCoA\\tO\\ndehydrogenase\\tO\\nactivity\\tO\\nin\\tO\\nskin\\tO\\nfibroblasts\\tO\\nfrom\\tO\\nseven\\tO\\npatients\\tO\\nwith\\tO\\nunidentified\\tO\\ndefects\\tO\\nof\\tO\\nfatty\\tO\\nacid\\tO\\noxidation\\tO\\nwas\\tO\\nmeasured\\tO\\nin\\tO\\nthe\\tO\\npresence\\tO\\nand\\tO\\nabsence\\tO\\nof\\tO\\nantibodies\\tO\\nagainst\\tO\\nmedium\\tO\\n-\\tO\\nchain\\tO\\n,\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\n,\\tO\\nand\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nacyl\\tO\\n-\\tO\\nCoA\\tO\\ndehydrogenases\\tO\\n(\\tO\\nVLCAD\\tO\\n)\\tO\\n.\\tO\\n\\nTwo\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\n,\\tO\\n4\\tO\\n-\\tO\\n5\\tO\\nmonth\\tO\\nold\\tO\\nboys\\tO\\n,\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nnovel\\tO\\ndisease\\tO\\n,\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nas\\tO\\njudged\\tO\\nfrom\\tO\\nthe\\tO\\nresults\\tO\\nof\\tO\\nvery\\tO\\nlow\\tO\\npalmitoyl\\tO\\n-\\tO\\nCoA\\tO\\ndehydrogenase\\tO\\nactivity\\tO\\nand\\tO\\nthe\\tO\\nlack\\tO\\nof\\tO\\nimmunoreactivity\\tO\\ntoward\\tO\\nantibody\\tO\\nraised\\tO\\nto\\tO\\npurified\\tO\\nVLCAD\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\ncharacterization\\tO\\nof\\tO\\nglucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\npatients\\tO\\nof\\tO\\nChinese\\tO\\ndescent\\tO\\nand\\tO\\nidentification\\tO\\nof\\tO\\nnew\\tO\\nbase\\tO\\nsubstitutions\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nG6PD\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nunderlying\\tO\\nDNA\\tO\\nchanges\\tO\\nassociated\\tO\\nwith\\tO\\nglucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nAsians\\tO\\nhave\\tO\\nnot\\tO\\nbeen\\tO\\nextensively\\tO\\ninvestigated\\tO\\n.\\tO\\n\\nTo\\tO\\nfill\\tO\\nthis\\tO\\ngap\\tO\\n,\\tO\\nwe\\tO\\nsequenced\\tO\\nthe\\tO\\nG6PD\\tO\\ngene\\tO\\nof\\tO\\n43\\tO\\nG6PD\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nChinese\\tO\\nwhose\\tO\\nG6PD\\tO\\nwas\\tO\\nwell\\tO\\ncharacterized\\tO\\nbiochemically\\tO\\n.\\tO\\n\\nDNA\\tO\\nsamples\\tO\\nwere\\tO\\nobtained\\tO\\nfrom\\tO\\nperipheral\\tO\\nblood\\tO\\nof\\tO\\nthese\\tO\\nindividuals\\tO\\nfor\\tO\\nsequencing\\tO\\nusing\\tO\\na\\tO\\ndirect\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\nsequencing\\tO\\nprocedure\\tO\\n.\\tO\\n\\nFrom\\tO\\nthese\\tO\\n43\\tO\\nsamples\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nidentified\\tO\\nfive\\tO\\ndifferent\\tO\\ntypes\\tO\\nof\\tO\\nnucleotide\\tO\\nsubstitutions\\tO\\nin\\tO\\nthe\\tO\\nG6PD\\tO\\ngene\\tO\\nat\\tO\\ncDNA\\tO\\n1388\\tO\\nfrom\\tO\\nG\\tO\\nto\\tO\\nA\\tO\\n(\\tO\\nArg\\tO\\nto\\tO\\nHis\\tO\\n)\\tO\\n;\\tO\\nat\\tO\\ncDNA\\tO\\n1376\\tO\\nfrom\\tO\\nG\\tO\\nto\\tO\\nT\\tO\\n(\\tO\\nArg\\tO\\nto\\tO\\nLeu\\tO\\n)\\tO\\n;\\tO\\nat\\tO\\ncDNA\\tO\\n1024\\tO\\nfrom\\tO\\nC\\tO\\nto\\tO\\nT\\tO\\n(\\tO\\nLeu\\tO\\nto\\tO\\nPhe\\tO\\n)\\tO\\n;\\tO\\nat\\tO\\ncDNA\\tO\\n392\\tO\\nfrom\\tO\\nG\\tO\\nto\\tO\\nT\\tO\\n(\\tO\\nGly\\tO\\nto\\tO\\nVal\\tO\\n)\\tO\\n;\\tO\\nat\\tO\\ncDNA\\tO\\n95\\tO\\nfrom\\tO\\nA\\tO\\nto\\tO\\nG\\tO\\n(\\tO\\nHis\\tO\\nto\\tO\\nArg\\tO\\n)\\tO\\n.\\tO\\n\\nThese\\tO\\nfive\\tO\\nnucleotide\\tO\\nsubstitutions\\tO\\naccount\\tO\\nfor\\tO\\nover\\tO\\n83\\tO\\n%\\tO\\nof\\tO\\nour\\tO\\n43\\tO\\nG6PD\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nsamples\\tO\\nand\\tO\\nthese\\tO\\nsubstitutions\\tO\\nhave\\tO\\nnot\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nAsians\\tO\\n.\\tO\\n\\nThe\\tO\\nsubstitutions\\tO\\nfound\\tO\\nat\\tO\\ncDNA\\tO\\n392\\tO\\nand\\tO\\ncDNA\\tO\\n1024\\tO\\nare\\tO\\nnew\\tO\\nfindings\\tO\\n.\\tO\\n\\nThe\\tO\\nsubstitutions\\tO\\nat\\tO\\ncDNA\\tO\\n1376\\tO\\nand\\tO\\n1388\\tO\\naccount\\tO\\nfor\\tO\\nover\\tO\\n50\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\n43\\tO\\nsamples\\tO\\nexamined\\tO\\nindicating\\tO\\na\\tO\\nhigh\\tO\\nprevalence\\tO\\nof\\tO\\nthese\\tO\\ntwo\\tO\\nalleles\\tO\\namong\\tO\\nG6PD\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nChinese\\tO\\n.\\tO\\n\\nOur\\tO\\nfindings\\tO\\nadd\\tO\\nsupport\\tO\\nto\\tO\\nthe\\tO\\nnotion\\tO\\nthat\\tO\\ndiverse\\tO\\npoint\\tO\\nmutations\\tO\\nmay\\tO\\naccount\\tO\\nlargely\\tO\\nfor\\tO\\nmuch\\tO\\nof\\tO\\nthe\\tO\\nphenotypic\\tO\\nheterogeneity\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nDanish\\tO\\nchoroideremia\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nsearched\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nchoroideremia\\tB-Disease\\ngene\\tO\\n(\\tO\\nCHM\\tB-Disease\\n)\\tO\\nin\\tO\\npatients\\tO\\nfrom\\tO\\n12\\tO\\nDanish\\tO\\nfamilies\\tO\\nin\\tO\\nwhich\\tO\\nCHM\\tB-Disease\\nis\\tO\\nsegregating\\tO\\n.\\tO\\n\\nEmploying\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\n,\\tO\\nsingle\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\nanalysis\\tO\\n,\\tO\\nand\\tO\\ndirect\\tO\\nDNA\\tO\\nsequencing\\tO\\n,\\tO\\ndifferent\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\n6\\tO\\npatients\\tO\\n.\\tO\\n\\nAll\\tO\\nthe\\tO\\nmutations\\tO\\nwill\\tO\\ninterfere\\tO\\nwith\\tO\\nthe\\tO\\ncorrect\\tO\\ntranslation\\tO\\nof\\tO\\nthe\\tO\\nmRNA\\tO\\npredicting\\tO\\na\\tO\\ntruncated\\tO\\nprotein\\tO\\nor\\tO\\nno\\tO\\ngene\\tO\\nproduct\\tO\\nat\\tO\\nall\\tO\\n.\\tO\\n.\\tO\\n\\nStructure\\tO\\nand\\tO\\ngenomic\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\nkinase\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\ncausing\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nidentified\\tO\\nas\\tO\\nan\\tO\\nunstable\\tO\\nCTG\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\na\\tO\\ngene\\tO\\nencoding\\tO\\nfor\\tO\\na\\tO\\nprotein\\tO\\nwith\\tO\\nputative\\tO\\nserine\\tO\\n-\\tO\\nthreonine\\tO\\nprotein\\tO\\nkinase\\tO\\nactivity\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nreport\\tO\\nwe\\tO\\npresent\\tO\\nthe\\tO\\ngenomic\\tO\\nsequences\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nand\\tO\\nmurine\\tO\\nDM\\tB-Disease\\nkinase\\tO\\ngene\\tO\\n.\\tO\\n\\nA\\tO\\ncomparison\\tO\\nof\\tO\\nthese\\tO\\nsequences\\tO\\nwith\\tO\\neach\\tO\\nother\\tO\\nand\\tO\\nwith\\tO\\nknown\\tO\\ncDNA\\tO\\nsequences\\tO\\nfrom\\tO\\nboth\\tO\\nspecies\\tO\\n,\\tO\\nled\\tO\\nus\\tO\\nto\\tO\\npredict\\tO\\na\\tO\\ntranslation\\tO\\ninitiation\\tO\\ncodon\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\ndetermine\\tO\\nthe\\tO\\norganization\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nkinase\\tO\\ngene\\tO\\n.\\tO\\n\\nSeveral\\tO\\npolymorphisms\\tO\\nwithin\\tO\\nthe\\tO\\nhuman\\tO\\nDM\\tB-Disease\\nkinase\\tO\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\n,\\tO\\nand\\tO\\nPCR\\tO\\nassays\\tO\\nto\\tO\\ndetect\\tO\\ntwo\\tO\\nof\\tO\\nthese\\tO\\nare\\tO\\ndescribed\\tO\\n.\\tO\\n\\nThe\\tO\\ncomplete\\tO\\nsequence\\tO\\nand\\tO\\ncharacterization\\tO\\nof\\tO\\nthe\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nkinase\\tO\\ngene\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\nnovel\\tO\\npolymorphisms\\tO\\nwithin\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nrepresent\\tO\\nan\\tO\\nimportant\\tO\\nstep\\tO\\nin\\tO\\na\\tO\\nfurther\\tO\\nunderstanding\\tO\\nof\\tO\\nthe\\tO\\ngenetics\\tO\\nof\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nand\\tO\\nthe\\tO\\nmolecular\\tO\\nbiology\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n.\\tO\\n\\nAutosomal\\tO\\nrecessive\\tO\\ntransmission\\tO\\nof\\tO\\nhemophilia\\tB-Disease\\nA\\tI-Disease\\ndue\\tO\\nto\\tO\\na\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\ndifferential\\tO\\ndiagnosis\\tO\\nof\\tO\\nthe\\tO\\ngenetic\\tB-Disease\\nbleeding\\tI-Disease\\ndisorders\\tI-Disease\\n,\\tO\\nhemophilia\\tB-Disease\\nA\\tI-Disease\\nand\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nis\\tO\\noccasionally\\tO\\nconfounded\\tO\\nby\\tO\\nthe\\tO\\nclose\\tO\\nmolecular\\tO\\nrelationship\\tO\\nof\\tO\\ncoagulation\\tO\\nfactor\\tO\\nVIII\\tO\\nand\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\n(\\tO\\nvWF\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nreport\\tO\\ndescribes\\tO\\nthe\\tO\\nautosomal\\tO\\ninheritance\\tO\\nof\\tO\\na\\tO\\nhemophilia\\tB-Disease\\nA\\tI-Disease\\nphenotype\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nmutation\\tO\\nof\\tO\\nvWF\\tO\\nthat\\tO\\nresults\\tO\\nin\\tO\\ndefective\\tO\\nfactor\\tO\\nVIII\\tO\\nbinding\\tO\\n.\\tO\\n\\nThe\\tO\\nproband\\tO\\nwas\\tO\\na\\tO\\nfemale\\tO\\npatient\\tO\\nwith\\tO\\nlow\\tO\\nlevels\\tO\\nof\\tO\\nfactor\\tO\\nVIII\\tO\\nactivity\\tO\\n.\\tO\\n\\nPolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\namplification\\tO\\nand\\tO\\nDNA\\tO\\nsequencing\\tO\\nwere\\tO\\nemployed\\tO\\nto\\tO\\nexamine\\tO\\nexons\\tO\\nencoding\\tO\\nthe\\tO\\nputative\\tO\\nfactor\\tO\\nVIII\\tO\\nbinding\\tO\\ndomain\\tO\\nof\\tO\\nvWF\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nsingle\\tO\\npoint\\tO\\nmutation\\tO\\ncausing\\tO\\na\\tO\\nThr\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nMet\\tO\\nsubstitution\\tO\\nat\\tO\\namino\\tO\\nacid\\tO\\nposition\\tO\\n28\\tO\\nin\\tO\\nthe\\tO\\nmature\\tO\\nvWF\\tO\\nsubunit\\tO\\n.\\tO\\n\\nThe\\tO\\nphenotypic\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\nwas\\tO\\ndetermined\\tO\\nto\\tO\\nbe\\tO\\nrecessive\\tO\\nbecause\\tO\\nheterozygous\\tO\\nfamily\\tO\\nmembers\\tO\\nwere\\tO\\nclinically\\tO\\nunaffected\\tO\\n.\\tO\\n\\nRecombinant\\tO\\nvWF\\tO\\ncontaining\\tO\\nthe\\tO\\nobserved\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\nwas\\tO\\nexpressed\\tO\\nin\\tO\\nCOS\\tO\\n-\\tO\\n1\\tO\\ncells\\tO\\n.\\tO\\n\\nThe\\tO\\nmutant\\tO\\nvWF\\tO\\nwas\\tO\\nprocessed\\tO\\nand\\tO\\nsecreted\\tO\\nnormally\\tO\\n,\\tO\\nand\\tO\\nwas\\tO\\nfunctionally\\tO\\nequivalent\\tO\\nto\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nvWF\\tO\\nin\\tO\\nits\\tO\\nability\\tO\\nto\\tO\\nbind\\tO\\nto\\tO\\nplatelets\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nmutant\\tO\\nfailed\\tO\\nto\\tO\\nbind\\tO\\nfactor\\tO\\nVIII\\tO\\n,\\tO\\ndemonstrating\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\nwas\\tO\\nfunctionally\\tO\\nrelated\\tO\\nto\\tO\\nthe\\tO\\nobserved\\tO\\nhemophilia\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nThe\\tO\\nfamily\\tO\\nwe\\tO\\ndescribe\\tO\\ndemonstrates\\tO\\nthe\\tO\\nrecessive\\tO\\ninheritance\\tO\\nof\\tO\\na\\tO\\nrecently\\tO\\nrecognized\\tO\\nclass\\tO\\nof\\tO\\ngenetic\\tO\\nbleeding\\tO\\ndisorders\\tO\\n,\\tO\\nwe\\tO\\ncall\\tO\\n\"\\tO\\nautosomal\\tO\\nhemophilia\\tB-Disease\\n.\\tO\\n\\n\"\\tO\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nvWF\\tO\\nmutation\\tO\\nmay\\tO\\nbe\\tO\\nan\\tO\\nunder\\tO\\nrecognized\\tO\\ncause\\tO\\nof\\tO\\nhemophilia\\tB-Disease\\n,\\tO\\nespecially\\tO\\nin\\tO\\ncases\\tO\\nwhere\\tO\\nthe\\tO\\ninheritance\\tO\\npattern\\tO\\nis\\tO\\nnot\\tO\\nconsistent\\tO\\nwith\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\ntransmission\\tO\\n.\\tO\\n\\nSomatic\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\nmutation\\tO\\nin\\tO\\nclear\\tO\\ncell\\tO\\npapillary\\tB-Disease\\ncystadenoma\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nepididymis\\tI-Disease\\n.\\tO\\n\\nPapillary\\tB-Disease\\ncystadenoma\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nepididymis\\tI-Disease\\nis\\tO\\nan\\tO\\nuncommon\\tO\\nbenign\\tO\\nlesion\\tO\\nthat\\tO\\nmay\\tO\\noccur\\tO\\nsporadically\\tO\\nor\\tO\\nas\\tO\\na\\tO\\nmanifestation\\tO\\nof\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\n(\\tI-Disease\\nVHL\\tI-Disease\\n)\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nNeither\\tO\\nimmunohistochemical\\tO\\nstudies\\tO\\nnor\\tO\\nmolecular\\tO\\ngenetic\\tO\\nanalyses\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\npreviously\\tO\\nfor\\tO\\nthis\\tO\\nlesion\\tO\\n.\\tO\\n\\nThe\\tO\\nauthors\\tO\\ndescribe\\tO\\ntwo\\tO\\ncases\\tO\\nof\\tO\\nclear\\tO\\ncell\\tO\\npapillary\\tB-Disease\\ncystadenoma\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nepididymis\\tI-Disease\\n,\\tO\\nboth\\tO\\nof\\tO\\nwhich\\tO\\nwere\\tO\\ninitially\\tO\\nconfused\\tO\\nwith\\tO\\nmetastatic\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\n.\\tO\\n\\nBoth\\tO\\nlesions\\tO\\nshowed\\tO\\npositive\\tO\\nimmunohistochemical\\tO\\nstaining\\tO\\nfor\\tO\\nlow\\tO\\nand\\tO\\nintermediate\\tO\\nmolecular\\tO\\nweight\\tO\\nkeratins\\tO\\n(\\tO\\nCam\\tO\\n5\\tO\\n.\\tO\\n2\\tO\\nand\\tO\\nAE1\\tO\\n/\\tO\\nAE3\\tO\\n)\\tO\\n,\\tO\\nEMA\\tO\\n,\\tO\\nvimentin\\tO\\n,\\tO\\nalpha\\tO\\n1\\tO\\n-\\tO\\nantitrypsin\\tO\\n,\\tO\\nand\\tO\\nalpha\\tO\\n1\\tO\\n-\\tO\\nantichymotrypsin\\tO\\n.\\tO\\n\\nEach\\tO\\nwas\\tO\\nnegative\\tO\\nfor\\tO\\nCEA\\tO\\n.\\tO\\n\\nBecause\\tO\\nclear\\tO\\ncell\\tO\\npapillary\\tB-Disease\\ncystadenoma\\tI-Disease\\nis\\tO\\nsimilar\\tO\\nto\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\nhistologically\\tO\\n,\\tO\\nand\\tO\\nbecause\\tO\\nboth\\tO\\noccur\\tO\\nas\\tO\\ncomponents\\tO\\nof\\tO\\nthe\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ndisease\\tI-Disease\\ncomplex\\tO\\n,\\tO\\nthe\\tO\\nauthors\\tO\\nanalyzed\\tO\\nboth\\tO\\ncases\\tO\\nfor\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nA\\tO\\nsomatic\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nmutation\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\ntumors\\tB-Disease\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nfollowed\\tO\\nby\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\nanalysis\\tO\\n.\\tO\\n\\nDirect\\tO\\nsequencing\\tO\\nrevealed\\tO\\na\\tO\\ncytosine\\tO\\nto\\tO\\nthymine\\tO\\ntransition\\tO\\nat\\tO\\nnucleotide\\tO\\n694\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nthe\\tO\\nreplacement\\tO\\nof\\tO\\nan\\tO\\narginine\\tO\\nwith\\tO\\na\\tO\\nstop\\tO\\ncodon\\tO\\nafter\\tO\\nthe\\tO\\nsixth\\tO\\namino\\tO\\nacid\\tO\\nof\\tO\\nexon\\tO\\n3\\tO\\n.\\tO\\n\\nAs\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nis\\tO\\nbelieved\\tO\\nto\\tO\\nfunction\\tO\\nas\\tO\\na\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n,\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nmutations\\tO\\nmay\\tO\\nplay\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\ninitiation\\tO\\nof\\tO\\ntumorigenesis\\tO\\nin\\tO\\nsporadic\\tO\\ncystadenomas\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nepididymis\\tI-Disease\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nWASP\\tO\\nmutations\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nisolated\\tB-Disease\\nthrombocytopenia\\tI-Disease\\nreveals\\tO\\nallelic\\tO\\nheterogeneity\\tO\\nat\\tO\\nthe\\tO\\nWAS\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nMutation\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nencoding\\tO\\nthe\\tO\\nrecently\\tO\\nisolated\\tO\\nWASP\\tO\\nprotein\\tO\\nhas\\tO\\nnow\\tO\\nbeen\\tO\\nidentified\\tO\\nas\\tO\\nthe\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nWiskott\\tI-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nprimary\\tO\\nimmunodeficiency\\tB-Disease\\ndisease\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nextensive\\tO\\nphenotypic\\tO\\nvariability\\tO\\n.\\tO\\n\\nTo\\tO\\nelucidate\\tO\\nthe\\tO\\nrange\\tO\\nof\\tO\\nWASP\\tO\\nmutations\\tO\\nresponsible\\tO\\nfor\\tO\\nWAS\\tB-Disease\\n,\\tO\\nwe\\tO\\nused\\tO\\nPCR\\tO\\n-\\tO\\nSSCP\\tO\\nanalysis\\tO\\nto\\tO\\nscreen\\tO\\nfor\\tO\\nWASP\\tO\\ngene\\tO\\nmutation\\tO\\nin\\tO\\n19\\tO\\nunrelated\\tO\\nboys\\tO\\nwith\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nclassical\\tO\\nor\\tO\\nattenuated\\tO\\nWAS\\tB-Disease\\nor\\tO\\nisolated\\tB-Disease\\nthrombocytopenia\\tI-Disease\\n.\\tO\\n\\nAll\\tO\\n19\\tO\\npatients\\tO\\nhad\\tO\\nWASP\\tO\\nmutations\\tO\\n,\\tO\\neach\\tO\\nof\\tO\\nwhich\\tO\\nlocalized\\tO\\nto\\tO\\nthe\\tO\\ninitial\\tO\\nthree\\tO\\nor\\tO\\nterminal\\tO\\nthree\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nwhich\\tO\\nwere\\tO\\nunique\\tO\\nin\\tO\\neach\\tO\\ncase\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nwhich\\tO\\nresults\\tO\\nin\\tO\\nsubstitution\\tO\\nof\\tO\\nthe\\tO\\narginine\\tO\\nat\\tO\\nWAS\\tB-Disease\\ncodon\\tO\\n86\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\nthree\\tO\\nboys\\tO\\nwith\\tO\\nsevere\\tO\\nWAS\\tB-Disease\\nas\\tO\\nwell\\tO\\nas\\tO\\nin\\tO\\none\\tO\\nboy\\tO\\npresenting\\tO\\nwith\\tO\\nthrombocytopenia\\tB-Disease\\nalone\\tO\\n.\\tO\\n\\nWhile\\tO\\nthe\\tO\\nthree\\tO\\nmutations\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nisolated\\tB-Disease\\nthrombocytopenia\\tI-Disease\\npatients\\tO\\nleave\\tO\\nthe\\tO\\nreading\\tO\\nframe\\tO\\nintact\\tO\\n,\\tO\\nabout\\tO\\none\\tO\\n-\\tO\\nhalf\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nalterations\\tO\\ndetected\\tO\\nin\\tO\\nboth\\tO\\nsevere\\tO\\nand\\tO\\nattenuated\\tO\\nWAS\\tB-Disease\\npatients\\tO\\nresult\\tO\\nin\\tO\\nframeshifted\\tO\\ntranscript\\tO\\nand\\tO\\npremature\\tO\\ntranslation\\tO\\ntermination\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\ntherefore\\tO\\nconfirm\\tO\\nthe\\tO\\nassociation\\tO\\nof\\tO\\nWAS\\tB-Disease\\nwith\\tO\\nWASP\\tO\\nmutation\\tO\\nand\\tO\\nidentify\\tO\\nWASP\\tO\\nmutation\\tO\\nas\\tO\\na\\tO\\ncause\\tO\\nfor\\tO\\nisolated\\tO\\ncongenital\\tB-Disease\\nthrombocytopenia\\tI-Disease\\nin\\tO\\nmales\\tO\\n.\\tO\\n\\nWhile\\tO\\nthe\\tO\\nWASP\\tO\\ngene\\tO\\ndefects\\tO\\nresponsible\\tO\\nfor\\tO\\nisolated\\tB-Disease\\nthrombocytopenia\\tI-Disease\\nand\\tO\\nother\\tO\\nmild\\tO\\npresentations\\tO\\nof\\tO\\nWAS\\tB-Disease\\ndo\\tO\\nnot\\tO\\nappear\\tO\\ndistinct\\tO\\nfrom\\tO\\nthose\\tO\\nresulting\\tO\\nin\\tO\\nsevere\\tO\\nWAS\\tB-Disease\\n,\\tO\\nthese\\tO\\ndata\\tO\\nindicate\\tO\\nthat\\tO\\nanalysis\\tO\\nof\\tO\\nWASP\\tO\\ngene\\tO\\nmutation\\tO\\nprovides\\tO\\na\\tO\\nvaluable\\tO\\ntool\\tO\\nfor\\tO\\ndistinguishing\\tO\\nthe\\tO\\nspectrum\\tO\\nof\\tO\\nWAS\\tB-Disease\\npatients\\tO\\nand\\tO\\nthe\\tO\\nsubset\\tO\\nof\\tO\\nmales\\tO\\nwith\\tO\\nisolated\\tB-Disease\\nthrombocytopenia\\tI-Disease\\nwho\\tO\\nrepresent\\tO\\nmild\\tO\\ncases\\tO\\nof\\tO\\nWAS\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nWASP\\tO\\ngene\\tO\\nmutations\\tO\\nin\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nthrombocytopenia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nWASP\\tO\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nrecently\\tO\\ncloned\\tO\\nfrom\\tO\\nXp11\\tO\\n.\\tO\\n\\n23\\tO\\nand\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\nmutated\\tO\\nin\\tO\\nthree\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndeveloped\\tO\\na\\tO\\nscreening\\tO\\nprotocol\\tO\\nfor\\tO\\nidentifying\\tO\\nWASP\\tO\\ngene\\tO\\nalterations\\tO\\nin\\tO\\ngenomic\\tO\\nDNA\\tO\\nand\\tO\\nhave\\tO\\nidentified\\tO\\na\\tO\\nspectrum\\tO\\nof\\tO\\nnovel\\tO\\nmutations\\tO\\nin\\tO\\n12\\tO\\nadditional\\tO\\nunrelated\\tO\\nfamilies\\tO\\n.\\tO\\n\\nThese\\tO\\nmissense\\tO\\n,\\tO\\nnonsense\\tO\\nand\\tO\\nframeshift\\tO\\nmutations\\tO\\ninvolve\\tO\\neight\\tO\\nof\\tO\\nthe\\tO\\n12\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nTwo\\tO\\nmutations\\tO\\ncreating\\tO\\npremature\\tO\\ntermination\\tO\\ncodons\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\nlack\\tO\\nof\\tO\\ndetectable\\tO\\nmRNA\\tO\\non\\tO\\nNorthern\\tO\\nblots\\tO\\n.\\tO\\n\\nFour\\tO\\namino\\tO\\nacid\\tO\\nsubstitutions\\tO\\n,\\tO\\nLeu27Phe\\tO\\n,\\tO\\nThr48Ile\\tO\\n,\\tO\\nVal75Met\\tO\\nand\\tO\\nArg477Lys\\tO\\n,\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\nthrombocytopenia\\tI-Disease\\nand\\tO\\nno\\tO\\nclinically\\tO\\nevident\\tO\\nimmune\\tO\\ndefect\\tO\\nindicating\\tO\\nthat\\tO\\nthe\\tO\\nWASP\\tO\\ngene\\tO\\nis\\tO\\nthe\\tO\\nsite\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nthrombocytopenia\\tI-Disease\\nas\\tO\\nwell\\tO\\nas\\tO\\nin\\tO\\nWAS\\tB-Disease\\n.\\tO\\n\\nA\\tO\\nT\\tO\\n-\\tO\\ncell\\tO\\nline\\tO\\nfrom\\tO\\na\\tO\\nWAS\\tB-Disease\\npatient\\tO\\ncontained\\tO\\ntwo\\tO\\nindependent\\tO\\nDNA\\tO\\nalterations\\tO\\n,\\tO\\na\\tO\\nconstitutional\\tO\\nframeshift\\tO\\nmutation\\tO\\n,\\tO\\nalso\\tO\\npresent\\tO\\nin\\tO\\nperipheral\\tO\\nblood\\tO\\nleukocytes\\tO\\nfrom\\tO\\nthe\\tO\\npatient\\tO\\n,\\tO\\nand\\tO\\ncompensatory\\tO\\nsplice\\tO\\nsite\\tO\\nmutation\\tO\\nunique\\tO\\nto\\tO\\nthe\\tO\\ncell\\tO\\nline\\tO\\n.\\tO\\n\\nThe\\tO\\ndistribution\\tO\\nof\\tO\\neight\\tO\\nmissense\\tO\\nmutations\\tO\\nprovides\\tO\\nvaluable\\tO\\ninformation\\tO\\non\\tO\\namino\\tO\\nacids\\tO\\nwhich\\tO\\nare\\tO\\nessential\\tO\\nfor\\tO\\nnormal\\tO\\nprotein\\tO\\nfunction\\tO\\n,\\tO\\nand\\tO\\nsuggests\\tO\\nthat\\tO\\nsites\\tO\\nin\\tO\\nthe\\tO\\nfirst\\tO\\ntwo\\tO\\nexons\\tO\\nare\\tO\\nhot\\tO\\n-\\tO\\nspots\\tO\\nfor\\tO\\nmutation\\tO\\n.\\tO\\n\\nEvidence\\tO\\nfor\\tO\\ninter\\tO\\n-\\tO\\ngenerational\\tO\\ninstability\\tO\\nin\\tO\\nthe\\tO\\nCAG\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\nMJD1\\tO\\ngene\\tO\\nand\\tO\\nfor\\tO\\nconserved\\tO\\nhaplotypes\\tO\\nat\\tO\\nflanking\\tO\\nmarkers\\tO\\namongst\\tO\\nJapanese\\tO\\nand\\tO\\nCaucasian\\tO\\nsubjects\\tO\\nwith\\tO\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\n(\\tO\\nCAG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\narray\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\n\\'\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\nMJD1\\tO\\ngene\\tO\\nand\\tO\\nthe\\tO\\nhaplotype\\tO\\nat\\tO\\na\\tO\\nseries\\tO\\nof\\tO\\nmicrosatellite\\tO\\nmarkers\\tO\\nsurrounding\\tO\\nthe\\tO\\nMJD1\\tO\\ngene\\tO\\nwere\\tO\\nexamined\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\ncohort\\tO\\nof\\tO\\nJapanese\\tO\\nand\\tO\\nCaucasian\\tO\\nsubjects\\tO\\naffected\\tO\\nwith\\tO\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nMJD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nprovide\\tO\\nfive\\tO\\nnovel\\tO\\nobservations\\tO\\n.\\tO\\n\\nFirst\\tO\\n,\\tO\\nMJD\\tB-Disease\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nexpansion\\tO\\nfo\\tO\\nthe\\tO\\narray\\tO\\nfrom\\tO\\nthe\\tO\\nnormal\\tO\\nrange\\tO\\nof\\tO\\n14\\tO\\n-\\tO\\n37\\tO\\nrepeats\\tO\\nto\\tO\\n68\\tO\\n-\\tO\\n84\\tO\\nrepeats\\tO\\nin\\tO\\nmost\\tO\\nJapanese\\tO\\nand\\tO\\nCaucasian\\tO\\nsubjects\\tO\\n,\\tO\\nbut\\tO\\nno\\tO\\nsubjects\\tO\\nwere\\tO\\nobserved\\tO\\nwith\\tO\\nexpansions\\tO\\nintermediate\\tO\\nin\\tO\\nsize\\tO\\nbetween\\tO\\nthose\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\nMJD\\tB-Disease\\naffected\\tO\\ngroups\\tO\\n.\\tO\\n\\nSecond\\tO\\n,\\tO\\nthe\\tO\\nexpanded\\tO\\nallele\\tO\\nassociated\\tO\\nwith\\tO\\nMJD\\tB-Disease\\ndisplays\\tO\\ninter\\tO\\n-\\tO\\ngenerational\\tO\\ninstability\\tO\\n,\\tO\\nparticularly\\tO\\nin\\tO\\nmale\\tO\\nmeioses\\tO\\n,\\tO\\nand\\tO\\nthis\\tO\\ninstability\\tO\\nwas\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nclinical\\tO\\nphenomenon\\tO\\nof\\tO\\nanticipation\\tO\\n.\\tO\\n\\nThird\\tO\\n,\\tO\\nthe\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\nexpanded\\tO\\nallele\\tO\\nis\\tO\\nnot\\tO\\nonly\\tO\\ninversely\\tO\\ncorrelated\\tO\\nwith\\tO\\nthe\\tO\\nage\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\nonset\\tO\\nof\\tO\\nMJD\\tB-Disease\\n(\\tO\\nr\\tO\\n=\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n738\\tO\\n,\\tO\\np\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n001\\tO\\n)\\tO\\n,\\tO\\nbut\\tO\\nis\\tO\\nalso\\tO\\ncorrelated\\tO\\nwith\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nother\\tO\\nclinical\\tO\\nfeatures\\tO\\n[\\tO\\ne\\tO\\n.\\tO\\ng\\tO\\n.\\tO\\npseudoexophthalmos\\tO\\nand\\tO\\npyramidal\\tO\\nsigns\\tO\\nwere\\tO\\nmore\\tO\\nfrequent\\tO\\nin\\tO\\nsubjects\\tO\\nwith\\tO\\nlarge\\tO\\nrepeats\\tO\\n(\\tO\\np\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n001\\tO\\nand\\tO\\np\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n05\\tO\\nrespectively\\tO\\n)\\tO\\n]\\tO\\n.\\tO\\n\\nFourth\\tO\\n,\\tO\\nthe\\tO\\ndisease\\tO\\nphenotype\\tO\\nis\\tO\\nsignificantly\\tO\\nmore\\tO\\nsevere\\tO\\nand\\tO\\nhad\\tO\\nan\\tO\\nearly\\tO\\nage\\tO\\nof\\tO\\nonset\\tO\\n(\\tO\\n16\\tO\\nyears\\tO\\n)\\tO\\nin\\tO\\na\\tO\\nsubject\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\nexpanded\\tO\\nallele\\tO\\n,\\tO\\nwhich\\tO\\ncontrasts\\tO\\nwith\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\nand\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nexpanded\\tO\\nallele\\tO\\nin\\tO\\nthe\\tO\\nMJD1\\tO\\ngene\\tO\\ncould\\tO\\nexert\\tO\\nits\\tO\\neffect\\tO\\neither\\tO\\nby\\tO\\na\\tO\\ndominant\\tO\\nnegative\\tO\\neffect\\tO\\n(\\tO\\nputatively\\tO\\nexcluded\\tO\\nin\\tO\\nHD\\tB-Disease\\n)\\tO\\nor\\tO\\nby\\tO\\na\\tO\\ngain\\tO\\nof\\tO\\nfunction\\tO\\neffect\\tO\\nas\\tO\\nproposed\\tO\\nfor\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nFinally\\tO\\n,\\tO\\nJapanese\\tO\\nand\\tO\\nCaucasian\\tO\\nsubjects\\tO\\naffected\\tO\\nwith\\tO\\nMJD\\tB-Disease\\nshare\\tO\\nhaplotypes\\tO\\nat\\tO\\nseveral\\tO\\nmarkers\\tO\\nsurrounding\\tO\\nthe\\tO\\nMJD1\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nare\\tO\\nuncommon\\tO\\nin\\tO\\nthe\\tO\\nnormal\\tO\\nJapanese\\tO\\nand\\tO\\nCaucasian\\tO\\npopulation\\tO\\n,\\tO\\nand\\tO\\nwhich\\tO\\nsuggests\\tO\\nthe\\tO\\nexistence\\tO\\neither\\tO\\nof\\tO\\ncommon\\tO\\nfounders\\tO\\nin\\tO\\nthese\\tO\\npopulations\\tO\\nor\\tO\\nof\\tO\\nchromosomes\\tO\\nsusceptible\\tO\\nto\\tO\\npathologic\\tO\\nexpansion\\tO\\nof\\tO\\nthe\\tO\\nCAG\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\nMJD1\\tO\\ngene\\tO\\n.\\tO\\n\\nA\\tO\\n4\\tO\\n-\\tO\\nmegabase\\tO\\nYAC\\tO\\ncontig\\tO\\nthat\\tO\\nspans\\tO\\nthe\\tO\\nLanger\\tB-Disease\\n-\\tI-Disease\\nGiedion\\tI-Disease\\nsyndrome\\tI-Disease\\nregion\\tO\\non\\tO\\nhuman\\tO\\nchromosome\\tO\\n8q24\\tO\\n.\\tO\\n1\\tO\\n:\\tO\\nuse\\tO\\nin\\tO\\nrefining\\tO\\nthe\\tO\\nlocation\\tO\\nof\\tO\\nthe\\tO\\ntrichorhinophalangeal\\tB-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nmultiple\\tO\\nexostoses\\tO\\ngenes\\tO\\n(\\tO\\nTRPS1\\tO\\nand\\tO\\nEXT1\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nconstructed\\tO\\na\\tO\\nphysical\\tO\\nmap\\tO\\ncovering\\tO\\nover\\tO\\n4\\tO\\nMb\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n8q24\\tO\\n.\\tO\\n\\n1\\tO\\nand\\tO\\nused\\tO\\nthis\\tO\\nmap\\tO\\nto\\tO\\nrefine\\tO\\nthe\\tO\\nlocations\\tO\\nof\\tO\\nthe\\tO\\ngenes\\tO\\nresponsible\\tO\\nfor\\tO\\nLanger\\tB-Disease\\n-\\tI-Disease\\nGiedion\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nmap\\tO\\nis\\tO\\ncomposed\\tO\\nof\\tO\\noverlapping\\tO\\nYAC\\tO\\nclones\\tO\\nthat\\tO\\nwere\\tO\\nidentified\\tO\\nand\\tO\\nordered\\tO\\nin\\tO\\nrelation\\tO\\nto\\tO\\nsequence\\tO\\ntagged\\tO\\nsites\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\nLanger\\tO\\n-\\tO\\nGiedion\\tO\\nchromosomal\\tO\\nregion\\tO\\non\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrids\\tO\\n.\\tO\\n\\nThe\\tO\\nminimal\\tO\\nregion\\tO\\nof\\tO\\noverlap\\tO\\nof\\tO\\nLanger\\tB-Disease\\n-\\tI-Disease\\nGiedion\\tI-Disease\\nsyndrome\\tI-Disease\\ndeletions\\tO\\n,\\tO\\npreviously\\tO\\nidentified\\tO\\nby\\tO\\nanalysis\\tO\\nof\\tO\\n15\\tO\\npatients\\tO\\n,\\tO\\nwas\\tO\\nplaced\\tO\\non\\tO\\nthe\\tO\\nmap\\tO\\nby\\tO\\nanalysis\\tO\\nof\\tO\\n2\\tO\\npatients\\tO\\nwhose\\tO\\ndeletions\\tO\\ndefine\\tO\\nthe\\tO\\nendpoints\\tO\\n.\\tO\\n\\nThe\\tO\\nchromosome\\tO\\n8\\tO\\nbreakpoint\\tO\\nof\\tO\\na\\tO\\nbalanced\\tO\\nt\\tO\\n(\\tO\\n8\\tO\\n;\\tO\\n9\\tO\\n)\\tO\\n(\\tO\\nq24\\tO\\n.\\tO\\n11\\tO\\n;\\tO\\nq33\\tO\\n.\\tO\\n3\\tO\\n)\\tO\\ntranslocation\\tO\\nfrom\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\ntrichorhinophalangeal\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nTRPS\\tB-Disease\\nI\\tO\\n)\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nlocated\\tO\\njust\\tO\\nwithin\\tO\\nthe\\tO\\nproximal\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\nminimal\\tO\\ndeletion\\tO\\nregion\\tO\\n.\\tO\\n\\nA\\tO\\ndeletion\\tO\\nof\\tO\\n8q24\\tO\\n.\\tO\\n\\n11\\tO\\n-\\tO\\nq24\\tO\\n.\\tO\\n\\n3\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nmultiple\\tO\\nexostoses\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\noverlap\\tO\\nthe\\tO\\ndistal\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\nLGS\\tB-Disease\\ndeletion\\tO\\nregion\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nthe\\tO\\nEXT1\\tO\\ngene\\tO\\nis\\tO\\ndistal\\tO\\nto\\tO\\nthe\\tO\\nTRPS1\\tO\\ngene\\tO\\nand\\tO\\nsupporting\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nLanger\\tB-Disease\\n-\\tI-Disease\\nGiedion\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\ndue\\tO\\nto\\tO\\nloss\\tO\\nof\\tO\\nfunctional\\tO\\ncopies\\tO\\nof\\tO\\nboth\\tO\\nthe\\tO\\nTRPS1\\tO\\nand\\tO\\nthe\\tO\\nEXT1\\tO\\ngenes\\tO\\n\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\nsample\\tO\\nof\\tO\\nyoung\\tO\\nwomen\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nBACKGROUND\\tO\\n.\\tO\\n\\nInherited\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nhigh\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nin\\tO\\nsome\\tO\\nfamilies\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nlittle\\tO\\nis\\tO\\nknown\\tO\\nabout\\tO\\nthe\\tO\\ncontribution\\tO\\nof\\tO\\nBRCA1\\tO\\nmutations\\tO\\nto\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\n.\\tO\\n\\nWe\\tO\\nanalyzed\\tO\\nDNA\\tO\\nsamples\\tO\\nfrom\\tO\\nwomen\\tO\\nenrolled\\tO\\nin\\tO\\na\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\nstudy\\tO\\nof\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nto\\tO\\nassess\\tO\\nthe\\tO\\nspectrum\\tO\\nand\\tO\\nfrequency\\tO\\nof\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\nyoung\\tO\\nwomen\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nMETHODS\\tO\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\n80\\tO\\nwomen\\tO\\nin\\tO\\nwhom\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nwas\\tO\\ndiagnosed\\tO\\nbefore\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\n35\\tO\\n,\\tO\\nand\\tO\\nwho\\tO\\nwere\\tO\\nnot\\tO\\nselected\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nfamily\\tO\\nhistory\\tO\\n.\\tO\\n\\nGenomic\\tO\\nDNA\\tO\\nwas\\tO\\nstudied\\tO\\nfor\\tO\\nBRCA1\\tO\\nmutations\\tO\\nby\\tO\\nanalysis\\tO\\ninvolving\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphisms\\tO\\nand\\tO\\nwith\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\nassays\\tO\\n.\\tO\\n\\nAlterations\\tO\\nwere\\tO\\ndefined\\tO\\nby\\tO\\nDNA\\tO\\nsequencing\\tO\\n.\\tO\\n\\nRESULTS\\tO\\n.\\tO\\n\\nGerm\\tO\\n-\\tO\\nline\\tO\\nBRCA1\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\n6\\tO\\nof\\tO\\nthe\\tO\\n80\\tO\\nwomen\\tO\\n.\\tO\\n\\nFour\\tO\\nadditional\\tO\\nrare\\tO\\nsequence\\tO\\nvariants\\tO\\nof\\tO\\nunknown\\tO\\nfunctional\\tO\\nimportance\\tO\\nwere\\tO\\nalso\\tO\\nidentified\\tO\\n.\\tO\\n\\nTwo\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nand\\tO\\nthree\\tO\\nof\\tO\\nthe\\tO\\nrare\\tO\\nsequence\\tO\\nvariants\\tO\\nwere\\tO\\nfound\\tO\\namong\\tO\\nthe\\tO\\n39\\tO\\nwomen\\tO\\nwho\\tO\\nreported\\tO\\nno\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nbreast\\tB-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nNone\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nand\\tO\\nonly\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nrare\\tO\\nvariants\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\na\\tO\\nreference\\tO\\npopulation\\tO\\nof\\tO\\n73\\tO\\nunrelated\\tO\\nsubjects\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\n.\\tO\\n\\nAlterations\\tO\\nin\\tO\\nBRCA1\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\napproximately\\tO\\n10\\tO\\npercent\\tO\\nof\\tO\\nthis\\tO\\ncohort\\tO\\nof\\tO\\nyoung\\tO\\nwomen\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nrisk\\tO\\nof\\tO\\nharboring\\tO\\na\\tO\\nmutation\\tO\\nwas\\tO\\nnot\\tO\\nlimited\\tO\\nto\\tO\\nwomen\\tO\\nwith\\tO\\nfamily\\tO\\nhistories\\tO\\nof\\tO\\nbreast\\tB-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nrepresent\\tO\\na\\tO\\nminimal\\tO\\nestimate\\tO\\nof\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\nthis\\tO\\npopulation\\tO\\n.\\tO\\n\\nComprehensive\\tO\\nmethods\\tO\\nof\\tO\\nidentifying\\tO\\nBRCA1\\tO\\nmutations\\tO\\nand\\tO\\nunderstanding\\tO\\ntheir\\tO\\nimportance\\tO\\nwill\\tO\\nbe\\tO\\nneeded\\tO\\nbefore\\tO\\ntesting\\tO\\nof\\tO\\nwomen\\tO\\nin\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\ncan\\tO\\nbe\\tO\\nundertaken\\tO\\n.\\tO\\n.\\tO\\n\\nNovel\\tO\\ninherited\\tO\\nmutations\\tO\\nand\\tO\\nvariable\\tO\\nexpressivity\\tO\\nof\\tO\\nBRCA1\\tO\\nalleles\\tO\\n,\\tO\\nincluding\\tO\\nthe\\tO\\nfounder\\tO\\nmutation\\tO\\n185delAG\\tO\\nin\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nfamilies\\tO\\n.\\tO\\n\\nThirty\\tO\\n-\\tO\\nseven\\tO\\nfamilies\\tO\\nwith\\tO\\nfour\\tO\\nor\\tO\\nmore\\tO\\ncases\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nor\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nwere\\tO\\nanalyzed\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nTwelve\\tO\\ndifferent\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\n,\\tO\\nfour\\tO\\nnovel\\tO\\nand\\tO\\neight\\tO\\npreviously\\tO\\nobserved\\tO\\n,\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\n16\\tO\\nfamilies\\tO\\n.\\tO\\n\\nFive\\tO\\nfamilies\\tO\\nof\\tO\\nAshkenazi\\tO\\nJewish\\tO\\ndescent\\tO\\ncarried\\tO\\nthe\\tO\\n185delAG\\tO\\nmutation\\tO\\nand\\tO\\nshared\\tO\\nthe\\tO\\nsame\\tO\\nhaplotype\\tO\\nat\\tO\\neight\\tO\\npolymorphic\\tO\\nmarkers\\tO\\nspanning\\tO\\napproximately\\tO\\n850\\tO\\nkb\\tO\\nat\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nExpressivity\\tO\\nof\\tO\\n185delAG\\tO\\nin\\tO\\nthese\\tO\\nfamilies\\tO\\nvaried\\tO\\n,\\tO\\nfrom\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nwithout\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nMutation\\tO\\n4184delTCAA\\tO\\noccurred\\tO\\nindependently\\tO\\nin\\tO\\ntwo\\tO\\nfamilies\\tO\\n.\\tO\\n\\nIn\\tO\\none\\tO\\nfamily\\tO\\n,\\tO\\npenetrance\\tO\\nwas\\tO\\ncomplete\\tO\\n,\\tO\\nwith\\tO\\nfemales\\tO\\ndeveloping\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nor\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\nthe\\tO\\nmale\\tO\\ncarrier\\tO\\ndeveloping\\tO\\nprostatic\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nwhereas\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nother\\tO\\nfamily\\tO\\n,\\tO\\npenetrance\\tO\\nwas\\tO\\nincomplete\\tO\\nand\\tO\\nonly\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\noccurred\\tO\\n,\\tO\\ndiagnosed\\tO\\nat\\tO\\nages\\tO\\n38\\tO\\n-\\tO\\n81\\tO\\nyears\\tO\\n.\\tO\\n\\nTwo\\tO\\nnovel\\tO\\nnonsense\\tO\\nmutations\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\nmutant\\tO\\nBRCA1\\tO\\ntranscript\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\n10\\tO\\nand\\tO\\n6\\tO\\ncases\\tO\\nof\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nA\\tO\\n665\\tO\\n-\\tO\\nnt\\tO\\nsegment\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\n3\\tO\\n-\\tO\\nUTR\\tO\\nand\\tO\\n1\\tO\\n.\\tO\\n\\n3\\tO\\nkb\\tO\\nof\\tO\\ngenomic\\tO\\nsequence\\tO\\nincluding\\tO\\nthe\\tO\\nputative\\tO\\npromoter\\tO\\nregion\\tO\\nwere\\tO\\ninvariant\\tO\\nby\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\nanalysis\\tO\\nin\\tO\\n13\\tO\\nfamilies\\tO\\nwithout\\tO\\ncoding\\tO\\n-\\tO\\nsequence\\tO\\nmutations\\tO\\n.\\tO\\n\\nOverall\\tO\\nin\\tO\\nour\\tO\\nseries\\tO\\n,\\tO\\nBRCA1\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\n26\\tO\\nfamilies\\tO\\n16\\tO\\nwith\\tO\\npositive\\tO\\nBRCA1\\tO\\nlod\\tO\\nscores\\tO\\n,\\tO\\n7\\tO\\nwith\\tO\\nnegative\\tO\\nlod\\tO\\nscores\\tO\\n(\\tO\\nreflecting\\tO\\nmultiple\\tO\\nsporadic\\tO\\nbreast\\tB-Disease\\ncancers\\tI-Disease\\n)\\tO\\n,\\tO\\nand\\tO\\n3\\tO\\nnot\\tO\\ntested\\tO\\nfor\\tO\\nlinkage\\tO\\n.\\tO\\n\\nThree\\tO\\nother\\tO\\nfamilies\\tO\\nhave\\tO\\npositive\\tO\\nlod\\tO\\nscores\\tO\\nfor\\tO\\nlinkage\\tO\\nto\\tO\\nBRCA2\\tO\\n,\\tO\\nbut\\tO\\n13\\tO\\nfamilies\\tO\\nwithout\\tO\\ndetected\\tO\\nBRCA1\\tO\\nmutations\\tO\\nhave\\tO\\nnegative\\tO\\nlod\\tO\\nscores\\tO\\nfor\\tO\\nboth\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nvariant\\tO\\n,\\tO\\nG6PD\\tO\\nOrissa\\tO\\n(\\tO\\n44\\tO\\nAla\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nGly\\tO\\n)\\tO\\n,\\tO\\nis\\tO\\nthe\\tO\\nmajor\\tO\\npolymorphic\\tO\\nvariant\\tO\\nin\\tO\\ntribal\\tO\\npopulations\\tO\\nin\\tO\\nIndia\\tO\\n.\\tO\\n\\nDeficiency\\tB-Disease\\nof\\tI-Disease\\nglucose\\tI-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tO\\nG6PD\\tO\\n)\\tO\\nis\\tO\\nusually\\tO\\nfound\\tO\\nat\\tO\\nhigh\\tO\\nfrequencies\\tO\\nin\\tO\\nareas\\tO\\nof\\tO\\nthe\\tO\\nworld\\tO\\nwhere\\tO\\nmalaria\\tB-Disease\\nhas\\tO\\nbeen\\tO\\nendemic\\tO\\n.\\tO\\n\\nThe\\tO\\nfrequency\\tO\\nand\\tO\\ngenetic\\tO\\nbasis\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nhave\\tO\\nbeen\\tO\\nstudied\\tO\\nin\\tO\\nAfrica\\tO\\n,\\tO\\naround\\tO\\nthe\\tO\\nMediterranean\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\nthe\\tO\\nFar\\tO\\nEast\\tO\\n,\\tO\\nbut\\tO\\nlittle\\tO\\nsuch\\tO\\ninformation\\tO\\nis\\tO\\navailable\\tO\\nabout\\tO\\nthe\\tO\\nsituation\\tO\\nin\\tO\\nIndia\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nextent\\tO\\nof\\tO\\nheterogeneity\\tO\\nof\\tO\\nG6PD\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nstudied\\tO\\nseveral\\tO\\ndifferent\\tO\\nIndian\\tO\\npopulations\\tO\\nby\\tO\\nscreening\\tO\\nfor\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nfollowed\\tO\\nby\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\ndeficient\\tO\\nalleles\\tO\\n.\\tO\\n\\nThe\\tO\\nfrequency\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nvaries\\tO\\nbetween\\tO\\n3\\tO\\n%\\tO\\nand\\tO\\n15\\tO\\n%\\tO\\nin\\tO\\ndifferent\\tO\\ntribal\\tO\\nand\\tO\\nurban\\tO\\ngroups\\tO\\n.\\tO\\n\\nRemarkably\\tO\\n,\\tO\\na\\tO\\npreviously\\tO\\nunreported\\tO\\ndeficient\\tO\\nvariant\\tO\\n,\\tO\\nG6PD\\tO\\nOrissa\\tO\\n(\\tO\\n44\\tO\\nAla\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nGly\\tO\\n)\\tO\\n,\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\ntribal\\tO\\nIndian\\tO\\npopulations\\tO\\nbut\\tO\\nis\\tO\\nnot\\tO\\nfound\\tO\\nin\\tO\\nurban\\tO\\npopulations\\tO\\n,\\tO\\nwhere\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\ndue\\tO\\nto\\tO\\nthe\\tO\\nG6PD\\tO\\nMediterranean\\tO\\n(\\tO\\n188\\tO\\nSer\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nPhe\\tO\\n)\\tO\\nvariant\\tO\\n.\\tO\\n\\nThe\\tO\\nKmNADP\\tO\\nof\\tO\\nG6PD\\tO\\nOrissa\\tO\\nis\\tO\\nfivefold\\tO\\nhigher\\tO\\nthan\\tO\\nthat\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nenzyme\\tO\\n.\\tO\\n\\nThis\\tO\\nmay\\tO\\nbe\\tO\\ndue\\tO\\nto\\tO\\nthe\\tO\\nfact\\tO\\nthat\\tO\\nthe\\tO\\nalanine\\tO\\nresidue\\tO\\nthat\\tO\\nis\\tO\\nreplaced\\tO\\nby\\tO\\nglycine\\tO\\nis\\tO\\npart\\tO\\nof\\tO\\na\\tO\\nputative\\tO\\ncoenzyme\\tO\\n-\\tO\\nbinding\\tO\\nsite\\tO\\n.\\tO\\n.\\tO\\n\\nEvidence\\tO\\nfor\\tO\\nlinkage\\tO\\nof\\tO\\nbipolar\\tB-Disease\\ndisorder\\tI-Disease\\nto\\tO\\nchromosome\\tO\\n18\\tO\\nwith\\tO\\na\\tO\\nparent\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\norigin\\tO\\neffect\\tO\\n.\\tO\\n\\nA\\tO\\nsusceptibility\\tO\\ngene\\tO\\non\\tO\\nchromosome\\tO\\n18\\tO\\nand\\tO\\na\\tO\\nparent\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\norigin\\tO\\neffect\\tO\\nhave\\tO\\nbeen\\tO\\nsuggested\\tO\\nfor\\tO\\nbipolar\\tB-Disease\\naffective\\tI-Disease\\ndisorder\\tI-Disease\\n(\\tO\\nBPAD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nstudied\\tO\\n28\\tO\\nnuclear\\tO\\nfamilies\\tO\\nselected\\tO\\nfor\\tO\\napparent\\tO\\nunilineal\\tO\\ntransmission\\tO\\nof\\tO\\nthe\\tO\\nBPAD\\tB-Disease\\nphenotype\\tO\\n,\\tO\\nby\\tO\\nusing\\tO\\n31\\tO\\npolymorphic\\tO\\nmarkers\\tO\\nspanning\\tO\\nchromosome\\tO\\n18\\tO\\n.\\tO\\n\\nEvidence\\tO\\nfor\\tO\\nlinkage\\tO\\nwas\\tO\\ntested\\tO\\nwith\\tO\\naffected\\tO\\n-\\tO\\nsib\\tO\\n-\\tO\\npair\\tO\\nand\\tO\\nLOD\\tO\\nscore\\tO\\nmethods\\tO\\nunder\\tO\\ntwo\\tO\\ndefinitions\\tO\\nof\\tO\\nthe\\tO\\naffected\\tO\\nphenotype\\tO\\n.\\tO\\n\\nThe\\tO\\naffected\\tO\\n-\\tO\\nsibpair\\tO\\nanalyses\\tO\\nindicated\\tO\\nexcess\\tO\\nallele\\tO\\nsharing\\tO\\nfor\\tO\\nmarkers\\tO\\non\\tO\\n18p\\tO\\nwithin\\tO\\nthe\\tO\\nregion\\tO\\nreported\\tO\\npreviously\\tO\\n.\\tO\\n\\nThe\\tO\\ngreatest\\tO\\nsharing\\tO\\nwas\\tO\\nat\\tO\\nD18S37\\tO\\n64\\tO\\n%\\tO\\nin\\tO\\nbipolar\\tO\\nand\\tO\\nrecurrent\\tO\\nunipolar\\tO\\n(\\tO\\nRUP\\tO\\n)\\tO\\nsib\\tO\\npairs\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n0006\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nexcess\\tO\\nsharing\\tO\\nof\\tO\\nthe\\tO\\npaternally\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nmaternally\\tO\\n,\\tO\\ntransmitted\\tO\\nalleles\\tO\\nwas\\tO\\nobserved\\tO\\nat\\tO\\nthree\\tO\\nmarkers\\tO\\non\\tO\\n18q\\tO\\nat\\tO\\nD18S41\\tO\\n,\\tO\\n51\\tO\\nbipolar\\tO\\nand\\tO\\nRUP\\tO\\nsib\\tO\\npairs\\tO\\nwere\\tO\\nconcordant\\tO\\nfor\\tO\\npaternally\\tO\\ntransmitted\\tO\\nalleles\\tO\\n,\\tO\\nand\\tO\\n21\\tO\\npairs\\tO\\nwere\\tO\\ndiscordant\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n0004\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nevidence\\tO\\nfor\\tO\\nlinkage\\tO\\nto\\tO\\nloci\\tO\\non\\tO\\nboth\\tO\\n18p\\tO\\nand\\tO\\n18q\\tO\\nwas\\tO\\nstrongest\\tO\\nin\\tO\\nthe\\tO\\n11\\tO\\npaternal\\tO\\npedigrees\\tO\\n,\\tO\\ni\\tO\\n.\\tO\\n\\ne\\tO\\ne\\tO\\n.\\tO\\n,\\tO\\nthose\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nfather\\tO\\nor\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nfathers\\tO\\nsibs\\tO\\nis\\tO\\naffected\\tO\\n.\\tO\\n\\nIn\\tO\\nthese\\tO\\npedigrees\\tO\\n,\\tO\\nthe\\tO\\ngreatest\\tO\\nallele\\tO\\nsharing\\tO\\n(\\tO\\n81\\tO\\n%\\tO\\n;\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n00002\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nhighest\\tO\\nLOD\\tO\\nscore\\tO\\n(\\tO\\n3\\tO\\n.\\tO\\n51\\tO\\n;\\tO\\nphi\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n0\\tO\\n)\\tO\\nwere\\tO\\nobserved\\tO\\nat\\tO\\nD18S41\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nprovide\\tO\\nfurther\\tO\\nsupport\\tO\\nfor\\tO\\nlinkage\\tO\\nof\\tO\\nBPAD\\tB-Disease\\nto\\tO\\nchromosome\\tO\\n18\\tO\\nand\\tO\\nthe\\tO\\nfirst\\tO\\nmolecular\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\nparent\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\norigin\\tO\\neffect\\tO\\noperating\\tO\\nin\\tO\\nthis\\tO\\ndisorder\\tO\\n.\\tO\\n\\nThe\\tO\\nnumber\\tO\\nof\\tO\\nloci\\tO\\ninvolved\\tO\\n,\\tO\\nand\\tO\\ntheir\\tO\\nprecise\\tO\\nlocation\\tO\\n,\\tO\\nrequire\\tO\\nfurther\\tO\\nstudy\\tO\\n\\nA\\tO\\nprevalent\\tO\\nmutation\\tO\\nfor\\tO\\ngalactosemia\\tB-Disease\\namong\\tO\\nblack\\tO\\nAmericans\\tO\\n.\\tO\\n\\nOBJECTIVE\\tO\\nTo\\tO\\ndefine\\tO\\nthe\\tO\\nmutation\\tO\\ncausing\\tO\\ngalactosemia\\tB-Disease\\nin\\tO\\npatients\\tO\\nof\\tO\\nblack\\tO\\nAmerican\\tO\\norigin\\tO\\nwho\\tO\\nhave\\tO\\nno\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridyltransferase\\tO\\n(\\tO\\nGALT\\tO\\n)\\tO\\nactivity\\tO\\nin\\tO\\nerythrocytes\\tO\\nbut\\tO\\ngood\\tO\\nclinical\\tO\\noutcome\\tO\\n.\\tO\\n\\nMETHODS\\tO\\nWe\\tO\\ndiscovered\\tO\\na\\tO\\nmutation\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransition\\tO\\nat\\tO\\nbase\\tO\\n-\\tO\\npair\\tO\\n1158\\tO\\nof\\tO\\nthe\\tO\\nGALT\\tO\\ngene\\tO\\nthat\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nserine\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nleucine\\tO\\nsubstitution\\tO\\nat\\tO\\ncodon\\tO\\n135\\tO\\n(\\tO\\nS135L\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\ndeveloped\\tO\\na\\tO\\nmethod\\tO\\nwith\\tO\\nwhich\\tO\\nto\\tO\\nscreen\\tO\\npopulations\\tO\\nfor\\tO\\nits\\tO\\nprevalence\\tO\\n.\\tO\\n\\nWe\\tO\\ncompared\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridyltransferase\\tO\\namong\\tO\\nerythrocytes\\tO\\n,\\tO\\nleukocytes\\tO\\n,\\tO\\nand\\tO\\ntransformed\\tO\\nlymphoblasts\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\ntotal\\tO\\nbody\\tO\\noxidation\\tO\\nof\\tO\\nD\\tO\\n-\\tO\\n(\\tO\\n13C\\tO\\n)\\tO\\n-\\tO\\ngalactose\\tO\\nto\\tO\\n13CO2\\tO\\namong\\tO\\nthree\\tO\\ngenotypes\\tO\\nfor\\tO\\nGALT\\tO\\n(\\tO\\nS135L\\tO\\n/\\tO\\nS135L\\tO\\n,\\tO\\nQ188R\\tO\\n/\\tO\\nQ188R\\tO\\n,\\tO\\nand\\tO\\nNormal\\tO\\n/\\tO\\nNormal\\tO\\n)\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nWe\\tO\\nfound\\tO\\na\\tO\\n48\\tO\\n%\\tO\\nprevalence\\tO\\nof\\tO\\nthe\\tO\\nS135L\\tO\\nmutation\\tO\\namong\\tO\\n17\\tO\\nblack\\tO\\nAmerican\\tO\\npatients\\tO\\nwith\\tO\\nclassic\\tB-Disease\\ngalactosemia\\tI-Disease\\nand\\tO\\na\\tO\\n1\\tO\\n%\\tO\\nprevalence\\tO\\nin\\tO\\na\\tO\\npopulation\\tO\\nof\\tO\\n50\\tO\\nblack\\tO\\nAmericans\\tO\\nwithout\\tO\\ngalactosemia\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nS135L\\tO\\nmutation\\tO\\nwas\\tO\\nnot\\tO\\nfound\\tO\\nin\\tO\\n84\\tO\\nwhite\\tO\\npatients\\tO\\nwith\\tO\\nG\\tO\\n/\\tO\\nG\\tO\\ngalactosemia\\tB-Disease\\nnor\\tO\\nin\\tO\\n87\\tO\\nwhite\\tO\\ncontrol\\tO\\nsubjects\\tO\\nwithout\\tO\\ngalactosemia\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nnormal\\tO\\nwhole\\tO\\nbody\\tO\\noxidation\\tO\\nof\\tO\\nD\\tO\\n-\\tO\\n(\\tO\\n13C\\tO\\n)\\tO\\n-\\tO\\ngalactose\\tO\\nby\\tO\\nthe\\tO\\npatient\\tO\\nhomozygous\\tO\\nfor\\tO\\nS135L\\tO\\nand\\tO\\nvarious\\tO\\ndegrees\\tO\\nof\\tO\\nenzyme\\tO\\nimpairment\\tO\\namong\\tO\\ndifferent\\tO\\ntissues\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nThe\\tO\\nS135L\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nGALT\\tO\\ngene\\tO\\nis\\tO\\na\\tO\\nprevalent\\tO\\ncause\\tO\\nof\\tO\\ngalactosemia\\tB-Disease\\namong\\tO\\nblack\\tO\\npatients\\tO\\n.\\tO\\n\\nBecause\\tO\\nGALT\\tO\\nactivity\\tO\\nvaries\\tO\\nin\\tO\\ndifferent\\tO\\ntissues\\tO\\nof\\tO\\npatients\\tO\\nhomozygous\\tO\\nfor\\tO\\nS135L\\tO\\n,\\tO\\nthey\\tO\\nmay\\tO\\nhave\\tO\\na\\tO\\nbetter\\tO\\nclinical\\tO\\noutcome\\tO\\nthan\\tO\\npatients\\tO\\nwho\\tO\\nare\\tO\\nhomozygous\\tO\\nfor\\tO\\nQ188R\\tO\\nwhen\\tO\\nboth\\tO\\nare\\tO\\ntreated\\tO\\nfrom\\tO\\ninfancy\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nhigh\\tO\\nincidence\\tO\\nof\\tO\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\n20\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nanalyzed\\tO\\n20\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n,\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nwhich\\tO\\nshow\\tO\\npositive\\tO\\nevidence\\tO\\nof\\tO\\nlinkage\\tO\\nto\\tO\\nchromosome\\tO\\n17q12\\tO\\nfor\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nmutations\\tO\\ncosegregating\\tO\\nwith\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\n16\\tO\\nfamilies\\tO\\n,\\tO\\nincluding\\tO\\n1\\tO\\nfamily\\tO\\nwith\\tO\\na\\tO\\ncase\\tO\\nof\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nNine\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nhave\\tO\\nnot\\tO\\nbeen\\tO\\nreported\\tO\\npreviously\\tO\\n.\\tO\\n\\nThe\\tO\\nmajority\\tO\\nof\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\ngenerate\\tO\\na\\tO\\npremature\\tO\\nstop\\tO\\ncodon\\tO\\nleading\\tO\\nto\\tO\\nthe\\tO\\nformation\\tO\\nof\\tO\\na\\tO\\ntruncated\\tO\\nBRCA1\\tO\\nprotein\\tO\\nof\\tO\\n2\\tO\\n%\\tO\\n-\\tO\\n88\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nexpected\\tO\\nnormal\\tO\\nlength\\tO\\n.\\tO\\n\\nTwo\\tO\\nmutations\\tO\\naltered\\tO\\nthe\\tO\\nRING\\tO\\nfinger\\tO\\ndomain\\tO\\n.\\tO\\n\\nSequencing\\tO\\nof\\tO\\ngenomic\\tO\\nDNA\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\n12\\tO\\nfamilies\\tO\\n,\\tO\\nand\\tO\\ncDNA\\tO\\nanalysis\\tO\\nrevealed\\tO\\nan\\tO\\nabnormal\\tO\\nor\\tO\\nmissing\\tO\\nBRCA1\\tO\\ntranscript\\tO\\nin\\tO\\n4\\tO\\nof\\tO\\nthe\\tO\\n8\\tO\\nremaining\\tO\\nfamilies\\tO\\n.\\tO\\n\\nA\\tO\\ntotal\\tO\\nof\\tO\\neight\\tO\\nmutations\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nreduced\\tO\\nquantity\\tO\\nof\\tO\\nBRCA1\\tO\\ntranscript\\tO\\n.\\tO\\n\\nWe\\tO\\nwere\\tO\\nunable\\tO\\nto\\tO\\ndetect\\tO\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\n4\\tO\\nof\\tO\\nthe\\tO\\n20\\tO\\nfamilies\\tO\\n,\\tO\\nbut\\tO\\nonly\\tO\\n1\\tO\\nof\\tO\\nthese\\tO\\nwas\\tO\\nclearly\\tO\\nlinked\\tO\\nto\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nexpected\\tO\\nthat\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nclear\\tO\\nexamples\\tO\\nof\\tO\\nthe\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\nsyndrome\\tI-Disease\\nwill\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nBRCA1\\tO\\n.\\tO\\n.\\tO\\n\\nBrca1\\tB-Disease\\ndeficiency\\tI-Disease\\nresults\\tO\\nin\\tO\\nearly\\tO\\nembryonic\\tB-Disease\\nlethality\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nneuroepithelial\\tB-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\ngene\\tO\\n,\\tO\\nBRCA1\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\ncloned\\tO\\nand\\tO\\nshown\\tO\\nto\\tO\\nencode\\tO\\na\\tO\\nzinc\\tO\\n-\\tO\\nfinger\\tO\\nprotein\\tO\\nof\\tO\\nunknown\\tO\\nfunction\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nBRCA1\\tO\\naccount\\tO\\nfor\\tO\\nat\\tO\\nleast\\tO\\n80\\tO\\n%\\tO\\nof\\tO\\nfamilies\\tO\\nwith\\tO\\nboth\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nsome\\tO\\nnon\\tO\\n-\\tO\\nfamilial\\tO\\nsporadic\\tO\\novarian\\tB-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nloss\\tO\\nof\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nBRCA1\\tO\\nin\\tO\\ntumours\\tB-Disease\\nof\\tO\\nindividuals\\tO\\ncarrying\\tO\\none\\tO\\nnonfunctional\\tO\\nBRCA1\\tO\\nallele\\tO\\nsuggests\\tO\\nthat\\tO\\nBRCA1\\tO\\nencodes\\tO\\na\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\nthat\\tO\\nmay\\tO\\ninhibit\\tO\\nthe\\tO\\nproliferation\\tO\\nof\\tO\\nmammary\\tO\\nepithelial\\tO\\ncells\\tO\\n.\\tO\\n\\nTo\\tO\\nexamine\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\nnormal\\tO\\ntissue\\tO\\ngrowth\\tO\\nand\\tO\\ndifferentiation\\tO\\n,\\tO\\nand\\tO\\nto\\tO\\ngenerate\\tO\\na\\tO\\npotential\\tO\\nmodel\\tO\\nfor\\tO\\nthe\\tO\\ncancer\\tB-Disease\\nsusceptibility\\tO\\nassociated\\tO\\nwith\\tO\\nloss\\tO\\nof\\tO\\nBRCA1\\tO\\nfunction\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ncreated\\tO\\na\\tO\\nmouse\\tO\\nline\\tO\\ncarrying\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\none\\tO\\nBrca1\\tO\\nallele\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nmice\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\nmutant\\tO\\nallele\\tO\\nindicate\\tO\\nthat\\tO\\nBrca1\\tO\\nis\\tO\\ncritical\\tO\\nfor\\tO\\nnormal\\tO\\ndevelopment\\tO\\n,\\tO\\nas\\tO\\nthese\\tO\\nmice\\tO\\ndied\\tO\\nin\\tO\\nutero\\tO\\nbetween\\tO\\n10\\tO\\nand\\tO\\n13\\tO\\ndays\\tO\\nof\\tO\\ngestation\\tO\\n(\\tO\\nE10\\tO\\n-\\tO\\nE13\\tO\\n)\\tO\\n.\\tO\\n\\nAbnormalities\\tO\\nin\\tO\\nBrca1\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nembryos\\tO\\nwere\\tO\\nmost\\tO\\nevident\\tO\\nin\\tO\\nthe\\tO\\nneural\\tO\\ntube\\tO\\n,\\tO\\nwith\\tO\\n40\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nembryos\\tO\\npresenting\\tO\\nwith\\tO\\nvarying\\tO\\ndegrees\\tO\\nof\\tO\\nspina\\tB-Disease\\nbifida\\tI-Disease\\nand\\tO\\nanencephaly\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nthe\\tO\\nneuroepithelium\\tO\\nin\\tO\\nBrca1\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nembryos\\tO\\nappeared\\tO\\ndisorganized\\tO\\n,\\tO\\nwith\\tO\\nsigns\\tO\\nof\\tO\\nboth\\tO\\nrapid\\tO\\nproliferation\\tO\\nand\\tO\\nexcessive\\tO\\ncell\\tO\\ndeath\\tO\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nALD\\tO\\n-\\tO\\ngene\\tO\\nof\\tO\\n20\\tO\\nfamilies\\tO\\nwith\\tO\\nadrenoleukodystrophy\\tB-Disease\\n/\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n.\\tO\\n\\nAdrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\n,\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ninherited\\tI-Disease\\nmetabolic\\tI-Disease\\ndisorder\\tI-Disease\\n,\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\nfrequent\\tO\\ninborn\\tB-Disease\\nperoxisomal\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nIt\\tO\\nleads\\tO\\nto\\tO\\ndemyelination\\tB-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\ncentral\\tI-Disease\\nand\\tI-Disease\\nperipheral\\tI-Disease\\nnervous\\tI-Disease\\nsystem\\tI-Disease\\n.\\tO\\n\\nDefective\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\nof\\tO\\nsaturated\\tO\\nvery\\tO\\nlong\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\n(\\tO\\nVLCFAs\\tO\\n;\\tO\\nC22\\tO\\n0\\tO\\n-\\tO\\nC26\\tO\\n0\\tO\\n)\\tO\\nin\\tO\\nperoxisomes\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nlead\\tO\\nto\\tO\\nan\\tO\\naccumulation\\tO\\nof\\tO\\nVLCFAs\\tO\\nin\\tO\\nleukoid\\tO\\nareas\\tO\\nof\\tO\\nthe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n,\\tO\\nperipheral\\tO\\nnerves\\tO\\n,\\tO\\nadrenal\\tO\\ngland\\tO\\n,\\tO\\nand\\tO\\nblood\\tO\\n.\\tO\\n\\nThe\\tO\\nALD\\tB-Disease\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nrecently\\tO\\nidentified\\tO\\nand\\tO\\nencodes\\tO\\na\\tO\\n745\\tO\\n-\\tO\\namino\\tO\\n-\\tO\\nacid\\tO\\nprotein\\tO\\n.\\tO\\n\\nWe\\tO\\nscreened\\tO\\npatients\\tO\\nwith\\tO\\nadrenoleukodystrophy\\tB-Disease\\n/\\tO\\nadrenomyeloneuropathy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n/\\tO\\nAMN\\tB-Disease\\n)\\tO\\nfrom\\tO\\n20\\tO\\nkindreds\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nALD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nEleven\\tO\\nmissense\\tO\\nand\\tO\\ntwo\\tO\\nnonsense\\tO\\nmutations\\tO\\n,\\tO\\nfive\\tO\\ndeletions\\tO\\n,\\tO\\nand\\tO\\none\\tO\\ninsertion\\tO\\nwere\\tO\\ndetected\\tO\\nby\\tO\\ndirect\\tO\\nsequencing\\tO\\nof\\tO\\neight\\tO\\nreverse\\tO\\ntranscribed\\tO\\nfragments\\tO\\nof\\tO\\nthe\\tO\\nALD\\tB-Disease\\n-\\tO\\ngene\\tO\\nmRNA\\tO\\n.\\tO\\n\\nFour\\tO\\nmutations\\tO\\ncould\\tO\\nbe\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\nde\\tO\\nnovo\\tO\\n.\\tO\\n\\nAll\\tO\\nmutations\\tO\\ncould\\tO\\nbe\\tO\\nconfirmed\\tO\\nin\\tO\\ncarriers\\tO\\nby\\tO\\nsequencing\\tO\\ngenomic\\tO\\nDNA\\tO\\n.\\tO\\n\\nNo\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\ntype\\tO\\nof\\tO\\nmutation\\tO\\nand\\tO\\nthe\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\nphenotype\\tO\\ncould\\tO\\nbe\\tO\\nobserved\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\nwere\\tO\\nnot\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nALD\\tB-Disease\\ngene\\tO\\nof\\tO\\n30\\tO\\nhealthy\\tO\\npersons\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nmurine\\tO\\nhomolog\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\ngene\\tO\\nBrca1\\tO\\nmaps\\tO\\nto\\tO\\nmouse\\tO\\nchromosome\\tO\\n11D\\tO\\n.\\tO\\n\\nThe\\tO\\nrecently\\tO\\ncloned\\tO\\nhuman\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\ngene\\tO\\n,\\tO\\nBRCA1\\tO\\n,\\tO\\nis\\tO\\nlocated\\tO\\non\\tO\\nhuman\\tO\\nchromosome\\tO\\n17q21\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nisolated\\tO\\nmurine\\tO\\ngenomic\\tO\\nclones\\tO\\ncontaining\\tO\\nBrca1\\tO\\nas\\tO\\na\\tO\\nfirst\\tO\\nstep\\tO\\nin\\tO\\ngenerating\\tO\\na\\tO\\nmouse\\tO\\nmodel\\tO\\nfor\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\nBRCA1\\tO\\nfunction\\tO\\n.\\tO\\n\\nA\\tO\\nmouse\\tO\\ngenomic\\tO\\nlibrary\\tO\\nwas\\tO\\nscreened\\tO\\nusing\\tO\\nprobes\\tO\\ncorresponding\\tO\\nto\\tO\\nexon\\tO\\n11\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nBRCA1\\tO\\ngene\\tO\\n.\\tO\\n\\nTwo\\tO\\noverlapping\\tO\\nmouse\\tO\\nclones\\tO\\nwere\\tO\\nidentified\\tO\\nthat\\tO\\nhybridized\\tO\\nto\\tO\\nhuman\\tO\\nBRCA1\\tO\\nexons\\tO\\n9\\tO\\n-\\tO\\n12\\tO\\n.\\tO\\n\\nSequence\\tO\\nanalysis\\tO\\nof\\tO\\n1\\tO\\n.\\tO\\n\\n4\\tO\\nkb\\tO\\nof\\tO\\nthe\\tO\\nregion\\tO\\nof\\tO\\nthese\\tO\\nclones\\tO\\ncorresponding\\tO\\nto\\tO\\npart\\tO\\nof\\tO\\nhuman\\tO\\nexon\\tO\\n11\\tO\\nrevealed\\tO\\n72\\tO\\n%\\tO\\nnucleic\\tO\\nacid\\tO\\nidentity\\tO\\nbut\\tO\\nonly\\tO\\n50\\tO\\n%\\tO\\namino\\tO\\nacid\\tO\\nidentity\\tO\\nwith\\tO\\nthe\\tO\\nhuman\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nlongest\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nBrca1\\tO\\ngenomic\\tO\\nclones\\tO\\nmaps\\tO\\nto\\tO\\nchromosome\\tO\\n11D\\tO\\n,\\tO\\nas\\tO\\ndetermined\\tO\\nby\\tO\\ntwo\\tO\\n-\\tO\\ncolor\\tO\\nfluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n.\\tO\\n\\nThe\\tO\\nsynteny\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\n17\\tO\\nwas\\tO\\nconfirmed\\tO\\nby\\tO\\ncohybridization\\tO\\nwith\\tO\\nthe\\tO\\nmouse\\tO\\nprobe\\tO\\nfor\\tO\\nthe\\tO\\nNF1\\tO\\n-\\tO\\ngene\\tO\\n.\\tO\\n\\nThis\\tO\\ncomparative\\tO\\nstudy\\tO\\nconfirms\\tO\\nthat\\tO\\nthe\\tO\\nrelative\\tO\\nlocation\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nconserved\\tO\\nbetween\\tO\\nmice\\tO\\nand\\tO\\nhumans\\tO\\n.\\tO\\n\\nAtelosteogenesis\\tB-Disease\\ntype\\tI-Disease\\nII\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\nsulfate\\tO\\n-\\tO\\ntransporter\\tO\\ngene\\tO\\n(\\tO\\nDTDST\\tO\\n)\\tO\\n:\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\nphenotypic\\tO\\nseries\\tO\\ninvolving\\tO\\nthree\\tO\\nchondrodysplasias\\tB-Disease\\n.\\tO\\n\\nAtelosteogenesis\\tB-Disease\\ntype\\tI-Disease\\nII\\tI-Disease\\n(\\tO\\nAO\\tB-Disease\\nII\\tI-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nneonatally\\tO\\nlethal\\tO\\nchondrodysplasia\\tB-Disease\\nwhose\\tO\\nclinical\\tO\\nand\\tO\\nhistological\\tO\\ncharacteristics\\tO\\nresemble\\tO\\nthose\\tO\\nof\\tO\\nanother\\tO\\nchondrodysplasia\\tB-Disease\\n,\\tO\\nthe\\tO\\nmuch\\tO\\nless\\tO\\nsevere\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\n(\\tO\\nDTD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nsimilarity\\tO\\nsuggests\\tO\\na\\tO\\nshared\\tO\\npathogenesis\\tO\\ninvolving\\tO\\nlesions\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\nbiochemical\\tO\\npathway\\tO\\nand\\tO\\nperhaps\\tO\\nthe\\tO\\nsame\\tO\\ngene\\tO\\n.\\tO\\n\\nDTD\\tB-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nrecently\\tO\\nidentified\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\nsulfate\\tO\\n-\\tO\\ntransporter\\tO\\ngene\\tO\\n(\\tO\\nDTDST\\tO\\n)\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\nAOII\\tB-Disease\\npatients\\tO\\nalso\\tO\\nhave\\tO\\nDTDST\\tO\\nmutations\\tO\\n,\\tO\\nwhich\\tO\\nlead\\tO\\nto\\tO\\ndefective\\tO\\nuptake\\tO\\nof\\tO\\ninorganic\\tO\\nsulfate\\tO\\nand\\tO\\ninsufficient\\tO\\nsulfation\\tO\\nof\\tO\\nmacromolecules\\tO\\nby\\tO\\npatient\\tO\\nmesenchymal\\tO\\ncells\\tO\\nin\\tO\\nvitro\\tO\\n.\\tO\\n\\nTogether\\tO\\nwith\\tO\\nour\\tO\\nrecent\\tO\\nobservation\\tO\\nthat\\tO\\na\\tO\\nthird\\tO\\neven\\tO\\nmore\\tO\\nsevere\\tO\\nchondrodysplasia\\tB-Disease\\n,\\tO\\nachondrogenesis\\tO\\ntype\\tO\\nIB\\tO\\n,\\tO\\nis\\tO\\nalso\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nDTDST\\tO\\n,\\tO\\nthese\\tO\\nresults\\tO\\ndemonstrate\\tO\\na\\tO\\nphenotypic\\tO\\nseries\\tO\\nof\\tO\\nthree\\tO\\nchondrodysplasias\\tB-Disease\\nof\\tO\\nincreasing\\tO\\nseverity\\tO\\ncaused\\tO\\nby\\tO\\nlesions\\tO\\nin\\tO\\na\\tO\\nsingle\\tO\\nsulfate\\tO\\n-\\tO\\ntransporter\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nseverity\\tO\\nof\\tO\\nthe\\tO\\nphenotype\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\ncorrelated\\tO\\nwith\\tO\\nthe\\tO\\npredicted\\tO\\neffect\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\non\\tO\\nthe\\tO\\nresidual\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nDTDST\\tO\\nprotein\\tO\\n.\\tO\\n.\\tO\\n\\nHaplotype\\tO\\nand\\tO\\nphenotype\\tO\\nanalysis\\tO\\nof\\tO\\nsix\\tO\\nrecurrent\\tO\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\n61\\tO\\nfamilies\\tO\\n:\\tO\\nresults\\tO\\nof\\tO\\nan\\tO\\ninternational\\tO\\nstudy\\tO\\n.\\tO\\n\\nSeveral\\tO\\nBRCA1\\tO\\nmutations\\tO\\nhave\\tO\\nnow\\tO\\nbeen\\tO\\nfound\\tO\\nto\\tO\\noccur\\tO\\nin\\tO\\ngeographically\\tO\\ndiverse\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nmutation\\tO\\norigin\\tO\\nand\\tO\\nmutation\\tO\\n-\\tO\\nspecific\\tO\\nphenotypes\\tO\\ndue\\tO\\nto\\tO\\nBRCA1\\tO\\n,\\tO\\nwe\\tO\\nconstructed\\tO\\na\\tO\\nhaplotype\\tO\\nof\\tO\\nnine\\tO\\npolymorphic\\tO\\nmarkers\\tO\\nwithin\\tO\\nor\\tO\\nimmediately\\tO\\nflanking\\tO\\nthe\\tO\\nBRCA1\\tO\\nlocus\\tO\\nin\\tO\\na\\tO\\nset\\tO\\nof\\tO\\n61\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nselected\\tO\\nfor\\tO\\nhaving\\tO\\none\\tO\\nof\\tO\\nsix\\tO\\nrecurrent\\tO\\nBRCA1\\tO\\nmutations\\tO\\n.\\tO\\n\\nTests\\tO\\nof\\tO\\nboth\\tO\\nmutations\\tO\\nand\\tO\\nfamily\\tO\\n-\\tO\\nspecific\\tO\\ndifferences\\tO\\nin\\tO\\nage\\tO\\nat\\tO\\ndiagnosis\\tO\\nwere\\tO\\nnot\\tO\\nsignificant\\tO\\n.\\tO\\n\\nA\\tO\\ncomparison\\tO\\nof\\tO\\nthe\\tO\\nsix\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nrelative\\tO\\nproportions\\tO\\nof\\tO\\ncases\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nwas\\tO\\nsuggestive\\tO\\nof\\tO\\nan\\tO\\neffect\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n069\\tO\\n)\\tO\\n,\\tO\\nwith\\tO\\n57\\tO\\n%\\tO\\nof\\tO\\nwomen\\tO\\npresumed\\tO\\naffected\\tO\\nbecause\\tO\\nof\\tO\\nthe\\tO\\n1294\\tO\\ndel\\tO\\n40\\tO\\nBRCA1\\tO\\nmutation\\tO\\nhaving\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\ncompared\\tO\\nwith\\tO\\n14\\tO\\n%\\tO\\nof\\tO\\naffected\\tO\\nwomen\\tO\\nwith\\tO\\nthe\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\nin\\tO\\nintron\\tO\\n5\\tO\\nof\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nFor\\tO\\nthe\\tO\\nBRCA1\\tO\\nmutations\\tO\\nstudied\\tO\\nhere\\tO\\n,\\tO\\nthe\\tO\\nindividual\\tO\\nmutations\\tO\\nare\\tO\\nestimated\\tO\\nto\\tO\\nhave\\tO\\narisen\\tO\\n9\\tO\\n-\\tO\\n170\\tO\\ngenerations\\tO\\nago\\tO\\n.\\tO\\n\\nIn\\tO\\ngeneral\\tO\\n,\\tO\\na\\tO\\nhigh\\tO\\ndegree\\tO\\nof\\tO\\nhaplotype\\tO\\nconservation\\tO\\nacross\\tO\\nthe\\tO\\nregion\\tO\\nwas\\tO\\nobserved\\tO\\n,\\tO\\nwith\\tO\\nhaplotype\\tO\\ndifferences\\tO\\nmost\\tO\\noften\\tO\\ndue\\tO\\nto\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nshort\\tO\\n-\\tO\\ntandem\\tO\\n-\\tO\\nrepeat\\tO\\nmarkers\\tO\\n,\\tO\\nalthough\\tO\\nsome\\tO\\nlikely\\tO\\ninstances\\tO\\nof\\tO\\nrecombination\\tO\\nalso\\tO\\nwere\\tO\\nobserved\\tO\\n.\\tO\\n\\nFor\\tO\\nseveral\\tO\\nof\\tO\\nthe\\tO\\ninstances\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\nevidence\\tO\\nfor\\tO\\nmultiple\\tO\\n,\\tO\\nindependent\\tO\\n,\\tO\\nBRCA1\\tO\\nmutational\\tO\\nevents\\tO\\n.\\tO\\n\\nIsolation\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nhomologue\\tO\\nof\\tO\\nBRCA1\\tO\\nand\\tO\\ngenetic\\tO\\nmapping\\tO\\nto\\tO\\nmouse\\tO\\nchromosome\\tO\\n11\\tO\\n.\\tO\\n\\nThe\\tO\\nBRCA1\\tO\\ngene\\tO\\nis\\tO\\nin\\tO\\nlarge\\tO\\npart\\tO\\nresponsible\\tO\\nfor\\tO\\nhereditary\\tB-Disease\\nhuman\\tI-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\nisolation\\tO\\nof\\tO\\nthe\\tO\\nmurine\\tO\\nBrca1\\tO\\nhomologue\\tO\\ncDNA\\tO\\nclones\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nidentified\\tO\\ngenomic\\tO\\nP1\\tO\\nclones\\tO\\nthat\\tO\\ncontain\\tO\\nmost\\tO\\n,\\tO\\nif\\tO\\nnot\\tO\\nall\\tO\\n,\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nBrca1\\tO\\nlocus\\tO\\n.\\tO\\n\\nDNA\\tO\\nsequence\\tO\\nanalysis\\tO\\nrevealed\\tO\\nthat\\tO\\nthe\\tO\\nmouse\\tO\\nand\\tO\\nhuman\\tO\\ncoding\\tO\\nregions\\tO\\nare\\tO\\n75\\tO\\n%\\tO\\nidentical\\tO\\nat\\tO\\nthe\\tO\\nnucleotide\\tO\\nlevel\\tO\\nwhile\\tO\\nthe\\tO\\npredicted\\tO\\namino\\tO\\nacid\\tO\\nidentity\\tO\\nis\\tO\\nonly\\tO\\n58\\tO\\n%\\tO\\n.\\tO\\n\\nA\\tO\\nDNA\\tO\\nsequence\\tO\\nvariant\\tO\\nin\\tO\\nthe\\tO\\nBrca1\\tO\\nlocus\\tO\\nwas\\tO\\nidentified\\tO\\nand\\tO\\nused\\tO\\nto\\tO\\nmap\\tO\\nthis\\tO\\ngene\\tO\\non\\tO\\na\\tO\\n(\\tO\\nMus\\tO\\nm\\tO\\n.\\tO\\nmusculus\\tO\\nCzech\\tO\\nII\\tO\\nx\\tO\\nC57BL\\tO\\n/\\tO\\nKsJ\\tO\\n)\\tO\\nF1\\tO\\nx\\tO\\nC57BL\\tO\\n/\\tO\\nKsJ\\tO\\nintersubspecific\\tO\\nbackcross\\tO\\nto\\tO\\ndistal\\tO\\nmouse\\tO\\nchromosome\\tO\\n11\\tO\\n.\\tO\\n\\nThe\\tO\\nmapping\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\nto\\tO\\na\\tO\\nregion\\tO\\nhighly\\tO\\nsyntenic\\tO\\nwith\\tO\\nhuman\\tO\\nchromosome\\tO\\n17\\tO\\n,\\tO\\ncoupled\\tO\\nwith\\tO\\nSouthern\\tO\\nand\\tO\\nNorthern\\tO\\nanalyses\\tO\\n,\\tO\\nconfirms\\tO\\nthat\\tO\\nwe\\tO\\nisolated\\tO\\nthe\\tO\\nmurine\\tO\\nBrca1\\tO\\nhomologue\\tO\\nrather\\tO\\nthan\\tO\\na\\tO\\nrelated\\tO\\nRING\\tO\\nfinger\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nisolation\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nBrca1\\tO\\nhomologue\\tO\\nwill\\tO\\nfacilitate\\tO\\nthe\\tO\\ncreation\\tO\\nof\\tO\\nmouse\\tO\\nmodels\\tO\\nfor\\tO\\ngermline\\tO\\nBRCA1\\tB-Disease\\ndefects\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nEmerin\\tB-Disease\\ndeficiency\\tI-Disease\\nat\\tO\\nthe\\tO\\nnuclear\\tO\\nmembrane\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nEmery\\tB-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nSTA\\tO\\ngene\\tO\\nat\\tO\\nthe\\tO\\nXq28\\tO\\nlocus\\tO\\nhave\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nEmery\\tI-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nEDMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\ngene\\tO\\nencodes\\tO\\na\\tO\\nhitherto\\tO\\nunknown\\tO\\nprotein\\tO\\nnamed\\tO\\nemerin\\tO\\n.\\tO\\n\\nTo\\tO\\nelucidate\\tO\\nthe\\tO\\nsubcellular\\tO\\nlocalization\\tO\\nof\\tO\\nemerin\\tO\\n,\\tO\\nwe\\tO\\nraised\\tO\\ntwo\\tO\\nantisera\\tO\\nagainst\\tO\\nsynthetic\\tO\\npeptide\\tO\\nfragments\\tO\\npredicted\\tO\\nfrom\\tO\\nemerin\\tO\\ncDNA\\tO\\n.\\tO\\n\\nUsing\\tO\\nboth\\tO\\nantisera\\tO\\n,\\tO\\nwe\\tO\\nfound\\tO\\npositive\\tO\\nnuclear\\tO\\nmembrane\\tO\\nstaining\\tO\\nin\\tO\\nskeletal\\tO\\n,\\tO\\ncardiac\\tO\\nand\\tO\\nsmooth\\tO\\nmuscles\\tO\\nin\\tO\\nthe\\tO\\nnormal\\tO\\ncontrols\\tO\\nand\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nneuromuscular\\tB-Disease\\ndiseases\\tI-Disease\\nother\\tO\\nthan\\tO\\nEDMD\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\na\\tO\\ndeficiency\\tO\\nin\\tO\\nimmunofluorescent\\tO\\nstaining\\tO\\nof\\tO\\nskeletal\\tO\\nand\\tO\\ncardiac\\tO\\nmuscle\\tO\\nfrom\\tO\\nEDMD\\tB-Disease\\npatients\\tO\\nwas\\tO\\nobserved\\tO\\n.\\tO\\n\\nA\\tO\\n34\\tO\\nkD\\tO\\nprotein\\tO\\nis\\tO\\nimmunoreactive\\tO\\nwith\\tO\\nthe\\tO\\nantisera\\tO\\n-\\tO\\n-\\tO\\nthe\\tO\\nprotein\\tO\\nis\\tO\\nequivalent\\tO\\nto\\tO\\nthat\\tO\\npredicted\\tO\\nfor\\tO\\nemerin\\tO\\n.\\tO\\n\\nTogether\\tO\\n,\\tO\\nour\\tO\\nfindings\\tO\\nsuggest\\tO\\nthe\\tO\\nspecific\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nemerin\\tI-Disease\\nin\\tO\\nthe\\tO\\nnuclear\\tO\\nmembrane\\tO\\nof\\tO\\nmuscle\\tO\\ncells\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nEDMD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nGrowth\\tB-Disease\\nretardation\\tI-Disease\\nand\\tO\\ntumour\\tB-Disease\\ninhibition\\tO\\nby\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nInherited\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\npredispose\\tO\\nto\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nbut\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\nsporadic\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nhas\\tO\\npreviously\\tO\\nbeen\\tO\\nelusive\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nshow\\tO\\nthat\\tO\\nretroviral\\tO\\ntransfer\\tO\\nof\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nBRCA1\\tO\\ngene\\tO\\ninhibits\\tO\\ngrowth\\tO\\nin\\tO\\nvitro\\tO\\nof\\tO\\nall\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ncell\\tO\\nlines\\tO\\ntested\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\ncolon\\tB-Disease\\nor\\tI-Disease\\nlung\\tI-Disease\\ncancer\\tI-Disease\\ncells\\tO\\nor\\tO\\nfibroblasts\\tO\\n.\\tO\\n\\nMutant\\tO\\nBRCA1\\tO\\nhas\\tO\\nno\\tO\\neffect\\tO\\non\\tO\\ngrowth\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\ncells\\tO\\n;\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\ncell\\tO\\ngrowth\\tO\\nis\\tO\\nnot\\tO\\naffected\\tO\\nby\\tO\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\n5\\tO\\nportion\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nbut\\tO\\nis\\tO\\ninhibited\\tO\\nby\\tO\\n3\\tO\\nBRCA1\\tO\\nmutations\\tO\\n.\\tO\\n\\nDevelopment\\tO\\nof\\tO\\nMCF\\tB-Disease\\n-\\tI-Disease\\n7\\tI-Disease\\ntumours\\tI-Disease\\nin\\tO\\nnude\\tO\\nmice\\tO\\nis\\tO\\ninhibited\\tO\\nwhen\\tO\\nMCF\\tO\\n-\\tO\\n7\\tO\\ncells\\tO\\nare\\tO\\ntransfected\\tO\\nwith\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nmutant\\tO\\n,\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nMost\\tO\\nimportantly\\tO\\n,\\tO\\namong\\tO\\nmice\\tO\\nwith\\tO\\nestablished\\tO\\nMCF\\tB-Disease\\n-\\tI-Disease\\n7\\tI-Disease\\ntumours\\tI-Disease\\n,\\tO\\nperitoneal\\tO\\ntreatment\\tO\\nwith\\tO\\na\\tO\\nretroviral\\tO\\nvector\\tO\\nexpressing\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nBRCA1\\tO\\nsignificantly\\tO\\ninhibits\\tO\\ntumour\\tB-Disease\\ngrowth\\tO\\nand\\tO\\nincreased\\tO\\nsurvival\\tO\\n.\\tO\\n.\\tO\\n\\n'"
            ]
          },
          "metadata": {},
          "execution_count": 56
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "with open(\"devel.tsv\") as f:\n",
        "  devel_data = f.read()\n",
        "devel_data"
      ],
      "metadata": {
        "id": "LiunkXpNTPuT",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 192
        },
        "outputId": "0b73be12-0cde-40da-e1c3-627979dbdba2"
      },
      "execution_count": 57,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'BRCA1\\tO\\nis\\tO\\nsecreted\\tO\\nand\\tO\\nexhibits\\tO\\nproperties\\tO\\nof\\tO\\na\\tO\\ngranin\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nmost\\tO\\ncases\\tO\\nof\\tO\\ninherited\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\nprotein\\tO\\nhas\\tO\\nremained\\tO\\nelusive\\tO\\n.\\tO\\n\\nWe\\tO\\nnow\\tO\\nshow\\tO\\nthat\\tO\\nBRCA1\\tO\\nencodes\\tO\\na\\tO\\n190\\tO\\n-\\tO\\nkD\\tO\\nprotein\\tO\\nwith\\tO\\nsequence\\tO\\nhomology\\tO\\nand\\tO\\nbiochemical\\tO\\nanalogy\\tO\\nto\\tO\\nthe\\tO\\ngranin\\tO\\nprotein\\tO\\nfamily\\tO\\n.\\tO\\n\\nInterestingly\\tO\\n,\\tO\\nBRCA2\\tO\\nalso\\tO\\nincludes\\tO\\na\\tO\\nmotif\\tO\\nsimilar\\tO\\nto\\tO\\nthe\\tO\\ngranin\\tO\\nconsensus\\tO\\nat\\tO\\nthe\\tO\\nC\\tO\\nterminus\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n.\\tO\\n\\nBoth\\tO\\nBRCA1\\tO\\nand\\tO\\nthe\\tO\\ngranins\\tO\\nlocalize\\tO\\nto\\tO\\nsecretory\\tO\\nvesicles\\tO\\n,\\tO\\nare\\tO\\nsecreted\\tO\\nby\\tO\\na\\tO\\nregulated\\tO\\npathway\\tO\\n,\\tO\\nare\\tO\\npost\\tO\\n-\\tO\\ntranslationally\\tO\\nglycosylated\\tO\\nand\\tO\\nare\\tO\\nresponsive\\tO\\nto\\tO\\nhormones\\tO\\n.\\tO\\n\\nAs\\tO\\na\\tO\\nregulated\\tO\\nsecretory\\tO\\nprotein\\tO\\n,\\tO\\nBRCA1\\tO\\nappears\\tO\\nto\\tO\\nfunction\\tO\\nby\\tO\\na\\tO\\nmechanism\\tO\\nnot\\tO\\npreviously\\tO\\ndescribed\\tO\\nfor\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\nproducts\\tO\\n.\\tO\\n.\\tO\\n\\nOvarian\\tB-Disease\\ncancer\\tI-Disease\\nrisk\\tO\\nin\\tO\\nBRCA1\\tO\\ncarriers\\tO\\nis\\tO\\nmodified\\tO\\nby\\tO\\nthe\\tO\\nHRAS1\\tO\\nvariable\\tO\\nnumber\\tO\\nof\\tO\\ntandem\\tO\\nrepeat\\tO\\n(\\tO\\nVNTR\\tO\\n)\\tO\\nlocus\\tO\\n.\\tO\\n\\nWomen\\tO\\nwho\\tO\\ncarry\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\n(\\tO\\non\\tO\\nchromosome\\tO\\n17q21\\tO\\n)\\tO\\n,\\tO\\nhave\\tO\\nan\\tO\\n80\\tO\\n%\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\na\\tO\\n40\\tO\\n%\\tO\\nrisk\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nby\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\n70\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nvariable\\tO\\npenetrance\\tO\\nof\\tO\\nBRCA1\\tO\\nsuggests\\tO\\nthat\\tO\\nother\\tO\\ngenetic\\tO\\nand\\tO\\nnon\\tO\\n-\\tO\\ngenetic\\tO\\nfactors\\tO\\nplay\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\ntumourigenesis\\tO\\nin\\tO\\nthese\\tO\\nindividuals\\tO\\n.\\tO\\n\\nThe\\tO\\nHRAS1\\tO\\nvariable\\tO\\nnumber\\tO\\nof\\tO\\ntandem\\tO\\nrepeats\\tO\\n(\\tO\\nVNTR\\tO\\n)\\tO\\npolymorphism\\tO\\n,\\tO\\nlocated\\tO\\n1\\tO\\nkilobase\\tO\\n(\\tO\\nkb\\tO\\n)\\tO\\ndownstream\\tO\\nof\\tO\\nthe\\tO\\nHRAS1\\tO\\nproto\\tO\\n-\\tO\\noncogene\\tO\\n(\\tO\\nchromosome\\tO\\n11p15\\tO\\n.\\tO\\n5\\tO\\n)\\tO\\nis\\tO\\none\\tO\\npossible\\tO\\ngenetic\\tO\\nmodifier\\tO\\nof\\tO\\ncancer\\tB-Disease\\npenetrance\\tO\\n.\\tO\\n\\nIndividuals\\tO\\nwho\\tO\\nhave\\tO\\nrare\\tO\\nalleles\\tO\\nof\\tO\\nthe\\tO\\nVNTR\\tO\\nhave\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\ncertain\\tO\\ntypes\\tO\\nof\\tO\\ncancers\\tB-Disease\\n,\\tO\\nincluding\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n(\\tO\\n2\\tO\\n-\\tO\\n4\\tO\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nwhether\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nrare\\tO\\nHRAS1\\tO\\nalleles\\tO\\nincreases\\tO\\nsusceptibility\\tO\\nto\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nwe\\tO\\nhave\\tO\\ntyped\\tO\\na\\tO\\npanel\\tO\\nof\\tO\\n307\\tO\\nfemale\\tO\\nBRCA1\\tO\\ncarriers\\tO\\nat\\tO\\nthis\\tO\\nlocus\\tO\\nusing\\tO\\na\\tO\\nPCR\\tO\\n-\\tO\\nbased\\tO\\ntechnique\\tO\\n.\\tO\\n\\nThe\\tO\\nrisk\\tO\\nfor\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nwas\\tO\\n2\\tO\\n.\\tO\\n\\n11\\tO\\ntimes\\tO\\ngreater\\tO\\nfor\\tO\\nBRCA1\\tO\\ncarriers\\tO\\nharbouring\\tO\\none\\tO\\nor\\tO\\ntwo\\tO\\nrare\\tO\\nHRAS1\\tO\\nalleles\\tO\\n,\\tO\\ncompared\\tO\\nto\\tO\\ncarriers\\tO\\nwith\\tO\\nonly\\tO\\ncommon\\tO\\nalleles\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n015\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmagnitude\\tO\\nof\\tO\\nthe\\tO\\nrelative\\tO\\nrisk\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nrare\\tO\\nHRAS1\\tO\\nallele\\tO\\nwas\\tO\\nnot\\tO\\naltered\\tO\\nby\\tO\\nadjusting\\tO\\nfor\\tO\\nthe\\tO\\nother\\tO\\nknown\\tO\\nrisk\\tO\\nfactors\\tO\\nfor\\tO\\nhereditary\\tB-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n(\\tO\\n5\\tO\\n)\\tO\\n.\\tO\\n\\nSusceptibility\\tO\\nto\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\ndid\\tO\\nnot\\tO\\nappear\\tO\\nto\\tO\\nbe\\tO\\naffected\\tO\\nby\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nrare\\tO\\nHRAS1\\tO\\nalleles\\tO\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nto\\tO\\nshow\\tO\\nthe\\tO\\neffect\\tO\\nof\\tO\\na\\tO\\nmodifying\\tO\\ngene\\tO\\non\\tO\\nthe\\tO\\npenetrance\\tO\\nof\\tO\\nan\\tO\\ninherited\\tB-Disease\\ncancer\\tI-Disease\\nsyndrome\\tI-Disease\\n\\nA\\tO\\nnovel\\tO\\nhomeodomain\\tO\\n-\\tO\\nencoding\\tO\\ngene\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nlarge\\tO\\nCpG\\tO\\nisland\\tO\\ninterrupted\\tO\\nby\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nunstable\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nexpansion\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\n-\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\na\\tO\\nprotein\\tO\\nkinase\\tO\\n-\\tO\\nencoding\\tO\\ngene\\tO\\n,\\tO\\nDMPK\\tO\\n,\\tO\\nwhich\\tO\\nmaps\\tO\\nto\\tO\\nchromosome\\tO\\n19q13\\tO\\n.\\tO\\n\\n3\\tO\\n.\\tO\\n\\nCharacterisation\\tO\\nof\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\nin\\tO\\npatient\\tO\\ntissues\\tO\\nhas\\tO\\nthus\\tO\\nfar\\tO\\ngenerated\\tO\\nconflicting\\tO\\ndata\\tO\\non\\tO\\nalterations\\tO\\nin\\tO\\nthe\\tO\\nsteady\\tO\\nstate\\tO\\nlevels\\tO\\nof\\tO\\nDMPK\\tO\\nmRNA\\tO\\n,\\tO\\nand\\tO\\non\\tO\\nthe\\tO\\nfinal\\tO\\nDMPK\\tO\\nprotein\\tO\\nlevels\\tO\\nin\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nexpansion\\tO\\n.\\tO\\n\\nThe\\tO\\nDM\\tB-Disease\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n19\\tO\\nis\\tO\\ngene\\tO\\nrich\\tO\\n,\\tO\\nand\\tO\\nit\\tO\\nis\\tO\\npossible\\tO\\nthat\\tO\\nthe\\tO\\nrepeat\\tO\\nexpansion\\tO\\nmay\\tO\\nlead\\tO\\nto\\tO\\ndysfunction\\tO\\nof\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\ntranscription\\tO\\nunits\\tO\\nin\\tO\\nthe\\tO\\nvicinity\\tO\\n,\\tO\\nperhaps\\tO\\nas\\tO\\na\\tO\\nconsequence\\tO\\nof\\tO\\nchromatin\\tO\\ndisruption\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nsearched\\tO\\nfor\\tO\\ngenes\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nCpG\\tO\\nisland\\tO\\nat\\tO\\nthe\\tO\\n3\\tO\\nend\\tO\\nof\\tO\\nDMPK\\tO\\n.\\tO\\n\\nSequencing\\tO\\nof\\tO\\nthis\\tO\\nregion\\tO\\nshows\\tO\\nthat\\tO\\nthe\\tO\\nisland\\tO\\nextends\\tO\\nover\\tO\\n3\\tO\\n.\\tO\\n\\n5\\tO\\nkb\\tO\\nand\\tO\\nis\\tO\\ninterrupted\\tO\\nby\\tO\\nthe\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\n.\\tO\\n\\nComparison\\tO\\nof\\tO\\ngenomic\\tO\\nsequences\\tO\\ndownstream\\tO\\n(\\tO\\ncentromeric\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\nin\\tO\\nhuman\\tO\\nand\\tO\\nmouse\\tO\\nidentified\\tO\\nregions\\tO\\nof\\tO\\nsignificant\\tO\\nhomology\\tO\\n.\\tO\\n\\nThese\\tO\\ncorrespond\\tO\\nto\\tO\\nexons\\tO\\nof\\tO\\na\\tO\\ngene\\tO\\npredicted\\tO\\nto\\tO\\nencode\\tO\\na\\tO\\nhomeodomain\\tO\\nprotein\\tO\\n.\\tO\\n\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nanalysis\\tO\\nshows\\tO\\nthat\\tO\\nthis\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nwe\\tO\\nhave\\tO\\ncalled\\tO\\nDM\\tB-Disease\\nlocus\\tO\\n-\\tO\\nassociated\\tO\\nhomeodomain\\tO\\nprotein\\tO\\n(\\tO\\nDMAHP\\tO\\n)\\tO\\n,\\tO\\nis\\tO\\nexpressed\\tO\\nin\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nhuman\\tO\\ntissues\\tO\\n,\\tO\\nincluding\\tO\\nskeletal\\tO\\nmuscle\\tO\\n,\\tO\\nheart\\tO\\nand\\tO\\nbrain\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nretinoblastoma\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nanalyzed\\tO\\nthe\\tO\\n27\\tO\\nexons\\tO\\nand\\tO\\nthe\\tO\\npromoter\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nor\\tI-Disease\\nsporadic\\tI-Disease\\nbilateral\\tI-Disease\\nretinoblastoma\\tI-Disease\\nby\\tO\\nusing\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\nanalysis\\tO\\n.\\tO\\n\\nFor\\tO\\nimprovement\\tO\\nover\\tO\\nprevious\\tO\\nstudies\\tO\\n,\\tO\\na\\tO\\nnew\\tO\\nset\\tO\\nof\\tO\\nprimers\\tO\\nhas\\tO\\nbeen\\tO\\ndesigned\\tO\\n,\\tO\\nwhich\\tO\\nallow\\tO\\nfor\\tO\\namplification\\tO\\nof\\tO\\nthe\\tO\\ncoding\\tO\\nand\\tO\\nsplicing\\tO\\nsequences\\tO\\nonly\\tO\\n.\\tO\\n\\nThe\\tO\\npositioning\\tO\\nof\\tO\\nthe\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\nprimers\\tO\\nwas\\tO\\nsuch\\tO\\nthat\\tO\\nthe\\tO\\nresulting\\tO\\nPCR\\tO\\nproducts\\tO\\nwere\\tO\\nof\\tO\\ndifferent\\tO\\nsizes\\tO\\n,\\tO\\nwhich\\tO\\nenabled\\tO\\nus\\tO\\nto\\tO\\nanalyze\\tO\\ntwo\\tO\\ndifferent\\tO\\nexons\\tO\\nsimultaneously\\tO\\nand\\tO\\nstill\\tO\\ndistinguish\\tO\\nbetween\\tO\\nthe\\tO\\nbanding\\tO\\nprofiles\\tO\\nfor\\tO\\nboth\\tO\\n(\\tO\\nbiplex\\tO\\nanalysis\\tO\\n)\\tO\\n.\\tO\\n\\nBy\\tO\\nusing\\tO\\nthis\\tO\\napproach\\tO\\n,\\tO\\nwe\\tO\\nwere\\tO\\nable\\tO\\nto\\tO\\nidentify\\tO\\nmutation\\tO\\nin\\tO\\n22\\tO\\nnew\\tO\\npatients\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\noverall\\tO\\nefficiency\\tO\\nof\\tO\\nthe\\tO\\nprocedure\\tO\\nwhen\\tO\\nwe\\tO\\nused\\tO\\na\\tO\\nsingle\\tO\\n-\\tO\\npass\\tO\\nregimen\\tO\\nwas\\tO\\nonly\\tO\\n48\\tO\\n%\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\nwere\\tO\\nsmall\\tO\\ninsertions\\tO\\nand\\tO\\ndeletions\\tO\\nand\\tO\\npoint\\tO\\nmutations\\tO\\nin\\tO\\nroughly\\tO\\nequal\\tO\\nproportions\\tO\\n.\\tO\\n.\\tO\\n\\nType\\tB-Disease\\nII\\tI-Disease\\nhuman\\tI-Disease\\ncomplement\\tI-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nAllele\\tO\\n-\\tO\\nspecific\\tO\\namino\\tO\\nacid\\tO\\nsubstitutions\\tO\\n(\\tO\\nSer189\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nPhe\\tO\\n;\\tO\\nGly444\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nArg\\tO\\n)\\tO\\ncause\\tO\\nimpaired\\tO\\nC2\\tO\\nsecretion\\tO\\n.\\tO\\n\\nType\\tB-Disease\\nII\\tI-Disease\\ncomplement\\tI-Disease\\nprotein\\tI-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\na\\tO\\nselective\\tO\\nblock\\tO\\nin\\tO\\nC2\\tO\\nsecretion\\tO\\n.\\tO\\n\\nThe\\tO\\nType\\tO\\nII\\tO\\nC2\\tO\\nnull\\tO\\nallele\\tO\\n(\\tO\\nC2Q0\\tO\\n)\\tO\\nis\\tO\\nlinked\\tO\\nto\\tO\\ntwo\\tO\\nmajor\\tO\\nhistocompatibility\\tO\\nhaplotypes\\tO\\n(\\tO\\nMHC\\tO\\n)\\tO\\nthat\\tO\\ndiffer\\tO\\nfrom\\tO\\nthe\\tO\\nMHC\\tO\\nof\\tO\\nthe\\tO\\nmore\\tO\\ncommon\\tO\\nType\\tB-Disease\\nI\\tI-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nType\\tB-Disease\\nII\\tI-Disease\\ndeficiency\\tI-Disease\\nthe\\tO\\ntwo\\tO\\nType\\tO\\nII\\tO\\nC2Q0\\tO\\ngenes\\tO\\nwere\\tO\\nisolated\\tO\\nand\\tO\\ntransfected\\tO\\nseparately\\tO\\ninto\\tO\\nL\\tO\\n-\\tO\\ncells\\tO\\n.\\tO\\n\\nSubsequent\\tO\\nmolecular\\tO\\nbiology\\tO\\n,\\tO\\nbiosynthetic\\tO\\n,\\tO\\nand\\tO\\nimmunofluorescence\\tO\\nstudies\\tO\\ndemonstrated\\tO\\nthat\\tO\\nC2\\tO\\nsecretion\\tO\\nis\\tO\\nimpaired\\tO\\nin\\tO\\nType\\tB-Disease\\nII\\tI-Disease\\nC2\\tI-Disease\\ndeficiency\\tI-Disease\\nbecause\\tO\\nof\\tO\\ndifferent\\tO\\nmissense\\tO\\nmutations\\tO\\nat\\tO\\nhighly\\tO\\nconserved\\tO\\nresidues\\tO\\nin\\tO\\neach\\tO\\nof\\tO\\nthe\\tO\\nC2Q0\\tO\\nalleles\\tO\\n.\\tO\\n\\nOne\\tO\\nis\\tO\\nin\\tO\\nexon\\tO\\n5\\tO\\n(\\tO\\nnucleotide\\tO\\nC566\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n;\\tO\\nSer189\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nPhe\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nC2Q0\\tO\\ngene\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nMHC\\tO\\nhaplotype\\tO\\nA11\\tO\\n,\\tO\\nB35\\tO\\n,\\tO\\nDRw1\\tO\\n,\\tO\\nBFS\\tO\\n,\\tO\\nC4A0B1\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nis\\tO\\nin\\tO\\nexon\\tO\\n11\\tO\\n(\\tO\\nG1930\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n;\\tO\\nGly444\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nArg\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nC2Q0\\tO\\ngene\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nMHC\\tO\\nhaplotype\\tO\\nA2\\tO\\n,\\tO\\nB5\\tO\\n,\\tO\\nDRw4\\tO\\n,\\tO\\nBFS\\tO\\n,\\tO\\nC4A3B1\\tO\\n.\\tO\\n\\nEach\\tO\\nmutant\\tO\\nC2\\tO\\ngene\\tO\\nproduct\\tO\\nis\\tO\\nretained\\tO\\nearly\\tO\\nin\\tO\\nthe\\tO\\nsecretory\\tO\\npathway\\tO\\n.\\tO\\n\\nThese\\tO\\nmutants\\tO\\nprovide\\tO\\nmodels\\tO\\nfor\\tO\\nelucidating\\tO\\nthe\\tO\\nC2\\tO\\nsecretory\\tO\\npathway\\tO\\n.\\tO\\n.\\tO\\n\\nDefective\\tO\\ndimerization\\tO\\nof\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\nsubunits\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nCys\\tO\\n-\\tO\\n>\\tO\\nArg\\tO\\nmutation\\tO\\nin\\tO\\ntype\\tB-Disease\\nIID\\tI-Disease\\nvon\\tI-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nsame\\tO\\nheterozygous\\tO\\nT\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\ntransition\\tO\\nat\\tO\\nnt\\tO\\n8567\\tO\\nof\\tO\\nthe\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tO\\n(\\tO\\nvWF\\tO\\n)\\tO\\ntranscript\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\ntwo\\tO\\nunrelated\\tO\\npatients\\tO\\nwith\\tO\\ntype\\tB-Disease\\nIID\\tI-Disease\\nvon\\tI-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nwith\\tO\\nno\\tO\\nother\\tO\\napparent\\tO\\nabnormality\\tO\\n.\\tO\\n\\nIn\\tO\\none\\tO\\nfamily\\tO\\n,\\tO\\nboth\\tO\\nalleles\\tO\\nwere\\tO\\nnormal\\tO\\nin\\tO\\nthe\\tO\\nparents\\tO\\nand\\tO\\none\\tO\\nsister\\tO\\n;\\tO\\nthus\\tO\\n,\\tO\\nthe\\tO\\nmutation\\tO\\noriginated\\tO\\nde\\tO\\nnovo\\tO\\nin\\tO\\nthe\\tO\\nproposita\\tO\\n.\\tO\\n\\nThe\\tO\\nsecond\\tO\\npatient\\tO\\nalso\\tO\\nhad\\tO\\nasymptomatic\\tO\\nparents\\tO\\nwho\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nwere\\tO\\nnot\\tO\\navailable\\tO\\nfor\\tO\\nstudy\\tO\\n.\\tO\\n\\nThe\\tO\\nstructural\\tO\\nconsequences\\tO\\nof\\tO\\nthe\\tO\\nidentified\\tO\\nmutation\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nthe\\tO\\nCyS2010\\tO\\n-\\tO\\n>\\tO\\nArg\\tO\\nsubstitution\\tO\\n,\\tO\\nwere\\tO\\nevaluated\\tO\\nby\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nvWF\\tO\\ncarboxyl\\tO\\n-\\tO\\nterminal\\tO\\ndomain\\tO\\ncontaining\\tO\\nresidues\\tO\\n1366\\tO\\n-\\tO\\n2050\\tO\\n.\\tO\\n\\nInsect\\tO\\ncells\\tO\\ninfected\\tO\\nwith\\tO\\nrecombinant\\tO\\nbaculovirus\\tO\\nexpressing\\tO\\nnormal\\tO\\nvWF\\tO\\nsequence\\tO\\nsecreted\\tO\\na\\tO\\ndisulfide\\tO\\nlinked\\tO\\ndimeric\\tO\\nmolecule\\tO\\nwith\\tO\\nan\\tO\\napparent\\tO\\nmolecular\\tO\\nmass\\tO\\nof\\tO\\n150\\tO\\nkDa\\tO\\nbefore\\tO\\nreduction\\tO\\n,\\tO\\nyielding\\tO\\na\\tO\\nsingle\\tO\\nband\\tO\\nof\\tO\\n80\\tO\\nkDa\\tO\\nafter\\tO\\ndisulfide\\tO\\nbond\\tO\\nreduction\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\ncells\\tO\\nexpressing\\tO\\nthe\\tO\\nmutant\\tO\\nfragment\\tO\\nsecreted\\tO\\na\\tO\\nmonomeric\\tO\\nmolecule\\tO\\nof\\tO\\napparent\\tO\\nmolecular\\tO\\nmass\\tO\\nof\\tO\\n80\\tO\\nkDa\\tO\\n,\\tO\\nwhich\\tO\\nremained\\tO\\nunchanged\\tO\\nafter\\tO\\nreduction\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nCyS2010\\tO\\nis\\tO\\nessential\\tO\\nfor\\tO\\nnormal\\tO\\ndimerization\\tO\\nof\\tO\\nvWF\\tO\\nsubunits\\tO\\nthrough\\tO\\ndisulfide\\tO\\nbonding\\tO\\nof\\tO\\ncarboxyl\\tO\\n-\\tO\\nterminal\\tO\\ndomains\\tO\\nand\\tO\\nthat\\tO\\na\\tO\\nheterozygous\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ncorresponding\\tO\\ncodon\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\ndefective\\tO\\nmultimer\\tO\\nformation\\tO\\nin\\tO\\ntype\\tB-Disease\\nIID\\tI-Disease\\nvon\\tI-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nprotein\\tO\\n,\\tO\\na\\tO\\nnovel\\tO\\neffector\\tO\\nfor\\tO\\nthe\\tO\\nGTPase\\tO\\nCDC42Hs\\tO\\n,\\tO\\nis\\tO\\nimplicated\\tO\\nin\\tO\\nactin\\tO\\npolymerization\\tO\\n.\\tO\\n\\nThe\\tO\\nRho\\tO\\nfamily\\tO\\nof\\tO\\nGTPases\\tO\\ncontrol\\tO\\ndiverse\\tO\\nbiological\\tO\\nprocesses\\tO\\n,\\tO\\nincluding\\tO\\ncell\\tO\\nmorphology\\tO\\nand\\tO\\nmitogenesis\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\nWASP\\tO\\n,\\tO\\nthe\\tO\\nprotein\\tO\\nthat\\tO\\nis\\tO\\ndefective\\tO\\nin\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\n,\\tO\\nas\\tO\\na\\tO\\nnovel\\tO\\neffector\\tO\\nfor\\tO\\nCDC42Hs\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nfor\\tO\\nthe\\tO\\nother\\tO\\nRho\\tO\\nfamily\\tO\\nmembers\\tO\\n,\\tO\\nRac\\tO\\nand\\tO\\nRho\\tO\\n.\\tO\\n\\nThis\\tO\\ninteraction\\tO\\nis\\tO\\ndependent\\tO\\non\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nG\\tO\\nprotein\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\n.\\tO\\n\\nCellular\\tO\\nexpression\\tO\\nof\\tO\\nepitope\\tO\\n-\\tO\\ntagged\\tO\\nWASP\\tO\\nproduces\\tO\\nclusters\\tO\\nof\\tO\\nWASP\\tO\\nthat\\tO\\nare\\tO\\nhighly\\tO\\nenriched\\tO\\nin\\tO\\npolymerized\\tO\\nactin\\tO\\n.\\tO\\n\\nThis\\tO\\nclustering\\tO\\nis\\tO\\nnot\\tO\\nobserved\\tO\\nwith\\tO\\na\\tO\\nC\\tO\\n-\\tO\\nterminally\\tO\\ndeleted\\tO\\nWASP\\tO\\nand\\tO\\nis\\tO\\ninhibited\\tO\\nby\\tO\\ncoexpression\\tO\\nwith\\tO\\ndominant\\tO\\nnegative\\tO\\nCDC42Hs\\tO\\n-\\tO\\nN17\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nwith\\tO\\ndominant\\tO\\nnegative\\tO\\nforms\\tO\\nof\\tO\\nRac\\tO\\nor\\tO\\nRho\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nWASP\\tO\\nprovides\\tO\\na\\tO\\nnovel\\tO\\nlink\\tO\\nbetween\\tO\\nCDC42Hs\\tO\\nand\\tO\\nthe\\tO\\nactin\\tO\\ncytoskeleton\\tO\\n,\\tO\\nwhich\\tO\\nsuggests\\tO\\na\\tO\\nmolecular\\tO\\nmechanism\\tO\\nfor\\tO\\nmany\\tO\\nof\\tO\\nthe\\tO\\ncellular\\tO\\nabnormalities\\tO\\nin\\tO\\nWAS\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nWASP\\tO\\nsequence\\tO\\ncontains\\tO\\ntwo\\tO\\nnovel\\tO\\ndomains\\tO\\nthat\\tO\\nare\\tO\\nhomologous\\tO\\nto\\tO\\nother\\tO\\nproteins\\tO\\ninvolved\\tO\\nin\\tO\\naction\\tO\\norganization\\tO\\n.\\tO\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\nis\\tO\\na\\tO\\nfrequent\\tO\\ncause\\tO\\nof\\tO\\nidiopathic\\tO\\nAddison\\tB-Disease\\n\\'\\tI-Disease\\ns\\tI-Disease\\ndisease\\tI-Disease\\nin\\tO\\nyoung\\tO\\nadult\\tO\\nmale\\tO\\npatients\\tO\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nLinked\\tI-Disease\\nadrenoleukodystrophy\\tI-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\ngenetic\\tB-Disease\\ndisease\\tI-Disease\\nassociated\\tO\\nwith\\tO\\ndemyelination\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\ncentral\\tI-Disease\\nnervous\\tI-Disease\\nsystem\\tI-Disease\\n,\\tO\\nadrenal\\tB-Disease\\ninsufficiency\\tI-Disease\\n,\\tO\\nand\\tO\\naccumulation\\tO\\nof\\tO\\nvery\\tO\\nlong\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\nin\\tO\\ntissue\\tO\\nand\\tO\\nbody\\tO\\nfluids\\tO\\n.\\tO\\n\\nALD\\tB-Disease\\nis\\tO\\ndue\\tO\\nto\\tO\\nmutation\\tO\\nof\\tO\\na\\tO\\ngene\\tO\\nlocated\\tO\\nin\\tO\\nXq28\\tO\\nthat\\tO\\nencodes\\tO\\na\\tO\\nperoxisomal\\tO\\ntransporter\\tO\\nprotein\\tO\\nof\\tO\\nunknown\\tO\\nfunction\\tO\\n.\\tO\\n\\nThe\\tO\\nmost\\tO\\ncommon\\tO\\nphenotype\\tO\\nof\\tO\\nALD\\tB-Disease\\nis\\tO\\nthe\\tO\\ncerebral\\tO\\nform\\tO\\n(\\tO\\n45\\tO\\n%\\tO\\n)\\tO\\nthat\\tO\\ndevelops\\tO\\nin\\tO\\nboys\\tO\\nbetween\\tO\\n5\\tO\\n-\\tO\\n12\\tO\\nyr\\tO\\n.\\tO\\n\\nAdrenomyeloneuropathy\\tB-Disease\\n(\\tO\\nAMN\\tB-Disease\\n)\\tO\\ninvolves\\tO\\nthe\\tO\\nspinal\\tO\\ncord\\tO\\nand\\tO\\nperipheral\\tO\\nnerves\\tO\\nin\\tO\\nyoung\\tO\\nadults\\tO\\n(\\tO\\n35\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nAdrenal\\tB-Disease\\ninsufficiency\\tI-Disease\\n(\\tO\\nAddisons\\tB-Disease\\ndisease\\tI-Disease\\n)\\tO\\nis\\tO\\nfrequently\\tO\\nassociated\\tO\\nwith\\tO\\nAMN\\tB-Disease\\nor\\tO\\ncerebral\\tB-Disease\\nALD\\tI-Disease\\nand\\tO\\nmay\\tO\\nremain\\tO\\nthe\\tO\\nonly\\tO\\nclinical\\tO\\nexpression\\tO\\nof\\tO\\nALD\\tB-Disease\\n(\\tO\\n8\\tO\\n%\\tO\\nof\\tO\\ncases\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nprevalence\\tO\\nof\\tO\\nALD\\tB-Disease\\namong\\tO\\nadults\\tO\\nwith\\tO\\nAddisons\\tB-Disease\\ndisease\\tI-Disease\\nremains\\tO\\nunknown\\tO\\n.\\tO\\n\\nTo\\tO\\nevaluate\\tO\\nthis\\tO\\nprevalence\\tO\\n,\\tO\\nwe\\tO\\nperformed\\tO\\nbiochemical\\tO\\nanalysis\\tO\\nof\\tO\\nvery\\tO\\nlong\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\nin\\tO\\n14\\tO\\nmale\\tO\\npatients\\tO\\n(\\tO\\nage\\tO\\nranging\\tO\\nfrom\\tO\\n12\\tO\\n-\\tO\\n45\\tO\\nyr\\tO\\nat\\tO\\ndiagnosis\\tO\\n)\\tO\\npreviously\\tO\\ndiagnosed\\tO\\nas\\tO\\nhaving\\tO\\nprimary\\tO\\nidiopathic\\tO\\nadrenocortical\\tB-Disease\\ninsufficiency\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\n5\\tO\\nof\\tO\\n14\\tO\\npatients\\tO\\n(\\tO\\n35\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nelevated\\tO\\nplasma\\tO\\nconcentrations\\tO\\nof\\tO\\nvery\\tO\\nlong\\tO\\nchain\\tO\\nfatty\\tO\\nacids\\tO\\nwere\\tO\\ndetected\\tO\\n.\\tO\\n\\nNone\\tO\\nof\\tO\\nthese\\tO\\npatients\\tO\\nhad\\tO\\nadrenocortical\\tO\\nantibodies\\tO\\n.\\tO\\n\\nBy\\tO\\nelectrophysiological\\tO\\ntests\\tO\\nand\\tO\\nmagnetic\\tO\\nresonance\\tO\\nimaging\\tO\\nit\\tO\\nwas\\tO\\ndetermined\\tO\\nthat\\tO\\ntwo\\tO\\npatients\\tO\\nhad\\tO\\ncerebral\\tB-Disease\\nALD\\tI-Disease\\n,\\tO\\none\\tO\\nhad\\tO\\nadrenomyeloneuropathy\\tB-Disease\\nwith\\tO\\ncerebral\\tO\\ninvolvement\\tO\\n,\\tO\\nand\\tO\\ntwo\\tO\\nhad\\tO\\npreclinical\\tO\\nAMN\\tB-Disease\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nsupport\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nALD\\tB-Disease\\nis\\tO\\na\\tO\\nfrequent\\tO\\ncause\\tO\\nof\\tO\\nidiopathic\\tO\\nAddisons\\tB-Disease\\ndisease\\tI-Disease\\nin\\tO\\nchildren\\tO\\nand\\tO\\nadults\\tO\\n.\\tO\\n.\\tO\\n\\nTumor\\tB-Disease\\nsuppression\\tO\\nand\\tO\\napoptosis\\tO\\nof\\tO\\nhuman\\tO\\nprostate\\tB-Disease\\ncarcinoma\\tI-Disease\\nmediated\\tO\\nby\\tO\\na\\tO\\ngenetic\\tO\\nlocus\\tO\\nwithin\\tO\\nhuman\\tO\\nchromosome\\tO\\n10pter\\tO\\n-\\tO\\nq11\\tO\\n.\\tO\\n\\nProstate\\tB-Disease\\ncancer\\tI-Disease\\nis\\tO\\nthe\\tO\\nsecond\\tO\\nleading\\tO\\ncause\\tO\\nof\\tO\\nmale\\tO\\ncancer\\tB-Disease\\ndeaths\\tO\\nin\\tO\\nthe\\tO\\nUnited\\tO\\nStates\\tO\\n.\\tO\\n\\nYet\\tO\\n,\\tO\\ndespite\\tO\\na\\tO\\nlarge\\tO\\ninternational\\tO\\neffort\\tO\\n,\\tO\\nlittle\\tO\\nis\\tO\\nknown\\tO\\nabout\\tO\\nthe\\tO\\nmolecular\\tO\\nmechanisms\\tO\\nthat\\tO\\nunderlie\\tO\\nthis\\tO\\ndevastating\\tO\\ndisease\\tO\\n.\\tO\\n\\nProstate\\tO\\nsecretory\\tO\\nepithelial\\tO\\ncells\\tO\\nand\\tO\\nandrogen\\tO\\n-\\tO\\ndependent\\tO\\nprostate\\tB-Disease\\ncarcinomas\\tI-Disease\\nundergo\\tO\\napoptosis\\tO\\nin\\tO\\nresponse\\tO\\nto\\tO\\nandrogen\\tO\\ndeprivation\\tO\\nand\\tO\\n,\\tO\\nfurthermore\\tO\\n,\\tO\\nmost\\tO\\nprostate\\tB-Disease\\ncarcinomas\\tI-Disease\\nbecome\\tO\\nandrogen\\tO\\nindependent\\tO\\nand\\tO\\nrefractory\\tO\\nto\\tO\\nfurther\\tO\\ntherapeutic\\tO\\nmanipulations\\tO\\nduring\\tO\\ndisease\\tO\\nprogression\\tO\\n.\\tO\\n\\nDefinition\\tO\\nof\\tO\\nthe\\tO\\ngenetic\\tO\\nevents\\tO\\nthat\\tO\\ntrigger\\tO\\napoptosis\\tO\\nin\\tO\\nthe\\tO\\nprostate\\tO\\ncould\\tO\\nprovide\\tO\\nimportant\\tO\\ninsights\\tO\\ninto\\tO\\ncritical\\tO\\npathways\\tO\\nin\\tO\\nnormal\\tO\\ndevelopment\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nelucidate\\tO\\nthe\\tO\\nperturbations\\tO\\nof\\tO\\nthose\\tO\\nkey\\tO\\npathways\\tO\\nin\\tO\\nneoplastic\\tO\\ntransformation\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nthe\\tO\\nfunctional\\tO\\ndefinition\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\ngenetic\\tO\\nlocus\\tO\\nwithin\\tO\\nhuman\\tO\\nchromosome\\tO\\n10pter\\tO\\n-\\tO\\nq11\\tO\\nthat\\tO\\nmediates\\tO\\nboth\\tO\\nin\\tO\\nvivo\\tO\\ntumor\\tO\\nsuppression\\tO\\nand\\tO\\nin\\tO\\nvitro\\tO\\napoptosis\\tO\\nof\\tO\\nprostatic\\tB-Disease\\nadenocarcinoma\\tI-Disease\\ncells\\tO\\n.\\tO\\n\\nA\\tO\\ndefined\\tO\\nfragment\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n10\\tO\\nwas\\tO\\ntransferred\\tO\\nvia\\tO\\nmicrocell\\tO\\nfusion\\tO\\ninto\\tO\\na\\tO\\nprostate\\tB-Disease\\nadenocarcinoma\\tI-Disease\\ncell\\tO\\nline\\tO\\n.\\tO\\n\\nMicrocell\\tO\\nhybrids\\tO\\ncontaining\\tO\\nonly\\tO\\nthe\\tO\\nregion\\tO\\n10pter\\tO\\n-\\tO\\nq11\\tO\\nwere\\tO\\nsuppressed\\tO\\nfor\\tO\\ntumorigenicity\\tO\\nfollowing\\tO\\ninjection\\tO\\nof\\tO\\nmicrocell\\tO\\nhybrids\\tO\\ninto\\tO\\nnude\\tO\\nmice\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nthe\\tO\\ncomplemented\\tO\\nhybrids\\tO\\nundergo\\tO\\nprogrammed\\tO\\ncell\\tO\\ndeath\\tO\\nin\\tO\\nvitro\\tO\\nvia\\tO\\na\\tO\\nmechanism\\tO\\nthat\\tO\\ndoes\\tO\\nnot\\tO\\nrequire\\tO\\nnuclear\\tO\\nlocalization\\tO\\nof\\tO\\np53\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nfunctionally\\tO\\ndefine\\tO\\na\\tO\\nnovel\\tO\\ngenetic\\tO\\nlocus\\tO\\n,\\tO\\ndesignated\\tO\\nPAC1\\tO\\n,\\tO\\nfor\\tO\\nprostate\\tO\\nadenocarcinoma\\tO\\n1\\tO\\n,\\tO\\ninvolved\\tO\\nin\\tO\\ntumor\\tO\\nsuppression\\tO\\nof\\tO\\nhuman\\tO\\nprostate\\tB-Disease\\ncarcinoma\\tI-Disease\\nand\\tO\\nfurthermore\\tO\\nstrongly\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\ncell\\tO\\ndeath\\tO\\npathway\\tO\\ncan\\tO\\nbe\\tO\\nfunctionally\\tO\\nrestored\\tO\\nin\\tO\\nprostatic\\tB-Disease\\nadenocarcinoma\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nLow\\tO\\nincidence\\tO\\nof\\tO\\nBRCA2\\tO\\nmutations\\tO\\nin\\tO\\nbreast\\tB-Disease\\ncarcinoma\\tI-Disease\\nand\\tO\\nother\\tO\\ncancers\\tB-Disease\\n.\\tO\\n\\nInherited\\tO\\nmutant\\tO\\nalleles\\tO\\nof\\tO\\nfamilial\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\ngenes\\tO\\npredispose\\tO\\nindividuals\\tO\\nto\\tO\\nparticular\\tO\\ntypes\\tO\\nof\\tO\\ncancer\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\nto\\tO\\nan\\tO\\ninvolvement\\tO\\nin\\tO\\ninherited\\tO\\nsusceptibility\\tO\\nto\\tO\\ncancer\\tB-Disease\\n,\\tO\\nthese\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\ngenes\\tO\\nare\\tO\\ntargets\\tO\\nfor\\tO\\nsomatic\\tO\\nmutations\\tO\\nin\\tO\\nsporadic\\tB-Disease\\ncancers\\tI-Disease\\nof\\tO\\nthe\\tO\\nsame\\tO\\ntype\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nfamilial\\tO\\nforms\\tO\\n.\\tO\\n\\nAn\\tO\\nexception\\tO\\nis\\tO\\nBRCA1\\tO\\n,\\tO\\nwhich\\tO\\ncontributes\\tO\\nto\\tO\\na\\tO\\nsignificant\\tO\\nfraction\\tO\\nof\\tO\\nfamilial\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nbut\\tO\\nundergoes\\tO\\nmutation\\tO\\nat\\tO\\nvery\\tO\\nlow\\tO\\nrates\\tO\\nin\\tO\\nsporadic\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nfinding\\tO\\nsuggests\\tO\\nthat\\tO\\nother\\tO\\ngenes\\tO\\nmay\\tO\\nbe\\tO\\nthe\\tO\\nprincipal\\tO\\ntargets\\tO\\nfor\\tO\\nsomatic\\tO\\nmutation\\tO\\nin\\tO\\nbreast\\tB-Disease\\ncarcinoma\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nsecond\\tO\\n,\\tO\\nrecently\\tO\\nidentified\\tO\\nfamilial\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\ngene\\tO\\n,\\tO\\nBRCA2\\tO\\n(\\tO\\nrefs\\tO\\n5\\tO\\n-\\tO\\n8\\tO\\n)\\tO\\n,\\tO\\naccounts\\tO\\nfor\\tO\\na\\tO\\nproportion\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nroughly\\tO\\nequal\\tO\\nto\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nLike\\tO\\nBRCA1\\tO\\n,\\tO\\nBRCA2\\tO\\nbehaves\\tO\\nas\\tO\\na\\tO\\ndominantly\\tO\\ninherited\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n.\\tO\\n\\nIndividuals\\tO\\nwho\\tO\\ninherit\\tO\\none\\tO\\nmutant\\tO\\nallele\\tO\\nare\\tO\\nat\\tO\\nincreased\\tO\\nrisk\\tO\\nfor\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nand\\tO\\nthe\\tO\\ntumours\\tB-Disease\\nthey\\tO\\ndevelop\\tO\\nlose\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nallele\\tO\\nby\\tO\\nheterozygous\\tO\\ndeletion\\tO\\n.\\tO\\n\\nThe\\tO\\nBRCA2\\tO\\ncoding\\tO\\nsequence\\tO\\nis\\tO\\nhuge\\tO\\n,\\tO\\ncomposed\\tO\\nof\\tO\\n26\\tO\\nexons\\tO\\nthat\\tO\\nspan\\tO\\n10\\tO\\n,\\tO\\n443\\tO\\nbp\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\ninvestigate\\tO\\nthe\\tO\\nrate\\tO\\nof\\tO\\nBRCA2\\tO\\nmutation\\tO\\nin\\tO\\nsporadic\\tB-Disease\\nbreast\\tI-Disease\\ncancers\\tI-Disease\\nand\\tO\\nin\\tO\\na\\tO\\nset\\tO\\nof\\tO\\ncell\\tO\\nlines\\tO\\nthat\\tO\\nrepresent\\tO\\ntwelve\\tO\\nother\\tO\\ntumour\\tB-Disease\\ntypes\\tO\\n.\\tO\\n\\nSurprisingly\\tO\\n,\\tO\\nmutations\\tO\\nin\\tO\\nBRCA2\\tO\\nare\\tO\\ninfrequent\\tO\\nin\\tO\\ncancers\\tB-Disease\\nincluding\\tO\\nbreast\\tB-Disease\\ncarcinoma\\tI-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\na\\tO\\nprobable\\tO\\ngermline\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\npancreatic\\tB-Disease\\ntumour\\tI-Disease\\ncell\\tO\\nline\\tO\\nsuggests\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nBRCA2\\tO\\nin\\tO\\nsusceptibility\\tO\\nto\\tO\\npancreatic\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nFounding\\tO\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nin\\tO\\nsouthern\\tO\\nSweden\\tO\\n.\\tO\\n\\nNine\\tO\\ndifferent\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\ngene\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\n15\\tO\\nof\\tO\\n47\\tO\\nkindreds\\tO\\nfrom\\tO\\nsouthern\\tO\\nSweden\\tO\\n,\\tO\\nby\\tO\\nuse\\tO\\nof\\tO\\nSSCP\\tO\\nand\\tO\\nheteroduplex\\tO\\nanalysis\\tO\\nof\\tO\\nall\\tO\\nexons\\tO\\nand\\tO\\nflanking\\tO\\nintron\\tO\\nregion\\tO\\nand\\tO\\nby\\tO\\na\\tO\\nprotein\\tO\\n-\\tO\\ntruncation\\tO\\ntest\\tO\\nfor\\tO\\nexon\\tO\\n11\\tO\\n,\\tO\\nfollowed\\tO\\nby\\tO\\ndirect\\tO\\nsequencing\\tO\\n.\\tO\\n\\nAll\\tO\\nbut\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nare\\tO\\npredicted\\tO\\nto\\tO\\ngive\\tO\\nrise\\tO\\nto\\tO\\npremature\\tO\\ntranslation\\tO\\ntermination\\tO\\nand\\tO\\ninclude\\tO\\nseven\\tO\\nframeshift\\tO\\ninsertions\\tO\\nor\\tO\\ndeletions\\tO\\n,\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nsplice\\tO\\nacceptor\\tO\\nsite\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nremaining\\tO\\nmutation\\tO\\nis\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nCys61Gly\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nzinc\\tO\\n-\\tO\\nbinding\\tO\\nmotif\\tO\\n.\\tO\\n\\nFour\\tO\\nnovel\\tO\\nSwedish\\tO\\nfounding\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nthe\\tO\\nnucleotide\\tO\\n2595\\tO\\ndeletion\\tO\\nA\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nfive\\tO\\nfamilies\\tO\\n,\\tO\\nthe\\tO\\nC\\tO\\n1806\\tO\\nT\\tO\\nnonsense\\tO\\nmutation\\tO\\nin\\tO\\nthree\\tO\\nfamilies\\tO\\n,\\tO\\nthe\\tO\\n3166\\tO\\ninsertion\\tO\\nTGAGA\\tO\\nin\\tO\\nthree\\tO\\nfamilies\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nnucleotide\\tO\\n1201\\tO\\ndeletion\\tO\\n11\\tO\\nin\\tO\\ntwo\\tO\\nfamilies\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nthe\\tO\\nintragenic\\tO\\npolymorphism\\tO\\nD17S855\\tO\\nsupports\\tO\\ncommon\\tO\\norigins\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\n.\\tO\\n\\nEleven\\tO\\nof\\tO\\nthe\\tO\\n15\\tO\\nkindreds\\tO\\nmanifesting\\tO\\nBRCA1\\tO\\nmutations\\tO\\nwere\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n,\\tO\\nseveral\\tO\\nof\\tO\\nthem\\tO\\nwith\\tO\\na\\tO\\npredominant\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nphenotype\\tO\\n.\\tO\\n\\nThe\\tO\\nset\\tO\\nof\\tO\\n32\\tO\\nfamilies\\tO\\nin\\tO\\nwhich\\tO\\nno\\tO\\nBRCA1\\tO\\nalterations\\tO\\nwere\\tO\\ndetected\\tO\\nincluded\\tO\\n1\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nkindred\\tO\\nmanifesting\\tO\\nclear\\tO\\nlinkage\\tO\\nto\\tO\\nthe\\tO\\nBRCA1\\tO\\nregion\\tO\\nand\\tO\\nloss\\tO\\nof\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nchromosome\\tO\\nin\\tO\\nassociated\\tO\\ntumors\\tB-Disease\\n.\\tO\\n\\nOther\\tO\\ntumor\\tB-Disease\\ntypes\\tO\\nfound\\tO\\nin\\tO\\nBRCA1\\tO\\nmutation\\tO\\n/\\tO\\nhaplotype\\tO\\ncarriers\\tO\\nincluded\\tO\\nprostatic\\tB-Disease\\n,\\tI-Disease\\npancreas\\tI-Disease\\n,\\tI-Disease\\nskin\\tI-Disease\\n,\\tI-Disease\\nand\\tI-Disease\\nlung\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\na\\tO\\nmalignant\\tB-Disease\\nmelanoma\\tI-Disease\\n,\\tO\\nan\\tO\\noligodendroglioma\\tB-Disease\\n,\\tO\\nand\\tO\\na\\tO\\ncarcinosarcoma\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\nall\\tO\\n,\\tO\\n12\\tO\\nof\\tO\\n16\\tO\\nkindreds\\tO\\nmanifesting\\tO\\nBRCA1\\tO\\nmutation\\tO\\nor\\tO\\nlinkage\\tO\\ncontained\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nas\\tO\\ncompared\\tO\\nwith\\tO\\nonly\\tO\\n6\\tO\\nof\\tO\\nthe\\tO\\nremaining\\tO\\n31\\tO\\nfamilies\\tO\\n(\\tO\\nP\\tO\\n<\\tO\\n.\\tO\\n001\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nstudy\\tO\\nconfirms\\tO\\nthe\\tO\\ninvolvement\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\ndisease\\tO\\npredisposition\\tO\\nfor\\tO\\na\\tO\\nsubset\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\noften\\tO\\ncharacterized\\tO\\nby\\tO\\novarian\\tB-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nRapid\\tO\\ndetection\\tO\\nof\\tO\\nregionally\\tO\\nclustered\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nBRCA1\\tO\\nmutations\\tO\\nby\\tO\\nmultiplex\\tO\\nheteroduplex\\tO\\nanalysis\\tO\\n.\\tO\\n\\nUKCCCR\\tO\\nFamilial\\tO\\nOvarian\\tB-Disease\\nCancer\\tI-Disease\\nStudy\\tO\\nGroup\\tO\\n.\\tO\\n\\nGerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\na\\tO\\nsubstantial\\tO\\nproportion\\tO\\nof\\tO\\nfamilies\\tO\\nwith\\tO\\nmultiple\\tO\\ncases\\tO\\nof\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nSince\\tO\\nthe\\tO\\nisolation\\tO\\nof\\tO\\nBRCA1\\tO\\nlast\\tO\\nyear\\tO\\n,\\tO\\n>\\tO\\n65\\tO\\ndistinct\\tO\\nmutations\\tO\\nscattered\\tO\\nthroughout\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nhave\\tO\\nbeen\\tO\\ndetected\\tO\\n,\\tO\\nmaking\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\ntime\\tO\\nconsuming\\tO\\nand\\tO\\ntechnically\\tO\\nchallenging\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndeveloped\\tO\\na\\tO\\nmultiplex\\tO\\nheteroduplex\\tO\\nanalysis\\tO\\nthat\\tO\\nis\\tO\\ndesigned\\tO\\nto\\tO\\nanalyze\\tO\\none\\tO\\n-\\tO\\nquarter\\tO\\nof\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\nin\\tO\\na\\tO\\nsingle\\tO\\n-\\tO\\nstep\\tO\\nscreening\\tO\\nprocedure\\tO\\nand\\tO\\nthat\\tO\\nwill\\tO\\ndetect\\tO\\napproximately\\tO\\n50\\tO\\n%\\tO\\nof\\tO\\nall\\tO\\nBRCA1\\tO\\nmutations\\tO\\nso\\tO\\nfar\\tO\\nreported\\tO\\nin\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nused\\tO\\nthis\\tO\\ntechnique\\tO\\nto\\tO\\nanalyze\\tO\\nBRCA1\\tO\\nin\\tO\\n162\\tO\\nfamilies\\tO\\nwith\\tO\\na\\tO\\nhistory\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\nidentified\\tO\\n12\\tO\\ndistinct\\tO\\nmutations\\tO\\nin\\tO\\n35\\tO\\nfamilies\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\npreviously\\tO\\nundescribed\\tO\\nmutation\\tO\\nwithin\\tO\\nthe\\tO\\ntetramerisation\\tO\\ndomain\\tO\\nof\\tO\\nTP53\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nLi\\tB-Disease\\n-\\tI-Disease\\nFraumeni\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\ndetails\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nclassic\\tO\\nLi\\tB-Disease\\n-\\tI-Disease\\nFraumeni\\tI-Disease\\nsyndrome\\tI-Disease\\nin\\tO\\nwhich\\tO\\nthere\\tO\\nis\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\ncodon\\tO\\n344\\tO\\nof\\tO\\nthe\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\nTP53\\tO\\n.\\tO\\n\\nCodon\\tO\\n344\\tO\\nis\\tO\\na\\tO\\nkey\\tO\\nresidue\\tO\\nwithin\\tO\\nthe\\tO\\ntetramerisation\\tO\\ndomain\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\nof\\tO\\na\\tO\\nproline\\tO\\nfor\\tO\\na\\tO\\nleucine\\tO\\nis\\tO\\npredicted\\tO\\nto\\tO\\nhave\\tO\\nprofound\\tO\\nimplications\\tO\\nfor\\tO\\ntetramerisation\\tO\\nand\\tO\\npotentially\\tO\\nDNA\\tO\\nbinding\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nreport\\tO\\nof\\tO\\na\\tO\\nmutation\\tO\\nat\\tO\\nthis\\tO\\nresidue\\tO\\nin\\tO\\neither\\tO\\nsporadic\\tB-Disease\\ntumours\\tI-Disease\\nor\\tO\\nin\\tO\\nthe\\tO\\ngermline\\tO\\nand\\tO\\nthe\\tO\\nfirst\\tO\\nreport\\tO\\nof\\tO\\na\\tO\\ngermline\\tO\\nmutation\\tO\\nwithin\\tO\\nthe\\tO\\ntetramerisation\\tO\\ndomain\\tO\\n.\\tO\\n\\nThe\\tO\\nfamily\\tO\\ndoes\\tO\\nnot\\tO\\nappear\\tO\\nto\\tO\\nbe\\tO\\nremarkable\\tO\\nin\\tO\\nthe\\tO\\nspectrum\\tO\\nof\\tO\\ntumours\\tB-Disease\\n,\\tO\\nand\\tO\\nthere\\tO\\nis\\tO\\nloss\\tO\\nof\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nallele\\tO\\nin\\tO\\na\\tO\\nleiomyosarcoma\\tB-Disease\\nfrom\\tO\\nthe\\tO\\nproband\\tO\\n.\\tO\\n\\nA\\tO\\ncell\\tO\\nline\\tO\\nhas\\tO\\nbeen\\tO\\nestablished\\tO\\nfrom\\tO\\nthe\\tO\\ntumour\\tB-Disease\\nof\\tO\\nthe\\tO\\nproband\\tO\\nand\\tO\\ncytogenetic\\tO\\nand\\tO\\nmolecular\\tO\\nstudies\\tO\\ncarried\\tO\\nout\\tO\\n,\\tO\\nproviding\\tO\\nan\\tO\\nextensive\\tO\\nanalysis\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nspectrum\\tO\\nof\\tO\\nRB1\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nhereditary\\tB-Disease\\nretinoblastoma\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nsearched\\tO\\nfor\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nRB1\\tO\\nmutations\\tO\\nin\\tO\\n119\\tO\\npatients\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nretinoblastoma\\tI-Disease\\n.\\tO\\n\\nPrevious\\tO\\ninvestigations\\tO\\nby\\tO\\nSouthern\\tO\\nblot\\tO\\nhybridization\\tO\\nand\\tO\\nPCR\\tO\\nfragment\\tO\\n-\\tO\\nlength\\tO\\nanalysis\\tO\\nhad\\tO\\nrevealed\\tO\\nmutations\\tO\\nin\\tO\\n48\\tO\\npatients\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\non\\tO\\nthe\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nremaining\\tO\\n71\\tO\\npatients\\tO\\n.\\tO\\n\\nBy\\tO\\napplying\\tO\\nheteroduplex\\tO\\nanalysis\\tO\\n,\\tO\\nnonisotopic\\tO\\nSSCP\\tO\\n,\\tO\\nand\\tO\\ndirect\\tO\\nsequencing\\tO\\n,\\tO\\nwe\\tO\\ndetected\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nresulting\\tO\\nin\\tO\\npremature\\tO\\ntermination\\tO\\ncodons\\tO\\nor\\tO\\ndisruption\\tO\\nof\\tO\\nsplice\\tO\\nsignals\\tO\\nin\\tO\\n51\\tO\\n(\\tO\\n72\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\n71\\tO\\npatients\\tO\\n.\\tO\\n\\nFour\\tO\\npatients\\tO\\nalso\\tO\\nshowed\\tO\\nrare\\tO\\nsequence\\tO\\nvariants\\tO\\n.\\tO\\n\\nNo\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nwas\\tO\\npreferentially\\tO\\ninvolved\\tO\\nin\\tO\\nsingle\\tO\\nbase\\tO\\nsubstitutions\\tO\\n.\\tO\\n\\nRecurrent\\tO\\ntransitions\\tO\\nwere\\tO\\nobserved\\tO\\nat\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\n14\\tO\\ncodons\\tO\\nwithin\\tO\\nthe\\tO\\nRB1\\tO\\n.\\tO\\n\\nNo\\tO\\nmutation\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\nexons\\tO\\n25\\tO\\n-\\tO\\n27\\tO\\n,\\tO\\nalthough\\tO\\nthis\\tO\\nregion\\tO\\ncontains\\tO\\ntwo\\tO\\nCGA\\tO\\ncodons\\tO\\n.\\tO\\n\\nThis\\tO\\nsuggests\\tO\\nthat\\tO\\nmutations\\tO\\nwithin\\tO\\nthe\\tO\\n3\\tO\\n-\\tO\\nterminal\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nmay\\tO\\nnot\\tO\\nbe\\tO\\noncogenic\\tO\\n.\\tO\\n\\nWhen\\tO\\nthese\\tO\\ndata\\tO\\nwere\\tO\\ncombined\\tO\\nwith\\tO\\nthe\\tO\\nresults\\tO\\nof\\tO\\nour\\tO\\nprevious\\tO\\ninvestigations\\tO\\n,\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\n99\\tO\\n(\\tO\\n83\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n119\\tO\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\nspectrum\\tO\\ncomprises\\tO\\n15\\tO\\n%\\tO\\nlarge\\tO\\ndeletions\\tO\\n,\\tO\\n26\\tO\\n%\\tO\\nsmall\\tO\\nlength\\tO\\nalterations\\tO\\n,\\tO\\nand\\tO\\n42\\tO\\n%\\tO\\nbase\\tO\\nsubstitutions\\tO\\n.\\tO\\n\\nNo\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\nlocation\\tO\\nof\\tO\\nframeshift\\tO\\nor\\tO\\nnonsense\\tO\\nmutations\\tO\\nand\\tO\\nphenotypic\\tO\\nfeatures\\tO\\n,\\tO\\nincluding\\tO\\nage\\tO\\nat\\tO\\ndiagnosis\\tO\\n,\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\ntumor\\tB-Disease\\nfoci\\tO\\n,\\tO\\nand\\tO\\nmanifestation\\tO\\nof\\tO\\nnonocular\\tB-Disease\\ntumors\\tI-Disease\\nwas\\tO\\nobserved\\tO\\n.\\tO\\n.\\tO\\n\\nPhenotypic\\tO\\ncharacterization\\tO\\nof\\tO\\nindividuals\\tO\\nwith\\tO\\n30\\tO\\n-\\tO\\n40\\tO\\nCAG\\tO\\nrepeats\\tO\\nin\\tO\\nthe\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\ngene\\tO\\nreveals\\tO\\nHD\\tB-Disease\\ncases\\tO\\nwith\\tO\\n36\\tO\\nrepeats\\tO\\nand\\tO\\napparently\\tO\\nnormal\\tO\\nelderly\\tO\\nindividuals\\tO\\nwith\\tO\\n36\\tO\\n-\\tO\\n39\\tO\\nrepeats\\tO\\n.\\tO\\n\\nAbnormal\\tO\\nCAG\\tO\\nexpansions\\tO\\nin\\tO\\nthe\\tO\\nIT\\tO\\n-\\tO\\n15\\tO\\ngene\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\ndiagnostic\\tO\\nsetting\\tO\\nit\\tO\\nis\\tO\\nnecessary\\tO\\nto\\tO\\ndefine\\tO\\nthe\\tO\\nlimits\\tO\\nof\\tO\\nthe\\tO\\nCAG\\tO\\nsize\\tO\\nranges\\tO\\non\\tO\\nnormal\\tO\\nand\\tO\\nHD\\tB-Disease\\n-\\tO\\nassociated\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nMost\\tO\\nlarge\\tO\\nanalyses\\tO\\nthat\\tO\\ndefined\\tO\\nthe\\tO\\nlimits\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\npathological\\tO\\nsize\\tO\\nranges\\tO\\nemployed\\tO\\nPCR\\tO\\nassays\\tO\\n,\\tO\\nwhich\\tO\\nincluded\\tO\\nthe\\tO\\nCAG\\tO\\nrepeats\\tO\\nand\\tO\\na\\tO\\nCCG\\tO\\nrepeat\\tO\\ntract\\tO\\nthat\\tO\\nwas\\tO\\nthought\\tO\\nto\\tO\\nbe\\tO\\ninvariant\\tO\\n.\\tO\\n\\nMany\\tO\\nof\\tO\\nthese\\tO\\nexperiments\\tO\\nfound\\tO\\nan\\tO\\noverlap\\tO\\nbetween\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\ndisease\\tO\\nsize\\tO\\nranges\\tO\\n.\\tO\\n\\nSubsequent\\tO\\nfindings\\tO\\nthat\\tO\\nthe\\tO\\nCCG\\tO\\nrepeats\\tO\\nvary\\tO\\nby\\tO\\n8\\tO\\ntrinucleotide\\tO\\nlengths\\tO\\nsuggested\\tO\\nthat\\tO\\nthe\\tO\\nlimits\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\ndisease\\tO\\nsize\\tO\\nranges\\tO\\nshould\\tO\\nbe\\tO\\nreevaluated\\tO\\nwith\\tO\\nassays\\tO\\nthat\\tO\\nexclude\\tO\\nthe\\tO\\nCCG\\tO\\npolymorphism\\tO\\n.\\tO\\n\\nSince\\tO\\npatients\\tO\\nwith\\tO\\nbetween\\tO\\n30\\tO\\nand\\tO\\n40\\tO\\nrepeats\\tO\\nare\\tO\\nrare\\tO\\n,\\tO\\na\\tO\\nconsortium\\tO\\nwas\\tO\\nassembled\\tO\\nto\\tO\\ncollect\\tO\\nsuch\\tO\\nindividuals\\tO\\n.\\tO\\n\\nAll\\tO\\n178\\tO\\nsamples\\tO\\nwere\\tO\\nreanalyzed\\tO\\nin\\tO\\nCambridge\\tO\\nby\\tO\\nusing\\tO\\nassays\\tO\\nspecific\\tO\\nfor\\tO\\nthe\\tO\\nCAG\\tO\\nrepeats\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\noptimized\\tO\\nmethods\\tO\\nfor\\tO\\nreliable\\tO\\nsizing\\tO\\nof\\tO\\nCAG\\tO\\nrepeats\\tO\\nand\\tO\\nshow\\tO\\ncases\\tO\\nthat\\tO\\ndemonstrate\\tO\\nthe\\tO\\ndangers\\tO\\nof\\tO\\nusing\\tO\\nPCR\\tO\\nassays\\tO\\nthat\\tO\\ninclude\\tO\\nboth\\tO\\nthe\\tO\\nCAG\\tO\\nand\\tO\\nCCG\\tO\\npolymorphisms\\tO\\n.\\tO\\n\\nSeven\\tO\\nHD\\tB-Disease\\npatients\\tO\\nhad\\tO\\n36\\tO\\nrepeats\\tO\\n,\\tO\\nwhich\\tO\\nconfirms\\tO\\nthat\\tO\\nthis\\tO\\nallele\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\ndisease\\tO\\n.\\tO\\n\\nIndividuals\\tO\\nwithout\\tO\\napparent\\tO\\nsymptoms\\tO\\nor\\tO\\nsigns\\tO\\nof\\tO\\nHD\\tB-Disease\\nwere\\tO\\nfound\\tO\\nat\\tO\\n36\\tO\\nrepeats\\tO\\n(\\tO\\naged\\tO\\n74\\tO\\n,\\tO\\n78\\tO\\n,\\tO\\n79\\tO\\n,\\tO\\nand\\tO\\n87\\tO\\nyears\\tO\\n)\\tO\\n,\\tO\\n37\\tO\\nrepeats\\tO\\n(\\tO\\naged\\tO\\n69\\tO\\nyears\\tO\\n)\\tO\\n,\\tO\\n38\\tO\\nrepeats\\tO\\n(\\tO\\naged\\tO\\n69\\tO\\nand\\tO\\n90\\tO\\nyears\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\n39\\tO\\nrepeats\\tO\\n(\\tO\\naged\\tO\\n67\\tO\\n,\\tO\\n90\\tO\\n,\\tO\\nand\\tO\\n95\\tO\\nyears\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ndetailed\\tO\\ncase\\tO\\nhistories\\tO\\nof\\tO\\nan\\tO\\nexceptional\\tO\\ncase\\tO\\nfrom\\tO\\nthis\\tO\\nseries\\tO\\nwill\\tO\\nbe\\tO\\npresented\\tO\\na\\tO\\n95\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nman\\tO\\nwith\\tO\\n39\\tO\\nrepeats\\tO\\nwho\\tO\\ndid\\tO\\nnot\\tO\\nhave\\tO\\nclassical\\tO\\nfeatures\\tO\\nof\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\napparently\\tO\\nhealthy\\tO\\nsurvival\\tO\\ninto\\tO\\nold\\tO\\nage\\tO\\nof\\tO\\nsome\\tO\\nindividuals\\tO\\nwith\\tO\\n36\\tO\\n-\\tO\\n39\\tO\\nrepeats\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nHD\\tB-Disease\\nmutation\\tO\\nmay\\tO\\nnot\\tO\\nalways\\tO\\nbe\\tO\\nfully\\tO\\npenetrant\\tO\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nand\\tO\\nexpression\\tO\\nof\\tO\\neight\\tO\\nnovel\\tO\\nmutations\\tO\\namong\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\npatients\\tO\\nwith\\tO\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\nis\\tO\\ninherited\\tO\\nas\\tO\\nan\\tO\\nautosomal\\tO\\nrecessive\\tO\\ntrait\\tO\\nthat\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nthe\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\naspartoacylase\\tI-Disease\\n(\\tO\\nASPA\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmajority\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\nare\\tO\\nfrom\\tO\\nan\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nbackground\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nASPA\\tO\\nthat\\tO\\nlead\\tO\\nto\\tO\\nloss\\tO\\nof\\tO\\nenzymatic\\tO\\nactivity\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\n,\\tO\\nand\\tO\\nE285A\\tO\\nand\\tO\\nY231X\\tO\\nare\\tO\\nthe\\tO\\ntwo\\tO\\npredominant\\tO\\nmutations\\tO\\nthat\\tO\\naccount\\tO\\nfor\\tO\\n97\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nchromosomes\\tO\\nin\\tO\\nAshkenazi\\tO\\nJewish\\tO\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\ncurrent\\tO\\nstudy\\tO\\nwas\\tO\\naimed\\tO\\nat\\tO\\nfinding\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\nin\\tO\\n25\\tO\\nindependent\\tO\\npatients\\tO\\nof\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nbackground\\tO\\n.\\tO\\n\\nEight\\tO\\nnovel\\tO\\nand\\tO\\nthree\\tO\\npreviously\\tO\\ncharacterized\\tO\\nmutations\\tO\\naccounted\\tO\\nfor\\tO\\n80\\tO\\n%\\tO\\n(\\tO\\n40\\tO\\n/\\tO\\n50\\tO\\n)\\tO\\nof\\tO\\nmutant\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nThe\\tO\\nA305E\\tO\\nmissense\\tO\\nmutation\\tO\\naccounted\\tO\\nfor\\tO\\n48\\tO\\n%\\tO\\n(\\tO\\n24\\tO\\n/\\tO\\n50\\tO\\n)\\tO\\nof\\tO\\nmutant\\tO\\nchromosomes\\tO\\nin\\tO\\npatients\\tO\\nof\\tO\\nwestern\\tO\\nEuropean\\tO\\ndescent\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\ntwo\\tO\\npredominant\\tO\\nJewish\\tO\\nmutations\\tO\\neach\\tO\\naccounted\\tO\\nfor\\tO\\na\\tO\\nsingle\\tO\\nmutant\\tO\\nchromosome\\tO\\n.\\tO\\n\\nThe\\tO\\neight\\tO\\nnovel\\tO\\nmutations\\tO\\nidentified\\tO\\nincluded\\tO\\n1\\tO\\n-\\tO\\nand\\tO\\n4\\tO\\n-\\tO\\nbp\\tO\\ndeletions\\tO\\n(\\tO\\n32\\tO\\ndeltaT\\tO\\nand\\tO\\n876\\tO\\ndeltaAGAA\\tO\\n,\\tO\\nrespectively\\tO\\n)\\tO\\nand\\tO\\nI16T\\tO\\n,\\tO\\nG27R\\tO\\n,\\tO\\nD114E\\tO\\n,\\tO\\nG123E\\tO\\n,\\tO\\nC152Y\\tO\\n,\\tO\\nand\\tO\\nR168C\\tO\\nmissense\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nhomozygous\\tO\\n32\\tO\\ndeltaT\\tO\\ndeletion\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\nonly\\tO\\nknown\\tO\\npatient\\tO\\nof\\tO\\nAfrican\\tO\\n-\\tO\\nAmerican\\tO\\norigin\\tO\\nwith\\tO\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nheterozygosity\\tO\\nfor\\tO\\n876\\tO\\ndeltaAGAA\\tO\\nmutation\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\nthree\\tO\\nindependent\\tO\\npatients\\tO\\nfrom\\tO\\nEngland\\tO\\n.\\tO\\n\\nSix\\tO\\nsingle\\tO\\n-\\tO\\nbase\\tO\\nchanges\\tO\\nleading\\tO\\nto\\tO\\nmissense\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\npatients\\tO\\nfrom\\tO\\nTurkey\\tO\\n(\\tO\\nD114E\\tO\\n,\\tO\\nR168C\\tO\\n)\\tO\\n,\\tO\\nThe\\tO\\nNetherlands\\tO\\n(\\tO\\nI16T\\tO\\n)\\tO\\n,\\tO\\nGermany\\tO\\n(\\tO\\nG27R\\tO\\n)\\tO\\n,\\tO\\nIreland\\tO\\n(\\tO\\nC152Y\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nCanada\\tO\\n(\\tO\\nG123E\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nPCR\\tO\\n-\\tO\\nbased\\tO\\nprotocol\\tO\\nis\\tO\\ndescribed\\tO\\nthat\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nintroduce\\tO\\nmutations\\tO\\nin\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\ncDNA\\tO\\n.\\tO\\n\\nIn\\tO\\nvitro\\tO\\nexpression\\tO\\nof\\tO\\nmutant\\tO\\ncDNA\\tO\\nclones\\tO\\ndemonstrated\\tO\\nthat\\tO\\nall\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nled\\tO\\nto\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nASPA\\tI-Disease\\nand\\tO\\nshould\\tO\\ntherefore\\tO\\nresult\\tO\\nin\\tO\\nCanavan\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nand\\tO\\nchromosomal\\tO\\nlocalization\\tO\\nof\\tO\\nAtm\\tO\\n,\\tO\\nthe\\tO\\nmouse\\tO\\nhomolog\\tO\\nof\\tO\\nthe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\ngene\\tO\\n.\\tO\\n\\nAtm\\tO\\n,\\tO\\nthe\\tO\\nmouse\\tO\\nhomolog\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nATM\\tO\\ngene\\tO\\ndefective\\tO\\nin\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\n.\\tO\\n\\nThe\\tO\\nentire\\tO\\ncoding\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\nAtm\\tO\\ntranscript\\tO\\nwas\\tO\\ncloned\\tO\\nand\\tO\\nfound\\tO\\nto\\tO\\ncontain\\tO\\nan\\tO\\nopen\\tO\\nreading\\tO\\nframe\\tO\\nencoding\\tO\\na\\tO\\nprotein\\tO\\nof\\tO\\n3066\\tO\\namino\\tO\\nacids\\tO\\nwith\\tO\\n84\\tO\\n%\\tO\\noverall\\tO\\nidentity\\tO\\nand\\tO\\n91\\tO\\n%\\tO\\nsimilarity\\tO\\nto\\tO\\nthe\\tO\\nhuman\\tO\\nATM\\tO\\nprotein\\tO\\n.\\tO\\n\\nVariable\\tO\\nlevels\\tO\\nof\\tO\\nexpression\\tO\\nof\\tO\\nAtm\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\ndifferent\\tO\\ntissues\\tO\\n.\\tO\\n\\nFluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\nand\\tO\\nlinkage\\tO\\nanalysis\\tO\\nlocated\\tO\\nthe\\tO\\nAtm\\tO\\ngene\\tO\\non\\tO\\nmouse\\tO\\nchromosome\\tO\\n9\\tO\\n,\\tO\\nband\\tO\\n9C\\tO\\n,\\tO\\nin\\tO\\na\\tO\\nregion\\tO\\nhomologous\\tO\\nto\\tO\\nthe\\tO\\nATM\\tO\\nregion\\tO\\non\\tO\\nhuman\\tO\\nchromosome\\tO\\n11q22\\tO\\n-\\tO\\nq23\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nmouse\\tO\\nhomolog\\tO\\nof\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nprotein\\tO\\n(\\tO\\nWASP\\tO\\n)\\tO\\ngene\\tO\\nis\\tO\\nhighly\\tO\\nconserved\\tO\\nand\\tO\\nmaps\\tO\\nnear\\tO\\nthe\\tO\\nscurfy\\tO\\n(\\tO\\nsf\\tO\\n)\\tO\\nmutation\\tO\\non\\tO\\nthe\\tO\\nX\\tO\\nchromosome\\tO\\n.\\tO\\n\\nThe\\tO\\nmouse\\tO\\nWASP\\tO\\ngene\\tO\\n,\\tO\\nthe\\tO\\nhomolog\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nmutated\\tO\\nin\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nisolated\\tO\\nand\\tO\\nsequenced\\tO\\n.\\tO\\nthe\\tO\\npredicted\\tO\\namino\\tO\\nacid\\tO\\nsequence\\tO\\nis\\tO\\n86\\tO\\n%\\tO\\nidentical\\tO\\nto\\tO\\nthe\\tO\\nhuman\\tO\\nWASP\\tO\\nsequence\\tO\\n.\\tO\\n\\nA\\tO\\ndistinct\\tO\\nfeature\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\ngene\\tO\\nis\\tO\\nan\\tO\\nexpanded\\tO\\npolymorphic\\tO\\nGGA\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nthat\\tO\\ncodes\\tO\\nfor\\tO\\npolyglycine\\tO\\nand\\tO\\nvaries\\tO\\nfrom\\tO\\n15\\tO\\nto\\tO\\n17\\tO\\ntriplets\\tO\\nin\\tO\\ndifferent\\tO\\nMus\\tO\\nmusculus\\tO\\nstrains\\tO\\n.\\tO\\n\\nThe\\tO\\ngenomic\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nWASP\\tO\\ngene\\tO\\nis\\tO\\nexpressed\\tO\\nas\\tO\\nan\\tO\\napproximately\\tO\\n2\\tO\\n.\\tO\\n\\n4\\tO\\n-\\tO\\nkb\\tO\\nmRNA\\tO\\nin\\tO\\nthymus\\tO\\nand\\tO\\nspleen\\tO\\n.\\tO\\n\\nChromosomal\\tO\\nmapping\\tO\\nin\\tO\\nan\\tO\\ninterspecific\\tO\\nM\\tO\\n.\\tO\\n\\nMusculus\\tO\\n/\\tO\\nM\\tO\\n.\\tO\\nspretus\\tO\\nbackcross\\tO\\nplaced\\tO\\nthe\\tO\\nWasp\\tO\\nlocus\\tO\\nnear\\tO\\nthe\\tO\\ncentromere\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nX\\tO\\nchromosome\\tO\\n,\\tO\\ninseparable\\tO\\nfrom\\tO\\nGata1\\tO\\n,\\tO\\nTcfe3\\tO\\n,\\tO\\nand\\tO\\nscurfy\\tO\\n(\\tO\\nsf\\tO\\n)\\tO\\n.\\tO\\n\\nThis\\tO\\nlocalization\\tO\\nmakes\\tO\\nWasp\\tO\\na\\tO\\ncandidate\\tO\\nfor\\tO\\ninvolvement\\tO\\nin\\tO\\nscurfy\\tO\\n,\\tO\\na\\tO\\nT\\tO\\ncell\\tO\\n-\\tO\\nmediated\\tO\\nfatal\\tB-Disease\\nlymphoreticular\\tI-Disease\\ndisease\\tI-Disease\\nof\\tO\\nmice\\tO\\nthat\\tO\\nhas\\tO\\npreviously\\tO\\nbeen\\tO\\nproposed\\tO\\nas\\tO\\na\\tO\\nmouse\\tO\\nhomolog\\tO\\nof\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nNorthern\\tO\\nanalysis\\tO\\nof\\tO\\nsf\\tO\\ntissue\\tO\\nsamples\\tO\\nindicated\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nWASP\\tO\\nmRNA\\tO\\nin\\tO\\nliver\\tO\\nand\\tO\\nskin\\tO\\n,\\tO\\npresumably\\tO\\nas\\tO\\na\\tO\\nconsequence\\tO\\nof\\tO\\nlymphocytic\\tO\\ninfiltration\\tO\\n,\\tO\\nbut\\tO\\nnon\\tO\\nabnormalities\\tO\\nin\\tO\\nthe\\tO\\namount\\tO\\nor\\tO\\nsize\\tO\\nof\\tO\\nmRNA\\tO\\npresent\\tO\\n.\\tO\\n\\nColchicine\\tO\\nin\\tO\\nbreast\\tO\\nmilk\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n.\\tO\\n\\nOBJECTIVE\\tO\\n.\\tO\\n\\nTo\\tO\\nclarify\\tO\\nwhether\\tO\\ncolchicine\\tO\\nis\\tO\\nexcreted\\tO\\nin\\tO\\nbreast\\tO\\nmilk\\tO\\n,\\tO\\nand\\tO\\nto\\tO\\ncompare\\tO\\nits\\tO\\nconcentrations\\tO\\nin\\tO\\nthe\\tO\\nserum\\tO\\nand\\tO\\nbreast\\tO\\nmilk\\tO\\nof\\tO\\nlactating\\tO\\nwomen\\tO\\nwho\\tO\\nhave\\tO\\nfamilial\\tB-Disease\\nMediterranean\\tI-Disease\\nfever\\tI-Disease\\n(\\tO\\nFMF\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nMETHODS\\tO\\n.\\tO\\n\\nUsing\\tO\\na\\tO\\nspecific\\tO\\nradioimmunoassay\\tO\\n,\\tO\\nwe\\tO\\ndetermined\\tO\\ncolchicine\\tO\\nconcentrations\\tO\\nin\\tO\\nthe\\tO\\nserum\\tO\\nand\\tO\\nbreast\\tO\\nmilk\\tO\\nof\\tO\\n4\\tO\\npatients\\tO\\nat\\tO\\nvarious\\tO\\ntime\\tO\\npoints\\tO\\n,\\tO\\nfollowing\\tO\\noral\\tO\\nadministration\\tO\\nof\\tO\\nthe\\tO\\ndrug\\tO\\n.\\tO\\n\\nThe\\tO\\nstudy\\tO\\nevaluated\\tO\\n4\\tO\\npatients\\tO\\nwith\\tO\\nFMF\\tB-Disease\\nwho\\tO\\nhad\\tO\\nbeen\\tO\\ntaking\\tO\\ncolchicine\\tO\\non\\tO\\na\\tO\\nlong\\tO\\n-\\tO\\nterm\\tO\\nbasis\\tO\\n.\\tO\\n\\nRESULTS\\tO\\n.\\tO\\n\\nColchicine\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nexcreted\\tO\\nin\\tO\\nbreast\\tO\\nmilk\\tO\\n.\\tO\\n\\nIts\\tO\\nlevels\\tO\\nranged\\tO\\nbetween\\tO\\n1\\tO\\n.\\tO\\n\\n9\\tO\\nand\\tO\\n8\\tO\\n.\\tO\\n\\n6\\tO\\nng\\tO\\n/\\tO\\nml\\tO\\n,\\tO\\nwhich\\tO\\nwere\\tO\\nsimilar\\tO\\nto\\tO\\nthose\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nserum\\tO\\n(\\tO\\nparallel\\tO\\nconcentration\\tO\\ntime\\tO\\ncurves\\tO\\n)\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthere\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nconsiderable\\tO\\nvariation\\tO\\nin\\tO\\ncolchicine\\tO\\nmilk\\tO\\nconcentration\\tO\\namong\\tO\\nthe\\tO\\ndifferent\\tO\\npatients\\tO\\n,\\tO\\nwhich\\tO\\nmight\\tO\\nbe\\tO\\nrelated\\tO\\nto\\tO\\nindividual\\tO\\nbreast\\tO\\nmilk\\tO\\ncomposition\\tO\\nand\\tO\\n,\\tO\\npossibly\\tO\\n,\\tO\\nto\\tO\\nother\\tO\\nnutritional\\tO\\nor\\tO\\nmetabolic\\tO\\nfactors\\tO\\n.\\tO\\n\\nCONCLUSION\\tO\\n.\\tO\\n\\nThe\\tO\\nextensive\\tO\\nperipheral\\tO\\ntissue\\tO\\nbinding\\tO\\nand\\tO\\nrelatively\\tO\\nlow\\tO\\nconcentration\\tO\\nof\\tO\\ncolchicine\\tO\\nin\\tO\\nbreast\\tO\\nmilk\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\namount\\tO\\ningested\\tO\\nby\\tO\\nthe\\tO\\ninfant\\tO\\nis\\tO\\nsmall\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nbased\\tO\\non\\tO\\nour\\tO\\nclinical\\tO\\nexperience\\tO\\n,\\tO\\nnursing\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\nsafe\\tO\\nfor\\tO\\nlactating\\tO\\nwomen\\tO\\nwith\\tO\\nFMF\\tB-Disease\\nwho\\tO\\ncontinue\\tO\\nto\\tO\\ntake\\tO\\ncolchicine\\tO\\n.\\tO\\n\\nAbnormal\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nprotein\\tO\\nkinase\\tO\\nlevels\\tO\\nproduce\\tO\\nonly\\tO\\nmild\\tO\\nmyopathy\\tB-Disease\\nin\\tO\\nmice\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\ncommonly\\tO\\nassociated\\tO\\nwith\\tO\\nCTG\\tO\\nrepeat\\tO\\nexpansions\\tO\\nwithin\\tO\\nthe\\tO\\ngene\\tO\\nfor\\tO\\nDM\\tO\\n-\\tO\\nprotein\\tO\\nkinase\\tO\\n(\\tO\\nDMPK\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\neffect\\tO\\nof\\tO\\naltered\\tO\\nexpression\\tO\\nlevels\\tO\\nof\\tO\\nDMPK\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nubiquitously\\tO\\nexpressed\\tO\\nin\\tO\\nall\\tO\\nmuscle\\tO\\ncell\\tO\\nlineages\\tO\\nduring\\tO\\ndevelopment\\tO\\n,\\tO\\nwas\\tO\\nexamined\\tO\\nby\\tO\\ndisrupting\\tO\\nthe\\tO\\nendogenous\\tO\\nDmpk\\tO\\ngene\\tO\\nand\\tO\\noverexpressing\\tO\\na\\tO\\nnormal\\tO\\nhuman\\tO\\nDMPK\\tO\\ntransgene\\tO\\nin\\tO\\nmice\\tO\\n.\\tO\\n\\nNullizygous\\tO\\n(\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\n)\\tO\\nmice\\tO\\nshowed\\tO\\nonly\\tO\\ninconsistent\\tO\\nand\\tO\\nminor\\tO\\nsize\\tO\\nchanges\\tO\\nin\\tO\\nhead\\tO\\nand\\tO\\nneck\\tO\\nmuscle\\tO\\nfibres\\tO\\nat\\tO\\nolder\\tO\\nage\\tO\\n,\\tO\\nanimals\\tO\\nwith\\tO\\nthe\\tO\\nhighest\\tO\\nDMPK\\tO\\ntransgene\\tO\\nexpression\\tO\\nshowed\\tO\\nhypertrophic\\tB-Disease\\ncardiomyopathy\\tI-Disease\\nand\\tO\\nenhanced\\tO\\nneonatal\\tO\\nmortality\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nboth\\tO\\nmodels\\tO\\nlack\\tO\\nother\\tO\\nfrequent\\tO\\nDM\\tB-Disease\\nsymptoms\\tO\\nincluding\\tO\\nthe\\tO\\nfibre\\tO\\n-\\tO\\ntype\\tO\\ndependent\\tO\\natrophy\\tB-Disease\\n,\\tO\\nmyotonia\\tB-Disease\\n,\\tO\\ncataract\\tB-Disease\\nand\\tO\\nmale\\tB-Disease\\n-\\tI-Disease\\ninfertility\\tI-Disease\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nstrengthen\\tO\\nthe\\tO\\ncontention\\tO\\nthat\\tO\\nsimple\\tO\\nloss\\tO\\n-\\tO\\nor\\tO\\ngain\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\nexpression\\tO\\nof\\tO\\nDMPK\\tO\\nis\\tO\\nnot\\tO\\nthe\\tO\\nonly\\tO\\ncrucial\\tO\\nrequirement\\tO\\nfor\\tO\\ndevelopment\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n.\\tO\\n\\nMice\\tO\\nlacking\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nprotein\\tO\\nkinase\\tO\\ndevelop\\tO\\na\\tO\\nlate\\tO\\nonset\\tO\\nprogressive\\tO\\nmyopathy\\tB-Disease\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisorder\\tI-Disease\\nresulting\\tO\\nfrom\\tO\\nthe\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nCTG\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\na\\tO\\nputative\\tO\\nprotein\\tO\\nkinase\\tO\\n(\\tO\\nDMPK\\tO\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\nelucidate\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nDMPK\\tO\\nin\\tO\\nDM\\tB-Disease\\npathogenesis\\tO\\nwe\\tO\\nhave\\tO\\ndeveloped\\tO\\nDmpk\\tB-Disease\\ndeficient\\tI-Disease\\n(\\tO\\nDmpk\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\n)\\tO\\nmice\\tO\\n.\\tO\\n\\nDmpk\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\ndevelop\\tO\\na\\tO\\nlate\\tO\\n-\\tO\\nonset\\tO\\n,\\tO\\nprogressive\\tB-Disease\\nskeletal\\tI-Disease\\nmyopathy\\tI-Disease\\nthat\\tO\\nshares\\tO\\nsome\\tO\\npathological\\tO\\nfeatures\\tO\\nwith\\tO\\nDM\\tB-Disease\\n.\\tO\\n\\nMuscles\\tO\\nfrom\\tO\\nmature\\tO\\nmice\\tO\\nshow\\tO\\nvariation\\tO\\nin\\tO\\nfibre\\tO\\nsize\\tO\\n,\\tO\\nincreased\\tO\\nfibre\\tB-Disease\\ndegeneration\\tI-Disease\\nand\\tO\\nfibrosis\\tB-Disease\\n.\\tO\\n\\nAdult\\tO\\nDmpk\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\nshow\\tO\\nultrastructural\\tO\\nchanges\\tO\\nin\\tO\\nmuscle\\tO\\nand\\tO\\na\\tO\\n50\\tO\\n%\\tO\\ndecrease\\tO\\nin\\tO\\nforce\\tO\\ngeneration\\tO\\ncompared\\tO\\nto\\tO\\nyoung\\tO\\nmice\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nDMPK\\tO\\nmay\\tO\\nbe\\tO\\nnecessary\\tO\\nfor\\tO\\nthe\\tO\\nmaintenance\\tO\\nof\\tO\\nskeletal\\tO\\nmuscle\\tO\\nstructure\\tO\\nand\\tO\\nfunction\\tO\\nand\\tO\\nsuggest\\tO\\nthat\\tO\\na\\tO\\ndecrease\\tO\\nin\\tO\\nDMPK\\tO\\nlevels\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\nDM\\tB-Disease\\npathology\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\nBrca1\\tO\\nis\\tO\\nrequired\\tO\\nfor\\tO\\nembryonic\\tO\\ncellular\\tO\\nproliferation\\tO\\nin\\tO\\nthe\\tO\\nmouse\\tO\\n.\\tO\\n\\nMutations\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ngone\\tO\\nin\\tO\\nhumans\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\npredisposition\\tO\\nto\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nhere\\tO\\nthat\\tO\\nBrca1\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\nare\\tO\\nnormal\\tO\\nand\\tO\\nfertile\\tO\\nand\\tO\\nlack\\tO\\ntumors\\tB-Disease\\nby\\tO\\nage\\tO\\neleven\\tO\\nmonths\\tO\\n.\\tO\\n\\nHomozygous\\tO\\nBrca1\\tO\\n(\\tO\\n5\\tO\\n-\\tO\\n6\\tO\\n)\\tO\\nmutant\\tO\\nmice\\tO\\ndie\\tO\\nbefore\\tO\\nday\\tO\\n7\\tO\\n.\\tO\\n\\n5\\tO\\nof\\tO\\nembryogenesis\\tO\\n.\\tO\\n\\nMutant\\tO\\nembryos\\tO\\nare\\tO\\npoorly\\tO\\ndeveloped\\tO\\n,\\tO\\nwith\\tO\\nno\\tO\\nevidence\\tO\\nof\\tO\\nmesoderm\\tO\\nformation\\tO\\n.\\tO\\n\\nThe\\tO\\nextraembryonic\\tO\\nregion\\tO\\nis\\tO\\nabnormal\\tO\\n,\\tO\\nbut\\tO\\naggregation\\tO\\nwith\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\ntetraploid\\tO\\nembryos\\tO\\ndoes\\tO\\nnot\\tO\\nrescue\\tO\\nthe\\tO\\nlethality\\tO\\n.\\tO\\n\\nIn\\tO\\nvivo\\tO\\n,\\tO\\nmutant\\tO\\nembryos\\tO\\ndo\\tO\\nnot\\tO\\nexhibit\\tO\\nincreased\\tO\\napoptosis\\tO\\nbut\\tO\\nshow\\tO\\nreduced\\tO\\ncell\\tO\\nproliferation\\tO\\naccompanied\\tO\\nby\\tO\\ndecreased\\tO\\nexpression\\tO\\nof\\tO\\ncyclin\\tO\\nE\\tO\\nand\\tO\\nmdm\\tO\\n-\\tO\\n2\\tO\\n,\\tO\\na\\tO\\nregulator\\tO\\nof\\tO\\np53\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\nexpression\\tO\\nof\\tO\\ncyclin\\tO\\n-\\tO\\ndependent\\tO\\nkinase\\tO\\ninhibitor\\tO\\np21\\tO\\nis\\tO\\ndramatically\\tO\\nincreased\\tO\\nin\\tO\\nthe\\tO\\nmutant\\tO\\nembryos\\tO\\n.\\tO\\n\\nButtressing\\tO\\nthese\\tO\\nin\\tO\\nvivo\\tO\\nobservations\\tO\\nis\\tO\\nthe\\tO\\nfact\\tO\\nthat\\tO\\nmutant\\tO\\nblastocyst\\tO\\ngrowth\\tO\\nis\\tO\\ngrossly\\tO\\nimpaired\\tO\\nin\\tO\\nvitro\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\ndeath\\tO\\nof\\tO\\nBrca1\\tO\\n(\\tO\\n5\\tO\\n-\\tO\\n6\\tO\\n)\\tO\\nmutant\\tO\\nembryos\\tO\\nprior\\tO\\nto\\tO\\ngastrulation\\tO\\nmay\\tO\\nbe\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nfailure\\tO\\nof\\tO\\nthe\\tO\\nproliferative\\tO\\nburst\\tO\\nrequired\\tO\\nfor\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nthe\\tO\\ndifferent\\tO\\ngerm\\tO\\nlayers\\tO\\n.\\tO\\n\\nIncreased\\tO\\ncoronary\\tB-Disease\\nheart\\tI-Disease\\ndisease\\tI-Disease\\nin\\tO\\nJapanese\\tO\\n-\\tO\\nAmerican\\tO\\nmen\\tO\\nwith\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ncholesteryl\\tO\\nester\\tO\\ntransfer\\tO\\nprotein\\tO\\ngene\\tO\\ndespite\\tO\\nincreased\\tO\\nHDL\\tO\\nlevels\\tO\\n.\\tO\\n\\nPlasma\\tO\\nhigh\\tO\\ndensity\\tO\\nlipoprotein\\tO\\n(\\tO\\nHDL\\tO\\n)\\tO\\nlevels\\tO\\nare\\tO\\nstrongly\\tO\\ngenetically\\tO\\ndetermined\\tO\\nand\\tO\\nshow\\tO\\na\\tO\\ngeneral\\tO\\ninverse\\tO\\nrelationship\\tO\\nwith\\tO\\ncoronary\\tB-Disease\\nheart\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nCHD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ncholesteryl\\tO\\nester\\tO\\ntransfer\\tO\\nprotein\\tO\\n(\\tO\\nCETP\\tO\\n)\\tO\\nmediates\\tO\\nthe\\tO\\ntransfer\\tO\\nof\\tO\\ncholesteryl\\tO\\nesters\\tO\\nfrom\\tO\\nHDL\\tO\\nto\\tO\\nother\\tO\\nlipoproteins\\tO\\nand\\tO\\nis\\tO\\na\\tO\\nkey\\tO\\nparticipant\\tO\\nin\\tO\\nthe\\tO\\nreverse\\tO\\ntransport\\tO\\nof\\tO\\ncholesterol\\tO\\nfrom\\tO\\nthe\\tO\\nperiphery\\tO\\nto\\tO\\nthe\\tO\\nliver\\tO\\n.\\tO\\n\\nA\\tO\\nhigh\\tO\\nprevalence\\tO\\nof\\tO\\ntwo\\tO\\ndifferent\\tO\\nCETP\\tO\\ngene\\tO\\nmutations\\tO\\n(\\tO\\nD442G\\tO\\n,\\tO\\n5\\tO\\n.\\tO\\n1\\tO\\n%\\tO\\n;\\tO\\nintron\\tO\\n14G\\tO\\nA\\tO\\n,\\tO\\n0\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\n3\\tO\\n,\\tO\\n469\\tO\\nmen\\tO\\nof\\tO\\nJapanese\\tO\\nancestry\\tO\\nin\\tO\\nthe\\tO\\nHonolulu\\tO\\nHeart\\tO\\nProgram\\tO\\nand\\tO\\nmutations\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\ndecreased\\tO\\nCETP\\tO\\n(\\tO\\n-\\tO\\n35\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\nincreased\\tO\\nHDL\\tO\\nchol\\tO\\nlevels\\tO\\n(\\tO\\n+\\tO\\n10\\tO\\n%\\tO\\nfor\\tO\\nD442G\\tO\\n)\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\noverall\\tO\\nprevalence\\tO\\nof\\tO\\ndefinite\\tO\\nCHD\\tB-Disease\\nwas\\tO\\n21\\tO\\n%\\tO\\nin\\tO\\nmen\\tO\\nwith\\tO\\nmutations\\tO\\nand\\tO\\n16\\tO\\n%\\tO\\nin\\tO\\nmen\\tO\\nwithout\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nrelative\\tO\\nrisk\\tO\\n(\\tO\\nRR\\tO\\n)\\tO\\nof\\tO\\nCHD\\tB-Disease\\nwas\\tO\\n1\\tO\\n.\\tO\\n\\n43\\tO\\nin\\tO\\nmen\\tO\\nwith\\tO\\nmutations\\tO\\n(\\tO\\nP\\tO\\n<\\tO\\n.\\tO\\n05\\tO\\n)\\tO\\n;\\tO\\nafter\\tO\\nadjustment\\tO\\nfor\\tO\\nCHD\\tB-Disease\\nrisk\\tO\\nfactors\\tO\\n,\\tO\\nthe\\tO\\nRR\\tO\\nwas\\tO\\n1\\tO\\n.\\tO\\n\\n55\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n02\\tO\\n)\\tO\\n;\\tO\\nafter\\tO\\nadditional\\tO\\nadjustment\\tO\\nfor\\tO\\nHDL\\tO\\nlevels\\tO\\n,\\tO\\nthe\\tO\\nRR\\tO\\nwas\\tO\\n1\\tO\\n.\\tO\\n\\n68\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n008\\tO\\n)\\tO\\n.\\tO\\n\\nSimilar\\tO\\nRR\\tO\\nvalues\\tO\\nwere\\tO\\nobtained\\tO\\nfor\\tO\\nthe\\tO\\nD442G\\tO\\nmutation\\tO\\nalone\\tO\\n.\\tO\\n\\nIncreased\\tO\\nCHD\\tB-Disease\\nin\\tO\\nmen\\tO\\nwith\\tO\\nmutations\\tO\\nwas\\tO\\nprimarily\\tO\\nobserved\\tO\\nfor\\tO\\nHDL\\tO\\nchol\\tO\\n41\\tO\\n-\\tO\\n60\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n;\\tO\\nfor\\tO\\nHDL\\tO\\nchol\\tO\\n>\\tO\\n60\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\nmen\\tO\\nwith\\tO\\nand\\tO\\nwithout\\tO\\nmutations\\tO\\nhad\\tO\\nlow\\tO\\nCHD\\tB-Disease\\nprevalence\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\ngenetic\\tO\\nCETP\\tB-Disease\\ndeficiency\\tI-Disease\\nappears\\tO\\nto\\tO\\nbe\\tO\\nan\\tO\\nindependent\\tO\\nrisk\\tO\\nfactor\\tO\\nfor\\tO\\nCHD\\tB-Disease\\n,\\tO\\nprimarily\\tO\\ndue\\tO\\nto\\tO\\nincreased\\tO\\nCHD\\tB-Disease\\nprevalence\\tO\\nin\\tO\\nmen\\tO\\nwith\\tO\\nthe\\tO\\nD442G\\tO\\nmutation\\tO\\nand\\tO\\nHDL\\tO\\ncholesterol\\tO\\nbetween\\tO\\n41\\tO\\nand\\tO\\n60\\tO\\nmg\\tO\\n/\\tO\\ndl\\tO\\n.\\tO\\n\\nThe\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nboth\\tO\\nHDL\\tO\\nconcentration\\tO\\nand\\tO\\nthe\\tO\\ndynamics\\tO\\nof\\tO\\ncholesterol\\tO\\ntransport\\tO\\nthrough\\tO\\nHDL\\tO\\n(\\tO\\ni\\tO\\n.\\tO\\ne\\tO\\n.\\tO\\n,\\tO\\nreverse\\tO\\ncholesterol\\tO\\ntransport\\tO\\n)\\tO\\ndetermine\\tO\\nthe\\tO\\nanti\\tO\\n-\\tO\\natherogenicity\\tO\\nof\\tO\\nthe\\tO\\nHDL\\tO\\nfraction\\tO\\n.\\tO\\n\\nMapping\\tO\\nthe\\tO\\nhomolog\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nRb1\\tO\\ngene\\tO\\nto\\tO\\nchromosome\\tO\\n14\\tO\\nof\\tO\\nhigher\\tO\\nprimates\\tO\\n.\\tO\\n\\nThe\\tO\\nRb1\\tO\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nimplicated\\tO\\nwith\\tO\\nretinoblastoma\\tB-Disease\\nand\\tO\\nis\\tO\\nlocated\\tO\\non\\tO\\nhuman\\tO\\nChromosome\\tO\\n(\\tO\\nChr\\tO\\n)\\tO\\n13q14\\tO\\n.\\tO\\n\\n2\\tO\\n2\\tO\\n.\\tO\\n\\nA\\tO\\nunique\\tO\\nsequence\\tO\\nhuman\\tO\\nRb1\\tO\\ncosmid\\tO\\nDNA\\tO\\nprobe\\tO\\nhas\\tO\\nbeen\\tO\\nused\\tO\\nto\\tO\\nlocalize\\tO\\nthis\\tO\\nregion\\tO\\non\\tO\\napes\\tO\\nChr\\tO\\n14\\tO\\nby\\tO\\nthe\\tO\\nFISH\\tO\\ntechnique\\tO\\n.\\tO\\n\\nThe\\tO\\nconservation\\tO\\nof\\tO\\nthe\\tO\\nRb1\\tO\\ngene\\tO\\nin\\tO\\nhigher\\tO\\nprimates\\tO\\nat\\tO\\nthe\\tO\\ncorresponding\\tO\\nequivalent\\tO\\nchromosome\\tO\\nlocus\\tO\\n(\\tO\\n14q14\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nmay\\tO\\nserve\\tO\\nas\\tO\\na\\tO\\nphylogenetic\\tO\\nmarker\\tO\\nto\\tO\\nfurther\\tO\\ntrace\\tO\\nthe\\tO\\nevolutionary\\tO\\npathway\\tO\\nof\\tO\\nhuman\\tO\\ndescent\\tO\\n.\\tO\\n\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\nno\\tO\\nstrict\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nbut\\tO\\nclustering\\tO\\nof\\tO\\nmissense\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\namino\\tO\\n-\\tO\\nterminal\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nWASP\\tO\\ngene\\tO\\nproduct\\tO\\n.\\tO\\n\\nThe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\nprotein\\tO\\n(\\tO\\nWASP\\tO\\n)\\tO\\ngene\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nmutated\\tO\\nin\\tO\\npatients\\tO\\npresenting\\tO\\nwith\\tO\\nWAS\\tB-Disease\\nand\\tO\\nin\\tO\\npatients\\tO\\nshowing\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nthrombocytopenia\\tI-Disease\\n.\\tO\\n\\nMutation\\tO\\nanalysis\\tO\\nin\\tO\\n19\\tO\\nfamilies\\tO\\nof\\tO\\nGerman\\tO\\n,\\tO\\nSwiss\\tO\\nand\\tO\\nTurkish\\tO\\ndescent\\tO\\nby\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\nand\\tO\\nsequencing\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\ndetection\\tO\\nof\\tO\\nseven\\tO\\nnovel\\tO\\nand\\tO\\n10\\tO\\nknown\\tO\\nmutations\\tO\\n.\\tO\\n\\nA\\tO\\nstriking\\tO\\nclustering\\tO\\nof\\tO\\nmissense\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nfirst\\tO\\nfour\\tO\\nexons\\tO\\ncontrasted\\tO\\nwith\\tO\\na\\tO\\nrandom\\tO\\ndistribution\\tO\\nof\\tO\\nnonsense\\tO\\nmutations\\tO\\n.\\tO\\n\\nMore\\tO\\nthan\\tO\\n85\\tO\\n%\\tO\\nof\\tO\\nall\\tO\\nknown\\tO\\nmissense\\tO\\nmutations\\tO\\nwere\\tO\\nlocalized\\tO\\nin\\tO\\nthe\\tO\\namino\\tO\\n-\\tO\\nterminal\\tO\\nstretch\\tO\\nof\\tO\\nthe\\tO\\nWASP\\tO\\ngene\\tO\\nproduct\\tO\\n;\\tO\\nthis\\tO\\nregion\\tO\\ncontained\\tO\\na\\tO\\nmutational\\tO\\nhot\\tO\\nspot\\tO\\nat\\tO\\ncodon\\tO\\n86\\tO\\n.\\tO\\n\\nNo\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelation\\tO\\nemerged\\tO\\nafter\\tO\\na\\tO\\ncomparison\\tO\\nof\\tO\\nthe\\tO\\nidentified\\tO\\nmutations\\tO\\nwith\\tO\\nthe\\tO\\nresulting\\tO\\nclinical\\tO\\npicture\\tO\\nfor\\tO\\na\\tO\\nclassical\\tO\\nWAS\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nA\\tO\\nsubstitution\\tO\\nat\\tO\\ncodon\\tO\\n86\\tO\\nresulted\\tO\\nin\\tO\\nan\\tO\\nextremely\\tO\\nvariable\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nSwiss\\tO\\nfamily\\tO\\n.\\tO\\n\\nAn\\tO\\nextended\\tO\\nhomology\\tO\\nsearch\\tO\\nrevealed\\tO\\na\\tO\\ndistant\\tO\\nrelationship\\tO\\nof\\tO\\nthis\\tO\\nstretch\\tO\\nto\\tO\\nthe\\tO\\nvasodilator\\tO\\n-\\tO\\nstimulated\\tO\\nphosphoprotein\\tO\\n(\\tO\\nVASP\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nmaintenance\\tO\\nof\\tO\\ncyto\\tO\\n-\\tO\\narchitecture\\tO\\nby\\tO\\ninteracting\\tO\\nwith\\tO\\nactin\\tO\\n-\\tO\\nlike\\tO\\nfilaments\\tO\\n.\\tO\\n.\\tO\\n\\nInfluence\\tO\\nof\\tO\\nPAX6\\tO\\ngene\\tO\\ndosage\\tO\\non\\tO\\ndevelopment\\tO\\n:\\tO\\noverexpression\\tO\\ncauses\\tO\\nsevere\\tO\\neye\\tB-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nAniridia\\tB-Disease\\nin\\tO\\nman\\tO\\nand\\tO\\nSmall\\tO\\neye\\tO\\nin\\tO\\nmice\\tO\\nare\\tO\\nsemidominant\\tB-Disease\\ndevelopmental\\tI-Disease\\ndisorders\\tI-Disease\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nwithin\\tO\\nthe\\tO\\npaired\\tO\\nbox\\tO\\ngene\\tO\\nPAX6\\tO\\n.\\tO\\n\\nWhereas\\tO\\nheterozygotes\\tO\\nsuffer\\tO\\nfrom\\tO\\niris\\tB-Disease\\nhypoplasia\\tI-Disease\\n,\\tO\\nhomozygous\\tO\\nmice\\tO\\nlack\\tO\\neyes\\tO\\nand\\tO\\nnasal\\tO\\ncavities\\tO\\nand\\tO\\nexhibit\\tO\\nbrain\\tB-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\ngene\\tO\\ndosage\\tO\\nin\\tO\\nmore\\tO\\ndetail\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ngenerated\\tO\\nyeast\\tO\\nartificial\\tO\\nchromosome\\tO\\ntransgenic\\tO\\nmice\\tO\\ncarrying\\tO\\nthe\\tO\\nhuman\\tO\\nPAX6\\tO\\nlocus\\tO\\n.\\tO\\n\\nWhen\\tO\\ncrossed\\tO\\nonto\\tO\\nthe\\tO\\nSmall\\tO\\neye\\tO\\nbackground\\tO\\n,\\tO\\nthe\\tO\\ntransgene\\tO\\nrescues\\tO\\nthe\\tO\\nmutant\\tO\\nphenotype\\tO\\n.\\tO\\n\\nStrikingly\\tO\\n,\\tO\\nmice\\tO\\ncarrying\\tO\\nmultiple\\tO\\ncopies\\tO\\non\\tO\\na\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nbackground\\tO\\nshow\\tO\\nspecific\\tO\\ndevelopmental\\tB-Disease\\nabnormalities\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\neye\\tI-Disease\\n,\\tO\\nbut\\tO\\nnot\\tO\\nof\\tO\\nother\\tO\\ntissues\\tO\\nexpressing\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nat\\tO\\nleast\\tO\\nfive\\tO\\ndifferent\\tO\\neye\\tO\\nphenotypes\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nchanges\\tO\\nin\\tO\\nPAX6\\tO\\nexpression\\tO\\n.\\tO\\n\\nWe\\tO\\nprovide\\tO\\nevidence\\tO\\nthat\\tO\\nnot\\tO\\nonly\\tO\\nreduced\\tO\\n,\\tO\\nbut\\tO\\nalso\\tO\\nincreased\\tO\\nlevels\\tO\\nof\\tO\\ntranscriptional\\tO\\nregulators\\tO\\ncan\\tO\\ncause\\tO\\ndevelopmental\\tB-Disease\\ndefects\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nHeterodimer\\tO\\nformation\\tO\\nand\\tO\\nactivity\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nenzyme\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridylyltransferase\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthe\\tO\\nfundamental\\tO\\nquestions\\tO\\nconcerning\\tO\\nexpression\\tO\\nand\\tO\\nfunction\\tO\\nof\\tO\\ndimeric\\tO\\nenzymes\\tO\\ninvolves\\tO\\nthe\\tO\\nimpact\\tO\\nof\\tO\\nnaturally\\tO\\noccurring\\tO\\nmutations\\tO\\non\\tO\\nsubunit\\tO\\nassembly\\tO\\nand\\tO\\nheterodimer\\tO\\nactivity\\tO\\n.\\tO\\n\\nThis\\tO\\nquestion\\tO\\nis\\tO\\nof\\tO\\nparticular\\tO\\ninterest\\tO\\nfor\\tO\\nthe\\tO\\nhuman\\tO\\nenzyme\\tO\\ngalactose\\tO\\n-\\tO\\nl\\tO\\n-\\tO\\nphosphate\\tO\\nuridylyl\\tO\\n-\\tO\\ntransferase\\tO\\n(\\tO\\nGALT\\tO\\n)\\tO\\n,\\tO\\nimpairment\\tO\\nof\\tO\\nwhich\\tO\\nresults\\tO\\nin\\tO\\nthe\\tO\\ninherited\\tB-Disease\\nmetabolic\\tI-Disease\\ndisorder\\tI-Disease\\ngalactosemia\\tB-Disease\\n,\\tO\\nbecause\\tO\\nmany\\tO\\nif\\tO\\nnot\\tO\\nmost\\tO\\npatients\\tO\\nstudied\\tO\\nto\\tO\\ndate\\tO\\nare\\tO\\ncompound\\tO\\nheterozygotes\\tO\\nrather\\tO\\nthan\\tO\\ntrue\\tO\\nmolecular\\tO\\nhomozygotes\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nthe\\tO\\nbroad\\tO\\nrange\\tO\\nof\\tO\\nphenotypic\\tO\\nseverity\\tO\\nobserved\\tO\\nin\\tO\\nthese\\tO\\npatients\\tO\\nraises\\tO\\nthe\\tO\\npossibility\\tO\\nthat\\tO\\nallelic\\tO\\ncombination\\tO\\n,\\tO\\nnot\\tO\\njust\\tO\\nallelic\\tO\\nconstitution\\tO\\n,\\tO\\nmay\\tO\\nplay\\tO\\nsome\\tO\\nrole\\tO\\nin\\tO\\ndetermining\\tO\\noutcome\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nwork\\tO\\ndescribed\\tO\\nherein\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nselected\\tO\\ntwo\\tO\\ndistinct\\tO\\nnaturally\\tO\\noccurring\\tO\\nnull\\tO\\nmutations\\tO\\nof\\tO\\nGALT\\tO\\n,\\tO\\nQ188R\\tO\\nand\\tO\\nR333W\\tO\\n,\\tO\\nand\\tO\\nasked\\tO\\nthe\\tO\\nquestions\\tO\\n(\\tO\\ni\\tO\\n)\\tO\\nwhat\\tO\\nare\\tO\\nthe\\tO\\nimpacts\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\non\\tO\\nsubunit\\tO\\nassembly\\tO\\n,\\tO\\nand\\tO\\n(\\tO\\nii\\tO\\n)\\tO\\nif\\tO\\nheterodimers\\tO\\ndo\\tO\\nform\\tO\\n,\\tO\\nare\\tO\\nthey\\tO\\nactive\\tO\\n?\\tO\\n\\nTo\\tO\\nanswer\\tO\\nthese\\tO\\nquestions\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nestablished\\tO\\na\\tO\\nyeast\\tO\\nsystem\\tO\\nfor\\tO\\nthe\\tO\\ncoexpression\\tO\\nof\\tO\\nepitope\\tO\\n-\\tO\\ntagged\\tO\\nalleles\\tO\\nof\\tO\\nhuman\\tO\\nGALT\\tO\\nand\\tO\\ninvestigated\\tO\\nboth\\tO\\nthe\\tO\\nextent\\tO\\nof\\tO\\nspecific\\tO\\nGALT\\tO\\nsubunit\\tO\\ninteractions\\tO\\nand\\tO\\nthe\\tO\\nactivity\\tO\\nof\\tO\\ndefined\\tO\\nheterodimer\\tO\\npools\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nfound\\tO\\nthat\\tO\\nboth\\tO\\nhomodimers\\tO\\nand\\tO\\nheterodimers\\tO\\ndo\\tO\\nform\\tO\\ninvolving\\tO\\neach\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nsubunits\\tO\\ntested\\tO\\nand\\tO\\nthat\\tO\\nboth\\tO\\nheterodimer\\tO\\npools\\tO\\nretain\\tO\\nsubstantial\\tO\\nenzymatic\\tO\\nactivity\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nare\\tO\\nsignificant\\tO\\nnot\\tO\\nonly\\tO\\nin\\tO\\nterms\\tO\\nof\\tO\\ntheir\\tO\\nimplications\\tO\\nfor\\tO\\nfurthering\\tO\\nour\\tO\\nunderstanding\\tO\\nof\\tO\\ngalactosemia\\tB-Disease\\nand\\tO\\nGALT\\tO\\nholoenzyme\\tO\\nstructure\\tO\\n-\\tO\\nfunction\\tO\\nrelationships\\tO\\nbut\\tO\\nalso\\tO\\nbecause\\tO\\nthe\\tO\\nsystem\\tO\\ndescribed\\tO\\nmay\\tO\\nserve\\tO\\nas\\tO\\na\\tO\\nmodel\\tO\\nfor\\tO\\nsimilar\\tO\\nstudies\\tO\\nof\\tO\\nother\\tO\\ncomplexes\\tO\\ncomposed\\tO\\nof\\tO\\nmultiple\\tO\\nsubunits\\tO\\n.\\tO\\n.\\tO\\n\\nCleavage\\tO\\nof\\tO\\nhuntingtin\\tO\\nby\\tO\\napopain\\tO\\n,\\tO\\na\\tO\\nproapoptotic\\tO\\ncysteine\\tO\\nprotease\\tO\\n,\\tO\\nis\\tO\\nmodulated\\tO\\nby\\tO\\nthe\\tO\\npolyglutamine\\tO\\ntract\\tO\\n.\\tO\\n\\nApoptosis\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nrecognized\\tO\\nas\\tO\\na\\tO\\nmode\\tO\\nof\\tO\\ncell\\tO\\ndeath\\tO\\nin\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nApopain\\tO\\n,\\tO\\na\\tO\\nhuman\\tO\\ncounterpart\\tO\\nof\\tO\\nthe\\tO\\nnematode\\tO\\ncysteine\\tO\\nprotease\\tO\\ndeath\\tO\\n-\\tO\\ngene\\tO\\nproduct\\tO\\n,\\tO\\nCED\\tO\\n-\\tO\\n3\\tO\\n,\\tO\\nhas\\tO\\na\\tO\\nkey\\tO\\nrole\\tO\\nin\\tO\\nproteolytic\\tO\\nevents\\tO\\nleading\\tO\\nto\\tO\\napoptosis\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nshow\\tO\\nthat\\tO\\napoptotic\\tO\\nextracts\\tO\\nand\\tO\\napopain\\tO\\nitself\\tO\\nspecifically\\tO\\ncleave\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\nproduct\\tO\\n,\\tO\\nhuntingtin\\tO\\n.\\tO\\n\\nThe\\tO\\nrate\\tO\\nof\\tO\\ncleavage\\tO\\nincreases\\tO\\nwith\\tO\\nthe\\tO\\nlength\\tO\\nof\\tO\\nthe\\tO\\nhuntingtin\\tO\\npolyglutamine\\tO\\ntract\\tO\\n,\\tO\\nproviding\\tO\\nan\\tO\\nexplanation\\tO\\nfor\\tO\\nthe\\tO\\ngain\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\nfunction\\tO\\nassociated\\tO\\nwith\\tO\\nCAG\\tO\\nexpansion\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nshow\\tO\\nthat\\tO\\nhuntingtin\\tO\\nis\\tO\\ncleaved\\tO\\nby\\tO\\ncysteine\\tO\\nproteases\\tO\\nand\\tO\\nsuggest\\tO\\nthat\\tO\\nHD\\tB-Disease\\nmight\\tO\\nbe\\tO\\na\\tO\\ndisorder\\tB-Disease\\nof\\tI-Disease\\ninappropriate\\tI-Disease\\napoptosis\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\n5\\tO\\n\\'\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nlies\\tO\\nwithin\\tO\\na\\tO\\nduplicated\\tO\\nregion\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n17q21\\tO\\n.\\tO\\n\\nTo\\tO\\nbegin\\tO\\nto\\tO\\naddress\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nabnormal\\tO\\nregulation\\tO\\nof\\tO\\nthe\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\ngene\\tO\\nBRCA1\\tO\\nis\\tO\\na\\tO\\ncritical\\tO\\nstep\\tO\\nin\\tO\\nsporadic\\tO\\nbreast\\tO\\n/\\tO\\novarian\\tO\\ntumorigenesis\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ndetermined\\tO\\nthe\\tO\\ndetailed\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ngenomic\\tO\\nregion\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nthis\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\ngenome\\tO\\ncontains\\tO\\na\\tO\\ntandem\\tO\\nduplication\\tO\\nof\\tO\\napproximately\\tO\\n30\\tO\\nkilobases\\tO\\n,\\tO\\nwhich\\tO\\nresults\\tO\\nin\\tO\\ntwo\\tO\\ncopies\\tO\\nof\\tO\\nBRCA1\\tO\\nexons\\tO\\n1\\tO\\nand\\tO\\n2\\tO\\n,\\tO\\nof\\tO\\nexons\\tO\\n1\\tO\\nand\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\nadjacent\\tO\\n1A1\\tO\\n-\\tO\\n3B\\tO\\ngene\\tO\\nand\\tO\\nof\\tO\\nthe\\tO\\npreviously\\tO\\nreported\\tO\\n295\\tO\\nbase\\tO\\npair\\tO\\nintergenic\\tO\\nregion\\tO\\n.\\tO\\n\\nSequence\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nduplicated\\tO\\nexons\\tO\\nof\\tO\\nBRCA1\\tO\\nand\\tO\\n1A1\\tO\\n-\\tO\\n3B\\tO\\nand\\tO\\nflanking\\tO\\ngenomic\\tO\\nDNA\\tO\\nreveals\\tO\\nmaintenance\\tO\\nof\\tO\\nthe\\tO\\nintron\\tO\\n-\\tO\\nexon\\tO\\nstructure\\tO\\nand\\tO\\na\\tO\\nhigh\\tO\\ndegree\\tO\\nof\\tO\\nnucleotide\\tO\\nsequence\\tO\\nidentity\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthese\\tO\\nare\\tO\\nnon\\tO\\n-\\tO\\nprocessed\\tO\\npseudogenes\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\nduplication\\tO\\nis\\tO\\na\\tO\\nrecent\\tO\\nevent\\tO\\nin\\tO\\nevolutionary\\tO\\nterms\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nshow\\tO\\nthat\\tO\\na\\tO\\nprocessed\\tO\\npseudogene\\tO\\nof\\tO\\nthe\\tO\\nacidic\\tO\\nribosomal\\tO\\nphosphoprotein\\tO\\nP1\\tO\\n(\\tO\\nARPP1\\tO\\n)\\tO\\nis\\tO\\ninserted\\tO\\ndirectly\\tO\\nupstream\\tO\\nof\\tO\\npseudo\\tO\\n-\\tO\\nBRCA1\\tO\\nexon\\tO\\n1A\\tO\\n.\\tO\\n\\nWe\\tO\\nbelieve\\tO\\nthat\\tO\\nthese\\tO\\nfindings\\tO\\ncould\\tO\\nnot\\tO\\nonly\\tO\\nconfound\\tO\\nBRCA1\\tO\\nmutation\\tO\\nanalysis\\tO\\n,\\tO\\nbut\\tO\\ncould\\tO\\nhave\\tO\\nimplications\\tO\\nfor\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\nabnormal\\tO\\nregulation\\tO\\nof\\tO\\nBRCA1\\tO\\ntranscription\\tO\\n,\\tO\\ntranslation\\tO\\nand\\tO\\nfunction\\tO\\n.\\tO\\n.\\tO\\n\\nDeletion\\tO\\nof\\tO\\nsmall\\tO\\nnuclear\\tO\\nribonucleoprotein\\tO\\npolypeptide\\tO\\nN\\tO\\n(\\tO\\nSNRPN\\tO\\n)\\tO\\nin\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\ndetected\\tO\\nby\\tO\\nfluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n:\\tO\\ntwo\\tO\\nsibs\\tO\\nwith\\tO\\nthe\\tO\\ntypical\\tO\\nphenotype\\tO\\nwithout\\tO\\na\\tO\\ncytogenetic\\tO\\ndeletion\\tO\\nin\\tO\\nchromosome\\tO\\n15q\\tO\\n.\\tO\\n\\nThe\\tO\\nsmall\\tO\\nnuclear\\tO\\nribonucleoprotein\\tO\\npolypeptide\\tO\\nN\\tO\\n(\\tO\\nSNRPN\\tO\\n)\\tO\\ngene\\tO\\nis\\tO\\nregarded\\tO\\nas\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ncandidates\\tO\\nfor\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\ntwo\\tO\\nsibs\\tO\\nwith\\tO\\ntypical\\tO\\nPWS\\tB-Disease\\npresenting\\tO\\ndeletion\\tO\\nof\\tO\\nSNRPN\\tO\\ndetected\\tO\\nby\\tO\\nfluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n(\\tO\\nFISH\\tO\\n)\\tO\\n.\\tO\\n\\nNeither\\tO\\na\\tO\\ncytogenetically\\tO\\ndetectable\\tO\\n15q12\\tO\\ndeletion\\tO\\nnor\\tO\\na\\tO\\ndeletion\\tO\\nfor\\tO\\nthe\\tO\\nD15S11\\tO\\n,\\tO\\nD15S10\\tO\\n,\\tO\\nand\\tO\\nGABRB3\\tO\\ncosmid\\tO\\nprobes\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\neither\\tO\\npatient\\tO\\n.\\tO\\n\\nThis\\tO\\nimplies\\tO\\na\\tO\\nsmaller\\tO\\ndeletion\\tO\\nlimited\\tO\\nto\\tO\\nthe\\tO\\nPWS\\tB-Disease\\ncritical\\tO\\nregion\\tO\\n.\\tO\\n\\nFISH\\tO\\nwith\\tO\\na\\tO\\nSNRPN\\tO\\nprobe\\tO\\nwill\\tO\\npermit\\tO\\nanalysis\\tO\\nof\\tO\\nPWS\\tB-Disease\\npatients\\tO\\nwith\\tO\\nlimited\\tO\\ndeletions\\tO\\nnot\\tO\\ndetectable\\tO\\nwith\\tO\\nother\\tO\\nprobes\\tO\\n.\\tO\\n.\\tO\\n\\nExpression\\tO\\nof\\tO\\nthe\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ndisease\\tI-Disease\\ntumour\\tI-Disease\\nsuppressor\\tO\\ngene\\tO\\nduring\\tO\\nhuman\\tO\\nembryogenesis\\tO\\n.\\tO\\n\\nThe\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\n(\\tI-Disease\\nVHL\\tI-Disease\\n)\\tI-Disease\\ndisease\\tI-Disease\\nproduct\\tO\\nis\\tO\\nthought\\tO\\nto\\tO\\ndown\\tO\\n-\\tO\\nregulate\\tO\\ntranscription\\tO\\nby\\tO\\nantagonizing\\tO\\nelongin\\tO\\n-\\tO\\nenhanced\\tO\\ntranscriptional\\tO\\nelongation\\tO\\n.\\tO\\n\\nGermline\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nmutations\\tO\\npredispose\\tO\\nto\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nretinal\\tB-Disease\\n,\\tI-Disease\\ncerebellar\\tI-Disease\\nand\\tI-Disease\\nspinal\\tI-Disease\\nhaemangioblastomas\\tI-Disease\\n,\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\nand\\tO\\nphaeochromocytoma\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nsomatic\\tO\\nInactivation\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nis\\tO\\nfrequent\\tO\\nin\\tO\\nsporadic\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\nand\\tO\\nhaemangioblastoma\\tB-Disease\\n.\\tO\\n\\nRegulation\\tO\\nof\\tO\\ntranscript\\tO\\nelongation\\tO\\nis\\tO\\nan\\tO\\nimportant\\tO\\ncontrol\\tO\\nmechanism\\tO\\nfor\\tO\\ngene\\tO\\nexpression\\tO\\nand\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nmight\\tO\\nmodify\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nproto\\tO\\n-\\tO\\noncogenes\\tO\\nand\\tO\\ngrowth\\tO\\nsuppressor\\tO\\ngenes\\tO\\nduring\\tO\\nembryogenesis\\tO\\n.\\tO\\n\\nWe\\tO\\ntherefore\\tO\\ninvestigated\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nVHL\\tB-Disease\\nmRNA\\tO\\nduring\\tO\\nhuman\\tO\\nembryogenesis\\tO\\nby\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\nstudies\\tO\\nat\\tO\\n4\\tO\\n,\\tO\\n6\\tO\\nand\\tO\\n10\\tO\\nweeks\\tO\\npost\\tO\\nconception\\tO\\n.\\tO\\n\\nAlthough\\tO\\nVHL\\tB-Disease\\nmRNA\\tO\\nwas\\tO\\nexpressed\\tO\\nin\\tO\\nall\\tO\\nthree\\tO\\ngerm\\tO\\nlayers\\tO\\n,\\tO\\nstrong\\tO\\nexpression\\tO\\nwas\\tO\\nnoted\\tO\\nin\\tO\\nthe\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n,\\tO\\nkidneys\\tO\\n,\\tO\\ntestis\\tO\\nand\\tO\\nlung\\tO\\n.\\tO\\n\\nWithin\\tO\\nthe\\tO\\nkidney\\tO\\n,\\tO\\nVHL\\tB-Disease\\nmRNA\\tO\\nwas\\tO\\ndifferentially\\tO\\nexpressed\\tO\\nwithin\\tO\\nrenal\\tO\\ntubules\\tO\\nsuggesting\\tO\\nthat\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nproduct\\tO\\nmay\\tO\\nhave\\tO\\na\\tO\\nspecific\\tO\\nrole\\tO\\nin\\tO\\nkidney\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nTwo\\tO\\nalternatively\\tO\\nspliced\\tO\\nVHL\\tB-Disease\\nmRNAs\\tO\\ncharacterized\\tO\\nby\\tO\\ninclusion\\tO\\n(\\tO\\nisoform\\tO\\nI\\tO\\n)\\tO\\nor\\tO\\nexclusion\\tO\\n(\\tO\\nisoform\\tO\\nII\\tO\\n)\\tO\\nof\\tO\\nexon\\tO\\n2\\tO\\nare\\tO\\ntranscribed\\tO\\nin\\tO\\nadult\\tO\\ntissues\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nif\\tO\\nthe\\tO\\ntwo\\tO\\nisoforms\\tO\\nare\\tO\\ndifferentially\\tO\\nexpressed\\tO\\nduring\\tO\\nembryogenesis\\tO\\n,\\tO\\nVHL\\tB-Disease\\nmRNA\\tO\\nwas\\tO\\nreverse\\tO\\ntranscribed\\tO\\nfrom\\tO\\n13\\tO\\nfetal\\tO\\ntissues\\tO\\n(\\tO\\n8\\tO\\n-\\tO\\n10\\tO\\nweeks\\tO\\ngestation\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nquantitative\\tO\\ndistribution\\tO\\nof\\tO\\nVHL\\tB-Disease\\nmRNA\\tO\\nwithin\\tO\\nfetal\\tO\\ntissues\\tO\\nreflected\\tO\\nthat\\tO\\nseen\\tO\\nby\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\nand\\tO\\nthe\\tO\\nratio\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nVHL\\tB-Disease\\nisoforms\\tO\\nwas\\tO\\nsimilar\\tO\\nbetween\\tO\\ntissues\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\ngenes\\tO\\nregulated\\tO\\nby\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nproduct\\tO\\nhave\\tO\\nnot\\tO\\nyet\\tO\\nbeen\\tO\\nidentified\\tO\\n,\\tO\\nour\\tO\\nfindings\\tO\\nare\\tO\\ncompatible\\tO\\nwith\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nVHL\\tB-Disease\\n-\\tO\\nmediated\\tO\\ncontrol\\tO\\nof\\tO\\ntranscriptional\\tO\\nelongation\\tO\\nmay\\tO\\nhave\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\nnormal\\tO\\nhuman\\tO\\ndevelopment\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nheterogeneity\\tO\\nin\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n:\\tO\\nrole\\tO\\nof\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nThe\\tO\\ncommon\\tO\\nhereditary\\tO\\nforms\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nhave\\tO\\nbeen\\tO\\nlargely\\tO\\nattributed\\tO\\nto\\tO\\nthe\\tO\\ninheritance\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\ngenes\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nit\\tO\\nis\\tO\\nnot\\tO\\nyet\\tO\\nclear\\tO\\nwhat\\tO\\nproportion\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nis\\tO\\nexplained\\tO\\nby\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nor\\tO\\nby\\tO\\nsome\\tO\\nother\\tO\\nunidentified\\tO\\nsusceptibility\\tO\\ngene\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nthe\\tO\\nproportion\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nexplained\\tO\\nby\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\nin\\tO\\na\\tO\\nsample\\tO\\nof\\tO\\nNorth\\tO\\nAmerican\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\ncancers\\tI-Disease\\nand\\tO\\nassess\\tO\\nthe\\tO\\nevidence\\tO\\nfor\\tO\\nadditional\\tO\\nsusceptibility\\tO\\ngenes\\tO\\nthat\\tO\\nmay\\tO\\nconfer\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nrisk\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\nthree\\tO\\nfamilies\\tO\\nwere\\tO\\nidentified\\tO\\nthrough\\tO\\ntwo\\tO\\nhigh\\tO\\n-\\tO\\nrisk\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nresearch\\tO\\nprograms\\tO\\n.\\tO\\n\\nGenetic\\tO\\nanalysis\\tO\\nwas\\tO\\nundertaken\\tO\\nto\\tO\\nestablish\\tO\\nlinkage\\tO\\nbetween\\tO\\nthe\\tO\\nbreast\\tB-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ncases\\tO\\nand\\tO\\nmarkers\\tO\\non\\tO\\nchromosomes\\tO\\n17q\\tO\\n(\\tO\\nBRCA1\\tO\\n)\\tO\\nand\\tO\\n13q\\tO\\n(\\tO\\nBRCA2\\tO\\n)\\tO\\n.\\tO\\n\\nMutation\\tO\\nanalysis\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\ngenes\\tO\\nwas\\tO\\nalso\\tO\\nundertaken\\tO\\nin\\tO\\nall\\tO\\nfamilies\\tO\\n.\\tO\\n\\nThe\\tO\\npattern\\tO\\nof\\tO\\nhereditary\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\n14\\tO\\n(\\tO\\n61\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\n23\\tO\\nfamilies\\tO\\nstudied\\tO\\nwas\\tO\\nattributed\\tO\\nto\\tO\\nBRCA1\\tO\\nby\\tO\\na\\tO\\ncombination\\tO\\nof\\tO\\nlinkage\\tO\\nand\\tO\\nmutation\\tO\\nanalyses\\tO\\n.\\tO\\n\\nNo\\tO\\nfamilies\\tO\\nwere\\tO\\nattributed\\tO\\nto\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nFive\\tO\\nfamilies\\tO\\n(\\tO\\n22\\tO\\n%\\tO\\n)\\tO\\nprovided\\tO\\nevidence\\tO\\nagainst\\tO\\nlinkage\\tO\\nto\\tO\\nboth\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nNo\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nthese\\tO\\nfive\\tO\\nfamilies\\tO\\n.\\tO\\n\\nThe\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\nstatus\\tO\\nof\\tO\\nfour\\tO\\nfamilies\\tO\\n(\\tO\\n17\\tO\\n%\\tO\\n)\\tO\\ncould\\tO\\nnot\\tO\\nbe\\tO\\ndetermined\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nprobably\\tO\\nexplain\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nthat\\tO\\nexists\\tO\\nin\\tO\\nthe\\tO\\nNorth\\tO\\nAmerican\\tO\\npopulation\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\none\\tO\\nor\\tO\\nmore\\tO\\nadditional\\tO\\ngenes\\tO\\nmay\\tO\\nyet\\tO\\nbe\\tO\\nfound\\tO\\nthat\\tO\\nexplain\\tO\\nsome\\tO\\nproportion\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nAn\\tO\\nintronic\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nlariat\\tO\\nbranchpoint\\tO\\nsequence\\tO\\nis\\tO\\na\\tO\\ndirect\\tO\\ncause\\tO\\nof\\tO\\nan\\tO\\ninherited\\tB-Disease\\nhuman\\tI-Disease\\ndisorder\\tI-Disease\\n(\\tO\\nfish\\tB-Disease\\n-\\tI-Disease\\neye\\tI-Disease\\ndisease\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\nstep\\tO\\nin\\tO\\nthe\\tO\\nsplicing\\tO\\nof\\tO\\nan\\tO\\nintron\\tO\\nfrom\\tO\\nnuclear\\tO\\nprecursors\\tO\\nof\\tO\\nmRNA\\tO\\nresults\\tO\\nin\\tO\\nthe\\tO\\nformation\\tO\\nof\\tO\\na\\tO\\nlariat\\tO\\nstructure\\tO\\n.\\tO\\n\\nA\\tO\\ndistinct\\tO\\nintronic\\tO\\nnucleotide\\tO\\nsequence\\tO\\n,\\tO\\nknown\\tO\\nas\\tO\\nthe\\tO\\nbranchpoint\\tO\\nregion\\tO\\n,\\tO\\nplays\\tO\\na\\tO\\ncentral\\tO\\nrole\\tO\\nin\\tO\\nthis\\tO\\nprocess\\tO\\n.\\tO\\n\\nWe\\tO\\nhere\\tO\\ndescribe\\tO\\na\\tO\\npoint\\tO\\nmutation\\tO\\nin\\tO\\nsuch\\tO\\na\\tO\\nsequence\\tO\\n.\\tO\\n\\nThree\\tO\\nsisters\\tO\\nwere\\tO\\nshown\\tO\\nto\\tO\\nsuffer\\tO\\nfrom\\tO\\nfish\\tB-Disease\\n-\\tI-Disease\\neye\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nFED\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\ndisorder\\tO\\nwhich\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\ncoding\\tO\\nfor\\tO\\nlecithin\\tO\\ncholesterol\\tO\\nacyltransferase\\tO\\n(\\tO\\nLCAT\\tO\\n)\\tO\\n.\\tO\\n\\nSequencing\\tO\\nof\\tO\\nthe\\tO\\nLCAT\\tO\\ngene\\tO\\nof\\tO\\nall\\tO\\nthree\\tO\\nprobands\\tO\\nrevealed\\tO\\ncompound\\tO\\nheterozygosity\\tO\\nfor\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n4\\tO\\nwhich\\tO\\nis\\tO\\nreported\\tO\\nto\\tO\\nunderlie\\tO\\nthe\\tO\\nFED\\tB-Disease\\nphenotype\\tO\\n,\\tO\\nand\\tO\\na\\tO\\npoint\\tO\\nmutation\\tO\\nlocated\\tO\\nin\\tO\\nintron\\tO\\n4\\tO\\n(\\tO\\nIVS4\\tO\\nT\\tO\\n-\\tO\\n22C\\tO\\n)\\tO\\n.\\tO\\n\\nBy\\tO\\nperforming\\tO\\nin\\tO\\nvitro\\tO\\nexpression\\tO\\nof\\tO\\nLCAT\\tO\\nminigenes\\tO\\nand\\tO\\nreverse\\tO\\ntranscriptase\\tO\\nPCR\\tO\\non\\tO\\nmRNA\\tO\\nisolated\\tO\\nfrom\\tO\\nleukocytes\\tO\\nof\\tO\\nthe\\tO\\npatient\\tO\\n,\\tO\\nthis\\tO\\ngene\\tO\\ndefect\\tO\\nwas\\tO\\nshown\\tO\\nto\\tO\\ncause\\tO\\na\\tO\\nnull\\tO\\nallele\\tO\\nas\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\ncomplete\\tO\\nintron\\tO\\nretention\\tO\\n.\\tO\\n\\nIn\\tO\\nconclusion\\tO\\n,\\tO\\nwe\\tO\\ndemonstrated\\tO\\nthat\\tO\\na\\tO\\npoint\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nlariat\\tO\\nbranchpoint\\tO\\nconsensus\\tO\\nsequence\\tO\\ncauses\\tO\\na\\tO\\nnull\\tO\\nallele\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nFED\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nour\\tO\\nfinding\\tO\\nillustrates\\tO\\nthe\\tO\\nimportance\\tO\\nof\\tO\\nthis\\tO\\nsequence\\tO\\nfor\\tO\\nnormal\\tO\\nhuman\\tO\\nmRNA\\tO\\nprocessing\\tO\\n.\\tO\\n\\nFinally\\tO\\n,\\tO\\nthis\\tO\\nreport\\tO\\nprovides\\tO\\na\\tO\\nwidely\\tO\\napplicable\\tO\\nstrategy\\tO\\nwhich\\tO\\nensures\\tO\\nfast\\tO\\nand\\tO\\neffective\\tO\\nscreening\\tO\\nfor\\tO\\nintronic\\tO\\ndefects\\tO\\nthat\\tO\\nunderlie\\tO\\ndifferential\\tO\\ngene\\tO\\nexpression\\tO\\n.\\tO\\n.\\tO\\n\\nMutations\\tO\\nassociated\\tO\\nwith\\tO\\nvariant\\tO\\nphenotypes\\tO\\nin\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\n14\\tO\\nfamilies\\tO\\nwith\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\nin\\tO\\nwhich\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nless\\tO\\nsevere\\tO\\nclinical\\tO\\nand\\tO\\ncellular\\tO\\nphenotype\\tO\\n(\\tO\\napproximately\\tO\\n10\\tO\\n%\\tO\\n-\\tO\\n15\\tO\\n%\\tO\\nof\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nfamilies\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\nUnited\\tO\\nKingdom\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\n10\\tO\\nof\\tO\\nthese\\tO\\nfamilies\\tO\\n,\\tO\\nall\\tO\\nthe\\tO\\nhomozygotes\\tO\\nhave\\tO\\na\\tO\\n137\\tO\\n-\\tO\\nbp\\tO\\ninsertion\\tO\\nin\\tO\\ntheir\\tO\\ncDNA\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\npoint\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nsequence\\tO\\nresembling\\tO\\na\\tO\\nsplice\\tO\\n-\\tO\\ndonor\\tO\\nsite\\tO\\n.\\tO\\n\\nThe\\tO\\nsecond\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nallele\\tO\\nhas\\tO\\na\\tO\\ndifferent\\tO\\nmutation\\tO\\nin\\tO\\neach\\tO\\npatient\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nless\\tO\\nsevere\\tO\\nphenotype\\tO\\nin\\tO\\nthese\\tO\\npatients\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nsome\\tO\\ndegree\\tO\\nof\\tO\\nnormal\\tO\\nsplicing\\tO\\n,\\tO\\nwhich\\tO\\noccurs\\tO\\nas\\tO\\nan\\tO\\nalternative\\tO\\nproduct\\tO\\nfrom\\tO\\nthe\\tO\\ninsertion\\tO\\n-\\tO\\ncontaining\\tO\\nallele\\tO\\n.\\tO\\n\\nThe\\tO\\nlevel\\tO\\nof\\tO\\nthe\\tO\\n137\\tO\\n-\\tO\\nbp\\tO\\nPCR\\tO\\nproduct\\tO\\ncontaining\\tO\\nthe\\tO\\ninsertion\\tO\\nwas\\tO\\nlowest\\tO\\nin\\tO\\ntwo\\tO\\npatients\\tO\\nwho\\tO\\nshowed\\tO\\na\\tO\\nlater\\tO\\nonset\\tO\\nof\\tO\\ncerebellar\\tB-Disease\\nataxia\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nfurther\\tO\\nfour\\tO\\nfamilies\\tO\\nwho\\tO\\ndo\\tO\\nnot\\tO\\nhave\\tO\\nthis\\tO\\ninsertion\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\n.\\tO\\n\\nMutations\\tO\\ndetected\\tO\\nin\\tO\\ntwo\\tO\\nof\\tO\\nfour\\tO\\nof\\tO\\nthese\\tO\\nare\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\nnormally\\tO\\nrare\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\ndemonstration\\tO\\nof\\tO\\nmutations\\tO\\ngiving\\tO\\nrise\\tO\\nto\\tO\\na\\tO\\nslightly\\tO\\nmilder\\tO\\nphenotype\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nraises\\tO\\nthe\\tO\\ninteresting\\tO\\nquestion\\tO\\nof\\tO\\nwhat\\tO\\nrange\\tO\\nof\\tO\\nphenotypes\\tO\\nmight\\tO\\noccur\\tO\\nin\\tO\\nindividuals\\tO\\nin\\tO\\nwhom\\tO\\nboth\\tO\\nmutations\\tO\\nare\\tO\\nmilder\\tO\\n.\\tO\\n\\nOne\\tO\\npossibility\\tO\\nmight\\tO\\nbe\\tO\\nthat\\tO\\nindividuals\\tO\\nwho\\tO\\nare\\tO\\ncompound\\tO\\nheterozygotes\\tO\\nfor\\tO\\nATM\\tO\\nmutations\\tO\\nare\\tO\\nmore\\tO\\ncommon\\tO\\nthan\\tO\\nwe\\tO\\nrealize\\tO\\n.\\tO\\n.\\tO\\n\\nMutation\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tO\\ngene\\tO\\nis\\tO\\nassociated\\tO\\nexclusively\\tO\\nwith\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\npapillary\\tI-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\ndefine\\tO\\nthe\\tO\\npossible\\tO\\nrole\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nin\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nsporadic\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\n,\\tO\\n91\\tO\\ndifferent\\tO\\nparenchymal\\tB-Disease\\ntumours\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nkidney\\tI-Disease\\nhave\\tO\\nbeen\\tO\\ninvestigated\\tO\\nfor\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nby\\tO\\nsingle\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nSSCP\\tO\\n)\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nheteroduplex\\tO\\n(\\tO\\nHD\\tO\\n)\\tO\\ntechniques\\tO\\n.\\tO\\n\\nChromosome\\tO\\n3p\\tO\\ndeletion\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\n98\\tO\\nper\\tO\\ncent\\tO\\nof\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\npapillary\\tI-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\nand\\tO\\nin\\tO\\n25\\tO\\nper\\tO\\ncent\\tO\\nof\\tO\\nchromophobe\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\n22\\tO\\nof\\tO\\nthe\\tO\\n43\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\npapillary\\tI-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\n,\\tO\\nabnormally\\tO\\nmigrating\\tO\\nDNA\\tO\\nbands\\tO\\nwere\\tO\\ndetected\\tO\\nby\\tO\\nSSCP\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nHD\\tO\\nanalysis\\tO\\n.\\tO\\n\\nNo\\tO\\nmobility\\tO\\nshift\\tO\\nwas\\tO\\nseen\\tO\\nin\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\n23\\tO\\nchromophobe\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\n15\\tO\\npapillary\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ntumours\\tI-Disease\\nand\\tO\\nten\\tO\\nrenal\\tB-Disease\\noncocytomas\\tI-Disease\\n,\\tO\\nwhich\\tO\\nare\\tO\\ncharacterized\\tO\\nby\\tO\\ngenetic\\tO\\nchanges\\tO\\nother\\tO\\nthan\\tO\\nloss\\tO\\nof\\tO\\nchromosome\\tO\\n3p\\tO\\nsequences\\tO\\n,\\tO\\nwere\\tO\\nanalysed\\tO\\nfor\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nNone\\tO\\nof\\tO\\nthese\\tO\\ntumours\\tB-Disease\\nshowed\\tO\\nabnormal\\tO\\nmigration\\tO\\npatterns\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nis\\tO\\nassociated\\tO\\nexclusively\\tO\\nwith\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\npapillary\\tI-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nEmery\\tB-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\nprotein\\tO\\n,\\tO\\nemerin\\tO\\n,\\tO\\nis\\tO\\na\\tO\\nnuclear\\tO\\nmembrane\\tO\\nprotein\\tO\\n.\\tO\\n\\nA\\tO\\nlarge\\tO\\nfragment\\tO\\nof\\tO\\nemerin\\tO\\ncDNA\\tO\\nwas\\tO\\nprepared\\tO\\nby\\tO\\nPCR\\tO\\nand\\tO\\nexpressed\\tO\\nas\\tO\\na\\tO\\nrecombinant\\tO\\nprotein\\tO\\nin\\tO\\nEscherichia\\tO\\ncoli\\tO\\n.\\tO\\n\\nUsing\\tO\\nthis\\tO\\nas\\tO\\nimmunogen\\tO\\n,\\tO\\nwe\\tO\\nprepared\\tO\\na\\tO\\npanel\\tO\\nof\\tO\\n12\\tO\\nmonoclonal\\tO\\nantibodies\\tO\\nwhich\\tO\\nrecognise\\tO\\nat\\tO\\nleast\\tO\\nfour\\tO\\ndifferent\\tO\\nepitopes\\tO\\non\\tO\\nemerin\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\nensure\\tO\\nthat\\tO\\nemerin\\tO\\ncan\\tO\\nbe\\tO\\ndistinguished\\tO\\nfrom\\tO\\nnon\\tO\\n-\\tO\\nspecific\\tO\\ncross\\tO\\n-\\tO\\nreacting\\tO\\nproteins\\tO\\n.\\tO\\n\\nAll\\tO\\nthe\\tO\\nmAbs\\tO\\nrecognised\\tO\\na\\tO\\n34\\tO\\nkDa\\tO\\nprotein\\tO\\nin\\tO\\nall\\tO\\ntissues\\tO\\ntested\\tO\\n,\\tO\\nthough\\tO\\nminor\\tO\\nemerin\\tO\\n-\\tO\\nrelated\\tO\\nbands\\tO\\nwere\\tO\\nalso\\tO\\ndetected\\tO\\nin\\tO\\nsome\\tO\\ntissues\\tO\\n.\\tO\\n\\nImmunofluorescence\\tO\\nmicroscopy\\tO\\nshowed\\tO\\nthat\\tO\\nemerin\\tO\\nis\\tO\\nlocated\\tO\\nat\\tO\\nthe\\tO\\nnuclear\\tO\\nrim\\tO\\nin\\tO\\nall\\tO\\ntissues\\tO\\nexamined\\tO\\n.\\tO\\n\\nA\\tO\\nmuscle\\tO\\nbiopsy\\tO\\nfrom\\tO\\nan\\tO\\nEmery\\tB-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nEMDM\\tB-Disease\\n)\\tO\\npatient\\tO\\nshowed\\tO\\ncomplete\\tO\\nabsence\\tO\\nof\\tO\\nemerin\\tO\\nby\\tO\\nboth\\tO\\nWestern\\tO\\nblotting\\tO\\nand\\tO\\nimmunohistochemistry\\tO\\n,\\tO\\nsuggesting\\tO\\na\\tO\\nsimple\\tO\\ndiagnostic\\tO\\nantibody\\tO\\ntest\\tO\\nfor\\tO\\nEDMD\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nBiochemical\\tO\\nfractionation\\tO\\nof\\tO\\nbrain\\tO\\nand\\tO\\nliver\\tO\\ntissues\\tO\\nshowed\\tO\\nthat\\tO\\nemerin\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\nnuclei\\tO\\npurified\\tO\\nby\\tO\\ncentrifugation\\tO\\nthrough\\tO\\n65\\tO\\n%\\tO\\nsucrose\\tO\\nand\\tO\\nwas\\tO\\nabsent\\tO\\nfrom\\tO\\nsoluble\\tO\\nfractions\\tO\\n(\\tO\\npost\\tO\\n-\\tO\\n100\\tO\\n,\\tO\\n000\\tO\\ng\\tO\\n)\\tO\\n.\\tO\\n\\nFrom\\tO\\nthese\\tO\\nresults\\tO\\n,\\tO\\ntogether\\tO\\nwith\\tO\\nsequence\\tO\\nand\\tO\\nstructural\\tO\\nhomologies\\tO\\nbetween\\tO\\nemerin\\tO\\n,\\tO\\nthymopoietins\\tO\\nand\\tO\\nthe\\tO\\nnuclear\\tO\\nlamina\\tO\\n-\\tO\\nassociated\\tO\\nprotein\\tO\\n,\\tO\\nLAP2\\tO\\n,\\tO\\nwe\\tO\\nsuggest\\tO\\nthat\\tO\\nemerin\\tO\\nwill\\tO\\nprove\\tO\\nto\\tO\\nbe\\tO\\none\\tO\\nmember\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\nof\\tO\\ninner\\tO\\nnuclear\\tO\\nmembrane\\tO\\nproteins\\tO\\n.\\tO\\n.\\tO\\n\\nMutation\\tO\\nof\\tO\\nMSH3\\tO\\nin\\tO\\nendometrial\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\nevidence\\tO\\nfor\\tO\\nits\\tO\\nfunctional\\tO\\nrole\\tO\\nin\\tO\\nheteroduplex\\tO\\nrepair\\tO\\n.\\tO\\n\\nMany\\tO\\nhuman\\tO\\ntumours\\tB-Disease\\nhave\\tO\\nlength\\tO\\nalterations\\tO\\nin\\tO\\nrepetitive\\tO\\nsequence\\tO\\nelements\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthis\\tO\\nmicrosatellite\\tB-Disease\\ninstability\\tI-Disease\\nhas\\tO\\nbeen\\tO\\nattributed\\tO\\nto\\tO\\nmutations\\tO\\nin\\tO\\nfour\\tO\\nDNA\\tO\\nmismatch\\tO\\nrepair\\tO\\ngenes\\tO\\nin\\tO\\nhereditary\\tB-Disease\\nnonpolyposis\\tI-Disease\\ncolorectal\\tI-Disease\\ncancer\\tI-Disease\\n(\\tO\\nHNPCC\\tB-Disease\\n)\\tO\\nkindreds\\tO\\n,\\tO\\nmany\\tO\\nsporadic\\tB-Disease\\ntumours\\tI-Disease\\nexhibit\\tO\\ninstability\\tO\\nbut\\tO\\nno\\tO\\ndetectable\\tO\\nmutations\\tO\\nin\\tO\\nthese\\tO\\ngenes\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\ntherefore\\tO\\nof\\tO\\ninterest\\tO\\nto\\tO\\nidentify\\tO\\nother\\tO\\ngenes\\tO\\nthat\\tO\\ncontribute\\tO\\nto\\tO\\nthis\\tO\\ninstability\\tO\\n.\\tO\\n\\nIn\\tO\\nyeast\\tO\\n,\\tO\\nmutations\\tO\\nin\\tO\\nseveral\\tO\\ngenes\\tO\\n,\\tO\\nincluding\\tO\\nRTH\\tO\\nand\\tO\\nMSH3\\tO\\n,\\tO\\ncause\\tO\\nmicrosatellite\\tO\\ninstability\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nwe\\tO\\nscreened\\tO\\n16\\tO\\nendometrial\\tB-Disease\\ncarcinomas\\tI-Disease\\nwith\\tO\\nmicrosatellite\\tO\\ninstability\\tO\\nfor\\tO\\nalterations\\tO\\nin\\tO\\nFEN1\\tO\\n(\\tO\\nthe\\tO\\nhuman\\tO\\nhomolog\\tO\\nof\\tO\\nRTH\\tO\\n)\\tO\\nand\\tO\\nin\\tO\\nMSH3\\tO\\n(\\tO\\nrefs\\tO\\n12\\tO\\n-\\tO\\n14\\tO\\n)\\tO\\n.\\tO\\n\\nAlthough\\tO\\nwe\\tO\\nfound\\tO\\nno\\tO\\nFEN1\\tO\\nmutations\\tO\\n,\\tO\\na\\tO\\nframeshift\\tO\\nmutation\\tO\\nin\\tO\\nMSH3\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\nan\\tO\\nendometrial\\tB-Disease\\ncarcinoma\\tI-Disease\\nand\\tO\\nin\\tO\\nan\\tO\\nendometrial\\tB-Disease\\ncarcinoma\\tI-Disease\\ncell\\tO\\nline\\tO\\n.\\tO\\n\\nExtracts\\tO\\nof\\tO\\nthe\\tO\\ncell\\tO\\nline\\tO\\nwere\\tO\\ndeficient\\tO\\nin\\tO\\nrepair\\tO\\nof\\tO\\nDNA\\tO\\nsubstrates\\tO\\ncontaining\\tO\\nmismatches\\tO\\nor\\tO\\nextra\\tO\\nnucleotides\\tO\\n.\\tO\\n\\nIntroducing\\tO\\nchromosome\\tO\\n5\\tO\\n,\\tO\\nencoding\\tO\\nthe\\tO\\nMSH3\\tO\\ngene\\tO\\n,\\tO\\ninto\\tO\\nthe\\tO\\nmutant\\tO\\ncell\\tO\\nline\\tO\\nincreased\\tO\\nthe\\tO\\nstability\\tO\\nof\\tO\\nsome\\tO\\nbut\\tO\\nnot\\tO\\nall\\tO\\nmicrosatellites\\tO\\n.\\tO\\n\\nExtracts\\tO\\nof\\tO\\nthese\\tO\\ncells\\tO\\nrepaired\\tO\\ncertain\\tO\\nsubstrates\\tO\\ncontaining\\tO\\nextra\\tO\\nnucleotides\\tO\\n,\\tO\\nbut\\tO\\nwere\\tO\\ndeficient\\tO\\nin\\tO\\nrepair\\tO\\nof\\tO\\nthose\\tO\\ncontaining\\tO\\nmismatches\\tO\\nor\\tO\\nother\\tO\\nextra\\tO\\nnucleotides\\tO\\n.\\tO\\n\\nA\\tO\\nsubsequent\\tO\\nsearch\\tO\\nrevealed\\tO\\na\\tO\\nsecond\\tO\\ngene\\tO\\nmutation\\tO\\nin\\tO\\nHHUA\\tO\\ncells\\tO\\n,\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nMSH6\\tO\\ngene\\tO\\n.\\tO\\n\\nTogether\\tO\\nthe\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nMSH3\\tO\\ngene\\tO\\nencodes\\tO\\na\\tO\\nproduct\\tO\\nthat\\tO\\nfunctions\\tO\\nin\\tO\\nrepair\\tO\\nof\\tO\\nsome\\tO\\nbut\\tO\\nnot\\tO\\nall\\tO\\npre\\tO\\n-\\tO\\nmutational\\tO\\nintermediates\\tO\\n,\\tO\\nits\\tO\\nmutation\\tO\\nin\\tO\\ntumours\\tB-Disease\\ncan\\tO\\nresult\\tO\\nin\\tO\\ngenomic\\tO\\ninstability\\tO\\nand\\tO\\n,\\tO\\nas\\tO\\nin\\tO\\nyeast\\tO\\n,\\tO\\nMSH3\\tO\\nand\\tO\\nMSH6\\tO\\nare\\tO\\npartially\\tO\\nredundant\\tO\\nfor\\tO\\nmismatch\\tO\\nrepair\\tO\\n.\\tO\\n.\\tO\\n\\nComparative\\tO\\ngenome\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nregion\\tO\\nin\\tO\\nmouse\\tO\\n,\\tO\\nrat\\tO\\n,\\tO\\nand\\tO\\nSyrian\\tO\\nhamster\\tO\\n.\\tO\\n\\nChromosomal\\tO\\nlocations\\tO\\nof\\tO\\nthe\\tO\\nAtm\\tO\\n(\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nAT\\tB-Disease\\n)\\tO\\n-\\tO\\nmutated\\tO\\n)\\tO\\nand\\tO\\nAcat1\\tO\\n(\\tO\\nmitochondrial\\tO\\nacetoacetyl\\tO\\n-\\tO\\nCoA\\tO\\nthiolase\\tO\\n)\\tO\\ngenes\\tO\\nin\\tO\\nmouse\\tO\\n,\\tO\\nrat\\tO\\n,\\tO\\nand\\tO\\nSyrian\\tO\\nhamster\\tO\\nwere\\tO\\ndetermined\\tO\\nby\\tO\\ndirect\\tO\\nR\\tO\\n-\\tO\\nbanding\\tO\\nFISH\\tO\\n.\\tO\\n\\nBoth\\tO\\ngenes\\tO\\nwere\\tO\\ncolocalized\\tO\\nto\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nD\\tO\\nband\\tO\\nof\\tO\\nmouse\\tO\\nchromosome\\tO\\n9\\tO\\n,\\tO\\nthe\\tO\\nproximal\\tO\\nend\\tO\\nof\\tO\\nq24\\tO\\n.\\tO\\n\\n1\\tO\\nof\\tO\\nrat\\tO\\nchromosome\\tO\\n8\\tO\\n,\\tO\\nand\\tO\\nqa4\\tO\\n-\\tO\\nqa5\\tO\\nof\\tO\\nSyrian\\tO\\nhamster\\tO\\nchromosome\\tO\\n12\\tO\\n.\\tO\\n\\nThe\\tO\\nregions\\tO\\nin\\tO\\nthe\\tO\\nmouse\\tO\\nand\\tO\\nrat\\tO\\nwere\\tO\\nhomologous\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\n11q\\tO\\n.\\tO\\n\\nFine\\tO\\ngenetic\\tO\\nlinkage\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nAT\\tB-Disease\\nregion\\tO\\nwas\\tO\\nperformed\\tO\\nusing\\tO\\nthe\\tO\\ninterspecific\\tO\\nbackcross\\tO\\nmice\\tO\\n.\\tO\\n\\nAtm\\tO\\n,\\tO\\nAcat1\\tO\\n,\\tO\\nand\\tO\\nNpat\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\na\\tO\\nnew\\tO\\ngene\\tO\\nisolated\\tO\\nfrom\\tO\\nthe\\tO\\nAT\\tO\\nregion\\tO\\n,\\tO\\nand\\tO\\n12\\tO\\nflanking\\tO\\nmicrosatellite\\tO\\nDNA\\tO\\nmarkers\\tO\\nwere\\tO\\nexamined\\tO\\n.\\tO\\n\\nNo\\tO\\nrecombinations\\tO\\nwere\\tO\\nfound\\tO\\namong\\tO\\nthe\\tO\\nAtm\\tO\\n,\\tO\\nNpat\\tO\\n,\\tO\\nAcat1\\tO\\n,\\tO\\nand\\tO\\nD9Mit6\\tO\\nloci\\tO\\n,\\tO\\nand\\tO\\nthese\\tO\\nloci\\tO\\nwere\\tO\\nmapped\\tO\\n2\\tO\\n.\\tO\\n\\n0\\tO\\ncM\\tO\\ndistal\\tO\\nto\\tO\\nD9Mit99\\tO\\nand\\tO\\n1\\tO\\n.\\tO\\n\\n3\\tO\\ncM\\tO\\nproximal\\tO\\nto\\tO\\nD9Mit102\\tO\\n.\\tO\\n\\nComparison\\tO\\nof\\tO\\nthe\\tO\\nlinkage\\tO\\nmap\\tO\\nof\\tO\\nmouse\\tO\\nchromosome\\tO\\n9\\tO\\n(\\tO\\nMMU9\\tO\\n)\\tO\\nand\\tO\\nthat\\tO\\nof\\tO\\nhuman\\tO\\nchromosome\\tO\\n11\\tO\\n(\\tO\\nHSA11\\tO\\n)\\tO\\nindicates\\tO\\nthat\\tO\\nthere\\tO\\nis\\tO\\na\\tO\\nchromosomal\\tO\\nrearrangement\\tO\\ndue\\tO\\nto\\tO\\nan\\tO\\ninversion\\tO\\nbetween\\tO\\nEts1\\tO\\nand\\tO\\nAtm\\tO\\n-\\tO\\nNpat\\tO\\n-\\tO\\nAcat1\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\ninversion\\tO\\nof\\tO\\nMMU9\\tO\\noriginated\\tO\\nfrom\\tO\\nthe\\tO\\nchromosomal\\tO\\nbreakage\\tO\\nat\\tO\\nthe\\tO\\nboundary\\tO\\nbetween\\tO\\nGria4\\tO\\nand\\tO\\nAtm\\tO\\n-\\tO\\nNpat\\tO\\n-\\tO\\nAcat1\\tO\\non\\tO\\nHSA11\\tO\\n.\\tO\\n\\nThis\\tO\\ntype\\tO\\nof\\tO\\ninversion\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\nconserved\\tO\\nin\\tO\\nthe\\tO\\nthree\\tO\\nrodent\\tO\\nspecies\\tO\\n,\\tO\\nmouse\\tO\\n,\\tO\\nrat\\tO\\n,\\tO\\nand\\tO\\nSyrian\\tO\\nhamster\\tO\\n,\\tO\\nusing\\tO\\nadditional\\tO\\ncomparative\\tO\\nmapping\\tO\\ndata\\tO\\nwith\\tO\\nthe\\tO\\nRck\\tO\\ngene\\tO\\n\\nAn\\tO\\nanimal\\tO\\nmodel\\tO\\nfor\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nND\\tB-Disease\\n)\\tO\\n:\\tO\\ngene\\tO\\ntargeting\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nND\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\nelucidate\\tO\\nthe\\tO\\ncellular\\tO\\nand\\tO\\nmolecular\\tO\\nprocesses\\tO\\nwhich\\tO\\nare\\tO\\ninvolved\\tO\\nin\\tO\\nNorrie\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nND\\tB-Disease\\n)\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nused\\tO\\ngene\\tO\\ntargeting\\tO\\ntechnology\\tO\\nto\\tO\\ngenerate\\tO\\nND\\tB-Disease\\nmutant\\tO\\nmice\\tO\\n.\\tO\\n\\nThe\\tO\\nmurine\\tO\\nhomologue\\tO\\nof\\tO\\nthe\\tO\\nND\\tB-Disease\\ngene\\tO\\nwas\\tO\\ncloned\\tO\\nand\\tO\\nshown\\tO\\nto\\tO\\nencode\\tO\\na\\tO\\npolypeptide\\tO\\nthat\\tO\\nshares\\tO\\n94\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\namino\\tO\\nacid\\tO\\nsequence\\tO\\nwith\\tO\\nits\\tO\\nhuman\\tO\\ncounterpart\\tO\\n.\\tO\\n\\nRNA\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\nrevealed\\tO\\nexpression\\tO\\nin\\tO\\nretina\\tO\\n,\\tO\\nbrain\\tO\\nand\\tO\\nthe\\tO\\nolfactory\\tO\\nbulb\\tO\\nand\\tO\\nepithelium\\tO\\nof\\tO\\n2\\tO\\nweek\\tO\\nold\\tO\\nmice\\tO\\n.\\tO\\n\\nHemizygous\\tO\\nmice\\tO\\ncarrying\\tO\\na\\tO\\nreplacement\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n2\\tO\\nof\\tO\\nthe\\tO\\nND\\tB-Disease\\ngene\\tO\\ndeveloped\\tO\\nretrolental\\tO\\nstructures\\tO\\nin\\tO\\nthe\\tO\\nvitreous\\tO\\nbody\\tO\\nand\\tO\\nshowed\\tO\\nan\\tO\\noverall\\tO\\ndisorganization\\tO\\nof\\tO\\nthe\\tO\\nretinal\\tO\\nganglion\\tO\\ncell\\tO\\nlayer\\tO\\n.\\tO\\n\\nThe\\tO\\nouter\\tO\\nplexiform\\tO\\nlayer\\tO\\ndisappears\\tO\\noccasionally\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\njuxtaposed\\tO\\ninner\\tO\\nand\\tO\\nouter\\tO\\nnuclear\\tO\\nlayer\\tO\\n.\\tO\\n\\nAt\\tO\\nthe\\tO\\nsame\\tO\\nregions\\tO\\n,\\tO\\nthe\\tO\\nouter\\tO\\nsegments\\tO\\nof\\tO\\nthe\\tO\\nphotoreceptor\\tO\\ncell\\tO\\nlayer\\tO\\nare\\tO\\nno\\tO\\nlonger\\tO\\npresent\\tO\\n.\\tO\\n\\nThese\\tO\\nocular\\tO\\nfindings\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\nobservations\\tO\\nin\\tO\\nND\\tB-Disease\\npatients\\tO\\nand\\tO\\nthe\\tO\\ngenerated\\tO\\nmouse\\tO\\nline\\tO\\nprovides\\tO\\na\\tO\\nfaithful\\tO\\nmodel\\tO\\nfor\\tO\\nstudy\\tO\\nof\\tO\\nearly\\tO\\npathogenic\\tO\\nevents\\tO\\nin\\tO\\nthis\\tO\\nsevere\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nrecessive\\tI-Disease\\nneurological\\tI-Disease\\ndisorder\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nhybrid\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nfusion\\tO\\nprotein\\tO\\nof\\tO\\nalveolar\\tB-Disease\\nrhabdomyosarcoma\\tI-Disease\\ntransforms\\tO\\nfibroblasts\\tO\\nin\\tO\\nculture\\tO\\n.\\tO\\n\\nPediatric\\tB-Disease\\nalveolar\\tI-Disease\\nrhabdomyosarcoma\\tI-Disease\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\na\\tO\\nchromosomal\\tO\\ntranslocation\\tO\\nthat\\tO\\nfuses\\tO\\nparts\\tO\\nof\\tO\\nthe\\tO\\nPAX3\\tO\\nand\\tO\\nFKHR\\tO\\ngenes\\tO\\n.\\tO\\n\\nPAX3\\tO\\ncodes\\tO\\nfor\\tO\\na\\tO\\ntranscriptional\\tO\\nregulator\\tO\\nthat\\tO\\ncontrols\\tO\\ndevelopmental\\tO\\nprograms\\tO\\n,\\tO\\nand\\tO\\nFKHR\\tO\\ncodes\\tO\\nfor\\tO\\na\\tO\\nforkhead\\tO\\n-\\tO\\nwinged\\tO\\nhelix\\tO\\nprotein\\tO\\n,\\tO\\nalso\\tO\\na\\tO\\nlikely\\tO\\ntranscription\\tO\\nfactor\\tO\\n.\\tO\\n\\nThe\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nfusion\\tO\\nproduct\\tO\\nretains\\tO\\nthe\\tO\\nDNA\\tO\\nbinding\\tO\\ndomains\\tO\\nof\\tO\\nthe\\tO\\nPAX3\\tO\\nprotein\\tO\\nand\\tO\\nthe\\tO\\nputative\\tO\\nactivator\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nFKHR\\tO\\nprotein\\tO\\n.\\tO\\n\\nThe\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nprotein\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nfunction\\tO\\nas\\tO\\na\\tO\\ntranscriptional\\tO\\nactivator\\tO\\n.\\tO\\n\\nUsing\\tO\\nthe\\tO\\nRCAS\\tO\\nretroviral\\tO\\nvector\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nintroduced\\tO\\nthe\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\ngene\\tO\\ninto\\tO\\nchicken\\tO\\nembryo\\tO\\nfibroblasts\\tO\\n.\\tO\\n\\nExpression\\tO\\nof\\tO\\nthe\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nprotein\\tO\\nin\\tO\\nthese\\tO\\ncells\\tO\\nleads\\tO\\nto\\tO\\ntransformation\\tO\\nthe\\tO\\ncells\\tO\\nbecome\\tO\\nenlarged\\tO\\n,\\tO\\ngrow\\tO\\ntightly\\tO\\npacked\\tO\\nand\\tO\\nin\\tO\\nmultiple\\tO\\nlayers\\tO\\n,\\tO\\nand\\tO\\nacquire\\tO\\nthe\\tO\\nability\\tO\\nfor\\tO\\nanchorage\\tO\\n-\\tO\\nindependent\\tO\\ngrowth\\tO\\n.\\tO\\n\\nThis\\tO\\ncellular\\tO\\ntransformation\\tO\\nin\\tO\\nvitro\\tO\\nwill\\tO\\nfacilitate\\tO\\nstudies\\tO\\non\\tO\\nthe\\tO\\nmechanism\\tO\\nof\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\n-\\tO\\ninduced\\tO\\noncogenesis\\tO\\n.\\tO\\n.\\tO\\n\\nSomatic\\tO\\n-\\tO\\ncell\\tO\\nselection\\tO\\nis\\tO\\na\\tO\\nmajor\\tO\\ndeterminant\\tO\\nof\\tO\\nthe\\tO\\nblood\\tO\\n-\\tO\\ncell\\tO\\nphenotype\\tO\\nin\\tO\\nheterozygotes\\tO\\nfor\\tO\\nglucose\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\nmutations\\tO\\ncausing\\tO\\nsevere\\tO\\nenzyme\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nX\\tO\\n-\\tO\\nchromosome\\tO\\ninactivation\\tO\\nin\\tO\\nmammals\\tO\\nis\\tO\\nregarded\\tO\\nas\\tO\\nan\\tO\\nessentially\\tO\\nrandom\\tO\\nprocess\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nresulting\\tO\\nsomatic\\tO\\n-\\tO\\ncell\\tO\\nmosaicism\\tO\\ncreates\\tO\\nthe\\tO\\nopportunity\\tO\\nfor\\tO\\ncell\\tO\\nselection\\tO\\n.\\tO\\n\\nIn\\tO\\nmost\\tO\\npeople\\tO\\nwith\\tO\\nred\\tO\\n-\\tO\\nblood\\tO\\n-\\tO\\ncell\\tO\\nglucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nG6PD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nthe\\tO\\nenzyme\\tO\\n-\\tO\\ndeficient\\tO\\nphenotype\\tO\\nis\\tO\\nonly\\tO\\nmoderately\\tO\\nexpressed\\tO\\nin\\tO\\nnucleated\\tO\\ncells\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nin\\tO\\na\\tO\\nsmall\\tO\\nsubset\\tO\\nof\\tO\\nhemizygous\\tO\\nmales\\tO\\nwho\\tO\\nsuffer\\tO\\nfrom\\tO\\nchronic\\tB-Disease\\nnonspherocytic\\tI-Disease\\nhemolytic\\tI-Disease\\nanemia\\tI-Disease\\n,\\tO\\nthe\\tO\\nunderlying\\tO\\nmutations\\tO\\n(\\tO\\ndesignated\\tO\\nclass\\tO\\nI\\tO\\n)\\tO\\ncause\\tO\\nmore\\tO\\n-\\tO\\nsevere\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nand\\tO\\nthis\\tO\\nmight\\tO\\nprovide\\tO\\nan\\tO\\nopportunity\\tO\\nfor\\tO\\nselection\\tO\\nin\\tO\\nheterozygous\\tO\\nfemales\\tO\\nduring\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\ntest\\tO\\nthis\\tO\\npossibility\\tO\\nwe\\tO\\nhave\\tO\\nanalyzed\\tO\\nfour\\tO\\nheterozygotes\\tO\\nfor\\tO\\nclass\\tO\\nI\\tO\\nG6PD\\tO\\nmutations\\tO\\ntwo\\tO\\nwith\\tO\\nG6PD\\tO\\nPortici\\tO\\n(\\tO\\n1178G\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n)\\tO\\nand\\tO\\ntwo\\tO\\nwith\\tO\\nG6PD\\tO\\nBari\\tO\\n(\\tO\\n1187C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nthat\\tO\\nin\\tO\\nfractionated\\tO\\nblood\\tO\\ncell\\tO\\ntypes\\tO\\n(\\tO\\nincluding\\tO\\nerythroid\\tO\\n,\\tO\\nmyeloid\\tO\\n,\\tO\\nand\\tO\\nlymphoid\\tO\\ncell\\tO\\nlineages\\tO\\n)\\tO\\nthere\\tO\\nwas\\tO\\na\\tO\\nsignificant\\tO\\nexcess\\tO\\nof\\tO\\nG6PD\\tO\\n-\\tO\\nnormal\\tO\\ncells\\tO\\n.\\tO\\n\\nThe\\tO\\nsignificant\\tO\\nconcordance\\tO\\nthat\\tO\\nwe\\tO\\nhave\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\ndegree\\tO\\nof\\tO\\nimbalance\\tO\\nin\\tO\\nthe\\tO\\ndifferent\\tO\\nblood\\tO\\n-\\tO\\ncell\\tO\\nlineages\\tO\\nindicates\\tO\\nthat\\tO\\na\\tO\\nselective\\tO\\nmechanism\\tO\\nis\\tO\\nlikely\\tO\\nto\\tO\\noperate\\tO\\nat\\tO\\nthe\\tO\\nlevel\\tO\\nof\\tO\\npluripotent\\tO\\nblood\\tO\\nstem\\tO\\ncells\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nit\\tO\\nappears\\tO\\nthat\\tO\\nsevere\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\naffects\\tO\\nadversely\\tO\\nthe\\tO\\nproliferation\\tO\\nor\\tO\\nthe\\tO\\nsurvival\\tO\\nof\\tO\\nnucleated\\tO\\nblood\\tO\\ncells\\tO\\nand\\tO\\nthat\\tO\\nthis\\tO\\nphenotypic\\tO\\ncharacteristic\\tO\\nis\\tO\\ncritical\\tO\\nduring\\tO\\nhematopoiesis\\tO\\n.\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nmeiotic\\tO\\nsegregation\\tO\\n,\\tO\\nusing\\tO\\nsingle\\tO\\n-\\tO\\nsperm\\tO\\ntyping\\tO\\n:\\tO\\nmeiotic\\tO\\ndrive\\tO\\nat\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nlocus\\tO\\n.\\tO\\n\\nMeiotic\\tO\\ndrive\\tO\\nat\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nlocus\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nsuggested\\tO\\nas\\tO\\nbeing\\tO\\nresponsible\\tO\\nfor\\tO\\nmaintaining\\tO\\nthe\\tO\\nfrequency\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\npopulation\\tO\\n,\\tO\\nof\\tO\\nDM\\tB-Disease\\nchromosomes\\tO\\ncapable\\tO\\nof\\tO\\nexpansion\\tO\\nto\\tO\\nthe\\tO\\ndisease\\tO\\nstate\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\ntest\\tO\\nthis\\tO\\nhypothesis\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nstudied\\tO\\nsamples\\tO\\nof\\tO\\nsingle\\tO\\nsperm\\tO\\nfrom\\tO\\nthree\\tO\\nindividuals\\tO\\nheterozygous\\tO\\nat\\tO\\nthe\\tO\\nDM\\tB-Disease\\nlocus\\tO\\n,\\tO\\neach\\tO\\nwith\\tO\\none\\tO\\nallele\\tO\\nlarger\\tO\\nand\\tO\\none\\tO\\nallele\\tO\\nsmaller\\tO\\nthan\\tO\\n19\\tO\\nCTG\\tO\\nrepeats\\tO\\n.\\tO\\n\\nTo\\tO\\nguard\\tO\\nagainst\\tO\\nthe\\tO\\npossible\\tO\\nproblem\\tO\\nof\\tO\\ndifferential\\tO\\nPCR\\tO\\namplification\\tO\\nrates\\tO\\nbased\\tO\\non\\tO\\nthe\\tO\\nlengths\\tO\\nof\\tO\\nthe\\tO\\nalleles\\tO\\n,\\tO\\nthe\\tO\\nsperm\\tO\\nwere\\tO\\nalso\\tO\\ntyped\\tO\\nat\\tO\\nanother\\tO\\nclosely\\tO\\nlinked\\tO\\nmarker\\tO\\nwhose\\tO\\nallele\\tO\\nsize\\tO\\nwas\\tO\\nunrelated\\tO\\nto\\tO\\nthe\\tO\\nallele\\tO\\nsize\\tO\\nat\\tO\\nthe\\tO\\nDM\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nUsing\\tO\\nstatistical\\tO\\nmodels\\tO\\nspecifically\\tO\\ndesigned\\tO\\nto\\tO\\nstudy\\tO\\nsingle\\tO\\n-\\tO\\nsperm\\tO\\nsegregation\\tO\\ndata\\tO\\n,\\tO\\nwe\\tO\\nfind\\tO\\nno\\tO\\nevidence\\tO\\nof\\tO\\nmeiotic\\tO\\nsegregation\\tO\\ndistortion\\tO\\n.\\tO\\n\\nThe\\tO\\nupper\\tO\\nlimit\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\n-\\tO\\nsided\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\nfor\\tO\\nthe\\tO\\nestimate\\tO\\nof\\tO\\nthe\\tO\\ncommon\\tO\\nsegregation\\tO\\nprobability\\tO\\nfor\\tO\\nthe\\tO\\nthree\\tO\\ndonors\\tO\\nis\\tO\\nat\\tO\\nor\\tO\\nbelow\\tO\\n.\\tO\\n\\n515\\tO\\nfor\\tO\\nall\\tO\\nmodels\\tO\\nconsidered\\tO\\n,\\tO\\nand\\tO\\nno\\tO\\nstatistically\\tO\\nsignificant\\tO\\ndifference\\tO\\nfrom\\tO\\n.\\tO\\n\\n5\\tO\\nis\\tO\\ndetected\\tO\\nin\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\nmodels\\tO\\n.\\tO\\n\\nThis\\tO\\nsuggests\\tO\\nthat\\tO\\nany\\tO\\ngreater\\tO\\namount\\tO\\nof\\tO\\nsegregation\\tO\\ndistortion\\tO\\nat\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nlocus\\tO\\nmust\\tO\\nresult\\tO\\nfrom\\tO\\nevents\\tO\\nfollowing\\tO\\nsperm\\tO\\nejaculation\\tO\\n.\\tO\\n\\nLPP\\tO\\n,\\tO\\nthe\\tO\\npreferred\\tO\\nfusion\\tO\\npartner\\tO\\ngene\\tO\\nof\\tO\\nHMGIC\\tO\\nin\\tO\\nlipomas\\tB-Disease\\n,\\tO\\nis\\tO\\na\\tO\\nnovel\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\nLIM\\tO\\nprotein\\tO\\ngene\\tO\\nfamily\\tO\\n.\\tO\\n\\nA\\tO\\nmajor\\tO\\ncytogenetic\\tO\\nsubgroup\\tO\\nof\\tO\\nlipomas\\tB-Disease\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nrecurrent\\tO\\nchromosome\\tO\\naberrations\\tO\\n,\\tO\\nmainly\\tO\\ntranslocations\\tO\\n,\\tO\\nthat\\tO\\ninvolve\\tO\\nchromosome\\tO\\nsegment\\tO\\n12q13\\tO\\n-\\tO\\nq15\\tO\\n.\\tO\\n\\nMultiple\\tO\\nchromosomes\\tO\\nhave\\tO\\nbeen\\tO\\nfound\\tO\\nas\\tO\\nthe\\tO\\ntranslocation\\tO\\npartners\\tO\\nof\\tO\\nchromosome\\tO\\n12\\tO\\nbut\\tO\\n3q27\\tO\\n-\\tO\\nq28\\tO\\nis\\tO\\npreferentially\\tO\\ninvolved\\tO\\n.\\tO\\n\\nIn\\tO\\nprevious\\tO\\nstudies\\tO\\n,\\tO\\nit\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nthat\\tO\\nthe\\tO\\nhigh\\tO\\nmobility\\tO\\ngroup\\tO\\n(\\tO\\nHMG\\tO\\n)\\tO\\nprotein\\tO\\ngene\\tO\\nHMGIC\\tO\\nat\\tO\\n12q15\\tO\\nis\\tO\\nconsistently\\tO\\nrearranged\\tO\\nas\\tO\\na\\tO\\nconsequence\\tO\\nof\\tO\\nthese\\tO\\ntranslocations\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthe\\tO\\nidentification\\tO\\nand\\tO\\ncharacterization\\tO\\nof\\tO\\nthe\\tO\\nchromosome\\tO\\n3\\tO\\n-\\tO\\nderived\\tO\\ntranslocation\\tO\\npartner\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nwe\\tO\\nhave\\tO\\ndesignated\\tO\\nLPP\\tO\\n(\\tO\\nlipoma\\tB-Disease\\npreferred\\tO\\npartner\\tO\\ngene\\tO\\n)\\tO\\n.\\tO\\n\\nUsing\\tO\\n3\\tO\\n-\\tO\\nRACE\\tO\\nanalysis\\tO\\nof\\tO\\nHMGIC\\tO\\nfusion\\tO\\ntranscripts\\tO\\nin\\tO\\nlipoma\\tB-Disease\\ncell\\tO\\nline\\tO\\nLi\\tO\\n-\\tO\\n501\\tO\\n/\\tO\\nSV40\\tO\\n,\\tO\\nectopic\\tO\\ngenetic\\tO\\nsequences\\tO\\nwere\\tO\\nobtained\\tO\\n,\\tO\\nwhich\\tO\\nby\\tO\\nCASH\\tO\\n(\\tO\\nchromosome\\tO\\nassignment\\tO\\nusing\\tO\\nsomatic\\tO\\ncell\\tO\\nhybrids\\tO\\n)\\tO\\nand\\tO\\nFISH\\tO\\n(\\tO\\nfluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n)\\tO\\nanalysis\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\noriginate\\tO\\nfrom\\tO\\nchromosome\\tO\\nsegment\\tO\\n3q27\\tO\\n-\\tO\\nq28\\tO\\n.\\tO\\n\\nIn\\tO\\nNorthern\\tO\\nblot\\tO\\nanalysis\\tO\\n,\\tO\\nan\\tO\\nmRNA\\tO\\nof\\tO\\nover\\tO\\n10\\tO\\nkb\\tO\\nwas\\tO\\ndetected\\tO\\nby\\tO\\nthese\\tO\\nectopic\\tO\\nsequences\\tO\\nin\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nhuman\\tO\\ntissues\\tO\\nbut\\tO\\nnot\\tO\\nin\\tO\\nbrain\\tO\\nand\\tO\\nperipheral\\tO\\nblood\\tO\\nleukocytes\\tO\\n.\\tO\\n\\nUpon\\tO\\npartial\\tO\\ncDNA\\tO\\ncloning\\tO\\n,\\tO\\nfeatures\\tO\\nof\\tO\\nthe\\tO\\ngenetic\\tO\\norganization\\tO\\nof\\tO\\nLPP\\tO\\nwere\\tO\\nestablished\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nspan\\tO\\na\\tO\\ngenomic\\tO\\nregion\\tO\\nof\\tO\\nover\\tO\\n400\\tO\\nkb\\tO\\n.\\tO\\n\\nNucleotide\\tO\\nsequence\\tO\\nanalysis\\tO\\nof\\tO\\na\\tO\\ncomposite\\tO\\ncDNA\\tO\\nof\\tO\\nLPP\\tO\\nrevealed\\tO\\nan\\tO\\nopen\\tO\\nreading\\tO\\nframe\\tO\\nof\\tO\\n1836\\tO\\nnucleotides\\tO\\nencoding\\tO\\na\\tO\\nproline\\tO\\n-\\tO\\nrich\\tO\\nprotein\\tO\\ncontaining\\tO\\na\\tO\\nleucine\\tO\\n-\\tO\\nzipper\\tO\\nmotif\\tO\\nin\\tO\\nits\\tO\\namino\\tO\\n-\\tO\\nterminal\\tO\\nregion\\tO\\nand\\tO\\nthree\\tO\\nLIM\\tO\\ndomains\\tO\\nin\\tO\\nits\\tO\\ncarboxy\\tO\\n-\\tO\\nterminal\\tO\\nregion\\tO\\n.\\tO\\n\\nThe\\tO\\nLPP\\tO\\n-\\tO\\nencoded\\tO\\nprotein\\tO\\nshould\\tO\\nbe\\tO\\nclassified\\tO\\nas\\tO\\na\\tO\\nnovel\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\ngroup\\tO\\n3\\tO\\nproteins\\tO\\nof\\tO\\nthe\\tO\\nLIM\\tO\\nprotein\\tO\\ngene\\tO\\nfamily\\tO\\n.\\tO\\n\\nUsing\\tO\\nreverse\\tO\\ntranscriptase\\tO\\ncombined\\tO\\nwith\\tO\\npolymerase\\tO\\nchain\\tO\\nreactions\\tO\\nin\\tO\\nthe\\tO\\nanalysis\\tO\\nof\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nlipoma\\tB-Disease\\ncell\\tO\\nlines\\tO\\nand\\tO\\nprimary\\tB-Disease\\nlipomas\\tI-Disease\\n,\\tO\\nit\\tO\\nappeared\\tO\\nthat\\tO\\nLPP\\tO\\nis\\tO\\nfrequently\\tO\\nrearranged\\tO\\nalso\\tO\\nin\\tO\\ncases\\tO\\nwithout\\tO\\na\\tO\\ncytogenetically\\tO\\ndetectable\\tO\\ninvolvement\\tO\\nof\\tO\\n3q27\\tO\\n-\\tO\\nq28\\tO\\n.\\tO\\n\\nTwo\\tO\\nalternative\\tO\\nHMGIC\\tO\\n/\\tO\\nLPP\\tO\\nhybrid\\tO\\ntranscripts\\tO\\nhave\\tO\\nbeen\\tO\\ndetected\\tO\\n;\\tO\\nthe\\tO\\ndifference\\tO\\nbetween\\tO\\nthem\\tO\\nis\\tO\\nmainly\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\neither\\tO\\ntwo\\tO\\nor\\tO\\nthree\\tO\\nLIM\\tO\\ndomains\\tO\\nin\\tO\\nthe\\tO\\npredicted\\tO\\nHMGI\\tO\\n-\\tO\\nC\\tO\\n/\\tO\\nLPP\\tO\\nfusion\\tO\\nproteins\\tO\\n.\\tO\\n.\\tO\\n\\nAbsence\\tO\\nof\\tO\\ndisease\\tO\\nphenotype\\tO\\nand\\tO\\nintergenerational\\tO\\nstability\\tO\\nof\\tO\\nthe\\tO\\nCAG\\tO\\nrepeat\\tO\\nin\\tO\\ntransgenic\\tO\\nmice\\tO\\nexpressing\\tO\\nthe\\tO\\nhuman\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\ntranscript\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nunderlying\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nis\\tO\\nCAG\\tO\\nexpansion\\tO\\nin\\tO\\nthe\\tO\\nfirst\\tO\\nexon\\tO\\nof\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nCAG\\tO\\nexpansion\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nHD\\tB-Disease\\n,\\tO\\nwe\\tO\\nhave\\tO\\nproduced\\tO\\ntransgenic\\tO\\nmice\\tO\\ncontaining\\tO\\nthe\\tO\\nfull\\tO\\nlength\\tO\\nhuman\\tO\\nHD\\tB-Disease\\ncDNA\\tO\\nwith\\tO\\n44\\tO\\nCAG\\tO\\nrepeats\\tO\\n.\\tO\\n\\nBy\\tO\\n1\\tO\\nyear\\tO\\n,\\tO\\nthese\\tO\\nmice\\tO\\nhave\\tO\\nno\\tO\\nbehavioral\\tB-Disease\\nabnormalities\\tI-Disease\\nand\\tO\\nmorphometric\\tO\\nanalysis\\tO\\nat\\tO\\n6\\tO\\n(\\tO\\none\\tO\\nanimal\\tO\\n)\\tO\\nand\\tO\\n9\\tO\\n(\\tO\\ntwo\\tO\\nanimals\\tO\\n)\\tO\\nmonths\\tO\\nage\\tO\\nrevealed\\tO\\nno\\tO\\nchanges\\tO\\n.\\tO\\n\\nDespite\\tO\\nhigh\\tO\\nlevels\\tO\\nof\\tO\\nmRNA\\tO\\nexpression\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\nno\\tO\\nevidence\\tO\\nof\\tO\\nthe\\tO\\nHD\\tB-Disease\\ngene\\tO\\nproduct\\tO\\nin\\tO\\nany\\tO\\nof\\tO\\nthese\\tO\\ntransgenic\\tO\\nmice\\tO\\n.\\tO\\n\\nIn\\tO\\nvitro\\tO\\ntransfection\\tO\\nstudies\\tO\\nindicated\\tO\\nthat\\tO\\nthe\\tO\\ninclusion\\tO\\nof\\tO\\n120\\tO\\nbp\\tO\\nof\\tO\\nthe\\tO\\n5\\tO\\nUTR\\tO\\nin\\tO\\nthe\\tO\\ncDNA\\tO\\nconstruct\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nframeshift\\tO\\nmutation\\tO\\nat\\tO\\nnucleotide\\tO\\n2349\\tO\\nprevented\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nHD\\tB-Disease\\ncDNA\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nHD\\tB-Disease\\nis\\tO\\nnot\\tO\\nmediated\\tO\\nthrough\\tO\\nDNA\\tO\\n-\\tO\\nprotein\\tO\\ninteraction\\tO\\nand\\tO\\nthat\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nRNA\\tO\\ntranscript\\tO\\nwith\\tO\\nan\\tO\\nexpanded\\tO\\nCAG\\tO\\nrepeat\\tO\\nis\\tO\\ninsufficient\\tO\\nto\\tO\\ncause\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nRather\\tO\\n,\\tO\\ntranslation\\tO\\nof\\tO\\nthe\\tO\\nCAG\\tO\\nis\\tO\\ncrucial\\tO\\nfor\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\nto\\tO\\nthat\\tO\\nseen\\tO\\nin\\tO\\nhumans\\tO\\n,\\tO\\nthe\\tO\\nCAG\\tO\\nrepeat\\tO\\nin\\tO\\nthese\\tO\\nmice\\tO\\nwas\\tO\\nremarkably\\tO\\nstable\\tO\\nin\\tO\\n97\\tO\\nmeioses\\tO\\n.\\tO\\n\\nThis\\tO\\nsuggests\\tO\\nthat\\tO\\ngenomic\\tO\\nsequences\\tO\\nmay\\tO\\nplay\\tO\\na\\tO\\ncritical\\tO\\nrole\\tO\\nin\\tO\\ninfluencing\\tO\\nrepeat\\tO\\ninstability\\tO\\n.\\tO\\n.\\tO\\n\\nFISH\\tO\\nstudies\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\nsporadic\\tB-Disease\\naniridia\\tI-Disease\\nand\\tO\\nt\\tO\\n(\\tO\\n7\\tO\\n;\\tO\\n11\\tO\\n)\\tO\\n(\\tO\\nq31\\tO\\n.\\tO\\n2\\tO\\n;\\tO\\np13\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\n2\\tO\\nyear\\tO\\nold\\tO\\nfemale\\tO\\npresenting\\tO\\nwith\\tO\\nbilateral\\tB-Disease\\nsporadic\\tI-Disease\\naniridia\\tI-Disease\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nan\\tO\\napparently\\tO\\nbalanced\\tO\\nreciprocal\\tO\\ntranslocation\\tO\\nwith\\tO\\na\\tO\\nchromosome\\tO\\n11\\tO\\nbreakpoint\\tO\\nwithin\\tO\\nband\\tO\\np13\\tO\\n.\\tO\\n\\nFluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridisation\\tO\\n(\\tO\\nFISH\\tO\\n)\\tO\\nstudies\\tO\\nwith\\tO\\ndistal\\tO\\n11p13\\tO\\nspecific\\tO\\ncosmids\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nchromosome\\tO\\n11\\tO\\nbreakpoint\\tO\\nlay\\tO\\nbetween\\tO\\nthe\\tO\\naniridia\\tB-Disease\\n(\\tO\\nPAX6\\tO\\n)\\tO\\nlocus\\tO\\nand\\tO\\na\\tO\\nregion\\tO\\napproximately\\tO\\n100\\tO\\nkb\\tO\\ndistal\\tO\\nto\\tO\\nPAX6\\tO\\ndefined\\tO\\nby\\tO\\nthe\\tO\\ncosmid\\tO\\nFO2121\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthis\\tO\\npatient\\tO\\ndid\\tO\\nnot\\tO\\nhave\\tO\\na\\tO\\ndetectable\\tO\\ndeletion\\tO\\nwithin\\tO\\nPAX6\\tO\\n,\\tO\\nher\\tO\\naniridia\\tB-Disease\\nmay\\tO\\nhave\\tO\\nresulted\\tO\\nfrom\\tO\\na\\tO\\ndisruption\\tO\\nof\\tO\\nthe\\tO\\ndistal\\tO\\nchromatin\\tO\\ndomain\\tO\\ncontaining\\tO\\neither\\tO\\nenhancers\\tO\\nor\\tO\\nregulators\\tO\\nfor\\tO\\nPAX6\\tO\\n.\\tO\\n\\nThis\\tO\\ncase\\tO\\nmay\\tO\\ntherefore\\tO\\nbe\\tO\\nanother\\tO\\nexample\\tO\\nof\\tO\\naniridia\\tB-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\nposition\\tO\\neffect\\tO\\nas\\tO\\nrecently\\tO\\ndescribed\\tO\\nin\\tO\\ntwo\\tO\\nfamilial\\tB-Disease\\naniridia\\tI-Disease\\npatients\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nphenotype\\tO\\ncosegregated\\tO\\nwith\\tO\\nchromosome\\tB-Disease\\nabnormalities\\tI-Disease\\nwith\\tO\\n11p13\\tO\\nbreakpoints\\tO\\n.\\tO\\n.\\tO\\n\\nMuscle\\tO\\nexpression\\tO\\nof\\tO\\nglucose\\tB-Disease\\n-\\tI-Disease\\n6\\tI-Disease\\n-\\tI-Disease\\nphosphate\\tI-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\ndifferent\\tO\\nvariants\\tO\\n.\\tO\\n\\nMuscle\\tO\\nexpression\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficiency\\tI-Disease\\nhas\\tO\\nbeen\\tO\\ninvestigated\\tO\\nin\\tO\\nMediterranean\\tO\\n,\\tO\\nSeattle\\tO\\n-\\tO\\nlike\\tO\\nand\\tO\\nA\\tO\\n-\\tO\\nvariants\\tO\\n.\\tO\\n\\nG6PD\\tO\\nactivity\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nsamples\\tO\\nobtained\\tO\\nfrom\\tO\\nbiopsies\\tO\\non\\tO\\nthe\\tO\\nquadriceps\\tO\\nmuscle\\tO\\nof\\tO\\nseven\\tO\\nmales\\tO\\nand\\tO\\none\\tO\\nfemale\\tO\\n.\\tO\\n\\nThe\\tO\\ntype\\tO\\nof\\tO\\ngenetic\\tO\\nvariant\\tO\\nwas\\tO\\ndetermined\\tO\\nby\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\nDNA\\tO\\n,\\tO\\nextracted\\tO\\nfrom\\tO\\nblood\\tO\\nsamples\\tO\\n.\\tO\\n\\nAll\\tO\\nvariants\\tO\\nshowed\\tO\\nthe\\tO\\nenzyme\\tO\\ndefect\\tO\\nin\\tO\\nmuscle\\tO\\n.\\tO\\n\\nA\\tO\\nstatistically\\tO\\nsignificant\\tO\\nrelationship\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nactivity\\tO\\nof\\tO\\nG6PD\\tO\\nbetween\\tO\\nerythrocytes\\tO\\nand\\tO\\nmuscle\\tO\\nof\\tO\\nthe\\tO\\nmale\\tO\\nsubjects\\tO\\n(\\tO\\nr\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n968\\tO\\n;\\tO\\np\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n00008\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nequation\\tO\\nfor\\tO\\nthe\\tO\\nbest\\tO\\nfit\\tO\\nline\\tO\\nwas\\tO\\nY\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n\\n390X\\tO\\n+\\tO\\n0\\tO\\n.\\tO\\n\\n198\\tO\\n198\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\n,\\tO\\nfor\\tO\\na\\tO\\ngiven\\tO\\nvariant\\tO\\n,\\tO\\nthe\\tO\\nextent\\tO\\nof\\tO\\nthe\\tO\\nenzyme\\tO\\ndefect\\tO\\nin\\tO\\nmuscle\\tO\\nmay\\tO\\nbe\\tO\\ndetermined\\tO\\n,\\tO\\nusing\\tO\\nthis\\tO\\nequation\\tO\\n,\\tO\\nfrom\\tO\\nthe\\tO\\nG6PD\\tO\\nactivity\\tO\\nof\\tO\\nerythrocytes\\tO\\n\\nGene\\tO\\ntherapy\\tO\\nfor\\tO\\nphenylketonuria\\tB-Disease\\n.\\tO\\n\\nClassical\\tO\\nphenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nhepatic\\tI-Disease\\nphenylalanine\\tI-Disease\\nhydroxylase\\tI-Disease\\n(\\tO\\nPAH\\tO\\n)\\tO\\n.\\tO\\n\\nLimitations\\tO\\nof\\tO\\nthe\\tO\\ncurrent\\tO\\ndietary\\tO\\ntreatment\\tO\\nfor\\tO\\nPKU\\tB-Disease\\nhave\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\npotential\\tO\\ntreatments\\tO\\nbased\\tO\\non\\tO\\nsomatic\\tO\\ngene\\tO\\ntransfer\\tO\\n.\\tO\\n\\nThree\\tO\\ndifferent\\tO\\nvector\\tO\\nsystems\\tO\\nhave\\tO\\nbeen\\tO\\nexamined\\tO\\n.\\tO\\n\\nVectors\\tO\\nderived\\tO\\nfrom\\tO\\na\\tO\\nrecombinant\\tO\\nretrovirus\\tO\\nor\\tO\\na\\tO\\nDNA\\tO\\n/\\tO\\nprotein\\tO\\ncomplex\\tO\\ncan\\tO\\nefficiently\\tO\\ntransduce\\tO\\nthe\\tO\\nPAH\\tO\\ncDNA\\tO\\ninto\\tO\\nPAH\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nhepatocytes\\tO\\nin\\tO\\nvitro\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\napplication\\tO\\nof\\tO\\nthese\\tO\\nvector\\tO\\nsystems\\tO\\nis\\tO\\npresently\\tO\\nlimited\\tO\\nby\\tO\\ntheir\\tO\\nlow\\tO\\ntransduction\\tO\\nefficiency\\tO\\nin\\tO\\nvivo\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\na\\tO\\nvector\\tO\\nderived\\tO\\nfrom\\tO\\na\\tO\\nrecombinant\\tO\\nadenovirus\\tO\\ncan\\tO\\nrestore\\tO\\n10\\tO\\n%\\tO\\n-\\tO\\n80\\tO\\n%\\tO\\nof\\tO\\nnormal\\tO\\nhepatic\\tO\\nPAH\\tO\\nactivity\\tO\\ninto\\tO\\nPAH\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nmice\\tO\\n,\\tO\\nwhich\\tO\\ncompletely\\tO\\nnormalizes\\tO\\nserum\\tO\\nphenylalanine\\tO\\nlevels\\tO\\n.\\tO\\n\\nThis\\tO\\ntreatment\\tO\\nis\\tO\\ntransient\\tO\\nand\\tO\\ncannot\\tO\\nbe\\tO\\neffectively\\tO\\nre\\tO\\n-\\tO\\nadministered\\tO\\ndue\\tO\\nto\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nneutralizing\\tO\\nantibodies\\tO\\ndirected\\tO\\nagainst\\tO\\nthe\\tO\\nrecombinant\\tO\\nadenoviral\\tO\\nvector\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthese\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nPKU\\tB-Disease\\ncan\\tO\\nbe\\tO\\ncompletely\\tO\\ncorrected\\tO\\nby\\tO\\nsomatic\\tO\\ngene\\tO\\ntherapy\\tO\\n,\\tO\\nand\\tO\\nprovide\\tO\\nsome\\tO\\ndirection\\tO\\nfor\\tO\\nthe\\tO\\nfuture\\tO\\ndevelopment\\tO\\nof\\tO\\nadenoviral\\tO\\nvectors\\tO\\n.\\tO\\n.\\tO\\n\\nExon\\tO\\n-\\tO\\nintron\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nneuronal\\tO\\nnicotinic\\tO\\nacetylcholine\\tO\\nreceptor\\tO\\nalpha\\tO\\n4\\tO\\nsubunit\\tO\\n(\\tO\\nCHRNA4\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\nneuronal\\tO\\nnicotinic\\tO\\nacetylcholine\\tO\\nreceptor\\tO\\nalpha\\tO\\n4\\tO\\nsubunit\\tO\\ngene\\tO\\n(\\tO\\nCHRNA4\\tO\\n)\\tO\\nis\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\ncandidate\\tO\\nregion\\tO\\nfor\\tO\\nthree\\tO\\ndifferent\\tO\\nphenotypes\\tO\\nbenign\\tB-Disease\\nfamilial\\tI-Disease\\nneonatal\\tI-Disease\\nconvulsions\\tI-Disease\\n,\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nnocturnal\\tI-Disease\\nfrontal\\tI-Disease\\nlobe\\tI-Disease\\nepilepsy\\tI-Disease\\n,\\tO\\nand\\tO\\nlow\\tO\\n-\\tO\\nvoltage\\tO\\nEEG\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\ntransmembrane\\tO\\ndomain\\tO\\n2\\tO\\nof\\tO\\nCHRNA4\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nnocturnal\\tI-Disease\\nfrontal\\tI-Disease\\nlobe\\tI-Disease\\nepilepsy\\tI-Disease\\nin\\tO\\none\\tO\\nextended\\tO\\npedigree\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndetermined\\tO\\nthe\\tO\\ngenomic\\tO\\norganization\\tO\\nof\\tO\\nCHRNA4\\tO\\n,\\tO\\nwhich\\tO\\nconsists\\tO\\nof\\tO\\nsix\\tO\\nexons\\tO\\ndistributed\\tO\\nover\\tO\\napproximately\\tO\\n17\\tO\\nkb\\tO\\nof\\tO\\ngenomic\\tO\\nDNA\\tO\\n.\\tO\\n\\nThe\\tO\\nnucleotide\\tO\\nsequence\\tO\\nobtained\\tO\\nfrom\\tO\\nthe\\tO\\ngenomic\\tO\\nregions\\tO\\nadjacent\\tO\\nto\\tO\\nthe\\tO\\nexon\\tO\\nboundaries\\tO\\nenabled\\tO\\nus\\tO\\nto\\tO\\ndevelop\\tO\\na\\tO\\nset\\tO\\nof\\tO\\nprimer\\tO\\npairs\\tO\\nfor\\tO\\nPCR\\tO\\namplification\\tO\\nof\\tO\\nthe\\tO\\ncomplete\\tO\\ncoding\\tO\\nregion\\tO\\n.\\tO\\n\\nThe\\tO\\nsequence\\tO\\nanalysis\\tO\\nprovides\\tO\\nthe\\tO\\nbasis\\tO\\nfor\\tO\\na\\tO\\ncomprehensive\\tO\\nmutation\\tO\\nscreening\\tO\\nof\\tO\\nCHRNA4\\tO\\nin\\tO\\nthe\\tO\\nabove\\tO\\n-\\tO\\nmentioned\\tO\\nphenotypes\\tO\\nand\\tO\\npossibly\\tO\\nin\\tO\\nother\\tO\\ntypes\\tO\\nof\\tO\\nidiopathic\\tB-Disease\\nepilepsies\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nAshkenazi\\tO\\nJewish\\tO\\npopulation\\tO\\nfrequencies\\tO\\nfor\\tO\\ncommon\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nare\\tO\\nthe\\tO\\ntwo\\tO\\nmajor\\tO\\nidentified\\tO\\ncauses\\tO\\nof\\tO\\ninherited\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nwith\\tO\\nmutations\\tO\\nin\\tO\\neither\\tO\\ngene\\tO\\nconferring\\tO\\nup\\tO\\nto\\tO\\n80\\tO\\n-\\tO\\n90\\tO\\n%\\tO\\nlifetime\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\ncarrier\\tO\\nfemales\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nBRCA1\\tO\\naccount\\tO\\nfor\\tO\\napproximately\\tO\\n45\\tO\\n%\\tO\\nof\\tO\\nfamilial\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\ninherited\\tB-Disease\\nbreast\\tI-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nwhereas\\tO\\nmutations\\tO\\nin\\tO\\nBRCA2\\tO\\naccount\\tO\\nfor\\tO\\na\\tO\\ncomparable\\tO\\npercentage\\tO\\nof\\tO\\ninherited\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\ncases\\tO\\n.\\tO\\n\\nOver\\tO\\n85\\tO\\ndistinct\\tO\\nBRCA1\\tO\\nmutations\\tO\\nand\\tO\\na\\tO\\ngrowing\\tO\\nlist\\tO\\nof\\tO\\nBRCA2\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\n,\\tO\\nwith\\tO\\nthe\\tO\\nmajority\\tO\\nresulting\\tO\\nin\\tO\\nprotein\\tO\\ntruncation\\tO\\n.\\tO\\n\\nA\\tO\\nspecific\\tO\\nBRCA1\\tO\\nmutation\\tO\\n,\\tO\\n185delAG\\tO\\n,\\tO\\nhas\\tO\\na\\tO\\nreported\\tO\\nincreased\\tO\\ncarrier\\tO\\nfrequency\\tO\\nof\\tO\\napproximately\\tO\\n0\\tO\\n.\\tO\\n\\n9\\tO\\n%\\tO\\nin\\tO\\nthe\\tO\\nAshkenazi\\tO\\nJewish\\tO\\npopulation\\tO\\n,\\tO\\nbut\\tO\\nis\\tO\\nalso\\tO\\nfound\\tO\\nin\\tO\\nrare\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\npatients\\tO\\nwith\\tO\\na\\tO\\ndifferent\\tO\\nhaplotype\\tO\\n.\\tO\\n\\nThe\\tO\\n6174delT\\tO\\nmutation\\tO\\nin\\tO\\nBRCA2\\tO\\nwas\\tO\\nrecently\\tO\\nidentified\\tO\\nas\\tO\\na\\tO\\nfrequent\\tO\\nmutation\\tO\\nin\\tO\\n8\\tO\\nout\\tO\\nof\\tO\\n107\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nwomen\\tO\\ndiagnosed\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nby\\tO\\nage\\tO\\n50\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n8\\tO\\n)\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nin\\tO\\nthree\\tO\\nAshkenazi\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nconducted\\tO\\na\\tO\\nlarge\\tO\\n-\\tO\\nscale\\tO\\npopulation\\tO\\nstudy\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\nprevalence\\tO\\nof\\tO\\nspecific\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nmutations\\tO\\nin\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nindividuals\\tO\\nwho\\tO\\nwere\\tO\\nunselected\\tO\\nfor\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nBRCA1\\tO\\nmutation\\tO\\nscreening\\tO\\non\\tO\\napproximately\\tO\\n3\\tO\\n,\\tO\\n000\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nsamples\\tO\\ndetermined\\tO\\na\\tO\\ncarrier\\tO\\nfrequency\\tO\\nof\\tO\\n1\\tO\\n.\\tO\\n\\n09\\tO\\n%\\tO\\nfor\\tO\\nthe\\tO\\n185delAG\\tO\\nmutation\\tO\\nand\\tO\\n0\\tO\\n.\\tO\\n\\n13\\tO\\n%\\tO\\nfor\\tO\\nthe\\tO\\n5382insC\\tO\\nmutation\\tO\\n.\\tO\\n\\nBRCA2\\tO\\nanalysis\\tO\\non\\tO\\n3\\tO\\n,\\tO\\n085\\tO\\nindividuals\\tO\\nfrom\\tO\\nthe\\tO\\nsame\\tO\\npopulation\\tO\\nshowed\\tO\\na\\tO\\ncarrier\\tO\\nfrequency\\tO\\nof\\tO\\n1\\tO\\n.\\tO\\n\\n52\\tO\\n%\\tO\\nfor\\tO\\nthe\\tO\\n6174delT\\tO\\nmutation\\tO\\n.\\tO\\n\\nThis\\tO\\nexpanded\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\nstudy\\tO\\nconfirms\\tO\\nthat\\tO\\nthe\\tO\\nBRCA1\\tO\\n185delAG\\tO\\nmutation\\tO\\nand\\tO\\nthe\\tO\\nBRCA2\\tO\\n6174delT\\tO\\nmutation\\tO\\nconstitute\\tO\\nthe\\tO\\ntwo\\tO\\nmost\\tO\\nfrequent\\tO\\nmutation\\tO\\nalleles\\tO\\npredisposing\\tO\\nto\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\namong\\tO\\nthe\\tO\\nAshkenazim\\tO\\n,\\tO\\nand\\tO\\nsuggests\\tO\\na\\tO\\nrelatively\\tO\\nlower\\tO\\npenetrance\\tO\\nfor\\tO\\nthe\\tO\\n6174delT\\tO\\nmutation\\tO\\nin\\tO\\nBRCA2\\tO\\n\\nDual\\tO\\nroles\\tO\\nof\\tO\\nATM\\tO\\nin\\tO\\nthe\\tO\\ncellular\\tO\\nresponse\\tO\\nto\\tO\\nradiation\\tO\\nand\\tO\\nin\\tO\\ncell\\tO\\ngrowth\\tO\\ncontrol\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nmutated\\tO\\nin\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nAT\\tB-Disease\\n)\\tO\\npatients\\tO\\n,\\tO\\ndenoted\\tO\\nATM\\tO\\n,\\tO\\nencodes\\tO\\na\\tO\\nputative\\tO\\nprotein\\tO\\nor\\tO\\nlipid\\tO\\nkinase\\tO\\n.\\tO\\n\\nTo\\tO\\nelucidate\\tO\\nthe\\tO\\nfunctions\\tO\\nof\\tO\\nATM\\tO\\n,\\tO\\nwe\\tO\\ndisrupted\\tO\\nthe\\tO\\nmouse\\tO\\nATM\\tO\\ngene\\tO\\nthrough\\tO\\nhomologous\\tO\\nrecombination\\tO\\nin\\tO\\nmice\\tO\\n.\\tO\\n\\nConsistent\\tO\\nwith\\tO\\ncellular\\tO\\ndefects\\tO\\nof\\tO\\nAT\\tB-Disease\\npatients\\tO\\n,\\tO\\nthe\\tO\\nATM\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\ncells\\tO\\nare\\tO\\nhypersensitive\\tO\\nto\\tO\\ngamma\\tO\\n-\\tO\\nirradiation\\tO\\nand\\tO\\ndefective\\tO\\nin\\tO\\ncell\\tO\\n-\\tO\\ncycle\\tO\\narrest\\tO\\nfollowing\\tO\\nradiation\\tO\\n,\\tO\\ncorrelating\\tO\\nwith\\tO\\na\\tO\\ndefective\\tO\\nup\\tO\\n-\\tO\\nregulation\\tO\\nof\\tO\\np53\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nATM\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmouse\\tO\\nthymocytes\\tO\\nare\\tO\\nmore\\tO\\nresistant\\tO\\nto\\tO\\napoptosis\\tO\\ninduced\\tO\\nby\\tO\\ngamma\\tO\\n-\\tO\\nirradiation\\tO\\nthan\\tO\\nnormal\\tO\\nthymocytes\\tO\\n.\\tO\\n\\nATM\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nfibroblasts\\tO\\nare\\tO\\ninefficient\\tO\\nin\\tO\\nG1\\tO\\nto\\tO\\nS\\tO\\n-\\tO\\nphase\\tO\\nprogression\\tO\\nfollowing\\tO\\nserum\\tO\\nstimulation\\tO\\nand\\tO\\nsenesce\\tO\\nafter\\tO\\nonly\\tO\\na\\tO\\nfew\\tO\\npassages\\tO\\nin\\tO\\nculture\\tO\\n.\\tO\\n\\nThey\\tO\\nhave\\tO\\nan\\tO\\nincreased\\tO\\nconstitutive\\tO\\nlevel\\tO\\nof\\tO\\np21CP1\\tO\\n/\\tO\\nWAF1\\tO\\n.\\tO\\n\\nThe\\tO\\nATM\\tO\\nprotein\\tO\\nis\\tO\\ntherefore\\tO\\ncritical\\tO\\nboth\\tO\\nfor\\tO\\ncellular\\tO\\nresponses\\tO\\nto\\tO\\nionizing\\tO\\nradiation\\tO\\nand\\tO\\nfor\\tO\\nnormal\\tO\\ncell\\tO\\n-\\tO\\ncycle\\tO\\nprogression\\tO\\n.\\tO\\n\\nATM\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\nfibroblasts\\tO\\nand\\tO\\nthymocytes\\tO\\nshowed\\tO\\nintermediately\\tO\\ndefective\\tO\\nresponses\\tO\\nto\\tO\\nirradiation\\tO\\nbut\\tO\\nno\\tO\\ngrowth\\tO\\ndefect\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthe\\tO\\nincreased\\tO\\ncancer\\tB-Disease\\nrisk\\tO\\nof\\tO\\nAT\\tB-Disease\\nheterozygotes\\tO\\ncould\\tO\\nbe\\tO\\nattributable\\tO\\nto\\tO\\npoor\\tO\\ncheckpoint\\tO\\nfunction\\tO\\n.\\tO\\n.\\tO\\n\\nTargeted\\tO\\ndisruption\\tO\\nof\\tO\\nATM\\tO\\nleads\\tO\\nto\\tO\\ngrowth\\tB-Disease\\nretardation\\tI-Disease\\n,\\tO\\nchromosomal\\tB-Disease\\nfragmentation\\tI-Disease\\nduring\\tI-Disease\\nmeiosis\\tI-Disease\\n,\\tO\\nimmune\\tB-Disease\\ndefects\\tI-Disease\\n,\\tO\\nand\\tO\\nthymic\\tB-Disease\\nlymphoma\\tI-Disease\\n.\\tO\\n\\nATM\\tO\\n,\\tO\\nthe\\tO\\ngene\\tO\\nmutated\\tO\\nin\\tO\\nthe\\tO\\ninherited\\tB-Disease\\nhuman\\tI-Disease\\ndisease\\tI-Disease\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n,\\tO\\nis\\tO\\na\\tO\\nmember\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\nof\\tO\\nkinases\\tO\\ninvolved\\tO\\nin\\tO\\nDNA\\tO\\nmetabolism\\tO\\nand\\tO\\ncell\\tO\\n-\\tO\\ncycle\\tO\\ncheckpoint\\tO\\ncontrol\\tO\\n.\\tO\\n\\nTo\\tO\\nhelp\\tO\\nclarify\\tO\\nthe\\tO\\nphysiological\\tO\\nroles\\tO\\nof\\tO\\nthe\\tO\\nATM\\tO\\nprotein\\tO\\n,\\tO\\nwe\\tO\\ndisrupted\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nin\\tO\\nmice\\tO\\nthrough\\tO\\nhomologous\\tO\\nrecombination\\tO\\n.\\tO\\n\\nInitial\\tO\\nevaluation\\tO\\nof\\tO\\nthe\\tO\\nATM\\tO\\nknockout\\tO\\nanimals\\tO\\nindicates\\tO\\nthat\\tO\\ninactivation\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nATM\\tO\\ngene\\tO\\nrecreates\\tO\\nmuch\\tO\\nof\\tO\\nthe\\tO\\nphenotype\\tO\\nof\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nhomozygous\\tO\\nmutant\\tO\\n(\\tO\\nATM\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\n)\\tO\\nmice\\tO\\nare\\tO\\nviable\\tO\\n,\\tO\\ngrowth\\tO\\n-\\tO\\nretarded\\tO\\n,\\tO\\nand\\tO\\ninfertile\\tO\\n.\\tO\\n\\nThe\\tO\\ninfertility\\tB-Disease\\nof\\tO\\nATM\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\nresults\\tO\\nfrom\\tO\\nmeiotic\\tO\\nfailure\\tO\\n.\\tO\\n\\nMeiosis\\tO\\nis\\tO\\narrested\\tO\\nat\\tO\\nthe\\tO\\nzygotene\\tO\\n/\\tO\\npachytene\\tO\\nstage\\tO\\nof\\tO\\nprophase\\tO\\nI\\tO\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\nabnormal\\tO\\nchromosomal\\tO\\nsynapsis\\tO\\nand\\tO\\nsubsequent\\tO\\nchromosome\\tO\\nfragmentation\\tO\\n.\\tO\\n\\nImmune\\tB-Disease\\ndefects\\tI-Disease\\nalso\\tO\\nare\\tO\\nevident\\tO\\nin\\tO\\nATM\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\n,\\tO\\nincluding\\tO\\nreduced\\tO\\nnumbers\\tO\\nof\\tO\\nB220\\tO\\n+\\tO\\nCD43\\tO\\n-\\tO\\npre\\tO\\n-\\tO\\nB\\tO\\ncells\\tO\\n,\\tO\\nthymocytes\\tO\\n,\\tO\\nand\\tO\\nperipheral\\tO\\nT\\tO\\ncells\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nfunctional\\tO\\nimpairment\\tO\\nof\\tO\\nT\\tO\\n-\\tO\\ncell\\tO\\n-\\tO\\ndependent\\tO\\nimmune\\tO\\nresponses\\tO\\n.\\tO\\n\\nThe\\tO\\ncerebella\\tO\\nof\\tO\\nATM\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\nmice\\tO\\nappear\\tO\\nnormal\\tO\\nby\\tO\\nhistologic\\tO\\nexamination\\tO\\nat\\tO\\n3\\tO\\nto\\tO\\n4\\tO\\nmonths\\tO\\nand\\tO\\nthe\\tO\\nmice\\tO\\nhave\\tO\\nno\\tO\\ngross\\tO\\nbehavioral\\tB-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nmajority\\tO\\nof\\tO\\nmutant\\tO\\nmice\\tO\\nrapidly\\tO\\ndevelop\\tO\\nthymic\\tB-Disease\\nlymphomas\\tI-Disease\\nand\\tO\\ndie\\tO\\nbefore\\tO\\n4\\tO\\nmonths\\tO\\nof\\tO\\nage\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nproduct\\tO\\nplays\\tO\\nan\\tO\\nessential\\tO\\nrole\\tO\\nin\\tO\\na\\tO\\ndiverse\\tO\\ngroup\\tO\\nof\\tO\\ncellular\\tO\\nprocesses\\tO\\n,\\tO\\nincluding\\tO\\nmeiosis\\tO\\n,\\tO\\nthe\\tO\\nnormal\\tO\\ngrowth\\tO\\nof\\tO\\nsomatic\\tO\\ntissues\\tO\\n,\\tO\\nimmune\\tO\\ndevelopment\\tO\\n,\\tO\\nand\\tO\\ntumor\\tB-Disease\\nsuppression\\tO\\n.\\tO\\n.\\tO\\n\\nCloning\\tO\\nand\\tO\\ncharacterization\\tO\\nof\\tO\\nhuman\\tO\\nvery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nacyl\\tO\\n-\\tO\\nCoA\\tO\\ndehydrogenase\\tO\\ncDNA\\tO\\n,\\tO\\nchromosomal\\tO\\nassignment\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nand\\tO\\nidentification\\tO\\nin\\tO\\nfour\\tO\\npatients\\tO\\nof\\tO\\nnine\\tO\\ndifferent\\tO\\nmutations\\tO\\nwithin\\tO\\nthe\\tO\\nVLCAD\\tO\\ngene\\tO\\n.\\tO\\n\\nVery\\tO\\n-\\tO\\nlong\\tO\\n-\\tO\\nchain\\tO\\nacyl\\tO\\n-\\tO\\nCoA\\tO\\ndehydrogenase\\tO\\n(\\tO\\nVLCAD\\tO\\n)\\tO\\nis\\tO\\none\\tO\\nof\\tO\\nfour\\tO\\nstraight\\tO\\n-\\tO\\nchain\\tO\\nacyl\\tO\\n-\\tO\\nCoA\\tO\\ndehydrogenase\\tO\\n(\\tO\\nACD\\tO\\n)\\tO\\nenzymes\\tO\\n,\\tO\\nwhich\\tO\\nare\\tO\\nall\\tO\\nnuclear\\tO\\nencoded\\tO\\nmitochondrial\\tO\\nflavoproteins\\tO\\ncatalyzing\\tO\\nthe\\tO\\ninitial\\tO\\nstep\\tO\\nin\\tO\\nfatty\\tO\\nacid\\tO\\nbeta\\tO\\n-\\tO\\noxidation\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nused\\tO\\nthe\\tO\\nvery\\tO\\nfast\\tO\\n,\\tO\\nRapid\\tO\\nAmplification\\tO\\nof\\tO\\ncDNA\\tO\\nEnds\\tO\\n(\\tO\\nRACE\\tO\\n)\\tO\\nbased\\tO\\nstrategy\\tO\\nto\\tO\\nobtain\\tO\\nthe\\tO\\nsequence\\tO\\nof\\tO\\ncDNAs\\tO\\nencoding\\tO\\nhuman\\tO\\nVLCAD\\tO\\nfrom\\tO\\nplacenta\\tO\\nand\\tO\\nfibroblasts\\tO\\n.\\tO\\n\\nAlignment\\tO\\nof\\tO\\nthe\\tO\\npredicted\\tO\\namino\\tO\\nacid\\tO\\nsequence\\tO\\nof\\tO\\nhuman\\tO\\nVLCAD\\tO\\nwith\\tO\\nthose\\tO\\nof\\tO\\nthe\\tO\\nother\\tO\\nhuman\\tO\\nACD\\tO\\nenzymes\\tO\\nrevealed\\tO\\nextensive\\tO\\nsequence\\tO\\nhomology\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nhuman\\tO\\nVLCAD\\tO\\nand\\tO\\nhuman\\tO\\nacyl\\tO\\n-\\tO\\nCoA\\tO\\noxidase\\tO\\nshowed\\tO\\nextensive\\tO\\nsequence\\tO\\nhomology\\tO\\ncorroborating\\tO\\nthe\\tO\\nnotion\\tO\\nthat\\tO\\nthese\\tO\\ngenes\\tO\\nare\\tO\\nevolutionarily\\tO\\nrelated\\tO\\n.\\tO\\n\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\nof\\tO\\ngenomic\\tO\\nDNA\\tO\\nfrom\\tO\\nhybrid\\tO\\ncell\\tO\\nlines\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nlocalize\\tO\\nthe\\tO\\nVLCAD\\tO\\ngene\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\n17p11\\tO\\n.\\tO\\n\\n2\\tO\\n-\\tO\\np11\\tO\\n.\\tO\\n\\n13105\\tO\\n.\\tO\\n\\nUsing\\tO\\nNorthern\\tO\\nand\\tO\\nWestern\\tO\\nblot\\tO\\nanalysis\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\ntissue\\tO\\nspecific\\tO\\ndistribution\\tO\\nof\\tO\\nVLCAD\\tO\\nmRNA\\tO\\nand\\tO\\nprotein\\tO\\nin\\tO\\nseveral\\tO\\nhuman\\tO\\ntissues\\tO\\nwe\\tO\\nshowed\\tO\\nthat\\tO\\nVLCAD\\tO\\nis\\tO\\nmost\\tO\\nabundant\\tO\\nin\\tO\\nheart\\tO\\nand\\tO\\nskeletal\\tO\\nmuscle\\tO\\n.\\tO\\n\\nThis\\tO\\nagrees\\tO\\nwell\\tO\\nwith\\tO\\nthe\\tO\\nfact\\tO\\nthat\\tO\\ncardiac\\tO\\nand\\tO\\nmuscle\\tO\\nsymptoms\\tO\\nare\\tO\\ncharacteristic\\tO\\nfor\\tO\\npatients\\tO\\nwith\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nNorthern\\tO\\nblot\\tO\\nanalysis\\tO\\nand\\tO\\nsequencing\\tO\\nof\\tO\\ncloned\\tO\\nPCR\\tO\\namplified\\tO\\nVLCAD\\tO\\ncDNA\\tO\\nfrom\\tO\\nfour\\tO\\nunrelated\\tO\\npatients\\tO\\nwith\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\nshowed\\tO\\nthat\\tO\\nVLCAD\\tO\\nmRNA\\tO\\nwas\\tO\\nundetectable\\tO\\nin\\tO\\none\\tO\\npatient\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\nother\\tO\\nthree\\tO\\nhave\\tO\\nmutations\\tO\\nin\\tO\\nboth\\tO\\nVLCAD\\tO\\nalleles\\tO\\n.\\tO\\n\\nWestern\\tO\\nblot\\tO\\nanalysis\\tO\\nof\\tO\\npatient\\tO\\nfibroblasts\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nidentified\\tO\\nmutations\\tO\\nresult\\tO\\nin\\tO\\nseverely\\tO\\nreduced\\tO\\namounts\\tO\\nof\\tO\\nVLCAD\\tO\\nprotein\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbases\\tO\\nof\\tO\\ncombined\\tB-Disease\\nsubtotal\\tI-Disease\\ndeficiencies\\tI-Disease\\nof\\tI-Disease\\nC6\\tI-Disease\\nand\\tI-Disease\\nC7\\tI-Disease\\n:\\tO\\ntheir\\tO\\neffects\\tO\\nin\\tO\\ncombination\\tO\\nwith\\tO\\nother\\tO\\nC6\\tB-Disease\\nand\\tI-Disease\\nC7\\tI-Disease\\ndeficiencies\\tI-Disease\\n.\\tO\\n\\nCombined\\tB-Disease\\nsubtotal\\tI-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nC6\\tI-Disease\\nand\\tI-Disease\\nC7\\tI-Disease\\n,\\tO\\nin\\tO\\nwhich\\tO\\nboth\\tO\\nproteins\\tO\\nare\\tO\\nexpressed\\tO\\nat\\tO\\nvery\\tO\\nlow\\tO\\nlevels\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nobserved\\tO\\nin\\tO\\nhomozygous\\tO\\nform\\tO\\nin\\tO\\ntwo\\tO\\nfamilies\\tO\\n.\\tO\\n\\nA\\tO\\ndefect\\tO\\nat\\tO\\nthe\\tO\\n5\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n15\\tO\\nof\\tO\\nthe\\tO\\nC6\\tO\\ngene\\tO\\nexplains\\tO\\nthe\\tO\\nlow\\tO\\nmolecular\\tO\\nweight\\tO\\nof\\tO\\nthe\\tO\\nC6\\tO\\nprotein\\tO\\nand\\tO\\nis\\tO\\nprobably\\tO\\nresponsible\\tO\\nfor\\tO\\nits\\tO\\nlow\\tO\\nexpressed\\tO\\nconcentration\\tO\\n.\\tO\\n\\nThe\\tO\\nC7\\tO\\ndefect\\tO\\nis\\tO\\nmore\\tO\\nenigmatic\\tO\\nthe\\tO\\nprotein\\tO\\nis\\tO\\nof\\tO\\nnormal\\tO\\nmolecular\\tO\\nweight\\tO\\n,\\tO\\nlow\\tO\\ncirculating\\tO\\nconcentration\\tO\\n,\\tO\\nand\\tO\\naltered\\tO\\nisoelectric\\tO\\npoint\\tO\\n.\\tO\\n\\nAn\\tO\\nArg\\tO\\n>\\tO\\nSer\\tO\\ncodon\\tO\\nsubstitution\\tO\\nin\\tO\\nexon\\tO\\n11\\tO\\nis\\tO\\nthe\\tO\\nonly\\tO\\nmolecular\\tO\\nalteration\\tO\\nwithin\\tO\\nthe\\tO\\nmature\\tO\\nC7\\tO\\nprotein\\tO\\n.\\tO\\n\\nThese\\tO\\ndefects\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\ncharacteristic\\tO\\nset\\tO\\nof\\tO\\npolymorphic\\tO\\nDNA\\tO\\nmarkers\\tO\\nin\\tO\\nthe\\tO\\nC6\\tO\\n/\\tO\\nC7\\tO\\nregion\\tO\\n,\\tO\\nforming\\tO\\na\\tO\\ndistinct\\tO\\nhaplotype\\tO\\n.\\tO\\n\\nThe\\tO\\nhaplotype\\tO\\nhas\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\ncombination\\tO\\nwith\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nother\\tO\\nhaplotypes\\tO\\ncontaining\\tO\\ndefective\\tO\\ngenes\\tO\\nthat\\tO\\nlead\\tO\\neither\\tO\\nto\\tO\\nC6\\tB-Disease\\nor\\tI-Disease\\nC7\\tI-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nbut\\tO\\nwith\\tO\\ndifferent\\tO\\nconsequences\\tO\\n.\\tO\\n\\nWhere\\tO\\nit\\tO\\nis\\tO\\ncombined\\tO\\nwith\\tO\\na\\tO\\nC6\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\ngene\\tO\\n,\\tO\\nthe\\tO\\nserum\\tO\\nC7\\tO\\nlevels\\tO\\ncan\\tO\\nbe\\tO\\nsurprisingly\\tO\\nhigh\\tO\\n,\\tO\\npossibly\\tO\\nbecause\\tO\\nthere\\tO\\nis\\tO\\nno\\tO\\nC6\\tO\\ngenerating\\tO\\nC56\\tO\\nto\\tO\\nconsume\\tO\\nthe\\tO\\nC7\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nwhere\\tO\\nthe\\tO\\nC7\\tO\\ngenes\\tO\\nare\\tO\\nboth\\tO\\ndefective\\tO\\n(\\tO\\nbut\\tO\\nstill\\tO\\npartially\\tO\\nfunctional\\tO\\n)\\tO\\n,\\tO\\nthere\\tO\\nmay\\tO\\nbe\\tO\\na\\tO\\nprofound\\tO\\ndeficit\\tO\\nof\\tO\\ncirculating\\tO\\nC7\\tO\\nbecause\\tO\\nthere\\tO\\nis\\tO\\nample\\tO\\nC6\\tO\\nto\\tO\\nproduce\\tO\\nC56\\tO\\nand\\tO\\nconsume\\tO\\nthe\\tO\\nalready\\tO\\nsmall\\tO\\namount\\tO\\nof\\tO\\nC7\\tO\\n.\\tO\\n\\nEach\\tO\\nmolecular\\tO\\ndefect\\tO\\nhas\\tO\\nalso\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\nisolation\\tO\\nand\\tO\\nhas\\tO\\nthe\\tO\\nexpected\\tO\\neffect\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nbases\\tO\\nof\\tO\\nhuman\\tO\\ncomplement\\tB-Disease\\nC7\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nComplement\\tB-Disease\\nC7\\tI-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nC7D\\tB-Disease\\n)\\tO\\nis\\tO\\nassociated\\tO\\nfrequently\\tO\\nwith\\tO\\nrecurrent\\tO\\nbacterial\\tB-Disease\\ninfections\\tI-Disease\\n,\\tO\\nespecially\\tO\\nmeningitis\\tB-Disease\\ncaused\\tO\\nby\\tO\\nNeisseria\\tB-Disease\\nmeningitidis\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nin\\tO\\nthis\\tO\\nwork\\tO\\nthe\\tO\\nmolecular\\tO\\nbases\\tO\\nof\\tO\\nC7D\\tB-Disease\\nin\\tO\\ntwo\\tO\\nunrelated\\tO\\nJapanese\\tO\\nmales\\tO\\n.\\tO\\n\\nWe\\tO\\nused\\tO\\nexon\\tO\\n-\\tO\\nspecific\\tO\\nPCR\\tO\\n/\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\nanalysis\\tO\\nas\\tO\\na\\tO\\nscreening\\tO\\nstep\\tO\\nfor\\tO\\nmutations\\tO\\n.\\tO\\n\\nSubsequent\\tO\\ndirect\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\ntarget\\tO\\nexons\\tO\\nidentified\\tO\\nhomozygous\\tO\\nmutations\\tO\\nin\\tO\\nexon\\tO\\n16\\tO\\nof\\tO\\ncase\\tO\\n1\\tO\\nand\\tO\\nin\\tO\\nexon\\tO\\n15\\tO\\nof\\tO\\ncase\\tO\\n2\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nof\\tO\\ncase\\tO\\n1\\tO\\nwas\\tO\\na\\tO\\nhomozygous\\tO\\nT\\tO\\nto\\tO\\nA\\tO\\ntransversion\\tO\\nat\\tO\\nnucleotide\\tO\\n2250\\tO\\n,\\tO\\nthe\\tO\\nthird\\tO\\nnucleotide\\tO\\nof\\tO\\nthe\\tO\\ncodon\\tO\\nTGT\\tO\\nfor\\tO\\nCys728\\tO\\n,\\tO\\nleading\\tO\\nto\\tO\\na\\tO\\nstop\\tO\\ncodon\\tO\\nTGA\\tO\\n(\\tO\\nC728X\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\ncase\\tO\\n2\\tO\\n,\\tO\\na\\tO\\nhomozygous\\tO\\n2\\tO\\n-\\tO\\nbp\\tO\\ndeletion\\tO\\n(\\tO\\n2137delTG\\tO\\n/\\tO\\n2138delGT\\tO\\n/\\tO\\n2139delTG\\tO\\n)\\tO\\ncaused\\tO\\na\\tO\\nframeshift\\tO\\n,\\tO\\ngenerating\\tO\\na\\tO\\npremature\\tO\\ntermination\\tO\\ncodon\\tO\\n4\\tO\\nto\\tO\\n6\\tO\\nnucleotides\\tO\\ndownstream\\tO\\n.\\tO\\n\\nFamily\\tO\\nstudy\\tO\\nin\\tO\\ncase\\tO\\n1\\tO\\nconfirmed\\tO\\nthe\\tO\\ngenetic\\tO\\nnature\\tO\\nof\\tO\\nthe\\tO\\ndefect\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nwe\\tO\\ndetected\\tO\\na\\tO\\nnovel\\tO\\npolymorphism\\tO\\nin\\tO\\nintron\\tO\\n11\\tO\\nthat\\tO\\npresumably\\tO\\nis\\tO\\nlinked\\tO\\nto\\tO\\nthe\\tO\\nmutation\\tO\\nresponsible\\tO\\nfor\\tO\\nC7D\\tB-Disease\\nin\\tO\\ncase\\tO\\n1\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nC7D\\tB-Disease\\nis\\tO\\nheterogeneous\\tO\\nlike\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\nother\\tO\\ndeficiencies\\tB-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\ncomponents\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nHPRT\\tB-Disease\\n-\\tI-Disease\\nAPRT\\tI-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nmice\\tO\\nare\\tO\\nnot\\tO\\na\\tO\\nmodel\\tO\\nfor\\tO\\nlesch\\tB-Disease\\n-\\tI-Disease\\nnyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nComplete\\tB-Disease\\nhypoxanthine\\tI-Disease\\n-\\tI-Disease\\nguanine\\tI-Disease\\nphosphoribosyl\\tI-Disease\\n-\\tI-Disease\\ntransferase\\tI-Disease\\n(\\tI-Disease\\nHPRT\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nhumans\\tO\\nresults\\tO\\nin\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\nwhich\\tO\\nis\\tO\\ncharacterized\\tO\\n,\\tO\\namong\\tO\\nother\\tO\\nfeatures\\tO\\n,\\tO\\nby\\tO\\ncompulsive\\tO\\nself\\tO\\n-\\tO\\ninjurious\\tO\\nbehavior\\tO\\n.\\tO\\n\\nHPRT\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nmice\\tO\\ngenerated\\tO\\nusing\\tO\\nmouse\\tO\\nembryonic\\tO\\nstem\\tO\\ncells\\tO\\nexhibit\\tO\\nnone\\tO\\nof\\tO\\nthe\\tO\\nbehavioral\\tO\\nsymptoms\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nAdministration\\tO\\nof\\tO\\ndrugs\\tO\\nthat\\tO\\ninhibit\\tO\\nadenine\\tO\\nphosphoribosyltransferase\\tO\\n(\\tO\\nAPRT\\tO\\n)\\tO\\nin\\tO\\nHPRT\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nmice\\tO\\nhas\\tO\\nproduced\\tO\\nthe\\tO\\nsuggestion\\tO\\nthat\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nAPRT\\tI-Disease\\nin\\tO\\ncombination\\tO\\nwith\\tO\\nHPRT\\tB-Disease\\n-\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nmice\\tO\\nmay\\tO\\nlead\\tO\\nto\\tO\\nself\\tO\\n-\\tO\\nmutilation\\tO\\nbehavior\\tO\\n[\\tO\\nC\\tO\\n.\\tO\\nL\\tO\\n.\\tO\\nWu\\tO\\nand\\tO\\nD\\tO\\n.\\tO\\nW\\tO\\n.\\tO\\nMelton\\tO\\n(\\tO\\n1993\\tO\\n)\\tO\\nNature\\tO\\nGenet\\tO\\n.\\tO\\n3\\tO\\n,\\tO\\n235\\tO\\n-\\tO\\n240\\tO\\n]\\tO\\n.\\tO\\n\\nTo\\tO\\ntest\\tO\\nthis\\tO\\nproposition\\tO\\n,\\tO\\nwe\\tO\\nbred\\tO\\nHPRT\\tB-Disease\\n-\\tI-Disease\\nAPRT\\tI-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nmice\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\ndoubly\\tO\\n-\\tO\\ndeficient\\tO\\nmice\\tO\\nexcrete\\tO\\nadenine\\tO\\nand\\tO\\nits\\tO\\nhighly\\tO\\ninsoluble\\tO\\nderivative\\tO\\n,\\tO\\n2\\tO\\n,\\tO\\n8\\tO\\n-\\tO\\ndihydroxyadenine\\tO\\n,\\tO\\nwhich\\tO\\nare\\tO\\nalso\\tO\\nassociated\\tO\\nwith\\tO\\nhuman\\tO\\nAPRT\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nadditional\\tO\\nabnormalities\\tO\\nor\\tO\\nany\\tO\\nself\\tO\\n-\\tO\\ninjurious\\tO\\nbehavior\\tO\\nwere\\tO\\nnot\\tO\\ndetected\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nAPRT\\tB-Disease\\n-\\tI-Disease\\nHPRT\\tI-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nmice\\tO\\n,\\tO\\nwhich\\tO\\nare\\tO\\ndevoid\\tO\\nof\\tO\\nany\\tO\\npurine\\tO\\nsalvage\\tO\\npathways\\tO\\n,\\tO\\nshow\\tO\\nno\\tO\\nnovel\\tO\\nphenotype\\tO\\nand\\tO\\nare\\tO\\nnot\\tO\\na\\tO\\nmodel\\tO\\nfor\\tO\\nthe\\tO\\nbehavioral\\tB-Disease\\nabnormalities\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nLesch\\tB-Disease\\n-\\tI-Disease\\nNyhan\\tI-Disease\\nsyndrome\\tI-Disease\\nas\\tO\\npreviously\\tO\\nsuggested\\tO\\n\\nSomatic\\tO\\nalterations\\tO\\nof\\tO\\nthe\\tO\\nDPC4\\tO\\ngene\\tO\\nin\\tO\\nhuman\\tO\\ncolorectal\\tB-Disease\\ncancers\\tI-Disease\\nin\\tO\\nvivo\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\n&\\tO\\nAIMS\\tO\\nThe\\tO\\nchromosome\\tO\\nregion\\tO\\n18q21\\tO\\nhas\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\nfrequently\\tO\\ndeleted\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncancers\\tI-Disease\\n,\\tO\\nand\\tO\\nsuch\\tO\\nfrequent\\tO\\nallelic\\tO\\nloss\\tO\\nis\\tO\\na\\tO\\nhallmark\\tO\\nof\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\ntumor\\tO\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nDPC4\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nlocated\\tO\\nat\\tO\\n18q21\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nas\\tO\\na\\tO\\ntumor\\tO\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\nfrom\\tO\\nexamination\\tO\\nof\\tO\\npancreatic\\tB-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\naim\\tO\\nof\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\nwas\\tO\\nto\\tO\\ndetermine\\tO\\nif\\tO\\nit\\tO\\nmight\\tO\\nalso\\tO\\nbe\\tO\\naltered\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nMETHODS\\tO\\nMutation\\tO\\nanalyses\\tO\\nof\\tO\\nthe\\tO\\nDPC4\\tO\\ngene\\tO\\nwere\\tO\\nperformed\\tO\\non\\tO\\ncomplementary\\tO\\nDNA\\tO\\nsamples\\tO\\nfrom\\tO\\n31\\tO\\nprimary\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nspecimens\\tO\\nusing\\tO\\na\\tO\\ncombination\\tO\\nof\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n,\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n,\\tO\\nand\\tO\\nDNA\\tO\\nsequencing\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nFour\\tO\\nmissense\\tO\\nmutations\\tO\\nproducing\\tO\\namino\\tO\\nacid\\tO\\nsubstitutions\\tO\\nand\\tO\\na\\tO\\nsomatic\\tO\\n12\\tO\\n-\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nDPC4\\tO\\ngene\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\n31\\tO\\ncancers\\tB-Disease\\n(\\tO\\n16\\tO\\n%\\tO\\n;\\tO\\n5\\tO\\nof\\tO\\n31\\tO\\n)\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nThe\\tO\\nDPC4\\tO\\ngene\\tO\\nmay\\tO\\nplay\\tO\\na\\tO\\nrole\\tO\\nas\\tO\\na\\tO\\ntumor\\tO\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nfraction\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ncancers\\tI-Disease\\n;\\tO\\nhowever\\tO\\n,\\tO\\nwhile\\tO\\nallelic\\tO\\nloss\\tO\\nat\\tO\\n18q21\\tO\\nis\\tO\\nvery\\tO\\noften\\tO\\nseen\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncancers\\tI-Disease\\n,\\tO\\nonly\\tO\\na\\tO\\nminority\\tO\\nshow\\tO\\nDPC4\\tO\\nmutations\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthere\\tO\\nmight\\tO\\nbe\\tO\\nanother\\tO\\ntumor\\tO\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\nin\\tO\\nthis\\tO\\nchromosome\\tO\\nregion\\tO\\n.\\tO\\n.\\tO\\n\\nPleiotropic\\tO\\ndefects\\tO\\nin\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nprotein\\tO\\n-\\tO\\ndeficient\\tO\\nmice\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ngenerated\\tO\\na\\tO\\nmouse\\tO\\nmodel\\tO\\nfor\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nby\\tO\\nusing\\tO\\ngene\\tO\\ntargeting\\tO\\nto\\tO\\ngenerate\\tO\\nmice\\tO\\nthat\\tO\\ndo\\tO\\nnot\\tO\\nexpress\\tO\\nthe\\tO\\nAtm\\tO\\nprotein\\tO\\n.\\tO\\n\\nAtm\\tO\\n-\\tO\\ndeficient\\tO\\nmice\\tO\\nare\\tO\\nretarded\\tO\\nin\\tO\\ngrowth\\tO\\n,\\tO\\ndo\\tO\\nnot\\tO\\nproduce\\tO\\nmature\\tO\\nsperm\\tO\\n,\\tO\\nand\\tO\\nexhibit\\tO\\nsevere\\tO\\ndefects\\tO\\nin\\tO\\nT\\tO\\ncell\\tO\\nmaturation\\tO\\nwhile\\tO\\ngoing\\tO\\non\\tO\\nto\\tO\\ndevelop\\tO\\nthymomas\\tB-Disease\\n.\\tO\\n\\nAtm\\tO\\n-\\tO\\ndeficient\\tO\\nfibroblasts\\tO\\ngrow\\tO\\npoorly\\tO\\nin\\tO\\nculture\\tO\\nand\\tO\\ndisplay\\tO\\na\\tO\\nhigh\\tO\\nlevel\\tO\\nof\\tO\\ndouble\\tO\\n-\\tO\\nstranded\\tO\\nchromosome\\tO\\nbreaks\\tO\\n.\\tO\\n\\nAtm\\tO\\n-\\tO\\ndeficient\\tO\\nthymocytes\\tO\\nundergo\\tO\\nspontaneous\\tO\\napoptosis\\tO\\nin\\tO\\nvitro\\tO\\nsignificantly\\tO\\nmore\\tO\\nthan\\tO\\ncontrols\\tO\\n.\\tO\\n\\nAtm\\tO\\n-\\tO\\ndeficient\\tO\\nmice\\tO\\nthen\\tO\\nexhibit\\tO\\nmany\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\nsymptoms\\tO\\nfound\\tO\\nin\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\npatients\\tO\\nand\\tO\\nin\\tO\\ncells\\tO\\nderived\\tO\\nfrom\\tO\\nthem\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nwe\\tO\\ndemonstrate\\tO\\nthat\\tO\\nthe\\tO\\nAtm\\tO\\nprotein\\tO\\nexists\\tO\\nas\\tO\\ntwo\\tO\\ndiscrete\\tO\\nmolecular\\tO\\nspecies\\tO\\n,\\tO\\nand\\tO\\nthat\\tO\\nloss\\tO\\nof\\tO\\none\\tO\\nor\\tO\\nof\\tO\\nboth\\tO\\nof\\tO\\nthese\\tO\\ncan\\tO\\nlead\\tO\\nto\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nDCC\\tO\\nprotein\\tO\\nand\\tO\\nprognosis\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nBACKGROUND\\tO\\nAllelic\\tO\\nloss\\tO\\nof\\tO\\nchromosome\\tO\\n18q\\tO\\npredicts\\tO\\na\\tO\\npoor\\tO\\noutcome\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nstage\\tB-Disease\\nII\\tI-Disease\\ncolorectal\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\nspecific\\tO\\ngene\\tO\\ninactivated\\tO\\nby\\tO\\nthis\\tO\\nallelic\\tO\\nloss\\tO\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\nelucidated\\tO\\n,\\tO\\nthe\\tO\\nDCC\\tO\\n(\\tO\\ndeleted\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n)\\tO\\ngene\\tO\\nis\\tO\\na\\tO\\ncandidate\\tO\\n.\\tO\\n\\nWe\\tO\\ninvestigated\\tO\\nwhether\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nDCC\\tO\\nprotein\\tO\\nin\\tO\\ntumor\\tB-Disease\\ncells\\tO\\nis\\tO\\na\\tO\\nprognostic\\tO\\nmarker\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncarcinoma\\tI-Disease\\n.\\tO\\n\\nMETHODS\\tO\\nThe\\tO\\nexpression\\tO\\nof\\tO\\nDCC\\tO\\nwas\\tO\\nevaluated\\tO\\nimmunohistochemically\\tO\\nin\\tO\\n132\\tO\\nparaffin\\tO\\n-\\tO\\nembedded\\tO\\nsamples\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\ncuratively\\tO\\nresected\\tO\\nstage\\tB-Disease\\nII\\tI-Disease\\nand\\tI-Disease\\nIII\\tI-Disease\\ncolorectal\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nCox\\tO\\nproportional\\tO\\n-\\tO\\nhazards\\tO\\nmodel\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nadjust\\tO\\nfor\\tO\\ncovariates\\tO\\nincluding\\tO\\nage\\tO\\n,\\tO\\nsex\\tO\\n,\\tO\\ntumor\\tB-Disease\\nsite\\tO\\n,\\tO\\ndegree\\tO\\nof\\tO\\ntumor\\tB-Disease\\ndifferentiation\\tO\\n,\\tO\\nand\\tO\\nuse\\tO\\nof\\tO\\nadjuvant\\tO\\ntherapy\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nThe\\tO\\nexpression\\tO\\nof\\tO\\nDCC\\tO\\nwas\\tO\\na\\tO\\nstrong\\tO\\npositive\\tO\\npredictive\\tO\\nfactor\\tO\\nfor\\tO\\nsurvival\\tO\\nin\\tO\\nboth\\tO\\nstage\\tB-Disease\\nII\\tI-Disease\\nand\\tI-Disease\\nstage\\tI-Disease\\nIII\\tI-Disease\\ncolorectal\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\npatients\\tO\\nwith\\tO\\nstage\\tO\\nII\\tO\\ndisease\\tO\\nwhose\\tO\\ntumors\\tB-Disease\\nexpressed\\tO\\nDCC\\tO\\n,\\tO\\nthe\\tO\\nfive\\tO\\n-\\tO\\nyear\\tO\\nsurvival\\tO\\nrate\\tO\\nwas\\tO\\n94\\tO\\n.\\tO\\n\\n3\\tO\\npercent\\tO\\n,\\tO\\nwhereas\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nDCC\\tB-Disease\\n-\\tI-Disease\\nnegative\\tI-Disease\\ntumors\\tI-Disease\\n,\\tO\\nthe\\tO\\nsurvival\\tO\\nrate\\tO\\nwas\\tO\\n61\\tO\\n.\\tO\\n\\n6\\tO\\npercent\\tO\\n(\\tO\\nP\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n001\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\npatients\\tO\\nwith\\tO\\nstage\\tB-Disease\\nIII\\tI-Disease\\ndisease\\tI-Disease\\n,\\tO\\nthe\\tO\\nrespective\\tO\\nsurvival\\tO\\nrates\\tO\\nwere\\tO\\n59\\tO\\n.\\tO\\n\\n3\\tO\\npercent\\tO\\nand\\tO\\n33\\tO\\n.\\tO\\n\\n2\\tO\\npercent\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n03\\tO\\n)\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nDCC\\tO\\nis\\tO\\na\\tO\\nprognostic\\tO\\nmarker\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nstage\\tB-Disease\\nII\\tI-Disease\\nor\\tI-Disease\\nstage\\tI-Disease\\nIII\\tI-Disease\\ncolorectal\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nstage\\tB-Disease\\nII\\tI-Disease\\ncolorectal\\tI-Disease\\ncarcinomas\\tI-Disease\\n,\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nDCC\\tO\\nidentifies\\tO\\na\\tO\\nsubgroup\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nlesions\\tO\\nthat\\tO\\nbehave\\tO\\nlike\\tO\\nstage\\tB-Disease\\nIII\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nmay\\tO\\nthus\\tO\\nhave\\tO\\ntherapeutic\\tO\\nimplications\\tO\\nin\\tO\\nthis\\tO\\ngroup\\tO\\nof\\tO\\npatients\\tO\\n\\nAssociation\\tO\\nof\\tO\\nanxiety\\tB-Disease\\n-\\tI-Disease\\nrelated\\tI-Disease\\ntraits\\tI-Disease\\nwith\\tO\\na\\tO\\npolymorphism\\tO\\nin\\tO\\nthe\\tO\\nserotonin\\tO\\ntransporter\\tO\\ngene\\tO\\nregulatory\\tO\\nregion\\tO\\n.\\tO\\n\\nTransporter\\tO\\n-\\tO\\nfacilitated\\tO\\nuptake\\tO\\nof\\tO\\nserotonin\\tO\\n(\\tO\\n5\\tO\\n-\\tO\\nhydroxytryptamine\\tO\\nor\\tO\\n5\\tO\\n-\\tO\\nHT\\tO\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nimplicated\\tO\\nin\\tO\\nanxiety\\tB-Disease\\nin\\tO\\nhumans\\tO\\nand\\tO\\nanimal\\tO\\nmodels\\tO\\nand\\tO\\nis\\tO\\nthe\\tO\\nsite\\tO\\nof\\tO\\naction\\tO\\nof\\tO\\nwidely\\tO\\nused\\tO\\nuptake\\tO\\n-\\tO\\ninhibiting\\tO\\nantidepressant\\tO\\nand\\tO\\nantianxiety\\tO\\ndrugs\\tO\\n.\\tO\\n\\nHuman\\tO\\n5\\tO\\n-\\tO\\nHT\\tO\\ntransporter\\tO\\n(\\tO\\n5\\tO\\n-\\tO\\nHTT\\tO\\n)\\tO\\ngene\\tO\\ntranscription\\tO\\nis\\tO\\nmodulated\\tO\\nby\\tO\\na\\tO\\ncommon\\tO\\npolymorphism\\tO\\nin\\tO\\nits\\tO\\nupstream\\tO\\nregulatory\\tO\\nregion\\tO\\n.\\tO\\n\\nThe\\tO\\nshort\\tO\\nvariant\\tO\\nof\\tO\\nthe\\tO\\npolymorphism\\tO\\nreduces\\tO\\nthe\\tO\\ntranscriptional\\tO\\nefficiency\\tO\\nof\\tO\\nthe\\tO\\n5\\tO\\n-\\tO\\nHTT\\tO\\ngene\\tO\\npromoter\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\ndecreased\\tO\\n5\\tO\\n-\\tO\\nHTT\\tO\\nexpression\\tO\\nand\\tO\\n5\\tO\\n-\\tO\\nHT\\tO\\nuptake\\tO\\nin\\tO\\nlymphoblasts\\tO\\n.\\tO\\n\\nAssociation\\tO\\nstudies\\tO\\nin\\tO\\ntwo\\tO\\nindependent\\tO\\nsamples\\tO\\ntotaling\\tO\\n505\\tO\\nindividuals\\tO\\nrevealed\\tO\\nthat\\tO\\nthe\\tO\\n5\\tO\\n-\\tO\\nHTT\\tO\\npolymorphism\\tO\\naccounts\\tO\\nfor\\tO\\n3\\tO\\nto\\tO\\n4\\tO\\npercent\\tO\\nof\\tO\\ntotal\\tO\\nvariation\\tO\\nand\\tO\\n7\\tO\\nto\\tO\\n9\\tO\\npercent\\tO\\nof\\tO\\ninherited\\tO\\nvariance\\tO\\nin\\tO\\nanxiety\\tB-Disease\\n-\\tI-Disease\\nrelated\\tI-Disease\\npersonality\\tI-Disease\\ntraits\\tI-Disease\\nin\\tO\\nindividuals\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nsibships\\tO\\n.\\tO\\n.\\tO\\n\\nPhenotypic\\tO\\nand\\tO\\ngenotypic\\tO\\noverlap\\tO\\nbetween\\tO\\natelosteogenesis\\tB-Disease\\ntype\\tI-Disease\\n2\\tI-Disease\\nand\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\nsulfate\\tO\\ntransporter\\tO\\ngene\\tO\\nDTDST\\tO\\nhave\\tO\\nbeen\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nfamily\\tO\\nof\\tO\\nchondrodysplasias\\tB-Disease\\nthat\\tO\\ncomprises\\tO\\n,\\tO\\nin\\tO\\norder\\tO\\nof\\tO\\nincreasing\\tO\\nseverity\\tO\\n,\\tO\\ndiastrophic\\tB-Disease\\ndysplasia\\tI-Disease\\n(\\tO\\nDTD\\tB-Disease\\n)\\tO\\n,\\tO\\natelosteogenesis\\tB-Disease\\ntype\\tI-Disease\\n2\\tI-Disease\\n(\\tO\\nAO2\\tB-Disease\\n)\\tO\\n,\\tO\\nand\\tO\\nachondrogenesis\\tB-Disease\\ntype\\tI-Disease\\n1B\\tI-Disease\\n(\\tO\\nACG1B\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\nlearn\\tO\\nmore\\tO\\nabout\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nDTDST\\tB-Disease\\nchondrodysplasias\\tI-Disease\\nand\\tO\\nabout\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\n,\\tO\\nwe\\tO\\nstudied\\tO\\nfibroblast\\tO\\ncultures\\tO\\nof\\tO\\nthree\\tO\\nnew\\tO\\npatients\\tO\\none\\tO\\nwith\\tO\\nAO\\tB-Disease\\n-\\tI-Disease\\n2\\tI-Disease\\n,\\tO\\none\\tO\\nwith\\tO\\nDTD\\tB-Disease\\n,\\tO\\nand\\tO\\none\\tO\\nwith\\tO\\nan\\tO\\nintermediate\\tO\\nphenotype\\tO\\n(\\tO\\nAO2\\tB-Disease\\n/\\tO\\nDTD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nReduced\\tO\\nincorporation\\tO\\nof\\tO\\ninorganic\\tO\\nsulfate\\tO\\ninto\\tO\\nmacromolecules\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nall\\tO\\nthree\\tO\\n.\\tO\\n\\nEach\\tO\\nof\\tO\\nthe\\tO\\nthree\\tO\\npatients\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nheterozygous\\tO\\nfor\\tO\\na\\tO\\nc862t\\tO\\ntransition\\tO\\npredicting\\tO\\na\\tO\\nR279W\\tO\\nsubstitution\\tO\\nin\\tO\\nthe\\tO\\nthird\\tO\\nextracellular\\tO\\nloop\\tO\\nof\\tO\\nDTDST\\tO\\n.\\tO\\n\\nIn\\tO\\ntwo\\tO\\npatients\\tO\\n(\\tO\\nDTD\\tB-Disease\\nand\\tO\\nAO2\\tB-Disease\\n/\\tO\\nDTD\\tB-Disease\\n)\\tO\\n,\\tO\\nno\\tO\\nother\\tO\\nstructural\\tO\\nmutation\\tO\\nwas\\tO\\nfound\\tO\\n,\\tO\\nbut\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\namplification\\tO\\nand\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\nanalysis\\tO\\nof\\tO\\nfibroblast\\tO\\ncDNA\\tO\\nshowed\\tO\\nreduced\\tO\\nmRNA\\tO\\nlevels\\tO\\nof\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nDTDST\\tO\\nallele\\tO\\nthese\\tO\\ntwo\\tO\\npatients\\tO\\nmay\\tO\\nbe\\tO\\ncompound\\tO\\nheterozygotes\\tO\\nfor\\tO\\nthe\\tO\\n\"\\tO\\nFinnish\\tO\\n\"\\tO\\nmutation\\tO\\n(\\tO\\nas\\tO\\nyet\\tO\\nuncharacterized\\tO\\nat\\tO\\nthe\\tO\\nDNA\\tO\\nlevel\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\ncauses\\tO\\nreduced\\tO\\nexpression\\tO\\nof\\tO\\nDTDST\\tO\\n.\\tO\\n\\nThe\\tO\\nthird\\tO\\npatient\\tO\\n(\\tO\\nwith\\tO\\nAO2\\tB-Disease\\n)\\tO\\nhad\\tO\\nthe\\tO\\nR279W\\tO\\nmutation\\tO\\ncompounded\\tO\\nwith\\tO\\na\\tO\\nnovel\\tO\\nmutation\\tO\\n,\\tO\\nthe\\tO\\ndeletion\\tO\\nof\\tO\\ncytosine\\tO\\n418\\tO\\n(\\tO\\ndelta\\tO\\nc418\\tO\\n)\\tO\\n,\\tO\\npredicting\\tO\\na\\tO\\nframeshift\\tO\\nwith\\tO\\npremature\\tO\\ntermination\\tO\\n.\\tO\\n\\nAlso\\tO\\nthe\\tO\\ndelta\\tO\\nc418\\tO\\nallele\\tO\\nwas\\tO\\nunderrepresented\\tO\\nin\\tO\\nthe\\tO\\ncDNA\\tO\\n,\\tO\\nin\\tO\\naccordance\\tO\\nwith\\tO\\nprevious\\tO\\nobservations\\tO\\nthat\\tO\\npremature\\tO\\nstop\\tO\\ncodons\\tO\\nreduce\\tO\\nmRNA\\tO\\nlevels\\tO\\n.\\tO\\n\\nThe\\tO\\npresence\\tO\\nof\\tO\\nthe\\tO\\nDTDST\\tO\\nR279W\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\n11\\tO\\npatients\\tO\\nwith\\tO\\nAO2\\tB-Disease\\nor\\tO\\nDTD\\tB-Disease\\nemphasizes\\tO\\nthe\\tO\\noverlap\\tO\\nbetween\\tO\\nthese\\tO\\nconditions\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\nfound\\tO\\nso\\tO\\nfar\\tO\\nin\\tO\\n8\\tO\\nanalyzed\\tO\\nACG1B\\tB-Disease\\npatients\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nit\\tO\\nallows\\tO\\nsome\\tO\\nresidual\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nsulfate\\tO\\ntransporter\\tO\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nWASP\\tO\\nmutations\\tO\\n,\\tO\\nmutation\\tO\\nhotspots\\tO\\nand\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ndisparities\\tO\\nin\\tO\\n24\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nWiskott\\tB-Disease\\n-\\tI-Disease\\nAldrich\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWAS\\tB-Disease\\n)\\tO\\n,\\tO\\nan\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nimmunodeficiency\\tI-Disease\\ndisease\\tI-Disease\\ncaused\\tO\\nby\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nrecently\\tO\\nisolated\\tO\\ngene\\tO\\nencoding\\tO\\nWAS\\tB-Disease\\nprotein\\tO\\n(\\tO\\nWASP\\tO\\n)\\tO\\n,\\tO\\nis\\tO\\nknown\\tO\\nto\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nextensive\\tO\\nclinical\\tO\\nheterogeneity\\tO\\n.\\tO\\n\\nCumulative\\tO\\nmutation\\tO\\ndata\\tO\\nhave\\tO\\nrevealed\\tO\\nthat\\tO\\nWASP\\tO\\ngenotypes\\tO\\nare\\tO\\nalso\\tO\\nhighly\\tO\\nvariable\\tO\\namong\\tO\\nWAS\\tB-Disease\\npatients\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\nrelationship\\tO\\nof\\tO\\nphenotype\\tO\\nwith\\tO\\ngenotype\\tO\\nin\\tO\\nthis\\tO\\ndisease\\tO\\nremains\\tO\\nunclear\\tO\\n.\\tO\\n\\nTo\\tO\\naddress\\tO\\nthis\\tO\\nissue\\tO\\nwe\\tO\\ncharacterized\\tO\\nWASP\\tO\\nmutations\\tO\\nin\\tO\\n24\\tO\\nunrelated\\tO\\nWAS\\tB-Disease\\npatients\\tO\\n,\\tO\\nincluding\\tO\\n18\\tO\\nboys\\tO\\nwith\\tO\\nsevere\\tO\\nclassical\\tO\\nWAS\\tB-Disease\\nand\\tO\\n6\\tO\\nboys\\tO\\nexpressing\\tO\\nmild\\tO\\nforms\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n,\\tO\\nand\\tO\\nthen\\tO\\nexamined\\tO\\nthe\\tO\\ndegree\\tO\\nof\\tO\\ncorrelation\\tO\\nof\\tO\\nthese\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nall\\tO\\npreviously\\tO\\npublished\\tO\\nWASP\\tO\\nmutations\\tO\\nwith\\tO\\ndisease\\tO\\nseverity\\tO\\n.\\tO\\n\\nBy\\tO\\nanalysis\\tO\\nof\\tO\\nthese\\tO\\ncompiled\\tO\\nmutation\\tO\\ndata\\tO\\n,\\tO\\nwe\\tO\\ndemonstrated\\tO\\nclustering\\tO\\nof\\tO\\nWASP\\tO\\nmutations\\tO\\nwithin\\tO\\nthe\\tO\\nfour\\tO\\nmost\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nand\\tO\\nalso\\tO\\nidentified\\tO\\nseveral\\tO\\nsites\\tO\\nwithin\\tO\\nthis\\tO\\nregion\\tO\\nas\\tO\\nhotspots\\tO\\nfor\\tO\\nWASP\\tO\\nmutation\\tO\\n.\\tO\\n\\nThese\\tO\\ncharacteristics\\tO\\nwere\\tO\\nobserved\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nin\\tO\\nboth\\tO\\nsevere\\tO\\nand\\tO\\nmild\\tO\\ncases\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nSimilarly\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\ncumulative\\tO\\ndata\\tO\\nrevealed\\tO\\na\\tO\\npredominance\\tO\\nof\\tO\\nmissense\\tO\\nmutations\\tO\\namong\\tO\\nthe\\tO\\nWASP\\tO\\ngene\\tO\\nlesions\\tO\\nobserved\\tO\\nin\\tO\\nboys\\tO\\nwith\\tO\\nisolated\\tB-Disease\\nthrombocytopenia\\tI-Disease\\n,\\tO\\nmissense\\tO\\nmutations\\tO\\nwere\\tO\\nnot\\tO\\nexclusively\\tO\\nassociated\\tO\\nwith\\tO\\nmilder\\tO\\nWAS\\tB-Disease\\nphenotypes\\tO\\n,\\tO\\nbut\\tO\\nalso\\tO\\ncomprised\\tO\\na\\tO\\nsubstantial\\tO\\nportion\\tO\\n(\\tO\\n38\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nWASP\\tO\\ngene\\tO\\ndefects\\tO\\nfound\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nsevere\\tO\\ndisease\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nthe\\tO\\ndetection\\tO\\nof\\tO\\nidentical\\tO\\nWASP\\tO\\nmutations\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\ndisparate\\tO\\nphenotypes\\tO\\n,\\tO\\nreveal\\tO\\na\\tO\\nlack\\tO\\nof\\tO\\nphenotype\\tO\\nconcordance\\tO\\nwith\\tO\\ngenotype\\tO\\nin\\tO\\nWAS\\tB-Disease\\nand\\tO\\nthus\\tO\\nimply\\tO\\nthat\\tO\\nphenotypic\\tO\\noutcome\\tO\\nin\\tO\\nthis\\tO\\ndisease\\tO\\ncannot\\tO\\nbe\\tO\\nreliably\\tO\\npredicted\\tO\\nsolely\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nWASP\\tO\\ngenotypes\\tO\\n.\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\n\\'\\tO\\npart\\tO\\nof\\tO\\nAPC\\tB-Disease\\nexon\\tO\\n15\\tO\\ndo\\tO\\nnot\\tO\\nresult\\tO\\nin\\tO\\ntruncated\\tO\\nproteins\\tO\\nand\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nattenuated\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n.\\tO\\n\\nFamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\ninherited\\tO\\npredisposition\\tO\\nto\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nnumerous\\tO\\nadenomatous\\tB-Disease\\npolyps\\tI-Disease\\npredominantly\\tO\\nin\\tO\\nthe\\tO\\ncolorectal\\tO\\nregion\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\ngene\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nmost\\tO\\ncases\\tO\\nof\\tO\\nFAP\\tB-Disease\\n.\\tO\\n\\nMutations\\tO\\nat\\tO\\nthe\\tO\\n5\\tO\\nend\\tO\\nof\\tO\\nAPC\\tB-Disease\\nare\\tO\\nknown\\tO\\nto\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nrelatively\\tO\\nmild\\tO\\nform\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n,\\tO\\ncalled\\tO\\nattenuated\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAAPC\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\na\\tO\\nframeshift\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\npart\\tO\\nof\\tO\\nexon\\tO\\n15\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\nstop\\tO\\ncodon\\tO\\nat\\tO\\n1862\\tO\\n,\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nDutch\\tO\\nkindred\\tO\\nwith\\tO\\nAAPC\\tB-Disease\\n.\\tO\\n\\nWestern\\tO\\nblot\\tO\\nanalysis\\tO\\nof\\tO\\nlymphoblastoid\\tO\\ncell\\tO\\nlines\\tO\\nderived\\tO\\nfrom\\tO\\naffected\\tO\\nfamily\\tO\\nmembers\\tO\\nfrom\\tO\\nthis\\tO\\nkindred\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nfrom\\tO\\na\\tO\\npreviously\\tO\\nreported\\tO\\nSwiss\\tO\\nfamily\\tO\\ncarrying\\tO\\na\\tO\\nframeshift\\tO\\nmutation\\tO\\nat\\tO\\ncodon\\tO\\n1987\\tO\\nand\\tO\\ndisplaying\\tO\\na\\tO\\nsimilar\\tO\\nattenuated\\tO\\nphenotype\\tO\\n,\\tO\\nshowed\\tO\\nonly\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nAPC\\tB-Disease\\nprotein\\tO\\n.\\tO\\n\\nOur\\tO\\nstudy\\tO\\nindicates\\tO\\nthat\\tO\\nchain\\tO\\n-\\tO\\nterminating\\tO\\nmutations\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\npart\\tO\\nof\\tO\\nAPC\\tB-Disease\\ndo\\tO\\nnot\\tO\\nresult\\tO\\nin\\tO\\ndetectable\\tO\\ntruncated\\tO\\npolypeptides\\tO\\nand\\tO\\nwe\\tO\\nhypothesize\\tO\\nthat\\tO\\nthis\\tO\\nis\\tO\\nlikely\\tO\\nto\\tO\\nbe\\tO\\nthe\\tO\\nbasis\\tO\\nfor\\tO\\nthe\\tO\\nobserved\\tO\\nAAPC\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n.\\tO\\n\\nComplete\\tO\\ngenomic\\tO\\nsequence\\tO\\nand\\tO\\nanalysis\\tO\\nof\\tO\\n117\\tO\\nkb\\tO\\nof\\tO\\nhuman\\tO\\nDNA\\tO\\ncontaining\\tO\\nthe\\tO\\ngene\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nOver\\tO\\n100\\tO\\ndistinct\\tO\\ndisease\\tO\\n-\\tO\\nassociated\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\nthe\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\ngene\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nLoss\\tO\\nof\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nallele\\tO\\nin\\tO\\n>\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\ntumors\\tB-Disease\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\ninherited\\tO\\nBRCA1\\tO\\nmutations\\tO\\nindicates\\tO\\ntumor\\tB-Disease\\nsuppressive\\tO\\nfunction\\tO\\n.\\tO\\n\\nThe\\tO\\nlow\\tO\\nincidence\\tO\\nof\\tO\\nsomatic\\tO\\nmutations\\tO\\nsuggests\\tO\\nthat\\tO\\nBRCA1\\tO\\ninactivation\\tO\\nin\\tO\\nsporadic\\tO\\ntumors\\tB-Disease\\noccurs\\tO\\nby\\tO\\nalternative\\tO\\nmechanisms\\tO\\n,\\tO\\nsuch\\tO\\nas\\tO\\ninterstitial\\tO\\nchromosomal\\tO\\ndeletion\\tO\\nor\\tO\\nreduced\\tO\\ntranscription\\tO\\n.\\tO\\n\\nTo\\tO\\nidentify\\tO\\npossible\\tO\\nfeatures\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ngenomic\\tO\\nregion\\tO\\nthat\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\nchromosomal\\tO\\ninstability\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\npotential\\tO\\ntranscriptional\\tO\\nregulatory\\tO\\nelements\\tO\\n,\\tO\\na\\tO\\n117\\tO\\n,\\tO\\n143\\tO\\n-\\tO\\nbp\\tO\\nDNA\\tO\\nsequence\\tO\\nencompassing\\tO\\nBRCA1\\tO\\nwas\\tO\\nobtained\\tO\\nby\\tO\\nrandom\\tO\\nsequencing\\tO\\nof\\tO\\nfour\\tO\\ncosmids\\tO\\nidentified\\tO\\nfrom\\tO\\na\\tO\\nhuman\\tO\\nchromosome\\tO\\n17\\tO\\nspecific\\tO\\nlibrary\\tO\\n.\\tO\\n\\nThe\\tO\\n24\\tO\\nexons\\tO\\nof\\tO\\nBRCA1\\tO\\nspan\\tO\\nan\\tO\\n81\\tO\\n-\\tO\\nkb\\tO\\nregion\\tO\\nthat\\tO\\nhas\\tO\\nan\\tO\\nunusually\\tO\\nhigh\\tO\\ndensity\\tO\\nof\\tO\\nAlu\\tO\\nrepetitive\\tO\\nDNA\\tO\\n(\\tO\\n41\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nbut\\tO\\nrelatively\\tO\\nlow\\tO\\ndensity\\tO\\n(\\tO\\n4\\tO\\n.\\tO\\n8\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nother\\tO\\nrepetitive\\tO\\nsequences\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nintron\\tO\\nlengths\\tO\\nrange\\tO\\nin\\tO\\nsize\\tO\\nfrom\\tO\\n403\\tO\\nbp\\tO\\nto\\tO\\n9\\tO\\n.\\tO\\n\\n2\\tO\\nkb\\tO\\nand\\tO\\ncontain\\tO\\nthe\\tO\\nintragenic\\tO\\nmicrosatellite\\tO\\nmarkers\\tO\\nD17S1323\\tO\\n,\\tO\\nD17S1322\\tO\\n,\\tO\\nand\\tO\\nD17S855\\tO\\n,\\tO\\nwhich\\tO\\nlocalize\\tO\\nto\\tO\\nintrons\\tO\\n12\\tO\\n,\\tO\\n19\\tO\\n,\\tO\\nand\\tO\\n20\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\nto\\tO\\nBRCA1\\tO\\n,\\tO\\nthe\\tO\\ncontig\\tO\\ncontains\\tO\\ntwo\\tO\\ncomplete\\tO\\ngenes\\tO\\nRho7\\tO\\n,\\tO\\na\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\nrho\\tO\\nfamily\\tO\\nof\\tO\\nGTP\\tO\\nbinding\\tO\\nproteins\\tO\\n,\\tO\\nand\\tO\\nVAT1\\tO\\n,\\tO\\nan\\tO\\nabundant\\tO\\nmembrane\\tO\\nprotein\\tO\\nof\\tO\\ncholinergic\\tO\\nsynaptic\\tO\\nvesicles\\tO\\n.\\tO\\n\\nPartial\\tO\\nsequences\\tO\\nof\\tO\\nthe\\tO\\n1A1\\tO\\n-\\tO\\n3B\\tO\\nB\\tO\\n-\\tO\\nbox\\tO\\nprotein\\tO\\npseudogene\\tO\\nand\\tO\\nIFP\\tO\\n35\\tO\\n,\\tO\\nan\\tO\\ninterferon\\tO\\ninduced\\tO\\nleucine\\tO\\nzipper\\tO\\nprotein\\tO\\n,\\tO\\nreside\\tO\\nwithin\\tO\\nthe\\tO\\ncontig\\tO\\n.\\tO\\n\\nAn\\tO\\nL21\\tO\\nribosomal\\tO\\nprotein\\tO\\npseudogene\\tO\\nis\\tO\\nembedded\\tO\\nin\\tO\\nBRCA1\\tO\\nintron\\tO\\n13\\tO\\n.\\tO\\n\\nThe\\tO\\norder\\tO\\nof\\tO\\ngenes\\tO\\non\\tO\\nthe\\tO\\nchromosome\\tO\\nis\\tO\\ncentromere\\tO\\n-\\tO\\n1FP\\tO\\n35\\tO\\n-\\tO\\nVAT1\\tO\\n-\\tO\\nRho7\\tO\\n-\\tO\\nBRCA1\\tO\\n-\\tO\\n1A1\\tO\\n-\\tO\\n3B\\tO\\n-\\tO\\ntelomere\\tO\\n\\nIdentification\\tO\\nof\\tO\\na\\tO\\nRING\\tO\\nprotein\\tO\\nthat\\tO\\ncan\\tO\\ninteract\\tO\\nin\\tO\\nvivo\\tO\\nwith\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nproduct\\tO\\n.\\tO\\n\\nThe\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ngene\\tO\\n,\\tO\\nBRCA1\\tO\\n,\\tO\\nencodes\\tO\\na\\tO\\nlarge\\tO\\npolypeptide\\tO\\nthat\\tO\\ncontains\\tO\\nthe\\tO\\ncysteine\\tO\\n-\\tO\\nrich\\tO\\nRING\\tO\\nmotif\\tO\\n,\\tO\\na\\tO\\nzinc\\tO\\n-\\tO\\nbinding\\tO\\ndomain\\tO\\nfound\\tO\\nin\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nregulatory\\tO\\nproteins\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\ndescribe\\tO\\na\\tO\\nnovel\\tO\\nprotein\\tO\\nthat\\tO\\ninteracts\\tO\\nin\\tO\\nvivo\\tO\\nwith\\tO\\nthe\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\nregion\\tO\\nof\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nThis\\tO\\nBRCA1\\tO\\n-\\tO\\nassociated\\tO\\nRING\\tO\\ndomain\\tO\\n(\\tO\\nBARD1\\tO\\n)\\tO\\nprotein\\tO\\ncontains\\tO\\nan\\tO\\nN\\tO\\n-\\tO\\nterminal\\tO\\nRING\\tO\\nmotif\\tO\\n,\\tO\\nthree\\tO\\ntandem\\tO\\nankyrin\\tO\\nrepeats\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nsequence\\tO\\nwith\\tO\\nsignificant\\tO\\nhomology\\tO\\nto\\tO\\nthe\\tO\\nphylogenetically\\tO\\nconserved\\tO\\nBRCT\\tO\\ndomains\\tO\\nthat\\tO\\nlie\\tO\\nnear\\tO\\nthe\\tO\\nC\\tO\\nterminus\\tO\\nof\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nThe\\tO\\nBARD1\\tO\\n/\\tO\\nBRCA1\\tO\\ninteraction\\tO\\nis\\tO\\ndisrupted\\tO\\nby\\tO\\nBRCA1\\tO\\nmissense\\tO\\nmutations\\tO\\nthat\\tO\\nsegregate\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nBARD1\\tO\\nmay\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\nmediating\\tO\\ntumour\\tB-Disease\\nsuppression\\tO\\nby\\tO\\nBRCA1\\tO\\n.\\tO\\n.\\tO\\n\\nDetection\\tO\\nof\\tO\\nheterozygous\\tO\\nmutations\\tO\\nin\\tO\\nBRCA1\\tO\\nusing\\tO\\nhigh\\tO\\ndensity\\tO\\noligonucleotide\\tO\\narrays\\tO\\nand\\tO\\ntwo\\tO\\n-\\tO\\ncolour\\tO\\nfluorescence\\tO\\nanalysis\\tO\\n.\\tO\\n\\nThe\\tO\\nability\\tO\\nto\\tO\\nscan\\tO\\na\\tO\\nlarge\\tO\\ngene\\tO\\nrapidly\\tO\\nand\\tO\\naccurately\\tO\\nfor\\tO\\nall\\tO\\npossible\\tO\\nheterozygous\\tO\\nmutations\\tO\\nin\\tO\\nlarge\\tO\\nnumbers\\tO\\nof\\tO\\npatient\\tO\\nsamples\\tO\\nwill\\tO\\nbe\\tO\\ncritical\\tO\\nfor\\tO\\nthe\\tO\\nfuture\\tO\\nof\\tO\\nmedicine\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ndesigned\\tO\\nhigh\\tO\\n-\\tO\\ndensity\\tO\\narrays\\tO\\nconsisting\\tO\\nof\\tO\\nover\\tO\\n96\\tO\\n,\\tO\\n600\\tO\\noligonucleotides\\tO\\n20\\tO\\n-\\tO\\nnucleotides\\tO\\n(\\tO\\nnt\\tO\\n)\\tO\\nin\\tO\\nlength\\tO\\nto\\tO\\nscreen\\tO\\nfor\\tO\\na\\tO\\nwide\\tO\\nrange\\tO\\nof\\tO\\nheterozygous\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\n.\\tO\\n\\n45\\tO\\n-\\tO\\nkilobases\\tO\\n(\\tO\\nkb\\tO\\n)\\tO\\nexon\\tO\\n11\\tO\\nof\\tO\\nthe\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ngene\\tO\\nBRCA1\\tO\\n.\\tO\\n\\nReference\\tO\\nand\\tO\\ntest\\tO\\nsamples\\tO\\nwere\\tO\\nco\\tO\\n-\\tO\\nhybridized\\tO\\nto\\tO\\nthese\\tO\\narrays\\tO\\nand\\tO\\ndifferences\\tO\\nin\\tO\\nhybridization\\tO\\npatterns\\tO\\nquantitated\\tO\\nby\\tO\\ntwo\\tO\\n-\\tO\\ncolour\\tO\\nanalysis\\tO\\n.\\tO\\n\\nFourteen\\tO\\nof\\tO\\nfifteen\\tO\\npatient\\tO\\nsamples\\tO\\nwith\\tO\\nknown\\tO\\nmutations\\tO\\nwere\\tO\\naccurately\\tO\\ndiagnosed\\tO\\n,\\tO\\nand\\tO\\nno\\tO\\nfalse\\tO\\npositive\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\n20\\tO\\ncontrol\\tO\\nsamples\\tO\\n.\\tO\\n\\nEight\\tO\\nsingle\\tO\\nnucleotide\\tO\\npolymorphisms\\tO\\nwere\\tO\\nalso\\tO\\nreadily\\tO\\ndetected\\tO\\n.\\tO\\n\\nDNA\\tO\\nchip\\tO\\n-\\tO\\nbased\\tO\\nassays\\tO\\nmay\\tO\\nprovide\\tO\\na\\tO\\nvaluable\\tO\\nnew\\tO\\ntechnology\\tO\\nfor\\tO\\nhigh\\tO\\n-\\tO\\nthroughput\\tO\\ncost\\tO\\n-\\tO\\nefficient\\tO\\ndetection\\tO\\nof\\tO\\ngenetic\\tO\\nalterations\\tO\\n.\\tO\\n\\nAutosomal\\tO\\ndominant\\tO\\nprimary\\tO\\nhyperparathyroidism\\tB-Disease\\nand\\tI-Disease\\njaw\\tI-Disease\\ntumor\\tI-Disease\\nsyndrome\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nrenal\\tB-Disease\\nhamartomas\\tI-Disease\\nand\\tO\\ncystic\\tB-Disease\\nkidney\\tI-Disease\\ndisease\\tI-Disease\\n:\\tO\\nlinkage\\tO\\nto\\tO\\n1q21\\tO\\n-\\tO\\nq32\\tO\\nand\\tO\\nloss\\tO\\nof\\tO\\nthe\\tO\\nwild\\tO\\ntype\\tO\\nallele\\tO\\nin\\tO\\nrenal\\tB-Disease\\nhamartomas\\tI-Disease\\n.\\tO\\n\\nHereditary\\tB-Disease\\nhyperparathyroidism\\tI-Disease\\n-\\tI-Disease\\njaw\\tI-Disease\\ntumor\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nHPT\\tB-Disease\\n-\\tI-Disease\\nJT\\tI-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nOMIM\\tO\\n145001\\tO\\n)\\tO\\nthat\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nchromosomal\\tO\\nregion\\tO\\n1q21\\tO\\n-\\tO\\nq32\\tO\\n(\\tO\\nHRPT2\\tO\\n)\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\ntwo\\tO\\nfamilies\\tO\\nwith\\tO\\nHPT\\tB-Disease\\n-\\tI-Disease\\nJT\\tI-Disease\\nsyndrome\\tI-Disease\\nin\\tO\\nwhich\\tO\\nadult\\tB-Disease\\nrenal\\tI-Disease\\nhamartomas\\tI-Disease\\nor\\tO\\ncystic\\tB-Disease\\nkidney\\tI-Disease\\ndisease\\tI-Disease\\nwere\\tO\\nprominent\\tO\\nassociated\\tO\\nfeatures\\tO\\n,\\tO\\npossibly\\tO\\nrepresenting\\tO\\na\\tO\\nnew\\tO\\nphenotypic\\tO\\nvariant\\tO\\nof\\tO\\nthe\\tO\\nHPT\\tB-Disease\\n-\\tI-Disease\\nJT\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nfirst\\tO\\nfamily\\tO\\n,\\tO\\nrenal\\tB-Disease\\nlesions\\tI-Disease\\nwere\\tO\\npresent\\tO\\nin\\tO\\nfive\\tO\\nout\\tO\\nof\\tO\\nsix\\tO\\naffected\\tO\\nindividuals\\tO\\n,\\tO\\nwhereas\\tO\\nHPT\\tB-Disease\\nand\\tO\\nJT\\tB-Disease\\nwere\\tO\\nseen\\tO\\nin\\tO\\nfour\\tO\\nand\\tO\\ntwo\\tO\\ncases\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nsecond\\tO\\nfamily\\tO\\n,\\tO\\nJT\\tB-Disease\\nwas\\tO\\nfound\\tO\\nin\\tO\\nthree\\tO\\nof\\tO\\nthe\\tO\\nfive\\tO\\naffected\\tO\\nindividuals\\tO\\nand\\tO\\ntwo\\tO\\naffected\\tO\\nmembers\\tO\\nalso\\tO\\nexhibited\\tO\\npolycystic\\tB-Disease\\nkidney\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\npossibility\\tO\\nof\\tO\\nthe\\tO\\nlatter\\tO\\ncosegregating\\tO\\nas\\tO\\na\\tO\\nseparate\\tO\\nautosomal\\tO\\ndominant\\tO\\ngene\\tO\\ncan\\tO\\nnot\\tO\\nbe\\tO\\nruled\\tO\\nout\\tO\\n.\\tO\\n\\nA\\tO\\nsex\\tO\\n-\\tO\\ndependent\\tO\\npenetrance\\tO\\nof\\tO\\nprimary\\tB-Disease\\nHPT\\tI-Disease\\n,\\tO\\nresulting\\tO\\nin\\tO\\npredominantly\\tO\\nmale\\tO\\n-\\tO\\naffected\\tO\\ncases\\tO\\nwas\\tO\\nevident\\tO\\nin\\tO\\nthe\\tO\\ntwo\\tO\\nfamilies\\tO\\n.\\tO\\n\\nTwenty\\tO\\nmicrosatellite\\tO\\nmarkers\\tO\\nin\\tO\\nthe\\tO\\nHRPT2\\tO\\nregion\\tO\\nwere\\tO\\ntyped\\tO\\n,\\tO\\nin\\tO\\naddition\\tO\\nto\\tO\\nmarkers\\tO\\nin\\tO\\nthe\\tO\\nmultiple\\tB-Disease\\nendocrine\\tI-Disease\\nneoplasia\\tI-Disease\\n(\\tI-Disease\\nMEN\\tI-Disease\\n)\\tI-Disease\\ntypes\\tI-Disease\\n1\\tI-Disease\\nand\\tI-Disease\\n2\\tI-Disease\\nregions\\tO\\nat\\tO\\n11q13\\tO\\nand\\tO\\n10q11\\tO\\n.\\tO\\n\\nThe\\tO\\ndisease\\tO\\nin\\tO\\nthese\\tO\\ntwo\\tO\\nkindreds\\tO\\nwas\\tO\\nlinked\\tO\\nto\\tO\\nfive\\tO\\nmarkers\\tO\\nin\\tO\\nthe\\tO\\n1q21\\tO\\n-\\tO\\nq32\\tO\\nregion\\tO\\n(\\tO\\nlogarithm\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\nodds\\tO\\nscores\\tO\\n3\\tO\\n.\\tO\\n2\\tO\\n-\\tO\\n4\\tO\\n2\\tO\\n-\\tO\\n4\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\n,\\tO\\nwhereas\\tO\\nlinkage\\tO\\nto\\tO\\nthe\\tO\\nMEN1\\tB-Disease\\nand\\tO\\nMEN2\\tB-Disease\\nregions\\tO\\nwas\\tO\\nexcluded\\tO\\n.\\tO\\n\\nMeiotic\\tO\\nrecombinations\\tO\\ndetected\\tO\\nin\\tO\\naffected\\tO\\nindividuals\\tO\\nplaced\\tO\\nthe\\tO\\nlocus\\tO\\ntelomeric\\tO\\nof\\tO\\nD1S215\\tO\\n,\\tO\\nthus\\tO\\nnarrowing\\tO\\nthe\\tO\\nHRPT2\\tO\\nregion\\tO\\nfrom\\tO\\n>\\tO\\n60\\tO\\nto\\tO\\napproximately\\tO\\n34\\tO\\ncentimorgans\\tO\\n.\\tO\\n\\nLoss\\tO\\nof\\tO\\nheterozygosity\\tO\\nwas\\tO\\nstudied\\tO\\nin\\tO\\nseven\\tO\\nrenal\\tB-Disease\\nhamartomas\\tI-Disease\\nfrom\\tO\\ntwo\\tO\\naffected\\tO\\nindividuals\\tO\\nin\\tO\\nthe\\tO\\nfirst\\tO\\nfamily\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nin\\tO\\na\\tO\\njaw\\tB-Disease\\ntumor\\tI-Disease\\nand\\tO\\na\\tO\\nparathyroid\\tB-Disease\\ntumor\\tI-Disease\\nfrom\\tO\\nthe\\tO\\nsecond\\tO\\nfamily\\tO\\n.\\tO\\n\\nAll\\tO\\nrenal\\tB-Disease\\nhamartomas\\tI-Disease\\nshowed\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\nat\\tO\\nthe\\tO\\n1q21\\tO\\n-\\tO\\nq32\\tO\\nregion\\tO\\n.\\tO\\n\\nThe\\tO\\nlosses\\tO\\ninvariably\\tO\\ninvolved\\tO\\nthe\\tO\\nwild\\tO\\ntype\\tO\\nallele\\tO\\nderived\\tO\\nfrom\\tO\\nthe\\tO\\nunaffected\\tO\\nparent\\tO\\n,\\tO\\nsuggesting\\tO\\nthe\\tO\\ninactivation\\tO\\nof\\tO\\na\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\nin\\tO\\nthis\\tO\\nregion\\tO\\n\\nIndependent\\tO\\norigin\\tO\\nof\\tO\\nsingle\\tO\\nand\\tO\\ndouble\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nglucose\\tO\\n6\\tO\\n-\\tO\\nphosphate\\tO\\ndehydrogenase\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nvast\\tO\\nmajority\\tO\\nof\\tO\\nboth\\tO\\npolymorphic\\tO\\nand\\tO\\nsporadic\\tO\\nG6PD\\tO\\nvariants\\tO\\nare\\tO\\ndue\\tO\\nto\\tO\\nsingle\\tO\\nmissense\\tO\\nmutations\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nfour\\tO\\npolymorphic\\tO\\nvariants\\tO\\nthat\\tO\\nhave\\tO\\ntwo\\tO\\npoint\\tO\\nmutations\\tO\\n,\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nis\\tO\\nalways\\tO\\n376\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\n(\\tO\\n126\\tO\\nAsn\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nAsp\\tO\\n)\\tO\\n,\\tO\\nwhich\\tO\\non\\tO\\nits\\tO\\nown\\tO\\ngives\\tO\\nrise\\tO\\nto\\tO\\nthe\\tO\\nnondeficient\\tO\\npolymorphic\\tO\\nvariant\\tO\\n,\\tO\\nG6PD\\tO\\nA\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nstudy\\tO\\nof\\tO\\nG6PD\\tB-Disease\\ndeficient\\tI-Disease\\npatients\\tO\\nwho\\tO\\npresented\\tO\\nwith\\tO\\nclinical\\tO\\nfavism\\tB-Disease\\nin\\tO\\nSpain\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nfound\\tO\\na\\tO\\nnew\\tO\\npolymorphic\\tO\\nvariant\\tO\\nthat\\tO\\nwe\\tO\\nhave\\tO\\ncalled\\tO\\nG6PD\\tO\\nMalaga\\tO\\n,\\tO\\nwhose\\tO\\nonly\\tO\\nabnormality\\tO\\nis\\tO\\na\\tO\\n542\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n(\\tO\\n181\\tO\\nAsp\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nVal\\tO\\n)\\tO\\nmutation\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nthe\\tO\\nsame\\tO\\nmutation\\tO\\nas\\tO\\npreviously\\tO\\nfound\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\nthe\\tO\\nmutation\\tO\\nof\\tO\\nG6PD\\tO\\nA\\tO\\nin\\tO\\nthe\\tO\\ndouble\\tO\\nmutant\\tO\\n,\\tO\\nG6PD\\tO\\nSantamaria\\tO\\n.\\tO\\n\\nG6PD\\tO\\nMalaga\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nenzyme\\tB-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nclass\\tO\\nIII\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nenzymic\\tO\\nproperties\\tO\\nof\\tO\\nG6PD\\tO\\nMalaga\\tO\\nand\\tO\\nG6PD\\tO\\nSantamaria\\tO\\nare\\tO\\nquite\\tO\\nsimilar\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nin\\tO\\nthis\\tO\\ncase\\tO\\nthe\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nmutations\\tO\\nare\\tO\\nadditive\\tO\\nrather\\tO\\nthan\\tO\\nsynergistic\\tO\\n.\\tO\\n\\nG6PD\\tO\\nSantamaria\\tO\\nmight\\tO\\nhave\\tO\\nbeen\\tO\\nproduced\\tO\\nby\\tO\\nrecombination\\tO\\nbetween\\tO\\nG6PD\\tO\\nA\\tO\\nand\\tO\\nG6PD\\tO\\nMalaga\\tO\\n;\\tO\\nhowever\\tO\\nhaplotype\\tO\\nanalysis\\tO\\n,\\tO\\nincluding\\tO\\nthe\\tO\\nuse\\tO\\nof\\tO\\na\\tO\\nnew\\tO\\nsilent\\tO\\npolymorphism\\tO\\n,\\tO\\nsuggests\\tO\\nthat\\tO\\nthe\\tO\\nsame\\tO\\n542\\tO\\nA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\nmutation\\tO\\nhas\\tO\\ntaken\\tO\\nplace\\tO\\nindependently\\tO\\nin\\tO\\na\\tO\\nG6PD\\tO\\nB\\tO\\ngene\\tO\\nto\\tO\\ngive\\tO\\nG6PD\\tO\\nMalaga\\tO\\nand\\tO\\nin\\tO\\na\\tO\\nG6PD\\tO\\nA\\tO\\ngene\\tO\\nto\\tO\\ngive\\tO\\nG6PD\\tO\\nSantamaria\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nhelp\\tO\\nto\\tO\\noutline\\tO\\nthe\\tO\\nrelationship\\tO\\nand\\tO\\nevolution\\tO\\nof\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nG6PD\\tO\\nlocus\\tO\\n.\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nR841W\\tO\\n:\\tO\\na\\tO\\nstrong\\tO\\ncandidate\\tO\\nfor\\tO\\na\\tO\\ncommon\\tO\\nmutation\\tO\\nwith\\tO\\nmoderate\\tO\\nphenotype\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nmutations\\tO\\ncause\\tO\\nincreased\\tO\\nrisk\\tO\\nfor\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n,\\tO\\nfrequently\\tO\\nof\\tO\\nearly\\tO\\nonset\\tO\\n.\\tO\\n\\nMany\\tO\\ndifferent\\tO\\nmutations\\tO\\noccur\\tO\\nin\\tO\\nBRCA1\\tO\\n,\\tO\\nincluding\\tO\\nseveral\\tO\\nexamples\\tO\\nof\\tO\\nrecurrent\\tO\\nmutations\\tO\\n,\\tO\\neach\\tO\\nof\\tO\\nwhich\\tO\\naccounts\\tO\\nfor\\tO\\na\\tO\\nsignificant\\tO\\nnumber\\tO\\nof\\tO\\nfamilies\\tO\\nwith\\tO\\nheritable\\tO\\ncancer\\tB-Disease\\npredisposition\\tO\\n.\\tO\\n\\nThese\\tO\\ncommon\\tO\\nmutations\\tO\\nhave\\tO\\nan\\tO\\netiological\\tO\\nrole\\tO\\nin\\tO\\nmany\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ncases\\tO\\nand\\tO\\nprovide\\tO\\nthe\\tO\\nopportunity\\tO\\nto\\tO\\nexamine\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nand\\tO\\ngenotype\\tO\\n-\\tO\\nenvironment\\tO\\ninteractions\\tO\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nthe\\tO\\nidentical\\tO\\nBRCA1\\tO\\nlesion\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\na\\tO\\nnovel\\tO\\nmissense\\tO\\nchange\\tO\\nin\\tO\\nBRCA1\\tO\\n,\\tO\\n2640\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n(\\tO\\nR841W\\tO\\n)\\tO\\n,\\tO\\nfound\\tO\\nin\\tO\\n3\\tO\\ncases\\tO\\nfrom\\tO\\na\\tO\\nsubject\\tO\\ngroup\\tO\\nof\\tO\\n305\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n79\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ncases\\tO\\nfrom\\tO\\nOrange\\tO\\nCounty\\tO\\n,\\tO\\nCA\\tO\\n.\\tO\\n\\nThese\\tO\\nare\\tO\\nconsecutive\\tO\\n,\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\ncases\\tO\\nnot\\tO\\nselected\\tO\\nfor\\tO\\nage\\tO\\nor\\tO\\nfamily\\tO\\nhistory\\tO\\n.\\tO\\n\\nIn\\tO\\nall\\tO\\nthree\\tO\\ncases\\tO\\n,\\tO\\nthere\\tO\\nis\\tO\\na\\tO\\nstrong\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nbreast\\tB-Disease\\n,\\tI-Disease\\novarian\\tI-Disease\\n,\\tI-Disease\\nor\\tI-Disease\\nother\\tI-Disease\\ncancers\\tI-Disease\\npossibly\\tO\\nrelated\\tO\\nto\\tO\\na\\tO\\nBRCA1\\tO\\ndefect\\tO\\nand\\tO\\nfamily\\tO\\nmembers\\tO\\nshowed\\tO\\na\\tO\\nhigh\\tO\\nconcordance\\tO\\nof\\tO\\ncancer\\tB-Disease\\nincidence\\tO\\nwith\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nR841W\\tO\\n.\\tO\\n\\nThe\\tO\\nage\\tO\\nof\\tO\\ncancer\\tB-Disease\\nonset\\tO\\nwas\\tO\\nnot\\tO\\nalways\\tO\\ndistinct\\tO\\nfrom\\tO\\ntypical\\tO\\nsporadic\\tO\\ncases\\tO\\n.\\tO\\n\\nTesting\\tO\\nof\\tO\\na\\tO\\nsample\\tO\\nof\\tO\\n413\\tO\\nunrelated\\tO\\nindividuals\\tO\\nto\\tO\\nexamine\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nR841W\\tO\\nmight\\tO\\nbe\\tO\\na\\tO\\nrare\\tO\\npolymorphism\\tO\\ndetected\\tO\\none\\tO\\nadditional\\tO\\ninstance\\tO\\nin\\tO\\na\\tO\\nwoman\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\ndiagnosed\\tO\\nat\\tO\\nage\\tO\\n77\\tO\\nyears\\tO\\n,\\tO\\nand\\tO\\ncancer\\tB-Disease\\nin\\tO\\none\\tO\\nparent\\tO\\n.\\tO\\n\\nR841W\\tO\\nis\\tO\\nlikely\\tO\\nto\\tO\\nbe\\tO\\nan\\tO\\netiologically\\tO\\nsignificant\\tO\\nlesion\\tO\\nwith\\tO\\ninvolvement\\tO\\nin\\tO\\nclose\\tO\\nto\\tO\\n1\\tO\\n%\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\nof\\tO\\n0\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n7\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nall\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\nin\\tO\\nthis\\tO\\npopulation\\tO\\n.\\tO\\n\\nAtaxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n:\\tO\\nfounder\\tO\\neffect\\tO\\namong\\tO\\nnorth\\tO\\nAfrican\\tO\\nJews\\tO\\n.\\tO\\n\\nThe\\tO\\nATM\\tO\\ngene\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\n,\\tO\\ncharacterized\\tO\\nby\\tO\\ncerebellar\\tB-Disease\\ndegeneration\\tI-Disease\\n,\\tO\\nimmunodeficiency\\tB-Disease\\nand\\tO\\ncancer\\tB-Disease\\npredisposition\\tI-Disease\\n.\\tO\\n\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\ncarriers\\tO\\nwere\\tO\\nreported\\tO\\nto\\tO\\nbe\\tO\\nmoderately\\tO\\ncancer\\tB-Disease\\n-\\tI-Disease\\nprone\\tI-Disease\\n.\\tO\\n\\nA\\tO\\nwide\\tO\\nvariety\\tO\\nof\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nmutations\\tO\\n,\\tO\\nmost\\tO\\nof\\tO\\nwhich\\tO\\nare\\tO\\nunique\\tO\\nto\\tO\\nsingle\\tO\\nfamilies\\tO\\n,\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nvarious\\tO\\nethnic\\tO\\ngroups\\tO\\n,\\tO\\nprecluding\\tO\\ncarrier\\tO\\nscreening\\tO\\nwith\\tO\\nmutation\\tO\\n-\\tO\\nspecific\\tO\\nassays\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\na\\tO\\nsingle\\tO\\nmutation\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\n32\\tO\\n/\\tO\\n33\\tO\\ndefective\\tO\\nATM\\tO\\nalleles\\tO\\nin\\tO\\nJewish\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nfamilies\\tO\\nof\\tO\\nNorth\\tO\\nAfrican\\tO\\norigin\\tO\\n,\\tO\\ncoming\\tO\\nfrom\\tO\\nvarious\\tO\\nregions\\tO\\nof\\tO\\nMorocco\\tO\\nand\\tO\\nTunisia\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\n,\\tO\\n103C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n,\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nstop\\tO\\ncodon\\tO\\nat\\tO\\nposition\\tO\\n35\\tO\\nof\\tO\\nthe\\tO\\nATM\\tO\\nprotein\\tO\\n.\\tO\\n\\nIn\\tO\\nkeeping\\tO\\nwith\\tO\\nthe\\tO\\nnature\\tO\\nof\\tO\\nthis\\tO\\nmutation\\tO\\n,\\tO\\nvarious\\tO\\nantibodies\\tO\\ndirected\\tO\\nagainst\\tO\\nthe\\tO\\nATM\\tO\\nprotein\\tO\\nfailed\\tO\\nto\\tO\\ndefect\\tO\\nthis\\tO\\nprotein\\tO\\nin\\tO\\npatient\\tO\\ncells\\tO\\n.\\tO\\n\\nA\\tO\\nrapid\\tO\\ncarrier\\tO\\ndetection\\tO\\nassay\\tO\\ndetected\\tO\\nthis\\tO\\nmutation\\tO\\nin\\tO\\nthree\\tO\\nout\\tO\\nof\\tO\\n488\\tO\\nATM\\tO\\nalleles\\tO\\nof\\tO\\nJewish\\tO\\nMoroccan\\tO\\nor\\tO\\nTunisian\\tO\\norigin\\tO\\n.\\tO\\n\\nThis\\tO\\nfounder\\tO\\neffect\\tO\\nprovides\\tO\\na\\tO\\nunique\\tO\\nopportunity\\tO\\nfor\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\nscreening\\tO\\nfor\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\ncarriers\\tO\\nin\\tO\\na\\tO\\nlarge\\tO\\nJewish\\tO\\ncommunity\\tO\\n.\\tO\\n.\\tO\\n\\nMutation\\tO\\nanalysis\\tO\\nof\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nin\\tO\\na\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\npopulation\\tO\\n.\\tO\\n\\nA\\tO\\npopulation\\tO\\n-\\tO\\nbased\\tO\\nseries\\tO\\nof\\tO\\n54\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\ncases\\tO\\nfrom\\tO\\nSouthern\\tO\\nCalifornia\\tO\\nwere\\tO\\nanalyzed\\tO\\nfor\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ninherited\\tB-Disease\\nbreast\\tI-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ngenes\\tO\\n,\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nNine\\tO\\n(\\tO\\n17\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nhad\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nin\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\nfirst\\tO\\n-\\tO\\ndegree\\tO\\nrelative\\tO\\n.\\tO\\n\\nA\\tO\\nfurther\\tO\\nseven\\tO\\n(\\tO\\n13\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nreported\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nin\\tO\\nat\\tO\\nleast\\tO\\none\\tO\\nsecond\\tO\\n-\\tO\\ndegree\\tO\\nrelative\\tO\\nand\\tO\\nin\\tO\\nno\\tO\\nfirst\\tO\\n-\\tO\\ndegree\\tO\\nrelatives\\tO\\n.\\tO\\n\\nNo\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nBRCA1\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nTwo\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\npatients\\tO\\n(\\tO\\n4\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ntotal\\tO\\n)\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\ncarry\\tO\\nnovel\\tO\\ntruncating\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA2\\tO\\ngene\\tO\\n.\\tO\\n\\nOnly\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\npatients\\tO\\ncarrying\\tO\\na\\tO\\nBRCA2\\tO\\nmutation\\tO\\nhad\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\ncancer\\tB-Disease\\n,\\tO\\nwith\\tO\\none\\tO\\ncase\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\na\\tO\\nfirst\\tO\\n-\\tO\\ndegree\\tO\\nrelative\\tO\\n.\\tO\\n\\nThe\\tO\\nremaining\\tO\\neight\\tO\\ncases\\tO\\n(\\tO\\n89\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nmale\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nwith\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nin\\tO\\nfirst\\tO\\n-\\tO\\ndegree\\tO\\nrelatives\\tO\\nremain\\tO\\nunaccounted\\tO\\nfor\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\neither\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nor\\tO\\nthe\\tO\\nBRCA2\\tO\\ngene\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbasis\\tO\\nfor\\tO\\nDuarte\\tB-Disease\\nand\\tI-Disease\\nLos\\tI-Disease\\nAngeles\\tI-Disease\\nvariant\\tI-Disease\\ngalactosemia\\tI-Disease\\n.\\tO\\n\\nHuman\\tO\\norythrocytes\\tO\\nthat\\tO\\nare\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\nDuarte\\tB-Disease\\nenzyme\\tI-Disease\\nvariant\\tI-Disease\\nof\\tI-Disease\\ngalactosemia\\tI-Disease\\n(\\tO\\nD\\tO\\n/\\tO\\nD\\tO\\n)\\tO\\nhave\\tO\\na\\tO\\ncharacteristic\\tO\\nisoform\\tO\\non\\tO\\nisoelectric\\tO\\nfocusing\\tO\\nand\\tO\\n50\\tO\\n%\\tO\\nreduction\\tO\\nin\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridyltransferase\\tO\\n(\\tO\\nGALT\\tO\\n)\\tO\\nenzyme\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\nDuarte\\tO\\nbiochemical\\tO\\nphenotype\\tO\\nhas\\tO\\na\\tO\\nmolecular\\tO\\ngenotype\\tO\\nof\\tO\\nN314D\\tO\\n/\\tO\\nN314D\\tO\\n.\\tO\\n\\nThe\\tO\\ncharacteristic\\tO\\nDuarte\\tO\\nisoform\\tO\\nis\\tO\\nalso\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nvariant\\tO\\ncalled\\tO\\nthe\\tO\\n\"\\tO\\nLos\\tO\\nAngeles\\tO\\n(\\tO\\nLA\\tO\\n)\\tO\\nphenotype\\tO\\n,\\tO\\n\"\\tO\\nwhich\\tO\\nhas\\tO\\nincreased\\tO\\nGALT\\tO\\nenzyme\\tO\\nactivity\\tO\\n.\\tO\\n\\nWe\\tO\\nevaluated\\tO\\nGALT\\tO\\nenzyme\\tO\\nactivity\\tO\\nand\\tO\\nscreened\\tO\\nthe\\tO\\nGALT\\tO\\ngenes\\tO\\nof\\tO\\n145\\tO\\npatients\\tO\\nwith\\tO\\none\\tO\\nor\\tO\\nmore\\tO\\nN314D\\tO\\n-\\tO\\ncontaining\\tO\\nalleles\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nseven\\tO\\nwith\\tO\\nthe\\tO\\nLA\\tO\\nbiochemical\\tO\\nphenotype\\tO\\n,\\tO\\nand\\tO\\nall\\tO\\nhad\\tO\\na\\tO\\n1721C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransition\\tO\\nin\\tO\\nexon\\tO\\n7\\tO\\nin\\tO\\ncis\\tO\\nwith\\tO\\nthe\\tO\\nN314D\\tO\\nmissense\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\n1721C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransition\\tO\\nis\\tO\\na\\tO\\nneutral\\tO\\npolymorphism\\tO\\nfor\\tO\\nleucine\\tO\\nat\\tO\\namino\\tO\\nacid\\tO\\n218\\tO\\n(\\tO\\nL218L\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\npedigree\\tO\\nanalyses\\tO\\n,\\tO\\nthis\\tO\\n1721C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransition\\tO\\nsegregated\\tO\\nwith\\tO\\nthe\\tO\\nLA\\tO\\nphenotype\\tO\\nof\\tO\\nincreased\\tO\\nGALT\\tO\\nactivity\\tO\\nin\\tO\\nthree\\tO\\ndifferent\\tO\\nbiochemical\\tO\\nphenotypes\\tO\\n(\\tO\\nLA\\tO\\n/\\tO\\nN\\tO\\n,\\tO\\nLA\\tO\\n/\\tO\\nG\\tO\\n,\\tO\\nand\\tO\\nLA\\tO\\n/\\tO\\nD\\tO\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nmechanism\\tO\\nfor\\tO\\nincreased\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nLA\\tO\\nvariant\\tO\\n,\\tO\\nwe\\tO\\ncompared\\tO\\nGALT\\tO\\nmRNA\\tO\\n,\\tO\\nprotein\\tO\\nabundance\\tO\\n,\\tO\\nand\\tO\\nenzyme\\tO\\nthermal\\tO\\nstability\\tO\\nin\\tO\\nlymphoblast\\tO\\ncell\\tO\\nlines\\tO\\nof\\tO\\nD\\tO\\nand\\tO\\nLA\\tO\\nphenotypes\\tO\\nwith\\tO\\ncomparable\\tO\\ngenotypes\\tO\\n.\\tO\\n\\nGALT\\tO\\nprotein\\tO\\nabundance\\tO\\nwas\\tO\\nincreased\\tO\\nin\\tO\\nLA\\tO\\ncompared\\tO\\nto\\tO\\nD\\tO\\nalleles\\tO\\n,\\tO\\nbut\\tO\\nmRNA\\tO\\nwas\\tO\\nsimilar\\tO\\namong\\tO\\nall\\tO\\ngenotypes\\tO\\n.\\tO\\n\\nWhen\\tO\\nLA\\tO\\n/\\tO\\nD\\tO\\nand\\tO\\nD\\tO\\n/\\tO\\nD\\tO\\nGALT\\tO\\nbiochemical\\tO\\nphenotypes\\tO\\nwere\\tO\\ncompared\\tO\\nto\\tO\\nN\\tO\\n/\\tO\\nN\\tO\\nGALT\\tO\\nphenotypes\\tO\\n,\\tO\\nboth\\tO\\nhad\\tO\\n50\\tO\\n%\\tO\\n,\\tO\\nas\\tO\\ncompared\\tO\\nto\\tO\\n21\\tO\\n%\\tO\\n,\\tO\\nreduction\\tO\\nin\\tO\\nGALT\\tO\\nactivity\\tO\\nin\\tO\\nthe\\tO\\nwild\\tO\\ntype\\tO\\n(\\tO\\nN\\tO\\n/\\tO\\nN\\tO\\n)\\tO\\nafter\\tO\\nexposure\\tO\\nat\\tO\\nidentical\\tO\\ninitial\\tO\\nenzyme\\tO\\nactivity\\tO\\nto\\tO\\n50\\tO\\ndegrees\\tO\\nC\\tO\\nfor\\tO\\n15\\tO\\nmin\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\ncodon\\tO\\nchange\\tO\\nN314D\\tO\\nin\\tO\\ncis\\tO\\nwith\\tO\\nthe\\tO\\nbase\\tO\\n-\\tO\\npair\\tO\\ntransition\\tO\\n1721C\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\nproduces\\tO\\nthe\\tO\\nLA\\tB-Disease\\nvariant\\tI-Disease\\nof\\tI-Disease\\ngalactosemia\\tI-Disease\\nand\\tO\\nthat\\tO\\nthis\\tO\\nnucleotide\\tO\\nchange\\tO\\nincreases\\tO\\nGALT\\tO\\nactivity\\tO\\nby\\tO\\nincreasing\\tO\\nGALT\\tO\\nprotein\\tO\\nabundance\\tO\\nwithout\\tO\\nincreasing\\tO\\ntranscription\\tO\\nor\\tO\\ndecreasing\\tO\\nthermal\\tO\\nlability\\tO\\n.\\tO\\n\\nA\\tO\\nfavorable\\tO\\ncodon\\tO\\nbias\\tO\\nfor\\tO\\nthe\\tO\\nmutated\\tO\\ncodon\\tO\\nwith\\tO\\nconsequently\\tO\\nincreased\\tO\\ntranslation\\tO\\nrates\\tO\\nis\\tO\\npostulated\\tO\\nas\\tO\\nthe\\tO\\nmechanism\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nTSG101\\tO\\ntumor\\tB-Disease\\nsusceptibility\\tO\\ngene\\tO\\nis\\tO\\nlocated\\tO\\nin\\tO\\nchromosome\\tO\\n11\\tO\\nband\\tO\\np15\\tO\\nand\\tO\\nis\\tO\\nmutated\\tO\\nin\\tO\\nhuman\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nRecent\\tO\\nwork\\tO\\nhas\\tO\\nidentified\\tO\\na\\tO\\nmouse\\tO\\ngene\\tO\\n(\\tO\\ntsg101\\tO\\n)\\tO\\nwhose\\tO\\ninactivation\\tO\\nin\\tO\\nfibroblasts\\tO\\nresults\\tO\\nin\\tO\\ncellular\\tO\\ntransformation\\tO\\nand\\tO\\nthe\\tO\\nability\\tO\\nto\\tO\\nproduce\\tO\\nmetastatic\\tB-Disease\\ntumors\\tI-Disease\\nin\\tO\\nnude\\tO\\nmice\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\nthe\\tO\\nhuman\\tO\\nhomolog\\tO\\n,\\tO\\nTSG101\\tO\\n,\\tO\\nwhich\\tO\\nwe\\tO\\nisolated\\tO\\nand\\tO\\nmapped\\tO\\nto\\tO\\nchromosome\\tO\\n11\\tO\\n,\\tO\\nbands\\tO\\n15\\tO\\n.\\tO\\n\\n1\\tO\\n-\\tO\\n15\\tO\\n1\\tO\\n-\\tO\\n15\\tO\\n.\\tO\\n\\n2\\tO\\n,\\tO\\na\\tO\\nregion\\tO\\nproposed\\tO\\nto\\tO\\ncontain\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\n,\\tO\\nis\\tO\\nmutated\\tO\\nat\\tO\\nhigh\\tO\\nfrequency\\tO\\nin\\tO\\nhuman\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\n7\\tO\\nof\\tO\\n15\\tO\\nuncultured\\tO\\nprimary\\tO\\nhuman\\tO\\nbreast\\tB-Disease\\ncarcinomas\\tI-Disease\\n,\\tO\\nintragenic\\tO\\ndeletions\\tO\\nwere\\tO\\nshown\\tO\\nin\\tO\\nTSG101\\tO\\ngenomic\\tO\\nDNA\\tO\\nand\\tO\\ntranscripts\\tO\\nby\\tO\\ngel\\tO\\nand\\tO\\nsequence\\tO\\nanalysis\\tO\\n,\\tO\\nand\\tO\\nmutations\\tO\\naffecting\\tO\\ntwo\\tO\\nTSG101\\tO\\nalleles\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nfour\\tO\\nof\\tO\\nthese\\tO\\ncancers\\tB-Disease\\n.\\tO\\n\\nNo\\tO\\nTSG101\\tO\\ndefects\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nmatched\\tO\\nnormal\\tO\\nbreast\\tO\\ntissue\\tO\\nfrom\\tO\\nthe\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nstrongly\\tO\\nimplicate\\tO\\nTSG101\\tO\\nmutations\\tO\\nin\\tO\\nhuman\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n\\nModerate\\tO\\nintergenerational\\tO\\nand\\tO\\nsomatic\\tO\\ninstability\\tO\\nof\\tO\\na\\tO\\n55\\tO\\n-\\tO\\nCTG\\tO\\nrepeat\\tO\\nin\\tO\\ntransgenic\\tO\\nmice\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nregion\\tO\\n(\\tO\\nUTR\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nprotein\\tO\\nkinase\\tO\\ngene\\tO\\n(\\tO\\nDMPK\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\nis\\tO\\npolymorphic\\tO\\nand\\tO\\nvaries\\tO\\nin\\tO\\nsize\\tO\\nbetween\\tO\\n5\\tO\\nand\\tO\\n37\\tO\\nrepeats\\tO\\nin\\tO\\nunaffected\\tO\\nindividuals\\tO\\nwhereas\\tO\\nin\\tO\\naffected\\tO\\npatients\\tO\\nthere\\tO\\nare\\tO\\nbetween\\tO\\n50\\tO\\nand\\tO\\n4\\tO\\n,\\tO\\n000\\tO\\nCTGs\\tO\\n.\\tO\\n\\nThe\\tO\\nsize\\tO\\nof\\tO\\nthe\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\n,\\tO\\nwhich\\tO\\nincreases\\tO\\nthrough\\tO\\ngenerations\\tO\\n,\\tO\\ngenerally\\tO\\ncorrelates\\tO\\nwith\\tO\\nclinical\\tO\\nseverity\\tO\\nand\\tO\\nage\\tO\\nof\\tO\\nonset\\tO\\n.\\tO\\n\\nThe\\tO\\ninstability\\tO\\nof\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nappears\\tO\\nto\\tO\\ndepend\\tO\\non\\tO\\nits\\tO\\nsize\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\non\\tO\\nthe\\tO\\nsex\\tO\\nof\\tO\\nthe\\tO\\ntransmitting\\tO\\nparent\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nmitotic\\tO\\ninstability\\tO\\nanalysis\\tO\\nof\\tO\\ndifferent\\tO\\nhuman\\tO\\nDM\\tB-Disease\\ntissues\\tO\\nshows\\tO\\nlength\\tO\\nmosaicism\\tO\\nbetween\\tO\\ndifferent\\tO\\ncell\\tO\\nlineages\\tO\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\nmechanisms\\tO\\nof\\tO\\ntriplet\\tO\\ninstability\\tO\\nremain\\tO\\nelusive\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\ngenomic\\tO\\nsequences\\tO\\nin\\tO\\ninstability\\tO\\n,\\tO\\nwe\\tO\\nproduced\\tO\\ntransgenic\\tO\\nmice\\tO\\ncontaining\\tO\\na\\tO\\n45\\tO\\n-\\tO\\nkb\\tO\\ngenomic\\tO\\nsegment\\tO\\nwith\\tO\\na\\tO\\n55\\tO\\n-\\tO\\nCTG\\tO\\nrepeat\\tO\\ncloned\\tO\\nfrom\\tO\\na\\tO\\nmildly\\tO\\naffected\\tO\\npatient\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\nto\\tO\\nother\\tO\\nmouse\\tO\\nmodels\\tO\\ncontaining\\tO\\nCAG\\tO\\nrepeats\\tO\\nwithin\\tO\\ncDNAs\\tO\\n,\\tO\\nthese\\tO\\nmice\\tO\\nshowed\\tO\\nboth\\tO\\nintergenerational\\tO\\nand\\tO\\nsomatic\\tO\\nrepeat\\tO\\ninstability\\tO\\n.\\tO\\n.\\tO\\n\\nMissense\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nFas\\tO\\ngene\\tO\\nresulting\\tO\\nin\\tO\\nautoimmune\\tB-Disease\\nlymphoproliferative\\tI-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\na\\tO\\nmolecular\\tO\\nand\\tO\\nimmunological\\tO\\nanalysis\\tO\\n.\\tO\\n\\nProgrammed\\tO\\ncell\\tO\\ndeath\\tO\\n(\\tO\\nor\\tO\\napoptosis\\tO\\n)\\tO\\nis\\tO\\na\\tO\\nphysiological\\tO\\nprocess\\tO\\nessential\\tO\\nto\\tO\\nthe\\tO\\nnormal\\tO\\ndevelopment\\tO\\nand\\tO\\nhomeostatic\\tO\\nmaintenance\\tO\\nof\\tO\\nthe\\tO\\nimmune\\tO\\nsystem\\tO\\n.\\tO\\n\\nThe\\tO\\nFas\\tO\\n/\\tO\\nApo\\tO\\n-\\tO\\n1\\tO\\nreceptor\\tO\\nplays\\tO\\na\\tO\\ncrucial\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\nregulation\\tO\\nof\\tO\\napoptosis\\tO\\n,\\tO\\nas\\tO\\ndemonstrated\\tO\\nby\\tO\\nlymphoproliferation\\tO\\nin\\tO\\nMRL\\tO\\n-\\tO\\nlpr\\tO\\n/\\tO\\nlpr\\tO\\nmice\\tO\\nand\\tO\\nby\\tO\\nthe\\tO\\nrecently\\tO\\ndescribed\\tO\\nautoimmune\\tB-Disease\\nlymphoproliferative\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nALPS\\tB-Disease\\n)\\tO\\nin\\tO\\nhumans\\tO\\n,\\tO\\nboth\\tO\\nof\\tO\\nwhich\\tO\\nare\\tO\\ndue\\tO\\nto\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nFas\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\na\\tO\\nnovel\\tO\\nfamily\\tO\\nwith\\tO\\nALPS\\tB-Disease\\nin\\tO\\nwhich\\tO\\nthree\\tO\\naffected\\tO\\nsiblings\\tO\\ncarry\\tO\\ntwo\\tO\\ndistinct\\tO\\nmissense\\tO\\nmutations\\tO\\non\\tO\\nboth\\tO\\nthe\\tO\\nFas\\tO\\ngene\\tO\\nalleles\\tO\\nand\\tO\\nshow\\tO\\nlack\\tO\\nof\\tO\\nFas\\tO\\n-\\tO\\ninduced\\tO\\napoptosis\\tO\\n.\\tO\\n\\nThe\\tO\\nchildren\\tO\\nshare\\tO\\ncommon\\tO\\nclinical\\tO\\nfeatures\\tO\\nincluding\\tO\\nsplenomegaly\\tB-Disease\\nand\\tO\\nlymphadenopathy\\tB-Disease\\n,\\tO\\nbut\\tO\\nonly\\tO\\none\\tO\\ndeveloped\\tO\\nsevere\\tO\\nautoimmune\\tB-Disease\\nmanifestations\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nall\\tO\\nthree\\tO\\nsiblings\\tO\\n,\\tO\\nwe\\tO\\ndemonstrated\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nanergic\\tO\\nCD3\\tO\\n+\\tO\\nCD4\\tO\\n-\\tO\\nCD8\\tO\\n-\\tO\\n(\\tO\\ndouble\\tO\\nnegative\\tO\\n,\\tO\\n[\\tO\\nDN\\tO\\n]\\tO\\n)\\tO\\nT\\tO\\ncells\\tO\\n;\\tO\\nmoreover\\tO\\n,\\tO\\na\\tO\\nchronic\\tO\\nlymphocyte\\tO\\nactivation\\tO\\nwas\\tO\\nfound\\tO\\n,\\tO\\nas\\tO\\ndemonstrated\\tO\\nby\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nhigh\\tO\\nlevels\\tO\\nof\\tO\\nHLA\\tO\\n-\\tO\\nDR\\tO\\nexpression\\tO\\non\\tO\\nperipheral\\tO\\nCD3\\tO\\n+\\tO\\ncells\\tO\\nand\\tO\\nby\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nhigh\\tO\\nlevels\\tO\\nof\\tO\\nserum\\tO\\nactivation\\tO\\nmarkers\\tO\\nsuch\\tO\\nas\\tO\\nsoluble\\tO\\ninterleukin\\tO\\n-\\tO\\n2\\tO\\nreceptor\\tO\\n(\\tO\\nslL\\tO\\n-\\tO\\n2R\\tO\\n)\\tO\\nand\\tO\\nsoluble\\tO\\nCD30\\tO\\n(\\tO\\nsCD30\\tO\\n)\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\ngene\\tO\\nproduct\\tO\\n,\\tO\\na\\tO\\nconstitutively\\tO\\nexpressed\\tO\\nnuclear\\tO\\nprotein\\tO\\nthat\\tO\\nis\\tO\\nnot\\tO\\nup\\tO\\n-\\tO\\nregulated\\tO\\nfollowing\\tO\\ngenome\\tO\\ndamage\\tO\\n.\\tO\\n\\nThe\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\ngene\\tO\\n(\\tO\\nATM\\tO\\n)\\tO\\nwas\\tO\\nidentified\\tO\\nby\\tO\\nusing\\tO\\nan\\tO\\nantiserum\\tO\\ndeveloped\\tO\\nto\\tO\\na\\tO\\npeptide\\tO\\ncorresponding\\tO\\nto\\tO\\nthe\\tO\\ndeduced\\tO\\namino\\tO\\nacid\\tO\\nsequence\\tO\\n.\\tO\\n\\nThe\\tO\\nATM\\tO\\nprotein\\tO\\nis\\tO\\na\\tO\\nsingle\\tO\\n,\\tO\\nhigh\\tO\\n-\\tO\\nmolecular\\tO\\nweight\\tO\\nprotein\\tO\\npredominantly\\tO\\nconfined\\tO\\nto\\tO\\nthe\\tO\\nnucleus\\tO\\nof\\tO\\nhuman\\tO\\nfibroblasts\\tO\\n,\\tO\\nbut\\tO\\nis\\tO\\npresent\\tO\\nin\\tO\\nboth\\tO\\nnuclear\\tO\\nand\\tO\\nmicrosomal\\tO\\nfractions\\tO\\nfrom\\tO\\nhuman\\tO\\nlymphoblast\\tO\\ncells\\tO\\nand\\tO\\nperipheral\\tO\\nblood\\tO\\nlymphocytes\\tO\\n.\\tO\\n\\nATM\\tO\\nprotein\\tO\\nlevels\\tO\\nand\\tO\\nlocalization\\tO\\nremain\\tO\\nconstant\\tO\\nthroughout\\tO\\nall\\tO\\nstages\\tO\\nof\\tO\\nthe\\tO\\ncell\\tO\\ncycle\\tO\\n.\\tO\\n\\nTruncated\\tO\\nATM\\tO\\nprotein\\tO\\nwas\\tO\\nnot\\tO\\ndetected\\tO\\nin\\tO\\nlymphoblasts\\tO\\nfrom\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\npatients\\tO\\nhomozygous\\tO\\nfor\\tO\\nmutations\\tO\\nleading\\tO\\nto\\tO\\npremature\\tO\\nprotein\\tO\\ntermination\\tO\\n.\\tO\\n\\nExposure\\tO\\nof\\tO\\nnormal\\tO\\nhuman\\tO\\ncells\\tO\\nto\\tO\\ngamma\\tO\\n-\\tO\\nirradiation\\tO\\nand\\tO\\nthe\\tO\\nradiomimetic\\tO\\ndrug\\tO\\nneocarzinostatin\\tO\\nhad\\tO\\nno\\tO\\neffect\\tO\\non\\tO\\nATM\\tO\\nprotein\\tO\\nlevels\\tO\\n,\\tO\\nin\\tO\\ncontrast\\tO\\nto\\tO\\na\\tO\\nnoted\\tO\\nrise\\tO\\nin\\tO\\np53\\tO\\nlevels\\tO\\nover\\tO\\nthe\\tO\\nsame\\tO\\ntime\\tO\\ninterval\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nthe\\tO\\nATM\\tO\\nprotein\\tO\\nin\\tO\\nensuring\\tO\\nthe\\tO\\nfidelity\\tO\\nof\\tO\\nDNA\\tO\\nrepair\\tO\\nand\\tO\\ncell\\tO\\ncycle\\tO\\nregulation\\tO\\nfollowing\\tO\\ngenome\\tO\\ndamage\\tO\\n.\\tO\\n.\\tO\\n\\nType\\tO\\nIII\\tO\\ncollagen\\tO\\nis\\tO\\ncrucial\\tO\\nfor\\tO\\ncollagen\\tO\\nI\\tO\\nfibrillogenesis\\tO\\nand\\tO\\nfor\\tO\\nnormal\\tO\\ncardiovascular\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nType\\tO\\nIII\\tO\\ncollagen\\tO\\nis\\tO\\na\\tO\\nfibrillar\\tO\\nforming\\tO\\ncollagen\\tO\\ncomprising\\tO\\nthree\\tO\\nalpha1\\tO\\n(\\tO\\nIII\\tO\\n)\\tO\\nchains\\tO\\nand\\tO\\nis\\tO\\nexpressed\\tO\\nin\\tO\\nearly\\tO\\nembryos\\tO\\nand\\tO\\nthroughout\\tO\\nembryogenesis\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nadult\\tO\\n,\\tO\\ntype\\tO\\nIII\\tO\\ncollagen\\tO\\nis\\tO\\na\\tO\\nmajor\\tO\\ncomponent\\tO\\nof\\tO\\nthe\\tO\\nextracellular\\tO\\nmatrix\\tO\\nin\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\ninternal\\tO\\norgans\\tO\\nand\\tO\\nskin\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nCOL3A1\\tO\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nimplicated\\tO\\nas\\tO\\na\\tO\\ncause\\tO\\nof\\tO\\ntype\\tB-Disease\\nIV\\tI-Disease\\nEhlers\\tI-Disease\\n-\\tI-Disease\\nDanlos\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\na\\tO\\ndisease\\tO\\nleading\\tO\\nto\\tO\\naortic\\tB-Disease\\nrupture\\tI-Disease\\nin\\tO\\nearly\\tO\\nadult\\tO\\nlife\\tO\\n.\\tO\\n\\nTo\\tO\\ndirectly\\tO\\nstudy\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nCol3a1\\tO\\nin\\tO\\ndevelopment\\tO\\nand\\tO\\ndisease\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ninactivated\\tO\\nthe\\tO\\nCol3a1\\tO\\ngene\\tO\\nin\\tO\\nembryonic\\tO\\nstem\\tO\\ncells\\tO\\nby\\tO\\nhomologous\\tO\\nrecombination\\tO\\n.\\tO\\n\\nThe\\tO\\nmutated\\tO\\nallele\\tO\\nwas\\tO\\ntransmitted\\tO\\nthrough\\tO\\nthe\\tO\\nmouse\\tO\\ngerm\\tO\\nline\\tO\\nand\\tO\\nhomozygous\\tO\\nmutant\\tO\\nanimals\\tO\\nwere\\tO\\nderived\\tO\\nfrom\\tO\\nheterozygous\\tO\\nintercrosses\\tO\\n.\\tO\\n\\nAbout\\tO\\n10\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nhomozygous\\tO\\nmutant\\tO\\nanimals\\tO\\nsurvived\\tO\\nto\\tO\\nadulthood\\tO\\nbut\\tO\\nhave\\tO\\na\\tO\\nmuch\\tO\\nshorter\\tO\\nlife\\tO\\nspan\\tO\\ncompared\\tO\\nwith\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nmice\\tO\\n.\\tO\\n\\nThe\\tO\\nmajor\\tO\\ncause\\tO\\nof\\tO\\ndeath\\tO\\nof\\tO\\nmutant\\tO\\nmice\\tO\\nwas\\tO\\nrupture\\tO\\nof\\tO\\nthe\\tO\\nmajor\\tO\\nblood\\tO\\nvessels\\tO\\n,\\tO\\nsimilar\\tO\\nto\\tO\\npatients\\tO\\nwith\\tO\\ntype\\tB-Disease\\nIV\\tI-Disease\\nEhlers\\tI-Disease\\n-\\tI-Disease\\nDanlos\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nUltrastructural\\tO\\nanalysis\\tO\\nof\\tO\\ntissues\\tO\\nfrom\\tO\\nmutant\\tO\\nmice\\tO\\nrevealed\\tO\\nthat\\tO\\ntype\\tO\\nIII\\tO\\ncollagen\\tO\\nis\\tO\\nessential\\tO\\nfor\\tO\\nnormal\\tO\\ncollagen\\tO\\nI\\tO\\nfibrillogenesis\\tO\\nin\\tO\\nthe\\tO\\ncardiovascular\\tO\\nsystem\\tO\\nand\\tO\\nother\\tO\\norgans\\tO\\n.\\tO\\n.\\tO\\n\\nNonsense\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\ngene\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nan\\tO\\nunusual\\tO\\nform\\tO\\nof\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\na\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\ntransition\\tO\\nat\\tO\\nnucleotide\\tO\\n431\\tO\\nof\\tO\\nthe\\tO\\nproteolipid\\tO\\nprotein\\tO\\ngene\\tO\\n(\\tO\\nPLP\\tO\\n)\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nnonsense\\tO\\ncodon\\tO\\nin\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nan\\tO\\nunusual\\tO\\nform\\tO\\nof\\tO\\nPelizaeus\\tB-Disease\\n-\\tI-Disease\\nMerzbacher\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nPMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\n,\\tO\\nwhich\\tO\\ncreates\\tO\\na\\tO\\nsecond\\tO\\nAluI\\tO\\nrestriction\\tO\\nsite\\tO\\n,\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nnonsense\\tO\\nmutation\\tO\\nin\\tO\\nPLP\\tO\\n.\\tO\\n\\nThe\\tO\\nclinical\\tO\\npicture\\tO\\nresembles\\tO\\nsomewhat\\tO\\nthat\\tO\\nof\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\nspastic\\tI-Disease\\nparaplegia\\tI-Disease\\n(\\tO\\nSPG\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIt\\tO\\ndiffers\\tO\\nfrom\\tO\\nthis\\tO\\nand\\tO\\nboth\\tO\\nthe\\tO\\nclassical\\tO\\nand\\tO\\nconnatal\\tO\\nforms\\tO\\nof\\tO\\nPMD\\tB-Disease\\nin\\tO\\nthat\\tO\\nit\\tO\\nis\\tO\\nrelatively\\tO\\nmild\\tO\\nin\\tO\\nform\\tO\\n,\\tO\\nonset\\tO\\nis\\tO\\ndelayed\\tO\\nbeyond\\tO\\nage\\tO\\n2\\tO\\nyears\\tO\\n,\\tO\\nnystagmus\\tB-Disease\\nis\\tO\\nabsent\\tO\\n,\\tO\\ntremors\\tB-Disease\\nare\\tO\\nprominent\\tO\\n,\\tO\\nmental\\tB-Disease\\nretardation\\tI-Disease\\nis\\tO\\nnot\\tO\\nsevere\\tO\\n,\\tO\\nsome\\tO\\npatients\\tO\\nshow\\tO\\ndementia\\tB-Disease\\nor\\tO\\npersonality\\tB-Disease\\ndisorders\\tI-Disease\\n,\\tO\\nthe\\tO\\ndisease\\tO\\nis\\tO\\nprogressive\\tO\\nrather\\tO\\nthan\\tO\\nstatic\\tO\\nin\\tO\\nsome\\tO\\n,\\tO\\nand\\tO\\nseveral\\tO\\nfemales\\tO\\nshow\\tO\\nsigns\\tO\\nof\\tO\\ndisease\\tO\\n.\\tO\\n\\nThe\\tO\\nnonsense\\tO\\nmutation\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nin\\tO\\nexon\\tO\\n3B\\tO\\n,\\tO\\nshould\\tO\\nblock\\tO\\nthe\\tO\\nsynthesis\\tO\\nof\\tO\\nnormal\\tO\\nPLP\\tO\\nbut\\tO\\nspare\\tO\\nDM20\\tO\\n,\\tO\\nthe\\tO\\nisoform\\tO\\nwhose\\tO\\npersistence\\tO\\nhas\\tO\\nbeen\\tO\\nassociated\\tO\\nwith\\tO\\nmild\\tO\\nforms\\tO\\nof\\tO\\nPLP\\tB-Disease\\n-\\tI-Disease\\nassociated\\tI-Disease\\ndisease\\tI-Disease\\nin\\tO\\nboth\\tO\\nhumans\\tO\\nand\\tO\\nmice\\tO\\n.\\tO\\n.\\tO\\n\\nCommon\\tO\\nBRCA1\\tO\\nvariants\\tO\\nand\\tO\\nsusceptibility\\tO\\nto\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nin\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\n.\\tO\\n\\nMost\\tO\\nmultiple\\tO\\ncase\\tO\\nfamilies\\tO\\nof\\tO\\nyoung\\tO\\nonset\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nare\\tO\\nthought\\tO\\nto\\tO\\nbe\\tO\\ndue\\tO\\nto\\tO\\nhighly\\tO\\npenetrant\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\npredisposing\\tO\\ngenes\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthese\\tO\\nmutations\\tO\\nare\\tO\\nuncommon\\tO\\nin\\tO\\nthe\\tO\\npopulation\\tO\\nand\\tO\\nthey\\tO\\nprobably\\tO\\naccount\\tO\\nfor\\tO\\nonly\\tO\\na\\tO\\nfew\\tO\\npercent\\tO\\nof\\tO\\nall\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nincidence\\tO\\n.\\tO\\n\\nA\\tO\\nmuch\\tO\\nlarger\\tO\\nfraction\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nmight\\tO\\n,\\tO\\nin\\tO\\nprinciple\\tO\\n,\\tO\\nbe\\tO\\ndue\\tO\\nto\\tO\\ncommon\\tO\\nvariants\\tO\\nwhich\\tO\\nconfer\\tO\\nmore\\tO\\nmodest\\tO\\nindividual\\tO\\nrisks\\tO\\n.\\tO\\n\\nThere\\tO\\nare\\tO\\nseveral\\tO\\ncommon\\tO\\npolymorphisms\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nwhich\\tO\\ngenerate\\tO\\namino\\tO\\nacid\\tO\\nsubstitutions\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexamined\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nfour\\tO\\nof\\tO\\nthese\\tO\\npolymorphisms\\tO\\nGln356Arg\\tO\\n,\\tO\\nPro871Leu\\tO\\n,\\tO\\nGlu1038Gly\\tO\\nand\\tO\\nSer1613Gly\\tO\\nin\\tO\\nlarge\\tO\\nseries\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\ncases\\tO\\nand\\tO\\nmatched\\tO\\ncontrols\\tO\\n.\\tO\\n\\nDue\\tO\\nto\\tO\\nstrong\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\n,\\tO\\nthese\\tO\\nfour\\tO\\nsites\\tO\\ngenerate\\tO\\nonly\\tO\\nthree\\tO\\nhaplotypes\\tO\\nwith\\tO\\na\\tO\\nfrequency\\tO\\n>\\tO\\n1\\tO\\n.\\tO\\n\\n3\\tO\\n%\\tO\\n.\\tO\\n\\nThe\\tO\\nmost\\tO\\ncommon\\tO\\nhaplotypes\\tO\\n,\\tO\\ndefined\\tO\\nby\\tO\\nthe\\tO\\nalleles\\tO\\nGln356Pro871Glu1038Ser1613\\tO\\nand\\tO\\nGln356Leu871Gly1038Gly1613\\tO\\n,\\tO\\nhave\\tO\\nfrequencies\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n57\\tO\\nand\\tO\\n0\\tO\\n.\\tO\\n\\n32\\tO\\nrespectively\\tO\\n,\\tO\\nand\\tO\\nthese\\tO\\nfrequencies\\tO\\ndo\\tO\\nnot\\tO\\ndiffer\\tO\\nsignificantly\\tO\\nbetween\\tO\\npatient\\tO\\nand\\tO\\ncontrol\\tO\\ngroups\\tO\\n.\\tO\\n\\nThus\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\npolymorphisms\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\ndo\\tO\\nnot\\tO\\nmake\\tO\\na\\tO\\nsignificant\\tO\\ncontribution\\tO\\nto\\tO\\nbreast\\tB-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nrisk\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nour\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nArg356\\tO\\nallele\\tO\\nmay\\tO\\nhave\\tO\\na\\tO\\ndifferent\\tO\\ngenotype\\tO\\ndistribution\\tO\\nin\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\nfrom\\tO\\nthat\\tO\\nin\\tO\\ncontrols\\tO\\n(\\tO\\nArg356\\tO\\nhomozygotes\\tO\\nare\\tO\\nmore\\tO\\nfrequent\\tO\\nin\\tO\\nthe\\tO\\ncontrol\\tO\\ngroups\\tO\\n,\\tO\\nP\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n01\\tO\\n)\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nit\\tO\\nmay\\tO\\nbe\\tO\\nprotective\\tO\\nagainst\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nIf\\tO\\nthis\\tO\\nfinding\\tO\\ncan\\tO\\nbe\\tO\\nconfirmed\\tO\\n,\\tO\\nit\\tO\\nmay\\tO\\nprovide\\tO\\nan\\tO\\ninsight\\tO\\ninto\\tO\\nthe\\tO\\nstructural\\tO\\nfeatures\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\nprotein\\tO\\nthat\\tO\\nare\\tO\\nimportant\\tO\\nfor\\tO\\nits\\tO\\nfunction\\tO\\n.\\tO\\n\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\n:\\tO\\nDr\\tO\\n.\\tO\\nW\\tO\\n.\\tO\\n\\nKniest\\tO\\n,\\tO\\nhis\\tO\\npatient\\tO\\n,\\tO\\nthe\\tO\\nmolecular\\tO\\ndefect\\tO\\n.\\tO\\n\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\nis\\tO\\na\\tO\\nsevere\\tO\\nchondrodysplasia\\tB-Disease\\ncaused\\tO\\nby\\tO\\nthe\\tO\\ndefective\\tB-Disease\\nformation\\tI-Disease\\nof\\tI-Disease\\ntype\\tI-Disease\\nII\\tI-Disease\\ncollagen\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nabout\\tO\\nDr\\tO\\n.\\tO\\nKniest\\tO\\n,\\tO\\nwho\\tO\\nfirst\\tO\\ndescribed\\tO\\nthe\\tO\\ncondition\\tO\\nin\\tO\\n1952\\tO\\n,\\tO\\nand\\tO\\nhis\\tO\\npatient\\tO\\n,\\tO\\nwho\\tO\\n,\\tO\\nat\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\n50\\tO\\nyears\\tO\\nis\\tO\\nseverely\\tB-Disease\\nhandicapped\\tI-Disease\\nwith\\tO\\nshort\\tB-Disease\\nstature\\tI-Disease\\n,\\tO\\nrestricted\\tB-Disease\\njoint\\tI-Disease\\nmobility\\tI-Disease\\n,\\tO\\nand\\tO\\nblindness\\tB-Disease\\nbut\\tO\\nis\\tO\\nmentally\\tO\\nalert\\tO\\nand\\tO\\nleads\\tO\\nan\\tO\\nactive\\tO\\nlife\\tO\\n.\\tO\\n\\nMolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nDNA\\tO\\nshowed\\tO\\na\\tO\\nsingle\\tO\\nbase\\tO\\n(\\tO\\nG\\tO\\n)\\tO\\ndeletion\\tO\\ninvolving\\tO\\nthe\\tO\\nGT\\tO\\ndinucleotide\\tO\\nat\\tO\\nthe\\tO\\nstart\\tO\\nof\\tO\\nintron\\tO\\n18\\tO\\ndestroying\\tO\\na\\tO\\nsplice\\tO\\nsite\\tO\\nof\\tO\\nthe\\tO\\nCOL2A1\\tO\\ngene\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\nin\\tO\\naccordance\\tO\\nwith\\tO\\nmolecular\\tO\\nfindings\\tO\\nin\\tO\\nother\\tO\\npatients\\tO\\nwith\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\nand\\tO\\nconfirms\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\noriginal\\tO\\npatient\\tO\\n,\\tO\\nthat\\tO\\nthe\\tO\\ndisorder\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nsmall\\tO\\ninframe\\tO\\ndeletions\\tO\\noften\\tO\\ndue\\tO\\nto\\tO\\nexon\\tO\\nskipping\\tO\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\nCOL2A1\\tO\\nsplice\\tO\\nsite\\tO\\nmutations\\tO\\n.\\tO\\n.\\tO\\n\\nCloning\\tO\\nof\\tO\\nthe\\tO\\nhomogentisate\\tO\\n1\\tO\\n,\\tO\\n2\\tO\\n-\\tO\\ndioxygenase\\tO\\ngene\\tO\\n,\\tO\\nthe\\tO\\nkey\\tO\\nenzyme\\tO\\nof\\tO\\nalkaptonuria\\tB-Disease\\nin\\tO\\nmouse\\tO\\n.\\tO\\n\\nWe\\tO\\ndetermined\\tO\\n48\\tO\\namino\\tO\\nacid\\tO\\nresidues\\tO\\nfrom\\tO\\nfive\\tO\\npeptides\\tO\\nfrom\\tO\\nthe\\tO\\nhomogeneous\\tO\\nmonomer\\tO\\nof\\tO\\nhomogentisate\\tO\\n1\\tO\\n,\\tO\\n2\\tO\\n-\\tO\\ndioxygenase\\tO\\n(\\tO\\nHGO\\tO\\n;\\tO\\nE\\tO\\n.\\tO\\nC\\tO\\n.\\tO\\n1\\tO\\n.\\tO\\n13\\tO\\n.\\tO\\n11\\tO\\n.\\tO\\n15\\tO\\n)\\tO\\nof\\tO\\nmouse\\tO\\nliver\\tO\\n.\\tO\\n\\nAfter\\tO\\ndigestion\\tO\\nwith\\tO\\ntrypsin\\tO\\n,\\tO\\npeptides\\tO\\nwere\\tO\\nseparated\\tO\\nby\\tO\\nreversed\\tO\\nphase\\tO\\nchromatography\\tO\\nand\\tO\\namino\\tO\\nacid\\tO\\nsequenced\\tO\\n.\\tO\\n\\nThe\\tO\\ndeduced\\tO\\ncodon\\tO\\nsequence\\tO\\nof\\tO\\nthree\\tO\\npeptides\\tO\\nwas\\tO\\nused\\tO\\nto\\tO\\nderive\\tO\\ndegenerated\\tO\\noligomeres\\tO\\n.\\tO\\n\\nBy\\tO\\ncombining\\tO\\nthese\\tO\\noligos\\tO\\n,\\tO\\nwe\\tO\\nwere\\tO\\nable\\tO\\nto\\tO\\namplify\\tO\\nfragments\\tO\\nfrom\\tO\\n100\\tO\\nto\\tO\\n300\\tO\\nbases\\tO\\n(\\tO\\nb\\tO\\n)\\tO\\nfrom\\tO\\nmouse\\tO\\nliver\\tO\\ncDNA\\tO\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nafter\\tO\\nreverse\\tO\\ntranscription\\tO\\n(\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nfragment\\tO\\nof\\tO\\n200\\tO\\nb\\tO\\nwas\\tO\\ncloned\\tO\\nand\\tO\\nused\\tO\\nas\\tO\\na\\tO\\nprobe\\tO\\nto\\tO\\nscreen\\tO\\na\\tO\\nmouse\\tO\\nliver\\tO\\ncDNA\\tO\\nlibrary\\tO\\n.\\tO\\n\\nOne\\tO\\nclone\\tO\\nfrom\\tO\\nthis\\tO\\nlibrary\\tO\\ncontained\\tO\\nthe\\tO\\ncomplete\\tO\\ncDNA\\tO\\n-\\tO\\ninsert\\tO\\nfor\\tO\\nHGO\\tO\\nas\\tO\\ndetermined\\tO\\nby\\tO\\nsequencing\\tO\\n.\\tO\\n\\nThe\\tO\\ncDNA\\tO\\nencodes\\tO\\nfor\\tO\\na\\tO\\nprotein\\tO\\nof\\tO\\n50\\tO\\nkDa\\tO\\n,\\tO\\nas\\tO\\npredicted\\tO\\n.\\tO\\n\\nThe\\tO\\ncDNA\\tO\\nof\\tO\\nmouse\\tO\\nHGO\\tO\\nhas\\tO\\nan\\tO\\noverall\\tO\\nidentity\\tO\\nof\\tO\\n41\\tO\\n%\\tO\\nto\\tO\\nthe\\tO\\ncorresponding\\tO\\ngene\\tO\\nhmgA\\tO\\nfrom\\tO\\nAspergillus\\tO\\n.\\tO\\n\\nSequence\\tO\\nsimilarities\\tO\\nto\\tO\\nhuman\\tO\\nexpressed\\tO\\nsequence\\tO\\ntags\\tO\\n(\\tO\\nEST\\tO\\n)\\tO\\nclones\\tO\\nranged\\tO\\nfrom\\tO\\n70\\tO\\n%\\tO\\nto\\tO\\n20\\tO\\n%\\tO\\n.\\tO\\n\\nThe\\tO\\npositions\\tO\\nof\\tO\\n122\\tO\\nconserved\\tO\\namino\\tO\\nacids\\tO\\ncould\\tO\\nbe\\tO\\ndetermined\\tO\\nby\\tO\\nmultiple\\tO\\nsequence\\tO\\nalignment\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\none\\tO\\nfirst\\tO\\nintron\\tO\\nof\\tO\\n928\\tO\\nb\\tO\\nin\\tO\\nthe\\tO\\nmouse\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nfor\\tO\\nHGO\\tO\\nseems\\tO\\nto\\tO\\nbe\\tO\\nexpressed\\tO\\nin\\tO\\nvarious\\tO\\ntissues\\tO\\n,\\tO\\nas\\tO\\nshown\\tO\\nby\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\non\\tO\\ndifferent\\tO\\ncDNAs\\tO\\n.\\tO\\n\\nFISH\\tO\\nexperiments\\tO\\nwith\\tO\\nthe\\tO\\nwhole\\tO\\nmurine\\tO\\ncDNA\\tO\\nas\\tO\\nprobe\\tO\\nclearly\\tO\\nrevealed\\tO\\nsignals\\tO\\nat\\tO\\nthe\\tO\\nhuman\\tO\\nchromosomal\\tO\\nband\\tO\\n3q13\\tO\\n.\\tO\\n\\n3\\tO\\n-\\tO\\nq21\\tO\\n.\\tO\\n\\nThis\\tO\\ncorresponds\\tO\\nwell\\tO\\nto\\tO\\nthe\\tO\\nprevious\\tO\\nassignment\\tO\\nof\\tO\\nthe\\tO\\nlocus\\tO\\nfor\\tO\\nthe\\tO\\nhuman\\tO\\nalkaptonuria\\tB-Disease\\ngene\\tO\\n(\\tO\\nAKU\\tO\\n)\\tO\\nto\\tO\\nthe\\tO\\nsame\\tO\\nchromosomal\\tO\\nregion\\tO\\nby\\tO\\nmultipoint\\tO\\nlinkage\\tO\\nanalysis\\tO\\n.\\tO\\n\\nWe\\tO\\ntherefore\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\nHGO\\tO\\ncDNA\\tO\\nencodes\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nalkaptonuria\\tB-Disease\\n.\\tO\\n\\nPTEN\\tO\\n,\\tO\\na\\tO\\nputative\\tO\\nprotein\\tO\\ntyrosine\\tO\\nphosphatase\\tO\\ngene\\tO\\nmutated\\tO\\nin\\tO\\nhuman\\tO\\nbrain\\tB-Disease\\n,\\tI-Disease\\nbreast\\tI-Disease\\n,\\tI-Disease\\nand\\tI-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nMapping\\tO\\nof\\tO\\nhomozygous\\tO\\ndeletions\\tO\\non\\tO\\nhuman\\tO\\nchromosome\\tO\\n10q23\\tO\\nhas\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nisolation\\tO\\nof\\tO\\na\\tO\\ncandidate\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n,\\tO\\nPTEN\\tO\\n,\\tO\\nthat\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\nmutated\\tO\\nat\\tO\\nconsiderable\\tO\\nfrequency\\tO\\nin\\tO\\nhuman\\tO\\ncancers\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\npreliminary\\tO\\nscreens\\tO\\n,\\tO\\nmutations\\tO\\nof\\tO\\nPTEN\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\n31\\tO\\n%\\tO\\n(\\tO\\n13\\tO\\n/\\tO\\n42\\tO\\n)\\tO\\nof\\tO\\nglioblastoma\\tB-Disease\\ncell\\tO\\nlines\\tO\\nand\\tO\\nxenografts\\tO\\n,\\tO\\n100\\tO\\n%\\tO\\n(\\tO\\n4\\tO\\n/\\tO\\n4\\tO\\n)\\tO\\nof\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\ncell\\tO\\nlines\\tO\\n,\\tO\\n6\\tO\\n%\\tO\\n(\\tO\\n4\\tO\\n/\\tO\\n65\\tO\\n)\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\ncell\\tO\\nlines\\tO\\nand\\tO\\nxenografts\\tO\\n,\\tO\\nand\\tO\\n17\\tO\\n%\\tO\\n(\\tO\\n3\\tO\\n/\\tO\\n18\\tO\\n)\\tO\\nof\\tO\\nprimary\\tB-Disease\\nglioblastomas\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\npredicted\\tO\\nPTEN\\tO\\nproduct\\tO\\nhas\\tO\\na\\tO\\nprotein\\tO\\ntyrosine\\tO\\nphosphatase\\tO\\ndomain\\tO\\nand\\tO\\nextensive\\tO\\nhomology\\tO\\nto\\tO\\ntensin\\tO\\n,\\tO\\na\\tO\\nprotein\\tO\\nthat\\tO\\ninteracts\\tO\\nwith\\tO\\nactin\\tO\\nfilaments\\tO\\nat\\tO\\nfocal\\tO\\nadhesions\\tO\\n.\\tO\\n\\nThese\\tO\\nhomologies\\tO\\nsuggest\\tO\\nthat\\tO\\nPTEN\\tO\\nmay\\tO\\nsuppress\\tO\\ntumor\\tB-Disease\\ncell\\tO\\ngrowth\\tO\\nby\\tO\\nantagonizing\\tO\\nprotein\\tO\\ntyrosine\\tO\\nkinases\\tO\\nand\\tO\\nmay\\tO\\nregulate\\tO\\ntumor\\tB-Disease\\ncell\\tO\\ninvasion\\tO\\nand\\tO\\nmetastasis\\tB-Disease\\nthrough\\tO\\ninteractions\\tO\\nat\\tO\\nfocal\\tO\\nadhesions\\tO\\n.\\tO\\n.\\tO\\n\\nHeterogeneity\\tO\\nin\\tO\\nSchwartz\\tB-Disease\\n-\\tI-Disease\\nJampel\\tI-Disease\\nchondrodystrophic\\tI-Disease\\nmyotonia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nSchwartz\\tB-Disease\\n-\\tI-Disease\\nJampel\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nSJS\\tB-Disease\\n;\\tO\\nchondrodystrophic\\tB-Disease\\nmyotonia\\tI-Disease\\n;\\tO\\nMcK\\tO\\n255\\tO\\n,\\tO\\n800\\tO\\n)\\tO\\nis\\tO\\na\\tO\\nrecessively\\tB-Disease\\ninherited\\tI-Disease\\ncondition\\tI-Disease\\ndefined\\tO\\nby\\tO\\nmyotonia\\tB-Disease\\n,\\tO\\nshort\\tB-Disease\\nstature\\tI-Disease\\n,\\tO\\nand\\tO\\nbone\\tB-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nGenetic\\tO\\nlinkage\\tO\\nbetween\\tO\\nSJS\\tB-Disease\\nand\\tO\\nchromosomal\\tO\\nregion\\tO\\n1q36\\tO\\n-\\tO\\n34\\tO\\nhas\\tO\\nbeen\\tO\\nobserved\\tO\\nin\\tO\\nseveral\\tO\\nfamilies\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\ngene\\tO\\nhas\\tO\\nnot\\tO\\nyet\\tO\\nbeen\\tO\\nidentified\\tO\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\nthe\\tO\\nclinical\\tO\\nand\\tO\\nradiological\\tO\\nfeatures\\tO\\nin\\tO\\n81\\tO\\npatients\\tO\\nfrom\\tO\\nthe\\tO\\nliterature\\tO\\nand\\tO\\n5\\tO\\nown\\tO\\npatients\\tO\\ntrying\\tO\\nto\\tO\\nidentify\\tO\\ndistinct\\tO\\nsubgroups\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\ntested\\tO\\ngenetic\\tO\\nlinkage\\tO\\nto\\tO\\nthe\\tO\\nSJS\\tB-Disease\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n1\\tO\\nin\\tO\\none\\tO\\nfamily\\tO\\nwith\\tO\\ntwo\\tO\\naffected\\tO\\nsibs\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nthat\\tO\\na\\tO\\ngroup\\tO\\nof\\tO\\npatients\\tO\\nhave\\tO\\nmild\\tO\\nskeletal\\tO\\nchanges\\tO\\nwhich\\tO\\nmay\\tO\\nbe\\tO\\nsecondary\\tO\\nconsequences\\tO\\nof\\tO\\nmyotonia\\tB-Disease\\n,\\tO\\nwhile\\tO\\nanother\\tO\\ngroup\\tO\\nof\\tO\\npatients\\tO\\nappear\\tO\\nto\\tO\\nhave\\tO\\nprimary\\tO\\nbone\\tB-Disease\\ndysplasia\\tI-Disease\\nwith\\tO\\nmyotonia\\tB-Disease\\n.\\tO\\n\\nWithin\\tO\\nthis\\tO\\nlatter\\tO\\ngroup\\tO\\n,\\tO\\nthere\\tO\\nare\\tO\\ndifferences\\tO\\nin\\tO\\nage\\tO\\nof\\tO\\nmanifestation\\tO\\n,\\tO\\nclinical\\tO\\ncourse\\tO\\nand\\tO\\npattern\\tO\\nof\\tO\\nbone\\tO\\nchanges\\tO\\n.\\tO\\n\\nWe\\tO\\ntentatively\\tO\\nisolate\\tO\\nthree\\tO\\ndifferent\\tO\\ntypes\\tO\\nof\\tO\\nSJS\\tB-Disease\\ntype\\tI-Disease\\n1A\\tI-Disease\\n,\\tO\\nusually\\tO\\nrecognized\\tO\\nin\\tO\\nchildhood\\tO\\n,\\tO\\nwith\\tO\\nmoderate\\tO\\nbone\\tB-Disease\\ndysplasia\\tI-Disease\\n,\\tO\\ncorresponding\\tO\\nto\\tO\\nthe\\tO\\noriginal\\tO\\ndescriptions\\tO\\nof\\tO\\nSchwartz\\tO\\n,\\tO\\nJampel\\tO\\nand\\tO\\nAberfeld\\tO\\n;\\tO\\ntype\\tO\\n1B\\tO\\n,\\tO\\nsimilar\\tO\\nto\\tO\\ntype\\tO\\n1A\\tO\\nbut\\tO\\nrecognizable\\tO\\nat\\tO\\nbirth\\tO\\n,\\tO\\nwith\\tO\\nmore\\tO\\npronounced\\tO\\nbone\\tB-Disease\\ndysplasia\\tI-Disease\\nresembling\\tO\\nKniest\\tB-Disease\\ndysplasia\\tI-Disease\\n;\\tO\\nand\\tO\\ntype\\tO\\n2\\tO\\n,\\tO\\nmanifest\\tO\\nat\\tO\\nbirth\\tO\\n,\\tO\\nwith\\tO\\nincreased\\tO\\nmortality\\tO\\nand\\tO\\nbone\\tB-Disease\\ndysplasia\\tI-Disease\\nresembling\\tO\\nPyle\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nGenetic\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nfamily\\tO\\nwith\\tO\\ntwo\\tO\\nsibs\\tO\\naffected\\tO\\nby\\tO\\nSJS\\tB-Disease\\ntype\\tI-Disease\\n2\\tI-Disease\\nshowed\\tO\\nevidence\\tO\\nagainst\\tO\\nlinkage\\tO\\nto\\tO\\nchromosome\\tO\\n1p36\\tO\\n-\\tO\\n34\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nSJS\\tB-Disease\\nis\\tO\\nclinically\\tO\\nand\\tO\\nradiologically\\tO\\nheterogeneous\\tO\\n.\\tO\\n\\nThe\\tO\\ncauses\\tO\\nof\\tO\\nheterogeneity\\tO\\nare\\tO\\nnot\\tO\\nknown\\tO\\nyet\\tO\\nbut\\tO\\nare\\tO\\nlikely\\tO\\nto\\tO\\ninclude\\tO\\nboth\\tO\\ndifferent\\tO\\nmutations\\tO\\nat\\tO\\nthe\\tO\\nSJS\\tB-Disease\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n1\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nsecond\\tO\\nSJS\\tB-Disease\\nlocus\\tO\\n.\\tO\\n\\nA\\tO\\ntentative\\tO\\nclinico\\tO\\n-\\tO\\nradiological\\tO\\nclassification\\tO\\ncan\\tO\\nbe\\tO\\nuseful\\tO\\nfor\\tO\\nthe\\tO\\ncharacterization\\tO\\nof\\tO\\npatients\\tO\\nand\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nclinical\\tO\\noverview\\tO\\nof\\tO\\nWT1\\tO\\ngene\\tO\\nmutations\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nWT1\\tO\\ngene\\tO\\nwere\\tO\\nanticipated\\tO\\nto\\tO\\nexplain\\tO\\nthe\\tO\\ngenetic\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\nchildhood\\tO\\nkidney\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nWilms\\tB-Disease\\ntumour\\tI-Disease\\n(\\tO\\nWT\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nSix\\tO\\nyears\\tO\\non\\tO\\n,\\tO\\nwe\\tO\\nreview\\tO\\n100\\tO\\nreports\\tO\\nof\\tO\\nintragenic\\tO\\nWT1\\tO\\nmutations\\tO\\nand\\tO\\nexamine\\tO\\nthe\\tO\\naccompanying\\tO\\nclinical\\tO\\nphenotypes\\tO\\n.\\tO\\n\\nWhile\\tO\\nonly\\tO\\n5\\tO\\n%\\tO\\nof\\tO\\nsporadic\\tB-Disease\\nWilms\\tI-Disease\\ntumours\\tI-Disease\\nhave\\tO\\nintragenic\\tO\\nWT1\\tO\\nmutations\\tO\\n,\\tO\\n>\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nrenal\\tB-Disease\\nnephropathy\\tI-Disease\\n,\\tO\\ngonadal\\tB-Disease\\nanomaly\\tI-Disease\\n,\\tO\\npredisposition\\tB-Disease\\nto\\tI-Disease\\nWT\\tI-Disease\\n)\\tO\\ncarry\\tO\\nconstitutional\\tO\\nintragenic\\tO\\nWT1\\tO\\nmutations\\tO\\n.\\tO\\n\\nWT1\\tO\\nmutations\\tO\\nhave\\tO\\nalso\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\njuvenile\\tB-Disease\\ngranulosa\\tI-Disease\\ncell\\tI-Disease\\ntumour\\tI-Disease\\n,\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nasbestos\\tI-Disease\\nrelated\\tI-Disease\\nmesothelioma\\tI-Disease\\n,\\tO\\ndesmoplastic\\tB-Disease\\nsmall\\tI-Disease\\nround\\tI-Disease\\ncell\\tI-Disease\\ntumour\\tI-Disease\\nand\\tO\\n,\\tO\\nmost\\tO\\nrecently\\tO\\n,\\tO\\nacute\\tB-Disease\\nmyeloid\\tI-Disease\\nleukemia\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nmutation\\tO\\nin\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nmyotonia\\tI-Disease\\ncongenita\\tI-Disease\\naffects\\tO\\npore\\tO\\nproperties\\tO\\nof\\tO\\nthe\\tO\\nmuscle\\tO\\nchloride\\tO\\nchannel\\tO\\n.\\tO\\n\\nAutosomal\\tB-Disease\\ndominant\\tI-Disease\\nmyotonia\\tI-Disease\\ncongenita\\tI-Disease\\nis\\tO\\nan\\tO\\ninherited\\tB-Disease\\ndisorder\\tI-Disease\\nof\\tI-Disease\\nskeletal\\tI-Disease\\nmuscle\\tI-Disease\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\nvoltage\\tO\\n-\\tO\\ngated\\tO\\nCl\\tO\\n-\\tO\\nchannel\\tO\\ngene\\tO\\n(\\tO\\nCLCN1\\tO\\n,\\tO\\n7q35\\tO\\n)\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\na\\tO\\nmutation\\tO\\npredicting\\tO\\nthe\\tO\\nsubstitution\\tO\\nof\\tO\\nGly\\tO\\n230\\tO\\nby\\tO\\nglutamic\\tO\\nacid\\tO\\n(\\tO\\nG230E\\tO\\n)\\tO\\nbetween\\tO\\nsegments\\tO\\nD3\\tO\\nand\\tO\\nD4\\tO\\ndramatically\\tO\\nalters\\tO\\nthe\\tO\\npore\\tO\\nproperties\\tO\\nof\\tO\\na\\tO\\nrecombinant\\tO\\nhuman\\tO\\nmuscle\\tO\\nCl\\tO\\n-\\tO\\nchannel\\tO\\n(\\tO\\nhCIC\\tO\\n-\\tO\\n1\\tO\\n)\\tO\\nexpressed\\tO\\nin\\tO\\na\\tO\\nmammalian\\tO\\ncell\\tO\\nline\\tO\\n(\\tO\\ntsA201\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nG230E\\tO\\nmutation\\tO\\ncauses\\tO\\nsubstantial\\tO\\nchanges\\tO\\nin\\tO\\nanion\\tO\\nand\\tO\\ncation\\tO\\nselectivity\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\na\\tO\\nfundamental\\tO\\nchange\\tO\\nin\\tO\\nrectification\\tO\\nof\\tO\\nthe\\tO\\ncurrent\\tO\\n-\\tO\\nvoltage\\tO\\nrelationship\\tO\\n.\\tO\\n\\nWhereas\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nchannels\\tO\\nare\\tO\\ncharacterized\\tO\\nby\\tO\\npronounced\\tO\\ninward\\tO\\nrectification\\tO\\nand\\tO\\na\\tO\\nCl\\tO\\n>\\tO\\nthiocyanate\\tO\\n>\\tO\\nBr\\tO\\n>\\tO\\nNO\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\n>\\tO\\nI\\tO\\n>\\tO\\nCH\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\nSO\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\nselectivity\\tO\\n,\\tO\\nG230E\\tO\\nexhibits\\tO\\noutward\\tO\\nrectification\\tO\\nat\\tO\\npositive\\tO\\npotentials\\tO\\nand\\tO\\na\\tO\\nthiocyanate\\tO\\n>\\tO\\nNO\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\n>\\tO\\nI\\tO\\n>\\tO\\nBr\\tO\\n>\\tO\\nCl\\tO\\n>\\tO\\nCH\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\nSO\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\nselectivity\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nthe\\tO\\ncation\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nanion\\tO\\npermeability\\tO\\nratio\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nis\\tO\\nmuch\\tO\\ngreater\\tO\\nthan\\tO\\nthat\\tO\\nof\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nchannel\\tO\\n.\\tO\\n\\nVoltage\\tO\\n-\\tO\\ndependent\\tO\\nblocks\\tO\\nby\\tO\\nintracellular\\tO\\nand\\tO\\nextracellular\\tO\\niodide\\tO\\nhelp\\tO\\nto\\tO\\ndistinguish\\tO\\ntwo\\tO\\ndistinct\\tO\\nion\\tO\\nbinding\\tO\\nsites\\tO\\nwithin\\tO\\nthe\\tO\\nhClC\\tO\\n-\\tO\\n1\\tO\\nconduction\\tO\\npathway\\tO\\n.\\tO\\n\\nBoth\\tO\\nbinding\\tO\\nsites\\tO\\nare\\tO\\npreserved\\tO\\nin\\tO\\nthe\\tO\\nmutant\\tO\\nbut\\tO\\nhave\\tO\\ndecreased\\tO\\naffinities\\tO\\nfor\\tO\\niodide\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nGly\\tO\\n230\\tO\\nis\\tO\\ncritical\\tO\\nfor\\tO\\nnormal\\tO\\nion\\tO\\nconductance\\tO\\nin\\tO\\nhClC\\tO\\n-\\tO\\n1\\tO\\nand\\tO\\nthat\\tO\\nthis\\tO\\nresidue\\tO\\nresides\\tO\\nwithin\\tO\\nthe\\tO\\nchannel\\tO\\npore\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nincidence\\tO\\nof\\tO\\nPAX6\\tO\\nmutation\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nsimple\\tO\\naniridia\\tB-Disease\\n:\\tO\\nan\\tO\\nevaluation\\tO\\nof\\tO\\nmutation\\tO\\ndetection\\tO\\nin\\tO\\n12\\tO\\ncases\\tO\\n.\\tO\\n\\nTwelve\\tO\\naniridia\\tB-Disease\\npatients\\tO\\n,\\tO\\nfive\\tO\\nwith\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nand\\tO\\nseven\\tO\\npresumed\\tO\\nto\\tO\\nbe\\tO\\nsporadic\\tO\\n,\\tO\\nwere\\tO\\nexhaustively\\tO\\nscreened\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\ntest\\tO\\nwhat\\tO\\nproportion\\tO\\nof\\tO\\npeople\\tO\\nwith\\tO\\naniridia\\tB-Disease\\n,\\tO\\nuncomplicated\\tO\\nby\\tO\\nassociated\\tO\\nanomalies\\tO\\n,\\tO\\ncarry\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nPAX6\\tO\\ngene\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ncases\\tO\\n.\\tO\\n\\nThree\\tO\\nmutation\\tO\\ndetection\\tO\\ntechniques\\tO\\nwere\\tO\\nused\\tO\\nto\\tO\\ndetermine\\tO\\nif\\tO\\none\\tO\\nmethod\\tO\\nwas\\tO\\nsuperior\\tO\\nfor\\tO\\nthis\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nprotein\\tO\\ntruncation\\tO\\ntest\\tO\\n(\\tO\\nPTT\\tO\\n)\\tO\\nwas\\tO\\nused\\tO\\non\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nproducts\\tO\\n,\\tO\\nSSCP\\tO\\non\\tO\\ngenomic\\tO\\nPCR\\tO\\namplifications\\tO\\n,\\tO\\nand\\tO\\nchemical\\tO\\ncleavage\\tO\\nof\\tO\\nmismatch\\tO\\non\\tO\\nboth\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nand\\tO\\ngenomic\\tO\\namplifications\\tO\\n.\\tO\\n\\nFor\\tO\\nRT\\tO\\n-\\tO\\nPCR\\tO\\nproducts\\tO\\n,\\tO\\nonly\\tO\\nthe\\tO\\ntranslated\\tO\\nportion\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nwas\\tO\\nscreened\\tO\\n.\\tO\\n\\nOn\\tO\\ngenomic\\tO\\nproducts\\tO\\nexons\\tO\\n1\\tO\\nto\\tO\\n13\\tO\\n(\\tO\\nincluding\\tO\\n740\\tO\\nbp\\tO\\nof\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nsequence\\tO\\nand\\tO\\nall\\tO\\nintron\\tO\\n/\\tO\\nexon\\tO\\nboundaries\\tO\\n)\\tO\\nwere\\tO\\nscreened\\tO\\n,\\tO\\nas\\tO\\nwas\\tO\\na\\tO\\nneuroretina\\tO\\nspecific\\tO\\nenhancer\\tO\\nin\\tO\\nintron\\tO\\n4\\tO\\n.\\tO\\n\\nTen\\tO\\nof\\tO\\nthe\\tO\\npossible\\tO\\n12\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nfive\\tO\\nfamilial\\tO\\ncases\\tO\\nand\\tO\\nfive\\tO\\nof\\tO\\nthe\\tO\\nsporadic\\tO\\npatients\\tO\\nwere\\tO\\nfound\\tO\\n,\\tO\\nall\\tO\\nof\\tO\\nwhich\\tO\\nconformed\\tO\\nto\\tO\\na\\tO\\nfunctional\\tO\\noutcome\\tO\\nof\\tO\\nhaploinsufficiency\\tO\\n.\\tO\\n\\nFive\\tO\\nwere\\tO\\nsplice\\tO\\nsite\\tO\\nmutations\\tO\\n(\\tO\\none\\tO\\nin\\tO\\nthe\\tO\\ndonor\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n4\\tO\\n,\\tO\\ntwo\\tO\\nin\\tO\\nthe\\tO\\ndonor\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n6\\tO\\n,\\tO\\none\\tO\\nin\\tO\\neach\\tO\\nof\\tO\\nthe\\tO\\nacceptor\\tO\\nsites\\tO\\nof\\tO\\nintrons\\tO\\n8\\tO\\nand\\tO\\n9\\tO\\n)\\tO\\nand\\tO\\nfive\\tO\\nwere\\tO\\nnonsense\\tO\\nmutations\\tO\\nin\\tO\\nexons\\tO\\n8\\tO\\n,\\tO\\n9\\tO\\n,\\tO\\n10\\tO\\n,\\tO\\n11\\tO\\n,\\tO\\nand\\tO\\n12\\tO\\n.\\tO\\n\\nSSCP\\tO\\nanalysis\\tO\\nof\\tO\\nindividually\\tO\\namplified\\tO\\nexons\\tO\\n,\\tO\\nwith\\tO\\nwhich\\tO\\nnine\\tO\\nof\\tO\\nthe\\tO\\n10\\tO\\nmutations\\tO\\nwere\\tO\\nseen\\tO\\n,\\tO\\nwas\\tO\\nthe\\tO\\nmost\\tO\\nuseful\\tO\\ndetection\\tO\\nmethod\\tO\\nfor\\tO\\nPAX6\\tO\\n.\\tO\\n.\\tO\\n\\nInsulin\\tO\\ngene\\tO\\nregion\\tO\\ncontributes\\tO\\nto\\tO\\ngenetic\\tO\\nsusceptibility\\tO\\nto\\tO\\n,\\tO\\nbut\\tO\\nmay\\tO\\nnot\\tO\\nto\\tO\\nlow\\tO\\nincidence\\tO\\nof\\tO\\n,\\tO\\ninsulin\\tB-Disease\\n-\\tI-Disease\\ndependent\\tI-Disease\\ndiabetes\\tI-Disease\\nmellitus\\tI-Disease\\nin\\tO\\nJapanese\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nCaucasian\\tO\\npopulation\\tO\\n,\\tO\\nit\\tO\\nhas\\tO\\nbeen\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\ninsulin\\tO\\ngene\\tO\\n(\\tO\\nINS\\tO\\n)\\tO\\nregion\\tO\\ncontains\\tO\\nthe\\tO\\ninsulin\\tB-Disease\\n-\\tI-Disease\\ndependent\\tI-Disease\\ndiabetes\\tI-Disease\\nmellitus\\tI-Disease\\nlocus\\tO\\n(\\tO\\nIDDM2\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nJapanese\\tO\\npopulation\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nthere\\tO\\nhas\\tO\\nbeen\\tO\\nno\\tO\\nreport\\tO\\ndemonstrating\\tO\\nthe\\tO\\ncontribution\\tO\\nof\\tO\\nIDDM2\\tO\\nto\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nIDDM\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nconducted\\tO\\nan\\tO\\nassociation\\tO\\nstudy\\tO\\nof\\tO\\nIDDM\\tB-Disease\\nin\\tO\\na\\tO\\nlarge\\tO\\nnumber\\tO\\nof\\tO\\nJapanese\\tO\\nsubjects\\tO\\nwith\\tO\\nmultiple\\tO\\npolymorphisms\\tO\\nin\\tO\\nINS\\tO\\nregion\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\na\\tO\\nsignificant\\tO\\nassociation\\tO\\nof\\tO\\nthe\\tO\\nINS\\tO\\nregion\\tO\\nwith\\tO\\nIDDM\\tB-Disease\\n.\\tO\\n\\nAlleles\\tO\\npositively\\tO\\nassociated\\tO\\nwith\\tO\\nIDDM\\tB-Disease\\nin\\tO\\nINS\\tO\\nregion\\tO\\nwere\\tO\\nthe\\tO\\nsame\\tO\\nas\\tO\\nthose\\tO\\npositively\\tO\\n-\\tO\\nassociated\\tO\\nwith\\tO\\nIDDM\\tB-Disease\\nin\\tO\\nCaucasian\\tO\\npopulation\\tO\\n,\\tO\\nalthough\\tO\\npositively\\tO\\n-\\tO\\nassociated\\tO\\nalleles\\tO\\nare\\tO\\nvery\\tO\\ncommon\\tO\\n(\\tO\\nallele\\tO\\nfrequencies\\tO\\n>\\tO\\n0\\tO\\n.\\tO\\n9\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nJapanese\\tO\\ngeneral\\tO\\npopulation\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nIDDM2\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\ngenetic\\tO\\nsusceptibility\\tO\\nto\\tO\\nIDDM\\tB-Disease\\nin\\tO\\nJapanese\\tO\\n.\\tO\\n\\nThe\\tO\\nhigh\\tO\\nfrequencies\\tO\\nof\\tO\\ndisease\\tO\\n-\\tO\\nassociated\\tO\\nalleles\\tO\\nin\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\nsuggest\\tO\\nthat\\tO\\nIDDM2\\tO\\nlocus\\tO\\nis\\tO\\nnot\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nlow\\tO\\nincidence\\tO\\nof\\tO\\nIDDM\\tB-Disease\\nin\\tO\\nJapanese\\tO\\n.\\tO\\n\\nThe\\tO\\nhuman\\tO\\ncomplement\\tO\\nC9\\tO\\ngene\\tO\\n:\\tO\\nidentification\\tO\\nof\\tO\\ntwo\\tO\\nmutations\\tO\\ncausing\\tO\\ndeficiency\\tO\\nand\\tO\\nrevision\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nstructure\\tO\\n.\\tO\\n\\nThe\\tO\\nninth\\tO\\ncomponent\\tO\\nof\\tO\\nhuman\\tO\\ncomplement\\tO\\n(\\tO\\nC9\\tO\\n)\\tO\\nis\\tO\\nthe\\tO\\nlast\\tO\\nof\\tO\\nthe\\tO\\nterminal\\tO\\ncomplement\\tO\\ncomponents\\tO\\ncreating\\tO\\nthe\\tO\\nmembrane\\tO\\nattack\\tO\\ncomplex\\tO\\n.\\tO\\n\\nC9\\tO\\nis\\tO\\na\\tO\\nsingle\\tO\\n-\\tO\\nchain\\tO\\nserum\\tO\\nprotein\\tO\\nthat\\tO\\nis\\tO\\nencoded\\tO\\nby\\tO\\na\\tO\\ngene\\tO\\nlocated\\tO\\non\\tO\\nchromosome\\tO\\n5p\\tO\\n.\\tO\\n\\nDeficiency\\tB-Disease\\nof\\tI-Disease\\nterminal\\tI-Disease\\ncomplement\\tI-Disease\\ncomponents\\tI-Disease\\nis\\tO\\ngenerally\\tO\\nassociated\\tO\\nwith\\tO\\nrecurrent\\tO\\nneisseria\\tB-Disease\\ninfections\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\na\\tO\\npreviously\\tO\\ndescribed\\tO\\nSwiss\\tO\\nfamily\\tO\\nwith\\tO\\ninherited\\tB-Disease\\nC9\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\nidentify\\tO\\nthe\\tO\\ngenetic\\tO\\nbasis\\tO\\nof\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nwe\\tO\\ndeveloped\\tO\\nan\\tO\\napproach\\tO\\nusing\\tO\\nexon\\tO\\n-\\tO\\nspecific\\tO\\nPCR\\tO\\nand\\tO\\ndirect\\tO\\nDNA\\tO\\nsequencing\\tO\\n.\\tO\\n\\nAs\\tO\\na\\tO\\ncause\\tO\\nof\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nwe\\tO\\nfound\\tO\\ntwo\\tO\\ndifferent\\tO\\npoint\\tO\\nmutations\\tO\\n,\\tO\\nboth\\tO\\ngenerating\\tO\\nTGA\\tO\\nstop\\tO\\ncodons\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\n.\\tO\\n\\nOne\\tO\\nmutation\\tO\\n,\\tO\\na\\tO\\nC\\tO\\nto\\tO\\nA\\tO\\nexchange\\tO\\n,\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nexon\\tO\\n2\\tO\\nat\\tO\\ncDNA\\tO\\nposition\\tO\\n166\\tO\\n,\\tO\\nthe\\tO\\nother\\tO\\n,\\tO\\na\\tO\\nC\\tO\\nto\\tO\\nT\\tO\\nexchange\\tO\\n,\\tO\\nwas\\tO\\nlocated\\tO\\nin\\tO\\nexon\\tO\\n4\\tO\\n(\\tO\\ncDNA\\tO\\nposition\\tO\\n464\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nfamily\\tO\\nstudies\\tO\\nof\\tO\\nthree\\tO\\nfirst\\tO\\n-\\tO\\ndegree\\tO\\nrelatives\\tO\\nwith\\tO\\nheterozygous\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nwe\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\ntwo\\tO\\nmutations\\tO\\nare\\tO\\nsegregating\\tO\\nindependently\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\nthese\\tO\\nmutations\\tO\\nare\\tO\\nsufficient\\tO\\nto\\tO\\nexplain\\tO\\nthe\\tO\\ncomplete\\tO\\ndeficiency\\tO\\nof\\tO\\nboth\\tO\\nthe\\tO\\nprobands\\tO\\nstudied\\tO\\n.\\tO\\n\\nDNA\\tO\\nsequencing\\tO\\nof\\tO\\nthe\\tO\\nexon\\tO\\n-\\tO\\nintron\\tO\\njunctions\\tO\\nrevealed\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nrevisions\\tO\\nregarding\\tO\\nthe\\tO\\nboundaries\\tO\\nbetween\\tO\\nexons\\tO\\n4\\tO\\n,\\tO\\n5\\tO\\n,\\tO\\nand\\tO\\n6\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nbetween\\tO\\nexons\\tO\\n10\\tO\\nand\\tO\\n11\\tO\\n.\\tO\\n\\nNo\\tO\\nadditional\\tO\\nintrons\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nexons\\tO\\n6\\tO\\nand\\tO\\n10\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nDNA\\tO\\nmarker\\tO\\nstudies\\tO\\nwere\\tO\\nconducted\\tO\\nusing\\tO\\nknown\\tO\\npolymorphisms\\tO\\nof\\tO\\nthe\\tO\\nC6\\tO\\n,\\tO\\nC7\\tO\\n,\\tO\\nand\\tO\\nC9\\tO\\ngenes\\tO\\n,\\tO\\nconfirming\\tO\\nthe\\tO\\nlinkage\\tO\\nof\\tO\\nthe\\tO\\nobserved\\tO\\nC9\\tO\\nmutations\\tO\\nwith\\tO\\ndefined\\tO\\nhaplotypes\\tO\\n.\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nmutations\\tO\\nin\\tO\\nwomen\\tO\\nattending\\tO\\nclinics\\tO\\nthat\\tO\\nevaluate\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nBACKGROUND\\tO\\nTo\\tO\\ndefine\\tO\\nthe\\tO\\nincidence\\tO\\nof\\tO\\nBRCA1\\tO\\nmutations\\tO\\namong\\tO\\npatients\\tO\\nseen\\tO\\nin\\tO\\nclinics\\tO\\nthat\\tO\\nevaluate\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nwe\\tO\\nanalyzed\\tO\\nDNA\\tO\\nsamples\\tO\\nfrom\\tO\\nwomen\\tO\\nseen\\tO\\nin\\tO\\nthis\\tO\\nsetting\\tO\\nand\\tO\\nconstructed\\tO\\nprobability\\tO\\ntables\\tO\\nto\\tO\\nprovide\\tO\\nestimates\\tO\\nof\\tO\\nthe\\tO\\nlikelihood\\tO\\nof\\tO\\nfinding\\tO\\na\\tO\\nBRCA1\\tO\\nmutation\\tO\\nin\\tO\\nindividual\\tO\\nfamilies\\tO\\n.\\tO\\n\\nMETHODS\\tO\\nClinical\\tO\\ninformation\\tO\\n,\\tO\\nfamily\\tO\\nhistories\\tO\\n,\\tO\\nand\\tO\\nblood\\tO\\nfor\\tO\\nDNA\\tO\\nanalysis\\tO\\nwere\\tO\\nobtained\\tO\\nfrom\\tO\\n263\\tO\\nwomen\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nConformation\\tO\\n-\\tO\\nsensitive\\tO\\ngel\\tO\\nelectrophoresis\\tO\\nand\\tO\\nDNA\\tO\\nsequencing\\tO\\nwere\\tO\\nused\\tO\\nto\\tO\\nidentify\\tO\\nBRCA1\\tO\\nmutations\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nBRCA1\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\n16\\tO\\npercent\\tO\\nof\\tO\\nwomen\\tO\\nwith\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nOnly\\tO\\n7\\tO\\npercent\\tO\\nof\\tO\\nwomen\\tO\\nfrom\\tO\\nfamilies\\tO\\nwith\\tO\\na\\tO\\nhistory\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nbut\\tO\\nnot\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nhad\\tO\\nBRCA1\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nrates\\tO\\nwere\\tO\\nhigher\\tO\\namong\\tO\\nwomen\\tO\\nfrom\\tO\\nfamilies\\tO\\nwith\\tO\\na\\tO\\nhistory\\tO\\nof\\tO\\nboth\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nAmong\\tO\\nfamily\\tO\\nmembers\\tO\\n,\\tO\\nan\\tO\\naverage\\tO\\nage\\tO\\nof\\tO\\nless\\tO\\nthan\\tO\\n55\\tO\\nyears\\tO\\nat\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nin\\tO\\nthe\\tO\\nsame\\tO\\nwoman\\tO\\n,\\tO\\nand\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nancestry\\tO\\nwere\\tO\\nall\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\ndetecting\\tO\\na\\tO\\nBRCA1\\tO\\nmutation\\tO\\n.\\tO\\n\\nNo\\tO\\nassociation\\tO\\nwas\\tO\\nfound\\tO\\nbetween\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nbilateral\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nor\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancers\\tI-Disease\\nin\\tO\\na\\tO\\nfamily\\tO\\nand\\tO\\nthe\\tO\\ndetection\\tO\\nof\\tO\\na\\tO\\nBRCA1\\tO\\nmutation\\tO\\n,\\tO\\nor\\tO\\nbetween\\tO\\nthe\\tO\\nposition\\tO\\nof\\tO\\nthe\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\na\\tO\\nfamily\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nAmong\\tO\\nwomen\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n,\\tO\\nthe\\tO\\npercentage\\tO\\nwith\\tO\\nBRCA1\\tO\\ncoding\\tO\\n-\\tO\\nregion\\tO\\nmutations\\tO\\nis\\tO\\nless\\tO\\nthan\\tO\\nthe\\tO\\n45\\tO\\npercent\\tO\\npredicted\\tO\\nby\\tO\\ngenetic\\tO\\n-\\tO\\nlinkage\\tO\\nanalysis\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\neven\\tO\\nin\\tO\\na\\tO\\nreferral\\tO\\nclinic\\tO\\nspecializing\\tO\\nin\\tO\\nscreening\\tO\\nwomen\\tO\\nfrom\\tO\\nhigh\\tO\\n-\\tO\\nrisk\\tO\\nfamilies\\tO\\n,\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\ntests\\tO\\nfor\\tO\\nBRCA1\\tO\\nmutations\\tO\\nwill\\tO\\nbe\\tO\\nnegative\\tO\\nand\\tO\\ntherefore\\tO\\nuninformative\\tO\\n.\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\narginine\\tO\\n-\\tO\\nrich\\tO\\nprotein\\tO\\ngene\\tO\\n(\\tO\\nARP\\tO\\n)\\tO\\nin\\tO\\npancreatic\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nARP\\tO\\ngene\\tO\\nencodes\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\narginine\\tO\\n-\\tO\\nrich\\tO\\nprotein\\tO\\nfrom\\tO\\nchromosomal\\tO\\nband\\tO\\n3p21\\tO\\n.\\tO\\n\\n1\\tO\\n1\\tO\\n.\\tO\\n\\nAt\\tO\\nthe\\tO\\ncytogenetic\\tO\\nlevel\\tO\\nthis\\tO\\nregion\\tO\\nis\\tO\\nfrequently\\tO\\ndeleted\\tO\\nin\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\ndifferent\\tO\\nsolid\\tB-Disease\\ntumors\\tI-Disease\\n,\\tO\\nalthough\\tO\\nnot\\tO\\nin\\tO\\npancreatic\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nreported\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nspecific\\tO\\nmutation\\tO\\n(\\tO\\nATG50\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nAGG\\tO\\n)\\tO\\nor\\tO\\ndeletion\\tO\\nof\\tO\\ncodon\\tO\\n50\\tO\\nof\\tO\\nthe\\tO\\nARP\\tO\\ngene\\tO\\nin\\tO\\ndifferent\\tO\\ntumor\\tB-Disease\\ntypes\\tI-Disease\\n(\\tO\\nShridhar\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1996\\tO\\n,\\tO\\n1996a\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nobserved\\tO\\nmutations\\tO\\ninvolving\\tO\\ncodon\\tO\\n50\\tO\\nin\\tO\\n11\\tO\\nof\\tO\\n37\\tO\\npancreatic\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nfrequency\\tO\\nof\\tO\\ncodon\\tO\\n50\\tO\\nmutation\\tO\\nis\\tO\\nroughly\\tO\\nthe\\tO\\nsame\\tO\\nin\\tO\\npancreatic\\tB-Disease\\ntumors\\tI-Disease\\nas\\tO\\nin\\tO\\nthe\\tO\\nother\\tO\\ntypes\\tO\\nof\\tO\\ntumors\\tB-Disease\\npreviously\\tO\\nexamined\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ndetected\\tO\\nmutations\\tO\\nat\\tO\\ncodon\\tO\\n51\\tO\\nin\\tO\\nmultiple\\tO\\nPCR\\tO\\nsubclones\\tO\\nin\\tO\\ntwo\\tO\\nother\\tO\\npancreatic\\tB-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nARP\\tO\\ngene\\tO\\nare\\tO\\nthus\\tO\\ncommonly\\tO\\nobserved\\tO\\nin\\tO\\npancreatic\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nmany\\tO\\nother\\tO\\ncancers\\tB-Disease\\n.\\tO\\n\\nDifficulties\\tO\\nin\\tO\\nthe\\tO\\nascertainment\\tO\\nof\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\nlessons\\tO\\nto\\tO\\nbe\\tO\\ndrawn\\tO\\nfrom\\tO\\na\\tO\\ncompound\\tO\\nheterozygote\\tO\\nC9\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nsubject\\tO\\n.\\tO\\n\\nA\\tO\\ngroup\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nlong\\tO\\n-\\tO\\nsurviving\\tO\\nmismatched\\tO\\nkidney\\tO\\nallografts\\tO\\nwere\\tO\\ninvestigated\\tO\\nfor\\tO\\ncomplement\\tO\\nfunction\\tO\\nusing\\tO\\nhaemolytic\\tO\\nassays\\tO\\nin\\tO\\nagarose\\tO\\ngels\\tO\\n.\\tO\\n\\nOne\\tO\\npatient\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nno\\tO\\nalternative\\tO\\npathway\\tO\\nactivity\\tO\\nbut\\tO\\na\\tO\\nlow\\tO\\nnormal\\tO\\nclassical\\tO\\npathway\\tO\\n.\\tO\\n\\nSurprisingly\\tO\\n,\\tO\\ninvestigation\\tO\\nrevealed\\tO\\nthat\\tO\\nthe\\tO\\npatients\\tO\\ncomplement\\tO\\nwas\\tO\\nnormal\\tO\\nfor\\tO\\nall\\tO\\ncomponents\\tO\\nexcept\\tO\\nC9\\tO\\n,\\tO\\nwhich\\tO\\nwas\\tO\\nfunctionally\\tO\\nabsent\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\nwas\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\nheterozygous\\tO\\nfor\\tO\\nDNA\\tO\\nmarkers\\tO\\nin\\tO\\nthe\\tO\\nC6\\tO\\n,\\tO\\nC7\\tO\\nand\\tO\\nC9\\tO\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n5\\tO\\nand\\tO\\ntherefore\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\ncompound\\tO\\nheterozygote\\tO\\nfor\\tO\\ntwo\\tO\\nuncharacterized\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\ngenes\\tO\\n.\\tO\\n\\nSerological\\tO\\nanalysis\\tO\\nby\\tO\\nELISA\\tO\\nrevealed\\tO\\nthat\\tO\\nhe\\tO\\nhas\\tO\\ntrace\\tO\\nconcentrations\\tO\\nof\\tO\\na\\tO\\nnon\\tO\\n-\\tO\\nfunctional\\tO\\nC9\\tO\\nmolecule\\tO\\n.\\tO\\n\\nWestern\\tO\\nblot\\tO\\nanalysis\\tO\\nwas\\tO\\nnot\\tO\\nsufficiently\\tO\\nsensitive\\tO\\nto\\tO\\npermit\\tO\\ndetection\\tO\\nof\\tO\\nthis\\tO\\nmolecule\\tO\\n.\\tO\\n\\nWe\\tO\\nhypothesize\\tO\\nthat\\tO\\nthe\\tO\\npatient\\tO\\nis\\tO\\nheterozygous\\tO\\nfor\\tO\\na\\tO\\ncomplete\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nC9\\tI-Disease\\nand\\tO\\nfor\\tO\\na\\tO\\ngene\\tO\\ndirecting\\tO\\nhyposynthesis\\tO\\nof\\tO\\na\\tO\\ndefective\\tO\\nC9\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nsuggest\\tO\\nthat\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\nmay\\tO\\nbe\\tO\\nmore\\tO\\ncommon\\tO\\namong\\tO\\nCaucasians\\tO\\nthan\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\n.\\tO\\n.\\tO\\n\\nScreening\\tO\\nfor\\tO\\nESR\\tO\\nmutations\\tO\\nin\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n,\\tO\\nleukocyte\\tO\\nDNA\\tO\\nfrom\\tO\\n143\\tO\\npatients\\tO\\nwith\\tO\\nfamilial\\tO\\nclustering\\tO\\nof\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\ntumour\\tB-Disease\\nDNA\\tO\\nfrom\\tO\\n96\\tO\\nbreast\\tB-Disease\\ncarcinomas\\tI-Disease\\nwere\\tO\\nscreened\\tO\\nfor\\tO\\nbase\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nestrogen\\tO\\nreceptor\\tO\\ngene\\tO\\n(\\tO\\nESR\\tO\\n)\\tO\\n.\\tO\\n\\nThree\\tO\\npatients\\tO\\nwith\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\ncancer\\tB-Disease\\nwere\\tO\\ncarrying\\tO\\na\\tO\\nGly160Cys\\tO\\ngermline\\tO\\nsubstitution\\tO\\n.\\tO\\n\\nThis\\tO\\nalteration\\tO\\nwas\\tO\\nalso\\tO\\ndetected\\tO\\nin\\tO\\neight\\tO\\n(\\tO\\nfour\\tO\\nfemales\\tO\\nand\\tO\\nfour\\tO\\nmales\\tO\\n)\\tO\\nof\\tO\\n729\\tO\\ncontrols\\tO\\n(\\tO\\n366\\tO\\nfemale\\tO\\n,\\tO\\n363\\tO\\nmales\\tO\\n)\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nthe\\tO\\nsubstitution\\tO\\nprobably\\tO\\nrepresents\\tO\\na\\tO\\npolymorphism\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\n229\\tO\\nfemale\\tO\\ncontrols\\tO\\nin\\tO\\nwhom\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\ncancer\\tB-Disease\\nwas\\tO\\nknown\\tO\\n,\\tO\\none\\tO\\nof\\tO\\ntwo\\tO\\nwho\\tO\\nhad\\tO\\na\\tO\\nsister\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nwas\\tO\\ncarrying\\tO\\nthe\\tO\\nvariant\\tO\\nallele\\tO\\n.\\tO\\n\\nHence\\tO\\n,\\tO\\na\\tO\\npossible\\tO\\nclinical\\tO\\nsignificance\\tO\\nof\\tO\\nthe\\tO\\nglycine\\tO\\ninto\\tO\\ncysteine\\tO\\ncannot\\tO\\nbe\\tO\\ncompletely\\tO\\nruled\\tO\\nout\\tO\\nand\\tO\\nshould\\tO\\nbe\\tO\\nfurther\\tO\\ninvestigated\\tO\\n.\\tO\\n\\nSomatic\\tO\\nmutations\\tO\\nwere\\tO\\nnot\\tO\\ndetected\\tO\\nin\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\ntumours\\tB-Disease\\nstudied\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\npresent\\tO\\ndata\\tO\\ndo\\tO\\nnot\\tO\\nprovide\\tO\\nsupport\\tO\\nfor\\tO\\nsomatic\\tO\\nESR\\tO\\nbase\\tO\\nmutations\\tO\\nas\\tO\\nan\\tO\\nimportant\\tO\\nmechanism\\tO\\nfor\\tO\\nhormonal\\tO\\ntherapy\\tO\\nresistance\\tO\\nin\\tO\\nestrogen\\tB-Disease\\nreceptor\\tI-Disease\\n-\\tI-Disease\\npositive\\tI-Disease\\nbreast\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nbases\\tO\\nof\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\nthree\\tO\\ndifferent\\tO\\ndefects\\tO\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\nhas\\tO\\nbeen\\tO\\ninvestigated\\tO\\nin\\tO\\ntwo\\tO\\nIrish\\tO\\nfamilies\\tO\\nand\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nIsraeli\\tO\\nfamilies\\tO\\nof\\tO\\nMoroccan\\tO\\nSephardic\\tO\\nJewish\\tO\\norigin\\tO\\n.\\tO\\n\\nExon\\tO\\nPCR\\tO\\nand\\tO\\nsequencing\\tO\\nrevealed\\tO\\na\\tO\\nheterozygous\\tO\\npoint\\tO\\nmutation\\tO\\nat\\tO\\nthe\\tO\\n3\\tO\\nsplice\\tO\\nacceptor\\tO\\nsite\\tO\\nof\\tO\\nintron\\tO\\n1\\tO\\nin\\tO\\none\\tO\\nIrish\\tO\\nfamily\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nother\\tO\\nIrish\\tO\\nfamily\\tO\\n,\\tO\\nexons\\tO\\n7\\tO\\nand\\tO\\n8\\tO\\nfailed\\tO\\nto\\tO\\namplify\\tO\\nand\\tO\\nthey\\tO\\nwere\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\ndeleted\\tO\\n.\\tO\\n\\nMarker\\tO\\nhaplotype\\tO\\nstudies\\tO\\nof\\tO\\nthe\\tO\\nC6\\tO\\nand\\tO\\nC7\\tO\\ngene\\tO\\nregion\\tO\\nand\\tO\\nSouthern\\tO\\nblots\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nIrish\\tO\\nfamily\\tO\\nwith\\tO\\nthe\\tO\\nsplice\\tO\\ndefect\\tO\\nalso\\tO\\nsegregate\\tO\\nfor\\tO\\nthe\\tO\\ndeletion\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nnot\\tO\\neasily\\tO\\ndetected\\tO\\nin\\tO\\nheterozygotes\\tO\\n.\\tO\\n\\nThe\\tO\\nIsraeli\\tO\\nC7\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\ncases\\tO\\nall\\tO\\nshare\\tO\\na\\tO\\nC7\\tO\\nhaplotype\\tO\\nand\\tO\\nare\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nmis\\tO\\n-\\tO\\nsense\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n9\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\none\\tO\\nindividual\\tO\\nis\\tO\\nheterozygous\\tO\\nfor\\tO\\nmarkers\\tO\\nat\\tO\\nadjacent\\tO\\nC6\\tO\\nloci\\tO\\n,\\tO\\nshowing\\tO\\nthat\\tO\\nthere\\tO\\nhas\\tO\\nbeen\\tO\\nan\\tO\\nintergenic\\tO\\nrecombination\\tO\\nand\\tO\\nsuggesting\\tO\\nthat\\tO\\nthe\\tO\\ndeficiency\\tO\\nmutation\\tO\\nis\\tO\\nof\\tO\\nappreciable\\tO\\nantiquity\\tO\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nheterogeneity\\tO\\nof\\tO\\nclassical\\tB-Disease\\nand\\tI-Disease\\nDuarte\\tI-Disease\\ngalactosemia\\tI-Disease\\n:\\tO\\nmutation\\tO\\nanalysis\\tO\\nby\\tO\\ndenaturing\\tO\\ngradient\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n.\\tO\\n\\nClassical\\tB-Disease\\ngalactosemia\\tI-Disease\\nis\\tO\\ncaused\\tO\\nby\\tO\\none\\tO\\ncommon\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nQ188R\\tO\\n)\\tO\\nand\\tO\\nby\\tO\\nseveral\\tO\\nrare\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ngalactose\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nphosphate\\tO\\nuridyltransferase\\tO\\n(\\tO\\nGALT\\tO\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nmost\\tO\\ncommon\\tO\\nvariant\\tO\\nof\\tO\\nGALT\\tO\\n,\\tO\\nthe\\tO\\nDuarte\\tO\\nvariant\\tO\\n,\\tO\\noccurs\\tO\\nas\\tO\\ntwo\\tO\\ntypes\\tO\\n,\\tO\\nDuarte\\tO\\n-\\tO\\n1\\tO\\n(\\tO\\nD\\tO\\n-\\tO\\n1\\tO\\n)\\tO\\nand\\tO\\nDuarte\\tO\\n-\\tO\\n2\\tO\\n(\\tO\\nD\\tO\\n-\\tO\\n2\\tO\\n)\\tO\\n,\\tO\\nboth\\tO\\nof\\tO\\nwhich\\tO\\ncarry\\tO\\nthe\\tO\\nsequence\\tO\\nchange\\tO\\nN314D\\tO\\n.\\tO\\n\\nD\\tO\\n-\\tO\\n1\\tO\\nincreases\\tO\\n,\\tO\\nwhereas\\tO\\nD\\tO\\n-\\tO\\n2\\tO\\ndecreases\\tO\\nGALT\\tO\\nactivity\\tO\\n.\\tO\\n\\nTo\\tO\\nstudy\\tO\\nthe\\tO\\nmolecular\\tO\\ngenetics\\tO\\nof\\tO\\nclassical\\tB-Disease\\nand\\tI-Disease\\nDuarte\\tI-Disease\\ngalactosemia\\tI-Disease\\n,\\tO\\nwe\\tO\\nanalyzed\\tO\\nthe\\tO\\nGALT\\tO\\nmutations\\tO\\nin\\tO\\n30\\tO\\nfamilies\\tO\\nwith\\tO\\nclassical\\tB-Disease\\ngalactosemia\\tI-Disease\\n,\\tO\\nin\\tO\\n10\\tO\\nfamilies\\tO\\nwith\\tO\\nthe\\tO\\nD\\tO\\n-\\tO\\n2\\tO\\nvariant\\tO\\nand\\tO\\nin\\tO\\n3\\tO\\nindividuals\\tO\\ncarrying\\tO\\nthe\\tO\\nD\\tO\\n-\\tO\\n1\\tO\\nallele\\tO\\nby\\tO\\ndenaturing\\tO\\ngradient\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n(\\tO\\nDGGE\\tO\\n)\\tO\\n.\\tO\\n\\nDGGE\\tO\\ndetected\\tO\\n59\\tO\\nof\\tO\\nthe\\tO\\n60\\tO\\nclassical\\tO\\ngalactosemia\\tB-Disease\\nalleles\\tO\\n.\\tO\\n\\nQ188R\\tO\\naccounted\\tO\\nfor\\tO\\n60\\tO\\n%\\tO\\n,\\tO\\nK285N\\tO\\naccounted\\tO\\nfor\\tO\\n28\\tO\\n%\\tO\\nof\\tO\\nthese\\tO\\nalleles\\tO\\n.\\tO\\n\\nEight\\tO\\nnovel\\tO\\ncandidate\\tO\\ngalactosemia\\tB-Disease\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nOn\\tO\\nall\\tO\\nD\\tO\\n-\\tO\\n2\\tO\\nalleles\\tO\\nN314D\\tO\\noccurred\\tO\\nin\\tO\\ncis\\tO\\nwith\\tO\\ntwo\\tO\\nintronic\\tO\\nsequence\\tO\\nchanges\\tO\\n,\\tO\\non\\tO\\nthe\\tO\\nD\\tO\\n-\\tO\\n1\\tO\\nalleles\\tO\\nin\\tO\\ncis\\tO\\nwith\\tO\\na\\tO\\nneutral\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n7\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\nmutations\\tO\\ncausing\\tO\\ngalactosemia\\tB-Disease\\nare\\tO\\nhighly\\tO\\nheterogeneous\\tO\\nand\\tO\\nthat\\tO\\nK285N\\tO\\nis\\tO\\na\\tO\\nsecond\\tO\\ncommon\\tO\\ngalactosemia\\tB-Disease\\nmutation\\tO\\nin\\tO\\nour\\tO\\npopulation\\tO\\n.\\tO\\n.\\tO\\n\\nIsolation\\tO\\nof\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\nATM\\tO\\ncDNA\\tO\\nand\\tO\\ncorrection\\tO\\nof\\tO\\nthe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\ncellular\\tO\\nphenotype\\tO\\n.\\tO\\n\\nA\\tO\\ngene\\tO\\nmutated\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\ngenetic\\tB-Disease\\ndisorder\\tI-Disease\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\n,\\tO\\nATM\\tO\\n,\\tO\\nwas\\tO\\nrecently\\tO\\nidentified\\tO\\nby\\tO\\npositional\\tO\\ncloning\\tO\\n.\\tO\\n\\nATM\\tO\\nis\\tO\\na\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\nphosphatidylinositol\\tO\\n-\\tO\\n3\\tO\\n-\\tO\\nkinase\\tO\\nsuperfamily\\tO\\n,\\tO\\nsome\\tO\\nof\\tO\\nwhich\\tO\\nare\\tO\\nprotein\\tO\\nkinases\\tO\\nand\\tO\\nappear\\tO\\nto\\tO\\nhave\\tO\\nimportant\\tO\\nroles\\tO\\nin\\tO\\ncell\\tO\\ncycle\\tO\\ncontrol\\tO\\nand\\tO\\nradiation\\tO\\nsignal\\tO\\ntransduction\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nherein\\tO\\n,\\tO\\nto\\tO\\nour\\tO\\nknowledge\\tO\\n,\\tO\\nfor\\tO\\nthe\\tO\\nfirst\\tO\\ntime\\tO\\n,\\tO\\nthe\\tO\\ncloning\\tO\\nof\\tO\\na\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\ncDNA\\tO\\nfor\\tO\\nATM\\tO\\nand\\tO\\ncorrection\\tO\\nof\\tO\\nmultiple\\tO\\naspects\\tO\\nof\\tO\\nthe\\tO\\nradio\\tO\\n-\\tO\\nsensitive\\tO\\nphenotype\\tO\\nof\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\ncells\\tO\\nby\\tO\\ntransfection\\tO\\nwith\\tO\\nthis\\tO\\ncDNA\\tO\\n.\\tO\\n\\nOverexpression\\tO\\nof\\tO\\nATM\\tO\\ncDNA\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\ncells\\tO\\nenhanced\\tO\\nthe\\tO\\nsurvival\\tO\\nof\\tO\\nthese\\tO\\ncells\\tO\\nin\\tO\\nresponse\\tO\\nto\\tO\\nradiation\\tO\\nexposure\\tO\\n,\\tO\\ndecreased\\tO\\nradiation\\tO\\n-\\tO\\ninduced\\tO\\nchromosome\\tO\\naberrations\\tO\\n,\\tO\\nreduced\\tO\\nradio\\tO\\n-\\tO\\nresistant\\tO\\nDNA\\tO\\nsynthesis\\tO\\n,\\tO\\nand\\tO\\npartially\\tO\\ncorrected\\tO\\ndefective\\tO\\ncell\\tO\\ncycle\\tO\\ncheckpoints\\tO\\nand\\tO\\ninduction\\tO\\nof\\tO\\nstress\\tO\\n-\\tO\\nactivated\\tO\\nprotein\\tO\\nkinase\\tO\\n.\\tO\\n\\nThis\\tO\\ncorrection\\tO\\nof\\tO\\nthe\\tO\\ndefects\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\ncells\\tO\\nprovides\\tO\\nfurther\\tO\\nevidence\\tO\\nof\\tO\\nthe\\tO\\nmultiplicity\\tO\\nof\\tO\\neffector\\tO\\nfunctions\\tO\\nof\\tO\\nthe\\tO\\nATM\\tO\\nprotein\\tO\\nand\\tO\\nsuggests\\tO\\npossible\\tO\\napproaches\\tO\\nto\\tO\\ngene\\tO\\ntherapy\\tO\\n.\\tO\\n.\\tO\\n\\nFusion\\tO\\ngenes\\tO\\nresulting\\tO\\nfrom\\tO\\nalternative\\tO\\nchromosomal\\tO\\ntranslocations\\tO\\nare\\tO\\noverexpressed\\tO\\nby\\tO\\ngene\\tO\\n-\\tO\\nspecific\\tO\\nmechanisms\\tO\\nin\\tO\\nalveolar\\tB-Disease\\nrhabdomyosarcoma\\tI-Disease\\n.\\tO\\n\\nChromosomal\\tO\\ntranslocations\\tO\\nidentified\\tO\\nin\\tO\\nhematopoietic\\tB-Disease\\nand\\tI-Disease\\nsolid\\tI-Disease\\ntumors\\tI-Disease\\nresult\\tO\\nin\\tO\\nderegulated\\tO\\nexpression\\tO\\nof\\tO\\nprotooncogenes\\tO\\nor\\tO\\ncreation\\tO\\nof\\tO\\nchimeric\\tO\\nproteins\\tO\\nwith\\tO\\ntumorigenic\\tO\\npotential\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npediatric\\tO\\nsolid\\tB-Disease\\ntumor\\tI-Disease\\nalveolar\\tB-Disease\\nrhabdomyosarcoma\\tI-Disease\\n,\\tO\\na\\tO\\nconsistent\\tO\\nt\\tO\\n(\\tO\\n2\\tO\\n;\\tO\\n13\\tO\\n)\\tO\\n(\\tO\\nq35\\tO\\n;\\tO\\nq14\\tO\\n)\\tO\\nor\\tO\\nvariant\\tO\\nt\\tO\\n(\\tO\\n1\\tO\\n;\\tO\\n13\\tO\\n)\\tO\\n(\\tO\\np36\\tO\\n;\\tO\\nq14\\tO\\n)\\tO\\ntranslocation\\tO\\ngenerates\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nor\\tO\\nPAX7\\tO\\n-\\tO\\nFKHR\\tO\\nfusion\\tO\\nproteins\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nreport\\tO\\n,\\tO\\nwe\\tO\\ndemonstrate\\tO\\nthat\\tO\\nin\\tO\\naddition\\tO\\nto\\tO\\nfunctional\\tO\\nalterations\\tO\\nthese\\tO\\ntranslocations\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nfusion\\tO\\nproduct\\tO\\noverexpression\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nand\\tO\\nPAX7\\tO\\n-\\tO\\nFKHR\\tO\\noverexpression\\tO\\noccurs\\tO\\nby\\tO\\ndistinct\\tO\\nmechanisms\\tO\\n.\\tO\\n\\nTranscription\\tO\\nof\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nis\\tO\\nincreased\\tO\\nrelative\\tO\\nto\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nPAX3\\tO\\nby\\tO\\na\\tO\\ncopy\\tO\\nnumber\\tO\\n-\\tO\\nindependent\\tO\\nprocess\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nPAX7\\tO\\n-\\tO\\nFKHR\\tO\\noverexpression\\tO\\nresults\\tO\\nfrom\\tO\\nfusion\\tO\\ngene\\tO\\namplification\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\ngene\\tO\\n-\\tO\\nspecific\\tO\\nmechanisms\\tO\\nwere\\tO\\nselected\\tO\\nto\\tO\\noverexpress\\tO\\nPAX3\\tO\\n-\\tO\\nFKHR\\tO\\nand\\tO\\nPAX7\\tO\\n-\\tO\\nFKHR\\tO\\nin\\tO\\nalveolar\\tB-Disease\\nrhabdomyosarcoma\\tI-Disease\\n,\\tO\\npresumably\\tO\\ndue\\tO\\nto\\tO\\ndifferences\\tO\\nin\\tO\\nregulation\\tO\\nbetween\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nloci\\tO\\n.\\tO\\n\\nWe\\tO\\npostulate\\tO\\nthat\\tO\\nthese\\tO\\noverexpression\\tO\\nmechanisms\\tO\\nensure\\tO\\na\\tO\\ncritical\\tO\\nlevel\\tO\\nof\\tO\\ngene\\tO\\nproduct\\tO\\nfor\\tO\\nthe\\tO\\noncogenic\\tO\\neffects\\tO\\nof\\tO\\nthese\\tO\\nfusions\\tO\\n.\\tO\\n.\\tO\\n\\natm\\tO\\nand\\tO\\np53\\tO\\ncooperate\\tO\\nin\\tO\\napoptosis\\tO\\nand\\tO\\nsuppression\\tO\\nof\\tO\\ntumorigenesis\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nin\\tO\\nresistance\\tO\\nto\\tO\\nacute\\tB-Disease\\nradiation\\tI-Disease\\ntoxicity\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\natm\\tO\\nand\\tO\\np53\\tO\\ncause\\tO\\nthe\\tO\\nhuman\\tO\\ncancer\\tB-Disease\\n-\\tI-Disease\\nassociated\\tI-Disease\\ndiseases\\tI-Disease\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nand\\tO\\nLi\\tB-Disease\\n-\\tI-Disease\\nFraumeni\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nThe\\tO\\ntwo\\tO\\ngenes\\tO\\nare\\tO\\nbelieved\\tO\\nto\\tO\\ninteract\\tO\\nin\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\npathways\\tO\\n,\\tO\\nincluding\\tO\\nregulation\\tO\\nof\\tO\\nDNA\\tO\\ndamage\\tO\\n-\\tO\\ninduced\\tO\\ncell\\tO\\n-\\tO\\ncycle\\tO\\ncheckpoints\\tO\\n,\\tO\\napoptosis\\tO\\nand\\tO\\nradiation\\tO\\nsensitivity\\tO\\n,\\tO\\nand\\tO\\ncellular\\tO\\nproliferation\\tO\\n.\\tO\\n\\nAtm\\tO\\n-\\tO\\nnull\\tO\\nmice\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nthose\\tO\\nnull\\tO\\nfor\\tO\\np53\\tO\\n,\\tO\\ndevelop\\tO\\nmainly\\tO\\nT\\tB-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\nlymphomas\\tI-Disease\\n,\\tO\\nsupporting\\tO\\nthe\\tO\\nview\\tO\\nthat\\tO\\nthese\\tO\\ngenes\\tO\\nhave\\tO\\nsimilar\\tO\\nroles\\tO\\nin\\tO\\nthymocyte\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nTo\\tO\\nstudy\\tO\\nthe\\tO\\ninteractions\\tO\\nof\\tO\\nthese\\tO\\ntwo\\tO\\ngenes\\tO\\non\\tO\\nan\\tO\\norganismal\\tO\\nlevel\\tO\\n,\\tO\\nwe\\tO\\nbred\\tO\\nmice\\tO\\nheterozygous\\tO\\nfor\\tO\\nnull\\tO\\nalleles\\tO\\nof\\tO\\nboth\\tO\\natm\\tO\\nand\\tO\\np53\\tO\\nto\\tO\\nproduce\\tO\\nall\\tO\\ngenotypic\\tO\\ncombinations\\tO\\n.\\tO\\n\\nMice\\tO\\ndoubly\\tO\\nnull\\tO\\nfor\\tO\\natm\\tO\\nand\\tO\\np53\\tO\\nexhibited\\tO\\na\\tO\\ndramatic\\tO\\nacceleration\\tO\\nof\\tO\\ntumour\\tB-Disease\\nformation\\tO\\nrelative\\tO\\nto\\tO\\nsingly\\tO\\nnull\\tO\\nmice\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nboth\\tO\\ngenes\\tO\\ncollaborate\\tO\\nin\\tO\\na\\tO\\nsignificant\\tO\\nmanner\\tO\\nto\\tO\\nprevent\\tO\\ntumorigenesis\\tO\\n.\\tO\\n\\nWith\\tO\\nrespect\\tO\\nto\\tO\\ntheir\\tO\\nroles\\tO\\nin\\tO\\napoptosis\\tO\\n,\\tO\\nloss\\tO\\nof\\tO\\natm\\tO\\nrendered\\tO\\nthymocytes\\tO\\nonly\\tO\\npartly\\tO\\nresistant\\tO\\nto\\tO\\nirradiation\\tO\\n-\\tO\\ninduced\\tO\\napoptosis\\tO\\n,\\tO\\nwhereas\\tO\\nadditional\\tO\\nloss\\tO\\nof\\tO\\np53\\tO\\nengendered\\tO\\ncomplete\\tO\\nresistance\\tO\\n.\\tO\\n\\nThis\\tO\\nimplies\\tO\\nthat\\tO\\nthe\\tO\\nirradiation\\tO\\n-\\tO\\ninduced\\tO\\natm\\tO\\nand\\tO\\np53\\tO\\napoptotic\\tO\\npathways\\tO\\nare\\tO\\nnot\\tO\\ncompletely\\tO\\ncongruent\\tO\\n.\\tO\\n\\nFinally\\tO\\n-\\tO\\nand\\tO\\nin\\tO\\ncontrast\\tO\\nto\\tO\\nprior\\tO\\npredictions\\tO\\n-\\tO\\natm\\tO\\nand\\tO\\np53\\tO\\ndo\\tO\\nnot\\tO\\nappear\\tO\\nto\\tO\\ninteract\\tO\\nin\\tO\\nacute\\tB-Disease\\nradiation\\tI-Disease\\ntoxicity\\tI-Disease\\n,\\tO\\nsuggesting\\tO\\na\\tO\\nseparate\\tO\\natm\\tO\\neffector\\tO\\npathway\\tO\\nfor\\tO\\nthis\\tO\\nDNA\\tO\\ndamage\\tO\\nresponse\\tO\\nand\\tO\\nhaving\\tO\\nimplications\\tO\\nfor\\tO\\nthe\\tO\\nprognosis\\tO\\nand\\tO\\ntreatment\\tO\\nof\\tO\\nhuman\\tO\\ntumours\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nTrinucleotide\\tO\\nrepeat\\tO\\nexpansion\\tO\\nat\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nlocus\\tO\\nreduces\\tO\\nexpression\\tO\\nof\\tO\\nDMAHP\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nor\\tO\\ndystrophia\\tB-Disease\\nmyotonica\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n,\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nmultisystem\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\nthe\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nCTG\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nDMPK\\tO\\nprotein\\tO\\nkinase\\tO\\ngene\\tO\\non\\tO\\nchromosome\\tO\\n19q13\\tO\\n.\\tO\\n\\n3\\tO\\n(\\tO\\nrefs\\tO\\n1\\tO\\n-\\tO\\n3\\tO\\n)\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\nDM\\tB-Disease\\nmutation\\tO\\nwas\\tO\\nidentified\\tO\\nmore\\tO\\nthan\\tO\\nfive\\tO\\nyears\\tO\\nago\\tO\\n,\\tO\\nthe\\tO\\npathogenic\\tO\\nmechanisms\\tO\\nunderlying\\tO\\nthis\\tO\\nmost\\tO\\nprevalent\\tO\\nform\\tO\\nof\\tO\\nhereditary\\tO\\nadult\\tO\\nneuromuscular\\tB-Disease\\ndisease\\tI-Disease\\nremain\\tO\\nelusive\\tO\\n.\\tO\\n\\nPrevious\\tO\\nwork\\tO\\nfrom\\tO\\nour\\tO\\nlaboratory\\tO\\ndemonstrated\\tO\\nthat\\tO\\na\\tO\\nDNase\\tO\\nl\\tO\\n-\\tO\\nhypersensitive\\tO\\nsite\\tO\\nlocated\\tO\\nadjacent\\tO\\nto\\tO\\nthe\\tO\\nrepeats\\tO\\non\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nallele\\tO\\nis\\tO\\neliminated\\tO\\nby\\tO\\nrepeat\\tO\\nexpansion\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nlarge\\tO\\nCTG\\tO\\n-\\tO\\nrepeat\\tO\\narrays\\tO\\nmay\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\nlocal\\tO\\nchromatin\\tO\\nenvironment\\tO\\nthat\\tO\\nrepresses\\tO\\ngene\\tO\\nexpression\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nreport\\tO\\nthat\\tO\\nthe\\tO\\nhypersensitive\\tO\\nsite\\tO\\ncontains\\tO\\nan\\tO\\nenhancer\\tO\\nelement\\tO\\nthat\\tO\\nregulates\\tO\\ntranscription\\tO\\nof\\tO\\nthe\\tO\\nadjacent\\tO\\nDMAHP\\tO\\nhomeobox\\tO\\ngene\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nDMAHP\\tO\\nexpression\\tO\\nin\\tO\\nthe\\tO\\ncells\\tO\\nof\\tO\\nDM\\tB-Disease\\npatients\\tO\\nwith\\tO\\nloss\\tO\\nof\\tO\\nthe\\tO\\nhypersensitive\\tO\\nsite\\tO\\nrevealed\\tO\\na\\tO\\ntwo\\tO\\n-\\tO\\nto\\tO\\nfourfold\\tO\\nreduction\\tO\\nin\\tO\\nsteady\\tO\\n-\\tO\\nstate\\tO\\nDMAHP\\tO\\ntranscript\\tO\\nlevels\\tO\\nrelative\\tO\\nto\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\ncontrols\\tO\\n.\\tO\\n\\nAllele\\tO\\n-\\tO\\nspecific\\tO\\nanalysis\\tO\\nof\\tO\\nDMAHP\\tO\\nexpression\\tO\\nshowed\\tO\\nthat\\tO\\nsteady\\tO\\n-\\tO\\nstate\\tO\\ntranscript\\tO\\nlevels\\tO\\nfrom\\tO\\nthe\\tO\\nexpanded\\tO\\nallele\\tO\\nwere\\tO\\ngreatly\\tO\\nreduced\\tO\\nin\\tO\\ncomparison\\tO\\nto\\tO\\nthose\\tO\\nfrom\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nallele\\tO\\n.\\tO\\n\\nTogether\\tO\\n,\\tO\\nthese\\tO\\nresults\\tO\\ndemonstrate\\tO\\nthat\\tO\\nCTG\\tO\\n-\\tO\\nrepeat\\tO\\nexpansions\\tO\\ncan\\tO\\nsuppress\\tO\\nlocal\\tO\\ngene\\tO\\nexpression\\tO\\nand\\tO\\nimplicate\\tO\\nDMAHP\\tO\\nin\\tO\\nDM\\tB-Disease\\npathogenesis\\tO\\n.\\tO\\n\\nConstitutively\\tO\\nmethylated\\tO\\nCpG\\tO\\ndinucleotides\\tO\\nas\\tO\\nmutation\\tO\\nhot\\tO\\nspots\\tO\\nin\\tO\\nthe\\tO\\nretinoblastoma\\tB-Disease\\ngene\\tO\\n(\\tO\\nRB1\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nwide\\tO\\nspectrum\\tO\\nof\\tO\\nmutations\\tO\\n,\\tO\\nranging\\tO\\nfrom\\tO\\npoint\\tO\\nmutations\\tO\\nto\\tO\\nlarge\\tO\\ndeletions\\tO\\n,\\tO\\nhave\\tO\\nbeen\\tO\\ndescribed\\tO\\nin\\tO\\nthe\\tO\\nretinoblastoma\\tB-Disease\\ngene\\tO\\n(\\tO\\nRB1\\tO\\n)\\tO\\n.\\tO\\n\\nMutations\\tO\\nhave\\tO\\nbeen\\tO\\nfound\\tO\\nthroughout\\tO\\nthe\\tO\\ngene\\tO\\n;\\tO\\nhowever\\tO\\n,\\tO\\nthese\\tO\\ngenetic\\tO\\nalterations\\tO\\ndo\\tO\\nnot\\tO\\nappear\\tO\\nto\\tO\\nbe\\tO\\nhomogeneously\\tO\\ndistributed\\tO\\n.\\tO\\n\\nIn\\tO\\nparticular\\tO\\n,\\tO\\na\\tO\\nsignificant\\tO\\nproportion\\tO\\nof\\tO\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\nmutations\\tO\\nresults\\tO\\nin\\tO\\nthe\\tO\\npremature\\tO\\ntermination\\tO\\nof\\tO\\nprotein\\tO\\nsynthesis\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\noccur\\tO\\nas\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\ntransitions\\tO\\nat\\tO\\nCpG\\tO\\ndinucleotides\\tO\\n(\\tO\\nCpGs\\tO\\n)\\tO\\n.\\tO\\n\\nSuch\\tO\\nrecurrent\\tO\\nCpG\\tO\\nmutations\\tO\\n,\\tO\\nincluding\\tO\\nthose\\tO\\nfound\\tO\\nin\\tO\\nRB1\\tO\\n,\\tO\\nare\\tO\\nlikely\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\nthe\\tO\\ndeamination\\tO\\nof\\tO\\n5\\tO\\n-\\tO\\nmethylcytosine\\tO\\nwithin\\tO\\nthese\\tO\\nCpGs\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nused\\tO\\nthe\\tO\\nsodiumbisulfite\\tO\\nconversion\\tO\\nmethod\\tO\\nto\\tO\\ndetect\\tO\\ncytosine\\tO\\nmethylation\\tO\\nin\\tO\\nrepresentative\\tO\\nexons\\tO\\nof\\tO\\nRB1\\tO\\n.\\tO\\n\\nWe\\tO\\nanalyzed\\tO\\nDNA\\tO\\nfrom\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\ntissues\\tO\\nand\\tO\\nspecifically\\tO\\ntargeted\\tO\\nCGA\\tO\\ncodons\\tO\\nin\\tO\\nRB1\\tO\\n,\\tO\\nwhere\\tO\\nrecurrent\\tO\\npremature\\tO\\ntermination\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nthat\\tO\\nDNA\\tO\\nmethylation\\tO\\nwithin\\tO\\nRB1\\tO\\nexons\\tO\\n8\\tO\\n,\\tO\\n14\\tO\\n,\\tO\\n25\\tO\\n,\\tO\\nand\\tO\\n27\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\nrestricted\\tO\\nto\\tO\\nCpGs\\tO\\n,\\tO\\nincluding\\tO\\nsix\\tO\\nCGA\\tO\\ncodons\\tO\\n.\\tO\\n\\nOther\\tO\\ncodons\\tO\\ncontaining\\tO\\nmethylated\\tO\\ncytosines\\tO\\nhave\\tO\\nnot\\tO\\nbeen\\tO\\nreported\\tO\\nto\\tO\\nbe\\tO\\nmutated\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\nmutations\\tO\\nat\\tO\\nCpGs\\tO\\nin\\tO\\nRB1\\tO\\nappear\\tO\\nto\\tO\\nbe\\tO\\ndetermined\\tO\\nby\\tO\\nseveral\\tO\\nfactors\\tO\\n,\\tO\\nincluding\\tO\\nthe\\tO\\nconstitutive\\tO\\npresence\\tO\\nof\\tO\\nDNA\\tO\\nmethylation\\tO\\nat\\tO\\ncytosines\\tO\\nwithin\\tO\\nCpGs\\tO\\n,\\tO\\nthe\\tO\\nspecific\\tO\\ncodon\\tO\\nwithin\\tO\\nwhich\\tO\\nthe\\tO\\nmethylated\\tO\\ncytosine\\tO\\nis\\tO\\nlocated\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nparticular\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nwithin\\tO\\nwhich\\tO\\nthat\\tO\\ncodon\\tO\\nresides\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ntumor\\tI-Disease\\nsuppressor\\tO\\ngene\\tO\\nproduct\\tO\\ninteracts\\tO\\nwith\\tO\\nSp1\\tO\\nto\\tO\\nrepress\\tO\\nvascular\\tO\\nendothelial\\tO\\ngrowth\\tO\\nfactor\\tO\\npromoter\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ntumor\\tI-Disease\\nsuppressor\\tO\\ngene\\tO\\n(\\tO\\nVHL\\tO\\n)\\tO\\nhas\\tO\\na\\tO\\ncritical\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nclear\\tB-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\n(\\tO\\nRCC\\tB-Disease\\n)\\tO\\n,\\tO\\nas\\tO\\nVHL\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\nboth\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ndisease\\tI-Disease\\n-\\tI-Disease\\nassociated\\tI-Disease\\nand\\tI-Disease\\nsporadic\\tI-Disease\\nRCCs\\tI-Disease\\n.\\tO\\n\\nRecent\\tO\\nstudies\\tO\\nsuggest\\tO\\nthat\\tO\\nvascular\\tO\\nendothelial\\tO\\ngrowth\\tO\\nfactor\\tO\\n(\\tO\\nVEGF\\tO\\n)\\tO\\nmRNA\\tO\\nis\\tO\\nupregulated\\tO\\nin\\tO\\nRCC\\tB-Disease\\n-\\tI-Disease\\nand\\tI-Disease\\nvon\\tI-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ndisease\\tI-Disease\\n-\\tI-Disease\\nassociated\\tI-Disease\\ntumors\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ntherefore\\tO\\nassessed\\tO\\nthe\\tO\\neffect\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tO\\ngene\\tO\\nproduct\\tO\\non\\tO\\nVEGF\\tO\\nexpression\\tO\\n.\\tO\\n\\nVEGF\\tO\\npromoter\\tO\\n-\\tO\\nluciferase\\tO\\nconstructs\\tO\\nwere\\tO\\ntransiently\\tO\\ncotransfected\\tO\\nwith\\tO\\na\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nVHL\\tO\\n(\\tO\\nwt\\tO\\n-\\tO\\nVHL\\tO\\n)\\tO\\nvector\\tO\\nin\\tO\\nseveral\\tO\\ncell\\tO\\nlines\\tO\\n,\\tO\\nincluding\\tO\\n293\\tO\\nembryonic\\tO\\nkidney\\tO\\nand\\tO\\nRCC\\tB-Disease\\ncell\\tO\\nlines\\tO\\n.\\tO\\n\\nwt\\tO\\n-\\tO\\nVHL\\tO\\nprotein\\tO\\ninhibited\\tO\\nVEGF\\tO\\npromoter\\tO\\nactivity\\tO\\nin\\tO\\na\\tO\\ndose\\tO\\n-\\tO\\ndependent\\tO\\nmanner\\tO\\nup\\tO\\nto\\tO\\n5\\tO\\n-\\tO\\nto\\tO\\n10\\tO\\n-\\tO\\nfold\\tO\\n.\\tO\\n\\nDeletion\\tO\\nanalysis\\tO\\ndefined\\tO\\na\\tO\\n144\\tO\\n-\\tO\\nbp\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nVEGF\\tO\\npromoter\\tO\\nnecessary\\tO\\nfor\\tO\\nVHL\\tO\\nrepression\\tO\\n.\\tO\\n\\nThis\\tO\\nVHL\\tO\\n-\\tO\\nresponsive\\tO\\nelement\\tO\\nis\\tO\\nGC\\tO\\nrich\\tO\\nand\\tO\\nspecifically\\tO\\nbinds\\tO\\nthe\\tO\\ntranscription\\tO\\nfactor\\tO\\nSp1\\tO\\nin\\tO\\ncrude\\tO\\nnuclear\\tO\\nextracts\\tO\\n.\\tO\\n\\nIn\\tO\\nDrosophila\\tO\\ncells\\tO\\n,\\tO\\ncotransfected\\tO\\nVHL\\tO\\nrepresses\\tO\\nSp1\\tO\\n-\\tO\\nmediated\\tO\\nactivation\\tO\\nbut\\tO\\nnot\\tO\\nbasal\\tO\\nactivity\\tO\\nof\\tO\\nthe\\tO\\nVEGF\\tO\\npromoter\\tO\\n.\\tO\\n\\nWe\\tO\\nnext\\tO\\ndemonstrated\\tO\\nin\\tO\\ncoimmunoprecipitates\\tO\\nthat\\tO\\nVHL\\tO\\nand\\tO\\nSp1\\tO\\nwere\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\ncomplex\\tO\\nand\\tO\\n,\\tO\\nby\\tO\\nusing\\tO\\na\\tO\\nglutathione\\tO\\n-\\tO\\nS\\tO\\n-\\tO\\ntransferase\\tO\\n-\\tO\\nVHL\\tO\\nfusion\\tO\\nprotein\\tO\\nand\\tO\\npurified\\tO\\nSp1\\tO\\n,\\tO\\nthat\\tO\\nVHL\\tO\\nand\\tO\\nSp1\\tO\\ndirectly\\tO\\ninteract\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nendogenous\\tO\\nVEGF\\tO\\nmRNA\\tO\\nlevels\\tO\\nwere\\tO\\nsuppressed\\tO\\nin\\tO\\npermanent\\tO\\nRCC\\tB-Disease\\ncell\\tO\\nlines\\tO\\nexpressing\\tO\\nwt\\tO\\n-\\tO\\nVHL\\tO\\n,\\tO\\nand\\tO\\nnuclear\\tO\\nrun\\tO\\n-\\tO\\non\\tO\\nstudies\\tO\\nindicated\\tO\\nthat\\tO\\nVHL\\tO\\nregulation\\tO\\nof\\tO\\nVEGF\\tO\\noccurs\\tO\\nat\\tO\\nleast\\tO\\npartly\\tO\\nat\\tO\\nthe\\tO\\ntranscriptional\\tO\\nlevel\\tO\\n.\\tO\\n\\nThese\\tO\\nobservations\\tO\\nsupport\\tO\\na\\tO\\nnew\\tO\\nmechanism\\tO\\nfor\\tO\\nVHL\\tO\\n-\\tO\\nmediated\\tO\\ntranscriptional\\tO\\nrepression\\tO\\nvia\\tO\\na\\tO\\ndirect\\tO\\ninhibitory\\tO\\naction\\tO\\non\\tO\\nSp1\\tO\\nand\\tO\\nsuggest\\tO\\nthat\\tO\\nloss\\tO\\nof\\tO\\nSp1\\tO\\ninhibition\\tO\\nmay\\tO\\nbe\\tO\\nimportant\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ndisease\\tI-Disease\\nand\\tO\\nRCC\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nAdult\\tB-Disease\\nonset\\tI-Disease\\ngloboid\\tI-Disease\\ncell\\tI-Disease\\nleukodystrophy\\tI-Disease\\n(\\tO\\nKrabbe\\tB-Disease\\ndisease\\tI-Disease\\n)\\tO\\n:\\tO\\nanalysis\\tO\\nof\\tO\\ngalactosylceramidase\\tO\\ncDNA\\tO\\nfrom\\tO\\nfour\\tO\\nJapanese\\tO\\npatients\\tO\\n.\\tO\\n\\nWe\\tO\\nexamined\\tO\\ngalactosylceramidase\\tO\\n(\\tO\\nGALC\\tO\\n)\\tO\\ncDNA\\tO\\nin\\tO\\nfour\\tO\\nJapanese\\tO\\npatients\\tO\\nwith\\tO\\nadult\\tB-Disease\\nonset\\tI-Disease\\ngloboid\\tI-Disease\\ncell\\tI-Disease\\nleukodystrophy\\tI-Disease\\n(\\tO\\nKrabbe\\tB-Disease\\ndisease\\tI-Disease\\n;\\tO\\nAO\\tB-Disease\\n-\\tI-Disease\\nGLD\\tI-Disease\\n)\\tO\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n/\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\n(\\tO\\nPCR\\tO\\n-\\tO\\nSSCP\\tO\\n)\\tO\\nanalysis\\tO\\n,\\tO\\nsubsequent\\tO\\nsequence\\tO\\ndetermination\\tO\\n,\\tO\\nand\\tO\\nrestriction\\tO\\nenzyme\\tO\\ndigestion\\tO\\nof\\tO\\nPCR\\tO\\nproducts\\tO\\n,\\tO\\ninitial\\tO\\nsymptoms\\tO\\nwere\\tO\\nthe\\tO\\nonset\\tO\\nof\\tO\\nslowly\\tO\\nprogressive\\tO\\nspastic\\tB-Disease\\nparaplegia\\tI-Disease\\nfrom\\tO\\nthe\\tO\\nmiddle\\tO\\nof\\tO\\nthe\\tO\\nsecond\\tO\\ndecade\\tO\\n,\\tO\\nand\\tO\\nall\\tO\\npatients\\tO\\nhad\\tO\\ndiminished\\tB-Disease\\nGALC\\tI-Disease\\nactivity\\tI-Disease\\nin\\tO\\ntheir\\tO\\nleukocytes\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\nthree\\tO\\nmissense\\tO\\nmutations\\tO\\n(\\tO\\nI66M\\tO\\n,\\tO\\nG270D\\tO\\n,\\tO\\nL618S\\tO\\n)\\tO\\nand\\tO\\none\\tO\\nexon\\tO\\n-\\tO\\n6\\tO\\nskipping\\tO\\n(\\tO\\n535\\tO\\n-\\tO\\n573del\\tO\\n)\\tO\\n.\\tO\\n\\nTwo\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nhad\\tO\\nonly\\tO\\nthe\\tO\\nI66M\\tO\\nmutant\\tO\\nmRNA\\tO\\n,\\tO\\nand\\tO\\none\\tO\\nonly\\tO\\nthe\\tO\\nG27OD\\tO\\nmutant\\tO\\nmRNA\\tO\\n.\\tO\\n\\nThe\\tO\\nfourth\\tO\\npatient\\tO\\ncarried\\tO\\na\\tO\\ncompound\\tO\\nheterozygous\\tO\\nmutation\\tO\\nof\\tO\\n535\\tO\\n-\\tO\\n573del\\tO\\nand\\tO\\nL618S\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nenzymatic\\tO\\nactivities\\tO\\nproduced\\tO\\nby\\tO\\nthese\\tO\\nmutations\\tO\\n,\\tO\\nwe\\tO\\nconstructed\\tO\\nmutated\\tO\\nGALC\\tO\\ncDNAs\\tO\\nand\\tO\\nexpressed\\tO\\nthem\\tO\\nin\\tO\\nCOS\\tO\\n-\\tO\\n1\\tO\\ncells\\tO\\n.\\tO\\n\\nThree\\tO\\nmutations\\tO\\n,\\tO\\nviz\\tO\\n.\\tO\\n,\\tO\\nG270D\\tO\\n,\\tO\\nL618S\\tO\\n,\\tO\\nand\\tO\\nexon\\tO\\n-\\tO\\n6\\tO\\nskipping\\tO\\n(\\tO\\n535\\tO\\n-\\tO\\n573del\\tO\\n)\\tO\\n,\\tO\\nproduced\\tO\\ndiminished\\tB-Disease\\nGALC\\tI-Disease\\nactivity\\tI-Disease\\nas\\tO\\nexpected\\tO\\n.\\tO\\n\\nThe\\tO\\nI66M\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nGALC\\tO\\ncDNA\\tO\\n(\\tO\\nI289\\tO\\n)\\tO\\nhad\\tO\\nnormal\\tO\\nactivity\\tO\\n,\\tO\\nbut\\tO\\nwhen\\tO\\nthis\\tO\\nmutation\\tO\\nand\\tO\\nthe\\tO\\nV289\\tO\\npolymorphism\\tO\\nwere\\tO\\nintroduced\\tO\\ninto\\tO\\nthe\\tO\\nsame\\tO\\nallele\\tO\\n,\\tO\\nit\\tO\\nhad\\tO\\ndecreased\\tO\\nactivity\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\ncombination\\tO\\nof\\tO\\na\\tO\\nunique\\tO\\nmutation\\tO\\nand\\tO\\npolymorphism\\tO\\ncauses\\tO\\nconformational\\tO\\nchange\\tO\\nin\\tO\\nthe\\tO\\nGALC\\tO\\nenzyme\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nlow\\tO\\nenzymatic\\tO\\nactivity\\tO\\n.\\tO\\n\\nAO\\tB-Disease\\n-\\tI-Disease\\nGLD\\tI-Disease\\nmutations\\tO\\n,\\tO\\nincluding\\tO\\nthose\\tO\\nfound\\tO\\nhere\\tO\\n,\\tO\\nare\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\nN\\tO\\n-\\tO\\nterminus\\tO\\n(\\tO\\nI66M\\tO\\n,\\tO\\nG270D\\tO\\n,\\tO\\n535\\tO\\n-\\tO\\n573del\\tO\\n)\\tO\\nor\\tO\\nC\\tO\\n-\\tO\\nterminus\\tO\\n(\\tO\\nL618S\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nGALC\\tO\\nenzyme\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nreported\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ninfantile\\tO\\nform\\tO\\n(\\tO\\nIF\\tB-Disease\\n-\\tI-Disease\\nGLD\\tI-Disease\\n)\\tO\\nare\\tO\\nin\\tO\\nthe\\tO\\ncentral\\tO\\ndomain\\tO\\n.\\tO\\n\\nThis\\tO\\ndifference\\tO\\nin\\tO\\nmutation\\tO\\nsites\\tO\\nmay\\tO\\naffect\\tO\\nthe\\tO\\nclinical\\tO\\nfeatures\\tO\\nof\\tO\\nGLD\\tB-Disease\\n.\\tO\\n\\n'"
            ]
          },
          "metadata": {},
          "execution_count": 57
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "with open(\"test.tsv\") as f:\n",
        "  test_data = f.read()\n",
        "test_data"
      ],
      "metadata": {
        "id": "9YqAyWGaTP6h",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 192
        },
        "outputId": "49d8c31b-757b-44df-ebca-e707a91cb973"
      },
      "execution_count": 58,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'Clustering\\tO\\nof\\tO\\nmissense\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\ngene\\tO\\nin\\tO\\na\\tO\\nsporadic\\tB-Disease\\nT\\tI-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\nleukaemia\\tI-Disease\\n.\\tO\\n\\nAtaxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nrecessive\\tB-Disease\\nmulti\\tI-Disease\\n-\\tI-Disease\\nsystem\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nat\\tO\\n11q22\\tO\\n-\\tO\\nq23\\tO\\n(\\tO\\nref\\tO\\n.\\tO\\n3\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nrisk\\tO\\nof\\tO\\ncancer\\tB-Disease\\n,\\tO\\nespecially\\tO\\nlymphoid\\tB-Disease\\nneoplasias\\tI-Disease\\n,\\tO\\nis\\tO\\nsubstantially\\tO\\nelevated\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\nand\\tO\\nhas\\tO\\nlong\\tO\\nbeen\\tO\\nassociated\\tO\\nwith\\tO\\nchromosomal\\tO\\ninstability\\tO\\n.\\tO\\n\\nBy\\tO\\nanalysing\\tO\\ntumour\\tB-Disease\\nDNA\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nsporadic\\tB-Disease\\nT\\tI-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\nprolymphocytic\\tI-Disease\\nleukaemia\\tI-Disease\\n(\\tO\\nT\\tB-Disease\\n-\\tI-Disease\\nPLL\\tI-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nrare\\tO\\nclonal\\tB-Disease\\nmalignancy\\tI-Disease\\nwith\\tO\\nsimilarities\\tO\\nto\\tO\\na\\tO\\nmature\\tB-Disease\\nT\\tI-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\nleukaemia\\tI-Disease\\nseen\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n,\\tO\\nwe\\tO\\ndemonstrate\\tO\\na\\tO\\nhigh\\tO\\nfrequency\\tO\\nof\\tO\\nATM\\tO\\nmutations\\tO\\nin\\tO\\nT\\tB-Disease\\n-\\tI-Disease\\nPLL\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nmarked\\tO\\ncontrast\\tO\\nto\\tO\\nthe\\tO\\nATM\\tO\\nmutation\\tO\\npattern\\tO\\nin\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n,\\tO\\nthe\\tO\\nmost\\tO\\nfrequent\\tO\\nnucleotide\\tO\\nchanges\\tO\\nin\\tO\\nthis\\tO\\nleukaemia\\tB-Disease\\nwere\\tO\\nmissense\\tO\\nmutations\\tO\\n.\\tO\\n\\nThese\\tO\\nclustered\\tO\\nin\\tO\\nthe\\tO\\nregion\\tO\\ncorresponding\\tO\\nto\\tO\\nthe\\tO\\nkinase\\tO\\ndomain\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nhighly\\tO\\nconserved\\tO\\nin\\tO\\nATM\\tO\\n-\\tO\\nrelated\\tO\\nproteins\\tO\\nin\\tO\\nmouse\\tO\\n,\\tO\\nyeast\\tO\\nand\\tO\\nDrosophila\\tO\\n.\\tO\\n\\nThe\\tO\\nresulting\\tO\\namino\\tO\\n-\\tO\\nacid\\tO\\nsubstitutions\\tO\\nare\\tO\\npredicted\\tO\\nto\\tO\\ninterfere\\tO\\nwith\\tO\\nATP\\tO\\nbinding\\tO\\nor\\tO\\nsubstrate\\tO\\nrecognition\\tO\\n.\\tO\\n\\nTwo\\tO\\nof\\tO\\nseventeen\\tO\\nmutated\\tO\\nT\\tB-Disease\\n-\\tI-Disease\\nPLL\\tI-Disease\\nsamples\\tO\\nhad\\tO\\na\\tO\\npreviously\\tO\\nreported\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nallele\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nno\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\np53\\tO\\ngene\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nthis\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\nis\\tO\\nnot\\tO\\nfrequently\\tO\\naltered\\tO\\nin\\tO\\nthis\\tO\\nleukaemia\\tB-Disease\\n.\\tO\\n\\nOccasional\\tO\\nmissense\\tO\\nmutations\\tO\\nin\\tO\\nATM\\tO\\nwere\\tO\\nalso\\tO\\nfound\\tO\\nin\\tO\\ntumour\\tB-Disease\\nDNA\\tO\\nfrom\\tO\\npatients\\tO\\nwith\\tO\\nB\\tB-Disease\\n-\\tI-Disease\\ncell\\tI-Disease\\nnon\\tI-Disease\\n-\\tI-Disease\\nHodgkins\\tI-Disease\\nlymphomas\\tI-Disease\\n(\\tO\\nB\\tB-Disease\\n-\\tI-Disease\\nNHL\\tI-Disease\\n)\\tO\\nand\\tO\\na\\tO\\nB\\tB-Disease\\n-\\tI-Disease\\nNHL\\tI-Disease\\ncell\\tO\\nline\\tO\\n.\\tO\\n\\nThe\\tO\\nevidence\\tO\\nof\\tO\\na\\tO\\nsignificant\\tO\\nproportion\\tO\\nof\\tO\\nloss\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\nfunction\\tO\\nmutations\\tO\\nand\\tO\\na\\tO\\ncomplete\\tO\\nabsence\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\ncopy\\tO\\nof\\tO\\nATM\\tO\\nin\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nmutated\\tO\\ntumours\\tB-Disease\\nestablishes\\tO\\nsomatic\\tO\\ninactivation\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nsporadic\\tB-Disease\\nT\\tI-Disease\\n-\\tI-Disease\\nPLL\\tI-Disease\\nand\\tO\\nsuggests\\tO\\nthat\\tO\\nATM\\tO\\nacts\\tO\\nas\\tO\\na\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\n.\\tO\\n\\nAs\\tO\\nconstitutional\\tO\\nDNA\\tO\\nwas\\tO\\nnot\\tO\\navailable\\tO\\n,\\tO\\na\\tO\\nputative\\tO\\nhereditary\\tO\\npredisposition\\tO\\nto\\tO\\nT\\tB-Disease\\n-\\tI-Disease\\nPLL\\tI-Disease\\nwill\\tO\\nrequire\\tO\\nfurther\\tO\\ninvestigation\\tO\\n.\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nprotein\\tO\\nkinase\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nmodulation\\tO\\nof\\tO\\nthe\\tO\\nCa2\\tO\\n+\\tO\\nhomeostasis\\tO\\nin\\tO\\nskeletal\\tO\\nmuscle\\tO\\ncells\\tO\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nmost\\tO\\nprevalent\\tO\\nmuscular\\tB-Disease\\ndisorder\\tI-Disease\\nin\\tO\\nadults\\tO\\n,\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\n-\\tO\\nrepeat\\tO\\nexpansion\\tO\\nin\\tO\\na\\tO\\ngene\\tO\\nencoding\\tO\\na\\tO\\nprotein\\tO\\nkinase\\tO\\n(\\tO\\nDM\\tB-Disease\\nprotein\\tO\\nkinase\\tO\\n;\\tO\\nDMPK\\tO\\n)\\tO\\nand\\tO\\ninvolves\\tO\\nchanges\\tO\\nin\\tO\\ncytoarchitecture\\tO\\nand\\tO\\nion\\tO\\nhomeostasis\\tO\\n.\\tO\\n\\nTo\\tO\\nobtain\\tO\\nclues\\tO\\nto\\tO\\nthe\\tO\\nnormal\\tO\\nbiological\\tO\\nrole\\tO\\nof\\tO\\nDMPK\\tO\\nin\\tO\\ncellular\\tO\\nion\\tO\\nhomeostasis\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ncompared\\tO\\nthe\\tO\\nresting\\tO\\n[\\tO\\nCa2\\tO\\n+\\tO\\n]\\tO\\ni\\tO\\n,\\tO\\nthe\\tO\\namplitude\\tO\\nand\\tO\\nshape\\tO\\nof\\tO\\ndepolarization\\tO\\n-\\tO\\ninduced\\tO\\nCa2\\tO\\n+\\tO\\ntransients\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\ncontent\\tO\\nof\\tO\\nATP\\tO\\n-\\tO\\ndriven\\tO\\nion\\tO\\npumps\\tO\\nin\\tO\\ncultured\\tO\\nskeletal\\tO\\nmuscle\\tO\\ncells\\tO\\nof\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nand\\tO\\nDMPK\\tO\\n[\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\n]\\tO\\nknockout\\tO\\nmice\\tO\\n.\\tO\\n\\nIn\\tO\\nvitro\\tO\\n-\\tO\\ndifferentiated\\tO\\nDMPK\\tO\\n[\\tO\\n-\\tO\\n/\\tO\\n-\\tO\\n]\\tO\\nmyotubes\\tO\\nexhibit\\tO\\na\\tO\\nhigher\\tO\\nresting\\tO\\n[\\tO\\nCa2\\tO\\n+\\tO\\n]\\tO\\ni\\tO\\nthan\\tO\\ndo\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nmyotubes\\tO\\nbecause\\tO\\nof\\tO\\nan\\tO\\naltered\\tO\\nopen\\tO\\nprobability\\tO\\nof\\tO\\nvoltage\\tO\\n-\\tO\\ndependent\\tO\\nl\\tO\\n-\\tO\\ntype\\tO\\nCa2\\tO\\n+\\tO\\nand\\tO\\nNa\\tO\\n+\\tO\\nchannels\\tO\\n.\\tO\\n\\nThe\\tO\\nmutant\\tO\\nmyotubes\\tO\\nexhibit\\tO\\nsmaller\\tO\\nand\\tO\\nslower\\tO\\nCa2\\tO\\n+\\tO\\nresponses\\tO\\nupon\\tO\\ntriggering\\tO\\nby\\tO\\nacetylcholine\\tO\\nor\\tO\\nhigh\\tO\\nexternal\\tO\\nK\\tO\\n+\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nobserved\\tO\\nthat\\tO\\nthese\\tO\\nCa2\\tO\\n+\\tO\\ntransients\\tO\\npartially\\tO\\nresult\\tO\\nfrom\\tO\\nan\\tO\\ninflux\\tO\\nof\\tO\\nextracellular\\tO\\nCa2\\tO\\n+\\tO\\nthrough\\tO\\nthe\\tO\\nl\\tO\\n-\\tO\\ntype\\tO\\nCa2\\tO\\n+\\tO\\nchannel\\tO\\n.\\tO\\n\\nNeither\\tO\\nthe\\tO\\ncontent\\tO\\nnor\\tO\\nthe\\tO\\nactivity\\tO\\nof\\tO\\nNa\\tO\\n+\\tO\\n/\\tO\\nK\\tO\\n+\\tO\\nATPase\\tO\\nand\\tO\\nsarcoplasmic\\tO\\nreticulum\\tO\\nCa2\\tO\\n+\\tO\\n-\\tO\\nATPase\\tO\\nare\\tO\\naffected\\tO\\nby\\tO\\nDMPK\\tO\\nabsence\\tO\\n.\\tO\\n\\nIn\\tO\\nconclusion\\tO\\n,\\tO\\nour\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nDMPK\\tO\\nis\\tO\\ninvolved\\tO\\nin\\tO\\nmodulating\\tO\\nthe\\tO\\ninitial\\tO\\nevents\\tO\\nof\\tO\\nexcitation\\tO\\n-\\tO\\ncontraction\\tO\\ncoupling\\tO\\nin\\tO\\nskeletal\\tO\\nmuscle\\tO\\n.\\tO\\n.\\tO\\n\\nConstitutional\\tO\\nRB1\\tO\\n-\\tO\\ngene\\tO\\nmutations\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nisolated\\tO\\nunilateral\\tB-Disease\\nretinoblastoma\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nmost\\tO\\npatients\\tO\\nwith\\tO\\nisolated\\tO\\nunilateral\\tB-Disease\\nretinoblastoma\\tI-Disease\\n,\\tO\\ntumor\\tB-Disease\\ndevelopment\\tO\\nis\\tO\\ninitiated\\tO\\nby\\tO\\nsomatic\\tO\\ninactivation\\tO\\nof\\tO\\nboth\\tO\\nalleles\\tO\\nof\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nsome\\tO\\nof\\tO\\nthese\\tO\\npatients\\tO\\ncan\\tO\\ntransmit\\tO\\nretinoblastoma\\tB-Disease\\npredisposition\\tO\\nto\\tO\\ntheir\\tO\\noffspring\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nfrequency\\tO\\nand\\tO\\nnature\\tO\\nof\\tO\\nconstitutional\\tO\\nRB1\\tO\\n-\\tO\\ngene\\tO\\nmutations\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nisolated\\tO\\nunilateral\\tB-Disease\\nretinoblastoma\\tI-Disease\\n,\\tO\\nwe\\tO\\nanalyzed\\tO\\nDNA\\tO\\nfrom\\tO\\nperipheral\\tO\\nblood\\tO\\nand\\tO\\nfrom\\tO\\ntumor\\tB-Disease\\ntissue\\tO\\n.\\tO\\n\\nThe\\tO\\nanalysis\\tO\\nof\\tO\\ntumors\\tB-Disease\\nfrom\\tO\\n54\\tO\\n(\\tO\\n71\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n76\\tO\\ninformative\\tO\\npatients\\tO\\nshowed\\tO\\nloss\\tO\\nof\\tO\\nconstitutional\\tO\\nheterozygosity\\tO\\n(\\tO\\nLOH\\tO\\n)\\tO\\nat\\tO\\nintragenic\\tO\\nloci\\tO\\n.\\tO\\n\\nThree\\tO\\nof\\tO\\n13\\tO\\nuninformative\\tO\\npatients\\tO\\nhad\\tO\\nconstitutional\\tO\\ndeletions\\tO\\n.\\tO\\n\\nFor\\tO\\n39\\tO\\nrandomly\\tO\\nselected\\tO\\ntumors\\tB-Disease\\n,\\tO\\nSSCP\\tO\\n,\\tO\\nhetero\\tO\\n-\\tO\\nduplex\\tO\\nanalysis\\tO\\n,\\tO\\nsequencing\\tO\\n,\\tO\\nand\\tO\\nSouthern\\tO\\nblot\\tO\\nanalysis\\tO\\nwere\\tO\\nused\\tO\\nto\\tO\\nidentify\\tO\\nmutations\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\n21\\tO\\n(\\tO\\n91\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n23\\tO\\ntumors\\tB-Disease\\nwith\\tO\\nLOH\\tO\\n.\\tO\\n\\nIn\\tO\\n6\\tO\\n(\\tO\\n38\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n16\\tO\\ntumors\\tB-Disease\\nwithout\\tO\\nLOH\\tO\\n,\\tO\\none\\tO\\nmutation\\tO\\nwas\\tO\\ndetected\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\n9\\tO\\n(\\tO\\n56\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\ntumors\\tB-Disease\\nwithout\\tO\\nLOH\\tO\\n,\\tO\\nboth\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\n45\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\ntumors\\tB-Disease\\nof\\tO\\n36\\tO\\npatients\\tO\\n.\\tO\\n\\nThirty\\tO\\n-\\tO\\nnine\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\n-\\tO\\nincluding\\tO\\n34\\tO\\nsmall\\tO\\nmutations\\tO\\n,\\tO\\n2\\tO\\nlarge\\tO\\nstructural\\tO\\nalterations\\tO\\n,\\tO\\nand\\tO\\nhypermethylation\\tO\\nin\\tO\\n3\\tO\\ntumors\\tO\\n-\\tO\\nwere\\tO\\nnot\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\ncorresponding\\tO\\nperipheral\\tO\\nblood\\tO\\nDNA\\tO\\n.\\tO\\n\\nIn\\tO\\n6\\tO\\n(\\tO\\n17\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\n36\\tO\\npatients\\tO\\n,\\tO\\na\\tO\\nmutation\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nconstitutional\\tO\\nDNA\\tO\\n,\\tO\\nand\\tO\\n1\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nis\\tO\\nknown\\tO\\nto\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nreduced\\tO\\nexpressivity\\tO\\n.\\tO\\n\\nThe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nconstitutional\\tO\\nmutation\\tO\\nwas\\tO\\nnot\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nearly\\tO\\nage\\tO\\nat\\tO\\ntreatment\\tO\\n.\\tO\\n\\nIn\\tO\\n1\\tO\\npatient\\tO\\n,\\tO\\nsomatic\\tO\\nmosaicism\\tO\\nwas\\tO\\ndemonstrated\\tO\\nby\\tO\\nmolecular\\tO\\nanalysis\\tO\\nof\\tO\\nDNA\\tO\\nand\\tO\\nRNA\\tO\\nfrom\\tO\\nperipheral\\tO\\nblood\\tO\\n.\\tO\\n\\nIn\\tO\\n2\\tO\\npatients\\tO\\nwithout\\tO\\na\\tO\\ndetectable\\tO\\nmutation\\tO\\nin\\tO\\nperipheral\\tO\\nblood\\tO\\n,\\tO\\nmosaicism\\tO\\nwas\\tO\\nsuggested\\tO\\nbecause\\tO\\n1\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nshowed\\tO\\nmultifocal\\tO\\ntumors\\tB-Disease\\nand\\tO\\nthe\\tO\\nother\\tO\\nlater\\tO\\ndeveloped\\tO\\nbilateral\\tB-Disease\\nretinoblastoma\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nconclusion\\tO\\n,\\tO\\nour\\tO\\nresults\\tO\\nemphasize\\tO\\nthat\\tO\\nthe\\tO\\nmanifestation\\tO\\nand\\tO\\ntransmissibility\\tO\\nof\\tO\\nretinoblastoma\\tB-Disease\\ndepend\\tO\\non\\tO\\nthe\\tO\\nnature\\tO\\nof\\tO\\nthe\\tO\\nfirst\\tO\\nmutation\\tO\\n,\\tO\\nits\\tO\\ntime\\tO\\nin\\tO\\ndevelopment\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nnumber\\tO\\nand\\tO\\ntypes\\tO\\nof\\tO\\ncells\\tO\\nthat\\tO\\nare\\tO\\naffected\\tO\\n.\\tO\\n.\\tO\\n\\nHereditary\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfifth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\nin\\tO\\nman\\tO\\n.\\tO\\n\\nI\\tO\\n.\\tO\\n\\nClinical\\tO\\n,\\tO\\nimmunochemical\\tO\\n,\\tO\\nand\\tO\\nfamily\\tO\\nstudies\\tO\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\nrecognized\\tO\\nhuman\\tO\\nkindred\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\ndeficiency\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nfifth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC5\\tO\\n)\\tO\\nis\\tO\\ndescribed\\tO\\n.\\tO\\n\\nThe\\tO\\nproband\\tO\\n,\\tO\\na\\tO\\n20\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nblack\\tO\\nfemale\\tO\\nwith\\tO\\nsystemic\\tB-Disease\\nlupus\\tI-Disease\\nerythematosus\\tI-Disease\\nsince\\tO\\nage\\tO\\n11\\tO\\n,\\tO\\nlacked\\tO\\nserum\\tO\\nhemolytic\\tO\\ncomplement\\tO\\nactivity\\tO\\n,\\tO\\neven\\tO\\nduring\\tO\\nremission\\tO\\n.\\tO\\n\\nC5\\tO\\nwas\\tO\\nundetectable\\tO\\nin\\tO\\nher\\tO\\nserum\\tO\\nby\\tO\\nboth\\tO\\nimmunodiffusion\\tO\\nand\\tO\\nhemolytic\\tO\\nassays\\tO\\n.\\tO\\n\\nOther\\tO\\ncomplement\\tO\\ncomponents\\tO\\nwere\\tO\\nnormal\\tO\\nduring\\tO\\nremission\\tO\\nof\\tO\\nlupus\\tO\\n,\\tO\\nbut\\tO\\nC1\\tO\\n,\\tO\\nC4\\tO\\n,\\tO\\nC2\\tO\\n,\\tO\\nand\\tO\\nC3\\tO\\nlevels\\tO\\nfell\\tO\\nduring\\tO\\nexacerbations\\tO\\n.\\tO\\n\\nA\\tO\\nyounger\\tO\\nhalf\\tO\\n-\\tO\\nsister\\tO\\n,\\tO\\nwho\\tO\\nhad\\tO\\nno\\tO\\nunderlying\\tO\\ndisease\\tO\\n,\\tO\\nwas\\tO\\nalso\\tO\\nfound\\tO\\nto\\tO\\nlack\\tO\\nimmunochemically\\tO\\ndetectable\\tO\\nC5\\tO\\n.\\tO\\n\\nBy\\tO\\nhemolytic\\tO\\nassay\\tO\\n,\\tO\\nshe\\tO\\nexhibited\\tO\\n1\\tO\\n-\\tO\\n2\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nserum\\tO\\nC5\\tO\\nlevel\\tO\\nand\\tO\\nnormal\\tO\\nconcentrations\\tO\\nof\\tO\\nother\\tO\\ncomplement\\tO\\ncomponents\\tO\\n.\\tO\\n\\nC5\\tO\\nlevels\\tO\\nof\\tO\\nother\\tO\\nfamily\\tO\\nmembers\\tO\\nwere\\tO\\neither\\tO\\nnormal\\tO\\nor\\tO\\napproximately\\tO\\nhalf\\tO\\n-\\tO\\nnormal\\tO\\n,\\tO\\nconsistent\\tO\\nwith\\tO\\nautosomal\\tO\\ncodominant\\tO\\ninheritance\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\ndetermining\\tO\\nC5\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nNormal\\tO\\nhemolytic\\tO\\ntiters\\tO\\nwere\\tO\\nrestored\\tO\\nto\\tO\\nboth\\tO\\nhomozygous\\tO\\nC5\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\n(\\tO\\nC5D\\tB-Disease\\n)\\tO\\nsera\\tO\\nby\\tO\\naddition\\tO\\nof\\tO\\nhighly\\tO\\npurified\\tO\\nhuman\\tO\\nC5\\tO\\n.\\tO\\n\\nIn\\tO\\nspecific\\tO\\nC5\\tO\\ntitrations\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nit\\tO\\nwas\\tO\\nnoted\\tO\\nthat\\tO\\nwhen\\tO\\nlimited\\tO\\namounts\\tO\\nof\\tO\\nC5\\tO\\nwere\\tO\\nassayed\\tO\\nin\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nlow\\tO\\ndilutions\\tO\\nof\\tO\\neither\\tO\\nC5D\\tB-Disease\\nserum\\tO\\n,\\tO\\ncurving\\tO\\nrather\\tO\\nthan\\tO\\nlinear\\tO\\ndose\\tO\\n-\\tO\\nresponse\\tO\\nplots\\tO\\nwere\\tO\\nconsistently\\tO\\nobtained\\tO\\n,\\tO\\nsuggesting\\tO\\nsome\\tO\\ninhibitory\\tO\\neffect\\tO\\n.\\tO\\n\\nFurther\\tO\\nstudies\\tO\\nsuggested\\tO\\nthat\\tO\\nlow\\tO\\ndilutions\\tO\\nof\\tO\\nC5D\\tB-Disease\\nserum\\tO\\ncontain\\tO\\na\\tO\\nfactor\\tO\\n(\\tO\\nor\\tO\\nfactors\\tO\\n)\\tO\\ninterfering\\tO\\nat\\tO\\nsome\\tO\\nstep\\tO\\nin\\tO\\nthe\\tO\\nhemolytic\\tO\\nassay\\tO\\nof\\tO\\nC5\\tO\\n,\\tO\\nrather\\tO\\nthan\\tO\\na\\tO\\ntrue\\tO\\nC5\\tO\\ninhibitor\\tO\\nor\\tO\\ninactivator\\tO\\n.\\tO\\n\\nOf\\tO\\nclinical\\tO\\ninterest\\tO\\nare\\tO\\n(\\tO\\na\\tO\\n)\\tO\\nthe\\tO\\ndocumentation\\tO\\nof\\tO\\nmembranous\\tO\\nglomerulonephritis\\tB-Disease\\n,\\tO\\nvasculitis\\tB-Disease\\n,\\tO\\nand\\tO\\narthritis\\tB-Disease\\nin\\tO\\nan\\tO\\nindividual\\tO\\nlacking\\tO\\nC5\\tO\\n(\\tO\\nand\\tO\\nits\\tO\\nbiologic\\tO\\nfunctions\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\n(\\tO\\nb\\tO\\n)\\tO\\na\\tO\\nremarkable\\tO\\npropensity\\tO\\nto\\tO\\nbacterial\\tB-Disease\\ninfections\\tI-Disease\\nin\\tO\\nthe\\tO\\nproband\\tO\\n,\\tO\\neven\\tO\\nduring\\tO\\nperiods\\tO\\nof\\tO\\nlow\\tO\\n-\\tO\\ndose\\tO\\nor\\tO\\nalternate\\tO\\n-\\tO\\nday\\tO\\ncorticosteroid\\tO\\ntherapy\\tO\\n.\\tO\\n\\nOther\\tO\\nobservations\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nC5D\\tB-Disease\\nstate\\tO\\nis\\tO\\ncompatible\\tO\\nwith\\tO\\nnormal\\tO\\ncoagulation\\tO\\nfunction\\tO\\nand\\tO\\nthe\\tO\\ncapacity\\tO\\nto\\tO\\nmount\\tO\\na\\tO\\nneutrophilic\\tO\\nleukocytosis\\tO\\nduring\\tO\\npyogenic\\tB-Disease\\ninfection\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nSusceptibility\\tO\\nto\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\nin\\tO\\ntwins\\tO\\n:\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\ngenes\\tO\\n,\\tO\\nHLA\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nenvironment\\tO\\n.\\tO\\n\\nOBJECTIVE\\tO\\nTo\\tO\\ndetermine\\tO\\nthe\\tO\\nrelative\\tO\\neffects\\tO\\nof\\tO\\ngenetic\\tO\\nand\\tO\\nenvironmental\\tO\\nfactors\\tO\\nin\\tO\\nsusceptibility\\tO\\nto\\tO\\nankylosing\\tB-Disease\\nspondylitis\\tI-Disease\\n(\\tO\\nAS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nMETHODS\\tO\\nTwins\\tO\\nwith\\tO\\nAS\\tB-Disease\\nwere\\tO\\nidentified\\tO\\nfrom\\tO\\nthe\\tO\\nRoyal\\tO\\nNational\\tO\\nHospital\\tO\\nfor\\tO\\nRheumatic\\tB-Disease\\nDiseases\\tI-Disease\\ndatabase\\tO\\n.\\tO\\n\\nClinical\\tO\\nand\\tO\\nradiographic\\tO\\nexaminations\\tO\\nwere\\tO\\nperformed\\tO\\nto\\tO\\nestablish\\tO\\ndiagnoses\\tO\\n,\\tO\\nand\\tO\\ndisease\\tO\\nseverity\\tO\\nwas\\tO\\nassessed\\tO\\nusing\\tO\\na\\tO\\ncombination\\tO\\nof\\tO\\nvalidated\\tO\\nscoring\\tO\\nsystems\\tO\\n.\\tO\\n\\nHLA\\tO\\ntyping\\tO\\nfor\\tO\\nHLA\\tO\\n-\\tO\\nB27\\tO\\n,\\tO\\nHLA\\tO\\n-\\tO\\nB60\\tO\\n,\\tO\\nand\\tO\\nHLA\\tO\\n-\\tO\\nDR1\\tO\\nwas\\tO\\nperformed\\tO\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nwith\\tO\\nsequence\\tO\\n-\\tO\\nspecific\\tO\\nprimers\\tO\\n,\\tO\\nand\\tO\\nzygosity\\tO\\nwas\\tO\\nassessed\\tO\\nusing\\tO\\nmicrosatellite\\tO\\nmarkers\\tO\\n.\\tO\\n\\nGenetic\\tO\\nand\\tO\\nenvironmental\\tO\\nvariance\\tO\\ncomponents\\tO\\nwere\\tO\\nassessed\\tO\\nwith\\tO\\nthe\\tO\\nprogram\\tO\\nMx\\tO\\n,\\tO\\nusing\\tO\\ndata\\tO\\nfrom\\tO\\nthis\\tO\\nand\\tO\\nprevious\\tO\\nstudies\\tO\\nof\\tO\\ntwins\\tO\\nwith\\tO\\nAS\\tB-Disease\\n.\\tO\\n\\nRESULTS\\tO\\nSix\\tO\\nof\\tO\\n8\\tO\\nmonozygotic\\tO\\n(\\tO\\nMZ\\tO\\n)\\tO\\ntwin\\tO\\npairs\\tO\\nwere\\tO\\ndisease\\tO\\nconcordant\\tO\\n,\\tO\\ncompared\\tO\\nwith\\tO\\n4\\tO\\nof\\tO\\n15\\tO\\nB27\\tO\\n-\\tO\\npositive\\tO\\ndizygotic\\tO\\n(\\tO\\nDZ\\tO\\n)\\tO\\ntwin\\tO\\npairs\\tO\\n(\\tO\\n27\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\n4\\tO\\nof\\tO\\n32\\tO\\nDZ\\tO\\ntwin\\tO\\npairs\\tO\\noverall\\tO\\n(\\tO\\n12\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nNonsignificant\\tO\\nincreases\\tO\\nin\\tO\\nsimilarity\\tO\\nwith\\tO\\nregard\\tO\\nto\\tO\\nage\\tO\\nat\\tO\\ndisease\\tO\\nonset\\tO\\nand\\tO\\nall\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nseverity\\tO\\nscores\\tO\\nassessed\\tO\\nwere\\tO\\nnoted\\tO\\nin\\tO\\ndisease\\tO\\n-\\tO\\nconcordant\\tO\\nMZ\\tO\\ntwins\\tO\\ncompared\\tO\\nwith\\tO\\nconcordant\\tO\\nDZ\\tO\\ntwins\\tO\\n.\\tO\\n\\nHLA\\tO\\n-\\tO\\nB27\\tO\\nand\\tO\\nB60\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\ndisease\\tO\\nin\\tO\\nprobands\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nrate\\tO\\nof\\tO\\ndisease\\tO\\nconcordance\\tO\\nwas\\tO\\nsignificantly\\tO\\nincreased\\tO\\namong\\tO\\nDZ\\tO\\ntwin\\tO\\npairs\\tO\\nin\\tO\\nwhich\\tO\\nthe\\tO\\nco\\tO\\n-\\tO\\ntwin\\tO\\nwas\\tO\\npositive\\tO\\nfor\\tO\\nboth\\tO\\nB27\\tO\\nand\\tO\\nDR1\\tO\\n.\\tO\\n\\nAdditive\\tO\\ngenetic\\tO\\neffects\\tO\\nwere\\tO\\nestimated\\tO\\nto\\tO\\ncontribute\\tO\\n97\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\npopulation\\tO\\nvariance\\tO\\n.\\tO\\n\\nCONCLUSION\\tO\\nSusceptibility\\tO\\nto\\tO\\nAS\\tB-Disease\\nis\\tO\\nlargely\\tO\\ngenetically\\tO\\ndetermined\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nenvironmental\\tO\\ntrigger\\tO\\nfor\\tO\\nthe\\tO\\ndisease\\tO\\nis\\tO\\nprobably\\tO\\nubiquitous\\tO\\n.\\tO\\n\\nHLA\\tO\\n-\\tO\\nB27\\tO\\naccounts\\tO\\nfor\\tO\\na\\tO\\nminority\\tO\\nof\\tO\\nthe\\tO\\noverall\\tO\\ngenetic\\tO\\nsusceptibility\\tO\\nto\\tO\\nAS\\tB-Disease\\n.\\tO\\n\\nCell\\tO\\ncycle\\tO\\n-\\tO\\ndependent\\tO\\ncolocalization\\tO\\nof\\tO\\nBARD1\\tO\\nand\\tO\\nBRCA1\\tO\\nproteins\\tO\\nin\\tO\\ndiscrete\\tO\\nnuclear\\tO\\ndomains\\tO\\n.\\tO\\n\\nGerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\npredispose\\tO\\nwomen\\tO\\nto\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nby\\tO\\ncompromising\\tO\\nthe\\tO\\ngenes\\tO\\npresumptive\\tO\\nfunction\\tO\\nas\\tO\\na\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\nbiochemical\\tO\\nproperties\\tO\\nof\\tO\\nBRCA1\\tO\\npolypeptides\\tO\\nare\\tO\\nnot\\tO\\nunderstood\\tO\\n,\\tO\\ntheir\\tO\\nexpression\\tO\\npattern\\tO\\nand\\tO\\nsubcellular\\tO\\nlocalization\\tO\\nsuggest\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\ncell\\tO\\n-\\tO\\ncycle\\tO\\nregulation\\tO\\n.\\tO\\n\\nWhen\\tO\\nresting\\tO\\ncells\\tO\\nare\\tO\\ninduced\\tO\\nto\\tO\\nproliferate\\tO\\n,\\tO\\nthe\\tO\\nsteady\\tO\\n-\\tO\\nstate\\tO\\nlevels\\tO\\nof\\tO\\nBRCA1\\tO\\nincrease\\tO\\nin\\tO\\nlate\\tO\\nG1\\tO\\nand\\tO\\nreach\\tO\\na\\tO\\nmaximum\\tO\\nduring\\tO\\nS\\tO\\nphase\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nin\\tO\\nS\\tO\\nphase\\tO\\ncells\\tO\\n,\\tO\\nBRCA1\\tO\\npolypeptides\\tO\\nare\\tO\\nhyperphosphorylated\\tO\\nand\\tO\\naccumulate\\tO\\ninto\\tO\\ndiscrete\\tO\\nsubnuclear\\tO\\nfoci\\tO\\ntermed\\tO\\n\"\\tO\\nBRCA1\\tO\\nnuclear\\tO\\ndots\\tO\\n.\\tO\\n\\n\"\\tO\\nBRCA1\\tO\\nassociates\\tO\\nin\\tO\\nvivo\\tO\\nwith\\tO\\na\\tO\\nstructurally\\tO\\nrelated\\tO\\nprotein\\tO\\ntermed\\tO\\nBARD1\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nsteady\\tO\\n-\\tO\\nstate\\tO\\nlevels\\tO\\nof\\tO\\nBARD1\\tO\\n,\\tO\\nunlike\\tO\\nthose\\tO\\nof\\tO\\nBRCA1\\tO\\n,\\tO\\nremain\\tO\\nrelatively\\tO\\nconstant\\tO\\nduring\\tO\\ncell\\tO\\ncycle\\tO\\nprogression\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nimmunostaining\\tO\\nrevealed\\tO\\nthat\\tO\\nBARD1\\tO\\nresides\\tO\\nwithin\\tO\\nBRCA1\\tO\\nnuclear\\tO\\ndots\\tO\\nduring\\tO\\nS\\tO\\nphase\\tO\\nof\\tO\\nthe\\tO\\ncell\\tO\\ncycle\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nduring\\tO\\nthe\\tO\\nG1\\tO\\nphase\\tO\\n.\\tO\\n\\nNevertheless\\tO\\n,\\tO\\nBARD1\\tO\\npolypeptides\\tO\\nare\\tO\\nfound\\tO\\nexclusively\\tO\\nin\\tO\\nthe\\tO\\nnuclear\\tO\\nfractions\\tO\\nof\\tO\\nboth\\tO\\nG1\\tO\\n-\\tO\\nand\\tO\\nS\\tO\\n-\\tO\\nphase\\tO\\ncells\\tO\\n.\\tO\\n\\nTherefore\\tO\\n,\\tO\\nprogression\\tO\\nto\\tO\\nS\\tO\\nphase\\tO\\nis\\tO\\naccompanied\\tO\\nby\\tO\\nthe\\tO\\naggregation\\tO\\nof\\tO\\nnuclear\\tO\\nBARD1\\tO\\npolypeptides\\tO\\ninto\\tO\\nBRCA1\\tO\\nnuclear\\tO\\ndots\\tO\\n.\\tO\\n\\nThis\\tO\\ncell\\tO\\ncycle\\tO\\n-\\tO\\ndependent\\tO\\ncolocalization\\tO\\nof\\tO\\nBARD1\\tO\\nand\\tO\\nBRCA1\\tO\\nindicates\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nBARD1\\tO\\nin\\tO\\nBRCA1\\tO\\n-\\tO\\nmediated\\tO\\ntumor\\tB-Disease\\nsuppression\\tO\\n.\\tO\\n\\nEthnic\\tO\\ndifferences\\tO\\nin\\tO\\nthe\\tO\\nHFE\\tO\\ncodon\\tO\\n282\\tO\\n(\\tO\\nCys\\tO\\n/\\tO\\nTyr\\tO\\n)\\tO\\npolymorphism\\tO\\n.\\tO\\n\\nRecent\\tO\\nstudies\\tO\\nhave\\tO\\nshown\\tO\\nthat\\tO\\nhereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\n(\\tO\\nHH\\tB-Disease\\n)\\tO\\nis\\tO\\nlikely\\tO\\nto\\tO\\nbe\\tO\\ncaused\\tO\\nby\\tO\\nhomozygosity\\tO\\nfor\\tO\\na\\tO\\nCys282Tyr\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nHFE\\tO\\ngene\\tO\\nlocated\\tO\\n4\\tO\\n.\\tO\\n\\n5\\tO\\nMb\\tO\\ntelomeric\\tO\\nto\\tO\\nHLA\\tO\\n-\\tO\\nA\\tO\\n.\\tO\\n\\nPopulation\\tO\\nstudies\\tO\\nof\\tO\\nthis\\tO\\npolymorphism\\tO\\nare\\tO\\nfacilitated\\tO\\nby\\tO\\nthe\\tO\\nfact\\tO\\nthat\\tO\\nthe\\tO\\nCys282Tyr\\tO\\nmutation\\tO\\ncreates\\tO\\na\\tO\\nRsal\\tO\\nrestriction\\tO\\nsite\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nstudied\\tO\\nthe\\tO\\ncodon\\tO\\n282\\tO\\n(\\tO\\nCys\\tO\\n/\\tO\\nTyr\\tO\\n)\\tO\\npolymorphism\\tO\\nin\\tO\\ndifferent\\tO\\nethnic\\tO\\ngroups\\tO\\n.\\tO\\n\\nIn\\tO\\nagreement\\tO\\nwith\\tO\\nprevious\\tO\\nobservations\\tO\\nthe\\tO\\nTyr\\tO\\nallele\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\nrare\\tO\\nor\\tO\\nabsent\\tO\\nin\\tO\\nAsiatic\\tO\\n(\\tO\\nIndian\\tO\\n,\\tO\\nChinese\\tO\\n)\\tO\\npopulations\\tO\\n.\\tO\\n\\nThe\\tO\\nhighest\\tO\\nallele\\tO\\nfrequency\\tO\\n(\\tO\\n7\\tO\\n.\\tO\\n5\\tO\\n%\\tO\\n)\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nSwedes\\tO\\n.\\tO\\n\\nSaamis\\tO\\n(\\tO\\n2\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\nMordvinians\\tO\\n(\\tO\\n1\\tO\\n.\\tO\\n8\\tO\\n%\\tO\\n)\\tO\\nhad\\tO\\nsignificantly\\tO\\nlower\\tO\\nfrequencies\\tO\\nof\\tO\\nthe\\tO\\nTyr\\tO\\nallele\\tO\\n.\\tO\\n\\nComparisons\\tO\\nwith\\tO\\nallele\\tO\\nfrequencies\\tO\\nbased\\tO\\non\\tO\\nprevalence\\tO\\nestimates\\tO\\nof\\tO\\nHH\\tB-Disease\\nshowed\\tO\\nsome\\tO\\ndisagreements\\tO\\nwith\\tO\\nthe\\tO\\nRFLP\\tO\\ndata\\tO\\n,\\tO\\nparticularly\\tO\\nin\\tO\\nFinns\\tO\\n.\\tO\\n\\nThe\\tO\\nnewly\\tO\\ndescribed\\tO\\nHFE\\tO\\nmarker\\tO\\nprovides\\tO\\na\\tO\\nnew\\tO\\napproach\\tO\\nto\\tO\\nthe\\tO\\nscreening\\tO\\nof\\tO\\nHH\\tB-Disease\\nas\\tO\\nwell\\tO\\nas\\tO\\nstudies\\tO\\nof\\tO\\nthe\\tO\\nrelationship\\tO\\nbetween\\tO\\nthe\\tO\\nHFE\\tO\\nTyr\\tO\\nallele\\tO\\nand\\tO\\ndifferent\\tO\\ndisorders\\tO\\nincluding\\tO\\ncancer\\tB-Disease\\n\\nAutosomal\\tB-Disease\\ndominant\\tI-Disease\\nneurohypophyseal\\tI-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\nassociated\\tO\\nwith\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nencoding\\tO\\nGly23\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nVal\\tO\\nin\\tO\\nneurophysin\\tO\\nII\\tO\\n.\\tO\\n\\nAutosomal\\tB-Disease\\ndominant\\tI-Disease\\nneurohypophyseal\\tI-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\n(\\tO\\nADNDI\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\ninherited\\tB-Disease\\ndisease\\tI-Disease\\ncaused\\tO\\nby\\tO\\nprogressive\\tO\\ndegeneration\\tO\\nof\\tO\\nthe\\tO\\nmagnocellular\\tO\\nneurons\\tO\\nof\\tO\\nthe\\tO\\nhypothalamus\\tO\\nleading\\tO\\nto\\tO\\ndecreased\\tO\\nability\\tO\\nto\\tO\\nproduce\\tO\\nthe\\tO\\nhormone\\tO\\narginine\\tO\\nvasopressin\\tO\\n(\\tO\\nAVP\\tO\\n)\\tO\\n.\\tO\\n\\nAffected\\tO\\nindividuals\\tO\\nare\\tO\\nnot\\tO\\nsymptomatic\\tO\\nat\\tO\\nbirth\\tO\\n,\\tO\\nbut\\tO\\nusually\\tO\\ndevelop\\tO\\ndiabetes\\tB-Disease\\ninsipidus\\tI-Disease\\nat\\tO\\n1\\tO\\n-\\tO\\n6\\tO\\nyr\\tO\\nof\\tO\\nage\\tO\\n.\\tO\\n\\nThe\\tO\\ngenetic\\tO\\nlocus\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nis\\tO\\nthe\\tO\\nAVP\\tO\\n-\\tO\\nneurophysin\\tO\\nII\\tO\\n(\\tO\\nNPII\\tO\\n)\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nmutations\\tO\\nthat\\tO\\ncause\\tO\\nADNDI\\tB-Disease\\nhave\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\nboth\\tO\\nthe\\tO\\nsignal\\tO\\npeptide\\tO\\nof\\tO\\nthe\\tO\\nprepro\\tO\\n-\\tO\\nAVP\\tO\\n-\\tO\\nNPII\\tO\\nprecursor\\tO\\nand\\tO\\nwithin\\tO\\nNPII\\tO\\nitself\\tO\\n.\\tO\\n\\nAn\\tO\\naffected\\tO\\ngirl\\tO\\nwho\\tO\\npresented\\tO\\nat\\tO\\n9\\tO\\nmonths\\tO\\nof\\tO\\nage\\tO\\nand\\tO\\nher\\tO\\nsimilarly\\tO\\naffected\\tO\\nyounger\\tO\\nbrother\\tO\\nand\\tO\\nfather\\tO\\nwere\\tO\\nall\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nnovel\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nG1758\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nT\\tO\\n)\\tO\\nencoding\\tO\\nthe\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\nGly23\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nVal\\tO\\nwithin\\tO\\nNPII\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nwas\\tO\\nconfirmed\\tO\\nby\\tO\\nrestriction\\tO\\nendonuclease\\tO\\nanalysis\\tO\\n.\\tO\\n\\nA\\tO\\nT1\\tO\\n-\\tO\\nweighted\\tO\\nmagnetic\\tO\\nresonance\\tO\\nimaging\\tO\\nof\\tO\\nthe\\tO\\nfathers\\tO\\npituitary\\tO\\ngland\\tO\\ndemonstrates\\tO\\nan\\tO\\nattenuated\\tO\\nposterior\\tO\\npituitary\\tO\\nbright\\tO\\nspot\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nmay\\tO\\nbe\\tO\\nvaluable\\tO\\nfor\\tO\\ndeveloping\\tO\\nmodels\\tO\\nof\\tO\\ndominantly\\tB-Disease\\ninherited\\tI-Disease\\nneurodegeneration\\tI-Disease\\n,\\tO\\nas\\tO\\nthe\\tO\\nearly\\tO\\nage\\tO\\nof\\tO\\nonset\\tO\\nof\\tO\\nsymptoms\\tO\\nsuggests\\tO\\nthat\\tO\\nthis\\tO\\nmutation\\tO\\nmay\\tO\\nbe\\tO\\nparticularly\\tO\\ndeleterious\\tO\\nto\\tO\\nthe\\tO\\nmagnocellular\\tO\\nneuron\\tO\\n.\\tO\\n.\\tO\\n\\nFrequent\\tO\\ninactivation\\tO\\nof\\tO\\nPTEN\\tO\\n/\\tO\\nMMAC1\\tO\\nin\\tO\\nprimary\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nSporadic\\tB-Disease\\nprostate\\tI-Disease\\ncarcinoma\\tI-Disease\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nmale\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\nthe\\tO\\nWestern\\tO\\nworld\\tO\\n,\\tO\\nyet\\tO\\nmany\\tO\\nof\\tO\\nthe\\tO\\nmajor\\tO\\ngenetic\\tO\\nevents\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nprogression\\tO\\nof\\tO\\nthis\\tO\\noften\\tO\\nfatal\\tO\\ncancer\\tB-Disease\\nremain\\tO\\nto\\tO\\nbe\\tO\\nelucidated\\tO\\n.\\tO\\n\\nNumerous\\tO\\ncytogenetic\\tO\\nand\\tO\\nallelotype\\tO\\nstudies\\tO\\nhave\\tO\\nreported\\tO\\nfrequent\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\non\\tO\\nchromosomal\\tO\\narm\\tO\\n10q\\tO\\nin\\tO\\nsporadic\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nDeletion\\tO\\nmapping\\tO\\nstudies\\tO\\nhave\\tO\\nunambiguously\\tO\\nidentified\\tO\\na\\tO\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n10q23\\tO\\nto\\tO\\nbe\\tO\\nthe\\tO\\nminimal\\tO\\narea\\tO\\nof\\tO\\nloss\\tO\\n.\\tO\\n\\nA\\tO\\nnew\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n,\\tO\\nPTEN\\tO\\n/\\tO\\nMMAC1\\tO\\n,\\tO\\nwas\\tO\\nisolated\\tO\\nrecently\\tO\\nat\\tO\\nthis\\tO\\nregion\\tO\\nof\\tO\\nchromosome\\tO\\n10q23\\tO\\nand\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ninactivated\\tO\\nby\\tO\\nmutation\\tO\\nin\\tO\\nthree\\tO\\nprostate\\tB-Disease\\ncancer\\tI-Disease\\ncell\\tO\\nlines\\tO\\n.\\tO\\n\\nWe\\tO\\nscreened\\tO\\n80\\tO\\nprostate\\tB-Disease\\ntumors\\tI-Disease\\nby\\tO\\nmicrosatellite\\tO\\nanalysis\\tO\\nand\\tO\\nfound\\tO\\nchromosome\\tO\\n10q23\\tO\\nto\\tO\\nbe\\tO\\ndeleted\\tO\\nin\\tO\\n23\\tO\\ncases\\tO\\n.\\tO\\n\\nWe\\tO\\nthen\\tO\\nproceeded\\tO\\nwith\\tO\\nsequence\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nentire\\tO\\nPTEN\\tO\\n/\\tO\\nMMAC1\\tO\\ncoding\\tO\\nregion\\tO\\nand\\tO\\ntested\\tO\\nfor\\tO\\nhomozygous\\tO\\ndeletion\\tO\\nwith\\tO\\nnew\\tO\\nintragenic\\tO\\nmarkers\\tO\\nin\\tO\\nthese\\tO\\n23\\tO\\ncases\\tO\\nwith\\tO\\n10q23\\tO\\nloss\\tO\\nof\\tO\\nheterozygosity\\tO\\n.\\tO\\n\\nThe\\tO\\nidentification\\tO\\nof\\tO\\nthe\\tO\\nsecond\\tO\\nmutational\\tO\\nevent\\tO\\nin\\tO\\n10\\tO\\n(\\tO\\n43\\tO\\n%\\tO\\n)\\tO\\ntumors\\tB-Disease\\nestablishes\\tO\\nPTEN\\tO\\n/\\tO\\nMMAC1\\tO\\nas\\tO\\na\\tO\\nmain\\tO\\ninactivation\\tO\\ntarget\\tO\\nof\\tO\\n10q\\tO\\nloss\\tO\\nin\\tO\\nsporadic\\tB-Disease\\nprostate\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nRisk\\tO\\nreversals\\tO\\nin\\tO\\npredictive\\tO\\ntesting\\tO\\nfor\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\npredictive\\tO\\ntesting\\tO\\nfor\\tO\\nHuntington\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nHD\\tB-Disease\\n)\\tO\\nwas\\tO\\nbased\\tO\\non\\tO\\nanalysis\\tO\\nof\\tO\\nlinked\\tO\\npolymorphic\\tO\\nDNA\\tO\\nmarkers\\tO\\nto\\tO\\nestimate\\tO\\nthe\\tO\\nlikelihood\\tO\\nof\\tO\\ninheriting\\tO\\nthe\\tO\\nmutation\\tO\\nfor\\tO\\nHD\\tB-Disease\\n.\\tO\\n\\nLimits\\tO\\nto\\tO\\naccuracy\\tO\\nincluded\\tO\\nrecombination\\tO\\nbetween\\tO\\nthe\\tO\\nDNA\\tO\\nmarkers\\tO\\nand\\tO\\nthe\\tO\\nmutation\\tO\\n,\\tO\\npedigree\\tO\\nstructure\\tO\\n,\\tO\\nand\\tO\\nwhether\\tO\\nDNA\\tO\\nsamples\\tO\\nwere\\tO\\navailable\\tO\\nfrom\\tO\\nfamily\\tO\\nmembers\\tO\\n.\\tO\\n\\nWith\\tO\\ndirect\\tO\\ntests\\tO\\nfor\\tO\\nthe\\tO\\nHD\\tB-Disease\\nmutation\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nassessed\\tO\\nthe\\tO\\naccuracy\\tO\\nof\\tO\\nresults\\tO\\nobtained\\tO\\nby\\tO\\nlinkage\\tO\\napproaches\\tO\\nwhen\\tO\\nrequested\\tO\\nto\\tO\\ndo\\tO\\nso\\tO\\nby\\tO\\nthe\\tO\\ntest\\tO\\nindividuals\\tO\\n.\\tO\\n\\nFor\\tO\\nsix\\tO\\nsuch\\tO\\nindividuals\\tO\\n,\\tO\\nthere\\tO\\nwas\\tO\\nsignificant\\tO\\ndisparity\\tO\\nbetween\\tO\\nthe\\tO\\ntests\\tO\\n.\\tO\\n\\nThree\\tO\\nwent\\tO\\nfrom\\tO\\na\\tO\\ndecreased\\tO\\nrisk\\tO\\nto\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\n,\\tO\\nwhile\\tO\\nin\\tO\\nanother\\tO\\nthree\\tO\\nthe\\tO\\nrisk\\tO\\nwas\\tO\\ndecreased\\tO\\n.\\tO\\n\\nKnowledge\\tO\\nof\\tO\\nthe\\tO\\npotential\\tO\\nreasons\\tO\\nfor\\tO\\nthese\\tO\\nchanges\\tO\\nin\\tO\\nresults\\tO\\nand\\tO\\nimpact\\tO\\nof\\tO\\nthese\\tO\\nrisk\\tO\\nreversals\\tO\\non\\tO\\nboth\\tO\\npatients\\tO\\nand\\tO\\nthe\\tO\\ncounseling\\tO\\nteam\\tO\\ncan\\tO\\nassist\\tO\\nin\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nstrategies\\tO\\nfor\\tO\\nthe\\tO\\nprevention\\tO\\nand\\tO\\n,\\tO\\nwhere\\tO\\nnecessary\\tO\\n,\\tO\\nmanagement\\tO\\nof\\tO\\na\\tO\\nrisk\\tO\\nreversal\\tO\\nin\\tO\\nany\\tO\\npredictive\\tO\\ntesting\\tO\\nprogram\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nnovel\\tO\\ncommon\\tO\\nmissense\\tO\\nmutation\\tO\\nG301C\\tO\\nin\\tO\\nthe\\tO\\nN\\tO\\n-\\tO\\nacetylgalactosamine\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nsulfate\\tO\\nsulfatase\\tO\\ngene\\tO\\nin\\tO\\nmucopolysaccharidosis\\tB-Disease\\nIVA\\tI-Disease\\n.\\tO\\n\\nMucopolysaccharidosis\\tB-Disease\\nIVA\\tI-Disease\\n(\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nlysosomal\\tI-Disease\\nstorage\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\nin\\tO\\nN\\tO\\n-\\tO\\nacetylgalactosamine\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nsulfate\\tO\\nsulfatase\\tO\\n(\\tO\\nGALNS\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nprevious\\tO\\nstudies\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nfound\\tO\\ntwo\\tO\\ncommon\\tO\\nmutations\\tO\\nin\\tO\\nCaucasians\\tO\\nand\\tO\\nJapanese\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nTo\\tO\\ncharacterize\\tO\\nthe\\tO\\nmutational\\tO\\nspectrum\\tO\\nin\\tO\\nvarious\\tO\\nethnic\\tO\\ngroups\\tO\\n,\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nGALNS\\tO\\ngene\\tO\\nin\\tO\\nColombian\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\npatients\\tO\\nwere\\tO\\ninvestigated\\tO\\n,\\tO\\nand\\tO\\ngenetic\\tO\\nbackgrounds\\tO\\nwere\\tO\\nextensively\\tO\\nanalyzed\\tO\\nto\\tO\\nidentify\\tO\\nracial\\tO\\norigin\\tO\\n,\\tO\\nbased\\tO\\non\\tO\\nmitochondrial\\tO\\nDNA\\tO\\n(\\tO\\nmtDNA\\tO\\n)\\tO\\nlineages\\tO\\n.\\tO\\n\\nThree\\tO\\nnovel\\tO\\nmissense\\tO\\nmutations\\tO\\nnever\\tO\\nidentified\\tO\\npreviously\\tO\\nin\\tO\\nother\\tO\\npopulations\\tO\\nand\\tO\\nfound\\tO\\nin\\tO\\n16\\tO\\nout\\tO\\nof\\tO\\n19\\tO\\nColombian\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\nunrelated\\tO\\nalleles\\tO\\naccount\\tO\\nfor\\tO\\n84\\tO\\n.\\tO\\n\\n2\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nalleles\\tO\\nin\\tO\\nthis\\tO\\nstudy\\tO\\n.\\tO\\n\\nThe\\tO\\nG301C\\tO\\nand\\tO\\nS162F\\tO\\nmutations\\tO\\naccount\\tO\\nfor\\tO\\n68\\tO\\n.\\tO\\n\\n4\\tO\\n%\\tO\\nand\\tO\\n10\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\nof\\tO\\nmutations\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nremaining\\tO\\nF69V\\tO\\nis\\tO\\nlimited\\tO\\nto\\tO\\na\\tO\\nsingle\\tO\\nallele\\tO\\n.\\tO\\n\\nThe\\tO\\nskewed\\tO\\nprevalence\\tO\\nof\\tO\\nG301C\\tO\\nin\\tO\\nonly\\tO\\nColombian\\tO\\npatients\\tO\\nand\\tO\\nhaplotype\\tO\\nanalysis\\tO\\nby\\tO\\nrestriction\\tO\\nfragment\\tO\\nlength\\tO\\npolymorphisms\\tO\\nin\\tO\\nthe\\tO\\nGALNS\\tO\\ngene\\tO\\nsuggest\\tO\\nthat\\tO\\nG301C\\tO\\noriginated\\tO\\nfrom\\tO\\na\\tO\\ncommon\\tO\\nancestor\\tO\\n.\\tO\\n\\nInvestigation\\tO\\nof\\tO\\nthe\\tO\\ngenetic\\tO\\nbackground\\tO\\nby\\tO\\nmeans\\tO\\nof\\tO\\nmtDNA\\tO\\nlineages\\tO\\nindicate\\tO\\nthat\\tO\\nall\\tO\\nour\\tO\\npatients\\tO\\nare\\tO\\nprobably\\tO\\nof\\tO\\nnative\\tO\\nAmerican\\tO\\ndescent\\tO\\n\\nLow\\tO\\nfrequency\\tO\\nof\\tO\\nBRCA1\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\n45\\tO\\nGerman\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\nwe\\tO\\ninvestigated\\tO\\n45\\tO\\nGerman\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nfor\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\ngene\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\nfour\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nthree\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nand\\tO\\nin\\tO\\none\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamily\\tO\\n.\\tO\\namong\\tO\\nthese\\tO\\nwere\\tO\\none\\tO\\nframeshift\\tO\\nmutation\\tO\\n,\\tO\\none\\tO\\nnonsense\\tO\\nmutation\\tO\\n,\\tO\\none\\tO\\nnovel\\tO\\nsplice\\tO\\nsite\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\none\\tO\\nmissense\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nmissense\\tO\\nmutation\\tO\\nwas\\tO\\nalso\\tO\\nfound\\tO\\nin\\tO\\n2\\tO\\n.\\tO\\n\\n8\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nit\\tO\\nis\\tO\\nnot\\tO\\ndisease\\tO\\nassociated\\tO\\n.\\tO\\n\\nThe\\tO\\naverage\\tO\\nage\\tO\\nof\\tO\\ndisease\\tO\\nonset\\tO\\nin\\tO\\nthose\\tO\\nfamilies\\tO\\nharbouring\\tO\\ncausative\\tO\\nmutations\\tO\\nwas\\tO\\nbetween\\tO\\n32\\tO\\n.\\tO\\n\\n3\\tO\\nand\\tO\\n37\\tO\\n.\\tO\\n\\n4\\tO\\nyears\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nfamily\\tO\\nharbouring\\tO\\nthe\\tO\\nmissense\\tO\\nmutation\\tO\\nhad\\tO\\nan\\tO\\naverage\\tO\\nage\\tO\\nof\\tO\\nonset\\tO\\nof\\tO\\n51\\tO\\n.\\tO\\n\\n2\\tO\\nyears\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nshow\\tO\\nthat\\tO\\nBRCA1\\tO\\nis\\tO\\nimplicated\\tO\\nin\\tO\\na\\tO\\nsmall\\tO\\nfraction\\tO\\nof\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nsuggesting\\tO\\nthe\\tO\\ninvolvement\\tO\\nof\\tO\\nanother\\tO\\nsusceptibility\\tO\\ngene\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\n\\nPaternal\\tO\\ntransmission\\tO\\nof\\tO\\ncongenital\\tB-Disease\\nmyotonic\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\na\\tO\\nrare\\tO\\ncase\\tO\\nof\\tO\\npaternally\\tO\\ntransmitted\\tO\\ncongenital\\tB-Disease\\nmyotonic\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nproband\\tO\\nis\\tO\\na\\tO\\n23\\tO\\nyear\\tO\\nold\\tO\\n,\\tO\\nmentally\\tB-Disease\\nretarded\\tI-Disease\\nmale\\tO\\nwho\\tO\\nsuffers\\tO\\nsevere\\tO\\nmuscular\\tB-Disease\\nweakness\\tI-Disease\\n.\\tO\\n\\nHe\\tO\\npresented\\tO\\nwith\\tO\\nrespiratory\\tO\\nand\\tO\\nfeeding\\tO\\ndifficulties\\tO\\nat\\tO\\nbirth\\tO\\n.\\tO\\n\\nHis\\tO\\ntwo\\tO\\nsibs\\tO\\nsuffer\\tO\\nfrom\\tO\\nchildhood\\tO\\nonset\\tO\\nDM\\tB-Disease\\n.\\tO\\n\\nTheir\\tO\\nlate\\tO\\nfather\\tO\\nhad\\tO\\nthe\\tO\\nadult\\tO\\ntype\\tO\\nof\\tO\\nDM\\tB-Disease\\n,\\tO\\nwith\\tO\\nonset\\tO\\naround\\tO\\n30\\tO\\nyears\\tO\\n.\\tO\\n\\nOnly\\tO\\nsix\\tO\\nother\\tO\\ncases\\tO\\nof\\tO\\npaternal\\tO\\ntransmission\\tO\\nof\\tO\\ncongenital\\tB-Disease\\nDM\\tI-Disease\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\nrecently\\tO\\n.\\tO\\n\\nWe\\tO\\nreview\\tO\\nthe\\tO\\nsex\\tO\\nrelated\\tO\\neffects\\tO\\non\\tO\\ntransmission\\tO\\nof\\tO\\ncongenital\\tB-Disease\\nDM\\tI-Disease\\n.\\tO\\n\\nDecreased\\tO\\nfertility\\tO\\nof\\tO\\nmales\\tO\\nwith\\tO\\nadult\\tO\\nonset\\tO\\nDM\\tB-Disease\\nand\\tO\\ncontraction\\tO\\nof\\tO\\nthe\\tO\\nrepeat\\tO\\nupon\\tO\\nmale\\tO\\ntransmission\\tO\\ncontribute\\tO\\nto\\tO\\nthe\\tO\\nalmost\\tO\\nabsent\\tO\\noccurrence\\tO\\nof\\tO\\npaternal\\tO\\ntransmission\\tO\\nof\\tO\\ncongenital\\tB-Disease\\nDM\\tI-Disease\\n.\\tO\\n\\nAlso\\tO\\nthe\\tO\\nfathers\\tO\\nof\\tO\\nthe\\tO\\nreported\\tO\\ncongenitally\\tO\\naffected\\tO\\nchildren\\tO\\nshowed\\tO\\n,\\tO\\non\\tO\\naverage\\tO\\n,\\tO\\nshorter\\tO\\nCTG\\tO\\nrepeat\\tO\\nlengths\\tO\\nand\\tO\\nhence\\tO\\nless\\tO\\nsevere\\tO\\nclinical\\tO\\nsymptoms\\tO\\nthan\\tO\\nthe\\tO\\nmothers\\tO\\nof\\tO\\nchildren\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\nDM\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\npaternal\\tO\\ntransmission\\tO\\nof\\tO\\ncongenital\\tB-Disease\\nDM\\tI-Disease\\nis\\tO\\nrare\\tO\\nand\\tO\\npreferentially\\tO\\noccurs\\tO\\nwith\\tO\\nonset\\tO\\nof\\tO\\nDM\\tB-Disease\\npast\\tO\\n30\\tO\\nyears\\tO\\nin\\tO\\nthe\\tO\\nfather\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nRB1\\tO\\ngene\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nchild\\tO\\nwith\\tO\\nectopic\\tB-Disease\\nintracranial\\tI-Disease\\nretinoblastoma\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nRB1\\tO\\ngene\\tO\\nmutation\\tO\\nwas\\tO\\ninvestigated\\tO\\nin\\tO\\na\\tO\\nchild\\tO\\nwith\\tO\\nectopic\\tB-Disease\\nintracranial\\tI-Disease\\nretinoblastoma\\tI-Disease\\nusing\\tO\\nDNA\\tO\\nobtained\\tO\\nfrom\\tO\\nboth\\tO\\nthe\\tO\\npineal\\tB-Disease\\nand\\tI-Disease\\nretinal\\tI-Disease\\ntumours\\tI-Disease\\nof\\tO\\nthe\\tO\\npatient\\tO\\n.\\tO\\n\\nA\\tO\\nnonsense\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n17\\tO\\n(\\tO\\ncodon\\tO\\n556\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\npresent\\tO\\nhomozygously\\tO\\nin\\tO\\nboth\\tO\\nthe\\tO\\nretinal\\tB-Disease\\nand\\tI-Disease\\nthe\\tI-Disease\\npineal\\tI-Disease\\ntumours\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nsame\\tO\\nmutation\\tO\\nwas\\tO\\npresent\\tO\\nheterozygously\\tO\\nin\\tO\\nthe\\tO\\nDNA\\tO\\nfrom\\tO\\nthe\\tO\\nconstitutional\\tO\\ncells\\tO\\nof\\tO\\nthe\\tO\\npatient\\tO\\n,\\tO\\nproving\\tO\\nit\\tO\\nto\\tO\\nbe\\tO\\nof\\tO\\ngermline\\tO\\norigin\\tO\\n.\\tO\\n\\nThe\\tO\\ninitial\\tO\\nmutation\\tO\\nwas\\tO\\nshown\\tO\\nto\\tO\\nhave\\tO\\noccurred\\tO\\nin\\tO\\nthe\\tO\\npaternally\\tO\\nderived\\tO\\nRB1\\tO\\nallele\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nis\\tO\\nin\\tO\\nan\\tO\\narea\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nthat\\tO\\nencodes\\tO\\nthe\\tO\\nprotein\\tO\\n-\\tO\\nbinding\\tO\\nregion\\tO\\nknown\\tO\\nas\\tO\\nthe\\tO\\npocket\\tO\\nregion\\tO\\nand\\tO\\nhas\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\nother\\tO\\ncases\\tO\\nof\\tO\\nretinoblastoma\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nLow\\tO\\nlevels\\tO\\nof\\tO\\nbeta\\tO\\nhexosaminidase\\tO\\nA\\tO\\nin\\tO\\nhealthy\\tO\\nindividuals\\tO\\nwith\\tO\\napparent\\tO\\ndeficiency\\tO\\nof\\tO\\nthis\\tO\\nenzyme\\tO\\n.\\tO\\n\\nAppreciable\\tO\\nbeta\\tO\\nhexosaminidase\\tO\\nA\\tO\\n(\\tO\\nhex\\tO\\nA\\tO\\n)\\tO\\nactivity\\tO\\nhas\\tO\\nbeen\\tO\\ndetected\\tO\\nin\\tO\\ncultured\\tO\\nskin\\tO\\nfibroblasts\\tO\\nand\\tO\\nmelanoma\\tB-Disease\\ntissue\\tO\\nfrom\\tO\\nhealthy\\tO\\nindividuals\\tO\\npreviously\\tO\\nreported\\tO\\nas\\tO\\nhaving\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nhex\\tI-Disease\\nA\\tI-Disease\\nactivity\\tO\\nindistinguishable\\tO\\nfrom\\tO\\nthat\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIdentification\\tO\\nand\\tO\\nquantitation\\tO\\nof\\tO\\nhex\\tO\\nA\\tO\\n,\\tO\\namounting\\tO\\nto\\tO\\n3\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\n-\\tO\\n6\\tO\\n.\\tO\\n\\n9\\tO\\n%\\tO\\nof\\tO\\ntotal\\tO\\nbeta\\tO\\nhexosaminidase\\tO\\nactivity\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nobtained\\tO\\nby\\tO\\ncellulose\\tO\\nacetate\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n,\\tO\\nDEAE\\tO\\n-\\tO\\ncellulose\\tO\\nion\\tO\\n-\\tO\\nexchange\\tO\\nchromatography\\tO\\n,\\tO\\nradial\\tO\\nimmunodiffusion\\tO\\n,\\tO\\nand\\tO\\nradioimmunoassay\\tO\\n.\\tO\\n\\nPrevious\\tO\\nfamily\\tO\\nstudies\\tO\\nsuggested\\tO\\nthat\\tO\\nthese\\tO\\nindividuals\\tO\\nmay\\tO\\nbe\\tO\\ncompound\\tO\\nheterozygotes\\tO\\nfor\\tO\\nthe\\tO\\ncommon\\tO\\nmutant\\tO\\nTSD\\tB-Disease\\ngene\\tO\\nand\\tO\\na\\tO\\nrare\\tO\\n(\\tO\\nallelic\\tO\\n)\\tO\\nmutant\\tO\\ngene\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\npostulated\\tO\\nrate\\tO\\nmutant\\tO\\ngene\\tO\\nappears\\tO\\nto\\tO\\ncode\\tO\\nfor\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nlow\\tO\\namounts\\tO\\nof\\tO\\nhex\\tO\\nA\\tO\\n.\\tO\\n\\nHeterozygotes\\tO\\nfor\\tO\\nthe\\tO\\nrare\\tO\\nmutant\\tO\\nmay\\tO\\nbe\\tO\\nindistinguishable\\tO\\nfrom\\tO\\nheterozygotes\\tO\\nfor\\tO\\nthe\\tO\\ncommon\\tO\\nTSD\\tB-Disease\\nmutant\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\ndirect\\tO\\nvisualization\\tO\\nand\\tO\\nquantitation\\tO\\nof\\tO\\nhex\\tO\\nA\\tO\\nby\\tO\\nthe\\tO\\nmethods\\tO\\ndescribed\\tO\\nmay\\tO\\nprevent\\tO\\nfalse\\tO\\n-\\tO\\npositive\\tO\\nprenatal\\tO\\ndiagnosis\\tO\\nof\\tO\\nTSD\\tB-Disease\\nin\\tO\\nfetuses\\tO\\nhaving\\tO\\nthe\\tO\\nincomplete\\tO\\nhex\\tB-Disease\\nA\\tI-Disease\\ndeficiency\\tI-Disease\\nof\\tO\\nthe\\tO\\ntype\\tO\\ndescribed\\tO\\nin\\tO\\nthe\\tO\\nfour\\tO\\nhealthy\\tO\\nindividuals\\tO\\n\\nThe\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\nSmad4\\tO\\n/\\tO\\nDpc4\\tO\\nis\\tO\\nrequired\\tO\\nfor\\tO\\ngastrulation\\tO\\nand\\tO\\nlater\\tO\\nfor\\tO\\nanterior\\tO\\ndevelopment\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\nembryo\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nSMAD4\\tO\\n/\\tO\\nDPC4\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\n,\\tO\\na\\tO\\nkey\\tO\\nsignal\\tO\\ntransducer\\tO\\nin\\tO\\nmost\\tO\\nTGFbeta\\tO\\n-\\tO\\nrelated\\tO\\npathways\\tO\\n,\\tO\\nare\\tO\\ninvolved\\tO\\nin\\tO\\n50\\tO\\n%\\tO\\nof\\tO\\npancreatic\\tB-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nHomozygous\\tO\\nSmad4\\tO\\nmutant\\tO\\nmice\\tO\\ndie\\tO\\nbefore\\tO\\nday\\tO\\n7\\tO\\n.\\tO\\n\\n5\\tO\\nof\\tO\\nembryogenesis\\tO\\n.\\tO\\n\\nMutant\\tO\\nembryos\\tO\\nhave\\tO\\nreduced\\tO\\nsize\\tO\\n,\\tO\\nfail\\tO\\nto\\tO\\ngastrulate\\tO\\nor\\tO\\nexpress\\tO\\na\\tO\\nmesodermal\\tO\\nmarker\\tO\\n,\\tO\\nand\\tO\\nshow\\tO\\nabnormal\\tO\\nvisceral\\tO\\nendoderm\\tO\\ndevelopment\\tO\\n.\\tO\\n\\nGrowth\\tB-Disease\\nretardation\\tI-Disease\\nof\\tO\\nthe\\tO\\nSmad4\\tO\\n-\\tO\\ndeficient\\tO\\nembryos\\tO\\nresults\\tO\\nfrom\\tO\\nreduced\\tO\\ncell\\tO\\nproliferation\\tO\\nrather\\tO\\nthan\\tO\\nincreased\\tO\\napoptosis\\tO\\n.\\tO\\n\\nAggregation\\tO\\nof\\tO\\nmutant\\tO\\nSmad4\\tO\\nES\\tO\\ncells\\tO\\nwith\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\ntetraploid\\tO\\nmorulae\\tO\\nrescues\\tO\\nthe\\tO\\ngastrulation\\tB-Disease\\ndefect\\tI-Disease\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nSmad4\\tO\\nis\\tO\\ninitially\\tO\\nrequired\\tO\\nfor\\tO\\nthe\\tO\\ndifferentiation\\tO\\nof\\tO\\nthe\\tO\\nvisceral\\tO\\nendoderm\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\ngastrulation\\tB-Disease\\ndefect\\tI-Disease\\nin\\tO\\nthe\\tO\\nepiblast\\tO\\nis\\tO\\nsecondary\\tO\\nand\\tO\\nnon\\tO\\n-\\tO\\ncell\\tO\\nautonomous\\tO\\n.\\tO\\n\\nRescued\\tO\\nembryos\\tO\\nshow\\tO\\nsevere\\tO\\nanterior\\tO\\ntruncations\\tO\\n,\\tO\\nindicating\\tO\\na\\tO\\nsecond\\tO\\nimportant\\tO\\nrole\\tO\\nfor\\tO\\nSmad4\\tO\\nin\\tO\\nanterior\\tO\\npatterning\\tO\\nduring\\tO\\nembryogenesis\\tO\\n.\\tO\\n\\nPrevalence\\tO\\nof\\tO\\np16\\tO\\nand\\tO\\nCDK4\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\n48\\tO\\nmelanoma\\tB-Disease\\n-\\tO\\nprone\\tO\\nfamilies\\tO\\nin\\tO\\nFrance\\tO\\n.\\tO\\n\\nThe\\tO\\nFrench\\tO\\nFamilial\\tB-Disease\\nMelanoma\\tI-Disease\\nStudy\\tO\\nGroup\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\np16\\tO\\nand\\tO\\nCDK4\\tO\\ngenes\\tO\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\na\\tO\\nsubset\\tO\\nof\\tO\\nmelanoma\\tB-Disease\\npedigrees\\tO\\n,\\tO\\nbut\\tO\\ntheir\\tO\\nprevalence\\tO\\nis\\tO\\nnot\\tO\\nwell\\tO\\nknown\\tO\\n.\\tO\\n\\nWe\\tO\\nsearched\\tO\\nfor\\tO\\nsuch\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\n48\\tO\\nFrench\\tO\\nmelanoma\\tB-Disease\\n-\\tO\\nprone\\tO\\nfamilies\\tO\\nselected\\tO\\naccording\\tO\\nto\\tO\\ntwo\\tO\\nmajor\\tO\\ncriteria\\tO\\nfamilies\\tO\\nwith\\tO\\nat\\tO\\nleast\\tO\\nthree\\tO\\naffected\\tO\\nmembers\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n20\\tO\\n)\\tO\\nor\\tO\\nfamilies\\tO\\nwith\\tO\\ntwo\\tO\\naffected\\tO\\nmembers\\tO\\n,\\tO\\none\\tO\\nof\\tO\\nthem\\tO\\naffected\\tO\\nbefore\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\n50\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n28\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\none\\tO\\nadditional\\tO\\nminor\\tO\\ncriterion\\tO\\n.\\tO\\n\\nSixteen\\tO\\ndifferent\\tO\\np16\\tO\\ngermline\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\n21\\tO\\nfamilies\\tO\\n,\\tO\\nwhile\\tO\\none\\tO\\ngermline\\tO\\nmutation\\tO\\n,\\tO\\nArg24His\\tO\\n,\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nCDK4\\tO\\ngene\\tO\\n.\\tO\\n\\nThe\\tO\\nfrequency\\tO\\nof\\tO\\np16\\tO\\ngene\\tO\\nmutation\\tO\\nin\\tO\\nour\\tO\\nsample\\tO\\n(\\tO\\n44\\tO\\n%\\tO\\n)\\tO\\nis\\tO\\namong\\tO\\nthe\\tO\\nhighest\\tO\\nrates\\tO\\nyet\\tO\\nreported\\tO\\nand\\tO\\nthe\\tO\\nCDK4\\tO\\nmutation\\tO\\nis\\tO\\nthe\\tO\\nsecond\\tO\\nmutation\\tO\\ndetected\\tO\\nin\\tO\\nthis\\tO\\ngene\\tO\\nworldwide\\tO\\n.\\tO\\n\\nIn\\tO\\nsummary\\tO\\n,\\tO\\nour\\tO\\nresults\\tO\\nshow\\tO\\nfrequent\\tO\\ninvolvement\\tO\\nof\\tO\\nthe\\tO\\np16\\tO\\ngene\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nmelanoma\\tI-Disease\\nand\\tO\\nconfirm\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nthe\\tO\\nCDK4\\tO\\ngene\\tO\\nas\\tO\\na\\tO\\nmelanoma\\tB-Disease\\n-\\tO\\npredisposing\\tO\\ngene\\tO\\n.\\tO\\n.\\tO\\n\\nProgression\\tO\\nof\\tO\\nsomatic\\tO\\nCTG\\tO\\nrepeat\\tO\\nlength\\tO\\nheterogeneity\\tO\\nin\\tO\\nthe\\tO\\nblood\\tO\\ncells\\tO\\nof\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\ngenetic\\tO\\nbasis\\tO\\nof\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\nthe\\tO\\nexpansion\\tO\\nof\\tO\\nan\\tO\\nunstable\\tO\\nCTG\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\n34\\tO\\nUTR\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nprotein\\tO\\nkinase\\tO\\ngene\\tO\\non\\tO\\nchromosome\\tO\\n19\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthe\\tO\\nprincipal\\tO\\nfeatures\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nmutation\\tO\\nis\\tO\\nan\\tO\\nextraordinarily\\tO\\nhigh\\tO\\nlevel\\tO\\nof\\tO\\nsomatic\\tO\\nmosaicism\\tO\\n,\\tO\\ndue\\tO\\nto\\tO\\nan\\tO\\nextremely\\tO\\nhigh\\tO\\ndegree\\tO\\nof\\tO\\nsomatic\\tO\\ninstability\\tO\\nboth\\tO\\nwithin\\tO\\nand\\tO\\nbetween\\tO\\ndifferent\\tO\\ntissues\\tO\\n.\\tO\\n\\nThis\\tO\\ninstability\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\nbiased\\tO\\ntowards\\tO\\nfurther\\tO\\nexpansion\\tO\\nand\\tO\\ncontinuous\\tO\\nthroughout\\tO\\nthe\\tO\\nlife\\tO\\nof\\tO\\nan\\tO\\nindividual\\tO\\n,\\tO\\nfeatures\\tO\\nthat\\tO\\ncould\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nprogressive\\tO\\nnature\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nAlthough\\tO\\nincreasing\\tO\\nmeasured\\tO\\nallele\\tO\\nsize\\tO\\nbetween\\tO\\npatients\\tO\\nclearly\\tO\\ncorrelates\\tO\\nwith\\tO\\nan\\tO\\nincreased\\tO\\nseverity\\tO\\nof\\tO\\nsymptoms\\tO\\nand\\tO\\nan\\tO\\nearlier\\tO\\nage\\tO\\nof\\tO\\nonset\\tO\\n,\\tO\\nthis\\tO\\ncorrelation\\tO\\nis\\tO\\nnot\\tO\\nprecise\\tO\\nand\\tO\\nmeasured\\tO\\nallele\\tO\\nlength\\tO\\ncannot\\tO\\nbe\\tO\\nused\\tO\\nas\\tO\\nan\\tO\\naccurate\\tO\\npredictor\\tO\\nof\\tO\\nage\\tO\\nof\\tO\\nonset\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\nfurther\\tO\\ncharacterize\\tO\\nthe\\tO\\ndynamics\\tO\\nof\\tO\\nDM\\tB-Disease\\nCTG\\tO\\nrepeat\\tO\\nsomatic\\tO\\ninstability\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nstudied\\tO\\nrepeat\\tO\\nlength\\tO\\nchanges\\tO\\nover\\tO\\ntime\\tO\\nin\\tO\\n111\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\npatients\\tO\\nwith\\tO\\nvarying\\tO\\nclinical\\tO\\nseverity\\tO\\nand\\tO\\nCTG\\tO\\nrepeat\\tO\\nsize\\tO\\nover\\tO\\ntime\\tO\\nintervals\\tO\\nof\\tO\\n1\\tO\\n-\\tO\\n7\\tO\\nyears\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nfound\\tO\\na\\tO\\ndirect\\tO\\nprogression\\tO\\nof\\tO\\nthe\\tO\\nsize\\tO\\nheterogeneity\\tO\\nover\\tO\\ntime\\tO\\nrelated\\tO\\nto\\tO\\ninitial\\tO\\nCTG\\tO\\nrepeat\\tO\\nsize\\tO\\nand\\tO\\nthe\\tO\\ntime\\tO\\ninterval\\tO\\nand\\tO\\nalways\\tO\\nbiased\\tO\\ntowards\\tO\\nfurther\\tO\\nexpansion\\tO\\n.\\tO\\n\\nAttempts\\tO\\nto\\tO\\nmathematically\\tO\\nmodel\\tO\\nthe\\tO\\ndynamics\\tO\\nhave\\tO\\nproved\\tO\\nonly\\tO\\npartially\\tO\\nsuccessful\\tO\\nsuggesting\\tO\\nthat\\tO\\nindividual\\tO\\nspecific\\tO\\ngenetic\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nenvironmental\\tO\\nfactors\\tO\\nalso\\tO\\nplay\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\nsomatic\\tO\\nmosaicism\\tO\\n.\\tO\\n.\\tO\\n\\nAspartylglucosaminuria\\tB-Disease\\namong\\tO\\nPalestinian\\tO\\nArabs\\tO\\n.\\tO\\n\\nAspartylglucosaminuria\\tB-Disease\\n(\\tO\\nAGU\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nrare\\tO\\ndisorder\\tB-Disease\\nof\\tI-Disease\\nglycoprotein\\tI-Disease\\nmetabolism\\tI-Disease\\ncaused\\tO\\nby\\tO\\nthe\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nlysosomal\\tI-Disease\\nenzyme\\tI-Disease\\naspartylglucosaminidase\\tI-Disease\\n(\\tO\\nAGA\\tO\\n)\\tO\\n.\\tO\\n\\nAGU\\tB-Disease\\nis\\tO\\ninherited\\tO\\nas\\tO\\nan\\tO\\nautosomal\\tO\\nrecessive\\tO\\ntrait\\tO\\nand\\tO\\noccurs\\tO\\nwith\\tO\\na\\tO\\nhigh\\tO\\nfrequency\\tO\\nin\\tO\\nFinland\\tO\\nbecause\\tO\\nof\\tO\\na\\tO\\nfounder\\tO\\neffect\\tO\\n.\\tO\\n\\nWhile\\tO\\nvery\\tO\\nfew\\tO\\npatients\\tO\\nwith\\tO\\nAGU\\tB-Disease\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\nfrom\\tO\\nnon\\tO\\n-\\tO\\nFinnish\\tO\\norigin\\tO\\n,\\tO\\nwe\\tO\\ndiagnosed\\tO\\nthe\\tO\\ndisorder\\tO\\nin\\tO\\n8\\tO\\npatients\\tO\\noriginating\\tO\\nfrom\\tO\\n3\\tO\\nunrelated\\tO\\nfamilies\\tO\\n,\\tO\\nall\\tO\\nPalestinian\\tO\\nArabs\\tO\\nfrom\\tO\\nthe\\tO\\nregion\\tO\\nof\\tO\\nJerusalem\\tO\\n.\\tO\\n\\nThe\\tO\\nclinical\\tO\\ndiagnosis\\tO\\nof\\tO\\nAGU\\tB-Disease\\nis\\tO\\noften\\tO\\ndifficult\\tO\\n,\\tO\\nin\\tO\\nparticular\\tO\\nearly\\tO\\nin\\tO\\nthe\\tO\\ncourse\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n,\\tO\\nand\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nare\\tO\\ndiagnosed\\tO\\nafter\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\n5\\tO\\nyears\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nsince\\tO\\nthese\\tO\\npatients\\tO\\nexcrete\\tO\\nearly\\tO\\nlarge\\tO\\namounts\\tO\\nof\\tO\\naspartylglucosamine\\tO\\nin\\tO\\nurine\\tO\\n,\\tO\\nbiochemical\\tO\\nscreening\\tO\\nis\\tO\\neasy\\tO\\nby\\tO\\nurine\\tO\\nchromatography\\tO\\n.\\tO\\n.\\tO\\n\\nDetection\\tO\\nof\\tO\\nheterozygous\\tO\\ncarriers\\tO\\nof\\tO\\nthe\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nATM\\tO\\n)\\tO\\ngene\\tO\\nby\\tO\\nG2\\tO\\nphase\\tO\\nchromosomal\\tO\\nradiosensitivity\\tO\\nof\\tO\\nperipheral\\tO\\nblood\\tO\\nlymphocytes\\tO\\n.\\tO\\n\\nIn\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\npatients\\tO\\n,\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\nsingle\\tO\\ngene\\tO\\n,\\tO\\nATM\\tO\\n,\\tO\\nresult\\tO\\nin\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nsyndrome\\tI-Disease\\nthat\\tO\\nembraces\\tO\\na\\tO\\nvariety\\tO\\nof\\tO\\nclinical\\tO\\nfeatures\\tO\\nand\\tO\\nmanifests\\tO\\nextreme\\tO\\nradiosensitivity\\tO\\nand\\tO\\na\\tO\\nstrong\\tO\\npre\\tO\\n-\\tO\\ndisposition\\tO\\nto\\tO\\nmalignancy\\tB-Disease\\n.\\tO\\n\\nHeterozygotes\\tO\\nfor\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nhave\\tO\\nno\\tO\\nclinical\\tO\\nexpression\\tO\\nof\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nbut\\tO\\nmay\\tO\\nbe\\tO\\ncancer\\tB-Disease\\nprone\\tO\\nwith\\tO\\na\\tO\\nmoderate\\tO\\nincrease\\tO\\nin\\tO\\nin\\tO\\nvitro\\tO\\nradiosensitivity\\tO\\n.\\tO\\n\\nWe\\tO\\nperformed\\tO\\na\\tO\\nblind\\tO\\nchromosomal\\tO\\nanalysis\\tO\\non\\tO\\nG2\\tO\\n-\\tO\\nphase\\tO\\nlymphocytes\\tO\\nfrom\\tO\\n7\\tO\\nunrelated\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\n,\\tO\\n13\\tO\\nobligate\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nheterozygotes\\tO\\n(\\tO\\nparents\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\n14\\tO\\nnormal\\tO\\ncontrols\\tO\\nfollowing\\tO\\nX\\tO\\n-\\tO\\nirradiation\\tO\\nwith\\tO\\n1\\tO\\nGy\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\nevaluate\\tO\\nthis\\tO\\ncytogenetic\\tO\\nmethod\\tO\\nas\\tO\\na\\tO\\ntool\\tO\\nfor\\tO\\ndetection\\tO\\nof\\tO\\nATM\\tO\\ncarriers\\tO\\n.\\tO\\n\\nBoth\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nhomozygotes\\tO\\nand\\tO\\nheterozygotes\\tO\\nshowed\\tO\\nsignificantly\\tO\\nincreased\\tO\\nlevels\\tO\\nof\\tO\\nradiation\\tO\\n-\\tO\\ninduced\\tO\\nchromatid\\tO\\ndamage\\tO\\nrelative\\tO\\nto\\tO\\nthat\\tO\\nof\\tO\\nnormal\\tO\\ncontrols\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\nG2\\tO\\n-\\tO\\nphase\\tO\\nchromosomal\\tO\\nradiosensitivity\\tO\\nassay\\tO\\ncan\\tO\\nbe\\tO\\nused\\tO\\nfor\\tO\\nthe\\tO\\ndetection\\tO\\nof\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nheterozygotes\\tO\\n.\\tO\\n\\nIn\\tO\\ncombination\\tO\\nwith\\tO\\nmolecular\\tO\\ngenetic\\tO\\nanalyses\\tO\\n,\\tO\\nthis\\tO\\ntest\\tO\\nmay\\tO\\nbe\\tO\\nof\\tO\\nvalue\\tO\\nin\\tO\\nstudies\\tO\\nof\\tO\\nfamilial\\tB-Disease\\nand\\tI-Disease\\nsporadic\\tI-Disease\\ncancers\\tI-Disease\\naimed\\tO\\nat\\tO\\ndetermination\\tO\\nof\\tO\\nthe\\tO\\npotential\\tO\\ninvolvement\\tO\\nof\\tO\\nATM\\tO\\nmutations\\tO\\nin\\tO\\ntumor\\tB-Disease\\nrisk\\tO\\nor\\tO\\ndevelopment\\tO\\n.\\tO\\n.\\tO\\n\\nAtaxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n:\\tO\\nidentification\\tO\\nand\\tO\\ndetection\\tO\\nof\\tO\\nfounder\\tO\\n-\\tO\\neffect\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nin\\tO\\nethnic\\tO\\npopulations\\tO\\n.\\tO\\n\\nTo\\tO\\nfacilitate\\tO\\nthe\\tO\\nevaluation\\tO\\nof\\tO\\nATM\\tO\\nheterozygotes\\tO\\nfor\\tO\\nsusceptibility\\tO\\nto\\tO\\nother\\tO\\ndiseases\\tO\\n,\\tO\\nsuch\\tO\\nas\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nwe\\tO\\nhave\\tO\\nattempted\\tO\\nto\\tO\\ndefine\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nmutations\\tO\\nand\\tO\\ntheir\\tO\\nfrequencies\\tO\\nin\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\nhomozygotes\\tO\\nfrom\\tO\\n10\\tO\\nethnic\\tO\\npopulations\\tO\\n.\\tO\\n\\nBoth\\tO\\ngenomic\\tO\\nmutations\\tO\\nand\\tO\\ntheir\\tO\\neffects\\tO\\non\\tO\\ncDNA\\tO\\nwere\\tO\\ncharacterized\\tO\\n.\\tO\\n\\nProtein\\tO\\n-\\tO\\ntruncation\\tO\\ntesting\\tO\\nof\\tO\\nthe\\tO\\nentire\\tO\\nATM\\tO\\ncDNA\\tO\\ndetected\\tO\\n92\\tO\\n(\\tO\\n66\\tO\\n%\\tO\\n)\\tO\\ntruncating\\tO\\nmutations\\tO\\nin\\tO\\n140\\tO\\nmutant\\tO\\nalleles\\tO\\nscreened\\tO\\n.\\tO\\n\\nThe\\tO\\nhaplotyping\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nidentical\\tO\\nmutations\\tO\\nindicates\\tO\\nthat\\tO\\nalmost\\tO\\nall\\tO\\nof\\tO\\nthese\\tO\\nrepresent\\tO\\ncommon\\tO\\nancestry\\tO\\nand\\tO\\nthat\\tO\\nvery\\tO\\nfew\\tO\\nspontaneously\\tO\\nrecurring\\tO\\nATM\\tO\\nmutations\\tO\\nexist\\tO\\n.\\tO\\n\\nAssays\\tO\\nrequiring\\tO\\nminimal\\tO\\namounts\\tO\\nof\\tO\\ngenomic\\tO\\nDNA\\tO\\nwere\\tO\\ndesigned\\tO\\nto\\tO\\nallow\\tO\\nrapid\\tO\\nscreening\\tO\\nfor\\tO\\ncommon\\tO\\nethnic\\tO\\nmutations\\tO\\n.\\tO\\n\\nThese\\tO\\nrapid\\tO\\nassays\\tO\\ndetected\\tO\\nmutations\\tO\\nin\\tO\\n76\\tO\\n%\\tO\\nof\\tO\\nCosta\\tO\\nRican\\tO\\npatients\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\n,\\tO\\n50\\tO\\n%\\tO\\nof\\tO\\nNorwegian\\tO\\npatients\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\n,\\tO\\n25\\tO\\n%\\tO\\nof\\tO\\nPolish\\tO\\npatients\\tO\\n(\\tO\\n4\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\n14\\tO\\n%\\tO\\nof\\tO\\nItalian\\tO\\npatients\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nin\\tO\\npatients\\tO\\nof\\tO\\nAmish\\tO\\n/\\tO\\nMennonite\\tO\\nand\\tO\\nIrish\\tO\\nEnglish\\tO\\nbackgrounds\\tO\\n.\\tO\\n\\nAdditional\\tO\\nmutations\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nJapanese\\tO\\n,\\tO\\nUtah\\tO\\nMormon\\tO\\n,\\tO\\nand\\tO\\nAfrican\\tO\\nAmerican\\tO\\npatients\\tO\\n.\\tO\\n\\nThese\\tO\\nassays\\tO\\nshould\\tO\\nfacilitate\\tO\\nscreening\\tO\\nfor\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nheterozygotes\\tO\\nin\\tO\\nthe\\tO\\npopulations\\tO\\nstudied\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ntumor\\tI-Disease\\nsuppressor\\tO\\ngene\\tO\\nis\\tO\\nrequired\\tO\\nfor\\tO\\ncell\\tO\\ncycle\\tO\\nexit\\tO\\nupon\\tO\\nserum\\tO\\nwithdrawal\\tO\\n.\\tO\\n\\nThe\\tO\\ninactivation\\tO\\nof\\tO\\nthe\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\n(\\tI-Disease\\nVHL\\tI-Disease\\n)\\tI-Disease\\ntumor\\tI-Disease\\nsuppressor\\tO\\ngene\\tO\\npredisposes\\tO\\naffected\\tO\\nindividuals\\tO\\nto\\tO\\nthe\\tO\\nhuman\\tO\\nVHL\\tB-Disease\\ncancer\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nsporadic\\tB-Disease\\nrenal\\tI-Disease\\ncell\\tI-Disease\\ncarcinomas\\tI-Disease\\n(\\tO\\nRCC\\tB-Disease\\n)\\tO\\nand\\tO\\nbrain\\tB-Disease\\nhemangioblastomas\\tI-Disease\\n.\\tO\\n\\nVHL\\tO\\n-\\tO\\nnegative\\tO\\n786\\tO\\n-\\tO\\n0\\tO\\nRCC\\tB-Disease\\ncells\\tO\\nare\\tO\\ntumorigenic\\tO\\nin\\tO\\nnude\\tO\\nmice\\tO\\nwhich\\tO\\nis\\tO\\nsuppressed\\tO\\nby\\tO\\nthe\\tO\\nreintroduction\\tO\\nof\\tO\\nVHL\\tB-Disease\\n.\\tO\\n\\nRemarkably\\tO\\n,\\tO\\nthis\\tO\\noccurs\\tO\\nwithout\\tO\\naffecting\\tO\\nthe\\tO\\ngrowth\\tO\\nrate\\tO\\nand\\tO\\ncell\\tO\\ncycle\\tO\\nprofile\\tO\\nof\\tO\\nthese\\tO\\ncells\\tO\\nin\\tO\\nculture\\tO\\n.\\tO\\n\\nThe\\tO\\n786\\tO\\n-\\tO\\n0\\tO\\ncell\\tO\\nline\\tO\\n,\\tO\\nlike\\tO\\nmany\\tO\\ncancer\\tB-Disease\\ncells\\tO\\n,\\tO\\nfails\\tO\\nto\\tO\\nexit\\tO\\nthe\\tO\\ncell\\tO\\ncycle\\tO\\nupon\\tO\\nserum\\tO\\nwithdrawal\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nit\\tO\\nis\\tO\\nshown\\tO\\nthat\\tO\\nreintroduction\\tO\\nof\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nrestores\\tO\\nthe\\tO\\nability\\tO\\nof\\tO\\nVHL\\tO\\n-\\tO\\nnegative\\tO\\nRCC\\tB-Disease\\ncancer\\tI-Disease\\ncells\\tO\\nto\\tO\\nexit\\tO\\nthe\\tO\\ncell\\tO\\ncycle\\tO\\nand\\tO\\nenter\\tO\\nG0\\tO\\n/\\tO\\nquiescence\\tO\\nin\\tO\\nlow\\tO\\nserum\\tO\\n.\\tO\\n\\nBoth\\tO\\nVHL\\tO\\n-\\tO\\npositive\\tO\\nand\\tO\\nVHL\\tO\\n-\\tO\\nnegative\\tO\\nRCC\\tB-Disease\\ncells\\tO\\nexit\\tO\\nthe\\tO\\ncell\\tO\\ncycle\\tO\\nby\\tO\\ncontact\\tO\\ninhibition\\tO\\n.\\tO\\n\\nThe\\tO\\ncyclin\\tO\\n-\\tO\\ndependent\\tO\\nkinase\\tO\\ninhibitor\\tO\\n,\\tO\\np27\\tO\\n,\\tO\\naccumulates\\tO\\nupon\\tO\\nserum\\tO\\nwithdrawal\\tO\\n,\\tO\\nonly\\tO\\nin\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nVHL\\tB-Disease\\n,\\tO\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\nthe\\tO\\nstabilization\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n.\\tO\\n\\nWe\\tO\\npropose\\tO\\nthat\\tO\\nthe\\tO\\nloss\\tO\\nof\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nVHL\\tB-Disease\\ngene\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nspecific\\tO\\ncellular\\tO\\ndefect\\tO\\nin\\tO\\nserum\\tO\\n-\\tO\\ndependent\\tO\\ngrowth\\tO\\ncontrol\\tO\\n,\\tO\\nwhich\\tO\\nmay\\tO\\ninitiate\\tO\\ntumor\\tB-Disease\\nformation\\tO\\n.\\tO\\n\\nThis\\tO\\nis\\tO\\ncorrected\\tO\\nby\\tO\\nthe\\tO\\nreintroduction\\tO\\nof\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nVHL\\tB-Disease\\n,\\tO\\nimplicating\\tO\\nVHL\\tB-Disease\\nas\\tO\\nthe\\tO\\nfirst\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nregulation\\tO\\nof\\tO\\ncell\\tO\\ncycle\\tO\\nexit\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nconsistent\\tO\\nwith\\tO\\nits\\tO\\ngatekeeper\\tO\\nfunction\\tO\\nin\\tO\\nthe\\tO\\nkidney\\tO\\n.\\tO\\n.\\tO\\n\\nPiebaldism\\tB-Disease\\nwith\\tO\\ndeafness\\tB-Disease\\n:\\tO\\nmolecular\\tO\\nevidence\\tO\\nfor\\tO\\nan\\tO\\nexpanded\\tO\\nsyndrome\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nSouth\\tO\\nAfrican\\tO\\ngirl\\tO\\nof\\tO\\nXhosa\\tO\\nstock\\tO\\nwith\\tO\\nsevere\\tO\\npiebaldism\\tB-Disease\\nand\\tO\\nprofound\\tO\\ncongenital\\tO\\nsensorineural\\tB-Disease\\ndeafness\\tI-Disease\\nwe\\tO\\nidentified\\tO\\na\\tO\\nnovel\\tO\\nmissense\\tO\\nsubstitution\\tO\\nat\\tO\\na\\tO\\nhighly\\tO\\nconserved\\tO\\nresidue\\tO\\nin\\tO\\nthe\\tO\\nintracellular\\tO\\nkinase\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nKIT\\tO\\nproto\\tO\\n-\\tO\\noncogene\\tO\\n,\\tO\\nR796G\\tO\\n.\\tO\\n\\nThough\\tO\\nauditory\\tB-Disease\\nanomalies\\tI-Disease\\nhave\\tO\\nbeen\\tO\\nobserved\\tO\\nin\\tO\\nmice\\tO\\nwith\\tO\\ndominant\\tO\\nwhite\\tO\\nspotting\\tO\\n(\\tO\\nW\\tO\\n)\\tO\\ndue\\tO\\nto\\tO\\nKIT\\tO\\nmutations\\tO\\n,\\tO\\ndeafness\\tB-Disease\\nis\\tO\\nnot\\tO\\ntypical\\tO\\nin\\tO\\nhuman\\tO\\npiebaldism\\tB-Disease\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\nsensorineural\\tB-Disease\\ndeafness\\tI-Disease\\nin\\tO\\nthis\\tO\\npatient\\tO\\nextends\\tO\\nconsiderably\\tO\\nthe\\tO\\nphenotypic\\tO\\nrange\\tO\\nof\\tO\\npiebaldism\\tB-Disease\\ndue\\tO\\nto\\tO\\nKIT\\tO\\ngene\\tO\\nmutation\\tO\\nin\\tO\\nhumans\\tO\\nand\\tO\\ntightens\\tO\\nthe\\tO\\nclinical\\tO\\nsimilarity\\tO\\nbetween\\tO\\npiebaldism\\tB-Disease\\nand\\tO\\nthe\\tO\\nvarious\\tO\\nforms\\tO\\nof\\tO\\nWaardenburg\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nCycloheximide\\tO\\nfacilitates\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\naberrant\\tO\\ntranscripts\\tO\\nresulting\\tO\\nfrom\\tO\\na\\tO\\nnovel\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\nin\\tO\\nCOL17A1\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\ngeneralized\\tO\\natrophic\\tB-Disease\\nbenign\\tI-Disease\\nepidermolysis\\tI-Disease\\nbullosa\\tI-Disease\\n.\\tO\\n\\nPatients\\tO\\nwith\\tO\\ngeneralized\\tO\\natrophic\\tB-Disease\\nbenign\\tI-Disease\\nepidermolysis\\tI-Disease\\nbullosa\\tI-Disease\\noften\\tO\\nshow\\tO\\ndecreased\\tO\\nexpression\\tO\\nof\\tO\\ntype\\tO\\nXVII\\tO\\ncollagen\\tO\\n,\\tO\\na\\tO\\ntransmembrane\\tO\\nhemidesmosomal\\tO\\nprotein\\tO\\nencoded\\tO\\nby\\tO\\nCOL17A1\\tO\\n.\\tO\\n\\nThis\\tO\\nreport\\tO\\ndocuments\\tO\\na\\tO\\nnovel\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\nin\\tO\\nCOL17A1\\tO\\nin\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\ngeneralized\\tO\\natrophic\\tB-Disease\\nbenign\\tI-Disease\\nepidermolysis\\tI-Disease\\nbullosa\\tI-Disease\\n,\\tO\\nand\\tO\\napplies\\tO\\na\\tO\\nnew\\tO\\nmethodology\\tO\\nto\\tO\\ndefine\\tO\\nand\\tO\\ncharacterize\\tO\\nthe\\tO\\nresulting\\tO\\nmRNA\\tO\\nsplice\\tO\\nvariants\\tO\\n.\\tO\\n\\nMutational\\tO\\nanalysis\\tO\\nof\\tO\\nCOL17A1\\tO\\nidentified\\tO\\na\\tO\\nmaternally\\tO\\ninherited\\tO\\nG\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nT\\tO\\ntransversion\\tO\\nat\\tO\\nthe\\tO\\n-\\tO\\n1\\tO\\nposition\\tO\\nof\\tO\\nexon\\tO\\n32\\tO\\n.\\tO\\n\\nThis\\tO\\nacceptor\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nformation\\tO\\nof\\tO\\naberrant\\tO\\ntranscripts\\tO\\npresent\\tO\\nat\\tO\\nextremely\\tO\\nlow\\tO\\nlevels\\tO\\n.\\tO\\n\\nBased\\tO\\non\\tO\\nour\\tO\\nrecent\\tO\\nfinding\\tO\\nthat\\tO\\ncycloheximide\\tO\\nstabilized\\tO\\nmutant\\tO\\nCOL17A1\\tO\\ntranscripts\\tO\\nin\\tO\\nkeratinocytes\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nframeshift\\tO\\nmutation\\tO\\n,\\tO\\nthe\\tO\\neffects\\tO\\nof\\tO\\nthe\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutation\\tO\\non\\tO\\nsplicing\\tO\\nof\\tO\\nCOL17A1\\tO\\ntranscripts\\tO\\nwere\\tO\\ndetermined\\tO\\nusing\\tO\\nreverse\\tO\\ntranscriptase\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nof\\tO\\ntotal\\tO\\nRNA\\tO\\nfrom\\tO\\nkeratinocytes\\tO\\nincubated\\tO\\nfor\\tO\\n2\\tO\\n.\\tO\\n\\n5\\tO\\nh\\tO\\nin\\tO\\nthe\\tO\\npresence\\tO\\nor\\tO\\nabsence\\tO\\nof\\tO\\n10\\tO\\nmicrog\\tO\\ncycloheximide\\tO\\nper\\tO\\nml\\tO\\n.\\tO\\n\\nUsing\\tO\\nthis\\tO\\napproach\\tO\\n,\\tO\\nan\\tO\\nabnormally\\tO\\nspliced\\tO\\ntranscript\\tO\\nwas\\tO\\nidentified\\tO\\nthat\\tO\\ncontains\\tO\\nan\\tO\\nextra\\tO\\n264\\tO\\nbases\\tO\\nupstream\\tO\\nfrom\\tO\\nexon\\tO\\n32\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\na\\tO\\npremature\\tO\\ntermination\\tO\\ncodon\\tO\\n27\\tO\\nbp\\tO\\ndownstream\\tO\\nfrom\\tO\\nthe\\tO\\ncryptic\\tO\\nsplice\\tO\\nsite\\tO\\n.\\tO\\n\\nThree\\tO\\nother\\tO\\nsplice\\tO\\nvariants\\tO\\n,\\tO\\nincluding\\tO\\none\\tO\\nderived\\tO\\nfrom\\tO\\nthe\\tO\\nskipping\\tO\\nof\\tO\\nexon\\tO\\n32\\tO\\n,\\tO\\nwere\\tO\\nalso\\tO\\nidentified\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nindicate\\tO\\nthe\\tO\\nusefulness\\tO\\nof\\tO\\ncycloheximide\\tO\\ntreatment\\tO\\nin\\tO\\nevaluating\\tO\\nthe\\tO\\nabnormal\\tO\\nprocessing\\tO\\nof\\tO\\nmRNA\\tO\\ndue\\tO\\nto\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutations\\tO\\n,\\tO\\nbecause\\tO\\n(\\tO\\ni\\tO\\n)\\tO\\naberrant\\tO\\nsplicing\\tO\\noften\\tO\\ngenerates\\tO\\na\\tO\\npremature\\tO\\ntermination\\tO\\ncodon\\tO\\n,\\tO\\n(\\tO\\nii\\tO\\n)\\tO\\ntranscripts\\tO\\nwith\\tO\\npremature\\tO\\ntermination\\tO\\ncodons\\tO\\ncan\\tO\\noccur\\tO\\nat\\tO\\nlow\\tO\\nor\\tO\\nundetectable\\tO\\nlevels\\tO\\ndue\\tO\\nto\\tO\\nnonsense\\tO\\n-\\tO\\nmediated\\tO\\nmRNA\\tO\\ndecay\\tO\\n,\\tO\\nand\\tO\\n(\\tO\\niii\\tO\\n)\\tO\\nthe\\tO\\nlevels\\tO\\nof\\tO\\nthese\\tO\\ntranscripts\\tO\\ncan\\tO\\nbe\\tO\\nincreased\\tO\\nby\\tO\\ncycloheximide\\tO\\n.\\tO\\n\\nA\\tO\\ndeletion\\tO\\nmutation\\tO\\nin\\tO\\nCOL17A1\\tO\\nin\\tO\\nfive\\tO\\nAustrian\\tO\\nfamilies\\tO\\nwith\\tO\\ngeneralized\\tO\\natrophic\\tB-Disease\\nbenign\\tI-Disease\\nepidermolysis\\tI-Disease\\nbullosa\\tI-Disease\\nrepresents\\tO\\npropagation\\tO\\nof\\tO\\nan\\tO\\nancestral\\tO\\nallele\\tO\\n.\\tO\\n\\nPatients\\tO\\nwith\\tO\\ngeneralized\\tO\\natrophic\\tB-Disease\\nbenign\\tI-Disease\\nepidermolysis\\tI-Disease\\nbullosa\\tI-Disease\\n,\\tO\\na\\tO\\nusually\\tO\\nnonlethal\\tO\\nform\\tO\\nof\\tO\\njunctional\\tB-Disease\\nepidermolysis\\tI-Disease\\nbullosa\\tI-Disease\\n,\\tO\\nhave\\tO\\ngeneralized\\tO\\nblistering\\tB-Disease\\n,\\tO\\nnail\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\npatchy\\tB-Disease\\nalopecia\\tI-Disease\\n,\\tO\\nand\\tO\\ndental\\tB-Disease\\nabnormalities\\tI-Disease\\n.\\tO\\n\\nSkin\\tB-Disease\\nfragility\\tI-Disease\\nin\\tO\\nmost\\tO\\ncases\\tO\\nis\\tO\\ndue\\tO\\nto\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nencoding\\tO\\ntype\\tO\\nXVII\\tO\\ncollagen\\tO\\n(\\tO\\nCOL17A1\\tO\\n)\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nwe\\tO\\nreported\\tO\\nfive\\tO\\nAustrian\\tO\\nfamilies\\tO\\nwith\\tO\\ngeneralized\\tO\\natrophic\\tB-Disease\\nbenign\\tI-Disease\\nepidermolysis\\tI-Disease\\nbullosa\\tI-Disease\\nwho\\tO\\nshare\\tO\\nthe\\tO\\nsame\\tO\\nCOL17A1\\tO\\nmutation\\tO\\n.\\tO\\n\\nAffected\\tO\\nindividuals\\tO\\nin\\tO\\nthree\\tO\\nfamilies\\tO\\nare\\tO\\nhomozygous\\tO\\nfor\\tO\\n4003delTC\\tO\\n,\\tO\\nwhereas\\tO\\nthose\\tO\\nin\\tO\\ntwo\\tO\\nothers\\tO\\nare\\tO\\ncompound\\tO\\nheterozygotes\\tO\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nif\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\n4003delTC\\tO\\nin\\tO\\nthese\\tO\\nunrelated\\tO\\nfamilies\\tO\\nsignifies\\tO\\npropagation\\tO\\nof\\tO\\nan\\tO\\nancestral\\tO\\nallele\\tO\\nor\\tO\\na\\tO\\nmutational\\tO\\nhot\\tO\\nspot\\tO\\n,\\tO\\nhaplotypes\\tO\\nwere\\tO\\ndetermined\\tO\\nfor\\tO\\npolymorphisms\\tO\\nboth\\tO\\nwithin\\tO\\nand\\tO\\nflanking\\tO\\nCOL17A1\\tO\\n.\\tO\\n\\nFive\\tO\\nintragenic\\tO\\npolymorphisms\\tO\\nwere\\tO\\nchosen\\tO\\nbased\\tO\\non\\tO\\ntheir\\tO\\ninformativeness\\tO\\n.\\tO\\n\\nOne\\tO\\nof\\tO\\nthese\\tO\\n,\\tO\\nnot\\tO\\npreviously\\tO\\nreported\\tO\\n,\\tO\\nwas\\tO\\n2988\\tO\\nA\\tO\\nor\\tO\\nC\\tO\\nthat\\tO\\nintroduces\\tO\\na\\tO\\nnew\\tO\\nrestriction\\tO\\nsite\\tO\\nfor\\tO\\nEco0109\\tO\\nI\\tO\\n.\\tO\\n\\nAll\\tO\\nthe\\tO\\n4003delTC\\tO\\nalleles\\tO\\nshowed\\tO\\nthe\\tO\\nsame\\tO\\nhaplotype\\tO\\nfor\\tO\\nthese\\tO\\nfive\\tO\\npolymorphic\\tO\\nmarkers\\tO\\n.\\tO\\n\\nFourteen\\tO\\nmicrosatellite\\tO\\npolymorphisms\\tO\\nwere\\tO\\nselected\\tO\\nbased\\tO\\non\\tO\\ntheir\\tO\\nhigh\\tO\\nheterozygosity\\tO\\nand\\tO\\ntheir\\tO\\nlocation\\tO\\nwithin\\tO\\n10q23\\tO\\n-\\tO\\nq25\\tO\\nnear\\tO\\nCOL17A1\\tO\\n.\\tO\\n\\nThree\\tO\\nfamilies\\tO\\nshared\\tO\\nmicrosatellite\\tO\\npolymorphisms\\tO\\ncovering\\tO\\nat\\tO\\nmost\\tO\\n19\\tO\\ncM\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nothers\\tO\\nshared\\tO\\nsmaller\\tO\\nregions\\tO\\nconsistent\\tO\\nwith\\tO\\ncross\\tO\\n-\\tO\\nover\\tO\\nevents\\tO\\nduring\\tO\\npassage\\tO\\nof\\tO\\nthis\\tO\\nmutation\\tO\\nthrough\\tO\\nseveral\\tO\\ngenerations\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\n4003delTC\\tO\\noccurs\\tO\\non\\tO\\na\\tO\\nsingle\\tO\\nancestral\\tO\\nallele\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nhaptoglobin\\tO\\n-\\tO\\ngene\\tO\\ndeletion\\tO\\nresponsible\\tO\\nfor\\tO\\nanhaptoglobinemia\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nfound\\tO\\nan\\tO\\nallelic\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nhaptoglobin\\tO\\n(\\tO\\nHp\\tO\\n)\\tO\\ngene\\tO\\nfrom\\tO\\nan\\tO\\nindividual\\tO\\nwith\\tO\\nanhaptoglobinemia\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nHp\\tO\\ngene\\tO\\ncluster\\tO\\nconsists\\tO\\nof\\tO\\ncoding\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\nalpha\\tO\\nchain\\tO\\nand\\tO\\nbeta\\tO\\nchain\\tO\\nof\\tO\\nthe\\tO\\nhaptoglobin\\tO\\ngene\\tO\\n(\\tO\\nHp\\tO\\n)\\tO\\nand\\tO\\nof\\tO\\nthe\\tO\\nalpha\\tO\\nchain\\tO\\nand\\tO\\nbeta\\tO\\nchain\\tO\\nof\\tO\\nthe\\tO\\nhaptoglobin\\tO\\n-\\tO\\nrelated\\tO\\ngene\\tO\\n(\\tO\\nHpr\\tO\\n)\\tO\\n,\\tO\\nin\\tO\\ntandem\\tO\\nfrom\\tO\\nthe\\tO\\n5\\tO\\nside\\tO\\n.\\tO\\n\\nSouthern\\tO\\nblot\\tO\\nand\\tO\\nPCR\\tO\\nanalyses\\tO\\nhave\\tO\\nindicated\\tO\\nthat\\tO\\nthe\\tO\\nindividual\\tO\\nwith\\tO\\nanhaptoglobinemia\\tB-Disease\\nwas\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\ngene\\tO\\ndeletion\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\ngene\\tO\\ndeletion\\tO\\nwas\\tO\\nincluded\\tO\\nat\\tO\\nleast\\tO\\nfrom\\tO\\nthe\\tO\\npromoter\\tO\\nregion\\tO\\nof\\tO\\nHp\\tO\\nto\\tO\\nHpr\\tO\\nalpha\\tO\\nbut\\tO\\nnot\\tO\\nto\\tO\\nHpr\\tO\\nbeta\\tO\\n(\\tO\\nHpdel\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nfound\\tO\\nseven\\tO\\nindividuals\\tO\\nwith\\tO\\nhypohaptoglobinemia\\tB-Disease\\nin\\tO\\nthree\\tO\\nfamilies\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\ngenotypes\\tO\\nof\\tO\\nsix\\tO\\nof\\tO\\nthe\\tO\\nseven\\tO\\nindividuals\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nHp2\\tO\\n/\\tO\\nHpdel\\tO\\n.\\tO\\n\\nThe\\tO\\nphenotypes\\tO\\nand\\tO\\ngenotypes\\tO\\nin\\tO\\none\\tO\\nof\\tO\\nthese\\tO\\nthree\\tO\\nfamilies\\tO\\nshowed\\tO\\nthe\\tO\\nfather\\tO\\nto\\tO\\nbe\\tO\\nhypohaptoglobinemic\\tB-Disease\\n(\\tO\\nHp2\\tO\\n)\\tO\\nand\\tO\\nHp2\\tO\\n/\\tO\\nHpdel\\tO\\n,\\tO\\nthe\\tO\\nmother\\tO\\nto\\tO\\nbe\\tO\\nHp2\\tO\\n-\\tO\\n1\\tO\\nand\\tO\\nHp1\\tO\\n/\\tO\\nHp2\\tO\\n,\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nchildren\\tO\\nto\\tO\\nbe\\tO\\nhypohaptoglobinemic\\tB-Disease\\n(\\tO\\nHp2\\tO\\n)\\tO\\nand\\tO\\nHp2\\tO\\n/\\tO\\nHpdel\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nother\\tO\\nchild\\tO\\nto\\tO\\nbe\\tO\\nHp1\\tO\\nand\\tO\\nHp1\\tO\\n/\\tO\\nHpdel\\tO\\n,\\tO\\nshowing\\tO\\nan\\tO\\nanomalous\\tO\\ninheritance\\tO\\nof\\tO\\nHp\\tO\\nphenotypes\\tO\\nin\\tO\\nthe\\tO\\nchild\\tO\\nwith\\tO\\nHp1\\tO\\n.\\tO\\n\\nThe\\tO\\nHp2\\tO\\n/\\tO\\nHpdel\\tO\\nindividuals\\tO\\nhad\\tO\\nan\\tO\\nextremely\\tO\\nlow\\tO\\nlevel\\tO\\nof\\tO\\nHp\\tO\\n(\\tO\\nmean\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\nSD\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n049\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n043\\tO\\nmg\\tO\\n/\\tO\\nml\\tO\\n;\\tO\\nn\\tO\\n=\\tO\\n6\\tO\\n)\\tO\\n,\\tO\\ncompared\\tO\\nwith\\tO\\nthe\\tO\\nlevel\\tO\\n(\\tO\\n1\\tO\\n.\\tO\\n64\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n07\\tO\\nmg\\tO\\n/\\tO\\nml\\tO\\n)\\tO\\nobtained\\tO\\nfrom\\tO\\n52\\tO\\nhealthy\\tO\\nvolunteers\\tO\\nhaving\\tO\\nphenotype\\tO\\nHp2\\tO\\n,\\tO\\nwhereas\\tO\\nthe\\tO\\nserum\\tO\\nHp\\tO\\nlevel\\tO\\nof\\tO\\nan\\tO\\nindividual\\tO\\nwith\\tO\\nHp1\\tO\\n/\\tO\\nHpdel\\tO\\nwas\\tO\\n0\\tO\\n.\\tO\\n\\n50\\tO\\nmg\\tO\\n/\\tO\\nml\\tO\\n,\\tO\\nwhich\\tO\\nwas\\tO\\napproximately\\tO\\nhalf\\tO\\nthe\\tO\\nlevel\\tO\\nof\\tO\\nHp\\tO\\nin\\tO\\ncontrol\\tO\\nsera\\tO\\nfrom\\tO\\nthe\\tO\\nHp1\\tO\\nphenotype\\tO\\n(\\tO\\n1\\tO\\n.\\tO\\n26\\tO\\n+\\tO\\n/\\tO\\n-\\tO\\n0\\tO\\n.\\tO\\n33\\tO\\nmg\\tO\\n/\\tO\\nml\\tO\\n;\\tO\\nn\\tO\\n=\\tO\\n9\\tO\\n)\\tO\\n,\\tO\\nshowing\\tO\\na\\tO\\ngene\\tO\\n-\\tO\\ndosage\\tO\\neffect\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nallele\\tO\\n(\\tO\\nHp2\\tO\\n)\\tO\\nof\\tO\\nindividuals\\tO\\nwith\\tO\\nHp2\\tO\\n/\\tO\\nHpdel\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\n,\\tO\\nin\\tO\\nall\\tO\\nexons\\tO\\n,\\tO\\nno\\tO\\nmutation\\tO\\n,\\tO\\nby\\tO\\nDNA\\tO\\nsequencing\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n,\\tO\\nthe\\tO\\nmechanism\\tO\\nof\\tO\\nanhaptoglobinemia\\tB-Disease\\nand\\tO\\nthe\\tO\\nmechanism\\tO\\nof\\tO\\nanomalous\\tO\\ninheritance\\tO\\nof\\tO\\nHp\\tO\\nphenotypes\\tO\\nwere\\tO\\nwell\\tO\\nexplained\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\nmechanism\\tO\\nof\\tO\\nhypohaptoglobinemia\\tB-Disease\\nremains\\tO\\nunknown\\tO\\n\\nATM\\tO\\nmutations\\tO\\nand\\tO\\nphenotypes\\tO\\nin\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\nfamilies\\tO\\nin\\tO\\nthe\\tO\\nBritish\\tO\\nIsles\\tO\\n:\\tO\\nexpression\\tO\\nof\\tO\\nmutant\\tO\\nATM\\tO\\nand\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\nleukemia\\tB-Disease\\n,\\tO\\nlymphoma\\tB-Disease\\n,\\tO\\nand\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nthe\\tO\\nspectrum\\tO\\nof\\tO\\n59\\tO\\nATM\\tO\\nmutations\\tO\\nobserved\\tO\\nin\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\npatients\\tO\\nin\\tO\\nthe\\tO\\nBritish\\tO\\nIsles\\tO\\n.\\tO\\n\\nOf\\tO\\n51\\tO\\nATM\\tO\\nmutations\\tO\\nidentified\\tO\\nin\\tO\\nfamilies\\tO\\nnative\\tO\\nto\\tO\\nthe\\tO\\nBritish\\tO\\nIsles\\tO\\n,\\tO\\n11\\tO\\nwere\\tO\\nfounder\\tO\\nmutations\\tO\\n,\\tO\\nand\\tO\\n2\\tO\\nof\\tO\\nthese\\tO\\n11\\tO\\nconferred\\tO\\na\\tO\\nmilder\\tO\\nclinical\\tO\\nphenotype\\tO\\nwith\\tO\\nrespect\\tO\\nto\\tO\\nboth\\tO\\ncerebellar\\tB-Disease\\ndegeneration\\tI-Disease\\nand\\tO\\ncellular\\tO\\nfeatures\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\n,\\tO\\nin\\tO\\ntwo\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nfamilies\\tO\\n,\\tO\\nan\\tO\\nATM\\tO\\nmutation\\tO\\n(\\tO\\n7271T\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\n)\\tO\\nthat\\tO\\nmay\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\nboth\\tO\\nhomozygotes\\tO\\nand\\tO\\nheterozygotes\\tO\\n(\\tO\\nrelative\\tO\\nrisk\\tO\\n12\\tO\\n.\\tO\\n7\\tO\\n;\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n0025\\tO\\n)\\tO\\n,\\tO\\nalthough\\tO\\nthere\\tO\\nis\\tO\\na\\tO\\nless\\tO\\nsevere\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nphenotype\\tO\\nin\\tO\\nterms\\tO\\nof\\tO\\nthe\\tO\\ndegree\\tO\\nof\\tO\\ncerebellar\\tB-Disease\\ndegeneration\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\n(\\tO\\n7271T\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\n)\\tO\\nalso\\tO\\nallows\\tO\\nexpression\\tO\\nof\\tO\\nfull\\tO\\n-\\tO\\nlength\\tO\\nATM\\tO\\nprotein\\tO\\nat\\tO\\na\\tO\\nlevel\\tO\\ncomparable\\tO\\nwith\\tO\\nthat\\tO\\nin\\tO\\nunaffected\\tO\\nindividuals\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nstudied\\tO\\n18\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\n,\\tO\\nin\\tO\\n15\\tO\\nfamilies\\tO\\n,\\tO\\nwho\\tO\\ndeveloped\\tO\\nleukemia\\tB-Disease\\n,\\tO\\nlymphoma\\tB-Disease\\n,\\tO\\npreleukemic\\tO\\nT\\tO\\n-\\tO\\ncell\\tO\\nproliferation\\tO\\n,\\tO\\nor\\tO\\nHodgkin\\tB-Disease\\nlymphoma\\tI-Disease\\n,\\tO\\nmostly\\tO\\nin\\tO\\nchildhood\\tO\\n.\\tO\\n\\nA\\tO\\nwide\\tO\\nvariety\\tO\\nof\\tO\\nATM\\tO\\nmutation\\tO\\ntypes\\tO\\n,\\tO\\nincluding\\tO\\nmissense\\tO\\nmutations\\tO\\nand\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletions\\tO\\n,\\tO\\nwere\\tO\\nseen\\tO\\nin\\tO\\nthese\\tO\\npatients\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nshow\\tO\\nthat\\tO\\n25\\tO\\n%\\tO\\nof\\tO\\nall\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\ncarried\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletions\\tO\\nor\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\nmany\\tO\\nof\\tO\\nwhich\\tO\\nwere\\tO\\nalso\\tO\\nassociated\\tO\\nwith\\tO\\nexpression\\tO\\nof\\tO\\nmutant\\tO\\nATM\\tO\\nprotein\\tO\\n.\\tO\\n\\nThe\\tO\\nDMPK\\tO\\ngene\\tO\\nof\\tO\\nseverely\\tO\\naffected\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\npatients\\tO\\nis\\tO\\nhypermethylated\\tO\\nproximal\\tO\\nto\\tO\\nthe\\tO\\nlargely\\tO\\nexpanded\\tO\\nCTG\\tO\\nrepeat\\tO\\n.\\tO\\n\\nUsing\\tO\\nmethylation\\tO\\n-\\tO\\nsensitive\\tO\\nrestriction\\tO\\nenzymes\\tO\\n,\\tO\\nwe\\tO\\ncharacterized\\tO\\nthe\\tO\\nmethylation\\tO\\npattern\\tO\\non\\tO\\nthe\\tO\\n5\\tO\\nside\\tO\\nof\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nin\\tO\\nthe\\tO\\nDMPK\\tO\\ngene\\tO\\nof\\tO\\nnormal\\tO\\nindividuals\\tO\\nand\\tO\\nof\\tO\\npatients\\tO\\naffected\\tO\\nwith\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n,\\tO\\nshowing\\tO\\nexpansions\\tO\\nof\\tO\\nthe\\tO\\nrepetitive\\tO\\nsequence\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nsegment\\tO\\nanalyzed\\tO\\ncorresponds\\tO\\nto\\tO\\nthe\\tO\\ngenomic\\tO\\nSacI\\tO\\n-\\tO\\nHindIII\\tO\\nfragment\\tO\\ncarrying\\tO\\nexons\\tO\\n11\\tO\\n-\\tO\\n15\\tO\\n.\\tO\\n\\nThere\\tO\\nis\\tO\\nconstitutive\\tO\\nmethylation\\tO\\nin\\tO\\nintron\\tO\\n12\\tO\\nat\\tO\\nrestriction\\tO\\nsites\\tO\\nof\\tO\\nSacII\\tO\\nand\\tO\\nHhaI\\tO\\n,\\tO\\nlocalized\\tO\\n1\\tO\\n,\\tO\\n159\\tO\\n-\\tO\\n1\\tO\\n,\\tO\\n232\\tO\\nbp\\tO\\nupstream\\tO\\nof\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\n,\\tO\\nwhereas\\tO\\nmost\\tO\\n,\\tO\\nif\\tO\\nnot\\tO\\nall\\tO\\n,\\tO\\nof\\tO\\nthe\\tO\\nother\\tO\\nsites\\tO\\nof\\tO\\nSacII\\tO\\n,\\tO\\nHhaI\\tO\\n,\\tO\\nand\\tO\\nHpaII\\tO\\nin\\tO\\nthis\\tO\\nregion\\tO\\nare\\tO\\nunmethylated\\tO\\n,\\tO\\nin\\tO\\nnormal\\tO\\nindividuals\\tO\\nand\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nyoung\\tO\\nand\\tO\\nseverely\\tO\\naffected\\tO\\npatients\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\ncomplete\\tO\\nmethylation\\tO\\nof\\tO\\nthese\\tO\\nrestriction\\tO\\nsites\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nthe\\tO\\nmutated\\tO\\nallele\\tO\\n.\\tO\\n\\nIn\\tO\\nmost\\tO\\nof\\tO\\nthese\\tO\\npatients\\tO\\n,\\tO\\nthe\\tO\\nonset\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nwas\\tO\\ncongenital\\tO\\n.\\tO\\n\\nPreliminary\\tO\\nin\\tO\\nvivo\\tO\\nfootprinting\\tO\\ndata\\tO\\ngave\\tO\\nevidence\\tO\\nfor\\tO\\nprotein\\tO\\n-\\tO\\nDNA\\tO\\ncontact\\tO\\nin\\tO\\nnormal\\tO\\ngenes\\tO\\nat\\tO\\nan\\tO\\nSp1\\tO\\nconsensus\\tO\\nbinding\\tO\\nsite\\tO\\nupstream\\tO\\nof\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nand\\tO\\nfor\\tO\\na\\tO\\nsignificant\\tO\\nreduction\\tO\\nof\\tO\\nthis\\tO\\ninteraction\\tO\\nin\\tO\\ncells\\tO\\nwith\\tO\\na\\tO\\nhypermethylated\\tO\\nDMPK\\tO\\ngene\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nhemochromatosis\\tB-Disease\\ngene\\tO\\nproduct\\tO\\ncomplexes\\tO\\nwith\\tO\\nthe\\tO\\ntransferrin\\tO\\nreceptor\\tO\\nand\\tO\\nlowers\\tO\\nits\\tO\\naffinity\\tO\\nfor\\tO\\nligand\\tO\\nbinding\\tO\\n.\\tO\\n\\nWe\\tO\\nrecently\\tO\\nreported\\tO\\nthe\\tO\\npositional\\tO\\ncloning\\tO\\nof\\tO\\na\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nhereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\ncalled\\tO\\nHFE\\tO\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\nproduct\\tO\\n,\\tO\\na\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\nmajor\\tO\\nhistocompatibility\\tO\\ncomplex\\tO\\nclass\\tO\\nI\\tO\\n-\\tO\\nlike\\tO\\nfamily\\tO\\n,\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nmutation\\tO\\n,\\tO\\nCys\\tO\\n-\\tO\\n282\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nTyr\\tO\\n(\\tO\\nC282Y\\tO\\n)\\tO\\n,\\tO\\nin\\tO\\n85\\tO\\n%\\tO\\nof\\tO\\npatient\\tO\\nchromosomes\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\neliminates\\tO\\nthe\\tO\\nability\\tO\\nof\\tO\\nHFE\\tO\\nto\\tO\\nassociate\\tO\\nwith\\tO\\nbeta2\\tO\\n-\\tO\\nmicroglobulin\\tO\\n(\\tO\\nbeta2m\\tO\\n)\\tO\\nand\\tO\\nprevents\\tO\\ncell\\tO\\n-\\tO\\nsurface\\tO\\nexpression\\tO\\n.\\tO\\n\\nA\\tO\\nsecond\\tO\\nmutation\\tO\\nthat\\tO\\nhas\\tO\\nno\\tO\\neffect\\tO\\non\\tO\\nbeta2m\\tO\\nassociation\\tO\\n,\\tO\\nH63D\\tO\\n,\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\neight\\tO\\nout\\tO\\nof\\tO\\nnine\\tO\\npatients\\tO\\nheterozygous\\tO\\nfor\\tO\\nthe\\tO\\nC282Y\\tO\\nmutant\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nreport\\tO\\n,\\tO\\nwe\\tO\\ndemonstrate\\tO\\nin\\tO\\ncultured\\tO\\n293\\tO\\ncells\\tO\\noverexpressing\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nor\\tO\\nmutant\\tO\\nHFE\\tO\\nproteins\\tO\\nthat\\tO\\nboth\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nand\\tO\\nH63D\\tO\\nHFE\\tO\\nproteins\\tO\\nform\\tO\\nstable\\tO\\ncomplexes\\tO\\nwith\\tO\\nthe\\tO\\ntransferrin\\tO\\nreceptor\\tO\\n(\\tO\\nTfR\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nC282Y\\tO\\nmutation\\tO\\nnearly\\tO\\ncompletely\\tO\\nprevents\\tO\\nthe\\tO\\nassociation\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nHFE\\tO\\nprotein\\tO\\nwith\\tO\\nthe\\tO\\nTfR\\tO\\n.\\tO\\n\\nStudies\\tO\\non\\tO\\ncell\\tO\\n-\\tO\\nassociated\\tO\\ntransferrin\\tO\\nat\\tO\\n37\\tO\\ndegrees\\tO\\nC\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\noverexpressed\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nHFE\\tO\\nprotein\\tO\\ndecreases\\tO\\nthe\\tO\\naffinity\\tO\\nof\\tO\\nthe\\tO\\nTfR\\tO\\nfor\\tO\\ntransferrin\\tO\\n.\\tO\\n\\nThe\\tO\\noverexpressed\\tO\\nH63D\\tO\\nprotein\\tO\\ndoes\\tO\\nnot\\tO\\nhave\\tO\\nthis\\tO\\neffect\\tO\\n,\\tO\\nproviding\\tO\\nthe\\tO\\nfirst\\tO\\ndirect\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\nfunctional\\tO\\nconsequence\\tO\\nof\\tO\\nthe\\tO\\nH63D\\tO\\nmutation\\tO\\n.\\tO\\n\\nAddition\\tO\\nof\\tO\\nsoluble\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nHFE\\tO\\n/\\tO\\nbeta2m\\tO\\nheterodimers\\tO\\nto\\tO\\ncultured\\tO\\ncells\\tO\\nalso\\tO\\ndecreased\\tO\\nthe\\tO\\napparent\\tO\\naffinity\\tO\\nof\\tO\\nthe\\tO\\nTfR\\tO\\nfor\\tO\\nits\\tO\\nligand\\tO\\nunder\\tO\\nsteady\\tO\\n-\\tO\\nstate\\tO\\nconditions\\tO\\n,\\tO\\nboth\\tO\\nin\\tO\\n293\\tO\\ncells\\tO\\nand\\tO\\nin\\tO\\nHeLa\\tO\\ncells\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nat\\tO\\n4\\tO\\ndegrees\\tO\\nC\\tO\\n,\\tO\\nthe\\tO\\nadded\\tO\\nsoluble\\tO\\ncomplex\\tO\\nof\\tO\\nHFE\\tO\\n/\\tO\\nbeta2m\\tO\\ninhibited\\tO\\nbinding\\tO\\nof\\tO\\ntransferrin\\tO\\nto\\tO\\nHeLa\\tO\\ncell\\tO\\nTfR\\tO\\nin\\tO\\na\\tO\\nconcentration\\tO\\n-\\tO\\ndependent\\tO\\nmanner\\tO\\n.\\tO\\n\\nScatchard\\tO\\nplots\\tO\\nof\\tO\\nthese\\tO\\ndata\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nadded\\tO\\nheterodimer\\tO\\nsubstantially\\tO\\nreduced\\tO\\nthe\\tO\\naffinity\\tO\\nof\\tO\\nTfR\\tO\\nfor\\tO\\ntransferrin\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nestablish\\tO\\na\\tO\\nmolecular\\tO\\nlink\\tO\\nbetween\\tO\\nHFE\\tO\\nand\\tO\\na\\tO\\nkey\\tO\\nprotein\\tO\\ninvolved\\tO\\nin\\tO\\niron\\tO\\ntransport\\tO\\n,\\tO\\nthe\\tO\\nTfR\\tO\\n,\\tO\\nand\\tO\\nraise\\tO\\nthe\\tO\\npossibility\\tO\\nthat\\tO\\nalterations\\tO\\nin\\tO\\nthis\\tO\\nregulatory\\tO\\nmechanism\\tO\\nmay\\tO\\nplay\\tO\\na\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nGenomic\\tO\\norganization\\tO\\nof\\tO\\nthe\\tO\\nUBE3A\\tO\\n/\\tO\\nE6\\tO\\n-\\tO\\nAP\\tO\\ngene\\tO\\nand\\tO\\nrelated\\tO\\npseudogenes\\tO\\n.\\tO\\n\\nThe\\tO\\nUBE3A\\tO\\ngene\\tO\\nencodes\\tO\\nthe\\tO\\nE6\\tO\\n-\\tO\\nAP\\tO\\nubiquitin\\tO\\n-\\tO\\nprotein\\tO\\nligase\\tO\\nand\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\nmutated\\tO\\nin\\tO\\nAngelman\\tB-Disease\\nsyndrome\\tI-Disease\\npatients\\tO\\nwho\\tO\\nlack\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\ndeletions\\tO\\nor\\tO\\nchromosome\\tO\\n15\\tO\\npaternal\\tO\\nuniparental\\tB-Disease\\ndisomy\\tI-Disease\\n.\\tO\\n\\nPrevious\\tO\\nUBE3A\\tO\\ncDNA\\tO\\nanalysis\\tO\\nhas\\tO\\nshown\\tO\\na\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\napproximately\\tO\\n2\\tO\\n.\\tO\\n\\n6\\tO\\nkb\\tO\\nand\\tO\\na\\tO\\n3\\tO\\n-\\tO\\nuntranslated\\tO\\nregion\\tO\\n(\\tO\\nUTR\\tO\\n)\\tO\\nof\\tO\\n<\\tO\\n50\\tO\\nbp\\tO\\n,\\tO\\nwhereas\\tO\\nNorthern\\tO\\nanalysis\\tO\\nhas\\tO\\nindicated\\tO\\nmRNA\\tO\\nsizes\\tO\\nof\\tO\\n5\\tO\\n-\\tO\\n8\\tO\\nkb\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nanalyzed\\tO\\nadditional\\tO\\ncDNA\\tO\\nclones\\tO\\nand\\tO\\nprovide\\tO\\nevidence\\tO\\nfor\\tO\\nan\\tO\\nadditional\\tO\\n0\\tO\\n.\\tO\\n\\n5\\tO\\nkb\\tO\\nof\\tO\\n5\\tO\\n-\\tO\\nUTR\\tO\\nand\\tO\\n>\\tO\\n2\\tO\\nkb\\tO\\nof\\tO\\n3\\tO\\n-\\tO\\nUTR\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nestablished\\tO\\nthe\\tO\\ngenomic\\tO\\norganization\\tO\\nof\\tO\\nUBE3A\\tO\\nand\\tO\\nthe\\tO\\nsequence\\tO\\nof\\tO\\nintron\\tO\\n-\\tO\\nexon\\tO\\nborders\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nalso\\tO\\nmapped\\tO\\ntwo\\tO\\nhighly\\tO\\nhomologous\\tO\\nprocessed\\tO\\npseudogenes\\tO\\n,\\tO\\nUBE3AP1\\tO\\nand\\tO\\nUBE3AP2\\tO\\n,\\tO\\nto\\tO\\nchromosomes\\tO\\n2\\tO\\nand\\tO\\n21\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nand\\tO\\ndetermined\\tO\\ntheir\\tO\\ngenomic\\tO\\norganization\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nwill\\tO\\nform\\tO\\nthe\\tO\\nbasis\\tO\\nfor\\tO\\nstudies\\tO\\nof\\tO\\nmutation\\tO\\nand\\tO\\nimprinting\\tO\\nof\\tO\\nUBE3A\\tO\\n.\\tO\\n\\nMutation\\tO\\nspectrum\\tO\\nand\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\nanalyses\\tO\\nin\\tO\\nCowden\\tB-Disease\\ndisease\\tI-Disease\\nand\\tO\\nBannayan\\tB-Disease\\n-\\tI-Disease\\nZonana\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\ntwo\\tO\\nhamartoma\\tB-Disease\\nsyndromes\\tI-Disease\\nwith\\tO\\ngermline\\tO\\nPTEN\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\ntumour\\tB-Disease\\nsuppressor\\tO\\ngene\\tO\\nPTEN\\tO\\n,\\tO\\nwhich\\tO\\nmaps\\tO\\nto\\tO\\n10q23\\tO\\n.\\tO\\n\\n3\\tO\\nand\\tO\\nencodes\\tO\\na\\tO\\n403\\tO\\namino\\tO\\nacid\\tO\\ndual\\tO\\nspecificity\\tO\\nphosphatase\\tO\\n(\\tO\\nprotein\\tO\\ntyrosine\\tO\\nphosphatase\\tO\\n;\\tO\\nPTPase\\tO\\n)\\tO\\n,\\tO\\nwas\\tO\\nshown\\tO\\nrecently\\tO\\nto\\tO\\nplay\\tO\\na\\tO\\nbroad\\tO\\nrole\\tO\\nin\\tO\\nhuman\\tO\\nmalignancy\\tB-Disease\\n.\\tO\\n\\nSomatic\\tO\\nPTEN\\tO\\ndeletions\\tO\\nand\\tO\\nmutations\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nsporadic\\tB-Disease\\nbreast\\tI-Disease\\n,\\tI-Disease\\nbrain\\tI-Disease\\n,\\tI-Disease\\nprostate\\tI-Disease\\nand\\tI-Disease\\nkidney\\tI-Disease\\ncancer\\tI-Disease\\ncell\\tO\\nlines\\tO\\nand\\tO\\nin\\tO\\nseveral\\tO\\nprimary\\tO\\ntumours\\tB-Disease\\nsuch\\tO\\nas\\tO\\nendometrial\\tB-Disease\\ncarcinomas\\tI-Disease\\n,\\tO\\nmalignant\\tB-Disease\\nmelanoma\\tI-Disease\\nand\\tO\\nthyroid\\tB-Disease\\ntumours\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nPTEN\\tO\\nwas\\tO\\nidentified\\tO\\nas\\tO\\nthe\\tO\\nsusceptibility\\tO\\ngene\\tO\\nfor\\tO\\ntwo\\tO\\nhamartoma\\tB-Disease\\nsyndromes\\tI-Disease\\nCowden\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nCD\\tB-Disease\\n;\\tO\\nMIM\\tO\\n158350\\tO\\n)\\tO\\nand\\tO\\nBannayan\\tB-Disease\\n-\\tI-Disease\\nZonana\\tI-Disease\\n(\\tI-Disease\\nBZS\\tI-Disease\\n)\\tI-Disease\\nor\\tI-Disease\\nRuvalcaba\\tI-Disease\\n-\\tI-Disease\\nRiley\\tI-Disease\\n-\\tI-Disease\\nSmith\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nMIM\\tO\\n153480\\tO\\n)\\tO\\n.\\tO\\n\\nConstitutive\\tO\\nDNA\\tO\\nfrom\\tO\\n37\\tO\\nCD\\tB-Disease\\nfamilies\\tO\\nand\\tO\\nseven\\tO\\nBZS\\tB-Disease\\nfamilies\\tO\\nwas\\tO\\nscreened\\tO\\nfor\\tO\\ngermline\\tO\\nPTEN\\tO\\nmutations\\tO\\n.\\tO\\n\\nPTEN\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\n30\\tO\\nof\\tO\\n37\\tO\\n(\\tO\\n81\\tO\\n%\\tO\\n)\\tO\\nCD\\tB-Disease\\nfamilies\\tO\\n,\\tO\\nincluding\\tO\\nmissense\\tO\\nand\\tO\\nnonsense\\tO\\npoint\\tO\\nmutations\\tO\\n,\\tO\\ndeletions\\tO\\n,\\tO\\ninsertions\\tO\\n,\\tO\\na\\tO\\ndeletion\\tO\\n/\\tO\\ninsertion\\tO\\nand\\tO\\nsplice\\tO\\nsite\\tO\\nmutations\\tO\\n.\\tO\\n\\nThese\\tO\\nmutations\\tO\\nwere\\tO\\nscattered\\tO\\nover\\tO\\nthe\\tO\\nentire\\tO\\nlength\\tO\\nof\\tO\\nPTEN\\tO\\n,\\tO\\nwith\\tO\\nthe\\tO\\nexception\\tO\\nof\\tO\\nthe\\tO\\nfirst\\tO\\n,\\tO\\nfourth\\tO\\nand\\tO\\nlast\\tO\\nexons\\tO\\n.\\tO\\n\\nA\\tO\\nhot\\tO\\nspot\\tO\\nfor\\tO\\nPTEN\\tO\\nmutation\\tO\\nin\\tO\\nCD\\tB-Disease\\nwas\\tO\\nidentified\\tO\\nin\\tO\\nexon\\tO\\n5\\tO\\nthat\\tO\\ncontains\\tO\\nthe\\tO\\nPTPase\\tO\\ncore\\tO\\nmotif\\tO\\n,\\tO\\nwith\\tO\\n13\\tO\\nof\\tO\\n30\\tO\\n(\\tO\\n43\\tO\\n%\\tO\\n)\\tO\\nCD\\tB-Disease\\nmutations\\tO\\nidentified\\tO\\nin\\tO\\nthis\\tO\\nexon\\tO\\n.\\tO\\n\\nSeven\\tO\\nof\\tO\\n30\\tO\\n(\\tO\\n23\\tO\\n%\\tO\\n)\\tO\\nwere\\tO\\nwithin\\tO\\nthe\\tO\\ncore\\tO\\nmotif\\tO\\n,\\tO\\nthe\\tO\\nmajority\\tO\\n(\\tO\\nfive\\tO\\nof\\tO\\nseven\\tO\\n)\\tO\\nof\\tO\\nwhich\\tO\\nwere\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\npossibly\\tO\\npointing\\tO\\nto\\tO\\nthe\\tO\\nfunctional\\tO\\nsignificance\\tO\\nof\\tO\\nthis\\tO\\nregion\\tO\\n.\\tO\\n\\nGermline\\tO\\nPTEN\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nfour\\tO\\nof\\tO\\nseven\\tO\\n(\\tO\\n57\\tO\\n%\\tO\\n)\\tO\\nBZS\\tB-Disease\\nfamilies\\tO\\nstudied\\tO\\n.\\tO\\n\\nInterestingly\\tO\\n,\\tO\\nnone\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\nPTPase\\tO\\ncore\\tO\\nmotif\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nalso\\tO\\nworthy\\tO\\nof\\tO\\nnote\\tO\\nthat\\tO\\na\\tO\\nsingle\\tO\\nnonsense\\tO\\npoint\\tO\\nmutation\\tO\\n,\\tO\\nR233X\\tO\\n,\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\nthe\\tO\\ngermline\\tO\\nDNA\\tO\\nfrom\\tO\\ntwo\\tO\\nunrelated\\tO\\nCD\\tB-Disease\\nfamilies\\tO\\nand\\tO\\none\\tO\\nBZS\\tB-Disease\\nfamily\\tO\\n.\\tO\\n\\nGenotype\\tO\\n-\\tO\\nphenotype\\tO\\nstudies\\tO\\nwere\\tO\\nnot\\tO\\nperformed\\tO\\non\\tO\\nthis\\tO\\nsmall\\tO\\ngroup\\tO\\nof\\tO\\nBZS\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\nanalysis\\tO\\ninthe\\tO\\ngroup\\tO\\nof\\tO\\nCD\\tB-Disease\\nfamilies\\tO\\nrevealed\\tO\\ntwo\\tO\\npossible\\tO\\nassociations\\tO\\nworthy\\tO\\nof\\tO\\nfollow\\tO\\n-\\tO\\nup\\tO\\nin\\tO\\nindependent\\tO\\nanalyses\\tO\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\nwas\\tO\\nan\\tO\\nassociation\\tO\\nnoted\\tO\\nin\\tO\\nthe\\tO\\ngroup\\tO\\nof\\tO\\nCD\\tB-Disease\\nfamilies\\tO\\nwith\\tO\\nbreast\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nA\\tO\\ncorrelation\\tO\\nwas\\tO\\nobserved\\tO\\nbetween\\tO\\nthe\\tO\\npresence\\tO\\n/\\tO\\nabsence\\tO\\nof\\tO\\na\\tO\\nPTEN\\tO\\nmutation\\tO\\nand\\tO\\nthe\\tO\\ntype\\tO\\nof\\tO\\nbreast\\tO\\ninvolvement\\tO\\n(\\tO\\nunaffected\\tO\\nversus\\tO\\nbenign\\tO\\nversus\\tO\\nmalignant\\tO\\n)\\tO\\n.\\tO\\n\\nSpecifically\\tO\\nand\\tO\\nmore\\tO\\ndirectly\\tO\\n,\\tO\\nan\\tO\\nassociation\\tO\\nwas\\tO\\nalso\\tO\\nobserved\\tO\\nbetween\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nPTEN\\tO\\nmutation\\tO\\nand\\tO\\nmalignant\\tB-Disease\\nbreast\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nSecondly\\tO\\n,\\tO\\nthere\\tO\\nappeared\\tO\\nto\\tO\\nbe\\tO\\nan\\tO\\ninterdependent\\tO\\nassociation\\tO\\nbetween\\tO\\nmutations\\tO\\nupstream\\tO\\nand\\tO\\nwithin\\tO\\nthe\\tO\\nPTPase\\tO\\ncore\\tO\\nmotif\\tO\\n,\\tO\\nthe\\tO\\ncore\\tO\\nmotif\\tO\\ncontaining\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\ninvolvement\\tO\\nof\\tO\\nall\\tO\\nmajor\\tO\\norgan\\tO\\nsystems\\tO\\n(\\tO\\ncentral\\tO\\nnervous\\tO\\nsystem\\tO\\n,\\tO\\nthyroid\\tO\\n,\\tO\\nbreast\\tO\\n,\\tO\\nskin\\tO\\nand\\tO\\ngastrointestinal\\tO\\ntract\\tO\\n)\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthese\\tO\\nobservations\\tO\\nwould\\tO\\nneed\\tO\\nto\\tO\\nbe\\tO\\nconfirmed\\tO\\nby\\tO\\nstudying\\tO\\na\\tO\\nlarger\\tO\\nnumber\\tO\\nof\\tO\\nCD\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nMolecular\\tO\\ndefects\\tO\\nleading\\tO\\nto\\tO\\nhuman\\tO\\ncomplement\\tB-Disease\\ncomponent\\tI-Disease\\nC6\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nan\\tO\\nAfrican\\tO\\n-\\tO\\nAmerican\\tO\\nfamily\\tO\\n.\\tO\\n\\nComplement\\tB-Disease\\ncomponent\\tI-Disease\\nC6\\tI-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nC6D\\tB-Disease\\n)\\tO\\nwas\\tO\\ndiagnosed\\tO\\nin\\tO\\na\\tO\\n16\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nAfrican\\tO\\n-\\tO\\nAmerican\\tO\\nmale\\tO\\nwith\\tO\\nmeningococcal\\tB-Disease\\nmeningitis\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\npatients\\tO\\nfather\\tO\\nand\\tO\\ntwo\\tO\\nbrothers\\tO\\nalso\\tO\\nhad\\tO\\nC6D\\tB-Disease\\n,\\tO\\nbut\\tO\\ngave\\tO\\nno\\tO\\nhistory\\tO\\nof\\tO\\nmeningitis\\tB-Disease\\nor\\tO\\nother\\tO\\nneisserial\\tB-Disease\\ninfection\\tI-Disease\\n.\\tO\\n\\nBy\\tO\\nusing\\tO\\nexon\\tO\\n-\\tO\\nspecific\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n(\\tO\\nPCR\\tO\\n)\\tO\\n/\\tO\\nsingle\\tO\\n-\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\nas\\tO\\na\\tO\\nscreening\\tO\\nstep\\tO\\nand\\tO\\nnucleotide\\tO\\nsequencing\\tO\\nof\\tO\\ntarget\\tO\\nexons\\tO\\n,\\tO\\nwe\\tO\\ndetermined\\tO\\nthat\\tO\\nthe\\tO\\nproband\\tO\\nwas\\tO\\na\\tO\\ncompound\\tO\\nheterozygote\\tO\\nfor\\tO\\ntwo\\tO\\nC6\\tO\\ngene\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nfirst\\tO\\n,\\tO\\n1195delC\\tO\\nlocated\\tO\\nin\\tO\\nexon\\tO\\n7\\tO\\n,\\tO\\nis\\tO\\na\\tO\\nnovel\\tO\\nmutation\\tO\\n,\\tO\\nwhile\\tO\\nthe\\tO\\nsecond\\tO\\n,\\tO\\n1936delG\\tO\\nin\\tO\\nexon\\tO\\n12\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\ndescribed\\tO\\nbefore\\tO\\nto\\tO\\ncause\\tO\\nC6D\\tB-Disease\\nin\\tO\\nan\\tO\\nunrelated\\tO\\nAfrican\\tO\\n-\\tO\\nAmerican\\tO\\nindividual\\tO\\n.\\tO\\n\\nBoth\\tO\\nmutations\\tO\\nresult\\tO\\nin\\tO\\npremature\\tO\\ntermination\\tO\\ncodons\\tO\\nand\\tO\\nC6\\tO\\nnull\\tO\\nalleles\\tO\\n.\\tO\\n\\nAllele\\tO\\n-\\tO\\nspecific\\tO\\nPCR\\tO\\nindicated\\tO\\nthat\\tO\\nthe\\tO\\nprobands\\tO\\ntwo\\tO\\nbrothers\\tO\\nalso\\tO\\ninherited\\tO\\nthe\\tO\\n1195delC\\tO\\nmutation\\tO\\nfrom\\tO\\ntheir\\tO\\nheterozygous\\tO\\nmother\\tO\\nand\\tO\\nthe\\tO\\n1936delG\\tO\\nmutation\\tO\\nfrom\\tO\\ntheir\\tO\\nhomozygous\\tO\\nfather\\tO\\n.\\tO\\n.\\tO\\n\\nPAX6\\tO\\nmutations\\tO\\nreviewed\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nPAX6\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nhuman\\tO\\naniridia\\tB-Disease\\nand\\tO\\nhave\\tO\\nalso\\tO\\nbeen\\tO\\nfound\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nPeters\\tB-Disease\\nanomaly\\tI-Disease\\n,\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\ncataracts\\tI-Disease\\n,\\tO\\nwith\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nkeratitis\\tI-Disease\\n,\\tO\\nand\\tO\\nwith\\tO\\nisolated\\tB-Disease\\nfoveal\\tI-Disease\\nhypoplasia\\tI-Disease\\n.\\tO\\n\\nNo\\tO\\nlocus\\tO\\nother\\tO\\nthan\\tO\\nchromosome\\tO\\n11p13\\tO\\nhas\\tO\\nbeen\\tO\\nimplicated\\tO\\nin\\tO\\naniridia\\tB-Disease\\n,\\tO\\nand\\tO\\nPAX6\\tO\\nis\\tO\\nclearly\\tO\\nthe\\tO\\nmajor\\tO\\n,\\tO\\nif\\tO\\nnot\\tO\\nonly\\tO\\n,\\tO\\ngene\\tO\\nresponsible\\tO\\n.\\tO\\n\\nTwenty\\tO\\n-\\tO\\neight\\tO\\npercent\\tO\\nof\\tO\\nidentified\\tO\\nPAX6\\tO\\nmutations\\tO\\nare\\tO\\nC\\tO\\n-\\tO\\nT\\tO\\nchanges\\tO\\nat\\tO\\nCpG\\tO\\ndinucleotides\\tO\\n,\\tO\\n20\\tO\\n%\\tO\\nare\\tO\\nsplicing\\tO\\nerrors\\tO\\n,\\tO\\nand\\tO\\nmore\\tO\\nthan\\tO\\n30\\tO\\n%\\tO\\nare\\tO\\ndeletion\\tO\\nor\\tO\\ninsertion\\tO\\nevents\\tO\\n.\\tO\\n\\nThere\\tO\\nis\\tO\\na\\tO\\nnoticeably\\tO\\nelevated\\tO\\nlevel\\tO\\nof\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\npaired\\tO\\ndomain\\tO\\ncompared\\tO\\nwith\\tO\\nthe\\tO\\nrest\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nIncreased\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nhomeodomain\\tO\\nis\\tO\\naccounted\\tO\\nfor\\tO\\nby\\tO\\nthe\\tO\\nhypermutable\\tO\\nCpG\\tO\\ndinucleotide\\tO\\nin\\tO\\ncodon\\tO\\n240\\tO\\n.\\tO\\n\\nVery\\tO\\nnearly\\tO\\nall\\tO\\nmutations\\tO\\nappear\\tO\\nto\\tO\\ncause\\tO\\nloss\\tO\\nof\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nallele\\tO\\n,\\tO\\nand\\tO\\nmore\\tO\\nthan\\tO\\n80\\tO\\n%\\tO\\nof\\tO\\nexonic\\tO\\nsubstitutions\\tO\\nresult\\tO\\nin\\tO\\nnonsense\\tO\\ncodons\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\ngene\\tO\\nwith\\tO\\nsuch\\tO\\nextraordinarily\\tO\\nhigh\\tO\\nsequence\\tO\\nconservation\\tO\\nthroughout\\tO\\nevolution\\tO\\n,\\tO\\nthere\\tO\\nare\\tO\\npresumed\\tO\\nundiscovered\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\nthese\\tO\\nare\\tO\\nhypothesized\\tO\\nto\\tO\\nexist\\tO\\nin\\tO\\nas\\tO\\n-\\tO\\nyet\\tO\\nunidentified\\tO\\nphenotypes\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nheterogeneity\\tO\\nand\\tO\\npenetrance\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\ngenes\\tO\\nin\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nThe\\tO\\nBreast\\tB-Disease\\nCancer\\tI-Disease\\nLinkage\\tO\\nConsortium\\tO\\n.\\tO\\n\\nThe\\tO\\ncontribution\\tO\\nof\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nto\\tO\\ninherited\\tB-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nwas\\tO\\nassessed\\tO\\nby\\tO\\nlinkage\\tO\\nand\\tO\\nmutation\\tO\\nanalysis\\tO\\nin\\tO\\n237\\tO\\nfamilies\\tO\\n,\\tO\\neach\\tO\\nwith\\tO\\nat\\tO\\nleast\\tO\\nfour\\tO\\ncases\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\ncollected\\tO\\nby\\tO\\nthe\\tO\\nBreast\\tB-Disease\\nCancer\\tI-Disease\\nLinkage\\tO\\nConsortium\\tO\\n.\\tO\\n\\nFamilies\\tO\\nwere\\tO\\nincluded\\tO\\nwithout\\tO\\nregard\\tO\\nto\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\novarian\\tB-Disease\\nor\\tI-Disease\\nother\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nOverall\\tO\\n,\\tO\\ndisease\\tO\\nwas\\tO\\nlinked\\tO\\nto\\tO\\nBRCA1\\tO\\nin\\tO\\nan\\tO\\nestimated\\tO\\n52\\tO\\n%\\tO\\nof\\tO\\nfamilies\\tO\\n,\\tO\\nto\\tO\\nBRCA2\\tO\\nin\\tO\\n32\\tO\\n%\\tO\\nof\\tO\\nfamilies\\tO\\n,\\tO\\nand\\tO\\nto\\tO\\nneither\\tO\\ngene\\tO\\nin\\tO\\n16\\tO\\n%\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nconfidence\\tO\\ninterval\\tO\\n[\\tO\\nCI\\tO\\n]\\tO\\n6\\tO\\n%\\tO\\n-\\tO\\n28\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nsuggesting\\tO\\nother\\tO\\npredisposition\\tO\\ngenes\\tO\\n.\\tO\\n\\nThe\\tO\\nmajority\\tO\\n(\\tO\\n81\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nbreast\\tB-Disease\\n-\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nwere\\tO\\ndue\\tO\\nto\\tO\\nBRCA1\\tO\\n,\\tO\\nwith\\tO\\nmost\\tO\\nothers\\tO\\n(\\tO\\n14\\tO\\n%\\tO\\n)\\tO\\ndue\\tO\\nto\\tO\\nBRCA2\\tO\\n.\\tO\\n\\nConversely\\tO\\n,\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nfamilies\\tO\\nwith\\tO\\nmale\\tB-Disease\\nand\\tI-Disease\\nfemale\\tI-Disease\\nbreast\\tI-Disease\\ncancer\\tI-Disease\\nwere\\tO\\ndue\\tO\\nto\\tO\\nBRCA2\\tO\\n(\\tO\\n76\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nlargest\\tO\\nproportion\\tO\\n(\\tO\\n67\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\nfamilies\\tO\\ndue\\tO\\nto\\tO\\nother\\tO\\ngenes\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\nfour\\tO\\nor\\tO\\nfive\\tO\\ncases\\tO\\nof\\tO\\nfemale\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nonly\\tO\\n.\\tO\\n\\nThese\\tO\\nestimates\\tO\\nwere\\tO\\nnot\\tO\\nsubstantially\\tO\\naffected\\tO\\neither\\tO\\nby\\tO\\nchanging\\tO\\nthe\\tO\\nassumed\\tO\\npenetrance\\tO\\nmodel\\tO\\nfor\\tO\\nBRCA1\\tO\\nor\\tO\\nby\\tO\\nincluding\\tO\\nor\\tO\\nexcluding\\tO\\nBRCA1\\tO\\nmutation\\tO\\ndata\\tO\\n.\\tO\\n\\nAmong\\tO\\nthose\\tO\\nfamilies\\tO\\nwith\\tO\\ndisease\\tO\\ndue\\tO\\nto\\tO\\nBRCA1\\tO\\nthat\\tO\\nwere\\tO\\ntested\\tO\\nby\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nstandard\\tO\\nscreening\\tO\\nmethods\\tO\\n,\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nsequence\\tO\\nor\\tO\\nsplice\\tO\\nsites\\tO\\nin\\tO\\nan\\tO\\nestimated\\tO\\n63\\tO\\n%\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nCI\\tO\\n51\\tO\\n%\\tO\\n-\\tO\\n77\\tO\\n%\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nestimated\\tO\\nsensitivity\\tO\\nwas\\tO\\nidentical\\tO\\nfor\\tO\\ndirect\\tO\\nsequencing\\tO\\nand\\tO\\nother\\tO\\ntechniques\\tO\\n.\\tO\\n\\nThe\\tO\\npenetrance\\tO\\nof\\tO\\nBRCA2\\tO\\nwas\\tO\\nestimated\\tO\\nby\\tO\\nmaximizing\\tO\\nthe\\tO\\nLOD\\tO\\nscore\\tO\\nin\\tO\\nBRCA2\\tO\\n-\\tO\\nmutation\\tO\\nfamilies\\tO\\n,\\tO\\nover\\tO\\nall\\tO\\npossible\\tO\\npenetrance\\tO\\nfunctions\\tO\\n.\\tO\\n\\nThe\\tO\\nestimated\\tO\\ncumulative\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nreached\\tO\\n28\\tO\\n%\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nCI\\tO\\n9\\tO\\n%\\tO\\n-\\tO\\n44\\tO\\n%\\tO\\n)\\tO\\nby\\tO\\nage\\tO\\n50\\tO\\nyears\\tO\\nand\\tO\\n84\\tO\\n%\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nCI\\tO\\n43\\tO\\n%\\tO\\n-\\tO\\n95\\tO\\n%\\tO\\n)\\tO\\nby\\tO\\nage\\tO\\n70\\tO\\nyears\\tO\\n.\\tO\\n\\nThe\\tO\\ncorresponding\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nrisks\\tO\\nwere\\tO\\n0\\tO\\n.\\tO\\n\\n4\\tO\\n%\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nCI\\tO\\n0\\tO\\n%\\tO\\n-\\tO\\n1\\tO\\n%\\tO\\n)\\tO\\nby\\tO\\nage\\tO\\n50\\tO\\nyears\\tO\\nand\\tO\\n27\\tO\\n%\\tO\\n(\\tO\\n95\\tO\\n%\\tO\\nCI\\tO\\n0\\tO\\n%\\tO\\n-\\tO\\n47\\tO\\n%\\tO\\n)\\tO\\nby\\tO\\nage\\tO\\n70\\tO\\nyears\\tO\\n.\\tO\\n\\nThe\\tO\\nlifetime\\tO\\nrisk\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nappears\\tO\\nsimilar\\tO\\nto\\tO\\nthe\\tO\\nrisk\\tO\\nin\\tO\\nBRCA1\\tO\\ncarriers\\tO\\n,\\tO\\nbut\\tO\\nthere\\tO\\nwas\\tO\\nsome\\tO\\nsuggestion\\tO\\nof\\tO\\na\\tO\\nlower\\tO\\nrisk\\tO\\nin\\tO\\nBRCA2\\tO\\ncarriers\\tO\\n<\\tO\\n50\\tO\\nyears\\tO\\nof\\tO\\nage\\tO\\n.\\tO\\n\\nEye\\tB-Disease\\nmovement\\tI-Disease\\nabnormalities\\tI-Disease\\ncorrelate\\tO\\nwith\\tO\\ngenotype\\tO\\nin\\tO\\nautosomal\\tO\\ndominant\\tO\\ncerebellar\\tB-Disease\\nataxia\\tI-Disease\\ntype\\tI-Disease\\nI\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\ncompared\\tO\\nhorizontal\\tO\\neye\\tO\\nmovements\\tO\\n(\\tO\\nvisually\\tO\\nguided\\tO\\nsaccades\\tO\\n,\\tO\\nantisaccades\\tO\\n,\\tO\\nand\\tO\\nsmooth\\tO\\npursuit\\tO\\n)\\tO\\nin\\tO\\ncontrol\\tO\\nsubjects\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n14\\tO\\n)\\tO\\nand\\tO\\npatients\\tO\\nwith\\tO\\nthree\\tO\\nforms\\tO\\nof\\tO\\nautosomal\\tO\\ndominant\\tO\\ncerebellar\\tB-Disease\\nataxias\\tI-Disease\\ntype\\tI-Disease\\nI\\tI-Disease\\nspinocerebellar\\tB-Disease\\nataxias\\tI-Disease\\n1\\tI-Disease\\nand\\tI-Disease\\n2\\tI-Disease\\n(\\tO\\nSCA1\\tB-Disease\\n,\\tO\\nn\\tO\\n=\\tO\\n11\\tO\\n;\\tO\\nSCA2\\tB-Disease\\n,\\tO\\nn\\tO\\n=\\tO\\n10\\tO\\n)\\tO\\nand\\tO\\nSCA3\\tB-Disease\\n/\\tO\\nMachado\\tB-Disease\\n-\\tI-Disease\\nJoseph\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nMJD\\tB-Disease\\n)\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n16\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nSCA1\\tB-Disease\\n,\\tO\\nsaccade\\tO\\namplitude\\tO\\nwas\\tO\\nsignificantly\\tO\\nincreased\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nhypermetria\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\nsmooth\\tO\\npursuit\\tO\\ngain\\tO\\nwas\\tO\\ndecreased\\tO\\n.\\tO\\n\\nIn\\tO\\nSCA2\\tB-Disease\\n,\\tO\\nsaccade\\tO\\nvelocity\\tO\\nwas\\tO\\nmarkedly\\tO\\ndecreased\\tO\\n.\\tO\\n\\nThe\\tO\\npercentage\\tO\\nof\\tO\\nerrors\\tO\\nin\\tO\\nantisaccades\\tO\\nwas\\tO\\ngreatly\\tO\\nincreased\\tO\\nand\\tO\\nwas\\tO\\nsignificantly\\tO\\ncorrelated\\tO\\nwith\\tO\\nage\\tO\\nat\\tO\\ndisease\\tO\\nonset\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\na\\tO\\ncorrelation\\tO\\nbetween\\tO\\nsmooth\\tO\\npursuit\\tO\\ngain\\tO\\nand\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\ntrinucleotide\\tO\\nrepeats\\tO\\nwas\\tO\\nfound\\tO\\n.\\tO\\n\\nIn\\tO\\nSCA3\\tB-Disease\\n,\\tO\\ngaze\\tB-Disease\\n-\\tI-Disease\\nevoked\\tI-Disease\\nnystagmus\\tI-Disease\\nwas\\tO\\noften\\tO\\npresent\\tO\\nas\\tO\\nwas\\tO\\nsaccade\\tO\\nhypometria\\tO\\nand\\tO\\nsmooth\\tO\\npursuit\\tO\\ngain\\tO\\nwas\\tO\\nmarkedly\\tO\\ndecreased\\tO\\n.\\tO\\n\\nThree\\tO\\nmajor\\tO\\ncriteria\\tO\\n,\\tO\\nsaccade\\tO\\namplitude\\tO\\n,\\tO\\nsaccade\\tO\\nvelocity\\tO\\n,\\tO\\nand\\tO\\npresence\\tO\\nof\\tO\\ngaze\\tB-Disease\\n-\\tI-Disease\\nevoked\\tI-Disease\\nnystagmus\\tI-Disease\\n,\\tO\\npermitted\\tO\\nthe\\tO\\ncorrect\\tO\\nassignment\\tO\\nof\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nSCA1\\tB-Disease\\n,\\tO\\n90\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nSCA2\\tB-Disease\\n,\\tO\\nand\\tO\\n93\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\npatients\\tO\\nwith\\tO\\nSCA3\\tB-Disease\\nto\\tO\\ntheir\\tO\\ngenetically\\tO\\nconfirmed\\tO\\npatient\\tO\\ngroup\\tO\\nand\\tO\\n,\\tO\\ntherefore\\tO\\n,\\tO\\nmay\\tO\\nhelp\\tO\\norient\\tO\\ndiagnoses\\tO\\nof\\tO\\nSCA1\\tB-Disease\\n,\\tO\\nSCA2\\tB-Disease\\n,\\tO\\nand\\tO\\nSCA3\\tB-Disease\\nat\\tO\\nearly\\tO\\nclinical\\tO\\nstages\\tO\\nof\\tO\\nthe\\tO\\ndiseases\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nbasis\\tO\\nand\\tO\\nmolecular\\tO\\nmechanism\\tO\\nfor\\tO\\nidiopathic\\tB-Disease\\nventricular\\tI-Disease\\nfibrillation\\tI-Disease\\n.\\tO\\n\\nVentricular\\tB-Disease\\nfibrillation\\tI-Disease\\ncauses\\tO\\nmore\\tO\\nthan\\tO\\n300\\tO\\n,\\tO\\n000\\tO\\nsudden\\tO\\ndeaths\\tO\\neach\\tO\\nyear\\tO\\nin\\tO\\nthe\\tO\\nUSA\\tO\\nalone\\tO\\n.\\tO\\n\\nIn\\tO\\napproximately\\tO\\n5\\tO\\n-\\tO\\n12\\tO\\n%\\tO\\nof\\tO\\nthese\\tO\\ncases\\tO\\n,\\tO\\nthere\\tO\\nare\\tO\\nno\\tO\\ndemonstrable\\tO\\ncardiac\\tO\\nor\\tO\\nnon\\tO\\n-\\tO\\ncardiac\\tO\\ncauses\\tO\\nto\\tO\\naccount\\tO\\nfor\\tO\\nthe\\tO\\nepisode\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\ntherefore\\tO\\nclassified\\tO\\nas\\tO\\nidiopathic\\tB-Disease\\nventricular\\tI-Disease\\nfibrillation\\tI-Disease\\n(\\tO\\nIVF\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nA\\tO\\ndistinct\\tO\\ngroup\\tO\\nof\\tO\\nIVF\\tB-Disease\\npatients\\tO\\nhas\\tO\\nbeen\\tO\\nfound\\tO\\nto\\tO\\npresent\\tO\\nwith\\tO\\na\\tO\\ncharacteristic\\tO\\nelectrocardiographic\\tO\\npattern\\tO\\n.\\tO\\n\\nBecause\\tO\\nof\\tO\\nthe\\tO\\nsmall\\tO\\nsize\\tO\\nof\\tO\\nmost\\tO\\npedigrees\\tO\\nand\\tO\\nthe\\tO\\nhigh\\tO\\nincidence\\tO\\nof\\tO\\nsudden\\tB-Disease\\ndeath\\tI-Disease\\n,\\tO\\nhowever\\tO\\n,\\tO\\nmolecular\\tO\\ngenetic\\tO\\nstudies\\tO\\nof\\tO\\nIVF\\tB-Disease\\nhave\\tO\\nnot\\tO\\nyet\\tO\\nbeen\\tO\\ndone\\tO\\n.\\tO\\n\\nBecause\\tO\\nIVF\\tB-Disease\\ncauses\\tO\\ncardiac\\tO\\nrhythm\\tO\\ndisturbance\\tO\\n,\\tO\\nwe\\tO\\ninvestigated\\tO\\nwhether\\tO\\nmalfunction\\tO\\nof\\tO\\nion\\tO\\nchannels\\tO\\ncould\\tO\\ncause\\tO\\nthe\\tO\\ndisorder\\tO\\nby\\tO\\nstudying\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ncardiac\\tO\\nsodium\\tO\\nchannel\\tO\\ngene\\tO\\nSCN5A\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nnow\\tO\\nidentified\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\na\\tO\\nsplice\\tO\\n-\\tO\\ndonor\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\na\\tO\\nframeshift\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nSCN5A\\tO\\nin\\tO\\nthree\\tO\\nIVF\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nshow\\tO\\nthat\\tO\\nsodium\\tO\\nchannels\\tO\\nwith\\tO\\nthe\\tO\\nmissense\\tO\\nmutation\\tO\\nrecover\\tO\\nfrom\\tO\\ninactivation\\tO\\nmore\\tO\\nrapidly\\tO\\nthan\\tO\\nnormal\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\nframeshift\\tO\\nmutation\\tO\\ncauses\\tO\\nthe\\tO\\nsodium\\tO\\nchannel\\tO\\nto\\tO\\nbe\\tO\\nnon\\tO\\n-\\tO\\nfunctional\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nindicate\\tO\\nthat\\tO\\nmutations\\tO\\nin\\tO\\ncardiac\\tO\\nion\\tO\\n-\\tO\\nchannel\\tO\\ngenes\\tO\\ncontribute\\tO\\nto\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\ndeveloping\\tO\\nIVF\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nMolecular\\tO\\nheterogeneity\\tO\\nin\\tO\\nmucopolysaccharidosis\\tB-Disease\\nIVA\\tI-Disease\\nin\\tO\\nAustralia\\tO\\nand\\tO\\nNorthern\\tO\\nIreland\\tO\\n:\\tO\\nnine\\tO\\nnovel\\tO\\nmutations\\tO\\nincluding\\tO\\nT312S\\tO\\n,\\tO\\na\\tO\\ncommon\\tO\\nallele\\tO\\nthat\\tO\\nconfers\\tO\\na\\tO\\nmild\\tO\\nphenotype\\tO\\n.\\tO\\n\\nMucopolysaccharidosis\\tB-Disease\\nIVA\\tI-Disease\\n(\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nlysosomal\\tI-Disease\\nstorage\\tI-Disease\\ndisorder\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\nin\\tO\\nN\\tO\\n-\\tO\\nacetylgalactosamine\\tO\\n-\\tO\\n6\\tO\\n-\\tO\\nsulfate\\tO\\nsulfatase\\tO\\n(\\tO\\nGALNS\\tO\\n)\\tO\\n.\\tO\\n\\nPrevious\\tO\\nstudies\\tO\\nof\\tO\\npatients\\tO\\nfrom\\tO\\na\\tO\\nBritish\\tO\\n-\\tO\\nIrish\\tO\\npopulation\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nI113F\\tO\\nmutation\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nsingle\\tO\\nmutation\\tO\\namong\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\npatients\\tO\\nand\\tO\\nproduces\\tO\\na\\tO\\nsevere\\tO\\nclinical\\tO\\nphenotype\\tO\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nGALNS\\tO\\ngene\\tO\\nfrom\\tO\\n23\\tO\\nadditional\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\npatients\\tO\\n(\\tO\\n15\\tO\\nfrom\\tO\\nAustralia\\tO\\n,\\tO\\n8\\tO\\nfrom\\tO\\nNorthern\\tO\\nIreland\\tO\\n)\\tO\\n,\\tO\\nwith\\tO\\nvarious\\tO\\nclinical\\tO\\nphenotypes\\tO\\n(\\tO\\nsevere\\tO\\n,\\tO\\n16\\tO\\ncases\\tO\\n;\\tO\\nintermediate\\tO\\n,\\tO\\n4\\tO\\ncases\\tO\\n;\\tO\\nmild\\tO\\n,\\tO\\n3\\tO\\ncases\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\ntwo\\tO\\ncommon\\tO\\nmutations\\tO\\nthat\\tO\\ntogether\\tO\\naccounted\\tO\\nfor\\tO\\n32\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\n44\\tO\\nunrelated\\tO\\nalleles\\tO\\nin\\tO\\nthese\\tO\\npatients\\tO\\n.\\tO\\n\\nOne\\tO\\nis\\tO\\nthe\\tO\\nT312S\\tO\\nmutation\\tO\\n,\\tO\\na\\tO\\nnovel\\tO\\nmutation\\tO\\nfound\\tO\\nexclusively\\tO\\nin\\tO\\nmilder\\tO\\npatients\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nis\\tO\\nthe\\tO\\npreviously\\tO\\ndescribed\\tO\\nI113F\\tO\\nthat\\tO\\nproduces\\tO\\na\\tO\\nsevere\\tO\\nphenotype\\tO\\n.\\tO\\n\\nThe\\tO\\nI113F\\tO\\nand\\tO\\nT312S\\tO\\nmutations\\tO\\naccounted\\tO\\nfor\\tO\\n8\\tO\\n(\\tO\\n18\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\n6\\tO\\n(\\tO\\n14\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n44\\tO\\nunrelated\\tO\\nalleles\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nThe\\tO\\nrelatively\\tO\\nhigh\\tO\\nresidual\\tO\\nGALNS\\tO\\nactivity\\tO\\nseen\\tO\\nwhen\\tO\\nthe\\tO\\nT312S\\tO\\nmutant\\tO\\ncDNA\\tO\\nis\\tO\\noverexpressed\\tO\\nin\\tO\\nmutant\\tO\\ncells\\tO\\nprovides\\tO\\nan\\tO\\nexplanation\\tO\\nfor\\tO\\nthe\\tO\\nmild\\tO\\nphenotype\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nthis\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\ndistribution\\tO\\nand\\tO\\nrelative\\tO\\nfrequencies\\tO\\nof\\tO\\nthe\\tO\\nI113F\\tO\\nand\\tO\\nT312S\\tO\\nmutations\\tO\\nin\\tO\\nAustralia\\tO\\ncorresponded\\tO\\nto\\tO\\nthose\\tO\\nobserved\\tO\\nin\\tO\\nNorthern\\tO\\nIreland\\tO\\nand\\tO\\nare\\tO\\nunique\\tO\\nto\\tO\\nthese\\tO\\ntwo\\tO\\npopulations\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nboth\\tO\\nmutations\\tO\\nwere\\tO\\nprobably\\tO\\nintroduced\\tO\\nto\\tO\\nAustralia\\tO\\nby\\tO\\nIrish\\tO\\nmigrants\\tO\\nduring\\tO\\nthe\\tO\\n19th\\tO\\ncentury\\tO\\n.\\tO\\n\\nHaplotype\\tO\\nanalysis\\tO\\nusing\\tO\\n6\\tO\\nRFLPs\\tO\\nprovides\\tO\\nadditional\\tO\\ndata\\tO\\nthat\\tO\\nthe\\tO\\nI113F\\tO\\nmutation\\tO\\noriginated\\tO\\nfrom\\tO\\na\\tO\\ncommon\\tO\\nancestor\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\n9\\tO\\nnovel\\tO\\nmutations\\tO\\nidentified\\tO\\nin\\tO\\nthese\\tO\\n23\\tO\\npatients\\tO\\nwere\\tO\\neach\\tO\\nlimited\\tO\\nto\\tO\\na\\tO\\nsingle\\tO\\nfamily\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nprovide\\tO\\nfurther\\tO\\nevidence\\tO\\nfor\\tO\\nextensive\\tO\\nallelic\\tO\\nheterogeneity\\tO\\nin\\tO\\nMPS\\tB-Disease\\nIVA\\tI-Disease\\nin\\tO\\nBritish\\tO\\n-\\tO\\nIrish\\tO\\npatients\\tO\\nand\\tO\\nprovide\\tO\\nevidence\\tO\\nfor\\tO\\ntheir\\tO\\ntransmission\\tO\\nto\\tO\\nAustralia\\tO\\nby\\tO\\nBritish\\tO\\n-\\tO\\nIrish\\tO\\nmigrants\\tO\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nconstitutional\\tO\\nWT1\\tO\\nmutations\\tO\\n,\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nisolated\\tO\\ndiffuse\\tB-Disease\\nmesangial\\tI-Disease\\nsclerosis\\tI-Disease\\n,\\tO\\nand\\tO\\nanalysis\\tO\\nof\\tO\\ngenotype\\tO\\n/\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nby\\tO\\nuse\\tO\\nof\\tO\\na\\tO\\ncomputerized\\tO\\nmutation\\tO\\ndatabase\\tO\\n.\\tO\\n\\nConstitutional\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nWT1\\tO\\ngene\\tO\\n,\\tO\\nencoding\\tO\\na\\tO\\nzinc\\tO\\n-\\tO\\nfinger\\tO\\ntranscription\\tO\\nfactor\\tO\\ninvolved\\tO\\nin\\tO\\nrenal\\tO\\nand\\tO\\ngonadal\\tO\\ndevelopment\\tO\\n,\\tO\\nare\\tO\\nfound\\tO\\nin\\tO\\nmost\\tO\\npatients\\tO\\nwith\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nDDS\\tB-Disease\\n)\\tO\\n,\\tO\\nor\\tO\\ndiffuse\\tB-Disease\\nmesangial\\tI-Disease\\nsclerosis\\tI-Disease\\n(\\tO\\nDMS\\tB-Disease\\n)\\tO\\nassociated\\tO\\nwith\\tO\\npseudohermaphroditism\\tB-Disease\\nand\\tO\\n/\\tO\\nor\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\n(\\tO\\nWT\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nMost\\tO\\nmutations\\tO\\nin\\tO\\nDDS\\tB-Disease\\npatients\\tO\\nlie\\tO\\nin\\tO\\nexon\\tO\\n8\\tO\\nor\\tO\\nexon\\tO\\n9\\tO\\n,\\tO\\nencoding\\tO\\nzinc\\tO\\nfinger\\tO\\n2\\tO\\nor\\tO\\nzinc\\tO\\nfinger\\tO\\n3\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\nhot\\tO\\nspot\\tO\\n(\\tO\\nR394W\\tO\\n)\\tO\\nin\\tO\\nexon\\tO\\n9\\tO\\n.\\tO\\n\\nWe\\tO\\nanalyzed\\tO\\na\\tO\\nseries\\tO\\nof\\tO\\n24\\tO\\npatients\\tO\\n,\\tO\\n10\\tO\\nwith\\tO\\nisolated\\tB-Disease\\nDMS\\tI-Disease\\n(\\tO\\nIDMS\\tB-Disease\\n)\\tO\\n,\\tO\\n10\\tO\\nwith\\tO\\nDDS\\tB-Disease\\n,\\tO\\nand\\tO\\n4\\tO\\nwith\\tO\\nurogenital\\tB-Disease\\nabnormalities\\tI-Disease\\nand\\tO\\n/\\tO\\nor\\tO\\nWT\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nWT1\\tO\\nheterozygous\\tO\\nmutations\\tO\\nin\\tO\\n16\\tO\\npatients\\tO\\n,\\tO\\n4\\tO\\nof\\tO\\nwhom\\tO\\npresented\\tO\\nwith\\tO\\nIDMS\\tB-Disease\\n.\\tO\\n\\nOne\\tO\\nmale\\tO\\nand\\tO\\ntwo\\tO\\nfemale\\tO\\nIDMS\\tB-Disease\\npatients\\tO\\nwith\\tO\\nWT1\\tO\\nmutations\\tO\\nunderwent\\tO\\nnormal\\tO\\npuberty\\tO\\n.\\tO\\n\\nTwo\\tO\\nmutations\\tO\\nassociated\\tO\\nwith\\tO\\nIDMS\\tB-Disease\\nare\\tO\\ndifferent\\tO\\nfrom\\tO\\nthose\\tO\\ndescribed\\tO\\nin\\tO\\nDDS\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nNo\\tO\\nWT1\\tO\\nmutations\\tO\\nwere\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nsix\\tO\\nother\\tO\\nIDMS\\tB-Disease\\npatients\\tO\\n,\\tO\\nsuggesting\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\nof\\tO\\nthis\\tO\\ndisease\\tO\\n.\\tO\\n\\nWe\\tO\\nanalyzed\\tO\\ngenotype\\tO\\n/\\tO\\nphenotype\\tO\\ncorrelations\\tO\\n,\\tO\\non\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\nconstitution\\tO\\nof\\tO\\na\\tO\\nWT1\\tO\\nmutation\\tO\\ndatabase\\tO\\nof\\tO\\n84\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\n,\\tO\\nto\\tO\\ncompare\\tO\\nthe\\tO\\ndistribution\\tO\\nand\\tO\\ntype\\tO\\nof\\tO\\nmutations\\tO\\n,\\tO\\naccording\\tO\\nto\\tO\\nthe\\tO\\ndifferent\\tO\\nsymptoms\\tO\\n.\\tO\\n\\nThis\\tO\\ndemonstrated\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nthe\\tO\\nassociation\\tO\\nbetween\\tO\\nmutations\\tO\\nin\\tO\\nexons\\tO\\n8\\tO\\nand\\tO\\n9\\tO\\nand\\tO\\nDMS\\tB-Disease\\n;\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\namong\\tO\\npatients\\tO\\nwith\\tO\\nDMS\\tB-Disease\\n,\\tO\\na\\tO\\nhigher\\tO\\nfrequency\\tO\\nof\\tO\\nexon\\tO\\n8\\tO\\nmutations\\tO\\namong\\tO\\n46\\tO\\n,\\tO\\nXY\\tO\\npatients\\tO\\nwith\\tO\\nfemale\\tO\\nphenotype\\tO\\nthan\\tO\\namong\\tO\\n46\\tO\\n,\\tO\\nXY\\tO\\npatients\\tO\\nwith\\tO\\nsexual\\tO\\nambiguity\\tO\\nor\\tO\\nmale\\tO\\nphenotype\\tO\\n;\\tO\\nand\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\nstatistically\\tO\\nsignificant\\tO\\nevidence\\tO\\nthat\\tO\\nmutations\\tO\\nin\\tO\\nexons\\tO\\n8\\tO\\nand\\tO\\n9\\tO\\npreferentially\\tO\\naffect\\tO\\namino\\tO\\nacids\\tO\\nwith\\tO\\ndifferent\\tO\\nfunctions\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\n185delAG\\tO\\nBRCA1\\tO\\nmutation\\tO\\noriginated\\tO\\nbefore\\tO\\nthe\\tO\\ndispersion\\tO\\nof\\tO\\nJews\\tO\\nin\\tO\\nthe\\tO\\ndiaspora\\tO\\nand\\tO\\nis\\tO\\nnot\\tO\\nlimited\\tO\\nto\\tO\\nAshkenazim\\tO\\n.\\tO\\n\\nThe\\tO\\n185delAG\\tO\\nmutation\\tO\\nin\\tO\\nBRCA1\\tO\\nis\\tO\\ndetected\\tO\\nin\\tO\\nAshkenazi\\tO\\nJews\\tO\\nboth\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\nin\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\n.\\tO\\n\\nAll\\tO\\ntested\\tO\\nAshkenazi\\tO\\nmutation\\tO\\ncarriers\\tO\\nshare\\tO\\nthe\\tO\\nsame\\tO\\nallelic\\tO\\npattern\\tO\\nat\\tO\\nthe\\tO\\nBRCA1\\tO\\nlocus\\tO\\n.\\tO\\n\\nOur\\tO\\nprevious\\tO\\nstudy\\tO\\nshowed\\tO\\nthat\\tO\\nthis\\tO\\nAshkenazi\\tO\\nmutation\\tO\\nalso\\tO\\noccurs\\tO\\nin\\tO\\nIraqi\\tO\\nJews\\tO\\nwith\\tO\\na\\tO\\nsimilar\\tO\\nallelic\\tO\\npattern\\tO\\n.\\tO\\n\\nWe\\tO\\nextended\\tO\\nour\\tO\\nanalysis\\tO\\nto\\tO\\nother\\tO\\nnon\\tO\\n-\\tO\\nAshkenazi\\tO\\nsubsets\\tO\\n354\\tO\\nof\\tO\\nMoroccan\\tO\\norigin\\tO\\n,\\tO\\n200\\tO\\nYemenites\\tO\\nand\\tO\\n150\\tO\\nIranian\\tO\\nJews\\tO\\n.\\tO\\n\\nHeteroduplex\\tO\\nanalysis\\tO\\ncomplemented\\tO\\nby\\tO\\ndirect\\tO\\nDNA\\tO\\nsequencing\\tO\\nof\\tO\\nabnormally\\tO\\nmigrating\\tO\\nbands\\tO\\nwere\\tO\\nemployed\\tO\\n.\\tO\\n\\nFour\\tO\\nof\\tO\\nMoroccan\\tO\\norigin\\tO\\n(\\tO\\n1\\tO\\n.\\tO\\n1\\tO\\n%\\tO\\n)\\tO\\nand\\tO\\nnone\\tO\\nof\\tO\\nthe\\tO\\nYemenites\\tO\\nor\\tO\\nIranians\\tO\\nwas\\tO\\na\\tO\\ncarrier\\tO\\nof\\tO\\nthe\\tO\\n185delAG\\tO\\nmutation\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nallelic\\tO\\npatterns\\tO\\nwere\\tO\\ndetermined\\tO\\nfor\\tO\\nfour\\tO\\nof\\tO\\nthese\\tO\\nindividuals\\tO\\nand\\tO\\nfor\\tO\\n12\\tO\\nadditional\\tO\\nnon\\tO\\n-\\tO\\nAshkenazi\\tO\\n185delAG\\tO\\nmutation\\tO\\ncarriers\\tO\\nwho\\tO\\nhad\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nSix\\tO\\nnon\\tO\\n-\\tO\\nAshkenazi\\tO\\nindividuals\\tO\\nshared\\tO\\nthe\\tO\\ncommon\\tO\\nAshkenazi\\tO\\nhaplotype\\tO\\n,\\tO\\nfour\\tO\\nhad\\tO\\na\\tO\\nclosely\\tO\\nrelated\\tO\\npattern\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nrest\\tO\\n(\\tO\\nn\\tO\\n=\\tO\\n6\\tO\\n)\\tO\\ndisplayed\\tO\\na\\tO\\ndistinct\\tO\\nBRCA1\\tO\\nallelic\\tO\\npattern\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\n185delAG\\tO\\nBRCA1\\tO\\nmutation\\tO\\noccurs\\tO\\nin\\tO\\nsome\\tO\\nnon\\tO\\n-\\tO\\nAshkenazi\\tO\\npopulations\\tO\\nat\\tO\\nrates\\tO\\ncomparable\\tO\\nwith\\tO\\nthat\\tO\\nof\\tO\\nAshkenazim\\tO\\n.\\tO\\n\\nThe\\tO\\nmajority\\tO\\nof\\tO\\nJewish\\tO\\n185delAG\\tO\\nmutation\\tO\\ncarriers\\tO\\nhave\\tO\\na\\tO\\ncommon\\tO\\nallelic\\tO\\npattern\\tO\\n,\\tO\\nsupporting\\tO\\nthe\\tO\\nfounder\\tO\\neffect\\tO\\nnotion\\tO\\n,\\tO\\nbut\\tO\\ndating\\tO\\nthe\\tO\\nmutations\\tO\\norigin\\tO\\nto\\tO\\nan\\tO\\nearlier\\tO\\ndate\\tO\\nthan\\tO\\ncurrently\\tO\\nestimated\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nthe\\tO\\ndifferent\\tO\\nallelic\\tO\\npattern\\tO\\nat\\tO\\nthe\\tO\\nBRCA1\\tO\\nlocus\\tO\\neven\\tO\\nin\\tO\\nsome\\tO\\nJewish\\tO\\nmutation\\tO\\ncarriers\\tO\\n,\\tO\\nmight\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\narose\\tO\\nindependently\\tO\\n.\\tO\\n.\\tO\\n\\nCrystal\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\nhemochromatosis\\tB-Disease\\nprotein\\tO\\nHFE\\tO\\nand\\tO\\ncharacterization\\tO\\nof\\tO\\nits\\tO\\ninteraction\\tO\\nwith\\tO\\ntransferrin\\tO\\nreceptor\\tO\\n.\\tO\\n\\nHFE\\tO\\nis\\tO\\nan\\tO\\nMHC\\tO\\n-\\tO\\nrelated\\tO\\nprotein\\tO\\nthat\\tO\\nis\\tO\\nmutated\\tO\\nin\\tO\\nthe\\tO\\niron\\tB-Disease\\n-\\tI-Disease\\noverload\\tI-Disease\\ndisease\\tI-Disease\\nhereditary\\tB-Disease\\nhemochromatosis\\tI-Disease\\n.\\tO\\n\\nHFE\\tO\\nbinds\\tO\\nto\\tO\\ntransferrin\\tO\\nreceptor\\tO\\n(\\tO\\nTfR\\tO\\n)\\tO\\nand\\tO\\nreduces\\tO\\nits\\tO\\naffinity\\tO\\nfor\\tO\\niron\\tO\\n-\\tO\\nloaded\\tO\\ntransferrin\\tO\\n,\\tO\\nimplicating\\tO\\nHFE\\tO\\nin\\tO\\niron\\tO\\nmetabolism\\tO\\n.\\tO\\n\\nThe\\tO\\n2\\tO\\n.\\tO\\n\\n6\\tO\\nA\\tO\\ncrystal\\tO\\nstructure\\tO\\nof\\tO\\nHFE\\tO\\nreveals\\tO\\nthe\\tO\\nlocations\\tO\\nof\\tO\\nhemochromatosis\\tB-Disease\\nmutations\\tO\\nand\\tO\\na\\tO\\npatch\\tO\\nof\\tO\\nhistidines\\tO\\nthat\\tO\\ncould\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\npH\\tO\\n-\\tO\\ndependent\\tO\\ninteractions\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\ndemonstrate\\tO\\nthat\\tO\\nsoluble\\tO\\nTfR\\tO\\nand\\tO\\nHFE\\tO\\nbind\\tO\\ntightly\\tO\\nat\\tO\\nthe\\tO\\nbasic\\tO\\npH\\tO\\nof\\tO\\nthe\\tO\\ncell\\tO\\nsurface\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nat\\tO\\nthe\\tO\\nacidic\\tO\\npH\\tO\\nof\\tO\\nintracellular\\tO\\nvesicles\\tO\\n.\\tO\\n\\nTfR\\tO\\nHFE\\tO\\nstoichiometry\\tO\\n(\\tO\\n2\\tO\\n1\\tO\\n)\\tO\\ndiffers\\tO\\nfrom\\tO\\nTfR\\tO\\ntransferrin\\tO\\nstoichiometry\\tO\\n(\\tO\\n2\\tO\\n2\\tO\\n)\\tO\\n,\\tO\\nimplying\\tO\\na\\tO\\ndifferent\\tO\\nmode\\tO\\nof\\tO\\nbinding\\tO\\nfor\\tO\\nHFE\\tO\\nand\\tO\\ntransferrin\\tO\\nto\\tO\\nTfR\\tO\\n,\\tO\\nconsistent\\tO\\nwith\\tO\\nour\\tO\\ndemonstration\\tO\\nthat\\tO\\nHFE\\tO\\n,\\tO\\ntransferrin\\tO\\n,\\tO\\nand\\tO\\nTfR\\tO\\nform\\tO\\na\\tO\\nternary\\tO\\ncomplex\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\nthree\\tO\\nnovel\\tO\\nmutations\\tO\\nand\\tO\\na\\tO\\nhigh\\tO\\nfrequency\\tO\\nof\\tO\\nthe\\tO\\nArg778Leu\\tO\\nmutation\\tO\\nin\\tO\\nKorean\\tO\\npatients\\tO\\nwith\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nFour\\tO\\nmutations\\tO\\n-\\tO\\n-\\tO\\nR778L\\tO\\n,\\tO\\nA874V\\tO\\n,\\tO\\nL1083F\\tO\\n,\\tO\\nand\\tO\\n2304delC\\tO\\n-\\tO\\n-\\tO\\nin\\tO\\nthe\\tO\\ncopper\\tO\\n-\\tO\\ntransporting\\tO\\nenzyme\\tO\\n,\\tO\\nP\\tO\\n-\\tO\\ntype\\tO\\nATPase\\tO\\n(\\tO\\nATP7B\\tO\\n)\\tO\\n,\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nKorean\\tO\\nPatients\\tO\\nwith\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nArg778Leu\\tO\\n,\\tO\\nthe\\tO\\nmost\\tO\\nfrequently\\tO\\nreported\\tO\\nmutation\\tO\\nof\\tO\\nthis\\tO\\nenzyme\\tO\\n,\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\nsix\\tO\\nof\\tO\\neight\\tO\\nunrelated\\tO\\npatients\\tO\\nstudied\\tO\\n,\\tO\\nan\\tO\\nallele\\tO\\nfrequency\\tO\\nof\\tO\\n37\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nconsiderably\\tO\\nhigher\\tO\\nthan\\tO\\nthose\\tO\\nin\\tO\\nother\\tO\\nAsian\\tO\\npopulations\\tO\\n.\\tO\\n\\nThe\\tO\\nnovel\\tO\\nsingle\\tO\\nnucleotide\\tO\\ndeletion\\tO\\n,\\tO\\n2304delC\\tO\\n,\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\none\\tO\\npatient\\tO\\n.\\tO\\n\\nSince\\tO\\na\\tO\\nmutation\\tO\\nat\\tO\\ncDNA\\tO\\nnucleotide\\tO\\n2302\\tO\\n(\\tO\\n2302insC\\tO\\n)\\tO\\nhad\\tO\\nbeen\\tO\\npreviously\\tO\\ndescribed\\tO\\n,\\tO\\nthis\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nATP7B\\tO\\ngene\\tO\\nmay\\tO\\nbe\\tO\\nsusceptible\\tO\\nto\\tO\\ngene\\tO\\nrearrangements\\tO\\ncausing\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nDisruption\\tO\\nof\\tO\\nsplicing\\tO\\nregulated\\tO\\nby\\tO\\na\\tO\\nCUG\\tO\\n-\\tO\\nbinding\\tO\\nprotein\\tO\\nin\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\nCTG\\tO\\nexpansion\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nuntranslated\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nOne\\tO\\nmodel\\tO\\nof\\tO\\nDM\\tB-Disease\\npathogenesis\\tO\\nsuggests\\tO\\nthat\\tO\\nRNAs\\tO\\nfrom\\tO\\nthe\\tO\\nexpanded\\tO\\nallele\\tO\\ncreate\\tO\\na\\tO\\ngain\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\nfunction\\tO\\nmutation\\tO\\nby\\tO\\nthe\\tO\\ninappropriate\\tO\\nbinding\\tO\\nof\\tO\\nproteins\\tO\\nto\\tO\\nthe\\tO\\nCUG\\tO\\nrepeats\\tO\\n.\\tO\\n\\nData\\tO\\npresented\\tO\\nhere\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nconserved\\tO\\nheterogeneous\\tO\\nnuclear\\tO\\nribonucleoprotein\\tO\\n,\\tO\\nCUG\\tO\\n-\\tO\\nbinding\\tO\\nprotein\\tO\\n(\\tO\\nCUG\\tO\\n-\\tO\\nBP\\tO\\n)\\tO\\n,\\tO\\nmay\\tO\\nmediate\\tO\\nthe\\tO\\ntrans\\tO\\n-\\tO\\ndominant\\tO\\neffect\\tO\\nof\\tO\\nthe\\tO\\nRNA\\tO\\n.\\tO\\n\\nCUG\\tO\\n-\\tO\\nBP\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbind\\tO\\nto\\tO\\nthe\\tO\\nhuman\\tO\\ncardiac\\tO\\ntroponin\\tO\\nT\\tO\\n(\\tO\\ncTNT\\tO\\n)\\tO\\npre\\tO\\n-\\tO\\nmessenger\\tO\\nRNA\\tO\\nand\\tO\\nregulate\\tO\\nits\\tO\\nalternative\\tO\\nsplicing\\tO\\n.\\tO\\n\\nSplicing\\tO\\nof\\tO\\ncTNT\\tO\\nwas\\tO\\ndisrupted\\tO\\nin\\tO\\nDM\\tB-Disease\\nstriated\\tO\\nmuscle\\tO\\nand\\tO\\nin\\tO\\nnormal\\tO\\ncells\\tO\\nexpressing\\tO\\ntranscripts\\tO\\nthat\\tO\\ncontain\\tO\\nCUG\\tO\\nrepeats\\tO\\n.\\tO\\n\\nAltered\\tO\\nexpression\\tO\\nof\\tO\\ngenes\\tO\\nregulated\\tO\\nposttranscriptionally\\tO\\nby\\tO\\nCUG\\tO\\n-\\tO\\nBP\\tO\\ntherefore\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\nDM\\tB-Disease\\npathogenesis\\tO\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\nnonsense\\tO\\nmutation\\tO\\nand\\tO\\na\\tO\\nmissense\\tO\\nsubstitution\\tO\\nin\\tO\\nthe\\tO\\nvasopressin\\tO\\n-\\tO\\nneurophysin\\tO\\nII\\tO\\ngene\\tO\\nin\\tO\\ntwo\\tO\\nSpanish\\tO\\nkindreds\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\nneurohypophyseal\\tI-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\n.\\tO\\n\\nFamilial\\tB-Disease\\nneurohypophyseal\\tI-Disease\\ndiabetes\\tI-Disease\\ninsipidus\\tI-Disease\\n(\\tO\\nFNDI\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisease\\tI-Disease\\ncaused\\tO\\nby\\tO\\ndeficiency\\tO\\nin\\tO\\nthe\\tO\\nantidiuretic\\tO\\nhormone\\tO\\narginine\\tO\\nvasopressin\\tO\\n(\\tO\\nAVP\\tO\\n)\\tO\\nencoded\\tO\\nby\\tO\\nthe\\tO\\nAVP\\tO\\n-\\tO\\nneurophysin\\tO\\nII\\tO\\n(\\tO\\nAVP\\tO\\n-\\tO\\nNPII\\tO\\n)\\tO\\ngene\\tO\\non\\tO\\nchromosome\\tO\\n20p13\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nanalyzed\\tO\\ntwo\\tO\\nfamilies\\tO\\nwith\\tO\\nFNDI\\tB-Disease\\nusing\\tO\\ndirect\\tO\\nautomated\\tO\\nfluorescent\\tO\\n,\\tO\\nsolid\\tO\\nphase\\tO\\n,\\tO\\nsingle\\tO\\n-\\tO\\nstranded\\tO\\nDNA\\tO\\nsequencing\\tO\\nof\\tO\\nPCR\\tO\\n-\\tO\\namplified\\tO\\nAVP\\tO\\n-\\tO\\nNPII\\tO\\nDNA\\tO\\n.\\tO\\n\\nIn\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nfamilies\\tO\\n,\\tO\\naffected\\tO\\nindividuals\\tO\\npresented\\tO\\na\\tO\\nnovel\\tO\\nnonsense\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nconsisting\\tO\\nin\\tO\\na\\tO\\nG\\tO\\nto\\tO\\nT\\tO\\ntransition\\tO\\nat\\tO\\nnucleotide\\tO\\n2101\\tO\\n,\\tO\\nwhich\\tO\\nproduces\\tO\\na\\tO\\nstop\\tO\\nsignal\\tO\\nin\\tO\\ncodon\\tO\\n82\\tO\\n(\\tO\\nGlu\\tO\\n)\\tO\\nof\\tO\\nNPII\\tO\\n.\\tO\\n\\nThe\\tO\\npremature\\tO\\ntermination\\tO\\neliminates\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\ndomain\\tO\\nof\\tO\\nNPII\\tO\\n,\\tO\\nincluding\\tO\\na\\tO\\ncysteine\\tO\\nresidue\\tO\\nin\\tO\\nposition\\tO\\n85\\tO\\n,\\tO\\nwhich\\tO\\ncould\\tO\\nbe\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\ncorrect\\tO\\nfolding\\tO\\nof\\tO\\nthe\\tO\\nprohormone\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nsecond\\tO\\nfamily\\tO\\n,\\tO\\na\\tO\\nG279A\\tO\\nsubstitution\\tO\\nat\\tO\\nposition\\tO\\n-\\tO\\n1\\tO\\nof\\tO\\nthe\\tO\\nsignal\\tO\\npeptide\\tO\\nwas\\tO\\nobserved\\tO\\nin\\tO\\nall\\tO\\naffected\\tO\\nindividuals\\tO\\n.\\tO\\n\\nThis\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\nwhich\\tO\\nreplaces\\tO\\nAla\\tO\\nwith\\tO\\nThr\\tO\\n,\\tO\\nis\\tO\\nfrequent\\tO\\namong\\tO\\nFNDI\\tB-Disease\\npatients\\tO\\nand\\tO\\nis\\tO\\nthought\\tO\\nto\\tO\\nreduce\\tO\\nthe\\tO\\nefficiency\\tO\\nof\\tO\\ncleavage\\tO\\nby\\tO\\nsignal\\tO\\npeptidases\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nheterogeneity\\tO\\nof\\tO\\nSaethre\\tB-Disease\\n-\\tI-Disease\\nChotzen\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\ndue\\tO\\nto\\tO\\nTWIST\\tO\\nand\\tO\\nFGFR\\tO\\nmutations\\tO\\n.\\tO\\n\\nThirty\\tO\\n-\\tO\\ntwo\\tO\\nunrelated\\tO\\npatients\\tO\\nwith\\tO\\nfeatures\\tO\\nof\\tO\\nSaethre\\tB-Disease\\n-\\tI-Disease\\nChotzen\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\na\\tO\\ncommon\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ncondition\\tI-Disease\\nof\\tO\\ncraniosynostosis\\tB-Disease\\nand\\tO\\nlimb\\tB-Disease\\nanomalies\\tI-Disease\\n,\\tO\\nwere\\tO\\nscreened\\tO\\nfor\\tO\\nmutations\\tO\\nin\\tO\\nTWIST\\tO\\n,\\tO\\nFGFR2\\tO\\n,\\tO\\nand\\tO\\nFGFR3\\tO\\n.\\tO\\n\\nNine\\tO\\nnovel\\tO\\nand\\tO\\nthree\\tO\\nrecurrent\\tO\\nTWIST\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\n12\\tO\\nfamilies\\tO\\n.\\tO\\n\\nSeven\\tO\\nfamilies\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nthe\\tO\\nFGFR3\\tO\\nP250R\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\none\\tO\\nindividual\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\nan\\tO\\nFGFR2\\tO\\nVV269\\tO\\n-\\tO\\n270\\tO\\ndeletion\\tO\\n.\\tO\\n\\nTo\\tO\\ndate\\tO\\n,\\tO\\nour\\tO\\ndetection\\tO\\nrate\\tO\\nfor\\tO\\nTWIST\\tO\\nor\\tO\\nFGFR\\tO\\nmutations\\tO\\nis\\tO\\n68\\tO\\n%\\tO\\nin\\tO\\nour\\tO\\nSaethre\\tB-Disease\\n-\\tI-Disease\\nChotzen\\tI-Disease\\nsyndrome\\tI-Disease\\npatients\\tO\\n,\\tO\\nincluding\\tO\\nour\\tO\\nfive\\tO\\npatients\\tO\\nelsewhere\\tO\\nreported\\tO\\nwith\\tO\\nTWIST\\tO\\nmutations\\tO\\n.\\tO\\n\\nMore\\tO\\nthan\\tO\\n35\\tO\\ndifferent\\tO\\nTWIST\\tO\\nmutations\\tO\\nare\\tO\\nnow\\tO\\nknown\\tO\\nin\\tO\\nthe\\tO\\nliterature\\tO\\n.\\tO\\n\\nThe\\tO\\nmost\\tO\\ncommon\\tO\\nphenotypic\\tO\\nfeatures\\tO\\n,\\tO\\npresent\\tO\\nin\\tO\\nmore\\tO\\nthan\\tO\\na\\tO\\nthird\\tO\\nof\\tO\\nour\\tO\\npatients\\tO\\nwith\\tO\\nTWIST\\tO\\nmutations\\tO\\n,\\tO\\nare\\tO\\ncoronal\\tB-Disease\\nsynostosis\\tI-Disease\\n,\\tO\\nbrachycephaly\\tB-Disease\\n,\\tO\\nlow\\tB-Disease\\nfrontal\\tI-Disease\\nhairline\\tI-Disease\\n,\\tO\\nfacial\\tB-Disease\\nasymmetry\\tI-Disease\\n,\\tO\\nptosis\\tB-Disease\\n,\\tO\\nhypertelorism\\tB-Disease\\n,\\tO\\nbroad\\tB-Disease\\ngreat\\tI-Disease\\ntoes\\tI-Disease\\n,\\tO\\nand\\tO\\nclinodactyly\\tB-Disease\\n.\\tO\\n\\nSignificant\\tO\\nintra\\tO\\n-\\tO\\nand\\tO\\ninterfamilial\\tO\\nphenotypic\\tO\\nvariability\\tO\\nis\\tO\\npresent\\tO\\nfor\\tO\\neither\\tO\\nTWIST\\tO\\nmutations\\tO\\nor\\tO\\nFGFR\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\noverlap\\tO\\nin\\tO\\nclinical\\tO\\nfeatures\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nsame\\tO\\ngenes\\tO\\n,\\tO\\nof\\tO\\nmutations\\tO\\nfor\\tO\\nmore\\tO\\nthan\\tO\\none\\tO\\ncraniosynostotic\\tB-Disease\\ncondition\\tI-Disease\\n-\\tO\\nsuch\\tO\\nas\\tO\\nSaethre\\tB-Disease\\n-\\tI-Disease\\nChotzen\\tI-Disease\\n,\\tI-Disease\\nCrouzon\\tI-Disease\\n,\\tI-Disease\\nand\\tI-Disease\\nPfeiffer\\tI-Disease\\nsyndromes\\tI-Disease\\n-\\tO\\nsupport\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nTWIST\\tO\\nand\\tO\\nFGFRs\\tO\\nare\\tO\\ncomponents\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\nmolecular\\tO\\npathway\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nmodulation\\tO\\nof\\tO\\ncraniofacial\\tO\\nand\\tO\\nlimb\\tO\\ndevelopment\\tO\\nin\\tO\\nhumans\\tO\\n.\\tO\\n.\\tO\\n\\nMutation\\tO\\nanalysis\\tO\\nof\\tO\\nUBE3A\\tO\\nin\\tO\\nAngelman\\tB-Disease\\nsyndrome\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nAngelman\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nAS\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nchromosome\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\ndeletions\\tO\\nof\\tO\\nmaternal\\tO\\norigin\\tO\\n,\\tO\\nby\\tO\\npaternal\\tO\\nuniparental\\tB-Disease\\ndisomy\\tI-Disease\\n(\\tO\\nUPD\\tB-Disease\\n)\\tO\\n15\\tO\\n,\\tO\\nby\\tO\\nimprinting\\tO\\ndefects\\tO\\n,\\tO\\nand\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nUBE3A\\tO\\ngene\\tO\\n.\\tO\\n\\nUBE3A\\tO\\nencodes\\tO\\na\\tO\\nubiquitin\\tO\\n-\\tO\\nprotein\\tO\\nligase\\tO\\nand\\tO\\nshows\\tO\\nbrain\\tO\\n-\\tO\\nspecific\\tO\\nimprinting\\tO\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\ndescribe\\tO\\nUBE3A\\tO\\ncoding\\tO\\n-\\tO\\nregion\\tO\\nmutations\\tO\\ndetected\\tO\\nby\\tO\\nSSCP\\tO\\nanalysis\\tO\\nin\\tO\\n13\\tO\\nAS\\tB-Disease\\nindividuals\\tO\\nor\\tO\\nfamilies\\tO\\n.\\tO\\n\\nTwo\\tO\\nidentical\\tO\\nde\\tO\\nnovo\\tO\\n5\\tO\\n-\\tO\\nbp\\tO\\nduplications\\tO\\nin\\tO\\nexon\\tO\\n16\\tO\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nAmong\\tO\\nthe\\tO\\nother\\tO\\n11\\tO\\nunique\\tO\\nmutations\\tO\\n,\\tO\\n8\\tO\\nwere\\tO\\nsmall\\tO\\ndeletions\\tO\\nor\\tO\\ninsertions\\tO\\npredicted\\tO\\nto\\tO\\ncause\\tO\\nframeshifts\\tO\\n,\\tO\\n1\\tO\\nwas\\tO\\na\\tO\\nmutation\\tO\\nto\\tO\\na\\tO\\nstop\\tO\\ncodon\\tO\\n,\\tO\\n1\\tO\\nwas\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\n,\\tO\\nand\\tO\\n1\\tO\\nwas\\tO\\npredicted\\tO\\nto\\tO\\ncause\\tO\\ninsertion\\tO\\nof\\tO\\nan\\tO\\nisoleucine\\tO\\nin\\tO\\nthe\\tO\\nhect\\tO\\ndomain\\tO\\nof\\tO\\nthe\\tO\\nUBE3A\\tO\\nprotein\\tO\\n,\\tO\\nwhich\\tO\\nfunctions\\tO\\nin\\tO\\nE2\\tO\\nbinding\\tO\\nand\\tO\\nubiquitin\\tO\\ntransfer\\tO\\n.\\tO\\n\\nEight\\tO\\nof\\tO\\nthe\\tO\\ncases\\tO\\nwere\\tO\\nfamilial\\tO\\n,\\tO\\nand\\tO\\nfive\\tO\\nwere\\tO\\nsporadic\\tO\\n.\\tO\\n\\nIn\\tO\\ntwo\\tO\\nfamilial\\tO\\ncases\\tO\\nand\\tO\\none\\tO\\nsporadic\\tO\\ncase\\tO\\n,\\tO\\nmosaicism\\tO\\nfor\\tO\\nUBE3A\\tO\\nmutations\\tO\\nwas\\tO\\ndetected\\tO\\nin\\tO\\nthe\\tO\\nmother\\tO\\nof\\tO\\nthree\\tO\\nAS\\tB-Disease\\nsons\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nmaternal\\tO\\ngrandfather\\tO\\nof\\tO\\ntwo\\tO\\nAS\\tB-Disease\\nfirst\\tO\\ncousins\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\nthe\\tO\\nmother\\tO\\nof\\tO\\nan\\tO\\nAS\\tB-Disease\\ndaughter\\tO\\n.\\tO\\n\\nThe\\tO\\nfrequencies\\tO\\nwith\\tO\\nwhich\\tO\\nwe\\tO\\ndetected\\tO\\nmutations\\tO\\nwere\\tO\\n5\\tO\\n(\\tO\\n14\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n35\\tO\\nin\\tO\\nsporadic\\tO\\ncases\\tO\\nand\\tO\\n8\\tO\\n(\\tO\\n80\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n10\\tO\\nin\\tO\\nfamilial\\tO\\ncases\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nhemochromatosis\\tB-Disease\\n845\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\nand\\tO\\n187\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\nmutations\\tO\\n:\\tO\\nprevalence\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nCaucasian\\tO\\npopulations\\tO\\n.\\tO\\n\\nHemochromatosis\\tB-Disease\\n,\\tO\\nthe\\tO\\ninherited\\tB-Disease\\ndisorder\\tI-Disease\\nof\\tI-Disease\\niron\\tI-Disease\\nmetabolism\\tI-Disease\\n,\\tO\\nleads\\tO\\n,\\tO\\nif\\tO\\nuntreated\\tO\\n,\\tO\\nto\\tO\\nprogressive\\tO\\niron\\tB-Disease\\noverload\\tI-Disease\\nand\\tO\\npremature\\tB-Disease\\ndeath\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nhemochromatosis\\tB-Disease\\ngene\\tO\\n,\\tO\\nHFE\\tO\\n,\\tO\\nrecently\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\n,\\tO\\nand\\tO\\ncharacterization\\tO\\nof\\tO\\nthis\\tO\\ngene\\tO\\nhas\\tO\\nshown\\tO\\nthat\\tO\\nit\\tO\\ncontains\\tO\\ntwo\\tO\\nmutations\\tO\\nthat\\tO\\nresult\\tO\\nin\\tO\\namino\\tO\\nacid\\tO\\nsubstitutions\\tO\\n-\\tO\\ncDNA\\tO\\nnucleotides\\tO\\n845\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\n(\\tO\\nC282Y\\tO\\n)\\tO\\nand\\tO\\n187\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\n(\\tO\\nH63D\\tO\\n)\\tO\\n.\\tO\\n\\nAlthough\\tO\\nhemochromatosis\\tB-Disease\\nis\\tO\\ncommon\\tO\\nin\\tO\\nCaucasians\\tO\\n,\\tO\\naffecting\\tO\\n>\\tO\\n=\\tO\\n1\\tO\\n/\\tO\\n300\\tO\\nindividuals\\tO\\nof\\tO\\nnorthern\\tO\\nEuropean\\tO\\norigin\\tO\\n,\\tO\\nit\\tO\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\nrecognized\\tO\\nin\\tO\\nother\\tO\\npopulations\\tO\\n.\\tO\\n\\nThe\\tO\\npresent\\tO\\nstudy\\tO\\nused\\tO\\nPCR\\tO\\nand\\tO\\nrestriction\\tO\\n-\\tO\\nenzyme\\tO\\ndigestion\\tO\\nto\\tO\\nanalyze\\tO\\nthe\\tO\\nfrequency\\tO\\nof\\tO\\nthe\\tO\\n845\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\nand\\tO\\n187\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\nmutations\\tO\\nin\\tO\\nHLA\\tO\\n-\\tO\\ntyped\\tO\\nsamples\\tO\\nfrom\\tO\\nnon\\tO\\n-\\tO\\nCaucasian\\tO\\npopulations\\tO\\n,\\tO\\ncomprising\\tO\\nAustralian\\tO\\nAboriginal\\tO\\n,\\tO\\nChinese\\tO\\n,\\tO\\nand\\tO\\nPacific\\tO\\nIslanders\\tO\\n.\\tO\\n\\nResults\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\n845\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\nmutation\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\nthese\\tO\\npopulations\\tO\\n(\\tO\\nallele\\tO\\nfrequency\\tO\\n0\\tO\\n.\\tO\\n32\\tO\\n%\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\n,\\tO\\nfurthermore\\tO\\n,\\tO\\nit\\tO\\nwas\\tO\\nalways\\tO\\nseen\\tO\\nin\\tO\\nconjunction\\tO\\nwith\\tO\\nHLA\\tO\\nhaplotypes\\tO\\ncommon\\tO\\nin\\tO\\nCaucasians\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\n845\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\nmay\\tO\\nhave\\tO\\nbeen\\tO\\nintroduced\\tO\\ninto\\tO\\nthese\\tO\\npopulations\\tO\\nby\\tO\\nCaucasian\\tO\\nadmixture\\tO\\n.\\tO\\n\\n187\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\nwas\\tO\\npresent\\tO\\nat\\tO\\nan\\tO\\nallele\\tO\\nfrequency\\tO\\nof\\tO\\n2\\tO\\n.\\tO\\n\\n68\\tO\\n%\\tO\\nin\\tO\\nthe\\tO\\ntwo\\tO\\npopulations\\tO\\nanalyzed\\tO\\n(\\tO\\nAustralian\\tO\\nAboriginal\\tO\\nand\\tO\\nChinese\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nAustralian\\tO\\nAboriginal\\tO\\nsamples\\tO\\n,\\tO\\n187\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nassociated\\tO\\nwith\\tO\\nHLA\\tO\\nhaplotypes\\tO\\ncommon\\tO\\nin\\tO\\nCaucasians\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nit\\tO\\nwas\\tO\\nintroduced\\tO\\nby\\tO\\nrecent\\tO\\nadmixture\\tO\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\nChinese\\tO\\nsamples\\tO\\nanalyzed\\tO\\n,\\tO\\n187\\tO\\nC\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nG\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\na\\tO\\nwide\\tO\\nvariety\\tO\\nof\\tO\\nHLA\\tO\\nhaplotypes\\tO\\n,\\tO\\nshowing\\tO\\nthis\\tO\\nmutation\\tO\\nto\\tO\\nbe\\tO\\nwidespread\\tO\\nand\\tO\\nlikely\\tO\\nto\\tO\\npredate\\tO\\nthe\\tO\\nmore\\tO\\ngenetically\\tO\\nrestricted\\tO\\n845\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\nmutation\\tO\\n.\\tO\\n\\nGenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nin\\tO\\nattenuated\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n.\\tO\\n\\nGerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\nAPC\\tO\\nare\\tO\\nimplicated\\tO\\nin\\tO\\nattenuated\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAAPC\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nvariant\\tO\\nof\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nAAPC\\tB-Disease\\nis\\tO\\nrecognized\\tO\\nby\\tO\\nthe\\tO\\noccurrence\\tO\\nof\\tO\\n<\\tO\\n100\\tO\\ncolonic\\tB-Disease\\nadenomas\\tI-Disease\\nand\\tO\\na\\tO\\nlater\\tO\\nonset\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n(\\tO\\nage\\tO\\n>\\tO\\n40\\tO\\nyears\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\naim\\tO\\nof\\tO\\nthis\\tO\\nstudy\\tO\\nwas\\tO\\nto\\tO\\nassess\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nin\\tO\\nAAPC\\tB-Disease\\nfamilies\\tO\\n.\\tO\\n\\nBy\\tO\\nprotein\\tO\\n-\\tO\\ntruncation\\tO\\ntest\\tO\\n(\\tO\\nPTT\\tO\\n)\\tO\\nassay\\tO\\n,\\tO\\nthe\\tO\\nentire\\tO\\ncoding\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nwas\\tO\\nscreened\\tO\\nin\\tO\\naffected\\tO\\nindividuals\\tO\\nfrom\\tO\\n11\\tO\\nAAPC\\tB-Disease\\nkindreds\\tO\\n,\\tO\\nand\\tO\\ntheir\\tO\\nphenotypic\\tO\\ndifferences\\tO\\nwere\\tO\\nexamined\\tO\\n.\\tO\\n\\nFive\\tO\\nnovel\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nseven\\tO\\nkindreds\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\nlocated\\tO\\nin\\tO\\nthree\\tO\\ndifferent\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n(\\tO\\n1\\tO\\n)\\tO\\nat\\tO\\nthe\\tO\\n5\\tO\\nend\\tO\\nspanning\\tO\\nexons\\tO\\n4\\tO\\nand\\tO\\n5\\tO\\n,\\tO\\n(\\tO\\n2\\tO\\n)\\tO\\nwithin\\tO\\nexon\\tO\\n9\\tO\\n,\\tO\\nand\\tO\\n(\\tO\\n3\\tO\\n)\\tO\\nat\\tO\\nthe\\tO\\n3\\tO\\ndistal\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nVariability\\tO\\nin\\tO\\nthe\\tO\\nnumber\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\nadenomas\\tI-Disease\\nwas\\tO\\nmost\\tO\\napparent\\tO\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nmutations\\tO\\nin\\tO\\nregion\\tO\\n1\\tO\\n,\\tO\\nand\\tO\\nupper\\tO\\n-\\tO\\ngastrointestinal\\tO\\nmanifestations\\tO\\nwere\\tO\\nmore\\tO\\nsevere\\tO\\nin\\tO\\nthem\\tO\\n.\\tO\\n\\nIn\\tO\\nindividuals\\tO\\nwith\\tO\\nmutations\\tO\\nin\\tO\\neither\\tO\\nregion\\tO\\n2\\tO\\nor\\tO\\nregion\\tO\\n3\\tO\\n,\\tO\\nthe\\tO\\naverage\\tO\\nnumber\\tO\\nof\\tO\\nadenomas\\tB-Disease\\ntended\\tO\\nto\\tO\\nbe\\tO\\nlower\\tO\\nthan\\tO\\nthose\\tO\\nin\\tO\\nindividuals\\tO\\nwith\\tO\\nmutations\\tO\\nin\\tO\\nregion\\tO\\n1\\tO\\n,\\tO\\nalthough\\tO\\nage\\tO\\nat\\tO\\ndiagnosis\\tO\\nwas\\tO\\nsimilar\\tO\\n.\\tO\\n\\nIn\\tO\\nall\\tO\\nAAPC\\tB-Disease\\nkindreds\\tO\\n,\\tO\\na\\tO\\npredominance\\tO\\nof\\tO\\nright\\tO\\n-\\tO\\nsided\\tO\\ncolorectal\\tB-Disease\\nadenomas\\tI-Disease\\nand\\tO\\nrectal\\tB-Disease\\npolyp\\tI-Disease\\nsparing\\tO\\nwas\\tO\\nobserved\\tO\\n.\\tO\\n\\nNo\\tO\\ndesmoid\\tB-Disease\\ntumors\\tI-Disease\\nwere\\tO\\nfound\\tO\\nin\\tO\\nthese\\tO\\nkindreds\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\n,\\tO\\nin\\tO\\nAAPC\\tB-Disease\\nfamilies\\tO\\n,\\tO\\nthe\\tO\\nlocation\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\nmutation\\tO\\nmay\\tO\\npartially\\tO\\npredict\\tO\\nspecific\\tO\\nphenotypic\\tO\\nexpression\\tO\\n.\\tO\\n\\nThis\\tO\\nshould\\tO\\nhelp\\tO\\nin\\tO\\nthe\\tO\\ndesign\\tO\\nof\\tO\\ntailored\\tO\\nclinical\\tO\\n-\\tO\\nmanagement\\tO\\nprotocols\\tO\\nin\\tO\\nthis\\tO\\nsubset\\tO\\nof\\tO\\nFAP\\tB-Disease\\npatients\\tO\\n.\\tO\\n.\\tO\\n\\nWilms\\tB-Disease\\n\\'\\tI-Disease\\ntumor\\tI-Disease\\n1\\tO\\nand\\tO\\nDax\\tO\\n-\\tO\\n1\\tO\\nmodulate\\tO\\nthe\\tO\\norphan\\tO\\nnuclear\\tO\\nreceptor\\tO\\nSF\\tO\\n-\\tO\\n1\\tO\\nin\\tO\\nsex\\tO\\n-\\tO\\nspecific\\tO\\ngene\\tO\\nexpression\\tO\\n.\\tO\\n\\nProducts\\tO\\nof\\tO\\nsteroidogenic\\tO\\nfactor\\tO\\n1\\tO\\n(\\tO\\nSF\\tO\\n-\\tO\\n1\\tO\\n)\\tO\\nand\\tO\\nWilms\\tB-Disease\\ntumor\\tI-Disease\\n1\\tO\\n(\\tO\\nWT1\\tO\\n)\\tO\\ngenes\\tO\\nare\\tO\\nessential\\tO\\nfor\\tO\\nmammalian\\tO\\ngonadogenesis\\tO\\nprior\\tO\\nto\\tO\\nsexual\\tO\\ndifferentiation\\tO\\n.\\tO\\n\\nIn\\tO\\nmales\\tO\\n,\\tO\\nSF\\tO\\n-\\tO\\n1\\tO\\nparticipates\\tO\\nin\\tO\\nsexual\\tO\\ndevelopment\\tO\\nby\\tO\\nregulating\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\npolypeptide\\tO\\nhormone\\tO\\nMullerian\\tO\\ninhibiting\\tO\\nsubstance\\tO\\n(\\tO\\nMIS\\tO\\n)\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nwe\\tO\\nshow\\tO\\nthat\\tO\\nWT1\\tO\\n-\\tO\\nKTS\\tO\\nisoforms\\tO\\nassociate\\tO\\nand\\tO\\nsynergize\\tO\\nwith\\tO\\nSF\\tO\\n-\\tO\\n1\\tO\\nto\\tO\\npromote\\tO\\nMIS\\tO\\nexpression\\tO\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nWT1\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\nassociated\\tO\\nwith\\tO\\nmale\\tB-Disease\\npseudohermaphroditism\\tI-Disease\\nin\\tO\\nDenys\\tB-Disease\\n-\\tI-Disease\\nDrash\\tI-Disease\\nsyndrome\\tI-Disease\\n,\\tO\\nfail\\tO\\nto\\tO\\nsynergize\\tO\\nwith\\tO\\nSF\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n\\nAdditionally\\tO\\n,\\tO\\nthe\\tO\\nX\\tO\\n-\\tO\\nlinked\\tO\\n,\\tO\\ncandidate\\tO\\ndosage\\tO\\n-\\tO\\nsensitive\\tO\\nsex\\tO\\n-\\tO\\nreversal\\tO\\ngene\\tO\\n,\\tO\\nDax\\tO\\n-\\tO\\n1\\tO\\n,\\tO\\nantagonizes\\tO\\nsynergy\\tO\\nbetween\\tO\\nSF\\tO\\n-\\tO\\n1\\tO\\nand\\tO\\nWT1\\tO\\n,\\tO\\nmost\\tO\\nlikely\\tO\\nthrough\\tO\\na\\tO\\ndirect\\tO\\ninteraction\\tO\\nwith\\tO\\nSF\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n\\nWe\\tO\\npropose\\tO\\nthat\\tO\\nWT1\\tO\\nand\\tO\\nDax\\tO\\n-\\tO\\n1\\tO\\nfunctionally\\tO\\noppose\\tO\\neach\\tO\\nother\\tO\\nin\\tO\\ntestis\\tO\\ndevelopment\\tO\\nby\\tO\\nmodulating\\tO\\nSF\\tO\\n-\\tO\\n1\\tO\\n-\\tO\\nmediated\\tO\\ntransactivation\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nmouse\\tO\\nmodel\\tO\\nfor\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\nimprinting\\tO\\n-\\tO\\ncentre\\tO\\nmutations\\tO\\n.\\tO\\n\\nImprinting\\tO\\nin\\tO\\nthe\\tO\\n15q11\\tO\\n-\\tO\\nq13\\tO\\nregion\\tO\\ninvolves\\tO\\nan\\tO\\nimprinting\\tO\\ncentre\\tO\\n(\\tO\\nIC\\tO\\n)\\tO\\n,\\tO\\nmapping\\tO\\nin\\tO\\npart\\tO\\nto\\tO\\nthe\\tO\\npromoter\\tO\\nand\\tO\\nfirst\\tO\\nexon\\tO\\nof\\tO\\nSNRPN\\tO\\n.\\tO\\n\\nDeletion\\tO\\nof\\tO\\nthis\\tO\\nIC\\tO\\nabolishes\\tO\\nlocal\\tO\\npaternally\\tO\\nderived\\tO\\ngene\\tO\\nexpression\\tO\\nand\\tO\\nresults\\tO\\nin\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ncreated\\tO\\ntwo\\tO\\ndeletion\\tO\\nmutations\\tO\\nin\\tO\\nmice\\tO\\nto\\tO\\nunderstand\\tO\\nPWS\\tB-Disease\\nand\\tO\\nthe\\tO\\nmechanism\\tO\\nof\\tO\\nthis\\tO\\nIC\\tO\\n.\\tO\\n\\nMice\\tO\\nharbouring\\tO\\nan\\tO\\nintragenic\\tO\\ndeletion\\tO\\nin\\tO\\nSnrpn\\tO\\nare\\tO\\nphenotypically\\tO\\nnormal\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nmutations\\tO\\nof\\tO\\nSNRPN\\tO\\nare\\tO\\nnot\\tO\\nsufficient\\tO\\nto\\tO\\ninduce\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nMice\\tO\\nwith\\tO\\na\\tO\\nlarger\\tO\\ndeletion\\tO\\ninvolving\\tO\\nboth\\tO\\nSnrpn\\tO\\nand\\tO\\nthe\\tO\\nputative\\tO\\nPWS\\tO\\n-\\tO\\nIC\\tO\\nlack\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nimprinted\\tO\\ngenes\\tO\\nZfp127\\tO\\n(\\tO\\nmouse\\tO\\nhomologue\\tO\\nof\\tO\\nZNF127\\tO\\n)\\tO\\n,\\tO\\nNdn\\tO\\nand\\tO\\nIpw\\tO\\n,\\tO\\nand\\tO\\nmanifest\\tO\\nseveral\\tO\\nphenotypes\\tO\\ncommon\\tO\\nto\\tO\\nPWS\\tB-Disease\\ninfants\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\ndemonstrate\\tO\\nthat\\tO\\nboth\\tO\\nthe\\tO\\nposition\\tO\\nof\\tO\\nthe\\tO\\nIC\\tO\\nand\\tO\\nits\\tO\\nrole\\tO\\nin\\tO\\nthe\\tO\\ncoordinate\\tO\\nexpression\\tO\\nof\\tO\\ngenes\\tO\\nis\\tO\\nconserved\\tO\\nbetween\\tO\\nmouse\\tO\\nand\\tO\\nhuman\\tO\\n,\\tO\\nand\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nmouse\\tO\\nis\\tO\\na\\tO\\nsuitable\\tO\\nmodel\\tO\\nsystem\\tO\\nin\\tO\\nwhich\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\nmolecular\\tO\\nmechanisms\\tO\\nof\\tO\\nimprinting\\tO\\nin\\tO\\nthis\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\ngenome\\tO\\n.\\tO\\n.\\tO\\n\\nMutations\\tO\\nof\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\ndetected\\tO\\nin\\tO\\nJapanese\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\npatients\\tO\\n:\\tO\\npossible\\tO\\npreponderance\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nfounder\\tO\\nmutations\\tO\\n4612del165\\tO\\nand\\tO\\n7883del5\\tO\\n.\\tO\\n\\nThe\\tO\\nATM\\tO\\n(\\tO\\nA\\tO\\n-\\tO\\nT\\tO\\n,\\tO\\nmutated\\tO\\n)\\tO\\ngene\\tO\\non\\tO\\nhuman\\tO\\nchromosome\\tO\\n11q22\\tO\\n.\\tO\\n\\n3\\tO\\nhas\\tO\\nrecently\\tO\\nbeen\\tO\\nidentified\\tO\\nas\\tO\\nthe\\tO\\ngene\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nhuman\\tO\\nrecessive\\tB-Disease\\ndisease\\tI-Disease\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\norder\\tO\\nto\\tO\\ndefine\\tO\\nthe\\tO\\ntypes\\tO\\nof\\tO\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\nATM\\tO\\nmutations\\tO\\nin\\tO\\nJapanese\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nto\\tO\\nlook\\tO\\nfor\\tO\\npossible\\tO\\nmutational\\tO\\nhotspots\\tO\\n,\\tO\\nreverse\\tO\\n-\\tO\\ntranscribed\\tO\\nRNA\\tO\\nderived\\tO\\nfrom\\tO\\nten\\tO\\npatients\\tO\\nbelonging\\tO\\nto\\tO\\neight\\tO\\nunrelated\\tO\\nJapanese\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nfamilies\\tO\\nwas\\tO\\nanalyzed\\tO\\nfor\\tO\\nmutations\\tO\\nby\\tO\\nthe\\tO\\nrestriction\\tO\\nendonuclease\\tO\\nfingerprinting\\tO\\nmethod\\tO\\n.\\tO\\n\\nAs\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\nby\\tO\\nothers\\tO\\n,\\tO\\nmutations\\tO\\nthat\\tO\\nlead\\tO\\nto\\tO\\nexon\\tO\\nskipping\\tO\\nor\\tO\\npremature\\tO\\nprotein\\tO\\ntruncation\\tO\\nwere\\tO\\nalso\\tO\\npredominant\\tO\\nin\\tO\\nour\\tO\\nmutants\\tO\\n.\\tO\\n\\nSix\\tO\\ndifferent\\tO\\nmutations\\tO\\nwere\\tO\\nidentified\\tO\\non\\tO\\n12\\tO\\nof\\tO\\nthe\\tO\\n16\\tO\\nalleles\\tO\\nexamined\\tO\\n.\\tO\\n\\nFour\\tO\\nwere\\tO\\ndeletions\\tO\\ninvolving\\tO\\na\\tO\\nloss\\tO\\nof\\tO\\na\\tO\\nsingle\\tO\\nexon\\tO\\nexon\\tO\\n7\\tO\\n,\\tO\\nexon\\tO\\n16\\tO\\n,\\tO\\nexon\\tO\\n33\\tO\\nor\\tO\\nexon\\tO\\n35\\tO\\n.\\tO\\n\\nThe\\tO\\nothers\\tO\\nwere\\tO\\nminute\\tO\\ndeletions\\tO\\n,\\tO\\n4649delA\\tO\\nin\\tO\\nexon\\tO\\n33\\tO\\nand\\tO\\n7883del5\\tO\\nin\\tO\\nexon\\tO\\n55\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\n4612del165\\tO\\nand\\tO\\n7883del5\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nmore\\tO\\nthan\\tO\\ntwo\\tO\\nunrelated\\tO\\nfamilies\\tO\\n;\\tO\\n44\\tO\\n%\\tO\\n(\\tO\\n7\\tO\\nof\\tO\\n16\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nmutant\\tO\\nalleles\\tO\\nhad\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\ntwo\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\n4612del165\\tO\\nmutations\\tO\\nin\\tO\\nthree\\tO\\ndifferent\\tO\\nfamilies\\tO\\nwere\\tO\\nall\\tO\\nascribed\\tO\\nto\\tO\\nthe\\tO\\nsame\\tO\\nT\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nA\\tO\\nsubstitution\\tO\\nat\\tO\\nthe\\tO\\nsplice\\tO\\ndonor\\tO\\nsite\\tO\\nin\\tO\\nintron\\tO\\n33\\tO\\n.\\tO\\n\\nMicrosatellite\\tO\\ngenotyping\\tO\\naround\\tO\\nthe\\tO\\nATM\\tO\\nlocus\\tO\\nalso\\tO\\nindicated\\tO\\nthat\\tO\\na\\tO\\ncommon\\tO\\nhaplotype\\tO\\nwas\\tO\\nshared\\tO\\nby\\tO\\nthe\\tO\\nmutant\\tO\\nalleles\\tO\\nin\\tO\\nboth\\tO\\nmutations\\tO\\n.\\tO\\n\\nThis\\tO\\nsuggests\\tO\\nthat\\tO\\nthese\\tO\\ntwo\\tO\\nfounder\\tO\\nmutations\\tO\\nmay\\tO\\nbe\\tO\\npredominant\\tO\\namong\\tO\\nJapanese\\tO\\nATM\\tO\\nmutant\\tO\\nalleles\\tO\\n.\\tO\\n\\nW474C\\tO\\namino\\tO\\nacid\\tO\\nsubstitution\\tO\\naffects\\tO\\nearly\\tO\\nprocessing\\tO\\nof\\tO\\nthe\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nof\\tO\\nbeta\\tO\\n-\\tO\\nhexosaminidase\\tO\\nA\\tO\\nand\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nsubacute\\tO\\nG\\tB-Disease\\n(\\tI-Disease\\nM2\\tI-Disease\\n)\\tI-Disease\\ngangliosidosis\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nHEXA\\tO\\ngene\\tO\\n,\\tO\\nencoding\\tO\\nthe\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nof\\tO\\nbeta\\tO\\n-\\tO\\nhexosaminidase\\tO\\nA\\tO\\n(\\tO\\nHex\\tO\\nA\\tO\\n)\\tO\\n,\\tO\\nthat\\tO\\nabolish\\tO\\nHex\\tO\\nA\\tO\\nenzyme\\tO\\nactivity\\tO\\ncause\\tO\\nTay\\tB-Disease\\n-\\tI-Disease\\nSachs\\tI-Disease\\ndisease\\tI-Disease\\n(\\tO\\nTSD\\tB-Disease\\n)\\tO\\n,\\tO\\nthe\\tO\\nfatal\\tO\\ninfantile\\tB-Disease\\nform\\tI-Disease\\nof\\tI-Disease\\nG\\tI-Disease\\n(\\tI-Disease\\nM2\\tI-Disease\\n)\\tI-Disease\\ngangliosidosis\\tI-Disease\\n,\\tI-Disease\\nType\\tI-Disease\\n1\\tI-Disease\\n.\\tO\\n\\nLess\\tO\\nsevere\\tO\\n,\\tO\\nsubacute\\tO\\n(\\tO\\njuvenile\\tO\\n-\\tO\\nonset\\tO\\n)\\tO\\nand\\tO\\nchronic\\tO\\n(\\tO\\nadult\\tO\\n-\\tO\\nonset\\tO\\n)\\tO\\nvariants\\tO\\nare\\tO\\ncharacterized\\tO\\nby\\tO\\na\\tO\\nbroad\\tO\\nspectrum\\tO\\nof\\tO\\nclinical\\tO\\nmanifestations\\tO\\nand\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\nresidual\\tO\\nlevels\\tO\\nof\\tO\\nHex\\tO\\nA\\tO\\nenzyme\\tO\\nactivity\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\na\\tO\\n1422\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\n(\\tO\\namino\\tO\\nacid\\tO\\nW474C\\tO\\n)\\tO\\nsubstitution\\tO\\nin\\tO\\nthe\\tO\\nfirst\\tO\\nposition\\tO\\nof\\tO\\nexon\\tO\\n13\\tO\\nof\\tO\\nHEXA\\tO\\nof\\tO\\na\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nproband\\tO\\nwho\\tO\\nmanifested\\tO\\na\\tO\\nsubacute\\tO\\nvariant\\tO\\nof\\tO\\nG\\tB-Disease\\n(\\tI-Disease\\nM2\\tI-Disease\\n)\\tI-Disease\\ngangliosidosis\\tI-Disease\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nsecond\\tO\\nmaternally\\tO\\ninherited\\tO\\nallele\\tO\\n,\\tO\\nwe\\tO\\nidentified\\tO\\nthe\\tO\\ncommon\\tO\\ninfantile\\tO\\ndisease\\tO\\n-\\tO\\ncausing\\tO\\n4\\tO\\n-\\tO\\nbp\\tO\\ninsertion\\tO\\n,\\tO\\n+\\tO\\nTATC\\tO\\n1278\\tO\\n,\\tO\\nin\\tO\\nexon\\tO\\n11\\tO\\n.\\tO\\n\\nPulse\\tO\\n-\\tO\\nchase\\tO\\nanalysis\\tO\\nusing\\tO\\nproband\\tO\\nfibroblasts\\tO\\nrevealed\\tO\\nthat\\tO\\nthe\\tO\\nW474C\\tO\\n-\\tO\\ncontaining\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nprecursor\\tO\\nwas\\tO\\nnormally\\tO\\nsynthesized\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nphosphorylated\\tO\\nor\\tO\\nsecreted\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nmature\\tO\\nlysosomal\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nwas\\tO\\nnot\\tO\\ndetected\\tO\\n.\\tO\\n\\nWhen\\tO\\nthe\\tO\\nW474C\\tO\\n-\\tO\\ncontaining\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nwas\\tO\\ntransiently\\tO\\nco\\tO\\n-\\tO\\nexpressed\\tO\\nwith\\tO\\nthe\\tO\\nbeta\\tO\\n-\\tO\\nsubunit\\tO\\nto\\tO\\nproduce\\tO\\nHex\\tO\\nA\\tO\\n(\\tO\\nalphabeta\\tO\\n)\\tO\\nin\\tO\\nCOS\\tO\\n-\\tO\\n7\\tO\\ncells\\tO\\n,\\tO\\nthe\\tO\\nmature\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nwas\\tO\\npresent\\tO\\n,\\tO\\nbut\\tO\\nits\\tO\\nlevel\\tO\\nwas\\tO\\nmuch\\tO\\nlower\\tO\\nthan\\tO\\nthat\\tO\\nfrom\\tO\\nnormal\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\ntransfections\\tO\\n,\\tO\\nalthough\\tO\\nhigher\\tO\\nthan\\tO\\nin\\tO\\nthose\\tO\\ncells\\tO\\ntransfected\\tO\\nwith\\tO\\nan\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nassociated\\tO\\nwith\\tO\\ninfantile\\tO\\nTSD\\tB-Disease\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nthe\\tO\\nprecursor\\tO\\nlevel\\tO\\nof\\tO\\nthe\\tO\\nW474C\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\naccumulate\\tO\\nin\\tO\\ncomparison\\tO\\nto\\tO\\nthe\\tO\\nnormal\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nprecursor\\tO\\nlevels\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\n1422\\tO\\nG\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nC\\tO\\nmutation\\tO\\nis\\tO\\nthe\\tO\\ncause\\tO\\nof\\tO\\nHex\\tB-Disease\\nA\\tI-Disease\\nenzyme\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthe\\tO\\nproband\\tO\\n.\\tO\\n\\nThe\\tO\\nresulting\\tO\\nW474C\\tO\\nsubstitution\\tO\\nclearly\\tO\\ninterferes\\tO\\nwith\\tO\\nalpha\\tO\\n-\\tO\\nsubunit\\tO\\nprocessing\\tO\\n,\\tO\\nbut\\tO\\nbecause\\tO\\nthe\\tO\\nbase\\tO\\nsubstitution\\tO\\nfalls\\tO\\nat\\tO\\nthe\\tO\\nfirst\\tO\\nposition\\tO\\nof\\tO\\nexon\\tO\\n13\\tO\\n,\\tO\\naberrant\\tO\\nsplicing\\tO\\nmay\\tO\\nalso\\tO\\ncontribute\\tO\\nto\\tO\\nHex\\tB-Disease\\nA\\tI-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthis\\tO\\nproband\\tO\\n.\\tO\\n.\\tO\\n\\nTwo\\tO\\nfrequent\\tO\\nmissense\\tO\\nmutations\\tO\\nin\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nearly\\tO\\nchildhood\\tO\\ndeafness\\tB-Disease\\nand\\tO\\ngoiter\\tB-Disease\\n.\\tO\\n\\nA\\tO\\ncentury\\tO\\nafter\\tO\\nits\\tO\\nrecognition\\tO\\nas\\tO\\na\\tO\\nsyndrome\\tO\\nby\\tO\\nVaughan\\tO\\nPendred\\tO\\n,\\tO\\nthe\\tO\\ndisease\\tO\\ngene\\tO\\n(\\tO\\nPDS\\tO\\n)\\tO\\nwas\\tO\\nmapped\\tO\\nto\\tO\\nchromosome\\tO\\n7q22\\tO\\n-\\tO\\nq31\\tO\\n.\\tO\\n\\n1\\tO\\nand\\tO\\n,\\tO\\nrecently\\tO\\n,\\tO\\nfound\\tO\\nto\\tO\\nencode\\tO\\na\\tO\\nputative\\tO\\nsulfate\\tO\\ntransporter\\tO\\n.\\tO\\n\\nWe\\tO\\nperformed\\tO\\nmutation\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nPDS\\tB-Disease\\ngene\\tO\\nin\\tO\\npatients\\tO\\nfrom\\tO\\n14\\tO\\nPendred\\tB-Disease\\nfamilies\\tO\\noriginating\\tO\\nfrom\\tO\\nseven\\tO\\ncountries\\tO\\nand\\tO\\nidentified\\tO\\nall\\tO\\nmutations\\tO\\n.\\tO\\n\\nThe\\tO\\nmutations\\tO\\ninclude\\tO\\nthree\\tO\\nsingle\\tO\\nbase\\tO\\ndeletions\\tO\\n,\\tO\\none\\tO\\nsplice\\tO\\nsite\\tO\\nmutation\\tO\\nand\\tO\\n10\\tO\\nmissense\\tO\\nmutations\\tO\\n.\\tO\\n\\nOne\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nL236P\\tO\\n)\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\na\\tO\\nhomozygous\\tO\\nstate\\tO\\nin\\tO\\ntwo\\tO\\nconsanguineous\\tO\\nfamilies\\tO\\nand\\tO\\nin\\tO\\na\\tO\\nheterozygous\\tO\\nstate\\tO\\nin\\tO\\nfive\\tO\\nadditional\\tO\\nnon\\tO\\n-\\tO\\nconsanguineous\\tO\\nfamilies\\tO\\n.\\tO\\n\\nAnother\\tO\\nmissense\\tO\\nmutation\\tO\\n(\\tO\\nT416P\\tO\\n)\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\na\\tO\\nhomozygous\\tO\\nstate\\tO\\nin\\tO\\none\\tO\\nfamily\\tO\\nand\\tO\\nin\\tO\\na\\tO\\nheterozygous\\tO\\nstate\\tO\\nin\\tO\\nfour\\tO\\nfamilies\\tO\\n.\\tO\\n\\nPendred\\tB-Disease\\npatients\\tO\\nin\\tO\\nthree\\tO\\nnon\\tO\\n-\\tO\\nconsanguineous\\tO\\nfamilies\\tO\\nwere\\tO\\nshown\\tO\\nto\\tO\\nbe\\tO\\ncompound\\tO\\nheterozygotes\\tO\\nfor\\tO\\nL236P\\tO\\nand\\tO\\nT416P\\tO\\n.\\tO\\n\\nIn\\tO\\ntotal\\tO\\n,\\tO\\none\\tO\\nor\\tO\\nboth\\tO\\nof\\tO\\nthese\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nnine\\tO\\nof\\tO\\nthe\\tO\\n14\\tO\\nfamilies\\tO\\nanalyzed\\tO\\n.\\tO\\n\\nThe\\tO\\nidentification\\tO\\nof\\tO\\ntwo\\tO\\nfrequent\\tO\\nPDS\\tB-Disease\\nmutations\\tO\\nwill\\tO\\nfacilitate\\tO\\nthe\\tO\\nmolecular\\tO\\ndiagnosis\\tO\\nof\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nInsertional\\tO\\nmutation\\tO\\nby\\tO\\ntransposable\\tO\\nelement\\tO\\n,\\tO\\nL1\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\nDMD\\tB-Disease\\ngene\\tO\\nresults\\tO\\nin\\tO\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndilated\\tI-Disease\\ncardiomyopathy\\tI-Disease\\n.\\tO\\n\\nX\\tB-Disease\\n-\\tI-Disease\\nlinked\\tI-Disease\\ndilated\\tI-Disease\\ncardiomyopathy\\tI-Disease\\n(\\tO\\nXLDCM\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nclinical\\tO\\nphenotype\\tO\\nof\\tO\\ndystrophinopathy\\tB-Disease\\nwhich\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\npreferential\\tO\\nmyocardial\\tB-Disease\\ninvolvement\\tI-Disease\\nwithout\\tO\\nany\\tO\\novert\\tO\\nclinical\\tO\\nsigns\\tO\\nof\\tO\\nskeletal\\tB-Disease\\nmyopathy\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\ndate\\tO\\n,\\tO\\nseveral\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\ngene\\tO\\n,\\tO\\nDMD\\tO\\n,\\tO\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nXLDCM\\tB-Disease\\n,\\tO\\nbut\\tO\\na\\tO\\npathogenic\\tO\\ncorrelation\\tO\\nof\\tO\\nthese\\tO\\ncardiospecific\\tO\\nmutations\\tO\\nin\\tO\\nDMD\\tO\\nwith\\tO\\nthe\\tO\\nXLDCM\\tB-Disease\\nphenotype\\tO\\nhas\\tO\\nremained\\tO\\nto\\tO\\nbe\\tO\\nelucidated\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthe\\tO\\nidentification\\tO\\nof\\tO\\na\\tO\\nunique\\tO\\nde\\tO\\nnovo\\tO\\nL1\\tO\\ninsertion\\tO\\nin\\tO\\nthe\\tO\\nmuscle\\tO\\nexon\\tO\\n1\\tO\\nin\\tO\\nDMD\\tO\\nin\\tO\\nthree\\tO\\nXLDCM\\tB-Disease\\npatients\\tO\\nfrom\\tO\\ntwo\\tO\\nunrelated\\tO\\nJapanese\\tO\\nfamilies\\tO\\n.\\tO\\n\\nThe\\tO\\ninsertion\\tO\\nwas\\tO\\na\\tO\\n5\\tO\\n-\\tO\\ntruncated\\tO\\nform\\tO\\nof\\tO\\nhuman\\tO\\nL1\\tO\\ninversely\\tO\\nintegrated\\tO\\nin\\tO\\nthe\\tO\\n5\\tO\\n-\\tO\\nuntranslated\\tO\\nregion\\tO\\nin\\tO\\nthe\\tO\\nmuscle\\tO\\nexon\\tO\\n1\\tO\\n,\\tO\\nwhich\\tO\\naffected\\tO\\nthe\\tO\\ntranscription\\tO\\nor\\tO\\nthe\\tO\\nstability\\tO\\nof\\tO\\nthe\\tO\\nmuscle\\tO\\nform\\tO\\nof\\tO\\ndystrophin\\tO\\ntranscripts\\tO\\nbut\\tO\\nnot\\tO\\nthat\\tO\\nof\\tO\\nthe\\tO\\nbrain\\tO\\nor\\tO\\nPurkinje\\tO\\ncell\\tO\\nform\\tO\\n,\\tO\\nprobably\\tO\\ndue\\tO\\nto\\tO\\nits\\tO\\nunique\\tO\\nsite\\tO\\nof\\tO\\nintegration\\tO\\n.\\tO\\n\\nWe\\tO\\nspeculate\\tO\\nthat\\tO\\nthis\\tO\\ninsertion\\tO\\nof\\tO\\nan\\tO\\nL1\\tO\\nsequence\\tO\\nin\\tO\\nDMD\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nsome\\tO\\nof\\tO\\nthe\\tO\\npopulation\\tO\\nof\\tO\\nJapanese\\tO\\npatients\\tO\\nwith\\tO\\nXLDCM\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nSevere\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nobesity\\tB-Disease\\n,\\tO\\nadrenal\\tB-Disease\\ninsufficiency\\tI-Disease\\nand\\tO\\nred\\tO\\nhair\\tO\\npigmentation\\tO\\ncaused\\tO\\nby\\tO\\nPOMC\\tO\\nmutations\\tO\\nin\\tO\\nhumans\\tO\\n.\\tO\\n\\nSequential\\tO\\ncleavage\\tO\\nof\\tO\\nthe\\tO\\nprecursor\\tO\\nprotein\\tO\\npre\\tO\\n-\\tO\\npro\\tO\\n-\\tO\\nopiomelanocortin\\tO\\n(\\tO\\nPOMC\\tO\\n)\\tO\\ngenerates\\tO\\nthe\\tO\\nmelanocortin\\tO\\npeptides\\tO\\nadrenocorticotrophin\\tO\\n(\\tO\\nACTH\\tO\\n)\\tO\\n,\\tO\\nmelanocyte\\tO\\n-\\tO\\nstimulating\\tO\\nhormones\\tO\\n(\\tO\\nMSH\\tO\\n)\\tO\\nalpha\\tO\\n,\\tO\\nbeta\\tO\\nand\\tO\\ngamma\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\nthe\\tO\\nopioid\\tO\\n-\\tO\\nreceptor\\tO\\nligand\\tO\\nbeta\\tO\\n-\\tO\\nendorphin\\tO\\n.\\tO\\n\\nWhile\\tO\\na\\tO\\nfew\\tO\\ncases\\tO\\nof\\tO\\nisolated\\tO\\nACTH\\tB-Disease\\ndeficiency\\tI-Disease\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\n(\\tO\\nOMIM\\tO\\n201400\\tO\\n)\\tO\\n,\\tO\\nan\\tO\\ninherited\\tO\\nPOMC\\tO\\ndefect\\tO\\nhas\\tO\\nnot\\tO\\nbeen\\tO\\ndescribed\\tO\\nso\\tO\\nfar\\tO\\n.\\tO\\n\\nRecent\\tO\\nstudies\\tO\\nin\\tO\\nanimal\\tO\\nmodels\\tO\\nelucidated\\tO\\na\\tO\\ncentral\\tO\\nrole\\tO\\nof\\tO\\nalpha\\tO\\n-\\tO\\nMSH\\tO\\nin\\tO\\nthe\\tO\\nregulation\\tO\\nof\\tO\\nfood\\tO\\nintake\\tO\\nby\\tO\\nactivation\\tO\\nof\\tO\\nthe\\tO\\nbrain\\tO\\nmelanocortin\\tO\\n-\\tO\\n4\\tO\\n-\\tO\\nreceptor\\tO\\n(\\tO\\nMC4\\tO\\n-\\tO\\nR\\tO\\n;\\tO\\nrefs\\tO\\n3\\tO\\n-\\tO\\n5\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nlinkage\\tO\\nof\\tO\\nhuman\\tO\\nobesity\\tB-Disease\\nto\\tO\\nchromosome\\tO\\n2\\tO\\nin\\tO\\nclose\\tO\\nproximity\\tO\\nto\\tO\\nthe\\tO\\nPOMC\\tO\\nlocus\\tO\\n,\\tO\\nled\\tO\\nto\\tO\\nthe\\tO\\nproposal\\tO\\nof\\tO\\nan\\tO\\nassociation\\tO\\nof\\tO\\nPOMC\\tO\\nwith\\tO\\nhuman\\tO\\nobesity\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\ndual\\tO\\nrole\\tO\\nof\\tO\\nalpha\\tO\\n-\\tO\\nMSH\\tO\\nin\\tO\\nregulating\\tO\\nfood\\tO\\nintake\\tO\\nand\\tO\\ninfluencing\\tO\\nhair\\tO\\npigmentation\\tO\\npredicts\\tO\\nthat\\tO\\nthe\\tO\\nphenotype\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\ndefect\\tO\\nin\\tO\\nPOMC\\tO\\nfunction\\tO\\nwould\\tO\\ninclude\\tO\\nobesity\\tB-Disease\\n,\\tO\\nalteration\\tO\\nin\\tO\\npigmentation\\tO\\nand\\tO\\nACTH\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nobservation\\tO\\nof\\tO\\nthese\\tO\\nsymptoms\\tO\\nin\\tO\\ntwo\\tO\\nprobands\\tO\\nprompted\\tO\\nus\\tO\\nto\\tO\\nsearch\\tO\\nfor\\tO\\nmutations\\tO\\nwithin\\tO\\ntheir\\tO\\nPOMC\\tO\\ngenes\\tO\\n.\\tO\\n\\nPatient\\tO\\n1\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\ncompound\\tO\\nheterozygote\\tO\\nfor\\tO\\ntwo\\tO\\nmutations\\tO\\nin\\tO\\nexon\\tO\\n3\\tO\\n(\\tO\\nG7013T\\tO\\n,\\tO\\nC7133delta\\tO\\n)\\tO\\nwhich\\tO\\ninterfere\\tO\\nwith\\tO\\nappropriate\\tO\\nsynthesis\\tO\\nof\\tO\\nACTH\\tO\\nand\\tO\\nalpha\\tO\\n-\\tO\\nMSH\\tO\\n.\\tO\\n\\nPatient\\tO\\n2\\tO\\nwas\\tO\\nhomozygous\\tO\\nfor\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n2\\tO\\n(\\tO\\nC3804A\\tO\\n)\\tO\\nwhich\\tO\\nabolishes\\tO\\nPOMC\\tO\\ntranslation\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nrepresent\\tO\\nthe\\tO\\nfirst\\tO\\nexamples\\tO\\nof\\tO\\na\\tO\\ngenetic\\tB-Disease\\ndefect\\tI-Disease\\nwithin\\tO\\nthe\\tO\\nPOMC\\tO\\ngene\\tO\\nand\\tO\\ndefine\\tO\\na\\tO\\nnew\\tO\\nmonogenic\\tB-Disease\\nendocrine\\tI-Disease\\ndisorder\\tI-Disease\\nresulting\\tO\\nin\\tO\\nearly\\tO\\n-\\tO\\nonset\\tO\\nobesity\\tB-Disease\\n,\\tO\\nadrenal\\tB-Disease\\ninsufficiency\\tI-Disease\\nand\\tO\\nred\\tO\\nhair\\tO\\npigmentation\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nEuropean\\tO\\nmulticenter\\tO\\nstudy\\tO\\nof\\tO\\nphenylalanine\\tB-Disease\\nhydroxylase\\tI-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\nclassification\\tO\\nof\\tO\\n105\\tO\\nmutations\\tO\\nand\\tO\\na\\tO\\ngeneral\\tO\\nsystem\\tO\\nfor\\tO\\ngenotype\\tO\\n-\\tO\\nbased\\tO\\nprediction\\tO\\nof\\tO\\nmetabolic\\tO\\nphenotype\\tO\\n.\\tO\\n\\nPhenylketonuria\\tB-Disease\\n(\\tO\\nPKU\\tB-Disease\\n)\\tO\\nand\\tO\\nmild\\tB-Disease\\nhyperphenylalaninemia\\tI-Disease\\n(\\tO\\nMHP\\tB-Disease\\n)\\tO\\nare\\tO\\nallelic\\tB-Disease\\ndisorders\\tI-Disease\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ngene\\tO\\nencoding\\tO\\nphenylalanine\\tO\\nhydroxylase\\tO\\n(\\tO\\nPAH\\tO\\n)\\tO\\n.\\tO\\n\\nPrevious\\tO\\nstudies\\tO\\nhave\\tO\\nsuggested\\tO\\nthat\\tO\\nthe\\tO\\nhighly\\tO\\nvariable\\tO\\nmetabolic\\tO\\nphenotypes\\tO\\nof\\tO\\nPAH\\tB-Disease\\ndeficiency\\tI-Disease\\ncorrelate\\tO\\nwith\\tO\\nPAH\\tO\\ngenotypes\\tO\\n.\\tO\\n\\nWe\\tO\\nidentified\\tO\\nboth\\tO\\ncausative\\tO\\nmutations\\tO\\nin\\tO\\n686\\tO\\npatients\\tO\\nfrom\\tO\\nseven\\tO\\nEuropean\\tO\\ncenters\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nthe\\tO\\nphenotypic\\tO\\ncharacteristics\\tO\\nof\\tO\\n297\\tO\\nfunctionally\\tO\\nhemizygous\\tO\\npatients\\tO\\n,\\tO\\n105\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\nwere\\tO\\nassigned\\tO\\nto\\tO\\none\\tO\\nof\\tO\\nfour\\tO\\narbitrary\\tO\\nphenotype\\tO\\ncategories\\tO\\n.\\tO\\n\\nWe\\tO\\nproposed\\tO\\nand\\tO\\ntested\\tO\\na\\tO\\nsimple\\tO\\nmodel\\tO\\nfor\\tO\\ncorrelation\\tO\\nbetween\\tO\\ngenotype\\tO\\nand\\tO\\nphenotypic\\tO\\noutcome\\tO\\n.\\tO\\n\\nThe\\tO\\nobserved\\tO\\nphenotype\\tO\\nmatched\\tO\\nthe\\tO\\npredicted\\tO\\nphenotype\\tO\\nin\\tO\\n79\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\ncases\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\nonly\\tO\\n5\\tO\\nof\\tO\\n184\\tO\\npatients\\tO\\nwas\\tO\\nthe\\tO\\nobserved\\tO\\nphenotype\\tO\\nmore\\tO\\nthan\\tO\\none\\tO\\ncategory\\tO\\naway\\tO\\nfrom\\tO\\nthat\\tO\\nexpected\\tO\\n.\\tO\\n\\nAmong\\tO\\nthe\\tO\\nseven\\tO\\ncontributing\\tO\\ncenters\\tO\\n,\\tO\\nthe\\tO\\nproportion\\tO\\nof\\tO\\npatients\\tO\\nfor\\tO\\nwhom\\tO\\nthe\\tO\\nobserved\\tO\\nphenotype\\tO\\ndid\\tO\\nnot\\tO\\nmatch\\tO\\nthe\\tO\\npredicted\\tO\\nphenotype\\tO\\nwas\\tO\\n4\\tO\\n%\\tO\\n-\\tO\\n23\\tO\\n%\\tO\\n(\\tO\\nP\\tO\\n<\\tO\\n.\\tO\\n0001\\tO\\n)\\tO\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\ndifferences\\tO\\nin\\tO\\nmethods\\tO\\nused\\tO\\nfor\\tO\\nmutation\\tO\\ndetection\\tO\\nor\\tO\\nphenotype\\tO\\nclassification\\tO\\nmay\\tO\\naccount\\tO\\nfor\\tO\\na\\tO\\nconsiderable\\tO\\nproportion\\tO\\nof\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ninconsistencies\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nindicate\\tO\\nthat\\tO\\nthe\\tO\\nPAH\\tO\\n-\\tO\\nmutation\\tO\\ngenotype\\tO\\nis\\tO\\nthe\\tO\\nmain\\tO\\ndeterminant\\tO\\nof\\tO\\nmetabolic\\tO\\nphenotype\\tO\\nin\\tO\\nmost\\tO\\npatients\\tO\\nwith\\tO\\nPAH\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nthe\\tO\\npresent\\tO\\nstudy\\tO\\n,\\tO\\nthe\\tO\\nclassification\\tO\\nof\\tO\\n105\\tO\\nPAH\\tO\\nmutations\\tO\\nmay\\tO\\nallow\\tO\\nthe\\tO\\nprediction\\tO\\nof\\tO\\nthe\\tO\\nbiochemical\\tO\\nphenotype\\tO\\nin\\tO\\n>\\tO\\n10\\tO\\n,\\tO\\n000\\tO\\ngenotypes\\tO\\n,\\tO\\nwhich\\tO\\nmay\\tO\\nbe\\tO\\nuseful\\tO\\nfor\\tO\\nthe\\tO\\nmanagement\\tO\\nof\\tO\\nhyperphenylalaninemia\\tB-Disease\\nin\\tO\\nnewborns\\tO\\n.\\tO\\n\\nSomatic\\tO\\ninstability\\tO\\nof\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nin\\tO\\nmice\\tO\\ntransgenic\\tO\\nfor\\tO\\nthe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nregion\\tO\\nis\\tO\\nage\\tO\\ndependent\\tO\\nbut\\tO\\nnot\\tO\\ncorrelated\\tO\\nto\\tO\\nthe\\tO\\nrelative\\tO\\nintertissue\\tO\\ntranscription\\tO\\nlevels\\tO\\nand\\tO\\nproliferative\\tO\\ncapacities\\tO\\n.\\tO\\n\\nA\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nnexpansion\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\n-\\tO\\nuntranslated\\tO\\nregion\\tO\\n(\\tO\\nUTR\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nDM\\tO\\nprotein\\tO\\nkinase\\tO\\ngene\\tO\\n(\\tO\\nDMPK\\tO\\n)\\tO\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\ncausing\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nMajor\\tO\\ninstability\\tO\\n,\\tO\\nwith\\tO\\nvery\\tO\\nlarge\\tO\\nexpansions\\tO\\nbetween\\tO\\ngenerations\\tO\\nand\\tO\\nhigh\\tO\\nlevels\\tO\\nof\\tO\\nsomatic\\tO\\nmosaicism\\tO\\n,\\tO\\nis\\tO\\nobserved\\tO\\nin\\tO\\npatients\\tO\\n.\\tO\\n\\nThere\\tO\\nis\\tO\\na\\tO\\ngood\\tO\\ncorrelation\\tO\\nbetween\\tO\\nrepeat\\tO\\nsize\\tO\\n(\\tO\\nat\\tO\\nleast\\tO\\nin\\tO\\nleucocytes\\tO\\n)\\tO\\n,\\tO\\nclinical\\tO\\nseverity\\tO\\nand\\tO\\nage\\tO\\nof\\tO\\nonset\\tO\\n.\\tO\\n\\nThe\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\ninstability\\tO\\nmechanisms\\tO\\ninvolved\\tO\\nin\\tO\\nDM\\tB-Disease\\nand\\tO\\nother\\tO\\nhuman\\tO\\ngenetic\\tB-Disease\\ndiseases\\tI-Disease\\nare\\tO\\nunknown\\tO\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\nsomatic\\tO\\ninstability\\tO\\nby\\tO\\nmeasuring\\tO\\nthe\\tO\\nCTG\\tO\\nrepeat\\tO\\nlength\\tO\\nat\\tO\\nseveral\\tO\\nages\\tO\\nin\\tO\\nvarious\\tO\\ntissues\\tO\\nof\\tO\\ntransgenic\\tO\\nmice\\tO\\ncarrying\\tO\\na\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\n55expansion\\tO\\nsurrounded\\tO\\nby\\tO\\n45\\tO\\nkb\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nDM\\tB-Disease\\nregion\\tO\\n,\\tO\\nusing\\tO\\nsmall\\tO\\n-\\tO\\npool\\tO\\nPCR\\tO\\n.\\tO\\n\\nThese\\tO\\nmice\\tO\\nhave\\tO\\nbeen\\tO\\nshown\\tO\\nto\\tO\\nreproduce\\tO\\nthe\\tO\\nintergenerational\\tO\\nand\\tO\\nsomatic\\tO\\ninstability\\tO\\nof\\tO\\nthe\\tO\\n55\\tO\\nCTG\\tO\\nrepeat\\tO\\nsuggesting\\tO\\nthat\\tO\\nsurrounding\\tO\\nsequences\\tO\\nand\\tO\\nthe\\tO\\nchromatin\\tO\\nenvironment\\tO\\nare\\tO\\ninvolved\\tO\\nin\\tO\\ninstability\\tO\\nmechanisms\\tO\\n.\\tO\\n\\nAs\\tO\\nobserved\\tO\\nin\\tO\\nsome\\tO\\nof\\tO\\nthe\\tO\\ntissues\\tO\\nof\\tO\\nDM\\tB-Disease\\npatients\\tO\\n,\\tO\\nthere\\tO\\nis\\tO\\na\\tO\\ntendency\\tO\\nfor\\tO\\nrepeat\\tO\\nlength\\tO\\nand\\tO\\nsomatic\\tO\\nmosaicism\\tO\\nto\\tO\\nincrease\\tO\\nwith\\tO\\nthe\\tO\\nage\\tO\\nof\\tO\\nthe\\tO\\nmouse\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nwe\\tO\\nobserved\\tO\\nno\\tO\\ncorrelation\\tO\\nbetween\\tO\\nthe\\tO\\nsomatic\\tO\\nmutation\\tO\\nrate\\tO\\nand\\tO\\ntissue\\tO\\nproliferation\\tO\\ncapacity\\tO\\n.\\tO\\n\\nThe\\tO\\nsomatic\\tO\\nmutation\\tO\\nrates\\tO\\nin\\tO\\ndifferent\\tO\\ntissues\\tO\\nwere\\tO\\nalso\\tO\\nnot\\tO\\ncorrelated\\tO\\nto\\tO\\nthe\\tO\\nrelative\\tO\\ninter\\tO\\n-\\tO\\ntissue\\tO\\ndifference\\tO\\nin\\tO\\ntranscriptional\\tO\\nlevels\\tO\\nof\\tO\\nthe\\tO\\nthree\\tO\\ngenes\\tO\\n(\\tO\\nDMAHP\\tO\\n,\\tO\\nDMPK\\tO\\nand\\tO\\n59\\tO\\n)\\tO\\nsurrounding\\tO\\nthe\\tO\\nrepeat\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nnovel\\tO\\nmissense\\tO\\nmutation\\tO\\nin\\tO\\npatients\\tO\\nfrom\\tO\\na\\tO\\nretinoblastoma\\tB-Disease\\npedigree\\tO\\nshowing\\tO\\nonly\\tO\\nmild\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\ntumor\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nused\\tO\\nsingle\\tO\\nstrand\\tO\\nconformation\\tO\\npolymorphism\\tO\\nanalysis\\tO\\nto\\tO\\nstudy\\tO\\nthe\\tO\\n27\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nin\\tO\\nindividuals\\tO\\nfrom\\tO\\na\\tO\\nfamily\\tO\\nshowing\\tO\\nmild\\tO\\nexpression\\tO\\nof\\tO\\nthe\\tO\\nretinoblastoma\\tB-Disease\\nphenotype\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nfamily\\tO\\naffected\\tO\\nindividuals\\tO\\ndeveloped\\tO\\nunilateral\\tB-Disease\\ntumors\\tI-Disease\\nand\\tO\\n,\\tO\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\nlinkage\\tO\\nanalysis\\tO\\n,\\tO\\nunaffected\\tO\\nmutation\\tO\\ncarriers\\tO\\nwere\\tO\\nalso\\tO\\nidentified\\tO\\nwithin\\tO\\nthe\\tO\\npedigree\\tO\\n.\\tO\\n\\nA\\tO\\nsingle\\tO\\nband\\tO\\nshift\\tO\\nusing\\tO\\nSSCP\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\nexon\\tO\\n21\\tO\\nwhich\\tO\\nresulted\\tO\\nin\\tO\\na\\tO\\nmissense\\tO\\nmutation\\tO\\nconverting\\tO\\na\\tO\\ncys\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\narg\\tO\\nat\\tO\\nnucleotide\\tO\\nposition\\tO\\n28\\tO\\nin\\tO\\nthe\\tO\\nexon\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\ndestroyed\\tO\\nan\\tO\\nNdeI\\tO\\nrestriction\\tO\\nenzyme\\tO\\nsite\\tO\\n.\\tO\\n\\nAnalysis\\tO\\nof\\tO\\nall\\tO\\nfamily\\tO\\nmembers\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nmissense\\tO\\nmutation\\tO\\nco\\tO\\n-\\tO\\nsegregated\\tO\\nwith\\tO\\npatients\\tO\\nwith\\tO\\ntumors\\tB-Disease\\nor\\tO\\nwho\\tO\\n,\\tO\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\nlinkage\\tO\\nanalysis\\tO\\nhad\\tO\\nbeen\\tO\\npredicted\\tO\\nto\\tO\\ncarry\\tO\\nthe\\tO\\npredisposing\\tO\\nmutation\\tO\\n.\\tO\\n\\nThese\\tO\\nobservations\\tO\\npoint\\tO\\nto\\tO\\nanother\\tO\\nregion\\tO\\nof\\tO\\nthe\\tO\\nRB1\\tO\\ngene\\tO\\nwhere\\tO\\nmutations\\tO\\nonly\\tO\\nmodify\\tO\\nthe\\tO\\nfunction\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nand\\tO\\nraise\\tO\\nimportant\\tO\\nquestions\\tO\\nfor\\tO\\ngenetic\\tO\\ncounseling\\tO\\nin\\tO\\nfamilies\\tO\\nwith\\tO\\nthese\\tO\\ndistinctive\\tO\\nphenotypes\\tO\\n.\\tO\\n.\\tO\\n\\nMaternal\\tB-Disease\\ndisomy\\tI-Disease\\nand\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\nconsistent\\tO\\nwith\\tO\\ngamete\\tO\\ncomplementation\\tO\\nin\\tO\\na\\tO\\ncase\\tO\\nof\\tO\\nfamilial\\tO\\ntranslocation\\tO\\n(\\tO\\n3\\tO\\n;\\tO\\n15\\tO\\n)\\tO\\n(\\tO\\np25\\tO\\n;\\tO\\nq11\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\n.\\tO\\n\\nMaternal\\tB-Disease\\nuniparental\\tI-Disease\\ndisomy\\tI-Disease\\n(\\tI-Disease\\nUPD\\tI-Disease\\n)\\tI-Disease\\nfor\\tI-Disease\\nchromosome\\tI-Disease\\n15\\tI-Disease\\nis\\tO\\nresponsible\\tO\\nfor\\tO\\nan\\tO\\nestimated\\tO\\n30\\tO\\n%\\tO\\nof\\tO\\ncases\\tO\\nof\\tO\\nPrader\\tB-Disease\\n-\\tI-Disease\\nWilli\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nPWS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\non\\tO\\nan\\tO\\nunusual\\tO\\ncase\\tO\\nof\\tO\\nmaternal\\tB-Disease\\ndisomy\\tI-Disease\\n15\\tI-Disease\\nin\\tO\\nPWS\\tB-Disease\\nthat\\tO\\nis\\tO\\nmost\\tO\\nconsistent\\tO\\nwith\\tO\\nadjacent\\tO\\n-\\tO\\n1\\tO\\nsegregation\\tO\\nof\\tO\\na\\tO\\npaternal\\tO\\nt\\tO\\n(\\tO\\n3\\tO\\n;\\tO\\n15\\tO\\n)\\tO\\n(\\tO\\np25\\tO\\n;\\tO\\nq11\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\nwith\\tO\\nsimultaneous\\tO\\nmaternal\\tO\\nmeiotic\\tO\\nnondisjunction\\tO\\nfor\\tO\\nchromosome\\tO\\n15\\tO\\n.\\tO\\n\\nThe\\tO\\npatient\\tO\\n(\\tO\\nJ\\tO\\n.\\tO\\nB\\tO\\n.\\tO\\n)\\tO\\n,\\tO\\na\\tO\\n17\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\nwhite\\tO\\nmale\\tO\\nwith\\tO\\nPWS\\tB-Disease\\n,\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nhave\\tO\\n47\\tO\\nchromosomes\\tO\\nwith\\tO\\na\\tO\\nsupernumerary\\tO\\n,\\tO\\npaternal\\tO\\nder\\tO\\n(\\tO\\n15\\tO\\n)\\tO\\nconsisting\\tO\\nof\\tO\\nthe\\tO\\nshort\\tO\\narm\\tO\\nand\\tO\\nthe\\tO\\nproximal\\tO\\nlong\\tO\\narm\\tO\\nof\\tO\\nchromosome\\tO\\n15\\tO\\n,\\tO\\nand\\tO\\ndistal\\tO\\nchromosome\\tO\\narm\\tO\\n3p\\tO\\n.\\tO\\n\\nThe\\tO\\nt\\tO\\n(\\tO\\n3\\tO\\n;\\tO\\n15\\tO\\n)\\tO\\nwas\\tO\\npresent\\tO\\nin\\tO\\nthe\\tO\\nbalanced\\tO\\nstate\\tO\\nin\\tO\\nthe\\tO\\npatients\\tO\\nfather\\tO\\nand\\tO\\na\\tO\\nsister\\tO\\n.\\tO\\n\\nFluorescent\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\nanalysis\\tO\\ndemonstrated\\tO\\nthat\\tO\\nthe\\tO\\nPWS\\tB-Disease\\ncritical\\tO\\nregion\\tO\\nresided\\tO\\non\\tO\\nthe\\tO\\nderivative\\tO\\nchromosome\\tO\\n3\\tO\\nand\\tO\\nthat\\tO\\nthere\\tO\\nwas\\tO\\nno\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nPWS\\tB-Disease\\nregion\\tO\\non\\tO\\nthe\\tO\\nnormal\\tO\\npair\\tO\\nof\\tO\\n15s\\tO\\npresent\\tO\\nin\\tO\\nJ\\tO\\n.\\tO\\n\\nB\\tO\\n.\\tO\\n\\nMethylation\\tO\\nanalysis\\tO\\nat\\tO\\nexon\\tO\\nalpha\\tO\\nof\\tO\\nthe\\tO\\nsmall\\tO\\nnuclear\\tO\\nribonucleoprotein\\tO\\n-\\tO\\nassociated\\tO\\npolypeptide\\tO\\nN\\tO\\n(\\tO\\nSNRPN\\tO\\n)\\tO\\ngene\\tO\\nshowed\\tO\\na\\tO\\npattern\\tO\\ncharacteristic\\tO\\nof\\tO\\nonly\\tO\\nthe\\tO\\nmaternal\\tO\\nchromosome\\tO\\n15\\tO\\nin\\tO\\nJ\\tO\\n.\\tO\\n\\nB\\tO\\n.\\tO\\n\\nMaternal\\tB-Disease\\ndisomy\\tI-Disease\\nwas\\tO\\nconfirmed\\tO\\nby\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nanalysis\\tO\\nof\\tO\\nmicrosatellite\\tO\\nrepeats\\tO\\nat\\tO\\nthe\\tO\\ngamma\\tO\\n-\\tO\\naminobutyric\\tO\\nacid\\tO\\nreceptor\\tO\\nbeta3\\tO\\nsubunit\\tO\\n(\\tO\\nGABRB3\\tO\\n)\\tO\\nlocus\\tO\\n.\\tO\\n\\nA\\tO\\nniece\\tO\\n(\\tO\\nB\\tO\\n.\\tO\\nB\\tO\\n.\\tO\\n)\\tO\\nwith\\tO\\n45\\tO\\nchromosomes\\tO\\nand\\tO\\nthe\\tO\\nderivative\\tO\\n3\\tO\\nbut\\tO\\nwithout\\tO\\nthe\\tO\\nder\\tO\\n(\\tO\\n15\\tO\\n)\\tO\\ndemonstrated\\tO\\na\\tO\\nphenotype\\tO\\nconsistent\\tO\\nwith\\tO\\nthat\\tO\\nreported\\tO\\nfor\\tO\\nhaploinsufficiency\\tO\\nof\\tO\\ndistal\\tO\\n3\\tO\\np\\tO\\n.\\tO\\n\\nUniparental\\tB-Disease\\ndisomy\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nunbalanced\\tO\\nsegregation\\tO\\nof\\tO\\nnon\\tO\\n-\\tO\\nRobertsonian\\tO\\ntranslocations\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\npreviously\\tO\\nbut\\tO\\nhas\\tO\\nnot\\tO\\n,\\tO\\nto\\tO\\nour\\tO\\nknowledge\\tO\\n,\\tO\\nbeen\\tO\\nobserved\\tO\\nin\\tO\\na\\tO\\ncase\\tO\\nof\\tO\\nPWS\\tB-Disease\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nour\\tO\\nfindings\\tO\\nare\\tO\\nbest\\tO\\ninterpreted\\tO\\nas\\tO\\ntrue\\tO\\ngamete\\tO\\ncomplementation\\tO\\nresulting\\tO\\nin\\tO\\nmaternal\\tB-Disease\\nUPD\\tI-Disease\\n15\\tI-Disease\\nand\\tO\\nPWS\\tB-Disease\\n\\nSchwartz\\tB-Disease\\n-\\tI-Disease\\nJampel\\tI-Disease\\nsyndrome\\tI-Disease\\ntype\\tI-Disease\\n2\\tI-Disease\\nand\\tO\\nStuve\\tB-Disease\\n-\\tI-Disease\\nWiedemann\\tI-Disease\\nsyndrome\\tI-Disease\\n:\\tO\\na\\tO\\ncase\\tO\\nfor\\tO\\n\"\\tO\\nlumping\\tO\\n\"\\tO\\n.\\tO\\n\\nRecent\\tO\\nstudies\\tO\\ndemonstrated\\tO\\nthe\\tO\\nexistence\\tO\\nof\\tO\\na\\tO\\ngenetically\\tO\\ndistinct\\tO\\n,\\tO\\nusually\\tO\\nlethal\\tO\\nform\\tO\\nof\\tO\\nthe\\tO\\nSchwartz\\tB-Disease\\n-\\tI-Disease\\nJampel\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nSJS\\tB-Disease\\n)\\tO\\nof\\tO\\nmyotonia\\tB-Disease\\nand\\tO\\nskeletal\\tB-Disease\\ndysplasia\\tI-Disease\\n,\\tO\\nwhich\\tO\\nwe\\tO\\ncalled\\tO\\nSJS\\tB-Disease\\ntype\\tI-Disease\\n2\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\ndisorder\\tO\\nis\\tO\\nreminiscent\\tO\\nof\\tO\\nanother\\tO\\nrare\\tO\\ncondition\\tO\\n,\\tO\\nthe\\tO\\nStuve\\tB-Disease\\n-\\tI-Disease\\nWiedemann\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nSWS\\tB-Disease\\n)\\tO\\n,\\tO\\nwhich\\tO\\ncomprises\\tO\\ncampomelia\\tB-Disease\\nat\\tO\\nbirth\\tO\\nwith\\tO\\nskeletal\\tB-Disease\\ndysplasia\\tI-Disease\\n,\\tO\\ncontractures\\tB-Disease\\n,\\tO\\nand\\tO\\nearly\\tB-Disease\\ndeath\\tI-Disease\\n.\\tO\\n\\nTo\\tO\\ntest\\tO\\nfor\\tO\\npossible\\tO\\nnosologic\\tO\\nidentity\\tO\\nbetween\\tO\\nthese\\tO\\ndisorders\\tO\\n,\\tO\\nwe\\tO\\nreviewed\\tO\\nthe\\tO\\nliterature\\tO\\nand\\tO\\nobtained\\tO\\na\\tO\\nfollow\\tO\\n-\\tO\\nup\\tO\\nof\\tO\\nthe\\tO\\nonly\\tO\\ntwo\\tO\\nsurviving\\tO\\npatients\\tO\\n,\\tO\\none\\tO\\nwith\\tO\\nSJS\\tB-Disease\\ntype\\tI-Disease\\n2\\tI-Disease\\nat\\tO\\nage\\tO\\n10\\tO\\nyears\\tO\\nand\\tO\\nanother\\tO\\nwith\\tO\\nSWS\\tB-Disease\\nat\\tO\\nage\\tO\\n7\\tO\\nyears\\tO\\n.\\tO\\n\\nPatients\\tO\\nreported\\tO\\nas\\tO\\nhaving\\tO\\neither\\tO\\nneonatal\\tO\\nSJS\\tB-Disease\\nor\\tO\\nSWS\\tB-Disease\\npresented\\tO\\na\\tO\\ncombination\\tO\\nof\\tO\\na\\tO\\nsevere\\tO\\n,\\tO\\nprenatal\\tO\\n-\\tO\\nonset\\tO\\nneuromuscular\\tB-Disease\\ndisorder\\tI-Disease\\n(\\tO\\nwith\\tO\\ncongenital\\tB-Disease\\njoint\\tI-Disease\\ncontractures\\tI-Disease\\n,\\tO\\nrespiratory\\tO\\nand\\tO\\nfeeding\\tO\\ndifficulties\\tO\\n,\\tO\\ntendency\\tO\\nto\\tO\\nhyperthermia\\tB-Disease\\n,\\tO\\nand\\tO\\nfrequent\\tO\\ndeath\\tO\\nin\\tO\\ninfancy\\tO\\n)\\tO\\nwith\\tO\\na\\tO\\ndistinct\\tO\\ncampomelic\\tB-Disease\\n-\\tI-Disease\\nmetaphyseal\\tI-Disease\\nskeletal\\tI-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nsimilarity\\tO\\nof\\tO\\nthe\\tO\\nclinical\\tO\\nand\\tO\\nradiographic\\tO\\nfindings\\tO\\nis\\tO\\nso\\tO\\nextensive\\tO\\nthat\\tO\\nthese\\tO\\ndisorders\\tO\\nappear\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nsingle\\tO\\nentity\\tO\\n.\\tO\\n\\nThe\\tO\\nfollow\\tO\\n-\\tO\\nup\\tO\\nobservation\\tO\\nof\\tO\\nan\\tO\\nidentical\\tO\\nand\\tO\\nunique\\tO\\npattern\\tO\\nof\\tO\\nprogressive\\tO\\nbone\\tB-Disease\\ndysplasia\\tI-Disease\\nin\\tO\\nthe\\tO\\ntwo\\tO\\npatients\\tO\\n(\\tO\\none\\tO\\nwith\\tO\\nSJS\\tB-Disease\\ntype\\tI-Disease\\n2\\tI-Disease\\n,\\tO\\none\\tO\\nwith\\tO\\nSWS\\tB-Disease\\n)\\tO\\nsurviving\\tO\\nbeyond\\tO\\ninfancy\\tO\\nadds\\tO\\nto\\tO\\nthe\\tO\\nevidence\\tO\\nin\\tO\\nfavor\\tO\\nof\\tO\\nidentity\\tO\\n.\\tO\\n\\nThe\\tO\\nhypothesis\\tO\\nthat\\tO\\nSWS\\tB-Disease\\nand\\tO\\nSJS\\tB-Disease\\ntype\\tI-Disease\\n2\\tI-Disease\\nare\\tO\\nthe\\tO\\nsame\\tO\\ndisorder\\tO\\nshould\\tO\\nbe\\tO\\ntestable\\tO\\nby\\tO\\nmolecular\\tO\\nmethods\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nmouse\\tO\\nmodel\\tO\\nof\\tO\\nsevere\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\n:\\tO\\ndefects\\tO\\nin\\tO\\nhemostasis\\tO\\nand\\tO\\nthrombosis\\tB-Disease\\n.\\tO\\n\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nfactor\\tI-Disease\\n(\\tI-Disease\\nvWf\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\ncauses\\tO\\nsevere\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\nin\\tO\\nhumans\\tO\\n.\\tO\\n\\nWe\\tO\\ngenerated\\tO\\na\\tO\\nmouse\\tO\\nmodel\\tO\\nfor\\tO\\nthis\\tO\\ndisease\\tO\\nby\\tO\\nusing\\tO\\ngene\\tO\\ntargeting\\tO\\n.\\tO\\n\\nvWf\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nmice\\tO\\nappeared\\tO\\nnormal\\tO\\nat\\tO\\nbirth\\tO\\n;\\tO\\nthey\\tO\\nwere\\tO\\nviable\\tO\\nand\\tO\\nfertile\\tO\\n.\\tO\\n\\nNeither\\tO\\nvWf\\tO\\nnor\\tO\\nvWf\\tO\\npropolypeptide\\tO\\n(\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\nantigen\\tO\\nII\\tO\\n)\\tO\\nwere\\tO\\ndetectable\\tO\\nin\\tO\\nplasma\\tO\\n,\\tO\\nplatelets\\tO\\n,\\tO\\nor\\tO\\nendothelial\\tO\\ncells\\tO\\nof\\tO\\nthe\\tO\\nhomozygous\\tO\\nmutant\\tO\\nmice\\tO\\n.\\tO\\n\\nThe\\tO\\nmutant\\tO\\nmice\\tO\\nexhibited\\tO\\ndefects\\tO\\nin\\tO\\nhemostasis\\tO\\nwith\\tO\\na\\tO\\nhighly\\tO\\nprolonged\\tO\\nbleeding\\tO\\ntime\\tO\\nand\\tO\\nspontaneous\\tO\\nbleeding\\tO\\nevents\\tO\\nin\\tO\\napproximately\\tO\\n10\\tO\\n%\\tO\\nof\\tO\\nneonates\\tO\\n.\\tO\\n\\nAs\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\ndisease\\tO\\n,\\tO\\nthe\\tO\\nfactor\\tO\\nVIII\\tO\\nlevel\\tO\\nin\\tO\\nthese\\tO\\nmice\\tO\\nwas\\tO\\nreduced\\tO\\nstrongly\\tO\\nas\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\nthe\\tO\\nlack\\tO\\nof\\tO\\nprotection\\tO\\nprovided\\tO\\nby\\tO\\nvWf\\tO\\n.\\tO\\n\\nDefective\\tO\\nthrombosis\\tB-Disease\\nin\\tO\\nmutant\\tO\\nmice\\tO\\nwas\\tO\\nalso\\tO\\nevident\\tO\\nin\\tO\\nan\\tO\\nin\\tO\\nvivo\\tO\\nmodel\\tO\\nof\\tO\\nvascular\\tB-Disease\\ninjury\\tI-Disease\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nmodel\\tO\\n,\\tO\\nthe\\tO\\nexteriorized\\tO\\nmesentery\\tO\\nwas\\tO\\nsuperfused\\tO\\nwith\\tO\\nferric\\tO\\nchloride\\tO\\nand\\tO\\nthe\\tO\\naccumulation\\tO\\nof\\tO\\nfluorescently\\tO\\nlabeled\\tO\\nplatelets\\tO\\nwas\\tO\\nobserved\\tO\\nby\\tO\\nintravital\\tO\\nmicroscopy\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nthese\\tO\\nmice\\tO\\nvery\\tO\\nclosely\\tO\\nmimic\\tO\\nsevere\\tO\\nhuman\\tO\\nvon\\tB-Disease\\nWillebrand\\tI-Disease\\ndisease\\tI-Disease\\nand\\tO\\nwill\\tO\\nbe\\tO\\nvery\\tO\\nuseful\\tO\\nfor\\tO\\ninvestigating\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nvWf\\tO\\nin\\tO\\nnormal\\tO\\nphysiology\\tO\\nand\\tO\\nin\\tO\\ndisease\\tO\\nmodels\\tO\\n.\\tO\\n.\\tO\\n\\nOral\\tO\\ncontraceptives\\tO\\nand\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\nhereditary\\tB-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nHereditary\\tB-Disease\\nOvarian\\tI-Disease\\nCancer\\tI-Disease\\nClinical\\tO\\nStudy\\tO\\nGroup\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\nWomen\\tO\\nwith\\tO\\nmutations\\tO\\nin\\tO\\neither\\tO\\nthe\\tO\\nBRCA1\\tO\\nor\\tO\\nthe\\tO\\nBRCA2\\tO\\ngene\\tO\\nhave\\tO\\na\\tO\\nhigh\\tO\\nlifetime\\tO\\nrisk\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nOral\\tO\\ncontraceptives\\tO\\nprotect\\tO\\nagainst\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\ngeneral\\tO\\n,\\tO\\nbut\\tO\\nit\\tO\\nis\\tO\\nnot\\tO\\nknown\\tO\\nwhether\\tO\\nthey\\tO\\nalso\\tO\\nprotect\\tO\\nagainst\\tO\\nhereditary\\tB-Disease\\nforms\\tI-Disease\\nof\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nMETHODS\\tO\\nWe\\tO\\nenrolled\\tO\\n207\\tO\\nwomen\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\n161\\tO\\nof\\tO\\ntheir\\tO\\nsisters\\tO\\nas\\tO\\ncontrols\\tO\\nin\\tO\\na\\tO\\ncase\\tO\\n-\\tO\\ncontrol\\tO\\nstudy\\tO\\n.\\tO\\n\\nAll\\tO\\nthe\\tO\\npatients\\tO\\ncarried\\tO\\na\\tO\\npathogenic\\tO\\nmutation\\tO\\nin\\tO\\neither\\tO\\nBRCA1\\tO\\n(\\tO\\n179\\tO\\nwomen\\tO\\n)\\tO\\nor\\tO\\nBRCA2\\tO\\n(\\tO\\n28\\tO\\nwomen\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ncontrol\\tO\\nwomen\\tO\\nwere\\tO\\nenrolled\\tO\\nregardless\\tO\\nof\\tO\\nwhether\\tO\\nor\\tO\\nnot\\tO\\nthey\\tO\\nhad\\tO\\neither\\tO\\nmutation\\tO\\n.\\tO\\n\\nLifetime\\tO\\nhistories\\tO\\nof\\tO\\noral\\tO\\n-\\tO\\ncontraceptive\\tO\\nuse\\tO\\nwere\\tO\\nobtained\\tO\\nby\\tO\\ninterview\\tO\\nor\\tO\\nby\\tO\\nwritten\\tO\\nquestionnaire\\tO\\nand\\tO\\nwere\\tO\\ncompared\\tO\\nbetween\\tO\\npatients\\tO\\nand\\tO\\ncontrol\\tO\\nwomen\\tO\\n,\\tO\\nafter\\tO\\nadjustment\\tO\\nfor\\tO\\nyear\\tO\\nof\\tO\\nbirth\\tO\\nand\\tO\\nparity\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nThe\\tO\\nadjusted\\tO\\nodds\\tO\\nratio\\tO\\nfor\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nany\\tO\\npast\\tO\\nuse\\tO\\nof\\tO\\noral\\tO\\ncontraceptives\\tO\\nwas\\tO\\n0\\tO\\n.\\tO\\n\\n5\\tO\\n(\\tO\\n95\\tO\\npercent\\tO\\nconfidence\\tO\\ninterval\\tO\\n,\\tO\\n0\\tO\\n.\\tO\\n3\\tO\\nto\\tO\\n0\\tO\\n.\\tO\\n8\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nrisk\\tO\\ndecreased\\tO\\nwith\\tO\\nincreasing\\tO\\nduration\\tO\\nof\\tO\\nuse\\tO\\n(\\tO\\nP\\tO\\nfor\\tO\\ntrend\\tO\\n,\\tO\\n<\\tO\\n0\\tO\\n.\\tO\\n001\\tO\\n)\\tO\\n;\\tO\\nuse\\tO\\nfor\\tO\\nsix\\tO\\nor\\tO\\nmore\\tO\\nyears\\tO\\nwas\\tO\\nassociated\\tO\\nwith\\tO\\na\\tO\\n60\\tO\\npercent\\tO\\nreduction\\tO\\nin\\tO\\nrisk\\tO\\n.\\tO\\n\\nOral\\tO\\n-\\tO\\ncontraceptive\\tO\\nuse\\tO\\nprotected\\tO\\nagainst\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nboth\\tO\\nfor\\tO\\ncarriers\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\nmutation\\tO\\n(\\tO\\nodds\\tO\\nratio\\tO\\n,\\tO\\n0\\tO\\n.\\tO\\n5\\tO\\n;\\tO\\n95\\tO\\npercent\\tO\\nconfidence\\tO\\ninterval\\tO\\n,\\tO\\n0\\tO\\n.\\tO\\n3\\tO\\nto\\tO\\n0\\tO\\n.\\tO\\n9\\tO\\n)\\tO\\nand\\tO\\nfor\\tO\\ncarriers\\tO\\nof\\tO\\nthe\\tO\\nBRCA2\\tO\\nmutation\\tO\\n(\\tO\\nodds\\tO\\nratio\\tO\\n,\\tO\\n0\\tO\\n.\\tO\\n4\\tO\\n;\\tO\\n95\\tO\\npercent\\tO\\nconfidence\\tO\\ninterval\\tO\\n,\\tO\\n0\\tO\\n.\\tO\\n2\\tO\\nto\\tO\\n1\\tO\\n.\\tO\\n1\\tO\\n)\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nOral\\tO\\n-\\tO\\ncontraceptive\\tO\\nuse\\tO\\nmay\\tO\\nreduce\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\nwomen\\tO\\nwith\\tO\\npathogenic\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nBRCA1\\tO\\nor\\tO\\nBRCA2\\tO\\ngene\\tO\\n\\nA\\tO\\nJapanese\\tO\\nfamily\\tO\\nwith\\tO\\nadrenoleukodystrophy\\tB-Disease\\nwith\\tO\\na\\tO\\ncodon\\tO\\n291\\tO\\ndeletion\\tO\\n:\\tO\\na\\tO\\nclinical\\tO\\n,\\tO\\nbiochemical\\tO\\n,\\tO\\npathological\\tO\\n,\\tO\\nand\\tO\\ngenetic\\tO\\nreport\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\na\\tO\\nJapanese\\tO\\nfamily\\tO\\nwith\\tO\\nadrenoleukodystrophy\\tB-Disease\\n(\\tO\\nALD\\tB-Disease\\n)\\tO\\nwith\\tO\\na\\tO\\nthree\\tO\\nbase\\tO\\npair\\tO\\ndeletion\\tO\\n(\\tO\\ndelGAG\\tO\\n291\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\nALD\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nA\\tO\\nvariety\\tO\\nof\\tO\\nphenotypes\\tO\\nwere\\tO\\nobserved\\tO\\nwithin\\tO\\nthis\\tO\\nfamily\\tO\\n.\\tO\\n\\nWhile\\tO\\nthe\\tO\\nproband\\tO\\n(\\tO\\npatient\\tO\\n1\\tO\\n)\\tO\\nwas\\tO\\nclassified\\tO\\nas\\tO\\nhaving\\tO\\na\\tO\\nrare\\tO\\nintermediate\\tO\\ntype\\tO\\nof\\tO\\nadult\\tO\\ncerebral\\tO\\nand\\tO\\ncerebello\\tO\\n-\\tO\\nbrain\\tO\\nstem\\tO\\nforms\\tO\\n,\\tO\\nhis\\tO\\nyounger\\tO\\nbrother\\tO\\n(\\tO\\npatient\\tO\\n2\\tO\\n)\\tO\\nand\\tO\\nnephew\\tO\\n(\\tO\\npatient\\tO\\n3\\tO\\n)\\tO\\nhad\\tO\\na\\tO\\nchildhood\\tO\\nALD\\tB-Disease\\ntype\\tO\\n.\\tO\\n\\nAnother\\tO\\nnephew\\tO\\n(\\tO\\npatient\\tO\\n4\\tO\\n)\\tO\\nof\\tO\\npatient\\tO\\n1\\tO\\nwas\\tO\\nclassified\\tO\\nas\\tO\\nhaving\\tO\\nan\\tO\\nadolescent\\tO\\nform\\tO\\n.\\tO\\n\\nThe\\tO\\ntau\\tO\\nlevel\\tO\\nin\\tO\\nthe\\tO\\ncerebrospinal\\tO\\nfluid\\tO\\n(\\tO\\nCSF\\tO\\n)\\tO\\nin\\tO\\npatient\\tO\\n1\\tO\\nwas\\tO\\nas\\tO\\nhigh\\tO\\nas\\tO\\nthat\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nAlzheimers\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nAD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nHis\\tO\\nbrain\\tO\\nmagnetic\\tO\\nresonance\\tO\\nimage\\tO\\n(\\tO\\nMRI\\tO\\n)\\tO\\nshowed\\tO\\nabnormalities\\tB-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\nbilateral\\tI-Disease\\ncerebellar\\tI-Disease\\nhemispheres\\tI-Disease\\nand\\tO\\nbrain\\tO\\nstem\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nin\\tO\\nthe\\tO\\ncerebral\\tO\\nwhite\\tO\\nmatter\\tO\\n,\\tO\\nwhere\\tO\\nmarked\\tO\\nreductions\\tO\\nof\\tO\\nthe\\tO\\ncerebral\\tO\\nblood\\tO\\nflow\\tO\\nand\\tO\\noxygen\\tO\\nmetabolism\\tO\\nwere\\tO\\nclearly\\tO\\ndemonstrated\\tO\\nby\\tO\\npositron\\tO\\nemission\\tO\\ntomography\\tO\\n(\\tO\\nPET\\tO\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\npatients\\tO\\n2\\tO\\nand\\tO\\n3\\tO\\n,\\tO\\nthe\\tO\\nautopsy\\tO\\nfindings\\tO\\nshowed\\tO\\nmassive\\tO\\ndemyelination\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\ncerebral\\tI-Disease\\nwhite\\tI-Disease\\nmatter\\tI-Disease\\nwith\\tO\\nsparing\\tO\\nof\\tO\\nthe\\tO\\nU\\tO\\n-\\tO\\nfibers\\tO\\n,\\tO\\ncompatible\\tO\\nwith\\tO\\nthe\\tO\\nfindings\\tO\\nof\\tO\\nchildhood\\tO\\nALD\\tB-Disease\\n.\\tO\\n\\nOleic\\tO\\nand\\tO\\nerucic\\tO\\nacids\\tO\\n(\\tO\\nLorenzos\\tO\\nOil\\tO\\n)\\tO\\nwere\\tO\\nadministered\\tO\\nto\\tO\\npatients\\tO\\n1\\tO\\nand\\tO\\n4\\tO\\n,\\tO\\nbut\\tO\\nsufficient\\tO\\neffectiveness\\tO\\nwas\\tO\\nnot\\tO\\nobtained\\tO\\n.\\tO\\n\\nThe\\tO\\nfindings\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\nsuggest\\tO\\nthat\\tO\\ndelGAG291\\tO\\nis\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\ncause\\tO\\nof\\tO\\nJapanese\\tO\\nALD\\tB-Disease\\nwith\\tO\\nphenotypic\\tO\\nvariations\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nalthough\\tO\\nthe\\tO\\nscale\\tO\\nof\\tO\\nthe\\tO\\nstudy\\tO\\nis\\tO\\nlimited\\tO\\n,\\tO\\nthere\\tO\\nis\\tO\\na\\tO\\npossibility\\tO\\nthat\\tO\\nPET\\tO\\ncan\\tO\\ndetect\\tO\\nan\\tO\\ninsidious\\tB-Disease\\nlesion\\tI-Disease\\nwhich\\tO\\nis\\tO\\nundetectable\\tO\\nby\\tO\\ncomputed\\tO\\ntomogram\\tO\\n(\\tO\\nCT\\tO\\n)\\tO\\nor\\tO\\nMRI\\tO\\nanalysis\\tO\\n,\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\nhigher\\tO\\nlevel\\tO\\nof\\tO\\ntau\\tO\\nreflects\\tO\\nthe\\tO\\nprocess\\tO\\nof\\tO\\nneuronal\\tB-Disease\\ndegeneration\\tI-Disease\\nin\\tO\\nALD\\tB-Disease\\n.\\tO\\n\\nLorenzos\\tO\\nOil\\tO\\nshould\\tO\\nbe\\tO\\ngiven\\tO\\nin\\tO\\nthe\\tO\\nearly\\tO\\nstage\\tO\\n.\\tO\\n.\\tO\\n\\nNonsense\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n4\\tO\\nof\\tO\\nhuman\\tO\\ncomplement\\tO\\nC9\\tO\\ngene\\tO\\nis\\tO\\nthe\\tO\\nmajor\\tO\\ncause\\tO\\nof\\tO\\nJapanese\\tO\\ncomplement\\tB-Disease\\nC9\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nDeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nninth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\nhuman\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC9\\tO\\n)\\tO\\nis\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\ncomplement\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nJapan\\tO\\nbut\\tO\\nis\\tO\\nrare\\tO\\nin\\tO\\nother\\tO\\ncountries\\tO\\n.\\tO\\n\\nWe\\tO\\nstudied\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nfour\\tO\\nJapanese\\tO\\nC9\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\npatients\\tO\\nwho\\tO\\nhad\\tO\\nsuffered\\tO\\nfrom\\tO\\nmeningococcal\\tB-Disease\\nmeningitis\\tI-Disease\\n.\\tO\\n\\nDirect\\tO\\nsequencing\\tO\\nof\\tO\\namplified\\tO\\nC9\\tO\\ncDNA\\tO\\nand\\tO\\nDNA\\tO\\nrevealed\\tO\\na\\tO\\nnonsense\\tO\\nsubstitution\\tO\\n(\\tO\\nCGA\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nTGA\\tO\\n)\\tO\\nat\\tO\\ncodon\\tO\\n95\\tO\\nin\\tO\\nexon\\tO\\n4\\tO\\nin\\tO\\nthe\\tO\\nfour\\tO\\nC9\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nindividuals\\tO\\n.\\tO\\n\\nAn\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\npolymerase\\tO\\nchain\\tO\\nreaction\\tO\\nsystem\\tO\\ndesigned\\tO\\nto\\tO\\ndetect\\tO\\nexclusively\\tO\\nonly\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nand\\tO\\nmutant\\tO\\nalleles\\tO\\nindicated\\tO\\nthat\\tO\\nall\\tO\\nthe\\tO\\nfour\\tO\\npatients\\tO\\nwere\\tO\\nhomozygous\\tO\\nfor\\tO\\nthe\\tO\\nmutation\\tO\\nin\\tO\\nexon\\tO\\n4\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\nparents\\tO\\nof\\tO\\npatient\\tO\\n2\\tO\\nwere\\tO\\nheterozygous\\tO\\n.\\tO\\n\\nThe\\tO\\ncommon\\tO\\nmutation\\tO\\nat\\tO\\ncodon\\tO\\n95\\tO\\nin\\tO\\nexon\\tO\\n4\\tO\\nmight\\tO\\nbe\\tO\\nresponsible\\tO\\nfor\\tO\\nmost\\tO\\nJapanese\\tO\\nC9\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nrequired\\tO\\nfor\\tO\\ntranscription\\tO\\n-\\tO\\ncoupled\\tO\\nrepair\\tO\\nof\\tO\\noxidative\\tO\\nDNA\\tO\\ndamage\\tO\\n.\\tO\\n\\nThe\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nsusceptibility\\tO\\ngene\\tO\\nBRCA1\\tO\\nencodes\\tO\\na\\tO\\nzinc\\tO\\nfinger\\tO\\nprotein\\tO\\nof\\tO\\nunknown\\tO\\nfunction\\tO\\n.\\tO\\n\\nAssociation\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\nprotein\\tO\\nwith\\tO\\nthe\\tO\\nDNA\\tO\\nrepair\\tO\\nprotein\\tO\\nRad51\\tO\\nand\\tO\\nchanges\\tO\\nin\\tO\\nthe\\tO\\nphosphorylation\\tO\\nand\\tO\\ncellular\\tO\\nlocalization\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\nafter\\tO\\nexposure\\tO\\nto\\tO\\nDNA\\tO\\n-\\tO\\ndamaging\\tO\\nagents\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nBRCA1\\tO\\nin\\tO\\nDNA\\tO\\nrepair\\tO\\n.\\tO\\n\\nHere\\tO\\n,\\tO\\nit\\tO\\nis\\tO\\nshown\\tO\\nthat\\tO\\nmouse\\tO\\nembryonic\\tO\\nstem\\tO\\ncells\\tO\\ndeficient\\tB-Disease\\nin\\tI-Disease\\nBRCA1\\tI-Disease\\nare\\tO\\ndefective\\tO\\nin\\tO\\nthe\\tO\\nability\\tO\\nto\\tO\\ncarry\\tO\\nout\\tO\\ntranscription\\tO\\n-\\tO\\ncoupled\\tO\\nrepair\\tO\\nof\\tO\\noxidative\\tO\\nDNA\\tO\\ndamage\\tO\\n,\\tO\\nand\\tO\\nare\\tO\\nhypersensitive\\tO\\nto\\tO\\nionizing\\tO\\nradiation\\tO\\nand\\tO\\nhydrogen\\tO\\nperoxide\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\nBRCA1\\tO\\nparticipates\\tO\\n,\\tO\\ndirectly\\tO\\nor\\tO\\nindirectly\\tO\\n,\\tO\\nin\\tO\\ntranscription\\tO\\n-\\tO\\ncoupled\\tO\\nrepair\\tO\\nof\\tO\\noxidative\\tO\\nDNA\\tO\\ndamage\\tO\\n.\\tO\\n.\\tO\\n\\nTruncation\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\ntransactivation\\tO\\nregion\\tO\\nof\\tO\\nPAX6\\tO\\nresult\\tO\\nin\\tO\\ndominant\\tO\\n-\\tO\\nnegative\\tO\\nmutants\\tO\\n.\\tO\\n\\nPAX6\\tO\\nis\\tO\\na\\tO\\ntranscription\\tO\\nfactor\\tO\\nwith\\tO\\ntwo\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\ndomains\\tO\\n(\\tO\\npaired\\tO\\nbox\\tO\\nand\\tO\\nhomeobox\\tO\\n)\\tO\\nand\\tO\\na\\tO\\nproline\\tO\\n-\\tO\\nserine\\tO\\n-\\tO\\nthreonine\\tO\\n(\\tO\\nPST\\tO\\n)\\tO\\n-\\tO\\nrich\\tO\\ntransactivation\\tO\\ndomain\\tO\\n.\\tO\\n\\nPAX6\\tO\\nregulates\\tO\\neye\\tO\\ndevelopment\\tO\\nin\\tO\\nanimals\\tO\\nranging\\tO\\nfrom\\tO\\njellyfish\\tO\\nto\\tO\\nDrosophila\\tO\\nto\\tO\\nhumans\\tO\\n.\\tO\\n\\nHeterozygous\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nhuman\\tO\\nPAX6\\tO\\ngene\\tO\\nresult\\tO\\nin\\tO\\nvarious\\tO\\nphenotypes\\tO\\n,\\tO\\nincluding\\tO\\naniridia\\tB-Disease\\n,\\tO\\nPeters\\tB-Disease\\nanomaly\\tI-Disease\\n,\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\nkeratitis\\tI-Disease\\n,\\tO\\nand\\tO\\nfamilial\\tB-Disease\\nfoveal\\tI-Disease\\ndysplasia\\tI-Disease\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nbelieved\\tO\\nthat\\tO\\nthe\\tO\\nmutated\\tO\\nallele\\tO\\nof\\tO\\nPAX6\\tO\\nproduces\\tO\\nan\\tO\\ninactive\\tO\\nprotein\\tO\\nand\\tO\\naniridia\\tB-Disease\\nis\\tO\\ncaused\\tO\\ndue\\tO\\nto\\tO\\ngenetic\\tO\\nhaploinsufficiency\\tO\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nseveral\\tO\\ntruncation\\tO\\nmutations\\tO\\nhave\\tO\\nbeen\\tO\\nfound\\tO\\nto\\tO\\noccur\\tO\\nin\\tO\\nthe\\tO\\nC\\tO\\n-\\tO\\nterminal\\tO\\nhalf\\tO\\nof\\tO\\nPAX6\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\nAniridia\\tB-Disease\\nresulting\\tO\\nin\\tO\\nmutant\\tO\\nproteins\\tO\\nthat\\tO\\nretain\\tO\\nthe\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\ndomains\\tO\\nbut\\tO\\nhave\\tO\\nlost\\tO\\nmost\\tO\\nof\\tO\\nthe\\tO\\ntransactivation\\tO\\ndomain\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\nnot\\tO\\nclear\\tO\\nwhether\\tO\\nsuch\\tO\\nmutants\\tO\\nreally\\tO\\nbehave\\tO\\nas\\tO\\nloss\\tO\\n-\\tO\\nof\\tO\\n-\\tO\\nfunction\\tO\\nmutants\\tO\\nas\\tO\\npredicted\\tO\\nby\\tO\\nhaploinsufficiency\\tO\\n.\\tO\\n\\nContrary\\tO\\nto\\tO\\nthis\\tO\\ntheory\\tO\\n,\\tO\\nour\\tO\\ndata\\tO\\nshowed\\tO\\nthat\\tO\\nthese\\tO\\nmutants\\tO\\nare\\tO\\ndominant\\tO\\n-\\tO\\nnegative\\tO\\nin\\tO\\ntransient\\tO\\ntransfection\\tO\\nassays\\tO\\nwhen\\tO\\nthey\\tO\\nare\\tO\\ncoexpressed\\tO\\nwith\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nPAX6\\tO\\n.\\tO\\n\\nWe\\tO\\nfound\\tO\\nthat\\tO\\nthe\\tO\\ndominant\\tO\\n-\\tO\\nnegative\\tO\\neffects\\tO\\nresult\\tO\\nfrom\\tO\\nthe\\tO\\nenhanced\\tO\\nDNA\\tO\\nbinding\\tO\\nability\\tO\\nof\\tO\\nthese\\tO\\nmutants\\tO\\n.\\tO\\n\\nKinetic\\tO\\nstudies\\tO\\nof\\tO\\nbinding\\tO\\nand\\tO\\ndissociation\\tO\\nrevealed\\tO\\nthat\\tO\\nvarious\\tO\\ntruncation\\tO\\nmutants\\tO\\nhave\\tO\\n3\\tO\\n-\\tO\\n5\\tO\\n-\\tO\\nfold\\tO\\nhigher\\tO\\naffinity\\tO\\nto\\tO\\nvarious\\tO\\nDNA\\tO\\n-\\tO\\nbinding\\tO\\nsites\\tO\\nwhen\\tO\\ncompared\\tO\\nwith\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nPAX6\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nprovide\\tO\\na\\tO\\nnew\\tO\\ninsight\\tO\\ninto\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nmutant\\tO\\nPAX6\\tO\\nin\\tO\\ncausing\\tO\\naniridia\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nReversal\\tO\\nof\\tO\\nsevere\\tO\\nhypertrophic\\tB-Disease\\ncardiomyopathy\\tI-Disease\\nand\\tO\\nexcellent\\tO\\nneuropsychologic\\tO\\noutcome\\tO\\nin\\tO\\nvery\\tB-Disease\\n-\\tI-Disease\\nlong\\tI-Disease\\n-\\tI-Disease\\nchain\\tI-Disease\\nacyl\\tI-Disease\\n-\\tI-Disease\\ncoenzyme\\tI-Disease\\nA\\tI-Disease\\ndehydrogenase\\tI-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\nVery\\tB-Disease\\n-\\tI-Disease\\nlong\\tI-Disease\\n-\\tI-Disease\\nchain\\tI-Disease\\nacyl\\tI-Disease\\n-\\tI-Disease\\ncoenzyme\\tI-Disease\\nA\\tI-Disease\\ndehydrogenase\\tI-Disease\\n(\\tI-Disease\\nVLCAD\\tI-Disease\\n)\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\na\\tO\\ndisorder\\tO\\nof\\tO\\nfatty\\tO\\nacid\\tO\\nbeta\\tO\\noxidation\\tO\\nthat\\tO\\nreportedly\\tO\\nhas\\tO\\nhigh\\tO\\nrates\\tO\\nof\\tO\\nmorbidity\\tO\\nand\\tO\\nmortality\\tO\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\nthe\\tO\\noutcome\\tO\\nof\\tO\\na\\tO\\n5\\tO\\n-\\tO\\nyear\\tO\\n-\\tO\\nold\\tO\\ngirl\\tO\\nwith\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\nwho\\tO\\nwas\\tO\\nfirst\\tO\\nseen\\tO\\nat\\tO\\n5\\tO\\nmonths\\tO\\nof\\tO\\nage\\tO\\nwith\\tO\\nsevere\\tO\\nhypertrophic\\tB-Disease\\ncardiomyopathy\\tI-Disease\\n,\\tO\\nhepatomegaly\\tB-Disease\\n,\\tO\\nencephalopathy\\tB-Disease\\n,\\tO\\nand\\tO\\nhypotonia\\tB-Disease\\n.\\tO\\n\\nBiochemical\\tO\\nstudies\\tO\\nindicated\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\ncaused\\tO\\nby\\tO\\na\\tO\\nstable\\tO\\nyet\\tO\\ninactive\\tO\\nenzyme\\tO\\n.\\tO\\n\\nMolecular\\tO\\ngenetic\\tO\\nanalysis\\tO\\nof\\tO\\nher\\tO\\nVLCAD\\tO\\ngene\\tO\\nrevealed\\tO\\na\\tO\\nT1372C\\tO\\n(\\tO\\nF458L\\tO\\n)\\tO\\nmissense\\tO\\nmutation\\tO\\nand\\tO\\na\\tO\\n1668\\tO\\nACAG\\tO\\n1669\\tO\\nsplice\\tO\\nsite\\tO\\nmutation\\tO\\n.\\tO\\n\\nAfter\\tO\\ninitial\\tO\\ntreatment\\tO\\nwith\\tO\\nintravenous\\tO\\nglucose\\tO\\nand\\tO\\ncarnitine\\tO\\n,\\tO\\nthe\\tO\\npatient\\tO\\nhas\\tO\\nthrived\\tO\\non\\tO\\na\\tO\\nlow\\tO\\n-\\tO\\nfat\\tO\\ndiet\\tO\\nsupplemented\\tO\\nwith\\tO\\nmedium\\tO\\n-\\tO\\nchain\\tO\\ntriglyceride\\tO\\noil\\tO\\nand\\tO\\ncarnitine\\tO\\nand\\tO\\navoidance\\tO\\nof\\tO\\nfasting\\tO\\n.\\tO\\n\\nHer\\tO\\nventricular\\tO\\nhypertrophy\\tO\\nresolved\\tO\\nsignificantly\\tO\\nover\\tO\\n1\\tO\\nyear\\tO\\n,\\tO\\nand\\tO\\ncognitively\\tO\\n,\\tO\\nshe\\tO\\nis\\tO\\nin\\tO\\nthe\\tO\\nsuperior\\tO\\nrange\\tO\\nfor\\tO\\nage\\tO\\n.\\tO\\n\\nClinical\\tO\\nrecognition\\tO\\nof\\tO\\nVLCAD\\tB-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nimportant\\tO\\nbecause\\tO\\nit\\tO\\nis\\tO\\none\\tO\\nof\\tO\\nthe\\tO\\nfew\\tO\\ndirectly\\tO\\ntreatable\\tO\\ncauses\\tO\\nof\\tO\\ncardiomyopathy\\tB-Disease\\nin\\tO\\nchildren\\tO\\n.\\tO\\n.\\tO\\n\\nCloning\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\nmember\\tO\\nof\\tO\\nthe\\tO\\nlow\\tO\\n-\\tO\\ndensity\\tO\\nlipoprotein\\tO\\nreceptor\\tO\\nfamily\\tO\\n.\\tO\\n\\nA\\tO\\ngene\\tO\\nencoding\\tO\\na\\tO\\nnovel\\tO\\ntransmembrane\\tO\\nprotein\\tO\\nwas\\tO\\nidentified\\tO\\nby\\tO\\nDNA\\tO\\nsequence\\tO\\nanalysis\\tO\\nwithin\\tO\\nthe\\tO\\ninsulin\\tB-Disease\\n-\\tI-Disease\\ndependent\\tI-Disease\\ndiabetes\\tI-Disease\\nmellitus\\tI-Disease\\n(\\tO\\nIDDM\\tB-Disease\\n)\\tO\\nlocus\\tO\\nIDDM4\\tO\\non\\tO\\nchromosome\\tO\\n11q13\\tO\\n.\\tO\\n\\nBased\\tO\\non\\tO\\nits\\tO\\nchromosomal\\tO\\nposition\\tO\\n,\\tO\\nthis\\tO\\ngene\\tO\\nis\\tO\\na\\tO\\ncandidate\\tO\\nfor\\tO\\nconferring\\tO\\nsusceptibility\\tO\\nto\\tO\\ndiabetes\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\ngene\\tO\\n,\\tO\\ntermed\\tO\\nlow\\tO\\n-\\tO\\ndensity\\tO\\nlipoprotein\\tO\\nreceptor\\tO\\nrelated\\tO\\nprotein\\tO\\n5\\tO\\n(\\tO\\nLRP5\\tO\\n)\\tO\\n,\\tO\\nencodes\\tO\\na\\tO\\nprotein\\tO\\nof\\tO\\n1615\\tO\\namino\\tO\\nacids\\tO\\nthat\\tO\\ncontains\\tO\\nconserved\\tO\\nmodules\\tO\\nwhich\\tO\\nare\\tO\\ncharacteristic\\tO\\nof\\tO\\nthe\\tO\\nlow\\tO\\n-\\tO\\ndensity\\tO\\nlipoprotein\\tO\\n(\\tO\\nLDL\\tO\\n)\\tO\\nreceptor\\tO\\nfamily\\tO\\n.\\tO\\n\\nThese\\tO\\nmodules\\tO\\ninclude\\tO\\na\\tO\\nputative\\tO\\nsignal\\tO\\npeptide\\tO\\nfor\\tO\\nprotein\\tO\\nexport\\tO\\n,\\tO\\nfour\\tO\\nepidermal\\tO\\ngrowth\\tO\\nfactor\\tO\\n(\\tO\\nEGF\\tO\\n)\\tO\\nrepeats\\tO\\nwith\\tO\\nassociated\\tO\\nspacer\\tO\\ndomains\\tO\\n,\\tO\\nthree\\tO\\nLDL\\tO\\n-\\tO\\nreceptor\\tO\\n(\\tO\\nLDLR\\tO\\n)\\tO\\nrepeats\\tO\\n,\\tO\\na\\tO\\nsingle\\tO\\ntransmembrane\\tO\\nspanning\\tO\\ndomain\\tO\\n,\\tO\\nand\\tO\\na\\tO\\ncytoplasmic\\tO\\ndomain\\tO\\n.\\tO\\n\\nThe\\tO\\nencoded\\tO\\nprotein\\tO\\nhas\\tO\\na\\tO\\nunique\\tO\\norganization\\tO\\nof\\tO\\nEGF\\tO\\nand\\tO\\nLDLR\\tO\\nrepeats\\tO\\n;\\tO\\ntherefore\\tO\\n,\\tO\\nLRP5\\tO\\nlikely\\tO\\nrepresents\\tO\\na\\tO\\nnew\\tO\\ncategory\\tO\\nof\\tO\\nthe\\tO\\nLDLR\\tO\\nfamily\\tO\\n.\\tO\\n\\nBoth\\tO\\nhuman\\tO\\nand\\tO\\nmouse\\tO\\nLRP5\\tO\\ncDNAs\\tO\\nhave\\tO\\nbeen\\tO\\nisolated\\tO\\nand\\tO\\nthe\\tO\\nencoded\\tO\\nmature\\tO\\nproteins\\tO\\nare\\tO\\n95\\tO\\n%\\tO\\nidentical\\tO\\n,\\tO\\nindicating\\tO\\na\\tO\\nhigh\\tO\\ndegree\\tO\\nof\\tO\\nevolutionary\\tO\\nconservation\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nAPC\\tB-Disease\\nvariants\\tO\\nI1307K\\tO\\nand\\tO\\nE1317Q\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\ncolorectal\\tB-Disease\\ntumors\\tI-Disease\\n,\\tO\\nbut\\tO\\nnot\\tO\\nalways\\tO\\nwith\\tO\\na\\tO\\nfamily\\tO\\nhistory\\tO\\n.\\tO\\n\\nClassical\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\nis\\tO\\na\\tO\\nhigh\\tO\\n-\\tO\\npenetrance\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisease\\tI-Disease\\nthat\\tO\\npredisposes\\tO\\nto\\tO\\nhundreds\\tO\\nor\\tO\\nthousands\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\nadenomas\\tI-Disease\\nand\\tI-Disease\\ncarcinoma\\tI-Disease\\nand\\tO\\nthat\\tO\\nresults\\tO\\nfrom\\tO\\ntruncating\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nA\\tO\\nvariant\\tO\\nof\\tO\\nFAP\\tB-Disease\\nis\\tO\\nattenuated\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n,\\tO\\nwhich\\tO\\nresults\\tO\\nfrom\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\n5\\tO\\nand\\tO\\n3\\tO\\nregions\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nAttenuated\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\npatients\\tO\\nhave\\tO\\n\"\\tO\\nmultiple\\tO\\n\"\\tO\\ncolorectal\\tB-Disease\\nadenomas\\tI-Disease\\n(\\tO\\ntypically\\tO\\nfewer\\tO\\nthan\\tO\\n100\\tO\\n)\\tO\\nwithout\\tO\\nthe\\tO\\nflorid\\tO\\nphenotype\\tO\\nof\\tO\\nclassical\\tO\\nFAP\\tB-Disease\\n.\\tO\\n\\nAnother\\tO\\ngroup\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nmultiple\\tO\\nadenomas\\tB-Disease\\nhas\\tO\\nno\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\n,\\tO\\nand\\tO\\ntheir\\tO\\nphenotype\\tO\\nprobably\\tO\\nresults\\tO\\nfrom\\tO\\nvariation\\tO\\nat\\tO\\na\\tO\\nlocus\\tO\\n,\\tO\\nor\\tO\\nloci\\tO\\n,\\tO\\nelsewhere\\tO\\nin\\tO\\nthe\\tO\\ngenome\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\na\\tO\\nmissense\\tO\\nvariant\\tO\\nof\\tO\\nAPC\\tB-Disease\\n(\\tO\\nI1307K\\tO\\n)\\tO\\nwas\\tO\\ndescribed\\tO\\nthat\\tO\\nconfers\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ntumors\\tI-Disease\\n,\\tO\\nincluding\\tO\\nmultiple\\tO\\nadenomas\\tB-Disease\\n,\\tO\\nin\\tO\\nAshkenazim\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nstudied\\tO\\na\\tO\\nset\\tO\\nof\\tO\\n164\\tO\\npatients\\tO\\nwith\\tO\\nmultiple\\tO\\ncolorectal\\tB-Disease\\nadenomas\\tI-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\ncarcinoma\\tI-Disease\\nand\\tO\\nanalyzed\\tO\\ncodons\\tO\\n1263\\tO\\n-\\tO\\n1377\\tO\\n(\\tO\\nexon\\tO\\n15G\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nfor\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nvariants\\tO\\n.\\tO\\n\\nThree\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\nI1307K\\tO\\nallele\\tO\\nwere\\tO\\ndetected\\tO\\n,\\tO\\neach\\tO\\nof\\tO\\nAshkenazi\\tO\\ndescent\\tO\\n.\\tO\\n\\nFour\\tO\\npatients\\tO\\nhad\\tO\\na\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nE1317Q\\tO\\nmissense\\tO\\nvariant\\tO\\nof\\tO\\nAPC\\tO\\nthat\\tO\\nwas\\tO\\nnot\\tO\\npresent\\tO\\nin\\tO\\ncontrols\\tO\\n;\\tO\\none\\tO\\nof\\tO\\nthese\\tO\\nindividuals\\tO\\nhad\\tO\\nan\\tO\\nunusually\\tO\\nlarge\\tO\\nnumber\\tO\\nof\\tO\\nmetaplastic\\tB-Disease\\npolyps\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\ncolorectum\\tI-Disease\\n.\\tO\\n\\nThere\\tO\\nis\\tO\\nincreasing\\tO\\nevidence\\tO\\nthat\\tO\\nthere\\tO\\nexist\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nvariants\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nthat\\tO\\npredispose\\tO\\nto\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\nmultiple\\tO\\ncolorectal\\tB-Disease\\nadenomas\\tI-Disease\\nand\\tI-Disease\\ncarcinoma\\tI-Disease\\n,\\tO\\nbut\\tO\\nwithout\\tO\\nthe\\tO\\nflorid\\tO\\nphenotype\\tO\\nof\\tO\\nclassical\\tO\\nFAP\\tB-Disease\\n,\\tO\\nand\\tO\\npossibly\\tO\\nwith\\tO\\nimportance\\tO\\nfor\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nrisk\\tO\\nin\\tO\\nthe\\tO\\ngeneral\\tO\\npopulation\\tO\\n.\\tO\\n.\\tO\\n\\nGenomic\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\ncongenital\\tB-Disease\\nchloride\\tI-Disease\\ndiarrhea\\tI-Disease\\n(\\tO\\nCLD\\tB-Disease\\n)\\tO\\ngene\\tO\\n.\\tO\\n\\nCongenital\\tB-Disease\\nchloride\\tI-Disease\\ndiarrhea\\tI-Disease\\n(\\tO\\nCLD\\tB-Disease\\n)\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\ngene\\tO\\nwhich\\tO\\nencodes\\tO\\nan\\tO\\nintestinal\\tO\\nanion\\tO\\ntransporter\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthe\\tO\\ncomplete\\tO\\ngenomic\\tO\\norganization\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nCLD\\tB-Disease\\ngene\\tO\\nwhich\\tO\\nspans\\tO\\napproximately\\tO\\n39kb\\tO\\n,\\tO\\nand\\tO\\ncomprises\\tO\\n21\\tO\\nexons\\tO\\n.\\tO\\n\\nAll\\tO\\nexon\\tO\\n/\\tO\\nintron\\tO\\nboundaries\\tO\\nconform\\tO\\nto\\tO\\nthe\\tO\\nGT\\tO\\n/\\tO\\nAG\\tO\\nrule\\tO\\n.\\tO\\n\\nAn\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nputative\\tO\\npromoter\\tO\\nregion\\tO\\nsequence\\tO\\nshows\\tO\\na\\tO\\nputative\\tO\\nTATA\\tO\\nbox\\tO\\nand\\tO\\npredicts\\tO\\nmultiple\\tO\\ntranscription\\tO\\nfactor\\tO\\nbinding\\tO\\nsites\\tO\\n.\\tO\\n\\nThe\\tO\\ngenomic\\tO\\nstructure\\tO\\nwas\\tO\\ndetermined\\tO\\nusing\\tO\\nDNA\\tO\\nfrom\\tO\\nseveral\\tO\\nsources\\tO\\nincluding\\tO\\nmultiple\\tO\\nlarge\\tO\\n-\\tO\\ninsert\\tO\\nlibaries\\tO\\nand\\tO\\ngenomic\\tO\\nDNA\\tO\\nfrom\\tO\\nFinnish\\tO\\nCLD\\tB-Disease\\npatients\\tO\\nand\\tO\\ncontrols\\tO\\n.\\tO\\n\\nExon\\tO\\n-\\tO\\nspecific\\tO\\nprimers\\tO\\ndeveloped\\tO\\nin\\tO\\nthis\\tO\\nstudy\\tO\\nwill\\tO\\nfacilitate\\tO\\nmutation\\tO\\nscreening\\tO\\nstudies\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nGenomic\\tO\\nsequencing\\tO\\nof\\tO\\na\\tO\\nBAC\\tO\\nclone\\tO\\nH\\tO\\n_\\tO\\nRG364P16\\tO\\nrevealed\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nanother\\tO\\n,\\tO\\nhighly\\tO\\nhomologous\\tO\\ngene\\tO\\n3\\tO\\nof\\tO\\nthe\\tO\\nCLD\\tB-Disease\\ngene\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\nsimilar\\tO\\ngenomic\\tO\\nstructure\\tO\\n,\\tO\\nrecently\\tO\\nidentified\\tO\\nas\\tO\\nthe\\tO\\nPendred\\tB-Disease\\nsyndrome\\tI-Disease\\ngene\\tO\\n(\\tO\\nPDS\\tB-Disease\\n)\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nAPCI1307K\\tO\\nallele\\tO\\nand\\tO\\ncancer\\tB-Disease\\nrisk\\tO\\nin\\tO\\na\\tO\\ncommunity\\tO\\n-\\tO\\nbased\\tO\\nstudy\\tO\\nof\\tO\\nAshkenazi\\tO\\nJews\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nAPC\\tO\\nare\\tO\\nclassically\\tO\\nassociated\\tO\\nwith\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nhighly\\tO\\npenetrant\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisorder\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nmultiple\\tO\\nintestinal\\tO\\npolyps\\tB-Disease\\nand\\tO\\n,\\tO\\nwithout\\tO\\nsurgical\\tO\\nintervention\\tO\\n,\\tO\\nthe\\tO\\ndevelopment\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n(\\tO\\nCRC\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nAPC\\tB-Disease\\nis\\tO\\na\\tO\\ntumour\\tO\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\n,\\tO\\nand\\tO\\nsomatic\\tO\\nloss\\tO\\noccurs\\tO\\nin\\tO\\ntumours\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\ngermline\\tO\\nT\\tO\\n-\\tO\\nto\\tO\\n-\\tO\\nA\\tO\\ntransversion\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nAPC\\tO\\nI1307K\\tO\\nallele\\tO\\nconverts\\tO\\nthe\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nsequence\\tO\\nto\\tO\\na\\tO\\nhomopolymer\\tO\\ntract\\tO\\n(\\tO\\nA8\\tO\\n)\\tO\\nthat\\tO\\nis\\tO\\ngenetically\\tO\\nunstable\\tO\\nand\\tO\\nprone\\tO\\nto\\tO\\nsomatic\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nI1307K\\tO\\nallele\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\n6\\tO\\n.\\tO\\n\\n1\\tO\\n%\\tO\\nof\\tO\\nunselected\\tO\\nAshkenazi\\tO\\nJews\\tO\\nand\\tO\\nhigher\\tO\\nproportions\\tO\\nof\\tO\\nAshkenazim\\tO\\nwith\\tO\\nfamily\\tO\\nor\\tO\\npersonal\\tO\\nhistories\\tO\\nof\\tO\\nCRC\\tB-Disease\\n(\\tO\\nref\\tO\\n.\\tO\\n2\\tO\\n)\\tO\\n.\\tO\\n\\nTo\\tO\\nevaluate\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nI1307K\\tO\\nin\\tO\\ncancer\\tB-Disease\\n,\\tO\\nwe\\tO\\ngenotyped\\tO\\n5\\tO\\n,\\tO\\n081\\tO\\nAshkenazi\\tO\\nvolunteers\\tO\\nin\\tO\\na\\tO\\ncommunity\\tO\\nsurvey\\tO\\n.\\tO\\n\\nRisk\\tO\\nof\\tO\\ndeveloping\\tO\\ncolorectal\\tB-Disease\\n,\\tI-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\nother\\tI-Disease\\ncancers\\tI-Disease\\nwere\\tO\\ncompared\\tO\\nbetween\\tO\\ngenotyped\\tO\\nI1307K\\tO\\ncarriers\\tO\\nand\\tO\\nnon\\tO\\n-\\tO\\ncarriers\\tO\\nand\\tO\\ntheir\\tO\\nfirst\\tO\\n-\\tO\\ndegree\\tO\\nrelatives\\tO\\n.\\tO\\n\\nSperm\\tO\\nDNA\\tO\\nanalysis\\tO\\nin\\tO\\na\\tO\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\npremutation\\tO\\ncarrier\\tO\\nsuggests\\tO\\nboth\\tO\\nmeiotic\\tO\\nand\\tO\\nmitotic\\tO\\nexpansion\\tO\\nin\\tO\\nthe\\tO\\nFRDA\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nFriedreich\\tB-Disease\\nataxia\\tI-Disease\\nis\\tO\\nusually\\tO\\ncaused\\tO\\nby\\tO\\nan\\tO\\nexpansion\\tO\\nof\\tO\\na\\tO\\nGAA\\tO\\ntrinucleotide\\tO\\nrepeat\\tO\\nin\\tO\\nintron\\tO\\n1\\tO\\nof\\tO\\nthe\\tO\\nFRDA\\tB-Disease\\ngene\\tO\\n.\\tO\\n\\nOccasionally\\tO\\n,\\tO\\na\\tO\\nfully\\tO\\nexpanded\\tO\\nallele\\tO\\nhas\\tO\\nbeen\\tO\\nfound\\tO\\nto\\tO\\narise\\tO\\nfrom\\tO\\na\\tO\\npremutation\\tO\\nof\\tO\\n100\\tO\\nor\\tO\\nless\\tO\\ntriplet\\tO\\nrepeats\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nexamined\\tO\\nthe\\tO\\nsperm\\tO\\nDNA\\tO\\nof\\tO\\na\\tO\\npremutation\\tO\\ncarrier\\tO\\n.\\tO\\n\\nThis\\tO\\nmans\\tO\\nleucocyte\\tO\\nDNA\\tO\\nshowed\\tO\\none\\tO\\nnormal\\tO\\nallele\\tO\\nand\\tO\\none\\tO\\nallele\\tO\\nof\\tO\\napproximately\\tO\\n100\\tO\\nrepeats\\tO\\n.\\tO\\n\\nHis\\tO\\nsperm\\tO\\nshowed\\tO\\nan\\tO\\nexpanded\\tO\\nallele\\tO\\nin\\tO\\na\\tO\\ntight\\tO\\nrange\\tO\\ncentering\\tO\\non\\tO\\na\\tO\\nsize\\tO\\nof\\tO\\napproximately\\tO\\n320\\tO\\ntrinucleotide\\tO\\nrepeats\\tO\\n.\\tO\\n\\nHis\\tO\\naffected\\tO\\nson\\tO\\nhas\\tO\\nrepeat\\tO\\nsizes\\tO\\nof\\tO\\n1040\\tO\\nand\\tO\\n540\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nexpansion\\tO\\noccurs\\tO\\nin\\tO\\ntwo\\tO\\nstages\\tO\\n,\\tO\\nthe\\tO\\nfirst\\tO\\nduring\\tO\\nmeiosis\\tO\\nfollowed\\tO\\nby\\tO\\na\\tO\\nsecond\\tO\\nmitotic\\tO\\nexpansion\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nshow\\tO\\nthat\\tO\\nin\\tO\\nall\\tO\\ninformative\\tO\\ncarrier\\tO\\nfather\\tO\\nto\\tO\\naffected\\tO\\nchild\\tO\\ntransmissions\\tO\\n,\\tO\\nwith\\tO\\nthe\\tO\\nnotable\\tO\\nexception\\tO\\nof\\tO\\nthe\\tO\\npremutation\\tO\\ncarrier\\tO\\n,\\tO\\nthe\\tO\\nexpansion\\tO\\nsize\\tO\\ndecreases\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nR496H\\tO\\nmutation\\tO\\nof\\tO\\narylsulfatase\\tO\\nA\\tO\\ndoes\\tO\\nnot\\tO\\ncause\\tO\\nmetachromatic\\tB-Disease\\nleukodystrophy\\tI-Disease\\n.\\tO\\n\\nDeficiency\\tB-Disease\\nof\\tI-Disease\\narylsulfatase\\tI-Disease\\nA\\tI-Disease\\n(\\tO\\nARSA\\tO\\n)\\tO\\nenzyme\\tO\\nactivity\\tO\\ncauses\\tO\\nmetachromatic\\tB-Disease\\nleukodystrophy\\tI-Disease\\n(\\tO\\nMLD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nA\\tO\\nnumber\\tO\\nof\\tO\\nARSA\\tO\\ngene\\tO\\nmutations\\tO\\nresponsible\\tO\\nfor\\tO\\nMLD\\tB-Disease\\nhave\\tO\\nbeen\\tO\\nidentified\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nthe\\tO\\nR496H\\tO\\nmutation\\tO\\nof\\tO\\nARSA\\tO\\nwas\\tO\\nproposed\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\ncause\\tO\\nof\\tO\\nMLD\\tB-Disease\\n(\\tO\\nDraghia\\tO\\net\\tO\\nal\\tO\\n.\\tO\\n,\\tO\\n1997\\tO\\n)\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\ninvestigated\\tO\\nthe\\tO\\nR496H\\tO\\nmutation\\tO\\nand\\tO\\nfound\\tO\\nthis\\tO\\nmutation\\tO\\nat\\tO\\na\\tO\\nrelatively\\tO\\nhigh\\tO\\nfrequency\\tO\\nin\\tO\\nan\\tO\\nAfrican\\tO\\nAmerican\\tO\\npopulation\\tO\\n(\\tO\\nf\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n09\\tO\\n,\\tO\\nn\\tO\\n=\\tO\\n61\\tO\\nsubjects\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nARSA\\tO\\nenzyme\\tO\\nactivity\\tO\\nin\\tO\\nsubjects\\tO\\nwith\\tO\\nand\\tO\\nwithout\\tO\\nthe\\tO\\nR496H\\tO\\nmutation\\tO\\nwas\\tO\\ndetermined\\tO\\nand\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nnormal\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\ntherefore\\tO\\nconcluded\\tO\\nthat\\tO\\nthe\\tO\\nR496H\\tO\\nmutation\\tO\\nof\\tO\\nARSA\\tO\\ndoes\\tO\\nnot\\tO\\nnegatively\\tO\\ninfluence\\tO\\nthe\\tO\\nactivity\\tO\\nof\\tO\\nARSA\\tO\\nand\\tO\\nis\\tO\\nnot\\tO\\na\\tO\\ncause\\tO\\nof\\tO\\nMLD\\tB-Disease\\n\\nDown\\tO\\n-\\tO\\nregulation\\tO\\nof\\tO\\ntransmembrane\\tO\\ncarbonic\\tO\\nanhydrases\\tO\\nin\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\ncell\\tO\\nlines\\tO\\nby\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\ntransgenes\\tO\\n.\\tO\\n\\nTo\\tO\\ndiscover\\tO\\ngenes\\tO\\ninvolved\\tO\\nin\\tO\\nvon\\tB-Disease\\nHippel\\tI-Disease\\n-\\tI-Disease\\nLindau\\tI-Disease\\n(\\tO\\nVHL\\tB-Disease\\n)\\tO\\n-\\tO\\nmediated\\tO\\ncarcinogenesis\\tO\\n,\\tO\\nwe\\tO\\nused\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\ncell\\tO\\nlines\\tO\\nstably\\tO\\ntransfected\\tO\\nwith\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nVHL\\tO\\n-\\tO\\nexpressing\\tO\\ntransgenes\\tO\\n.\\tO\\n\\nLarge\\tO\\n-\\tO\\nscale\\tO\\nRNA\\tO\\ndifferential\\tO\\ndisplay\\tO\\ntechnology\\tO\\napplied\\tO\\nto\\tO\\nthese\\tO\\ncell\\tO\\nlines\\tO\\nidentified\\tO\\nseveral\\tO\\ndifferentially\\tO\\nexpressed\\tO\\ngenes\\tO\\n,\\tO\\nincluding\\tO\\nan\\tO\\nalpha\\tO\\ncarbonic\\tO\\nanhydrase\\tO\\ngene\\tO\\n,\\tO\\ntermed\\tO\\nCA12\\tO\\n.\\tO\\n\\nThe\\tO\\ndeduced\\tO\\nprotein\\tO\\nsequence\\tO\\nwas\\tO\\nclassified\\tO\\nas\\tO\\na\\tO\\none\\tO\\n-\\tO\\npass\\tO\\ntransmembrane\\tO\\nCA\\tO\\npossessing\\tO\\nan\\tO\\napparently\\tO\\nintact\\tO\\ncatalytic\\tO\\ndomain\\tO\\nin\\tO\\nthe\\tO\\nextracellular\\tO\\nCA\\tO\\nmodule\\tO\\n.\\tO\\n\\nReintroduced\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nVHL\\tB-Disease\\nstrongly\\tO\\ninhibited\\tO\\nthe\\tO\\noverexpression\\tO\\nof\\tO\\nthe\\tO\\nCA12\\tO\\ngene\\tO\\nin\\tO\\nthe\\tO\\nparental\\tO\\nrenal\\tB-Disease\\ncell\\tI-Disease\\ncarcinoma\\tI-Disease\\ncell\\tO\\nlines\\tO\\n.\\tO\\n\\nSimilar\\tO\\nresults\\tO\\nwere\\tO\\nobtained\\tO\\nwith\\tO\\nCA9\\tO\\n,\\tO\\nencoding\\tO\\nanother\\tO\\ntransmembrane\\tO\\nCA\\tO\\nwith\\tO\\nan\\tO\\nintact\\tO\\ncatalytic\\tO\\ndomain\\tO\\n.\\tO\\n\\nAlthough\\tO\\nboth\\tO\\ndomains\\tO\\nof\\tO\\nthe\\tO\\nVHL\\tB-Disease\\nprotein\\tO\\ncontribute\\tO\\nto\\tO\\nregulation\\tO\\nof\\tO\\nCA12\\tO\\nexpression\\tO\\n,\\tO\\nthe\\tO\\nelongin\\tO\\nbinding\\tO\\ndomain\\tO\\nalone\\tO\\ncould\\tO\\neffectively\\tO\\nregulate\\tO\\nCA9\\tO\\nexpression\\tO\\n.\\tO\\n\\nWe\\tO\\nmapped\\tO\\nCA12\\tO\\nand\\tO\\nCA9\\tO\\nloci\\tO\\nto\\tO\\nchromosome\\tO\\nbands\\tO\\n15q22\\tO\\nand\\tO\\n17q21\\tO\\n.\\tO\\n\\n2\\tO\\nrespectively\\tO\\n,\\tO\\nregions\\tO\\nprone\\tO\\nto\\tO\\namplification\\tO\\nin\\tO\\nsome\\tO\\nhuman\\tO\\ncancers\\tB-Disease\\n.\\tO\\n\\nAdditional\\tO\\nexperiments\\tO\\nare\\tO\\nneeded\\tO\\nto\\tO\\ndefine\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nCA\\tO\\nIX\\tO\\nand\\tO\\nCA\\tO\\nXII\\tO\\nenzymes\\tO\\nin\\tO\\nthe\\tO\\nregulation\\tO\\nof\\tO\\npH\\tO\\nin\\tO\\nthe\\tO\\nextracellular\\tO\\nmicroenvironment\\tO\\nand\\tO\\nits\\tO\\npotential\\tO\\nimpact\\tO\\non\\tO\\ncancer\\tB-Disease\\ncell\\tO\\ngrowth\\tO\\n.\\tO\\n\\nA\\tO\\ngene\\tO\\nencoding\\tO\\na\\tO\\ntransmembrane\\tO\\nprotein\\tO\\nis\\tO\\nmutated\\tO\\nin\\tO\\npatients\\tO\\nwith\\tO\\ndiabetes\\tB-Disease\\nmellitus\\tI-Disease\\nand\\tO\\noptic\\tB-Disease\\natrophy\\tI-Disease\\n(\\tO\\nWolfram\\tB-Disease\\nsyndrome\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nWolfram\\tB-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nWFS\\tB-Disease\\n;\\tO\\nOMIM\\tO\\n222300\\tO\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nneurodegenerative\\tI-Disease\\ndisorder\\tI-Disease\\ndefined\\tO\\nby\\tO\\nyoung\\tO\\n-\\tO\\nonset\\tO\\nnon\\tO\\n-\\tO\\nimmune\\tO\\ninsulin\\tB-Disease\\n-\\tI-Disease\\ndependent\\tI-Disease\\ndiabetes\\tI-Disease\\nmellitus\\tI-Disease\\nand\\tO\\nprogressive\\tO\\noptic\\tB-Disease\\natrophy\\tI-Disease\\n.\\tO\\n\\nLinkage\\tO\\nto\\tO\\nmarkers\\tO\\non\\tO\\nchromosome\\tO\\n4p\\tO\\nwas\\tO\\nconfirmed\\tO\\nin\\tO\\nfive\\tO\\nfamilies\\tO\\n.\\tO\\n\\nOn\\tO\\nthe\\tO\\nbasis\\tO\\nof\\tO\\nmeiotic\\tO\\nrecombinants\\tO\\nand\\tO\\ndisease\\tO\\n-\\tO\\nassociated\\tO\\nhaplotypes\\tO\\n,\\tO\\nthe\\tO\\nWFS\\tB-Disease\\ngene\\tO\\nwas\\tO\\nlocalized\\tO\\nto\\tO\\na\\tO\\nBAC\\tO\\n/\\tO\\nP1\\tO\\ncontig\\tO\\nof\\tO\\nless\\tO\\nthan\\tO\\n250\\tO\\nkb\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\na\\tO\\nnovel\\tO\\ngene\\tO\\n(\\tO\\nWFS1\\tO\\n)\\tO\\nencoding\\tO\\na\\tO\\nputative\\tO\\ntransmembrane\\tO\\nprotein\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nall\\tO\\naffected\\tO\\nindividuals\\tO\\nin\\tO\\nsix\\tO\\nWFS\\tB-Disease\\nfamilies\\tO\\n,\\tO\\nand\\tO\\nthese\\tO\\nmutations\\tO\\nwere\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\ndisease\\tO\\nphenotype\\tO\\n.\\tO\\n\\nWFS1\\tO\\nappears\\tO\\nto\\tO\\nfunction\\tO\\nin\\tO\\nsurvival\\tO\\nof\\tO\\nislet\\tO\\nbeta\\tO\\n-\\tO\\ncells\\tO\\nand\\tO\\nneurons\\tO\\n.\\tO\\n.\\tO\\n\\nStable\\tO\\ninteraction\\tO\\nbetween\\tO\\nthe\\tO\\nproducts\\tO\\nof\\tO\\nthe\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\ntumor\\tB-Disease\\nsuppressor\\tO\\ngenes\\tO\\nin\\tO\\nmitotic\\tO\\nand\\tO\\nmeiotic\\tO\\ncells\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\naccount\\tO\\nfor\\tO\\nmost\\tO\\ncases\\tO\\nof\\tO\\nfamilial\\tO\\n,\\tO\\nearly\\tO\\nonset\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nand\\tO\\nencode\\tO\\nproducts\\tO\\nthat\\tO\\neach\\tO\\ninteract\\tO\\nwith\\tO\\nhRAD51\\tO\\n.\\tO\\n\\nResults\\tO\\npresented\\tO\\nhere\\tO\\nshow\\tO\\nthat\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\ncoexist\\tO\\nin\\tO\\na\\tO\\nbiochemical\\tO\\ncomplex\\tO\\nand\\tO\\ncolocalize\\tO\\nin\\tO\\nsubnuclear\\tO\\nfoci\\tO\\nin\\tO\\nsomatic\\tO\\ncells\\tO\\nand\\tO\\non\\tO\\nthe\\tO\\naxial\\tO\\nelements\\tO\\nof\\tO\\ndeveloping\\tO\\nsynaptonemal\\tO\\ncomplexes\\tO\\n.\\tO\\n\\nLike\\tO\\nBRCA1\\tO\\nand\\tO\\nRAD51\\tO\\n,\\tO\\nBRCA2\\tO\\nrelocates\\tO\\nto\\tO\\nPCNA\\tO\\n+\\tO\\nreplication\\tO\\nsites\\tO\\nfollowing\\tO\\nexposure\\tO\\nof\\tO\\nS\\tO\\nphase\\tO\\ncells\\tO\\nto\\tO\\nhydroxyurea\\tO\\nor\\tO\\nUV\\tO\\nirradiation\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nparticipate\\tO\\n,\\tO\\ntogether\\tO\\n,\\tO\\nin\\tO\\na\\tO\\npathway\\tO\\n(\\tO\\ns\\tO\\n)\\tO\\nassociated\\tO\\nwith\\tO\\nthe\\tO\\nactivation\\tO\\nof\\tO\\ndouble\\tO\\n-\\tO\\nstrand\\tO\\nbreak\\tO\\nrepair\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nhomologous\\tO\\nrecombination\\tO\\n.\\tO\\n\\nDysfunction\\tO\\nof\\tO\\nthis\\tO\\npathway\\tO\\nmay\\tO\\nbe\\tO\\na\\tO\\ngeneral\\tO\\nphenomenon\\tO\\nin\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\ncases\\tO\\nof\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\n/\\tI-Disease\\nor\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nA\\tO\\nnovel\\tO\\nArg362Ser\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nsterol\\tO\\n27\\tO\\n-\\tO\\nhydroxylase\\tO\\ngene\\tO\\n(\\tO\\nCYP27\\tO\\n)\\tO\\n:\\tO\\nits\\tO\\neffects\\tO\\non\\tO\\npre\\tO\\n-\\tO\\nmRNA\\tO\\nsplicing\\tO\\nand\\tO\\nenzyme\\tO\\nactivity\\tO\\n.\\tO\\n\\nA\\tO\\nnovel\\tO\\nC\\tO\\nto\\tO\\nA\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nsterol\\tO\\n27\\tO\\n-\\tO\\nhydroxylase\\tO\\ngene\\tO\\n(\\tO\\nCYP27\\tO\\n)\\tO\\nwas\\tO\\nidentified\\tO\\nby\\tO\\nsequencing\\tO\\namplified\\tO\\nCYP27\\tO\\ngene\\tO\\nproducts\\tO\\nfrom\\tO\\na\\tO\\npatient\\tO\\nwith\\tO\\ncerebrotendinous\\tB-Disease\\nxanthomatosis\\tI-Disease\\n(\\tO\\nCTX\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nmutation\\tO\\nchanged\\tO\\nthe\\tO\\nadrenodoxin\\tO\\ncofactor\\tO\\nbinding\\tO\\nresidue\\tO\\n362Arg\\tO\\nto\\tO\\n362Ser\\tO\\n(\\tO\\nCGT\\tO\\n362Arg\\tO\\nto\\tO\\nAGT\\tO\\n362Ser\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\nwas\\tO\\nresponsible\\tO\\nfor\\tO\\ndeficiency\\tO\\nin\\tO\\nthe\\tO\\nsterol\\tO\\n27\\tO\\n-\\tO\\nhydroxylase\\tO\\nactivity\\tO\\n,\\tO\\nas\\tO\\nconfirmed\\tO\\nby\\tO\\nexpression\\tO\\nof\\tO\\nmutant\\tO\\ncDNA\\tO\\ninto\\tO\\nCOS\\tO\\n-\\tO\\n1\\tO\\ncells\\tO\\n.\\tO\\n\\nQuantitative\\tO\\nanalysis\\tO\\nshowed\\tO\\nthat\\tO\\nthe\\tO\\nexpression\\tO\\nof\\tO\\nCYP27\\tO\\ngene\\tO\\nmRNA\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\nrepresented\\tO\\n52\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\nlevel\\tO\\n.\\tO\\n\\nAs\\tO\\nthe\\tO\\nmutation\\tO\\noccurred\\tO\\nat\\tO\\nthe\\tO\\npenultimate\\tO\\nnucleotide\\tO\\nof\\tO\\nexon\\tO\\n6\\tO\\n(\\tO\\n-\\tO\\n2\\tO\\nposition\\tO\\nof\\tO\\nexon\\tO\\n6\\tO\\n-\\tO\\nintron\\tO\\n6\\tO\\nsplice\\tO\\nsite\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nwe\\tO\\nhypothesized\\tO\\nthat\\tO\\nthe\\tO\\nmutation\\tO\\nmay\\tO\\npartially\\tO\\naffect\\tO\\nthe\\tO\\nnormal\\tO\\nsplicing\\tO\\nefficiency\\tO\\nin\\tO\\nexon\\tO\\n6\\tO\\nand\\tO\\ncause\\tO\\nalternative\\tO\\nsplicing\\tO\\nelsewhere\\tO\\n,\\tO\\nwhich\\tO\\nresulted\\tO\\nin\\tO\\ndecreased\\tO\\ntranscript\\tO\\nin\\tO\\nthe\\tO\\npatient\\tO\\n.\\tO\\n\\nTransfection\\tO\\nof\\tO\\nconstructed\\tO\\nminigenes\\tO\\n,\\tO\\nwith\\tO\\nor\\tO\\nwithout\\tO\\nthe\\tO\\nmutation\\tO\\n,\\tO\\ninto\\tO\\nCOS\\tO\\n-\\tO\\n1\\tO\\ncells\\tO\\nconfirmed\\tO\\nthat\\tO\\nthe\\tO\\nmutant\\tO\\nminigene\\tO\\nwas\\tO\\nresponsible\\tO\\nfor\\tO\\na\\tO\\nmRNA\\tO\\nspecies\\tO\\nalternatively\\tO\\nspliced\\tO\\nat\\tO\\nan\\tO\\nactivated\\tO\\ncryptic\\tO\\n5\\tO\\nsplice\\tO\\nsite\\tO\\n88\\tO\\nbp\\tO\\nupstream\\tO\\nfrom\\tO\\nthe\\tO\\n3\\tO\\nend\\tO\\nof\\tO\\nexon\\tO\\n6\\tO\\n.\\tO\\n\\nOur\\tO\\ndata\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\nC\\tO\\nto\\tO\\nA\\tO\\nmutation\\tO\\nat\\tO\\nthe\\tO\\npenultimate\\tO\\nnucleotide\\tO\\nof\\tO\\nexon\\tO\\n6\\tO\\nof\\tO\\nthe\\tO\\nCYP27\\tO\\ngene\\tO\\nnot\\tO\\nonly\\tO\\ncauses\\tO\\nthe\\tO\\ndeficiency\\tB-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\nsterol\\tI-Disease\\n27\\tI-Disease\\n-\\tI-Disease\\nhydroxylase\\tI-Disease\\nactivity\\tI-Disease\\n,\\tO\\nbut\\tO\\nalso\\tO\\npartially\\tO\\nleads\\tO\\nto\\tO\\nalternative\\tO\\npre\\tO\\n-\\tO\\nmRNA\\tO\\nsplicing\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n.\\tO\\n\\nTo\\tO\\nour\\tO\\nknowledge\\tO\\n,\\tO\\nthis\\tO\\nis\\tO\\nthe\\tO\\nfirst\\tO\\nreport\\tO\\nregarding\\tO\\neffects\\tO\\non\\tO\\npre\\tO\\n-\\tO\\nmRNA\\tO\\nsplicing\\tO\\nof\\tO\\na\\tO\\nmutation\\tO\\nat\\tO\\nthe\\tO\\n-\\tO\\n2\\tO\\nposition\\tO\\nof\\tO\\na\\tO\\n5\\tO\\nsplice\\tO\\nsite\\tO\\n.\\tO\\n\\nATM\\tO\\ngermline\\tO\\nmutations\\tO\\nin\\tO\\nclassical\\tO\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\npatients\\tO\\nin\\tO\\nthe\\tO\\nDutch\\tO\\npopulation\\tO\\n.\\tO\\n\\nGermline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nATM\\tO\\ngene\\tO\\nare\\tO\\nresponsible\\tO\\nfor\\tO\\nthe\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\ndisorder\\tI-Disease\\nataxia\\tB-Disease\\n-\\tI-Disease\\ntelangiectasia\\tI-Disease\\n(\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\n)\\tO\\n.\\tO\\n\\nIn\\tO\\nour\\tO\\nstudy\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ndetermined\\tO\\nthe\\tO\\nATM\\tO\\nmutation\\tO\\nspectrum\\tO\\nin\\tO\\n19\\tO\\nclassical\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\npatients\\tO\\n,\\tO\\nincluding\\tO\\nsome\\tO\\nimmigrant\\tO\\npopulations\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\n12\\tO\\nof\\tO\\nDutch\\tO\\nethnic\\tO\\norigin\\tO\\n.\\tO\\n\\nBoth\\tO\\nthe\\tO\\nprotein\\tO\\ntruncation\\tO\\ntest\\tO\\n(\\tO\\nPTT\\tO\\n)\\tO\\nand\\tO\\nthe\\tO\\nrestriction\\tO\\nendonuclease\\tO\\nfingerprinting\\tO\\n(\\tO\\nREF\\tO\\n)\\tO\\nmethod\\tO\\nwere\\tO\\nused\\tO\\nand\\tO\\ncompared\\tO\\nfor\\tO\\ntheir\\tO\\ndetection\\tO\\nefficiency\\tO\\n,\\tO\\nidentifying\\tO\\n76\\tO\\n%\\tO\\nand\\tO\\n60\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nmutations\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nMost\\tO\\npatients\\tO\\nwere\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\ncompound\\tO\\nheterozygote\\tO\\n.\\tO\\n\\nSeventeen\\tO\\nmutations\\tO\\nwere\\tO\\ndistinct\\tO\\n,\\tO\\nof\\tO\\nwhich\\tO\\n10\\tO\\nwere\\tO\\nnot\\tO\\nreported\\tO\\npreviously\\tO\\n.\\tO\\n\\nMutations\\tO\\nare\\tO\\nsmall\\tO\\ndeletions\\tO\\nor\\tO\\npoint\\tO\\nmutations\\tO\\nfrequently\\tO\\naffecting\\tO\\nsplice\\tO\\nsites\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\na\\tO\\n16\\tO\\n.\\tO\\n\\n7\\tO\\n-\\tO\\nkb\\tO\\ngenomic\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\n3\\tO\\nend\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n,\\tO\\nmost\\tO\\nlikely\\tO\\na\\tO\\nresult\\tO\\nof\\tO\\nrecombination\\tO\\nbetween\\tO\\ntwo\\tO\\nLINE\\tO\\nelements\\tO\\n,\\tO\\nwas\\tO\\nidentified\\tO\\n.\\tO\\n\\nThe\\tO\\nmost\\tO\\nfrequently\\tO\\nfound\\tO\\nmutation\\tO\\n,\\tO\\nidentified\\tO\\nin\\tO\\nthree\\tO\\nunrelated\\tO\\nTurkish\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nindividuals\\tO\\n,\\tO\\nwas\\tO\\npreviously\\tO\\ndescribed\\tO\\nto\\tO\\nbe\\tO\\na\\tO\\nTurkish\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nfounder\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nfounder\\tO\\nmutation\\tO\\namong\\tO\\nrelatively\\tO\\nsmall\\tO\\nethnic\\tO\\npopulation\\tO\\ngroups\\tO\\nin\\tO\\nWestern\\tO\\nEurope\\tO\\ncould\\tO\\nindicate\\tO\\na\\tO\\nhigh\\tO\\ncarrier\\tO\\nfrequency\\tO\\nin\\tO\\nsuch\\tO\\ncommunities\\tO\\n.\\tO\\n\\nIn\\tO\\npatients\\tO\\nof\\tO\\nDutch\\tO\\nethnic\\tO\\norigin\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nno\\tO\\nsignificant\\tO\\nfounder\\tO\\neffect\\tO\\ncould\\tO\\nbe\\tO\\nidentified\\tO\\n.\\tO\\n\\nThe\\tO\\nobserved\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\nincluding\\tO\\nthe\\tO\\nrelative\\tO\\nhigh\\tO\\npercentage\\tO\\nof\\tO\\nsplice\\tO\\n-\\tO\\nsite\\tO\\nmutations\\tO\\nhad\\tO\\nno\\tO\\nreflection\\tO\\non\\tO\\nthe\\tO\\nphenotype\\tO\\n.\\tO\\n\\nAll\\tO\\npatients\\tO\\nmanifested\\tO\\nclassical\\tO\\nA\\tB-Disease\\n-\\tI-Disease\\nT\\tI-Disease\\nand\\tO\\nincreased\\tO\\ncellular\\tO\\nradioresistant\\tO\\nDNA\\tO\\nsynthesis\\tO\\n.\\tO\\n\\nDetermination\\tO\\nof\\tO\\nthe\\tO\\ngenomic\\tO\\nstructure\\tO\\nof\\tO\\nthe\\tO\\nCOL4A4\\tO\\ngene\\tO\\nand\\tO\\nof\\tO\\nnovel\\tO\\nmutations\\tO\\ncausing\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nAlport\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nAutosomal\\tB-Disease\\nrecessive\\tI-Disease\\nAlport\\tI-Disease\\nsyndrome\\tI-Disease\\nis\\tO\\na\\tO\\nprogressive\\tO\\nhematuric\\tB-Disease\\nglomerulonephritis\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\nglomerular\\tB-Disease\\nbasement\\tI-Disease\\nmembrane\\tI-Disease\\nabnormalities\\tI-Disease\\nand\\tO\\nassociated\\tO\\nwith\\tO\\nmutations\\tO\\nin\\tO\\neither\\tO\\nthe\\tO\\nCOL4A3\\tO\\nor\\tO\\nthe\\tO\\nCOL4A4\\tO\\ngene\\tO\\n,\\tO\\nwhich\\tO\\nencode\\tO\\nthe\\tO\\nalpha3\\tO\\nand\\tO\\nalpha4\\tO\\ntype\\tO\\nIV\\tO\\ncollagen\\tO\\nchains\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nTo\\tO\\ndate\\tO\\n,\\tO\\nmutation\\tO\\nscreening\\tO\\nin\\tO\\nthe\\tO\\ntwo\\tO\\ngenes\\tO\\nhas\\tO\\nbeen\\tO\\nhampered\\tO\\nby\\tO\\nthe\\tO\\nlack\\tO\\nof\\tO\\ngenomic\\tO\\nstructure\\tO\\ninformation\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nhere\\tO\\nthe\\tO\\ncomplete\\tO\\ncharacterization\\tO\\nof\\tO\\nthe\\tO\\n48\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\nCOL4A4\\tO\\ngene\\tO\\n,\\tO\\na\\tO\\ncomprehensive\\tO\\ngene\\tO\\nscreen\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nsubsequent\\tO\\ndetection\\tO\\nof\\tO\\n10\\tO\\nnovel\\tO\\nmutations\\tO\\nin\\tO\\neight\\tO\\npatients\\tO\\ndiagnosed\\tO\\nwith\\tO\\nautosomal\\tB-Disease\\nrecessive\\tI-Disease\\nAlport\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\nwe\\tO\\nidentified\\tO\\na\\tO\\nglycine\\tO\\nto\\tO\\nalanine\\tO\\nsubstitution\\tO\\nin\\tO\\nthe\\tO\\ncollagenous\\tO\\ndomain\\tO\\nthat\\tO\\nis\\tO\\napparently\\tO\\nsilent\\tO\\nin\\tO\\nthe\\tO\\nheterozygous\\tO\\ncarriers\\tO\\n,\\tO\\nin\\tO\\n11\\tO\\n.\\tO\\n\\n5\\tO\\n%\\tO\\nof\\tO\\nall\\tO\\ncontrol\\tO\\nindividuals\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\none\\tO\\ncontrol\\tO\\nindividual\\tO\\nhomozygous\\tO\\nfor\\tO\\nthis\\tO\\nglycine\\tO\\nsubstitution\\tO\\n.\\tO\\n\\nThere\\tO\\nhas\\tO\\nbeen\\tO\\nno\\tO\\nprevious\\tO\\nfinding\\tO\\nof\\tO\\na\\tO\\nglycine\\tO\\nsubstitution\\tO\\nthat\\tO\\nis\\tO\\nnot\\tO\\nassociated\\tO\\nwith\\tO\\nany\\tO\\nobvious\\tO\\nphenotype\\tO\\nin\\tO\\nhomozygous\\tO\\nindividuals\\tO\\n.\\tO\\n\\nFounder\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nmutations\\tO\\nin\\tO\\nFrench\\tO\\nCanadian\\tO\\nbreast\\tB-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\nfour\\tO\\nmutations\\tO\\nin\\tO\\neach\\tO\\nof\\tO\\nthe\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\n-\\tO\\nsusceptibility\\tO\\ngenes\\tO\\n,\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\n,\\tO\\nin\\tO\\nFrench\\tO\\nCanadian\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\nfrom\\tO\\nQuebec\\tO\\n.\\tO\\n\\nTo\\tO\\nidentify\\tO\\nfounder\\tO\\neffects\\tO\\n,\\tO\\nwe\\tO\\nexamined\\tO\\nindependently\\tO\\nascertained\\tO\\nFrench\\tO\\nCanadian\\tO\\ncancer\\tB-Disease\\nfamilies\\tO\\nfor\\tO\\nthe\\tO\\ndistribution\\tO\\nof\\tO\\nthese\\tO\\neight\\tO\\nmutations\\tO\\n.\\tO\\n\\nMutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\n41\\tO\\nof\\tO\\n97\\tO\\nfamilies\\tO\\n.\\tO\\n\\nSix\\tO\\nof\\tO\\neight\\tO\\nmutations\\tO\\nwere\\tO\\nobserved\\tO\\nat\\tO\\nleast\\tO\\ntwice\\tO\\n.\\tO\\n\\nThe\\tO\\nBRCA1\\tO\\nC4446T\\tO\\nmutation\\tO\\nwas\\tO\\nthe\\tO\\nmost\\tO\\ncommon\\tO\\nmutation\\tO\\nfound\\tO\\n,\\tO\\nfollowed\\tO\\nby\\tO\\nthe\\tO\\nBRCA2\\tO\\n8765delAG\\tO\\nmutation\\tO\\n.\\tO\\n\\nTogether\\tO\\n,\\tO\\nthese\\tO\\nmutations\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\n28\\tO\\nof\\tO\\n41\\tO\\nfamilies\\tO\\nidentified\\tO\\nto\\tO\\nhave\\tO\\na\\tO\\nmutation\\tO\\n.\\tO\\n\\nThe\\tO\\nodds\\tO\\nof\\tO\\ndetection\\tO\\nof\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\nfour\\tO\\nBRCA1\\tO\\nmutations\\tO\\nwas\\tO\\n18\\tO\\n.\\tO\\n\\n7x\\tO\\ngreater\\tO\\nif\\tO\\none\\tO\\nor\\tO\\nmore\\tO\\ncases\\tO\\nof\\tO\\novarian\\tB-Disease\\ncancer\\tI-Disease\\nwere\\tO\\nalso\\tO\\npresent\\tO\\nin\\tO\\nthe\\tO\\nfamily\\tO\\n.\\tO\\n\\nThe\\tO\\nodds\\tO\\nof\\tO\\ndetection\\tO\\nof\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\nfour\\tO\\nBRCA2\\tO\\nmutations\\tO\\nwas\\tO\\n5\\tO\\n.\\tO\\n\\n3x\\tO\\ngreater\\tO\\nif\\tO\\nthere\\tO\\nwere\\tO\\nat\\tO\\nleast\\tO\\nfive\\tO\\ncases\\tO\\nof\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\nthe\\tO\\nfamily\\tO\\n.\\tO\\n\\nInterestingly\\tO\\n,\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\ncase\\tO\\n<\\tO\\n36\\tO\\nyears\\tO\\nof\\tO\\nage\\tO\\nwas\\tO\\nstrongly\\tO\\npredictive\\tO\\nof\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\nany\\tO\\nof\\tO\\nthe\\tO\\neight\\tO\\nmutations\\tO\\nscreened\\tO\\n.\\tO\\n\\nCarriers\\tO\\nof\\tO\\nthe\\tO\\nsame\\tO\\nmutation\\tO\\n,\\tO\\nfrom\\tO\\ndifferent\\tO\\nfamilies\\tO\\n,\\tO\\nshared\\tO\\nsimilar\\tO\\nhaplotypes\\tO\\n,\\tO\\nindicating\\tO\\nthat\\tO\\nthe\\tO\\nmutant\\tO\\nalleles\\tO\\nwere\\tO\\nlikely\\tO\\nto\\tO\\nbe\\tO\\nidentical\\tO\\nby\\tO\\ndescent\\tO\\nfor\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nfounder\\tO\\npopulation\\tO\\n.\\tO\\n\\nThe\\tO\\nidentification\\tO\\nof\\tO\\ncommon\\tO\\nBRCA1\\tO\\nand\\tO\\nBRCA2\\tO\\nmutations\\tO\\nwill\\tO\\nfacilitate\\tO\\ncarrier\\tO\\ndetection\\tO\\nin\\tO\\nFrench\\tO\\nCanadian\\tO\\nbreast\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\nbreast\\tB-Disease\\n/\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nfamilies\\tO\\n.\\tO\\n\\nAre\\tO\\nDp71\\tO\\nand\\tO\\nDp140\\tO\\nbrain\\tO\\ndystrophin\\tO\\nisoforms\\tO\\nrelated\\tO\\nto\\tO\\ncognitive\\tB-Disease\\nimpairment\\tI-Disease\\nin\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n?\\tO\\n\\nMolecular\\tO\\nstudy\\tO\\nand\\tO\\nneuropsychological\\tO\\nanalysis\\tO\\nwere\\tO\\nperformed\\tO\\nconcurrently\\tO\\non\\tO\\n49\\tO\\npatients\\tO\\nwith\\tO\\nDuchenne\\tB-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDMD\\tB-Disease\\n)\\tO\\nin\\tO\\norder\\tO\\nto\\tO\\nfind\\tO\\na\\tO\\nmolecular\\tO\\nexplanation\\tO\\nfor\\tO\\nthe\\tO\\ncognitive\\tB-Disease\\nimpairment\\tI-Disease\\nobserved\\tO\\nin\\tO\\nmost\\tO\\nDMD\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nComplete\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\ndystrophin\\tO\\ngene\\tO\\nwas\\tO\\nperformed\\tO\\nto\\tO\\ndefine\\tO\\nthe\\tO\\nlocalization\\tO\\nof\\tO\\ndeletions\\tO\\nand\\tO\\nduplications\\tO\\nin\\tO\\nrelation\\tO\\nto\\tO\\nthe\\tO\\ndifferent\\tO\\nDMD\\tB-Disease\\npromoters\\tO\\n.\\tO\\n\\nQualitative\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nDp71\\tO\\ntranscript\\tO\\nand\\tO\\ntesting\\tO\\nfor\\tO\\nthe\\tO\\nspecific\\tO\\nfirst\\tO\\nexon\\tO\\nof\\tO\\nDp140\\tO\\nwere\\tO\\nalso\\tO\\ncarried\\tO\\nout\\tO\\n.\\tO\\n\\nNeuropsychological\\tO\\nanalysis\\tO\\nassessed\\tO\\nverbal\\tO\\nand\\tO\\nvisuospatial\\tO\\nintelligence\\tO\\n,\\tO\\nverbal\\tO\\nmemory\\tO\\n,\\tO\\nand\\tO\\nreading\\tO\\nskills\\tO\\n.\\tO\\n\\nComparison\\tO\\nof\\tO\\nmolecular\\tO\\nand\\tO\\npsychometric\\tO\\nfindings\\tO\\ndemonstrated\\tO\\nthat\\tO\\ndeletions\\tO\\nand\\tO\\nduplications\\tO\\nthat\\tO\\nwere\\tO\\nlocalized\\tO\\nin\\tO\\nthe\\tO\\ndistal\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nseemed\\tO\\nto\\tO\\nbe\\tO\\npreferentially\\tO\\nassociated\\tO\\nwith\\tO\\ncognitive\\tB-Disease\\nimpairment\\tI-Disease\\n.\\tO\\n\\nTwo\\tO\\naltered\\tO\\nDp71\\tO\\ntranscripts\\tO\\nand\\tO\\ntwo\\tO\\ndeleted\\tO\\nDp140\\tO\\nDNA\\tO\\nsequences\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\nfour\\tO\\npatients\\tO\\nwith\\tO\\nsevere\\tO\\ncerebral\\tB-Disease\\ndysfunction\\tI-Disease\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nsuggest\\tO\\nthat\\tO\\nsome\\tO\\nsequences\\tO\\nlocated\\tO\\nin\\tO\\nthe\\tO\\ndistal\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nand\\tO\\n,\\tO\\nin\\tO\\nparticular\\tO\\n,\\tO\\nsome\\tO\\nDMD\\tB-Disease\\nisoforms\\tO\\nexpressed\\tO\\nin\\tO\\nthe\\tO\\nbrain\\tO\\nmay\\tO\\nbe\\tO\\nrelated\\tO\\nto\\tO\\nthe\\tO\\ncognitive\\tB-Disease\\nimpairment\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nDMD\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nI1307K\\tO\\nAPC\\tO\\nand\\tO\\nhMLH1\\tO\\nmutations\\tO\\nin\\tO\\na\\tO\\nnon\\tO\\n-\\tO\\nJewish\\tO\\nfamily\\tO\\nwith\\tO\\nhereditary\\tB-Disease\\nnon\\tI-Disease\\n-\\tI-Disease\\npolyposis\\tI-Disease\\ncolorectal\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\ndescribe\\tO\\na\\tO\\nFrench\\tO\\nCanadian\\tO\\nhereditary\\tB-Disease\\nnon\\tI-Disease\\n-\\tI-Disease\\npolyposis\\tI-Disease\\ncolorectal\\tI-Disease\\ncancer\\tI-Disease\\n(\\tO\\nHNPCC\\tB-Disease\\n)\\tO\\nkindred\\tO\\nwhich\\tO\\ncarries\\tO\\na\\tO\\nnovel\\tO\\ntruncating\\tO\\nmutation\\tO\\nin\\tO\\nhMLH1\\tO\\n.\\tO\\n\\nInterestingly\\tO\\n,\\tO\\nthe\\tO\\nI1307K\\tO\\nAPC\\tO\\npolymorphism\\tO\\n,\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nincreased\\tO\\nrisk\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nis\\tO\\nalso\\tO\\npresent\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n.\\tO\\n\\nThe\\tO\\nI1307K\\tO\\npolymorphism\\tO\\nhas\\tO\\npreviously\\tO\\nonly\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\nindividuals\\tO\\nof\\tO\\nself\\tO\\n-\\tO\\nreported\\tO\\nAshkenazi\\tO\\nJewish\\tO\\norigins\\tO\\n.\\tO\\n\\nIn\\tO\\naddition\\tO\\n,\\tO\\nin\\tO\\nthis\\tO\\nfamily\\tO\\n,\\tO\\nthere\\tO\\nappears\\tO\\nto\\tO\\nbe\\tO\\nno\\tO\\nrelationship\\tO\\nbetween\\tO\\nthe\\tO\\nI1307K\\tO\\npolymorphism\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\nor\\tO\\nabsence\\tO\\nof\\tO\\ncancer\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nIdentification\\tO\\nof\\tO\\na\\tO\\nnovel\\tO\\nmutation\\tO\\nof\\tO\\nthe\\tO\\nCPO\\tO\\ngene\\tO\\nin\\tO\\na\\tO\\nJapanese\\tO\\nhereditary\\tB-Disease\\ncoproporphyria\\tI-Disease\\nfamily\\tO\\n.\\tO\\n\\nHereditary\\tB-Disease\\ncoproporphyria\\tI-Disease\\n(\\tO\\nHCP\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisease\\tI-Disease\\ncharacterized\\tO\\nby\\tO\\na\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\ncoproporphyrinogen\\tI-Disease\\noxidase\\tI-Disease\\n(\\tO\\nCPO\\tO\\n)\\tO\\ncaused\\tO\\nby\\tO\\na\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nCPO\\tO\\ngene\\tO\\n.\\tO\\n\\nOnly\\tO\\n11\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\nhave\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\nHCP\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nWe\\tO\\nreport\\tO\\nanother\\tO\\nmutation\\tO\\nin\\tO\\na\\tO\\nJapanese\\tO\\nfamily\\tO\\n.\\tO\\n\\nPolymerase\\tO\\nchain\\tO\\nreaction\\tO\\n-\\tO\\nsingle\\tO\\nstrand\\tO\\nconformational\\tO\\npolymorphism\\tO\\nand\\tO\\ndirect\\tO\\nsequence\\tO\\nanalyses\\tO\\ndemonstrated\\tO\\na\\tO\\nC\\tO\\nto\\tO\\nT\\tO\\nsubstitution\\tO\\nin\\tO\\nexon\\tO\\n1\\tO\\nof\\tO\\nthe\\tO\\nCPO\\tO\\ngene\\tO\\nat\\tO\\nnucleotide\\tO\\nposition\\tO\\n85\\tO\\n,\\tO\\nwhich\\tO\\nlies\\tO\\nin\\tO\\nthe\\tO\\nputative\\tO\\npresequence\\tO\\nfor\\tO\\ntargeting\\tO\\nto\\tO\\nmitochondria\\tO\\n.\\tO\\n\\nThis\\tO\\nmutation\\tO\\nchanges\\tO\\nthe\\tO\\ncodon\\tO\\nfor\\tO\\nglutamine\\tO\\nto\\tO\\na\\tO\\ntermination\\tO\\ncodon\\tO\\nat\\tO\\namino\\tO\\nacid\\tO\\nposition\\tO\\n29\\tO\\n.\\tO\\n\\nMaeI\\tO\\nrestriction\\tO\\nanalysis\\tO\\nshowed\\tO\\ntwo\\tO\\nother\\tO\\ncarriers\\tO\\nin\\tO\\nthe\\tO\\nfamily\\tO\\n.\\tO\\n\\nThe\\tO\\nC\\tO\\n-\\tO\\nT\\tO\\nmutation\\tO\\nis\\tO\\nlocated\\tO\\nwithin\\tO\\na\\tO\\nrecently\\tO\\nproposed\\tO\\nputative\\tO\\nalternative\\tO\\ntranslation\\tO\\ninitiation\\tO\\ncodon\\tO\\n(\\tO\\nTIC\\tO\\n-\\tO\\n1\\tO\\n)\\tO\\n,\\tO\\nsupporting\\tO\\nthat\\tO\\nTIC\\tO\\n-\\tO\\n1\\tO\\nis\\tO\\nthe\\tO\\nreal\\tO\\nTIC\\tO\\nrather\\tO\\nthan\\tO\\nTIC\\tO\\n-\\tO\\n2\\tO\\n.\\tO\\n.\\tO\\n\\nHuman\\tB-Disease\\ncomplement\\tI-Disease\\nfactor\\tI-Disease\\nH\\tI-Disease\\ndeficiency\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nhemolytic\\tB-Disease\\nuremic\\tI-Disease\\nsyndrome\\tI-Disease\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\nreports\\tO\\non\\tO\\nsix\\tO\\ncases\\tO\\nof\\tO\\ndeficiency\\tB-Disease\\nin\\tI-Disease\\nthe\\tI-Disease\\nhuman\\tI-Disease\\ncomplement\\tI-Disease\\nregulatory\\tI-Disease\\nprotein\\tI-Disease\\nFactor\\tI-Disease\\nH\\tI-Disease\\n(\\tO\\nFH\\tO\\n)\\tO\\nin\\tO\\nthe\\tO\\ncontext\\tO\\nof\\tO\\nan\\tO\\nacute\\tB-Disease\\nrenal\\tI-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nFive\\tO\\nof\\tO\\nthe\\tO\\ncases\\tO\\nwere\\tO\\nobserved\\tO\\nin\\tO\\nchildren\\tO\\npresenting\\tO\\nwith\\tO\\nidiopathic\\tO\\nhemolytic\\tB-Disease\\nuremic\\tI-Disease\\nsyndrome\\tI-Disease\\n(\\tO\\nHUS\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nTwo\\tO\\nof\\tO\\nthe\\tO\\nchildren\\tO\\nexhibited\\tO\\na\\tO\\nhomozygous\\tO\\ndeficiency\\tO\\ncharacterized\\tO\\nby\\tO\\nthe\\tO\\nabsence\\tO\\nof\\tO\\nthe\\tO\\n150\\tO\\n-\\tO\\nkD\\tO\\nform\\tO\\nof\\tO\\nFactor\\tO\\nH\\tO\\nand\\tO\\nthe\\tO\\npresence\\tO\\n,\\tO\\nupon\\tO\\nimmunoblotting\\tO\\n,\\tO\\nof\\tO\\nthe\\tO\\n42\\tO\\n-\\tO\\nkD\\tO\\nFactor\\tO\\nH\\tO\\n-\\tO\\nlike\\tO\\nprotein\\tO\\n1\\tO\\n(\\tO\\nFHL\\tO\\n-\\tO\\n1\\tO\\n)\\tO\\nand\\tO\\nother\\tO\\nFH\\tO\\n-\\tO\\nrelated\\tO\\nprotein\\tO\\n(\\tO\\nFHR\\tO\\n)\\tO\\nbands\\tO\\n.\\tO\\n\\nSouthern\\tO\\nblot\\tO\\nand\\tO\\nPCR\\tO\\nanalysis\\tO\\nof\\tO\\nDNA\\tO\\nof\\tO\\none\\tO\\npatient\\tO\\nwith\\tO\\nhomozygous\\tO\\ndeficiency\\tO\\nruled\\tO\\nout\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\na\\tO\\nlarge\\tO\\ndeletion\\tO\\nof\\tO\\nthe\\tO\\nFH\\tO\\ngene\\tO\\nas\\tO\\nthe\\tO\\nunderlying\\tO\\ndefect\\tO\\nfor\\tO\\nthe\\tO\\ndeficiency\\tO\\n.\\tO\\n\\nThe\\tO\\nother\\tO\\nfour\\tO\\nchildren\\tO\\npresented\\tO\\nwith\\tO\\nheterozygous\\tO\\ndeficiency\\tO\\nand\\tO\\nexhibited\\tO\\na\\tO\\nnormal\\tO\\nimmunoblotting\\tO\\npattern\\tO\\nof\\tO\\nproteins\\tO\\nof\\tO\\nthe\\tO\\nFH\\tO\\nfamily\\tO\\n.\\tO\\n\\nFactor\\tB-Disease\\nH\\tI-Disease\\ndeficiency\\tI-Disease\\nis\\tO\\nthe\\tO\\nonly\\tO\\ncomplement\\tB-Disease\\ndeficiency\\tI-Disease\\nassociated\\tO\\nwith\\tO\\nHUS\\tB-Disease\\n.\\tO\\n\\nThese\\tO\\nobservations\\tO\\nsuggest\\tO\\na\\tO\\nrole\\tO\\nfor\\tO\\nFH\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nFH\\tO\\nreceptors\\tO\\nin\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\nidiopathic\\tO\\nHUS\\tB-Disease\\n.\\tO\\n.\\tO\\n\\nFurther\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\nmajor\\tO\\nancient\\tO\\nmutation\\tO\\nunderlying\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\nfrom\\tO\\nlinkage\\tO\\ndisequilibrium\\tO\\nstudies\\tO\\nin\\tO\\nthe\\tO\\nJapanese\\tO\\npopulation\\tO\\n.\\tO\\n\\nThe\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nmutation\\tO\\nis\\tO\\nan\\tO\\nunstable\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\n,\\tO\\npresent\\tO\\nat\\tO\\na\\tO\\ncopy\\tO\\nnumber\\tO\\nof\\tO\\n5\\tO\\n-\\tO\\n37\\tO\\nrepeats\\tO\\non\\tO\\nnormal\\tO\\nchromosomes\\tO\\nbut\\tO\\namplified\\tO\\nto\\tO\\n50\\tO\\n-\\tO\\n3000\\tO\\ncopies\\tO\\non\\tO\\nDM\\tB-Disease\\nchromosomes\\tO\\n.\\tO\\n\\nPrevious\\tO\\nfindings\\tO\\nin\\tO\\nCaucasian\\tO\\npopulations\\tO\\nof\\tO\\na\\tO\\nDM\\tB-Disease\\nfounder\\tO\\nchromosome\\tO\\nraise\\tO\\na\\tO\\nquestion\\tO\\nabout\\tO\\nthe\\tO\\nmolecular\\tO\\nevents\\tO\\ninvolved\\tO\\nin\\tO\\nthe\\tO\\nexpansion\\tO\\nmutation\\tO\\n.\\tO\\n\\nTo\\tO\\ninvestigate\\tO\\nwhether\\tO\\na\\tO\\nfounder\\tO\\nchromosome\\tO\\nfor\\tO\\nthe\\tO\\nDM\\tB-Disease\\nmutation\\tO\\nexists\\tO\\nin\\tO\\nthe\\tO\\nJapanese\\tO\\npopulation\\tO\\n,\\tO\\nwe\\tO\\ngenotyped\\tO\\nfamilies\\tO\\nusing\\tO\\npolymorphic\\tO\\nmarkers\\tO\\nnear\\tO\\nthe\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\nregion\\tO\\nand\\tO\\nconstructed\\tO\\nhaplotypes\\tO\\n.\\tO\\n\\nSix\\tO\\ndifferent\\tO\\nhaplotypes\\tO\\nwere\\tO\\nfound\\tO\\nand\\tO\\nDM\\tB-Disease\\nalleles\\tO\\nwere\\tO\\nalways\\tO\\nhaplotype\\tO\\nA\\tO\\n.\\tO\\n\\nTo\\tO\\nfind\\tO\\nan\\tO\\norigin\\tO\\nof\\tO\\nthe\\tO\\n(\\tO\\nCTG\\tO\\n)\\tO\\nn\\tO\\nrepeat\\tO\\nmutation\\tO\\nand\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\nmechanism\\tO\\nof\\tO\\nthe\\tO\\nexpansion\\tO\\nmutation\\tO\\nin\\tO\\nthe\\tO\\nJapanese\\tO\\npopulation\\tO\\nwe\\tO\\nhave\\tO\\nstudied\\tO\\n90\\tO\\nJapanese\\tO\\nDM\\tB-Disease\\nfamilies\\tO\\ncomprising\\tO\\n190\\tO\\naffected\\tO\\nand\\tO\\n130\\tO\\nunaffected\\tO\\nmembers\\tO\\n.\\tO\\n\\nThe\\tO\\nresults\\tO\\nsuggest\\tO\\nthat\\tO\\na\\tO\\nfew\\tO\\ncommon\\tO\\nancestral\\tO\\nmutations\\tO\\nin\\tO\\nboth\\tO\\nCaucasian\\tO\\nand\\tO\\nJapanese\\tO\\npopulations\\tO\\nhave\\tO\\noriginated\\tO\\nby\\tO\\nexpansion\\tO\\nof\\tO\\nan\\tO\\nancestral\\tO\\nn\\tO\\n=\\tO\\n5\\tO\\nrepeat\\tO\\nto\\tO\\nn\\tO\\n=\\tO\\n19\\tO\\n-\\tO\\n37\\tO\\ncopies\\tO\\n.\\tO\\n\\nThese\\tO\\ndata\\tO\\nsupport\\tO\\nmultistep\\tO\\nmodels\\tO\\nof\\tO\\ntriplet\\tO\\nrepeat\\tO\\nexpansion\\tO\\nthat\\tO\\nhave\\tO\\nbeen\\tO\\nproposed\\tO\\nfor\\tO\\nboth\\tO\\nDM\\tB-Disease\\nand\\tO\\nFriedreichs\\tB-Disease\\nataxia\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nC6\\tB-Disease\\ndeficiency\\tI-Disease\\nin\\tO\\nthe\\tO\\nwestern\\tO\\nCape\\tO\\n,\\tO\\nSouth\\tO\\nAfrica\\tO\\n.\\tO\\n\\nDeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nsixth\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\nhuman\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC6\\tO\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nreported\\tO\\nin\\tO\\na\\tO\\nnumber\\tO\\nof\\tO\\nfamilies\\tO\\nfrom\\tO\\nthe\\tO\\nwestern\\tO\\nCape\\tO\\n,\\tO\\nSouth\\tO\\nAfrica\\tO\\n.\\tO\\n\\nMeningococcal\\tB-Disease\\ndisease\\tI-Disease\\nis\\tO\\nendemic\\tO\\nin\\tO\\nthe\\tO\\nCape\\tO\\nand\\tO\\nalmost\\tO\\nall\\tO\\npedigrees\\tO\\nof\\tO\\ntotal\\tO\\nC6\\tB-Disease\\ndeficiency\\tI-Disease\\n(\\tO\\nC6Q0\\tO\\n)\\tO\\nhave\\tO\\nbeen\\tO\\nascertained\\tO\\nbecause\\tO\\nof\\tO\\nrecurrent\\tO\\ndisease\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nsequenced\\tO\\nthe\\tO\\nexpressed\\tO\\nexons\\tO\\nof\\tO\\nthe\\tO\\nC6\\tO\\ngene\\tO\\nfrom\\tO\\nselected\\tO\\ncases\\tO\\nand\\tO\\nhave\\tO\\nfound\\tO\\nthree\\tO\\nmolecular\\tO\\ndefects\\tO\\nleading\\tO\\nto\\tO\\ntotal\\tO\\ndeficiency\\tO\\n879delG\\tO\\n,\\tO\\nwhich\\tO\\nis\\tO\\nthe\\tO\\ncommon\\tO\\ndefect\\tO\\nin\\tO\\nthe\\tO\\nCape\\tO\\nand\\tO\\nhitherto\\tO\\nunreported\\tO\\n,\\tO\\nand\\tO\\n1195delC\\tO\\nand\\tO\\n1936delG\\tO\\n,\\tO\\nwhich\\tO\\nhave\\tO\\nbeen\\tO\\npreviously\\tO\\nreported\\tO\\nin\\tO\\nAfrican\\tO\\n-\\tO\\nAmericans\\tO\\n.\\tO\\n\\nWe\\tO\\nalso\\tO\\nshow\\tO\\nthat\\tO\\nthe\\tO\\n879delG\\tO\\nand\\tO\\n1195delC\\tO\\ndefects\\tO\\nare\\tO\\nassociated\\tO\\nwith\\tO\\ncharacteristic\\tO\\nC6\\tO\\n/\\tO\\nC7\\tO\\nregion\\tO\\nDNA\\tO\\nmarker\\tO\\nhaplotypes\\tO\\n,\\tO\\nalthough\\tO\\nsmall\\tO\\nvariations\\tO\\nwere\\tO\\nobserved\\tO\\n.\\tO\\n\\nThe\\tO\\n1936delG\\tO\\ndefect\\tO\\nwas\\tO\\nobserved\\tO\\nonly\\tO\\nonce\\tO\\nin\\tO\\nthe\\tO\\nCape\\tO\\n,\\tO\\nbut\\tO\\nits\\tO\\nassociated\\tO\\nhaplotype\\tO\\ncould\\tO\\nbe\\tO\\ndeduced\\tO\\n.\\tO\\n\\nThe\\tO\\ndata\\tO\\nfrom\\tO\\nthe\\tO\\nhaplotypes\\tO\\nindicate\\tO\\nthat\\tO\\nthese\\tO\\nthree\\tO\\nmolecular\\tO\\ndefects\\tO\\naccount\\tO\\nfor\\tO\\nthe\\tO\\ndefects\\tO\\nin\\tO\\nall\\tO\\nthe\\tO\\n38\\tO\\nunrelated\\tO\\nC6Q0\\tO\\nindividuals\\tO\\nwe\\tO\\nhave\\tO\\nstudied\\tO\\nfrom\\tO\\nthe\\tO\\nCape\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nalso\\tO\\nobserved\\tO\\nthe\\tO\\n879delG\\tO\\ndefect\\tO\\nin\\tO\\ntwo\\tO\\nDutch\\tO\\nC6\\tB-Disease\\n-\\tI-Disease\\ndeficient\\tI-Disease\\nkindreds\\tO\\n,\\tO\\nbut\\tO\\nthe\\tO\\n879delG\\tO\\ndefect\\tO\\nin\\tO\\nthe\\tO\\nCape\\tO\\nprobably\\tO\\ndid\\tO\\nnot\\tO\\ncome\\tO\\nfrom\\tO\\nThe\\tO\\nNetherlands\\tO\\n.\\tO\\n.\\tO\\n\\nComplement\\tB-Disease\\nC7\\tI-Disease\\ndeficiency\\tI-Disease\\n:\\tO\\nseven\\tO\\nfurther\\tO\\nmolecular\\tO\\ndefects\\tO\\nand\\tO\\ntheir\\tO\\nassociated\\tO\\nmarker\\tO\\nhaplotypes\\tO\\n.\\tO\\n\\nSeven\\tO\\nfurther\\tO\\nmolecular\\tO\\nbases\\tO\\nof\\tO\\nC7\\tB-Disease\\ndeficiency\\tI-Disease\\nare\\tO\\ndescribed\\tO\\n.\\tO\\n\\nAll\\tO\\nthese\\tO\\nnew\\tO\\nmolecular\\tO\\ndefects\\tO\\ninvolve\\tO\\nsingle\\tO\\n-\\tO\\nnucleotide\\tO\\nevents\\tO\\n,\\tO\\ndeletions\\tO\\nand\\tO\\nsubstitutions\\tO\\n,\\tO\\nsome\\tO\\nof\\tO\\nwhich\\tO\\nalter\\tO\\nsplice\\tO\\nsites\\tO\\n,\\tO\\nand\\tO\\nothers\\tO\\ncodons\\tO\\n.\\tO\\n\\nThey\\tO\\nare\\tO\\ndistributed\\tO\\nalong\\tO\\nthe\\tO\\nC7\\tO\\ngene\\tO\\n,\\tO\\nbut\\tO\\npredominantly\\tO\\ntowards\\tO\\nthe\\tO\\n3\\tO\\nend\\tO\\n.\\tO\\n\\nAll\\tO\\nwere\\tO\\nfound\\tO\\nin\\tO\\ncompound\\tO\\nheterozygous\\tO\\nindividuals\\tO\\n.\\tO\\n\\nThe\\tO\\nC6\\tO\\n/\\tO\\nC7\\tO\\nmarker\\tO\\nhaplotypes\\tO\\nassociated\\tO\\nwith\\tO\\nmost\\tO\\nC7\\tB-Disease\\ndefects\\tI-Disease\\nare\\tO\\ntabulated\\tO\\n.\\tO\\n.\\tO\\n\\nA\\tO\\ngenome\\tO\\n-\\tO\\nwide\\tO\\nsearch\\tO\\nfor\\tO\\nchromosomal\\tO\\nloci\\tO\\nlinked\\tO\\nto\\tO\\nmental\\tO\\nhealth\\tO\\nwellness\\tO\\nin\\tO\\nrelatives\\tO\\nat\\tO\\nhigh\\tO\\nrisk\\tO\\nfor\\tO\\nbipolar\\tB-Disease\\naffective\\tI-Disease\\ndisorder\\tI-Disease\\namong\\tO\\nthe\\tO\\nOld\\tO\\nOrder\\tO\\nAmish\\tO\\n.\\tO\\n\\nBipolar\\tB-Disease\\naffective\\tI-Disease\\ndisorder\\tI-Disease\\n(\\tO\\nBPAD\\tB-Disease\\n;\\tO\\nmanic\\tB-Disease\\n-\\tI-Disease\\ndepressive\\tI-Disease\\nillness\\tI-Disease\\n)\\tO\\nis\\tO\\ncharacterized\\tO\\nby\\tO\\nepisodes\\tO\\nof\\tO\\nmania\\tB-Disease\\nand\\tO\\n/\\tO\\nor\\tO\\nhypomania\\tB-Disease\\ninterspersed\\tO\\nwith\\tO\\nperiods\\tO\\nof\\tO\\ndepression\\tB-Disease\\n.\\tO\\n\\nCompelling\\tO\\nevidence\\tO\\nsupports\\tO\\na\\tO\\nsignificant\\tO\\ngenetic\\tO\\ncomponent\\tO\\nin\\tO\\nthe\\tO\\nsusceptibility\\tO\\nto\\tO\\ndevelop\\tO\\nBPAD\\tB-Disease\\n.\\tO\\n\\nTo\\tO\\ndate\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nlinkage\\tO\\nstudies\\tO\\nhave\\tO\\nattempted\\tO\\nonly\\tO\\nto\\tO\\nidentify\\tO\\nchromosomal\\tO\\nloci\\tO\\nthat\\tO\\ncause\\tO\\nor\\tO\\nincrease\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\ndeveloping\\tO\\nBPAD\\tB-Disease\\n.\\tO\\n\\nTo\\tO\\ndetermine\\tO\\nwhether\\tO\\nthere\\tO\\ncould\\tO\\nbe\\tO\\nprotective\\tO\\nalleles\\tO\\nthat\\tO\\nprevent\\tO\\nor\\tO\\nreduce\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\ndeveloping\\tO\\nBPAD\\tB-Disease\\n,\\tO\\nsimilar\\tO\\nto\\tO\\nwhat\\tO\\nis\\tO\\nobserved\\tO\\nin\\tO\\nother\\tO\\ngenetic\\tB-Disease\\ndisorders\\tI-Disease\\n,\\tO\\nwe\\tO\\nused\\tO\\nmental\\tO\\nhealth\\tO\\nwellness\\tO\\n(\\tO\\nabsence\\tO\\nof\\tO\\nany\\tO\\npsychiatric\\tB-Disease\\ndisorder\\tI-Disease\\n)\\tO\\nas\\tO\\nthe\\tO\\nphenotype\\tO\\nin\\tO\\nour\\tO\\ngenome\\tO\\n-\\tO\\nwide\\tO\\nlinkage\\tO\\nscan\\tO\\nof\\tO\\nseveral\\tO\\nlarge\\tO\\nmultigeneration\\tO\\nOld\\tO\\nOrder\\tO\\nAmish\\tO\\npedigrees\\tO\\nexhibiting\\tO\\nan\\tO\\nextremely\\tO\\nhigh\\tO\\nincidence\\tO\\nof\\tO\\nBPAD\\tB-Disease\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nfound\\tO\\nstrong\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n4p\\tO\\nat\\tO\\nD4S2949\\tO\\n(\\tO\\nmaximum\\tO\\nGENEHUNTER\\tO\\n-\\tO\\nPLUS\\tO\\nnonparametric\\tO\\nlinkage\\tO\\nscore\\tO\\n=\\tO\\n4\\tO\\n.\\tO\\n05\\tO\\n,\\tO\\nP\\tO\\n=\\tO\\n5\\tO\\n.\\tO\\n22\\tO\\nx\\tO\\n10\\tO\\n(\\tO\\n-\\tO\\n4\\tO\\n)\\tO\\n;\\tO\\nSIBPAL\\tO\\nPempirical\\tO\\nvalue\\tO\\n<\\tO\\n3\\tO\\nx\\tO\\n10\\tO\\n(\\tO\\n-\\tO\\n5\\tO\\n)\\tO\\n)\\tO\\nand\\tO\\nsuggestive\\tO\\nevidence\\tO\\nfor\\tO\\na\\tO\\nlocus\\tO\\non\\tO\\nchromosome\\tO\\n4q\\tO\\nat\\tO\\nD4S397\\tO\\n(\\tO\\nmaximum\\tO\\nGENEHUNTER\\tO\\n-\\tO\\nPLUS\\tO\\nnonparametric\\tO\\nlinkage\\tO\\nscore\\tO\\n=\\tO\\n3\\tO\\n.\\tO\\n29\\tO\\n,\\tO\\nP\\tO\\n=\\tO\\n2\\tO\\n.\\tO\\n57\\tO\\nx\\tO\\n10\\tO\\n(\\tO\\n-\\tO\\n3\\tO\\n)\\tO\\n;\\tO\\nSIBPAL\\tO\\nPempirical\\tO\\nvalue\\tO\\n<\\tO\\n1\\tO\\nx\\tO\\n10\\tO\\n(\\tO\\n-\\tO\\n3\\tO\\n)\\tO\\n)\\tO\\nthat\\tO\\nare\\tO\\nlinked\\tO\\nto\\tO\\nmental\\tO\\nhealth\\tO\\nwellness\\tO\\n.\\tO\\n\\nThese\\tO\\nfindings\\tO\\nare\\tO\\nconsistent\\tO\\nwith\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\ncertain\\tO\\nalleles\\tO\\ncould\\tO\\nprevent\\tO\\nor\\tO\\nmodify\\tO\\nthe\\tO\\nclinical\\tO\\nmanifestations\\tO\\nof\\tO\\nBPAD\\tB-Disease\\nand\\tO\\nperhaps\\tO\\nother\\tO\\nrelated\\tO\\naffective\\tB-Disease\\ndisorders\\tI-Disease\\n.\\tO\\n\\nSegregation\\tO\\ndistortion\\tO\\nin\\tO\\nmyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nMyotonic\\tB-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nDM\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nautosomal\\tB-Disease\\ndominant\\tI-Disease\\ndisease\\tI-Disease\\nwhich\\tO\\n,\\tO\\nin\\tO\\nthe\\tO\\ntypical\\tO\\npedigree\\tO\\n,\\tO\\nshows\\tO\\na\\tO\\nthree\\tO\\ngeneration\\tO\\nanticipation\\tO\\ncascade\\tO\\n.\\tO\\n\\nThis\\tO\\nresults\\tO\\nin\\tO\\ninfertility\\tB-Disease\\nand\\tO\\ncongenital\\tB-Disease\\nmyotonic\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nCDM\\tB-Disease\\n)\\tO\\nwith\\tO\\nthe\\tO\\ndisappearance\\tO\\nof\\tO\\nDM\\tB-Disease\\nin\\tO\\nthat\\tO\\npedigree\\tO\\n.\\tO\\n\\nThe\\tO\\nconcept\\tO\\nof\\tO\\nsegregation\\tO\\ndistortion\\tO\\n,\\tO\\nwhere\\tO\\nthere\\tO\\nis\\tO\\npreferential\\tO\\ntransmission\\tO\\nof\\tO\\nthe\\tO\\nlarger\\tO\\nallele\\tO\\nat\\tO\\nthe\\tO\\nDM\\tB-Disease\\nlocus\\tO\\n,\\tO\\nhas\\tO\\nbeen\\tO\\nput\\tO\\nforward\\tO\\nto\\tO\\nexplain\\tO\\npartially\\tO\\nthe\\tO\\nmaintenance\\tO\\nof\\tO\\nDM\\tB-Disease\\nin\\tO\\nthe\\tO\\npopulation\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nsurvey\\tO\\nof\\tO\\nDM\\tB-Disease\\nin\\tO\\nNorthern\\tO\\nIreland\\tO\\n,\\tO\\n59\\tO\\npedigrees\\tO\\nwere\\tO\\nascertained\\tO\\n.\\tO\\n\\nSibships\\tO\\nwhere\\tO\\nthe\\tO\\nstatus\\tO\\nof\\tO\\nall\\tO\\nthe\\tO\\nmembers\\tO\\nhad\\tO\\nbeen\\tO\\nidentified\\tO\\nwere\\tO\\nexamined\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\ntransmission\\tO\\nof\\tO\\nthe\\tO\\nDM\\tB-Disease\\nexpansion\\tO\\nfrom\\tO\\naffected\\tO\\nparents\\tO\\nto\\tO\\ntheir\\tO\\noffspring\\tO\\n.\\tO\\n\\nWhere\\tO\\nthe\\tO\\ntransmitting\\tO\\nparent\\tO\\nwas\\tO\\nmale\\tO\\n,\\tO\\n58\\tO\\n.\\tO\\n\\n3\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\noffspring\\tO\\nwere\\tO\\naffected\\tO\\n,\\tO\\nand\\tO\\nin\\tO\\nthe\\tO\\ncase\\tO\\nof\\tO\\na\\tO\\nfemale\\tO\\ntransmitting\\tO\\nparent\\tO\\n,\\tO\\n68\\tO\\n.\\tO\\n\\n7\\tO\\n%\\tO\\nwere\\tO\\naffected\\tO\\n.\\tO\\n\\nStudies\\tO\\non\\tO\\nmeiotic\\tO\\ndrive\\tO\\nin\\tO\\nDM\\tB-Disease\\nhave\\tO\\nshown\\tO\\nincreased\\tO\\ntransmission\\tO\\nof\\tO\\nthe\\tO\\nlarger\\tO\\nallele\\tO\\nat\\tO\\nthe\\tO\\nDM\\tB-Disease\\nlocus\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nDM\\tO\\nheterozygotes\\tO\\nfor\\tO\\nCTGn\\tO\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\nprovides\\tO\\nfurther\\tO\\nevidence\\tO\\nthat\\tO\\nthe\\tO\\nDM\\tB-Disease\\nexpansion\\tO\\ntends\\tO\\nto\\tO\\nbe\\tO\\ntransmitted\\tO\\npreferentially\\tO\\n.\\tO\\n\\nDiagnosis\\tO\\nof\\tO\\nhemochromatosis\\tB-Disease\\n.\\tO\\n\\nIf\\tO\\nuntreated\\tO\\n,\\tO\\nhemochromatosis\\tB-Disease\\ncan\\tO\\ncause\\tO\\nserious\\tO\\nillness\\tO\\nand\\tO\\nearly\\tB-Disease\\ndeath\\tI-Disease\\n,\\tO\\nbut\\tO\\nthe\\tO\\ndisease\\tO\\nis\\tO\\nstill\\tO\\nsubstantially\\tO\\nunder\\tO\\n-\\tO\\ndiagnosed\\tO\\n.\\tO\\n\\nThe\\tO\\ncornerstone\\tO\\nof\\tO\\nscreening\\tO\\nand\\tO\\ncase\\tO\\ndetection\\tO\\nis\\tO\\nthe\\tO\\nmeasurement\\tO\\nof\\tO\\nserum\\tO\\ntransferrin\\tO\\nsaturation\\tO\\nand\\tO\\nthe\\tO\\nserum\\tO\\nferritin\\tO\\nlevel\\tO\\n.\\tO\\n\\nOnce\\tO\\nthe\\tO\\ndiagnosis\\tO\\nis\\tO\\nsuspected\\tO\\n,\\tO\\nphysicians\\tO\\nmust\\tO\\nuse\\tO\\nserum\\tO\\nferritin\\tO\\nlevels\\tO\\nand\\tO\\nhepatic\\tO\\niron\\tO\\nstores\\tO\\non\\tO\\nliver\\tO\\nbiopsy\\tO\\nspecimens\\tO\\nto\\tO\\nassess\\tO\\npatients\\tO\\nfor\\tO\\nthe\\tO\\npresence\\tO\\nof\\tO\\niron\\tB-Disease\\noverload\\tI-Disease\\n.\\tO\\n\\nLiver\\tO\\nbiopsy\\tO\\nis\\tO\\nalso\\tO\\nused\\tO\\nto\\tO\\nestablish\\tO\\nthe\\tO\\npresence\\tO\\nor\\tO\\nabsence\\tO\\nof\\tO\\ncirrhosis\\tB-Disease\\n,\\tO\\nwhich\\tO\\ncan\\tO\\naffect\\tO\\nprognosis\\tO\\nand\\tO\\nmanagement\\tO\\n.\\tO\\n\\nA\\tO\\nDNA\\tO\\n-\\tO\\nbased\\tO\\ntest\\tO\\nfor\\tO\\nthe\\tO\\nHFE\\tO\\ngene\\tO\\nis\\tO\\ncommercially\\tO\\navailable\\tO\\n,\\tO\\nbut\\tO\\nits\\tO\\nplace\\tO\\nin\\tO\\nthe\\tO\\ndiagnosis\\tO\\nof\\tO\\nhemochromatosis\\tB-Disease\\nis\\tO\\nstill\\tO\\nbeing\\tO\\nevaluated\\tO\\n.\\tO\\n\\nCurrently\\tO\\n,\\tO\\nthe\\tO\\nmost\\tO\\nuseful\\tO\\nrole\\tO\\nfor\\tO\\nthis\\tO\\ntest\\tO\\nis\\tO\\nin\\tO\\nthe\\tO\\ndetection\\tO\\nof\\tO\\nhemochromatosis\\tB-Disease\\nin\\tO\\nthe\\tO\\nfamily\\tO\\nmembers\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\na\\tO\\nproven\\tO\\ncase\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\ncrucial\\tO\\nto\\tO\\ndiagnose\\tO\\nhemochromatosis\\tB-Disease\\nbefore\\tO\\nhepatic\\tB-Disease\\ncirrhosis\\tI-Disease\\ndevelops\\tO\\nbecause\\tO\\nphlebotomy\\tO\\ntherapy\\tO\\ncan\\tO\\navert\\tO\\nserious\\tO\\nchronic\\tO\\ndisease\\tO\\nand\\tO\\ncan\\tO\\neven\\tO\\nlead\\tO\\nto\\tO\\nnormal\\tO\\nlife\\tO\\nexpectancy\\tO\\n.\\tO\\n.\\tO\\n\\nPrevalence\\tO\\nof\\tO\\nthe\\tO\\nI1307K\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nvariant\\tO\\nin\\tO\\nIsraeli\\tO\\nJews\\tO\\nof\\tO\\ndiffering\\tO\\nethnic\\tO\\norigin\\tO\\nand\\tO\\nrisk\\tO\\nfor\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nBACKGROUND\\tO\\n&\\tO\\nAIMS\\tO\\nIsraeli\\tO\\nJews\\tO\\nof\\tO\\nEuropean\\tO\\nbirth\\tO\\n,\\tO\\ni\\tO\\n.\\tO\\ne\\tO\\n.\\tO\\n,\\tO\\nAshkenazim\\tO\\n,\\tO\\nhave\\tO\\nthe\\tO\\nhighest\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nincidence\\tO\\nof\\tO\\nany\\tO\\nIsraeli\\tO\\nethnic\\tO\\ngroup\\tO\\n.\\tO\\n\\nThe\\tO\\nI1307K\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nvariant\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\n6\\tO\\n.\\tO\\n\\n1\\tO\\n%\\tO\\nof\\tO\\nAmerican\\tO\\nJews\\tO\\n,\\tO\\n28\\tO\\n%\\tO\\nof\\tO\\ntheir\\tO\\nfamilial\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\ncases\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nJews\\tO\\n.\\tO\\n\\nWe\\tO\\nassessed\\tO\\nthe\\tO\\nI1307K\\tO\\nprevalence\\tO\\nin\\tO\\nIsraeli\\tO\\nJews\\tO\\nof\\tO\\ndiffering\\tO\\nethnic\\tO\\norigin\\tO\\nand\\tO\\nrisk\\tO\\nfor\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nMETHODS\\tO\\nDNA\\tO\\nsamples\\tO\\nfrom\\tO\\n500\\tO\\nunrelated\\tO\\nJews\\tO\\nof\\tO\\nEuropean\\tO\\nor\\tO\\nnon\\tO\\n-\\tO\\nEuropean\\tO\\norigin\\tO\\n,\\tO\\nwith\\tO\\nor\\tO\\nwithout\\tO\\na\\tO\\npersonal\\tO\\nand\\tO\\n/\\tO\\nor\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nneoplasia\\tB-Disease\\n,\\tO\\nwere\\tO\\nexamined\\tO\\nfor\\tO\\nthe\\tO\\nI1307K\\tO\\nvariant\\tO\\nby\\tO\\nthe\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\noligonucleotide\\tO\\n(\\tO\\nASO\\tO\\n)\\tO\\nmethod\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nIn\\tO\\npersons\\tO\\nat\\tO\\naverage\\tO\\nrisk\\tO\\nfor\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n,\\tO\\nI1307K\\tO\\nwas\\tO\\nfound\\tO\\nin\\tO\\n5\\tO\\n.\\tO\\n\\n0\\tO\\n%\\tO\\nof\\tO\\n120\\tO\\nEuropean\\tO\\nand\\tO\\n1\\tO\\n.\\tO\\n\\n6\\tO\\n%\\tO\\nof\\tO\\n188\\tO\\nnon\\tO\\n-\\tO\\nEuropean\\tO\\nJews\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n08\\tO\\n)\\tO\\n.\\tO\\n\\nIt\\tO\\noccurred\\tO\\nin\\tO\\n15\\tO\\n.\\tO\\n\\n4\\tO\\n%\\tO\\nof\\tO\\n52\\tO\\nAshkenazi\\tO\\nIsraelis\\tO\\nwith\\tO\\nfamilial\\tO\\ncancer\\tB-Disease\\n(\\tO\\nP\\tO\\n=\\tO\\n0\\tO\\n.\\tO\\n02\\tO\\n)\\tO\\nand\\tO\\nwas\\tO\\nnot\\tO\\ndetected\\tO\\nin\\tO\\n51\\tO\\nnon\\tO\\n-\\tO\\nEuropean\\tO\\nJews\\tO\\nat\\tO\\nincreased\\tO\\ncancer\\tB-Disease\\nrisk\\tO\\n.\\tO\\n\\nColorectal\\tB-Disease\\nneoplasia\\tI-Disease\\noccurred\\tO\\npersonally\\tO\\nor\\tO\\nin\\tO\\nthe\\tO\\nfamilies\\tO\\nof\\tO\\n13\\tO\\nof\\tO\\n20\\tO\\nAshkenazi\\tO\\nI1307K\\tO\\ncarriers\\tO\\n,\\tO\\n8\\tO\\nof\\tO\\nwhom\\tO\\nalso\\tO\\nhad\\tO\\na\\tO\\npersonal\\tO\\nor\\tO\\nfamily\\tO\\nhistory\\tO\\nof\\tO\\nnoncolonic\\tO\\nneoplasia\\tB-Disease\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nThe\\tO\\nI1307K\\tO\\nAPC\\tO\\nvariant\\tO\\nmay\\tO\\nrepresent\\tO\\na\\tO\\nsusceptibility\\tO\\ngene\\tO\\nfor\\tO\\ncolorectal\\tB-Disease\\n,\\tI-Disease\\nor\\tI-Disease\\nother\\tI-Disease\\n,\\tI-Disease\\ncancers\\tI-Disease\\nin\\tO\\nAshkenazi\\tO\\nJews\\tO\\n,\\tO\\nand\\tO\\npartially\\tO\\nexplains\\tO\\nthe\\tO\\nhigher\\tO\\nincidence\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nin\\tO\\nEuropean\\tO\\nIsraelis\\tO\\n.\\tO\\n\\nSystematic\\tO\\nanalysis\\tO\\nof\\tO\\ncoproporphyrinogen\\tO\\noxidase\\tO\\ngene\\tO\\ndefects\\tO\\nin\\tO\\nhereditary\\tB-Disease\\ncoproporphyria\\tI-Disease\\nand\\tO\\nmutation\\tO\\nupdate\\tO\\n.\\tO\\n\\nHereditary\\tB-Disease\\ncoproporphyria\\tI-Disease\\n(\\tO\\nHC\\tB-Disease\\n)\\tO\\nis\\tO\\nan\\tO\\nacute\\tO\\nhepatic\\tB-Disease\\nporphyria\\tI-Disease\\nwith\\tO\\nautosomal\\tO\\ndominant\\tO\\ninheritance\\tO\\ncaused\\tO\\nby\\tO\\ndeficient\\tB-Disease\\nactivity\\tI-Disease\\nof\\tI-Disease\\ncoproporphyrinogen\\tI-Disease\\nIII\\tI-Disease\\noxidase\\tI-Disease\\n(\\tO\\nCPO\\tO\\n)\\tO\\n.\\tO\\n\\nClinical\\tO\\nmanifestations\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\nare\\tO\\ncharacterized\\tO\\nby\\tO\\nacute\\tO\\nattacks\\tO\\nof\\tO\\nneurological\\tB-Disease\\ndysfunction\\tI-Disease\\noften\\tO\\nprecipitated\\tO\\nby\\tO\\ndrugs\\tO\\n,\\tO\\nfasting\\tO\\n,\\tO\\ncyclical\\tO\\nhormonal\\tO\\nchanges\\tO\\n,\\tO\\nor\\tO\\ninfectious\\tB-Disease\\ndiseases\\tI-Disease\\n.\\tO\\n\\nSkin\\tO\\nphotosensitivity\\tO\\nmay\\tO\\nalso\\tO\\nbe\\tO\\npresent\\tO\\n.\\tO\\n\\nThe\\tO\\nseven\\tO\\nexons\\tO\\n,\\tO\\nthe\\tO\\nexon\\tO\\n/\\tO\\nintron\\tO\\nboundaries\\tO\\nand\\tO\\npart\\tO\\nof\\tO\\n3\\tO\\nnoncoding\\tO\\nsequence\\tO\\nof\\tO\\nthe\\tO\\nCPO\\tO\\ngene\\tO\\nwere\\tO\\nsystematically\\tO\\nanalyzed\\tO\\nby\\tO\\nan\\tO\\nexon\\tO\\n-\\tO\\nby\\tO\\n-\\tO\\nexon\\tO\\ndenaturing\\tO\\ngradient\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n(\\tO\\nDGGE\\tO\\n)\\tO\\nstrategy\\tO\\nfollowed\\tO\\nby\\tO\\ndirect\\tO\\nsequencing\\tO\\nin\\tO\\nseven\\tO\\nunrelated\\tO\\nheterozygous\\tO\\nHC\\tB-Disease\\npatients\\tO\\nfrom\\tO\\nFrance\\tO\\n,\\tO\\nHolland\\tO\\n,\\tO\\nand\\tO\\nCzech\\tO\\nRepublic\\tO\\n.\\tO\\n\\nSeven\\tO\\nnovel\\tO\\nmutations\\tO\\nand\\tO\\ntwo\\tO\\nnew\\tO\\npolymorphisms\\tO\\nwere\\tO\\ndetected\\tO\\n.\\tO\\n\\nAmong\\tO\\nthese\\tO\\nmutations\\tO\\ntwo\\tO\\nare\\tO\\nmissense\\tO\\n(\\tO\\nG197W\\tO\\n,\\tO\\nW427R\\tO\\n)\\tO\\n,\\tO\\ntwo\\tO\\nare\\tO\\nnonsense\\tO\\n(\\tO\\nQ306X\\tO\\n,\\tO\\nQ385X\\tO\\n)\\tO\\n,\\tO\\ntwo\\tO\\nare\\tO\\nsmall\\tO\\ndeletions\\tO\\n(\\tO\\n662de14bp\\tO\\n;\\tO\\n1168del3bp\\tO\\nremoving\\tO\\na\\tO\\nglycine\\tO\\nat\\tO\\nposition\\tO\\n390\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\none\\tO\\nis\\tO\\na\\tO\\nsplicing\\tO\\nmutation\\tO\\n(\\tO\\nIVS1\\tO\\n-\\tO\\n15c\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\ng\\tO\\n)\\tO\\nwhich\\tO\\ncreates\\tO\\na\\tO\\nnew\\tO\\nacceptor\\tO\\nsplice\\tO\\nsite\\tO\\n.\\tO\\n\\nThe\\tO\\npathological\\tO\\nsignificance\\tO\\nof\\tO\\nthe\\tO\\npoint\\tO\\nmutations\\tO\\nG197W\\tO\\n,\\tO\\nW427R\\tO\\n,\\tO\\nand\\tO\\nthe\\tO\\nin\\tO\\n-\\tO\\nframe\\tO\\ndeletion\\tO\\n390delGly\\tO\\nwere\\tO\\nassessed\\tO\\nby\\tO\\ntheir\\tO\\nrespective\\tO\\nexpression\\tO\\nin\\tO\\na\\tO\\nprokaryotic\\tO\\nsystem\\tO\\nusing\\tO\\nsite\\tO\\n-\\tO\\ndirected\\tO\\nmutagenesis\\tO\\n.\\tO\\n\\nThese\\tO\\nmutations\\tO\\nresulted\\tO\\nin\\tO\\nthe\\tO\\nabsence\\tO\\nor\\tO\\na\\tO\\ndramatic\\tO\\ndecrease\\tO\\nof\\tO\\nCPO\\tO\\nactivity\\tO\\n.\\tO\\n\\nThe\\tO\\ntwo\\tO\\npolymorphisms\\tO\\nwere\\tO\\nlocalized\\tO\\nin\\tO\\nnoncoding\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\ngene\\tO\\n1\\tO\\n)\\tO\\na\\tO\\nC\\tO\\n/\\tO\\nG\\tO\\npolymorphism\\tO\\nin\\tO\\nthe\\tO\\npromotor\\tO\\nregion\\tO\\n,\\tO\\n142\\tO\\nbp\\tO\\nupstream\\tO\\nfrom\\tO\\nthe\\tO\\ntranscriptional\\tO\\ninitiation\\tO\\nsite\\tO\\n(\\tO\\n-\\tO\\n142C\\tO\\n/\\tO\\nG\\tO\\n)\\tO\\n,\\tO\\nand\\tO\\n2\\tO\\n)\\tO\\na\\tO\\n6\\tO\\nbp\\tO\\ndeletion\\tO\\npolymorphism\\tO\\nin\\tO\\nthe\\tO\\n3\\tO\\nnoncoding\\tO\\npart\\tO\\nof\\tO\\nthe\\tO\\nCPO\\tO\\ngene\\tO\\n,\\tO\\n574\\tO\\nbp\\tO\\ndownstream\\tO\\nof\\tO\\nthe\\tO\\nlast\\tO\\nbase\\tO\\nof\\tO\\nthe\\tO\\nnormal\\tO\\ntermination\\tO\\ncodon\\tO\\n(\\tO\\n+\\tO\\n574\\tO\\ndelATTCTT\\tO\\n)\\tO\\n.\\tO\\n\\nFive\\tO\\nintragenic\\tO\\ndimorphisms\\tO\\nare\\tO\\nnow\\tO\\nwell\\tO\\ncharacterized\\tO\\nand\\tO\\nthe\\tO\\nhigh\\tO\\ndegree\\tO\\nof\\tO\\nallelic\\tO\\nheterogeneity\\tO\\nin\\tO\\nHC\\tB-Disease\\nis\\tO\\ndemonstrated\\tO\\nwith\\tO\\nseven\\tO\\nnew\\tO\\ndifferent\\tO\\nmutations\\tO\\nmaking\\tO\\na\\tO\\ntotal\\tO\\nof\\tO\\nnineteen\\tO\\nCPO\\tO\\ngene\\tB-Disease\\ndefects\\tI-Disease\\nreported\\tO\\nso\\tO\\nfar\\tO\\n.\\tO\\n.\\tO\\n\\nCoincidence\\tO\\nof\\tO\\ntwo\\tO\\nnovel\\tO\\narylsulfatase\\tO\\nA\\tO\\nalleles\\tO\\nand\\tO\\nmutation\\tO\\n459\\tO\\n+\\tO\\n1G\\tO\\n>\\tO\\nA\\tO\\nwithin\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nmetachromatic\\tB-Disease\\nleukodystrophy\\tI-Disease\\n:\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nphenotypic\\tO\\nheterogeneity\\tO\\n.\\tO\\n\\nIn\\tO\\na\\tO\\nfamily\\tO\\nwith\\tO\\nthree\\tO\\nsiblings\\tO\\n,\\tO\\none\\tO\\ndeveloped\\tO\\nclassical\\tO\\nlate\\tO\\ninfantile\\tO\\nmetachromatic\\tB-Disease\\nleukodystrophy\\tI-Disease\\n(\\tO\\nMLD\\tB-Disease\\n)\\tO\\n,\\tO\\nfatal\\tO\\nat\\tO\\nage\\tO\\n5\\tO\\nyears\\tO\\n,\\tO\\nwith\\tO\\ndeficient\\tO\\narylsulfatase\\tO\\nA\\tO\\n(\\tO\\nARSA\\tO\\n)\\tO\\nactivity\\tO\\nand\\tO\\nincreased\\tO\\ngalactosylsulfatide\\tO\\n(\\tO\\nGS\\tO\\n)\\tO\\nexcretion\\tO\\n.\\tO\\n\\nThe\\tO\\ntwo\\tO\\nother\\tO\\nsiblings\\tO\\n,\\tO\\napparently\\tO\\nhealthy\\tO\\nat\\tO\\n12\\tO\\n(\\tO\\n1\\tO\\n/\\tO\\n2\\tO\\n)\\tO\\nand\\tO\\n15\\tO\\nyears\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\nand\\tO\\ntheir\\tO\\nfather\\tO\\n,\\tO\\napparently\\tO\\nhealthy\\tO\\nas\\tO\\nwell\\tO\\n,\\tO\\npresented\\tO\\nARSA\\tO\\nand\\tO\\nGS\\tO\\nvalues\\tO\\nwithin\\tO\\nthe\\tO\\nrange\\tO\\nof\\tO\\nMLD\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nMutation\\tO\\nscreening\\tO\\nand\\tO\\nsequence\\tO\\nanalysis\\tO\\ndisclosed\\tO\\nthe\\tO\\ninvolvement\\tO\\nof\\tO\\nthree\\tO\\ndifferent\\tO\\nARSA\\tO\\nmutations\\tO\\nbeing\\tO\\nthe\\tO\\nmolecular\\tO\\nbasis\\tO\\nof\\tO\\nintrafamilial\\tO\\nphenotypic\\tO\\nheterogeneity\\tO\\n.\\tO\\n\\nThe\\tO\\nlate\\tO\\ninfantile\\tO\\npatient\\tO\\ninherited\\tO\\nfrom\\tO\\nhis\\tO\\nmother\\tO\\nthe\\tO\\nfrequent\\tO\\n0\\tO\\n-\\tO\\ntype\\tO\\nmutation\\tO\\n459\\tO\\n+\\tO\\n1G\\tO\\n>\\tO\\nA\\tO\\n,\\tO\\nand\\tO\\nfrom\\tO\\nhis\\tO\\nfather\\tO\\na\\tO\\nnovel\\tO\\n,\\tO\\nsingle\\tO\\nbasepair\\tO\\nmicrodeletion\\tO\\nof\\tO\\nguanine\\tO\\nat\\tO\\nnucleotide\\tO\\n7\\tO\\nin\\tO\\nexon\\tO\\n1\\tO\\n(\\tO\\n7delG\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\ntwo\\tO\\nclinically\\tO\\nunaffected\\tO\\nsiblings\\tO\\ncarried\\tO\\nthe\\tO\\nmaternal\\tO\\nmutation\\tO\\n459\\tO\\n+\\tO\\n1G\\tO\\n>\\tO\\nA\\tO\\nand\\tO\\n,\\tO\\non\\tO\\ntheir\\tO\\npaternal\\tO\\nallele\\tO\\n,\\tO\\na\\tO\\nnovel\\tO\\ncytosine\\tO\\nto\\tO\\nthymidine\\tO\\ntransition\\tO\\nat\\tO\\nnucleotide\\tO\\n2435\\tO\\nin\\tO\\nexon\\tO\\n8\\tO\\n,\\tO\\nresulting\\tO\\nin\\tO\\nsubstitution\\tO\\nof\\tO\\nalanine\\tO\\n464\\tO\\nby\\tO\\nvaline\\tO\\n(\\tO\\nA464V\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nfathers\\tO\\ngenotype\\tO\\nthus\\tO\\nwas\\tO\\n7delG\\tO\\n/\\tO\\nA464V\\tO\\n.\\tO\\n\\nMutation\\tO\\nA464V\\tO\\nwas\\tO\\nnot\\tO\\nfound\\tO\\nin\\tO\\n18\\tO\\nunrelated\\tO\\nMLD\\tB-Disease\\npatients\\tO\\nand\\tO\\n50\\tO\\ncontrols\\tO\\n.\\tO\\n\\nA464V\\tO\\n,\\tO\\nalthough\\tO\\nclearly\\tO\\nmodifying\\tO\\nARSA\\tO\\nand\\tO\\nGS\\tO\\nlevels\\tO\\n,\\tO\\napparently\\tO\\nbears\\tO\\nlittle\\tO\\nsignificance\\tO\\nfor\\tO\\nclinical\\tO\\nmanifestation\\tO\\nof\\tO\\nMLD\\tB-Disease\\n,\\tO\\nmimicking\\tO\\nthe\\tO\\nfrequent\\tO\\nARSA\\tO\\npseudodeficiency\\tO\\nallele\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\ndemonstrate\\tO\\nthat\\tO\\nin\\tO\\ncertain\\tO\\ngenetic\\tO\\nconditions\\tO\\nMLD\\tB-Disease\\n-\\tO\\nlike\\tO\\nARSA\\tO\\nand\\tO\\nGS\\tO\\nvalues\\tO\\nneed\\tO\\nnot\\tO\\nbe\\tO\\nparalleled\\tO\\nby\\tO\\nclinical\\tO\\ndisease\\tO\\n,\\tO\\na\\tO\\nfinding\\tO\\nwith\\tO\\nserious\\tO\\ndiagnostic\\tO\\nand\\tO\\nprognostic\\tO\\nimplications\\tO\\n.\\tO\\n\\nMoreover\\tO\\n,\\tO\\nfurther\\tO\\nARSA\\tO\\nalleles\\tO\\nfunctionally\\tO\\nsimilar\\tO\\nto\\tO\\nA464V\\tO\\nmight\\tO\\nexist\\tO\\nwhich\\tO\\n,\\tO\\ntogether\\tO\\nwith\\tO\\n0\\tO\\n-\\tO\\ntype\\tO\\nmutations\\tO\\n,\\tO\\nmay\\tO\\ncause\\tO\\npathological\\tO\\nARSA\\tO\\nand\\tO\\nGS\\tO\\nlevels\\tO\\n,\\tO\\nbut\\tO\\nnot\\tO\\nclinical\\tO\\noutbreak\\tO\\nof\\tO\\nthe\\tO\\ndisease\\tO\\n.\\tO\\n.\\tO\\n\\nHuman\\tO\\nMLH1\\tO\\ndeficiency\\tO\\npredisposes\\tO\\nto\\tO\\nhematological\\tB-Disease\\nmalignancy\\tI-Disease\\nand\\tO\\nneurofibromatosis\\tB-Disease\\ntype\\tI-Disease\\n1\\tI-Disease\\n.\\tO\\n\\nHeterozygous\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nDNA\\tO\\nmismatch\\tO\\nrepair\\tO\\ngenes\\tO\\nlead\\tO\\nto\\tO\\nhereditary\\tB-Disease\\nnonpolyposis\\tI-Disease\\ncolorectal\\tI-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\ndisease\\tO\\nsusceptibility\\tO\\nof\\tO\\nindividuals\\tO\\nwho\\tO\\nconstitutionally\\tO\\nlack\\tO\\nboth\\tO\\nwild\\tO\\n-\\tO\\ntype\\tO\\nalleles\\tO\\nis\\tO\\nunknown\\tO\\n.\\tO\\n\\nWe\\tO\\nhave\\tO\\nidentified\\tO\\nthree\\tO\\noffspring\\tO\\nin\\tO\\na\\tO\\nhereditary\\tB-Disease\\nnonpolyposis\\tI-Disease\\ncolorectal\\tI-Disease\\ncancer\\tI-Disease\\nfamily\\tO\\nwho\\tO\\ndeveloped\\tO\\nhematological\\tB-Disease\\nmalignancy\\tI-Disease\\nat\\tO\\na\\tO\\nvery\\tO\\nearly\\tO\\nage\\tO\\n,\\tO\\nand\\tO\\nat\\tO\\nleast\\tO\\ntwo\\tO\\nof\\tO\\nthem\\tO\\ndisplayed\\tO\\nsigns\\tO\\nof\\tO\\nneurofibromatosis\\tB-Disease\\ntype\\tI-Disease\\n1\\tI-Disease\\n(\\tO\\nNF1\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nDNA\\tO\\nsequence\\tO\\nanalysis\\tO\\nand\\tO\\nallele\\tO\\n-\\tO\\nspecific\\tO\\namplification\\tO\\nin\\tO\\ntwo\\tO\\nsiblings\\tO\\nrevealed\\tO\\na\\tO\\nhomozygous\\tO\\nMLH1\\tO\\nmutation\\tO\\n(\\tO\\nC676T\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nArg226Stop\\tO\\n)\\tO\\n.\\tO\\n\\nThus\\tO\\n,\\tO\\na\\tO\\nhomozygous\\tO\\ngerm\\tO\\n-\\tO\\nline\\tO\\nMLH1\\tO\\nmutation\\tO\\nand\\tO\\nconsequent\\tO\\nmismatch\\tO\\nrepair\\tO\\ndeficiency\\tO\\nresults\\tO\\nin\\tO\\na\\tO\\nmutator\\tO\\nphenotype\\tO\\ncharacterized\\tO\\nby\\tO\\nleukemia\\tB-Disease\\nand\\tO\\n/\\tO\\nor\\tO\\nlymphoma\\tB-Disease\\nassociated\\tO\\nwith\\tO\\nneurofibromatosis\\tB-Disease\\ntype\\tI-Disease\\n1\\tI-Disease\\n.\\tO\\n.\\tO\\n\\nMissense\\tO\\nmutations\\tO\\nin\\tO\\nthe\\tO\\nmost\\tO\\nancient\\tO\\nresidues\\tO\\nof\\tO\\nthe\\tO\\nPAX6\\tO\\npaired\\tO\\ndomain\\tO\\nunderlie\\tO\\na\\tO\\nspectrum\\tO\\nof\\tO\\nhuman\\tO\\ncongenital\\tB-Disease\\neye\\tI-Disease\\nmalformations\\tI-Disease\\n.\\tO\\n\\nMutations\\tO\\nof\\tO\\nthe\\tO\\nhuman\\tO\\nPAX6\\tO\\ngene\\tO\\nunderlie\\tO\\naniridia\\tB-Disease\\n(\\tO\\ncongenital\\tB-Disease\\nabsence\\tI-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\niris\\tI-Disease\\n)\\tO\\n,\\tO\\na\\tO\\nrare\\tO\\ndominant\\tO\\nmalformation\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\neye\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nspectrum\\tO\\nof\\tO\\nPAX6\\tO\\nmutations\\tO\\nin\\tO\\naniridia\\tB-Disease\\npatients\\tO\\nis\\tO\\nhighly\\tO\\nbiased\\tO\\n,\\tO\\nwith\\tO\\n92\\tO\\n%\\tO\\nof\\tO\\nall\\tO\\nreported\\tO\\nmutations\\tO\\nleading\\tO\\nto\\tO\\npremature\\tO\\ntruncation\\tO\\nof\\tO\\nthe\\tO\\nprotein\\tO\\n(\\tO\\nnonsense\\tO\\n,\\tO\\nsplicing\\tO\\n,\\tO\\ninsertions\\tO\\nand\\tO\\ndeletions\\tO\\n)\\tO\\nand\\tO\\njust\\tO\\n2\\tO\\n%\\tO\\nleading\\tO\\nto\\tO\\nsubstitution\\tO\\nof\\tO\\none\\tO\\namino\\tO\\nacid\\tO\\nby\\tO\\nanother\\tO\\n(\\tO\\nmissense\\tO\\n)\\tO\\n.\\tO\\n\\nThe\\tO\\nextraordinary\\tO\\nconservation\\tO\\nof\\tO\\nthe\\tO\\nPAX6\\tO\\nprotein\\tO\\nat\\tO\\nthe\\tO\\namino\\tO\\nacid\\tO\\nlevel\\tO\\namongst\\tO\\nvertebrates\\tO\\npredicts\\tO\\nthat\\tO\\npathological\\tO\\nmissense\\tO\\nmutations\\tO\\nshould\\tO\\nin\\tO\\nfact\\tO\\nbe\\tO\\ncommon\\tO\\neven\\tO\\nthough\\tO\\nthey\\tO\\nare\\tO\\nhardly\\tO\\never\\tO\\nseen\\tO\\nin\\tO\\naniridia\\tB-Disease\\npatients\\tO\\n.\\tO\\n\\nThis\\tO\\nindicates\\tO\\nthat\\tO\\nthere\\tO\\nis\\tO\\na\\tO\\nheavy\\tO\\nascertainment\\tO\\nbias\\tO\\nin\\tO\\nthe\\tO\\nselection\\tO\\nof\\tO\\npatients\\tO\\nfor\\tO\\nPAX6\\tO\\nmutation\\tO\\nanalysis\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\nmissing\\tO\\nPAX6\\tO\\nmissense\\tO\\nmutations\\tO\\nfrequently\\tO\\nmay\\tO\\nunderlie\\tO\\nphenotypes\\tO\\ndistinct\\tO\\nfrom\\tO\\ntextbook\\tO\\naniridia\\tB-Disease\\n.\\tO\\n\\nHere\\tO\\nwe\\tO\\npresent\\tO\\nfour\\tO\\nnovel\\tO\\nPAX6\\tO\\nmissense\\tO\\nmutations\\tO\\n,\\tO\\ntwo\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\natypical\\tO\\nphenotypes\\tO\\nectopia\\tB-Disease\\npupillae\\tI-Disease\\n(\\tO\\ndisplaced\\tB-Disease\\npupils\\tI-Disease\\n)\\tO\\nand\\tO\\ncongenital\\tB-Disease\\nnystagmus\\tI-Disease\\n(\\tO\\nsearching\\tB-Disease\\ngaze\\tI-Disease\\n)\\tO\\n,\\tO\\nand\\tO\\ntwo\\tO\\nin\\tO\\nassociation\\tO\\nwith\\tO\\nmore\\tO\\nrecognizable\\tO\\naniridia\\tB-Disease\\nphenotypes\\tO\\n.\\tO\\n\\nStrikingly\\tO\\n,\\tO\\nall\\tO\\nfour\\tO\\nmutations\\tO\\nare\\tO\\nlocated\\tO\\nwithin\\tO\\nthe\\tO\\nPAX6\\tO\\npaired\\tO\\ndomain\\tO\\nand\\tO\\naffect\\tO\\namino\\tO\\nacids\\tO\\nwhich\\tO\\nare\\tO\\nhighly\\tO\\nconserved\\tO\\nin\\tO\\nall\\tO\\nknown\\tO\\npaired\\tO\\ndomain\\tO\\nproteins\\tO\\n.\\tO\\n\\nOur\\tO\\nresults\\tO\\nsupport\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\nthe\\tO\\nunder\\tO\\n-\\tO\\nrepresentation\\tO\\nof\\tO\\nmissense\\tO\\nmutations\\tO\\nis\\tO\\ncaused\\tO\\nby\\tO\\nascertainment\\tO\\nbias\\tO\\nand\\tO\\nsuggest\\tO\\nthat\\tO\\na\\tO\\nsubstantial\\tO\\nburden\\tO\\nof\\tO\\nPAX6\\tB-Disease\\n-\\tI-Disease\\nrelated\\tI-Disease\\ndisease\\tI-Disease\\nremains\\tO\\nto\\tO\\nbe\\tO\\nuncovered\\tO\\n.\\tO\\n.\\tO\\n\\nThe\\tO\\nchromosomal\\tO\\norder\\tO\\nof\\tO\\ngenes\\tO\\ncontrolling\\tO\\nthe\\tO\\nmajor\\tO\\nhistocompatibility\\tO\\ncomplex\\tO\\n,\\tO\\nproperdin\\tO\\nfactor\\tO\\nB\\tO\\n,\\tO\\nand\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nsecond\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nrelationship\\tO\\nof\\tO\\nthe\\tO\\ngenes\\tO\\ncoding\\tO\\nfor\\tO\\nHLA\\tO\\nto\\tO\\nthose\\tO\\ncoding\\tO\\nfor\\tO\\nproperdin\\tO\\nFactor\\tO\\nB\\tO\\nallotypes\\tO\\nand\\tO\\nfor\\tO\\ndeficiency\\tB-Disease\\nof\\tI-Disease\\nthe\\tI-Disease\\nsecond\\tI-Disease\\ncomponent\\tI-Disease\\nof\\tI-Disease\\ncomplement\\tI-Disease\\n(\\tO\\nC2\\tO\\n)\\tO\\nwas\\tO\\nstudied\\tO\\nin\\tO\\nfamilies\\tO\\nof\\tO\\npatients\\tO\\nwith\\tO\\nconnective\\tO\\ntissue\\tO\\ndisorders\\tO\\n.\\tO\\n\\nPatients\\tO\\nwere\\tO\\nselected\\tO\\nbecause\\tO\\nthey\\tO\\nwere\\tO\\nheterozygous\\tO\\nor\\tO\\nhomozygous\\tO\\nfor\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\n.\\tO\\n\\n12\\tO\\nfamilies\\tO\\nwith\\tO\\n15\\tO\\nmatings\\tO\\ninformative\\tO\\nfor\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nOf\\tO\\n57\\tO\\ninformative\\tO\\nmeioses\\tO\\n,\\tO\\ntwo\\tO\\ncrossovers\\tO\\nwere\\tO\\nnoted\\tO\\nbetween\\tO\\nthe\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\ngene\\tO\\nand\\tO\\nthe\\tO\\nHLA\\tO\\n-\\tO\\nB\\tO\\ngene\\tO\\n,\\tO\\nwith\\tO\\na\\tO\\nrecombinant\\tO\\nfraction\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n035\\tO\\n.\\tO\\n\\nA\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\n13\\tO\\nwas\\tO\\ncalculated\\tO\\nfor\\tO\\nlinkage\\tO\\nbetween\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nHLA\\tO\\n-\\tO\\nB\\tO\\nat\\tO\\na\\tO\\nmaximum\\tO\\nlikelihood\\tO\\nvalue\\tO\\nof\\tO\\nthe\\tO\\nrecombinant\\tO\\nfraction\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n04\\tO\\n.\\tO\\n\\n18\\tO\\nfamilies\\tO\\nwith\\tO\\n21\\tO\\ninformative\\tO\\nmatings\\tO\\nfor\\tO\\nboth\\tO\\nproperdin\\tO\\nFactor\\tO\\nB\\tO\\nallotype\\tO\\nand\\tO\\nHLA\\tO\\n-\\tO\\nB\\tO\\nwere\\tO\\nfound\\tO\\n.\\tO\\n\\nOf\\tO\\n72\\tO\\ninformative\\tO\\nmeioses\\tO\\n,\\tO\\nthree\\tO\\nrecombinants\\tO\\nwere\\tO\\nfound\\tO\\n,\\tO\\ngiving\\tO\\na\\tO\\nrecombinant\\tO\\nfraction\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n042\\tO\\n.\\tO\\n\\nA\\tO\\nlod\\tO\\nscore\\tO\\nof\\tO\\n16\\tO\\nbetween\\tO\\nHLA\\tO\\n-\\tO\\nB\\tO\\nand\\tO\\nFactor\\tO\\nB\\tO\\nallotypes\\tO\\nwas\\tO\\ncalculated\\tO\\nat\\tO\\na\\tO\\nmaximum\\tO\\nlikelihood\\tO\\nvalue\\tO\\nof\\tO\\nthe\\tO\\nrecombinant\\tO\\nfraction\\tO\\nof\\tO\\n0\\tO\\n.\\tO\\n\\n04\\tO\\n.\\tO\\n\\nA\\tO\\ncrossover\\tO\\nwas\\tO\\nshown\\tO\\nto\\tO\\nhave\\tO\\noccurred\\tO\\nbetween\\tO\\ngenes\\tO\\nfor\\tO\\nFactor\\tO\\nB\\tO\\nand\\tO\\nHLA\\tO\\n-\\tO\\nD\\tO\\n,\\tO\\nin\\tO\\nwhich\\tO\\nHLA\\tO\\n-\\tO\\nD\\tO\\nsegregared\\tO\\nwith\\tO\\nHLA\\tO\\n-\\tO\\nA\\tO\\nand\\tO\\nB\\tO\\n.\\tO\\n\\nThese\\tO\\nstudies\\tO\\nsuggest\\tO\\nthat\\tO\\nthe\\tO\\ngenes\\tO\\nfor\\tO\\nFactor\\tO\\nB\\tO\\nand\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nare\\tO\\nlocated\\tO\\noutside\\tO\\nthose\\tO\\nfor\\tO\\nHLA\\tO\\n,\\tO\\nthat\\tO\\nthe\\tO\\norder\\tO\\nof\\tO\\ngenese\\tO\\nis\\tO\\nHLA\\tO\\n-\\tO\\nA\\tO\\n,\\tO\\n-\\tO\\nB\\tO\\n,\\tO\\n-\\tO\\nD\\tO\\n,\\tO\\nFactor\\tO\\nB\\tO\\nallotype\\tO\\n,\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\n,\\tO\\nthat\\tO\\nthe\\tO\\ngenes\\tO\\ncoding\\tO\\nfor\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\nand\\tO\\nFactor\\tO\\nB\\tO\\nallotypes\\tO\\nare\\tO\\napproximately\\tO\\n3\\tO\\n-\\tO\\n-\\tO\\n5\\tO\\ncentimorgans\\tO\\nfrom\\tO\\nthe\\tO\\nHLA\\tO\\n-\\tO\\nA\\tO\\nand\\tO\\nHLA\\tO\\n-\\tO\\nB\\tO\\nloci\\tO\\n,\\tO\\nand\\tO\\nthat\\tO\\nthe\\tO\\napparent\\tO\\nlack\\tO\\nof\\tO\\nrecombinants\\tO\\nbetween\\tO\\nthe\\tO\\nFactor\\tO\\nB\\tO\\ngene\\tO\\nand\\tO\\nC2\\tB-Disease\\ndeficiency\\tI-Disease\\ngene\\tO\\nsuggests\\tO\\nthat\\tO\\nthese\\tO\\ntwo\\tO\\ngenes\\tO\\nlie\\tO\\nin\\tO\\nclose\\tO\\nproximity\\tO\\nto\\tO\\none\\tO\\nanother\\tO\\n.\\tO\\n\\nDistribution\\tO\\nof\\tO\\nemerin\\tO\\nand\\tO\\nlamins\\tO\\nin\\tO\\nthe\\tO\\nheart\\tO\\nand\\tO\\nimplications\\tO\\nfor\\tO\\nEmery\\tB-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n.\\tO\\n\\nEmerin\\tO\\nis\\tO\\na\\tO\\nnuclear\\tO\\nmembrane\\tO\\nprotein\\tO\\nwhich\\tO\\nis\\tO\\nmissing\\tO\\nor\\tO\\ndefective\\tO\\nin\\tO\\nEmery\\tB-Disease\\n-\\tI-Disease\\nDreifuss\\tI-Disease\\nmuscular\\tI-Disease\\ndystrophy\\tI-Disease\\n(\\tO\\nEDMD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nIt\\tO\\nis\\tO\\none\\tO\\nmember\\tO\\nof\\tO\\na\\tO\\nfamily\\tO\\nof\\tO\\nlamina\\tO\\n-\\tO\\nassociated\\tO\\nproteins\\tO\\nwhich\\tO\\nincludes\\tO\\nLAP1\\tO\\n,\\tO\\nLAP2\\tO\\nand\\tO\\nlamin\\tO\\nB\\tO\\nreceptor\\tO\\n(\\tO\\nLBR\\tO\\n)\\tO\\n.\\tO\\n\\nA\\tO\\npanel\\tO\\nof\\tO\\n16\\tO\\nmonoclonal\\tO\\nantibodies\\tO\\n(\\tO\\nmAbs\\tO\\n)\\tO\\nhas\\tO\\nbeen\\tO\\nmapped\\tO\\nto\\tO\\nsix\\tO\\nspecific\\tO\\nsites\\tO\\nthroughout\\tO\\nthe\\tO\\nemerin\\tO\\nmolecule\\tO\\nusing\\tO\\nphage\\tO\\n-\\tO\\ndisplayed\\tO\\npeptide\\tO\\nlibraries\\tO\\nand\\tO\\nhas\\tO\\nbeen\\tO\\nused\\tO\\nto\\tO\\nlocalize\\tO\\nemerin\\tO\\nin\\tO\\nhuman\\tO\\nand\\tO\\nrabbit\\tO\\nheart\\tO\\n.\\tO\\n\\nSeveral\\tO\\nmAbs\\tO\\nagainst\\tO\\ndifferent\\tO\\nemerin\\tO\\nepitopes\\tO\\ndid\\tO\\nnot\\tO\\nrecognize\\tO\\nintercalated\\tO\\ndiscs\\tO\\nin\\tO\\nthe\\tO\\nheart\\tO\\n,\\tO\\nthough\\tO\\nthey\\tO\\nrecognized\\tO\\ncardiomyocyte\\tO\\nnuclei\\tO\\nstrongly\\tO\\n,\\tO\\nboth\\tO\\nat\\tO\\nthe\\tO\\nrim\\tO\\nand\\tO\\nin\\tO\\nintranuclear\\tO\\nspots\\tO\\nor\\tO\\nchannels\\tO\\n.\\tO\\n\\nA\\tO\\npolyclonal\\tO\\nrabbit\\tO\\nantiserum\\tO\\nagainst\\tO\\nemerin\\tO\\ndid\\tO\\nrecognize\\tO\\nboth\\tO\\nnuclear\\tO\\nmembrane\\tO\\nand\\tO\\nintercalated\\tO\\ndiscs\\tO\\nbut\\tO\\n,\\tO\\nafter\\tO\\naffinity\\tO\\npurification\\tO\\nagainst\\tO\\na\\tO\\npure\\tO\\n-\\tO\\nemerin\\tO\\nband\\tO\\non\\tO\\na\\tO\\nwestern\\tO\\nblot\\tO\\n,\\tO\\nit\\tO\\nstained\\tO\\nonly\\tO\\nthe\\tO\\nnuclear\\tO\\nmembrane\\tO\\n.\\tO\\n\\nThese\\tO\\nresults\\tO\\nwould\\tO\\nnot\\tO\\nbe\\tO\\nexpected\\tO\\nif\\tO\\nimmunostaining\\tO\\nat\\tO\\nintercalated\\tO\\ndiscs\\tO\\nwere\\tO\\ndue\\tO\\nto\\tO\\na\\tO\\nproduct\\tO\\nof\\tO\\nthe\\tO\\nemerin\\tO\\ngene\\tO\\nand\\tO\\n,\\tO\\ntherefore\\tO\\n,\\tO\\ncast\\tO\\nsome\\tO\\ndoubt\\tO\\nupon\\tO\\nthe\\tO\\nhypothesis\\tO\\nthat\\tO\\ncardiac\\tB-Disease\\ndefects\\tI-Disease\\nin\\tO\\nEDMD\\tB-Disease\\nare\\tO\\ncaused\\tO\\nby\\tO\\nabsence\\tO\\nof\\tO\\nemerin\\tO\\nfrom\\tO\\nintercalated\\tO\\ndiscs\\tO\\n.\\tO\\n\\nAlthough\\tO\\nemerin\\tO\\nwas\\tO\\nabundant\\tO\\nin\\tO\\nthe\\tO\\nmembranes\\tO\\nof\\tO\\ncardiomyocyte\\tO\\nnuclei\\tO\\n,\\tO\\nit\\tO\\nwas\\tO\\nabsent\\tO\\nfrom\\tO\\nmany\\tO\\nnon\\tO\\n-\\tO\\nmyocyte\\tO\\ncells\\tO\\nin\\tO\\nthe\\tO\\nheart\\tO\\n.\\tO\\n\\nThis\\tO\\ndistribution\\tO\\nof\\tO\\nemerin\\tO\\nwas\\tO\\nsimilar\\tO\\nto\\tO\\nthat\\tO\\nof\\tO\\nlamin\\tO\\nA\\tO\\n,\\tO\\na\\tO\\ncandidate\\tO\\ngene\\tO\\nfor\\tO\\nan\\tO\\nautosomal\\tO\\nform\\tO\\nof\\tO\\nEDMD\\tB-Disease\\n.\\tO\\n\\nIn\\tO\\ncontrast\\tO\\n,\\tO\\nlamin\\tO\\nB1\\tO\\nwas\\tO\\nabsent\\tO\\nfrom\\tO\\ncardiomyocyte\\tO\\nnuclei\\tO\\n,\\tO\\nshowing\\tO\\nthat\\tO\\nlamin\\tO\\nB1\\tO\\nis\\tO\\nnot\\tO\\nessential\\tO\\nfor\\tO\\nlocalization\\tO\\nof\\tO\\nemerin\\tO\\nto\\tO\\nthe\\tO\\nnuclear\\tO\\nlamina\\tO\\n.\\tO\\n\\nLamin\\tO\\nB1\\tO\\nis\\tO\\nalso\\tO\\nalmost\\tO\\ncompletely\\tO\\nabsent\\tO\\nfrom\\tO\\nskeletal\\tO\\nmuscle\\tO\\nnuclei\\tO\\n.\\tO\\n\\nIn\\tO\\nEDMD\\tB-Disease\\n,\\tO\\nthe\\tO\\nadditional\\tO\\nabsence\\tO\\nof\\tO\\nlamin\\tO\\nB1\\tO\\nfrom\\tO\\nheart\\tO\\nand\\tO\\nskeletal\\tO\\nmuscle\\tO\\nnuclei\\tO\\nwhich\\tO\\nalready\\tO\\nlack\\tO\\nemerin\\tO\\nmay\\tO\\noffer\\tO\\nan\\tO\\nalternative\\tO\\nexplanation\\tO\\nof\\tO\\nwhy\\tO\\nthese\\tO\\ntissues\\tO\\nare\\tO\\nparticularly\\tO\\naffected\\tO\\n.\\tO\\n.\\tO\\n\\nGenetic\\tO\\nmapping\\tO\\nof\\tO\\nthe\\tO\\ncopper\\tB-Disease\\ntoxicosis\\tI-Disease\\nlocus\\tO\\nin\\tO\\nBedlington\\tO\\nterriers\\tO\\nto\\tO\\ndog\\tO\\nchromosome\\tO\\n10\\tO\\n,\\tO\\nin\\tO\\na\\tO\\nregion\\tO\\nsyntenic\\tO\\nto\\tO\\nhuman\\tO\\nchromosome\\tO\\nregion\\tO\\n2p13\\tO\\n-\\tO\\np16\\tO\\n.\\tO\\n\\nAbnormal\\tO\\nhepatic\\tB-Disease\\ncopper\\tI-Disease\\naccumulation\\tI-Disease\\nis\\tO\\nrecognized\\tO\\nas\\tO\\nan\\tO\\ninherited\\tB-Disease\\ndisorder\\tI-Disease\\nin\\tO\\nman\\tO\\n,\\tO\\nmouse\\tO\\n,\\tO\\nrat\\tO\\nand\\tO\\ndog\\tO\\n.\\tO\\n\\nThe\\tO\\nmajor\\tO\\ncause\\tO\\nof\\tO\\nhepatic\\tB-Disease\\ncopper\\tI-Disease\\naccumulation\\tI-Disease\\nin\\tO\\nman\\tO\\nis\\tO\\na\\tO\\ndysfunctional\\tO\\nATP7B\\tO\\ngene\\tO\\n,\\tO\\ncausing\\tO\\nWilson\\tB-Disease\\ndisease\\tI-Disease\\n(\\tO\\nWD\\tB-Disease\\n)\\tO\\n.\\tO\\n\\nMutations\\tO\\nin\\tO\\nthe\\tO\\nATP7B\\tO\\ngenes\\tO\\nhave\\tO\\nalso\\tO\\nbeen\\tO\\ndemonstrated\\tO\\nin\\tO\\nmouse\\tO\\nand\\tO\\nrat\\tO\\n.\\tO\\n\\nThe\\tO\\nATP7B\\tO\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nexcluded\\tO\\nin\\tO\\nthe\\tO\\nmuch\\tO\\nrarer\\tO\\nhuman\\tO\\ncopper\\tB-Disease\\noverload\\tI-Disease\\ndisease\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nIndian\\tI-Disease\\nchildhood\\tI-Disease\\ncirrhosis\\tI-Disease\\n,\\tO\\nindicating\\tO\\ngenetic\\tO\\nheterogeneity\\tO\\n.\\tO\\n\\nBy\\tO\\ninvestigating\\tO\\nthe\\tO\\ncommon\\tO\\nautosomal\\tO\\nrecessive\\tO\\ncopper\\tB-Disease\\ntoxicosis\\tI-Disease\\n(\\tO\\nCT\\tB-Disease\\n)\\tO\\nin\\tO\\nBedlington\\tO\\nterriers\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nidentified\\tO\\na\\tO\\nnew\\tO\\nlocus\\tO\\ninvolved\\tO\\nin\\tO\\nprogressive\\tO\\nliver\\tB-Disease\\ndisease\\tI-Disease\\n.\\tO\\n\\nWe\\tO\\nexamined\\tO\\nwhether\\tO\\nthe\\tO\\nWD\\tB-Disease\\ngene\\tO\\nATP7B\\tO\\nwas\\tO\\nalso\\tO\\ncausative\\tO\\nfor\\tO\\nCT\\tB-Disease\\nby\\tO\\ninvestigating\\tO\\nthe\\tO\\nchromosomal\\tO\\nco\\tO\\n-\\tO\\nlocalization\\tO\\nof\\tO\\nATP7B\\tO\\nand\\tO\\nC04107\\tO\\n,\\tO\\nusing\\tO\\nfluorescence\\tO\\nin\\tO\\nsitu\\tO\\nhybridization\\tO\\n(\\tO\\nFISH\\tO\\n)\\tO\\n.\\tO\\n\\nC04107\\tO\\nis\\tO\\nan\\tO\\nanonymous\\tO\\nmicrosatellite\\tO\\nmarker\\tO\\nclosely\\tO\\nlinked\\tO\\nto\\tO\\nCT\\tB-Disease\\n.\\tO\\n\\nHowever\\tO\\n,\\tO\\nBAC\\tO\\nclones\\tO\\ncontaining\\tO\\nATP7B\\tO\\nand\\tO\\nC04107\\tO\\nmapped\\tO\\nto\\tO\\nthe\\tO\\ncanine\\tO\\nchromosome\\tO\\nregions\\tO\\nCFA22q11\\tO\\nand\\tO\\nCFA10q26\\tO\\n,\\tO\\nrespectively\\tO\\n,\\tO\\ndemonstrating\\tO\\nthat\\tO\\nWD\\tB-Disease\\ncannot\\tO\\nbe\\tO\\nhomologous\\tO\\nto\\tO\\nCT\\tB-Disease\\n.\\tO\\n\\nThe\\tO\\ncopper\\tO\\ntransport\\tO\\ngenes\\tO\\nCTR1\\tO\\nand\\tO\\nCTR2\\tO\\nwere\\tO\\nalso\\tO\\nexcluded\\tO\\nas\\tO\\ncandidate\\tO\\ngenes\\tO\\nfor\\tO\\nCT\\tB-Disease\\nsince\\tO\\nthey\\tO\\nboth\\tO\\nmapped\\tO\\nto\\tO\\ncanine\\tO\\nchromosome\\tO\\nregion\\tO\\nCFA11q22\\tO\\n.\\tO\\n\\n2\\tO\\n-\\tO\\n22\\tO\\n.\\tO\\n\\n5\\tO\\n.\\tO\\n\\nA\\tO\\ntranscribed\\tO\\nsequence\\tO\\nidentified\\tO\\nfrom\\tO\\nthe\\tO\\nC04107\\tO\\n-\\tO\\ncontaining\\tO\\nBAC\\tO\\nwas\\tO\\nfound\\tO\\nto\\tO\\nbe\\tO\\nhomologous\\tO\\nto\\tO\\na\\tO\\ngene\\tO\\nexpressed\\tO\\nfrom\\tO\\nhuman\\tO\\nchromosome\\tO\\n2p13\\tO\\n-\\tO\\np16\\tO\\n,\\tO\\na\\tO\\nregion\\tO\\ndevoid\\tO\\nof\\tO\\nany\\tO\\npositional\\tO\\ncandidate\\tO\\ngenes\\tO\\n.\\tO\\n\\nMolecular\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nin\\tO\\n205\\tO\\nfamilies\\tO\\n:\\tO\\nextended\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nin\\tO\\nFAP\\tB-Disease\\nand\\tO\\nevidence\\tO\\nfor\\tO\\nthe\\tO\\nrole\\tO\\nof\\tO\\nAPC\\tB-Disease\\namino\\tO\\nacid\\tO\\nchanges\\tO\\nin\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\npredisposition\\tO\\n.\\tO\\n\\nBACKGROUND\\tO\\n/\\tO\\nAIMS\\tO\\nThe\\tO\\ndevelopment\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nand\\tO\\na\\tO\\nvariable\\tO\\nrange\\tO\\nof\\tO\\nextracolonic\\tO\\nmanifestations\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\n(\\tO\\nFAP\\tB-Disease\\n)\\tO\\nis\\tO\\nthe\\tO\\nresult\\tO\\nof\\tO\\nthe\\tO\\ndominant\\tO\\ninheritance\\tO\\nof\\tO\\nadenomatous\\tB-Disease\\npolyposis\\tI-Disease\\ncoli\\tI-Disease\\n(\\tO\\nAPC\\tB-Disease\\n)\\tO\\ngene\\tO\\nmutations\\tO\\n.\\tO\\n\\nIn\\tO\\nthis\\tO\\nstudy\\tO\\n,\\tO\\ndirect\\tO\\nmutation\\tO\\nanalysis\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nwas\\tO\\nperformed\\tO\\nto\\tO\\ndetermine\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nfor\\tO\\nnine\\tO\\nextracolonic\\tO\\nmanifestations\\tO\\nand\\tO\\nto\\tO\\ninvestigate\\tO\\nthe\\tO\\nincidence\\tO\\nof\\tO\\nAPC\\tB-Disease\\nmutations\\tO\\nin\\tO\\nnon\\tO\\n-\\tO\\nFAP\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nMETHODS\\tO\\nThe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nwas\\tO\\nanalysed\\tO\\nin\\tO\\n190\\tO\\nunrelated\\tO\\nFAP\\tB-Disease\\nand\\tO\\n15\\tO\\nnon\\tO\\n-\\tO\\nFAP\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\nusing\\tO\\ndenaturing\\tO\\ngradient\\tO\\ngel\\tO\\nelectrophoresis\\tO\\n,\\tO\\nthe\\tO\\nprotein\\tO\\ntruncation\\tO\\ntest\\tO\\n,\\tO\\nand\\tO\\ndirect\\tO\\nsequencing\\tO\\n.\\tO\\n\\nRESULTS\\tO\\nChain\\tO\\nterminating\\tO\\nsignals\\tO\\nwere\\tO\\nonly\\tO\\nidentified\\tO\\nin\\tO\\npatients\\tO\\nbelonging\\tO\\nto\\tO\\nthe\\tO\\nFAP\\tB-Disease\\ngroup\\tO\\n(\\tO\\n105\\tO\\npatients\\tO\\n)\\tO\\n.\\tO\\n\\nAmino\\tO\\nacid\\tO\\nchanges\\tO\\nwere\\tO\\nidentified\\tO\\nin\\tO\\nfour\\tO\\npatients\\tO\\n,\\tO\\nthree\\tO\\nof\\tO\\nwhom\\tO\\nbelonged\\tO\\nto\\tO\\nthe\\tO\\nnon\\tO\\n-\\tO\\nFAP\\tO\\ngroup\\tO\\nof\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\n.\\tO\\n\\nGenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nidentified\\tO\\nsignificant\\tO\\ndifferences\\tO\\nin\\tO\\nthe\\tO\\nnature\\tO\\nof\\tO\\ncertain\\tO\\nextracolonic\\tO\\nmanifestations\\tO\\nin\\tO\\nFAP\\tB-Disease\\npatients\\tO\\nbelonging\\tO\\nto\\tO\\nthree\\tO\\nmutation\\tO\\nsubgroups\\tO\\n.\\tO\\n\\nCONCLUSIONS\\tO\\nExtended\\tO\\ngenotype\\tO\\n-\\tO\\nphenotype\\tO\\ncorrelations\\tO\\nmade\\tO\\nin\\tO\\nthis\\tO\\nstudy\\tO\\nmay\\tO\\nhave\\tO\\nthe\\tO\\npotential\\tO\\nto\\tO\\ndetermine\\tO\\nthe\\tO\\nmost\\tO\\nappropriate\\tO\\nsurveillance\\tO\\nand\\tO\\nprophylactic\\tO\\ntreatment\\tO\\nregimens\\tO\\nfor\\tO\\nthose\\tO\\npatients\\tO\\nwith\\tO\\nmutations\\tO\\nassociated\\tO\\nwith\\tO\\nlife\\tO\\nthreatening\\tO\\nconditions\\tO\\n.\\tO\\n\\nThis\\tO\\nstudy\\tO\\nalso\\tO\\nprovided\\tO\\nevidence\\tO\\nfor\\tO\\nthe\\tO\\npathological\\tO\\nnature\\tO\\nof\\tO\\namino\\tO\\nacid\\tO\\nchanges\\tO\\nin\\tO\\nAPC\\tO\\nassociated\\tO\\nwith\\tO\\nboth\\tO\\nFAP\\tB-Disease\\nand\\tO\\nnon\\tO\\n-\\tO\\nFAP\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\npatients\\tO\\n.\\tO\\n.\\tO\\n\\nInherited\\tB-Disease\\ncolorectal\\tI-Disease\\npolyposis\\tI-Disease\\nand\\tO\\ncancer\\tB-Disease\\nrisk\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tO\\nI1307K\\tO\\npolymorphism\\tO\\n.\\tO\\n\\nGerm\\tO\\n-\\tO\\nline\\tO\\nand\\tO\\nsomatic\\tO\\ntruncating\\tO\\nmutations\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nare\\tO\\nthought\\tO\\nto\\tO\\ninitiate\\tO\\ncolorectal\\tB-Disease\\ntumor\\tI-Disease\\nformation\\tO\\nin\\tO\\nfamilial\\tB-Disease\\nadenomatous\\tI-Disease\\npolyposis\\tI-Disease\\nsyndrome\\tI-Disease\\nand\\tO\\nsporadic\\tO\\ncolorectal\\tO\\ncarcinogenesis\\tO\\n,\\tO\\nrespectively\\tO\\n.\\tO\\n\\nRecently\\tO\\n,\\tO\\nan\\tO\\nisoleucine\\tO\\n-\\tO\\n-\\tO\\n>\\tO\\nlysine\\tO\\npolymorphism\\tO\\nat\\tO\\ncodon\\tO\\n1307\\tO\\n(\\tO\\nI1307K\\tO\\n)\\tO\\nof\\tO\\nthe\\tO\\nAPC\\tB-Disease\\ngene\\tO\\nhas\\tO\\nbeen\\tO\\nidentified\\tO\\nin\\tO\\n6\\tO\\n%\\tO\\n-\\tO\\n7\\tO\\n%\\tO\\nof\\tO\\nthe\\tO\\nAshkenazi\\tO\\nJewish\\tO\\npopulation\\tO\\n.\\tO\\n\\nTo\\tO\\nassess\\tO\\nthe\\tO\\nrisk\\tO\\nof\\tO\\nthis\\tO\\ncommon\\tO\\nAPC\\tB-Disease\\nallelic\\tO\\nvariant\\tO\\nin\\tO\\ncolorectal\\tO\\ncarcinogenesis\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\nanalyzed\\tO\\na\\tO\\nlarge\\tO\\ncohort\\tO\\nof\\tO\\nunselected\\tO\\nAshkenazi\\tO\\nJewish\\tO\\nsubjects\\tO\\nwith\\tO\\nadenomatous\\tB-Disease\\npolyps\\tI-Disease\\nand\\tO\\n.\\tO\\nor\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n,\\tI-Disease\\nfor\\tO\\nthe\\tO\\nAPC\\tO\\nI1307K\\tO\\npolymorphism\\tO\\n.\\tO\\n\\nThe\\tO\\nAPC\\tO\\nI1307K\\tO\\nallele\\tO\\nwas\\tO\\nidentified\\tO\\nin\\tO\\n48\\tO\\n(\\tO\\n10\\tO\\n.\\tO\\n1\\tO\\n%\\tO\\n)\\tO\\nof\\tO\\n476\\tO\\npatients\\tO\\n.\\tO\\n\\nCompared\\tO\\nwith\\tO\\nthe\\tO\\nfrequency\\tO\\nin\\tO\\ntwo\\tO\\nseparate\\tO\\npopulation\\tO\\ncontrol\\tO\\ngroups\\tO\\n,\\tO\\nthe\\tO\\nAPC\\tO\\nI1307K\\tO\\nallele\\tO\\nis\\tO\\nassociated\\tO\\nwith\\tO\\nan\\tO\\nestimated\\tO\\nrelative\\tO\\nrisk\\tO\\nof\\tO\\n1\\tO\\n.\\tO\\n\\n5\\tO\\n-\\tO\\n1\\tO\\n.\\tO\\n\\n7\\tO\\nfor\\tO\\ncolorectal\\tB-Disease\\nneoplasia\\tI-Disease\\n(\\tO\\nboth\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n01\\tO\\n)\\tO\\n.\\tO\\n\\nFurthermore\\tO\\n,\\tO\\ncompared\\tO\\nwith\\tO\\nnoncarriers\\tO\\n,\\tO\\nAPC\\tO\\nI1307K\\tO\\ncarriers\\tO\\nhad\\tO\\nincreased\\tO\\nnumbers\\tO\\nof\\tO\\nadenomas\\tB-Disease\\nand\\tO\\ncolorectal\\tB-Disease\\ncancers\\tI-Disease\\nper\\tO\\npatient\\tO\\n(\\tO\\nP\\tO\\n=\\tO\\n.\\tO\\n03\\tO\\n)\\tO\\n,\\tO\\nas\\tO\\nwell\\tO\\nas\\tO\\na\\tO\\nyounger\\tO\\nage\\tO\\nat\\tO\\ndiagnosis\\tO\\n.\\tO\\n\\nWe\\tO\\nconclude\\tO\\nthat\\tO\\nthe\\tO\\nAPC\\tO\\nI1307K\\tO\\nvariant\\tO\\nleads\\tO\\nto\\tO\\nincreased\\tO\\nadenoma\\tB-Disease\\nformation\\tO\\nand\\tO\\ndirectly\\tO\\ncontributes\\tO\\nto\\tO\\n3\\tO\\n%\\tO\\n-\\tO\\n4\\tO\\n%\\tO\\nof\\tO\\nall\\tO\\nAshkenazi\\tO\\nJewish\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\n.\\tO\\n\\nThe\\tO\\nestimated\\tO\\nrelative\\tO\\nrisk\\tO\\nfor\\tO\\ncarriers\\tO\\nmay\\tO\\njustify\\tO\\nspecific\\tO\\nclinical\\tO\\nscreening\\tO\\nfor\\tO\\nthe\\tO\\n360\\tO\\n,\\tO\\n000\\tO\\nAmericans\\tO\\nexpected\\tO\\nto\\tO\\nharbor\\tO\\nthis\\tO\\nallele\\tO\\n,\\tO\\nand\\tO\\ngenetic\\tO\\ntesting\\tO\\nin\\tO\\nthe\\tO\\nsetting\\tO\\nof\\tO\\nlong\\tO\\n-\\tO\\nterm\\tO\\n-\\tO\\noutcome\\tO\\nstudies\\tO\\nmay\\tO\\nimpact\\tO\\nsignificantly\\tO\\non\\tO\\ncolorectal\\tB-Disease\\ncancer\\tI-Disease\\nprevention\\tO\\nin\\tO\\nthis\\tO\\npopulation\\tO\\n.\\tO\\n\\nLocalization\\tO\\nof\\tO\\nhuman\\tO\\nBRCA1\\tO\\nand\\tO\\nits\\tO\\nloss\\tO\\nin\\tO\\nhigh\\tO\\n-\\tO\\ngrade\\tO\\n,\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\ninherited\\tI-Disease\\nbreast\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n\\nAlthough\\tO\\nthe\\tO\\nlink\\tO\\nbetween\\tO\\nthe\\tO\\nBRCA1\\tO\\ntumour\\tB-Disease\\n-\\tO\\nsuppressor\\tO\\ngene\\tO\\nand\\tO\\nhereditary\\tB-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancer\\tI-Disease\\nis\\tO\\nestablished\\tO\\n,\\tO\\nthe\\tO\\nrole\\tO\\n,\\tO\\nif\\tO\\nany\\tO\\n,\\tO\\nof\\tO\\nBRCA1\\tO\\nin\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nfamilial\\tI-Disease\\ncancers\\tI-Disease\\nis\\tO\\nunclear\\tO\\n.\\tO\\n\\nBRCA1\\tO\\nmutations\\tO\\nare\\tO\\nrare\\tO\\nin\\tO\\nsporadic\\tB-Disease\\ncancers\\tI-Disease\\n,\\tO\\nbut\\tO\\nloss\\tO\\nof\\tO\\nBRCA1\\tO\\nresulting\\tO\\nfrom\\tO\\nreduced\\tO\\nexpression\\tO\\nor\\tO\\nincorrect\\tO\\nsubcellular\\tO\\nlocalization\\tO\\nis\\tO\\npostulated\\tO\\nto\\tO\\nbe\\tO\\nimportant\\tO\\nin\\tO\\nnon\\tB-Disease\\n-\\tI-Disease\\nfamilial\\tI-Disease\\nbreast\\tI-Disease\\nand\\tI-Disease\\novarian\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n\\nEpigenetic\\tO\\nloss\\tO\\n,\\tO\\nhowever\\tO\\n,\\tO\\nhas\\tO\\nnot\\tO\\nreceived\\tO\\ngeneral\\tO\\nacceptance\\tO\\ndue\\tO\\nto\\tO\\ncontroversy\\tO\\nregarding\\tO\\nthe\\tO\\nsubcellular\\tO\\nlocalization\\tO\\nof\\tO\\nBRCA1\\tO\\nproteins\\tO\\n,\\tO\\nreports\\tO\\nof\\tO\\nwhich\\tO\\nhave\\tO\\nranged\\tO\\nfrom\\tO\\nexclusively\\tO\\nnuclear\\tO\\n,\\tO\\nto\\tO\\nconditionally\\tO\\nnuclear\\tO\\n,\\tO\\nto\\tO\\nthe\\tO\\nER\\tO\\n/\\tO\\ngolgi\\tO\\n,\\tO\\nto\\tO\\ncytoplasmic\\tO\\ninvaginations\\tO\\ninto\\tO\\nthe\\tO\\nnucleus\\tO\\n.\\tO\\n\\nIn\\tO\\nan\\tO\\nattempt\\tO\\nto\\tO\\nresolve\\tO\\nthis\\tO\\nissue\\tO\\n,\\tO\\nwe\\tO\\nhave\\tO\\ncomprehensively\\tO\\ncharacterized\\tO\\n19\\tO\\nanti\\tO\\n-\\tO\\nBRCA1\\tO\\nantibodies\\tO\\n.\\tO\\n\\nThese\\tO\\nreagents\\tO\\ndetect\\tO\\na\\tO\\n220\\tO\\n-\\tO\\nkD\\tO\\nprotein\\tO\\nlocalized\\tO\\nin\\tO\\ndiscrete\\tO\\nnuclear\\tO\\nfoci\\tO\\nin\\tO\\nall\\tO\\nepithelial\\tO\\ncell\\tO\\nlines\\tO\\n,\\tO\\nincluding\\tO\\nthose\\tO\\nderived\\tO\\nfrom\\tO\\nbreast\\tB-Disease\\nmalignancies\\tI-Disease\\n.\\tO\\n\\nImmunohistochemical\\tO\\nstaining\\tO\\nof\\tO\\nhuman\\tO\\nbreast\\tO\\nspecimens\\tO\\nalso\\tO\\nrevealed\\tO\\nBRCA1\\tO\\nnuclear\\tO\\nfoci\\tO\\nin\\tO\\nbenign\\tO\\nbreast\\tO\\n,\\tO\\ninvasive\\tB-Disease\\nlobular\\tI-Disease\\ncancers\\tI-Disease\\nand\\tO\\nlow\\tB-Disease\\n-\\tI-Disease\\ngrade\\tI-Disease\\nductal\\tI-Disease\\ncarcinomas\\tI-Disease\\n.\\tO\\n\\nConversely\\tO\\n,\\tO\\nBRCA1\\tO\\nexpression\\tO\\nwas\\tO\\nreduced\\tO\\nor\\tO\\nundetectable\\tO\\nin\\tO\\nthe\\tO\\nmajority\\tO\\nof\\tO\\nhigh\\tO\\n-\\tO\\ngrade\\tO\\n,\\tO\\nductal\\tB-Disease\\ncarcinomas\\tI-Disease\\n,\\tO\\nsuggesting\\tO\\nthat\\tO\\nabsence\\tO\\nof\\tO\\nBRCA1\\tO\\nmay\\tO\\ncontribute\\tO\\nto\\tO\\nthe\\tO\\npathogenesis\\tO\\nof\\tO\\na\\tO\\nsignificant\\tO\\npercentage\\tO\\nof\\tO\\nsporadic\\tB-Disease\\nbreast\\tI-Disease\\ncancers\\tI-Disease\\n.\\tO\\n.\\tO\\n\\n'"
            ]
          },
          "metadata": {},
          "execution_count": 58
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Generic DF Function\n",
        "\n",
        "**Only train data is selected as an example.**"
      ],
      "metadata": {
        "id": "s8PGzqEBvzbT"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "def data_prepare_function(data):\n",
        "\n",
        "  result = []\n",
        "\n",
        "  for i in data.split(\"\\n\"):\n",
        "    if i == \"\": # Each sentence ends \"\"\n",
        "      result.append(\"None\\tNone\") # We add \"None\" between each sentences\n",
        "    else:\n",
        "      result.append(i)\n",
        "  \n",
        "  df = pd.DataFrame(result)\n",
        "\n",
        "  return df"
      ],
      "metadata": {
        "id": "hVq1xqn_TGQ4"
      },
      "execution_count": 59,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def conll_function(data, filename):\n",
        "\n",
        "  data = data_prepare_function(data)\n",
        "\n",
        "  data.to_csv(filename) # We saved the return value of the data_prepare_function as csv file\n",
        "\n",
        "  df = pd.read_csv(filename, sep = \"\\t\", usecols = [0,1],names = ['token','entity'])\n",
        "\n",
        "  # We read csv file , add column name and assigned a NaN value to first row \n",
        "  df.iloc[0,:] = np.nan\n",
        "  \n",
        "  # After reading the data, we cleaned the unnecessary characters in the columns.\n",
        "  df[\"token\"] = df[\"token\"].map(lambda x: x.split(\",\")[1], na_action = \"ignore\")\n",
        "  df[\"token\"] = df[\"token\"].map(lambda x: ',' if x == '\"' else x, na_action = \"ignore\")\n",
        "  df[\"entity\"] = df[\"entity\"].map(lambda x: x.strip('\"'), na_action = \"ignore\")\n",
        "\n",
        "  # We assigned the value np.nan to the places that are None\n",
        "  df[\"token\"]= df[\"token\"].map(lambda x: np.nan if x == 'None' else x)\n",
        "  df[\"entity\"] = df[\"entity\"].map(lambda x: np.nan if x == 'None' else x)\n",
        "\n",
        "  # We added two new columns with value \"NN\" excluding NaN values\n",
        "  df[\"pos1\"] = df[\"token\"].map(lambda x: np.nan if type(x)== float else 'NN')\n",
        "  df[\"pos2\"] = df[\"token\"].map(lambda x: np.nan if type(x)== float else 'NN')\n",
        "\n",
        "  df = df[[\"token\",\"pos1\",\"pos2\",\"entity\"]]\n",
        "\n",
        "  # We changed the column names according to the conll format\n",
        "  df.columns = [\"-DOCSTART-\", \"-X-\", \"-X-\", \"O\"]\n",
        "\n",
        "  return df"
      ],
      "metadata": {
        "id": "EJF8EnWXghj8"
      },
      "execution_count": 60,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "data = train_data\n",
        "\n",
        "filename = \"train_data.csv\"\n",
        "\n",
        "train_data = conll_function(data, filename)"
      ],
      "metadata": {
        "id": "DQKQAzieghmm"
      },
      "execution_count": 61,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "train_data.head(20)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 677
        },
        "id": "44zuGW8Nghpj",
        "outputId": "cc9e1a82-3baf-42f0-d3a7-7e33c4a0bb85"
      },
      "execution_count": 63,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/html": [
              "\n",
              "  <div id=\"df-edba9386-d5aa-48cc-abce-549e4f2bb77c\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>-DOCSTART-</th>\n",
              "      <th>-X-</th>\n",
              "      <th>-X-</th>\n",
              "      <th>O</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Identification</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>of</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>APC2</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>,</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>a</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>homologue</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>of</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>the</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>adenomatous</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>B-Disease</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>10</th>\n",
              "      <td>polyposis</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>I-Disease</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>11</th>\n",
              "      <td>coli</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>I-Disease</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>12</th>\n",
              "      <td>tumour</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>I-Disease</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>13</th>\n",
              "      <td>suppressor</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>14</th>\n",
              "      <td>.</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>15</th>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>16</th>\n",
              "      <td>The</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>O</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>17</th>\n",
              "      <td>adenomatous</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>B-Disease</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>18</th>\n",
              "      <td>polyposis</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>I-Disease</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>19</th>\n",
              "      <td>coli</td>\n",
              "      <td>NN</td>\n",
              "      <td>NN</td>\n",
              "      <td>I-Disease</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-edba9386-d5aa-48cc-abce-549e4f2bb77c')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-edba9386-d5aa-48cc-abce-549e4f2bb77c button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-edba9386-d5aa-48cc-abce-549e4f2bb77c');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ],
            "text/plain": [
              "        -DOCSTART-  -X-  -X-          O\n",
              "0              NaN  NaN  NaN        NaN\n",
              "1   Identification   NN   NN          O\n",
              "2               of   NN   NN          O\n",
              "3             APC2   NN   NN          O\n",
              "4                ,   NN   NN          O\n",
              "5                a   NN   NN          O\n",
              "6        homologue   NN   NN          O\n",
              "7               of   NN   NN          O\n",
              "8              the   NN   NN          O\n",
              "9      adenomatous   NN   NN  B-Disease\n",
              "10       polyposis   NN   NN  I-Disease\n",
              "11            coli   NN   NN  I-Disease\n",
              "12          tumour   NN   NN  I-Disease\n",
              "13      suppressor   NN   NN          O\n",
              "14               .   NN   NN          O\n",
              "15             NaN  NaN  NaN        NaN\n",
              "16             The   NN   NN          O\n",
              "17     adenomatous   NN   NN  B-Disease\n",
              "18       polyposis   NN   NN  I-Disease\n",
              "19            coli   NN   NN  I-Disease"
            ]
          },
          "metadata": {},
          "execution_count": 63
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "train_data.to_csv(\"NCBI-disease-IOB_train.conll\", index = False, sep = \" \")"
      ],
      "metadata": {
        "id": "m3mMiufNghsb"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}